Psyllid ID: psy11359
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 520 | 2.2.26 [Sep-21-2011] | |||||||
| Q6P9R2 | 527 | Serine/threonine-protein | yes | N/A | 0.921 | 0.908 | 0.535 | 1e-158 | |
| Q863I2 | 529 | Serine/threonine-protein | yes | N/A | 0.921 | 0.905 | 0.521 | 1e-158 | |
| Q5R495 | 527 | Serine/threonine-protein | yes | N/A | 0.921 | 0.908 | 0.530 | 1e-157 | |
| O95747 | 527 | Serine/threonine-protein | yes | N/A | 0.921 | 0.908 | 0.530 | 1e-157 | |
| Q9Z1W9 | 556 | STE20/SPS1-related prolin | no | N/A | 0.901 | 0.843 | 0.555 | 1e-155 | |
| O88506 | 553 | STE20/SPS1-related prolin | no | N/A | 0.905 | 0.851 | 0.554 | 1e-154 | |
| Q9UEW8 | 545 | STE20/SPS1-related prolin | no | N/A | 0.903 | 0.862 | 0.551 | 1e-154 | |
| Q551H4 | 1028 | Serine/threonine-protein | yes | N/A | 0.561 | 0.284 | 0.462 | 8e-80 | |
| Q54XL6 | 574 | Serine/threonine-protein | no | N/A | 0.542 | 0.491 | 0.386 | 3e-57 | |
| O61122 | 478 | Serine/threonine-protein | no | N/A | 0.486 | 0.529 | 0.444 | 6e-57 |
| >sp|Q6P9R2|OXSR1_MOUSE Serine/threonine-protein kinase OSR1 OS=Mus musculus GN=Oxsr1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 559 bits (1440), Expect = e-158, Method: Compositional matrix adjust.
Identities = 291/543 (53%), Positives = 369/543 (67%), Gaps = 64/543 (11%)
Query: 16 SSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKAR 75
S S ++PW D YE++EVIG GATAVV +AY CA KK
Sbjct: 2 SEDSSALPWSINRDDYELQEVIGSGATAVVQAAY-------CAPKK-------------- 40
Query: 76 AEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGS 135
E+ AIK+INLEK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKDELWLV++LL GGS
Sbjct: 41 -ERVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99
Query: 136 LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195
+LDIIKH + K GV DEPTIAT+LREVL+GLEY H NGQIHRD+KAGNILLGEDG+
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDEPTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159
Query: 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255
VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKADIWS GITAIE
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
Query: 256 MATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315
+ATG APYHKYP MKVLMLTLQNDPP+L+TG +K+ K YGK+FRKMIS CLQKDP KR
Sbjct: 220 LATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279
Query: 316 PTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTGEWVW 375
PTA+ELL++ FF+KAK+K+F+Q+ ++ PT R K ++ PG+SGRLH+T G W W
Sbjct: 280 PTAAELLRHKFFQKAKNKEFLQEKILQRAPTISER-SKKVRRVPGSSGRLHKTEDGGWEW 338
Query: 376 SSE---------------------DEGDKSSDDEKKEKPMNCLQEV---------DSSGE 405
S + + SS+ +PM L +V +G+
Sbjct: 339 SDDEFDEESEEGRAAISQLRSPRVKDSLSSSELFAAAEPMGTLLQVPEQISAHLPQPAGQ 398
Query: 406 EEDRVVNLIL--------RMRNVSSGE--EEDRV-VNLILRMRNVRRELNDIRFEFCIGK 454
+ + L + SSGE +E ++ ++L+LR+RN ++ELNDIRFEF G+
Sbjct: 399 MPTQPAQVSLLPPAEPAKPAQAQSSGERSQETKIPISLVLRLRNSKKELNDIRFEFTPGR 458
Query: 455 DTSDGIAGELVGAGLVDARDTEAISQNLELVVNGTPRKKSVTFPLSSTLQPGEVADEKAL 514
DT++G++ EL+ AGLVD RD ++ NL+ +V +SVTF L+S ++ ++ D+ L
Sbjct: 459 DTAEGVSQELISAGLVDGRDLVIVAANLQKIVEEPQSNRSVTFKLASGVEGSDIPDDGKL 518
Query: 515 LGL 517
+G
Sbjct: 519 IGF 521
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q863I2|OXSR1_PIG Serine/threonine-protein kinase OSR1 OS=Sus scrofa GN=OXSR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 557 bits (1436), Expect = e-158, Method: Compositional matrix adjust.
Identities = 284/545 (52%), Positives = 369/545 (67%), Gaps = 66/545 (12%)
Query: 16 SSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKAR 75
S S ++PW +D YE++EVIG GATAVV +AY C +
Sbjct: 2 SEDSSALPWSINKDDYELQEVIGSGATAVVQAAY----------------------CTPK 39
Query: 76 AEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGS 135
EK AIK+INLEK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKDELWLV++LL GGS
Sbjct: 40 KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99
Query: 136 LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195
+LDIIKH + K GV DE TIAT+LREVL+GLEY H NGQIHRD+KAGNILLGEDG+
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDEATIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159
Query: 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255
VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKADIWS GITAIE
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
Query: 256 MATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315
+ATG APYHKYP MKVLMLTLQNDPP+L+TG +K+ K YGK+FRKMIS CLQKDP KR
Sbjct: 220 LATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279
Query: 316 PTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTGEWVW 375
PTA+ELL++ FF+KAK+K+++Q+ ++ PT R +K ++ PG+SGRLH+T G W W
Sbjct: 280 PTAAELLRHKFFQKAKNKEYLQEKILQRAPTISERAKK-VRRVPGSSGRLHKTEDGGWEW 338
Query: 376 SSE---------------------DEGDKSSDDEKKEKPMNCLQEV---------DSSGE 405
S + E +S+ P+ L +V S+G+
Sbjct: 339 SDDEFDEESEEGKAAISQLRSPRVKESLTNSELFSTTHPVGTLLQVPEQISAHLPQSAGQ 398
Query: 406 EEDRVVNLIL------------RMRNVSSGEEEDRV-VNLILRMRNVRRELNDIRFEFCI 452
++ + L + ++ +G +E ++ ++L+LR+RN ++ELNDIRFEF
Sbjct: 399 MPAQLTPVSLPPAAELAPVQAAQAQSSGAGSQETKIPISLVLRLRNSKKELNDIRFEFTP 458
Query: 453 GKDTSDGIAGELVGAGLVDARDTEAISQNLELVVNGTPRKKSVTFPLSSTLQPGEVADEK 512
G+DT++G++ EL+ AGLVD RD ++ NL+ +V +SVTF L+S ++ ++ D+
Sbjct: 459 GRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVEEPQSNRSVTFKLASGVEGSDIPDDS 518
Query: 513 ALLGL 517
L+G
Sbjct: 519 KLIGF 523
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Sus scrofa (taxid: 9823) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R495|OXSR1_PONAB Serine/threonine-protein kinase OSR1 OS=Pongo abelii GN=OXSR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 556 bits (1433), Expect = e-157, Method: Compositional matrix adjust.
Identities = 288/543 (53%), Positives = 367/543 (67%), Gaps = 64/543 (11%)
Query: 16 SSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKAR 75
S S ++PW D YE++EVIG GATAVV +AY CA KK
Sbjct: 2 SEDSSALPWSINRDDYELQEVIGSGATAVVQAAY-------CAPKK-------------- 40
Query: 76 AEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGS 135
EK AIK+INLEK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKDELWLV++LL GGS
Sbjct: 41 -EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99
Query: 136 LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195
+LDIIKH + K GV DE TIAT+LREVL+GLEY H NGQIHRD+KAGNILLGEDG+
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159
Query: 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255
VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKADIWS GITAIE
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
Query: 256 MATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315
+ATG APYHKYP MKVLMLTLQNDPP+L+TG +K+ K YGK+FRKMIS CLQKDP KR
Sbjct: 220 LATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279
Query: 316 PTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTGEWVW 375
PTA+ELL++ FF+KAK+K+F+Q+ ++ PT R +K ++ PG+SGRLH+T G W W
Sbjct: 280 PTAAELLRHKFFQKAKNKEFLQEKILQRAPTISERAKK-VRRVPGSSGRLHKTEDGGWEW 338
Query: 376 SSE---------------------DEGDKSSDDEKKEKPMNCLQEV---------DSSGE 405
S + E +S+ P+ L +V +G+
Sbjct: 339 SDDEFDEESEEGKAAISQLRSPRVKESISNSELFPTTDPVGTLLQVPEQISAHLPQPAGQ 398
Query: 406 EEDRVVNLIL----------RMRNVSSGEEEDRV-VNLILRMRNVRRELNDIRFEFCIGK 454
+ + L + + SG +E ++ ++L+LR+RN ++ELNDIRFEF G+
Sbjct: 399 MPTQPTQVSLPPTAEPAKTAQALSSGSGSQETKIPISLVLRLRNSKKELNDIRFEFTPGR 458
Query: 455 DTSDGIAGELVGAGLVDARDTEAISQNLELVVNGTPRKKSVTFPLSSTLQPGEVADEKAL 514
DT++G++ EL+ AGLVD RD ++ NL+ +V +SVTF L+S ++ ++ D+ L
Sbjct: 459 DTAEGVSQELISAGLVDGRDLVIVAANLQKIVEEPQSNRSVTFKLASGVEGSDIPDDGKL 518
Query: 515 LGL 517
+G
Sbjct: 519 IGF 521
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O95747|OXSR1_HUMAN Serine/threonine-protein kinase OSR1 OS=Homo sapiens GN=OXSR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 555 bits (1429), Expect = e-157, Method: Compositional matrix adjust.
Identities = 288/543 (53%), Positives = 366/543 (67%), Gaps = 64/543 (11%)
Query: 16 SSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKAR 75
S S ++PW D YE++EVIG GATAVV +AY CA KK
Sbjct: 2 SEDSSALPWSINRDDYELQEVIGSGATAVVQAAY-------CAPKK-------------- 40
Query: 76 AEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGS 135
EK AIK+INLEK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKDELWLV++LL GGS
Sbjct: 41 -EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99
Query: 136 LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195
+LDIIKH + K GV DE TIAT+LREVL+GLEY H NGQIHRD+KAGNILLGEDG+
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159
Query: 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255
VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKADIWS GITAIE
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
Query: 256 MATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315
+ATG APYHKYP MKVLMLTLQNDPP+L+TG +K+ K YGK+FRKMIS CLQKDP KR
Sbjct: 220 LATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279
Query: 316 PTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTGEWVW 375
PTA+ELL++ FF+KAK+K+F+Q+ + PT R +K ++ PG+SGRLH+T G W W
Sbjct: 280 PTAAELLRHKFFQKAKNKEFLQEKTLQRAPTISERAKK-VRRVPGSSGRLHKTEDGGWEW 338
Query: 376 SSE---------------------DEGDKSSDDEKKEKPMNCLQEV---------DSSGE 405
S + E +S+ P+ L +V +G+
Sbjct: 339 SDDEFDEESEEGKAAISQLRSPRVKESISNSELFPTTDPVGTLLQVPEQISAHLPQPAGQ 398
Query: 406 EEDRVVNLIL----------RMRNVSSGEEEDRV-VNLILRMRNVRRELNDIRFEFCIGK 454
+ + L + + SG +E ++ ++L+LR+RN ++ELNDIRFEF G+
Sbjct: 399 IATQPTQVSLPPTAEPAKTAQALSSGSGSQETKIPISLVLRLRNSKKELNDIRFEFTPGR 458
Query: 455 DTSDGIAGELVGAGLVDARDTEAISQNLELVVNGTPRKKSVTFPLSSTLQPGEVADEKAL 514
DT++G++ EL+ AGLVD RD ++ NL+ +V +SVTF L+S ++ ++ D+ L
Sbjct: 459 DTAEGVSQELISAGLVDGRDLVIVAANLQKIVEEPQSNRSVTFKLASGVEGSDIPDDGKL 518
Query: 515 LGL 517
+G
Sbjct: 519 IGF 521
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Z1W9|STK39_MOUSE STE20/SPS1-related proline-alanine-rich protein kinase OS=Mus musculus GN=Stk39 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 547 bits (1410), Expect = e-155, Method: Compositional matrix adjust.
Identities = 282/508 (55%), Positives = 358/508 (70%), Gaps = 39/508 (7%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
WP D YE++EVIG GATAVV +A CK R E+ AIK+
Sbjct: 68 WPICRDAYELQEVIGSGATAVVQAALCKP----------------------RQERVAIKR 105
Query: 84 INLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHR 143
INLEK TSMDELLKEIQAMS C H NVVTY+TSFVVKDELWLV++LL GGS+LDIIK+
Sbjct: 106 INLEKCQTSMDELLKEIQAMSQCSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYI 165
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
+ K+GV +E IAT+L+EVL+GL+Y H NGQIHRD+KAGNILLGEDG+VQIADFGV
Sbjct: 166 VNRGEHKNGVLEEAIIATILKEVLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGV 225
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263
SA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKAD+WS GITAIE+ATG APY
Sbjct: 226 SAFLATGGDVTRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPY 285
Query: 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
HKYP MKVLMLTLQNDPPTL+TG +K+ K YGK+FRK++S CLQKDP+KRPTA+ELLK
Sbjct: 286 HKYPPMKVLMLTLQNDPPTLETGVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLK 345
Query: 324 NPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTGEWVWSSEDEGDK 383
FF+KAK+++++ + L++ P R +K ++ PG+SG LH+T G+W W S+DE D+
Sbjct: 346 CKFFQKAKNREYLIEKLLTRTPDIAQRAKK-VRRVPGSSGHLHKTEDGDWEW-SDDEMDE 403
Query: 384 SSDDEK----KEKPMNCLQE-----VDSSGEEEDRVVNLILRMRNVSSGEEEDR-----V 429
S++ K +EK +E V++ G E ++ +L + ED
Sbjct: 404 KSEEGKAAASQEKSRRVKEENSEISVNAGGIPE-QIQSLSVHDSQAQPNANEDYREGPCA 462
Query: 430 VNLILRMRNVRRELNDIRFEFCIGKDTSDGIAGELVGAGLVDARDTEAISQNLELVVNGT 489
VNL+LR+RN R+ELNDIRFEF G+DT+DG++ EL AGLVD D ++ NL+ +V+
Sbjct: 463 VNLVLRLRNSRKELNDIRFEFTPGRDTADGVSQELFSAGLVDGHDVVIVAANLQKIVDDP 522
Query: 490 PRKKSVTFPLSSTLQPGEVADEKALLGL 517
K++TF L+S E+ DE L+G
Sbjct: 523 KALKTLTFKLASGCDGSEIPDEVKLIGF 550
|
May act as a mediator of stress-activated signals. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O88506|STK39_RAT STE20/SPS1-related proline-alanine-rich protein kinase OS=Rattus norvegicus GN=Stk39 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 546 bits (1408), Expect = e-154, Method: Compositional matrix adjust.
Identities = 283/510 (55%), Positives = 359/510 (70%), Gaps = 39/510 (7%)
Query: 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAI 81
V WP D YE++EVIG GATAVV +A CK R E+ AI
Sbjct: 63 VGWPICRDAYELQEVIGSGATAVVQAALCKP----------------------RQERVAI 100
Query: 82 KKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIK 141
K+INLEK TSMDELLKEIQAMS C H NVVTY+TSFVVKDELWLV++LL GGS+LDIIK
Sbjct: 101 KRINLEKCQTSMDELLKEIQAMSQCSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIK 160
Query: 142 HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADF 201
+ + K+GV +E IAT+L+EVL+GL+Y H NGQIHRD+KAGNILLGEDG+VQIADF
Sbjct: 161 YIVNRGEHKNGVLEEAIIATILKEVLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADF 220
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261
GVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKAD+WS GITAIE+ATG A
Sbjct: 221 GVSAFLATGGDVTRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAA 280
Query: 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
PYHKYP MKVLMLTLQNDPPTL+TG +K+ K YGK+FRK++S CLQKDP+KRPTA+EL
Sbjct: 281 PYHKYPPMKVLMLTLQNDPPTLETGVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAEL 340
Query: 322 LKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTGEWVWSSEDEG 381
LK FF+KAK+++++ + L++ P R +K ++ PG+SG LH+T G+W W S+DE
Sbjct: 341 LKCKFFQKAKNREYLIEKLLTRTPDIAQRAKK-VRRVPGSSGHLHKTEDGDWEW-SDDEM 398
Query: 382 DKSSDDEK----KEKPMNCLQE-----VDSSGEEEDRVVNLILRMRNVSSGEEEDR---- 428
D+ S++ K +EK +E V++ G E ++ +L + ED
Sbjct: 399 DEKSEEGKAAASQEKSRRVKEENPEISVNAGGIPE-QIQSLSVHDSQGQPNANEDYREGP 457
Query: 429 -VVNLILRMRNVRRELNDIRFEFCIGKDTSDGIAGELVGAGLVDARDTEAISQNLELVVN 487
VNL+LR+RN R+ELNDIRFEF G+DT+DG++ EL AGLVD D ++ NL+ +V+
Sbjct: 458 CAVNLVLRLRNSRKELNDIRFEFTPGRDTADGVSQELFSAGLVDGHDVVIVAANLQKIVD 517
Query: 488 GTPRKKSVTFPLSSTLQPGEVADEKALLGL 517
K++TF L+S E+ DE L+G
Sbjct: 518 DPKALKTLTFKLASGCDGAEIPDEVKLIGF 547
|
May act as a mediator of stress-activated signals. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9UEW8|STK39_HUMAN STE20/SPS1-related proline-alanine-rich protein kinase OS=Homo sapiens GN=STK39 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 545 bits (1403), Expect = e-154, Method: Compositional matrix adjust.
Identities = 280/508 (55%), Positives = 356/508 (70%), Gaps = 38/508 (7%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
WP D YE++EVIG GATAVV +A CK R E+ AIK+
Sbjct: 56 WPICRDAYELQEVIGSGATAVVQAALCKP----------------------RQERVAIKR 93
Query: 84 INLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHR 143
INLEK TSMDELLKEIQAMS C H NVVTY+TSFVVKDELWLV++LL GGS+LDIIK+
Sbjct: 94 INLEKCQTSMDELLKEIQAMSQCSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYI 153
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
+ K+GV +E IAT+L+EVL+GL+Y H NGQIHRD+KAGNILLGEDG+VQIADFGV
Sbjct: 154 VNRGEHKNGVLEEAIIATILKEVLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGV 213
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263
SA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKAD+WS GITAIE+ATG APY
Sbjct: 214 SAFLATGGDVTRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPY 273
Query: 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
HKYP MKVLMLTLQNDPPTL+TG +K+ K YGK+FRK++S CLQKDP+KRPTA+ELLK
Sbjct: 274 HKYPPMKVLMLTLQNDPPTLETGVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLK 333
Query: 324 NPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTGEWVWSSEDEGDK 383
FF+KAK+++++ + L++ P R +K ++ PG+SG LH+T G+W W S+DE D+
Sbjct: 334 CKFFQKAKNREYLIEKLLTRTPDIAQRAKK-VRRVPGSSGHLHKTEDGDWEW-SDDEMDE 391
Query: 384 SSDDEK----KEKPMNCLQE----VDSSGEEEDRVVNLILRMRNVSSGEEEDR------V 429
S++ K +EK +E S+ +++ +L + ED
Sbjct: 392 KSEEGKAAFSQEKSRRVKEENPEIAVSASTIPEQIQSLSVHDSQGPPNANEDYREASSCA 451
Query: 430 VNLILRMRNVRRELNDIRFEFCIGKDTSDGIAGELVGAGLVDARDTEAISQNLELVVNGT 489
VNL+LR+RN R+ELNDIRFEF G+DT+DG++ EL AGLVD D ++ NL+ +V+
Sbjct: 452 VNLVLRLRNSRKELNDIRFEFTPGRDTADGVSQELFSAGLVDGHDVVIVAANLQKIVDDP 511
Query: 490 PRKKSVTFPLSSTLQPGEVADEKALLGL 517
K++TF L+S E+ DE L+G
Sbjct: 512 KALKTLTFKLASGCDGSEIPDEVKLIGF 539
|
May act as a mediator of stress-activated signals. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q551H4|FRAY2_DICDI Serine/threonine-protein kinase fray2 OS=Dictyostelium discoideum GN=fray2 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (762), Expect = 8e-80, Method: Compositional matrix adjust.
Identities = 152/329 (46%), Positives = 206/329 (62%), Gaps = 37/329 (11%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
+PN+ DQYE++E IG G + +V A C E AIK I+L +CK
Sbjct: 64 YPNSADQYELKETIGKGGSGLVQRAICLPFQENVAIKIIDLE-----HCK---------- 108
Query: 84 INLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHR 143
N S++E+ KEIQAMS CHH NVV YHTSFV + LW+++ L GS DI++
Sbjct: 109 ------NVSLEEIRKEIQAMSLCHHPNVVAYHTSFVYNESLWVIMDFLSAGSCSDIMRFS 162
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
G +E IAT+L+E LK + YFH G+IHRDIK+GNIL+ +G +Q++DFGV
Sbjct: 163 FP-----QGF-EEHVIATILKEALKAICYFHKTGRIHRDIKSGNILIDSNGNIQLSDFGV 216
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263
SA L + S R+TFVGTPCWMAPE+MEQ + YD+ DIWS GITA+E+A G AP+
Sbjct: 217 SATLIDTGETS----RNTFVGTPCWMAPEIMEQVN-YDYAVDIWSFGITALELARGKAPF 271
Query: 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+YP MKVL+LTLQN PP+L E D + +F+ ++ CLQKDP+KRP S+LL+
Sbjct: 272 AEYPPMKVLLLTLQNPPPSL-----EGDGESKWSHSFKDLVEKCLQKDPSKRPLPSKLLE 326
Query: 324 NPFFKKAKDKKFIQQTLVSVGPTFETRIQ 352
+ FFK+AK ++ Q +++ P R Q
Sbjct: 327 HRFFKQAKKPDYLVQHILAKLPPLGQRYQ 355
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54XL6|FRAY1_DICDI Serine/threonine-protein kinase fray1 OS=Dictyostelium discoideum GN=fray1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (567), Expect = 3e-57, Method: Compositional matrix adjust.
Identities = 123/318 (38%), Positives = 178/318 (55%), Gaps = 36/318 (11%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
+P+ +QY + E IG G V AYC E AIK + L + + K
Sbjct: 90 YPSQANQYNLIEPIGEGTEGRVFKAYCIPLKENVAIKVVELDKMDPQFVK---------- 139
Query: 84 INLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHR 143
+++KE++ M+ +H N++ YHTSF+ ++LWLV+ L GGSL DI+K +
Sbjct: 140 -----------DVIKEVKVMNGNNHPNLIHYHTSFLENNQLWLVMDYLGGGSLADIMKFK 188
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
E TVL+ +LKGLEY HS+ +IHRD+K+ NIL+GEDG +++ADFGV
Sbjct: 189 YPDG------IPEVLAVTVLKSLLKGLEYLHSHQRIHRDLKSDNILIGEDGAIELADFGV 242
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263
SA SR+ T VGTPCWMAPE++ + GY+ DIWS GITAIE+ G P
Sbjct: 243 SAMFEKNTCCSRK----TIVGTPCWMAPEIISER-GYNQGVDIWSFGITAIELIRGKPPG 297
Query: 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ P KV M L + P+L E++ ++ ++ CLQK+P+KRP AS+LL+
Sbjct: 298 YDLPPSKVFMNLLFGNSPSLQ----EEEDKGVCSHLYKDLVDKCLQKEPSKRPNASKLLE 353
Query: 324 NPFFKKAKDKKFIQQTLV 341
+ FK+AK +I L+
Sbjct: 354 HKVFKQAKKNNYIVSHLL 371
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O61122|SVKA_DICDI Serine/threonine-protein kinase svkA OS=Dictyostelium discoideum GN=svkA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 222 bits (565), Expect = 6e-57, Method: Compositional matrix adjust.
Identities = 124/279 (44%), Positives = 163/279 (58%), Gaps = 26/279 (9%)
Query: 53 RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVV 112
R EK I K + V K E AIK I+LE ++++ +EI +S C V
Sbjct: 14 RQEK--IGKGSFGEVFKGINKKTNETIAIKTIDLEDAEDEIEDIQQEINVLSQCESPFVT 71
Query: 113 TYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEY 172
Y SF+ +LW+++ L GGS+LD++K G DE IA +LRE+LKGLEY
Sbjct: 72 KYFGSFLKGSKLWIIMEYLAGGSVLDLMKP---------GPFDEGYIAIILRELLKGLEY 122
Query: 173 FHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPE 232
HS G+IHRDIKA N+LL G V++ADFGVS L + R+TFVGTP WMAPE
Sbjct: 123 LHSEGKIHRDIKAANVLLSASGDVKLADFGVSGQLT-----DQMTKRNTFVGTPFWMAPE 177
Query: 233 VMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQ 292
V++Q GYD KADIWS+GITA+EMA G P M+ L L ++ PPTL+
Sbjct: 178 VIKQT-GYDSKADIWSMGITALEMAKGEPPRADLHPMRALFLIPKDPPPTLEGN------ 230
Query: 293 YKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331
+ K F++ + CL KDP +RPTA +LLK+ F K AK
Sbjct: 231 ---FSKGFKEFCALCLNKDPNQRPTAKDLLKHKFIKAAK 266
|
Involved in regulation of actin cytoskeleton organization during cell motility; F-actin fragmenting and capping protein allowing dynamic rearrangements of the actin cytoskeleton. Also part of a regulatory pathway from the centrosome to the midzone, thus regulating the completion of cell division. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 520 | ||||||
| 91083035 | 544 | PREDICTED: similar to serine/threonine p | 0.921 | 0.880 | 0.713 | 0.0 | |
| 157129773 | 527 | serine/threonine protein kinase [Aedes a | 0.915 | 0.903 | 0.697 | 0.0 | |
| 242020676 | 479 | serine/threonine-protein kinase OSR1, pu | 0.907 | 0.985 | 0.705 | 0.0 | |
| 195452878 | 726 | GK13090 [Drosophila willistoni] gi|19416 | 0.907 | 0.650 | 0.666 | 0.0 | |
| 170060084 | 528 | serine/threonine-protein kinase OSR1 [Cu | 0.926 | 0.912 | 0.691 | 0.0 | |
| 328778504 | 652 | PREDICTED: serine/threonine-protein kina | 0.925 | 0.737 | 0.692 | 0.0 | |
| 383851174 | 656 | PREDICTED: serine/threonine-protein kina | 0.928 | 0.736 | 0.692 | 0.0 | |
| 380017380 | 651 | PREDICTED: serine/threonine-protein kina | 0.930 | 0.743 | 0.692 | 0.0 | |
| 194743236 | 706 | GF16907 [Drosophila ananassae] gi|190627 | 0.907 | 0.668 | 0.654 | 0.0 | |
| 194900174 | 702 | GG22936 [Drosophila erecta] gi|190651335 | 0.948 | 0.702 | 0.639 | 0.0 |
| >gi|91083035|ref|XP_974782.1| PREDICTED: similar to serine/threonine protein kinase [Tribolium castaneum] gi|270007652|gb|EFA04100.1| hypothetical protein TcasGA2_TC014335 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1964), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/517 (71%), Positives = 418/517 (80%), Gaps = 38/517 (7%)
Query: 3 NCSNVPGRIMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKI 62
N N+ R MAAS+S SVPWPN++D YE+ +VIG GATAVVH A+
Sbjct: 57 NIGNILSRKMAASTSQP-SVPWPNSKDDYELGKVIGVGATAVVHGAF------------- 102
Query: 63 NLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD 122
CK R EKCAIK+INLEKWNTSMDELLKEIQAMSSC+HENVVTY+TSFVV++
Sbjct: 103 ---------CKPRNEKCAIKRINLEKWNTSMDELLKEIQAMSSCNHENVVTYYTSFVVRE 153
Query: 123 ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182
ELWLVLRLLEGGSLLDIIKH+++++NCKHGV DE TIATVLREVLKGLEYFHSNGQIHRD
Sbjct: 154 ELWLVLRLLEGGSLLDIIKHKMRVANCKHGVFDESTIATVLREVLKGLEYFHSNGQIHRD 213
Query: 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF 242
IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF
Sbjct: 214 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF 273
Query: 243 KADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRK 302
KADIWS GITAIEMATGTAPYHKYP MKVLMLTLQNDPP LDTGA EKDQYKAYGKTFRK
Sbjct: 274 KADIWSFGITAIEMATGTAPYHKYPPMKVLMLTLQNDPPNLDTGAEEKDQYKAYGKTFRK 333
Query: 303 MISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGAS 362
MI+DCLQKD +KRPTASELLK+PFFKKAKDKK++QQTLV++GP+ ETR+QKA+K+ PGAS
Sbjct: 334 MITDCLQKDASKRPTASELLKHPFFKKAKDKKYLQQTLVAIGPSLETRVQKASKRQPGAS 393
Query: 363 GRLHRTVTGEWVWSSEDEGDK--SSDDEKKEKPMNCLQEVDSSGEEEDRVVNLILRMRNV 420
GRLHR TGEWVWSSEDEG+ SS+ + KPMN L SSG + +
Sbjct: 394 GRLHRKETGEWVWSSEDEGEDAASSESDTDSKPMNTLASAGSSGSDHE------------ 441
Query: 421 SSGEEEDRVVNLILRMRNVRRELNDIRFEFCIGKDTSDGIAGELVGAGLVDARDTEAISQ 480
S E + VNL+LRMRN +RELNDIRFEF +GKD+++GIA ELVGAGLVD +D E I+Q
Sbjct: 442 -SSEGDPPPVNLVLRMRNAKRELNDIRFEFAVGKDSAEGIASELVGAGLVDGKDIEVITQ 500
Query: 481 NLELVVNGTPRKKSVTFPLSSTLQPGEVADEKALLGL 517
NL+ +++ K VTFPL+S L E D+KAL+G
Sbjct: 501 NLQKLIDSRDMIKVVTFPLNSGLTNNETPDDKALIGF 537
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|157129773|ref|XP_001661758.1| serine/threonine protein kinase [Aedes aegypti] gi|108872096|gb|EAT36321.1| AAEL011578-PA [Aedes aegypti] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1911), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/516 (69%), Positives = 411/516 (79%), Gaps = 40/516 (7%)
Query: 20 VSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKC 79
V+ PWPN++D YE+REVIG GATAVVH A YC R EKC
Sbjct: 27 VNTPWPNSKDDYELREVIGVGATAVVHGA----------------------YCIPRNEKC 64
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
AIK+INLEKWNTSMDELLKEIQAMSSC+HENVVTYHTSFVVK+ELWLVLRLLEGGSLLDI
Sbjct: 65 AIKRINLEKWNTSMDELLKEIQAMSSCNHENVVTYHTSFVVKEELWLVLRLLEGGSLLDI 124
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
IKHR+K NCKHGV DE TIATVL+EVLKGLEYFHSNGQIHRDIKAGNILLG++GTVQIA
Sbjct: 125 IKHRMKTVNCKHGVFDEATIATVLKEVLKGLEYFHSNGQIHRDIKAGNILLGDEGTVQIA 184
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259
DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWS GITAIEMATG
Sbjct: 185 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSFGITAIEMATG 244
Query: 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319
TAPYHKYP MKVLMLTLQNDPPT+DTGA EKDQYKAYGKTFRKMI +CLQK+P+KRP+AS
Sbjct: 245 TAPYHKYPPMKVLMLTLQNDPPTIDTGADEKDQYKAYGKTFRKMIVECLQKEPSKRPSAS 304
Query: 320 ELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTGEWVWSSED 379
ELLK+PFFKKAKD+K++ QTL++ GP+ TR+ KAAK+ PGASGRLHRTVTGEWVWSSE+
Sbjct: 305 ELLKHPFFKKAKDRKYLTQTLLATGPSMATRVHKAAKRQPGASGRLHRTVTGEWVWSSEE 364
Query: 380 E--GDKSSDDEKKEKPMNCLQEVDSS------GEEEDRVVNLILRMRNVSSGEEEDRV-- 429
E G SSD E +E+PMNCL+++DSS E+ V V+S + + V
Sbjct: 365 EDNGKNSSDSESEERPMNCLEQMDSSASETEDASEQSEVTVTAPTGSEVTSADVTNAVGG 424
Query: 430 --------VNLILRMRNVRRELNDIRFEFCIGKDTSDGIAGELVGAGLVDARDTEAISQN 481
+NL+LRMRN RELNDIRFEF +GKD+++GIA ELVGAGLVD RD ++ N
Sbjct: 425 LNLDDLPPINLVLRMRNASRELNDIRFEFAVGKDSAEGIATELVGAGLVDGRDIVVMAAN 484
Query: 482 LELVVNGTPRKKSVTFPLSSTLQPGEVADEKALLGL 517
L+ +++ K+VTF L+S GE DEK+L+G
Sbjct: 485 LQKLIDQRNTLKTVTFQLNSGFGSGEQPDEKSLIGF 520
|
Source: Aedes aegypti Species: Aedes aegypti Genus: Aedes Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242020676|ref|XP_002430778.1| serine/threonine-protein kinase OSR1, putative [Pediculus humanus corporis] gi|212515975|gb|EEB18040.1| serine/threonine-protein kinase OSR1, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/506 (70%), Positives = 414/506 (81%), Gaps = 34/506 (6%)
Query: 12 MAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAY 71
MA + S +V PWPN++D YE++EVIG GATAVVH+A
Sbjct: 1 MATAGSGNVQ-PWPNSKDDYELKEVIGVGATAVVHAAI---------------------- 37
Query: 72 CKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLL 131
CK R EKCAIK+INLEKWNTSMDELLKEIQAMSSC+HENVVTY+TSFVV++ELWLVL+LL
Sbjct: 38 CKPRQEKCAIKRINLEKWNTSMDELLKEIQAMSSCNHENVVTYYTSFVVREELWLVLKLL 97
Query: 132 EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
EGGSLLD+IKH++++SNCKHGV DE TIATVL+EVLKGLEYFH NGQIHRDIKAGNILLG
Sbjct: 98 EGGSLLDVIKHKMRVSNCKHGVFDESTIATVLKEVLKGLEYFHCNGQIHRDIKAGNILLG 157
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251
EDG+VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWS GI
Sbjct: 158 EDGSVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSFGI 217
Query: 252 TAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311
TAIEMATGTAPYHKYP MKVLMLTLQN+PPTLDTGA EKDQYKAYGKTFRKM+ DCLQKD
Sbjct: 218 TAIEMATGTAPYHKYPPMKVLMLTLQNEPPTLDTGAEEKDQYKAYGKTFRKMVVDCLQKD 277
Query: 312 PTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTG 371
P+KRP ASELLK+PFF+KAKDKK++QQTLV++GP+ E R+QKA+K+ GASGRLHRTVTG
Sbjct: 278 PSKRPPASELLKHPFFRKAKDKKYLQQTLVAIGPSVEARVQKASKRQSGASGRLHRTVTG 337
Query: 372 EWVWSSEDEGDKSSDDEKKEKPMNCLQEVDSSGEEEDRVVNLILRMRNVSSGEEEDRVVN 431
EWVWSSE+E DKSSDDE EKPMN + S E+E V +N + +N
Sbjct: 338 EWVWSSEEE-DKSSDDEVTEKPMNSIAAASSGSEDE---VEAEGSTQNAAP-------IN 386
Query: 432 LILRMRNVRRELNDIRFEFCIGKDTSDGIAGELVGAGLVDARDTEAISQNLELVVNGTPR 491
L+LRMRN ++ELNDIRFEF IGKD+++GIA EL+ AGLVD +D AI+ NL+ +++
Sbjct: 387 LVLRMRNPKKELNDIRFEFGIGKDSAEGIATELMQAGLVDGKDIIAIAANLQKLIDSQGL 446
Query: 492 KKSVTFPLSSTLQPGEVADEKALLGL 517
++VTFPL+S EVAD+KAL+G
Sbjct: 447 LRAVTFPLNSGCGTNEVADDKALIGF 472
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195452878|ref|XP_002073540.1| GK13090 [Drosophila willistoni] gi|194169625|gb|EDW84526.1| GK13090 [Drosophila willistoni] | Back alignment and taxonomy information |
|---|
Score = 732 bits (1889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/530 (66%), Positives = 413/530 (77%), Gaps = 58/530 (10%)
Query: 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIK 82
PWPN++D YE+R+VIG GATAVVH A YC R EKCAIK
Sbjct: 211 PWPNSKDDYELRDVIGVGATAVVHGA----------------------YCIPRNEKCAIK 248
Query: 83 KINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
+INLEKWNTSMDELLKEIQAMSSC+HENVVTYHTSFVV++ELWLVLRLLEGGSLLDIIKH
Sbjct: 249 RINLEKWNTSMDELLKEIQAMSSCNHENVVTYHTSFVVREELWLVLRLLEGGSLLDIIKH 308
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202
+++ +NCK GV DE TIATVL+EVLKGLEYFHSNGQIHRDIKAGNIL+G+DGT+QIADFG
Sbjct: 309 KMRTANCKQGVFDEATIATVLKEVLKGLEYFHSNGQIHRDIKAGNILIGDDGTIQIADFG 368
Query: 203 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262
VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWS GITAIEMATGTAP
Sbjct: 369 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSFGITAIEMATGTAP 428
Query: 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
YHKYP MKVLMLTLQNDPPTLDTGA +KDQYKAYGKTFRKMI +CLQK+P+KRPTASELL
Sbjct: 429 YHKYPPMKVLMLTLQNDPPTLDTGADDKDQYKAYGKTFRKMIVECLQKEPSKRPTASELL 488
Query: 323 KNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTGEWVWSSEDEGD 382
K+ FFKKAKD+K++ QTL+ GP+ ETR+ KAAK+ PGASGRLHRTVTGEWVWSSE+E +
Sbjct: 489 KHAFFKKAKDRKYLAQTLLQSGPSMETRVNKAAKRQPGASGRLHRTVTGEWVWSSEEEDN 548
Query: 383 ----------KSSDDEKKEKPMNCLQEVDSSGEEED------------------------ 408
SSD E ++P+N L+ VDSS + D
Sbjct: 549 GGSGNGGRKQPSSDSESDDRPINKLERVDSSDSDRDEPSPEITPSLSSATVTPGATAATV 608
Query: 409 --RVVNLILRMRNVSSGEEEDRVVNLILRMRNVRRELNDIRFEFCIGKDTSDGIAGELVG 466
++ + ++ S E VNL+LRMRN+RREL+DIRFEF +GKDT++GIA ELV
Sbjct: 609 TQQITAGVAQLPLPSEAASEAPPVNLVLRMRNLRRELHDIRFEFVVGKDTAEGIATELVD 668
Query: 467 AGLVDARDTEAISQNLELVVNGTPRKKSVTFPLSSTLQPGEVADEKALLG 516
AGLVDA DT+ ++Q+L+ ++ + K++TF LSS +QPGEV DE++L+G
Sbjct: 669 AGLVDALDTQPMAQHLDQLIAQSATMKTITFQLSSGVQPGEVPDERSLVG 718
|
Source: Drosophila willistoni Species: Drosophila willistoni Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|170060084|ref|XP_001865646.1| serine/threonine-protein kinase OSR1 [Culex quinquefasciatus] gi|167878653|gb|EDS42036.1| serine/threonine-protein kinase OSR1 [Culex quinquefasciatus] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1885), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/519 (69%), Positives = 416/519 (80%), Gaps = 37/519 (7%)
Query: 13 AASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYC 72
A + + + PWPN++D YE+REVIG GATAVVH A YC
Sbjct: 24 APAVAPPTNTPWPNSKDDYELREVIGVGATAVVHGA----------------------YC 61
Query: 73 KARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLE 132
R EKCAIK+INLEKWNTSMDELLKEIQAMSSC+HENVVTYHTSFVVK+ELWLVLRLLE
Sbjct: 62 APRNEKCAIKRINLEKWNTSMDELLKEIQAMSSCNHENVVTYHTSFVVKEELWLVLRLLE 121
Query: 133 GGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE 192
GGSLLDIIKHR+K NCKHGV DE TIATVL+EVLKGLEYFHSNGQIHRDIKAGNILLG+
Sbjct: 122 GGSLLDIIKHRMKSVNCKHGVFDEATIATVLKEVLKGLEYFHSNGQIHRDIKAGNILLGD 181
Query: 193 DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252
DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWS GIT
Sbjct: 182 DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSFGIT 241
Query: 253 AIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312
AIEMATGTAPYHKYP MKVLMLTLQNDPP++DTGA EKDQYKAYGKTFRKMI +CLQK+P
Sbjct: 242 AIEMATGTAPYHKYPPMKVLMLTLQNDPPSIDTGADEKDQYKAYGKTFRKMIVECLQKEP 301
Query: 313 TKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTGE 372
+KRPTASELLK+PFFKKAKD+K++ TL++ GP+ TR+ KAAK+ PGASGRLHRTVTGE
Sbjct: 302 SKRPTASELLKHPFFKKAKDRKYLTATLLATGPSMATRVHKAAKRQPGASGRLHRTVTGE 361
Query: 373 WVWSSEDE--GDKSSDDEKKE-KPMNCLQEVDSSGEE-EDRVVNLILRMRNVSSG----- 423
WVWSSE+E G +SSD + +E +PMN L+++DSS E ED + + + G
Sbjct: 362 WVWSSEEEDNGKQSSDSDSEEPRPMNRLEQMDSSASETEDASEPSTVTVAPTTDGLAALS 421
Query: 424 ---EEEDRV--VNLILRMRNVRRELNDIRFEFCIGKDTSDGIAGELVGAGLVDARDTEAI 478
+++D + +NL+LRMRN RELNDIRFEF +GKD+++GIA ELVGAGLVD RD +
Sbjct: 422 LAADDDDGLPPINLVLRMRNANRELNDIRFEFAVGKDSAEGIASELVGAGLVDTRDIVVM 481
Query: 479 SQNLELVVN-GTPRKKSVTFPLSSTLQPGEVADEKALLG 516
+ NL+ +++ K+VTF L+S GE ADEK+L+G
Sbjct: 482 AANLQKLIDLRATGLKTVTFQLNSGFGSGETADEKSLIG 520
|
Source: Culex quinquefasciatus Species: Culex quinquefasciatus Genus: Culex Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328778504|ref|XP_396480.3| PREDICTED: serine/threonine-protein kinase OSR1-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/524 (69%), Positives = 417/524 (79%), Gaps = 43/524 (8%)
Query: 12 MAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAY 71
MA+SSS +V WPNT+D YE++EVIG GATAVVH+A+
Sbjct: 147 MASSSSTTVVQGWPNTKDDYELKEVIGVGATAVVHAAF---------------------- 184
Query: 72 CKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLL 131
C R EKCAIK+INLEKWNTSMDELLKEIQAMSSC+HENVVTY+TSFVVK+ELWLVLRLL
Sbjct: 185 CIPRQEKCAIKRINLEKWNTSMDELLKEIQAMSSCNHENVVTYYTSFVVKEELWLVLRLL 244
Query: 132 EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
EGGSLLDIIKH+ + +NCKHGV DE TIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG
Sbjct: 245 EGGSLLDIIKHKTRTTNCKHGVFDEATIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 304
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251
EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI
Sbjct: 305 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 364
Query: 252 TAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311
TAIEMA+GTAPYHKYP MKVLMLTLQNDPPTLDT A +KDQYKAYGKTFRKMI DCLQKD
Sbjct: 365 TAIEMASGTAPYHKYPPMKVLMLTLQNDPPTLDTAADDKDQYKAYGKTFRKMIVDCLQKD 424
Query: 312 PTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTG 371
PTKRPTA+ELLK+PFFKKAKDKK++QQTLV+ GP+ ETR+QKA+K+ PG SGRLHRTVTG
Sbjct: 425 PTKRPTATELLKHPFFKKAKDKKYLQQTLVACGPSLETRVQKASKRQPGTSGRLHRTVTG 484
Query: 372 EWVWSSEDEGDKSSDDEKKEK-PMNCLQEVDSSGEEEDRVVNLILRMRNVSS----GEEE 426
EWVWSSE+E SS DE KE P+N ++ V SS E+E+ R+++ S E
Sbjct: 485 EWVWSSEEEDSVSSGDESKEALPVNTIENVSSSDEDEEEFFG---RLKSAQSHIVVQHEP 541
Query: 427 DRVVNLILRMR-------------NVRRELNDIRFEFCIGKDTSDGIAGELVGAGLVDAR 473
+NL+LR+R N +RELNDIRFEF +G D+++GIA ELVGAGLVD +
Sbjct: 542 SIPINLVLRLRRPETHFSLMDKFDNQKRELNDIRFEFAVGVDSAEGIAAELVGAGLVDGK 601
Query: 474 DTEAISQNLELVVNGTPRKKSVTFPLSSTLQPGEVADEKALLGL 517
D I+ NL+ +++ + ++VTF L+S P EV D+KAL+G
Sbjct: 602 DIVVIAANLQKLIDSAGQLRTVTFSLNSGHAPNEVPDDKALIGF 645
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383851174|ref|XP_003701114.1| PREDICTED: serine/threonine-protein kinase OSR1-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/523 (69%), Positives = 418/523 (79%), Gaps = 40/523 (7%)
Query: 12 MAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAY 71
MA+SSS +V WPNT+D YE++EVIG GATAVVH+A+
Sbjct: 150 MASSSSTTVVQGWPNTKDDYELKEVIGVGATAVVHAAF---------------------- 187
Query: 72 CKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLL 131
C R EKCAIK+INLEKWNTSMDELLKEIQAMSSC+HENVVTY+TSFVVK+ELWLVLRLL
Sbjct: 188 CIPRQEKCAIKRINLEKWNTSMDELLKEIQAMSSCNHENVVTYYTSFVVKEELWLVLRLL 247
Query: 132 EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
EGGSLLDIIKH+ + +NCKHGV DE TIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG
Sbjct: 248 EGGSLLDIIKHKTRTTNCKHGVFDEATIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 307
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251
EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI
Sbjct: 308 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 367
Query: 252 TAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311
TAIEMA+GTAPYHKYP MKVLMLTLQNDPPTLDT A +KDQYKAYGKTFRKMI DCLQKD
Sbjct: 368 TAIEMASGTAPYHKYPPMKVLMLTLQNDPPTLDTAADDKDQYKAYGKTFRKMIVDCLQKD 427
Query: 312 PTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTG 371
PTKRPTA+ELLK+PFFKKAKDKK++QQTLV++GP+ ETR+QKA+K+ PG SGRLHRTVTG
Sbjct: 428 PTKRPTATELLKHPFFKKAKDKKYLQQTLVAIGPSLETRVQKASKRQPGTSGRLHRTVTG 487
Query: 372 EWVWSSEDE-GDKSSDDEKKEK-PMNCLQEVDSSGEEEDRVVNLILRMRN--VSSGEEED 427
EWVWSSE+E D SS DE KE P+N + E SS EEE+ ++ + V +++
Sbjct: 488 EWVWSSEEEDSDASSGDEGKEALPVNTI-ENPSSEEEEEEFYGVVKSAPSQLVVQATDQN 546
Query: 428 RVVNLILRMR-------------NVRRELNDIRFEFCIGKDTSDGIAGELVGAGLVDARD 474
+NL+LR+R N +RELNDIRFEF +G D+++GIA ELVGAGLVD +D
Sbjct: 547 VPINLVLRLRRPESHFATEDNSINQKRELNDIRFEFAVGVDSAEGIAAELVGAGLVDGKD 606
Query: 475 TEAISQNLELVVNGTPRKKSVTFPLSSTLQPGEVADEKALLGL 517
I+ NL+ +++ + ++VTF L+S EV D+KAL+G
Sbjct: 607 IVVIAANLQKLIDSAGQLRTVTFSLNSGHAANEVPDDKALIGF 649
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380017380|ref|XP_003692635.1| PREDICTED: serine/threonine-protein kinase OSR1-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1878), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/521 (69%), Positives = 417/521 (80%), Gaps = 37/521 (7%)
Query: 12 MAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAY 71
MA+SSS +V WPNT+D YE++EVIG GATAVVH+A+
Sbjct: 146 MASSSSTTVVQGWPNTKDDYELKEVIGVGATAVVHAAF---------------------- 183
Query: 72 CKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLL 131
C R EKCAIK+INLEKWNTSMDELLKEIQAMSSC+HENVVTY+TSFVVK+ELWLVLRLL
Sbjct: 184 CIPRQEKCAIKRINLEKWNTSMDELLKEIQAMSSCNHENVVTYYTSFVVKEELWLVLRLL 243
Query: 132 EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
EGGSLLDIIKH+ + +NCKHGV DE TIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG
Sbjct: 244 EGGSLLDIIKHKTRTTNCKHGVFDEATIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 303
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251
EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI
Sbjct: 304 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 363
Query: 252 TAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311
TAIEMA+GTAPYHKYP MKVLMLTLQNDPPTLDT A +KDQYKAYGKTFRKMI DCLQKD
Sbjct: 364 TAIEMASGTAPYHKYPPMKVLMLTLQNDPPTLDTAADDKDQYKAYGKTFRKMIVDCLQKD 423
Query: 312 PTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTG 371
PTKRPTA+ELLK+PFFKKAKDKK++QQTLV+ GP+ ETR+QKA+K+ PG SGRLHRTVTG
Sbjct: 424 PTKRPTATELLKHPFFKKAKDKKYLQQTLVACGPSLETRVQKASKRQPGTSGRLHRTVTG 483
Query: 372 EWVWSSEDEGDKSSDDEKKEK-PMNCLQEVDSSGEEEDRVVNLILRMRNVSSGEEEDRV- 429
EWVWSSE+E SS DE KE P+N ++ V +S EEE+ + ++ + E +
Sbjct: 484 EWVWSSEEEDSVSSGDESKEALPVNTIENVSTSDEEEEEFFGQLKSAQSHIVVQHEPSIP 543
Query: 430 VNLILRMR-------------NVRRELNDIRFEFCIGKDTSDGIAGELVGAGLVDARDTE 476
+NL+LR+R N +RELNDIRFEF +G D+++GIA ELVGAGLVD +D
Sbjct: 544 INLVLRLRSPETHFSLVDKFDNHKRELNDIRFEFAVGVDSAEGIAAELVGAGLVDGKDIV 603
Query: 477 AISQNLELVVNGTPRKKSVTFPLSSTLQPGEVADEKALLGL 517
I+ NL+ +++ + ++VTF L+S P EV D+KAL+G
Sbjct: 604 VIAANLQKLIDSAGQLRTVTFSLNSGHAPNEVPDDKALIGF 644
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|194743236|ref|XP_001954106.1| GF16907 [Drosophila ananassae] gi|190627143|gb|EDV42667.1| GF16907 [Drosophila ananassae] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1875), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/536 (65%), Positives = 412/536 (76%), Gaps = 64/536 (11%)
Query: 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIK 82
PWPN++D YE+R+VIG GATAVVH A YC R EKCAIK
Sbjct: 185 PWPNSKDDYELRDVIGVGATAVVHGA----------------------YCIPRNEKCAIK 222
Query: 83 KINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
+INLEKWNTSMDELLKEIQAMSSC+HENVVTYHTSFVV++ELWLVLRLLEGGSLLDIIKH
Sbjct: 223 RINLEKWNTSMDELLKEIQAMSSCNHENVVTYHTSFVVREELWLVLRLLEGGSLLDIIKH 282
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202
+++ +NCK GV DE TIATVL+EVLKGLEYFHSNGQIHRDIKAGNIL+G+DGT+QIADFG
Sbjct: 283 KMRTANCKQGVFDEATIATVLKEVLKGLEYFHSNGQIHRDIKAGNILIGDDGTIQIADFG 342
Query: 203 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262
VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWS GITAIEMATGTAP
Sbjct: 343 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSFGITAIEMATGTAP 402
Query: 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
YHKYP MKVLMLTLQNDPPTLDTGA +KDQYKAYGKTFRKMI +CLQK+P+KRPTASELL
Sbjct: 403 YHKYPPMKVLMLTLQNDPPTLDTGADDKDQYKAYGKTFRKMIVECLQKEPSKRPTASELL 462
Query: 323 KNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTGEWVWSSEDEGD 382
K+ FFKKAKD+K++ QTL+ GP+ ETR+ KAAK+ PGASGRLHRTVTGEWVWSSE+E +
Sbjct: 463 KHAFFKKAKDRKYLTQTLLQSGPSMETRVHKAAKRQPGASGRLHRTVTGEWVWSSEEEDN 522
Query: 383 K---------------SSDDEKKEKPMNCLQEVDSSGEEEDR------------------ 409
SSD + +++PMN L+ DSS + D
Sbjct: 523 GGSAGGSGSGGGRKQPSSDSDSEDRPMNRLERADSSDSDRDEPSPEVTHSVSSATVTPGA 582
Query: 410 ---------VVNLILRMRNVSSGEEEDRVVNLILRMRNVRRELNDIRFEFCIGKDTSDGI 460
+ + ++ S E VNL+LRMRN+RREL+DIRFEF +GKD+++GI
Sbjct: 583 IPAGGAAQEITAGLSQLPLPSDASAEAPPVNLVLRMRNLRRELHDIRFEFVVGKDSAEGI 642
Query: 461 AGELVGAGLVDARDTEAISQNLELVVNGTPRKKSVTFPLSSTLQPGEVADEKALLG 516
A ELV AGLVDA DT+ ++Q+L+ ++ + K++TF LSS +QPGEV DE++L+G
Sbjct: 643 ATELVDAGLVDALDTQPMAQHLDQLIAASATMKTITFQLSSGVQPGEVPDERSLVG 698
|
Source: Drosophila ananassae Species: Drosophila ananassae Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|194900174|ref|XP_001979632.1| GG22936 [Drosophila erecta] gi|190651335|gb|EDV48590.1| GG22936 [Drosophila erecta] | Back alignment and taxonomy information |
|---|
Score = 725 bits (1872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/557 (63%), Positives = 420/557 (75%), Gaps = 64/557 (11%)
Query: 2 LNCSNVPGR-IMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIK 60
L+ +NV G + +++ PWPN++D YE+R+VIG GATAVVH A+
Sbjct: 160 LSSNNVAGAATLPGAAAPPEKQPWPNSKDDYELRDVIGVGATAVVHGAF----------- 208
Query: 61 KINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVV 120
C R EKCAIK+INLEKWNTSMDELLKEIQAMSSC HENVVTYHTSFVV
Sbjct: 209 -----------CIPRNEKCAIKRINLEKWNTSMDELLKEIQAMSSCFHENVVTYHTSFVV 257
Query: 121 KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180
++ELWLVLRLLEGGSLLDIIKH+++ SNCK GV DE TIATVL+EVLKGLEYFHSNGQIH
Sbjct: 258 REELWLVLRLLEGGSLLDIIKHKMRTSNCKQGVFDEATIATVLKEVLKGLEYFHSNGQIH 317
Query: 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGY 240
RDIKAGNIL+G+DGT+QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGY
Sbjct: 318 RDIKAGNILIGDDGTIQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGY 377
Query: 241 DFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTF 300
DFKADIWS GITAIEMATGTAPYHKYP MKVLMLTLQNDPPTLDTGA +KDQYKAYGKTF
Sbjct: 378 DFKADIWSFGITAIEMATGTAPYHKYPPMKVLMLTLQNDPPTLDTGADDKDQYKAYGKTF 437
Query: 301 RKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPG 360
RKMI +CLQK+P+KRPTASELLK+ FFKKAKD+K++ QTL+ GP+ ETR+ KAAK+ PG
Sbjct: 438 RKMIVECLQKEPSKRPTASELLKHAFFKKAKDRKYLTQTLLQSGPSMETRVHKAAKRQPG 497
Query: 361 ASGRLHRTVTGEWVWSSEDEGDK--------------SSDDEKKEKPMNCLQEVDSSGEE 406
ASGRLHRTVTGEWVWSSE+E + SSD + +++PMN L+ DSS +
Sbjct: 498 ASGRLHRTVTGEWVWSSEEEDNGGSAAGSGSGGRKHPSSDSDSEDRPMNRLERADSSDSD 557
Query: 407 EDR---------------------------VVNLILRMRNVSSGEEEDRVVNLILRMRNV 439
+ V I ++ S E VNL+LRMRN+
Sbjct: 558 REEPSPEITHSVSSATVTPGAPVGAAAAQEVTAGIAQLPLPSEAAGEAPPVNLVLRMRNL 617
Query: 440 RRELNDIRFEFCIGKDTSDGIAGELVGAGLVDARDTEAISQNLELVVNGTPRKKSVTFPL 499
RREL+DIRFEF +GKDT++GIA ELV AGLVDA DT+ ++ +L+ ++ + K++TF L
Sbjct: 618 RRELHDIRFEFVVGKDTAEGIATELVDAGLVDALDTQPMATHLDQLIAASATMKTITFQL 677
Query: 500 SSTLQPGEVADEKALLG 516
SS +QPGEV DE++L+G
Sbjct: 678 SSGVQPGEVPDERSLVG 694
|
Source: Drosophila erecta Species: Drosophila erecta Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 520 | ||||||
| FB|FBgn0023083 | 552 | fray "frayed" [Drosophila mela | 0.690 | 0.650 | 0.701 | 3.9e-177 | |
| ZFIN|ZDB-GENE-070620-25 | 515 | oxsr1a "oxidative-stress respo | 0.596 | 0.601 | 0.652 | 1.5e-142 | |
| ZFIN|ZDB-GENE-040426-723 | 520 | oxsr1b "oxidative-stress respo | 0.596 | 0.596 | 0.652 | 2.1e-141 | |
| UNIPROTKB|E2RAI8 | 527 | OXSR1 "Uncharacterized protein | 0.596 | 0.588 | 0.652 | 9.1e-141 | |
| UNIPROTKB|Q5R495 | 527 | OXSR1 "Serine/threonine-protei | 0.596 | 0.588 | 0.652 | 1.5e-140 | |
| UNIPROTKB|Q863I2 | 529 | OXSR1 "Serine/threonine-protei | 0.596 | 0.586 | 0.652 | 1.5e-140 | |
| MGI|MGI:1917378 | 527 | Oxsr1 "oxidative-stress respon | 0.596 | 0.588 | 0.652 | 1.9e-140 | |
| UNIPROTKB|O95747 | 527 | OXSR1 "Serine/threonine-protei | 0.596 | 0.588 | 0.652 | 3.1e-140 | |
| UNIPROTKB|F1MYV9 | 527 | OXSR1 "Uncharacterized protein | 0.596 | 0.588 | 0.649 | 3.9e-140 | |
| UNIPROTKB|E1C6W3 | 533 | OXSR1 "Uncharacterized protein | 0.596 | 0.581 | 0.643 | 4.4e-139 |
| FB|FBgn0023083 fray "frayed" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1320 (469.7 bits), Expect = 3.9e-177, Sum P(3) = 3.9e-177
Identities = 254/362 (70%), Positives = 278/362 (76%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDXX 124
AVVH AYC R EKCAIK+INLEKWNTSMDELLKEIQAMSSC HENVVTYHTSFVV++
Sbjct: 50 AVVHGAYCIPRNEKCAIKRINLEKWNTSMDELLKEIQAMSSCFHENVVTYHTSFVVREEL 109
Query: 125 XXXXXXXXXXXXXDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
DIIKH+++ SNCK GV DE TIATVL+EVLKGLEYFHSNGQIHRDIK
Sbjct: 110 WLVLRLLEGGSLLDIIKHKMRTSNCKQGVFDEATIATVLKEVLKGLEYFHSNGQIHRDIK 169
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
AGNIL+G+DGT+QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA
Sbjct: 170 AGNILIGDDGTIQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 229
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
DIWS GITAIEMATGTAPYHKYP MKVLMLTLQNDPPTLDTGA +KDQYKAYGKTFRKMI
Sbjct: 230 DIWSFGITAIEMATGTAPYHKYPPMKVLMLTLQNDPPTLDTGADDKDQYKAYGKTFRKMI 289
Query: 305 SDCLQKDPTKRPTASELLXXXXXXXXXXXXXIQQTLVSVGPTFETRIQKAAKKNPGASGR 364
+CLQK+P+KRPTASELL + QTL+ GP+ ETR+ KAAK+ PGASGR
Sbjct: 290 VECLQKEPSKRPTASELLKHAFFKKAKDRKYLTQTLLQSGPSMETRVHKAAKRQPGASGR 349
Query: 365 LHRTVTGEWVWXXXXXXXXXXXXXXXXXPMNCLQEVDSSGEEEDRVVNLILRMRNVSSGE 424
LHRTVTGEWVW + S + EDR +N + R + S
Sbjct: 350 LHRTVTGEWVWSSEEEDNGGSATGSGTGDR---KHPSSDSDSEDRPMNRLERADSSDSDR 406
Query: 425 EE 426
EE
Sbjct: 407 EE 408
|
|
| ZFIN|ZDB-GENE-070620-25 oxsr1a "oxidative-stress responsive 1a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1054 (376.1 bits), Expect = 1.5e-142, Sum P(3) = 1.5e-142
Identities = 203/311 (65%), Positives = 234/311 (75%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDXX 124
AVV +AYCK R EK AIK+INLEK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKD
Sbjct: 29 AVVQAAYCKPRKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88
Query: 125 XXXXXXXXXXXXXDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
D IK+ + K GV DEP+IAT+LREVL+GLEY H NGQIHRD+K
Sbjct: 89 WLVMKLLSGGSVLDFIKYIISKGEHKSGVMDEPSIATILREVLEGLEYLHKNGQIHRDVK 148
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
AGNILLGEDG+VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKA
Sbjct: 149 AGNILLGEDGSVQIADFGVSAFLATGGDMTRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA 208
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
D+WS GITAIE+ATG APYHKYP MKVLMLTLQNDPP L+TG +K+ K YGK+FRKMI
Sbjct: 209 DLWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPCLETGVTDKEMVKKYGKSFRKMI 268
Query: 305 SDCLQKDPTKRPTASELLXXXXXXXXXXXXXIQQTLVSVGPTFETRIQKAAKKNPGASGR 364
S CLQKDP KRPTA+ELL +++ L+ PT R +K ++ PG+SGR
Sbjct: 269 SLCLQKDPEKRPTAAELLKHKFFTKAKNTDYLKEKLLERAPTIGERSRKV-RRVPGSSGR 327
Query: 365 LHRTVTGEWVW 375
LH+T GEW W
Sbjct: 328 LHKTEDGEWEW 338
|
|
| ZFIN|ZDB-GENE-040426-723 oxsr1b "oxidative-stress responsive 1b" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1049 (374.3 bits), Expect = 2.1e-141, Sum P(3) = 2.1e-141
Identities = 203/311 (65%), Positives = 233/311 (74%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDXX 124
AVV +AYC R EK AIK+INLEK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKD
Sbjct: 29 AVVQAAYCVPRKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88
Query: 125 XXXXXXXXXXXXXDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
D+IKH + K GV DEP+IATVL+EVL+GLEY H NGQIHRD+K
Sbjct: 89 WLVMKLLSGGSVLDVIKHIISKGEHKTGVLDEPSIATVLKEVLQGLEYLHKNGQIHRDLK 148
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
AGNILLGEDG+VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKA
Sbjct: 149 AGNILLGEDGSVQIADFGVSAFLATGGDMTRNKVRKTFVGTPCWMAPEVMEQVKGYDFKA 208
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
DIWS GITAIE+ATG APYHKYP MKVLMLTLQNDPP L+TG +K+ K YGK+ RKMI
Sbjct: 209 DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPCLETGITDKEMVKKYGKSLRKMI 268
Query: 305 SDCLQKDPTKRPTASELLXXXXXXXXXXXXXIQQTLVSVGPTFETRIQKAAKKNPGASGR 364
S CLQK+P KRPT+SELL +Q+ L+ PT R +K ++ PG+SGR
Sbjct: 269 SQCLQKEPEKRPTSSELLKHKFFQKAKNNEFLQEKLLHRAPTITERARKV-RRVPGSSGR 327
Query: 365 LHRTVTGEWVW 375
LH+T GEW W
Sbjct: 328 LHKTEDGEWEW 338
|
|
| UNIPROTKB|E2RAI8 OXSR1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1053 (375.7 bits), Expect = 9.1e-141, Sum P(3) = 9.1e-141
Identities = 203/311 (65%), Positives = 234/311 (75%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDXX 124
AVV +AYC + EK AIK+INLEK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKD
Sbjct: 29 AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88
Query: 125 XXXXXXXXXXXXXDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
DIIKH + K GV DEPTIAT+L+EVL+GLEY H NGQIHRD+K
Sbjct: 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEPTIATILKEVLEGLEYLHKNGQIHRDVK 148
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
AGNILLGEDG+VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKA
Sbjct: 149 AGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA 208
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
DIWS GITAIE+ATG APYHKYP MKVLMLTLQNDPP+L+TG +K+ K YGK+FRKMI
Sbjct: 209 DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMI 268
Query: 305 SDCLQKDPTKRPTASELLXXXXXXXXXXXXXIQQTLVSVGPTFETRIQKAAKKNPGASGR 364
S CLQKDP KRPTA+ELL +Q+ ++ PT R +K ++ PG+SGR
Sbjct: 269 SLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKILQRAPTISERAKKV-RRVPGSSGR 327
Query: 365 LHRTVTGEWVW 375
LH+T G W W
Sbjct: 328 LHKTEDGGWEW 338
|
|
| UNIPROTKB|Q5R495 OXSR1 "Serine/threonine-protein kinase OSR1" [Pongo abelii (taxid:9601)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 1.5e-140, Sum P(3) = 1.5e-140
Identities = 203/311 (65%), Positives = 233/311 (74%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDXX 124
AVV +AYC + EK AIK+INLEK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKD
Sbjct: 29 AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88
Query: 125 XXXXXXXXXXXXXDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
DIIKH + K GV DE TIAT+LREVL+GLEY H NGQIHRD+K
Sbjct: 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVK 148
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
AGNILLGEDG+VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKA
Sbjct: 149 AGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA 208
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
DIWS GITAIE+ATG APYHKYP MKVLMLTLQNDPP+L+TG +K+ K YGK+FRKMI
Sbjct: 209 DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMI 268
Query: 305 SDCLQKDPTKRPTASELLXXXXXXXXXXXXXIQQTLVSVGPTFETRIQKAAKKNPGASGR 364
S CLQKDP KRPTA+ELL +Q+ ++ PT R +K ++ PG+SGR
Sbjct: 269 SLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKILQRAPTISERAKKV-RRVPGSSGR 327
Query: 365 LHRTVTGEWVW 375
LH+T G W W
Sbjct: 328 LHKTEDGGWEW 338
|
|
| UNIPROTKB|Q863I2 OXSR1 "Serine/threonine-protein kinase OSR1" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 1.5e-140, Sum P(3) = 1.5e-140
Identities = 203/311 (65%), Positives = 233/311 (74%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDXX 124
AVV +AYC + EK AIK+INLEK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKD
Sbjct: 29 AVVQAAYCTPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88
Query: 125 XXXXXXXXXXXXXDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
DIIKH + K GV DE TIAT+LREVL+GLEY H NGQIHRD+K
Sbjct: 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEATIATILREVLEGLEYLHKNGQIHRDVK 148
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
AGNILLGEDG+VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKA
Sbjct: 149 AGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA 208
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
DIWS GITAIE+ATG APYHKYP MKVLMLTLQNDPP+L+TG +K+ K YGK+FRKMI
Sbjct: 209 DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMI 268
Query: 305 SDCLQKDPTKRPTASELLXXXXXXXXXXXXXIQQTLVSVGPTFETRIQKAAKKNPGASGR 364
S CLQKDP KRPTA+ELL +Q+ ++ PT R +K ++ PG+SGR
Sbjct: 269 SLCLQKDPEKRPTAAELLRHKFFQKAKNKEYLQEKILQRAPTISERAKKV-RRVPGSSGR 327
Query: 365 LHRTVTGEWVW 375
LH+T G W W
Sbjct: 328 LHKTEDGGWEW 338
|
|
| MGI|MGI:1917378 Oxsr1 "oxidative-stress responsive 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1052 (375.4 bits), Expect = 1.9e-140, Sum P(3) = 1.9e-140
Identities = 203/311 (65%), Positives = 234/311 (75%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDXX 124
AVV +AYC + E+ AIK+INLEK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKD
Sbjct: 29 AVVQAAYCAPKKERVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88
Query: 125 XXXXXXXXXXXXXDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
DIIKH + K GV DEPTIAT+LREVL+GLEY H NGQIHRD+K
Sbjct: 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEPTIATILREVLEGLEYLHKNGQIHRDVK 148
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
AGNILLGEDG+VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKA
Sbjct: 149 AGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA 208
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
DIWS GITAIE+ATG APYHKYP MKVLMLTLQNDPP+L+TG +K+ K YGK+FRKMI
Sbjct: 209 DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMI 268
Query: 305 SDCLQKDPTKRPTASELLXXXXXXXXXXXXXIQQTLVSVGPTFETRIQKAAKKNPGASGR 364
S CLQKDP KRPTA+ELL +Q+ ++ PT R +K ++ PG+SGR
Sbjct: 269 SLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKILQRAPTISERSKKV-RRVPGSSGR 327
Query: 365 LHRTVTGEWVW 375
LH+T G W W
Sbjct: 328 LHKTEDGGWEW 338
|
|
| UNIPROTKB|O95747 OXSR1 "Serine/threonine-protein kinase OSR1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1045 (372.9 bits), Expect = 3.1e-140, Sum P(3) = 3.1e-140
Identities = 203/311 (65%), Positives = 232/311 (74%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDXX 124
AVV +AYC + EK AIK+INLEK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKD
Sbjct: 29 AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88
Query: 125 XXXXXXXXXXXXXDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
DIIKH + K GV DE TIAT+LREVL+GLEY H NGQIHRD+K
Sbjct: 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVK 148
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
AGNILLGEDG+VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKA
Sbjct: 149 AGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA 208
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
DIWS GITAIE+ATG APYHKYP MKVLMLTLQNDPP+L+TG +K+ K YGK+FRKMI
Sbjct: 209 DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMI 268
Query: 305 SDCLQKDPTKRPTASELLXXXXXXXXXXXXXIQQTLVSVGPTFETRIQKAAKKNPGASGR 364
S CLQKDP KRPTA+ELL +Q+ + PT R +K ++ PG+SGR
Sbjct: 269 SLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKTLQRAPTISERAKKV-RRVPGSSGR 327
Query: 365 LHRTVTGEWVW 375
LH+T G W W
Sbjct: 328 LHKTEDGGWEW 338
|
|
| UNIPROTKB|F1MYV9 OXSR1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1047 (373.6 bits), Expect = 3.9e-140, Sum P(3) = 3.9e-140
Identities = 202/311 (64%), Positives = 234/311 (75%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDXX 124
AVV +AYC + EK AIK+INLEK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKD
Sbjct: 29 AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88
Query: 125 XXXXXXXXXXXXXDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
DIIKH + K+GV DE TIAT+L+EVL+GLEY H NGQIHRD+K
Sbjct: 89 WLVMKLLSGGSVLDIIKHIVAKGEHKNGVLDEATIATILKEVLEGLEYLHKNGQIHRDVK 148
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
AGNILLGEDG+VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKA
Sbjct: 149 AGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA 208
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
DIWS GITAIE+ATG APYHKYP MKVLMLTLQNDPP+L+TG +K+ K YGK+FRKMI
Sbjct: 209 DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMI 268
Query: 305 SDCLQKDPTKRPTASELLXXXXXXXXXXXXXIQQTLVSVGPTFETRIQKAAKKNPGASGR 364
S CLQKDP KRPTA+ELL +Q+ ++ PT R +K ++ PG+SGR
Sbjct: 269 SLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKILQRAPTISERAKKV-RRVPGSSGR 327
Query: 365 LHRTVTGEWVW 375
LH+T G W W
Sbjct: 328 LHKTEDGGWEW 338
|
|
| UNIPROTKB|E1C6W3 OXSR1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1041 (371.5 bits), Expect = 4.4e-139, Sum P(3) = 4.4e-139
Identities = 200/311 (64%), Positives = 233/311 (74%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDXX 124
AVV +A+C + EK AIK+INLEK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKD
Sbjct: 29 AVVQAAFCVPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88
Query: 125 XXXXXXXXXXXXXDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
DIIKH + K GV DEP IAT+L+EVL+GL+Y H NGQIHRD+K
Sbjct: 89 WLVMKLLSGGSVLDIIKHIVAKGEHKTGVLDEPCIATILKEVLEGLDYLHKNGQIHRDVK 148
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
AGNILLGEDG+VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKA
Sbjct: 149 AGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA 208
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
DIWS GITAIE+ATG APYHKYP MKVLMLTLQNDPP+L+TG +K+ K YGK+FRKMI
Sbjct: 209 DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMI 268
Query: 305 SDCLQKDPTKRPTASELLXXXXXXXXXXXXXIQQTLVSVGPTFETRIQKAAKKNPGASGR 364
S CLQKDP KRPTA+ELL +Q+ ++ PT R +K ++ PG+SGR
Sbjct: 269 SSCLQKDPEKRPTAAELLRHKFFTKAKNKEFLQEKMLQRAPTITERSKKV-RRVPGSSGR 327
Query: 365 LHRTVTGEWVW 375
LH+T G W W
Sbjct: 328 LHKTEDGGWEW 338
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6P9R2 | OXSR1_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.5359 | 0.9211 | 0.9089 | yes | N/A |
| Q9UEW8 | STK39_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.5511 | 0.9038 | 0.8623 | no | N/A |
| Q9Z1W9 | STK39_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.5551 | 0.9019 | 0.8435 | no | N/A |
| O88506 | STK39_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.5549 | 0.9057 | 0.8517 | no | N/A |
| Q5R495 | OXSR1_PONAB | 2, ., 7, ., 1, 1, ., 1 | 0.5303 | 0.9211 | 0.9089 | yes | N/A |
| O95747 | OXSR1_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.5303 | 0.9211 | 0.9089 | yes | N/A |
| Q863I2 | OXSR1_PIG | 2, ., 7, ., 1, 1, ., 1 | 0.5211 | 0.9211 | 0.9054 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 520 | |||
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-175 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-107 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-101 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-94 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-87 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-82 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-80 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-75 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-74 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-73 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-69 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-68 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-68 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-65 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-65 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-64 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-64 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-63 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-60 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-59 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-59 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-58 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-57 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-56 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-53 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-52 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-52 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-52 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-52 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-52 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-52 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-52 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-52 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-50 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-50 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-50 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-49 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-48 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-48 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-46 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-45 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-45 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-44 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-44 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-43 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-43 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-43 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-42 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-42 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-39 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-39 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-38 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-37 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-37 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-37 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-36 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-36 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-35 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-35 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-35 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-35 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-35 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-35 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-34 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-34 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-33 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-33 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-33 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-33 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-32 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-32 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-32 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-32 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-32 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-31 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-31 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-30 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-30 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-30 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-30 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-30 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-28 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-28 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-28 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-28 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-28 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-27 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-27 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-26 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-26 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-26 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-25 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-25 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-25 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-25 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-24 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-24 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-23 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-23 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-23 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-23 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-22 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-22 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-22 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-22 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-21 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-21 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-21 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-20 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-20 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-20 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-20 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-19 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-19 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-18 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-18 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-17 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-16 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-16 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-16 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-15 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-14 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-14 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-14 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-14 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-08 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| pfam12202 | 38 | pfam12202, OSR1_C, Oxidative-stress-responsive kin | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 494 bits (1274), Expect = e-175
Identities = 201/299 (67%), Positives = 222/299 (74%), Gaps = 32/299 (10%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
D YE+ EVIG GATAVV++A C EK AIK+I+L EK
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL----------------------EK 38
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
TS+DEL KE+QAMS C+H NVV Y+TSFVV DELWLV+ L GGSLLDI+K
Sbjct: 39 CQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP--- 95
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
G DE IATVL+EVLKGLEY HSNGQIHRDIKAGNILLGEDG+V+IADFGVSA LA
Sbjct: 96 --RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
G D +R KVR TFVGTPCWMAPEVMEQ HGYDFKADIWS GITAIE+ATG APY KYP
Sbjct: 154 DGGDRTR-KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212
Query: 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
MKVLMLTLQNDPP+L+TGA YK Y K+FRKMIS CLQKDP+KRPTA ELLK+ FF
Sbjct: 213 MKVLMLTLQNDPPSLETGA----DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 319 bits (819), Expect = e-107
Identities = 128/296 (43%), Positives = 164/296 (55%), Gaps = 44/296 (14%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
+E+ E IG G V+ A K ++ AIK I L E K+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL------------ESKEKKE------- 42
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
+++ EIQ + C H N+V Y+ S++ KDELW+V+ GGSL D++K
Sbjct: 43 ----KIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST------- 91
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
+ E IA V +E+LKGLEY HSNG IHRDIKA NILL DG V++ DFG+SA
Sbjct: 92 NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA----- 146
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270
LS K R+T VGTP WMAPEV+ YD+KADIWSLGITAIE+A G PY + P MK
Sbjct: 147 -QLSDTKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMK 204
Query: 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
L N PP L + + F+ + CLQK+P KRPTA +LLK+PF
Sbjct: 205 ALFKIATNGPPGLRNP-------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 305 bits (784), Expect = e-101
Identities = 126/278 (45%), Positives = 168/278 (60%), Gaps = 23/278 (8%)
Query: 59 IKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSF 118
I K + V+ A K + AIK I+LE+ ++++ +EIQ +S C + Y+ SF
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 119 VVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178
+ +LW+++ GGS LD++K G DE IA +LREVL GLEY H G+
Sbjct: 69 LKGSKLWIIMEYCGGGSCLDLLKP---------GKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH 238
IHRDIKA NILL E+G V++ADFGVS L S R+TFVGTP WMAPEV++Q
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLT-----STMSKRNTFVGTPFWMAPEVIKQS- 173
Query: 239 GYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGK 298
GYD KADIWSLGITAIE+A G P M+VL L +N+PP+L+ + K
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGN--------KFSK 225
Query: 299 TFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFI 336
F+ +S CL KDP +RP+A ELLK+ F KKAK ++
Sbjct: 226 PFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYL 263
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 286 bits (735), Expect = 8e-94
Identities = 121/303 (39%), Positives = 164/303 (54%), Gaps = 44/303 (14%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
Y+ E IG GA+ V+ A +A ++ AIKK+ L
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR------------------------K 56
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
+ + ++ EI M C H N+V Y+ S++V DELW+V+ ++GGSL DII
Sbjct: 57 QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR---- 112
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
+EP IA V REVL+GLEY HS IHRDIK+ NILL +DG+V++ADFG +A L
Sbjct: 113 ---MNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270
+ R++ VGTP WMAPEV+ + Y K DIWSLGI IEMA G PY + P ++
Sbjct: 170 KS-----KRNSVVGTPYWMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223
Query: 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330
L L P L + + F+ ++ CL KDP KRP+A ELL++PF KKA
Sbjct: 224 ALFLITTKGIPPLKNP-------EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276
Query: 331 KDK 333
K
Sbjct: 277 CPK 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 268 bits (687), Expect = 4e-87
Identities = 112/300 (37%), Positives = 156/300 (52%), Gaps = 45/300 (15%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
E+ +++ E +G G+ V+ A K + AIK + +
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV----------------------- 38
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ E++KEI + C +V Y+ S+ +LW+V+ GS+ DI+K K
Sbjct: 39 --EEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-- 94
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
E IA +L + LKGLEY HSN +IHRDIKAGNILL E+G ++ADFGVS L
Sbjct: 95 -----TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL 149
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267
R+T +GTP WMAPEV+++ GY+ KADIWSLGITAIEMA G PY
Sbjct: 150 TD-----TMAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIH 203
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
M+ + + PPTL D K + F + CL KDP +RP+A +LL++PF
Sbjct: 204 PMRAIFMIPNKPPPTL------SDPEK-WSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 254 bits (651), Expect = 9e-82
Identities = 97/297 (32%), Positives = 137/297 (46%), Gaps = 43/297 (14%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
YE+ E +G G+ V+ A K + AIK I + +
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERIL--------------- 45
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
+EI+ + H N+V + F +D+L+LV+ EGG L D++K R ++S
Sbjct: 46 -------REIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLS--- 95
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
E LR++L LEY HS G +HRD+K NILL EDG V++ADFG++
Sbjct: 96 -----EDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLA------ 144
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270
R L + TFVGTP +MAPEV+ GY DIWSLG+ E+ TG P+ +
Sbjct: 145 RQLDPGEKLTTFVGTPEYMAPEVL-LGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLL 203
Query: 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
L + P + +I L KDP KR TA E L++PFF
Sbjct: 204 ELFKKIGKPKPPFP------PPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 251 bits (644), Expect = 2e-80
Identities = 124/303 (40%), Positives = 161/303 (53%), Gaps = 46/303 (15%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
++ YE+ + IG G V+ KAR A E AIK I LE
Sbjct: 2 QEDYELIQRIGSGTYGDVY----KARD------------------IATGELVAIKVIKLE 39
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ + + +EI + C H N+V Y S++ +D+LW+V+ GGSL DI
Sbjct: 40 PGDD-FEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIY------- 91
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
G E IA V RE LKGL Y H G+IHRDIK NILL EDG V++ADFGVSA L
Sbjct: 92 QVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQL 151
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVM--EQDHGYDFKADIWSLGITAIEMATGTAPYHK 265
+++ R +F+GTP WMAPEV E+ GYD K DIW+LGITAIE+A P
Sbjct: 152 --TATIAK---RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206
Query: 266 YPAMKVLMLTLQN--DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
M+ L L ++ PP L KD+ K + F I CL KDP KRPTA++LL+
Sbjct: 207 LHPMRALFLISKSNFPPPKL------KDKEK-WSPVFHDFIKKCLTKDPKKRPTATKLLQ 259
Query: 324 NPF 326
+PF
Sbjct: 260 HPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 238 bits (608), Expect = 5e-75
Identities = 115/280 (41%), Positives = 166/280 (59%), Gaps = 24/280 (8%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWL 126
V+ A K A K I +E D ++ EI +S C H N+V + ++ +++LW+
Sbjct: 21 VYKAQHKETGLFAAAKIIQIESEEELEDFMV-EIDILSECKHPNIVGLYEAYFYENKLWI 79
Query: 127 VLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186
++ +GG+L I+ L++ + G+ EP I V R++L+ L + HS+ IHRD+KAG
Sbjct: 80 LIEFCDGGALDSIM---LEL---ERGL-TEPQIRYVCRQMLEALNFLHSHKVIHRDLKAG 132
Query: 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM----EQDHGYDF 242
NILL DG V++ADFGVSA + + QK R TF+GTP WMAPEV+ +D+ YD+
Sbjct: 133 NILLTLDGDVKLADFGVSAKNKS----TLQK-RDTFIGTPYWMAPEVVACETFKDNPYDY 187
Query: 243 KADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRK 302
KADIWSLGIT IE+A P+H+ M+VL+ L+++PPTL DQ + +F
Sbjct: 188 KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-------DQPSKWSSSFND 240
Query: 303 MISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTLVS 342
+ CL KDP RPTA+ELLK+PF D K I+ L
Sbjct: 241 FLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLLAE 280
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 6e-74
Identities = 114/312 (36%), Positives = 163/312 (52%), Gaps = 49/312 (15%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
P+ +E+ EVIG G V+ A K + AIK +++ + ++I
Sbjct: 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI------------IEDEEEEI 49
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVK------DELWLVLRLLEGGSLLD 138
E +L++ +H N+ T++ +F+ K D+LWLV+ L GGS+ D
Sbjct: 50 KEEY------NILRKY-----SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD 98
Query: 139 IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQI 198
++K K E IA +LRE L+GL Y H N IHRDIK NILL ++ V++
Sbjct: 99 LVKGLRKKGKRL----KEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKL 154
Query: 199 ADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEV---MEQ-DHGYDFKADIWSLGITAI 254
DFGVSA L + + + R+TF+GTP WMAPEV EQ D YD ++D+WSLGITAI
Sbjct: 155 VDFGVSAQLDS----TLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAI 209
Query: 255 EMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK 314
E+A G P M+ L +N PPTL + + K F IS+CL K+ +
Sbjct: 210 ELADGKPPLCDMHPMRALFKIPRNPPPTL-------KSPENWSKKFNDFISECLIKNYEQ 262
Query: 315 RPTASELLKNPF 326
RP ELL++PF
Sbjct: 263 RPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 5e-73
Identities = 106/298 (35%), Positives = 150/298 (50%), Gaps = 44/298 (14%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
Y++ ++IG GA VV+ + AIK+I+L +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLE---------------------KIK 39
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
++ +++EI + + H N+V Y S D L+++L E GSL IIK
Sbjct: 40 EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK-------- 91
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
K G E +A + +VL+GL Y H G IHRDIKA NIL +DG V++ADFGV+ L
Sbjct: 92 KFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLN- 150
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269
D+S+ + VGTP WMAPEV+E G +DIWSLG T IE+ TG PY+ M
Sbjct: 151 --DVSKD--DASVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPM 205
Query: 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
L +Q+D P L G + + + + C QKDP RPTA +LLK+P+
Sbjct: 206 AALFRIVQDDHPPLPEGISPE---------LKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 2e-69
Identities = 97/256 (37%), Positives = 138/256 (53%), Gaps = 26/256 (10%)
Query: 77 EKCAIKKINLEKWNTS-MDELLKEIQAMSSCHHENVVTYHTSFVVKDE--LWLVLRLLEG 133
E A+K + L + ++ L +EI+ +SS H N+V Y+ S +++ L + L + G
Sbjct: 26 ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85
Query: 134 GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
GSL ++K K G EP I R++L+GL Y HSNG +HRDIK NIL+ D
Sbjct: 86 GSLSSLLK--------KFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD 137
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
G V++ADFG + L + + GTP WMAPEV+ + Y ADIWSLG T
Sbjct: 138 GVVKLADFGCAKRLGDIET---GEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTV 193
Query: 254 IEMATGTAPYHKYP-AMKVLM-LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311
IEMATG P+ + M L + +PP + +E+ K F + CL++D
Sbjct: 194 IEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEE------AKDF---LRKCLRRD 244
Query: 312 PTKRPTASELLKNPFF 327
P KRPTA ELL++PF
Sbjct: 245 PKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 2e-68
Identities = 99/266 (37%), Positives = 144/266 (54%), Gaps = 25/266 (9%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH---ENVVTYHTSFVVKD 122
V+ A+K INL+ + + ++ +E+ +S N+ Y+ S++
Sbjct: 16 AVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP 75
Query: 123 ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182
LW+++ EGGS+ ++K G E I+ ++REVL L+Y H G IHRD
Sbjct: 76 RLWIIMEYAEGGSVRTLMKA---------GPIAEKYISVIIREVLVALKYIHKVGVIHRD 126
Query: 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF 242
IKA NIL+ G V++ DFGV+A L S+ R TFVGTP WMAPEV+ + YD
Sbjct: 127 IKAANILVTNTGNVKLCDFGVAALLNQNS--SK---RSTFVGTPYWMAPEVITEGKYYDT 181
Query: 243 KADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRK 302
KADIWSLGIT EMATG PY A + +ML ++ PP L + Y K R+
Sbjct: 182 KADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRL--------EDNGYSKLLRE 233
Query: 303 MISDCLQKDPTKRPTASELLKNPFFK 328
++ CL ++P +R +A ELLK+ + K
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 7e-68
Identities = 117/257 (45%), Positives = 156/257 (60%), Gaps = 24/257 (9%)
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSL 136
E AIK I+LE+ ++++ +EI +S C + Y+ S++ +LW+++ L GGS
Sbjct: 30 EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89
Query: 137 LDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196
LD++K G +E IAT+LRE+LKGL+Y HS +IHRDIKA N+LL E G V
Sbjct: 90 LDLLKP---------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDV 140
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256
++ADFGV+ L Q R+TFVGTP WMAPEV++Q YDFKADIWSLGITAIE+
Sbjct: 141 KLADFGVAGQLT-----DTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIEL 194
Query: 257 ATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
A G P M+VL L +N PPTL+ Y K F++ + CL KDP RP
Sbjct: 195 AKGEPPNSDLHPMRVLFLIPKNSPPTLE---------GQYSKPFKEFVEACLNKDPRFRP 245
Query: 317 TASELLKNPFFKKAKDK 333
TA ELLK+ F + K
Sbjct: 246 TAKELLKHKFITRYTKK 262
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 1e-65
Identities = 100/304 (32%), Positives = 146/304 (48%), Gaps = 51/304 (16%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
YE+ +G G+ V+ A K + A+K + + +K
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILK-----------------KRSEKSKKD- 42
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
+EI+ + H N+V +F KD L+LV+ EGG L D + +
Sbjct: 43 ---QTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS--------R 91
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
G E + ++L+GLEY HSNG IHRD+K NILL E+G V+IADFG++ L
Sbjct: 92 GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKL--- 148
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY------- 263
L TFVGTP +MAPEV+ +GY K D+WSLG+ E+ TG P+
Sbjct: 149 --LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILD 206
Query: 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
++L L+ D P +G+ E + +I CL KDP+KRPTA E+L+
Sbjct: 207 QLQLIRRILGPPLEFDEPKWSSGSEE----------AKDLIKKCLNKDPSKRPTAEEILQ 256
Query: 324 NPFF 327
+P+F
Sbjct: 257 HPWF 260
|
Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 211 bits (538), Expect = 9e-65
Identities = 116/262 (44%), Positives = 162/262 (61%), Gaps = 25/262 (9%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
AIK I+LE+ ++++ +EI +S C V Y+ S++ +LW+++ L GGS LD+
Sbjct: 33 AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL 92
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
++ G DE IAT+LRE+LKGL+Y HS +IHRDIKA N+LL E G V++A
Sbjct: 93 LEP---------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 143
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259
DFGV+ L Q R+TFVGTP WMAPEV++Q YD KADIWSLGITAIE+A G
Sbjct: 144 DFGVAGQLT-----DTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKG 197
Query: 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319
P+ + MKVL L +N+PPTL+ Y K ++ + CL K+P+ RPTA
Sbjct: 198 EPPHSELHPMKVLFLIPKNNPPTLEGN---------YSKPLKEFVEACLNKEPSFRPTAK 248
Query: 320 ELLKNPF-FKKAKDKKFIQQTL 340
ELLK+ F + AK ++ + +
Sbjct: 249 ELLKHKFIVRFAKKTSYLTELI 270
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 211 bits (538), Expect = 1e-64
Identities = 118/254 (46%), Positives = 157/254 (61%), Gaps = 24/254 (9%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
AIK I+LE+ ++++ +EI +S C V Y+ S++ +LW+++ L GGS LD+
Sbjct: 33 AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDL 92
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
++ G DE IAT+L+E+LKGL+Y HS +IHRDIKA N+LL E G V++A
Sbjct: 93 LRA---------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLA 143
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259
DFGV+ L Q R+TFVGTP WMAPEV++Q YD KADIWSLGITAIE+A G
Sbjct: 144 DFGVAGQLT-----DTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKG 197
Query: 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319
P M+VL L +N+PPTL TG + K F++ I CL KDP+ RPTA
Sbjct: 198 EPPNSDMHPMRVLFLIPKNNPPTL-TG--------EFSKPFKEFIDACLNKDPSFRPTAK 248
Query: 320 ELLKNPFFKKAKDK 333
ELLK+ F K K
Sbjct: 249 ELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 3e-64
Identities = 107/277 (38%), Positives = 152/277 (54%), Gaps = 27/277 (9%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSMDELL-KEIQAMSSCHHENVVTYHTSFVVKDEL 124
+V A K+ + A+KK++L K ELL E+ M H N+V ++S++V DEL
Sbjct: 34 IVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL 91
Query: 125 WLVLRLLEGGSLLDIIKH-RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183
W+V+ LEGG+L DI+ H R+ +E IATV VLK L + H+ G IHRDI
Sbjct: 92 WVVMEFLEGGALTDIVTHTRM----------NEEQIATVCLAVLKALSFLHAQGVIHRDI 141
Query: 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFK 243
K+ +ILL DG V+++DFG A ++ +++ R R + VGTP WMAPEV+ + Y +
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVS--KEVPR---RKSLVGTPYWMAPEVISRLP-YGTE 195
Query: 244 ADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKM 303
DIWSLGI IEM G PY P ++ + N PP L K+ +K R
Sbjct: 196 VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL------KNLHKV-SPRLRSF 248
Query: 304 ISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTL 340
+ L +DP +R TA+ELL +PF KA I +
Sbjct: 249 LDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVPLM 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 2e-63
Identities = 91/262 (34%), Positives = 130/262 (49%), Gaps = 54/262 (20%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
V+ A K +K AIK I E ++ ++ELL+EI+ + +H N+V + F ++ L
Sbjct: 7 GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHL 66
Query: 125 WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
+LV+ EGGSL D++K G E I +L ++L+GLEY HSNG IHRD+K
Sbjct: 67 YLVMEYCEGGSLKDLLKE-------NEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 185 AGNILLGED-GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFK 243
NILL D G V++ADFG+S L + + L T VGTP +MAPEV+ Y K
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLL-----KTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 244 ADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKM 303
+DIWSLG+ E+ + +
Sbjct: 175 SDIWSLGVILYEL-----------------------------------------PELKDL 193
Query: 304 ISDCLQKDPTKRPTASELLKNP 325
I LQKDP KRP+A E+L++
Sbjct: 194 IRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 198 bits (507), Expect = 3e-60
Identities = 102/269 (37%), Positives = 150/269 (55%), Gaps = 26/269 (9%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELW 125
VV+ K + A+KKI+++ +LL+E++ + SC VV + +F + E+
Sbjct: 16 VVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEIS 75
Query: 126 LVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN-GQIHRDIK 184
+VL ++GGSL D++K KI EP +A + R++LKGL+Y H+ IHRDIK
Sbjct: 76 IVLEYMDGGSLADLLKKVGKIP--------EPVLAYIARQILKGLDYLHTKRHIIHRDIK 127
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
N+L+ G V+IADFG+S L D +TFVGT +M+PE ++ + Y + A
Sbjct: 128 PSNLLINSKGEVKIADFGISKVLENTLD-----QCNTFVGTVTYMSPERIQGES-YSYAA 181
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMK--VLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFR 301
DIWSLG+T +E A G P+ LM + + P P+L + FR
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPE--------FR 233
Query: 302 KMISDCLQKDPTKRPTASELLKNPFFKKA 330
IS CLQKDP KRP+A+ELL++PF KKA
Sbjct: 234 DFISACLQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 2e-59
Identities = 110/316 (34%), Positives = 158/316 (50%), Gaps = 56/316 (17%)
Query: 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNT 91
++RE IG G+ V+ A E AIKK++ + K + EKW
Sbjct: 19 DLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYS----------------GKQSNEKWQ- 60
Query: 92 SMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGS--LLDIIKHRLKISNC 149
+++KE++ + H N + Y ++ + WLV+ G + +L++ K L+
Sbjct: 61 ---DIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQ---- 113
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
E IA + L+GL Y HS+ +IHRDIKAGNILL E GTV++ADFG ++ ++
Sbjct: 114 ------EVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEV-MEQDHG-YDFKADIWSLGITAIEMATGTAPYHKYP 267
++FVGTP WMAPEV + D G YD K D+WSLGIT IE+A P
Sbjct: 168 A---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
AM L QND PTL + + FR + CLQK P RP++ ELLK+ F
Sbjct: 219 AMSALYHIAQNDSPTLSSN--------DWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270
Query: 328 KKAKD----KKFIQQT 339
+ + IQ+T
Sbjct: 271 LRERPPTVIIDLIQRT 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 9e-59
Identities = 94/254 (37%), Positives = 137/254 (53%), Gaps = 30/254 (11%)
Query: 79 CAIKKINLEKWNTSMDELLK----EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGG 134
A+K+++L + E +K EI +S H N+V Y + +D L++ L L+ GG
Sbjct: 28 FAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGG 87
Query: 135 SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194
SL ++K K+G EP I R++L GLEY H +HRDIK NIL+ +G
Sbjct: 88 SLAKLLK--------KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG 139
Query: 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254
V++ADFG++ + + +F G+P WMAPEV+ Q GY ADIWSLG T +
Sbjct: 140 VVKLADFGMA------KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVL 193
Query: 255 EMATGTAPYHKYPAMKVL--MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312
EMATG P+ + + + + + PP D + E K F I CLQ+DP
Sbjct: 194 EMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDE-------AKDF---ILKCLQRDP 243
Query: 313 TKRPTASELLKNPF 326
+ RPTA+ELL++PF
Sbjct: 244 SLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 3e-58
Identities = 125/313 (39%), Positives = 162/313 (51%), Gaps = 49/313 (15%)
Query: 20 VSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKC 79
VSV P +Y E IG GA+ V++A A ++ AIK++NL + + +K
Sbjct: 12 VSVGDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL--------QQQPKKE 61
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
I IN EI M H N+V Y S++V DELW+V+ L GGSL D+
Sbjct: 62 LI--IN-------------EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 106
Query: 140 IKHRLKISNCKHGVC-DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQI 198
+ C DE IA V RE L+ LE+ HSN IHRDIK+ NILLG DG+V++
Sbjct: 107 VTE----------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKL 156
Query: 199 ADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258
DFG A + Q R T VGTP WMAPEV+ + Y K DIWSLGI AIEM
Sbjct: 157 TDFGFCAQIT-----PEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVE 210
Query: 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA 318
G PY ++ L L N P L ++ A FR ++ CL+ D KR +A
Sbjct: 211 GEPPYLNENPLRALYLIATNGTPEL----QNPEKLSA---IFRDFLNRCLEMDVEKRGSA 263
Query: 319 SELLKNPFFKKAK 331
ELL++PF K AK
Sbjct: 264 KELLQHPFLKIAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 7e-57
Identities = 86/299 (28%), Positives = 148/299 (49%), Gaps = 42/299 (14%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+YE+ + IG G+ V+ K+ + +K+I+L+ + E+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS------NMSEKER----------- 43
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
++ L E++ + +H N++ Y+ SF K +L +V+ +GG L IK + K
Sbjct: 44 ----EDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKK---- 95
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
+ E I ++ L+Y HS +HRDIK NI L +G V++ DFG+S L++
Sbjct: 96 EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269
DL+ T VGTP +++PE+ Q+ Y++K+DIWSLG E+ T P+ +
Sbjct: 156 TVDLA-----KTVVGTPYYLSPELC-QNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NL 208
Query: 270 KVLMLT-LQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
L L L+ P + + Y R ++S LQKDP +RP+ +++L++PF
Sbjct: 209 LELALKILKGQYPPIPSQ---------YSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 1e-56
Identities = 96/302 (31%), Positives = 153/302 (50%), Gaps = 44/302 (14%)
Query: 63 NLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELL-KEIQAMSSCHHENVVTYHTSFVVK 121
+L +VH A K A+KKINL+ + +LL +EI H N++ Y TSF+V
Sbjct: 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 122 DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181
EL++V L+ GS D++K ++ G+ E IA +L++VL L+Y HS G IHR
Sbjct: 72 SELYVVSPLMAYGSCEDLLK-----THFPEGL-PELAIAFILKDVLNALDYIHSKGFIHR 125
Query: 182 DIKAGNILLGEDGTVQIADFGVSA-------WLATGRDLSRQKVRHTFVGTPCWMAPEVM 234
+KA +ILL DG V ++ S D + V++ W++PEV+
Sbjct: 126 SVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP-----WLSPEVL 180
Query: 235 EQD-HGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPP--------TLDT 285
+Q+ GY+ K+DI+S+GITA E+A G P+ PA ++L+ ++ P L
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240
Query: 286 GAAEKDQYK--------AYGKTFRKMISD--------CLQKDPTKRPTASELLKNPFFKK 329
+ + + + + + S+ CLQ+DP RP+AS+LL + FFK+
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300
Query: 330 AK 331
K
Sbjct: 301 CK 302
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 6e-53
Identities = 116/312 (37%), Positives = 157/312 (50%), Gaps = 48/312 (15%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
+P+ D +E+ E IG G V K K A+K ++ +H + AE +K
Sbjct: 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEIEAEYNILKA 70
Query: 84 INLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD-----ELWLVLRLLEGGSLLD 138
++ H NVV ++ + KD +LWLVL L GGS+ D
Sbjct: 71 LS---------------------DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD 109
Query: 139 IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQI 198
++K LK + +EP IA +L E L GL++ H N IHRD+K NILL +G V++
Sbjct: 110 LVKGFLK----RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKL 165
Query: 199 ADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM--EQ--DHGYDFKADIWSLGITAI 254
DFGVSA L + R R+T VGTP WMAPEV+ EQ D YD + D+WSLGITAI
Sbjct: 166 VDFGVSAQLTSTR-----LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAI 220
Query: 255 EMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK 314
E+ G P M+ L +N PPTL Q + + F I CL KD K
Sbjct: 221 ELGDGDPPLADLHPMRALFKIPRNPPPTL-------HQPELWSNEFNDFIRKCLTKDYEK 273
Query: 315 RPTASELLKNPF 326
RPT S+LL++ F
Sbjct: 274 RPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 1e-52
Identities = 104/258 (40%), Positives = 145/258 (56%), Gaps = 32/258 (12%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSS-CHHENVVTYHTSFVVK------DELWLVLRLLE 132
AIK +++ + +E+ EI + HH N+ TY+ +F+ K D+LWLV+
Sbjct: 45 AIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCG 102
Query: 133 GGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE 192
GS+ D++K N K E IA + RE+L+GL + H++ IHRDIK N+LL E
Sbjct: 103 AGSVTDLVK------NTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE 156
Query: 193 DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM----EQDHGYDFKADIWS 248
+ V++ DFGVSA L R + R R+TF+GTP WMAPEV+ D YD+++DIWS
Sbjct: 157 NAEVKLVDFGVSAQL--DRTVGR---RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWS 211
Query: 249 LGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCL 308
LGITAIEMA G P M+ L L +N PP L + K + K F I CL
Sbjct: 212 LGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS--------KKWSKKFIDFIEGCL 263
Query: 309 QKDPTKRPTASELLKNPF 326
K+ RP+ +LLK+PF
Sbjct: 264 VKNYLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 179 bits (454), Expect = 2e-52
Identities = 102/244 (41%), Positives = 140/244 (57%), Gaps = 30/244 (12%)
Query: 94 DELLKEIQAMSS-CHHENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKHRLKI 146
+E+ +EI + HH N+ TY+ +F+ K D+LWLV+ GS+ D+IK
Sbjct: 47 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK----- 101
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
N K E IA + RE+L+GL + H + IHRDIK N+LL E+ V++ DFGVSA
Sbjct: 102 -NTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160
Query: 207 LATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG----YDFKADIWSLGITAIEMATGTAP 262
L R + R R+TF+GTP WMAPEV+ D YDFK+D+WSLGITAIEMA G P
Sbjct: 161 L--DRTVGR---RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
Query: 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
M+ L L +N P L + K + K F+ I CL K+ ++RPT +L+
Sbjct: 216 LCDMHPMRALFLIPRNPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPTTEQLM 267
Query: 323 KNPF 326
K+PF
Sbjct: 268 KHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 2e-52
Identities = 105/267 (39%), Positives = 151/267 (56%), Gaps = 25/267 (9%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
+V A K+ + A+KK++L K + L E+ M HENVV + S++V DEL
Sbjct: 34 GIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 92
Query: 125 WLVLRLLEGGSLLDIIKH-RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183
W+V+ LEGG+L DI+ H R+ +E IA V VLK L H+ G IHRDI
Sbjct: 93 WVVMEFLEGGALTDIVTHTRM----------NEEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFK 243
K+ +ILL DG V+++DFG A ++ +++ R+K + VGTP WMAPE++ + Y +
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRK---SLVGTPYWMAPELISR-LPYGPE 196
Query: 244 ADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKM 303
DIWSLGI IEM G PY P +K + + N PP L K+ +K + +
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL------KNLHKV-SPSLKGF 249
Query: 304 ISDCLQKDPTKRPTASELLKNPFFKKA 330
+ L +DP +R TA+ELLK+PF KA
Sbjct: 250 LDRLLVRDPAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 179 bits (454), Expect = 3e-52
Identities = 107/267 (40%), Positives = 146/267 (54%), Gaps = 23/267 (8%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
V++A A ++ AIK++NL++ + ++ EI M + N+V Y S++V DEL
Sbjct: 33 GTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91
Query: 125 WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
W+V+ L GGSL D++ C DE IA V RE L+ L++ HSN IHRDIK
Sbjct: 92 WVVMEYLAGGSLTDVVTE-----TCM----DEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
+ NILLG DG+V++ DFG A + Q R T VGTP WMAPEV+ + Y K
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQIT-----PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKV 196
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
DIWSLGI AIEM G PY ++ L L N P L + FR +
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-------ERLSAVFRDFL 249
Query: 305 SDCLQKDPTKRPTASELLKNPFFKKAK 331
+ CL+ D +R +A ELL++PF K AK
Sbjct: 250 NRCLEMDVDRRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 4e-52
Identities = 94/263 (35%), Positives = 151/263 (57%), Gaps = 23/263 (8%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
A K+ K +++ + EI+ +++C+H +V +F +LW+++ GG++ D
Sbjct: 40 AAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV-DA 98
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
I L G+ EP I + R++L+ L+Y HS IHRD+KAGN+LL DG +++A
Sbjct: 99 IMLELD-----RGL-TEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLA 152
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM----EQDHGYDFKADIWSLGITAIE 255
DFGVSA +++ + R +F+GTP WMAPEV+ +D YD+KADIWSLGIT IE
Sbjct: 153 DFGVSA-----KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 207
Query: 256 MATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315
MA P+H+ M+VL+ +++PPTL + + FR + L K P R
Sbjct: 208 MAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS-------KWSMEFRDFLKTALDKHPETR 260
Query: 316 PTASELLKNPFFKKAKDKKFIQQ 338
P+A++LL++PF + +++
Sbjct: 261 PSAAQLLEHPFVSSVTSNRPLRE 283
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 4e-52
Identities = 102/259 (39%), Positives = 149/259 (57%), Gaps = 25/259 (9%)
Query: 73 KARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLE 132
K ++ A+KK++L K + L E+ M HHENVV + S++V DELW+V+ LE
Sbjct: 44 KHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102
Query: 133 GGSLLDIIKH-RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
GG+L DI+ H R+ +E IATV VL+ L Y H+ G IHRDIK+ +ILL
Sbjct: 103 GGALTDIVTHTRM----------NEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 152
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251
DG ++++DFG A ++ +++ ++K + VGTP WMAPEV+ + Y + DIWSLGI
Sbjct: 153 SDGRIKLSDFGFCAQVS--KEVPKRK---SLVGTPYWMAPEVISR-LPYGTEVDIWSLGI 206
Query: 252 TAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311
IEM G PY P ++ + N PP + KD +K R + L ++
Sbjct: 207 MVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV------KDSHKV-SSVLRGFLDLMLVRE 259
Query: 312 PTKRPTASELLKNPFFKKA 330
P++R TA ELL++PF K A
Sbjct: 260 PSQRATAQELLQHPFLKLA 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 6e-52
Identities = 106/264 (40%), Positives = 148/264 (56%), Gaps = 25/264 (9%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWL 126
V+ A E AIK I LE + +EI M C H N+V Y S++ +D+LW+
Sbjct: 25 VYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83
Query: 127 VLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186
+ GGSL DI G E IA V RE L+GL Y HS G++HRDIK
Sbjct: 84 CMEFCGGGSLQDIYH--------VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGA 135
Query: 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEV--MEQDHGYDFKA 244
NILL ++G V++ADFGVSA + ++++K +F+GTP WMAPEV +E+ GY+
Sbjct: 136 NILLTDNGHVKLADFGVSAQITA--TIAKRK---SFIGTPYWMAPEVAAVERKGGYNQLC 190
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND--PPTLDTGAAEKDQYKAYGKTFRK 302
DIW++GITAIE+A P M+ L L +++ PP L KD+ K + +F
Sbjct: 191 DIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL------KDKMK-WSNSFHH 243
Query: 303 MISDCLQKDPTKRPTASELLKNPF 326
+ L K+P KRPTA +LL++PF
Sbjct: 244 FVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 7e-52
Identities = 86/259 (33%), Positives = 132/259 (50%), Gaps = 29/259 (11%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
A+K I LE ++L+E+ + C+ +V ++ +F ++ + + ++GGSL I
Sbjct: 30 AVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKI 89
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI-HRDIKAGNILLGEDGTVQI 198
+K G E + + VLKGL Y H +I HRD+K NIL+ G +++
Sbjct: 90 LKE-------VQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKL 142
Query: 199 ADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258
DFGVS L + TFVGT +MAPE + Q + Y K+DIWSLG++ IE+AT
Sbjct: 143 CDFGVSGQLV-------NSLAKTFVGTSSYMAPERI-QGNDYSVKSDIWSLGLSLIELAT 194
Query: 259 GTAPY--HKYPAMKVLML---TLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
G PY P + L + PP L +G + F+ ++ CL KDP
Sbjct: 195 GRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGK--------FSPDFQDFVNLCLIKDPR 246
Query: 314 KRPTASELLKNPFFKKAKD 332
+RP+ ELL++PF KK +
Sbjct: 247 ERPSYKELLEHPFIKKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 2e-50
Identities = 110/267 (41%), Positives = 146/267 (54%), Gaps = 23/267 (8%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
V +A A ++ AIK+INL+K + ++ EI M + N+V + SF+V DEL
Sbjct: 33 GTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91
Query: 125 WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
++V+ L GGSL D++ C DE IA V RE L+ LE+ H+N IHRDIK
Sbjct: 92 FVVMEYLAGGSLTDVVTE-----TCM----DEAQIAAVCRECLQALEFLHANQVIHRDIK 142
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
+ N+LLG DG+V++ DFG A + Q R T VGTP WMAPEV+ + Y K
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQIT-----PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKV 196
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
DIWSLGI AIEM G PY ++ L L N P L EK FR +
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN--PEK-----LSPIFRDFL 249
Query: 305 SDCLQKDPTKRPTASELLKNPFFKKAK 331
+ CL+ D KR +A ELL++PF K AK
Sbjct: 250 NRCLEMDVEKRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 4e-50
Identities = 95/258 (36%), Positives = 144/258 (55%), Gaps = 23/258 (8%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
A K+ K +++ + EI ++SC H N+V +F ++ LW+++ GG++ D
Sbjct: 33 AAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DA 91
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
+ L+ EP I V ++ L+ L Y H N IHRD+KAGNIL DG +++A
Sbjct: 92 VMLELERP------LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLA 145
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM----EQDHGYDFKADIWSLGITAIE 255
DFGVSA R + R R +F+GTP WMAPEV+ +D YD+KAD+WSLGIT IE
Sbjct: 146 DFGVSA--KNTRTIQR---RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 200
Query: 256 MATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315
MA P+H+ M+VL+ +++PPTL Q + F+ + CL+K+ R
Sbjct: 201 MAQIEPPHHELNPMRVLLKIAKSEPPTL-------AQPSRWSSEFKDFLKKCLEKNVDAR 253
Query: 316 PTASELLKNPFFKKAKDK 333
T ++LL++PF +K
Sbjct: 254 WTTTQLLQHPFVTVNSNK 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 6e-50
Identities = 109/267 (40%), Positives = 145/267 (54%), Gaps = 23/267 (8%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
V++A A ++ AI+++NL++ + ++ EI M + N+V Y S++V DEL
Sbjct: 34 GTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92
Query: 125 WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
W+V+ L GGSL D++ C DE IA V RE L+ LE+ HSN IHRDIK
Sbjct: 93 WVVMEYLAGGSLTDVVTE-----TCM----DEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
+ NILLG DG+V++ DFG A + Q R T VGTP WMAPEV+ + Y K
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQIT-----PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKV 197
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
DIWSLGI AIEM G PY ++ L L N P L EK FR +
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN--PEK-----LSAIFRDFL 250
Query: 305 SDCLQKDPTKRPTASELLKNPFFKKAK 331
+ CL D KR +A ELL++ F K AK
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLKIAK 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 175 bits (443), Expect = 7e-50
Identities = 89/318 (27%), Positives = 134/318 (42%), Gaps = 36/318 (11%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
Y + +G G+ V+ A + + A+K + + +
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK--------------------S 38
Query: 91 TSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
++ L+EIQ ++S H N+V + F + L+LV+ ++GGSL D++K +
Sbjct: 39 KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGR---- 94
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT-VQIADFGVSAWLA 208
G E +L ++L LEY HS G IHRDIK NILL DG V++ DFG++ L
Sbjct: 95 -KGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153
Query: 209 TGRDLSRQKVRH-TFVGTPCWMAPEVMEQ--DHGYDFKADIWSLGITAIEMATGTAPYHK 265
S T VGTP +MAPEV+ +DIWSLGIT E+ TG P+
Sbjct: 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213
Query: 266 YPAMKVLMLTLQ---NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
TL+ P + K ++ L KDP R ++S L
Sbjct: 214 EKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
Query: 323 KNPFFKKAKDKKFIQQTL 340
+ K K+ L
Sbjct: 274 SHDLLAHLKLKESDLSDL 291
|
Length = 384 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 172 bits (436), Expect = 1e-49
Identities = 114/318 (35%), Positives = 158/318 (49%), Gaps = 58/318 (18%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
+ D +E+ E IG G V+ K A+K ++
Sbjct: 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI------------------- 58
Query: 85 NLEKWNTSMDELLKEIQA-----MSSCHHENVVTYHTSFVVKD-----ELWLVLRLLEGG 134
+ +DE EI+A S +H NVV ++ F D +LWLVL L GG
Sbjct: 59 ------SDVDE---EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGG 109
Query: 135 SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194
S+ +++K L C + DE I+ +L L GL++ H+N IHRD+K NILL +G
Sbjct: 110 SVTELVKGLLI---CGQRL-DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG 165
Query: 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM--EQ--DHGYDFKADIWSLG 250
V++ DFGVSA L + R R+T VGTP WMAPEV+ EQ D+ YD + D+WSLG
Sbjct: 166 GVKLVDFGVSAQLTSTR-----LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLG 220
Query: 251 ITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQK 310
ITAIE+ G P +K L +N PPTL EK + ++F IS CL K
Sbjct: 221 ITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH--PEK-----WCRSFNHFISQCLIK 273
Query: 311 DPTKRPTASELLKNPFFK 328
D RP+ + LL++PF K
Sbjct: 274 DFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-48
Identities = 84/265 (31%), Positives = 138/265 (52%), Gaps = 22/265 (8%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDELLK-EIQAMSSCHHENVVTYHTSFVVKDELW 125
V++A E A+K+I ++ + + + E++ + H N+V Y+ V +++++
Sbjct: 16 VYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVY 75
Query: 126 LVLRLLEGGSLLDIIKHRLKISNCKHG-VCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
+ + GG+L ++ +HG + DE I ++L+GL Y HS+G +HRDIK
Sbjct: 76 IFMEYCSGGTLEEL---------LEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM--EQDHGYDF 242
NI L +G +++ DFG + L ++V+ GTP +MAPEV+ + G+
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL-AGTPAYMAPEVITGGKGKGHGR 185
Query: 243 KADIWSLGITAIEMATGTAPYHKYPAMKVLMLTL-QNDPPTLDTGAAEKDQYKAYGKTFR 301
ADIWSLG +EMATG P+ + +M + P + + Q GK F
Sbjct: 186 AADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPI----PDSLQLSPEGKDF- 240
Query: 302 KMISDCLQKDPTKRPTASELLKNPF 326
+ CL+ DP KRPTASELL++PF
Sbjct: 241 --LDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 9e-48
Identities = 102/262 (38%), Positives = 145/262 (55%), Gaps = 29/262 (11%)
Query: 73 KAR----AEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVL 128
KAR E A+K I LE + + +EI + C H N+V Y S++ +++LW+ +
Sbjct: 27 KARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85
Query: 129 RLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188
GGSL DI +S + IA V RE L+GL Y HS G++HRDIK NI
Sbjct: 86 EYCGGGSLQDIYHVTGPLSELQ--------IAYVCRETLQGLAYLHSKGKMHRDIKGANI 137
Query: 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEV--MEQDHGYDFKADI 246
LL ++G V++ADFGV+A + + R +F+GTP WMAPEV +E++ GY+ DI
Sbjct: 138 LLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDI 192
Query: 247 WSLGITAIEMATGTAPYHKYPAMKVLMLTLQND--PPTLDTGAAEKDQYKAYGKTFRKMI 304
W++GITAIE+A P M+ L L +++ PP L KD+ K + TF +
Sbjct: 193 WAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL------KDKTK-WSSTFHNFV 245
Query: 305 SDCLQKDPTKRPTASELLKNPF 326
L K+P KRPTA LL + F
Sbjct: 246 KISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 7e-46
Identities = 109/311 (35%), Positives = 156/311 (50%), Gaps = 55/311 (17%)
Query: 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDEL 96
IG G+ V+ A E A+KK++ + K+ N EKW ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSG---------------KQTN-EKWQ----DI 68
Query: 97 LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGS--LLDIIKHRLKISNCKHGVC 154
+KE++ + H N + Y ++ + WLV+ G + LL++ K L+
Sbjct: 69 IKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQ--------- 119
Query: 155 DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLS 214
E IA + L+GL Y HS+ IHRDIKAGNILL E G V++ADFG + S
Sbjct: 120 -EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA---------S 169
Query: 215 RQKVRHTFVGTPCWMAPEV-MEQDHG-YDFKADIWSLGITAIEMATGTAPYHKYPAMKVL 272
+ ++FVGTP WMAPEV + D G YD K D+WSLGIT IE+A P AM L
Sbjct: 170 KSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 229
Query: 273 MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332
QND PTL Q + +FR + CLQK P +RP ++ELL++ F ++ +
Sbjct: 230 YHIAQNDSPTL--------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281
Query: 333 KK----FIQQT 339
+ IQ+T
Sbjct: 282 ARVLIDLIQRT 292
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 2e-45
Identities = 97/313 (30%), Positives = 149/313 (47%), Gaps = 54/313 (17%)
Query: 63 NLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK-EIQAMSSCHHENVVTYHTSFVVK 121
+L V+ A K E +++INLE M L+ E+ +H N+V Y +F+
Sbjct: 12 DLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 71
Query: 122 DELWLVLRLLEGGSLLDIIKHRLKISNCKHGV--CDEPTIATVLREVLKGLEYFHSNGQI 179
+ELW+V + GS D+I C H + E IA +L+ VLK L+Y H G +
Sbjct: 72 NELWVVTSFMAYGSAKDLI--------CTHFMDGMSELAIAYILQGVLKALDYIHHMGYV 123
Query: 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTF----VGTPCWMAPEVME 235
HR +KA +IL+ DG V ++ G+ + L+ R +V H F V W++PEV++
Sbjct: 124 HRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQ 181
Query: 236 QD-HGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPT-LDTGAAEKDQ- 292
Q+ GYD K+DI+S+GITA E+A G P+ PA ++L+ L P LDT ++
Sbjct: 182 QNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241
Query: 293 ----------------------------------YKAYGKTFRKMISDCLQKDPTKRPTA 318
+ + F + CLQ++P RP+A
Sbjct: 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA 301
Query: 319 SELLKNPFFKKAK 331
S LL + FFK+ K
Sbjct: 302 STLLNHSFFKQIK 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 4e-45
Identities = 87/275 (31%), Positives = 130/275 (47%), Gaps = 22/275 (8%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE--L 124
V K A+K I + ++L+E++ SC +V Y+ +F+ + +
Sbjct: 17 VTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76
Query: 125 WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
+ + EGGSL I K K + G E + + VLKGL Y HS IHRDIK
Sbjct: 77 GIAMEYCEGGSLDSIYKKVKK----RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIK 132
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
NILL G V++ DFGVS L + TF GT +MAPE + Q Y +
Sbjct: 133 PSNILLTRKGQVKLCDFGVSGELVN-------SLAGTFTGTSFYMAPERI-QGKPYSITS 184
Query: 245 DIWSLGITAIEMATGTAPY-----HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKT 299
D+WSLG+T +E+A P+ +++L + P L E + +
Sbjct: 185 DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD---EPGNGIKWSEE 241
Query: 300 FRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334
F+ I CL+KDPT+RPT ++L++P+ K KK
Sbjct: 242 FKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK 276
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-44
Identities = 108/299 (36%), Positives = 149/299 (49%), Gaps = 52/299 (17%)
Query: 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNT 91
++RE IG G+ V+ A E AIKK++ + K + EKW
Sbjct: 29 DLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYS----------------GKQSNEKWQ- 70
Query: 92 SMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGS--LLDIIKHRLKISNC 149
+++KE++ + H N + Y ++ + WLV+ G + LL++ K L+
Sbjct: 71 ---DIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ---- 123
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
E IA + L+GL Y HS+ IHRDIKAGNILL E G V++ADFG ++ +
Sbjct: 124 ------EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEV-MEQDHG-YDFKADIWSLGITAIEMATGTAPYHKYP 267
++FVGTP WMAPEV + D G YD K D+WSLGIT IE+A P
Sbjct: 178 A---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
AM L QN+ PTL Q + FR + CLQK P RPT+ ELLK+ F
Sbjct: 229 AMSALYHIAQNESPTL--------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-44
Identities = 106/292 (36%), Positives = 152/292 (52%), Gaps = 47/292 (16%)
Query: 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDEL 96
IG G+T +V C AR EK HS + A+K ++L K + L
Sbjct: 29 IGEGSTGIV----CIAR-EK-----------HSG------RQVAVKMMDLRK-QQRRELL 65
Query: 97 LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKH-RLKISNCKHGVCD 155
E+ M H+NVV + S++V +ELW+++ L+GG+L DI+ RL +
Sbjct: 66 FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRL----------N 115
Query: 156 EPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSR 215
E IATV VL+ L Y HS G IHRDIK+ +ILL DG V+++DFG A ++ +D+ +
Sbjct: 116 EEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--KDVPK 173
Query: 216 QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLT 275
R + VGTP WMAPEV+ + Y + DIWSLGI IEM G PY ++ +
Sbjct: 174 ---RKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229
Query: 276 LQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
+ PP L K+ +K R + L ++P +R TA ELL +PF
Sbjct: 230 RDSPPPKL------KNAHKI-SPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 94/297 (31%), Positives = 141/297 (47%), Gaps = 42/297 (14%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+++ + IG G +VV+ A C A+KK+ + + A KAR + C
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA--KAR-QDC--------- 49
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
LKEI + H NV+ Y SF+ +EL +VL L + G L +IKH K
Sbjct: 50 --------LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKK--- 98
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
+ + E TI ++ LE+ HS +HRDIK N+ + G V++ D G+
Sbjct: 99 -QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL----- 152
Query: 209 TGRDLSRQKVR-HTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH--K 265
GR S + H+ VGTP +M+PE + ++GY+FK+DIWSLG EMA +P++ K
Sbjct: 153 -GRFFSSKTTAAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
Query: 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
+ + D P L D Y R ++S C+ DP KRP S +L
Sbjct: 211 MNLYSLCKKIEKCDYPPL-----PADHYSE---ELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 93/293 (31%), Positives = 144/293 (49%), Gaps = 35/293 (11%)
Query: 36 VIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDE 95
+IG G+ V+ + E A+K++ L V ++ + + +D
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKR--------------SMLDA 52
Query: 96 LLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCD 155
L +EI + HEN+V Y S + D L + L + GGS+ ++ + +G +
Sbjct: 53 LAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN--------YGAFE 104
Query: 156 EPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL-ATGRDLS 214
E + +R++LKGL Y H+ G IHRDIK NIL+ G ++I+DFG+S L A
Sbjct: 105 ETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTK 164
Query: 215 RQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLML 274
R + G+ WMAPEV++Q Y KADIWSLG +EM TG P+ ++ +
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK 223
Query: 275 TLQNDPPTL-DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
+N P + ++E + KTF + D KRPTA+ELLK+PF
Sbjct: 224 IGENASPEIPSNISSEAIDFLE--KTF--------EIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 99/274 (36%), Positives = 137/274 (50%), Gaps = 41/274 (14%)
Query: 77 EKCAIKKINL------EKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRL 130
E AIKK++ EKW +++KE++ + H N + Y ++ + WLV+
Sbjct: 41 EVVAIKKMSYSGKQSNEKWQ----DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96
Query: 131 LEGGS--LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188
G + LL++ K L+ E IA V L+GL Y HS+ IHRD+KAGNI
Sbjct: 97 CLGSASDLLEVHKKPLQ----------EVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146
Query: 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEV-MEQDHG-YDFKADI 246
LL E G V++ DFG ++ +A + FVGTP WMAPEV + D G YD K D+
Sbjct: 147 LLSEPGLVKLGDFGSASIMAPA---------NXFVGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 247 WSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISD 306
WSLGIT IE+A P AM L QN+ P L Q + + FR +
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--------QSGHWSEYFRNFVDS 249
Query: 307 CLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTL 340
CLQK P RPT+ LLK+ F + + I +
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 4e-42
Identities = 78/253 (30%), Positives = 122/253 (48%), Gaps = 25/253 (9%)
Query: 80 AIKKINLEKWNTS----MDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGS 135
A+K++ + + ++ L EIQ + + HE +V Y+ + L + + + GGS
Sbjct: 31 AVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGS 90
Query: 136 LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195
+ D +K +G E R++L+G+EY HSN +HRDIK NIL G
Sbjct: 91 VKDQLK--------AYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN 142
Query: 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255
V++ DFG S L T S + GTP WM+PEV+ GY KAD+WS+G T +E
Sbjct: 143 VKLGDFGASKRLQTIC--SSGTGMKSVTGTPYWMSPEVI-SGEGYGRKADVWSVGCTVVE 199
Query: 256 MATGTAPYHKYPAMKVLM-LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK 314
M T P+ ++ AM + + Q P L + + R + ++ K
Sbjct: 200 MLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP---------DARNFLRRTFVENAKK 250
Query: 315 RPTASELLKNPFF 327
RP+A ELL++ F
Sbjct: 251 RPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (380), Expect = 6e-42
Identities = 80/257 (31%), Positives = 115/257 (44%), Gaps = 39/257 (15%)
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSL 136
+K I K + L E +S +H +V H +F +++L+LVL GG L
Sbjct: 27 KKKKIIKRKEVEH------TLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80
Query: 137 LDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196
+ + E E++ LEY HS G I+RD+K NILL DG +
Sbjct: 81 FSHLSKEGRF--------SEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHI 132
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256
++ DFG++ S +TF GTP ++APEV+ GY D WSLG+ EM
Sbjct: 133 KLTDFGLAK-----ELSSEGSRTNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEM 186
Query: 257 ATGTAPYHKYPAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
TG P++ ++ L++ P L A R +IS LQKDPT
Sbjct: 187 LTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEA-------------RDLISGLLQKDPT 233
Query: 314 KRPT---ASELLKNPFF 327
KR A E+ +PFF
Sbjct: 234 KRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 80/309 (25%), Positives = 125/309 (40%), Gaps = 57/309 (18%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCK-ARAEKCAIKKINLEK 88
YEV E IG G+ V K+ + K+I+ Y EK
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEID-------YGNMTEKEK---------- 43
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE--LWLVLRLLEGGSLLDIIKHRLKI 146
+L+ E+ + H N+V Y+ + + L++V+ EGG L +I+
Sbjct: 44 -----QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQ----- 93
Query: 147 SNCK--HGVCDEPTIATVLREVLKGLEYFHSNGQ------IHRDIKAGNILLGEDGTVQI 198
CK +E I +L ++L L H N +HRD+K NI L + V++
Sbjct: 94 -KCKKERKYIEEEFIWRILTQLLLALYECH-NRSDPGNTVLHRDLKPANIFLDANNNVKL 151
Query: 199 ADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258
DFG++ L + T+VGTP +M+PE + YD K+DIWSLG E+
Sbjct: 152 GDFGLAKILGHDSSFA-----KTYVGTPYYMSPEQL-NHMSYDEKSDIWSLGCLIYELCA 205
Query: 259 GTAPYHKYPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT 317
+ P+ L ++ + Y ++I L DP KRP+
Sbjct: 206 LSPPFTAR-NQLQLASKIKEGKFRRIPYR---------YSSELNEVIKSMLNVDPDKRPS 255
Query: 318 ASELLKNPF 326
ELL+ P
Sbjct: 256 TEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 5e-39
Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 30/279 (10%)
Query: 55 EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114
E+ + K +V++A + + AIK+I E+ + + L +EI S H N+V Y
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIP-ERDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH 174
S + + + GGSL ++ R K K +E TI +++L+GL+Y H
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALL--RSKWGPLKD---NEQTIIFYTKQILEGLKYLH 125
Query: 175 SNGQIHRDIKAGNILLGE-DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEV 233
N +HRDIK N+L+ G V+I+DFG S LA TF GT +MAPEV
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-----GINPCTETFTGTLQYMAPEV 180
Query: 234 MEQD-HGYDFKADIWSLGITAIEMATGTAPYHK----YPAM-KVLMLTLQNDPPTLDTGA 287
+++ GY ADIWSLG T +EMATG P+ + AM KV M + + P +
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240
Query: 288 AEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
A + I C + DP KR +A +LL++PF
Sbjct: 241 A------------KNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 7e-39
Identities = 70/247 (28%), Positives = 121/247 (48%), Gaps = 22/247 (8%)
Query: 81 IKKINLEKWNTS-MDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
K++NL + + + L EI +S H N++ Y+ F+ + L + + GG+L D
Sbjct: 30 WKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDK 89
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
I + K + +E + L +++ + Y H G +HRDIK NI L + G +++
Sbjct: 90 IVRQ------KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLG 143
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259
DFG+S L + ++ T VGTP +M+PE + Q Y+FK+DIW+LG E+ T
Sbjct: 144 DFGISKILGSEYSMAE-----TVVGTPYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTL 197
Query: 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319
+ + +++ +Q + + + Y ++ LQ+DP KRPTA
Sbjct: 198 KRTFDATNPLNLVVKIVQGNYTPVVSV---------YSSELISLVHSLLQQDPEKRPTAD 248
Query: 320 ELLKNPF 326
E+L P
Sbjct: 249 EVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 77/301 (25%), Positives = 120/301 (39%), Gaps = 63/301 (20%)
Query: 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMD 94
+ +G GA V+ K E K A+K + +
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETK------------------VAVKTLKEGASEEERE 46
Query: 95 ELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLD-IIKHRLKISNCKHGV 153
E L+E M H N+V + L++V + GG LLD + KH K++
Sbjct: 47 EFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLT------ 100
Query: 154 CDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDL 213
+ + ++ KG+EY S +HRD+ A N L+ E+ V+I+DFG+S RD+
Sbjct: 101 --LKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLS------RDI 152
Query: 214 ---SRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAM 269
+ R WMAPE + +D + K+D+WS G+ E+ T G PY
Sbjct: 153 YEDDYYRKRGGGKLPIKWMAPESL-KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE 211
Query: 270 KVL--------MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
+VL + +N P L +++ C DP RPT SEL
Sbjct: 212 EVLELLEDGYRLPRPENCPDEL-----------------YELMLQCWAYDPEDRPTFSEL 254
Query: 322 L 322
+
Sbjct: 255 V 255
|
Length = 258 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 9e-38
Identities = 96/329 (29%), Positives = 155/329 (47%), Gaps = 59/329 (17%)
Query: 63 NLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ-AMSSCH---HENVVTYHTSF 118
NL V+ A ++ +LE +E LK +Q + H H N++T T F
Sbjct: 12 NLTSVYLARHTPTGTLVTVRITDLENCT---EEHLKALQNEVVLSHFFRHPNIMTSWTVF 68
Query: 119 VVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178
LW++ + GS ++K G+ E I +L L+GL Y H NG
Sbjct: 69 TTGSWLWVISPFMAYGSANSLLKTYFP-----EGM-SEALIGNILFGALRGLNYLHQNGY 122
Query: 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTF----VGTPCWMAPEVM 234
IHR+IKA +IL+ DG V ++ G+S + R+ + KV + F W++PE++
Sbjct: 123 IHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL 180
Query: 235 EQD-HGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPT----------- 282
QD +GY+ K+DI+S+GITA E+ATG P+ ++L+ L+ P +
Sbjct: 181 RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240
Query: 283 ---------LDTGAAEK-----------------DQYKAYGKTFRKMISDCLQKDPTKRP 316
+D+G E K + F+ ++ CLQ+DP KRP
Sbjct: 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP 300
Query: 317 TASELLKNPFFKKAKDKKFIQQTLVSVGP 345
+AS LL + FFK+ K++ Q +++S+ P
Sbjct: 301 SASSLLSHAFFKQVKEQT--QGSILSLLP 327
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 79/258 (30%), Positives = 111/258 (43%), Gaps = 27/258 (10%)
Query: 80 AIKKINLEKWNTSM--DELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
AIK I D++L E +S VV + SF K L+LV+ L GG L
Sbjct: 22 AIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLA 81
Query: 138 DIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQ 197
++++ G DE + E++ LEY HSNG IHRD+K NIL+ +G ++
Sbjct: 82 SLLEN--------VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLK 133
Query: 198 IADFGVSAWLATGRDLSRQKVR---HTFVGTPCWMAPEVME-QDHGYDFKADIWSLGITA 253
+ DFG+S R ++ VGTP ++APEV+ Q H D WSLG
Sbjct: 134 LTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHS--KTVDWWSLGCIL 191
Query: 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
E G P+H ++ L E + +IS L DP
Sbjct: 192 YEFLVGIPPFHGETPEEIFQNILNGK--------IEWPEDVEVSDEAIDLISKLLVPDPE 243
Query: 314 KRPTA---SELLKNPFFK 328
KR A E+ +PFFK
Sbjct: 244 KRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 5e-37
Identities = 80/268 (29%), Positives = 120/268 (44%), Gaps = 28/268 (10%)
Query: 66 VVHSAYCKARAEK---CAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVT-YHTSFVVK 121
V+ K + K A+K + + + LKE + M H NVV +
Sbjct: 10 EVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC-TEE 68
Query: 122 DELWLVLRLLEGGSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180
+ L+LVL +EGG LLD + K R + + + + ++ KG+EY S +H
Sbjct: 69 EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVH 128
Query: 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC---WMAPEVMEQD 237
RD+ A N L+GED V+I+DFG+S RD+ G WMAPE ++ D
Sbjct: 129 RDLAARNCLVGEDLVVKISDFGLS------RDVYDDDYYRKKTGGKLPIRWMAPESLK-D 181
Query: 238 HGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAA-EKDQYKA 295
+ K+D+WS G+ E+ T G PY +VL L G K +Y
Sbjct: 182 GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL--------EYLRKGYRLPKPEY-- 231
Query: 296 YGKTFRKMISDCLQKDPTKRPTASELLK 323
+++ C Q DP RPT SEL++
Sbjct: 232 CPDELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 9e-37
Identities = 77/256 (30%), Positives = 124/256 (48%), Gaps = 28/256 (10%)
Query: 80 AIKKINLEKWNTSMDE-----LLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGG 134
A+K++ L+ N E L +E+ + S H N+V Y + + + + + + + GG
Sbjct: 28 AVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGG 87
Query: 135 SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194
S+ I+ + G EP +++L G+ Y H+N +HRDIK N++L +G
Sbjct: 88 SISSILN--------RFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG 139
Query: 195 TVQIADFGVSAWLA-TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
+++ DFG + LA G + + + GTP WMAPEV+ + GY K+DIWS+G T
Sbjct: 140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTV 198
Query: 254 IEMATGTAPYHKYPAMKVLMLTLQNDP---PTLDTGAAEKDQYKAYGKTFRKMISDCLQK 310
EMATG P + M + P L D + A F CL +
Sbjct: 199 FEMATGKPPLASMDRLAA-MFYIGAHRGLMPRLP------DSFSAAAIDFVTS---CLTR 248
Query: 311 DPTKRPTASELLKNPF 326
D +RP+A +LL++ F
Sbjct: 249 DQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 9e-37
Identities = 72/237 (30%), Positives = 111/237 (46%), Gaps = 20/237 (8%)
Query: 93 MDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHG 152
+ L EI+ + H N+V Y ++ L + L + GGS+ ++ +G
Sbjct: 52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--------TYG 103
Query: 153 VCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRD 212
+E + +VL+GL Y HS G +HRD+KA N+L+ DG +I+DFG+S D
Sbjct: 104 RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGIS---KKSDD 160
Query: 213 LSRQKVRHTFVGTPCWMAPEVMEQDH-GYDFKADIWSLGITAIEMATGTAPYHKYPAMKV 271
+ + G+ WMAPEV+ GY K DIWSLG +EM G P+ A+
Sbjct: 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
Query: 272 L--MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
+ + ++ PP D ++ C +P RPTA ELL++PF
Sbjct: 221 MFKLGNKRSAPPI------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 74/268 (27%), Positives = 128/268 (47%), Gaps = 22/268 (8%)
Query: 59 IKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSM-DELLKEIQAMSSCHHENVVTYHTS 117
I K + VV KA A+K+I+L K N +E + E + ++ ++ Y+ S
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 118 FVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG 177
F+ K +L +V+ E G L ++K + E + ++L GL + HS
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRP------LPEDQVWRFFIQILLGLAHLHSKK 121
Query: 178 QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD 237
+HRDIK+ N+ L V+I D GV+ L+ + + T VGTP +++PE + +D
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN-----TIVGTPYYLSPE-LCED 175
Query: 238 HGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYG 297
Y+ K+D+W+LG+ E TG P+ +++ ++ P + Y
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM---------YS 226
Query: 298 KTFRKMISDCLQKDPTKRPTASELLKNP 325
+ ++I CL KD +RP +LL+NP
Sbjct: 227 QQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 3e-36
Identities = 72/258 (27%), Positives = 118/258 (45%), Gaps = 42/258 (16%)
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE-LWLVLRLLEGGS 135
+ A+K + + ++E L+E + M H NVV ++E L++V+ +EGG
Sbjct: 29 VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL-GVCTEEEPLYIVMEYMEGGD 87
Query: 136 LLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194
LL + K+R K+S + + ++ +G+EY S IHRD+ A N L+GE+
Sbjct: 88 LLSYLRKNRPKLSL--------SDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL 139
Query: 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC---WMAPEVMEQDHGYDFKADIWSLGI 251
V+I+DFG+S RDL + G WMAPE + ++ + K+D+WS G+
Sbjct: 140 VVKISDFGLS------RDLYDDDY-YRKRGGKLPIRWMAPESL-KEGKFTSKSDVWSFGV 191
Query: 252 TAIEMATGTAPYHKYPAMKV--LMLTLQN----DPPTLDTGAAEKDQYKAYGKTFRKMIS 305
E+ T YP M ++ L+N P ++
Sbjct: 192 LLWEIFTLGEQP--YPGMSNEEVLEYLKNGYRLPQPPNCP------------PELYDLML 237
Query: 306 DCLQKDPTKRPTASELLK 323
C +DP RPT SEL++
Sbjct: 238 QCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 6e-36
Identities = 72/249 (28%), Positives = 120/249 (48%), Gaps = 26/249 (10%)
Query: 80 AIKKINLEKWNTS-MDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLD 138
A+K+++L + ++ + EI+ ++S +H N+++Y +F+ ++L +V+ G L
Sbjct: 29 ALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSK 88
Query: 139 IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQI 198
I R K + E I + ++L+GL+ H +HRD+K+ NILL + V+I
Sbjct: 89 AISKRKKKRK----LIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKI 144
Query: 199 ADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258
D G+S + Q +GTP +MAPEV + Y +K+DIWSLG EMAT
Sbjct: 145 GDLGISK-VLKKNMAKTQ------IGTPHYMAPEVW-KGRPYSYKSDIWSLGCLLYEMAT 196
Query: 259 GTAPYHKYPAMKVLMLTLQND--PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
P+ +M+ L +Q PP Y + + I LQ P RP
Sbjct: 197 FAPPFEA-RSMQDLRYKVQRGKYPPIPPI----------YSQDLQNFIRSMLQVKPKLRP 245
Query: 317 TASELLKNP 325
++L +P
Sbjct: 246 NCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 9e-36
Identities = 67/257 (26%), Positives = 113/257 (43%), Gaps = 39/257 (15%)
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE-LWLVLRLLEGGS 135
+ A+K + + ++E L+E + M H N+V ++E L +V+ + GG
Sbjct: 29 VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL-GVCTEEEPLMIVMEYMPGGD 87
Query: 136 LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195
LLD ++ + + + ++ +G+EY S IHRD+ A N L+GE+
Sbjct: 88 LLDYLR------KNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV 141
Query: 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPC---WMAPEVMEQDHGYDFKADIWSLGIT 252
V+I+DFG+S RDL + G WMAPE + ++ + K+D+WS G+
Sbjct: 142 VKISDFGLS------RDLYDDDY-YKVKGGKLPIRWMAPESL-KEGKFTSKSDVWSFGVL 193
Query: 253 AIEMATGTAPYHKYPAMKV--LMLTLQN----DPPTLDTGAAEKDQYKAYGKTFRKMISD 306
E+ T YP M ++ L+ P K++
Sbjct: 194 LWEIFTLGEEP--YPGMSNAEVLEYLKKGYRLPKPPNCPPE------------LYKLMLQ 239
Query: 307 CLQKDPTKRPTASELLK 323
C +DP RPT SEL++
Sbjct: 240 CWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 86/288 (29%), Positives = 140/288 (48%), Gaps = 40/288 (13%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
+ + + IG G + V+ A C A+KK+ + + A KARA+
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA--KARAD------------- 48
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
+KEI + +H NV+ Y+ SF+ +EL +VL L + G L +IKH K +
Sbjct: 49 -----CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK----Q 99
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
+ E T+ ++ LE+ HS +HRDIK N+ + G V++ D G+ + +
Sbjct: 100 KRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-- 157
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH--KYPA 268
S+ H+ VGTP +M+PE + ++ GY+FK+DIWSLG EMA +P++ K
Sbjct: 158 ---SKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
+ Q D P L + Y + R++++ C+ DP KRP
Sbjct: 214 YSLCKKIEQCDYPPLPS--------DHYSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 78/248 (31%), Positives = 123/248 (49%), Gaps = 36/248 (14%)
Query: 95 ELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVC 154
++L+E+Q M C +V+++ +F+ ++ + + + ++ GSL I K K G
Sbjct: 49 QILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK--------KGGPI 100
Query: 155 DEPTIATVLREVLKGLEYFHSNGQI-HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDL 213
+ + V++GL Y ++ +I HRDIK NIL+ G +++ DFGVS L
Sbjct: 101 PVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI----- 155
Query: 214 SRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP------ 267
+ TFVGT +M+PE + Q Y K+D+WSLGI+ IE+A G P+
Sbjct: 156 --NSIADTFVGTSTYMSPERI-QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ 212
Query: 268 --AMKVLML---TLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
M +L L +Q PP L + +D R + CL KDPT+RPT +L
Sbjct: 213 DDPMGILDLLQQIVQEPPPRLPSSDFPED--------LRDFVDACLLKDPTERPTPQQLC 264
Query: 323 KNPFFKKA 330
P F +A
Sbjct: 265 AMPPFIQA 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 6e-35
Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 27/270 (10%)
Query: 80 AIKKINLEKWNTSMDELLKEIQ-AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLD 138
A+K+I + LL ++ +M S VT++ + + ++W+ + +++ SL
Sbjct: 30 AVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDK 88
Query: 139 IIKHRLKISNCKHGV-CDEPTIATVLREVLKGLEYFHSN-GQIHRDIKAGNILLGEDGTV 196
K G+ E + + ++K LEY HS IHRD+K N+L+ +G V
Sbjct: 89 FYKKVYD-----KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQV 143
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD---HGYDFKADIWSLGITA 253
++ DFG+S +L S K G +MAPE + + GYD K+D+WSLGIT
Sbjct: 144 KLCDFGISGYLVD----SVAKTID--AGCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197
Query: 254 IEMATGTAPYHKYPAM-KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312
IE+ATG PY + + L ++ P L + F+ ++ CL+K+
Sbjct: 198 IELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE--------FQDFVNKCLKKNY 249
Query: 313 TKRPTASELLKNPFFKKAKDKKFIQQTLVS 342
+RP ELL++PFF+ K + VS
Sbjct: 250 KERPNYPELLQHPFFELHLSKNTDVASFVS 279
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 8e-35
Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 30/280 (10%)
Query: 61 KINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVV 120
K N V+ + A+K+I LE + ++++ E+ + +V ++ +F +
Sbjct: 11 KGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI 70
Query: 121 KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI- 179
+ +++ + ++ GSL +L E + + V+KGL++ I
Sbjct: 71 EGAVYMCMEYMDAGSL-----DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPE-----VM 234
HRD+K N+L+ +G V++ DFGVS L + T +G +MAPE
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLV-------ASLAKTNIGCQSYMAPERIKSGGP 178
Query: 235 EQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKV---LMLTLQNDPPTLDTGAAEKD 291
Q+ Y ++D+WSLG++ +EMA G PY + L + DPPTL +G
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG----- 233
Query: 292 QYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331
Y + ++ CL K P +RPT ++LL++P+ K K
Sbjct: 234 ----YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 9e-35
Identities = 87/327 (26%), Positives = 139/327 (42%), Gaps = 75/327 (22%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
D ++ ++IG G+ + V A K ++ AIK ++ +++ EK
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILD-----------------KRQLIKEK 43
Query: 89 WNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ + E + ++ H ++ + +F ++ L+ VL G LL I+
Sbjct: 44 ---KVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR------ 94
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
K+G DE E+L LEY HS G IHRD+K NILL +D ++I DFG + L
Sbjct: 95 --KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152
Query: 208 ------------ATGRDLSRQKVRH---TFVGTPCWMAPEVM-EQDHGYDFKADIWSLGI 251
AT D +K R +FVGT +++PE++ E+ G +D+W+LG
Sbjct: 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK--SSDLWALGC 210
Query: 252 TAIEMATGTAPYHK---YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCL 308
+M TG P+ Y LT Q K +Y + F D +
Sbjct: 211 IIYQMLTGKPPFRGSNEY-------LTFQK---------ILKLEYS-FPPNFPPDAKDLI 253
Query: 309 QK----DPTKRPTAS----ELLKNPFF 327
+K DP R + EL +PFF
Sbjct: 254 EKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 9e-35
Identities = 85/298 (28%), Positives = 146/298 (48%), Gaps = 46/298 (15%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
+++ + IG G + V+ A C + A+KK+ + + A KAR
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDA--KAR--------------- 46
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
+ +KEI + +H NV+ Y SF+ +EL +VL L + G L +IK+ K +
Sbjct: 47 ---QDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKK----Q 99
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
+ E T+ ++ +E+ HS +HRDIK N+ + G V++ D G+ + +
Sbjct: 100 KRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-- 157
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270
S+ H+ VGTP +M+PE + ++ GY+FK+DIWSLG EMA +P++ K
Sbjct: 158 ---SKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFY---GDK 210
Query: 271 VLMLTL-----QNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ + +L Q D P L T + Y + R+++S C+ DP +RP + +
Sbjct: 211 MNLFSLCQKIEQCDYPPLPT--------EHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 76/257 (29%), Positives = 114/257 (44%), Gaps = 32/257 (12%)
Query: 76 AEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGS 135
A K K+ +EK S+ +L E + + +H +V SF ++ ++LV+ LL GG
Sbjct: 29 AMKYMNKQKCVEK--GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGD 86
Query: 136 LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195
L R +S + E + + E++ LEY HS G IHRDIK NILL E G
Sbjct: 87 L------RYHLS--QKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH 138
Query: 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255
V I DF ++ ++ + + GTP +MAPEV+ GY D WSLG+TA E
Sbjct: 139 VHITDFNIA------TKVTPDTLTTSTSGTPGYMAPEVL-CRQGYSVAVDWWSLGVTAYE 191
Query: 256 MATGTAPYHKY---PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312
G PY + ++ D + I+ L++DP
Sbjct: 192 CLRGKRPYRGHSRTIRDQIRAKQETADVLY----------PATWSTEAIDAINKLLERDP 241
Query: 313 TKR--PTASELLKNPFF 327
KR +L +P+F
Sbjct: 242 QKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 85/313 (27%), Positives = 124/313 (39%), Gaps = 95/313 (30%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWN-----TSMDE--LLKEIQAMSSCHHENVVTYHTSF 118
VV+ A K E A+KKI L+ T++ E LLKE++ H N+V
Sbjct: 14 VVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK------HPNIVKLLDVI 67
Query: 119 VVKDELWLVLRLLEGGSLLDIIKHRLK--ISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176
+ +L+LV + LK + + I +++ ++L+GL Y HS+
Sbjct: 68 HTERKLYLVFEYCD---------MDLKKYLDKRPGPL-SPNLIKSIMYQLLRGLAYCHSH 117
Query: 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTF-VGTPCWMAPEVME 235
+HRD+K NIL+ DG +++ADFG LA R +T V T + APE++
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFG----LA--RAFGIPLRTYTHEVVTLWYRAPEILL 171
Query: 236 QDHGYDFKADIWSLG-ITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQ-- 292
Y DIWS+G I A EM TG + G +E DQ
Sbjct: 172 GSKHYSTAVDIWSVGCIFA-EMITGKPLFP---------------------GDSEIDQLF 209
Query: 293 -------------------YKAYGKTFRKM-------------------ISDCLQKDPTK 314
Y TF K +S LQ +P K
Sbjct: 210 KIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK 269
Query: 315 RPTASELLKNPFF 327
R +A E LK+P+F
Sbjct: 270 RISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 82/243 (33%), Positives = 124/243 (51%), Gaps = 33/243 (13%)
Query: 95 ELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVC 154
++ +EI+ + +H NVV H F E+ ++L ++GGSL +
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG------------THIA 165
Query: 155 DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLS 214
DE +A V R++L G+ Y H +HRDIK N+L+ V+IADFGVS LA D
Sbjct: 166 DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225
Query: 215 RQKVRHTFVGTPCWMAPEVMEQD--HG-YD-FKADIWSLGITAIEMATGTAPY--HKYPA 268
++ VGT +M+PE + D HG YD + DIWSLG++ +E G P+ +
Sbjct: 226 -----NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280
Query: 269 MKVLMLTL-QNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
LM + + PP A+ + FR IS CLQ++P KR +A +LL++PF
Sbjct: 281 WASLMCAICMSQPPEAPATASRE---------FRHFISCCLQREPAKRWSAMQLLQHPFI 331
Query: 328 KKA 330
+A
Sbjct: 332 LRA 334
|
Length = 353 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 76/267 (28%), Positives = 124/267 (46%), Gaps = 31/267 (11%)
Query: 72 CKARAEKC----AIKKINLEKWNTSMDELLKEIQAMSSCHH-ENVVTYHTSFVVKDELWL 126
K R +K A+K++ +L ++ + H +V + F+ ++++
Sbjct: 32 YKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91
Query: 127 VLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN-GQIHRDIKA 185
+ L+ + LD + R++ G E + + ++K L Y G IHRD+K
Sbjct: 92 CMELM--STCLDKLLKRIQ------GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKP 143
Query: 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG---YDF 242
NILL G V++ DFG+S L + +R G +MAPE ++ YD
Sbjct: 144 SNILLDASGNVKLCDFGISGRLVDSKAKTRSA------GCAAYMAPERIDPPDPNPKYDI 197
Query: 243 KADIWSLGITAIEMATGTAPYHKYPA-MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFR 301
+AD+WSLGI+ +E+ATG PY +VL LQ +PP+L + + F
Sbjct: 198 RADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN-------EGFSPDFC 250
Query: 302 KMISDCLQKDPTKRPTASELLKNPFFK 328
+ CL KD KRP ELL++PF +
Sbjct: 251 SFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-33
Identities = 73/230 (31%), Positives = 113/230 (49%), Gaps = 24/230 (10%)
Query: 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHG--VCDE 156
E Q +S H +V +H SF+ +D ++ EG L K+ KH E
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDC------KLEELKHTGKTLSE 105
Query: 157 PTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQ 216
+ ++L G+ Y H +HRD+KA NI L ++ ++I DFGVS L DL+
Sbjct: 106 NQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLAT- 163
Query: 217 KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTL 276
TF GTP +M+PE ++ GYD K+DIWSLG EM + + V++ +
Sbjct: 164 ----TFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV 218
Query: 277 QNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
+ P+L + Y + ++ L KDP+ RP+A+E+L+NPF
Sbjct: 219 EGPTPSLP---------ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 89/333 (26%), Positives = 132/333 (39%), Gaps = 68/333 (20%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
YE+ + IG GA VV SA K K AIKKI+ K R
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK-RI-------------- 46
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKD-----ELWLVLRLLEGGSLLD---IIKH 142
L+EI+ + HEN++ ++++V L+E D +IK
Sbjct: 47 ------LREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME----TDLHKVIKS 96
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202
+++ H I L ++L+GL+Y HS IHRD+K NIL+ + ++I DFG
Sbjct: 97 PQPLTD-DH-------IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFG 148
Query: 203 VSAWLATGRDLSRQKVRH-T-FVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260
LA G D + T +V T + APE++ Y DIWS+G E+ T
Sbjct: 149 ----LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
Query: 261 A--PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY--------GKTFRKMISD---- 306
P Y L++ + P D ++ + Y K K+
Sbjct: 205 PLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPE 264
Query: 307 -------CLQKDPTKRPTASELLKNPFFKKAKD 332
L DP KR TA E L +P+ + D
Sbjct: 265 AIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 80/310 (25%), Positives = 140/310 (45%), Gaps = 57/310 (18%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+ +E++G G V+ AY A+K I L + + L+K
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT----------------VELQK- 44
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
+++ E++ + C ++ ++ +F V++ + + ++GGSL D+
Sbjct: 45 -----QIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL-DV---------- 88
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
+ E + + V+KGL Y S +HRD+K N+L+ G V++ DFGVS L
Sbjct: 89 -YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV- 146
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269
+ T+VGT +MAPE + + Y +D+WSLGI+ +E+A G PY +
Sbjct: 147 ------NSIAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKN 199
Query: 270 KVLMLTLQ-------NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
+ ++ LQ DPP L G + + F I+ C++K P +RP L+
Sbjct: 200 QGSLMPLQLLQCIVDEDPPVLPVG--------QFSEKFVHFITQCMRKQPKERPAPENLM 251
Query: 323 KNPFFKKAKD 332
+PF + D
Sbjct: 252 DHPFIVQYND 261
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 89/327 (27%), Positives = 134/327 (40%), Gaps = 74/327 (22%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
Y+ IG G VV+ A K E AIKKI K R E I K L
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI----------KLRFESEGIPKTAL---- 46
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
+EI+ + +H N++ F K +L+LV ++ L +IK R +
Sbjct: 47 -------REIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQR----- 93
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
E I + L ++L+GL + HS+G +HRD+K N+L+ +G +++ADFG LA
Sbjct: 94 --GLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFG----LA-- 145
Query: 211 RDLSRQKVRHT-FVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA--PYHKY- 266
R +T +V T + APE++ D GY DIWS+G E+ + P
Sbjct: 146 RSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI 205
Query: 267 ------------PAMKVL--MLTLQN------------DPPTLDTGAAEKDQYKAYGKTF 300
P +V +L P L A+ +
Sbjct: 206 DQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQ---------A 256
Query: 301 RKMISDCLQKDPTKRPTASELLKNPFF 327
++S L DP KR TA + L +P+F
Sbjct: 257 LDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 77/261 (29%), Positives = 118/261 (45%), Gaps = 32/261 (12%)
Query: 80 AIKKINLEKWNTSMDELLKEIQA-MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLD 138
A+K+I LL ++ M S +V ++ + + + W+ + L+ D
Sbjct: 33 AVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM------D 86
Query: 139 IIKHRL-KISNCKHGVC-DEPTIATVLREVLKGLEYFHSNGQI-HRDIKAGNILLGEDGT 195
I + K E + + +K L Y +I HRD+K NILL +G
Sbjct: 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN 146
Query: 196 VQIADFGVSAWL----ATGRDLSRQKVRHTFVGTPCWMAPEVM--EQDHGYDFKADIWSL 249
+++ DFG+S L A RD G +MAPE + GYD ++D+WSL
Sbjct: 147 IKLCDFGISGQLVDSIAKTRD----------AGCRPYMAPERIDPSARDGYDVRSDVWSL 196
Query: 250 GITAIEMATGTAPYHKY-PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCL 308
GIT E+ATG PY K+ L ++ DPP L + + + +F I+ CL
Sbjct: 197 GITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSN-----SEEREFSPSFVNFINLCL 251
Query: 309 QKDPTKRPTASELLKNPFFKK 329
KD +KRP ELL++PF K
Sbjct: 252 IKDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 2e-32
Identities = 82/293 (27%), Positives = 127/293 (43%), Gaps = 55/293 (18%)
Query: 64 LAVVHSAYCKARAEKCAIKKIN--LEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVV 120
LA E AIKK+ W M L+E++++ H N+V F
Sbjct: 17 LARNKETG-----ELVAIKKMKKKFYSWEECM--NLREVKSLRKLNEHPNIVKLKEVFRE 69
Query: 121 KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180
DEL+ V +EG +L ++K R K E I +++ ++L+GL + H +G H
Sbjct: 70 NDELYFVFEYMEG-NLYQLMKDR------KGKPFSESVIRSIIYQILQGLAHIHKHGFFH 122
Query: 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGY 240
RD+K N+L+ V+IADFG LA R++ + +V T + APE++ + Y
Sbjct: 123 RDLKPENLLVSGPEVVKIADFG----LA--REIRSRPPYTDYVSTRWYRAPEILLRSTSY 176
Query: 241 DFKADIWSLGITAIEMATGTAPY-------HKYPAMKVLMLTLQNDPPTLDT---GA--A 288
DIW+LG E+ T + Y VL PT G A
Sbjct: 177 SSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVL------GTPTKQDWPEGYKLA 230
Query: 289 EKDQYK---AYGKTFRKMI-----------SDCLQKDPTKRPTASELLKNPFF 327
K ++ + ++I D L+ DP KRPTAS+ L++P+F
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-32
Identities = 80/231 (34%), Positives = 119/231 (51%), Gaps = 24/231 (10%)
Query: 99 EIQAMSSCHHENVVTYHTSFVVKDE--LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDE 156
EIQ + + HE +V Y+ + E L + + + GGS+ D +K +G E
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK--------AYGALTE 105
Query: 157 PTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQ 216
R++L+G+ Y HSN +HRDIK NIL G V++ DFG S L T +S
Sbjct: 106 SVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT-ICMSGT 164
Query: 217 KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM-KVLMLT 275
+R + GTP WM+PEV+ + GY KAD+WSLG T +EM T P+ +Y AM + +
Sbjct: 165 GIR-SVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA 222
Query: 276 LQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
Q P L + +E + + F C+ + RP+A ELL++PF
Sbjct: 223 TQPTNPQLPSHISE------HARDFLG----CIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-31
Identities = 87/299 (29%), Positives = 137/299 (45%), Gaps = 48/299 (16%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+YE V+G GA +VH KA + IK+I V + E+ A
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP---VEQM---TKDERLAA-------- 46
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
E Q + H N++ Y+ +F+ L +V+ GG+L + I+ R
Sbjct: 47 -------QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR------ 93
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV-QIADFGVSAWLA 208
+ + DE TI ++L L + H+ +HRD+K NILL + V +I DFG+S
Sbjct: 94 CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS---- 149
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH--KY 266
+ LS + +T VGTPC+++PE+ E Y+ K+DIW+LG E+A+ +
Sbjct: 150 --KILSSKSKAYTVVGTPCYISPELCE-GKPYNQKSDIWALGCVLYELASLKRAFEAANL 206
Query: 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325
PA+ VL + P D Y R++I L DP+KRP S+++ P
Sbjct: 207 PAL-VLKIMSGTFAPISDR----------YSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 61/288 (21%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
A K I+LE +++++E++ + C+ +V ++ +F E+ + + ++GGSL +
Sbjct: 30 ARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 89
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI-HRDIKAGNILLGEDGTVQI 198
+K K G E + + VL+GL Y +I HRD+K NIL+ G +++
Sbjct: 90 LK--------KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKL 141
Query: 199 ADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258
DFGVS L + ++FVGT +M+PE ++ H Y ++DIWSLG++ +EMA
Sbjct: 142 CDFGVSGQLI-------DSMANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAI 193
Query: 259 GTAP------------------------------YH---KYPAMKVLML---TLQNDPPT 282
G P H M + L + PP
Sbjct: 194 GRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPK 253
Query: 283 LDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330
L +GA + F+ + CL+K+P +R EL K+PF K+A
Sbjct: 254 LPSGAFSDE--------FQDFVDKCLKKNPKERADLKELTKHPFIKRA 293
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 76/310 (24%), Positives = 125/310 (40%), Gaps = 62/310 (20%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
D +E + +G G+ V K + A+K K I K+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALK--------------ILSKAKIVKLKQV- 45
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE--LWLVLRLLEGGSLLDIIKHRLKI 146
+ +L E + + S H +V + SF +D+ L+LV+ + GG L ++
Sbjct: 46 -----EHVLNEKRILQSIRHPFLVNLYGSF--QDDSNLYLVMEYVPGGELFSHLR----- 93
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
K G EP +V+ LEY HS ++RD+K N+LL DG ++I DFG +
Sbjct: 94 ---KSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR 150
Query: 207 LATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266
+ +T GTP ++APE++ GY D W+LGI EM G P+
Sbjct: 151 VKGR--------TYTLCGTPEYLAPEII-LSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201
Query: 267 PAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTA 318
+++ L+ P + +I + LQ D TKR
Sbjct: 202 NPIQIYEKILEGKVRFPSFFS-------------PDAKDLIRNLLQVDLTKRLGNLKNGV 248
Query: 319 SELLKNPFFK 328
+++ +P+F
Sbjct: 249 NDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 45/300 (15%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+YE+ + IG G+ ++ A K+ +E C IK+I+L K +K+ K
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDL------------TKMPVKEKEASK- 47
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
KE+ ++ H N+VT+ SF L++V+ +GG L+ I N
Sbjct: 48 --------KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRI-------NR 92
Query: 150 KHGVC-DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV-QIADFGVSAWL 207
+ GV E I + ++ GL++ H +HRDIK+ NI L ++G V ++ DFG++ L
Sbjct: 93 QRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267
+L+ T VGTP +++PE+ Q+ Y+ K DIWSLG E+ T P+
Sbjct: 153 NDSMELAY-----TCVGTPYYLSPEIC-QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
++++ Q + + + R +IS + P RP+ + +LK PF
Sbjct: 207 LHQLVLKICQGYFAPISPN---------FSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 68/237 (28%), Positives = 111/237 (46%), Gaps = 32/237 (13%)
Query: 98 KEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEP 157
KEI + C+H +V + +F K +++++ GG L I++ G+ DE
Sbjct: 44 KEI--LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILR--------DRGLFDEY 93
Query: 158 TIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK 217
T + V+ EY H+ G I+RD+K N+LL +G V++ DFG + L +
Sbjct: 94 TARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFG------FAKKLKSGQ 147
Query: 218 VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH--KYPAMKVLMLT 275
TF GTP ++APE++ GYDF D WSLGI E+ TG P+ M++
Sbjct: 148 KTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206
Query: 276 LQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLKNPFF 327
L+ G E Y K + +I L+++P +R ++ K+ +F
Sbjct: 207 LKG------NGKLEFPNY--IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 83/323 (25%), Positives = 136/323 (42%), Gaps = 59/323 (18%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++YEV V+G GA VV KA E AIKK K + +KK
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF----------KESEDDEDVKKT---- 46
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
L+E++ + HEN+V +F K L+LV +E +LL++++
Sbjct: 47 -------ALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEAS----- 93
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
G+ + + + ++L+ + Y HS+ IHRDIK NIL+ E G +++ DFG +
Sbjct: 94 -PGGL-PPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFA---- 147
Query: 209 TGRDLSRQKVRH--TFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY--- 263
R L + +V T + APE++ D Y D+W++G E+ G +
Sbjct: 148 --RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205
Query: 264 ----HKYPAMKVL-------MLTLQNDP-------PTLDTGAAEKDQY-KAYGKTFRKMI 304
Y K L ++P P + + +Y +
Sbjct: 206 SDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFL 265
Query: 305 SDCLQKDPTKRPTASELLKNPFF 327
CL+ DP +R T ELL++P+F
Sbjct: 266 KACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 7e-30
Identities = 74/260 (28%), Positives = 121/260 (46%), Gaps = 31/260 (11%)
Query: 80 AIKKINLEKWNTS-----MDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGG 134
A+K++ + +S ++ L KEI+ M+ +H +++ + L + + GG
Sbjct: 29 AVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGG 88
Query: 135 SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194
S + H L K+G E I ++L+GL Y H N IHRD+K N+L+ G
Sbjct: 89 S----VSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG 140
Query: 195 T-VQIADFGVSAWLATGRDLSRQ-KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252
++IADFG +A LA + + + +GT +MAPEV+ + Y D+WS+G
Sbjct: 141 QRLRIADFGAAARLAA--KGTGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCV 197
Query: 253 AIEMATGTAPYHKYPAMKVLMLTLQ----NDPPTLDTGAAEKDQYKAYGKTFRKMISDCL 308
IEMAT P++ L L + P++ + R + CL
Sbjct: 198 IIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP---------EHLSPGLRDVTLRCL 248
Query: 309 QKDPTKRPTASELLKNPFFK 328
+ P RP + ELLK+P F+
Sbjct: 249 ELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 8e-30
Identities = 80/260 (30%), Positives = 129/260 (49%), Gaps = 32/260 (12%)
Query: 73 KARAEKCAIKKINLEKW-NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLL 131
K ++ IK+IN+ K +E KE+ +S+ H N+V Y SF L++V+
Sbjct: 22 KEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81
Query: 132 EGGSLLDIIKHRLKISNCKHGVC-DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190
EGG L I N + GV E I ++ L++ H +HRDIK+ NI L
Sbjct: 82 EGGDLYKKI-------NAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL 134
Query: 191 GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG 250
+DGT+++ DFG++ L + +L+R T +GTP +++PE+ E + Y+ K+DIW+LG
Sbjct: 135 TKDGTIKLGDFGIARVLNSTVELAR-----TCIGTPYYLSPEICE-NRPYNNKSDIWALG 188
Query: 251 ITAIEMATGTAPYHKYPA--MKVLMLTLQND--PPTLDTGAAEKDQYKAYGKTFRKMISD 306
EM T H + A MK L+L + PP Y R ++S
Sbjct: 189 CVLYEMCTLK---HAFEAGNMKNLVLKIIRGSYPPV----------SSHYSYDLRNLVSQ 235
Query: 307 CLQKDPTKRPTASELLKNPF 326
+++P RP+ + +L+ F
Sbjct: 236 LFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 76/266 (28%), Positives = 117/266 (43%), Gaps = 34/266 (12%)
Query: 73 KARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLE 132
K A K KK ++ M K+I S +V+ +F KD+L LV+ L+
Sbjct: 19 KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSLAYAFETKDDLCLVMTLMN 76
Query: 133 GGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE 192
GG L + I N E +++ GLE+ H ++RD+K N+LL +
Sbjct: 77 GGDL------KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD 130
Query: 193 DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252
G V+I+D G++ +L K GTP +MAPEV+ Q YDF D ++LG T
Sbjct: 131 HGNVRISDLGLAV------ELKGGKKIKGRAGTPGYMAPEVL-QGEVYDFSVDWFALGCT 183
Query: 253 AIEMATGTAPYHKYPAMK----VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCL 308
EM G +P+ + + TL+ A + K + + + L
Sbjct: 184 LYEMIAGRSPFRQRKEKVEKEELKRRTLEM---------AVEYPDK-FSPEAKDLCEALL 233
Query: 309 QKDPTKR-----PTASELLKNPFFKK 329
QKDP KR +A E+ ++P FK
Sbjct: 234 QKDPEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 78/231 (33%), Positives = 116/231 (50%), Gaps = 24/231 (10%)
Query: 99 EIQAMSSCHHENVVTYHTSFVVKDE--LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDE 156
EIQ + + HE +V Y+ E L + + + GGS+ D +K +G E
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--------SYGALTE 105
Query: 157 PTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQ 216
R++L+G+ Y HSN +HRDIK NIL G V++ DFG S L T LS
Sbjct: 106 NVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT-ICLSGT 164
Query: 217 KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM-KVLMLT 275
++ + GTP WM+PEV+ + GY KADIWS+G T +EM T P+ ++ AM + +
Sbjct: 165 GMK-SVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 222
Query: 276 LQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
Q P L ++ + + F K I + RP+A ELL++ F
Sbjct: 223 TQPTNPVLPPHVSD------HCRDFLKRIF----VEAKLRPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 88/320 (27%), Positives = 140/320 (43%), Gaps = 55/320 (17%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++YE ++G G+ +V K + AIKK + +KKI
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKF----------LESEDDKMVKKI---- 46
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
++EI+ + HEN+V F K L+LV ++ ++LD +
Sbjct: 47 -------AMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH-TVLD------DLEK 92
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
+G+ DE + L ++L+G+E+ HS+ IHRDIK NIL+ + G V++ DFG + LA
Sbjct: 93 YPNGL-DESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 151
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA--P---- 262
+V +V T + APE++ D Y DIW++G EM TG P
Sbjct: 152 AP-----GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD 206
Query: 263 ----YHKYPAMKVLMLTLQN----DPPTLDTGAAEKDQYKAYGKTFRK-------MISDC 307
YH + L+ Q +P E + + K F K + C
Sbjct: 207 IDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQC 266
Query: 308 LQKDPTKRPTASELLKNPFF 327
L+ DP RP++S+LL + FF
Sbjct: 267 LRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 6e-28
Identities = 76/231 (32%), Positives = 117/231 (50%), Gaps = 24/231 (10%)
Query: 99 EIQAMSSCHHENVVTYHTSFVVKDE--LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDE 156
EIQ + + H+ +V Y+ +E L + + + GGS+ D +K +G E
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK--------AYGALTE 105
Query: 157 PTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQ 216
R++L+G+ Y HSN +HRDIK NIL G V++ DFG S + T +S
Sbjct: 106 NVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT-ICMSGT 164
Query: 217 KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM-KVLMLT 275
++ + GTP WM+PEV+ + GY KAD+WS+ T +EM T P+ +Y AM + +
Sbjct: 165 GIK-SVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA 222
Query: 276 LQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
Q P L G ++ + F K I + +RPTA LL++PF
Sbjct: 223 TQPTKPMLPDGVSDA------CRDFLKQIF----VEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 80/294 (27%), Positives = 122/294 (41%), Gaps = 51/294 (17%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDEL----LKEIQAMSSCHHENVVTYHTSFVV 120
AVV+ A K AIKKI L + + D + L+EI+ + H N++ F
Sbjct: 14 AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH 73
Query: 121 KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180
K + LV +E L +IK K V I + + L+GLEY HSN +H
Sbjct: 74 KSNINLVFEFMET-DLEKVIKD-------KSIVLTPADIKSYMLMTLRGLEYLHSNWILH 125
Query: 181 RDIKAGNILLGEDGTVQIADFGVSAWLAT-----GRDLSRQKVRHTFVGTPCWMAPEVME 235
RD+K N+L+ DG +++ADFG LA R ++ Q V T + APE++
Sbjct: 126 RDLKPNNLLIASDGVLKLADFG----LARSFGSPNRKMTHQ------VVTRWYRAPELLF 175
Query: 236 QDHGYDFKADIWSLG---------------------ITAIEMATGTAPYHKYPAMKVLML 274
Y D+WS+G + I A GT +P + L
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235
Query: 275 TLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328
++ P K + A ++ L +P KR TA + L++P+F
Sbjct: 236 YVEFKP---FPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 88/340 (25%), Positives = 135/340 (39%), Gaps = 74/340 (21%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
+Y+ E IG GA VV SA +K AIKKI A
Sbjct: 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI---------PHAFDVP--------- 45
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL----WLVLRLLEGGSLLDIIKHR 143
T L+E++ + H+N++ ++V+ L+E L II
Sbjct: 46 ---TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIH-- 99
Query: 144 LKISNCKHGVCDEPT----IATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
D+P I L ++L+GL+Y HS IHRD+K N+L+ ED ++I
Sbjct: 100 ----------SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIG 149
Query: 200 DFGVSAWLATGRDLSRQKVRHTF-----VGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254
DFG++ R LS H + V T + APE++ Y D+WS+G
Sbjct: 150 DFGMA------RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFA 203
Query: 255 EMATGTA--PYHKYPAMKVLMLTLQNDPPT--LDTGAAEK----------DQYKAYGKTF 300
EM P Y L+L++ P L+ +++ Q + K F
Sbjct: 204 EMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIF 263
Query: 301 RK-------MISDCLQKDPTKRPTASELLKNPFFKKAKDK 333
K ++S LQ DP +R T + L++PF + D
Sbjct: 264 PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 71/255 (27%), Positives = 104/255 (40%), Gaps = 27/255 (10%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
+KK ++ N + + M V + SF KD L+LV+ L GG +
Sbjct: 28 VLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASL 87
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
IK G E + EV+ G+E H G IHRDIK N+L+ + G +++
Sbjct: 88 IK--------TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLT 139
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259
DFG+S + FVGTP ++APE + G D +D WSLG E G
Sbjct: 140 DFGLSRNGLENKK---------FVGTPDYLAPETIL-GVGDDKMSDWWSLGCVIFEFLFG 189
Query: 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319
P+H V L ++ + +I+ L DP KR A+
Sbjct: 190 YPPFHAETPDAVFDNILSRRI------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN 243
Query: 320 ---ELLKNPFFKKAK 331
E+ +PFFK
Sbjct: 244 GYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 81/327 (24%), Positives = 138/327 (42%), Gaps = 71/327 (21%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+Y++ IG GA +V A + E A+KK+ L LE
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALR-------------------RLEGG 41
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK-ISN 148
++ L+EI+A+ +C H VV F LV+ + L ++++ + +
Sbjct: 42 IP--NQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLP- 97
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
E + + +R +LKG+ Y H+NG +HRD+K N+L+ DG ++IADFG++ +
Sbjct: 98 -------EAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFS 150
Query: 209 TG--RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266
R S Q V T + APE++ YD D+W++G E+ G +P +
Sbjct: 151 EEEPRLYSHQ------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG-SPL--F 201
Query: 267 PA----------MKVLMLTLQNDPPTLDTGAAEKDQYKAY-----GKTFRKMISDC---- 307
P + L + P L + D K ++ D
Sbjct: 202 PGENDIEQLAIVFRTLGTPNEETWPGL---TSLPDYNKITFPESKPIPLEEIFPDASPEA 258
Query: 308 ---LQK----DPTKRPTASELLKNPFF 327
L+ DP+KR +A+E L++P+F
Sbjct: 259 LDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 68/259 (26%), Positives = 113/259 (43%), Gaps = 53/259 (20%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
D +EV +VIG GA V K + A+K + + + ++ I + E+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI--------KRNQIAHVRAER 52
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
++ +V + SF ++ L+LV+ + GG L++++
Sbjct: 53 ------------DILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL-------- 92
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSA--- 205
+ V E T + E++ L+ H G IHRDIK NIL+ DG +++ADFG+
Sbjct: 93 IRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152
Query: 206 --------------------WLATGRDLSRQKVR-HTFVGTPCWMAPEVMEQDHGYDFKA 244
L RD +++VR ++ VGTP ++APEV+ Y +
Sbjct: 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLEC 211
Query: 245 DIWSLGITAIEMATGTAPY 263
D WSLG+ EM G P+
Sbjct: 212 DWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 54/294 (18%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWN-----TSMDELLKEIQAMSSCHHENVVTYH---TSF 118
V+ A K E A+KKI +E T++ +EI+ + H N+V TS
Sbjct: 15 VYKARNKKTGELVALKKIRMENEKEGFPITAI----REIKLLQKLRHPNIVRLKEIVTSK 70
Query: 119 VVKDELWLVLRLLEG--GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176
K +++V ++ LLD + + S K ++++L+GL+Y HSN
Sbjct: 71 G-KGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC----------YMKQLLEGLQYLHSN 119
Query: 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTF-VGTPCWMAPEVME 235
G +HRDIK NIL+ DG +++ADFG++ R +T V T + PE++
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYT-----KRNSADYTNRVITLWYRPPELLL 174
Query: 236 QDHGYDFKADIWSLGITAIEMATGTAPYH---------------------KYPAMKVLML 274
Y + D+WS+G E+ G + +P + +
Sbjct: 175 GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS-KLP 233
Query: 275 TLQNDPPTLDTGAAEKDQYKAY-GKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
+N P ++ +K + ++ L DP KR +A + L++ +F
Sbjct: 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 81/293 (27%), Positives = 132/293 (45%), Gaps = 43/293 (14%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEK-CAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
Y V E +G GA V+ K + A+K+IN V + A+ K + E+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEIN--VHNPAFGKDKRER----------- 48
Query: 90 NTSMDELLKEIQAM-SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+ S+ +++ E+ + H N+V Y+ +F+ D L++V+ L+EG L + + LK
Sbjct: 49 DKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF-NSLKE-- 105
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQI-HRDIKAGNILLGEDGTVQIADFGVSAWL 207
K E I + +++ L Y H +I HRD+ NI+LGED V I DFG
Sbjct: 106 -KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG----- 159
Query: 208 ATGRDLSRQKVRHTF----VGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263
L++QK + VGT + PE++ ++ Y KAD+W+ G +M T P+
Sbjct: 160 -----LAKQKQPESKLTSVVGTILYSCPEIV-KNEPYGEKADVWAFGCILYQMCTLQPPF 213
Query: 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
+ ML+L + E Y + +I+ CL D RP
Sbjct: 214 YSTN-----MLSLATK---IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-26
Identities = 69/246 (28%), Positives = 122/246 (49%), Gaps = 21/246 (8%)
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSL 136
+K A+K+I L K ++++++ KE ++ H N+V + SF L++V+ +GG L
Sbjct: 26 QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL 85
Query: 137 LDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196
+ IK + + + E TI ++ G+++ H +HRDIK+ NI L ++G V
Sbjct: 86 MQKIKLQ------RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKV 139
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256
++ DFG + L S T+VGTP ++ PE+ E + Y+ K+DIWSLG E+
Sbjct: 140 KLGDFGSARLLT-----SPGAYACTYVGTPYYVPPEIWE-NMPYNNKSDIWSLGCILYEL 193
Query: 257 ATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
T P+ +++ Q L + Y R +I +++P RP
Sbjct: 194 CTLKHPFQANSWKNLILKVCQGSYKPLPS---------HYSYELRSLIKQMFKRNPRSRP 244
Query: 317 TASELL 322
+A+ +L
Sbjct: 245 SATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 80/322 (24%), Positives = 136/322 (42%), Gaps = 71/322 (22%)
Query: 57 CAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHT 116
+ N VV K A K I+LE +++++E+Q + C+ +V ++
Sbjct: 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 117 SFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176
+F E+ + + ++GGSL ++K +I E + V VL+GL Y
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIP--------EEILGKVSIAVLRGLAYLREK 122
Query: 177 GQI-HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME 235
QI HRD+K NIL+ G +++ DFGVS L + ++FVGT +M+PE ++
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVGTRSYMSPERLQ 175
Query: 236 QDHGYDFKADIWSLGITAIEMATGTAP--------------------------------- 262
H Y ++DIWS+G++ +E+A G P
Sbjct: 176 GTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234
Query: 263 ----------YHKYPAMKVLML---TLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQ 309
PAM + L + PP L G D F++ ++ CL
Sbjct: 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPD--------FQEFVNKCLI 286
Query: 310 KDPTKRPTASELLKNPFFKKAK 331
K+P +R L+ + F K+++
Sbjct: 287 KNPAERADLKMLMNHTFIKRSE 308
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 76/290 (26%), Positives = 134/290 (46%), Gaps = 55/290 (18%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
A K I+LE +++++E+Q + C+ +V ++ +F E+ + + ++GGSL +
Sbjct: 34 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 93
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI-HRDIKAGNILLGEDGTVQI 198
+K K G E + V V+KGL Y +I HRD+K NIL+ G +++
Sbjct: 94 LK--------KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKL 145
Query: 199 ADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258
DFGVS L + ++FVGT +M+PE ++ H Y ++DIWS+G++ +EMA
Sbjct: 146 CDFGVSGQLI-------DSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAI 197
Query: 259 GTAPYHKYPAMKVLML----TLQNDPPTLDTGAAEKDQYK-------------------- 294
G P P K L L ++ DP +T + +
Sbjct: 198 GRYPIPP-PDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLD 256
Query: 295 -------------AYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331
+G F+ ++ CL K+P +R +L+ + F K+++
Sbjct: 257 YIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 71/240 (29%), Positives = 111/240 (46%), Gaps = 37/240 (15%)
Query: 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPT 158
E+ +++C H +V + F D+L L++ GG L IK RLK +H E
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK----EHLPFQEYE 170
Query: 159 IATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKV 218
+ + +++ L+ HS +HRD+K+ NI L G +++ DFG S + L V
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD---V 227
Query: 219 RHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQN 278
+F GTP ++APE+ E+ Y KAD+WSLG+ E+ T P+ K P+ + +M
Sbjct: 228 ASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPF-KGPSQREIM----- 280
Query: 279 DPPTLDTGAAEKDQYKAYGK----------TFRKMISDCLQKDPTKRPTASELLKNPFFK 328
Q YGK + ++ L K+P RPT +LL F K
Sbjct: 281 -------------QQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 55/198 (27%), Positives = 80/198 (40%), Gaps = 26/198 (13%)
Query: 134 GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
SL DI++ R + N E I V + L L H K+GNILL D
Sbjct: 1 VSLADILEVRGRPLN-------EEEIWAVCLQCLGALRELHRQA------KSGNILLTWD 47
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
G + G A + SR P +MAPEV+ Q Y KADI+SLGIT
Sbjct: 48 GLL--KLDGSVA--FKTPEQSRP--------DPYFMAPEVI-QGQSYTEKADIYSLGITL 94
Query: 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
E PY++ + ++ L N P D + + ++F + C + P
Sbjct: 95 YEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQ 154
Query: 314 KRPTASELLKNPFFKKAK 331
+R A+ L + A+
Sbjct: 155 RREAANHYLAHCRALFAE 172
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 67/239 (28%), Positives = 104/239 (43%), Gaps = 35/239 (14%)
Query: 97 LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDE 156
L E + + + H + SF D L V+ GG L +S V E
Sbjct: 43 LTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF------FHLSRE--RVFSE 94
Query: 157 PTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQ 216
E++ L Y HS ++RD+K N++L +DG ++I DFG+ +S
Sbjct: 95 DRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGISDG 149
Query: 217 KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTL 276
TF GTP ++APEV+E D+ Y D W LG+ EM G P++ K+ L L
Sbjct: 150 ATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
Query: 277 QND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLKNPFF 327
+ P TL A + +++ L+KDP +R A E++++ FF
Sbjct: 209 MEEIRFPRTLSPEA-------------KSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 70/227 (30%), Positives = 106/227 (46%), Gaps = 30/227 (13%)
Query: 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170
+VT H +F +L L+L + GG L + R E + + E++ L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHF--------TESEVRVYIAEIVLAL 118
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMA 230
++ H G I+RDIK NILL +G V + DFG+S + R ++F GT +MA
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERA---YSFCGTIEYMA 174
Query: 231 PEVMEQ-DHGYDFKADIWSLGITAIEMATGTAPY----HKYPAMKVLMLTLQNDPPTLDT 285
PEV+ G+D D WSLG+ E+ TG +P+ + ++ L++ PP T
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT 234
Query: 286 GAAEKDQYKAYGKTFRKMISDCLQKDPTKR---PTASELLKNPFFKK 329
+AE R I L+KDP KR A E+ +PFF+
Sbjct: 235 MSAEA----------RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 78/284 (27%), Positives = 134/284 (47%), Gaps = 33/284 (11%)
Query: 48 AYCKARA-EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDE---LLKEIQAM 103
AYC R K + +++L V H + ++ IKK+NL N S E +E Q +
Sbjct: 1 AYCFVRVVGKGSYGEVSL-VRH----RTDGKQYVIKKLNLR--NASRRERKAAEQEAQLL 53
Query: 104 SSCHHENVVTYHTSFVVKD-ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATV 162
S H N+V Y S+ +D L++V+ EGG L H+LK K + E +
Sbjct: 54 SQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLY----HKLK--EQKGKLLPENQVVEW 107
Query: 163 LREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTF 222
++ L+Y H +HRD+K N+ L +++ D G++ L D++ T
Sbjct: 108 FVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS-----TL 162
Query: 223 VGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPT 282
+GTP +M+PE+ + Y++K+D+W+LG EMAT ++ ++ ++ P
Sbjct: 163 IGTPYYMSPELF-SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP 221
Query: 283 LDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
+ K Y ++I+ L K P KRP+ +L+ P+
Sbjct: 222 MP---------KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 78/302 (25%), Positives = 139/302 (46%), Gaps = 42/302 (13%)
Query: 76 AEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGS 135
A K K + LE + + + + A++ H + +F K+ L+ V+ L GG
Sbjct: 24 AIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHLFCTFQTKEHLFFVMEYLNGGD 82
Query: 136 LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195
L+ I+ + DE E++ GL++ H G I+RD+K N+LL +DG
Sbjct: 83 LMFHIQSSGRF--------DEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH 134
Query: 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255
++IADFG+ +++ + TF GTP ++APE++ + Y+ D WS G+ E
Sbjct: 135 IKIADFGMCK-----ENMNGEGKASTFCGTPDYIAPEIL-KGQKYNESVDWWSFGVLLYE 188
Query: 256 MATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCL----QKD 311
M G +P+H + L ++ ND P + + K DCL ++D
Sbjct: 189 MLIGQSPFHGEDEDE-LFDSILNDRPH-------------FPRWISKEAKDCLSKLFERD 234
Query: 312 PTKR-PTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVT 370
PTKR ++ ++PFF+ ++ ++ + P F+ ++ K+P + R T
Sbjct: 235 PTKRLGVDGDIRQHPFFRGIDWERLEKR---EIPPPFKPKV-----KSPSDASNFDREFT 286
Query: 371 GE 372
E
Sbjct: 287 NE 288
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 23/263 (8%)
Query: 73 KARAEKCAIKKINLE--KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRL 130
+A + A KK+N + K + + E + ++ H +V+ +F K +L LV+ +
Sbjct: 15 RATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTI 74
Query: 131 LEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190
+ GG D+ H + G EP +++ GLE+ H I+RD+K N+LL
Sbjct: 75 MNGG---DLRYHIYNVDEENPGF-PEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL 130
Query: 191 GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG 250
DG V+I+D G++ L G+ ++ + GTP +MAPE++ Q YDF D ++LG
Sbjct: 131 DNDGNVRISDLGLAVELKDGQSKTK-----GYAGTPGFMAPELL-QGEEYDFSVDYFALG 184
Query: 251 ITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQK 310
+T EM P+ + KV L+ L+ D++ K+F + + L K
Sbjct: 185 VTLYEMIAARGPF-RARGEKVENKELKQR--ILNDSVTYPDKFSPASKSFCEAL---LAK 238
Query: 311 DPTKR-----PTASELLKNPFFK 328
DP KR L +P F+
Sbjct: 239 DPEKRLGFRDGNCDGLRTHPLFR 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 88/331 (26%), Positives = 138/331 (41%), Gaps = 68/331 (20%)
Query: 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKIN 85
+ +Y+ IG GA +V SA K K AIKKI+ H +C+ R
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQ-RT--------- 50
Query: 86 LEKWNTSMDELLKEIQAMSSCHHENVVTYH-----TSFVVKDELWLVLRLLEGGSLLDII 140
L+EI+ + HEN++ SF +++++V L+E D+
Sbjct: 51 -----------LREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME----TDL- 94
Query: 141 KHRL----KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196
++L +SN H I L ++L+GL+Y HS +HRD+K N+LL + +
Sbjct: 95 -YKLIKTQHLSN-DH-------IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDL 145
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256
+I DFG++ D + +V T + APE+M GY DIWS+G EM
Sbjct: 146 KICDFGLARIADPEHDHTGFLTE--YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
Query: 257 ATGTA--PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKT--FRKMIS------- 305
+ P Y L+L + P D + + Y K+ F+ +
Sbjct: 204 LSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPN 263
Query: 306 ------DCLQK----DPTKRPTASELLKNPF 326
D L K +P KR T E L +P+
Sbjct: 264 ADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 80/324 (24%), Positives = 133/324 (41%), Gaps = 63/324 (19%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++YE IG G+ VV + + AIKK V S + IKKI
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKF----VESE------DDPVIKKI---- 46
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
L+EI+ + H N+V F K +L LV + L ++ K+
Sbjct: 47 -------ALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN------ 93
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
GV E I ++ + L+ + + H + IHRD+K NIL+ + G +++ DFG +
Sbjct: 94 -PRGV-PEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFA---- 147
Query: 209 TGRDLSRQKVRHT-FVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267
R L+ +T +V T + APE++ D Y D+W++G E+ TG +
Sbjct: 148 --RILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205
Query: 268 AMKVLMLTLQN------------------------DPPTLDTGAAEKDQYKAYGKTFRKM 303
+ L L + +P T + + ++
Sbjct: 206 DVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREP---LESKFPNISSPALSF 262
Query: 304 ISDCLQKDPTKRPTASELLKNPFF 327
+ CLQ DPT+R + ELL++P+F
Sbjct: 263 LKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 79/302 (26%), Positives = 130/302 (43%), Gaps = 38/302 (12%)
Query: 97 LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDE 156
L E + + + H + + SF KD L V+ + GG L +S + V E
Sbjct: 43 LTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELF------FHLS--RERVFSE 94
Query: 157 PTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQ 216
E++ L+Y HS ++RD+K N++L +DG ++I DFG+ ++
Sbjct: 95 DRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCK-----EGITDA 149
Query: 217 KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTL 276
TF GTP ++APEV+E D+ Y D W LG+ EM G P++ K+ L L
Sbjct: 150 ATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
Query: 277 QND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLKNPFFK 328
D P TL A + ++S L KDP KR A E++++ FF
Sbjct: 209 MEDIKFPRTLSADA-------------KSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255
Query: 329 KAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVTGEWVWSSEDEGDKSSDDE 388
+ + LV P F+ ++ +T+T +++G D+E
Sbjct: 256 GVNWQDVYDKKLV---PPFKPQVTSETDTRYFDEEFTAQTITITPPEKYDEDGMDCMDNE 312
Query: 389 KK 390
++
Sbjct: 313 RR 314
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 5e-23
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH 174
+ +F K+ L+ V+ L GG L+ I+ + G D E++ GL++ H
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDK--------GRFDLYRATFYAAEIVCGLQFLH 113
Query: 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM 234
S G I+RD+K N++L DG ++IADFG+ G + + TF GTP ++APE++
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS-----TFCGTPDYIAPEIL 168
Query: 235 EQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYK 294
Q Y F D WS G+ EM G +P+H + L +++ D P Y
Sbjct: 169 -QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-LFESIRVDTP----------HYP 216
Query: 295 AY-GKTFRKMISDCLQKDPTKRPTASELLK-NPFFK 328
+ K + ++ ++DPT+R ++ +PFFK
Sbjct: 217 RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-23
Identities = 71/230 (30%), Positives = 110/230 (47%), Gaps = 34/230 (14%)
Query: 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170
+VT H +F +L L+L + GG L + R + E + E++ L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK--------EQEVQIYSGEIVLAL 118
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMA 230
E+ H G I+RDIK NILL +G V + DFG+S + ++F GT +MA
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE----DEVERAYSFCGTIEYMA 174
Query: 231 PEVME-QDHGYDFKADIWSLGITAIEMATGTAPY----HKYPAMKVLMLTLQNDPP-TLD 284
P+++ D G+D D WS+G+ E+ TG +P+ K ++ L+++PP +
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 234
Query: 285 TGAAEKDQYKAYGKTFRKMISDCLQKDPTKR----PT-ASELLKNPFFKK 329
A KD +I L KDP KR P+ A E+ K+PFF+K
Sbjct: 235 MSALAKD-----------IIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 8e-23
Identities = 67/242 (27%), Positives = 108/242 (44%), Gaps = 38/242 (15%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++V+ ++G G V KA + A+K + K + L +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMK------------------KSVLLAQ 42
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
S E ++I ++S+ + +F KD L+LV+ GG LL ++ N
Sbjct: 43 ETVSFFEEERDILSISN--SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-------N 93
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
DE L E++ + H G +HRDIK N+L+ G +++ADFG +A L
Sbjct: 94 RYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153
Query: 209 TGRDLSRQKVRHTF-VGTPCWMAPEVMEQDHG-----YDFKADIWSLGITAIEMATGTAP 262
+ + V VGTP ++APEV+ +G Y + D WSLG+ A EM G +P
Sbjct: 154 -----ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
Query: 263 YH 264
+H
Sbjct: 209 FH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 55/158 (34%), Positives = 85/158 (53%), Gaps = 14/158 (8%)
Query: 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREV 166
+H +V H +F + +L+L+L L GG L RL K + E + L E+
Sbjct: 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT----RLS----KEVMFTEEDVKFYLAEL 107
Query: 167 LKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTP 226
L++ HS G I+RD+K NILL E+G +++ DFG+S + +K ++F GT
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHEKKAYSFCGTV 162
Query: 227 CWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264
+MAPEV+ + G+ AD WS G+ EM TG+ P+
Sbjct: 163 EYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 67/239 (28%), Positives = 110/239 (46%), Gaps = 36/239 (15%)
Query: 98 KEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEP 157
K + A++ H + H+ F KD L+ V+ + GG L+ I+ + G DEP
Sbjct: 46 KRVLALAG-KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ--------RSGRFDEP 96
Query: 158 TIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK 217
E++ GL++ H G I+RD+K N+LL +G ++IADFG+ G +
Sbjct: 97 RARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS-- 154
Query: 218 VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQ 277
TF GTP ++APE++ Y D W+LG+ EM G +P+ ++ L+
Sbjct: 155 ---TFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
Query: 278 ND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR----PTA-SELLKNPFFK 328
++ P L A ++ L K+P KR PT ++ +PFF+
Sbjct: 211 DEVRYPRWLSKEAK-------------SILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 87/308 (28%), Positives = 137/308 (44%), Gaps = 40/308 (12%)
Query: 39 FGATAVVHSAYCKARAEKCAIKKI-NLAVVHSAYCKARA---EKCAIKKINLEKWNTS-M 93
F T A K +A+K I ++ + C R E A+K +++E + +
Sbjct: 16 FPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADK 75
Query: 94 DELLKEIQAMSSCHHENVVTYHTSFVVKDE--------LWLVLRLLEGGSLLDIIKHRLK 145
+ E+ + +C ++V H F KD + LVL G L IK R K
Sbjct: 76 NRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK 135
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSA 205
+ E + +VL + + HS IHRDIK+ NILL +G V++ DFG S
Sbjct: 136 TNR----TFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191
Query: 206 -WLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264
+ AT D V TF GTP ++APE+ + Y KAD++SLG+ E+ T P+
Sbjct: 192 MYAATVSD----DVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFD 246
Query: 265 KYPAMKVLMLTLQND----PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320
+V+ TL PP++ +++++ L DP +RP++S+
Sbjct: 247 GENMEEVMHKTLAGRYDPLPPSIS-------------PEMQEIVTALLSSDPKRRPSSSK 293
Query: 321 LLKNPFFK 328
LL P K
Sbjct: 294 LLNMPICK 301
|
Length = 496 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 73/269 (27%), Positives = 122/269 (45%), Gaps = 30/269 (11%)
Query: 71 YCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRL 130
Y + EK IKK E + ++L+++ + VV+ ++ KD L LVL L
Sbjct: 28 YACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF------VVSLAYAYETKDALCLVLTL 81
Query: 131 LEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190
+ GG L + I N + DE E+ GLE H ++RD+K NILL
Sbjct: 82 MNGGDL------KFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL 135
Query: 191 GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG 250
+ G ++I+D G++ + G + +R VGT +MAPEV++ + Y F D W LG
Sbjct: 136 DDYGHIRISDLGLAVEIPEG-----ETIRGR-VGTVGYMAPEVVKNER-YTFSPDWWGLG 188
Query: 251 ITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQK 310
EM G +P+ + K + + + + +++ ++ + + L K
Sbjct: 189 CLIYEMIEGKSPFRQR---KEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL---LTK 242
Query: 311 DPTKR-----PTASELLKNPFFKKAKDKK 334
DP R A E+ +PFF+ A K+
Sbjct: 243 DPGFRLGCRGEGAEEVKAHPFFRTANFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 3e-22
Identities = 72/267 (26%), Positives = 117/267 (43%), Gaps = 30/267 (11%)
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
+ + L E ++ + +V SF ++L+LVL + GG L H L+ +
Sbjct: 35 SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELF----HHLQ----R 86
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
G D E+L LE H I+RD+K NILL G + + DFG+
Sbjct: 87 EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL---- 142
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270
++ +TF GTP ++APE++ HGY D W+LG+ EM TG P++ +
Sbjct: 143 -NMKDDDKTNTFCGTPEYLAPELL-LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200
Query: 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR---PTASELLKNPFF 327
+ LQ +P G + ++ L +DPT+R A E+ +PFF
Sbjct: 201 MYRKILQ-EPLRFPDGFDRDA---------KDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
Query: 328 KKAKDKKFIQQTLVSVGPTFETRIQKA 354
+ KK + + + P F+ + A
Sbjct: 251 SQLSWKKLLMKGIQ---PPFKPAVSSA 274
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYH--TSFVVKDELWLVLRLLEGG 134
E+ A+K +N + +EI+ + + HEN+V Y L L++ L G
Sbjct: 34 EQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSG 93
Query: 135 SLLDII-KHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
SL D + +HR +I+ + ++ KG++Y S IHRD+ A NIL+ +
Sbjct: 94 SLRDYLQRHRDQINL--------KRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE 145
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYDFKADIWSLGIT 252
V+I+DFG++ L +D K P W APE + +D+WS G+T
Sbjct: 146 DLVKISDFGLAKVLPEDKDYYYVKEPGES---PIFWYAPECLRTSKFS-SASDVWSFGVT 201
Query: 253 AIEMATGTAPYHKYPAMKVLMLTLQNDPPTL 283
E+ T P PA + M+ + +
Sbjct: 202 LYELFTYGDPSQSPPAEFLRMIGIAQGQMIV 232
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 90/311 (28%), Positives = 131/311 (42%), Gaps = 47/311 (15%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
QY V GFG C+ RA Y R EK IKK E
Sbjct: 4 QYRVLGKGGFGEVCA-----CQVRA------------TGKMYACKRLEKKRIKKRKGE-- 44
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
SM L E Q + + + VV ++ KD L LVL ++ GG L + I N
Sbjct: 45 --SM--ALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDL------KFHIYNM 94
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
+ +E E+L GLE H ++RD+K NILL + G ++I+D G++ +
Sbjct: 95 GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269
G + R + VGT +MAPEV+ Y D W LG EM G +P+
Sbjct: 155 G-ESIRGR-----VGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFR---GR 204
Query: 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLKN 324
K + + D L+T ++ K+ KM+ L KDP +R A E+ ++
Sbjct: 205 KEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML---LTKDPKQRLGCQEEGAGEVKRH 261
Query: 325 PFFKKAKDKKF 335
PFF+ K+
Sbjct: 262 PFFRNMNFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 37/263 (14%)
Query: 98 KEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEP 157
K I A+++ H + H F KD L+ V+ + GG L+ I+ K DEP
Sbjct: 46 KRILALAA-KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKF--------DEP 96
Query: 158 TIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK 217
EV L + H +G I+RD+K NILL +G ++ADFG+ +
Sbjct: 97 RSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCK-----EGILNGV 151
Query: 218 VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQ 277
TF GTP ++APE++ Q+ Y D W+LG+ EM G P+
Sbjct: 152 TTTTFCGTPDYIAPEIL-QELEYGPSVDWWALGVLMYEMMAGQPPFEA-----------D 199
Query: 278 NDPPTLDTGAAEKDQYKAY-GKTFRKMISDCLQKDPTKR-------PTASELLKNPFFKK 329
N+ ++ + Y + K ++ + K+P KR + ++PFFK+
Sbjct: 200 NEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259
Query: 330 AKDKKFIQQTLVSVGPTFETRIQ 352
Q+ + P F+ +I+
Sbjct: 260 IDWVLLEQR---KIKPPFKPKIK 279
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 6e-22
Identities = 68/243 (27%), Positives = 105/243 (43%), Gaps = 19/243 (7%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
A+K + +K + MD+ LKE M S HEN++ + V+ L +V L GSLLD
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY-GVVLTHPLMMVTELAPLGSLLDR 85
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
++ +CD ++ G+ Y S IHRD+ A NILL D V+I
Sbjct: 86 LRKDALGHFLISTLCDYAV------QIANGMRYLESKRFIHRDLAARNILLASDDKVKIG 139
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT- 258
DFG+ L D + H V W APE + + +D+W G+T EM T
Sbjct: 140 DFGLMRALPQNEDHYVMEE-HLKVPFA-WCAPESLRT-RTFSHASDVWMFGVTLWEMFTY 196
Query: 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA 318
G P+ ++L +D ++ +A + ++ C +P RPT
Sbjct: 197 GEEPWAGLSGSQILK--------KIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTF 248
Query: 319 SEL 321
+ L
Sbjct: 249 AAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 7e-22
Identities = 77/267 (28%), Positives = 133/267 (49%), Gaps = 38/267 (14%)
Query: 73 KARAEKCAIKK-INLEKWNT-SMDE-LLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLR 129
K A KC KK I +++ T +++E ++ + + C ++Y +F D+L +L
Sbjct: 20 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY--AFHTPDKLSFILD 77
Query: 130 LLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189
L+ GG L + L +HGV E + E++ GLE+ H+ ++RD+K NIL
Sbjct: 78 LMNGGDL----HYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 129
Query: 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSL 249
L E G V+I+D G++ D S++K H VGT +MAPEV+++ YD AD +SL
Sbjct: 130 LDEHGHVRISDLGLAC------DFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSL 182
Query: 250 GITAIEMATGTAPYHKYPA---MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISD 306
G ++ G +P+ ++ ++ +TL D+ + E R ++
Sbjct: 183 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL----------RSLLEG 232
Query: 307 CLQKDPTKR-----PTASELLKNPFFK 328
LQ+D +R A E+ ++PFF+
Sbjct: 233 LLQRDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 9e-22
Identities = 65/258 (25%), Positives = 110/258 (42%), Gaps = 47/258 (18%)
Query: 96 LLKEIQAMSSCHHENVVTYHTSFVVKD-----ELWLVLRLLEGGSLLDIIKHRLKISNCK 150
LLK+++ S H N+V +L LV ++ D+ +S C
Sbjct: 51 LLKQLE---SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ----DL---ATYLSKCP 100
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
TI ++R++L+G+++ HS+ +HRD+K NIL+ DG V+IADFG++
Sbjct: 101 KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA------ 154
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA------------- 257
R S + + V T + APEV+ Q Y D+WS+G E+
Sbjct: 155 RIYSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEAD 213
Query: 258 --------TGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQ 309
G ++P + + L + P T + K + ++ L
Sbjct: 214 QLDKIFDVIGLPSEEEWP--RNVSLPRSSFPSY--TPRSFKSFVPEICEEGLDLLKKMLT 269
Query: 310 KDPTKRPTASELLKNPFF 327
+P KR +A E L++P+F
Sbjct: 270 FNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 59/233 (25%), Positives = 102/233 (43%), Gaps = 31/233 (13%)
Query: 92 SMD--ELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
+MD + L E Q M H ++ + +++ +++V L++ GSLL+ ++
Sbjct: 42 TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG------ 95
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
P + + +V G+ Y + IHRD+ A N+L+GE+ ++ADFG++ +
Sbjct: 96 AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPA 268
+R+ + W APE + + K+D+WS GI E+ T G PY
Sbjct: 156 DIYEAREGAKFPIK----WTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210
Query: 269 MKVLMLTLQN----DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT 317
+VL Q PP K ++ DC ++DP RPT
Sbjct: 211 AEVLQQVDQGYRMPCPPGCP-------------KELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 67/267 (25%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 64 LAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE 123
VVH + + AIK I + S D+ ++E + M H N+V + +
Sbjct: 17 FGVVHLGKWRGK-IDVAIKMIR--EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP 73
Query: 124 LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183
+++V + G LL+ ++ R + + + +V + +EY SNG IHRD+
Sbjct: 74 IFIVTEYMANGCLLNYLRERKGKLGTE-------WLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHG-YD 241
A N L+GED V+++DFG++ ++ L Q P W PEV D+ +
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYV-----LDDQYTSSQGTKFPVKWAPPEVF--DYSRFS 179
Query: 242 FKADIWSLGITAIEMAT-GTAPYHKYPAMKVL---MLTLQNDPPTLDTGAAEKDQYKAYG 297
K+D+WS G+ E+ + G PY ++ +V+ + P L A + Y
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL----APTEVY---- 231
Query: 298 KTFRKMISDCLQKDPTKRPTASELLKN 324
++ C + P RP +LL
Sbjct: 232 ----TIMYSCWHEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 72/228 (31%), Positives = 109/228 (47%), Gaps = 33/228 (14%)
Query: 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170
+VT H +F + +L L+L + GG + + R S E + E++ L
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS--------EDEVRFYSGEIILAL 118
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVR-HTFVGTPCWM 229
E+ H G ++RDIK NILL +G V + DFG+S LS +K R ++F GT +M
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-----LSEEKERTYSFCGTIEYM 173
Query: 230 APEVMEQDHGYDFKADIWSLGITAIEMATGTAPY----HKYPAMKVLMLTLQNDPPTLDT 285
APE++ G+ D WSLGI E+ TG +P+ + +V L+ DPP
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF 233
Query: 286 GAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLKNPFFK 328
G + ++ L+KDP KR ASE+ ++PFFK
Sbjct: 234 ----------IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 81/289 (28%), Positives = 142/289 (49%), Gaps = 43/289 (14%)
Query: 73 KARAEKCAIKK-INLEKWNT-SMDE-LLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLR 129
K A KC KK I +++ T +++E ++ + + C +TY +F D+L +L
Sbjct: 20 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTY--AFHTPDKLCFILD 77
Query: 130 LLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189
L+ GG L + L +HGV E + E++ GLE+ H+ ++RD+K NIL
Sbjct: 78 LMNGGDL----HYHLS----QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANIL 129
Query: 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSL 249
L E G V+I+D G++ D S++K H VGT +MAPEV+++ YD AD +SL
Sbjct: 130 LDEHGHVRISDLGLAC------DFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSL 182
Query: 250 GITAIEMATGTAPYHKYPA-----MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
G ++ G +P+ ++ + + LT+ + P D+ + E + ++
Sbjct: 183 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP--DSFSPE----------LKSLL 230
Query: 305 SDCLQKDPTKR-----PTASELLKNPFFKKAK-DKKFIQQTLVSVGPTF 347
LQ+D +KR A E+ ++ FFK + ++Q+ + P
Sbjct: 231 EGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIPPR 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 71/264 (26%), Positives = 122/264 (46%), Gaps = 35/264 (13%)
Query: 66 VVHSAYCKARAE-KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
VVH K RA+ K AIK IN + S ++ ++E + M H +V + + L
Sbjct: 19 VVHLG--KWRAQIKVAIKAIN--EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL 74
Query: 125 WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
++V +E G LL+ ++ R G + + ++ ++V +G+EY N IHRD+
Sbjct: 75 YIVTEFMENGCLLNYLRQR-------QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYDFK 243
A N L+ G V+++DFG++ ++ L + + P W PEV Y K
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYV-----LDDEYTSSSGAKFPVKWSPPEVFNFSK-YSSK 181
Query: 244 ADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKT 299
+D+WS G+ E+ T G P+ K +V+ + + P L + T
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLAS------------MT 229
Query: 300 FRKMISDCLQKDPTKRPTASELLK 323
+++ C + P RPT +ELL+
Sbjct: 230 VYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 66/255 (25%), Positives = 117/255 (45%), Gaps = 39/255 (15%)
Query: 75 RAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGG 134
R +K A+K + + +T+ L E M++ H N+V + + L++V + G
Sbjct: 28 RGQKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85
Query: 135 SLLDIIKHRLKISN---CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
SL+D ++ R + + G +V +G+EY +HRD+ A N+L+
Sbjct: 86 SLVDYLRSRGRAVITLAQQLGFA---------LDVCEGMEYLEEKNFVHRDLAARNVLVS 136
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251
ED +++DFG++ + G+D + V+ W APE + + + K+D+WS GI
Sbjct: 137 EDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKK-FSTKSDVWSFGI 187
Query: 252 TAIEM-ATGTAPYHKYPAMKVLMLTLQN---DPPTLDTGAAEKDQYKAYGKTFRKMISDC 307
E+ + G PY + P V+ + + P E + Y K++ DC
Sbjct: 188 LLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAP-------EGCPPEVY-----KVMKDC 235
Query: 308 LQKDPTKRPTASELL 322
+ DP KRPT +L
Sbjct: 236 WELDPAKRPTFKQLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 78/310 (25%), Positives = 124/310 (40%), Gaps = 56/310 (18%)
Query: 59 IKKI---NLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK------EIQAMSSCHHE 109
IK + ++ V K + A+K ++ + M + K E + +++ H
Sbjct: 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKK----EMIKRNKVKRVLTEQEILATLDHP 61
Query: 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKG 169
+ T + SF + L LV+ GG L +++ + E EVL
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQ------PGKCLSEEVARFYAAEVLLA 115
Query: 170 LEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT--------GRDLSRQKVRHT 221
LEY H G ++RD+K NILL E G + ++DF +S R SR+ ++
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 222 ----------------FVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265
FVGT ++APEV+ D G+ D W+LGI EM GT P+ K
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPF-K 233
Query: 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR----PTASEL 321
+ T + R +I L KDP+KR A+E+
Sbjct: 234 GSNRDETFSNILKKEVTF-------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286
Query: 322 LKNPFFKKAK 331
++PFF+
Sbjct: 287 KQHPFFRGVN 296
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 9e-21
Identities = 77/320 (24%), Positives = 123/320 (38%), Gaps = 66/320 (20%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
+E+ E +G G+ V A K E AIK C + E +K++
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIK-----------CLKKREILKMKQV------ 62
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
+ +E + H +V SF ++ ++ +L + GG L ++ + N
Sbjct: 63 ---QHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN-- 117
Query: 151 HGVCDEPTIATVLR-EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
+A E++ EY HS I+RD+K N+LL G V++ DFG +
Sbjct: 118 -------DVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA----- 165
Query: 210 GRDLSRQKVR---HTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266
+KV T GTP ++APEV+ Q G+ D W++G+ E G P+
Sbjct: 166 ------KKVPDRTFTLCGTPEYLAPEVI-QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218
Query: 267 PAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR----PTAS 319
++ L P D A R ++ LQ D TKR
Sbjct: 219 TPFRIYEKILAGRLKFPNWFDGRA-------------RDLVKGLLQTDHTKRLGTLKGGV 265
Query: 320 ELLKN-PFFKKAKDKKFIQQ 338
+KN P+F A K +
Sbjct: 266 ADVKNHPYFHGANWDKLYAR 285
|
Length = 329 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 78/304 (25%), Positives = 126/304 (41%), Gaps = 68/304 (22%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSMDEL----LKEIQAMSSCHHENVVTYHTSFVVK 121
+V+ A E A+KK+ ++ D + L+EI + + H N+V V K
Sbjct: 22 IVYRARDTTSGEIVALKKVRMDN---ERDGIPISSLREITLLLNLRHPNIVELKEVVVGK 78
Query: 122 --DELWLVLRLLEG--GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG 177
D ++LV+ E SLLD + E + ++ ++L+GL+Y H N
Sbjct: 79 HLDSIFLVMEYCEQDLASLLDNMPTPFS----------ESQVKCLMLQLLRGLQYLHENF 128
Query: 178 QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC----WM-APE 232
IHRD+K N+LL + G ++IADFG L+R TP W APE
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFG----------LARTYGLPAKPMTPKVVTLWYRAPE 178
Query: 233 VMEQDHGYDFKADIWSLG------------------ITAIEMAT---GTAPYHKYPAMKV 271
++ Y D+W++G I +++ GT +P
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238
Query: 272 LML----TLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
L L TL P L K ++ + ++++ L DP KR TA E L++ +
Sbjct: 239 LPLVGKFTLPKQPYNNL------KHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292
Query: 327 FKKA 330
FK+
Sbjct: 293 FKEK 296
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 70/263 (26%), Positives = 117/263 (44%), Gaps = 38/263 (14%)
Query: 97 LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDE 156
+ E + + + H + +F D L V+ GG L +S + V E
Sbjct: 43 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF------FHLS--RERVFTE 94
Query: 157 PTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQ 216
E++ LEY HS ++RDIK N++L +DG ++I DFG+ +S
Sbjct: 95 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDG 149
Query: 217 KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTL 276
TF GTP ++APEV+E D+ Y D W LG+ EM G P++ ++ L L
Sbjct: 150 ATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208
Query: 277 QND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLKNPFFK 328
+ P TL A + +++ L+KDP +R A E++++ FF
Sbjct: 209 MEEIRFPRTLSPEA-------------KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255
Query: 329 KAKDKKFIQQTLVSVGPTFETRI 351
+ +Q+ L+ P F+ ++
Sbjct: 256 SINWQDVVQKKLL---PPFKPQV 275
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 85/355 (23%), Positives = 130/355 (36%), Gaps = 111/355 (31%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
YE+ +G G V+ A A+KKI ++H+ K A+++I
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKI---LMHNE--KDGFPITALREI------ 58
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
++LK+++ H NVV L+D+ R S K
Sbjct: 59 ----KILKKLK------HPNVV----------------------PLIDMAVERPDKSKRK 86
Query: 151 HGVC----------------------DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188
G E I + ++L+G+ Y H N +HRDIKA NI
Sbjct: 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANI 146
Query: 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVG-----TPC----WM-APEVMEQDH 238
L+ G ++IADFG LA D + G T W PE++ +
Sbjct: 147 LIDNQGILKIADFG----LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER 202
Query: 239 GYDFKADIWSLGITAIEMAT---------------------GTAPYHKYPAMKVL----- 272
Y DIW +G EM T GT +P + L
Sbjct: 203 RYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEG 262
Query: 273 MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
+ + N P TL ++++ G ++S L DP KR TAS+ L++P+F
Sbjct: 263 VHSFTNYPRTL------EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 91/336 (27%), Positives = 150/336 (44%), Gaps = 76/336 (22%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAI--KKINL 86
D+Y+ +G GA V SA+ K AIKK+ +R + AI K+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL-----------SRPFQSAIHAKRTYR 63
Query: 87 EKWNTSMDELLKEIQAMSSCHHENVV----TYHTSFVVKD--ELWLVLRLLEGGSLLDII 140
E L+ ++ M HENV+ + + ++D +++LV L+ G L +I+
Sbjct: 64 E---------LRLLKHM---DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV 110
Query: 141 KHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIAD 200
K + K+S D+ I ++ ++L+GL+Y HS G IHRD+K NI + ED ++I D
Sbjct: 111 KCQ-KLS-------DD-HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD 161
Query: 201 FGVSAWLATGRDLSRQKVRH--TFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258
FG L+R +V T + APE+M Y+ DIWS+G E+ T
Sbjct: 162 FG----------LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
Query: 259 GTA--PYHKYPAMKVLMLTLQNDPPT-----LDTGAAEKDQYKAYGKTFRKMIS------ 305
G P + ++ L P + + +A ++ ++ + +K
Sbjct: 212 GKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA-RNYIQSLPQMPKKDFKEVFSGA 270
Query: 306 -----DCLQK----DPTKRPTASELLKNPFFKKAKD 332
D L+K DP KR TA+E L +P+ + D
Sbjct: 271 NPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 69/228 (30%), Positives = 102/228 (44%), Gaps = 33/228 (14%)
Query: 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVL 167
H +V +F +L+L+L L GG L ++ + G+ E T L E+
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE--------REGIFMEDTACFYLSEIS 110
Query: 168 KGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC 227
LE+ H G I+RD+K NILL G V++ DFG+ + V HTF GT
Sbjct: 111 LALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK-----ESIHEGTVTHTFCGTIE 165
Query: 228 WMAPE-VMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTG 286
+MAPE +M HG D WSLG +M TG P+ T +N T+D
Sbjct: 166 YMAPEILMRSGHGKA--VDWWSLGALMYDMLTGAPPF-----------TAENRKKTIDKI 212
Query: 287 AAEKDQYKAY-GKTFRKMISDCLQKDPTKR-----PTASELLKNPFFK 328
K Y R ++ L+++P+ R A+E+ +PFF+
Sbjct: 213 LKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 54/230 (23%)
Query: 117 SFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176
SF +L+LV + GG L ++ + S E + E++ LE+ H
Sbjct: 64 SFQTDSDLYLVTDYMSGGELFWHLQKEGRFS--------EDRAKFYIAELVLALEHLHKY 115
Query: 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ 236
++RD+K NILL G + + DFG+S +L+ K +TF GT ++APEV+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK-----ANLTDNKTTNTFCGTTEYLAPEVLLD 170
Query: 237 DHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQ--YK 294
+ GY D WSLG+ EM G +P++ AE Q Y+
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFY-----------------------AEDTQQMYR 207
Query: 295 --AYGKTF----------RKMISDCLQKDPTKR----PTASELLKNPFFK 328
A+GK R+ + L ++P R A EL ++PFF
Sbjct: 208 NIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 73/288 (25%)
Query: 80 AIKKINLEKWNTSMDEL--LKEIQAMSSC-HHENVVTYHTSFVVKDE----LWLVLRLLE 132
AIK ++K S++++ L+EIQA+ H N++ V+ D L LV L++
Sbjct: 28 AIKC--MKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE--VLFDRKTGRLALVFELMD 83
Query: 133 GGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE 192
+L ++IK R K + E + + + ++LK L++ H NG HRDIK NIL+ +
Sbjct: 84 M-NLYELIKGR------KRPL-PEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI-K 134
Query: 193 DGTVQIADFGVSAWLATGRDLSRQKVRHT-FVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251
D +++ADFG + R + K +T ++ T + APE + D Y K DIW++G
Sbjct: 135 DDILKLADFG------SCRGIY-SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGC 187
Query: 252 TAIEMAT------GT------APYHKY---PAMKVLMLTLQND------PPTLDTGAAEK 290
E+ + GT A H P +VL ++ P TG
Sbjct: 188 VFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTG---- 243
Query: 291 DQYKAYGKTFRKMISDC-----------LQKDPTKRPTASELLKNPFF 327
RK++ + L DP +R TA + L++P+F
Sbjct: 244 ---------LRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 81/293 (27%), Positives = 133/293 (45%), Gaps = 47/293 (16%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSM--DELLKEIQAMSSCHHENVVTYHTSFVVKDE 123
+V SA + + AIKKI ++ ++T + +E++ + HEN+++ F+ E
Sbjct: 25 LVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83
Query: 124 -LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182
++ V LL G L HRL ++ I L ++L+GL+Y HS G +HRD
Sbjct: 84 DIYFVTELL-GTDL-----HRL----LTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133
Query: 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSR-QKVRHT-FVGTPCWMAPEVMEQDHGY 240
+K NIL+ E+ ++I DFG L+R Q + T +V T + APE+M Y
Sbjct: 134 LKPSNILINENCDLKICDFG----------LARIQDPQMTGYVSTRYYRAPEIMLTWQKY 183
Query: 241 DFKADIWSLGITAIEMATGTA--PYHKYPAMKVLMLTLQNDPP--TLDTGAAE------- 289
D + DIWS G EM G P + ++ L PP ++T +E
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 290 ----------KDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332
+++K + ++ L DP KR +A+E L +P+ D
Sbjct: 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 4e-20
Identities = 65/246 (26%), Positives = 121/246 (49%), Gaps = 29/246 (11%)
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSL 136
+K A+K I K + + L+E M+ HH+N+V ++ + L++V+ L+ G+L
Sbjct: 30 QKVAVKNI---KCDVTAQAFLEETAVMTKLHHKNLVRL-LGVILHNGLYIVMELMSKGNL 85
Query: 137 LDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196
++ ++ R + + + +V +G+EY S +HRD+ A NIL+ EDG
Sbjct: 86 VNFLRTRGR------ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVA 139
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256
+++DFG++ + G D S+ V+ W APE ++ + K+D+WS G+ E+
Sbjct: 140 KVSDFGLARVGSMGVDNSKLPVK--------WTAPEALKHKK-FSSKSDVWSYGVLLWEV 190
Query: 257 -ATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315
+ G APY K ++L+ ++ G + + M S C + +P KR
Sbjct: 191 FSYGRAPYPK--------MSLKEVKECVEKGYRMEPPEGCPADVYVLMTS-CWETEPKKR 241
Query: 316 PTASEL 321
P+ +L
Sbjct: 242 PSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 24/261 (9%)
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE--LWLVLRLLEGG 134
E A+K + E + KEI + + +HEN+V Y + L L++ + G
Sbjct: 34 EMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLG 93
Query: 135 SLLDII-KHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
SL D + KH+L ++ + +++ +G+ Y HS IHRD+ A N+LL D
Sbjct: 94 SLRDYLPKHKLNLAQ----------LLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND 143
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
V+I DFG++ + G + R VR W A E ++++ + +D+WS G+T
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTL 200
Query: 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLD--TGAAEKDQY----KAYGKTFRKMISDC 307
E+ T P M+ + T+ E+ K + ++ +C
Sbjct: 201 YELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNC 260
Query: 308 LQKDPTKRPTASELLKNPFFK 328
+ + RPT L+ P K
Sbjct: 261 WETEAKFRPTFRSLI--PILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 78/317 (24%), Positives = 124/317 (39%), Gaps = 72/317 (22%)
Query: 67 VHSAYCKA--RAEKCAIKKINLEKWNT---SMDELLKEIQAMSSCHHENVVTYHTSFVVK 121
V+ A K ++ AIKK +K S +EI + HENVV+ F+
Sbjct: 16 VYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC-REIALLRELKHENVVSLVEVFLEH 74
Query: 122 DE--LWLVLRLLEGGSLLDIIK-HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178
+ ++L+ E L IIK HR + ++L ++L G+ Y HSN
Sbjct: 75 ADKSVYLLFDYAEH-DLWQIIKFHRQAKRV----SIPPSMVKSLLWQILNGVHYLHSNWV 129
Query: 179 IHRDIKAGNILL----GEDGTVQIADFGVS-------AWLATGRDLSRQKVRHTFVGTPC 227
+HRD+K NIL+ E G V+I D G++ LA V T
Sbjct: 130 LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL-----DPVVVTI----- 179
Query: 228 WM-APEVMEQDHGYDFKADIWSLGITAIEMAT-------------GTAPYHKYPAMKVLM 273
W APE++ Y DIW++G E+ T + P+ + ++
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239
Query: 274 L----------TLQNDP--PTLDTGAAEK-----------DQYKAYGKTFRKMISDCLQK 310
+ ++ P TL K +++K ++ L+
Sbjct: 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299
Query: 311 DPTKRPTASELLKNPFF 327
DPTKR TA E L++P+F
Sbjct: 300 DPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 82/312 (26%), Positives = 126/312 (40%), Gaps = 53/312 (16%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
E + E +V+G GA V+ EK + + V AIK + E
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEK-----VKIPV-------------AIKVLREE 47
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIK-HRLKI 146
+ E+L E M+S H +VV + ++ L+ +L+ G LLD ++ H+ I
Sbjct: 48 TSPKANKEILDEAYVMASVDHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNI 106
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
+ ++ KG+ Y +HRD+ A N+L+ V+I DFG++
Sbjct: 107 --------GSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158
Query: 207 LATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYH 264
L + P WMA E + Y K+D+WS G+T E+ T G PY
Sbjct: 159 LDVDEK----EYHAEGGKVPIKWMALESI-LHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
Query: 265 KYPAMKVLMLTLQND----PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320
PA+++ L + + PP D Y K C D RPT E
Sbjct: 214 GIPAVEIPDLLEKGERLPQPPICTI-----DVYMVLVK--------CWMIDAESRPTFKE 260
Query: 321 LLKNPFFKKAKD 332
L+ N F K A+D
Sbjct: 261 LI-NEFSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 82/311 (26%), Positives = 130/311 (41%), Gaps = 47/311 (15%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
QY V GFG C+ RA Y + EK IKK E
Sbjct: 4 QYRVLGKGGFGEVCA-----CQVRA------------TGKMYACKKLEKKRIKKRKGE-- 44
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
SM L E Q + + VV+ ++ KD L LVL L+ GG L + I +
Sbjct: 45 --SM--ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL------KFHIYHM 94
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
+E E+ GLE H ++RD+K NILL + G ++I+D G++ +
Sbjct: 95 GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269
G+ + + VGT +MAPEV++ + Y F D W+LG EM G +P+ +
Sbjct: 155 GQTIKGR------VGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKK- 206
Query: 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLKN 324
++ + +++ + + R + L KDP +R A E+ ++
Sbjct: 207 -----KIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261
Query: 325 PFFKKAKDKKF 335
P FK+ K+
Sbjct: 262 PLFKQINFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 52/157 (33%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVL 167
H + + +F K+ L+ V+ L GG L+ I +C D P E++
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLM------FHIQSCHK--FDLPRATFYAAEII 106
Query: 168 KGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC 227
GL++ HS G ++RD+K NILL DG ++IADFG+ G TF GTP
Sbjct: 107 CGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-----DAKTCTFCGTPD 161
Query: 228 WMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264
++APE++ Y+ D WS G+ EM G +P+H
Sbjct: 162 YIAPEIL-LGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 36/235 (15%)
Query: 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIAT 161
+S H +V F +D + V+ GG L+ I H V EP
Sbjct: 55 TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HT--------DVFSEPRAVF 105
Query: 162 VLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHT 221
V+ GL+Y H N ++RD+K N+LL +G V+IADFG+ + T
Sbjct: 106 YAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTST 160
Query: 222 FVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPP 281
F GTP ++APEV+ + Y D W LG+ EM G +P+ +V + ++
Sbjct: 161 FCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR 219
Query: 282 ---TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLKNPFFK 328
L A R++ L+++P +R A ++ K PFF+
Sbjct: 220 YPRFLSREAIS---------IMRRL----LRRNPERRLGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 65/241 (26%), Positives = 109/241 (45%), Gaps = 24/241 (9%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
K AIK L+ + L+E Q M H+ +V + + V ++ +++V + GSLL
Sbjct: 32 KVAIK--TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLY-AVVSEEPIYIVTEFMGKGSLL 88
Query: 138 DIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQ 197
D +K + K+ P + + ++ G+ Y IHRD++A NIL+G++ +
Sbjct: 89 DFLKE----GDGKY--LKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCK 142
Query: 198 IADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257
IADFG++ + +RQ + W APE + K+D+WS GI E+
Sbjct: 143 IADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYGR-FTIKSDVWSFGILLTELV 197
Query: 258 T-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
T G PY +VL + G E + +++ C +KDP +RP
Sbjct: 198 TKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE---------SLHELMKLCWKKDPDERP 248
Query: 317 T 317
T
Sbjct: 249 T 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 78/317 (24%), Positives = 124/317 (39%), Gaps = 98/317 (30%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWN-----TSMDELLKEIQAMSSCHHENVVTYHTSFVV 120
VV+ A K E A+KK+ +EK TS L+EI + H N+VT V
Sbjct: 20 VVYRARDKKTGEIVALKKLKMEKEKEGFPITS----LREINILLKLQHPNIVT------V 69
Query: 121 K--------DELWLVLRLLEGG--SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170
K D++++V+ +E SL++ +K S K ++ ++L G+
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK----------CLMLQLLSGV 119
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQ-----KVRHTFVGT 225
+ H N +HRD+K N+LL G ++I DFG L+R+ K V T
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRGILKICDFG----------LAREYGSPLKPYTQLVVT 169
Query: 226 PCWMAPEVMEQDHGYDFKADIWSLG---------------------ITAIEMATGTAP-- 262
+ APE++ Y D+WS+G + I GT P
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGT-PTE 228
Query: 263 -----YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKT---FRKMISDCLQK---- 310
+ + P K T + ++ A + F D L +
Sbjct: 229 KIWPGFSELPGAKKKTFTKY-------PYNQLRKKFPALSLSDNGF-----DLLNRLLTY 276
Query: 311 DPTKRPTASELLKNPFF 327
DP KR +A + LK+P+F
Sbjct: 277 DPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 66/252 (26%), Positives = 102/252 (40%), Gaps = 36/252 (14%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELW-LVLRLLEGGSL 136
+ A+K + E E L+E M+ H +V V K E LV+ L G L
Sbjct: 25 EVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIG--VCKGEPLMLVMELAPLGPL 82
Query: 137 LDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196
L +K K + + +V G+ Y S +HRD+ A N+LL
Sbjct: 83 LKYLK--------KRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQA 134
Query: 197 QIADFGVSAWLATGRDLSRQK------VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG 250
+I+DFG+S L G D R ++ W APE + + K+D+WS G
Sbjct: 135 KISDFGMSRALGAGSDYYRATTAGRWPLK--------WYAPECINY-GKFSSKSDVWSYG 185
Query: 251 ITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQ 309
+T E + G PY + +V+ + L++G + + + M C +
Sbjct: 186 VTLWEAFSYGAKPYGEMKGAEVIAM--------LESGERLPRPEECPQEIYSIM-LSCWK 236
Query: 310 KDPTKRPTASEL 321
P RPT SEL
Sbjct: 237 YRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 71/264 (26%), Positives = 115/264 (43%), Gaps = 39/264 (14%)
Query: 97 LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDE 156
L E + + + H + SF D L V+ GG L +S + V E
Sbjct: 43 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF------FHLS--RERVFSE 94
Query: 157 PTIATVLREVLKGLEYFHSNGQI-HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSR 215
E++ L+Y HS + +RD+K N++L +DG ++I DFG+ +
Sbjct: 95 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKD 149
Query: 216 QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLT 275
TF GTP ++APEV+E D+ Y D W LG+ EM G P++ K+ L
Sbjct: 150 GATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208
Query: 276 LQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLKNPFF 327
L + P TL A + ++S L+KDP +R A E++++ FF
Sbjct: 209 LMEEIRFPRTLSPEA-------------KSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
Query: 328 KKAKDKKFIQQTLVSVGPTFETRI 351
+ ++ LV P F+ ++
Sbjct: 256 AGIVWQDVYEKKLV---PPFKPQV 276
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 64/268 (23%), Positives = 117/268 (43%), Gaps = 35/268 (13%)
Query: 72 CKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRL 130
A+K + + + +L+ E++ M H+N++ + L++V+
Sbjct: 38 NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEY 97
Query: 131 LEGGSLLDIIK-HRLKISNCKHGVCDEPTIATVLR-------EVLKGLEYFHSNGQIHRD 182
G+L D ++ R P + +V +G+E+ S IHRD
Sbjct: 98 AAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRD 157
Query: 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKV--RHTFVGTPC-WMAPEVMEQDHG 239
+ A N+L+ ED ++IADFG++ RD+ + T P WMAPE + D
Sbjct: 158 LAARNVLVTEDHVMKIADFGLA------RDIHHIDYYRKTTNGRLPVKWMAPEALF-DRV 210
Query: 240 YDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQN---DPPTLDTGAAEKDQYKA 295
Y ++D+WS G+ E+ T G +PY P ++ L + + P T ++ Y
Sbjct: 211 YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCT----QELY-- 264
Query: 296 YGKTFRKMISDCLQKDPTKRPTASELLK 323
++ DC + P++RPT +L++
Sbjct: 265 ------HLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 83/297 (27%), Positives = 126/297 (42%), Gaps = 62/297 (20%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSMDE-----LLKEIQAMSSCHHENVVTYHTSFVV 120
VV+ A K E A+KKI LE + DE ++EI + +H N+V VV
Sbjct: 14 VVYKARDKLTGEIVALKKIRLE----TEDEGVPSTAIREISLLKELNHPNIVRLLD--VV 67
Query: 121 KDE--LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178
E L+LV L+ LD+ K+ + + D P I + L ++L+G+ Y HS+
Sbjct: 68 HSENKLYLVFEFLD----LDLKKY---MDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120
Query: 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH 238
+HRD+K N+L+ +G +++ADFG LA + + H V T + APE++
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFG----LARAFGVPVRTYTHEVV-TLWYRAPEILLGSR 175
Query: 239 GYDFKADIWSLGITAIEMATGTAPYHK-------YPAMKVLMLTLQNDPPTLDT--GAAE 289
Y DIWS+G EM + + + L P D G
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL------GTPDEDVWPGVTS 229
Query: 290 KDQYKAYGKTFRK-------------------MISDCLQKDPTKRPTASELLKNPFF 327
YK TF K ++S L DP KR +A L++P+F
Sbjct: 230 LPDYKP---TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 8e-19
Identities = 91/337 (27%), Positives = 141/337 (41%), Gaps = 76/337 (22%)
Query: 31 YEVREV------IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
+EV + +G GA V SA + K AIKK+ + + K A +++
Sbjct: 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-----YRPFQSELFAKRAYREL 65
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVV------TYHTSFVVKDELWLVLRLLEGGSLLD 138
LLK ++ HENV+ T S + +LV+ + G L
Sbjct: 66 ----------RLLKHMK------HENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGK 108
Query: 139 IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQI 198
++KH K+S E I ++ ++LKGL+Y H+ G IHRD+K GN+ + ED ++I
Sbjct: 109 LMKHE-KLS--------EDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKI 159
Query: 199 ADFGVSAWLATGRDLSRQKVRHT--FVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256
DFG L+RQ +V T + APEV+ Y DIWS+G EM
Sbjct: 160 LDFG----------LARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM 209
Query: 257 ATGTAPYHKYPAMKVLM--LTLQNDPPTLDTGAAEKDQYKAY--------GKTFR----- 301
TG + + + LM + + P + + K Y K FR
Sbjct: 210 LTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPN 269
Query: 302 ------KMISDCLQKDPTKRPTASELLKNPFFKKAKD 332
++ L D R TA+E L +P+F++ D
Sbjct: 270 ANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 54/190 (28%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
+ AIK + + + KE+QA+ H+++++ V + ++++ L+E GSLL
Sbjct: 32 RVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90
Query: 138 DIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQ 197
L+ + V ++ + +V +G+ Y IHRD+ A NIL+GED +
Sbjct: 91 ----AFLRSPEGQ--VLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCK 144
Query: 198 IADFGVSAWLATGRDLSRQK---VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254
+ADFG++ + LS K + W APE + K+D+WS GI
Sbjct: 145 VADFGLARLIKEDVYLSSDKKIPYK--------WTAPEAASHGT-FSTKSDVWSFGILLY 195
Query: 255 EMAT-GTAPY 263
EM T G PY
Sbjct: 196 EMFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 84/329 (25%), Positives = 130/329 (39%), Gaps = 65/329 (19%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+Y+++EVIG G+ VV SA EK AIKKIN H +
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS------------------- 41
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD-----ELWLVLRLLEGGSLLDIIKHRL 144
+L+EI+ + H ++V + ++++V L+E L +IK
Sbjct: 42 --DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND 98
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS 204
++ H L ++L+ L+Y H+ HRD+K NIL D ++I DFG++
Sbjct: 99 DLTPEHHQF--------FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 150
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG-YDFKADIWSLGITAIEMATGTAPY 263
D +V T + APE+ Y DIWS+G E+ TG P
Sbjct: 151 R--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PL 207
Query: 264 HKYPAMKV-----LMLTLQNDPPTLDTGAAEKDQYKAYGKTFRK---------------- 302
+P V L+ L P ++ + Y + RK
Sbjct: 208 --FPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPL 265
Query: 303 ---MISDCLQKDPTKRPTASELLKNPFFK 328
++ L DP RPTA E L +P+FK
Sbjct: 266 ALRLLERLLAFDPKDRPTAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170
+ H+ F D L+ V+ + GG L+ I+ + G EP E+ GL
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ--------QVGKFKEPHAVFYAAEIAIGL 114
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMA 230
+ HS G I+RD+K N++L +G ++IADFG+ G +R TF GTP ++A
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR-----TFCGTPDYIA 169
Query: 231 PEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEK 290
PE++ Y D W+ G+ EM G P+ D L E
Sbjct: 170 PEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDG------------EDEDELFQSIME- 215
Query: 291 DQYKAYGKTF-RKMISDC---LQKDPTKR----PTASELLK-NPFFK 328
+Y K+ ++ +S C L K P KR PT ++ + FF+
Sbjct: 216 -HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 62/253 (24%), Positives = 114/253 (45%), Gaps = 38/253 (15%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
AIK I ++ + S DE ++E + M HE +V + + +++V + G LL+
Sbjct: 32 AIKMI--KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY 89
Query: 140 IKHRLKISNCKHGVCDEPTIATVL---REVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196
++ K + +L ++V +G+ Y S IHRD+ A N L+ + G V
Sbjct: 90 LREHGK----------RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCV 139
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYDFKADIWSLGITAIE 255
+++DFG+S ++ L + P W PEV+ + K+D+W+ G+ E
Sbjct: 140 KVSDFGLSRYV-----LDDEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWE 193
Query: 256 MAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYK---AYGKTFRKMISDCLQKD 311
+ + G PY ++ N+ T++ + Y+ A K + M S C +
Sbjct: 194 VYSLGKMPYERF-----------NNSETVEKVSQGLRLYRPHLASEKVYAIMYS-CWHEK 241
Query: 312 PTKRPTASELLKN 324
+RPT +LL +
Sbjct: 242 AEERPTFQQLLSS 254
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 64/257 (24%), Positives = 110/257 (42%), Gaps = 39/257 (15%)
Query: 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLR 164
+ +H + + F D L+ V+ + GG L+ I + DE
Sbjct: 52 ARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLM------FHIQKSRR--FDEARARFYAA 103
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVG 224
E+ L + H G I+RD+K N+LL +G ++ADFG+ + K TF G
Sbjct: 104 EITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGIFNGKTTSTFCG 158
Query: 225 TPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND---PP 281
TP ++APE++ Q+ Y D W++G+ EM G AP+ + L ++ P
Sbjct: 159 TPDYIAPEIL-QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 217
Query: 282 TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA------SELLKNPFFKKAKDKKF 335
L A + ++ + K+PT R + +L++PFFK+ +K
Sbjct: 218 WLSQDAVD-------------ILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264
Query: 336 IQQTLVSVGPTFETRIQ 352
++ + P F RI+
Sbjct: 265 NRR---QIEPPFRPRIK 278
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 29/249 (11%)
Query: 75 RAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVV-KDELWLVLRLLEG 133
R K A+K I K + + L E M+ H N+V V K L++V +
Sbjct: 28 RGNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84
Query: 134 GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
GSL+D ++ R + V + +V + +EY +N +HRD+ A N+L+ ED
Sbjct: 85 GSLVDYLRSRGR------SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED 138
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
+++DFG++ ++ +D + V+ W APE + + + K+D+WS GI
Sbjct: 139 NVAKVSDFGLTKEASSTQDTGKLPVK--------WTAPEALREKK-FSTKSDVWSFGILL 189
Query: 254 IEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312
E+ + G PY + P V+ P ++ G + D ++ C D
Sbjct: 190 WEIYSFGRVPYPRIPLKDVV--------PRVEKG-YKMDAPDGCPPVVYDVMKQCWHLDA 240
Query: 313 TKRPTASEL 321
RP+ +L
Sbjct: 241 ATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 50/292 (17%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
A V+ + E A+K+I+L+ + ++EI M HEN+V H +++L
Sbjct: 14 ATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKL 73
Query: 125 WLVLRLLEGG--SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182
LV ++ +D R G D T+ + ++LKG+ + H N +HRD
Sbjct: 74 MLVFEYMDKDLKKYMDTHGVR--------GALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125
Query: 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTF---VGTPCWMAPEVMEQDHG 239
+K N+L+ + G +++ADFG++ A G ++ TF V T + AP+V+
Sbjct: 126 LKPQNLLINKRGELKLADFGLAR--AFGIPVN------TFSNEVVTLWYRAPDVLLGSRT 177
Query: 240 YDFKADIWSLGITAIEMAT---------------------GTAPYHKYPAMKVLMLTLQN 278
Y DIWS+G EM T GT +P + L
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237
Query: 279 DPPTLDTGAAEKDQYKAYGKTFRKMIS---DCLQKDPTKRPTASELLKNPFF 327
P +D + + I LQ +P R +A + L++P+F
Sbjct: 238 FPR-----YPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 94/324 (29%), Positives = 136/324 (41%), Gaps = 69/324 (21%)
Query: 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDEL 96
+G GA V SA K EK AIKK++ + K RA
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAK-RA-------------------- 61
Query: 97 LKEIQAMSSCHHENVV------TYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
+E+ + HENV+ T S + +LV+ ++ L I+ H L
Sbjct: 62 YRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLS----- 115
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
E + ++ ++L GL+Y HS G IHRD+K GN+ + ED ++I DFG LA
Sbjct: 116 -----EDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFG----LARH 166
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270
D +V T + APEV+ Y+ DIWS+G EM TG + +
Sbjct: 167 ADAEMTG----YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222
Query: 271 VL--MLTLQNDPPT-----LDTGAAEKDQYKAYGKTFRKMIS-----------DCLQK-- 310
L +L + P L+ AA K K+ K RK S D L+K
Sbjct: 223 QLTQILKVTGVPGPEFVQKLEDKAA-KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKML 281
Query: 311 --DPTKRPTASELLKNPFFKKAKD 332
D KR TA+E L++P+F +D
Sbjct: 282 ELDVDKRLTATEALEHPYFDSFRD 305
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 70/257 (27%), Positives = 120/257 (46%), Gaps = 25/257 (9%)
Query: 77 EKCAIKKIN---LEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEG 133
E A+K++ L K N + +L E +++ E +V +F + L+L + + G
Sbjct: 27 EIVALKRMKKSLLFKLN-EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85
Query: 134 GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
G R ++N GV E + E+ + ++ H G IHRD+K N L+
Sbjct: 86 GDF------RTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS 137
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
G +++ DFG+S + T ++ VG+P +MAPEV+ + GYDF D WSLG
Sbjct: 138 GHIKLTDFGLSKGIVT--------YANSVVGSPDYMAPEVL-RGKGYDFTVDYWSLGCML 188
Query: 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
E G P+ + L+ TL + ++ + + +I+ + DP+
Sbjct: 189 YEFLCGFPPFSGSTPNET-WENLKYWKETLQRPVYDDPRFNLSDEAW-DLITKLIN-DPS 245
Query: 314 KRPTASELLKN-PFFKK 329
+R + E +KN PFFK+
Sbjct: 246 RRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 80/340 (23%), Positives = 140/340 (41%), Gaps = 84/340 (24%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKIN---LAVVHSAYCKARAEKCAIKKIN 85
++Y+ +G GA V +A+ + A+KK++ +++H+
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---------------- 60
Query: 86 LEKWNTSMDELLKEIQAMSSCHHENVV------TYHTSFVVKDELWLVLRLLEGGSLLDI 139
+E++ + HENV+ T S ++++LV L+ G L +I
Sbjct: 61 --------KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI 111
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
+K C+ D + ++ ++L+GL+Y HS IHRD+K N+ + ED ++I
Sbjct: 112 VK-------CQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 162
Query: 200 DFGVSAWLATGRDLSRQKVRHT------FVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
DFG++ RHT +V T + APE+M Y+ DIWS+G
Sbjct: 163 DFGLA--------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 208
Query: 254 IEMATGTA--PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMIS------ 305
E+ TG P + L+L L P + + Y ++ +M
Sbjct: 209 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 268
Query: 306 ---------DCLQK----DPTKRPTASELLKNPFFKKAKD 332
D L+K D KR TA++ L + +F + D
Sbjct: 269 FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 78/258 (30%), Positives = 108/258 (41%), Gaps = 39/258 (15%)
Query: 77 EKCAIKKINLEKWNTSMDE---LLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEG 133
+K AI K +K M E LLK ++ H +V H SF D+L+ VL + G
Sbjct: 29 QKKAILKKKEQK--HIMAERNVLLKNVK------HPFLVGLHYSFQTADKLYFVLDYVNG 80
Query: 134 GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
G L ++ EP E+ L Y HS I+RD+K NILL
Sbjct: 81 GELFFHLQRERSFP--------EPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ 132
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
G V + DFG+ + K TF GTP ++APEV+ + YD D W LG
Sbjct: 133 GHVVLTDFGLCK-----EGIEHSKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVL 186
Query: 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
EM G P++ ++ L N P L + + R ++ LQKD T
Sbjct: 187 YEMLYGLPPFYSRDTAEMYDNIL-NKPLRLKPNISV---------SARHLLEGLLQKDRT 236
Query: 314 KRPTAS----ELLKNPFF 327
KR A E+ + FF
Sbjct: 237 KRLGAKDDFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 91/332 (27%), Positives = 138/332 (41%), Gaps = 69/332 (20%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
DQYE E IG G VV+ A + E A+KKI L AI++I+L
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG-----VPSTAIREISL-- 54
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
LKE+Q H N+V + L+LV L+ LD+ KH + +
Sbjct: 55 --------LKEMQ------HGNIVRLQDVVHSEKRLYLVFEYLD----LDLKKH---MDS 93
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE-DGTVQIADFGVSAWL 207
+ I T L ++L+G+ Y HS+ +HRD+K N+L+ +++ADFG L
Sbjct: 94 SPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG----L 149
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT------GTA 261
A + + H V T + APE++ Y DIWS+G EM G +
Sbjct: 150 ARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208
Query: 262 PYHKYPAMKVLMLTLQNDPPTLDT--GAAEKDQYKAYGKTFRK----------------- 302
+ + ++ T P +T G YK+ F K
Sbjct: 209 EIDELFKIFRILGT-----PNEETWPGVTSLPDYKS---AFPKWPPKDLATVVPTLEPAG 260
Query: 303 --MISDCLQKDPTKRPTASELLKNPFFKKAKD 332
++S L+ DP+KR TA L++ +FK D
Sbjct: 261 VDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292
|
Length = 294 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 68/253 (26%), Positives = 111/253 (43%), Gaps = 48/253 (18%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
K A+K L+ S + L+E Q M H+ +V + + V ++ +++V + GSLL
Sbjct: 32 KVAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLL 88
Query: 138 DIIK----HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
D +K LK+ P + + +V G+ Y IHRD+++ NIL+G+
Sbjct: 89 DFLKDGEGRALKL----------PNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG 138
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
+IADFG++ + +RQ + W APE + K+D+WS GI
Sbjct: 139 LVCKIADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYGR-FTIKSDVWSFGILL 193
Query: 254 IEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
E+ T G PY +VL M Q+ P +L +++
Sbjct: 194 TELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISL-----------------HELM 236
Query: 305 SDCLQKDPTKRPT 317
C +KDP +RPT
Sbjct: 237 LQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 71/258 (27%), Positives = 114/258 (44%), Gaps = 57/258 (22%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
K A+K L+ S + L+E Q M H+ +V + ++ +++V + GSLL
Sbjct: 32 KVAVK--TLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89
Query: 138 DIIK----HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
D +K +L++ P + + ++ +G+ Y S IHRD+ A NIL+GE+
Sbjct: 90 DFLKSGEGKKLRL----------PQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN 139
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHG-YDFKADIWSLGI 251
+IADFG++ + +R+ + P W APE ++G + K+D+WS GI
Sbjct: 140 LVCKIADFGLARLIEDDEYTAREGAKF-----PIKWTAPEAA--NYGRFTIKSDVWSFGI 192
Query: 252 TAIEMAT-GTAPYHKYPAM---KVL--------MLTLQNDPPTLDTGAAEKDQYKAYGKT 299
E+ T G P YP M +VL M N P L
Sbjct: 193 LLTEIVTYGRVP---YPGMTNREVLEQVERGYRMPRPPNCPEEL---------------- 233
Query: 300 FRKMISDCLQKDPTKRPT 317
++ C KDP +RPT
Sbjct: 234 -YDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 69/243 (28%), Positives = 103/243 (42%), Gaps = 30/243 (12%)
Query: 73 KARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLE 132
K +K +KK + + + LLK ++ H +V H SF D+L+ VL +
Sbjct: 26 KVLQKKAILKKKEEKHIMSERNVLLKNVK------HPFLVGLHFSFQTADKLYFVLDYIN 79
Query: 133 GGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE 192
GG L + L+ C EP E+ L Y HS ++RD+K NILL
Sbjct: 80 GGELF----YHLQRERCFL----EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS 131
Query: 193 DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252
G + + DFG+ ++ TF GTP ++APEV+ + YD D W LG
Sbjct: 132 QGHIVLTDFGLCK-----ENIEHNGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAV 185
Query: 253 AIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312
EM G P++ + + + N P L + R ++ LQKD
Sbjct: 186 LYEMLYGLPPFYSRNTAE-MYDNILNKPLQLKPNIT---------NSARHLLEGLLQKDR 235
Query: 313 TKR 315
TKR
Sbjct: 236 TKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 31/269 (11%)
Query: 72 CKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLL 131
CK + EK IKK E + +L+++ + VV+ ++ KD L LVL ++
Sbjct: 30 CK-KLEKKRIKKRKGEAMALNEKRILEKVNS------RFVVSLAYAYETKDALCLVLTIM 82
Query: 132 EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
GG L + I N + DE E+ GLE ++RD+K NILL
Sbjct: 83 NGGDL------KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD 136
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251
+ G ++I+D G++ + G + VR VGT +MAPEV+ + Y F D W LG
Sbjct: 137 DRGHIRISDLGLAVQIPEG-----ETVRGR-VGTVGYMAPEVI-NNEKYTFSPDWWGLGC 189
Query: 252 TAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311
EM G +P+ K K + + D + +++ K+ +M+ L K+
Sbjct: 190 LIYEMIQGQSPFRKR---KERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML---LTKN 243
Query: 312 PTKR-----PTASELLKNPFFKKAKDKKF 335
P +R A+ + ++P FK K+
Sbjct: 244 PKERLGCRGNGAAGVKQHPIFKNINFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 70/309 (22%), Positives = 122/309 (39%), Gaps = 63/309 (20%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDE-------------LLKEIQAMSSCHHENVVT 113
V AY + AIKK+ + + + + + L+E++ M+ HEN++
Sbjct: 25 VEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84
Query: 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYF 173
+V D + LV+ ++ L ++ +++++ E + +L ++L GL
Sbjct: 85 LVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLT--------ESQVKCILLQILNGLNVL 135
Query: 174 HSNGQIHRDIKAGNILLGEDGTVQIADFGVS---AWLATGRDLSRQKV-----RHTF-VG 224
H +HRD+ NI + G +IADFG++ + LS+ + T V
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV 195
Query: 225 TPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT---------------------GTAPY 263
T + APE++ Y F D+WS+G E+ T GT
Sbjct: 196 TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNE 255
Query: 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQK----DPTKRPTAS 319
+P K L L + P + K D LQ +P +R +A
Sbjct: 256 DNWPQAKKLPLYTEFTP-------RKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308
Query: 320 ELLKNPFFK 328
E LK+ +FK
Sbjct: 309 EALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 28/198 (14%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
K AIK +L++ + S + L E M H +V + + V ++ ++++ +E GSL+
Sbjct: 32 KVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGSLV 88
Query: 138 DIIK----HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
D +K +L I + + ++ +G+ + IHRD++A NIL+ E
Sbjct: 89 DFLKTPEGIKLTI----------NKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET 138
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG-YDFKADIWSLGIT 252
+IADFG++ + +R+ + W APE + ++G + K+D+WS GI
Sbjct: 139 LCCKIADFGLARLIEDNEYTAREGAKFPIK----WTAPEAI--NYGTFTIKSDVWSFGIL 192
Query: 253 AIEMAT-GTAPYHKYPAM 269
E+ T G P YP M
Sbjct: 193 LTEIVTYGRIP---YPGM 207
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 73/262 (27%), Positives = 113/262 (43%), Gaps = 52/262 (19%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLV-LRLLEGGSL 136
CA+K +N +++ LKE M H NV++ + + LV L ++ G L
Sbjct: 25 HCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDL 84
Query: 137 LDIIKHRLKISNCKHGVCDEPTIATVLR---EVLKGLEYFHSNGQIHRDIKAGNILLGED 193
+ I+ + H PT+ ++ +V KG+EY S +HRD+ A N +L E
Sbjct: 85 RNFIR------SETH----NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES 134
Query: 194 GTVQIADFGVSAWLATGRDLSRQKV----RHTFVGTPC-WMAPEVMEQDHGYDFKADIWS 248
TV++ADFG++ RD+ ++ HT P WMA E + Q + K+D+WS
Sbjct: 135 FTVKVADFGLA------RDIYDKEYYSVHNHTGAKLPVKWMALESL-QTQKFTTKSDVWS 187
Query: 249 LGITAIEMAT-GTAPYHKYPAMKVLMLTLQND--------PPTLDTGAAEKDQYKAYGKT 299
G+ E+ T G PY + + + LQ P L
Sbjct: 188 FGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPL---------------- 231
Query: 300 FRKMISDCLQKDPTKRPTASEL 321
+ M+S C P RPT SEL
Sbjct: 232 YEVMLS-CWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 92/336 (27%), Positives = 150/336 (44%), Gaps = 76/336 (22%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKIN---LAVVHSAYCKARAEKCAIKKIN 85
++Y+ +G GA V SAY +K A+KK++ +++H+
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHAR--------------- 59
Query: 86 LEKWNTSMDELLKEIQAMSSCHHENVV------TYHTSFVVKDELWLVLRLLEGGSLLDI 139
+E++ + HENV+ T TS +E++LV L+ G L +I
Sbjct: 60 ---------RTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNI 109
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
+K C+ + DE + ++ ++L+GL+Y HS G IHRD+K N+ + ED ++I
Sbjct: 110 VK-------CQK-LSDE-HVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 160
Query: 200 DFGVSAWLATGRDLSRQKVRHT--FVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257
DFG L+RQ +V T + APE+M Y+ DIWS+G E+
Sbjct: 161 DFG----------LARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
Query: 258 TGTA--PYHKY-PAMKVLMLTLQN-DPPTLDTGAAEKDQ----------YKAYGKTFR-- 301
G A P + Y +K +M + P L ++E + + K FR
Sbjct: 211 KGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGA 270
Query: 302 -KMISDCLQK----DPTKRPTASELLKNPFFKKAKD 332
+ D L+K D KR +ASE L +P+F + D
Sbjct: 271 NPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 3e-17
Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 38/248 (15%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
+ AIK L+ S + L+E Q M HE +V + + V ++ +++V + GSLL
Sbjct: 32 RVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLL 88
Query: 138 DIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQ 197
D +K + P + + ++ G+ Y +HRD++A NIL+GE+ +
Sbjct: 89 DFLKGEMGK------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK 142
Query: 198 IADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257
+ADFG++ + +RQ + W APE + K+D+WS GI E+
Sbjct: 143 VADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYGR-FTIKSDVWSFGILLTELT 197
Query: 258 T-GTAPYHKYPAMKVLMLTLQND-------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQ 309
T G P YP M + Q + PP ++ ++ C +
Sbjct: 198 TKGRVP---YPGMVNREVLDQVERGYRMPCPPECP-------------ESLHDLMCQCWR 241
Query: 310 KDPTKRPT 317
K+P +RPT
Sbjct: 242 KEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 35/262 (13%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWL 126
V+ K + A+K L++ ++E LKE M H N+V + ++
Sbjct: 22 VYEGVWKKYSLTVAVK--TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79
Query: 127 VLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVL-----REVLKGLEYFHSNGQIHR 181
+ + G+LLD ++ C+ + V+ ++ +EY IHR
Sbjct: 80 ITEFMTYGNLLDYLRE-----------CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128
Query: 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGY 240
D+ A N L+GE+ V++ADFG+S L TG + H P W APE + + +
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSR-LMTGDTYT----AHAGAKFPIKWTAPESLAYNK-F 182
Query: 241 DFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKT 299
K+D+W+ G+ E+AT G +P YP + L L+ G + K
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSP---YPGID-----LSQVYELLEKGYRMERPEGCPPKV 234
Query: 300 FRKMISDCLQKDPTKRPTASEL 321
+ M + C Q +P+ RP+ +E+
Sbjct: 235 YELMRA-CWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 75/300 (25%), Positives = 126/300 (42%), Gaps = 50/300 (16%)
Query: 59 IKKI---NLAVVHSAYCKARAEKCAIKKINLEKWNTSMDE-----LLKEIQAMSSCHHEN 110
I+KI VV+ K + A+KKI LE S +E ++EI + H N
Sbjct: 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE----SEEEGVPSTAIREISLLKELQHPN 60
Query: 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170
+V + + L+L+ L +D+ K+ + ++ D + + L ++L+G+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQY--MDAELVKSYLYQILQGI 114
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMA 230
+ HS +HRD+K N+L+ G +++ADFG LA + + H V T + A
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFG----LARAFGIPVRVYTHEVV-TLWYRA 169
Query: 231 PEVMEQDHGYDFKADIWSLGITAIEMAT---------------------GTAPYHKYPAM 269
PEV+ Y DIWS+G EMAT GT +P +
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229
Query: 270 KVLMLTLQNDPPTLD--TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
+L + T + + K + ++ L DP KR +A + L +P+F
Sbjct: 230 T----SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 87/316 (27%), Positives = 127/316 (40%), Gaps = 60/316 (18%)
Query: 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMD 94
E IG G VV+ A K E A+KKI L AI++I+L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-----VPSTAIREISL-------- 52
Query: 95 ELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVC 154
LKE+ H N+V +++L+LV L D+ K +
Sbjct: 53 --LKELN------HPNIVKLLDVIHTENKLYLVFEFLHQ----DLKKF---MDASPLSGI 97
Query: 155 DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLS 214
P I + L ++L+GL + HS+ +HRD+K N+L+ +G +++ADFG LA +
Sbjct: 98 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG----LARAFGVP 153
Query: 215 RQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLML 274
+ H V T + APE++ Y DIWSLG EM T A + + L
Sbjct: 154 VRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212
Query: 275 TLQNDPPTLDT-------GAAEKDQYKA----------------YGKTFRKMISDCLQKD 311
+ TL T G YK + R ++S L D
Sbjct: 213 IFR----TLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYD 268
Query: 312 PTKRPTASELLKNPFF 327
P KR +A L +PFF
Sbjct: 269 PNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 74/268 (27%), Positives = 112/268 (41%), Gaps = 56/268 (20%)
Query: 78 KCAIKKINLEKWNTSMD---ELLKEIQAMS--SCHHENVVTYHTSFVVKDE--LWLVLRL 130
+ AIK +N N SM E L E M +CHH VV VV +V+ L
Sbjct: 38 RVAIKTVNE---NASMRERIEFLNEASVMKEFNCHH--VVRLLG--VVSTGQPTLVVMEL 90
Query: 131 LEGGSLLDIIK-HRLKISNCKHGVCDEPTIATVLR---EVLKGLEYFHSNGQIHRDIKAG 186
+ G L ++ R + N PT+ ++ E+ G+ Y + +HRD+ A
Sbjct: 91 MAKGDLKSYLRSRRPEAENN--PGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAAR 148
Query: 187 NILLGEDGTVQIADFGVSAWLATGRDL-----------SRQKVRHTFVGTPCWMAPEVME 235
N ++ ED TV+I DFG++ RD+ VR WMAPE +
Sbjct: 149 NCMVAEDLTVKIGDFGMT------RDIYETDYYRKGGKGLLPVR--------WMAPESL- 193
Query: 236 QDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYK 294
+D + K+D+WS G+ EMAT PY +VL + L +K
Sbjct: 194 KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDK---- 249
Query: 295 AYGKTFRKMISDCLQKDPTKRPTASELL 322
+++ C Q +P RPT E++
Sbjct: 250 -----LLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 62/235 (26%), Positives = 107/235 (45%), Gaps = 37/235 (15%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
D E + +G G VH + A+K + + V R ++ + ++ EK
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV------IRLKQ--EQHVHNEK 52
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+LKE+ H ++ + + L++++ + GG L +++ + SN
Sbjct: 53 ------RVLKEVS------HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN 100
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
T E++ LEY HS ++RD+K NILL ++G +++ DFG + L
Sbjct: 101 --------STGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL- 151
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263
RD + T GTP ++APEV+ Q G++ D W+LGI EM G P+
Sbjct: 152 --RDRT-----WTLCGTPEYLAPEVI-QSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 76/304 (25%), Positives = 115/304 (37%), Gaps = 64/304 (21%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMD-ELLKEIQAMSSCHHENVV----------TYH 115
V A K + A+KK+ +E L+EI+ + HENVV T +
Sbjct: 28 VFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87
Query: 116 TSFVVKDELWLVLRLLEGGSLLDIIKHRL-KISNCKHGVCDEPTIATVLREVLKGLEYFH 174
+ K +LV E H L + + K+ I V++ +L GL Y H
Sbjct: 88 NRY--KGSFYLVFEFCE---------HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTF---VGTPCWMAP 231
N +HRD+KA NIL+ +DG +++ADFG LA LS+ + + V T + P
Sbjct: 137 RNKILHRDMKAANILITKDGILKLADFG----LARAFSLSKNSKPNRYTNRVVTLWYRPP 192
Query: 232 EVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM------KVLMLTLQ-------- 277
E++ + Y D+W G EM T + P M L L Q
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWT------RSPIMQGNTEQHQLTLISQLCGSITPE 246
Query: 278 -----NDPPTLDTGAAEKDQYKAYGKTFRKMISD---------CLQKDPTKRPTASELLK 323
+ + Q + + + + D L DP KR A L
Sbjct: 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306
Query: 324 NPFF 327
+ FF
Sbjct: 307 HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 84/336 (25%), Positives = 137/336 (40%), Gaps = 89/336 (26%)
Query: 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDEL 96
IG GA +V SA EK AIKKI A ++ +D
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-----------------------FDNRIDAK 49
Query: 97 --LKEIQAMSSCHHENVVTYHTSFVVKD-----------ELWLVLRLLEGGSLLDIIKHR 143
L+EI+ + HENV+ +KD ++++V L++ L II+
Sbjct: 50 RTLREIKLLRHLDHENVIA------IKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSS 102
Query: 144 LKISN--CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADF 201
+S+ C++ L ++L+GL+Y HS +HRD+K N+LL + ++I DF
Sbjct: 103 QTLSDDHCQY----------FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 152
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT--- 258
G LA + +V T + APE++ Y D+WS+G E+
Sbjct: 153 G----LARTTSEKGDFMT-EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
Query: 259 ---GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY--------GKTFRKMIS-- 305
G H+ +K++ L P D G ++ + Y ++F ++
Sbjct: 208 LFPGKDYVHQ---LKLITELL-GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHA 263
Query: 306 -----DCLQK----DPTKRPTASELLKNPFFKKAKD 332
D L+K DP+KR T E L +P+ D
Sbjct: 264 NPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 56/198 (28%), Positives = 85/198 (42%), Gaps = 55/198 (27%)
Query: 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLK 168
E VV + SF KD L+ V+ + GG ++ ++ + G+ +E + E+
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL--------IRLGIFEEDLARFYIAELTC 112
Query: 169 GLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG------------------ 210
+E H G IHRDIK NIL+ DG +++ DFG L TG
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFG----LCTGFRWTHDSKYYQKGDHHRQ 168
Query: 211 -----------------RDLSRQKVR-------HTFVGTPCWMAPEVMEQDHGYDFKADI 246
+ L R++ R H+ VGTP ++APEV+ + GY D
Sbjct: 169 DSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDW 227
Query: 247 WSLGITAIEMATGTAPYH 264
WS+G+ EM G P+
Sbjct: 228 WSVGVILYEMLVGQPPFL 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 15/185 (8%)
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYH-TSFVV-KDELWLVLRLLEGG 134
E A+KK+ + + +EI+ + S H+N+V Y + + L LV+ L G
Sbjct: 34 EVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 135 SLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
SL D + KHR + D + ++ KG+EY S +HRD+ NIL+ +
Sbjct: 93 SLRDYLQKHRER--------LDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE 144
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
V+I DFG++ L ++ KVR W APE + + + +D+WS G+
Sbjct: 145 NRVKIGDFGLTKVLPQDKEY--YKVREPGESPIFWYAPESL-TESKFSVASDVWSFGVVL 201
Query: 254 IEMAT 258
E+ T
Sbjct: 202 YELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 73/286 (25%), Positives = 128/286 (44%), Gaps = 40/286 (13%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSM-DELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
V A + E A+K++ L+ + + L+EI + H+N+V + +L
Sbjct: 15 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL 74
Query: 125 WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
LV + D+ K+ +C G D + + + ++LKGL + HS+ +HRD+K
Sbjct: 75 TLVFEYCDQ----DLKKY---FDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLK 126
Query: 185 AGNILLGEDGTVQIADFGVS-AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFK 243
N+L+ ++G +++ADFG++ A+ R S + V T + P+V+ Y
Sbjct: 127 PQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV------TLWYRPPDVLFGAKLYSTS 180
Query: 244 ADIWSLGITAIEMATGTAPYHKYPAMKV---LMLTLQN-DPPTLDT--GAAEKDQYKAY- 296
D+WS G E+A P +P V L + PT ++ G ++ YK Y
Sbjct: 181 IDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238
Query: 297 --------GKTFRKMIS---DCLQK----DPTKRPTASELLKNPFF 327
K+ S D LQ +P +R +A E L++P+F
Sbjct: 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 68/249 (27%), Positives = 107/249 (42%), Gaps = 34/249 (13%)
Query: 96 LLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCD 155
LLK ++ H +V H SF ++L+ VL + GG L ++ +
Sbjct: 49 LLKNVK------HPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ--------RERSFP 94
Query: 156 EPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSR 215
EP E+ L Y HS ++RD+K NILL G V + DFG+ +++
Sbjct: 95 EPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCK-----EGIAQ 149
Query: 216 QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLT 275
TF GTP ++APEV+ + YD D W LG EM G P++ ++
Sbjct: 150 SDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
Query: 276 LQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS----ELLKNPFFKKAK 331
L P L GA+ T ++ + L+KD +R A E+ ++PFF+
Sbjct: 209 LHK-PLVLRPGAS---------LTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258
Query: 332 DKKFIQQTL 340
Q+ +
Sbjct: 259 WTDLEQKKI 267
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170
+V H+ F L+LV+ + GG L+ ++ + K+ E E+ L
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLP--------EEHARFYAAEICIAL 109
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMA 230
+ H G I+RD+K N+LL DG +++ D+G+ L TF GTP ++A
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-----EGLGPGDTTSTFCGTPNYIA 164
Query: 231 PEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263
PE++ + Y F D W+LG+ EM G +P+
Sbjct: 165 PEILRGEE-YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 82/326 (25%), Positives = 130/326 (39%), Gaps = 63/326 (19%)
Query: 31 YEVREVIGFGATAVVHSAYCKAR--AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
YE+ + +G GA +V SA E AIKKI K RA
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAK-RA------------ 48
Query: 89 WNTSMDELLKEIQAMSSCH---HENVVT-YHTSFVVKD---ELWLVLRLLEGGSLLDIIK 141
L+E++ + H H+N+ Y V EL+L L+E L II+
Sbjct: 49 --------LRELKLLR--HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIR 97
Query: 142 HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADF 201
+++ H + + ++L GL+Y HS +HRD+K GN+L+ D ++I DF
Sbjct: 98 SGQPLTDA-H-------FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDF 149
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261
G++ + + + +V T + APE+M Y D+WS+G E+
Sbjct: 150 GLARGFSENPGENAGFMTE-YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
Query: 262 PYHKYPAMKVLMLTLQ--NDPP--TLDTGAAEKDQ----------YKAYGKTFRK----- 302
+ + L LQ P TL + K Q K + F
Sbjct: 209 VFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLA 268
Query: 303 --MISDCLQKDPTKRPTASELLKNPF 326
++ L DPTKR + E L++P+
Sbjct: 269 LDLLEKLLAFDPTKRISVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 76/314 (24%), Positives = 132/314 (42%), Gaps = 51/314 (16%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ +E ++I GA V+ K ++ A+KKIN K NL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN-------------------KQNLIL 41
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
N + ++ E ++ + VV+ SF K L +V+ +EGG ++K+
Sbjct: 42 RN-QIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI----- 95
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW-- 206
G E + LEY H+ G +HRD+K N+L+ G +++ DFG+S
Sbjct: 96 ---GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152
Query: 207 --LATG-------RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257
L T +D +R+ + GTP ++APEV+ + GY D W++GI E
Sbjct: 153 MSLTTNLYEGHIEKD-TREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFL 210
Query: 258 TGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-- 315
G P+ ++ + +D + A + +IS L+++P +R
Sbjct: 211 VGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQ-------DLISRLLRQNPLERLG 263
Query: 316 -PTASELLKNPFFK 328
A E+ ++ FF
Sbjct: 264 TGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 79/331 (23%), Positives = 129/331 (38%), Gaps = 67/331 (20%)
Query: 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPT 158
E ++ +E VV + SF KD L+ V+ + GG ++ ++ + G+ E
Sbjct: 51 ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL--------IRMGIFPEDL 102
Query: 159 IATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV---------SAWLAT 209
+ E+ +E H G IHRDIK NIL+ DG +++ DFG+ S + +
Sbjct: 103 ARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162
Query: 210 G------------------------------RDLSRQKVR---HTFVGTPCWMAPEVMEQ 236
G R +RQ R H+ VGTP ++APEV+ +
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 237 DHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY 296
GY D WS+G+ EM G P+ ++ M + T Q K
Sbjct: 223 T-GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN-----WQTSLHIPPQAKLS 276
Query: 297 GKTFRKMISDCL-QKDPTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAA 355
+ +I C +D + A E+ +PFFK ++Q P T +
Sbjct: 277 PEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKI-THPTDTS 335
Query: 356 KKNPGASGRLHRTVTGEWVWSSEDEGDKSSD 386
+P V + +WS +D+ +D
Sbjct: 336 NFDP---------VDPDKLWSDDDKEGNVND 357
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 73/255 (28%), Positives = 104/255 (40%), Gaps = 25/255 (9%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
AIK I + E+ + AM S H +V L LV +L GSLLD
Sbjct: 40 AIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL-LGICPGASLQLVTQLSPLGSLLDH 98
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
++ D + ++ KG+ Y + +HR++ A NILL D VQIA
Sbjct: 99 VRQH-------RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIA 151
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258
DFGV+ L +K ++ TP WMA E + Y ++D+WS G+T EM +
Sbjct: 152 DFGVADLLYP----DDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMS 206
Query: 259 -GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT 317
G PY + P L+ G + M+ C D RPT
Sbjct: 207 YGAEPYAG--------MRPHEVPDLLEKGERLAQPQICTIDVYMVMVK-CWMIDENVRPT 257
Query: 318 ASELLKNPFFKKAKD 332
E L N F + A+D
Sbjct: 258 FKE-LANEFTRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 68/266 (25%), Positives = 123/266 (46%), Gaps = 35/266 (13%)
Query: 75 RAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEG 133
R K A+K + + + +L+ E++ M H+N++ + L++++
Sbjct: 49 RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 108
Query: 134 GSLLDIIKHR----LKISNCKHGVCDE----PTIATVLREVLKGLEYFHSNGQIHRDIKA 185
G+L + ++ R ++ V +E + + +V +G+EY S IHRD+ A
Sbjct: 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168
Query: 186 GNILLGEDGTVQIADFGVSAWLATGRDLSR-QKVRHTFVGT-PC-WMAPEVMEQDHGYDF 242
N+L+ ED ++IADFG++ RD+ + T G P WMAPE + D Y
Sbjct: 169 RNVLVTEDNVMKIADFGLA------RDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTH 221
Query: 243 KADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQN---DPPTLDTGAAEKDQYKAYGK 298
++D+WS G+ E+ T G +PY P ++ L + D P+ T
Sbjct: 222 QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCT------------N 269
Query: 299 TFRKMISDCLQKDPTKRPTASELLKN 324
M+ DC P++RPT +L+++
Sbjct: 270 ELYMMMRDCWHAVPSQRPTFKQLVED 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 5e-16
Identities = 67/255 (26%), Positives = 116/255 (45%), Gaps = 46/255 (18%)
Query: 95 ELLKEIQAMSSCHHENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHG 152
+L+ E+ M H+N+V Y F+ K +L++++ + G L I+ K+ G
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM----FG 113
Query: 153 VCDEPTIATVLREVLKGLEYFHS-----NGQ--IHRDIKAGNILLGED----GTV----- 196
+E I + R++L L Y H+ NG+ +HRD+K NI L G +
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173
Query: 197 --------QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM-EQDHGYDFKADIW 247
+I DFG+S +++ + + H+ VGTP + +PE++ + YD K+D+W
Sbjct: 174 NLNGRPIAKIGDFGLS------KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMW 227
Query: 248 SLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDC 307
+LG E+ +G P+HK L+ L+ P K K +I +
Sbjct: 228 ALGCIIYELCSGKTPFHKANNFSQLISELKRGPDL---------PIKGKSKELNILIKNL 278
Query: 308 LQKDPTKRPTASELL 322
L +RP+A + L
Sbjct: 279 LNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 14/162 (8%)
Query: 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATV 162
+ + H +V H SF ++L+ VL + GG L L+ C EP
Sbjct: 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELF----FHLQRERC----FLEPRARFY 101
Query: 163 LREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTF 222
EV + Y HS I+RD+K NILL G V + DFG+ + ++ TF
Sbjct: 102 AAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-----EGVEPEETTSTF 156
Query: 223 VGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264
GTP ++APEV+ ++ YD D W LG EM G P++
Sbjct: 157 CGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 55/202 (27%), Positives = 81/202 (40%), Gaps = 43/202 (21%)
Query: 161 TVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW-LATGRDLSRQKVR 219
+ +++L+GL Y H+ IHRD+K NI + + V I D G + + + L
Sbjct: 161 IIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG----- 215
Query: 220 HTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM-----------ATGTAPYHKYPA 268
GT APEV+ +D Y+ KADIWS GI EM + Y K
Sbjct: 216 --LAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCH 272
Query: 269 MKVLML--TLQNDPPTL--DTGAAEKDQYKAYGKTFRKMIS--DCLQK------------ 310
+L + TL+ P D G+ + Y R+ + C Q+
Sbjct: 273 SHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVH 332
Query: 311 -----DPTKRPTASELLKNPFF 327
D RP+A E+L P F
Sbjct: 333 KMLTFDAAMRPSAEEILNYPMF 354
|
Length = 357 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 57/245 (23%), Positives = 107/245 (43%), Gaps = 32/245 (13%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
K A+K ++ + S++ L E M + H+ +V H + V K+ ++++ + GSLL
Sbjct: 32 KVAVK--TMKPGSMSVEAFLAEANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLL 88
Query: 138 DIIK----HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
D +K + + P + ++ +G+ + IHRD++A NIL+
Sbjct: 89 DFLKSDEGSKQPL----------PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS 138
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
+IADFG++ + +R+ + W APE + + K+D+WS GI
Sbjct: 139 LVCKIADFGLARVIEDNEYTAREGAKFPIK----WTAPEAINFG-SFTIKSDVWSFGILL 193
Query: 254 IEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312
+E+ T G PY +V+ L+ ++ Y ++ C + P
Sbjct: 194 MEIVTYGRIPYPGMSNPEVIR-ALERGYRMPRPENCPEELY--------NIMMRCWKNRP 244
Query: 313 TKRPT 317
+RPT
Sbjct: 245 EERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 71/285 (24%), Positives = 124/285 (43%), Gaps = 37/285 (12%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
A V+ K A+K+I LE + ++E+ + H N+VT H + L
Sbjct: 20 ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79
Query: 125 WLVLRLLEGG--SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182
LV L+ LD + + + N K L ++L+GL Y H +HRD
Sbjct: 80 TLVFEYLDKDLKQYLDDCGNSINMHNVK----------LFLFQLLRGLNYCHRRKVLHRD 129
Query: 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF 242
+K N+L+ E G +++ADFG LA + + + + V T + P+++ Y
Sbjct: 130 LKPQNLLINERGELKLADFG----LARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 243 KADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQN-DPPTLDT--GAAEKDQYKAYG-K 298
+ D+W +G EM+TG + + L + PT +T G +++K+Y
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244
Query: 299 TFR----------------KMISDCLQKDPTKRPTASELLKNPFF 327
+R +++S LQ + KR +A E +K+P+F
Sbjct: 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 37/265 (13%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELW 125
+V Y + K AIK I + S ++ ++E Q M H +V + + +
Sbjct: 19 LVWLGYWLEK-RKVAIKTI--REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC 75
Query: 126 LVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185
LV +E G L D ++ + G + T+ + +V +G+ Y S+ IHRD+ A
Sbjct: 76 LVFEFMEHGCLSDYLR-------AQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAA 128
Query: 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYDFKA 244
N L+GE+ V+++DFG++ ++ L Q T P W +PEV Y K+
Sbjct: 129 RNCLVGENQVVKVSDFGMTRFV-----LDDQYTSSTGTKFPVKWSSPEVFSFSK-YSSKS 182
Query: 245 DIWSLGITAIEM-ATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY-----GK 298
D+WS G+ E+ + G PY +V+ T++ G ++ Y +
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNSEVV--------ETINAG------FRLYKPRLASQ 228
Query: 299 TFRKMISDCLQKDPTKRPTASELLK 323
+ +++ C ++ P RP+ S LL
Sbjct: 229 SVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH 174
H+ F D L+ V+ + GG L+ I+ + G EP E+ GL + H
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQ--------QVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM 234
S G I+RD+K N++L +G ++IADFG+ ++ TF GTP ++APE++
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAPEII 173
Query: 235 EQDHGYDFKADIWSLGITAIEMATGTAPY 263
Y D W+ G+ EM G AP+
Sbjct: 174 AY-QPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 71/249 (28%), Positives = 106/249 (42%), Gaps = 50/249 (20%)
Query: 95 ELLKEIQAMSSCHHENVVTYHTSFVVKDEL--WLVLRLLEGGSLLDIIKH-RLKISNCKH 151
+ L E MS +H+N+V V + L +++L L+ GG L ++ R +
Sbjct: 55 DFLMEALIMSKFNHQNIV--RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPER--- 109
Query: 152 GVCDEPTIATVL------REVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIADFG 202
P+ T+ R+V KG +Y N IHRDI A N LL G +IADFG
Sbjct: 110 -----PSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164
Query: 203 VSAWLATGRDLSR----QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE-MA 257
++ RD+ R +K + WM PE D + K D+WS G+ E +
Sbjct: 165 MA------RDIYRASYYRKGGRAMLPIK-WMPPEAF-LDGIFTSKTDVWSFGVLLWEIFS 216
Query: 258 TGTAPYHKYPAMKVL-MLTL--QNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK 314
G PY +V+ +T + DPP G +R M +DC Q P
Sbjct: 217 LGYMPYPGRTNQEVMEFVTGGGRLDPP-----------KGCPGPVYRIM-TDCWQHTPED 264
Query: 315 RPTASELLK 323
RP + +L+
Sbjct: 265 RPNFATILE 273
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVL 167
H +V H+ F + L+ V+ + GG L+ ++ + K+ E E+
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLP--------EEHARFYSAEIS 106
Query: 168 KGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC 227
L + H G I+RD+K N+LL +G +++ D+G+ + TF GTP
Sbjct: 107 LALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-----EGIRPGDTTSTFCGTPN 161
Query: 228 WMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263
++APE++ + Y F D W+LG+ EM G +P+
Sbjct: 162 YIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 78/335 (23%), Positives = 135/335 (40%), Gaps = 67/335 (20%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
+ +YE+ + +G GA +V A + E A+KK + A+ A
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKK-----IFDAFRNA---------- 47
Query: 85 NLEKWNTSMDELLKEI---QAMSSCHHENVV---TYHTSFVVKDELWLVLRLLEGGSLLD 138
T +EI Q + H N+V + KD ++LV +E L
Sbjct: 48 ------TDAQRTFREIMFLQELG--DHPNIVKLLNVIKAENDKD-IYLVFEYMET-DLHA 97
Query: 139 IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQI 198
+I+ + ++ ++ ++LK L+Y HS IHRD+K NILL D V++
Sbjct: 98 VIRA---------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKL 148
Query: 199 ADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258
ADFG++ L+ + V +V T + APE++ Y D+WS+G EM
Sbjct: 149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
Query: 259 GTAPYHKYPAM----KVLMLTLQNDPPTLDTGAAEKDQYKA---------YGKTFRKMIS 305
G + + K++ + PP+ + + K + A K +++
Sbjct: 209 GKPLFPGTSTLNQLEKIIEVI---GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLP 265
Query: 306 D-----------CLQKDPTKRPTASELLKNPFFKK 329
L +P KR TA E L++P+ +
Sbjct: 266 KASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 72/270 (26%), Positives = 116/270 (42%), Gaps = 30/270 (11%)
Query: 59 IKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSF 118
I K N V+ K E A+K + L+E + + H N+V
Sbjct: 3 IGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 119 VVKDELWLVLRLLEGGSLLDII---KHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS 175
V K +++V+ L+ GGSLL + K+RL + + + G+EY S
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQ----------MSLDAAAGMEYLES 111
Query: 176 NGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME 235
IHRD+ A N L+GE+ ++I+DFG+S G ++ + W APE +
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK---WTAPEAL- 167
Query: 236 QDHG-YDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQY 293
++G Y ++D+WS GI E + G P YP M + Q +++G
Sbjct: 168 -NYGRYTSESDVWSYGILLWETFSLGDTP---YPGM-----SNQQTRERIESGYRMPAPQ 218
Query: 294 KAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ +R M+ C DP RP+ SE+
Sbjct: 219 LCPEEIYRLMLQ-CWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 29/193 (15%)
Query: 75 RAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGG 134
R EK I K +D + E + ++ +H V + SF + L+LVL + GG
Sbjct: 63 RFEKSKIIK------QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG 116
Query: 135 SLLDIIKHRLKISN---CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
++ + N C + +++ EY S ++RD+K N+LL
Sbjct: 117 EFFTFLRRNKRFPNDVGCFYAA-----------QIVLIFEYLQSLNIVYRDLKPENLLLD 165
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251
+DG +++ DFG + + T +T GTP ++APE++ + G+ AD W+LGI
Sbjct: 166 KDGFIKMTDFGFAKVVDTR--------TYTLCGTPEYIAPEIL-LNVGHGKAADWWTLGI 216
Query: 252 TAIEMATGTAPYH 264
E+ G P++
Sbjct: 217 FIYEILVGCPPFY 229
|
Length = 340 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLR 164
+ +H +V H+ F + L+ V+ + GG L+ ++ + K+ E
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP--------EEHARFYSA 103
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVG 224
E+ L Y H G I+RD+K N+LL +G +++ D+G+ L TF G
Sbjct: 104 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCG 158
Query: 225 TPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263
TP ++APE++ + Y F D W+LG+ EM G +P+
Sbjct: 159 TPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 71/286 (24%), Positives = 120/286 (41%), Gaps = 37/286 (12%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
A V K A+K+I LE + ++E+ + H N+VT H L
Sbjct: 20 ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSL 79
Query: 125 WLVLRLLEGG--SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182
LV L+ +D + + + N K L ++L+GL Y H +HRD
Sbjct: 80 TLVFEYLDKDLKQYMDDCGNIMSMHNVK----------IFLYQILRGLAYCHRRKVLHRD 129
Query: 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF 242
+K N+L+ E G +++ADFG LA + + + + V T + P+V+ Y
Sbjct: 130 LKPQNLLINERGELKLADFG----LARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 243 KADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQ-NDPPTLDT--GAAEKDQYKAYGKT 299
+ D+W +G EMA+G + L L + PT +T G + D++K Y
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFP 244
Query: 300 FRK-----------------MISDCLQKDPTKRPTASELLKNPFFK 328
K +++ LQ + KR +A E +K+ +F+
Sbjct: 245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 94 DELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKH---RLKISNCK 150
+ L+E + + H N+V K +++V+ L++GG L ++ RLK+
Sbjct: 38 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVK--- 94
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
+ ++ G+EY S IHRD+ A N L+ E ++I+DFG+S G
Sbjct: 95 -------ELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHG-YDFKADIWSLGITAIE-MATGTAPYHKYPA 268
S ++ V W APE + ++G Y ++D+WS GI E + G PY
Sbjct: 148 VYASTGGMKQIPVK---WTAPEAL--NYGRYSSESDVWSFGILLWEAFSLGAVPYAN--- 199
Query: 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319
L+ Q ++ G +R M C + DP +RP+ S
Sbjct: 200 -----LSNQQTREAIEQGVRLPCPELCPDAVYRLMER-CWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 14/149 (9%)
Query: 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH 174
H+ F D L+ V+ + GG D++ H ++ K EP E+ GL + H
Sbjct: 67 HSCFQTVDRLYFVMEYVNGG---DLMYHIQQVGKFK-----EPQAVFYAAEISVGLFFLH 118
Query: 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM 234
G I+RD+K N++L +G ++IADFG+ + TF GTP ++APE++
Sbjct: 119 RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAPEII 173
Query: 235 EQDHGYDFKADIWSLGITAIEMATGTAPY 263
Y D W+ G+ EM G P+
Sbjct: 174 AY-QPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 16/186 (8%)
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE----LWLVLRLLE 132
E+ A+K + E + +L KEI+ + + +HEN+V Y + ++ + L++ L
Sbjct: 34 EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKG--ICTEDGGNGIKLIMEFLP 91
Query: 133 GGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE 192
GSL + + N K ++ KG++Y S +HRD+ A N+L+
Sbjct: 92 SGSLKEYLPRNKNKINLK-------QQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 193 DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252
+ V+I DFG++ + T D V+ W APE + Q Y +D+WS G+T
Sbjct: 145 EHQVKIGDFGLTKAIET--DKEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVT 201
Query: 253 AIEMAT 258
E+ T
Sbjct: 202 LYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 80/322 (24%), Positives = 137/322 (42%), Gaps = 58/322 (18%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ Y+ + +G G+ A V+ K + A+K+I L A A I++ +L
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA------IREASL-- 56
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
LK+++ H N+VT H K L LV L+ D+ ++ + +
Sbjct: 57 --------LKDLK------HANIVTLHDIIHTKKTLTLVFEYLDT----DLKQY---MDD 95
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
C G+ + L ++L+GL Y H +HRD+K N+L+ E G +++ADFG LA
Sbjct: 96 CGGGL-SMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFG----LA 150
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA--PYHKY 266
+ + + + V T + P+V+ Y D+W +G EMATG P
Sbjct: 151 RAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209
Query: 267 PAMKVLMLTLQNDPPTLDT--GAAEKDQYKAYGKTFRK-------------------MIS 305
++ + PT +T G + ++K Y F +
Sbjct: 210 VEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELAL 269
Query: 306 DCLQKDPTKRPTASELLKNPFF 327
LQ +P KR +A+E +K+P+F
Sbjct: 270 KFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 86/342 (25%), Positives = 144/342 (42%), Gaps = 91/342 (26%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+Y+ + IG GA +V +AY AIKK++ + + K RA
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RA------------- 63
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL------WLVLRLLEGGSLLDIIKHR 143
+E+ M +H+N+++ F + L +LV+ L++ +L +I+
Sbjct: 64 -------YRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME 115
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
L D ++ +L ++L G+++ HS G IHRD+K NI++ D T++I DFG+
Sbjct: 116 L----------DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263
+ T ++ +V T + APEV+ GY DIWS+G EM
Sbjct: 166 ARTAGTSFMMT------PYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVR----- 213
Query: 264 HK--YPA---------------------MKVLMLTLQND----------------PPTLD 284
HK +P MK L T++N P +L
Sbjct: 214 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF 273
Query: 285 TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
+E ++ KA R ++S L DP KR + E L++P+
Sbjct: 274 PADSEHNKLKA--SQARDLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 65/237 (27%), Positives = 111/237 (46%), Gaps = 45/237 (18%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+Y+ + IG GA +V +AY + AIKK++ + + K RA
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAK-RA------------- 62
Query: 90 NTSMDELLKEIQAMSSCHHENVV------TYHTSFVVKDELWLVLRLLEGGSLLDIIKHR 143
+E+ M +H+N++ T S +++LV+ L++ +L +I+
Sbjct: 63 -------YRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD 114
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
L D ++ +L ++L G+++ HS G IHRD+K NI++ D T++I DFG+
Sbjct: 115 L----------DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 164
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260
+ T ++ +V T + APEV+ GY DIWS+G EM GT
Sbjct: 165 ARTAGTSFMMT------PYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 83/319 (26%), Positives = 137/319 (42%), Gaps = 70/319 (21%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
D +E+ +VIG GA E +K N V+ A+K +N K
Sbjct: 1 DDFEILKVIGRGAFG-----------EVAVVKMKNTGQVY-----------AMKILN--K 36
Query: 89 WNTSMDELLKEIQAMSSCHHEN-----------VVTYHTSFVVKDELWLVLRLLEGGSLL 137
W E+LK +A ++C E + H +F ++ L+LV+ GG LL
Sbjct: 37 W-----EMLK--RAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLL 89
Query: 138 DII-KHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196
++ K ++ E L E++ ++ H G +HRDIK N+LL ++G +
Sbjct: 90 TLLSKFEDRLP--------EDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHI 141
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEV---MEQDHG-YDFKADIWSLGIT 252
++ADFG + L D + Q + VGTP +++PE+ ME G Y + D WSLG+
Sbjct: 142 RLADFG--SCLRLLADGTVQS--NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVC 197
Query: 253 AIEMATGTAPYHKYPAM----KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCL 308
EM G P++ + K++ P T +E+ + R++I C
Sbjct: 198 MYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAK-----DLIRRLI--CS 250
Query: 309 QKDPTKRPTASELLKNPFF 327
+ R + +PFF
Sbjct: 251 PETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-15
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 32/252 (12%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
+ A+K + + E LKE MS+ +H N+V ++ + ++++ L+EGG LL
Sbjct: 28 RVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLL 87
Query: 138 DIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG--- 194
++ + + + L +V KG Y IHRD+ A N L+ E G
Sbjct: 88 SYLRDARVERFGPPLLTLKELLDICL-DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDA 146
Query: 195 --TVQIADFGVSAWLATGRDLSRQ---KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSL 249
V+I DFG++ RD+ + + + WMAPE + D + ++D+WS
Sbjct: 147 DRVVKIGDFGLA------RDIYKSDYYRKEGEGLLPVRWMAPESL-LDGKFTTQSDVWSF 199
Query: 250 GITAIEMAT-GTAPYHKYPAMKVLMLTLQN---DPPTLDTGAAEKDQYKAYGKTFRKMIS 305
G+ E+ T G PY +VL P ++++
Sbjct: 200 GVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPD------------KIYQLMT 247
Query: 306 DCLQKDPTKRPT 317
+C +DP++RPT
Sbjct: 248 NCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 65/258 (25%), Positives = 120/258 (46%), Gaps = 29/258 (11%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLD 138
A+K + + + +L+ E++ M H+N++ + L++++ G+L +
Sbjct: 51 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 110
Query: 139 IIKHR----LKISNCKHGVCDEPT----IATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190
++ R ++ S V DE + + +V +G+EY S IHRD+ A N+L+
Sbjct: 111 YLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170
Query: 191 GEDGTVQIADFGVSAWLATGRDLSR-QKVRHTFVGT-PC-WMAPEVMEQDHGYDFKADIW 247
E+ ++IADFG++ RD++ + T G P WMAPE + D Y ++D+W
Sbjct: 171 TENNVMKIADFGLA------RDVNNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVW 223
Query: 248 SLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISD 306
S G+ E+ T G +PY P ++ L + D+ M+ D
Sbjct: 224 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKE---------GHRMDKPANCTNELYMMMRD 274
Query: 307 CLQKDPTKRPTASELLKN 324
C P+ RPT +L+++
Sbjct: 275 CWHAIPSHRPTFKQLVED 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 33/283 (11%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
A V K A+K+I LE + ++E+ + + H N+VT H + L
Sbjct: 19 ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL 78
Query: 125 WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
LV L+ +K L NC + + + + ++L+GL Y H +HRD+K
Sbjct: 79 TLVFEYLDSD-----LKQYL--DNCGNLMSMH-NVKIFMFQLLRGLSYCHKRKILHRDLK 130
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
N+L+ E G +++ADFG LA + + + + V T + P+V+ Y
Sbjct: 131 PQNLLINEKGELKLADFG----LARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPI 185
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQ-NDPPTLDT--GAAEKDQYKAYGKT-F 300
D+W +G EMATG + + L L + PT +T G +++++Y +
Sbjct: 186 DMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQY 245
Query: 301 R----------------KMISDCLQKDPTKRPTASELLKNPFF 327
R ++S L + R +A L++ +F
Sbjct: 246 RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 54/164 (32%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK--VRHTF 222
+V KG+E+ S IHRD+ A NILL E+ V+I DFG++ RD+ + VR
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RDIYKDPDYVRKGD 240
Query: 223 VGTPC-WMAPEVMEQDHGYDFKADIWSLGITAIEM-ATGTAPYHKYPAMKVLMLTLQNDP 280
P WMAPE + D Y ++D+WS G+ E+ + G +P YP +K+ +
Sbjct: 241 ARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKI----DEEFC 292
Query: 281 PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324
L G + + ++ M+ DC +P++RPT SEL+++
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTML-DCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 67/282 (23%), Positives = 130/282 (46%), Gaps = 39/282 (13%)
Query: 55 EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114
E CA++ N +++ CK + +K +KK + EK M L KEI + +V
Sbjct: 8 EVCAVQVKNTGKMYA--CK-KLDKKRLKKKSGEK----MALLEKEILEKVNSPF--IVNL 58
Query: 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH 174
+F K L LV+ L+ GG L + I N + + ++ G+ + H
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDL------KYHIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM 234
S ++RD+K N+LL + G +++D G++ L G+ ++++ GT +MAPE++
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR------AGTNGYMAPEIL 166
Query: 235 EQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM----KVLMLTLQNDPPTLDTGAAEK 290
+++ Y + D +++G + EM G P+ + ++ TL+++ K
Sbjct: 167 KEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV---------K 216
Query: 291 DQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP----FFK 328
+++ + + + + L K P R + E +P FFK
Sbjct: 217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 42/107 (39%), Positives = 58/107 (54%), Gaps = 8/107 (7%)
Query: 153 VCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRD 212
+CD I + R VL+ ++Y H N IHRDIKA NI + G V + DFG + + D
Sbjct: 181 ICD---ILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV---D 234
Query: 213 LSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259
++ K + + GT APE++ +D Y DIWS GI EMAT
Sbjct: 235 INANKY-YGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 33/246 (13%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
K A+K L+ S+ L+E M + H+ +V + ++ ++++ + GSLL
Sbjct: 32 KVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89
Query: 138 DIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQ 197
D +K + G P + ++ +G+ Y IHRD++A N+L+ E +
Sbjct: 90 DFLKSD------EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCK 143
Query: 198 IADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG-YDFKADIWSLGITAIEM 256
IADFG++ + +R+ + W APE + + G + K+D+WS GI E+
Sbjct: 144 IADFGLARVIEDNEYTAREGAKFPIK----WTAPEAI--NFGSFTIKSDVWSFGILLYEI 197
Query: 257 AT-GTAPYHKYPAMKV--LMLTLQND--PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311
T G P YP M +M LQ P ++ E ++ C ++
Sbjct: 198 VTYGKIP---YPGMSNSDVMSALQRGYRMPRMENCPDE----------LYDIMKTCWKEK 244
Query: 312 PTKRPT 317
+RPT
Sbjct: 245 AEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 63/265 (23%), Positives = 120/265 (45%), Gaps = 36/265 (13%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
A+K + ++ + +LL E + +H +V+ + + L L++ + GSL
Sbjct: 34 AVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSF 93
Query: 140 IKHRLKI--------SNCKHGVCDEP-----TIATVLR---EVLKGLEYFHSNGQIHRDI 183
++ K+ N D P T+ ++ ++ +G++Y +HRD+
Sbjct: 94 LRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL 153
Query: 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK--VRHTFVGTPC-WMAPEVMEQDHGY 240
A N+L+ E ++I+DFG+S RD+ + V+ + P WMA E + DH Y
Sbjct: 154 AARNVLVAEGRKMKISDFGLS------RDVYEEDSYVKRSKGRIPVKWMAIESL-FDHIY 206
Query: 241 DFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKT 299
++D+WS G+ E+ T G PY ++ L L TG + +
Sbjct: 207 TTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL--------LKTGYRMERPENCSEEM 258
Query: 300 FRKMISDCLQKDPTKRPTASELLKN 324
+ M++ C +++P KRPT +++ K
Sbjct: 259 YNLMLT-CWKQEPDKRPTFADISKE 282
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 46/211 (21%)
Query: 77 EKCAIKKINLEKWNTS-MDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGS 135
+K A+K + + +++S ++E L+E M H NV+ L G S
Sbjct: 28 QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK-----------------LIGVS 70
Query: 136 LLDIIKHRLKISNC-----KHG----------VCDEP------TIATVLREVLKGLEYFH 174
L K RL I KHG + +EP T+ + ++ G+EY
Sbjct: 71 LRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS 130
Query: 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEV 233
S IHRD+ A N +L E+ TV +ADFG+S + +G D RQ P W+A E
Sbjct: 131 SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG-DYYRQGCASKL---PVKWLALES 186
Query: 234 MEQDHGYDFKADIWSLGITAIEMAT-GTAPY 263
+ D+ Y +D+W+ G+T E+ T G PY
Sbjct: 187 L-ADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 66/263 (25%), Positives = 117/263 (44%), Gaps = 31/263 (11%)
Query: 75 RAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEG 133
+ A+K + + + +L+ E++ M H+N++ + L++++
Sbjct: 43 QTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAK 102
Query: 134 GSLLDIIKHR--------LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185
G+L + ++ R I+ + + +V +G+EY S IHRD+ A
Sbjct: 103 GNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA 162
Query: 186 GNILLGEDGTVQIADFGVSAWLATG-RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
N+L+ ED ++IADFG LA G D+ K WMAPE + D Y ++
Sbjct: 163 RNVLVTEDNVMKIADFG----LARGVHDIDYYKKTSNGRLPVKWMAPEAL-FDRVYTHQS 217
Query: 245 DIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQN---DPPTLDTGAAEKDQYKAYGKTF 300
D+WS GI E+ T G +PY P ++ L + D P+ T ++ Y
Sbjct: 218 DVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCT-------HELYML-- 268
Query: 301 RKMISDCLQKDPTKRPTASELLK 323
+ +C PT+RPT +L++
Sbjct: 269 ---MRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 53/183 (28%), Positives = 83/183 (45%), Gaps = 39/183 (21%)
Query: 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170
VV SF K L+L++ L GG ++ ++ + +S E + E + +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS--------EEATQFYIAETVLAI 114
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG------RDLS---------- 214
+ H G IHRDIK N+LL G V+++DFG+ L R+L+
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 215 --------------RQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260
R+++ ++ VGTP ++APEV Q GY+ D WSLG+ EM G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGY 233
Query: 261 APY 263
P+
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 55/163 (33%), Positives = 85/163 (52%), Gaps = 19/163 (11%)
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK--VRHTF 222
+V +G+E+ S IHRD+ A NILL E+ V+I DFG++ RD+ + VR
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RDIYKDPDYVRKGS 235
Query: 223 VGTPC-WMAPEVMEQDHGYDFKADIWSLGITAIEM-ATGTAPYHKYPAMKVLMLTLQNDP 280
P WMAPE + D Y ++D+WS G+ E+ + G +P YP +++ Q
Sbjct: 236 ARLPLKWMAPESI-FDKVYTTQSDVWSFGVLLWEIFSLGASP---YPGVQINEEFCQR-- 289
Query: 281 PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
L G + A + +R M++ C Q DP +RPT S L++
Sbjct: 290 --LKDGTRMRAPENATPEIYRIMLA-CWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 67/307 (21%), Positives = 124/307 (40%), Gaps = 32/307 (10%)
Query: 47 SAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106
S Y R C + + V S K + A+KKI L S+ L+EI+ +
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDK----RVAVKKIVLTD-PQSVKHALREIKIIRRL 59
Query: 107 HHENVV-TYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK---HGVCDEPTIATV 162
H+N+V Y +L + L + + I++ ++ G E
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF 119
Query: 163 LREVLKGLEYFHSNGQIHRDIKAGNILLG-EDGTVQIADFGVSAWLATGRDLSRQKVRHT 221
+ ++L+GL+Y HS +HRD+K N+ + ED ++I DFG++ + S +
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP--HYSHKGYLSE 177
Query: 222 FVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPP 281
+ T + +P ++ + Y D+W+ G EM TG + ++ + L L++ P
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237
Query: 282 T--------LDTGAAEKDQYKAYGKT-FRKMIS-------DCLQK----DPTKRPTASEL 321
L+ + + R ++ D L++ +P R TA E
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA 297
Query: 322 LKNPFFK 328
L +P+
Sbjct: 298 LMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 88/398 (22%), Positives = 159/398 (39%), Gaps = 98/398 (24%)
Query: 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDEL 96
IG+GA VV S ++ A+KK+ + CK R
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCK-RV-------------------- 46
Query: 97 LKEIQAMSSCHHENVV-------TYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
+E++ + H+NV+ H +E+++V L++ D+ H++ +S
Sbjct: 47 FRELKMLCFFKHDNVLSALDILQPPHIDPF--EEIYVVTELMQS----DL--HKIIVSP- 97
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
+ D + L ++L+GL+Y HS G +HRDIK GN+L+ + ++I DFG LA
Sbjct: 98 QPLSSDH--VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFG----LAR 151
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG------------------I 251
+ K V T + APE++ Y DIWS+G I
Sbjct: 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211
Query: 252 TAIEMAT---GTAP----YHKYPAMKVLMLTLQNDPPTLDT--GAAEKDQYKAYGKTFRK 302
+++ T GT + +L + PP+L + + ++A
Sbjct: 212 QQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAV-----H 266
Query: 303 MISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGAS 362
++ L DP KR +A++ L +P+ + + + T + K +
Sbjct: 267 LLCRMLVFDPDKRISAADALAHPYLDEGR-------------LRYHTCMCKCCY--TTSG 311
Query: 363 GRLHRTVTGEWVWSSEDEGDKSSDDEKKEKPMNCLQEV 400
GR++ T ++ E + DDE EK + +++V
Sbjct: 312 GRVY---TSDF----EPSANPPFDDE-YEKNLTSVRQV 341
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 52/196 (26%), Positives = 81/196 (41%), Gaps = 53/196 (27%)
Query: 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170
VV+ + SF L+L++ L GG L+ ++ K+ E + E + +
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMAECVLAI 114
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSA------------------------- 205
E H G IHRDIK NIL+ G ++++DFG+S
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 206 ----------WL--------ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIW 247
L AT + +R+ + ++ VGTP ++APE+ Q GY + D W
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKK-NRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWW 232
Query: 248 SLGITAIEMATGTAPY 263
SLG E G P+
Sbjct: 233 SLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 81/331 (24%), Positives = 140/331 (42%), Gaps = 69/331 (20%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+Y+ + IG GA +V +A+ A+KK++ + + K RA + +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK-RAYRELV-------- 72
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
LLK + + NV T S +++LV+ L++ +L +I
Sbjct: 73 ------LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI--------- 116
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
H D ++ +L ++L G+++ HS G IHRD+K NI++ D T++I DFG++
Sbjct: 117 -HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----- 170
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH----- 264
R + +V T + APEV+ GY DIWS+G E+ G+ +
Sbjct: 171 -RTACTNFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI 228
Query: 265 ----------KYPA---MKVLMLTLQND----------------PPTLDTGAAEKDQYKA 295
P+ M L T++N P + +E+D+ K
Sbjct: 229 DQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKT 288
Query: 296 YGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
R ++S L DP KR + E L++P+
Sbjct: 289 --SQARDLLSKMLVIDPDKRISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSL--- 136
AIK + E + DE+++E + M + +V + L LV+ + GG L
Sbjct: 26 AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM-IGVCEAEALMLVMEMASGGPLNKF 84
Query: 137 LDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196
L K + +SN + ++ +V G++Y +HRD+ A N+LL
Sbjct: 85 LSGKKDEITVSN----------VVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYA 134
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYDFKADIWSLGITAIE 255
+I+DFG+S A G D S K R + P W APE + + ++D+WS GIT E
Sbjct: 135 KISDFGLSK--ALGADDSYYKAR-SAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWE 190
Query: 256 -MATGTAPYHKYPAMKVLMLTLQN 278
+ G PY K +V+ Q
Sbjct: 191 AFSYGQKPYKKMKGPEVMSFIEQG 214
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 70/273 (25%), Positives = 110/273 (40%), Gaps = 59/273 (21%)
Query: 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPT 158
E ++ +E VV + SF KD L+ V+ + GG ++ ++ + V E
Sbjct: 51 ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL--------IRMEVFPEVL 102
Query: 159 IATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSA---WLATGR---- 211
+ E+ +E H G IHRDIK NIL+ DG +++ DFG+ W +
Sbjct: 103 ARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQK 162
Query: 212 ----------------DLS----------------RQKVR---HTFVGTPCWMAPEVMEQ 236
D+S +Q R H+ VGTP ++APEV+ +
Sbjct: 163 GSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 237 DHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY 296
GY D WS+G+ EM G P+ P L + N TL K +A
Sbjct: 223 K-GYTQLCDWWSVGVILFEMLVGQPPFLA-PTPTETQLKVINWENTLHIPPQVKLSPEA- 279
Query: 297 GKTFRKMISD--CLQKDPTKRPTASELLKNPFF 327
+I+ C ++ R A ++ +PFF
Sbjct: 280 ----VDLITKLCCSAEERLGRNGADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMD-ELLKEIQAMSSCHHENVVTYHTSFVVKDELW 125
V+ A K E A+KK+ L+ ++EI+ + +H N+V +V D+
Sbjct: 23 VYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE--IVTDKQD 80
Query: 126 LVLRLLEGGS---LLDIIKHRLKISNCKHGVCD--EPTIATVLREVLKGLEYFHSNGQIH 180
+ + G+ + + + H L + + G+ E I + ++++L+GL Y H +H
Sbjct: 81 ALDFKKDKGAFYLVFEYMDHDL-MGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLH 139
Query: 181 RDIKAGNILLGEDGTVQIADFGVSA-WLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG 239
RDIK NILL G +++ADFG++ + + KV T + PE++ +
Sbjct: 140 RDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-----TLWYRPPELLLGEER 194
Query: 240 YDFKADIWSLGITAIEMAT 258
Y D+WS G E+ T
Sbjct: 195 YGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 59/251 (23%), Positives = 105/251 (41%), Gaps = 37/251 (14%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
Y++ +IG G V+ AY + + A+KKI + + K R
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR--------------- 48
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
L+E + + H +V ++ D ++ + +EG +L ++K + +
Sbjct: 49 -----FLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLS 103
Query: 151 HGVCDEPTIATVLR---EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
+ ++ ++ L ++ +EY HS G +HRD+K NILLG G V I D+G + +
Sbjct: 104 KELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163
Query: 208 -------------ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254
S + VGTP +MAPE + DI++LG+
Sbjct: 164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL-LGVPASESTDIYALGVILY 222
Query: 255 EMATGTAPYHK 265
+M T + PY +
Sbjct: 223 QMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 53/163 (32%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK--VRHTF 222
+V +G+E+ S IHRD+ A NILL E+ V+I DFG++ RD+ + VR
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RDIYKDPDYVRKGD 234
Query: 223 VGTPC-WMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDP 280
P WMAPE + D Y ++D+WS G+ E+ + G +P YP +++ +
Sbjct: 235 ARLPLKWMAPESI-FDKVYTTQSDVWSFGVLLWEIFSLGASP---YPGVQIDEEFCRR-- 288
Query: 281 PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
L G + A + + M+ DC +P RPT SEL++
Sbjct: 289 --LKEGTRMRAPEYATPEIYSIML-DCWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 85/338 (25%), Positives = 142/338 (42%), Gaps = 83/338 (24%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+Y+ + IG GA +V +AY AIKK++ + + K RA
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK-RA------------- 70
Query: 90 NTSMDELLKEIQAMSSCHHENVV------TYHTSFVVKDELWLVLRLLEGGSLLDIIKHR 143
+E+ M +H+N++ T S ++++V+ L++ +L +I+
Sbjct: 71 -------YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME 122
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
L D ++ +L ++L G+++ HS G IHRD+K NI++ D T++I DFG+
Sbjct: 123 L----------DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263
+ R + +V T + APEV+ GY DIWS+G EM G +
Sbjct: 173 A------RTAGTSFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLF 225
Query: 264 ----HKYPAMKVL----------MLTLQNDPPTLDTGAAEKDQYKAYG--KTF------- 300
H KV+ M LQ PT+ T + +Y Y K F
Sbjct: 226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQ---PTVRTYVENRPKYAGYSFEKLFPDVLFPA 282
Query: 301 ------------RKMISDCLQKDPTKRPTASELLKNPF 326
R ++S L D +KR + E L++P+
Sbjct: 283 DSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 70/254 (27%), Positives = 109/254 (42%), Gaps = 63/254 (24%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
D +E+ +VIG GA V K A+K +N K
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN------------------------K 36
Query: 89 WNTSMDELLKEIQAMSSCHHEN-----------VVTYHTSFVVKDELWLVLRLLEGGSLL 137
W E+LK +A ++C E + T H +F ++ L+LV+ GG LL
Sbjct: 37 W-----EMLK--RAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLL 89
Query: 138 DII---KHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194
++ + RL E + E++ + H +HRDIK N+LL +G
Sbjct: 90 TLLSKFEDRLP----------EDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG 139
Query: 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEV---MEQDHG-YDFKADIWSLG 250
+++ADFG + L +D + Q VGTP +++PE+ ME G Y + D WSLG
Sbjct: 140 HIRLADFG--SCLKMNQDGTVQS--SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLG 195
Query: 251 ITAIEMATGTAPYH 264
+ EM G P++
Sbjct: 196 VCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 62/264 (23%), Positives = 119/264 (45%), Gaps = 29/264 (10%)
Query: 74 ARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLE 132
+ A+K + + + + +L+ E++ M H+N++ + L++++
Sbjct: 42 NKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYAS 101
Query: 133 GGSLLDIIKHRLKIS-NCKHGVCDEPT-------IATVLREVLKGLEYFHSNGQIHRDIK 184
G+L + ++ R + C P + + +V +G+EY S IHRD+
Sbjct: 102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA 161
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSR-QKVRHTFVGT-PC-WMAPEVMEQDHGYD 241
A N+L+ ED ++IADFG++ RD+ + T G P WMAPE + D Y
Sbjct: 162 ARNVLVTEDNVMKIADFGLA------RDVHNIDYYKKTTNGRLPVKWMAPEAL-FDRVYT 214
Query: 242 FKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTF 300
++D+WS G+ E+ T G +PY P ++ L + D+
Sbjct: 215 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE---------GHRMDKPANCTHEL 265
Query: 301 RKMISDCLQKDPTKRPTASELLKN 324
++ +C P++RPT +L+++
Sbjct: 266 YMIMRECWHAVPSQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 55/183 (30%), Positives = 83/183 (45%), Gaps = 39/183 (21%)
Query: 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170
VV SF K L+L++ L GG ++ ++ K + +E T + VL +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK-------KDTLTEEETQFYIAETVL-AI 114
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG------RDL----------- 213
+ H G IHRDIK N+LL G V+++DFG+ L R+L
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 214 -------------SRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260
+R+++ + VGTP ++APEV Q GY+ D WSLG+ EM G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGY 233
Query: 261 APY 263
P+
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 61/250 (24%), Positives = 110/250 (44%), Gaps = 28/250 (11%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSL 136
K A+K + ++ + L+ E++ MS +HEN+V + + + ++ G L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 137 LDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196
L+ ++ + + + + +V KG+ + S IHRD+ A N+LL V
Sbjct: 127 LNFLRRK------RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIV 180
Query: 197 QIADFGVSAWLATGRDL---SRQKVR-HTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252
+I DFG++ RD+ S V+ + + WMAPE + + Y F++D+WS GI
Sbjct: 181 KICDFGLA------RDIMNDSNYVVKGNARLPVK-WMAPESI-FNCVYTFESDVWSYGIL 232
Query: 253 AIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311
E+ + G+ PY P ++ A + Y ++ C D
Sbjct: 233 LWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIY--------DIMKTCWDAD 284
Query: 312 PTKRPTASEL 321
P KRPT ++
Sbjct: 285 PLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 65/241 (26%), Positives = 107/241 (44%), Gaps = 40/241 (16%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ Y+V +VIG GA V V H + K A K K +++
Sbjct: 43 EDYDVVKVIGRGAFGEVQ------------------LVRHKSSQKVYAMKLLSKFEMIKR 84
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+++ +E M+ + VV +F L++V+ + GG L++++ SN
Sbjct: 85 SDSAF--FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM------SN 136
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
E EV+ L+ HS G IHRD+K N+LL + G +++ADFG
Sbjct: 137 YD---VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG------ 187
Query: 209 TGRDLSRQKVRH--TFVGTPCWMAPEVMEQDHG---YDFKADIWSLGITAIEMATGTAPY 263
T + + T VGTP +++PEV++ G Y + D WS+G+ EM G P+
Sbjct: 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
Query: 264 H 264
+
Sbjct: 248 Y 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 71/275 (25%), Positives = 112/275 (40%), Gaps = 49/275 (17%)
Query: 98 KEIQAMSSCHHENVVTYHTSFV--VKDELWLVLRLLEGGSLLDIIK-HRLKISNCKHGVC 154
+EI + H NV++ F+ ++WL+ E L IIK HR +N K
Sbjct: 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 105
Query: 155 DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL----GEDGTVQIADFGVSAWLATG 210
+ ++L ++L G+ Y H+N +HRD+K NIL+ E G V+IAD G + +
Sbjct: 106 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS- 164
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG----------- 259
L V T + APE++ Y DIW++G E+ T
Sbjct: 165 -PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223
Query: 260 --TAPYH-----------------------KYPAMKVLMLTLQNDPPTLDT--GAAEKDQ 292
+ PYH K P LM + + T + EK +
Sbjct: 224 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 283
Query: 293 YKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
K K F ++ L DP KR T+ + +++P+F
Sbjct: 284 VKPDSKAFH-LLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 80/351 (22%), Positives = 122/351 (34%), Gaps = 109/351 (31%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
D YE E IG G V+ A K + A+KK L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRL------------------------ 36
Query: 89 WNTSMDE------LLKEI---QAMSSCHH-------ENVVTYHTSFVVKDELWLVLRLLE 132
MDE L+EI Q +S + E+V + K L+LV L+
Sbjct: 37 ---EMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG----KPSLYLVFEYLD 89
Query: 133 GGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE 192
+ + TI + + ++LKG+ + H +G +HRD+K N+L+ +
Sbjct: 90 SDLKKFMDSNGRGPGR----PLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK 145
Query: 193 D-GTVQIADFGVSAWLATGRDLS--RQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSL 249
G ++IAD G+ GR S + H V T + APEV+ Y DIWS+
Sbjct: 146 QKGLLKIADLGL------GRAFSIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSV 198
Query: 250 GITAIEMATGTA---------------------------------PYHKYPAMKVLMLTL 276
G EM+ +H++P K L
Sbjct: 199 GCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWK--PQDL 256
Query: 277 QNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
P L + ++ L+ DP KR +A L +P+F
Sbjct: 257 SRAVPDLSPEGLD-------------LLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 74/275 (26%), Positives = 113/275 (41%), Gaps = 49/275 (17%)
Query: 98 KEIQAMSSCHHENVVTYHTSFVVKDE--LWLVLRLLEGGSLLDIIK-HRLKISNCKHGVC 154
+EI + H NV+ F+ + +WL+ E L IIK HR +N K
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQL 105
Query: 155 DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL----GEDGTVQIADFGVSAWLATG 210
+ ++L ++L G+ Y H+N +HRD+K NIL+ E G V+IAD G + +
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS- 164
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG----------- 259
L V T + APE++ Y DIW++G E+ T
Sbjct: 165 -PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223
Query: 260 --TAPYHK-----------YPAMKVL--------MLTLQNDPPTLDTGAA------EKDQ 292
+ P+H +PA K TLQ D + EK +
Sbjct: 224 KTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHK 283
Query: 293 YKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
K K F ++ L DPTKR T+ + L++P+F
Sbjct: 284 VKPDSKVFL-LLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 50/198 (25%)
Query: 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLD-IIKHRLKISNCKHGVCDEPT--- 158
++ + VV + SF ++ L+L++ L GG ++ ++K K +E T
Sbjct: 55 LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK--------KDTFTEEETRFY 106
Query: 159 IATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL----------- 207
IA E + ++ H G IHRDIK N+LL G ++++DFG+ L
Sbjct: 107 IA----ETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162
Query: 208 -----------ATGRDLSRQKVRHTF-----------VGTPCWMAPEVMEQDHGYDFKAD 245
+ +S ++ T+ VGTP ++APEV Q GY+ + D
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECD 221
Query: 246 IWSLGITAIEMATGTAPY 263
WSLG+ EM G P+
Sbjct: 222 WWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 40/207 (19%)
Query: 76 AEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN-----------VVTYHTSFVVKDEL 124
A+K KI L KW E+LK +A ++C E + T H +F ++ L
Sbjct: 25 ADKVFAMKI-LNKW-----EMLK--RAETACFREERDVLVNGDNQWITTLHYAFQDENNL 76
Query: 125 WLVLRLLEGGSLLDII---KHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181
+LV+ GG LL ++ + RL E L E++ ++ H +HR
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLP----------EDMARFYLAEMVIAIDSVHQLHYVHR 126
Query: 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEV---MEQDH 238
DIK NIL+ +G +++ADFG + L D + Q VGTP +++PE+ ME
Sbjct: 127 DIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQS--SVAVGTPDYISPEILQAMEDGK 182
Query: 239 G-YDFKADIWSLGITAIEMATGTAPYH 264
G Y + D WSLG+ EM G P++
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 52/169 (30%), Positives = 79/169 (46%), Gaps = 36/169 (21%)
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVG 224
++ G+EY + IHRD+ A N +L ED TV +ADFG+S + +G D RQ
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQG---RIAK 176
Query: 225 TPC-WMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPT 282
P W+A E + D Y K+D+W+ G+T E+AT G P YP ++N
Sbjct: 177 MPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTP---YPG-------VEN---- 221
Query: 283 LDTGAAEKDQYKAYGKTFRK----------MISDCLQKDPTKRPTASEL 321
E Y +G ++ ++ C + DP RPT ++L
Sbjct: 222 -----HEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKL 265
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 51/167 (30%), Positives = 83/167 (49%), Gaps = 20/167 (11%)
Query: 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATV 162
M+ + E +V H +F L++V+ + GG L++++ SN E
Sbjct: 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM------SNYD---IPEKWARFY 147
Query: 163 LREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRH-- 220
EV+ L+ HS G IHRD+K N+LL + G +++ADFG T + +
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG------TCMKMDANGMVRCD 201
Query: 221 TFVGTPCWMAPEVME---QDHGYDFKADIWSLGITAIEMATGTAPYH 264
T VGTP +++PEV++ D Y + D WS+G+ EM G P++
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 22/209 (10%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
A V+ K + A+K I L++ + ++E + H N+V H K+ L
Sbjct: 19 ATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78
Query: 125 WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
LV + + KH G + L ++L+GL Y H +HRD+K
Sbjct: 79 TLVFEYVHTDLCQYMDKHP--------GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLK 130
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTF---VGTPCWMAPEVMEQDHGYD 241
N+L+ + G +++ADFG++ ++ HT+ V T + P+V+ Y
Sbjct: 131 PQNLLISDTGELKLADFGLAR--------AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 242 FKADIWSLGITAIEMATGTAPYHKYPAMK 270
D+W +G +EM G A +P MK
Sbjct: 183 TCLDMWGVGCIFVEMIQGVA---AFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 71/277 (25%), Positives = 107/277 (38%), Gaps = 39/277 (14%)
Query: 61 KINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVV 120
K+ L H KAR +K++ L+E+Q +H NV+ +
Sbjct: 10 KVLLGEAHRGMSKARV---VVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE 66
Query: 121 KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLR---EVLKGLEYFHSNG 177
LVL G L K+ L+ + + V + R EV GL + H
Sbjct: 67 SIPYLLVLEFCPLGDL----KNYLR--SNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 178 QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQ 236
IH D+ N L D +V+I D+G+ A D K H P W+APE++E
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGL-ALEQYPEDYYITKDCHAV---PLRWLAPELVEI 176
Query: 237 DHGYDFKAD------IWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQN-----DPPTLD 284
D IWSLG+T E+ T PY +VL ++ P LD
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236
Query: 285 TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
+++ + +++ C DP RPTA E+
Sbjct: 237 LKYSDR---------WYEVMQFCWL-DPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 42/242 (17%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ YEV +VIG GA V V H + K A K K +++
Sbjct: 43 EDYEVVKVIGRGAFGEVQ------------------LVRHKSTRKVYAMKLLSKFEMIKR 84
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+++ +E M+ + VV +F L++V+ + GG L++++ +
Sbjct: 85 SDSAF--FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY----- 137
Query: 149 CKHGVCDEPT--IATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
D P EV+ L+ HS G IHRD+K N+LL + G +++ADFG
Sbjct: 138 ------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-- 189
Query: 207 LATGRDLSRQKVR-HTFVGTPCWMAPEVMEQDHG---YDFKADIWSLGITAIEMATGTAP 262
+ ++ VR T VGTP +++PEV++ G Y + D WS+G+ EM G P
Sbjct: 190 MKMNKE---GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
Query: 263 YH 264
++
Sbjct: 247 FY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 38/99 (38%), Positives = 56/99 (56%), Gaps = 7/99 (7%)
Query: 158 TIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK 217
TI ++R+ L+GL++ H+N +HRD+K NIL+ G V++ADFG++ R S Q
Sbjct: 109 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA------RIYSCQM 162
Query: 218 VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256
V T + APEV+ Q Y D+WS+G EM
Sbjct: 163 ALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 75/314 (23%), Positives = 128/314 (40%), Gaps = 57/314 (18%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
E +++ +V+G GA V+ EK I AIK++
Sbjct: 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP------------------VAIKELREA 47
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ E+L E M+S + +V + + L+ +L+ G LLD ++
Sbjct: 48 TSPKANKEILDEAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREH---- 102
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
K + + + + ++ KG+ Y +HRD+ A N+L+ V+I DFG++ L
Sbjct: 103 --KDNIGSQYLLNWCV-QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159
Query: 208 ATGRDLSRQKVRHTFVG-TPC-WMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYH 264
+ +K H G P WMA E + Y ++D+WS G+T E+ T G+ PY
Sbjct: 160 G-----ADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD 213
Query: 265 KYPAMKVLMLTLQND----PP--TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA 318
PA ++ + + + PP T+D ++ C D RP
Sbjct: 214 GIPASEISSILEKGERLPQPPICTIDV---------------YMIMVKCWMIDADSRPKF 258
Query: 319 SELLKNPFFKKAKD 332
EL+ F K A+D
Sbjct: 259 RELIIE-FSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 58/232 (25%), Positives = 112/232 (48%), Gaps = 36/232 (15%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+++EV V+G GA VV KC K+ E AIKK +
Sbjct: 1 NKFEVLGVVGEGAYGVVL---------KCRHKETK-------------EIVAIKKFKDSE 38
Query: 89 WNTSMDEL-LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
N + E L+E++ + + EN+V +F + +L+LV +E ++L++++
Sbjct: 39 ENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEM---- 93
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
+GV E + + + +++K + + H N +HRDIK N+L+ + +++ DFG + L
Sbjct: 94 --PNGVPPE-KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL 150
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259
+ G + + + +V T + +PE++ Y D+WS+G E++ G
Sbjct: 151 SEGSNANYTE----YVATRWYRSPELL-LGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 68/258 (26%), Positives = 112/258 (43%), Gaps = 40/258 (15%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
A+K + + T+ ++ LKEI+ MS + N++ V D L ++ +E G L
Sbjct: 48 AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQF 107
Query: 140 IKHR-----LKISNCKHGVCDEPTIATVLR---EVLKGLEYFHSNGQIHRDIKAGNILLG 191
+ R +N V +IA +L ++ G++Y S +HRD+ N L+G
Sbjct: 108 LSQREIESTFTHANNIPSV----SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYDFKADIWSLG 250
T++IADFG+S L +G D R + R P WMA E + + +D+W+ G
Sbjct: 164 NHYTIKIADFGMSRNLYSG-DYYRIQGRAVL---PIRWMAWESILLGK-FTTASDVWAFG 218
Query: 251 ITAIEMAT--GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY---------GKT 299
+T EM T PY L ++ +TG ++Q +
Sbjct: 219 VTLWEMFTLCKEQPYS----------LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPV 268
Query: 300 FRKMISDCLQKDPTKRPT 317
F+ M+ C +D RPT
Sbjct: 269 FKLMMR-CWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 24/170 (14%)
Query: 158 TIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQ- 216
+ + ++ G+EY S IHRD+ A N +L E+ V +ADFG+S + G D RQ
Sbjct: 113 MLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG-DYYRQG 171
Query: 217 KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLT 275
++ V W+A E + D Y K+D+WS G+T E+AT G PY ++
Sbjct: 172 RIAKMPVK---WIAIESL-ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227
Query: 276 LQND----PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
Q + PP G ++S C +P RP+ L
Sbjct: 228 RQGNRLKQPPDCLDGLYS-------------LMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 32/241 (13%)
Query: 95 ELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVC 154
+ L+E Q S H N++ LV+ G L ++ K
Sbjct: 41 KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELM---TP 97
Query: 155 DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLS 214
D T+ + E+ GL + H N IH D+ N LL D TV+I D+G LS
Sbjct: 98 DPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYG----------LS 147
Query: 215 RQKVRHTFVGTP-------CWMAPEVMEQDHGYDFKAD------IWSLGITAIEM-ATGT 260
K + + TP W+APE++++ HG D +WSLG+T E+ G+
Sbjct: 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGS 207
Query: 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320
PY +VL T++ L + + + + M LQ P +RP+A E
Sbjct: 208 QPYRHLSDEQVLTYTVREQQLKL---PKPRLKLPLSDRWYEVMQFCWLQ--PEQRPSAEE 262
Query: 321 L 321
+
Sbjct: 263 V 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 69/310 (22%), Positives = 114/310 (36%), Gaps = 80/310 (25%)
Query: 32 EVREVIGFGATAVVHSA-YCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
+ IG G V+ Y EK I +AV CK +K
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEK-----IAVAV---KTCKNCTSPSVREKF------ 54
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLL---EGGSLLDIIKHRLKIS 147
L+E M H ++V + ++ +W+V+ L E S L + K+ L ++
Sbjct: 55 ------LQEAYIMRQFDHPHIVKL-IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLA 107
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
++ ++ L Y S +HRDI A N+L+ V++ DFG+S +
Sbjct: 108 ----------SLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY- 156
Query: 208 ATGRDLSRQKVRHTFVGT-PC-WMAPEVMEQDHGYDFK-----ADIWSLGITAIE-MATG 259
L + G P WMAPE + +F+ +D+W G+ E + G
Sbjct: 157 -----LEDESYYKASKGKLPIKWMAPESI------NFRRFTSASDVWMFGVCMWEILMLG 205
Query: 260 TAPYHKYPAMKVLMLTLQND--------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311
P+ V+ + PPTL + +++ C D
Sbjct: 206 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS-----------------LMTKCWAYD 248
Query: 312 PTKRPTASEL 321
P+KRP +EL
Sbjct: 249 PSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 38/245 (15%)
Query: 94 DELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVL-RLLEGGSLLDIIKHRLKISNCKHG 152
E +E + MS H N+V K++ +L L G L + + S+
Sbjct: 53 QEFRQEAELMSDLQHPNIVCL-LGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111
Query: 153 VCDEPTIATVLR---------EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
DE T+ + L ++ G+EY S+ +HRD+ A N L+GE TV+I+DFG+
Sbjct: 112 SGDE-TVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGL 170
Query: 204 SAWLATGRDLSRQKVRHTFVGTPC-WMAPE-VMEQDHGYDF--KADIWSLGITAIEM-AT 258
S + + D R + + P WM PE ++ F ++DIWS G+ E+ +
Sbjct: 171 SRDIYSA-DYYRVQSKSLL---PVRWMPPEAILY----GKFTTESDIWSFGVVLWEIFSY 222
Query: 259 GTAPYHKYPAMKVLML--TLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
G PY+ + +V+ + + Q P D A + MI +C + P +RP
Sbjct: 223 GLQPYYGFSNQEVIEMIRSRQLLPCPEDCPAR----------VYALMI-ECWNEIPARRP 271
Query: 317 TASEL 321
++
Sbjct: 272 RFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 40/187 (21%)
Query: 96 LLKEIQAMSSCHHENVVT-YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVC 154
LL+E + H+N++ H + +++ + G+L +L + C+ G
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNL------KLFLQQCRLGEA 108
Query: 155 DEP----TIATVLR--EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
+ P T V ++ G+ Y H G IH+DI A N ++ E+ V+I D +S
Sbjct: 109 NNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS---- 164
Query: 209 TGRDL-----------SRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257
RDL + V+ WMA E + Y +D+WS G+ E+
Sbjct: 165 --RDLFPMDYHCLGDNENRPVK--------WMALESLVNKE-YSSASDVWSFGVLLWELM 213
Query: 258 T-GTAPY 263
T G PY
Sbjct: 214 TLGQTPY 220
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 63/263 (23%), Positives = 115/263 (43%), Gaps = 47/263 (17%)
Query: 76 AEKCAIKKI----NLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLL 131
A+ AIK + N ++W E +E M+ HH N+V + + ++ L
Sbjct: 34 AQLVAIKTLKDINNPQQWG----EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89
Query: 132 EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLR---------EVLKGLEYFHSNGQIHRD 182
G L + + R S+ ++ T+ + L ++ G+EY S+ +H+D
Sbjct: 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKD 149
Query: 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF 242
+ A NIL+GE V+I+D G+S + + D R V+ + WM PE + +
Sbjct: 150 LAARNILIGEQLHVKISDLGLSREIYSA-DYYR--VQPKSLLPIRWMPPEAIMYGK-FSS 205
Query: 243 KADIWSLGITAIEMAT-GTAPYHKYPAMKVL-------MLTLQND-PPTLDTGAAEKDQY 293
+DIWS G+ E+ + G PY+ + +V+ +L D PP +
Sbjct: 206 DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRM---------- 255
Query: 294 KAYGKTFRKMISDCLQKDPTKRP 316
++++C Q+ P++RP
Sbjct: 256 -------YSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 58 AIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTS 117
A K+ L + + E A+K + N + + +E + +++ HEN+V ++
Sbjct: 17 AFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGV 76
Query: 118 FVVKDELWLVLRLLEGGSLLDIIK------HRLKISNCKHGVCDEPTIATVLREVLKGLE 171
D +V +E G L ++ LK + G + + ++ G+
Sbjct: 77 CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMV 136
Query: 172 YFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDL---SRQKVRHTFVGTPCW 228
Y S +HRD+ N L+G D V+I DFG+S RD+ +V + W
Sbjct: 137 YLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RDVYTTDYYRVGGHTMLPIRW 190
Query: 229 MAPE-VMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKY 266
M PE +M + + ++D+WS G+ E+ T G P++
Sbjct: 191 MPPESIMYRK--FTTESDVWSFGVVLWEIFTYGKQPWYGL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 61/241 (25%), Positives = 101/241 (41%), Gaps = 43/241 (17%)
Query: 94 DELLKEIQAMSSCHHENVVTYHTSFVVKDE-LWLVLRLLEGGSLLDIIKHRLKISNCKHG 152
+ L E M H N++ V K + ++ +E GSL ++
Sbjct: 50 LDFLTEASIMGQFDHPNII-RLEGVVTKSRPVMIITEYMENGSLDKFLREN--------- 99
Query: 153 VCDEPTIATVLREVL----KGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
D L +L G++Y +HRD+ A NIL+ + +++DFG+S
Sbjct: 100 --DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS---- 153
Query: 209 TGRDLSRQKVRHTFVG--TPC-WMAPEVMEQDHGYDFKADIWSLGITAIE-MATGTAPYH 264
R L + +T G P W APE + + +D+WS GI E M+ G PY
Sbjct: 154 --RRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYW 210
Query: 265 KYPAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
V + +++ PP +D +A ++ M+ DC QKD +RPT S++
Sbjct: 211 DMSNQDV-IKAVEDGYRLPPPMDCPSA----------LYQLML-DCWQKDRNERPTFSQI 258
Query: 322 L 322
+
Sbjct: 259 V 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 36/99 (36%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 158 TIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK 217
TI ++ ++L+GL++ HS+ +HRD+K NIL+ G +++ADFG++ R S Q
Sbjct: 111 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------RIYSFQM 164
Query: 218 VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256
+ V T + APEV+ Q Y D+WS+G EM
Sbjct: 165 ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 83/329 (25%), Positives = 131/329 (39%), Gaps = 64/329 (19%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
Y++ +IG G+ VV+ A C +EK AIKK V+ K R
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKK----VLQDPQYKNR--------------- 108
Query: 91 TSMDELLKEIQAMSSCHHENVV----TYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI 146
E+ M + +H N++ Y+T K+E + L ++ + K+
Sbjct: 109 --------ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHY 160
Query: 147 SNCKHGVCDEPTIATVLR--EVLKGLEYFHSNGQIHRDIKAGNILLGEDG-TVQIADFGV 203
+ H + P L ++ + L Y HS HRD+K N+L+ + T+++ DFG
Sbjct: 161 ARNNHAL---PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217
Query: 204 SAWLATG-RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262
+ L G R +S ++ + + APE+M Y D+WSLG EM G
Sbjct: 218 AKNLLAGQRSVS-------YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPI 270
Query: 263 YHKYPAMKVLMLTLQN-DPPTLDTGAAEKDQY----------KAYGKTFRK--------M 303
+ ++ L+ +Q PT D Y K K F K
Sbjct: 271 FSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINF 330
Query: 304 ISDCLQKDPTKRPTASELLKNPFFKKAKD 332
IS L+ +P KR E L +PFF +D
Sbjct: 331 ISQFLKYEPLKRLNPIEALADPFFDDLRD 359
|
Length = 440 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 61/241 (25%), Positives = 100/241 (41%), Gaps = 42/241 (17%)
Query: 95 ELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVC 154
+ L E + + H N+V + +++V+ L+ GG L ++ +
Sbjct: 38 KFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK---------- 87
Query: 155 DEPTIATVLR---EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGR 211
DE +++ + G+ Y S IHRD+ A N L+GE+ ++I+DFG
Sbjct: 88 DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFG--------- 138
Query: 212 DLSRQKVRHTFVGTPC------WMAPEVMEQDHG-YDFKADIWSLGITAIE-MATGTAPY 263
+SRQ+ + + W APE + ++G Y ++D+WS GI E + G P
Sbjct: 139 -MSRQEDDGIYSSSGLKQIPIKWTAPEAL--NYGRYSSESDVWSYGILLWETFSLGVCP- 194
Query: 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
YP M T Q ++ G K ++ M C P RP SEL K
Sbjct: 195 --YPGM-----TNQQAREQVEKGYRMSCPQKCPDDVYKVM-QRCWDYKPENRPKFSELQK 246
Query: 324 N 324
Sbjct: 247 E 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 28/256 (10%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMS--SCHHENVVTYHTSFVVKDELWLVLRLLEGGS 135
+ AIK +N E L E M +CHH VV +++ L+ G
Sbjct: 38 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGD 95
Query: 136 LLDIIKHRLKISNCKHGVCDEPTIATVLR---EVLKGLEYFHSNGQIHRDIKAGNILLGE 192
L ++ L+ + V P++ +++ E+ G+ Y ++N +HRD+ A N ++ E
Sbjct: 96 LKSYLR-SLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 154
Query: 193 DGTVQIADFGVSAWLATGRDLSRQK-VRHTFVG-TPC-WMAPEVMEQDHGYDFKADIWSL 249
D TV+I DFG++ RD+ R G P WM+PE + +D + +D+WS
Sbjct: 155 DFTVKIGDFGMT------RDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSF 207
Query: 250 GITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCL 308
G+ E+AT PY +VL ++ G +K +++ C
Sbjct: 208 GVVLWEIATLAEQPYQGMSNEQVLRFVMEG-------GLLDKPDNCP--DMLFELMRMCW 258
Query: 309 QKDPTKRPTASELLKN 324
Q +P RP+ E++ +
Sbjct: 259 QYNPKMRPSFLEIISS 274
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 56/254 (22%), Positives = 108/254 (42%), Gaps = 31/254 (12%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
+K + K E +E+ H+NVV + +++L + G L
Sbjct: 39 LVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL--- 95
Query: 140 IKHRLKISNCKHGVCDEPTIATVLR-----EVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194
K L+ + K P ++T + ++ G+++ + +HRD+ A N L+
Sbjct: 96 -KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR 154
Query: 195 TVQIADFGVSAWLATGRDLSRQ---KVRHTFVGTPC-WMAPEVMEQDHGYDFKADIWSLG 250
V+++ +S +D+ K+R+ + P W+APE +++D + K+D+WS G
Sbjct: 155 EVKVSLLSLS------KDVYNSEYYKLRNALI--PLRWLAPEAVQEDD-FSTKSDVWSFG 205
Query: 251 ITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQ 309
+ E+ T G P++ +VL L G E + K+++ C
Sbjct: 206 VLMWEVFTQGELPFYGLSDEEVLN--------RLQAGKLELPVPEGCPSRLYKLMTRCWA 257
Query: 310 KDPTKRPTASELLK 323
+P RP+ SEL+
Sbjct: 258 VNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 52/201 (25%), Positives = 80/201 (39%), Gaps = 33/201 (16%)
Query: 158 TIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK 217
T+ R +L+ L Y H G IHRD+K NI L E + DFG + L D +
Sbjct: 186 QAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC- 244
Query: 218 VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH--KYPA----MKV 271
+ + GT +PE++ D Y K DIWS G+ EM+ + + ++
Sbjct: 245 --YGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS 301
Query: 272 LMLTLQNDP---PTLDTGAAEKDQYKAYGKTFRK-------------------MISDCLQ 309
++ +Q P P + K +K Y R +I+ L
Sbjct: 302 IIRCMQVHPLEFPQNGSTNLCK-HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLT 360
Query: 310 KDPTKRPTASELLKNPFFKKA 330
D RP+A ++L P F K
Sbjct: 361 FDQEFRPSAQDILSLPLFTKE 381
|
Length = 392 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 30/191 (15%)
Query: 162 VLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHT 221
+++++L +EY H IHRDIK NI L DG + + DFG A + R+ +
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGT----AMPFEKEREAFDYG 327
Query: 222 FVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT--------GTAPYHKYPAMKVLM 273
+VGT +PE++ D GY DIWS G+ ++M + G K +
Sbjct: 328 WVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386
Query: 274 LTLQN----DPPTLDTGAAEKDQYKAYGKTFRKMISDC-------------LQKDPTKRP 316
L++ + DPP + + G + +I + L D RP
Sbjct: 387 LSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP 446
Query: 317 TASELLKNPFF 327
A+ELL P F
Sbjct: 447 GAAELLALPLF 457
|
Length = 501 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 51/235 (21%), Positives = 93/235 (39%), Gaps = 23/235 (9%)
Query: 98 KEIQAMSSCHHENVVTYHTSFVVKDE-LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDE 156
+E + +H N+V S L+ V + G +L +++ G
Sbjct: 27 RETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLA--------ADGALPA 78
Query: 157 PTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT---VQIADFGVSAWLATGRDL 213
++ +VL L H+ G +HRD+K NI++ + G ++ DFG+ L RD
Sbjct: 79 GETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138
Query: 214 SRQKV--RHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKV 271
+ +GTP + APE + + +D+++ G+ +E TG ++
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEI 197
Query: 272 LMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
L L +L A G +++ L KDP +R ++ L F
Sbjct: 198 LYQQLSPVDVSLPPWIA--------GHPLGQVLRKALNKDPRQRAASAPALAERF 244
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 73 KARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLE 132
K R A+K + + + ++ LKE++ +S N++ V +D L ++ +E
Sbjct: 43 KGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYME 102
Query: 133 GGSLLDIIKHRLKISNCKHG-----------VCDEPTIATVLREVLKGLEYFHSNGQIHR 181
G L + ++G ++ V ++ G++Y S +HR
Sbjct: 103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162
Query: 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGY 240
D+ N L+GE+ T++IADFG+S L G D R + R P WMA E + +
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSRNLYAG-DYYRIQGRAVL---PIRWMAWECILMGK-F 217
Query: 241 DFKADIWSLGITAIEM 256
+D+W+ G+T E+
Sbjct: 218 TTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 63/259 (24%), Positives = 119/259 (45%), Gaps = 35/259 (13%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
A+K + + + ++ LKEI+ MS N++ + D L ++ +E G L
Sbjct: 50 AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109
Query: 140 I-KHRLKISNCKHGVCDEPTIA-TVLR----EVLKGLEYFHSNGQIHRDIKAGNILLGED 193
+ +H + + K D TI+ + L ++ G++Y S +HRD+ N L+G++
Sbjct: 110 LSRHEPQEAAEKA---DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN 166
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYDFKADIWSLGIT 252
T++IADFG+S L +G D R + R P WM+ E + + +D+W+ G+T
Sbjct: 167 YTIKIADFGMSRNLYSG-DYYRIQGRAVL---PIRWMSWESILLGK-FTTASDVWAFGVT 221
Query: 253 AIEMAT--GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY--------GKTFRK 302
E+ T PY + +V+ +TG +DQ + + K
Sbjct: 222 LWEILTLCKEQPYSQLSDEQVIE----------NTGEFFRDQGRQVYLPKPALCPDSLYK 271
Query: 303 MISDCLQKDPTKRPTASEL 321
++ C +++ +RP+ E+
Sbjct: 272 LMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/254 (23%), Positives = 102/254 (40%), Gaps = 47/254 (18%)
Query: 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHR--------LKISNCKHGVCDEPT 158
HH N++ + + L+L + G+LLD ++ I+N
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 159 IATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS--AWLATGRDLSRQ 216
+ +V +G++Y IHRD+ A NIL+GE+ +IADFG+S + + + R
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 185
Query: 217 KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP---------YHKY 266
VR WMA E + Y +D+WS G+ E+ + G P Y K
Sbjct: 186 PVR--------WMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
Query: 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
P L L D D ++ C ++ P +RP+ +++L +
Sbjct: 237 PQGYRLEKPLNCDDEVYD------------------LMRQCWREKPYERPSFAQILVSLN 278
Query: 327 FKKAKDKKFIQQTL 340
+ K ++ TL
Sbjct: 279 RMLEERKTYVNTTL 292
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 20/168 (11%)
Query: 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN-----CKHGVCDEPTIAT 161
HH N++ + + L+L + G+LLD ++ + + +
Sbjct: 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 162 VLR---EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS--AWLATGRDLSRQ 216
+L +V +G++Y IHRD+ A NIL+GE+ +IADFG+S + + + R
Sbjct: 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 217 KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPY 263
VR WMA E + Y +D+WS G+ E+ + G PY
Sbjct: 174 PVR--------WMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 16/194 (8%)
Query: 73 KARAEKCAIKKINLEKWNTSM-DELLKEIQAMSSCHHENVVTYHTSFVVKDELW-LVLRL 130
K + A+K + + + ++ DELL+E M + +V + + E W LV+ L
Sbjct: 19 KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIV--RMIGICEAESWMLVMEL 76
Query: 131 LEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190
E G L ++ ++ E I ++ +V G++Y +HRD+ A N+LL
Sbjct: 77 AELGPLNKFLQKNKHVT--------EKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL 128
Query: 191 GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG 250
+I+DFG+S A G D + K + W APE M + + K+D+WS G
Sbjct: 129 VTQHYAKISDFGLSK--ALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFG 185
Query: 251 ITAIE-MATGTAPY 263
+ E + G PY
Sbjct: 186 VLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 34/107 (31%), Positives = 48/107 (44%), Gaps = 4/107 (3%)
Query: 155 DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLS 214
+ V R++L ++Y H G IHRDIK N+L+ + + DFG + +
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-- 315
Query: 215 RQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261
+ GT APEV+ D Y DIWS G+ E A TA
Sbjct: 316 -TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTA 360
|
Length = 461 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 47/195 (24%), Positives = 80/195 (41%), Gaps = 13/195 (6%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
A V+ + + A+K I+++ ++E + H N+V H K+ L
Sbjct: 19 ATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78
Query: 125 WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
V + +I+H + + + ++L+GL Y H +HRD+K
Sbjct: 79 TFVFEYMHTDLAQYMIQHPGGLHPY--------NVRLFMFQLLRGLAYIHGQHILHRDLK 130
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
N+L+ G +++ADFG LA + + Q V T + P+V+ Y
Sbjct: 131 PQNLLISYLGELKLADFG----LARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSAL 185
Query: 245 DIWSLGITAIEMATG 259
DIW G IEM G
Sbjct: 186 DIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 60/226 (26%), Positives = 90/226 (39%), Gaps = 42/226 (18%)
Query: 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKG 169
N+V H V +D ++LVL+ EGG L I L I E + E++
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP--------EECVKRWAAEMVVA 97
Query: 170 LEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWM 229
L+ H G + RD+ NILL + G +Q+ F W + V + +
Sbjct: 98 LDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENMYC------ 149
Query: 230 APEV---MEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTG 286
APEV E+ D+ WSLG E+ TG +P+ TL N P +
Sbjct: 150 APEVGGISEETEACDW----WSLGAILFELLTGKTLVECHPSGINTHTTL-NIPEWVSEE 204
Query: 287 AAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA-----SELLKNPFF 327
A R ++ LQ +PT+R A ++ +PFF
Sbjct: 205 A-------------RSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 20/168 (11%)
Query: 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDII-KHRLKISNC----KHGVCDEPTIAT 161
HH N++ + + L++ + G+LLD + K R+ ++ +HG T
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 162 VLR---EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS--AWLATGRDLSRQ 216
+L+ +V G++Y IHRD+ A N+L+GE+ +IADFG+S + + + R
Sbjct: 121 LLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180
Query: 217 KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPY 263
VR WMA E + Y K+D+WS G+ E+ + G PY
Sbjct: 181 PVR--------WMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 61/253 (24%), Positives = 111/253 (43%), Gaps = 23/253 (9%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
A+K + + + + ++ LKE++ +S N+ V L +++ +E G L
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 140 I-KHRLKISNCKHGVCDEPTIATVLR---EVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195
+ KH + S + +T+L ++ G+ Y S +HRD+ N L+G++ T
Sbjct: 110 LQKHVAETSGLACNS-KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT 168
Query: 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPC---WMAPEVMEQDHGYDFKADIWSLGIT 252
++IADFG+S L + D R + R P WMA E + + K+D+W+ G+T
Sbjct: 169 IKIADFGMSRNLYSS-DYYRVQGR-----APLPIRWMAWESVLLGK-FTTKSDVWAFGVT 221
Query: 253 AIEMAT--GTAPYHKYPAMKVL--MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCL 308
E+ T PY +V+ D D + K +++ +C
Sbjct: 222 LWEILTLCREQPYEHLTDQQVIENAGHFFRD----DGRQIYLPRPPNCPKDIYELMLECW 277
Query: 309 QKDPTKRPTASEL 321
++D RPT E+
Sbjct: 278 RRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 51/179 (28%)
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV-------SAWLATGRDLSRQK 217
+V KG+ + S IHRD+ A NILL +I DFG+ S ++ G +R
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN--ARLP 279
Query: 218 VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM-ATGTAPYHKYPAMKVLMLTL 276
V+ WMAPE + + Y F++D+WS GI E+ + G++P YP M V
Sbjct: 280 VK--------WMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSSP---YPGMPV----- 322
Query: 277 QNDPPTLDTGAAEKDQYKAYGKTFRKM------------ISDCLQKDPTKRPTASELLK 323
+ YK + +R + + C DP KRPT ++++
Sbjct: 323 ------------DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 67/256 (26%), Positives = 109/256 (42%), Gaps = 30/256 (11%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMS--SCHHENVVTYHTSFVVKDELWLV-LRLLEGG 134
+ A+K +N E L E M +CHH V V K + LV + L+ G
Sbjct: 38 RVAVKTVNESASLRERIEFLNEASVMKGFTCHH---VVRLLGVVSKGQPTLVVMELMAHG 94
Query: 135 SLLDIIKHRLKISNCKHGVCDEPTIATVLR---EVLKGLEYFHSNGQIHRDIKAGNILLG 191
L ++ + G PT+ +++ E+ G+ Y ++ +HRD+ A N ++
Sbjct: 95 DLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA 153
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQK-VRHTFVG-TPC-WMAPEVMEQDHGYDFKADIWS 248
D TV+I DFG++ RD+ R G P WMAPE + +D + +D+WS
Sbjct: 154 HDFTVKIGDFGMT------RDIYETDYYRKGGKGLLPVRWMAPESL-KDGVFTTSSDMWS 206
Query: 249 LGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDC 307
G+ E+ + PY +VL +D G DQ + ++ C
Sbjct: 207 FGVVLWEITSLAEQPYQGLSNEQVLKF-------VMDGGYL--DQPDNCPERVTDLMRMC 257
Query: 308 LQKDPTKRPTASELLK 323
Q +P RPT E++
Sbjct: 258 WQFNPKMRPTFLEIVN 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 61/250 (24%), Positives = 102/250 (40%), Gaps = 32/250 (12%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
AIK + + L E M H N++ + +V +E GSL
Sbjct: 36 AIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAF 95
Query: 140 IKHRLKISNCKH-GVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQI 198
++ KH G + +LR + G++Y G +HRD+ A NIL+ + ++
Sbjct: 96 LR--------KHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKV 147
Query: 199 ADFGVSAWLATGRDLSRQKVRHTFVGTPC---WMAPEVMEQDHGYDFKADIWSLGITAIE 255
+DFG+S L + + +T G W APE + + +D+WS GI E
Sbjct: 148 SDFGLSRVLEDDPEAA-----YTTRGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWE 201
Query: 256 -MATGTAPYHKYPAMKVLMLTLQND--PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312
M+ G PY + V+ + P +D AA +++ DC QKD
Sbjct: 202 VMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAA-----------LHQLMLDCWQKDR 250
Query: 313 TKRPTASELL 322
+RP +++
Sbjct: 251 NERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 9e-10
Identities = 54/234 (23%), Positives = 95/234 (40%), Gaps = 28/234 (11%)
Query: 95 ELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVC 154
+ L E M H N++ + ++ +E G+L ++ G
Sbjct: 51 DFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ-------NDGQF 103
Query: 155 DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLS 214
+ +LR + G++Y +HRD+ A NIL+ + +++DFG+S +L D +
Sbjct: 104 TVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL---EDDT 160
Query: 215 RQKVRHTFVGTPC---WMAPEVMEQDHGYDFKADIWSLGITAIE-MATGTAPYHKYPAMK 270
+ +G W APE + + +D+WS GI E M+ G PY
Sbjct: 161 SDPTYTSSLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219
Query: 271 VLMLTLQND--PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
V+ Q+ PP +D A +++ DC QKD RP +++
Sbjct: 220 VINAIEQDYRLPPPMDCPTA-----------LHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 126 LVLRLLEGGSLLDIIK-HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
LV +L+ G LLD ++ ++ +I + + ++ KG+ Y +HRD+
Sbjct: 85 LVTQLMPYGCLLDYVRENKDRIGS--------QDLLNWCVQIAKGMSYLEEVRLVHRDLA 136
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYDFK 243
A N+L+ V+I DFG++ L D+ + P WMA E + + +
Sbjct: 137 ARNVLVKSPNHVKITDFGLARLL----DIDETEYHADGGKVPIKWMALESILHRR-FTHQ 191
Query: 244 ADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRK 302
+D+WS G+T E+ T G PY PA ++ P L+ G +
Sbjct: 192 SDVWSYGVTVWELMTFGAKPYDGIPAREI--------PDLLEKGERLPQPPICTIDVYMI 243
Query: 303 MISDCLQKDPTKRPTASELLKNPFFKKAKD 332
M+ C D RP EL+ + F + A+D
Sbjct: 244 MVK-CWMIDSECRPRFRELV-DEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 51/192 (26%), Positives = 91/192 (47%), Gaps = 22/192 (11%)
Query: 98 KEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIK-HRLKISNCKHGVCDE 156
+E + +++ HE++V ++ V D L +V ++ G L ++ H G +
Sbjct: 56 REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG--NR 113
Query: 157 PTIAT------VLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
P T + +++ G+ Y S +HRD+ N L+GE+ V+I DFG+S
Sbjct: 114 PAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS------ 167
Query: 211 RDL-SRQKVR---HTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHK 265
RD+ S R HT + WM PE + + ++D+WSLG+ E+ T G P+++
Sbjct: 168 RDVYSTDYYRVGGHTMLPIR-WMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225
Query: 266 YPAMKVLMLTLQ 277
+V+ Q
Sbjct: 226 LSNNEVIECITQ 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 56/264 (21%), Positives = 101/264 (38%), Gaps = 42/264 (15%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
A+K + E + +E M+ H N+V V + L+ + G L +
Sbjct: 39 AVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 98
Query: 140 IKHR------------LKISNCKHGVCD--EPTIATVLREVLKGLEYFHSNGQIHRDIKA 185
++HR C + ++V G+ Y +HRD+
Sbjct: 99 LRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158
Query: 186 GNILLGEDGTVQIADFGVSA-------WLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH 238
N L+GE+ V+IADFG+S + A+ D +R WM PE + +
Sbjct: 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI--PIR--------WMPPESIFYNR 208
Query: 239 GYDFKADIWSLGITAIEM-ATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYG 297
Y ++D+W+ G+ E+ + G PY+ +V+ D L + + Y
Sbjct: 209 -YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV--RDGNVL--SCPDNCPLELY- 262
Query: 298 KTFRKMISDCLQKDPTKRPTASEL 321
++ C K P+ RP+ + +
Sbjct: 263 ----NLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVG 224
+V +G+E+ S +HRD+ A N+LL + V+I DFG++ + D + TF+
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIM--HDSNYVSKGSTFLP 302
Query: 225 TPCWMAPEVMEQDHGYDFKADIWSLGITAIEM-ATGTAPYHKYPAMKVLMLTLQNDPPTL 283
WMAPE + D+ Y +D+WS GI E+ + G P YP M ++ T N +
Sbjct: 303 VK-WMAPESI-FDNLYTTLSDVWSYGILLWEIFSLGGTP---YPGM-IVDSTFYN---KI 353
Query: 284 DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT 317
+G A + + M+ C +P KRP+
Sbjct: 354 KSGYRMAKPDHATQEVYDIMVK-CWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 38/108 (35%), Positives = 56/108 (51%), Gaps = 13/108 (12%)
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQ----KVRH 220
+V G+E+ S +HRD+ A N+L+ E V+I DFG++ RD+ R
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA------RDIMRDSNYISKGS 300
Query: 221 TFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYP 267
TF+ WMAPE + + Y +D+WS GI E+ T G PY + P
Sbjct: 301 TFLPLK-WMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELP 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 41/172 (23%)
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV-------SAWLATGRDLSRQK 217
+V +G+++ S IHRD+ A N+LL + +I DFG+ S ++ G +R
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN--ARLP 277
Query: 218 VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM-ATGTAPYHKYPAM------- 269
V+ WMAPE + D Y ++D+WS GI E+ + G +P YP +
Sbjct: 278 VK--------WMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGKSP---YPGILVNSKFY 325
Query: 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
K++ Q P A + Y + KM C +PT+RPT S++
Sbjct: 326 KMVKRGYQMSRPDF----APPEIY-----SIMKM---CWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 37/165 (22%), Positives = 72/165 (43%), Gaps = 25/165 (15%)
Query: 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREV 166
+ N + + S L++ ++ G L D++K K+ E + ++R++
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKL--------SEAEVKKIIRQL 118
Query: 167 LKGLEYFHSNGQIHRDIKAGNILL-GEDGTVQIADFGVSAWLATGRDLSRQKVRHT---F 222
++ L H + IH DIK N+L + + D+G+ K+ T +
Sbjct: 119 VEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC------------KIIGTPSCY 166
Query: 223 VGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267
GT + +PE ++ H YD D W++G+ E+ TG P+ +
Sbjct: 167 DGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 55/243 (22%), Positives = 108/243 (44%), Gaps = 38/243 (15%)
Query: 98 KEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSL-----------LDIIKHRLKI 146
+E + +++ HE++V ++ D L +V ++ G L + ++ + +
Sbjct: 56 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
+ + G+ IA+ ++ G+ Y S +HRD+ N L+G + V+I DFG+S
Sbjct: 116 AKGELGLSQMLHIAS---QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS-- 170
Query: 207 LATGRDL-SRQKVR---HTFVGTPCWMAPE-VMEQDHGYDFKADIWSLGITAIEMAT-GT 260
RD+ S R HT + WM PE +M + + ++D+WS G+ E+ T G
Sbjct: 171 ----RDVYSTDYYRVGGHTMLPIR-WMPPESIMYRK--FTTESDVWSFGVILWEIFTYGK 223
Query: 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320
P+ + +V+ Q ++ + K ++ C Q++P +R E
Sbjct: 224 QPWFQLSNTEVIECITQ---------GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKE 274
Query: 321 LLK 323
+ K
Sbjct: 275 IYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 14/84 (16%)
Query: 124 LWLVLRLLEGG---SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180
++LV+ L GG SLL I +G DE + EV L+Y H +G IH
Sbjct: 79 VYLVMEYLIGGDVKSLLHI-----------YGYFDEEMAVKYISEVALALDYLHRHGIIH 127
Query: 181 RDIKAGNILLGEDGTVQIADFGVS 204
RD+K N+L+ +G +++ DFG+S
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 26/56 (46%), Positives = 34/56 (60%)
Query: 155 DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
D I V+R+VL GL H G +HRDIK N+L+ DG V+I DFG + + TG
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG 362
|
Length = 507 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 63/262 (24%), Positives = 106/262 (40%), Gaps = 35/262 (13%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
AIK +N + E + E M+S H ++V + + LV +L+ G LLD
Sbjct: 40 AIKILNETTGPKANVEFMDEALIMASMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLDY 98
Query: 140 I-KHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQI 198
+ +H+ I + + ++ KG+ Y +HRD+ A N+L+ V+I
Sbjct: 99 VHEHKDNIGS--------QLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKI 150
Query: 199 ADFGVSAWLATGR-----DLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
DFG++ L D + ++ WMA E + + ++D+WS G+T
Sbjct: 151 TDFGLARLLEGDEKEYNADGGKMPIK--------WMALECIHY-RKFTHQSDVWSYGVTI 201
Query: 254 IEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312
E+ T G PY P ++ P L+ G + M+ C D
Sbjct: 202 WELMTFGGKPYDGIPTREI--------PDLLEKGERLPQPPICTIDVYMVMVK-CWMIDA 252
Query: 313 TKRPTASELLKNPFFKKAKDKK 334
RP EL F + A+D +
Sbjct: 253 DSRPKFKELAAE-FSRMARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 53/245 (21%), Positives = 88/245 (35%), Gaps = 58/245 (23%)
Query: 96 LLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKH-GVC 154
L E + H N+V + + +V + G+L ++ KH G
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR--------KHEGQL 104
Query: 155 DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLS 214
+ +L + G++Y G +H+ + A +L+ D +I+ F R L
Sbjct: 105 VAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGF---------RRLQ 155
Query: 215 RQKVRHTFV-----GTPCWMAPEVMEQDHGYDFKADIWSLGITAIE-MATGTAPYHKYPA 268
K + W APE + Q H + +D+WS GI E M+ G PY
Sbjct: 156 EDKSEAIYTTMSGKSPVLWAAPEAI-QYHHFSSASDVWSFGIVMWEVMSYGERPY----- 209
Query: 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFR------------KMISDCLQKDPTKRP 316
D +D KA FR +++ DC QK+ +RP
Sbjct: 210 --------------WDMS--GQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERP 253
Query: 317 TASEL 321
S++
Sbjct: 254 RFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 42/126 (33%), Positives = 64/126 (50%), Gaps = 19/126 (15%)
Query: 121 KDELWLVLRLLEGGS-LLDIIKHRLKISNCK----HGVCDEP--------TIATVLREVL 167
+DE WLV R EG S L D+++ + N + V D P I T++R++L
Sbjct: 207 EDEYWLVWRY-EGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQIL 265
Query: 168 KGLEYFHSNGQIHRDIKAGNILLGE-DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTP 226
L+ HS G +HRD+K NI+ E G+ +I D G +A L G + ++ F+ P
Sbjct: 266 FALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKE----FLLDP 321
Query: 227 CWMAPE 232
+ APE
Sbjct: 322 RYAAPE 327
|
Length = 566 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 58/267 (21%), Positives = 110/267 (41%), Gaps = 24/267 (8%)
Query: 58 AIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTS 117
A K+ LA H+ + A+K + + D +E + ++ H+++V ++
Sbjct: 17 AFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD-FQREAELLTVLQHQHIVRFYGV 75
Query: 118 FVVKDELWLVLRLLEGGSLLDIIKHR---LKISNCKHGV-CDEPTIATVLR---EVLKGL 170
L +V + G L ++ KI V + T+ +L ++ G+
Sbjct: 76 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGM 135
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WM 229
Y S +HRD+ N L+G+ V+I DFG+S + + D R R P WM
Sbjct: 136 VYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TDYYRVGGRTML---PIRWM 191
Query: 230 APEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAA 288
PE + + ++DIWS G+ E+ T G P+++ + + Q
Sbjct: 192 PPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ---------GR 241
Query: 289 EKDQYKAYGKTFRKMISDCLQKDPTKR 315
E ++ + ++ C Q++P +R
Sbjct: 242 ELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 54/231 (23%), Positives = 87/231 (37%), Gaps = 53/231 (22%)
Query: 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATV 162
M H+++V + V E +V +E G L D+ HR K V P V
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHR------KSDVLTTPWKFKV 110
Query: 163 LREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT-------VQIADFGVSAWLATGRDLSR 215
+++ L Y +H ++ NILL +G ++++D G+ + LSR
Sbjct: 111 AKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV-----LSR 165
Query: 216 QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLT 275
Q+ V W+APE +E AD WS G T E+
Sbjct: 166 QEC----VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEIC------------------ 203
Query: 276 LQNDPPTLDTGAAEKDQYKAYGKTFR----------KMISDCLQKDPTKRP 316
+ P D AEK+++ Y +++ C+ DP +RP
Sbjct: 204 YNGEIPLKDKTLAEKERF--YEGQCMLVTPSCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 55/243 (22%), Positives = 93/243 (38%), Gaps = 30/243 (12%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
AIK + + L E M H N++ ++ +E G+L
Sbjct: 37 AIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKY 96
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
++ G + +LR + G++Y +HRD+ A NIL+ + +++
Sbjct: 97 LRD-------HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVS 149
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYDFKADIWSLGITAIE-MA 257
DFG+S L D + P W APE + + +D+WS GI E M+
Sbjct: 150 DFGLSRVL---EDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMS 205
Query: 258 TGTAPYHKYPAMKVLMLTLQND----PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
G PY +V+ ND P +D +A +++ C Q+D
Sbjct: 206 FGERPYWDMSNHEVMKAI--NDGFRLPAPMDCPSA-----------VYQLMLQCWQQDRA 252
Query: 314 KRP 316
+RP
Sbjct: 253 RRP 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 49/182 (26%), Positives = 79/182 (43%), Gaps = 48/182 (26%)
Query: 161 TVLREVLKGLEYFHSNGQIHRDIKAGNILLG----EDGT---VQIADFGVSAWLATGRDL 213
TV +++ L Y +H ++ A NILL +GT ++++D GVS L
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA-----L 175
Query: 214 SRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA-TGTAPYHKYPAMKVL 272
SR++ V W+APE + + AD WS G T +E+ G P
Sbjct: 176 SREER----VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP---------- 221
Query: 273 MLTLQNDPPTLDTGAAEKDQYKAYGKTFR----------KMISDCLQKDPTKRPTASELL 322
L+ P +EK+++ Y K R +IS CL +PT+RP+ +L
Sbjct: 222 ---LKERTP------SEKERF--YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTIL 270
Query: 323 KN 324
++
Sbjct: 271 RD 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 52/227 (22%), Positives = 85/227 (37%), Gaps = 39/227 (17%)
Query: 100 IQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTI 159
MS H+++V + V+DE +V ++ G L D+ HR K N
Sbjct: 52 ASLMSQLSHKHLVKLY-GVCVRDENIMVEEYVKFGPL-DVFLHREK--NNVSLHW----K 103
Query: 160 ATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT-------VQIADFGVSAWLATGRD 212
V +++ L Y +H ++ NIL+ G ++++D G+
Sbjct: 104 LDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI------PIT 157
Query: 213 LSRQKVRHTFVGTPCWMAPEVMEQDHGY-DFKADIWSLGITAIEMAT-GTAPYHKY-PAM 269
+ ++ R V W+APE + AD WS G T +E+ + G P +
Sbjct: 158 VLSREER---VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214
Query: 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
K Q+ P D +I+ C DPTKRP
Sbjct: 215 KERFYQDQHRLPMPDCA------------ELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 31/106 (29%), Positives = 46/106 (43%), Gaps = 10/106 (9%)
Query: 223 VGTPCWMAPEVM-EQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPP 281
+GTP ++APE++ + HG D W+LG+ E TG P++ +V L D P
Sbjct: 541 LGTPDYLAPELLLGKPHG--PAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIP 598
Query: 282 TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
+ + I L DPTKR EL ++P F
Sbjct: 599 WPEGEEKLSVNA-------QNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 29/171 (16%)
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVG 224
E+ G+ + H + +H D+ N L D TV++ D+G+ SR K ++
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIG--------PSRYK--EDYIE 156
Query: 225 T------PC-WMAPEVMEQDHGYDFKAD------IWSLGITAIEMATGTA-PYHKYPAMK 270
T P W+APE++ + HG A+ +W+LG+T E+ A PY +
Sbjct: 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE 216
Query: 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
VL +++ L E Y + + +++ C P KR TA E+
Sbjct: 217 VLNHVIKDQQVKLFKPQLE----LPYSERWYEVLQFCWLS-PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|221460 pfam12202, OSR1_C, Oxidative-stress-responsive kinase 1 C terminal | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 2e-05
Identities = 14/38 (36%), Positives = 23/38 (60%), Gaps = 6/38 (15%)
Query: 430 VNLILRMRNVRR------ELNDIRFEFCIGKDTSDGIA 461
+ L LR+R+ ++ E I FEF +GKDT++ +A
Sbjct: 1 IALRLRVRDPKKLKGKHKENEAIEFEFDLGKDTAEEVA 38
|
This domain family is found in eukaryotes, and is approximately 40 amino acids in length. The family is found in association with pfam00069. There is a single completely conserved residue F that may be functionally important. OSR1 is involved in the signalling cascade which activates Na/K/2Cl cotransporter during osmotic stress. This domain is the C terminal domain of OSR1 which recognises a motif (Arg-Phe-Xaa-Val) on the OSR1-activating protein WNK1. Length = 38 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 30/124 (24%), Positives = 57/124 (45%), Gaps = 15/124 (12%)
Query: 155 DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV--SAWLATGRD 212
+ ++ ++ G+E+ S+ +H+D+ N+L+ + V+I+D G+ + A
Sbjct: 122 EPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 213 L---SRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM-ATGTAPYHKYPA 268
L S +R WM+PE + + +DIWS G+ E+ + G PY Y
Sbjct: 182 LMGNSLLPIR--------WMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232
Query: 269 MKVL 272
V+
Sbjct: 233 QDVI 236
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 44/195 (22%), Positives = 80/195 (41%), Gaps = 42/195 (21%)
Query: 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKC----AIKKIN----------LAVVHSAYC 72
T ++++ ++IG G V+ C ++ C A+ KI V ++ Y
Sbjct: 10 TGKEWKIDKLIGCGGFGCVYETQC--ASDHCINNQAVAKIENLENETIVMETLVYNNIY- 66
Query: 73 KARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLE 132
I KI L K ++D L I C + F++ ++L
Sbjct: 67 -------DIDKIALWKNIHNIDHL--GIPKYYGCGSFKRCRMYYRFILLEKLVE------ 111
Query: 133 GGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE 192
+ +I K R+K N + I +++++L LEY H +G H DIK NI++
Sbjct: 112 --NTKEIFK-RIKCKN-------KKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG 161
Query: 193 DGTVQIADFGVSAWL 207
+ I D+G+++
Sbjct: 162 NNRGYIIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 36/142 (25%), Positives = 58/142 (40%), Gaps = 26/142 (18%)
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQI-HRDIKAGNILLGEDGT------------- 195
KHG +A ++ + L+YFH+ + H D+K NIL+ T
Sbjct: 224 KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283
Query: 196 ---VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252
V+I D G + R V T + +PEV+ G+ + D+WS+G
Sbjct: 284 PCRVRICDLGGCC--------DERHSRTAIVSTRHYRSPEVV-LGLGWMYSTDMWSMGCI 334
Query: 253 AIEMATGTAPYHKYPAMKVLML 274
E+ TG Y + ++ L L
Sbjct: 335 IYELYTGKLLYDTHDNLEHLHL 356
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 520 | |||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0584|consensus | 632 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0579|consensus | 1187 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0589|consensus | 426 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0576|consensus | 829 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG1167|consensus | 418 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653|consensus | 534 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| KOG2052|consensus | 513 | 100.0 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345|consensus | 378 | 99.97 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1024|consensus | 563 | 99.96 | ||
| KOG0590|consensus | 601 | 99.95 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG1164|consensus | 322 | 99.94 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1163|consensus | 341 | 99.93 | ||
| KOG1165|consensus | 449 | 99.93 | ||
| KOG0603|consensus | 612 | 99.91 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG0606|consensus | 1205 | 99.89 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG4158|consensus | 598 | 99.88 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1240|consensus | 1431 | 99.87 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG1033|consensus | 516 | 99.87 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1166|consensus | 974 | 99.81 | ||
| KOG0590|consensus | 601 | 99.81 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG0195|consensus | 448 | 99.8 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG1023|consensus | 484 | 99.76 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1266|consensus | 458 | 99.75 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| KOG0601|consensus | 524 | 99.66 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0606|consensus | 1205 | 99.61 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG1243|consensus | 690 | 99.46 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| KOG0601|consensus | 524 | 99.33 | ||
| KOG3087|consensus | 229 | 99.27 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| KOG3741|consensus | 655 | 99.23 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| KOG2137|consensus | 700 | 99.09 | ||
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.06 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.88 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.8 | |
| KOG0576|consensus | 829 | 98.71 | ||
| PRK09902 | 216 | hypothetical protein; Provisional | 98.7 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.55 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.48 | |
| KOG1035|consensus | 1351 | 98.48 | ||
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.41 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.26 | |
| KOG1235|consensus | 538 | 98.21 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.15 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.04 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.98 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.82 | |
| KOG1826|consensus | 2724 | 97.76 | ||
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.7 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.65 | |
| KOG2268|consensus | 465 | 97.59 | ||
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.59 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.57 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.45 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.42 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.32 | |
| KOG1093|consensus | 725 | 97.25 | ||
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.17 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.09 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.03 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.02 | |
| KOG2270|consensus | 520 | 96.8 | ||
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.56 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.5 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.5 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.41 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.31 | |
| PLN02236 | 344 | choline kinase | 96.3 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.23 | |
| KOG1236|consensus | 565 | 96.16 | ||
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.92 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.76 | |
| KOG0584|consensus | 632 | 95.48 | ||
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.44 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.43 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.24 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.12 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.55 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.62 |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-81 Score=617.79 Aligned_cols=463 Identities=50% Similarity=0.774 Sum_probs=388.4
Q ss_pred CCCCCCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHH
Q psy11359 16 SSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDE 95 (520)
Q Consensus 16 ~~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~ 95 (520)
........|+...++|++.++||.|+.++||+|++..++ +.||||++++++++..++.
T Consensus 13 ~~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~----------------------e~VAIK~inLEkc~~~ld~ 70 (516)
T KOG0582|consen 13 SASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTN----------------------EVVAIKIINLEKCNNDLDA 70 (516)
T ss_pred ccccccccCCCCccceeEEEEEeccceeEeeeeeecccC----------------------CEEEEEEeehhhhhhhHHH
Confidence 444556789999999999999999999999999999984 5555566778888999999
Q ss_pred HHHHHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11359 96 LLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS 175 (520)
Q Consensus 96 l~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~ 175 (520)
+.+|++.|+.++||||++++.+|..+..+|+||.|+.+|++.++++.. ....++|..|..|++++++||.|||+
T Consensus 71 l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~------~~~Gl~E~~Ia~iLre~LkaL~YLH~ 144 (516)
T KOG0582|consen 71 LRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTY------YPDGLEEASIATILREVLKALDYLHQ 144 (516)
T ss_pred HHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHH------ccccccHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999999999999999999999976 33459999999999999999999999
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccc-cccccccccCCcce-ecccCCCCcchhHHHHHHHH
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVR-HTFVGTPCWMAPEV-MEQDHGYDFKADIWSLGITA 253 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~-~~~~gt~~y~APE~-~~~~~~~~~~~DIwSlG~il 253 (520)
+|.||||||+.||||+.+|.|||+|||++..+..... +...+ .+++|||+|||||+ +.+-.+|+.|+||||||++.
T Consensus 145 ~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~--R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA 222 (516)
T KOG0582|consen 145 NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD--RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITA 222 (516)
T ss_pred cCceecccccccEEEcCCCcEEEcCceeeeeecccCc--eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHH
Confidence 9999999999999999999999999999988877653 44444 88999999999999 66778899999999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 254 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
.||.+|..||+.++++++++..+++.|+.+.......+..+.++..|+.+|..||++||++||||+++|+|+||++.+.+
T Consensus 223 ~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 223 CELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred HHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 99999999999999999999999999999888888888999999999999999999999999999999999999999999
Q ss_pred hHHHhhhhccCCchHHHHHHHhhcCC----CCCCc-cccccCCccccCCCCCCCCCC--------ccccccCcccccccc
Q psy11359 334 KFIQQTLVSVGPTFETRIQKAAKKNP----GASGR-LHRTVTGEWVWSSEDEGDKSS--------DDEKKEKPMNCLQEV 400 (520)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 400 (520)
.+....+..-.|+...+..+...+.. +.++. ++....|+|.|+.++...+.+ +.+..+...+.....
T Consensus 303 ~~~~~~~l~~l~~l~~r~~~~q~~~~~~~~~~~~~~~~e~~~~~W~f~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~ 382 (516)
T KOG0582|consen 303 EYLVKKLLQSLPPLGTRFKKSQSKEESQISGLSGNPLSEYQKGEWNFDYEDLDEEASLGDKSSSEDSPREEPQCENKETA 382 (516)
T ss_pred hhcchhhhccCCcHHHHHHHHHhhhccccccccCCchhhhcCCCccccccchhcccccccccccccccccchhhhccccc
Confidence 99988888888888887766544432 45555 567777899998877543322 111111111111111
Q ss_pred CCCCchhhhhhhHH----------------------hhhccCCCCcccccceeEEEEeecccCCcceeEEeeecCCCchh
Q psy11359 401 DSSGEEEDRVVNLI----------------------LRMRNVSSGEEEDRVVNLILRMRNVRRELNDIRFEFCIGKDTSD 458 (520)
Q Consensus 401 ~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~l~lr~~~~~~~~~~i~f~f~~~~dt~~ 458 (520)
+.+... ..+.... ...+....-.....+++|++|++|++.++++|+ +
T Consensus 383 ~s~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~l~~r~~~~~~~~~~ir----------~ 451 (516)
T KOG0582|consen 383 DSTTSS-ELPSSNSEHGALSAQLASGAPLAALSGAAEASESGSALNPTPEPLNLVLRLRNSKAELNQIR----------E 451 (516)
T ss_pred Cccccc-cCCcccccccccccccccCCcccccccchhhhccccccCCCCchhhhhhhhccccchhhhhh----------h
Confidence 111100 0000000 000000101223368999999999999999999 9
Q ss_pred hHHHHHHhccCCCCccHHHHHHHHHHHHccCCCceeEEEeccCCCCCCCCCcccceeceec
Q psy11359 459 GIAGELVGAGLVDARDTEAISQNLELVVNGTPRKKSVTFPLSSTLQPGEVADEKALLGLEI 519 (520)
Q Consensus 459 ~va~e~v~~~~~~~~d~~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (520)
+|++|++.|++++++|++++|.++++++..+..++++||.|+||+.+.++||++.|+||||
T Consensus 452 ~~~q~l~~~~~i~~~~~~~~a~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~q 512 (516)
T KOG0582|consen 452 GILQELFSANLIQRDDLVITAGNLQKILDEPKSNKTITFFLASGVERLEIPDERRLIGFAQ 512 (516)
T ss_pred HHHHHHHhcccccccceeeecchhcccccchhccchhhhhhcccccccccccHHHhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999997
|
|
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-66 Score=532.83 Aligned_cols=409 Identities=25% Similarity=0.412 Sum_probs=303.8
Q ss_pred CCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 21 SVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 21 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
.+.........+..++||+|+|.+||+|.|..+|..|||-.++...+.+ .+...++|+.|+
T Consensus 32 ~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q-------------------~~~~leR~~~Ev 92 (632)
T KOG0584|consen 32 FVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQ-------------------SPEELERLYSEV 92 (632)
T ss_pred ccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhc-------------------ChHHHHHHHHHH
Confidence 3444455555688899999999999999999999999998776543322 255678999999
Q ss_pred HHHhcCCCCCceEEEEEEEECC--EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKD--ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG- 177 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~--~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g- 177 (520)
++|+.|+|||||++|++|.+.. .+.+|+|++++|+|+.|++ +++.++.+.++.|++|||+||.|||++.
T Consensus 93 ~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~k--------k~~~vn~kaik~W~RQILkGL~yLHs~~P 164 (632)
T KOG0584|consen 93 HLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRK--------KHRRVNIKAIKSWCRQILKGLVYLHSQDP 164 (632)
T ss_pred HHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHH--------HhccCCHHHHHHHHHHHHHHhhhhhcCCC
Confidence 9999999999999999999755 4999999999999999999 5788899999999999999999999996
Q ss_pred -cEecccCCCcEEE-cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 178 -QIHRDIKAGNILL-GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 178 -iiHrDLKp~NILl-~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
|||||||++|||| +..|.|||+|+|+|..+ +.......+|||.|||||++... |++.+|||||||||+|
T Consensus 165 PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~-------r~s~aksvIGTPEFMAPEmYEE~--YnE~VDVYaFGMCmLE 235 (632)
T KOG0584|consen 165 PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL-------RKSHAKSVIGTPEFMAPEMYEEN--YNELVDVYAFGMCMLE 235 (632)
T ss_pred CccccccccceEEEcCCcCceeecchhHHHHh-------hccccceeccCccccChHHHhhh--cchhhhhhhhhHHHHH
Confidence 9999999999999 56899999999999887 45556678999999999999744 9999999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHH-hcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh-
Q psy11359 256 MATGTAPYHKYPAMKVLMLT-LQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK- 333 (520)
Q Consensus 256 lltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~- 333 (520)
|+|+.+||..+....+++.. ..+. .+....+.-++++++||.+||.. .+.|+|+.|||+||||+....-
T Consensus 236 MvT~eYPYsEC~n~AQIYKKV~SGi--------KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g~~ 306 (632)
T KOG0584|consen 236 MVTSEYPYSECTNPAQIYKKVTSGI--------KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGGIV 306 (632)
T ss_pred HHhccCChhhhCCHHHHHHHHHcCC--------CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccccccc
Confidence 99999999999877666543 3333 33444566689999999999999 9999999999999999865321
Q ss_pred hHHHhhhh-ccCCchHHHHHHHhhcCCCCCCccccccCC--ccccCCCCCCCCCCccccccCccccccccCCCC---chh
Q psy11359 334 KFIQQTLV-SVGPTFETRIQKAAKKNPGASGRLHRTVTG--EWVWSSEDEGDKSSDDEKKEKPMNCLQEVDSSG---EEE 407 (520)
Q Consensus 334 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 407 (520)
..+..... .....+..+... .++.. +...+ ...|.-..+ ...+ -.+++..++ +++
T Consensus 307 ~~~~e~d~~~~~~~~~~~~~~-~~~~~-------~~~~n~i~~~~~~~~D--~~e~---------v~~em~~~~~~~edd 367 (632)
T KOG0584|consen 307 ELAPEDDMSDPALSLSLRDED-GKKNK-------RPKANAIQFDYNLNTD--ESEE---------VAQEMVEEEIVSEDD 367 (632)
T ss_pred cccchhhcccccccccccccc-hhhcC-------CcccccccceeecCCC--chhH---------HHHHHHHhccCCcch
Confidence 00000000 000000000000 00000 11111 111111111 0000 000011111 111
Q ss_pred hhhhhHHh--hhccCCCCccccc-ceeEEEEeecccCCcceeEEeeecCCCchhhHHHHHHhccCCCCccHHHHHHHHHH
Q psy11359 408 DRVVNLIL--RMRNVSSGEEEDR-VVNLILRMRNVRRELNDIRFEFCIGKDTSDGIAGELVGAGLVDARDTEAISQNLEL 484 (520)
Q Consensus 408 ~~~~~~~~--~~~~~~~~~~~~~-~~~l~lr~~~~~~~~~~i~f~f~~~~dt~~~va~e~v~~~~~~~~d~~~~a~~~~~ 484 (520)
........ ..-.+++...++. .++|.|||++.+|+.|||+|||++..|||.+||.|||+++.+++++|+.||++||.
T Consensus 368 ~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~eMv~el~~~dq~v~~ia~mid~ 447 (632)
T KOG0584|consen 368 SREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAHEMVEELEITDQPVVNIAEMIDG 447 (632)
T ss_pred HHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHHHHHhhcCCcccchhhHHHHHhc
Confidence 01110110 0011222333334 89999999999999999999999999999999999999999999999999999999
Q ss_pred HHccCCCce
Q psy11359 485 VVNGTPRKK 493 (520)
Q Consensus 485 ~~~~~~~~~ 493 (520)
.+.++.++|
T Consensus 448 ~i~~L~p~~ 456 (632)
T KOG0584|consen 448 EISALVPNW 456 (632)
T ss_pred hhhhcCCcc
Confidence 999999888
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-57 Score=444.55 Aligned_cols=271 Identities=31% Similarity=0.468 Sum_probs=228.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
..++.|.+.+.||+|+||.|-+|..+.+|+.||||++++.-..... . + ........+|+++|++
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s------~---~-------~~~~~~v~~EieILkk 232 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCS------R---A-------IAKTRDVQNEIEILKK 232 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccc------c---c-------ccchhhhHHHHHHHHh
Confidence 4678899999999999999999999999999999999754221110 0 0 0112236899999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
|+|||||+++++|+..+..|+||||++||+|++.+- .++.+.+..-+.+++||+.||.|||++||+||||||
T Consensus 233 L~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv--------~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKP 304 (475)
T KOG0615|consen 233 LSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVV--------ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKP 304 (475)
T ss_pred cCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHH--------hccccccchhHHHHHHHHHHHHHHHHcCcccccCCc
Confidence 999999999999999999999999999999999998 567888999999999999999999999999999999
Q ss_pred CcEEEcCC---CCeEEeccCcceeeccCccccccccccccccccccCCcceeccc--CCCCcchhHHHHHHHHHHHHhCC
Q psy11359 186 GNILLGED---GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD--HGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 186 ~NILl~~~---g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~~~DIwSlG~il~elltG~ 260 (520)
+|||+..+ -.+||+|||+|...+ ......++||||.|.|||++... ..|..++||||+||+||.+++|.
T Consensus 305 eNILl~~~~e~~llKItDFGlAK~~g------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~ 378 (475)
T KOG0615|consen 305 ENILLSNDAEDCLLKITDFGLAKVSG------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGY 378 (475)
T ss_pred ceEEeccCCcceEEEecccchhhccc------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccC
Confidence 99999765 579999999998865 34456789999999999999743 33556899999999999999999
Q ss_pred CCCCCCcHHH-HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 261 APYHKYPAMK-VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 261 ~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
+||....... ....+.++.... ....|..++.+.++||.+||..||++|||+.|+|+||||+....
T Consensus 379 pPFS~~~~~~sl~eQI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 379 PPFSEEYTDPSLKEQILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred CCcccccCCccHHHHHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 9998755444 444555554332 23467889999999999999999999999999999999997653
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-56 Score=433.00 Aligned_cols=260 Identities=37% Similarity=0.666 Sum_probs=232.1
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
...+.+.+..||+|..|+||+++++.+++.+|+|.+. .+..++...++.+|+++++.+
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~----------------------~~~~~~~~~Qi~rEl~il~~~ 134 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL----------------------LNIDPALQKQILRELEILRSC 134 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec----------------------ccCCHHHHHHHHHHHHHHhhC
Confidence 3457889999999999999999999998888888763 333355678899999999999
Q ss_pred CCCCceEEEEEEEECC-EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccC
Q psy11359 107 HHENVVTYHTSFVVKD-ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIK 184 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~-~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLK 184 (520)
+|||||.+|+.|..+. .++|+||||.||+|.++++. .+.++|..+..++.+|++||.|||. ++|||||||
T Consensus 135 ~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~--------~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIK 206 (364)
T KOG0581|consen 135 QSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKR--------VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIK 206 (364)
T ss_pred CCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCC
Confidence 9999999999999998 59999999999999999984 4789999999999999999999995 899999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|.|||++..|.|||||||++..+.+ ....+++||..|||||.+.+.. |+.++||||||++++||++|++||.
T Consensus 207 PsNlLvNskGeVKicDFGVS~~lvn-------S~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~ 278 (364)
T KOG0581|consen 207 PSNLLVNSKGEVKICDFGVSGILVN-------SIANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYP 278 (364)
T ss_pred HHHeeeccCCCEEeccccccHHhhh-------hhcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCC
Confidence 9999999999999999999988743 2567899999999999998876 9999999999999999999999998
Q ss_pred CC-----cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 265 KY-----PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 265 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
.. ...+.+..+..+.+|.++.. .+|++|++||..||++||.+|||+.|+++|||+++...
T Consensus 279 ~~~~~~~~~~~Ll~~Iv~~ppP~lP~~--------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 279 PPNPPYLDIFELLCAIVDEPPPRLPEG--------EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred CcCCCCCCHHHHHHHHhcCCCCCCCcc--------cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 74 45666677777777777642 48999999999999999999999999999999997654
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-55 Score=452.16 Aligned_cols=270 Identities=29% Similarity=0.521 Sum_probs=235.4
Q ss_pred CCCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 19 SVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 19 ~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
...+.-+.. .+|+..++||+|||+.||.+++..+|..||+|++.+..+.+ ....+.+.+
T Consensus 9 p~~i~D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k--------------------~~~reKv~~ 67 (592)
T KOG0575|consen 9 PEVIEDPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK--------------------PKQREKVLN 67 (592)
T ss_pred CCeeecCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC--------------------cchHHHHHH
Confidence 333444444 88999999999999999999999999999999997654432 234567999
Q ss_pred HHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
||++.++|+|||||++|++|++.+++|||+|+|..++|..++++ .+.++|.+++.+++||+.||.|||+++|
T Consensus 68 EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr--------rk~ltEpEary~l~QIv~GlkYLH~~~I 139 (592)
T KOG0575|consen 68 EIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR--------RKPLTEPEARYFLRQIVEGLKYLHSLGI 139 (592)
T ss_pred HHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh--------cCCCCcHHHHHHHHHHHHHHHHHHhcCc
Confidence 99999999999999999999999999999999999999999983 5789999999999999999999999999
Q ss_pred EecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 179 iHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
||||||..|+|++++.+|||+|||+|..+... .....+.||||.|.|||++.. .+++..+||||+||+||-|++
T Consensus 140 iHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-----~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~ 213 (592)
T KOG0575|consen 140 IHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-----GERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLV 213 (592)
T ss_pred eecccchhheeecCcCcEEecccceeeeecCc-----ccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhh
Confidence 99999999999999999999999999988642 234568999999999999984 459999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
|++||....-.+.+..+..+.... + ..++.+.++||.++|.++|.+|||++++|.|+||.+....
T Consensus 214 G~PPFetk~vkety~~Ik~~~Y~~-P---------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 214 GRPPFETKTVKETYNKIKLNEYSM-P---------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred CCCCcccchHHHHHHHHHhcCccc-c---------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence 999999877777776666554322 1 3578899999999999999999999999999999654433
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=414.27 Aligned_cols=273 Identities=31% Similarity=0.486 Sum_probs=239.9
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|+++++||+|+||+||.++.+.+++.+|+|++++... ++ ....+....|..+|.+
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~i-------------v~-------~~e~~~~~~Er~IL~~ 81 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKI-------------VE-------KKEVRHTKAERNILSK 81 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHh-------------hh-------hhhHHHHHHHHHHHHh
Confidence 456889999999999999999999999999999999865322 11 1345678999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||.||+++-.|.+.+.+|||+||+.||.|+-.|+ ..+.|+|..++-++..|+.||.|||++|||||||||
T Consensus 82 v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~--------~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKP 153 (357)
T KOG0598|consen 82 IKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQ--------REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKP 153 (357)
T ss_pred CCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHH--------hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCH
Confidence 999999999999999999999999999999999998 578899999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.+|+++|+|||+++..-. ......++|||+.|||||++.+.. |+.++|.||||+++|+|++|.+||..
T Consensus 154 ENILLd~~GHi~LtDFgL~k~~~~-----~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 154 ENILLDEQGHIKLTDFGLCKEDLK-----DGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred HHeeecCCCcEEEeccccchhccc-----CCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcC
Confidence 999999999999999999975432 223456799999999999998764 99999999999999999999999999
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC----CHHHHhcCccccccchhhHHHhhhh
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP----TASELLKNPFFKKAKDKKFIQQTLV 341 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----ta~elL~hp~~~~~~~~~~~~~~~~ 341 (520)
.+..+....+.+...+..+ ..++.+.+++|.++|+.||++|. .+.++-+||||...++.+..+..+.
T Consensus 228 ~~~~~~~~~I~~~k~~~~p---------~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~ 298 (357)
T KOG0598|consen 228 EDVKKMYDKILKGKLPLPP---------GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLS 298 (357)
T ss_pred ccHHHHHHHHhcCcCCCCC---------ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCC
Confidence 9888888888877633322 33688999999999999999995 7999999999999998876555443
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-54 Score=404.04 Aligned_cols=271 Identities=27% Similarity=0.427 Sum_probs=228.9
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|+.+.++|+|+||+||+|+++.+|+.||||++-. .+..+...+-.+|||++|++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~E---------------------sedd~~VkKIAlREIrmLKqLkH 60 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVE---------------------SEDDPVVKKIALREIRMLKQLKH 60 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeecc---------------------CCccHHHHHHHHHHHHHHHhccc
Confidence 679999999999999999999999999999998732 12222233447899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
||+|.++++|..+..++||+|||+. ++.+-+.+ ....+++..++.+++|++.|+.|||++++|||||||+||
T Consensus 61 ~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~-------~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENI 132 (396)
T KOG0593|consen 61 ENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELER-------YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENI 132 (396)
T ss_pred chHHHHHHHHHhcceeEEEeeecch-HHHHHHHh-------ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhhe
Confidence 9999999999999999999999965 66666765 455688999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
||+.+|.+||||||+|+.++... .....++.|.+|+|||++.+..+|+..+||||+||++.||+||++.|++.++
T Consensus 133 Lit~~gvvKLCDFGFAR~L~~pg-----d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD 207 (396)
T KOG0593|consen 133 LITQNGVVKLCDFGFARTLSAPG-----DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD 207 (396)
T ss_pred EEecCCcEEeccchhhHhhcCCc-----chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence 99999999999999999886322 2244578999999999999988899999999999999999999999999999
Q ss_pred HHHHHHHhcCC---------------------CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQND---------------------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.+++..+...- .|...........+..++.-+.+|+.+||..||.+|++.+|+|.|+||
T Consensus 208 iDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 208 IDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred HHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 88886543221 122222233344566778889999999999999999999999999999
Q ss_pred cccchh
Q psy11359 328 KKAKDK 333 (520)
Q Consensus 328 ~~~~~~ 333 (520)
+....+
T Consensus 288 d~~~er 293 (396)
T KOG0593|consen 288 DGFIER 293 (396)
T ss_pred HHHHHH
Confidence 654443
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=428.61 Aligned_cols=278 Identities=30% Similarity=0.497 Sum_probs=238.7
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
.-.+|...+.||.|+|++|++|+++.+++.+|||++.+... +|. .-.+-+.+|-.+|.+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I-------------ike-------~KvkYV~~Ek~~l~~L 130 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI-------------IKE-------KKVKYVTREKEALTQL 130 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH-------------Hhh-------cccchhhHHHHHHHHh
Confidence 34679999999999999999999999999999999865433 221 1123366788889999
Q ss_pred -CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 -HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 -~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
.||+|+++|..|.++..+|+|+||+++|+|.++|+ +.|.|++...+.++.||+.||+|||++|||||||||
T Consensus 131 ~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~--------K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKP 202 (604)
T KOG0592|consen 131 SGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIK--------KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKP 202 (604)
T ss_pred hCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHH--------HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCCh
Confidence 89999999999999999999999999999999999 568999999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccc--------cccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDL--------SRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~--------~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
+|||++.+|++||+|||.|..+...... .......+|+||..|.+||++.... .++.+|||+||||||+|+
T Consensus 203 ENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQml 281 (604)
T KOG0592|consen 203 ENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQML 281 (604)
T ss_pred hheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHh
Confidence 9999999999999999999987543221 1111235699999999999998765 899999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhhHHH
Q psy11359 258 TGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQ 337 (520)
Q Consensus 258 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~~ 337 (520)
.|.+||.+.++..++..++.-+.... ..+++.+++||+++|..||.+|+|+.+|..||||...++....+
T Consensus 282 aG~PPFra~NeyliFqkI~~l~y~fp----------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~ 351 (604)
T KOG0592|consen 282 AGQPPFRAANEYLIFQKIQALDYEFP----------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQ 351 (604)
T ss_pred cCCCCCccccHHHHHHHHHHhcccCC----------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhh
Confidence 99999999999888877766543322 45678999999999999999999999999999999999987666
Q ss_pred hhhhcc
Q psy11359 338 QTLVSV 343 (520)
Q Consensus 338 ~~~~~~ 343 (520)
+....+
T Consensus 352 ~~PP~l 357 (604)
T KOG0592|consen 352 QTPPKL 357 (604)
T ss_pred cCCCcc
Confidence 554433
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-52 Score=411.97 Aligned_cols=263 Identities=29% Similarity=0.495 Sum_probs=227.1
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|.+.+.||+|+||+||+|+++.++..||||.+.+..+ ..+..+-+..||.+|+.
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l---------------------~~k~~e~L~~Ei~iLke 65 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL---------------------NKKLVELLLSEIKILKE 65 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---------------------CHHHHHHHHHHHHHHHh
Confidence 456889999999999999999999999999999997753311 14456778999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++|||||.++++..+.+.+|||||||+||+|.+||+ .++.+++..++.++.||+.||++||+++||||||||
T Consensus 66 l~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~--------~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKP 137 (429)
T KOG0595|consen 66 LKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIR--------RRGRLPEATARHFMQQLASALQFLHENNIIHRDLKP 137 (429)
T ss_pred cCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHH--------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCc
Confidence 999999999999999999999999999999999999 457899999999999999999999999999999999
Q ss_pred CcEEEcCC------CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 186 GNILLGED------GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 186 ~NILl~~~------g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG 259 (520)
+|||++.. -.+||+|||+|+.+. ......+.+|+|.|||||++...+ |+.|+|+||+|+++|+|++|
T Consensus 138 QNiLLs~~~~~~~~~~LKIADFGfAR~L~------~~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g 210 (429)
T KOG0595|consen 138 QNILLSTTARNDTSPVLKIADFGFARFLQ------PGSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTG 210 (429)
T ss_pred ceEEeccCCCCCCCceEEecccchhhhCC------chhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhC
Confidence 99999754 468999999999886 344567899999999999997666 99999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
++||......+.+..+-++...... .....+..+.+++...|+.+|..|.+..+.+.|+++....
T Consensus 211 ~~Pf~a~t~~eL~~~~~k~~~~~~~-------~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 211 KPPFDAETPKELLLYIKKGNEIVPV-------LPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred CCCccccCHHHHHHHHhccccccCc-------hhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 9999998888877654443221111 1234566778999999999999999999999999998654
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-54 Score=402.55 Aligned_cols=254 Identities=32% Similarity=0.570 Sum_probs=223.0
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
....+|+++++||+|.||.||++.+..+|..+|+|.++++.+. ......+..|+.+|++
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md---------------------~k~rq~~v~Ei~lLkQ 74 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD---------------------AKARQDCVKEISLLKQ 74 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc---------------------HHHHHHHHHHHHHHHh
Confidence 4556799999999999999999999999999999988765332 2356678999999999
Q ss_pred CCCCCceEEEE-EEEECCE-EEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--cE
Q psy11359 106 CHHENVVTYHT-SFVVKDE-LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS--NG--QI 179 (520)
Q Consensus 106 l~HpnIv~~~~-~~~~~~~-~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~--~g--ii 179 (520)
|+|||||++|+ .|..++. ++||||||.+|+|.+.|++..+ .++.++|..+++++.|++.||..||+ .+ |+
T Consensus 75 L~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~----qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm 150 (375)
T KOG0591|consen 75 LNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKK----QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM 150 (375)
T ss_pred cCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHh----ccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence 99999999998 6666655 9999999999999999998765 56889999999999999999999999 44 99
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG 259 (520)
||||||.||+++.+|.+||+|||+++.+.+ ....+++++|||.||+||.+.+.. |+.++||||+||++|||+.-
T Consensus 151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s-----~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL 224 (375)
T KOG0591|consen 151 HRDIKPANIFLTANGVVKLGDFGLGRFLSS-----KTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCAL 224 (375)
T ss_pred eccCcchheEEcCCCceeeccchhHhHhcc-----hhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhc
Confidence 999999999999999999999999998865 344567899999999999998765 99999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA 318 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta 318 (520)
++||.+..-......+-+++.+.++. ..+|..++.+|..|+..||+.||+.
T Consensus 225 ~~PF~g~n~~~L~~KI~qgd~~~~p~--------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 225 QSPFYGDNLLSLCKKIEQGDYPPLPD--------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCcccccHHHHHHHHHcCCCCCCcH--------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 99999987666666677766554432 5688999999999999999999987
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-52 Score=420.93 Aligned_cols=266 Identities=41% Similarity=0.689 Sum_probs=234.9
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
.....+|...++||+|+.|.||.|+...+++.||||.+... + +...+-+.+|+.+|+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~----------------------~-Q~~keLilnEi~Vm~ 325 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR----------------------K-QPKKELLLNEILVMR 325 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEec----------------------c-CCchhhhHHHHHHHH
Confidence 45667899999999999999999999999888888877532 1 223345889999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
.++|+|||+|++.|...+++|.||||++||+|.|.+. ...++|.+|+.++++++.||+|||.+||||||||
T Consensus 326 ~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt---------~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIK 396 (550)
T KOG0578|consen 326 DLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVT---------KTRMTEGQIAAICREILQGLKFLHARGIIHRDIK 396 (550)
T ss_pred hccchHHHHHHHHhcccceeEEEEeecCCCchhhhhh---------cccccHHHHHHHHHHHHHHHHHHHhcceeeeccc
Confidence 9999999999999999999999999999999999996 4569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
.+|||++.+|.+||+|||++..+... ...+.+.+|||.|||||+..... |++++||||||++++||+-|++||-
T Consensus 397 SDnILL~~~g~vKltDFGFcaqi~~~-----~~KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 397 SDNILLTMDGSVKLTDFGFCAQISEE-----QSKRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred cceeEeccCCcEEEeeeeeeeccccc-----cCccccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCcc
Confidence 99999999999999999999877543 23467889999999999997765 9999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhhH
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~ 335 (520)
...+...+.++..+..+.+. ....+|+.|++|+.+||+.|+.+|+||.|||+||||+.+.....
T Consensus 471 nE~PlrAlyLIa~ng~P~lk-------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ss 534 (550)
T KOG0578|consen 471 NENPLRALYLIATNGTPKLK-------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPESS 534 (550)
T ss_pred CCChHHHHHHHhhcCCCCcC-------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCHHH
Confidence 88888888877777666554 23678999999999999999999999999999999987765543
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-51 Score=385.12 Aligned_cols=268 Identities=25% Similarity=0.444 Sum_probs=239.6
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
-.-++|++++.||.|+||.|.+++++.+|..+|+|++++..+-+ -...+...+|..+|+.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk--------------------lKQveH~~nEk~vL~~ 100 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK--------------------LKQVEHTHNEKRVLKA 100 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH--------------------HHHHHHHhhHHHHHhh
Confidence 45678999999999999999999999999999999997654422 2346778999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+.||.+++++..|.+.+.+|+||||+.||.|+.+++ +.+.|++..++-++.||+.||+|||+++|++|||||
T Consensus 101 v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lr--------k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKP 172 (355)
T KOG0616|consen 101 VSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLR--------KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKP 172 (355)
T ss_pred ccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHH--------hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCCh
Confidence 999999999999999999999999999999999998 568899999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.+|.+||+|||+|..+.. ...+.||||.|+|||++.... |+.++|.||||+++|||+.|.+||..
T Consensus 173 ENiLlD~~G~iKitDFGFAK~v~~--------rT~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 173 ENLLLDQNGHIKITDFGFAKRVSG--------RTWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred HHeeeccCCcEEEEeccceEEecC--------cEEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 999999999999999999987632 256789999999999997654 99999999999999999999999999
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCC-----CCHHHHhcCccccccchhhHHHhhh
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLKNPFFKKAKDKKFIQQTL 340 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R-----pta~elL~hp~~~~~~~~~~~~~~~ 340 (520)
..++..+..++.++.... ..+++++++||.++|+.|-.+| .-..++..||||+...+....++.+
T Consensus 244 ~~~~~iY~KI~~~~v~fP----------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~i 313 (355)
T KOG0616|consen 244 DNPIQIYEKILEGKVKFP----------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKI 313 (355)
T ss_pred CChHHHHHHHHhCcccCC----------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccc
Confidence 999999988887754332 4578899999999999999999 4578999999999998877666544
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=414.66 Aligned_cols=271 Identities=27% Similarity=0.432 Sum_probs=228.0
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
-...++|.++++||.|+||.||+|..+.+|..||||.++..... +.+ ---+||++.|+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s--------------------~ee--~~nLREvksL~ 63 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS--------------------WEE--CMNLREVKSLR 63 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc--------------------HHH--HHHHHHHHHHH
Confidence 35678999999999999999999999999999999977532111 111 11368999999
Q ss_pred cCC-CCCceEEEEEEEECC-EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 105 SCH-HENVVTYHTSFVVKD-ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 105 ~l~-HpnIv~~~~~~~~~~-~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
+|+ |||||++.+++.+.+ .+|+||||+ ..+|.++++.+ ...|++..|+.|+.||++||+|+|.+|+.|||
T Consensus 64 kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R-------~r~fse~~irnim~QilqGL~hiHk~GfFHRD 135 (538)
T KOG0661|consen 64 KLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDR-------NRLFSESDIRNIMYQILQGLAHIHKHGFFHRD 135 (538)
T ss_pred hcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhc-------CCcCCHHHHHHHHHHHHHHHHHHHhcCccccc
Confidence 998 999999999999888 999999999 46999999984 67899999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|||+|||+..+..+||+|||+|+...+ ......++.|.+|+|||++.+...|+.++|||++|||++|+.+-++.
T Consensus 136 lKPENiLi~~~~~iKiaDFGLARev~S------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPL 209 (538)
T KOG0661|consen 136 LKPENILISGNDVIKIADFGLAREVRS------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPL 209 (538)
T ss_pred CChhheEecccceeEeccccccccccc------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhccc
Confidence 999999999889999999999987653 33455789999999999999888899999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCC-CCCCCC-------------------chhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 263 YHKYPAMKVLMLTLQNDP-PTLDTG-------------------AAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~-~~~~~~-------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
|.+..+.+++..+..--. |....+ ..........+.++.+||.+||++||.+||||.|+|
T Consensus 210 FPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al 289 (538)
T KOG0661|consen 210 FPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQAL 289 (538)
T ss_pred CCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHh
Confidence 999999998876653211 111111 011122234678999999999999999999999999
Q ss_pred cCccccccc
Q psy11359 323 KNPFFKKAK 331 (520)
Q Consensus 323 ~hp~~~~~~ 331 (520)
+||||+...
T Consensus 290 ~~pffq~~~ 298 (538)
T KOG0661|consen 290 QHPFFQVGR 298 (538)
T ss_pred cCccccccc
Confidence 999999654
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-53 Score=416.20 Aligned_cols=263 Identities=47% Similarity=0.789 Sum_probs=236.1
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
....|..++.||+|+||.||+|.+..+++.||||+++ ++......+++.+|+.+|.+|
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~----------------------Le~~~deIediqqei~~Ls~~ 68 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIID----------------------LEEAEDEIEDIQQEISVLSQC 68 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEec----------------------hhhcchhhHHHHHHHHHHHhc
Confidence 3455888899999999999999999997777777654 444466788999999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+++||.++|+.|..+..+|++||||.||++.+.++ ..+.+++..+..++++++.||.|||.++.+|||||+.
T Consensus 69 ~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~--------~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaa 140 (467)
T KOG0201|consen 69 DSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLK--------SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAA 140 (467)
T ss_pred CcchHHhhhhheeecccHHHHHHHhcCcchhhhhc--------cCCCCccceeeeehHHHHHHhhhhhhcceeccccccc
Confidence 99999999999999999999999999999999997 4566699999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||+..+|.+||+|||++..+... ...+.+++|||.|||||++.+ .+|+.++||||||++++||++|.+||...
T Consensus 141 nil~s~~g~vkl~DfgVa~ql~~~-----~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~ 214 (467)
T KOG0201|consen 141 NILLSESGDVKLADFGVAGQLTNT-----VKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKL 214 (467)
T ss_pred ceeEeccCcEEEEecceeeeeech-----hhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCccc
Confidence 999999999999999999887542 233478999999999999985 45999999999999999999999999999
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhh
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~ 334 (520)
.++.++..+.+..||.+.. .+++.|++||..||.+||+.||||.++|+|+|++.+....
T Consensus 215 hPmrvlflIpk~~PP~L~~---------~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s 273 (467)
T KOG0201|consen 215 HPMRVLFLIPKSAPPRLDG---------DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTS 273 (467)
T ss_pred CcceEEEeccCCCCCcccc---------ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCch
Confidence 9999998888888887753 5788999999999999999999999999999999866443
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=414.43 Aligned_cols=264 Identities=28% Similarity=0.475 Sum_probs=225.8
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+|+.|.+..+|..||+|+++..... ... ....+.+.+|+.++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~-----------------~~~-~~~~~~i~rEi~~~~~ 75 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVS-----------------SKS-QKLDELIKREISILRR 75 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhccc-----------------ccc-cccchhhHHHHHHHHH
Confidence 4667899999999999999999999999999999977532110 000 1123456789999999
Q ss_pred CC-CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 106 CH-HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 106 l~-HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
++ ||||+++++++.....+|+||||+.||+|++++. ..+.+.|..++.+++||+.|++|||++||+|||||
T Consensus 76 ~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~--------~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK 147 (370)
T KOG0583|consen 76 LRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIV--------NKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLK 147 (370)
T ss_pred hccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHH--------HcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence 98 9999999999999999999999999999999998 45789999999999999999999999999999999
Q ss_pred CCcEEEcCC-CCeEEeccCcceeeccCccccccccccccccccccCCcceecccC-CCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 185 AGNILLGED-GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH-GYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 185 p~NILl~~~-g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~DIwSlG~il~elltG~~P 262 (520)
|+|||++.+ +++||+|||++.... .......+++|||.|+|||++.+.. +.+.++||||+|++||.|++|..|
T Consensus 148 ~ENilld~~~~~~Kl~DFG~s~~~~-----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~P 222 (370)
T KOG0583|consen 148 PENILLDGNEGNLKLSDFGLSAISP-----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLP 222 (370)
T ss_pred HHHEEecCCCCCEEEeccccccccC-----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence 999999998 999999999998763 1334567889999999999998866 456899999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHh-cHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY-GKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
|...........+..+... ++ ..+ ++++++||.+||.+||.+|+|+.+++.||||+..
T Consensus 223 F~d~~~~~l~~ki~~~~~~-~p---------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 223 FDDSNVPNLYRKIRKGEFK-IP---------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CCCccHHHHHHHHhcCCcc-CC---------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 9987766666664444322 22 223 8899999999999999999999999999999963
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=409.81 Aligned_cols=273 Identities=25% Similarity=0.416 Sum_probs=230.6
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
.+...+.|+.+++||+|+||.||+|++..+|+.||+|.++++... .....-..|||.+|
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~---------------------~~~~~t~~REI~IL 170 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK---------------------EGFPITAIREIKIL 170 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC---------------------CcchHHHHHHHHHH
Confidence 345668899999999999999999999999999999988764321 22344578999999
Q ss_pred hcCCCCCceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 104 SSCHHENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
++|+||||+++.+..... ..+|||+||++. +|.-++.. ..-.|++.+|+.+++||+.||+|||++||+||
T Consensus 171 r~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~-------p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHR 242 (560)
T KOG0600|consen 171 RRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS-------PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHR 242 (560)
T ss_pred HhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcC-------CCcccChHHHHHHHHHHHHHHHHHhhcCeeec
Confidence 999999999999998876 689999999964 88888763 45579999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|||+.||||+++|.+||+|||+|+++..... ......+-|.+|+|||++.+...|+.++|+||+||||.||++|++
T Consensus 243 DIK~SNiLidn~G~LKiaDFGLAr~y~~~~~----~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 243 DIKGSNILIDNNGVLKIADFGLARFYTPSGS----APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred cccccceEEcCCCCEEeccccceeeccCCCC----cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence 9999999999999999999999998754432 124566789999999999999999999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhc--CCCCC-----------------CCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 262 PYHKYPAMKVLMLTLQ--NDPPT-----------------LDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~--~~~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
.|.+..+.+++..+.. +.|.. ........+.++.++....+|+..+|..||.+|.||.++|
T Consensus 319 I~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 319 ILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred CcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 9999999988866543 22211 0111122334567889999999999999999999999999
Q ss_pred cCccccc
Q psy11359 323 KNPFFKK 329 (520)
Q Consensus 323 ~hp~~~~ 329 (520)
+|+||..
T Consensus 399 ~seyF~t 405 (560)
T KOG0600|consen 399 QSEYFTT 405 (560)
T ss_pred cCccccc
Confidence 9999953
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-51 Score=418.01 Aligned_cols=263 Identities=27% Similarity=0.428 Sum_probs=230.0
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
+..+-|++.+.||.|+.|.|.+|++..||+.+|||++.+.. +-.......+.+||-+|+.
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~--------------------~~s~s~~~~IerEIviMkL 68 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS--------------------ELSSSQPAGIEREIVIMKL 68 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeecccc--------------------ccccccccchhhhhHHHHH
Confidence 44566899999999999999999999999999999986431 0112344568899999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+.||||+++|++|+.+.++|+|.||+.||.|++|+. ..|.+++.++.++++||+.|+.|||..+|+||||||
T Consensus 69 i~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv--------~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKp 140 (786)
T KOG0588|consen 69 IEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLV--------RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKP 140 (786)
T ss_pred hcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHH--------hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCc
Confidence 999999999999999999999999999999999998 568899999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|+|++..+++||+|||+|..-. ..+...+.||+|+|.|||++.+..+.+.++||||+|||||.|+||++||.+
T Consensus 141 ENlLLd~~~nIKIADFGMAsLe~------~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 141 ENLLLDVKNNIKIADFGMASLEV------PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred hhhhhhcccCEeeeccceeeccc------CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 99999999999999999997643 345567889999999999999999888999999999999999999999996
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
.+-...+..+.++... + ...+++++++||.+||..||.+|+|.+|+++|||+.....
T Consensus 215 dNir~LLlKV~~G~f~-M---------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 215 DNIRVLLLKVQRGVFE-M---------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred ccHHHHHHHHHcCccc-C---------CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 5555555555444332 2 2567899999999999999999999999999999986543
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=375.14 Aligned_cols=268 Identities=28% Similarity=0.413 Sum_probs=226.1
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|...++||+|.||+||+|++.++|+.||||.++.....+. ..-...|||+.|+.++|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG---------------------i~~talREIK~Lqel~h 60 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG---------------------INRTALREIKLLQELKH 60 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC---------------------ccHHHHHHHHHHHHccC
Confidence 579999999999999999999999999999998865422111 12247899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
+||+.++++|...+.+.||+||++ .+|...|+. +...++..+++.|+.++++||+|||++.|+||||||.|+
T Consensus 61 ~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd-------~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNL 132 (318)
T KOG0659|consen 61 PNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKD-------KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNL 132 (318)
T ss_pred cchhhhhhhccCCCceEEEEEecc-ccHHHHhcc-------cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccce
Confidence 999999999999999999999995 699999986 567899999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.+|.+||+|||+|+.+.+.... ....+-|.+|+|||++.+...|+..+||||.|||+.||+-|.+-|.+.++
T Consensus 133 Lis~~g~lKiADFGLAr~f~~p~~~-----~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD 207 (318)
T KOG0659|consen 133 LISSDGQLKIADFGLARFFGSPNRI-----QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD 207 (318)
T ss_pred EEcCCCcEEeecccchhccCCCCcc-----cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence 9999999999999999988654322 22237899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCCCch------------------hhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 269 MKVLMLTLQNDPPTLDTGAA------------------EKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.+++..++..-....+..+. ....+...+.+..+|+.+||..||.+|+|+.|+|+|+||...
T Consensus 208 idQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 208 IDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred HHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 88886655432111111000 111334556788999999999999999999999999999853
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=397.06 Aligned_cols=263 Identities=34% Similarity=0.591 Sum_probs=216.7
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
..+|...+.||+|+||+||++.+..+|..+|+|.+... ... ..+.+.+|+.+|++|+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~----------------------~~~-~~~~l~~Ei~iL~~l~ 72 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE----------------------DSP-TSESLEREIRILSRLN 72 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc----------------------cch-hHHHHHHHHHHHHhCC
Confidence 56689999999999999999999999888888876432 111 1567999999999999
Q ss_pred CCCceEEEEEEEECC--EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 108 HENVVTYHTSFVVKD--ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 108 HpnIv~~~~~~~~~~--~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
|||||++++...... .+++.|||+.||+|.++++.. .+.+++..++.+.+||++||.|||++|||||||||
T Consensus 73 ~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~-------g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~ 145 (313)
T KOG0198|consen 73 HPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRY-------GGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKP 145 (313)
T ss_pred CCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCccc
Confidence 999999999855544 699999999999999999852 23799999999999999999999999999999999
Q ss_pred CcEEEcC-CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 186 GNILLGE-DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 186 ~NILl~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
+|||++. +|.+||+|||++..... ..........+.|||.|||||++........++|||||||++.||+||.+||.
T Consensus 146 ~NiLl~~~~~~~KlaDFG~a~~~~~--~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 146 ANILLDPSNGDVKLADFGLAKKLES--KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred ceEEEeCCCCeEEeccCcccccccc--ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence 9999999 79999999999987653 11122334467899999999999864323459999999999999999999998
Q ss_pred C-CcHHHHHHHHhcCC-CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 265 K-YPAMKVLMLTLQND-PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 265 ~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
. ......+..+.... .|.+ ...++.+.++||.+||..+|.+||||.++|+|||.+...
T Consensus 224 ~~~~~~~~~~~ig~~~~~P~i---------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 224 EFFEEAEALLLIGREDSLPEI---------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred hhcchHHHHHHHhccCCCCCC---------CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 7 34444444444332 2222 245789999999999999999999999999999998653
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-50 Score=403.53 Aligned_cols=274 Identities=27% Similarity=0.418 Sum_probs=232.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|+++.+||+||||.||+|+.+.||..+|+|++++..... ....+.++.|-.+|..
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~--------------------~~Qv~hV~aERdiL~~ 197 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK--------------------KNQVEHVRAERDILAE 197 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh--------------------hhhHHHHHHHHHHhhh
Confidence 46789999999999999999999999999999999998765432 2346678889999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
-++|.||++|-+|.+.+++||||||++||++..+|. ..+.|++..++.++.+++.|++.||++|+|||||||
T Consensus 198 ~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~--------~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKP 269 (550)
T KOG0605|consen 198 VDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLM--------RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKP 269 (550)
T ss_pred cCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHH--------hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCCh
Confidence 999999999999999999999999999999999998 568999999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccC-------------------c--ccc---------------------ccccccccc
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATG-------------------R--DLS---------------------RQKVRHTFV 223 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~-------------------~--~~~---------------------~~~~~~~~~ 223 (520)
+|+||+..|++||+|||++.-+... . ... +.......+
T Consensus 270 dNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StV 349 (550)
T KOG0605|consen 270 DNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTV 349 (550)
T ss_pred hheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhccc
Confidence 9999999999999999998533210 0 000 011123568
Q ss_pred cccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHH
Q psy11359 224 GTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKM 303 (520)
Q Consensus 224 gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 303 (520)
|||.|||||++.+.. |+..+|+|||||||||||.|.+||....+.+....+......... .....++++.+||
T Consensus 350 GTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f------P~~~~~s~eA~DL 422 (550)
T KOG0605|consen 350 GTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF------PEEVDLSDEAKDL 422 (550)
T ss_pred CCccccchHHHhcCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC------CCcCcccHHHHHH
Confidence 999999999998766 999999999999999999999999999999988776654321111 1113456899999
Q ss_pred HHhhhccCCCCCC---CHHHHhcCccccccchhhH
Q psy11359 304 ISDCLQKDPTKRP---TASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 304 i~~~L~~dP~~Rp---ta~elL~hp~~~~~~~~~~ 335 (520)
|.+||. ||.+|. .++||.+||||+...+...
T Consensus 423 I~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l 456 (550)
T KOG0605|consen 423 ITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHL 456 (550)
T ss_pred HHHHhc-CHHHhcCcccHHHHhcCCccccCCcchh
Confidence 999999 999996 4999999999999988653
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=377.67 Aligned_cols=264 Identities=29% Similarity=0.487 Sum_probs=230.1
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...+.|++.++||+|.|++||++.+..+|+.+|+|+++..-+ . ....+++.+|+.+-+.
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~-----------------~----~~~~e~l~rEarIC~~ 66 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-----------------S----ARDFQKLEREARICRK 66 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh-----------------c----cccHHHHHHHHHHHHh
Confidence 456789999999999999999999999988888887753211 1 1256789999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
|+|||||++.+.+......|+|+|+++|++|+.-|-.+ -.++|..+..+++||+.+|.|||.+||||||+||
T Consensus 67 LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R--------~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP 138 (355)
T KOG0033|consen 67 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--------EFYSEADASHCIQQILEALAYCHSNGIVHRDLKP 138 (355)
T ss_pred cCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH--------HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCCh
Confidence 99999999999999999999999999999999888754 4578999999999999999999999999999999
Q ss_pred CcEEEc---CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 186 GNILLG---EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 186 ~NILl~---~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
+|+|+- ...-+||+|||+|..+. .......++|||.|||||++.... |+..+|||+.|++||-|+.|.+|
T Consensus 139 ~nllLASK~~~A~vKL~~FGvAi~l~------~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~P 211 (355)
T KOG0033|consen 139 ENLLLASKAKGAAVKLADFGLAIEVN------DGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPP 211 (355)
T ss_pred hheeeeeccCCCceeecccceEEEeC------CccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCC
Confidence 999993 33469999999998876 234456789999999999998776 99999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
|.+.+....+..+.++..... ...|..++++.++||++||..||.+|+|+.|+|+|||++...
T Consensus 212 F~~~~~~rlye~I~~g~yd~~------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 212 FWDEDQHRLYEQIKAGAYDYP------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred CCCccHHHHHHHHhccccCCC------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 999888888877777653322 234678899999999999999999999999999999998654
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=397.27 Aligned_cols=279 Identities=30% Similarity=0.458 Sum_probs=228.1
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
..-+.|++.+.||+|.||.|.+|++..+++.||||++.+......+.. ....+.++. .++..++||.+|++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~--~~~~a~~~~-------~~ekv~~EIailKk 164 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGF--PRQPAMKLM-------PIEKVRREIAILKK 164 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhccc--ccccccccC-------cHHHHHHHHHHHHh
Confidence 344779999999999999999999999999999999987654332211 122344433 35679999999999
Q ss_pred CCCCCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 106 CHHENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGV-CDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 106 l~HpnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~-l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
|+|||||+++++..+ .+.+|||+|||..|.+...- ..+. +++.+++.+++.++.||+|||.+||||||
T Consensus 165 l~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---------~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRD 235 (576)
T KOG0585|consen 165 LHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---------PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRD 235 (576)
T ss_pred cCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC---------CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccc
Confidence 999999999999875 56799999999988765432 2334 89999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc---CCCCcchhHHHHHHHHHHHHhC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD---HGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~~~DIwSlG~il~elltG 259 (520)
|||.|+|++++|++||+|||++.....+.+..........+|||.|||||.+.++ ...+.+.||||+||+||.|+.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 9999999999999999999999887655433333333346899999999998763 3457899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
+.||-+....+.+..+... +..++.. +.+...+++||.+||.+||.+|++..++..|||....
T Consensus 316 ~~PF~~~~~~~l~~KIvn~-pL~fP~~-------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 316 QLPFFDDFELELFDKIVND-PLEFPEN-------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cCCcccchHHHHHHHHhcC-cccCCCc-------ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9999988887777665543 3333322 2467789999999999999999999999999999865
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=407.70 Aligned_cols=270 Identities=29% Similarity=0.488 Sum_probs=236.3
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|.++++||+|.||+|++|..+.+++.+|||++++..+ +. ....+..+.|..++.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I-------------l~-------~d~Ve~~~~EkrI~~ 423 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI-------------LQ-------RDEVESLMCEKRIFE 423 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce-------------ec-------cccHHHHHHHHHHHH
Confidence 4567899999999999999999999999999999999875432 11 345778899999988
Q ss_pred cC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 105 SC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 105 ~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
.. +||.+++++.+|.+++++|+||||+.||++..++ ..+.|++..++-++..|+.||+|||++|||||||
T Consensus 424 la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~---------~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDl 494 (694)
T KOG0694|consen 424 LANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI---------HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDL 494 (694)
T ss_pred HhccCCeEeecccccccCCeEEEEEEecCCCcEEEEE---------ecccccHHHHHHHHHHHHHHHHHHHhcCceeeec
Confidence 77 6999999999999999999999999999955544 4578999999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
|.+|||++.+|++||+|||+++..- .....+.++||||.|||||++.+.. |+.++|.|||||+||||+.|+.||
T Consensus 495 KLdNiLLD~eGh~kiADFGlcKe~m-----~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF 568 (694)
T KOG0694|consen 495 KLDNLLLDTEGHVKIADFGLCKEGM-----GQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPF 568 (694)
T ss_pred chhheEEcccCcEEecccccccccC-----CCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999987532 2344567899999999999998776 999999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchhhHHHh
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDKKFIQQ 338 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~~~~ 338 (520)
++.+..+++..++..++... ..++.+..++++++|.++|++|.- +.+|..||||+...+......
T Consensus 569 ~gddEee~FdsI~~d~~~yP----------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r 638 (694)
T KOG0694|consen 569 PGDDEEEVFDSIVNDEVRYP----------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNR 638 (694)
T ss_pred CCCCHHHHHHHHhcCCCCCC----------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhc
Confidence 99999999988877654332 457889999999999999999976 578899999999998765554
Q ss_pred h
Q psy11359 339 T 339 (520)
Q Consensus 339 ~ 339 (520)
.
T Consensus 639 ~ 639 (694)
T KOG0694|consen 639 R 639 (694)
T ss_pred c
Confidence 4
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=379.16 Aligned_cols=272 Identities=25% Similarity=0.365 Sum_probs=224.4
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....+.|+.+..|++|+||.||+|+++.+++.||+|.++..-- .+.++ ---+|||.+|.
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke------------------k~GFP---ItsLREIniLl 130 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE------------------KEGFP---ITSLREINILL 130 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc------------------cCCCc---chhHHHHHHHH
Confidence 4566889999999999999999999999988888887764311 01111 12578999999
Q ss_pred cCCCCCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 105 SCHHENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
+++|||||.+.++.+- -+.+|+|||||+. +|..++.. ....|.+.+++.++.|+++||+|||.+.|+|||
T Consensus 131 ~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~-------m~q~F~~~evK~L~~QlL~glk~lH~~wilHRD 202 (419)
T KOG0663|consen 131 KARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMET-------MKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRD 202 (419)
T ss_pred hcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHh-------ccCCCchHHHHHHHHHHHHHHHHHhhceeEecc
Confidence 9999999999998874 4679999999975 89999986 346899999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|||.|+|+++.|.+||+|||+|+.+++. .+.....+-|.+|+|||++.+...|++++||||+|||+.||+++++.
T Consensus 203 LK~SNLLm~~~G~lKiaDFGLAR~ygsp-----~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPl 277 (419)
T KOG0663|consen 203 LKTSNLLLSHKGILKIADFGLAREYGSP-----LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPL 277 (419)
T ss_pred cchhheeeccCCcEEecccchhhhhcCC-----cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCC
Confidence 9999999999999999999999988653 23345678899999999999999999999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCC---CCCCCCCchhh-----------------hhHHH--hcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 263 YHKYPAMKVLMLTLQND---PPTLDTGAAEK-----------------DQYKA--YGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~---~~~~~~~~~~~-----------------~~~~~--~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
|.+....+++..+.+.- ...+..+.... ..+.. ++....+|+..+|.+||.+|.||.|
T Consensus 278 f~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~ 357 (419)
T KOG0663|consen 278 FPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED 357 (419)
T ss_pred CCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence 99999888886654321 11111111111 11112 4578899999999999999999999
Q ss_pred HhcCcccccc
Q psy11359 321 LLKNPFFKKA 330 (520)
Q Consensus 321 lL~hp~~~~~ 330 (520)
.|+|.||...
T Consensus 358 ~L~h~~F~e~ 367 (419)
T KOG0663|consen 358 GLKHEYFRET 367 (419)
T ss_pred hhcccccccC
Confidence 9999999863
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-50 Score=403.84 Aligned_cols=257 Identities=31% Similarity=0.531 Sum_probs=227.5
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+.. +....+..+.+|+++++.|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g---------------------r~~k~l~~l~~ev~i~r~lkH 60 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG---------------------RNEKELKNLRQEVRILRSLKH 60 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC---------------------CchHHHHHHHHHHHHHHhcCC
Confidence 67999999999999999999999999999999875321 123467779999999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
||||.++++|+...++|+|+||+.| +|+.++. ..+.++|+.++.++.|++.||.|||+++|+|||+||.||
T Consensus 61 pniv~m~esfEt~~~~~vVte~a~g-~L~~il~--------~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqni 131 (808)
T KOG0597|consen 61 PNIVEMLESFETSAHLWVVTEYAVG-DLFTILE--------QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNI 131 (808)
T ss_pred cchhhHHHhhcccceEEEEehhhhh-hHHHHHH--------hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCccee
Confidence 9999999999999999999999976 9999998 467899999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|+...|.+|+||||+|+.+..+. .+.....|||.|||||++.++. |+..+|+||+||++|||++|++||....-
T Consensus 132 Ll~~~~~~KlcdFg~Ar~m~~~t-----~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si 205 (808)
T KOG0597|consen 132 LLEKGGTLKLCDFGLARAMSTNT-----SVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSI 205 (808)
T ss_pred eecCCCceeechhhhhhhcccCc-----eeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHH
Confidence 99999999999999999876533 2345678999999999998766 99999999999999999999999988777
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
......++....... ...+..|+.|+..+|.+||.+|.|..+++.|||.+..-
T Consensus 206 ~~Lv~~I~~d~v~~p----------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 206 TQLVKSILKDPVKPP----------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred HHHHHHHhcCCCCCc----------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 766666666554433 25688999999999999999999999999999998543
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=382.08 Aligned_cols=273 Identities=30% Similarity=0.412 Sum_probs=227.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
...+|..++.||+|++|.|+.|.++.+|+.||||++.... ......++..+|+++|+.+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F---------------------~~~~~akRtlRElklLr~~ 78 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF---------------------ENQIDAKRTLRELKLLRHL 78 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh---------------------hchHHHHHHHHHHHHHHHh
Confidence 4456777899999999999999999999999999774211 1134567789999999999
Q ss_pred CCCCceEEEEEEEE-----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 107 HHENVVTYHTSFVV-----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 107 ~HpnIv~~~~~~~~-----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+|+||+.+++++.. -+.+|+|+|++ +.+|.+.|+ ....+++..++.+++||++||.|+|+.|++||
T Consensus 79 ~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik--------~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHR 149 (359)
T KOG0660|consen 79 RHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIK--------SQQDLTDDHAQYFLYQILRGLKYIHSANVIHR 149 (359)
T ss_pred cCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHH--------cCccccHHHHHHHHHHHHHhcchhhccccccc
Confidence 99999999999875 34699999999 679999997 44559999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||.|+|++.+..+||+|||+|+.+... ........++.|.+|+|||++.....|+.++||||+|||+.||++|++
T Consensus 150 DLKPsNll~n~~c~lKI~DFGLAR~~~~~---~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkp 226 (359)
T KOG0660|consen 150 DLKPSNLLLNADCDLKICDFGLARYLDKF---FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKP 226 (359)
T ss_pred ccchhheeeccCCCEEeccccceeecccc---CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCC
Confidence 99999999999999999999999987644 344555678999999999999888889999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCC---------------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLD---------------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
.|.+.+...++..++..-+..-+ ....-...++..++...+|+++||..||.+|+|++|
T Consensus 227 lFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 227 LFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred CCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 99998877776555433221100 011112334567789999999999999999999999
Q ss_pred HhcCccccccch
Q psy11359 321 LLKNPFFKKAKD 332 (520)
Q Consensus 321 lL~hp~~~~~~~ 332 (520)
+|.||||....+
T Consensus 307 AL~hPYl~~~hd 318 (359)
T KOG0660|consen 307 ALAHPYLAPYHD 318 (359)
T ss_pred HhcChhhhhhcC
Confidence 999999986654
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=408.89 Aligned_cols=273 Identities=40% Similarity=0.681 Sum_probs=241.3
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
+..+.|+|+..||-|+||.||+|..+.++-..|.|++.- +..+.+++++-||.||..
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-----------------------kseEELEDylVEIeILa~ 85 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-----------------------KSEEELEDYLVEIEILAE 85 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-----------------------cchhHHhhhhhhhhhhhc
Confidence 556789999999999999999999999887777776631 125578889999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
|+||+||++++.|..++.+||..|||.||-+..++-. -...|.+.+|+.+++|++.||.|||+++|||||||.
T Consensus 86 CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlE-------L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKA 158 (1187)
T KOG0579|consen 86 CDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLE-------LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKA 158 (1187)
T ss_pred CCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHH-------hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccc
Confidence 9999999999999999999999999999999988876 467899999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceec----ccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME----QDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~----~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
.|||++-+|.++|+|||++.... .....+.+|+|||+|||||++. ....|++++||||||++|.+|.-+.+
T Consensus 159 GNiL~TldGdirLADFGVSAKn~-----~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEP 233 (1187)
T KOG0579|consen 159 GNILLTLDGDIRLADFGVSAKNK-----STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEP 233 (1187)
T ss_pred cceEEEecCcEeeecccccccch-----hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCC
Confidence 99999999999999999986432 2344567899999999999864 34459999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhhHHHhhh
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTL 340 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~~~~~ 340 (520)
|-+...++.++..+....||++.. ...++..|.||+.+||.+||..||++.++|+||||+.+..++.+...+
T Consensus 234 PHhelnpMRVllKiaKSePPTLlq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ireLl 305 (1187)
T KOG0579|consen 234 PHHELNPMRVLLKIAKSEPPTLLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIRELL 305 (1187)
T ss_pred CccccchHHHHHHHhhcCCCcccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHHHHH
Confidence 999999999999999999988754 245678999999999999999999999999999999887776555443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=388.39 Aligned_cols=262 Identities=24% Similarity=0.422 Sum_probs=223.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||.||+|.++.+++.||+|+++...... ....+.+.+|+.+++++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~E~~~l~~l 75 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK--------------------MKQVQHVAQEKSILMEL 75 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--------------------hhhHHHHHHHHHHHHhC
Confidence 4578999999999999999999999999999999886432110 12345688999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++..++.+|+||||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+
T Consensus 76 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~ 147 (329)
T PTZ00263 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK--------AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPE 147 (329)
T ss_pred CCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence 999999999999999999999999999999999973 467889999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.+|.+||+|||++..+... .....||+.|+|||++.+.. ++.++|||||||++|+|+||..||...
T Consensus 148 NIll~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 148 NLLLDNKGHVKVTDFGFAKKVPDR--------TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred HEEECCCCCEEEeeccCceEcCCC--------cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCC
Confidence 999999999999999998765321 22457999999999997655 899999999999999999999999887
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchhhH
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~ 335 (520)
........+..+... ++ ..++..+++||.+||++||.+|++ +.+++.||||....+...
T Consensus 219 ~~~~~~~~i~~~~~~-~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~ 282 (329)
T PTZ00263 219 TPFRIYEKILAGRLK-FP---------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKL 282 (329)
T ss_pred CHHHHHHHHhcCCcC-CC---------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHH
Confidence 776666655544322 11 235778999999999999999997 799999999997665543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=382.98 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=220.5
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.++++++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h 60 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR--------------------LKQEQHVHNEKRVLKEVSH 60 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh--------------------hHHHHHHHHHHHHHHhCCC
Confidence 47999999999999999999999999999999876432110 1234568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++.+.+.+|+||||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||
T Consensus 61 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NI 132 (291)
T cd05612 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN--------SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENI 132 (291)
T ss_pred CcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence 9999999999999999999999999999999973 46789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.+|.+||+|||++..+... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus 133 li~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 133 LLDKEGHIKLTDFGFAKKLRDR--------TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred EECCCCCEEEEecCcchhccCC--------cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999998765321 22457999999999987654 89999999999999999999999988777
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchh
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDK 333 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~ 333 (520)
......+...... ++ ..++..+++||.+||+.||.+||+ +.++++||||+.....
T Consensus 204 ~~~~~~i~~~~~~-~~---------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 204 FGIYEKILAGKLE-FP---------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred HHHHHHHHhCCcC-CC---------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 6666655554322 11 235778999999999999999995 9999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=379.79 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=227.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
+..-+|++.+.||+|.||.|-+|++...|+.||||.+++.-.. ....+-.+++||++|+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk--------------------deqDlvhIRREIeIMSs 109 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK--------------------DEQDLVHIRREIEIMSS 109 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc--------------------cHHHHHHHHHHHHHHhh
Confidence 4556899999999999999999999999999999988654221 13456679999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
|+||||+.+|++|+..+.+.|||||..+|.|.|||.. .+.+++.+++++++||..|+.|||.++++|||||.
T Consensus 110 LNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe--------r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKL 181 (668)
T KOG0611|consen 110 LNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE--------RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKL 181 (668)
T ss_pred cCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH--------hccccHHHHHHHHHHHHHHHHHHhhccceecccch
Confidence 9999999999999999999999999999999999985 47899999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.++++||+|||++..+. ..+...+|||+|.|.+||++.+..+-++.+|.||||++||-|+.|..||.+
T Consensus 182 ENILLD~N~NiKIADFGLSNly~------~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 182 ENILLDQNNNIKIADFGLSNLYA------DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred hheeecCCCCeeeeccchhhhhc------cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 99999999999999999998876 445667899999999999999988778999999999999999999999999
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
.+.......+..+..... .-+....-||+.||..+|++|.|+.++-.|=|+.
T Consensus 256 ~Dhk~lvrQIs~GaYrEP-----------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 256 RDHKRLVRQISRGAYREP-----------ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred chHHHHHHHhhcccccCC-----------CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 887766665555432221 2244567899999999999999999999998875
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=375.11 Aligned_cols=272 Identities=25% Similarity=0.353 Sum_probs=235.2
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
.-++|++++.||.|.-|+||+|+.+.++..+|+|++.+..+.. ...+.+...|-+||+.+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~--------------------rkKl~Ra~tE~eIL~~l 134 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS--------------------RKKLKRAQTEREILSLL 134 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh--------------------hhHHHHHHHHHHHHHhc
Confidence 4467899999999999999999999999999999997654432 12345678899999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||.++.+|..|+.++..|++||||.||+|..++++. .++.|++..++-++..++.||+|||-.|||+|||||+
T Consensus 135 DHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQ------p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPE 208 (459)
T KOG0610|consen 135 DHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQ------PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPE 208 (459)
T ss_pred CCCccchhhheeeccceeEEEEecCCCccHHHHHhhC------CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcc
Confidence 9999999999999999999999999999999999875 7789999999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccC----------------------------------cc-----------------ccc
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATG----------------------------------RD-----------------LSR 215 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~----------------------------------~~-----------------~~~ 215 (520)
||||.++|+|.|+||.++...... .. ...
T Consensus 209 NILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~ 288 (459)
T KOG0610|consen 209 NILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPT 288 (459)
T ss_pred eeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCC
Confidence 999999999999999998543110 00 000
Q ss_pred cccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHH
Q psy11359 216 QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKA 295 (520)
Q Consensus 216 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (520)
......++||-.|.|||++.+.. .+.++|+|+|||.+|||+.|..||.+....+.+..++......... ..
T Consensus 289 ~~RSnSFVGThEYlAPEvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~--------~~ 359 (459)
T KOG0610|consen 289 GARSNSFVGTHEYLAPEVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE--------PE 359 (459)
T ss_pred CccccccccccccccceeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC--------Cc
Confidence 11234689999999999998764 8999999999999999999999999999999998888765443322 25
Q ss_pred hcHHHHHHHHhhhccCCCCCCC----HHHHhcCccccccchh
Q psy11359 296 YGKTFRKMISDCLQKDPTKRPT----ASELLKNPFFKKAKDK 333 (520)
Q Consensus 296 ~~~~~~~li~~~L~~dP~~Rpt----a~elL~hp~~~~~~~~ 333 (520)
++..++|||+++|.+||++|.- |.||-+||||+..++.
T Consensus 360 vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 360 VSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred chhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 6788999999999999999999 9999999999999886
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=364.34 Aligned_cols=268 Identities=27% Similarity=0.504 Sum_probs=231.9
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC- 106 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l- 106 (520)
-..|+-.+.||+|..++|.++.++.+|..+|+|++....-.. ..+....-.+.-.+|+.+|+++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~---------------~~e~~~~~~EaT~~Ev~ILRqv~ 80 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTE---------------SGETPYEMREATRQEISILRQVM 80 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEeccccc---------------CCccHHHHHHHHHHHHHHHHHhc
Confidence 356888999999999999999999999999999886432111 0111123456678899999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
.||+|+++.++|+.+..+++|+|++..|.|+||+.. .-.++++..+++++|++.|++|||.++|+||||||+
T Consensus 81 GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts--------~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpE 152 (411)
T KOG0599|consen 81 GHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS--------KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPE 152 (411)
T ss_pred CCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhh--------heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChh
Confidence 799999999999999999999999999999999983 467899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceec-----ccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME-----QDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|||++++.++||+|||+|+.+..+.. ....||||+|.|||.+. +..+|+..+|+|++|+|||-|+.|.+
T Consensus 153 NILlddn~~i~isDFGFa~~l~~Gek------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcp 226 (411)
T KOG0599|consen 153 NILLDDNMNIKISDFGFACQLEPGEK------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCP 226 (411)
T ss_pred heeeccccceEEeccceeeccCCchh------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCC
Confidence 99999999999999999998876544 35689999999999874 45679999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
||.....+-.+..+.++....- .+.|.+++...++||.+||+.||.+|.|++|+|.||||...
T Consensus 227 PFwHRkQmlMLR~ImeGkyqF~------speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 227 PFWHRKQMLMLRMIMEGKYQFR------SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred chhHHHHHHHHHHHHhcccccC------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 9988887777777777754432 34567899999999999999999999999999999999754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=378.36 Aligned_cols=266 Identities=23% Similarity=0.337 Sum_probs=214.7
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||.|+||+||+|.+..++..||+|+++... .......+.+|+.+++++
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------------~~~~~~~~~~E~~~l~~l 60 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH----------------------EEGAPCTAIREVSLLKNL 60 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc----------------------cCCcchhHHHHHHHHHhC
Confidence 4567999999999999999999999999999999774221 011234577899999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+..++||||+. ++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+
T Consensus 61 ~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~ 132 (288)
T cd07871 61 KHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDN-------CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQ 132 (288)
T ss_pred CCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 99999999999999999999999996 499999874 3446789999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.++.+||+|||++....... .......||+.|+|||++.+...++.++||||+||++|+|+||.+||...
T Consensus 133 Nil~~~~~~~kl~DfG~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 133 NLLINEKGELKLADFGLARAKSVPT-----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred HEEECCCCCEEECcCcceeeccCCC-----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999987543221 11234578999999999877666899999999999999999999999887
Q ss_pred cHHHHHHHHhcCCCCCCCC--------------------CchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcc
Q psy11359 267 PAMKVLMLTLQNDPPTLDT--------------------GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~ 326 (520)
...+.+..+.......... ..........++.++++||.+||++||.+|||+.|+|+|||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 208 TVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred CHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 7665554433221110000 00001112346788999999999999999999999999999
Q ss_pred c
Q psy11359 327 F 327 (520)
Q Consensus 327 ~ 327 (520)
|
T Consensus 288 f 288 (288)
T cd07871 288 F 288 (288)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=389.33 Aligned_cols=264 Identities=28% Similarity=0.538 Sum_probs=232.7
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
......|++.+.||+|.||+||+|.++.+|+.+|+|++.+..... ..+.+.+.+|+++|+
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~--------------------~~~~~~v~~Ev~il~ 90 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG--------------------KEDREDVRREVAILQ 90 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc--------------------cccHHHHHHHHHHHH
Confidence 445678999999999999999999999999999999886542211 114567999999999
Q ss_pred cCC-CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 105 SCH-HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 105 ~l~-HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++. |||||.++++|++...+++|||+|+||.|++.|... .+++..+..+++||+.++.|||+.|++||||
T Consensus 91 ~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---------~~sE~da~~~~~~il~av~~lH~~gvvHrDl 161 (382)
T KOG0032|consen 91 QLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK---------HYSERDAAGIIRQILEAVKYLHSLGVVHRDL 161 (382)
T ss_pred hccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc---------cCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Confidence 997 999999999999999999999999999999999852 3999999999999999999999999999999
Q ss_pred CCCcEEEcC----CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 184 KAGNILLGE----DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 184 Kp~NILl~~----~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG 259 (520)
||+|+|+.. ++.+|++|||++..... .......+|||.|+|||++.+.. |+..+||||+|+++|.|++|
T Consensus 162 KpEN~L~~~~~~~~~~ik~~DFGla~~~~~------~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G 234 (382)
T KOG0032|consen 162 KPENLLLASKDEGSGRIKLIDFGLAKFIKP------GERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSG 234 (382)
T ss_pred CHHHeeeccccCCCCcEEEeeCCCceEccC------CceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhC
Confidence 999999943 35899999999988753 33456789999999999997654 99999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.+||.+.........+..+.... ....|..++..+++||.+||..||.+|+|+.++|+|||++..
T Consensus 235 ~~PF~~~~~~~~~~~i~~~~~~f------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 235 VPPFWGETEFEIFLAILRGDFDF------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CCCCcCCChhHHHHHHHcCCCCC------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999888888888776522 234567889999999999999999999999999999999865
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=385.20 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=215.7
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~ 114 (520)
+.||+|+||.||+|.++.+|+.||+|+++...... ......+.+|+.++++++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~hp~i~~~ 60 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA--------------------KDEVAHTLTESRVLQNTRHPFLTAL 60 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hHHHHHHHHHHHHHHhCCCCCCCCE
Confidence 47999999999999999999999999886432110 2234567889999999999999999
Q ss_pred EEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCC
Q psy11359 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194 (520)
Q Consensus 115 ~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g 194 (520)
++++...+.+|+||||+.|++|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 61 ~~~~~~~~~~~lv~e~~~~~~L~~~l~--------~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~ 132 (323)
T cd05571 61 KYSFQTHDRLCFVMEYANGGELFFHLS--------RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG 132 (323)
T ss_pred EEEEEcCCEEEEEEeCCCCCcHHHHHH--------HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC
Confidence 999999999999999999999999997 356789999999999999999999999999999999999999999
Q ss_pred CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q psy11359 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLML 274 (520)
Q Consensus 195 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~ 274 (520)
.+||+|||++...... .......+||+.|+|||++.+.. ++.++|||||||++|+|+||..||...........
T Consensus 133 ~~kl~DfG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~ 206 (323)
T cd05571 133 HIKITDFGLCKEGISD-----GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (323)
T ss_pred CEEEeeCCCCcccccC-----CCcccceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH
Confidence 9999999998643211 11233568999999999997655 89999999999999999999999987766655554
Q ss_pred HhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhh
Q psy11359 275 TLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKK 334 (520)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~ 334 (520)
+..... .+ ...+++++.+||.+||++||++|| ++.++++||||....+..
T Consensus 207 ~~~~~~-~~---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~ 261 (323)
T cd05571 207 ILMEEI-RF---------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQD 261 (323)
T ss_pred HHcCCC-CC---------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 443322 11 134678899999999999999999 899999999998876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=377.59 Aligned_cols=271 Identities=24% Similarity=0.369 Sum_probs=213.2
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||.|+||+||+|.++.+++.||+|+++... .......+.+|+.+++.+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------------------~~~~~~~~~~E~~~l~~l 60 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE----------------------EEGTPFTAIREASLLKGL 60 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc----------------------ccccchhHHHHHHHHhhC
Confidence 5688999999999999999999999999999999874221 111233577899999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++......|+||||+. ++|.+++.. ..+.+++..++.++.||+.||.|||++||+||||||+
T Consensus 61 ~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~ 132 (303)
T cd07869 61 KHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDK-------HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQ 132 (303)
T ss_pred CCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 99999999999999999999999994 688888864 3466899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.+|.+||+|||++....... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.
T Consensus 133 Nill~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 133 NLLISDTGELKLADFGLARAKSVPS-----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred HEEECCCCCEEECCCCcceeccCCC-----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999986543211 12234578999999999876666899999999999999999999999875
Q ss_pred cHHH-HHHHHhc--CCCCC-----------C-----C--CCchhhhhHH--HhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 267 PAMK-VLMLTLQ--NDPPT-----------L-----D--TGAAEKDQYK--AYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 267 ~~~~-~~~~~~~--~~~~~-----------~-----~--~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.+.. .+..... +.+.. . . ........+. .+++.+.+||.+||++||++|||+.|+|+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 208 KDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 4432 2211111 00000 0 0 0000000111 24578899999999999999999999999
Q ss_pred Cccccccch
Q psy11359 324 NPFFKKAKD 332 (520)
Q Consensus 324 hp~~~~~~~ 332 (520)
||||+....
T Consensus 288 h~~f~~~~~ 296 (303)
T cd07869 288 HEYFSDLPP 296 (303)
T ss_pred CcccccCCh
Confidence 999987643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=384.69 Aligned_cols=266 Identities=23% Similarity=0.348 Sum_probs=223.5
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCC-ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARA-EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
.......++|++.+.||+|+||.||+|.+..++ ..||+|++....... ....+.+.+|+
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~~E~ 82 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK--------------------QKQVDHVFSER 82 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh--------------------hhhHHHHHHHH
Confidence 335567789999999999999999999877665 678888775432110 22345688999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
.+++.++||||+++++++...+.+|+||||+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+|
T Consensus 83 ~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 154 (340)
T PTZ00426 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR--------NKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154 (340)
T ss_pred HHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEc
Confidence 999999999999999999999999999999999999999973 467899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+|||++.+|.+||+|||++..+... ....+||+.|||||++.+.. ++.++|||||||++|+|++|.
T Consensus 155 rDLkp~NILl~~~~~ikL~DFG~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~ 225 (340)
T PTZ00426 155 RDLKPENLLLDKDGFIKMTDFGFAKVVDTR--------TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGC 225 (340)
T ss_pred cCCCHHHEEECCCCCEEEecCCCCeecCCC--------cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCC
Confidence 999999999999999999999998765321 23568999999999997654 899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhh
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKK 334 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~ 334 (520)
+||...........+...... ++ ..+++.++++|.+||+.||.+|+ |++++++||||....+..
T Consensus 226 ~Pf~~~~~~~~~~~i~~~~~~-~p---------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~ 294 (340)
T PTZ00426 226 PPFYANEPLLIYQKILEGIIY-FP---------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294 (340)
T ss_pred CCCCCCCHHHHHHHHhcCCCC-CC---------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999987776655555544321 11 34577899999999999999995 899999999998766543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=374.10 Aligned_cols=265 Identities=26% Similarity=0.400 Sum_probs=217.4
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
.|++.+.||+|+||+||+|.+..+|+.||+|.+....... ......+.+|+.++++++|+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--------------------~~~~~~~~~E~~il~~l~~~ 60 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--------------------RKGEAMALNEKRILEKVNSR 60 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh--------------------hhhHHHHHHHHHHHHhcCCC
Confidence 3889999999999999999999999999999876432211 11234577899999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++.+.+.+++||||+.+|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 61 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil 134 (285)
T cd05631 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM------GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL 134 (285)
T ss_pred cEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEE
Confidence 9999999999999999999999999999888643 3346899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
+++++.++|+|||++..+.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......
T Consensus 135 l~~~~~~kl~Dfg~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~ 207 (285)
T cd05631 135 LDDRGHIRISDLGLAVQIPEGE------TVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207 (285)
T ss_pred ECCCCCEEEeeCCCcEEcCCCC------eecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence 9999999999999987653221 123457999999999997665 899999999999999999999999865432
Q ss_pred HH---HHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchhhHH
Q psy11359 270 KV---LMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDKKFI 336 (520)
Q Consensus 270 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~~ 336 (520)
.. ....+...... ....++..+.+||.+||++||.+||| ++++++||||+....+...
T Consensus 208 ~~~~~~~~~~~~~~~~---------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~ 273 (285)
T cd05631 208 VKREEVDRRVKEDQEE---------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLE 273 (285)
T ss_pred hhHHHHHHHhhccccc---------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHH
Confidence 21 21111111111 12356889999999999999999997 8999999999987765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=374.16 Aligned_cols=265 Identities=42% Similarity=0.736 Sum_probs=235.0
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.+-|.++++||+|+||.||+|.++++|..+|||.+.. .+.+.++.+||.+|.+|+
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-------------------------~sDLQEIIKEISIMQQC~ 86 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-------------------------DTDLQEIIKEISIMQQCK 86 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-------------------------cchHHHHHHHHHHHHHcC
Confidence 3458899999999999999999999999999997753 356788999999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
.|++|+||++|-....+|+|||||..|++.|.++. .++.+++.++..+++..++||+|||...-||||||..|
T Consensus 87 S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~-------R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGN 159 (502)
T KOG0574|consen 87 SKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA-------RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGN 159 (502)
T ss_pred CchhhhhhhhhccCCceEeehhhcCCCcHHHHHHH-------hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhccccc
Confidence 99999999999999999999999999999999987 46789999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
||+..+|..||+|||+|..+.. .-..+++.+|||.|||||++.. .+|+.++||||||++..||.-|++||....
T Consensus 160 ILLNT~G~AKLADFGVAGQLTD-----TMAKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 160 ILLNTDGIAKLADFGVAGQLTD-----TMAKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred EEEcccchhhhhhccccchhhh-----hHHhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 9999999999999999987743 2223567899999999999965 459999999999999999999999999988
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhhHHH
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQ 337 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~~ 337 (520)
++..++.+--+.||++.. ....|.+|.+||+.||.+.|++|.||.++++|||++++......+
T Consensus 234 PMRAIFMIPT~PPPTF~K-------PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~ 296 (502)
T KOG0574|consen 234 PMRAIFMIPTKPPPTFKK-------PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQ 296 (502)
T ss_pred ccceeEeccCCCCCCCCC-------hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHH
Confidence 888777666666665532 345788999999999999999999999999999999887655433
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=372.20 Aligned_cols=266 Identities=29% Similarity=0.424 Sum_probs=219.1
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
-.|+-.+++|+|+||+||.|...+++..||||.+-.+. .--.+|+++|+.++|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---------------------------r~knrEl~im~~l~H 76 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---------------------------RYKNRELQIMRKLDH 76 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC---------------------------CcCcHHHHHHHhcCC
Confidence 35899999999999999999999998888888763211 012469999999999
Q ss_pred CCceEEEEEEEEC--C---EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 109 ENVVTYHTSFVVK--D---ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 109 pnIv~~~~~~~~~--~---~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
||||++.-+|... . .+.+||||+ ..+|.+++++... ....++.-.++-+..||++||.|||+.||+||||
T Consensus 77 pNIV~L~~~f~~~~~~d~~~lnlVleym-P~tL~~~~r~~~~----~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDI 151 (364)
T KOG0658|consen 77 PNIVRLLYFFSSSTESDEVYLNLVLEYM-PETLYRVIRHYTR----ANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDI 151 (364)
T ss_pred cCeeeEEEEEEecCCCchhHHHHHHHhc-hHHHHHHHHHHhh----cCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCC
Confidence 9999998888742 2 367899999 5799999987543 4567889999999999999999999999999999
Q ss_pred CCCcEEEcCC-CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 184 KAGNILLGED-GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 184 Kp~NILl~~~-g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
||.|+|++.+ |.+||||||.|..+..+.. ..+++.|..|+|||++.+...|+.++||||.||++.||+-|++.
T Consensus 152 KPqNlLvD~~tg~LKicDFGSAK~L~~~ep------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~pl 225 (364)
T KOG0658|consen 152 KPQNLLVDPDTGVLKICDFGSAKVLVKGEP------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPL 225 (364)
T ss_pred ChheEEEcCCCCeEEeccCCcceeeccCCC------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcc
Confidence 9999999864 9999999999998865433 35678899999999999999999999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCC-------------------CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDP-------------------PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|.+.+..+++..+++--. +.+......+-..+..+++..+|+.++|+.+|.+|.++.|+|.
T Consensus 226 FpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 226 FPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 999988888765543210 1111111111133567899999999999999999999999999
Q ss_pred Cccccccch
Q psy11359 324 NPFFKKAKD 332 (520)
Q Consensus 324 hp~~~~~~~ 332 (520)
||||+....
T Consensus 306 h~fFdelr~ 314 (364)
T KOG0658|consen 306 HPFFDELRD 314 (364)
T ss_pred chhhHHhhC
Confidence 999986554
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=367.50 Aligned_cols=275 Identities=28% Similarity=0.402 Sum_probs=223.1
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
...|..+++||+|+||+||+|+.+.+|+.||+|+++...-. +-......+|+.+|+.|+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~---------------------EG~P~taiREisllk~L~ 68 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE---------------------EGVPSTAIREISLLKRLS 68 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc---------------------cCCCchhhHHHHHHHHhC
Confidence 45688899999999999999999999999999988643110 012234789999999999
Q ss_pred CCC-ceEEEEEEEECC------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 108 HEN-VVTYHTSFVVKD------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 108 Hpn-Iv~~~~~~~~~~------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
|+| ||++++++.+.+ .+++|+||+ .-+|.+|+...... ...++...++.+++||++||.|||++||+|
T Consensus 69 ~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~----~~g~~~~~ik~~m~Qll~gl~~~H~~~IlH 143 (323)
T KOG0594|consen 69 HANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKK----PQGLPPRLIKSFMRQLLRGLAFLHSHGILH 143 (323)
T ss_pred CCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhcccc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 999 999999999877 899999999 56999999864221 146778999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||.||||+++|.+||+|||+|+.++-. .....+-++|.+|+|||++.+...|+..+||||+|||++||++++
T Consensus 144 RDLKPQNlLi~~~G~lKlaDFGlAra~~ip-----~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~ 218 (323)
T KOG0594|consen 144 RDLKPQNLLISSSGVLKLADFGLARAFSIP-----MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR 218 (323)
T ss_pred ccCCcceEEECCCCcEeeeccchHHHhcCC-----cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC
Confidence 999999999999999999999999865422 122445689999999999999988999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCC--C-----CC----------CCCC---chhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 261 APYHKYPAMKVLMLTLQND--P-----PT----------LDTG---AAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~--~-----~~----------~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
+.|.+..+.+++..+...- | +. .... .......+..++...+++.+||+.+|.+|.|+..
T Consensus 219 ~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~ 298 (323)
T KOG0594|consen 219 PLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKG 298 (323)
T ss_pred CCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHH
Confidence 9999999988876654321 1 00 0000 0011112233458899999999999999999999
Q ss_pred HhcCccccccchh
Q psy11359 321 LLKNPFFKKAKDK 333 (520)
Q Consensus 321 lL~hp~~~~~~~~ 333 (520)
+|.||||+.....
T Consensus 299 al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 299 ALTHPYFSELPEK 311 (323)
T ss_pred HhcChhhcccccc
Confidence 9999999976543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=373.10 Aligned_cols=265 Identities=23% Similarity=0.398 Sum_probs=212.5
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||+||+|.++.+++.||+|++.... ......+.+.+|+.+++.++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l~h 59 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE---------------------ENEEVKETTLRELKMLRTLKQ 59 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc---------------------ccccchhhHHHHHHHHHhCCC
Confidence 47999999999999999999999999999999875321 012234567889999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++..++.+|+||||+.++.|..+.. ....+++..++.++.||+.||.|||++|++||||||+||
T Consensus 60 ~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni 131 (287)
T cd07848 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE--------MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENL 131 (287)
T ss_pred ccccchhhhEecCCEEEEEEecCCCCHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 999999999999999999999998876655443 345689999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++.++.+||+|||++..+..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.....
T Consensus 132 ll~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~ 206 (287)
T cd07848 132 LISHNDVLKLCDFGFARNLSEGSN----ANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESE 206 (287)
T ss_pred EEcCCCcEEEeeccCccccccccc----ccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999877643221 1123457899999999997665 89999999999999999999999987665
Q ss_pred HHHHHHHhcCCCC---------------------CCC-CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcc
Q psy11359 269 MKVLMLTLQNDPP---------------------TLD-TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326 (520)
Q Consensus 269 ~~~~~~~~~~~~~---------------------~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~ 326 (520)
.+..........+ ... ...........++..+.+||.+||++||++|||++++|+|||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 207 IDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286 (287)
T ss_pred HHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 5443322111000 000 000111222347889999999999999999999999999999
Q ss_pred c
Q psy11359 327 F 327 (520)
Q Consensus 327 ~ 327 (520)
|
T Consensus 287 f 287 (287)
T cd07848 287 F 287 (287)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=382.26 Aligned_cols=265 Identities=23% Similarity=0.410 Sum_probs=220.9
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||.||+|.+..+++.||+|+++...... ......+.+|+.++..++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~h 60 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK--------------------LNEVRHVLTERDILTTTKS 60 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--------------------hhHHHHHHHHHHHHHhCCC
Confidence 47999999999999999999999999999999886432211 1234568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+.+|+||||+.|++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 61 ~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 132 (333)
T cd05600 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN--------NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF 132 (333)
T ss_pred CCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHH--------HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 999999999999999999999999999999997 346789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.++.+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus 133 l~~~~~~~kL~Dfg~a~~~~~--------~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 133 LIDASGHIKLTDFGLSKGIVT--------YANSVVGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred EECCCCCEEEEeCcCCccccc--------ccCCcccCccccChhHhcCCC-CCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 999999999999999875432 234568999999999997764 89999999999999999999999988776
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
.+........... +..... ......++.++.+||.+||..+|.+|||+.++++||||.....
T Consensus 204 ~~~~~~i~~~~~~-~~~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 204 NETWENLKYWKET-LQRPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHHHHhcccc-ccCCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 6655444322111 100000 0001356889999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=384.43 Aligned_cols=269 Identities=25% Similarity=0.389 Sum_probs=218.6
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||+||+|.+..+++.||+|+++...... ......+.+|+.++..++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~E~~il~~~~~ 60 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE--------------------KEQVGHIRAERDILVEADS 60 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH--------------------hhHHHHHHHHHHHHHhCCC
Confidence 57999999999999999999999999999999886432211 1234568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++.+...+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 61 ~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--------~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NI 132 (363)
T cd05628 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK--------KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNL 132 (363)
T ss_pred CCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence 9999999999999999999999999999999973 46789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccc------------------------------cccccccccccccccCCcceecccC
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDL------------------------------SRQKVRHTFVGTPCWMAPEVMEQDH 238 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~------------------------------~~~~~~~~~~gt~~y~APE~~~~~~ 238 (520)
|++.+|.+||+|||++..+...... .........+||+.|+|||++.+..
T Consensus 133 Li~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~ 212 (363)
T cd05628 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 212 (363)
T ss_pred EECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC
Confidence 9999999999999998754321100 0001123468999999999997654
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCC---C
Q psy11359 239 GYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT---K 314 (520)
Q Consensus 239 ~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~---~ 314 (520)
++.++|||||||++|+|++|..||......+....+..... ..++. ...+++++++||.+|+. +|. .
T Consensus 213 -~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------~~~~s~~~~~li~~l~~-~~~~r~~ 283 (363)
T cd05628 213 -YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPP-------EVPISEKAKDLILRFCC-EWEHRIG 283 (363)
T ss_pred -CCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCC-------cCCCCHHHHHHHHHHcC-ChhhcCC
Confidence 89999999999999999999999988777766665554221 11111 12367889999998765 344 4
Q ss_pred CCCHHHHhcCccccccchhh
Q psy11359 315 RPTASELLKNPFFKKAKDKK 334 (520)
Q Consensus 315 Rpta~elL~hp~~~~~~~~~ 334 (520)
||++.|+++||||+...+..
T Consensus 284 r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 284 APGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CCCHHHHhCCCCCCCCCHHH
Confidence 68999999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=386.72 Aligned_cols=268 Identities=25% Similarity=0.395 Sum_probs=220.3
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||+||+|.+..+|+.||+|++....... ......+.+|+.+++.++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~E~~il~~l~h 60 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE--------------------KEQVAHVRAERDILAEADN 60 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHHhCCC
Confidence 47999999999999999999999999999999886432111 1234567889999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++.+++.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 61 ~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~--------~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NI 132 (364)
T cd05599 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK--------KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNL 132 (364)
T ss_pred CCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence 9999999999999999999999999999999973 45789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCcccc---------------------------------ccccccccccccccCCcceec
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLS---------------------------------RQKVRHTFVGTPCWMAPEVME 235 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~---------------------------------~~~~~~~~~gt~~y~APE~~~ 235 (520)
|++.+|.++|+|||++..+....... +.......+||+.|+|||++.
T Consensus 133 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 212 (364)
T cd05599 133 LLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL 212 (364)
T ss_pred EECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc
Confidence 99999999999999987653221100 000112357999999999987
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCC
Q psy11359 236 QDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315 (520)
Q Consensus 236 ~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 315 (520)
+.. ++.++|||||||++|+|++|.+||......+............... ....+++.+++||.+||. +|.+|
T Consensus 213 ~~~-~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------~~~~~s~~~~~li~~ll~-~p~~R 284 (364)
T cd05599 213 QTG-YNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFP------DEVPLSPEAKDLIKRLCC-EAERR 284 (364)
T ss_pred CCC-CCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCC------CCCCCCHHHHHHHHHHcc-CHhhc
Confidence 654 8999999999999999999999999887776665554432111100 012467899999999997 89999
Q ss_pred CC---HHHHhcCccccccch
Q psy11359 316 PT---ASELLKNPFFKKAKD 332 (520)
Q Consensus 316 pt---a~elL~hp~~~~~~~ 332 (520)
++ +.+++.||||+....
T Consensus 285 ~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 285 LGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CCCCCHHHHhcCCCcCCCCH
Confidence 98 999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=387.47 Aligned_cols=268 Identities=24% Similarity=0.384 Sum_probs=216.6
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
.|++++.||+|+||+||+|.+..+++.||+|+++...... ......+.+|+.+++.++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~--------------------~~~~~~~~~E~~il~~l~h~ 61 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN--------------------RNQVAHVKAERDILAEADNE 61 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hHHHHHHHHHHHHHHhcCCC
Confidence 6999999999999999999999999999999886432211 22355689999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++.+.+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 62 ~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~--------~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nil 133 (381)
T cd05626 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR--------MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL 133 (381)
T ss_pred CeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEE
Confidence 999999999999999999999999999999973 467899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCcc------------------------------------------ccccccccccccccc
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRD------------------------------------------LSRQKVRHTFVGTPC 227 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~------------------------------------------~~~~~~~~~~~gt~~ 227 (520)
++.+|.+||+|||++..+..... ........+++||+.
T Consensus 134 i~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (381)
T cd05626 134 IDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPN 213 (381)
T ss_pred ECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCcc
Confidence 99999999999998754311000 000011235689999
Q ss_pred cCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC-CCCCCCCchhhhhHHHhcHHHHHHHHh
Q psy11359 228 WMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND-PPTLDTGAAEKDQYKAYGKTFRKMISD 306 (520)
Q Consensus 228 y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ 306 (520)
|+|||++.+.. ++.++|||||||++|+|+||..||...........+.... ...++ ....+++++.+||.+
T Consensus 214 Y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-------~~~~~s~~~~dli~~ 285 (381)
T cd05626 214 YIAPEVLLRKG-YTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIP-------PQVKLSPEAVDLITK 285 (381)
T ss_pred ccCHHHHcCCC-CCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCC-------CCCCCCHHHHHHHHH
Confidence 99999987654 8999999999999999999999998877655554443221 11111 112468899999998
Q ss_pred hh--ccCCCCCCCHHHHhcCccccccchh
Q psy11359 307 CL--QKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 307 ~L--~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
|| ..+|..|+++.+++.||||+.....
T Consensus 286 ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 286 LCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HccCcccccCCCCHHHHhcCcccCCCChh
Confidence 55 4556669999999999999876554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=387.56 Aligned_cols=269 Identities=26% Similarity=0.400 Sum_probs=218.8
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|+++++||+|+||+||+|.+..+++.||+|++....... ......+.+|+.++++++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~--------------------~~~~~~~~~E~~il~~~~h~ 61 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLL--------------------RNQVAHVKAERDILAEADNE 61 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhh--------------------HHHHHHHHHHHHHHHhCCCC
Confidence 6999999999999999999999999999999886432110 22345688999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++.+++.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 62 ~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--------~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NIL 133 (382)
T cd05625 62 WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR--------MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133 (382)
T ss_pred cCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 999999999999999999999999999999973 467899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCcc------------------------------------------ccccccccccccccc
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRD------------------------------------------LSRQKVRHTFVGTPC 227 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~------------------------------------------~~~~~~~~~~~gt~~ 227 (520)
++.+|.+||+|||++..+..... ........+.+||+.
T Consensus 134 l~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (382)
T cd05625 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN 213 (382)
T ss_pred ECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcc
Confidence 99999999999999753311000 000111234679999
Q ss_pred cCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhh
Q psy11359 228 WMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDC 307 (520)
Q Consensus 228 y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 307 (520)
|+|||++.+.. |+.++|||||||++|+|++|.+||...........+......... .....+++++.++|.+|
T Consensus 214 Y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~------p~~~~~s~~~~~li~~l 286 (382)
T cd05625 214 YIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHI------PPQAKLSPEASDLIIKL 286 (382)
T ss_pred cCCHHHhcCCC-CCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCC------CCcccCCHHHHHHHHHH
Confidence 99999997655 899999999999999999999999987776666555432211110 01134678899999997
Q ss_pred hccCCCCCCC---HHHHhcCccccccchhh
Q psy11359 308 LQKDPTKRPT---ASELLKNPFFKKAKDKK 334 (520)
Q Consensus 308 L~~dP~~Rpt---a~elL~hp~~~~~~~~~ 334 (520)
+ .+|.+|++ +.++++||||+......
T Consensus 287 ~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~ 315 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKAHPFFKTIDFSS 315 (382)
T ss_pred c-cCHhHcCCCCCHHHHhcCCCcCCcChHH
Confidence 6 59999997 99999999998765543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=378.62 Aligned_cols=259 Identities=27% Similarity=0.455 Sum_probs=216.0
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCce-EEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEK-CAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~-vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
..|........+.+.||+|+||+||++.... +. ||+|++...... ....+.+.+|+
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~---------------------~~~~~~f~~E~ 90 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFD---------------------DESRKAFRREA 90 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcC---------------------hHHHHHHHHHH
Confidence 3466666777888889999999999998764 34 777766432111 11266899999
Q ss_pred HHHhcCCCCCceEEEEEEEECC-EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-c
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKD-ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG-Q 178 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~-~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g-i 178 (520)
.+|.+|+|||||++++++.... .+++||||+.+|+|.+++... ..+.++...+..|+.||++||+|||+++ |
T Consensus 91 ~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~------~~~~l~~~~~l~~aldiArGm~YLH~~~~i 164 (362)
T KOG0192|consen 91 SLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK------RKRKLPLKVRLRIALDIARGMEYLHSEGPI 164 (362)
T ss_pred HHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCe
Confidence 9999999999999999999887 799999999999999999853 2578999999999999999999999999 9
Q ss_pred EecccCCCcEEEcCCC-CeEEeccCcceeeccCccccccccccccccccccCCcceeccc-CCCCcchhHHHHHHHHHHH
Q psy11359 179 IHRDIKAGNILLGEDG-TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 179 iHrDLKp~NILl~~~g-~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DIwSlG~il~el 256 (520)
|||||||+|||++.++ ++||+|||+++...... .......||+.|||||++.+. ..|+.++||||||++||||
T Consensus 165 IHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl 239 (362)
T KOG0192|consen 165 IHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWEL 239 (362)
T ss_pred eecccChhhEEEcCCCCEEEECCCccceeecccc-----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHH
Confidence 9999999999999998 99999999998764321 112236899999999999853 3499999999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHh-cCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 257 ATGTAPYHKYPAMKVLMLTL-QNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 257 ltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+||+.||............. .+..+.++. .+++.+..+|..||..||.+||++.+++.
T Consensus 240 ~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~---------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 240 LTGEIPFEDLAPVQVASAVVVGGLRPPIPK---------ECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHCCCCCCCCCHHHHHHHHHhcCCCCCCCc---------cCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999998866666554 444454442 37788999999999999999999999974
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=384.67 Aligned_cols=262 Identities=31% Similarity=0.512 Sum_probs=230.6
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++++++|+|+||.+++++++.+++.+++|.++..... ........+|+.++++++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t---------------------~~~r~~A~~E~~lis~~~ 61 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT---------------------EPERRSAIQEMDLLSKLL 61 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC---------------------chhhHHHHHHHHHHHhcc
Confidence 47899999999999999999999999877777776543221 113346789999999999
Q ss_pred CCCceEEEEEEEECCE-EEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 108 HENVVTYHTSFVVKDE-LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~-~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
|||||.++++|+.++. ++|||+||+||+|.+.|+.. +...|+++.+..|+.||+.|+.|||+++|+|||||+.
T Consensus 62 hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~------k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~ 135 (426)
T KOG0589|consen 62 HPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQ------KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCA 135 (426)
T ss_pred CCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHH------hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhh
Confidence 9999999999999888 99999999999999999875 4578999999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.++.|+|+|||+|+.+.+.. ....+++|||.||.||++.+.. |+.++|||||||++|||++-+++|...
T Consensus 136 Nifltk~~~VkLgDfGlaK~l~~~~-----~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~ 209 (426)
T KOG0589|consen 136 NIFLTKDKKVKLGDFGLAKILNPED-----SLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKAS 209 (426)
T ss_pred hhhccccCceeecchhhhhhcCCch-----hhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCcc
Confidence 9999999999999999999886432 2566889999999999998776 999999999999999999999999998
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
+.......+.+.....++ ..++.+++.+|..||.++|..||++.++|.+|.++...
T Consensus 210 ~m~~Li~ki~~~~~~Plp---------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 210 NMSELILKINRGLYSPLP---------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred chHHHHHHHhhccCCCCC---------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 888888877776644333 46788999999999999999999999999999887554
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=348.90 Aligned_cols=260 Identities=27% Similarity=0.385 Sum_probs=228.1
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
.-++|++.+.||+|-||.||.|+.+.++-.||+|++.+..... .....++.+|+++-+.|
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~--------------------~~v~~qlrREiEIqs~L 79 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK--------------------TQVEHQLRREIEIQSHL 79 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH--------------------hcchhhhhheeEeeccc
Confidence 6688999999999999999999999999999999986543321 12345689999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++|++|.+...+||++||..+|+|+..++.. ....+++...+.+++|++.||.|||..++|||||||+
T Consensus 80 ~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~------~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpe 153 (281)
T KOG0580|consen 80 RHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEG------RMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPE 153 (281)
T ss_pred CCccHHhhhhheeccceeEEEEEecCCchHHHHHHhc------ccccccccchhHHHHHHHHHHHHhccCCcccCCCCHH
Confidence 9999999999999999999999999999999999854 5678999999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|+|++..|.+||+|||-+..-. ...+.+.|||..|.+||...+.. ++..+|+|++|++.||++.|.+||...
T Consensus 154 nlLlg~~~~lkiAdfGwsV~~p-------~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 154 NLLLGSAGELKIADFGWSVHAP-------SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred HhccCCCCCeeccCCCceeecC-------CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 9999999999999999886532 34467899999999999998765 999999999999999999999999887
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
...+.+..+..-+.... ..++..++|+|.+||.++|.+|.+..|++.|||+...
T Consensus 226 ~~~etYkrI~k~~~~~p----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 226 SHSETYKRIRKVDLKFP----------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred hhHHHHHHHHHccccCC----------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 76666665554432211 4578899999999999999999999999999999753
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=385.33 Aligned_cols=270 Identities=26% Similarity=0.399 Sum_probs=217.9
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
.+|++++.||+|+||+||+|.+..+++.||+|++....... ......+.+|+.+|+.++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~--------------------~~~~~~~~~E~~il~~l~h 60 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM--------------------RNQAAHVKAERDILAEADN 60 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh--------------------hhhHHHHHHHHHHHHhCCC
Confidence 37999999999999999999999999999999886432111 1234568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++.|..++.+|+||||++||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 61 ~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Ni 132 (376)
T cd05598 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI--------RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 132 (376)
T ss_pred CCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHE
Confidence 999999999999999999999999999999997 346789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccc--------------------------------------cccccccccccccccCC
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDL--------------------------------------SRQKVRHTFVGTPCWMA 230 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~--------------------------------------~~~~~~~~~~gt~~y~A 230 (520)
|++.++.+||+|||++..+...... ........++||+.|||
T Consensus 133 ll~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 212 (376)
T cd05598 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIA 212 (376)
T ss_pred EECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccC
Confidence 9999999999999997533110000 00011124689999999
Q ss_pred cceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhcc
Q psy11359 231 PEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQK 310 (520)
Q Consensus 231 PE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (520)
||++.+.. ++.++|||||||++|+|++|+.||......+....+...... ... .....+++.+.++|.+|+ .
T Consensus 213 PE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-~~~-----~~~~~~s~~~~~li~~l~-~ 284 (376)
T cd05598 213 PEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETT-LHI-----PSQAKLSREASDLILRLC-C 284 (376)
T ss_pred HHHHcCCC-CCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcc-ccC-----CCCCCCCHHHHHHHHHHh-c
Confidence 99997655 899999999999999999999999887766655444322111 100 011346788999999977 5
Q ss_pred CCCCCC---CHHHHhcCccccccchhh
Q psy11359 311 DPTKRP---TASELLKNPFFKKAKDKK 334 (520)
Q Consensus 311 dP~~Rp---ta~elL~hp~~~~~~~~~ 334 (520)
+|.+|+ |+.++++||||+......
T Consensus 285 ~p~~R~~~~t~~ell~h~~~~~~~~~~ 311 (376)
T cd05598 285 GAEDRLGKNGADEIKAHPFFKGIDFAS 311 (376)
T ss_pred CHhhcCCCCCHHHHhCCCCcCCCCHHH
Confidence 999999 999999999999765443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=376.01 Aligned_cols=252 Identities=28% Similarity=0.444 Sum_probs=212.8
Q ss_pred eeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEEE
Q psy11359 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHT 116 (520)
Q Consensus 37 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~~ 116 (520)
||+|+||+||+|.+..+++.||+|+++...... ......+.+|+.++++++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 60 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS--------------------RSEVTHTLAERTVLAQVNCPFIVPLKF 60 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHHhCCCCcEeceee
Confidence 799999999999999999999999876432110 223456888999999999999999999
Q ss_pred EEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCe
Q psy11359 117 SFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196 (520)
Q Consensus 117 ~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~v 196 (520)
++...+.+|+||||+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+
T Consensus 61 ~~~~~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~ 132 (312)
T cd05585 61 SFQSPEKLYLVLAFINGGELFHHLQR--------EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHI 132 (312)
T ss_pred EEecCCeEEEEEcCCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcE
Confidence 99999999999999999999999973 4578999999999999999999999999999999999999999999
Q ss_pred EEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh
Q psy11359 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTL 276 (520)
Q Consensus 197 kL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~ 276 (520)
+|+|||++...... .......+||+.|+|||++.+.. ++.++|||||||++|+|+||..||......+......
T Consensus 133 kl~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~ 206 (312)
T cd05585 133 ALCDFGLCKLNMKD-----DDKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206 (312)
T ss_pred EEEECcccccCccC-----CCccccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence 99999998653221 11234567999999999997655 8999999999999999999999998877666665554
Q ss_pred cCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC---CHHHHhcCccccccch
Q psy11359 277 QNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP---TASELLKNPFFKKAKD 332 (520)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---ta~elL~hp~~~~~~~ 332 (520)
.... .++ ..+++.+++||.+||.+||.+|| ++.++++||||.....
T Consensus 207 ~~~~-~~~---------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 207 QEPL-RFP---------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred cCCC-CCC---------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence 4322 221 34678899999999999999997 5899999999987643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=375.94 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=215.5
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~ 114 (520)
+.||+|+||.||++.+..+|..||+|+++...... ......+.+|+.+++.++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~hp~i~~~ 60 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--------------------KDEVAHTVTESRVLQNTRHPFLTAL 60 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hHHHHHHHHHHHHHHhCCCCCCcce
Confidence 47999999999999999999999999886432210 2234567889999999999999999
Q ss_pred EEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCC
Q psy11359 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194 (520)
Q Consensus 115 ~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g 194 (520)
++++...+.+|+||||+.+|+|..++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 61 ~~~~~~~~~~~lv~E~~~~~~L~~~l~--------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 132 (323)
T cd05595 61 KYAFQTHDRLCFVMEYANGGELFFHLS--------RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 132 (323)
T ss_pred eeEEecCCEEEEEEeCCCCCcHHHHHH--------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC
Confidence 999999999999999999999999887 346789999999999999999999999999999999999999999
Q ss_pred CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q psy11359 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLML 274 (520)
Q Consensus 195 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~ 274 (520)
.+||+|||++...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........
T Consensus 133 ~~kL~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~ 206 (323)
T cd05595 133 HIKITDFGLCKEGISD-----GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206 (323)
T ss_pred CEEecccHHhccccCC-----CCccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999988643211 11223467999999999997655 89999999999999999999999987766655554
Q ss_pred HhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhhH
Q psy11359 275 TLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~ 335 (520)
....... + ...+++.+.+||.+||++||.+|+ ++.++++||||....+...
T Consensus 207 ~~~~~~~-~---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 262 (323)
T cd05595 207 ILMEEIR-F---------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 262 (323)
T ss_pred HhcCCCC-C---------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 4433221 1 134678999999999999999998 9999999999998765543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=377.18 Aligned_cols=255 Identities=29% Similarity=0.471 Sum_probs=214.8
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~ 114 (520)
+.||+|+||.||+|.+..+|+.||+|+++...... ......+.+|+.+++.++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~hp~iv~~ 60 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA--------------------KDEVAHTLTESRVLKNTRHPFLTSL 60 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHHhCCCCCCcce
Confidence 47999999999999999999999999886432110 2234568889999999999999999
Q ss_pred EEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCC
Q psy11359 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194 (520)
Q Consensus 115 ~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g 194 (520)
+.++...+.+|+||||+.+|+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 61 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~--------~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 132 (328)
T cd05593 61 KYSFQTKDRLCFVMEYVNGGELFFHLS--------RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG 132 (328)
T ss_pred EEEEEcCCEEEEEEeCCCCCCHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC
Confidence 999999999999999999999999987 346789999999999999999999999999999999999999999
Q ss_pred CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q psy11359 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLML 274 (520)
Q Consensus 195 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~ 274 (520)
.+||+|||++...... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........
T Consensus 133 ~~kL~DfG~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~ 206 (328)
T cd05593 133 HIKITDFGLCKEGITD-----AATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (328)
T ss_pred cEEEecCcCCccCCCc-----ccccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH
Confidence 9999999998653211 11223467999999999997655 89999999999999999999999987766665554
Q ss_pred HhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchh
Q psy11359 275 TLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDK 333 (520)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~ 333 (520)
+...... + ...+++++.+||.+||++||.+|+ ++.++++||||......
T Consensus 207 ~~~~~~~-~---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 207 ILMEDIK-F---------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred hccCCcc-C---------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 4433221 1 134678899999999999999997 89999999999876554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=391.01 Aligned_cols=267 Identities=25% Similarity=0.389 Sum_probs=210.6
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
...+|++.+.||+|+||+||+|.+..+++.||+|++... .....+|+.+|+.+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---------------------------~~~~~~Ei~il~~l 116 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---------------------------PQYKNRELLIMKNL 116 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---------------------------cchHHHHHHHHHhc
Confidence 346799999999999999999999999999999876311 11245799999999
Q ss_pred CCCCceEEEEEEEEC--------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 107 HHENVVTYHTSFVVK--------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~--------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
+||||++++++|... ..+++||||+. ++|.+++..... ....+++..++.++.||+.||.|||++||
T Consensus 117 ~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~----~~~~l~~~~~~~~~~qi~~gL~yLH~~~I 191 (440)
T PTZ00036 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYAR----NNHALPLFLVKLYSYQLCRALAYIHSKFI 191 (440)
T ss_pred CCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 999999999887532 24779999996 588888865322 45678999999999999999999999999
Q ss_pred EecccCCCcEEEcCCC-CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 179 IHRDIKAGNILLGEDG-TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 179 iHrDLKp~NILl~~~g-~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
+||||||+|||++.++ .+||+|||++..+..+. .....+||+.|+|||++.+...|+.++|||||||++|+|+
T Consensus 192 iHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell 265 (440)
T PTZ00036 192 CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265 (440)
T ss_pred ecCCcCHHHEEEcCCCCceeeeccccchhccCCC------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999998654 79999999997664322 1234678999999999877666999999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhcCC--C-----------------CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH
Q psy11359 258 TGTAPYHKYPAMKVLMLTLQND--P-----------------PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA 318 (520)
Q Consensus 258 tG~~Pf~~~~~~~~~~~~~~~~--~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta 318 (520)
||.+||.+....+.+..+.+.. + +...............++++.+||.+||++||.+|||+
T Consensus 266 tG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta 345 (440)
T PTZ00036 266 LGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP 345 (440)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH
Confidence 9999999877666554443211 0 00000000011112357889999999999999999999
Q ss_pred HHHhcCccccccc
Q psy11359 319 SELLKNPFFKKAK 331 (520)
Q Consensus 319 ~elL~hp~~~~~~ 331 (520)
.|+|+||||+...
T Consensus 346 ~e~l~hp~f~~~~ 358 (440)
T PTZ00036 346 IEALADPFFDDLR 358 (440)
T ss_pred HHHhCChhHHhhh
Confidence 9999999997643
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=373.85 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=215.4
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH---hcCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM---SSCH 107 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l---~~l~ 107 (520)
|++++.||+|+||.||+|.+..+|+.||+|+++...... ....+.+.+|+.++ +.++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~l~~e~~~~~~~~~l~ 60 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA--------------------RDEVESLMCEKRIFETANSER 60 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHHhccccC
Confidence 789999999999999999999999999999886432111 12234566666554 5678
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++...+.+|+||||+.|++|..++. .+.+++..+..++.||+.||.|||++|++||||||+|
T Consensus 61 hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~---------~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~N 131 (324)
T cd05589 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH---------TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDN 131 (324)
T ss_pred CCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHH
Confidence 9999999999999999999999999999998874 3568999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
||++.++.+||+|||++..... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||....
T Consensus 132 ill~~~~~~kL~Dfg~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 132 LLLDTEGFVKIADFGLCKEGMG-----FGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred eEECCCCcEEeCcccCCccCCC-----CCCcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999998764321 112234578999999999987655 8999999999999999999999999887
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhh
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKK 334 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~ 334 (520)
.......+....+. .+ ..+++.+.++|.+||+.||.+|| ++.++++||||+......
T Consensus 206 ~~~~~~~i~~~~~~-~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~ 267 (324)
T cd05589 206 EEEVFDSIVNDEVR-YP---------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDD 267 (324)
T ss_pred HHHHHHHHHhCCCC-CC---------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHH
Confidence 77666555544322 11 34678899999999999999999 799999999998765543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=383.28 Aligned_cols=268 Identities=25% Similarity=0.380 Sum_probs=216.4
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++++.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.++++++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~E~~il~~l~h 60 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK--------------------KDQLAHVKAERDVLAESDS 60 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHH--------------------hHHHHHHHHHHHHHHhCCC
Confidence 47999999999999999999999999999999876432110 2235668899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++.+...+|+||||+.||+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 61 p~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~--------~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NI 132 (377)
T cd05629 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI--------KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNI 132 (377)
T ss_pred CCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 999999999999999999999999999999997 346789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccc-----------cc-------------------------------ccccccccccc
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDL-----------SR-------------------------------QKVRHTFVGTP 226 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~-----------~~-------------------------------~~~~~~~~gt~ 226 (520)
|++.+|.+||+|||++..+...... .. .......+||+
T Consensus 133 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 212 (377)
T cd05629 133 LIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTP 212 (377)
T ss_pred EECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCc
Confidence 9999999999999998643211000 00 00011357999
Q ss_pred ccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHh
Q psy11359 227 CWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISD 306 (520)
Q Consensus 227 ~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 306 (520)
.|+|||++.+.. ++.++|||||||++|+|+||.+||........+..+..... .+.. .....++.++.+||.+
T Consensus 213 ~y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~-----p~~~~~s~~~~dli~~ 285 (377)
T cd05629 213 DYIAPEIFLQQG-YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE-TLYF-----PDDIHLSVEAEDLIRR 285 (377)
T ss_pred cccCHHHHccCC-CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC-ccCC-----CCCCCCCHHHHHHHHH
Confidence 999999987655 89999999999999999999999988776665554443211 1110 0112467889999999
Q ss_pred hhccCCCCC---CCHHHHhcCccccccch
Q psy11359 307 CLQKDPTKR---PTASELLKNPFFKKAKD 332 (520)
Q Consensus 307 ~L~~dP~~R---pta~elL~hp~~~~~~~ 332 (520)
||. +|.+| +|+.+++.||||+....
T Consensus 286 lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 286 LIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred Hhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 997 67665 59999999999987554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=376.47 Aligned_cols=270 Identities=27% Similarity=0.421 Sum_probs=210.1
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.++||+|+||.||+|.+..+|..||+|.++.... .......+.+|+.++++++||
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~~E~~~l~~l~hp 59 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE---------------------HVSDATRILREIKLLRLLRHP 59 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc---------------------cchhHHHHHHHHHHHHhCCCC
Confidence 69999999999999999999999999999997752110 012234688999999999999
Q ss_pred CceEEEEEEEEC-----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 110 NVVTYHTSFVVK-----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 110 nIv~~~~~~~~~-----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
||+++++++... ..+|+||||+ +++|.+++. ..+.+++..+..++.||+.||.|||++||+|||||
T Consensus 60 niv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~--------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 130 (338)
T cd07859 60 DIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIK--------ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLK 130 (338)
T ss_pred CEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHH--------hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 999999988643 3589999999 579999987 34568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc-CCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
|+|||++.++.+||+|||++........ ........+||+.|+|||++.+. ..++.++|||||||++|+|+||++||
T Consensus 131 p~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf 208 (338)
T cd07859 131 PKNILANADCKLKICDFGLARVAFNDTP--TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208 (338)
T ss_pred HHHeEECCCCcEEEccCccccccccccC--ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999875432111 11122346799999999998652 34899999999999999999999999
Q ss_pred CCCcHHHHHHHHhc--CCCCCC-------------------CCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 264 HKYPAMKVLMLTLQ--NDPPTL-------------------DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 264 ~~~~~~~~~~~~~~--~~~~~~-------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
.+......+..... +.++.. .........+..+++.+.++|.+||+.||++|||+.|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 209 PGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 87655433321111 000000 000001112234678899999999999999999999999
Q ss_pred cCccccccc
Q psy11359 323 KNPFFKKAK 331 (520)
Q Consensus 323 ~hp~~~~~~ 331 (520)
+||||+...
T Consensus 289 ~hp~f~~~~ 297 (338)
T cd07859 289 ADPYFKGLA 297 (338)
T ss_pred cCchhhhcC
Confidence 999998643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=385.27 Aligned_cols=263 Identities=38% Similarity=0.642 Sum_probs=232.0
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
..|.-++.||.|+||.||-|+|..+...||||.+.+... .. .+...++.+|+..|++++|
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK----------Qs----------~EKWqDIlKEVrFL~~l~H 85 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK----------QS----------NEKWQDILKEVRFLRQLRH 85 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeecccccc----------cc----------HHHHHHHHHHHHHHHhccC
Confidence 447788999999999999999999999999998876521 11 2345679999999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
||+|.|.++|..+...||||||| -|+-.|++.- ..+++-+.+|..|+.+.+.||.|||+++.||||||..||
T Consensus 86 PntieYkgCyLre~TaWLVMEYC-lGSAsDlleV-------hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNI 157 (948)
T KOG0577|consen 86 PNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEV-------HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNI 157 (948)
T ss_pred CCcccccceeeccchHHHHHHHH-hccHHHHHHH-------HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccce
Confidence 99999999999999999999999 5688888864 346788999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ--DHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|+++.|.|||+|||.|.... ...+|+|||.|||||++.. ...|+-++||||||++..||.-.++|+..+
T Consensus 158 LLse~g~VKLaDFGSAsi~~---------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 158 LLSEPGLVKLADFGSASIMA---------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred EecCCCeeeeccccchhhcC---------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence 99999999999999987653 3568999999999999752 234999999999999999999999999999
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhhHH
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFI 336 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~ 336 (520)
+.+..++.+.++.+|.+.. ..++..|+.|+..||++-|..|||.+++|+|+|.........+
T Consensus 229 NAMSALYHIAQNesPtLqs--------~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi 290 (948)
T KOG0577|consen 229 NAMSALYHIAQNESPTLQS--------NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVI 290 (948)
T ss_pred hHHHHHHHHHhcCCCCCCC--------chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHH
Confidence 9999999999999999875 3567889999999999999999999999999999876655433
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=372.43 Aligned_cols=261 Identities=26% Similarity=0.443 Sum_probs=218.6
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||+|+||.||+|.+..+++.||+|+++...... ....+.+..|+.++..++|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~~~ 60 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ--------------------DDDVECTMVEKRVLALPGKP 60 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHHhcCCC
Confidence 5899999999999999999999999999999886432210 22345678899999999664
Q ss_pred -CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 110 -NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 110 -nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
+|+++++++...+.+|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Ni 132 (324)
T cd05587 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--------VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132 (324)
T ss_pred CceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence 688899999999999999999999999999973 46788999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.+|.+||+|||++..... ........+||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.....
T Consensus 133 ll~~~~~~kL~Dfg~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (324)
T cd05587 133 MLDAEGHIKIADFGMCKENIF-----GGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206 (324)
T ss_pred EEcCCCCEEEeecCcceecCC-----CCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999864321 112233567999999999998765 89999999999999999999999998877
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH-----HHHhcCccccccchhh
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA-----SELLKNPFFKKAKDKK 334 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~elL~hp~~~~~~~~~ 334 (520)
......+...... ++ ..+++.+.++|.+||.+||.+|+++ .++++||||+...+..
T Consensus 207 ~~~~~~i~~~~~~-~~---------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~ 267 (324)
T cd05587 207 DELFQSIMEHNVS-YP---------KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEK 267 (324)
T ss_pred HHHHHHHHcCCCC-CC---------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 7666655543321 11 3467889999999999999999986 8999999998866543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=382.04 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=208.0
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
....+|++++.||+|+||.||+|.+..+++.||+|... ...+.+|++++++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------------------------~~~~~~E~~il~~ 139 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------------------------RGGTATEAHILRA 139 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------------------------hhhhHHHHHHHHh
Confidence 45578999999999999999999999999999988532 1236789999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
|+||||++++++|..+...++|||++ +++|..++.. .+.+++..+..++.||+.||.|||++||+||||||
T Consensus 140 l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--------~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP 210 (391)
T PHA03212 140 INHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAA--------KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKA 210 (391)
T ss_pred CCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 99999999999999999999999999 5789998863 35688999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.++.+||+|||++...... ........+||+.|+|||++.+.. |+.++|||||||++|+|+||..||..
T Consensus 211 ~NIll~~~~~vkL~DFG~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 211 ENIFINHPGDVCLGDFGAACFPVDI----NANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred HhEEEcCCCCEEEEeCCcccccccc----cccccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 9999999999999999998653221 111233568999999999997655 89999999999999999999988643
Q ss_pred Cc-------HHHHHHHHh---cCCCCCCCC----------------------CchhhhhHHHhcHHHHHHHHhhhccCCC
Q psy11359 266 YP-------AMKVLMLTL---QNDPPTLDT----------------------GAAEKDQYKAYGKTFRKMISDCLQKDPT 313 (520)
Q Consensus 266 ~~-------~~~~~~~~~---~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~ 313 (520)
.. ....+..++ ...+..... ..........++.++.+||.+||++||.
T Consensus 286 ~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~ 365 (391)
T PHA03212 286 KDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAH 365 (391)
T ss_pred cccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChh
Confidence 21 111111111 111111000 0001112234577899999999999999
Q ss_pred CCCCHHHHhcCcccccc
Q psy11359 314 KRPTASELLKNPFFKKA 330 (520)
Q Consensus 314 ~Rpta~elL~hp~~~~~ 330 (520)
+|||+.|+|+||||+..
T Consensus 366 ~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 366 HRPSAEALLDFAAFQDI 382 (391)
T ss_pred hCCCHHHHhcChhhccC
Confidence 99999999999999764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=372.41 Aligned_cols=266 Identities=27% Similarity=0.513 Sum_probs=215.7
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||.||++.+..+|..+|+|+++.. ......+.+.+|+++|+++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~----------------------~~~~~~~~~~~E~~~l~~l 60 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE----------------------IKPAIRNQIIRELQVLHEC 60 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc----------------------cCHHHHHHHHHHHHHHHHC
Confidence 468899999999999999999999999888888876421 1123456789999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecccCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN-GQIHRDIKA 185 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~-giiHrDLKp 185 (520)
+||||+++++++..++.+++||||+.|++|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||
T Consensus 61 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp 132 (331)
T cd06649 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE--------AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKP 132 (331)
T ss_pred CCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCCh
Confidence 999999999999999999999999999999999974 45689999999999999999999986 699999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.++.+||+|||++..+.. .......||+.|+|||++.+.. ++.++|||||||++|+|+||+.||..
T Consensus 133 ~Nil~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 133 SNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred hhEEEcCCCcEEEccCcccccccc-------cccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999875532 1223467999999999997665 89999999999999999999999976
Q ss_pred CcHHHHHHHHhcCCCC--------CCC----------------CC--c-------------hhhhhHHHhcHHHHHHHHh
Q psy11359 266 YPAMKVLMLTLQNDPP--------TLD----------------TG--A-------------AEKDQYKAYGKTFRKMISD 306 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~--------~~~----------------~~--~-------------~~~~~~~~~~~~~~~li~~ 306 (520)
....+... .+..... ... .. . ........+++++++||.+
T Consensus 205 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 283 (331)
T cd06649 205 PDAKELEA-IFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNK 283 (331)
T ss_pred CCHHHHHH-HhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHH
Confidence 55443322 1111000 000 00 0 0000012367889999999
Q ss_pred hhccCCCCCCCHHHHhcCccccccc
Q psy11359 307 CLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 307 ~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
||++||++|||+.++++||||+...
T Consensus 284 ~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 284 CLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred HccCCcccCCCHHHHhcChHHhhcc
Confidence 9999999999999999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=384.94 Aligned_cols=262 Identities=30% Similarity=0.476 Sum_probs=216.6
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC-C
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH-H 108 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~-H 108 (520)
+|+++++||+|+||.|.+|.+..+++.||||+++.. .....+...|+.+|..|+ |
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~------------------------k~f~~Q~~~Ei~iL~~ln~~ 242 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK------------------------KRFLRQAQIEIRILELLNKH 242 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC------------------------hHHHHHHHHHHHHHHHHhcc
Confidence 689999999999999999999999999999988622 233456778999999996 4
Q ss_pred -----CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 109 -----ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 109 -----pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
-|||+++++|..++++|||+|++ +.+|.++++.. +...|+...++.++.||+.||.+||..||||+||
T Consensus 243 d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n------~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDL 315 (586)
T KOG0667|consen 243 DPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNN------KFRGLSLPLVRKFAQQILTALLFLHELGIIHCDL 315 (586)
T ss_pred CCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 38999999999999999999999 67999999975 6677999999999999999999999999999999
Q ss_pred CCCcEEEcCC--CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 184 KAGNILLGED--GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 184 Kp~NILl~~~--g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||+||||.+- ..|||+|||+|+... +.+ .+++.+..|+|||++.+.. |+.+.||||||||++||++|.+
T Consensus 316 KPENILL~~~~r~~vKVIDFGSSc~~~-------q~v-ytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~P 386 (586)
T KOG0667|consen 316 KPENILLKDPKRSRIKVIDFGSSCFES-------QRV-YTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEP 386 (586)
T ss_pred ChhheeeccCCcCceeEEecccccccC-------Ccc-eeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCcc
Confidence 9999999543 379999999998752 223 3789999999999999887 9999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcC--CCCC------------CCC----------Cc-----------------------h------
Q psy11359 262 PYHKYPAMKVLMLTLQN--DPPT------------LDT----------GA-----------------------A------ 288 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~--~~~~------------~~~----------~~-----------------------~------ 288 (520)
.|.+.+..+++..+..- .|+. ++. .. .
T Consensus 387 LfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l 466 (586)
T KOG0667|consen 387 LFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSL 466 (586)
T ss_pred ccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCccc
Confidence 99999988887554322 1100 000 00 0
Q ss_pred hhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 289 EKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
.......-...|.+||.+||..||.+|+|+.++|+||||....
T Consensus 467 ~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 467 ESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred chhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence 0000012335789999999999999999999999999998543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=379.50 Aligned_cols=268 Identities=28% Similarity=0.427 Sum_probs=222.2
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||+||+|.+..+|+.||+|+++...... ......+.+|+.++..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~~ 60 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK--------------------RNQIAHVRAERDILADADS 60 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh--------------------ccHHHHHHHHHHHHHhcCC
Confidence 47999999999999999999999999999999886432211 1234568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++.+++.+|+||||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NI 132 (350)
T cd05573 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR--------KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNI 132 (350)
T ss_pred CCccchhhheecCCeEEEEEcCCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence 9999999999999999999999999999999974 36789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCcc------------------------ccccccccccccccccCCcceecccCCCCcch
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRD------------------------LSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~------------------------~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~ 244 (520)
|++.++.+||+|||++..+..... ...........||+.|+|||++.+.. ++.++
T Consensus 133 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~ 211 (350)
T cd05573 133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLEC 211 (350)
T ss_pred EECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCce
Confidence 999999999999999876643320 00011223467999999999998764 89999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-HHHHh
Q psy11359 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-ASELL 322 (520)
Q Consensus 245 DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-a~elL 322 (520)
|||||||++|+|++|..||...........+..... ..++. ...+++.+.+||.+||. ||.+||+ +.+++
T Consensus 212 DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 212 DWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPP-------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred eeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCC-------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 999999999999999999988776666555444111 11111 12268899999999997 9999999 99999
Q ss_pred cCccccccchh
Q psy11359 323 KNPFFKKAKDK 333 (520)
Q Consensus 323 ~hp~~~~~~~~ 333 (520)
+||||+.....
T Consensus 284 ~hp~~~~~~~~ 294 (350)
T cd05573 284 SHPFFKGIDWE 294 (350)
T ss_pred cCCCcCCCCHH
Confidence 99999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=374.25 Aligned_cols=262 Identities=29% Similarity=0.429 Sum_probs=212.8
Q ss_pred CeEEEeeeeecCceEEEEEEEc---CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCK---ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
+|++.+.||+|+||+||++++. .+++.||+|++....... .....+.+.+|+.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-------------------~~~~~~~~~~e~~~l~~l 61 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ-------------------KAKTVEHTRTERNVLEHV 61 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh-------------------hhhHHHHHHHHHHHHHhc
Confidence 5899999999999999999764 468888998875432110 122345688899999999
Q ss_pred -CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 -HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 -~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+||||+++++++..++.+++||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||
T Consensus 62 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp 133 (332)
T cd05614 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--------RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKL 133 (332)
T ss_pred cCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCH
Confidence 599999999999999999999999999999999973 46689999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.+|.+||+|||++..+..... ......+||+.|+|||++.+...++.++|||||||++|+|+||..||..
T Consensus 134 ~Nili~~~~~~kl~DfG~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 134 ENILLDSEGHVVLTDFGLSKEFLSEEK----ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred HHeEECCCCCEEEeeCcCCccccccCC----CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 999999999999999999876532211 1223467999999999998665588999999999999999999999964
Q ss_pred Cc----HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccch
Q psy11359 266 YP----AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKD 332 (520)
Q Consensus 266 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~ 332 (520)
.. ............+ .+ ...+++.+.+||.+||+.||++|| +++++++||||+....
T Consensus 210 ~~~~~~~~~~~~~~~~~~~-~~---------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 210 EGERNTQSEVSRRILKCDP-PF---------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred CCCCCCHHHHHHHHhcCCC-CC---------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 32 1222222222221 11 134678899999999999999999 8889999999987544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=372.96 Aligned_cols=255 Identities=26% Similarity=0.434 Sum_probs=214.2
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~HpnIv~ 113 (520)
+.||+|+||+||+|.++.+++.||+|+++...... ....+.+.+|+.++..+ +||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~~h~~iv~ 60 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ--------------------DDDVECTMTEKRILSLARNHPFLTQ 60 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh--------------------ccHHHHHHHHHHHHHhccCCCchhc
Confidence 47999999999999999999999999886432110 12345677888888876 7999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++...+.+|+||||+.||+|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~--------~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~ 132 (320)
T cd05590 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQK--------SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE 132 (320)
T ss_pred eeeEEEcCCEEEEEEcCCCCchHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC
Confidence 99999999999999999999999999873 4678999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
+.+||+|||++...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||..........
T Consensus 133 ~~~kL~DfG~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~ 206 (320)
T cd05590 133 GHCKLADFGMCKEGIFN-----GKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 206 (320)
T ss_pred CcEEEeeCCCCeecCcC-----CCcccccccCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 99999999998653211 11233567999999999987654 8999999999999999999999999887777666
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH------HHHhcCccccccchh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA------SELLKNPFFKKAKDK 333 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta------~elL~hp~~~~~~~~ 333 (520)
.+...... .+ ..++.++.+||.+||+.||.+||++ .++++||||+...+.
T Consensus 207 ~i~~~~~~-~~---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 207 AILNDEVV-YP---------TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred HHhcCCCC-CC---------CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 65544322 11 2367889999999999999999998 999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=375.13 Aligned_cols=267 Identities=27% Similarity=0.414 Sum_probs=221.4
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|.+.+.||+|+||+||+|.+..+|+.||+|+++...... ......+.+|+.+++.++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~i~~~~~~ 60 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA--------------------QETVSFFEEERDILSISNS 60 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHHhCCC
Confidence 47999999999999999999999999999999886432210 2234568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+.+|+||||+.||+|.+++.. ..+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NI 133 (330)
T cd05601 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR-------YEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133 (330)
T ss_pred CCCcceeeEEecCCeEEEEECCCCCCCHHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHhe
Confidence 9999999999999999999999999999999975 235789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc-----cCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ-----DHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
|++.+|.+||+|||++..+...... ......||+.|+|||++.. ...++.++|||||||++|+|++|..||
T Consensus 134 ll~~~~~~kL~Dfg~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf 209 (330)
T cd05601 134 LIDRTGHIKLADFGSAARLTANKMV----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209 (330)
T ss_pred EECCCCCEEeccCCCCeECCCCCce----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCC
Confidence 9999999999999999776432211 2234579999999999863 334789999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
........+..+........ . .....+++.+.+||.+||+ +|.+|||+.+++.||||......
T Consensus 210 ~~~~~~~~~~~i~~~~~~~~-~-----~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 210 HEGTSAKTYNNIMNFQRFLK-F-----PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred CCCCHHHHHHHHHcCCCccC-C-----CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence 88777666655544321110 0 0113467889999999998 99999999999999999876543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=379.81 Aligned_cols=269 Identities=25% Similarity=0.388 Sum_probs=222.1
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+....++|++.+.||+|+||+||+|.++.+++.||+|+++...... ....+.+.+|+.++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~il 97 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK--------------------RSDSAFFWEERDIM 97 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhhHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999886432110 12234577899999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+.++||||+++++++.+++.+|+||||+.||+|.+++.. ..+++..+..++.||+.||.|||++||+||||
T Consensus 98 ~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDL 168 (370)
T cd05596 98 AHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN---------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDV 168 (370)
T ss_pred HhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 999999999999999999999999999999999999863 35789999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc---CCCCcchhHHHHHHHHHHHHhCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD---HGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~~~DIwSlG~il~elltG~ 260 (520)
||+|||++.+|.+||+|||++..+..... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|.
T Consensus 169 kp~NILl~~~~~~kL~DfG~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~ 244 (370)
T cd05596 169 KPDNMLLDKSGHLKLADFGTCMKMDANGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244 (370)
T ss_pred CHHHEEEcCCCCEEEEeccceeeccCCCc----ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCC
Confidence 99999999999999999999876532211 112356799999999998643 23789999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCC-CCCCCchhhhhHHHhcHHHHHHHHhhhccCCCC--CCCHHHHhcCccccccch
Q psy11359 261 APYHKYPAMKVLMLTLQNDPP-TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK--RPTASELLKNPFFKKAKD 332 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~~~~~~~ 332 (520)
.||........+..+...... .++ ....++.++.+||.+||+.+|.+ |+|+.++++||||+...+
T Consensus 245 ~Pf~~~~~~~~~~~i~~~~~~~~~~-------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 245 TPFYADSLVGTYSKIMDHKNSLTFP-------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred CCcCCCCHHHHHHHHHcCCCcCCCC-------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 999987776666555443211 111 11246889999999999999988 999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=377.96 Aligned_cols=269 Identities=26% Similarity=0.401 Sum_probs=219.9
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||+||+|.++.+++.||+|+++...... ......+.+|+.++.+++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~~ 60 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE--------------------KEQVAHIRAERDILVEADG 60 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhh--------------------hhhHHHHHHHHHHHHhCCC
Confidence 47999999999999999999999999999999886432111 2235568889999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+.+|+||||+.||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 61 ~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~--------~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NI 132 (360)
T cd05627 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--------KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNL 132 (360)
T ss_pred CCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence 999999999999999999999999999999997 346789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccc------------------------------cccccccccccccccCCcceecccC
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDL------------------------------SRQKVRHTFVGTPCWMAPEVMEQDH 238 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~------------------------------~~~~~~~~~~gt~~y~APE~~~~~~ 238 (520)
|++.+|.++|+|||++..+...... .........+||+.|+|||++.+..
T Consensus 133 li~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 212 (360)
T cd05627 133 LLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG 212 (360)
T ss_pred EECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC
Confidence 9999999999999998754321100 0011122468999999999987655
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-
Q psy11359 239 GYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP- 316 (520)
Q Consensus 239 ~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp- 316 (520)
++.++|||||||++|+|+||.+||...........+..... ..++. ...+++++++||.+|+. +|.+|+
T Consensus 213 -~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------~~~~s~~~~~li~~l~~-~p~~R~~ 283 (360)
T cd05627 213 -YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPP-------EVPISEKAKDLILRFCT-DSENRIG 283 (360)
T ss_pred -CCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCC-------CCCCCHHHHHHHHHhcc-ChhhcCC
Confidence 89999999999999999999999988777766655543211 11111 12367889999999874 999998
Q ss_pred --CHHHHhcCccccccchhh
Q psy11359 317 --TASELLKNPFFKKAKDKK 334 (520)
Q Consensus 317 --ta~elL~hp~~~~~~~~~ 334 (520)
++.++++||||+...+..
T Consensus 284 ~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 284 SNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred CCCHHHHhcCCCCCCCCHHH
Confidence 489999999999876654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=371.16 Aligned_cols=258 Identities=28% Similarity=0.413 Sum_probs=214.0
Q ss_pred EeeeeecCceEEEEEEEc---CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC
Q psy11359 34 REVIGFGATAVVHSAYCK---ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
++.||+|+||.||+|.+. .+++.||+|+++...... .......+.+|+.+|+.++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~-------------------~~~~~~~~~~E~~il~~l~hp~ 61 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR-------------------NQKDTAHTKAERNILEAVKHPF 61 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh-------------------hhhhHHHHHHHHHHHHhCCCCc
Confidence 368999999999999864 467888888876432211 0123345788999999999999
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl 190 (520)
|+++++++..++.+|+||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 62 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~ 133 (323)
T cd05584 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLER--------EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL 133 (323)
T ss_pred hhceeeEEecCCeEEEEEeCCCCchHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 99999999999999999999999999999973 4678899999999999999999999999999999999999
Q ss_pred cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q psy11359 191 GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270 (520)
Q Consensus 191 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~ 270 (520)
+.+|.+||+|||++...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~ 207 (323)
T cd05584 134 DAQGHVKLTDFGLCKESIHE-----GTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKK 207 (323)
T ss_pred CCCCCEEEeeCcCCeecccC-----CCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999998643221 12234567999999999997654 8899999999999999999999999877776
Q ss_pred HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhh
Q psy11359 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKK 334 (520)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~ 334 (520)
....+...... ++ ..+++.+.+||.+||+++|++|| ++.+++.||||.......
T Consensus 208 ~~~~~~~~~~~-~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~ 266 (323)
T cd05584 208 TIDKILKGKLN-LP---------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDD 266 (323)
T ss_pred HHHHHHcCCCC-CC---------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 66655544322 11 34578899999999999999999 899999999998765443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=369.35 Aligned_cols=262 Identities=26% Similarity=0.435 Sum_probs=218.8
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HH 108 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~H 108 (520)
+|++.+.||+|+||.||+|.+..+++.||+|+++...... ....+.+..|..++..+ +|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~~~ 60 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ--------------------DDDVECTMVEKRVLALSGKP 60 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHHhccCC
Confidence 5899999999999999999999999999999886432110 12344567788888777 68
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
++|+++++++...+.+|+||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Ni 132 (323)
T cd05616 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ--------VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132 (323)
T ss_pred CeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHe
Confidence 9999999999999999999999999999999873 46789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.++.+||+|||++...... .......+||+.|+|||++.+.. ++.++|||||||++|+|+||..||.....
T Consensus 133 ll~~~~~~kL~DfG~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~ 206 (323)
T cd05616 133 MLDSEGHIKIADFGMCKENMWD-----GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206 (323)
T ss_pred EECCCCcEEEccCCCceecCCC-----CCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence 9999999999999998653211 11233567999999999997655 89999999999999999999999998877
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH-----HHHhcCccccccchhhH
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA-----SELLKNPFFKKAKDKKF 335 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~elL~hp~~~~~~~~~~ 335 (520)
......+...... ++ ..++.++.+++.+||+++|.+|++. .++++||||+...+...
T Consensus 207 ~~~~~~i~~~~~~-~p---------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~ 268 (323)
T cd05616 207 DELFQSIMEHNVA-YP---------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268 (323)
T ss_pred HHHHHHHHhCCCC-CC---------CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 7666655543321 11 3467889999999999999999984 89999999987765543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=370.83 Aligned_cols=255 Identities=29% Similarity=0.447 Sum_probs=214.8
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~HpnIv~ 113 (520)
++||+|+||.||+|.+..+++.||+|+++...... ....+.+..|..++..+ +||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~il~~~~~hp~i~~ 60 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ--------------------DDDVDCTMTEKRILALAAKHPFLTA 60 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh--------------------hhHHHHHHHHHHHHHhccCCCCccc
Confidence 46999999999999999999999999886432211 22345577888888866 8999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++..++.+|+||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~lv~E~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~ 132 (321)
T cd05591 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQR--------SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE 132 (321)
T ss_pred eeeEEEcCCeEEEEEeCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC
Confidence 99999999999999999999999999873 4678999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
|.+||+|||++...... ........||+.|+|||++.+.. ++.++|||||||++|+|+||..||........+.
T Consensus 133 ~~~kL~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~ 206 (321)
T cd05591 133 GHCKLADFGMCKEGILN-----GVTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206 (321)
T ss_pred CCEEEeecccceecccC-----CccccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999998753221 12233567999999999987655 8999999999999999999999999888777776
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-------CHHHHhcCccccccchh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-------TASELLKNPFFKKAKDK 333 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-------ta~elL~hp~~~~~~~~ 333 (520)
.+....... + ..+++++.++|.+||++||.+|+ ++.++++||||....+.
T Consensus 207 ~i~~~~~~~-p---------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 207 SILHDDVLY-P---------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred HHHcCCCCC-C---------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 665543221 1 23578899999999999999999 99999999999876554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=366.42 Aligned_cols=270 Identities=23% Similarity=0.350 Sum_probs=215.7
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.++.++..||+|.++... .......+.+|+.+++++
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------------~~~~~~~~~~E~~~l~~l 61 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH----------------------EEGAPCTAIREVSLLKDL 61 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc----------------------cCCcchhHHHHHHHHHhC
Confidence 4578999999999999999999999998888888765321 111223467899999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++..++..++||||+. ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 62 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~ 133 (309)
T cd07872 62 KHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDD-------CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQ 133 (309)
T ss_pred CCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 99999999999999999999999996 589888864 3456889999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.++.+||+|||++....... .......+|+.|+|||++.+...++.++|||||||++|+|+||++||...
T Consensus 134 Nill~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 134 NLLINERGELKLADFGLARAKSVPT-----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred HEEECCCCCEEECccccceecCCCc-----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999987543221 11223468999999999876656899999999999999999999999877
Q ss_pred cHHHHHHHHhcCCCCCCCC--------------------CchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcc
Q psy11359 267 PAMKVLMLTLQNDPPTLDT--------------------GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~ 326 (520)
...+.+............. ..........+++++++||.+||+.||.+|||+.|+++|||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 209 TVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 6554443332211100000 00001112346788999999999999999999999999999
Q ss_pred ccccc
Q psy11359 327 FKKAK 331 (520)
Q Consensus 327 ~~~~~ 331 (520)
|+...
T Consensus 289 ~~~~~ 293 (309)
T cd07872 289 FRSLG 293 (309)
T ss_pred hhhcc
Confidence 98654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=373.61 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=213.2
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~ 114 (520)
+.||+|+||+||+|.+..+|..||+|++....... ......+.+|+++++.++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~hp~i~~~ 60 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA--------------------KDEVAHTLTENRVLQNSRHPFLTAL 60 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHHhCCCCCCCce
Confidence 47999999999999999999999999886432110 1234567889999999999999999
Q ss_pred EEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccCCCcEEEcCC
Q psy11359 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGNILLGED 193 (520)
Q Consensus 115 ~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLKp~NILl~~~ 193 (520)
++++...+.+|+||||+.||+|.+++. ..+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~lv~E~~~~~~L~~~l~--------~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~ 132 (325)
T cd05594 61 KYSFQTHDRLCFVMEYANGGELFFHLS--------RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD 132 (325)
T ss_pred EEEEEcCCEEEEEEeCCCCCcHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC
Confidence 999999999999999999999999886 34678999999999999999999998 799999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
|.+||+|||++...... ........||+.|+|||++.+.. ++.++|||||||++|+|+||..||..........
T Consensus 133 ~~~kL~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~ 206 (325)
T cd05594 133 GHIKITDFGLCKEGIKD-----GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 206 (325)
T ss_pred CCEEEecCCCCeecCCC-----CcccccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHH
Confidence 99999999998653211 11123467999999999997655 8999999999999999999999998876655555
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDK 333 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~ 333 (520)
.+..... .++ ..+++++.+||.+||++||.+|+ ++.++++||||......
T Consensus 207 ~i~~~~~-~~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 207 LILMEEI-RFP---------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred HHhcCCC-CCC---------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 4443322 111 34678899999999999999997 99999999999876544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=370.59 Aligned_cols=256 Identities=30% Similarity=0.434 Sum_probs=211.0
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH-HHhcCCCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ-AMSSCHHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~-~l~~l~HpnIv~ 113 (520)
++||+|+||+||+|.+..+|+.||+|++....... .....++..|.. +++.++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~e~~~~~~~l~hp~iv~ 60 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK--------------------KKEQKHIMAERNVLLKNVKHPFLVG 60 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh--------------------hhHHHHHHHHHHHHHhhCCCCCCCC
Confidence 47999999999999999999999999886432211 112234555554 567899999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++...+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~ 132 (323)
T cd05575 61 LHYSFQTADKLYFVLDYVNGGELFFHLQR--------ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ 132 (323)
T ss_pred eeEEEEeCCEEEEEEcCCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC
Confidence 99999999999999999999999999973 4678999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
|.+||+|||++..... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+...
T Consensus 133 ~~~kl~Dfg~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 206 (323)
T cd05575 133 GHVVLTDFGLCKEGIE-----HSKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206 (323)
T ss_pred CcEEEeccCCCccccc-----CCCccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 9999999998864321 112233567999999999987655 8999999999999999999999998877666555
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH----HHHhcCccccccchhh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA----SELLKNPFFKKAKDKK 334 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta----~elL~hp~~~~~~~~~ 334 (520)
.+..... .+. ..++..+.++|.+||++||.+||++ .++++||||....+..
T Consensus 207 ~i~~~~~-~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~ 261 (323)
T cd05575 207 NILNKPL-RLK---------PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDD 261 (323)
T ss_pred HHHcCCC-CCC---------CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 5544322 111 2457889999999999999999998 6999999998766544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=362.60 Aligned_cols=264 Identities=25% Similarity=0.355 Sum_probs=206.9
Q ss_pred CCeEEEeeeeecCceEEEEEEEcC-CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKA-RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC- 106 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l- 106 (520)
++|++.+.||+|+||+||+|.+.. .+..||+|.++..... ......+.+|+.+++.+
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~ 59 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE---------------------EGMPLSTIREVAVLRHLE 59 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC---------------------CCchHHHHHHHHHHHhhc
Confidence 479999999999999999999865 4677888876532110 11223455677766655
Q ss_pred --CCCCceEEEEEEEE-----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 107 --HHENVVTYHTSFVV-----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 107 --~HpnIv~~~~~~~~-----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+||||+++++++.. ...+++||||+. ++|.+++... ....+++..+..++.||+.||.|||++|++
T Consensus 60 ~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~~~~~i~~qi~~aL~~lH~~~ii 132 (290)
T cd07862 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV------PEPGVPTETIKDMMFQLLRGLDFLHSHRVV 132 (290)
T ss_pred ccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 79999999998863 456999999995 6999998753 345689999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG 259 (520)
||||||+|||++.++.+||+|||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 133 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g 205 (290)
T cd07862 133 HRDLKPQNILVTSSGQIKLADFGLARIYSFQ------MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRR 205 (290)
T ss_pred eCCCCHHHEEEcCCCCEEEccccceEeccCC------cccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcC
Confidence 9999999999999999999999998765432 2233567999999999987654 89999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCC-----------------CchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDT-----------------GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
.+||.+....+.+..+........+. ..........+++.+.+||.+||++||++|||+.|+|
T Consensus 206 ~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 206 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred CCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 99999887766665544321110000 0001112235678899999999999999999999999
Q ss_pred cCccc
Q psy11359 323 KNPFF 327 (520)
Q Consensus 323 ~hp~~ 327 (520)
+||||
T Consensus 286 ~hp~f 290 (290)
T cd07862 286 SHPYF 290 (290)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=368.95 Aligned_cols=264 Identities=26% Similarity=0.434 Sum_probs=231.8
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
.....+=|.+.+.||+|-|++|-+|++.-+|.+||+|++.+.-+. .-+-..+.+|+..|
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD---------------------~~st~hlfqEVRCM 71 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD---------------------TLSTGHLFQEVRCM 71 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc---------------------hhhhhHHHHHHHHH
Confidence 345667799999999999999999999999999999988643111 22456799999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+...|||||++|++..+...+|||+|+=.+|+|+|||-+ ....+.|..+++++.||+.|+.|||+..+|||||
T Consensus 72 KLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImK-------He~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDL 144 (864)
T KOG4717|consen 72 KLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMK-------HEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDL 144 (864)
T ss_pred HHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHh-------hhccccHHHHHHHHHHHHHHHHHHhhhhhhcccC
Confidence 999999999999999999999999999999999999975 3567899999999999999999999999999999
Q ss_pred CCCcEEE-cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 184 KAGNILL-GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 184 Kp~NILl-~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
||+||.+ .+-|.|||.|||++..+..+.. ..++||+..|-|||++.+..+..+++||||||+|||.|++|++|
T Consensus 145 KPENVVFFEKlGlVKLTDFGFSNkf~PG~k------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~P 218 (864)
T KOG4717|consen 145 KPENVVFFEKLGLVKLTDFGFSNKFQPGKK------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPP 218 (864)
T ss_pred CcceeEEeeecCceEeeeccccccCCCcch------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCc
Confidence 9999988 5689999999999987765544 45789999999999999998677899999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
|...++.+.+-.++.... .+ ...++.++++||..||..||.+|.|.+++..++|++...
T Consensus 219 FqeANDSETLTmImDCKY-tv---------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 219 FQEANDSETLTMIMDCKY-TV---------PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred cccccchhhhhhhhcccc-cC---------chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 999998888876665432 22 256789999999999999999999999999999999654
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=370.86 Aligned_cols=256 Identities=25% Similarity=0.460 Sum_probs=208.8
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~HpnIv~ 113 (520)
++||+|+||.||+|.+..+++.||+|+++...... ....+.+.+|+.++..+ +||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~--------------------~~~~~~~~~e~~il~~~~~hp~Iv~ 60 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND--------------------DEDIDWVQTEKHVFETASNHPFLVG 60 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHHhccCCCCCCc
Confidence 47999999999999999999999999886432211 22345688899999988 7999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++...+.+|+||||++||+|.+++. ..+.+++..++.++.||+.||.|||++|++||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~lv~e~~~~g~L~~~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~ 132 (329)
T cd05588 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQ--------RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE 132 (329)
T ss_pred eEEEEEcCCEEEEEEeCCCCCCHHHHHH--------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC
Confidence 9999999999999999999999999987 34679999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc------
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP------ 267 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~------ 267 (520)
+.+||+|||++..... ........+||+.|+|||++.+.. ++.++|+|||||++|+|+||..||....
T Consensus 133 ~~~kL~Dfg~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~ 206 (329)
T cd05588 133 GHIKLTDYGMCKEGIR-----PGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206 (329)
T ss_pred CCEEECcCcccccccc-----CCCccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCccccccccccc
Confidence 9999999998864211 112234568999999999997655 8999999999999999999999996321
Q ss_pred --HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC------HHHHhcCccccccchh
Q psy11359 268 --AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT------ASELLKNPFFKKAKDK 333 (520)
Q Consensus 268 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------a~elL~hp~~~~~~~~ 333 (520)
..+.....+......++ ..++..+.++|.+||++||.+|+| +.++++||||....+.
T Consensus 207 ~~~~~~~~~~~~~~~~~~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 207 QNTEDYLFQVILEKQIRIP---------RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred ccchHHHHHHHHcCCCCCC---------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 11222222222222221 246788999999999999999987 7899999999876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=367.43 Aligned_cols=255 Identities=30% Similarity=0.511 Sum_probs=210.9
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc-CCCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS-CHHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~-l~HpnIv~ 113 (520)
++||+|+||+||+|.+..+++.||+|+++...... ....+.+..|..++.. ++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~~hp~i~~ 60 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE--------------------DDDVECTMVERRVLALAWEHPFLTH 60 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhhHHHHHHHHHHHHhccCCCCccc
Confidence 47999999999999999999999999886532211 1223445667777765 48999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++..++.+|+||||+.||+|.++++. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~lv~e~~~gg~L~~~~~~--------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~ 132 (316)
T cd05592 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQS--------SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD 132 (316)
T ss_pred eeeEEEcCCEEEEEEcCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC
Confidence 99999999999999999999999999973 4578999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
+.+||+|||++....... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+......+.
T Consensus 133 ~~~kL~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~ 206 (316)
T cd05592 133 GHIKIADFGMCKENMNGE-----GKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD 206 (316)
T ss_pred CCEEEccCcCCeECCCCC-----CccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999987543211 2234567999999999997665 8999999999999999999999999887766665
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH-HHHhcCccccccchh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA-SELLKNPFFKKAKDK 333 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-~elL~hp~~~~~~~~ 333 (520)
.+.... +.++ ..++.++.+||.+||+.||.+||++ .++++||||......
T Consensus 207 ~i~~~~-~~~~---------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05592 207 SILNDR-PHFP---------RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWE 257 (316)
T ss_pred HHHcCC-CCCC---------CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHH
Confidence 544332 2221 2467889999999999999999986 588899999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=376.36 Aligned_cols=267 Identities=25% Similarity=0.388 Sum_probs=218.7
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||.||+|.+..+++.+|+|++....... ......+.+|+.+++
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~i~~ 98 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK--------------------RSDSAFFWEERDIMA 98 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhhHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999886422110 122345788999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
.++||||+++++++..++.+|+||||+.||+|.+++.. ..+++..++.++.||+.||+|||++||+|||||
T Consensus 99 ~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLK 169 (370)
T cd05621 99 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN---------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVK 169 (370)
T ss_pred hCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 99999999999999999999999999999999999963 357899999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC---CCCcchhHHHHHHHHHHHHhCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH---GYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~~~~DIwSlG~il~elltG~~ 261 (520)
|+|||++.+|.+||+|||++..+..... ....+.+||+.|||||++.+.. .++.++|||||||++|+|++|..
T Consensus 170 p~NILl~~~~~~kL~DFG~a~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~ 245 (370)
T cd05621 170 PDNMLLDKHGHLKLADFGTCMKMDETGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 245 (370)
T ss_pred HHHEEECCCCCEEEEecccceecccCCc----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCC
Confidence 9999999999999999999976632211 1123568999999999986532 37889999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCC-CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCC--CCCHHHHhcCccccccc
Q psy11359 262 PYHKYPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK--RPTASELLKNPFFKKAK 331 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~~~~~~ 331 (520)
||...........+..... ..++ ....++..++++|..||..++.+ |+|+.|+++||||+...
T Consensus 246 Pf~~~~~~~~~~~i~~~~~~~~~p-------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 246 PFYADSLVGTYSKIMDHKNSLNFP-------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred CCCCCCHHHHHHHHHhCCcccCCC-------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 9988777666655544321 1111 11246788999999999865543 89999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=384.24 Aligned_cols=265 Identities=28% Similarity=0.462 Sum_probs=221.9
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCC-CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKAR-AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
.....|.+.+.||+|+||.||+|....+ +..||+|.+... . ......+.+|+.+++
T Consensus 64 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----------------------~-~~~~~~~~~E~~~l~ 120 (478)
T PTZ00267 64 PREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----------------------D-ERQAAYARSELHCLA 120 (478)
T ss_pred CcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----------------------C-HHHHHHHHHHHHHHH
Confidence 3455699999999999999999998887 677777754211 1 223346788999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
.++|||||++++++...+.+||||||+.||+|.++++.... ....+++..+..++.||+.||.|||++||+|||||
T Consensus 121 ~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlk 196 (478)
T PTZ00267 121 ACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK----EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK 196 (478)
T ss_pred hCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcC
Confidence 99999999999999999999999999999999999875422 35678999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.++.+||+|||++..+.... ........+||+.|+|||++.+.. ++.++|||||||++|+|+||..||.
T Consensus 197 p~NIll~~~~~~kL~DFgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~ 272 (478)
T PTZ00267 197 SANIFLMPTGIIKLGDFGFSKQYSDSV---SLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFK 272 (478)
T ss_pred HHhEEECCCCcEEEEeCcCceecCCcc---ccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999998764322 112234568999999999987654 8999999999999999999999998
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.....+.+.....+.....+ ..++..+++||.+||.++|.+|||+.+++.|+|++..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 273 GPSQREIMQQVLYGKYDPFP---------CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred CCCHHHHHHHHHhCCCCCCC---------ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 87777766666554433221 2467889999999999999999999999999999754
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=361.03 Aligned_cols=263 Identities=29% Similarity=0.423 Sum_probs=216.7
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
.|++.++||+|+||+||++.+..+++.||+|++....... ......+.+|+.+++.++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h~ 60 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--------------------RKGEAMALNEKQILEKVNSR 60 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh--------------------hhhHHHHHHHHHHHHhcCCC
Confidence 4899999999999999999999999999999875432111 11234567899999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++..++.+++||||+.||+|.+++... ....+++..+..++.||+.||.|||++|++||||||+||+
T Consensus 61 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 134 (285)
T cd05605 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM------GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL 134 (285)
T ss_pred CEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhc------CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEE
Confidence 9999999999999999999999999999988642 3356899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
+++++.++|+|||++..+.... ......|++.|+|||++.+.. ++.++||||+||++|+|++|..||......
T Consensus 135 ~~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~ 207 (285)
T cd05605 135 LDDYGHIRISDLGLAVEIPEGE------TIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207 (285)
T ss_pred ECCCCCEEEeeCCCceecCCCC------ccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchh
Confidence 9999999999999987653221 123457899999999997655 899999999999999999999999876543
Q ss_pred HHHH---HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhh
Q psy11359 270 KVLM---LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKK 334 (520)
Q Consensus 270 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~ 334 (520)
.... ..+...+... ...++..+.+||.+||..||.+|| ++.++++||||.....+.
T Consensus 208 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05605 208 VKREEVERRVKEDQEEY---------SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271 (285)
T ss_pred hHHHHHHHHhhhccccc---------CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence 3221 1122111111 134688899999999999999999 999999999999866654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=366.24 Aligned_cols=255 Identities=28% Similarity=0.486 Sum_probs=210.6
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~HpnIv~ 113 (520)
++||+|+||.||+|.++.+|..||+|+++...... ....+.+..|..++..+ +||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~~~~~i~~ 60 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI--------------------DDDVECTMVEKRVLALAWENPFLTH 60 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--------------------cchHHHHHHHHHHHHhccCCCCccC
Confidence 47999999999999999999999999886432210 12234567788887754 8999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++..++.+|+||||+.||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~lv~E~~~~g~L~~~i~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~ 132 (316)
T cd05620 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQD--------KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD 132 (316)
T ss_pred eeEEEEeCCEEEEEECCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC
Confidence 99999999999999999999999999873 4678999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
+.++|+|||++...... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||..........
T Consensus 133 ~~~kl~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~ 206 (316)
T cd05620 133 GHIKIADFGMCKENVFG-----DNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206 (316)
T ss_pred CCEEeCccCCCeecccC-----CCceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999988643211 12234568999999999997665 8999999999999999999999998877665554
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH-HHHhcCccccccchh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA-SELLKNPFFKKAKDK 333 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-~elL~hp~~~~~~~~ 333 (520)
.+.... +.++ ..++.++++||.+||+.||.+||++ +++++||||+.....
T Consensus 207 ~~~~~~-~~~~---------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 207 SIRVDT-PHYP---------RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred HHHhCC-CCCC---------CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence 443322 2221 2357889999999999999999998 588899999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=367.77 Aligned_cols=267 Identities=29% Similarity=0.539 Sum_probs=213.1
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||.|+||.||+|.+..++..+|+|++... ......+.+.+|+++++++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~----------------------~~~~~~~~~~~E~~~l~~l 60 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE----------------------IKPAIRNQIIRELQVLHEC 60 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc----------------------cCHHHHHHHHHHHHHHHHC
Confidence 468899999999999999999999999888888876421 1123446689999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecccCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN-GQIHRDIKA 185 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~-giiHrDLKp 185 (520)
+||||+++++++..++.+|+||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++ +++||||||
T Consensus 61 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp 132 (333)
T cd06650 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--------AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 132 (333)
T ss_pred CCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCh
Confidence 999999999999999999999999999999999973 45688999999999999999999985 799999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.+|.+||+|||++..+.. .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||..
T Consensus 133 ~Nili~~~~~~kL~Dfg~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 133 SNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hhEEEcCCCCEEEeeCCcchhhhh-------hccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999865422 1223457999999999997654 89999999999999999999999976
Q ss_pred CcHHHHHHHHh---cCCCCCCC--------------------CCchhh-------------hhHHHhcHHHHHHHHhhhc
Q psy11359 266 YPAMKVLMLTL---QNDPPTLD--------------------TGAAEK-------------DQYKAYGKTFRKMISDCLQ 309 (520)
Q Consensus 266 ~~~~~~~~~~~---~~~~~~~~--------------------~~~~~~-------------~~~~~~~~~~~~li~~~L~ 309 (520)
........... ...+.... ...... .....++.++++||.+||+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 284 (333)
T cd06650 205 PDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLI 284 (333)
T ss_pred cchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhcc
Confidence 54432221110 00000000 000000 0001356789999999999
Q ss_pred cCCCCCCCHHHHhcCccccccc
Q psy11359 310 KDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 310 ~dP~~Rpta~elL~hp~~~~~~ 331 (520)
+||.+|||+.|++.||||+...
T Consensus 285 ~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 285 KNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred CCcccCcCHHHHhhCHHHhcCc
Confidence 9999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=365.90 Aligned_cols=255 Identities=28% Similarity=0.502 Sum_probs=213.7
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~HpnIv~ 113 (520)
+.||+|+||+||+|.+..++..||+|+++...... ....+.+.+|+.++..+ +||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~il~~~~~h~~i~~ 60 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ--------------------DDDVECTMTEKRVLALAGKHPFLTQ 60 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh--------------------hhHHHHHHHHHHHHHhccCCCCccc
Confidence 47999999999999999999999999886542211 12345677899999888 7999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++...+.+|+||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~ 132 (318)
T cd05570 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQR--------SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE 132 (318)
T ss_pred eeeEEEcCCEEEEEEcCCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC
Confidence 99999999999999999999999999873 4578999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
+.+||+|||++...... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||..........
T Consensus 133 ~~~kl~Dfg~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~ 206 (318)
T cd05570 133 GHIKIADFGMCKEGILG-----GVTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206 (318)
T ss_pred CcEEecccCCCeecCcC-----CCcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 99999999988643211 11223457999999999997665 8999999999999999999999998877666555
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH-----HHHhcCccccccchh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA-----SELLKNPFFKKAKDK 333 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~elL~hp~~~~~~~~ 333 (520)
.+..... ..+ ..++..+.+||.+||+.||.+|||+ .+++.||||+...+.
T Consensus 207 ~i~~~~~-~~~---------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~ 261 (318)
T cd05570 207 SILEDEV-RYP---------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD 261 (318)
T ss_pred HHHcCCC-CCC---------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 4443322 111 3467889999999999999999999 999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=384.29 Aligned_cols=268 Identities=31% Similarity=0.462 Sum_probs=223.2
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||+|.+..+|+.||+|+++.... .......+.+|+.++.
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---------------------~~~~~~~~~~Ei~~l~ 86 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---------------------SEADKNRAQAEVCCLL 86 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---------------------CHHHHHHHHHHHHHHh
Confidence 3456899999999999999999999999999999998753211 1223456889999999
Q ss_pred cCCCCCceEEEEEEEECC--------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 105 SCHHENVVTYHTSFVVKD--------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~--------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
.++|+||++++..+...+ .+++||||+.+|+|.++++.+.. ....+++..+..++.||+.||.|||++
T Consensus 87 ~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~----~~~~l~e~~~~~i~~qll~aL~~lH~~ 162 (496)
T PTZ00283 87 NCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK----TNRTFREHEAGLLFIQVLLAVHHVHSK 162 (496)
T ss_pred cCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 999999999988876432 37899999999999999976433 346799999999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
||+||||||+|||++.++.+||+|||+++.+.... ........+||+.|+|||++.+.. |+.++|||||||++|+|
T Consensus 163 ~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeL 238 (496)
T PTZ00283 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATV---SDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYEL 238 (496)
T ss_pred CEecCCCCHHHEEEeCCCCEEEEecccCeeccccc---cccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHH
Confidence 99999999999999999999999999997764321 112234568999999999997755 89999999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 257 ATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 257 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
++|..||......+.+...+.+....++ ..+++++.++|.+||+.||.+|||+.++++|||++..
T Consensus 239 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 239 LTLKRPFDGENMEEVMHKTLAGRYDPLP---------PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred HHCCCCCCCCCHHHHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 9999999987777666666554433222 3467889999999999999999999999999998753
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=364.78 Aligned_cols=261 Identities=26% Similarity=0.433 Sum_probs=217.6
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC-C
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH-H 108 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~-H 108 (520)
+|+..+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|+.++..+. |
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~~~ 60 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ--------------------DDDVECTMVEKRVLALQDKP 60 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHHhccCC
Confidence 4789999999999999999999999999999886432211 123455778888888885 5
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
++|+++++++...+.+|+||||+.||+|.+++. ..+.+++..+..++.||+.||.|||++||+||||||+||
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~--------~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Ni 132 (323)
T cd05615 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ--------QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNV 132 (323)
T ss_pred CchhheeeEEecCCEEEEEEcCCCCCcHHHHHH--------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence 778889999999999999999999999999997 346799999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.++.+||+|||++...... ........||+.|+|||++.+.. ++.++|||||||++|+|+||..||.....
T Consensus 133 ll~~~~~ikL~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 133 MLDSEGHIKIADFGMCKEHMVD-----GVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred EECCCCCEEEeccccccccCCC-----CccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999998653221 11223467999999999987655 89999999999999999999999998877
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchhh
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDKK 334 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~ 334 (520)
......+...... . ...++..+.+++.+||+++|.+|++ ..++++||||+...+..
T Consensus 207 ~~~~~~i~~~~~~-~---------p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~ 267 (323)
T cd05615 207 DELFQSIMEHNVS-Y---------PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDK 267 (323)
T ss_pred HHHHHHHHhCCCC-C---------CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHH
Confidence 7666655544321 1 1346788999999999999999997 57899999999876544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=358.60 Aligned_cols=258 Identities=28% Similarity=0.455 Sum_probs=209.6
Q ss_pred eeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEEE
Q psy11359 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHT 116 (520)
Q Consensus 37 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~~ 116 (520)
||+|+||+||++.+..+|+.||+|.+....... ....+.+..|+.+++.++||||++++.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--------------------~~~~~~~~~E~~il~~l~~~~i~~~~~ 60 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--------------------RKGYEGAMVEKRILAKVHSRFIVSLAY 60 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh--------------------hHHHHHHHHHHHHHHhCCCCcEeeeeE
Confidence 799999999999999999999999876432110 123456788999999999999999999
Q ss_pred EEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCe
Q psy11359 117 SFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196 (520)
Q Consensus 117 ~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~v 196 (520)
++..+..+|+||||+.||+|.+++..... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 61 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 136 (280)
T cd05608 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDE----ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNV 136 (280)
T ss_pred EEcCCCeEEEEEeCCCCCCHHHHHHhccc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 99999999999999999999988854221 34578999999999999999999999999999999999999999999
Q ss_pred EEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH---HHH
Q psy11359 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK---VLM 273 (520)
Q Consensus 197 kL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~---~~~ 273 (520)
+|+|||++..+..+.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ...
T Consensus 137 ~l~dfg~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 210 (280)
T cd05608 137 RISDLGLAVELKDGQS-----KTKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 210 (280)
T ss_pred EEeeCccceecCCCCc-----cccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH
Confidence 9999999876643221 123467999999999998765 8999999999999999999999997643221 111
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDK 333 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~ 333 (520)
......+.. ....++..+.+++.+||+.||++|| |++++++||||+...+.
T Consensus 211 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 211 QRILNDSVT---------YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred HhhcccCCC---------CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 111111111 1235788999999999999999999 88999999999875543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=372.17 Aligned_cols=269 Identities=25% Similarity=0.372 Sum_probs=219.4
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+....++|++.+.||+|+||.||+|.++.+++.+|+|++....... ......+.+|+.++
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~--------------------~~~~~~~~~e~~i~ 97 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK--------------------RSDSAFFWEERDIM 97 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh--------------------hHHHHHHHHHHHHH
Confidence 3456689999999999999999999999999999999886432111 11234578899999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+.++||||+++++++.....+|+||||+.||+|.++++. ..+++..++.++.||+.||.|||++||+||||
T Consensus 98 ~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDL 168 (371)
T cd05622 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 168 (371)
T ss_pred HhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 999999999999999999999999999999999999863 35789999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC---CCCcchhHHHHHHHHHHHHhCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH---GYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~~~~DIwSlG~il~elltG~ 260 (520)
||+|||++.+|.+||+|||++..+..... ......+||+.|||||++.+.. .++.++|||||||++|+|++|.
T Consensus 169 kp~NIll~~~~~ikL~DfG~a~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~ 244 (371)
T cd05622 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244 (371)
T ss_pred CHHHEEECCCCCEEEEeCCceeEcCcCCc----ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCC
Confidence 99999999999999999999976643211 1123568999999999986532 3789999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCC--CCCHHHHhcCccccccc
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK--RPTASELLKNPFFKKAK 331 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~~~~~~ 331 (520)
.||...........+...... +.. .....++..++++|.+||..++.+ |+++.++++||||+...
T Consensus 245 ~Pf~~~~~~~~~~~i~~~~~~-~~~-----~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 245 TPFYADSLVGTYSKIMNHKNS-LTF-----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred CCCCCCCHHHHHHHHHcCCCc-ccC-----CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 999987776666555543211 110 112357889999999999854433 78999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=357.20 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=205.6
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC---
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC--- 106 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l--- 106 (520)
+|++.+.||+|+||+||+|.++.+|+.||+|.++..... ......+.+|+.+++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~~~ 59 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE---------------------DGLPLSTVREVALLKRLEAF 59 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC---------------------CCCchHHHHHHHHHHHhhhc
Confidence 599999999999999999999999999999987532110 01112345666666554
Q ss_pred CCCCceEEEEEEEE-----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 107 HHENVVTYHTSFVV-----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 107 ~HpnIv~~~~~~~~-----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+||||+++++++.. ...+++||||+. ++|.+++... ....+++..++.++.||+.||.|||++|++||
T Consensus 60 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~ 132 (288)
T cd07863 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKV------PPPGLPAETIKDLMRQFLRGLDFLHANCIVHR 132 (288)
T ss_pred CCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 79999999998864 345899999996 5899998753 33458999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||++.++.+||+|||++..+.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+
T Consensus 133 dikp~Nili~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~ 205 (288)
T cd07863 133 DLKPENILVTSGGQVKLADFGLARIYSCQM------ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKP 205 (288)
T ss_pred CCCHHHEEECCCCCEEECccCccccccCcc------cCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCc
Confidence 999999999999999999999987653221 123457899999999987655 8999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCC--CC--CCC-------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 262 PYHKYPAMKVLMLTLQND--PP--TLD-------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~--~~--~~~-------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
||........+..+.... +. ... ...........++..+.++|.+||++||.+|||+.|++.|
T Consensus 206 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 206 LFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 998776655544332210 00 000 0000112234567889999999999999999999999999
Q ss_pred ccc
Q psy11359 325 PFF 327 (520)
Q Consensus 325 p~~ 327 (520)
|||
T Consensus 286 p~f 288 (288)
T cd07863 286 PFF 288 (288)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=362.94 Aligned_cols=255 Identities=27% Similarity=0.477 Sum_probs=210.5
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc-CCCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS-CHHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~-l~HpnIv~ 113 (520)
+.||+|+||+||+|.+..+++.||+|+++...... .........|..++.. ++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~~hp~iv~ 60 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM--------------------DDDVECTMVEKRVLSLAWEHPFLTH 60 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--------------------cchHHHHHHHHHHHHhccCCCcCcc
Confidence 47999999999999999999999999886542210 1223446667777775 49999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++.+.+.+|+||||+.||+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--------~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~ 132 (316)
T cd05619 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQS--------CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132 (316)
T ss_pred eEEEEEeCCEEEEEEeCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC
Confidence 99999999999999999999999999973 4568899999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
+.+||+|||++...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+...
T Consensus 133 ~~~kl~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~ 206 (316)
T cd05619 133 GHIKIADFGMCKENMLG-----DAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206 (316)
T ss_pred CCEEEccCCcceECCCC-----CCceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999998653221 11223567999999999987655 8999999999999999999999998877665554
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH-HHhcCccccccchh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS-ELLKNPFFKKAKDK 333 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~-elL~hp~~~~~~~~ 333 (520)
.+.... +..+ ..++.++++||.+||+.||.+||++. ++++||||+.....
T Consensus 207 ~i~~~~-~~~~---------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 207 SIRMDN-PCYP---------RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred HHHhCC-CCCC---------ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 443322 2221 23577899999999999999999996 89999999886553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=359.06 Aligned_cols=271 Identities=23% Similarity=0.347 Sum_probs=216.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||.|+||.||+|.+..++..||+|.++.. ........+.+|+.+++.
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~----------------------~~~~~~~~~~~E~~~l~~ 60 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLE----------------------HEEGAPCTAIREVSLLKD 60 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecc----------------------cccCchhHHHHHHHHHHh
Confidence 3567899999999999999999999999888888876422 111223457789999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++...+..++||||+. ++|.+++.. ....+++..+..++.||+.||.|||++|++||||||
T Consensus 61 l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-------~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp 132 (301)
T cd07873 61 LKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD-------CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132 (301)
T ss_pred cCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCH
Confidence 999999999999999999999999996 699998864 345688999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.++.++|+|||++....... .......+++.|+|||++.+...++.++|||||||++|+|+||++||..
T Consensus 133 ~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 133 QNLLINERGELKLADFGLARAKSIPT-----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred HHEEECCCCcEEECcCcchhccCCCC-----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999986543211 1122346789999999987766688999999999999999999999987
Q ss_pred CcHHHHHHHHhcCCCCCCCC--------------------CchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDT--------------------GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp 325 (520)
....+............... ..........+++.+++||.+||+.||.+|||+.|+|+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 208 STVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred CCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 76654443322211000000 0000112235688899999999999999999999999999
Q ss_pred cccccc
Q psy11359 326 FFKKAK 331 (520)
Q Consensus 326 ~~~~~~ 331 (520)
||+...
T Consensus 288 ~f~~~~ 293 (301)
T cd07873 288 YFHCLG 293 (301)
T ss_pred cccccc
Confidence 998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=364.08 Aligned_cols=267 Identities=24% Similarity=0.387 Sum_probs=216.3
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||+||++.+..+++.||+|+++...... ....+.+.+|+.++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~~ 60 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK--------------------RAETACFREERDVLVNGDR 60 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--------------------hhhHHHHHHHHHHHHhCCC
Confidence 57999999999999999999999999999999886422110 1234558889999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
+||+++++++..++.+|+||||+.||+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 133 (331)
T cd05597 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK-------FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNV 133 (331)
T ss_pred CCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHE
Confidence 9999999999999999999999999999999974 345789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc----cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----DHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|++.+|.+||+|||++..+..... .......||+.|||||++.. ...++.++|||||||++|+|++|..||.
T Consensus 134 ll~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 134 LLDKNGHIRLADFGSCLRLLADGT----VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred EECCCCCEEEEECCceeecCCCCC----ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 999999999999999876543221 11123579999999999863 2347889999999999999999999998
Q ss_pred CCcHHHHHHHHhcCCC-CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCC--CCCHHHHhcCccccccch
Q psy11359 265 KYPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK--RPTASELLKNPFFKKAKD 332 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~~~~~~~ 332 (520)
.....+....+..... ..+. .....++..+++||.+||..++.+ |+++.++++||||.....
T Consensus 210 ~~~~~~~~~~i~~~~~~~~~~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 210 AESLVETYGKIMNHKEHFQFP------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred CCCHHHHHHHHHcCCCcccCC------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 8766655554443221 1111 111337889999999988764443 789999999999987644
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=366.71 Aligned_cols=255 Identities=25% Similarity=0.453 Sum_probs=206.9
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~HpnIv~ 113 (520)
+.||+|+||+||+|.+..+++.||+|+++..... .......+.+|+.++.++ +||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------------------~~~~~~~~~~E~~~l~~~~~hp~iv~ 60 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN--------------------DDEDIDWVQTEKHVFEQASNHPFLVG 60 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc--------------------chhHHHHHHHHHHHHHhcCCCCcCCc
Confidence 4799999999999999999999999988643211 122345678899988877 8999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++...+.+|+||||+.+|+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~ 132 (329)
T cd05618 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQR--------QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 132 (329)
T ss_pred eeeEEEeCCEEEEEEeCCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence 99999999999999999999999998863 4678999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc------
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP------ 267 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~------ 267 (520)
+.+||+|||++...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||....
T Consensus 133 ~~~kL~DfG~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~ 206 (329)
T cd05618 133 GHIKLTDYGMCKEGLRP-----GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206 (329)
T ss_pred CCEEEeeCCccccccCC-----CCccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcc
Confidence 99999999998643211 11223568999999999997665 8999999999999999999999995211
Q ss_pred --HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC------HHHHhcCccccccch
Q psy11359 268 --AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT------ASELLKNPFFKKAKD 332 (520)
Q Consensus 268 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------a~elL~hp~~~~~~~ 332 (520)
....+..........++ ..++..+.++|.+||+.||.+||| +.++++||||+...+
T Consensus 207 ~~~~~~~~~~i~~~~~~~p---------~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 207 QNTEDYLFQVILEKQIRIP---------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred cccHHHHHHHHhcCCCCCC---------CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 11112222222222221 346778999999999999999998 589999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=373.42 Aligned_cols=268 Identities=25% Similarity=0.376 Sum_probs=213.8
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||+|+||+||+|.+..+|+.||+|.+.... .......++.+|+.+++.++||
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l~h~ 59 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---------------------QNLVSCKRVFRELKMLCFFKHD 59 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc---------------------cchHHHHHHHHHHHHHHhCCCC
Confidence 4788999999999999999999999999999763210 0122345688999999999999
Q ss_pred CceEEEEEEEECC-----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 110 NVVTYHTSFVVKD-----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 110 nIv~~~~~~~~~~-----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
||+++++++...+ .+|+||||+. ++|.+++. ..+.+++..++.++.||+.||.|||++|++|||||
T Consensus 60 niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--------~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlk 130 (372)
T cd07853 60 NVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIV--------SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIK 130 (372)
T ss_pred CcCCHhheecCCCccccceEEEEeeccc-cCHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 9999999998776 7999999995 68888886 45678999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.++.+||+|||++....... ........+|+.|+|||++.+...++.++|||||||++|+|++|+.||.
T Consensus 131 p~Nili~~~~~~kL~Dfg~a~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 131 PGNLLVNSNCVLKICDFGLARVEEPDE----SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred hHHEEECCCCCEEeccccceeecccCc----cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 999999999999999999987653221 1122345689999999999876668999999999999999999999998
Q ss_pred CCcHHHHHHHHhcCC----------------------CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 265 KYPAMKVLMLTLQND----------------------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
+......+..+.... +................++++.+||.+||+.||.+|||+.|+|
T Consensus 207 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 207 AQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 877665544332210 0000000000011123578899999999999999999999999
Q ss_pred cCccccccc
Q psy11359 323 KNPFFKKAK 331 (520)
Q Consensus 323 ~hp~~~~~~ 331 (520)
+||||+...
T Consensus 287 ~hp~~~~~~ 295 (372)
T cd07853 287 AHPYLDEGR 295 (372)
T ss_pred cCHhhCCCc
Confidence 999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=365.81 Aligned_cols=256 Identities=29% Similarity=0.425 Sum_probs=209.7
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH-HHHhcCCCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI-QAMSSCHHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei-~~l~~l~HpnIv~ 113 (520)
+.||+|+||+||+|.+..+++.||+|++....... ......+..|. .+++.++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~~l~~~~h~~Iv~ 60 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK--------------------KKEEKHIMSERNVLLKNVKHPFLVG 60 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh--------------------hhHHHHHHHHHHHHHHhCCCCCCCc
Confidence 47999999999999999999999999886432111 11122344444 4567899999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++...+.+|+||||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~ 132 (325)
T cd05602 61 LHFSFQTADKLYFVLDYINGGELFYHLQR--------ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 132 (325)
T ss_pred eeEEEEcCCeEEEEEeCCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC
Confidence 99999999999999999999999999973 4568899999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
+.+||+|||++..... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||......+.+.
T Consensus 133 ~~~kl~DfG~a~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (325)
T cd05602 133 GHIVLTDFGLCKENIE-----HNGTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206 (325)
T ss_pred CCEEEccCCCCccccc-----CCCCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999864321 112234567999999999997655 8999999999999999999999998877766655
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH----HHhcCccccccchhh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS----ELLKNPFFKKAKDKK 334 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~----elL~hp~~~~~~~~~ 334 (520)
.+..... .. ...+++.+.++|.+||++||.+|+++. ++++|+||....+..
T Consensus 207 ~i~~~~~-~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~ 261 (325)
T cd05602 207 NILNKPL-QL---------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD 261 (325)
T ss_pred HHHhCCc-CC---------CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence 5443321 11 134678899999999999999999876 899999998766544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=368.48 Aligned_cols=264 Identities=26% Similarity=0.416 Sum_probs=206.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+|..||+|++..... .......+.+|+.+++.+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~~E~~~l~~l 77 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ---------------------NQTHAKRAYRELVLLKCV 77 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc---------------------chhHHHHHHHHHHHHHhC
Confidence 45889999999999999999999999999999998743210 022345678999999999
Q ss_pred CCCCceEEEEEEEECC------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVKD------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+||||+++++++.... .+|+||||+. ++|.+.+. ..+++..+..++.||+.||.|||++||+|
T Consensus 78 ~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH 146 (359)
T cd07876 78 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH----------MELDHERMSYLLYQMLCGIKHLHSAGIIH 146 (359)
T ss_pred CCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHh----------ccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 9999999999987543 5799999996 46777664 24788999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+|||++.+|.+||+|||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|+||.
T Consensus 147 rDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~ 219 (359)
T cd07876 147 RDLKPSNIVVKSDCTLKILDFGLARTACTN------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGS 219 (359)
T ss_pred CCCCHHHEEECCCCCEEEecCCCccccccC------ccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCC
Confidence 999999999999999999999998654221 1223457899999999997655 899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCC---------------------CCCCCCCch-----------hhhhHHHhcHHHHHHHHhhh
Q psy11359 261 APYHKYPAMKVLMLTLQND---------------------PPTLDTGAA-----------EKDQYKAYGKTFRKMISDCL 308 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~---------------------~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~L 308 (520)
.||.+......+....... .+....... ........++.+++||.+||
T Consensus 220 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL 299 (359)
T cd07876 220 VIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKML 299 (359)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHh
Confidence 9998765543332211110 000000000 00011224678899999999
Q ss_pred ccCCCCCCCHHHHhcCccccc
Q psy11359 309 QKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 309 ~~dP~~Rpta~elL~hp~~~~ 329 (520)
+.||++|||+.|+|+||||+.
T Consensus 300 ~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 300 VIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred ccCcccCCCHHHHhcCchhhh
Confidence 999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=366.43 Aligned_cols=256 Identities=28% Similarity=0.427 Sum_probs=210.6
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH-HHhcCCCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ-AMSSCHHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~-~l~~l~HpnIv~ 113 (520)
+.||+|+||+||+|.+..+|+.||+|++....... .....++..|.. +++.++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~~l~~~~hp~iv~ 60 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN--------------------RKEQKHIMAERNVLLKNVKHPFLVG 60 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHHHhCCCCCCcc
Confidence 47999999999999999999999999886432111 112334555554 567899999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++...+.+|+||||+.||+|..++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~--------~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~ 132 (325)
T cd05604 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQ--------RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ 132 (325)
T ss_pred EEEEEecCCEEEEEEcCCCCCCHHHHHH--------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC
Confidence 9999999999999999999999999887 35678999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
|.+||+|||++..... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+...
T Consensus 133 ~~~kL~DfG~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~ 206 (325)
T cd05604 133 GHVVLTDFGLCKEGIA-----QSDTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206 (325)
T ss_pred CCEEEeecCCcccCCC-----CCCCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHH
Confidence 9999999999864321 112233567999999999997665 8999999999999999999999998877766665
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH----HHHhcCccccccchhh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA----SELLKNPFFKKAKDKK 334 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta----~elL~hp~~~~~~~~~ 334 (520)
........ . ....+..+.++|.+||+++|.+||++ .++++||||....+..
T Consensus 207 ~~~~~~~~-~---------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~ 261 (325)
T cd05604 207 NILHKPLV-L---------RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTD 261 (325)
T ss_pred HHHcCCcc-C---------CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHH
Confidence 55543221 1 12457788999999999999999987 5899999998765543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=366.66 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=212.2
Q ss_pred EeeeeecCceEEEEEEE---cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC
Q psy11359 34 REVIGFGATAVVHSAYC---KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~---~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
++.||+|+||.||++.+ ..+|+.||+|++...... ......+.+|+.++++++|||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h~n 59 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---------------------VRDRVRTKMERDILAEVNHPF 59 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh---------------------hhhHHHHHHHHHHHHhCCCCC
Confidence 36899999999999976 357888888887643211 112345678999999999999
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl 190 (520)
|+++++++..++.+|+||||+.+++|.+++. +...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 60 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 131 (318)
T cd05582 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLS--------KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 131 (318)
T ss_pred cccEEEEEEcCCEEEEEEcCCCCCcHHHHHH--------HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE
Confidence 9999999999999999999999999999986 34578999999999999999999999999999999999999
Q ss_pred cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q psy11359 191 GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270 (520)
Q Consensus 191 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~ 270 (520)
+.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.......
T Consensus 132 ~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 205 (318)
T cd05582 132 DEEGHIKLTDFGLSKESIDHE-----KKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKE 205 (318)
T ss_pred CCCCcEEEeeccCCcccCCCC-----CceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHH
Confidence 999999999999987543221 1223567999999999987654 8999999999999999999999998877766
Q ss_pred HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchh
Q psy11359 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDK 333 (520)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~ 333 (520)
....+...... ++ ..+++.+.+||.+||++||.+||| +.++++||||+.....
T Consensus 206 ~~~~i~~~~~~-~p---------~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~ 263 (318)
T cd05582 206 TMTMILKAKLG-MP---------QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263 (318)
T ss_pred HHHHHHcCCCC-CC---------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence 66555443321 11 346788999999999999999999 7779999999976543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=368.78 Aligned_cols=259 Identities=34% Similarity=0.530 Sum_probs=208.1
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||+|.+..+|+.||+|++... ........+.+|+.+++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------------~~~~~~~~~~~E~~~l~ 127 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN----------------------HEDTVRRQICREIEILR 127 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC----------------------CcHHHHHHHHHHHHHHH
Confidence 33457899999999999999999999999999999876421 11223457889999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
.++|+||+++++++...+.+|+||||+.+++|.+. ...++..+..++.||+.||.|||++||+|||||
T Consensus 128 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 195 (353)
T PLN00034 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT------------HIADEQFLADVARQILSGIAYLHRRHIVHRDIK 195 (353)
T ss_pred hCCCCCcceeeeEeccCCeEEEEEecCCCCccccc------------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCC
Confidence 99999999999999999999999999999998643 235678899999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc----CCCCcchhHHHHHHHHHHHHhCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD----HGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~~~~DIwSlG~il~elltG~ 260 (520)
|+|||++.++.+||+|||++..+..... ......||+.|+|||++... ..++.++|||||||++|+|++|+
T Consensus 196 p~NIll~~~~~~kL~DfG~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~ 270 (353)
T PLN00034 196 PSNLLINSAKNVKIADFGVSRILAQTMD-----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270 (353)
T ss_pred HHHEEEcCCCCEEEcccccceecccccc-----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCC
Confidence 9999999999999999999876643211 12345799999999987432 22457899999999999999999
Q ss_pred CCCCCCcHH--HHHH-HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 261 APYHKYPAM--KVLM-LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 261 ~Pf~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
.||...... ..+. .......+.. ...++.++++||.+||+.||++|||+.|+|+||||....
T Consensus 271 ~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 271 FPFGVGRQGDWASLMCAICMSQPPEA---------PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CCCCCCCCccHHHHHHHHhccCCCCC---------CCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 999743221 1111 1111111111 135678899999999999999999999999999998754
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=368.27 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=208.6
Q ss_pred eeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC---CCCCceE
Q psy11359 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC---HHENVVT 113 (520)
Q Consensus 37 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l---~HpnIv~ 113 (520)
||+|+||+||+|.+..+|+.||+|++....... .........|..++..+ +||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~~~~~p~i~~ 60 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA--------------------KKEVAHTIGERNILVRTLLDESPFIVG 60 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh--------------------hhHHHHHHHHHHHHHHhccCCCCcCcc
Confidence 799999999999999999999999886432211 11223455566666654 7999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
++.++...+.+|+||||+.+|+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~--------~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~ 132 (330)
T cd05586 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQ--------KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT 132 (330)
T ss_pred eEEEEecCCeEEEEEcCCCCChHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC
Confidence 9999999999999999999999999987 34678999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
+.++|+|||++...... .......+||+.|+|||++.+...++.++|||||||++|+|+||..||..........
T Consensus 133 ~~~kl~Dfg~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~ 207 (330)
T cd05586 133 GHIALCDFGLSKANLTD-----NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR 207 (330)
T ss_pred CCEEEecCCcCcCCCCC-----CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH
Confidence 99999999998653221 1223456899999999998766668999999999999999999999998876665555
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC----CHHHHhcCccccccch
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP----TASELLKNPFFKKAKD 332 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----ta~elL~hp~~~~~~~ 332 (520)
.+...... +.. ..+++.+++||.+||++||.+|| ++.++++||||.....
T Consensus 208 ~i~~~~~~-~~~--------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 208 NIAFGKVR-FPK--------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred HHHcCCCC-CCC--------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 44433221 111 23678899999999999999998 7999999999987554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=361.70 Aligned_cols=256 Identities=28% Similarity=0.411 Sum_probs=209.1
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH-HHhcCCCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ-AMSSCHHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~-~l~~l~HpnIv~ 113 (520)
++||+|+||+||+|.+..+|+.||+|++....... ......+..|.. +++.++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~~l~~~~h~~iv~ 60 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK--------------------KKEQNHIMAERNVLLKNLKHPFLVG 60 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH--------------------hhHHHHHHHHHHHHHHhCCCCCccc
Confidence 47999999999999999999999999886432211 112234555554 678899999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++...+.+|+||||+.|++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~ 132 (321)
T cd05603 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQR--------ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ 132 (321)
T ss_pred eeeEEEcCCEEEEEEcCCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC
Confidence 99999999999999999999999998863 4568899999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
|.+||+|||++..... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||..........
T Consensus 133 ~~~kl~Dfg~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (321)
T cd05603 133 GHVVLTDFGLCKEGVE-----PEETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206 (321)
T ss_pred CCEEEccCCCCccCCC-----CCCccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 9999999998864321 112234567999999999987655 8999999999999999999999998877655555
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH----HHHhcCccccccchhh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA----SELLKNPFFKKAKDKK 334 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta----~elL~hp~~~~~~~~~ 334 (520)
.+... +..++ ...+..+.++|.+||++||.+|+++ .++++|+||.......
T Consensus 207 ~i~~~-~~~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T cd05603 207 NILHK-PLQLP---------GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDD 261 (321)
T ss_pred HHhcC-CCCCC---------CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHH
Confidence 44433 22221 2356788999999999999999876 4999999998766543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=362.88 Aligned_cols=256 Identities=26% Similarity=0.458 Sum_probs=209.7
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~HpnIv~ 113 (520)
++||+|+||+||+|.+..+++.||+|+++...... ....+.+.+|+.++.++ +||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~~~~~~~~~~i~~ 60 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD--------------------DEDIDWVQTEKHVFEQASSNPFLVG 60 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHHhhcCCCCEee
Confidence 47999999999999999999999999886432211 23455688999999888 7999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++...+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+|||++.+
T Consensus 61 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~ 132 (327)
T cd05617 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQR--------QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD 132 (327)
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC
Confidence 99999999999999999999999999873 4679999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC------c
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY------P 267 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~------~ 267 (520)
+.+||+|||++...... .......+||+.|+|||++.+.. ++.++|||||||++|+|+||..||... .
T Consensus 133 ~~~kl~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~ 206 (327)
T cd05617 133 GHIKLTDYGMCKEGLGP-----GDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206 (327)
T ss_pred CCEEEeccccceeccCC-----CCceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccc
Confidence 99999999998643211 11234568999999999997655 899999999999999999999999532 1
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC------HHHHhcCccccccchh
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT------ASELLKNPFFKKAKDK 333 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------a~elL~hp~~~~~~~~ 333 (520)
............+..++ ..++..+.++|.+||++||.+|++ +.++++||||+...+.
T Consensus 207 ~~~~~~~~~~~~~~~~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 207 TEDYLFQVILEKPIRIP---------RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred cHHHHHHHHHhCCCCCC---------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 22223333333222222 245778899999999999999998 5799999999987644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=361.33 Aligned_cols=269 Identities=23% Similarity=0.364 Sum_probs=218.0
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.++||+|+||+||++.++.+++.+|+|++....... ......+.+|+.++..++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~~ 60 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK--------------------RAETACFREERDVLVNGDN 60 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHH--------------------hhHHHHHHHHHHHHhhCCC
Confidence 47999999999999999999999999999999885432111 1223457889999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
+||+++++++...+.+|+||||+.+|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-------~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Ni 133 (332)
T cd05623 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK-------FEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133 (332)
T ss_pred CCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence 9999999999999999999999999999999975 245689999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc----cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----DHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|++.++.+||+|||++..+..... ......+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.
T Consensus 134 li~~~~~~kL~DfG~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 134 LMDMNGHIRLADFGSCLKLMEDGT----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred EECCCCCEEEeecchheecccCCc----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 999999999999999865532211 11234579999999999862 3348899999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCC--CCCHHHHhcCccccccchh
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK--RPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~~~~~~~~ 333 (520)
.....+....+...... ... ......+++.+++||.+||..++.+ |+++.++++||||+...+.
T Consensus 210 ~~~~~~~~~~i~~~~~~-~~~----p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 210 AESLVETYGKIMNHKER-FQF----PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred CCCHHHHHHHHhCCCcc-ccC----CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 87776666655443211 100 0112356889999999999764444 6899999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=348.21 Aligned_cols=268 Identities=28% Similarity=0.465 Sum_probs=233.0
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|..+++||+|.||.|.+++.+.+|+.+|+|++++. ++|. ......-+.|-.+|+.+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKe-------------viia-------kdEVAHTlTE~RVL~~~ 225 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKE-------------VIIA-------KDEVAHTLTENRVLQNC 225 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhh-------------heee-------hHHhhhhhhHHHHHHhc
Confidence 557899999999999999999999999999999998643 3332 23455667899999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||.+..+.-+|...+.+|+||||.+||.|+-.+. ....|++...+-+...|+.||.|||+++||.||||.+
T Consensus 226 ~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLs--------rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLE 297 (516)
T KOG0690|consen 226 RHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLS--------RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLE 297 (516)
T ss_pred cCcHHHHhhhhhccCceEEEEEEEccCceEeeehh--------hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhh
Confidence 99999999999999999999999999999999887 4578999999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|+|++.+|++||+|||++..- ........++||||.|+|||++.... |+.++|.|.+|++||||++|+.||...
T Consensus 298 NLlLDkDGHIKitDFGLCKE~-----I~~g~t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 298 NLLLDKDGHIKITDFGLCKEE-----IKYGDTTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred hheeccCCceEeeecccchhc-----ccccceeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCccccc
Confidence 999999999999999998642 22344567899999999999997655 999999999999999999999999988
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhhHHHh
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKKFIQQ 338 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~~~~ 338 (520)
+..+.+..++..+... ...++++.+.|+..+|.+||.+|. .+.|+.+|+||....+......
T Consensus 372 dh~kLFeLIl~ed~kF----------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~K 438 (516)
T KOG0690|consen 372 DHEKLFELILMEDLKF----------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRK 438 (516)
T ss_pred chhHHHHHHHhhhccC----------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHh
Confidence 8888777776654322 246789999999999999999995 4899999999999888654443
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=366.45 Aligned_cols=265 Identities=27% Similarity=0.422 Sum_probs=210.9
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.+..++..||+|++...... ......+.+|+.++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~ 72 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS---------------------LIHARRTYRELRLLKHMK 72 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh---------------------hHHHHHHHHHHHHHHhcC
Confidence 47899999999999999999999999999999987532110 123445778999999999
Q ss_pred CCCceEEEEEEEEC------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 108 HENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 108 HpnIv~~~~~~~~~------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
||||+++++++... ..+|++|+++ +++|.++++ .+.+++..++.++.||+.||.|||++||+||
T Consensus 73 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 142 (343)
T cd07878 73 HENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK---------CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHR 142 (343)
T ss_pred CCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 99999999888643 4579999998 789988874 3568999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||++.++.+||+|||++..... .....+||+.|+|||++.+...++.++|||||||++|+|++|..
T Consensus 143 dikp~Nil~~~~~~~kl~Dfg~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 214 (343)
T cd07878 143 DLKPSNVAVNEDCELRILDFGLARQADD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214 (343)
T ss_pred cCChhhEEECCCCCEEEcCCccceecCC--------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999999999999999999876532 12346799999999998775558999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCC---------------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLD---------------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
||........+............ ............++.+.+||.+||..||.+|||+.|
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~e 294 (343)
T cd07878 215 LFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASE 294 (343)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 99876554444332211100000 000001112345677899999999999999999999
Q ss_pred HhcCccccccc
Q psy11359 321 LLKNPFFKKAK 331 (520)
Q Consensus 321 lL~hp~~~~~~ 331 (520)
+|.||||....
T Consensus 295 ll~hp~~~~~~ 305 (343)
T cd07878 295 ALAHPYFSQYH 305 (343)
T ss_pred HhcCcchhccC
Confidence 99999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=363.13 Aligned_cols=265 Identities=24% Similarity=0.384 Sum_probs=205.2
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEc-----CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCK-----ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
|....++|++.++||+|+||.||+|.+. .++..||+|+++ ..........+.+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~----------------------~~~~~~~~~~~~~ 59 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLK----------------------EGATASEHKALMS 59 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccc----------------------cccchHHHHHHHH
Confidence 7778899999999999999999999753 233456666543 2222234567899
Q ss_pred HHHHHhcC-CCCCceEEEEEEEEC-CEEEEEEEccCCCCHHHHHHHhhccc-----------------------------
Q psy11359 99 EIQAMSSC-HHENVVTYHTSFVVK-DELWLVLRLLEGGSLLDIIKHRLKIS----------------------------- 147 (520)
Q Consensus 99 Ei~~l~~l-~HpnIv~~~~~~~~~-~~~~lV~E~~~ggsL~~~i~~~~~~~----------------------------- 147 (520)
|+.++..+ +||||+++++++... ..+++||||+.+|+|.+++.......
T Consensus 60 E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (338)
T cd05102 60 ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEA 139 (338)
T ss_pred HHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccccccc
Confidence 99999999 899999999988754 46899999999999999997532100
Q ss_pred -------------------------cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccC
Q psy11359 148 -------------------------NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202 (520)
Q Consensus 148 -------------------------~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG 202 (520)
......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG 219 (338)
T cd05102 140 GQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 219 (338)
T ss_pred ccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecc
Confidence 0012458889999999999999999999999999999999999999999999999
Q ss_pred cceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCC-C
Q psy11359 203 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQND-P 280 (520)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~-~ 280 (520)
++..+...... .......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||........+...+... .
T Consensus 220 ~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 295 (338)
T cd05102 220 LARDIYKDPDY---VRKGSARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295 (338)
T ss_pred cccccccCcch---hcccCCCCCccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC
Confidence 98765322111 1112345678899999987655 8999999999999999997 999998765443333333221 1
Q ss_pred CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 281 PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
... ...+++.+.++|.+||+.||.+|||+.|+++
T Consensus 296 ~~~---------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 296 MRA---------PENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 1345778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=377.68 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=200.4
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.++||+|+||+||+|.+..+++.||||+++.. .........|+.+++.++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~------------------------~~~~~~~~~e~~~l~~l~ 183 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV------------------------PKYTRDAKIEIQFMEKVR 183 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc------------------------hhhHHHHHHHHHHHHHHh
Confidence 47899999999999999999999999999999987421 011223445666655554
Q ss_pred ------CCCceEEEEEEEEC-CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcE
Q psy11359 108 ------HENVVTYHTSFVVK-DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQI 179 (520)
Q Consensus 108 ------HpnIv~~~~~~~~~-~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~gii 179 (520)
|++|++++++|... ..+|+||+++ |++|.+++. ..+.+++..++.++.||+.||.|||+ .|||
T Consensus 184 ~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~--------~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIi 254 (467)
T PTZ00284 184 QADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIM--------KHGPFSHRHLAQIIFQTGVALDYFHTELHLM 254 (467)
T ss_pred hcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHH--------HcCCCCHHHHHHHHHHHHHHHHHHHhcCCee
Confidence 45689999988754 5799999998 789999987 34679999999999999999999998 5999
Q ss_pred ecccCCCcEEEcCCC----------------CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcc
Q psy11359 180 HRDIKAGNILLGEDG----------------TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFK 243 (520)
Q Consensus 180 HrDLKp~NILl~~~g----------------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 243 (520)
||||||+|||++.++ .+||+|||.+.... ......+||+.|||||++.+.. |+.+
T Consensus 255 HrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~--------~~~~~~~gt~~Y~APE~~~~~~-~~~~ 325 (467)
T PTZ00284 255 HTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER--------HSRTAIVSTRHYRSPEVVLGLG-WMYS 325 (467)
T ss_pred cCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc--------cccccccCCccccCcHHhhcCC-CCcH
Confidence 999999999997665 49999999875321 1223568999999999998765 8999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC---CCCCCC-------------------CCchhhhh---------
Q psy11359 244 ADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQN---DPPTLD-------------------TGAAEKDQ--------- 292 (520)
Q Consensus 244 ~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~~~~-------------------~~~~~~~~--------- 292 (520)
+|||||||++|||+||++||.+....+.+..+... .+..+. ........
T Consensus 326 ~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (467)
T PTZ00284 326 TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPV 405 (467)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccch
Confidence 99999999999999999999877665544322211 000000 00000000
Q ss_pred -HHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 293 -YKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 293 -~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
....++.+.+||.+||++||.+|||+.|+|+||||++..
T Consensus 406 ~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 406 REVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred hhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence 001246688999999999999999999999999998643
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=365.28 Aligned_cols=265 Identities=26% Similarity=0.406 Sum_probs=209.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l 80 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---------------------QNQTHAKRAYRELVLMKCV 80 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc---------------------cCchhHHHHHHHHHHHHhc
Confidence 4578999999999999999999999999999998764211 0122345678999999999
Q ss_pred CCCCceEEEEEEEEC------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+||||+++++++... ..+|+||||+. ++|.+++.. .+++..+..++.||+.||.|||++||+|
T Consensus 81 ~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~ivH 149 (364)
T cd07875 81 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----------ELDHERMSYLLYQMLCGIKHLHSAGIIH 149 (364)
T ss_pred CCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh----------cCCHHHHHHHHHHHHHHHHHHhhCCeec
Confidence 999999999987643 35899999995 578887752 3778999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+|||++.++.+||+|||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+
T Consensus 150 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~ 222 (364)
T cd07875 150 RDLKPSNIVVKSDCTLKILDFGLARTAGTS------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGG 222 (364)
T ss_pred CCCCHHHEEECCCCcEEEEeCCCccccCCC------CcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCC
Confidence 999999999999999999999998765321 1223467899999999997655 899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCC---------------------Cc-----------hhhhhHHHhcHHHHHHHHhhh
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDT---------------------GA-----------AEKDQYKAYGKTFRKMISDCL 308 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------~~-----------~~~~~~~~~~~~~~~li~~~L 308 (520)
.||.+....+.+..++.......+. .. .........+..+++||.+||
T Consensus 223 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 302 (364)
T cd07875 223 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302 (364)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhc
Confidence 9998877666554443321110000 00 000001123467899999999
Q ss_pred ccCCCCCCCHHHHhcCcccccc
Q psy11359 309 QKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 309 ~~dP~~Rpta~elL~hp~~~~~ 330 (520)
+.||.+|||+.|+|+||||...
T Consensus 303 ~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 303 VIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred CcCcccCCCHHHHhcCcccccc
Confidence 9999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=358.10 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=195.7
Q ss_pred EeeeeecCceEEEEEEEcC--CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCc
Q psy11359 34 REVIGFGATAVVHSAYCKA--RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENV 111 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnI 111 (520)
..+||+|+||+||+|.++. +++.||+|.+... .....+.+|+.++++++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-------------------------~~~~~~~~E~~~l~~l~h~ni 60 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-------------------------GISMSACREIALLRELKHPNV 60 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC-------------------------CCcHHHHHHHHHHHhcCCCCC
Confidence 4589999999999998763 5667777765311 112347789999999999999
Q ss_pred eEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhcc-ccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 112 VTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKI-SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 112 v~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~-~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
+++++++.. ...+|+||||+ +++|.+++...... .......+++..++.++.||+.||.|||++||+||||||+||
T Consensus 61 v~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Ni 139 (317)
T cd07868 61 ISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANI 139 (317)
T ss_pred cceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHE
Confidence 999999864 46789999999 46899988643211 111234689999999999999999999999999999999999
Q ss_pred EE----cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 189 LL----GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 189 Ll----~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+ +.++.+||+|||++..+..... .........||+.|+|||++.+...++.++||||+||++|+|++|.+||.
T Consensus 140 l~~~~~~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 140 LVMGEGPERGRVKIADMGFARLFNSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred EEecCCCCcCcEEEeecCceeccCCCCc--cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 99 4567899999999987643221 11223456889999999999876668999999999999999999999996
Q ss_pred CCcHH---------HHHHHHhc--CCCCCC--------CCC------------------chhhhhHHHhcHHHHHHHHhh
Q psy11359 265 KYPAM---------KVLMLTLQ--NDPPTL--------DTG------------------AAEKDQYKAYGKTFRKMISDC 307 (520)
Q Consensus 265 ~~~~~---------~~~~~~~~--~~~~~~--------~~~------------------~~~~~~~~~~~~~~~~li~~~ 307 (520)
..... ..+..+.. +.+... ... ..........+..+.+||.+|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 297 (317)
T cd07868 218 CRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 297 (317)
T ss_pred CCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHH
Confidence 43321 11111110 000000 000 000000012345788999999
Q ss_pred hccCCCCCCCHHHHhcCccc
Q psy11359 308 LQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 308 L~~dP~~Rpta~elL~hp~~ 327 (520)
|++||.+|||++|+|+||||
T Consensus 298 L~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 298 LTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hccCcccCCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=375.07 Aligned_cols=253 Identities=34% Similarity=0.543 Sum_probs=216.4
Q ss_pred eeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEE
Q psy11359 36 VIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYH 115 (520)
Q Consensus 36 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~ 115 (520)
+||+|.||+||.|+|..+....|||-+.. +......-+..||.+.++|+|.|||+|+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe-----------------------kdsr~~QPLhEEIaLH~~LrHkNIVrYL 638 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE-----------------------KDSREVQPLHEEIALHSTLRHKNIVRYL 638 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc-----------------------ccchhhccHHHHHHHHHHHhhHhHHHHh
Confidence 79999999999999999988888887631 1133344588999999999999999999
Q ss_pred EEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEE-cC
Q psy11359 116 TSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVC--DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL-GE 192 (520)
Q Consensus 116 ~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l--~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl-~~ 192 (520)
+++..++.+-|.||-++||+|.++++. +-|++ .|..+..+.+||++||.|||.+.|||||||-+|||| +-
T Consensus 639 Gs~senGf~kIFMEqVPGGSLSsLLrs-------kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy 711 (1226)
T KOG4279|consen 639 GSVSENGFFKIFMEQVPGGSLSSLLRS-------KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY 711 (1226)
T ss_pred hccCCCCeEEEEeecCCCCcHHHHHHh-------ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec
Confidence 999999999999999999999999986 56777 788999999999999999999999999999999999 46
Q ss_pred CCCeEEeccCcceeeccCccccccccccccccccccCCcceecc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q psy11359 193 DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ-DHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKV 271 (520)
Q Consensus 193 ~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~ 271 (520)
.|.+||+|||-+..++. -.+...+|.||..|||||++.+ ..+|+.++|||||||++.||.||++||........
T Consensus 712 SGvlKISDFGTsKRLAg-----inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA 786 (1226)
T KOG4279|consen 712 SGVLKISDFGTSKRLAG-----INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA 786 (1226)
T ss_pred cceEEecccccchhhcc-----CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH
Confidence 89999999999988753 3445678999999999999964 46799999999999999999999999987766555
Q ss_pred HHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 272 LMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.|....-.... ......++.+++.||.+|+.+||.+||+|.++|.+||++..
T Consensus 787 AMFkVGmyKvH-------P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 787 AMFKVGMYKVH-------PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred hhhhhcceecC-------CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 54433221111 11225678899999999999999999999999999999865
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=365.43 Aligned_cols=265 Identities=27% Similarity=0.424 Sum_probs=207.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+++.||+|.+.... ........+.+|+.+++.+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l 73 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---------------------QNQTHAKRAYRELVLMKCV 73 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc---------------------cChHHHHHHHHHHHHHHHh
Confidence 4578999999999999999999999998889988764221 0122345678899999999
Q ss_pred CCCCceEEEEEEEEC------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+||||+++++++... ...|+||||+. ++|.+++.. .+++..+..++.||+.||.|||++||+|
T Consensus 74 ~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~givH 142 (355)
T cd07874 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----------ELDHERMSYLLYQMLCGIKHLHSAGIIH 142 (355)
T ss_pred CCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 999999999988643 35799999996 477777742 4788999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+|||++.++.+||+|||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+
T Consensus 143 rDikp~Nill~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~ 215 (355)
T cd07874 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTS------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHK 215 (355)
T ss_pred CCCChHHEEECCCCCEEEeeCcccccCCCc------cccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999998764322 1223467999999999997654 899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCC---------------------CCCCC---------C--chhhhhHHHhcHHHHHHHHhhh
Q psy11359 261 APYHKYPAMKVLMLTLQNDP---------------------PTLDT---------G--AAEKDQYKAYGKTFRKMISDCL 308 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~---------------------~~~~~---------~--~~~~~~~~~~~~~~~~li~~~L 308 (520)
.||.+......+...+.... +.... . ..........+..+++||.+||
T Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL 295 (355)
T cd07874 216 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295 (355)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHh
Confidence 99987665444332221100 00000 0 0000011224567899999999
Q ss_pred ccCCCCCCCHHHHhcCcccccc
Q psy11359 309 QKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 309 ~~dP~~Rpta~elL~hp~~~~~ 330 (520)
+.||++|||+.|+|+||||+..
T Consensus 296 ~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 296 VIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred cCCchhcCCHHHHhcCcchhcc
Confidence 9999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=349.19 Aligned_cols=266 Identities=26% Similarity=0.387 Sum_probs=212.3
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||.|++|.||+|.+..++..||+|.++.... .......+.+|+.++++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~h~ 59 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE---------------------EEGVPSTAIREISLLKELQHP 59 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc---------------------cCCchHHHHHHHHHHHhcCCC
Confidence 58999999999999999999999999999997643210 012235678899999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++..+..+|+||||+. ++|.+++.... ....+++..++.++.||+.||.|||++|++||||||+||+
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil 133 (285)
T cd07861 60 NIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLP-----KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLL 133 (285)
T ss_pred CEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCC-----CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEE
Confidence 99999999999999999999996 68999886421 2357899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.+|.++|+|||++....... .......+++.|+|||++.+...++.++|||||||++|+|+||.+||.+....
T Consensus 134 ~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~ 208 (285)
T cd07861 134 IDNKGVIKLADFGLARAFGIPV-----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI 208 (285)
T ss_pred EcCCCcEEECcccceeecCCCc-----ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 9999999999999987653221 11223467899999999876655889999999999999999999999876655
Q ss_pred HHHHHHhcCCCCCC-----------------C--CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 270 KVLMLTLQNDPPTL-----------------D--TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 270 ~~~~~~~~~~~~~~-----------------~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.............. . ...........+++++.+||.+||+.||.+|||+.++++||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 209 DQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 44433222110000 0 0000111123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=358.86 Aligned_cols=272 Identities=33% Similarity=0.558 Sum_probs=210.9
Q ss_pred EEeeeeec--CceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC
Q psy11359 33 VREVIGFG--ATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 33 i~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
++++||+| +|++||++.++.+|+.||+|.++.... .....+.+.+|+.+++.++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~hpn 60 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC---------------------TNEMVTFLQGELHVSKLFNHPN 60 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc---------------------cHHHHHHHHHHHHHHHhcCCCC
Confidence 57899999 689999999999998888887753211 0123456788999999999999
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl 190 (520)
|+++++++..++..|+||||+++|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 61 iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~ 134 (327)
T cd08227 61 IVPYRATFIADNELWVVTSFMAYGSAKDLICTH------FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 134 (327)
T ss_pred eeeEEEEEEECCEEEEEEeccCCCcHHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE
Confidence 999999999999999999999999999999753 23458999999999999999999999999999999999999
Q ss_pred cCCCCeEEeccCcceeeccCcccc--ccccccccccccccCCcceeccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 191 GEDGTVQIADFGVSAWLATGRDLS--RQKVRHTFVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 191 ~~~g~vkL~DFG~a~~~~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
+.++.++++||+....+....... .........++..|+|||++.+. ..|+.++|||||||++|+|++|..||....
T Consensus 135 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 135 SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 999999999998654332111100 00111234577889999998753 348999999999999999999999998766
Q ss_pred HHHHHHHHhcCCCCCCCCC------------------------------------chhhhhHHHhcHHHHHHHHhhhccC
Q psy11359 268 AMKVLMLTLQNDPPTLDTG------------------------------------AAEKDQYKAYGKTFRKMISDCLQKD 311 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~li~~~L~~d 311 (520)
.............+..... .........+++.+.+||.+||+.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 294 (327)
T cd08227 215 ATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRN 294 (327)
T ss_pred hhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhC
Confidence 5554444333222111000 0000112345788999999999999
Q ss_pred CCCCCCHHHHhcCccccccc
Q psy11359 312 PTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 312 P~~Rpta~elL~hp~~~~~~ 331 (520)
|++|||+.|+++||||+..+
T Consensus 295 P~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 295 PDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred chhcCCHHHHhcChhhhhcc
Confidence 99999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=349.51 Aligned_cols=267 Identities=37% Similarity=0.653 Sum_probs=221.0
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...+.|++++.||.|+||.||+|.+..++..+++|.+... .....+.+.+|+.+++.
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----------------------~~~~~~~~~~e~~~l~~ 65 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----------------------SEEELEDYMVEIEILAT 65 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----------------------CHHHHHHHHHHHHHHHh
Confidence 4568899999999999999999999999888888876421 12345678899999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++..+..+|+||||+.|++|..++.. ....+++..+..++.||+.||.|||++|++||||||
T Consensus 66 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp 138 (292)
T cd06644 66 CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE-------LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138 (292)
T ss_pred CCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCc
Confidence 9999999999999999999999999999999988764 345689999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc----cCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----DHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
+||+++.++.++|+|||++...... ........+++.|+|||++.+ ...++.++|+|||||++|+|++|.+
T Consensus 139 ~Nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 213 (292)
T cd06644 139 GNVLLTLDGDIKLADFGVSAKNVKT-----LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213 (292)
T ss_pred ceEEEcCCCCEEEccCccceecccc-----ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCC
Confidence 9999999999999999987654221 111234578899999999852 2336889999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhh
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~ 334 (520)
||................++... ....++..+.++|.+||..+|++||++.++++||||......+
T Consensus 214 p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 214 PHHELNPMRVLLKIAKSEPPTLS-------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred CCccccHHHHHHHHhcCCCccCC-------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 99877666555544443332221 1234677899999999999999999999999999998776654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=349.59 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=205.6
Q ss_pred eeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEEE
Q psy11359 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHT 116 (520)
Q Consensus 37 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~~ 116 (520)
||+|+||.||++.++.+|+.||+|.+....... ......+..|++++++++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--------------------~~~~~~~~~E~~il~~l~hp~i~~~~~ 60 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--------------------KSGEKMALLEKEILEKVNSPFIVNLAY 60 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc--------------------chhhHHHHHHHHHHHhcCCCcEEEEEE
Confidence 799999999999999999999999875432110 111234567999999999999999999
Q ss_pred EEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCe
Q psy11359 117 SFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196 (520)
Q Consensus 117 ~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~v 196 (520)
++..+..+|+||||+.|++|.+++... ....+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 61 ~~~~~~~~~lv~e~~~g~~L~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~ 134 (277)
T cd05607 61 AFESKTHLCLVMSLMNGGDLKYHIYNV------GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNC 134 (277)
T ss_pred EEecCCeEEEEEecCCCCCHHHHHHhc------cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCE
Confidence 999999999999999999999988643 33458899999999999999999999999999999999999999999
Q ss_pred EEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH----HHHH
Q psy11359 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA----MKVL 272 (520)
Q Consensus 197 kL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~----~~~~ 272 (520)
+|+|||++..+.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ....
T Consensus 135 ~l~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~ 207 (277)
T cd05607 135 RLSDLGLAVELKDGK------TITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK 207 (277)
T ss_pred EEeeceeeeecCCCc------eeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Confidence 999999987664322 122346899999999997766 89999999999999999999999975432 1222
Q ss_pred HHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH----HHHhcCccccccch
Q psy11359 273 MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA----SELLKNPFFKKAKD 332 (520)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta----~elL~hp~~~~~~~ 332 (520)
.......... ....+++++++||.+||++||.+||++ .++++||||+....
T Consensus 208 ~~~~~~~~~~---------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 208 RRTLEDEVKF---------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred HHhhcccccc---------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 2222211111 113568889999999999999999999 67889999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=346.38 Aligned_cols=257 Identities=35% Similarity=0.611 Sum_probs=208.4
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
|++.+.||+|+||+||++.+..+++.+|+|++....... .......+|+.++++++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~---------------------~~~~~~~~e~~~~~~l~~~~ 59 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE---------------------EEREENIREIKILRRLRHPN 59 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH---------------------HHHHHHHHHHHHHHHHTBTT
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc---------------------cccchhhhhhhccccccccc
Confidence 899999999999999999999998888988876442211 12223456999999999999
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl 190 (520)
|+++++++......++||||+.+++|.+++.. .+.+++..+..++.||++||.+||++|++|+||||+||++
T Consensus 60 i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~ 131 (260)
T PF00069_consen 60 IVQILDVFQDDNYLYIVMEYCPGGSLQDYLQK--------NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL 131 (260)
T ss_dssp BCHEEEEEEESSEEEEEEEEETTEBHHHHHHH--------HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE
T ss_pred cccccccccccccccccccccccccccccccc--------cccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999999983 4667899999999999999999999999999999999999
Q ss_pred cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH--
Q psy11359 191 GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA-- 268 (520)
Q Consensus 191 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~-- 268 (520)
+.++.++|+|||.+..+.. .........+|+.|+|||++.....++.++||||||+++|+|++|..||.....
T Consensus 132 ~~~~~~~l~Dfg~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~ 206 (260)
T PF00069_consen 132 DENGEVKLIDFGSSVKLSE-----NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD 206 (260)
T ss_dssp STTSEEEESSGTTTEESTS-----TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH
T ss_pred ccccccccccccccccccc-----cccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence 9999999999999875411 222334567899999999987344489999999999999999999999988732
Q ss_pred -HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 -MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.............. ........+..+.++|.+||+.||++|||+.++++||||
T Consensus 207 ~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 207 QLEIIEKILKRPLPS------SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHHTHHHH------HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred hhhhhhhcccccccc------cccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 22222222110000 000001123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=359.05 Aligned_cols=268 Identities=22% Similarity=0.347 Sum_probs=217.6
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||+||++.++.+++.||+|++....... ......+.+|+.++..++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~~~~ 60 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLK--------------------RAETACFREERNVLVNGDC 60 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHh--------------------hHHHHHHHHHHHHHHhCCC
Confidence 57999999999999999999999999999999876421110 1233457889999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
+||+++++++...+.+|+||||+.||+|.+++.. ..+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 61 ~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-------~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Ni 133 (331)
T cd05624 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK-------FEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133 (331)
T ss_pred CCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHE
Confidence 9999999999999999999999999999999975 245789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc----CCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD----HGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|++.+|.+||+|||++..+..... .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.
T Consensus 134 ll~~~~~~kl~DfG~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 134 LLDMNGHIRLADFGSCLKMNQDGT----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred EEcCCCCEEEEeccceeeccCCCc----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 999999999999999876543221 112245799999999998642 237889999999999999999999998
Q ss_pred CCcHHHHHHHHhcCCC-CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCC--CCCHHHHhcCccccccchh
Q psy11359 265 KYPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK--RPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~~~~~~~~ 333 (520)
.....+.+..+..... ..++ .....++..++++|.+||..++.+ |++++++++||||+...+.
T Consensus 210 ~~~~~~~~~~i~~~~~~~~~p------~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 210 AESLVETYGKIMNHEERFQFP------SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred CCCHHHHHHHHHcCCCcccCC------CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 8776666555443321 1111 111346789999999999875544 5799999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=343.99 Aligned_cols=267 Identities=75% Similarity=1.154 Sum_probs=224.4
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||.|+||+||+|.+..++..+|+|++.. .........+.+|+.+++.++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~----------------------~~~~~~~~~~~~e~~~l~~l~~ 58 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL----------------------EKCQTSVDELRKEVQAMSQCNH 58 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEecc----------------------CCcchHHHHHHHHHHHHHhcCC
Confidence 579999999999999999999998888888887642 2222345678999999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
+||+++++.+...+..|+|||++.|++|.+++.... ....+++..+..++.||+.||.|||++|++||||+|+||
T Consensus 59 ~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni 133 (267)
T cd06610 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSY-----PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNI 133 (267)
T ss_pred CCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhc-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhE
Confidence 999999999999999999999999999999997521 125689999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
++++++.++|+|||++..+....... ........|++.|+|||.+.....++.++|+|||||++|+|++|+.||...+.
T Consensus 134 ~~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 134 LLGEDGSVKIADFGVSASLADGGDRT-RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred EEcCCCCEEEcccchHHHhccCcccc-ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 99999999999999987765433221 12234567899999999987664589999999999999999999999998887
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.+.+.......++...... .+..++..+.+++.+||..||.+|||+.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 213 MKVLMLTLQNDPPSLETGA----DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred hhhHHHHhcCCCCCcCCcc----ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 7777666665544333211 134678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=342.92 Aligned_cols=262 Identities=30% Similarity=0.491 Sum_probs=214.8
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
+.|++.+.||+|++|.||.|.+..++.+||+|.+....... ........+.+|+.++++++|
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~------------------~~~~~~~~~~~e~~~l~~l~~ 63 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP------------------ETKKEVNALECEIQLLKNLQH 63 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccch------------------hhHHHHHHHHHHHHHHHhCCC
Confidence 45999999999999999999999999999999875321110 001234568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++..++.+++||||+.|++|.+++.. .+.+++..+..++.||+.||.|||+.|++||||+|+||
T Consensus 64 ~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni 135 (263)
T cd06625 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA--------YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANI 135 (263)
T ss_pred CCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHH--------hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 9999999999999999999999999999999974 45688999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++.++.++|+|||++..+..... .........|++.|+|||++.+.. ++.++||||||+++|+|++|+.||.....
T Consensus 136 lv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~ 212 (263)
T cd06625 136 LRDSAGNVKLGDFGASKRLQTICS--SGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEA 212 (263)
T ss_pred EEcCCCCEEEeecccceecccccc--ccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccch
Confidence 999999999999999876532211 111113456889999999998765 89999999999999999999999977655
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.............. .....++..+.++|.+||.++|.+|||+.++++||||
T Consensus 213 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 213 MAAIFKIATQPTNP--------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHhccCCCC--------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 55444333221110 1123567889999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=350.52 Aligned_cols=262 Identities=28% Similarity=0.421 Sum_probs=213.0
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
.|++.++||+|+||+||+|.+..+++.||+|.+...... .......+.+|+.++++++|+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~--------------------~~~~~~~~~~E~~il~~l~~~ 60 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--------------------KRKGESMALNEKQILEKVNSR 60 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc--------------------chHHHHHHHHHHHHHHhCCCC
Confidence 488999999999999999999999999999977532110 012234577899999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++.+..++.+|+||||+.|++|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 61 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~------~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil 134 (285)
T cd05630 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM------GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENIL 134 (285)
T ss_pred CeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEE
Confidence 9999999999999999999999999999998643 3346899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.++.++|+|||++.....+.. .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||......
T Consensus 135 ~~~~~~~~l~Dfg~~~~~~~~~~------~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~ 207 (285)
T cd05630 135 LDDHGHIRISDLGLAVHVPEGQT------IKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207 (285)
T ss_pred ECCCCCEEEeeccceeecCCCcc------ccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCcc
Confidence 99999999999999865432211 12347999999999997665 899999999999999999999999764321
Q ss_pred ---HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchh
Q psy11359 270 ---KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDK 333 (520)
Q Consensus 270 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~ 333 (520)
..........+. .....+++++++||.+||+.||.+||| +.|+++||||+.....
T Consensus 208 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 208 IKREEVERLVKEVQE---------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred chHHHHHhhhhhhhh---------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 112111111111 112346788999999999999999999 9999999999875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=349.85 Aligned_cols=267 Identities=42% Similarity=0.711 Sum_probs=222.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||.|+||+||++.+..++..+|+|.+... .....+.+.+|+.+++++
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----------------------~~~~~~~~~~e~~~l~~l 59 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----------------------SEEELEDFMVEIDILSEC 59 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----------------------CHHHHHHHHHHHHHHHhC
Confidence 457899999999999999999999999888888876421 122446688999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++..+...|+||||+.+++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-------~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ 132 (280)
T cd06611 60 KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE-------LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAG 132 (280)
T ss_pred CCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChh
Confidence 999999999999999999999999999999999875 3456899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc----cCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----DHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
||+++.++.++|+|||++...... ........||+.|+|||++.. ...++.++|+|||||++|+|++|..|
T Consensus 133 nili~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p 207 (280)
T cd06611 133 NILLTLDGDVKLADFGVSAKNKST-----LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207 (280)
T ss_pred hEEECCCCCEEEccCccchhhccc-----ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999987654321 112234578999999999752 23367899999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhhH
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~ 335 (520)
|................++.+.. ...++..+.++|.+||+.+|.+|||+.++++||||......+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 273 (280)
T cd06611 208 HHELNPMRVLLKILKSEPPTLDQ-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKA 273 (280)
T ss_pred cccCCHHHHHHHHhcCCCCCcCC-------cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchhHH
Confidence 98877766665555444333321 1346788999999999999999999999999999998755443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=363.95 Aligned_cols=257 Identities=26% Similarity=0.456 Sum_probs=219.2
Q ss_pred CCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 21 SVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 21 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
...|....+.+.+.+.||+|-||.||.|....+ .+||+|.++.. ....+.+.+|+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~------------------------~m~~~~f~~Ea 252 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG------------------------SMSPEAFLREA 252 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc------------------------ccChhHHHHHH
Confidence 456778888888999999999999999988753 46777765421 22346688999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
++|++|+|+|||++|+++..++.+||||||+..|+|.+|++.. .++.+...+...++.||++|++||+++++||
T Consensus 253 ~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~------~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IH 326 (468)
T KOG0197|consen 253 QIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTR------EGGLLNLPQLLDFAAQIAEGMAYLESKNYIH 326 (468)
T ss_pred HHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhc------CCCccchHHHHHHHHHHHHHHHHHHhCCccc
Confidence 9999999999999999999999999999999999999999963 5678899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-C
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G 259 (520)
|||-+.||||++++.+||+|||+|+.........+. ..--...|.|||.+.... ++.++|||||||+|+||+| |
T Consensus 327 RDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~----~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G 401 (468)
T KOG0197|consen 327 RDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE----GGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYG 401 (468)
T ss_pred hhhhhhheeeccCceEEEcccccccccCCCceeecC----CCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccC
Confidence 999999999999999999999999954332221111 112244699999998777 8999999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
+.||.+.+..+++..+-++....-+ ..+|+++.+++..||..+|++|||++.+.
T Consensus 402 ~~py~~msn~ev~~~le~GyRlp~P---------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 402 RVPYPGMSNEEVLELLERGYRLPRP---------EGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCCCCCCHHHHHHHHhccCcCCCC---------CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999999888887654333 46789999999999999999999999664
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.72 Aligned_cols=256 Identities=27% Similarity=0.510 Sum_probs=214.1
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
.|++.+.||+|++|.||++.++.+++.||+|.+..... .....+.+.+|+.++++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~~~ 59 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA---------------------SRRERKAAEQEAQLLSQLKHP 59 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc---------------------CHHHHHHHHHHHHHHHhCCCC
Confidence 49999999999999999999999988888887653211 122345688899999999999
Q ss_pred CceEEEEEEEE-CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 110 NVVTYHTSFVV-KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 110 nIv~~~~~~~~-~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
||+++++.+.. +..+|+||||+.+++|.+++... ....+++.++..++.||+.||.|||++|++||||||+||
T Consensus 60 ~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~------~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~ni 133 (257)
T cd08223 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ------KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNV 133 (257)
T ss_pred CeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhE
Confidence 99999998864 44689999999999999999753 345689999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++.++.++|+|||++..+.... .......|++.|+|||++.+.. ++.++|+|||||++++|++|+.||...+.
T Consensus 134 l~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~ 207 (257)
T cd08223 134 FLTRTNIIKVGDLGIARVLENQC-----DMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDM 207 (257)
T ss_pred EEecCCcEEEecccceEEecccC-----CccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 99999999999999987764322 1223467899999999987665 88999999999999999999999987766
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
............+... ..+++.+.+||.+||+++|.+|||+.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 208 NSLVYRIIEGKLPPMP---------KDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHhcCCCCCc---------cccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 5555544444332221 3467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=340.05 Aligned_cols=256 Identities=29% Similarity=0.529 Sum_probs=218.2
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|.+.+.||+|++|.||+|.++.++..|++|.+...... ......+.+|+.+++.++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~h~ 59 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN---------------------RREREEAIDEARVLAKLDSS 59 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC---------------------HHHHHHHHHHHHHHHhcCCC
Confidence 589999999999999999999999988998876532111 22456788999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++...+..|+||||+.|++|.+++... ....+++..+..++.||+.||.|||++|++|+||||+||+
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nil 133 (256)
T cd08529 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ------RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLF 133 (256)
T ss_pred CeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence 9999999999999999999999999999999753 3467899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.++.++|+|||++..+.... .......|++.|+|||++.+.. ++.++|+|||||++++|++|..||......
T Consensus 134 i~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 207 (256)
T cd08529 134 LDAYDNVKIGDLGVAKLLSDNT-----NFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQG 207 (256)
T ss_pred EeCCCCEEEcccccceeccCcc-----chhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999987664322 1123457899999999987665 889999999999999999999999887766
Q ss_pred HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
...........+.+. ..++..+.++|.+||+.+|++||++.++++|||+
T Consensus 208 ~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 208 ALILKIIRGVFPPVS---------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHcCCCCCCc---------cccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 666555554433332 2467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=347.94 Aligned_cols=265 Identities=26% Similarity=0.388 Sum_probs=215.7
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
.|+..+.||.|+||+||+|.+..+++.+|+|.+....... ......+.+|+.++++++|+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~E~~il~~l~~~ 60 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK--------------------RKGESMALNEKQILEKVNSQ 60 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh--------------------hhHHHHHHHHHHHHHHcCCc
Confidence 4888999999999999999999999999999875321110 12234578899999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++.+..++.+++||||+.+++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 61 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nil 134 (285)
T cd05632 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM------GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENIL 134 (285)
T ss_pred CceeEEEEEecCCEEEEEEEeccCccHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEE
Confidence 9999999999999999999999999999988643 3446999999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
+++++.++|+|||++....... ......|++.|+|||++.+.. ++.++|+|||||++|+|++|..||......
T Consensus 135 i~~~~~~kl~Dfg~~~~~~~~~------~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~ 207 (285)
T cd05632 135 LDDYGHIRISDLGLAVKIPEGE------SIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207 (285)
T ss_pred ECCCCCEEEecCCcceecCCCC------cccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999987653221 123457999999999997655 899999999999999999999999876554
Q ss_pred HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchh
Q psy11359 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDK 333 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~ 333 (520)
............... .....++..+.+|+.+||++||.+||| +.+++.|+||+....+
T Consensus 208 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 208 VKREEVDRRVLETEE------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHHHHHHhhhcccc------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 332222211111000 012346778999999999999999999 8999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=388.85 Aligned_cols=269 Identities=28% Similarity=0.475 Sum_probs=218.6
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
+.+...++|++++.||+|+||+||+|.+..++..+|+|++...... ......+.+|+.+
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~---------------------e~~~~~~~~EI~I 65 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK---------------------EREKSQLVIEVNV 65 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC---------------------HHHHHHHHHHHHH
Confidence 3455678999999999999999999999999988999877532110 2234668899999
Q ss_pred HhcCCCCCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC----
Q psy11359 103 MSSCHHENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN---- 176 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~---- 176 (520)
|++|+|||||+++++|.. ...+||||||+.+++|.++|..... ..+.+++..++.|+.||+.||.|||+.
T Consensus 66 L~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~----~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~ 141 (1021)
T PTZ00266 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK----MFGKIEEHAIVDITRQLLHALAYCHNLKDGP 141 (1021)
T ss_pred HHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhccccc
Confidence 999999999999999865 4579999999999999999975322 346799999999999999999999995
Q ss_pred ---CcEecccCCCcEEEcC-----------------CCCeEEeccCcceeeccCccccccccccccccccccCCcceecc
Q psy11359 177 ---GQIHRDIKAGNILLGE-----------------DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ 236 (520)
Q Consensus 177 ---giiHrDLKp~NILl~~-----------------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 236 (520)
+||||||||+||||+. .+.+||+|||++..+... ......+||+.|+|||++.+
T Consensus 142 ~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~------s~~~s~vGTp~YmAPEvL~g 215 (1021)
T PTZ00266 142 NGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE------SMAHSCVGTPYYWSPELLLH 215 (1021)
T ss_pred ccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc------ccccccCCCccccCHHHHhc
Confidence 4999999999999954 235899999998765321 12345689999999999864
Q ss_pred c-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCC
Q psy11359 237 D-HGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315 (520)
Q Consensus 237 ~-~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 315 (520)
. ..++.++||||||||||+|+||..||........+...+...+... ...++.++.+||..||+++|.+|
T Consensus 216 e~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp---------i~~~S~eL~dLI~~~L~~dPeeR 286 (1021)
T PTZ00266 216 ETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP---------IKGKSKELNILIKNLLNLSAKER 286 (1021)
T ss_pred cCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC---------cCCCCHHHHHHHHHHhcCChhHC
Confidence 3 3488999999999999999999999987766666555544432211 12357889999999999999999
Q ss_pred CCHHHHhcCccccccc
Q psy11359 316 PTASELLKNPFFKKAK 331 (520)
Q Consensus 316 pta~elL~hp~~~~~~ 331 (520)
||+.|+|.||||+...
T Consensus 287 PSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 287 PSALQCLGYQIIKNVG 302 (1021)
T ss_pred cCHHHHhccHHHhhcC
Confidence 9999999999997543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.61 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=220.9
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||.||++.+..+++.||+|++....... ....+.+.+|++++++++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~h 60 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK--------------------LKQVEHVLNEKRILQSIRH 60 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHHhCCC
Confidence 47999999999999999999999999999999875432110 2234668899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+.+|+||||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++||||+|.||
T Consensus 61 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--------~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~ni 132 (290)
T cd05580 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK--------SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENL 132 (290)
T ss_pred CCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 9999999999999999999999999999999974 46789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.++.+||+|||++...... .....|++.|+|||.+.+.. ++.++||||||+++|+|++|..||.....
T Consensus 133 li~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~ 203 (290)
T cd05580 133 LLDSDGYIKITDFGFAKRVKGR--------TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNP 203 (290)
T ss_pred EECCCCCEEEeeCCCccccCCC--------CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999998765432 23457899999999987654 78999999999999999999999987776
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhhH
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~ 335 (520)
.........+..+ ++ ..++..++++|.+||..+|.+|+ +++|+++||||+...+...
T Consensus 204 ~~~~~~~~~~~~~-~~---------~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 265 (290)
T cd05580 204 IQIYEKILEGKVR-FP---------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265 (290)
T ss_pred HHHHHHHhcCCcc-CC---------ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHH
Confidence 5555554433322 11 23478899999999999999999 9999999999987765443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=343.37 Aligned_cols=266 Identities=33% Similarity=0.575 Sum_probs=216.5
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|.+...||.|++|.||+|.+..+++.+|+|.+......... ........+.+.+|+.++++++||
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~--------------~~~~~~~~~~~~~e~~~l~~l~h~ 66 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASS--------------KDRKRSMLDALAREIALLKELQHE 66 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccch--------------hHHHHHHHHHHHHHHHHHHhcCCC
Confidence 478889999999999999999999999999987543211100 000122346788999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++...+..++||||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++||||+|+||+
T Consensus 67 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil 138 (267)
T cd06628 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN--------YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL 138 (267)
T ss_pred CeeeEEEEEEeCCccEEEEEecCCCCHHHHHHh--------ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEE
Confidence 999999999999999999999999999999973 467889999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccc-cccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDL-SRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++++.++|+|||++..+...... ..........|++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||.....
T Consensus 139 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 217 (267)
T cd06628 139 VDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217 (267)
T ss_pred EcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccH
Confidence 999999999999998766422111 1111223456899999999987654 78999999999999999999999988766
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
............+.++ ..++..+.++|.+||++||.+||++.++++||||
T Consensus 218 ~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 218 LQAIFKIGENASPEIP---------SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHhccCCCcCC---------cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 5555444333222221 3467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=343.74 Aligned_cols=265 Identities=27% Similarity=0.427 Sum_probs=213.9
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||.||+|.++.+|+.||+|.+.... ......+.+.+|+.++++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------------------~~~~~~~~~~~e~~~l~~~~h 59 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE---------------------DDPVIKKIALREIRMLKQLKH 59 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc---------------------cCccccHHHHHHHHHHHhCCC
Confidence 57999999999999999999999999999999764210 001123457889999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++......++||||+++++|..++. ....+++..+..++.||+.||.|||++|++||||||+||
T Consensus 60 ~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~--------~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~ni 131 (286)
T cd07847 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK--------NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENI 131 (286)
T ss_pred CCEeeeeeEEeeCCEEEEEEeccCccHHHHHHh--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhE
Confidence 999999999999999999999999988887765 345689999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++.++.++|+|||++..+..... ......++..|+|||.+.+...++.++||||||+++|+|++|.+||.+...
T Consensus 132 l~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 132 LITKQGQIKLCDFGFARILTGPGD-----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred EEcCCCcEEECccccceecCCCcc-----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999977643221 122456889999999987655588999999999999999999999987776
Q ss_pred HHHHHHHhcCCC---------------------CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQNDP---------------------PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.+.......... +..............++..+.+||.+||+++|++|||+.|++.||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 207 VDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 555443221100 00000011112234568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=351.00 Aligned_cols=264 Identities=30% Similarity=0.543 Sum_probs=212.3
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||.||++.+..++..+|+|.+... .......++.+|++++++++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~----------------------~~~~~~~~~~~E~~~l~~l~h 58 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE----------------------IKPAIRNQIIRELKVLHECNS 58 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc----------------------cCHHHHHHHHHHHHHHHhCCC
Confidence 4799999999999999999999999888888876421 112334568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccCCCc
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGN 187 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLKp~N 187 (520)
|||+++++++..++.+++||||+.|++|.++++. .+.+++..+..++.||+.||.|||+ ++++||||||+|
T Consensus 59 ~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~n 130 (308)
T cd06615 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--------AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSN 130 (308)
T ss_pred CCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHH
Confidence 9999999999999999999999999999999973 4678999999999999999999998 599999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
||++.++.++|+|||++..+.. .......|++.|+|||++.+.. ++.++|+||||+++|+|++|..||....
T Consensus 131 il~~~~~~~~l~dfg~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 131 ILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred EEEecCCcEEEccCCCcccccc-------cccccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999999999998865422 1224568899999999987654 8899999999999999999999997654
Q ss_pred HHHHHHHHhcCCCCCCCCC----------------ch-------------hhhhHHHhcHHHHHHHHhhhccCCCCCCCH
Q psy11359 268 AMKVLMLTLQNDPPTLDTG----------------AA-------------EKDQYKAYGKTFRKMISDCLQKDPTKRPTA 318 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~----------------~~-------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpta 318 (520)
..... ............. .. .......++.++++||.+||..+|++|||+
T Consensus 203 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 281 (308)
T cd06615 203 AKELE-AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL 281 (308)
T ss_pred hhhHH-HhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH
Confidence 33322 2221111111000 00 000001367789999999999999999999
Q ss_pred HHHhcCccccccc
Q psy11359 319 SELLKNPFFKKAK 331 (520)
Q Consensus 319 ~elL~hp~~~~~~ 331 (520)
.++++||||....
T Consensus 282 ~~ll~~~~~~~~~ 294 (308)
T cd06615 282 KELTKHPFIKRAE 294 (308)
T ss_pred HHHhcChhhhhcc
Confidence 9999999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=349.17 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=208.0
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||+|+||.||+|.+..+|+.||+|.++.... .......+.+|+.++++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~---------------------~~~~~~~~~~ei~~l~~l~h~ 59 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---------------------DEGVPSSALREICLLKELKHK 59 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc---------------------cccCccchhHHHHHHHhcCCC
Confidence 59999999999999999999999999999998753211 011223577899999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++.+...+|+|+||+. ++|.+++.. ..+.+++..++.++.||++||.|||++|++||||||+||+
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil 131 (284)
T cd07839 60 NIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDS-------CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLL 131 (284)
T ss_pred CeeeHHHHhccCCceEEEEecCC-CCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence 99999999999999999999996 588888764 3456899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC-CCCcH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY-HKYPA 268 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf-~~~~~ 268 (520)
++.++.++|+|||++..+..... ......+++.|+|||++.+...++.++|||||||++|+|+||..|| .+.+.
T Consensus 132 ~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~ 206 (284)
T cd07839 132 INKNGELKLADFGLARAFGIPVR-----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 206 (284)
T ss_pred EcCCCcEEECccchhhccCCCCC-----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH
Confidence 99999999999999876533211 1223467899999999877665899999999999999999998885 44333
Q ss_pred HHHHHHHhcCC-------------------CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQND-------------------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.+.+..+.... .+..............+++++++||.+||+.||.+|||+.++++||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 207 DDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 33322211100 000000000011223578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=368.24 Aligned_cols=261 Identities=22% Similarity=0.327 Sum_probs=205.2
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
...|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+++|++|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----------------------------~~~~~~E~~iL~~L~ 218 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----------------------------YASSVHEARLLRRLS 218 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----------------------------ccCHHHHHHHHHHCC
Confidence 457999999999999999999999998888888431 112568999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||||++++++...+..++|||++ .++|.+++.. ..+.+++..+..|+.||+.||.|||++||+||||||+|
T Consensus 219 HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~N 290 (461)
T PHA03211 219 HPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGA-------RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTEN 290 (461)
T ss_pred CCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHH
Confidence 999999999999999999999999 4789998864 23578999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
||++.++.+||+|||+++.+.... .........||+.|+|||++.+.. ++.++|||||||+||||++|..|+....
T Consensus 291 ILl~~~~~vkL~DFGla~~~~~~~---~~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~ 366 (461)
T PHA03211 291 VLVNGPEDICLGDFGAACFARGSW---STPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSAS 366 (461)
T ss_pred EEECCCCCEEEcccCCceeccccc---ccccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCC
Confidence 999999999999999997653221 111223467999999999997765 8999999999999999999876542211
Q ss_pred -------HHHHHHHHhcC-C--CCCCCCC----------------------chhhhhHHHhcHHHHHHHHhhhccCCCCC
Q psy11359 268 -------AMKVLMLTLQN-D--PPTLDTG----------------------AAEKDQYKAYGKTFRKMISDCLQKDPTKR 315 (520)
Q Consensus 268 -------~~~~~~~~~~~-~--~~~~~~~----------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R 315 (520)
....+..++.. . ...+... ......+..++..+.+||.+||+.||.+|
T Consensus 367 ~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~R 446 (461)
T PHA03211 367 RGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARR 446 (461)
T ss_pred cccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhC
Confidence 11122222111 0 0000000 00011122456789999999999999999
Q ss_pred CCHHHHhcCccccc
Q psy11359 316 PTASELLKNPFFKK 329 (520)
Q Consensus 316 pta~elL~hp~~~~ 329 (520)
||+.|+|+||||+.
T Consensus 447 Psa~elL~hp~f~~ 460 (461)
T PHA03211 447 PSAAELLRLPLFQS 460 (461)
T ss_pred cCHHHHhhCcccCC
Confidence 99999999999974
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=344.47 Aligned_cols=254 Identities=30% Similarity=0.584 Sum_probs=208.2
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.++||+|+||+||+|.+..++..||+|.+... .......++.+|+.++++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~----------------------~~~~~~~~~~~E~~~l~~l~h 58 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD----------------------ITVELQKQIMSELEILYKCDS 58 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC----------------------CChHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999999999999888888876421 112234568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+..++||||+++++|..+. .+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 59 ~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 126 (279)
T cd06619 59 PYIIGFYGAFFVENRISICTEFMDGGSLDVYR------------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNM 126 (279)
T ss_pred CCeeeEEEEEEECCEEEEEEecCCCCChHHhh------------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHE
Confidence 99999999999999999999999999996542 367889999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.++.++|+|||++..+... ......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.....
T Consensus 127 ll~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~ 198 (279)
T cd06619 127 LVNTRGQVKLCDFGVSTQLVNS-------IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQK 198 (279)
T ss_pred EECCCCCEEEeeCCcceecccc-------cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcc
Confidence 9999999999999998765321 223467999999999997655 89999999999999999999999965321
Q ss_pred H-------HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 269 M-------KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 269 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
. ..........++... ...+++++++||.+||+.+|.+||++.++++||||+..+.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 199 NQGSLMPLQLLQCIVDEDPPVLP--------VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred cccccchHHHHHHHhccCCCCCC--------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 1 111111112222111 1235778999999999999999999999999999987644
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=350.14 Aligned_cols=270 Identities=27% Similarity=0.388 Sum_probs=222.1
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|++|+||+|.+..+++.+|+|.+....... ......+.+|+++++.++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~~ 60 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK--------------------RNKVKRVLTEQEILATLDH 60 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch--------------------HHHHHHHHHHHHHHHhCCC
Confidence 47999999999999999999999999999999875321110 1245668899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++.+...+..|+||||+.|++|.+++... ....+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 134 (316)
T cd05574 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQ------PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENI 134 (316)
T ss_pred CCchhheeeeecCCEEEEEEEecCCCCHHHHHHhC------CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHe
Confidence 99999999999999999999999999999998743 346789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCcccc------------------------ccccccccccccccCCcceecccCCCCcch
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLS------------------------RQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~ 244 (520)
+++.++.++|+|||++.......... .......+.||..|+|||++.+.. ++.++
T Consensus 135 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~ 213 (316)
T cd05574 135 LLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAV 213 (316)
T ss_pred EEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchH
Confidence 99999999999999987553221110 001122457899999999987654 89999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC----HHH
Q psy11359 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT----ASE 320 (520)
Q Consensus 245 DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----a~e 320 (520)
||||||+++|+|++|..||........+............ ...++..++++|.+||+.+|.+||| +.+
T Consensus 214 Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ 285 (316)
T cd05574 214 DWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPG--------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE 285 (316)
T ss_pred HHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCC--------ccccCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence 9999999999999999999887776666555443322111 1226789999999999999999999 999
Q ss_pred HhcCccccccchh
Q psy11359 321 LLKNPFFKKAKDK 333 (520)
Q Consensus 321 lL~hp~~~~~~~~ 333 (520)
+|.||||+...+.
T Consensus 286 ll~~~~~~~~~~~ 298 (316)
T cd05574 286 IKQHPFFRGVNWA 298 (316)
T ss_pred HHcCchhhcCChh
Confidence 9999999876543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.18 Aligned_cols=265 Identities=23% Similarity=0.339 Sum_probs=206.1
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcC--CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKA--RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
...+|++++.||.|+||.||+|.... ++..||+|.+. .. ....+|+.+|+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~----------------------~~------~~~~~E~~il~ 141 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT----------------------GG------KTPGREIDILK 141 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecc----------------------cc------ccHHHHHHHHH
Confidence 45679999999999999999997543 45566666542 11 12467999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++.....+|+|||++. ++|.+++. ..+.+++..+..++.||+.||.|||++||+|||||
T Consensus 142 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~--------~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlk 212 (392)
T PHA03207 142 TISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVD--------RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVK 212 (392)
T ss_pred hcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 9999999999999999999999999994 78999885 45678999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.++.++|+|||++..+..... ........||+.|+|||++.+.. |+.++|||||||++|+|++|..||.
T Consensus 213 p~Nill~~~~~~~l~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~ 288 (392)
T PHA03207 213 TENIFLDEPENAVLGDFGAACKLDAHPD---TPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLF 288 (392)
T ss_pred HHHEEEcCCCCEEEccCccccccCcccc---cccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999999876543221 11223568999999999997655 8999999999999999999999997
Q ss_pred CCcH---HHHHH---HHhcCCCCCCCCCch---------------------hhhhHHHhcHHHHHHHHhhhccCCCCCCC
Q psy11359 265 KYPA---MKVLM---LTLQNDPPTLDTGAA---------------------EKDQYKAYGKTFRKMISDCLQKDPTKRPT 317 (520)
Q Consensus 265 ~~~~---~~~~~---~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 317 (520)
+... ...+. ..++..+...+.... .......++.++.+||.+||..||.+|||
T Consensus 289 ~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps 368 (392)
T PHA03207 289 GKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS 368 (392)
T ss_pred CCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC
Confidence 6432 11111 111111111111000 00001234678899999999999999999
Q ss_pred HHHHhcCccccccch
Q psy11359 318 ASELLKNPFFKKAKD 332 (520)
Q Consensus 318 a~elL~hp~~~~~~~ 332 (520)
+.|+|.||||.+...
T Consensus 369 a~e~l~~p~f~~~~~ 383 (392)
T PHA03207 369 AQDILSLPLFTKEPI 383 (392)
T ss_pred HHHHhhCchhhccch
Confidence 999999999986543
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.19 Aligned_cols=258 Identities=41% Similarity=0.716 Sum_probs=211.4
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..+.|++.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.+++++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~------------------------~~~~~~~~~e~~~l~~~ 59 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------------------GDEEEEIKQEINMLKKY 59 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC------------------------CccHHHHHHHHHHHHHh
Confidence 356799999999999999999999999888898876421 12235688899999998
Q ss_pred -CCCCceEEEEEEEEC------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 107 -HHENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 107 -~HpnIv~~~~~~~~~------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+||||+++++++... ..+|+||||+.+++|.+++... ....+++..+..++.||+.||.|||+++++
T Consensus 60 ~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~------~~~~l~~~~~~~~~~qi~~~l~~LH~~~iv 133 (272)
T cd06637 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT------KGNTLKEEWIAYICREILRGLSHLHQHKVI 133 (272)
T ss_pred cCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 799999999998753 4689999999999999999753 345789999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc----cCCCCcchhHHHHHHHHHH
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----DHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~~~~DIwSlG~il~e 255 (520)
||||||+||++++++.++|+|||++..+.... .......|++.|+|||++.+ ...++.++|||||||++|+
T Consensus 134 h~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~e 208 (272)
T cd06637 134 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208 (272)
T ss_pred cCCCCHHHEEECCCCCEEEccCCCceeccccc-----ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHH
Confidence 99999999999999999999999987653211 12335679999999999853 2348889999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 256 MATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 256 lltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
|++|..||..................... ...++..+.+||.+||..+|.+|||+.++++||||
T Consensus 209 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 209 MAEGAPPLCDMHPMRALFLIPRNPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHhCCCCccccCHHHHHHHHhcCCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 99999999776655544433332211111 12457789999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=343.69 Aligned_cols=266 Identities=26% Similarity=0.477 Sum_probs=215.8
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||.|+||.||+|.+..+|..||+|++...... ....+.+.+|+.++++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---------------------~~~~~~~~~e~~~l~~~~~~ 59 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---------------------GGIPNQALREIKALQACQHP 59 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---------------------chhhHHHHHHHHHHHhCCCC
Confidence 599999999999999999999999999999977532110 12345688999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++.....+|+||||+ +++|.+++.. ....+++..++.++.||+.||.|||++|++|+||||+||+
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~ 131 (286)
T cd07832 60 YVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD-------EERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLL 131 (286)
T ss_pred CCcceeeEEecCCeeEEEeccc-CCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEE
Confidence 9999999999999999999999 9999999875 3467899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.++.++|+|||++..+..... .......|++.|+|||.+.+...++.++||||+||++|+|+||.+||......
T Consensus 132 ~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~ 207 (286)
T cd07832 132 ISADGVLKIADFGLARLFSEEEP----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI 207 (286)
T ss_pred EcCCCcEEEeeeeecccccCCCC----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH
Confidence 99999999999999876643221 11234578999999999876665799999999999999999999999877665
Q ss_pred HHHHHHhcCCCCCCC--------------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 270 KVLMLTLQNDPPTLD--------------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
..+...+........ ............+..+.+||.+||.++|.+|||++++|+||||.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 208 EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 554433321100000 00001112234578899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=346.34 Aligned_cols=265 Identities=42% Similarity=0.690 Sum_probs=219.1
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.......+|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-----------------------~~~~~~~~~e~~~ 70 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----------------------QPKKELIINEILV 70 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-----------------------cchHHHHHHHHHH
Confidence 44566789999999999999999999999998888888764211 1224568899999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
++.++||||+++++.+......|+||||+.|++|.+++.. ..+++.++..++.||+.||.|||++|++|||
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~d 141 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 9999999999999999999999999999999999999853 3578999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|||+||+++.++.++|+|||++....... .......|++.|+|||.+.+.. ++.++|||||||++|+|++|..|
T Consensus 142 Lkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~p 215 (296)
T cd06654 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQ-----SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPP 215 (296)
T ss_pred CCHHHEEEcCCCCEEECccccchhccccc-----cccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999886543221 1123457899999999987654 78999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
|........+........+.+. ....++..+.++|.+||.++|.+|||+.++++||||.....
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 216 YLNENPLRALYLIATNGTPELQ-------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred CCCCCHHHhHHHHhcCCCCCCC-------CccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 9876665444333322211111 12356788999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=340.84 Aligned_cols=263 Identities=42% Similarity=0.706 Sum_probs=216.8
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
+...++|++.+.||.|++|+||+|.++.+++.+++|++... ....+.+.+|+.+++
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~------------------------~~~~~~~~~e~~~l~ 57 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------------------------EDEEEEIKEEYNILR 57 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC------------------------chhHHHHHHHHHHHH
Confidence 45678999999999999999999999999888888876422 113456889999999
Q ss_pred cC-CCCCceEEEEEEEECC------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy11359 105 SC-HHENVVTYHTSFVVKD------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG 177 (520)
Q Consensus 105 ~l-~HpnIv~~~~~~~~~~------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g 177 (520)
++ .||||+++++++.... .+|+||||+.+++|.+++..... ....+++..++.++.||+.||.|||++|
T Consensus 58 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lH~~~ 133 (275)
T cd06608 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK----KGKRLKEEWIAYILRETLRGLAYLHENK 133 (275)
T ss_pred HhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 99 7999999999997644 48999999999999999875421 2467899999999999999999999999
Q ss_pred cEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc----CCCCcchhHHHHHHHH
Q psy11359 178 QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD----HGYDFKADIWSLGITA 253 (520)
Q Consensus 178 iiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~~~~DIwSlG~il 253 (520)
++|+||+|+||+++.++.++|+|||++....... .......|++.|+|||++... ..++.++|||||||++
T Consensus 134 i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il 208 (275)
T cd06608 134 VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL-----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITA 208 (275)
T ss_pred cccCCCCHHHEEEccCCeEEECCCccceecccch-----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHH
Confidence 9999999999999999999999999987653321 122345789999999987532 3377899999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 254 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
|+|++|..||................++.+.. ...++..+++||.+||..||++|||+.++++|||+
T Consensus 209 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 209 IELADGKPPLCDMHPMRALFKIPRNPPPTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHHHhCCCCccccchHHHHHHhhccCCCCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 99999999998766655555544443332211 12467889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=342.69 Aligned_cols=262 Identities=48% Similarity=0.805 Sum_probs=222.7
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||.|++|.||+|.+..+++.||+|.+... ........+.+|+.+++.++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~----------------------~~~~~~~~~~~e~~~l~~l~h 58 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE----------------------EAEDEIEDIQQEIQFLSQCRS 58 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecc----------------------ccchHHHHHHHHHHHHHHcCC
Confidence 4799999999999999999999999888888876422 112234568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++.....+|+|+||+.+++|.+++.. ..+++..+..++.||+.||.|||+++++||||+|+||
T Consensus 59 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni 129 (274)
T cd06609 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP---------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANI 129 (274)
T ss_pred CCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 9999999999999999999999999999999863 3789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
++++++.++|+|||++..+.... .......|++.|+|||.+.+.. ++.++||||||+++|+|+||..||.....
T Consensus 130 ~i~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~ 203 (274)
T cd06609 130 LLSEEGDVKLADFGVSGQLTSTM-----SKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHP 203 (274)
T ss_pred EECCCCCEEEcccccceeecccc-----cccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCch
Confidence 99999999999999998775332 1223457899999999997766 89999999999999999999999987776
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhhH
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~ 335 (520)
...........++.+.. ..++..+.+++.+||..+|++|||+.++++||||+......+
T Consensus 204 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 262 (274)
T cd06609 204 MRVLFLIPKNNPPSLEG--------NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSY 262 (274)
T ss_pred HHHHHHhhhcCCCCCcc--------cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcccH
Confidence 66655555544443321 126788999999999999999999999999999998776543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=358.49 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=201.2
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
...|++.+.||+|+||.||+|.+..++..||+|+... .....|+.++++++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------------------------~~~~~E~~~l~~l~ 115 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------------------------GTTLIEAMLLQNVN 115 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------------------------cccHHHHHHHHhCC
Confidence 3469999999999999999999999988888886321 11346899999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++......++||||+ .++|.+++.. ....+++..+..|+.||+.||.|||++||+||||||+|
T Consensus 116 h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 187 (357)
T PHA03209 116 HPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTK-------RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTEN 187 (357)
T ss_pred CCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 999999999999999999999999 4689998865 35678999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC-CCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY-HKY 266 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf-~~~ 266 (520)
||++.++.+||+|||++..... ........||+.|+|||++.+.. ++.++|||||||++|+|+++..|+ ...
T Consensus 188 ill~~~~~~kl~DfG~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~ 260 (357)
T PHA03209 188 IFINDVDQVCIGDLGAAQFPVV------APAFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDP 260 (357)
T ss_pred EEECCCCCEEEecCcccccccc------CcccccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCC
Confidence 9999999999999999864321 11223467999999999997765 899999999999999999855444 322
Q ss_pred cHH---------HHHH---HHhcCCCCCCCCCch---------------------hhhhHHHhcHHHHHHHHhhhccCCC
Q psy11359 267 PAM---------KVLM---LTLQNDPPTLDTGAA---------------------EKDQYKAYGKTFRKMISDCLQKDPT 313 (520)
Q Consensus 267 ~~~---------~~~~---~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~li~~~L~~dP~ 313 (520)
+.. ..+. ..+...+..+..... .......++..+.+||.+||+.||.
T Consensus 261 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 340 (357)
T PHA03209 261 PSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAA 340 (357)
T ss_pred CCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcc
Confidence 110 0111 111111111110000 0001123566788899999999999
Q ss_pred CCCCHHHHhcCccccc
Q psy11359 314 KRPTASELLKNPFFKK 329 (520)
Q Consensus 314 ~Rpta~elL~hp~~~~ 329 (520)
+|||+.|+|+||||++
T Consensus 341 ~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 341 MRPSAEEILNYPMFAQ 356 (357)
T ss_pred cCcCHHHHhcCchhcc
Confidence 9999999999999975
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=343.27 Aligned_cols=263 Identities=37% Similarity=0.656 Sum_probs=218.3
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.+.|++.+.||.|+||.||+|.+..++..+++|.+... .....+.+.+|+++++.++
T Consensus 4 ~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-----------------------~~~~~~~~~~e~~~l~~l~ 60 (282)
T cd06643 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----------------------SEEELEDYMVEIDILASCD 60 (282)
T ss_pred HHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-----------------------CHHHHHHHHHHHHHHHHCC
Confidence 34588999999999999999999999888888876321 1234566889999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++...+..|+||||+.+++|..++.. ..+.+++..+..++.||+.||.|||++|++||||||+|
T Consensus 61 h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-------~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~n 133 (282)
T cd06643 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-------LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGN 133 (282)
T ss_pred CCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCccc
Confidence 99999999999999999999999999999998764 34578999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceec----ccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME----QDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~----~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
|+++.++.++|+|||++....... .......||+.|+|||++. ....++.++|||||||++|+|++|.+||
T Consensus 134 ili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~ 208 (282)
T cd06643 134 ILFTLDGDIKLADFGVSAKNTRTI-----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH 208 (282)
T ss_pred EEEccCCCEEEccccccccccccc-----cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCc
Confidence 999999999999999986543211 1223457899999999974 2233788999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
................++.... ...++.++++||.+||+++|.+|||+.++++||||.....
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 209 HELNPMRVLLKIAKSEPPTLAQ-------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred cccCHHHHHHHHhhcCCCCCCC-------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 8877666665555443332211 1346788999999999999999999999999999987544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=341.23 Aligned_cols=260 Identities=38% Similarity=0.647 Sum_probs=210.6
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----------------------~~~~~~~~~e~~~l~~ 62 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-----------------------GDDFSLIQQEIFMVKE 62 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-----------------------cchHHHHHHHHHHHHh
Confidence 34568999999999999999999999999999999774210 1223457889999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++..++.+|+||||+.+++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||
T Consensus 63 ~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 134 (267)
T cd06646 63 CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV--------TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKG 134 (267)
T ss_pred cCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH
Confidence 9999999999999999999999999999999999863 45689999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc--cCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ--DHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
+||+++.++.++|+|||++..+.... .......|++.|+|||.+.. ...++.++|+|||||++|+|++|..||
T Consensus 135 ~nill~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~ 209 (267)
T cd06646 135 ANILLTDNGDVKLADFGVAAKITATI-----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209 (267)
T ss_pred HHEEECCCCCEEECcCccceeecccc-----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCc
Confidence 99999999999999999987663221 11234578999999998742 333788999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcc
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~ 326 (520)
....+.............. .. ......++..+.+||.+||+.+|++|||++++++|+|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 210 FDLHPMRALFLMSKSNFQP-PK----LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cccchhhhheeeecCCCCC-CC----CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 7655443322211111110 00 0011246789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=344.02 Aligned_cols=263 Identities=42% Similarity=0.703 Sum_probs=219.1
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
.....+|++.+.||.|++|+||+|.+..+|+.||+|.+.... ....+.+.+|+.+++
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-----------------------~~~~~~~~~e~~~l~ 71 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-----------------------QPKKELIINEILVMK 71 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-----------------------CchHHHHHHHHHHHH
Confidence 345577999999999999999999999999999998764210 123456889999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
.++||||+++++++...+.+|+|+||+.+++|..++.. ..+++.++..++.|++.||.|||++|++|||||
T Consensus 72 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~ 142 (296)
T cd06655 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE---------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142 (296)
T ss_pred hcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 99999999999999999999999999999999999863 358899999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+||+++.++.++|+|||++..+..... ......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.
T Consensus 143 p~Nili~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~ 216 (296)
T cd06655 143 SDNVLLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYL 216 (296)
T ss_pred HHHEEECCCCCEEEccCccchhcccccc-----cCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999998876533211 122356899999999987654 8899999999999999999999998
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
................+.+. ....+++.+.+||.+||..||.+|||+.++++||||+....
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 217 NENPLRALYLIATNGTPELQ-------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred CCCHHHHHHHHHhcCCcccC-------CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 87665554443332222211 12356788999999999999999999999999999986653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=346.39 Aligned_cols=266 Identities=42% Similarity=0.695 Sum_probs=218.7
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.......+|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~~e~~~ 69 (297)
T cd06656 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-----------------------QPKKELIINEILV 69 (297)
T ss_pred ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-----------------------cchHHHHHHHHHH
Confidence 34566789999999999999999999999999999988764211 1123567899999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
++.++||||+++++++...+..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|||
T Consensus 70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~d 140 (297)
T cd06656 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALDFLHSNQVIHRD 140 (297)
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 9999999999999999999999999999999999999863 3578899999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|||+|||++.++.++|+|||++....... .......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..|
T Consensus 141 L~p~Nili~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~p 214 (297)
T cd06656 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQ-----SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPP 214 (297)
T ss_pred CCHHHEEECCCCCEEECcCccceEccCCc-----cCcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999987653221 1123457899999999987654 88999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
|.................+... ....++..+++||.+||..+|.+|||+.++++||||+.....
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 215 YLNENPLRALYLIATNGTPELQ-------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred CCCCCcchheeeeccCCCCCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 9775544333222211111111 123467889999999999999999999999999999977654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.17 Aligned_cols=259 Identities=44% Similarity=0.739 Sum_probs=215.1
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... ....+.+.+|+.++++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----------------------~~~~~~~~~e~~~l~~~~ 58 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-----------------------GDDFEIIQQEISMLKECR 58 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-----------------------hhhHHHHHHHHHHHHhCC
Confidence 478999999999999999999999998888888774221 123567899999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++...+.+|++|||+.+++|.+++.. ....+++..+..++.|++.||.|||++|++|+||+|+|
T Consensus 59 h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~-------~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~n 131 (262)
T cd06613 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV-------TRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGAN 131 (262)
T ss_pred CCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHh-------hccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhh
Confidence 99999999999999999999999999999999874 23578999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD--HGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
|+++.++.++|+|||++..+.... .......++..|+|||.+.+. ..++.++|+|||||++|+|+||.+||..
T Consensus 132 i~i~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~ 206 (262)
T cd06613 132 ILLTEDGDVKLADFGVSAQLTATI-----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206 (262)
T ss_pred EEECCCCCEEECccccchhhhhhh-----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999987653221 122345789999999998654 2378999999999999999999999988
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~ 326 (520)
.................... .....++.++.+||.+||..+|..|||+.+++.|+|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 207 LHPMRALFLISKSNFPPPKL-----KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred CCHHHHHHHHHhccCCCccc-----cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 77665554433331111100 112346778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=341.42 Aligned_cols=259 Identities=39% Similarity=0.677 Sum_probs=211.3
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----------------------~~~~~~~~~e~~~~~~l 63 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----------------------GEDFAVVQQEIIMMKDC 63 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----------------------hhHHHHHHHHHHHHHhC
Confidence 4568999999999999999999999999999998764321 11234578899999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+.+|+||||+++++|.+++.. .+.+++.++..++.||+.||.|||++|++|+||||+
T Consensus 64 ~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ 135 (267)
T cd06645 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV--------TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGA 135 (267)
T ss_pred CCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 999999999999999999999999999999999873 467899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceec--ccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME--QDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
||+++.++.++|+|||++..+.... .......|++.|+|||++. ....++.++|+|||||++|+|++|..||.
T Consensus 136 nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 136 NILLTDNGHVKLADFGVSAQITATI-----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred HEEECCCCCEEECcceeeeEccCcc-----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 9999999999999999987653211 1123457899999999874 23347899999999999999999999997
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~ 326 (520)
................... . . .....++..+.++|.+||+.+|++|||+.+++.|||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~-~-~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 211 DLHPMRALFLMTKSNFQPP-K-L---KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred cccchhhHHhhhccCCCCC-c-c---cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 6555444333222211110 0 0 001235778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=334.57 Aligned_cols=256 Identities=28% Similarity=0.515 Sum_probs=216.6
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||+|+||.||++.+..+|+.||+|.+...... .....++.+|+.++++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~~~ 59 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS---------------------PKEREESRKEVAVLSNMKHP 59 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC---------------------hHHHHHHHHHHHHHHhCCCC
Confidence 699999999999999999999999888898877532110 12345688999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++...+..|+||||+.+++|.+++... ....+++..+..|+.||+.||.|||++|++|+||+|+||+
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil 133 (256)
T cd08218 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ------RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 133 (256)
T ss_pred CeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 9999999999999999999999999999999742 2346789999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.++.++|+|||++..+..... ......|++.|+|||++.+.. ++.++|+|||||++++|++|..||......
T Consensus 134 ~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~ 207 (256)
T cd08218 134 LTKDGTIKLGDFGIARVLNSTVE-----LARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMK 207 (256)
T ss_pred EcCCCCEEEeeccceeecCcchh-----hhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHH
Confidence 99999999999999876533211 123456899999999987655 889999999999999999999999877766
Q ss_pred HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
........+..+... ..++.++.++|.+||+.+|.+||++.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 208 NLVLKIIRGSYPPVS---------SHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHhcCCCCCCc---------ccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 666555555433321 3467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=342.31 Aligned_cols=258 Identities=41% Similarity=0.706 Sum_probs=211.4
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..+.|++.+.||.|+||.||+|.+..+++.+|+|++... .....++..|+.+++++
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------------------------~~~~~~~~~e~~~l~~~ 69 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------------------EDEEEEIKLEINMLKKY 69 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------------------------hHHHHHHHHHHHHHHHh
Confidence 457899999999999999999999999888888876421 12345678899999988
Q ss_pred -CCCCceEEEEEEEE------CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 107 -HHENVVTYHTSFVV------KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 107 -~HpnIv~~~~~~~~------~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+||||+++++++.. ...+|++|||+.+|+|.+++... ....+++..+..++.||+.||.|||++|++
T Consensus 70 ~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~LH~~~iv 143 (282)
T cd06636 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT------KGNALKEDWIAYICREILRGLAHLHAHKVI 143 (282)
T ss_pred cCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 79999999999863 46789999999999999999753 345688999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc----cCCCCcchhHHHHHHHHHH
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----DHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~~~~DIwSlG~il~e 255 (520)
||||||+||+++.++.++|+|||++....... .......|++.|+|||++.. ...++.++|+|||||++|+
T Consensus 144 H~dl~~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~e 218 (282)
T cd06636 144 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218 (282)
T ss_pred cCCCCHHHEEECCCCCEEEeeCcchhhhhccc-----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHH
Confidence 99999999999999999999999886543211 11234678999999999853 2347889999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 256 MATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 256 lltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
|++|..||................++... ...++..+.+||.+||+.||.+|||+.|+++||||
T Consensus 219 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 219 MAEGAPPLCDMHPMRALFLIPRNPPPKLK--------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHhCCCCccccCHHhhhhhHhhCCCCCCc--------ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 99999999776655544433332222211 13567899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=348.03 Aligned_cols=266 Identities=26% Similarity=0.368 Sum_probs=194.8
Q ss_pred EeeeeecCceEEEEEEEcC--CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCc
Q psy11359 34 REVIGFGATAVVHSAYCKA--RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENV 111 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnI 111 (520)
..+||+|+||+||+|.++. ++..||+|.+.. . .....+.+|+.+++.++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~----------------------~---~~~~~~~~E~~~l~~l~h~ni 60 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEG----------------------T---GISMSACREIALLRELKHPNV 60 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecC----------------------C---CCcHHHHHHHHHHHhCCCCCe
Confidence 3589999999999998764 456677775531 1 112347789999999999999
Q ss_pred eEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhcc-ccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 112 VTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKI-SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 112 v~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~-~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
+++++++.. +..+|+||||+. ++|.+++...... .......+++..++.++.||+.||.|||++|++||||||+||
T Consensus 61 v~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Ni 139 (317)
T cd07867 61 IALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANI 139 (317)
T ss_pred eeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHE
Confidence 999999864 567899999995 6898888643211 111234689999999999999999999999999999999999
Q ss_pred EE----cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 189 LL----GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 189 Ll----~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+ +.++.+||+|||++..+..... .........||+.|+|||++.+...++.++|||||||++|+|+||.+||.
T Consensus 140 l~~~~~~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 140 LVMGEGPERGRVKIADMGFARLFNSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred EEccCCCCCCcEEEeeccceeccCCCcc--cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 99 4567999999999987643321 11223356789999999998776568999999999999999999999996
Q ss_pred CCcHH---------HHHHHHhc--CCCCC-----------CCC------------Cch---hhhhHHHhcHHHHHHHHhh
Q psy11359 265 KYPAM---------KVLMLTLQ--NDPPT-----------LDT------------GAA---EKDQYKAYGKTFRKMISDC 307 (520)
Q Consensus 265 ~~~~~---------~~~~~~~~--~~~~~-----------~~~------------~~~---~~~~~~~~~~~~~~li~~~ 307 (520)
..... ..+..... +.+.. ... ... ........+..+.+||.+|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 297 (317)
T cd07867 218 CRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKL 297 (317)
T ss_pred cccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHH
Confidence 43321 11111000 00000 000 000 0000012346688999999
Q ss_pred hccCCCCCCCHHHHhcCccc
Q psy11359 308 LQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 308 L~~dP~~Rpta~elL~hp~~ 327 (520)
|+.||.+|||+.|+|+||||
T Consensus 298 l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 298 LTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hccCcccccCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.24 Aligned_cols=270 Identities=25% Similarity=0.397 Sum_probs=219.2
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||.||++.+..+++.||+|.+...... .....+.+.+|+.+++.++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--------------------~~~~~~~~~~e~~~l~~~~~ 60 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI--------------------LRNQIQQVFVERDILTFAEN 60 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh--------------------hHHHHHHHHHHHHHHHhCCC
Confidence 4799999999999999999999999999999987543210 01234568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++..++.+++||||+.|++|.++++. .+.+++..+..++.|++.||.|||++|++||||||+||
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NI 132 (305)
T cd05609 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN--------IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNL 132 (305)
T ss_pred CCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHE
Confidence 9999999999999999999999999999999973 45689999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCcc----------ccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRD----------LSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~----------~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
+++.+|.++|+|||++........ ...........|++.|+|||.+.+.. ++.++|+|||||++|+|++
T Consensus 133 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~ 211 (305)
T cd05609 133 LITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLV 211 (305)
T ss_pred EECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHh
Confidence 999999999999998763211000 00011112346788999999987654 8999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC---HHHHhcCccccccchhh
Q psy11359 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT---ASELLKNPFFKKAKDKK 334 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~elL~hp~~~~~~~~~ 334 (520)
|..||.+....+............... ...++..+.++|.+||+++|.+||+ +.++|+||||.......
T Consensus 212 g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 212 GCVPFFGDTPEELFGQVISDDIEWPEG-------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCc-------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 999998877666555544433221111 1246788999999999999999998 79999999998766554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=345.30 Aligned_cols=271 Identities=25% Similarity=0.365 Sum_probs=215.4
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||.|+||.||+|.+..+|+.||+|.++..... ......+.+|+.++++
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---------------------~~~~~~~~~E~~~l~~ 62 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER---------------------DGIPISSLREITLLLN 62 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC---------------------CCCcchhhHHHHHHHh
Confidence 3567899999999999999999999999999999977532100 1112235679999999
Q ss_pred CCCCCceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 106 CHHENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++|+||+++++++... +.+++||||+. ++|.+++.. ....+++..+..++.||+.||.|||++|++||||
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 134 (309)
T cd07845 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDN-------MPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDL 134 (309)
T ss_pred CCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHh-------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 9999999999998755 57899999996 589988874 2367899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
||+||+++.++.+||+|||++..+..... ......+++.|+|||.+.+...++.++|||||||++|+|++|.+||
T Consensus 135 ~p~nil~~~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f 209 (309)
T cd07845 135 KVSNLLLTDKGCLKIADFGLARTYGLPAK-----PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL 209 (309)
T ss_pred CHHHEEECCCCCEEECccceeeecCCccC-----CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999887643221 1122346888999999876666899999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCC------------------C--chhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDT------------------G--AAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~------------------~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
........+..+.......... . .........+++.+.+||.+||++||++|||+.+++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 210 PGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 8887776665444321110000 0 0001112235788999999999999999999999999
Q ss_pred Ccccccc
Q psy11359 324 NPFFKKA 330 (520)
Q Consensus 324 hp~~~~~ 330 (520)
||||+..
T Consensus 290 h~~f~~~ 296 (309)
T cd07845 290 SSYFKEK 296 (309)
T ss_pred ChhhccC
Confidence 9999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=359.21 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=227.2
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
.+.....|.+.+.||+|.|++|.+|++..+|..||||++.+.... ......+.+|+++|
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln---------------------~~~~~k~~rev~im 109 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN---------------------PSKRQKLGREVDIM 109 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC---------------------hHHHHHHHHHHHHH
Confidence 456678899999999999999999999999999999988654321 23455689999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+.|+|||||+++.+.+.+..+|+||||+.+|.+++|+. +++...+..++.++.|+.++++|||+++|+||||
T Consensus 110 k~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~--------~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdL 181 (596)
T KOG0586|consen 110 KSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLV--------KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDL 181 (596)
T ss_pred HhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHH--------hcccchhhhhhhhhHHHHHHHHHHhhcceecccc
Confidence 99999999999999999999999999999999999998 6788888999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
|++|||++.+.++||+|||++..+.. .....+++|+|.|.|||++.+..+.++.+|+||+|+++|.|+.|.+||
T Consensus 182 k~eNilL~~~mnikIaDfgfS~~~~~------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPF 255 (596)
T KOG0586|consen 182 KAENILLDENMNIKIADFGFSTFFDY------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPF 255 (596)
T ss_pred chhhcccccccceeeeccccceeecc------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccccc
Confidence 99999999999999999999998863 334568899999999999999887889999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
.+..-.......+.+.. ..+.-++.++.++|+++|.++|.+|++.+++.+|.|......
T Consensus 256 DG~~lk~Lr~rvl~gk~----------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 256 DGQNLKELRPRVLRGKY----------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred CCcccccccchheeeee----------cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 87443322222222211 112346778999999999999999999999999999875443
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=340.49 Aligned_cols=265 Identities=42% Similarity=0.691 Sum_probs=213.5
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.++...++|++.+.||+|+||.||+|.+..+++.+|+|++... ......+..|+.+
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~------------------------~~~~~~~~~e~~~ 67 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI------------------------HDIDEEIEAEYNI 67 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc------------------------cchHHHHHHHHHH
Confidence 3556788999999999999999999999999999999875321 1123457789999
Q ss_pred HhcC-CCCCceEEEEEEE-----ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 103 MSSC-HHENVVTYHTSFV-----VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 103 l~~l-~HpnIv~~~~~~~-----~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
++.+ +||||+++++++. ..+.+++||||++|++|.+++..... ....+++..+..++.|++.||.|||++
T Consensus 68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~ 143 (286)
T cd06638 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK----RGERMEEPIIAYILHEALMGLQHLHVN 143 (286)
T ss_pred HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhc----cCccccHHHHHHHHHHHHHHHHHHHhC
Confidence 9999 7999999999874 34579999999999999999864322 345789999999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc----CCCCcchhHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD----HGYDFKADIWSLGIT 252 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~~~~DIwSlG~i 252 (520)
+++||||||+||+++.++.++|+|||++..+.... .......|++.|+|||++... ..++.++|||||||+
T Consensus 144 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi 218 (286)
T cd06638 144 KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-----LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT 218 (286)
T ss_pred CccccCCCHHhEEECCCCCEEEccCCceeecccCC-----CccccccCCCcccChhhhchhhhccccccchhhhhhHHHH
Confidence 99999999999999999999999999987653221 112345689999999987532 337889999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 253 AIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 253 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
+|+|++|..||........+.......++... ....++..+.++|.+||+.+|.+|||+.|+++|+||
T Consensus 219 ~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 219 AIELGDGDPPLADLHPMRALFKIPRNPPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHhcCCCCCCCCchhHHHhhccccCCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 99999999999877665544433322222111 112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=357.62 Aligned_cols=270 Identities=21% Similarity=0.345 Sum_probs=210.2
Q ss_pred CCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCC-----ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHH
Q psy11359 20 VSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARA-----EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMD 94 (520)
Q Consensus 20 ~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~ 94 (520)
....|....++|++.+.||+|+||.||+|.+...| ..||+|++ .........+
T Consensus 29 ~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~----------------------~~~~~~~~~~ 86 (374)
T cd05106 29 YNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML----------------------KASAHTDERE 86 (374)
T ss_pred ccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEec----------------------cCCCCHHHHH
Confidence 34457778889999999999999999999876554 24555544 3333334456
Q ss_pred HHHHHHHHHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc---------------------------
Q psy11359 95 ELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI--------------------------- 146 (520)
Q Consensus 95 ~l~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~--------------------------- 146 (520)
.+.+|+.+++.+ +||||+++++++.....+++||||+.+|+|.+++......
T Consensus 87 ~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (374)
T cd05106 87 ALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKY 166 (374)
T ss_pred HHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccc
Confidence 788999999999 8999999999999999999999999999999999653210
Q ss_pred -----------------------------------ccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEc
Q psy11359 147 -----------------------------------SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191 (520)
Q Consensus 147 -----------------------------------~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~ 191 (520)
.......+++..+..++.||+.||.|||++|++||||||+|||++
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~ 246 (374)
T cd05106 167 IRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT 246 (374)
T ss_pred ccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe
Confidence 000123578899999999999999999999999999999999999
Q ss_pred CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHH
Q psy11359 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMK 270 (520)
Q Consensus 192 ~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~ 270 (520)
+++.+||+|||++..+...... .......+++.|||||++.+.. ++.++|||||||++|+|++ |..||.......
T Consensus 247 ~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~ 322 (374)
T cd05106 247 DGRVAKICDFGLARDIMNDSNY---VVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322 (374)
T ss_pred CCCeEEEeeceeeeeccCCcce---eeccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccH
Confidence 9999999999998765432211 1122334567899999987655 8999999999999999997 999998765544
Q ss_pred HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.+............ ...+++++.++|.+||+.||.+|||+.++++
T Consensus 323 ~~~~~~~~~~~~~~--------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 323 KFYKMVKRGYQMSR--------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHcccCccC--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 33333322111100 1235788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=339.13 Aligned_cols=263 Identities=40% Similarity=0.635 Sum_probs=214.6
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||.||+|.+..+++.+|+|++... ....+.+.+|+.++++
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~------------------------~~~~~~~~~e~~~l~~ 74 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI------------------------SDVDEEIEAEYNILQS 74 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc------------------------ccHHHHHHHHHHHHHH
Confidence 3568899999999999999999999999999999976421 1123457789999999
Q ss_pred C-CCCCceEEEEEEEEC-----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 106 C-HHENVVTYHTSFVVK-----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 106 l-~HpnIv~~~~~~~~~-----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+ +||||+++++++... ...|+||||+.|++|.++++.... ....+++..++.++.|++.||.|||++|++
T Consensus 75 l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 150 (291)
T cd06639 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI----CGQRLDEAMISYILYGALLGLQHLHNNRII 150 (291)
T ss_pred hcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 8 899999999998754 368999999999999999875322 345789999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC----CCCcchhHHHHHHHHHH
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH----GYDFKADIWSLGITAIE 255 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~~~~DIwSlG~il~e 255 (520)
||||||+||+++.++.++|+|||++..+..... ......|++.|+|||.+.... .++.++|||||||++|+
T Consensus 151 H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~e 225 (291)
T cd06639 151 HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225 (291)
T ss_pred ccCCCHHHEEEcCCCCEEEeecccchhcccccc-----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHH
Confidence 999999999999999999999999876543211 112346899999999975432 26889999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 256 MATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 256 lltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
|++|.+||........+.......++.+.. ...++..+.++|.+||+++|.+||++.+++.||||+
T Consensus 226 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 226 LGDGDPPLFDMHPVKTLFKIPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HhhCCCCCCCCcHHHHHHHHhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 999999998877666555554443332211 123566899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=332.29 Aligned_cols=256 Identities=29% Similarity=0.507 Sum_probs=217.0
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++++.||.|+||.||.+.+..++..+++|.+..... ......++.+|+.++++++|+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~---------------------~~~~~~~~~~e~~~l~~~~h~ 59 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL---------------------SEKERRDALNEIVILSLLQHP 59 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc---------------------chhHHHHHHHHHHHHHhCCCC
Confidence 69999999999999999999999988888887642211 123345688999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++...+.++++|||+.+++|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus 60 ~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~ 133 (256)
T cd08221 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ------KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIF 133 (256)
T ss_pred CeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhc------cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEE
Confidence 9999999999999999999999999999999753 2456899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.++.+||+|||++........ ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......
T Consensus 134 ~~~~~~~kl~d~~~~~~~~~~~~-----~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~ 207 (256)
T cd08221 134 LTKAGLIKLGDFGISKILGSEYS-----MAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPL 207 (256)
T ss_pred EeCCCCEEECcCcceEEcccccc-----cccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 99999999999999876643221 223457899999999987665 789999999999999999999999887766
Q ss_pred HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
+.............. ..++..+.++|.+||.++|.+|||+.++++|||+
T Consensus 208 ~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 208 NLVVKIVQGNYTPVV---------SVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHcCCCCCCc---------cccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 666555544332221 3567889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=334.18 Aligned_cols=255 Identities=42% Similarity=0.755 Sum_probs=214.6
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||.|+||.||+|....++..+++|.++.. ...+++.+|+.++++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------------------------~~~~~~~~e~~~~~~l~ 56 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------------------------EDLQEIIKEISILKQCD 56 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------------------------HHHHHHHHHHHHHHhCC
Confidence 46899999999999999999999998888888876421 11567899999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++.....+|+++||+.+++|.+++.. ....+++..+..++.||+.||.|||+.|++||||+|+|
T Consensus 57 ~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~-------~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~n 129 (256)
T cd06612 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI-------TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGN 129 (256)
T ss_pred CCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh-------CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcce
Confidence 99999999999999999999999999999999964 34578999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
|+++.++.++|+|||++..+..... ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||....
T Consensus 130 i~~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 130 ILLNEEGQAKLADFGVSGQLTDTMA-----KRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred EEECCCCcEEEcccccchhcccCcc-----ccccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999999999999876543211 123456889999999987654 8999999999999999999999998766
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
................. ....++..+.++|.+||+.+|.+|||+.|+|.||||
T Consensus 204 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 204 PMRAIFMIPNKPPPTLS-------DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hhhhhhhhccCCCCCCC-------chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 55444333222221111 123567889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=341.15 Aligned_cols=265 Identities=27% Similarity=0.389 Sum_probs=211.9
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
.|++.+.||.|++|.||+|.+..+|..||+|.++.... .......+.+|++++++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------------~~~~~~~~~~E~~~l~~l~h~ 59 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---------------------TEGVPSTAIREISLLKELNHP 59 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc---------------------ccccchHHHHHHHHHHhcCCC
Confidence 48999999999999999999999999999987642210 011234688999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++...+..++||||+. ++|.+++... ..+.+++..+..++.||+.||.|||++|++||||+|+||+
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nil 132 (284)
T cd07860 60 NIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDAS------PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 132 (284)
T ss_pred CCcchhhhcccCCcEEEEeeccc-cCHHHHHHhC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 99999999999999999999995 6899988643 3467899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.++.++|+|||++..+.... .......+++.|+|||++.+...++.++||||||+++|+|+||..||......
T Consensus 133 l~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~ 207 (284)
T cd07860 133 INTEGAIKLADFGLARAFGVPV-----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207 (284)
T ss_pred ECCCCCEEEeeccchhhcccCc-----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 9999999999999987553221 11223457889999999877665788999999999999999999999877655
Q ss_pred HHHHHHhcCCCCCCC-----------------C--CchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 270 KVLMLTLQNDPPTLD-----------------T--GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~-----------------~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
............... . ..........+++.++++|.+||+.||.+|||+.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 208 DQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 544333321111000 0 000111123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=332.80 Aligned_cols=252 Identities=29% Similarity=0.517 Sum_probs=212.4
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||.|+||.||++.+..++..+|+|.++.. ......+.+.+|+.+++.++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----------------------~~~~~~~~~~~e~~~l~~l~h~ 58 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP----------------------KSSSAVEDSRKEAVLLAKMKHP 58 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcC----------------------cchHHHHHHHHHHHHHHhCCCC
Confidence 589999999999999999999999888888876421 1123456788899999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++..++.+|+||||+++++|.+++... ....+++..+..++.||+.||.|||++|++|+||||+||+
T Consensus 59 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nil 132 (255)
T cd08219 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQ------RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIF 132 (255)
T ss_pred CcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEE
Confidence 9999999999999999999999999999998643 3456899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
+++++.++|+|||++..+.... .......|++.|+|||++.+.. ++.++|+||||+++|+|++|..||......
T Consensus 133 i~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~ 206 (255)
T cd08219 133 LTQNGKVKLGDFGSARLLTSPG-----AYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWK 206 (255)
T ss_pred ECCCCcEEEcccCcceeecccc-----cccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHH
Confidence 9999999999999987664321 1123467899999999987655 899999999999999999999999887766
Q ss_pred HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
........+....++ ..++..+.+||.+||+.||.+|||+.+++.-
T Consensus 207 ~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 207 NLILKVCQGSYKPLP---------SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHhcCCCCCCC---------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 655555444433222 2356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=344.78 Aligned_cols=281 Identities=21% Similarity=0.324 Sum_probs=211.4
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||.||+|.+.......+.+ +.... .......+|+|.+..........++.+|+.++.++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l 76 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQ-FPFNV-----RKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL 76 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCccccccc-ccccc-----cCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc
Confidence 4578999999999999999999886654333322 11100 01124467777776554445567899999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc-----------cCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS-----------NCKHGVCDEPTIATVLREVLKGLEYFHS 175 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~-----------~~~~~~l~~~~i~~i~~qIl~gL~yLH~ 175 (520)
+||||+++++++...+..++||||+.+++|.+++....... ......+++..+..++.||+.||.|||+
T Consensus 77 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 77 KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999996532110 1122457888999999999999999999
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
+||+||||||+|||++.++.+||+|||++..+..... ........+++.|+|||++.... ++.++|||||||++|+
T Consensus 157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~e 232 (304)
T cd05096 157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY---YRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWE 232 (304)
T ss_pred CCccccCcchhheEEcCCccEEECCCccceecccCce---eEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHH
Confidence 9999999999999999999999999999876543221 11122345678899999987655 8999999999999999
Q ss_pred HHh--CCCCCCCCcHHHHHHHHhc---CCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 256 MAT--GTAPYHKYPAMKVLMLTLQ---NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 256 llt--G~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
|++ +..||........+..... ....... ......++..+.+||.+||+.||.+|||+.++.
T Consensus 233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHHccCCCCCCcCCHHHHHHHHHHHhhhcccccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 987 6688887665554432211 1100000 001134577899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.70 Aligned_cols=278 Identities=27% Similarity=0.361 Sum_probs=213.3
Q ss_pred CCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHH
Q psy11359 20 VSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKE 99 (520)
Q Consensus 20 ~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~E 99 (520)
..+++....++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|
T Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~---------------------~~~~~~~~~~e 61 (310)
T cd07865 3 YEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---------------------KEGFPITALRE 61 (310)
T ss_pred ccCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC---------------------cCCchhHHHHH
Confidence 345677788899999999999999999999999999999997643210 01112345689
Q ss_pred HHHHhcCCCCCceEEEEEEEECC--------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHH
Q psy11359 100 IQAMSSCHHENVVTYHTSFVVKD--------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLE 171 (520)
Q Consensus 100 i~~l~~l~HpnIv~~~~~~~~~~--------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~ 171 (520)
+.++++++||||+++++++.... ..++||||+. ++|.+++.. ....+++.+++.++.||+.||.
T Consensus 62 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-------~~~~~~~~~~~~i~~qi~~al~ 133 (310)
T cd07865 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN-------KNVKFTLSEIKKVMKMLLNGLY 133 (310)
T ss_pred HHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh-------cccCCCHHHHHHHHHHHHHHHH
Confidence 99999999999999999887543 4699999995 588888864 3346899999999999999999
Q ss_pred HHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHH
Q psy11359 172 YFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251 (520)
Q Consensus 172 yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~ 251 (520)
|||++|++|+||||+||+++.++.+||+|||++..+....... ........+++.|+|||.+.+...++.++||||||+
T Consensus 134 ~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 212 (310)
T cd07865 134 YIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK-PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGC 212 (310)
T ss_pred HHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccC-CCCccCcccCccccCcHHhcCCcccCchhhhHHHHH
Confidence 9999999999999999999999999999999997664332211 112234567899999999876655789999999999
Q ss_pred HHHHHHhCCCCCCCCcHHHHHHHHhc---CCCCCCCC---------------Cc----hhhhhHHHhcHHHHHHHHhhhc
Q psy11359 252 TAIEMATGTAPYHKYPAMKVLMLTLQ---NDPPTLDT---------------GA----AEKDQYKAYGKTFRKMISDCLQ 309 (520)
Q Consensus 252 il~elltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~---------------~~----~~~~~~~~~~~~~~~li~~~L~ 309 (520)
++|+|+||..||.............. ..++.... .. .........+..+.+||.+||.
T Consensus 213 ~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~ 292 (310)
T cd07865 213 IMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLV 292 (310)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhc
Confidence 99999999999987665544322211 11110000 00 0000001235678899999999
Q ss_pred cCCCCCCCHHHHhcCccc
Q psy11359 310 KDPTKRPTASELLKNPFF 327 (520)
Q Consensus 310 ~dP~~Rpta~elL~hp~~ 327 (520)
.||.+|||++++|+||||
T Consensus 293 ~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 293 LDPAKRIDADTALNHDFF 310 (310)
T ss_pred CChhhccCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=338.30 Aligned_cols=266 Identities=25% Similarity=0.364 Sum_probs=206.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||.|++|+||+|.++.+++.||+|.+..... ......+.+|+.+++++
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~----------------------~~~~~~~~~E~~~l~~l 60 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE----------------------EGAPFTAIREASLLKDL 60 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc----------------------cCCchhHHHHHHHHhhC
Confidence 45789999999999999999999999988899987643210 11122366899999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+..++||||+. ++|.+++.. ..+.+++..++.++.||+.||.|||++|++||||||+
T Consensus 61 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~ 132 (291)
T cd07844 61 KHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDD-------CGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQ 132 (291)
T ss_pred CCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHH
Confidence 99999999999999999999999997 599998874 3357899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
||+++.+|.+||+|||++....... .......+++.|+|||++.+...++.++||||||+++|+|++|..||...
T Consensus 133 nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 133 NLLISERGELKLADFGLARAKSVPS-----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred HEEEcCCCCEEECccccccccCCCC-----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999886542211 11122356889999999876555899999999999999999999999765
Q ss_pred cH-HHHHHHHhcC--CC-CCC-----------------CCCchhhhhHHHhc--HHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 267 PA-MKVLMLTLQN--DP-PTL-----------------DTGAAEKDQYKAYG--KTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 267 ~~-~~~~~~~~~~--~~-~~~-----------------~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.. .+.+...... .+ ... ............++ ..+.++|.+||+++|++|||+.+++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 208 TDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 52 2222111110 00 000 00000011112233 78899999999999999999999999
Q ss_pred Cccc
Q psy11359 324 NPFF 327 (520)
Q Consensus 324 hp~~ 327 (520)
||||
T Consensus 288 ~~~f 291 (291)
T cd07844 288 HPYF 291 (291)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=341.54 Aligned_cols=265 Identities=29% Similarity=0.465 Sum_probs=212.5
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~---------------------~~~~~~~~~~~e~~~l~~l~h 59 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE---------------------DDKMVKKIAMREIRMLKQLRH 59 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhcc---------------------CcchhhHHHHHHHHHHHhcCC
Confidence 47999999999999999999999999999998763210 001234567889999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++..++..|+||||+.+++|..+.. ....+++..+..++.||+.||.|||++|++|+||+|+||
T Consensus 60 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni 131 (286)
T cd07846 60 ENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK--------YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENI 131 (286)
T ss_pred cchhhHHHhcccCCeEEEEEecCCccHHHHHHh--------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 999999999999999999999999988887765 334589999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
++++++.++|+|||++..+.... .......+++.|+|||.+.+...++.++||||||+++|+|++|.+||.....
T Consensus 132 ~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~ 206 (286)
T cd07846 132 LVSQSGVVKLCDFGFARTLAAPG-----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD 206 (286)
T ss_pred EECCCCcEEEEeeeeeeeccCCc-----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch
Confidence 99999999999999987654322 1123456899999999987655578899999999999999999999976654
Q ss_pred HHHHHHHhcCC---------------------CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQND---------------------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.+....+.... .+............+.++..+.+|+.+||..+|.+|||+.++++||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 207 IDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 43332222100 000111111122234678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.43 Aligned_cols=255 Identities=30% Similarity=0.506 Sum_probs=214.1
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+.++++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------------~~~~~~~~~~e~~~l~~~~~~ 59 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM---------------------TKDERLAAQNECQVLKLLSHP 59 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc---------------------ccHHHHHHHHHHHHHhhCCCC
Confidence 59999999999999999999999988888887753211 122356788999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++.+..++..++||||+.|++|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil 133 (256)
T cd08220 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR------CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNIL 133 (256)
T ss_pred chhheeeeEecCCEEEEEEecCCCCCHHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9999999999999999999999999999999753 2345899999999999999999999999999999999999
Q ss_pred EcCC-CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 190 LGED-GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 190 l~~~-g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
++.+ +.++|+|||++..+.... ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.....
T Consensus 134 ~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 206 (256)
T cd08220 134 LDKHKMVVKIGDFGISKILSSKS------KAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANL 206 (256)
T ss_pred EcCCCCEEEEccCCCceecCCCc------cccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCch
Confidence 9754 468999999987764322 122356899999999987654 78999999999999999999999987766
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
..............+. ..++..+.++|.+||.++|.+|||+.|++.||||
T Consensus 207 ~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 207 PALVLKIMSGTFAPIS---------DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHHHhcCCCCCC---------CCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 6555555444333222 2367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.05 Aligned_cols=264 Identities=28% Similarity=0.524 Sum_probs=211.4
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||+|+||.||+|.+ .+|..+|+|.+...... ..........+.+|+.++++++|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~-----------------~~~~~~~~~~~~~e~~~l~~l~~~ 62 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSN-----------------VLAAEKEYEKLQEEVDLLKSLKHV 62 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccc-----------------hhhHHHHHHHHHHHHHHHHhcCCC
Confidence 588999999999999999986 46788888876532110 000122345688999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++...+.+++||||+.|++|.+++.. .+.+++..+..++.||+.||.|||+.|++|+||+|+||+
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 134 (265)
T cd06631 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNR--------FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVM 134 (265)
T ss_pred CEeeEeeEeecCCeEEEEEecCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEE
Confidence 999999999999999999999999999999973 456889999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCcc-ccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRD-LSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~-~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++++.++|+|||++........ ...........|++.|+|||++.+.. ++.++|+|||||++|+|++|..||.....
T Consensus 135 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 213 (265)
T cd06631 135 LMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDR 213 (265)
T ss_pred ECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCCh
Confidence 99999999999999876532111 11112223457899999999987655 88999999999999999999999987665
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.............. + .....++..+.++|.+||.++|.+|||+.++++||||
T Consensus 214 ~~~~~~~~~~~~~~-~------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 214 LAAMFYIGAHRGLM-P------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHhhhccCCC-C------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 54443322221110 0 0113567889999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=341.46 Aligned_cols=271 Identities=27% Similarity=0.370 Sum_probs=215.5
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||.|++|.||+|.+..+|+.||+|.++...... ........+.+|+.+++.++|+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~------------------~~~~~~~~~~~e~~~l~~~~h~ 62 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE------------------AKDGINFTALREIKLLQELKHP 62 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc------------------ccchhhHHHHHHHHHHhhcCCC
Confidence 5899999999999999999999999999999876432110 0011234577899999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++...+.+++||||+ +++|.+++.. ....+++..+..++.||++||.|||++|++|+||||+||+
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~-------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 134 (298)
T cd07841 63 NIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKD-------KSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLL 134 (298)
T ss_pred CChhhhheeecCCEEEEEEccc-CCCHHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEE
Confidence 9999999999999999999999 8999999974 2237899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.+|.++|+|||++........ ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||......
T Consensus 135 l~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~ 209 (298)
T cd07841 135 IASDGVLKLADFGLARSFGSPNR-----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI 209 (298)
T ss_pred EcCCCCEEEccceeeeeccCCCc-----cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH
Confidence 99999999999999977644321 1223456889999999866555889999999999999999998888876665
Q ss_pred HHHHHHhcCCCCCCC------------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 270 KVLMLTLQNDPPTLD------------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
+.+............ ............+..+.+||.+||+++|++|||+.|++.||||+...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 210 DQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred HHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 544333221100000 00001112244578899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=339.61 Aligned_cols=270 Identities=24% Similarity=0.325 Sum_probs=212.1
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-C
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-H 107 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~ 107 (520)
++|++.+.||.|+||.||+|.+..+|+.||+|.++.... .......+.+|+.+++.+ +
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~---------------------~~~~~~~~~~E~~~l~~l~~ 59 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD---------------------EEGIPPTALREISLLQMLSE 59 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc---------------------ccCCchHHHHHHHHHHHccC
Confidence 479999999999999999999999999999997643210 011234578899999999 5
Q ss_pred CCCceEEEEEEEECCE-----EEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 108 HENVVTYHTSFVVKDE-----LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~-----~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
||||+++++++...+. +|+||||+.+ +|.+++...... ....+++..++.++.||+.||.|||++|++|||
T Consensus 60 ~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~d 135 (295)
T cd07837 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRG---PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRD 135 (295)
T ss_pred CCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhccc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 6999999999987665 8999999975 899998653221 245689999999999999999999999999999
Q ss_pred cCCCcEEEcC-CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 183 IKAGNILLGE-DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 183 LKp~NILl~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|||+||+++. ++.++|+|||++..+..... ......+++.|+|||.+.+...++.++||||||+++|+|++|.+
T Consensus 136 l~~~nil~~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 210 (295)
T cd07837 136 LKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-----SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210 (295)
T ss_pred CChHHEEEecCCCeEEEeecccceecCCCcc-----ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCC
Confidence 9999999998 88999999999876532211 11233578899999998765558999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCC--CCCC--------------C--CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 262 PYHKYPAMKVLMLTLQND--PPTL--------------D--TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~--~~~~--------------~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
||........+....... +... . .........+.++..+.+||.+||.++|.+|||+.|++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 211 LFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 998877666554433211 0000 0 000111122457889999999999999999999999999
Q ss_pred Ccccc
Q psy11359 324 NPFFK 328 (520)
Q Consensus 324 hp~~~ 328 (520)
||||+
T Consensus 291 ~~~~~ 295 (295)
T cd07837 291 HPYFD 295 (295)
T ss_pred CCCcC
Confidence 99995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.75 Aligned_cols=266 Identities=29% Similarity=0.458 Sum_probs=212.4
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|++++++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~~ 59 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---------------------DEDVKKTALREVKVLRQLRH 59 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---------------------cccchhHHHHHHHHHHhcCC
Confidence 479999999999999999999999999999997642210 12234668999999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
+||+++++++...+..++||||+.++.|..++. ....+++..+..++.||+.||.|||++|++||||+|+||
T Consensus 60 ~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni 131 (288)
T cd07833 60 ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--------SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENI 131 (288)
T ss_pred CCeeehhheEEECCEEEEEEecCCCCHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 999999999999999999999998866665554 345689999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
++++++.++|+|||++..+..... .......+++.|+|||++.+...++.++|+||||+++|+|++|.+||.....
T Consensus 132 ~~~~~~~~kl~d~g~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 207 (288)
T cd07833 132 LVSESGVLKLCDFGFARALRARPA----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207 (288)
T ss_pred EECCCCCEEEEeeecccccCCCcc----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999876643321 1223467889999999998774589999999999999999999999987665
Q ss_pred HHHHHHHhcC---CCC------------------CCCCCch-hhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcc
Q psy11359 269 MKVLMLTLQN---DPP------------------TLDTGAA-EKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326 (520)
Q Consensus 269 ~~~~~~~~~~---~~~------------------~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~ 326 (520)
.+.+...... .++ ....... .......++.++++||.+||..+|++|||+.++++|||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 287 (288)
T cd07833 208 IDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287 (288)
T ss_pred HHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence 5444322110 000 0000000 00111234888999999999999999999999999999
Q ss_pred c
Q psy11359 327 F 327 (520)
Q Consensus 327 ~ 327 (520)
|
T Consensus 288 f 288 (288)
T cd07833 288 F 288 (288)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.59 Aligned_cols=260 Identities=46% Similarity=0.780 Sum_probs=219.0
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
...|+..+.||.|+||.||+|.+..++..||+|++... ........+.+|+.+++++.
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~----------------------~~~~~~~~~~~e~~~l~~l~ 60 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE----------------------EAEDEIEDIQQEITVLSQCD 60 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc----------------------ccHHHHHHHHHHHHHHHhCC
Confidence 34688899999999999999999999888888876421 11234567899999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++......|+||||+.|++|.+++.. +.+++..+..++.|++.||.|||+++++|+||+|+|
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~---------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~N 131 (277)
T cd06640 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA---------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAAN 131 (277)
T ss_pred CCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhh
Confidence 99999999999999999999999999999999852 458899999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
|+++.++.++|+|||++..+..... ......++..|+|||.+.+.. ++.++|+|||||++|+|+||..||....
T Consensus 132 il~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 132 VLLSEQGDVKLADFGVAGQLTDTQI-----KRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred EEEcCCCCEEEcccccceeccCCcc-----ccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 9999999999999999876543211 122356888999999987654 8999999999999999999999998877
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
............++.+ ...++..+.++|.+||+.+|.+|||+.++++|+||.....+
T Consensus 206 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 206 PMRVLFLIPKNNPPTL---------TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred hHhHhhhhhcCCCCCC---------chhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 6666554443333322 23467889999999999999999999999999999876654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=333.49 Aligned_cols=255 Identities=24% Similarity=0.411 Sum_probs=210.9
Q ss_pred CCCCeEEE-eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 27 TEDQYEVR-EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 27 ~~~~Y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
..++|.+- ++||-|-.|.|..+.++.+|+++|+|++.. ....++|+++.-.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----------------------------s~KARrEVeLHw~ 110 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----------------------------SPKARREVELHWM 110 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----------------------------CHHHHhHhhhhhh
Confidence 34667765 489999999999999999999999997642 2347788888665
Q ss_pred C-CCCCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 106 C-HHENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 106 l-~HpnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
. .|||||.++++|+. ...+.+|||.++||.|+..|+.+ ..+.|+|.++..|++||..|+.|||+.+|.|
T Consensus 111 ~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~------g~~afTErea~eI~~qI~~Av~~lH~~nIAH 184 (400)
T KOG0604|consen 111 ASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDR------GDQAFTEREASEIMKQIGLAVRYLHSMNIAH 184 (400)
T ss_pred hcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHc------ccccchHHHHHHHHHHHHHHHHHHHhcchhh
Confidence 5 79999999999873 46789999999999999999976 5677999999999999999999999999999
Q ss_pred cccCCCcEEEcC---CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 181 RDIKAGNILLGE---DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 181 rDLKp~NILl~~---~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
|||||+|+|++. |..+||+|||+|..-.. .....+.+-||.|.|||++.... |+..+|+||+|++||.|+
T Consensus 185 RDlKpENLLyt~t~~na~lKLtDfGFAK~t~~------~~~L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlL 257 (400)
T KOG0604|consen 185 RDLKPENLLYTTTSPNAPLKLTDFGFAKETQE------PGDLMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILL 257 (400)
T ss_pred ccCChhheeeecCCCCcceEecccccccccCC------CccccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhh
Confidence 999999999954 55799999999975432 23345668899999999997666 999999999999999999
Q ss_pred hCCCCCCCCcH------HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 258 TGTAPYHKYPA------MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 258 tG~~Pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
+|.+||..... ++.....-+ . ..+.+.|..+|+..+++|+++|..+|++|.|+.+++.|||+...
T Consensus 258 CGyPPFYS~hg~aispgMk~rI~~gq---y-----~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 258 CGYPPFYSNHGLAISPGMKRRIRTGQ---Y-----EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred cCCCcccccCCccCChhHHhHhhccC---c-----cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 99999965332 222211111 1 12345578899999999999999999999999999999999754
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=336.60 Aligned_cols=266 Identities=22% Similarity=0.320 Sum_probs=206.2
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~----------------------~~~~~~~~~~e~~~l~~l 60 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT----------------------EEGVPFTAIREASLLKGL 60 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC----------------------cCCCcHHHHHHHHHHHhc
Confidence 3478999999999999999999999999999999764221 011223467899999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+|+||+++++++..++..|+||||+. ++|.+++.. ..+.+++..+..++.||+.||.|||++|++||||||+
T Consensus 61 ~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~ 132 (291)
T cd07870 61 KHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ-------HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQ 132 (291)
T ss_pred CCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChH
Confidence 99999999999999999999999995 788887754 3356788899999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.++.++|+|||++....... .......+++.|+|||.+.+...++.++||||||+++|+|++|..||...
T Consensus 133 Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 133 NLLISYLGELKLADFGLARAKSIPS-----QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred HEEEcCCCcEEEeccccccccCCCC-----CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999886542211 11233467999999999876555889999999999999999999999765
Q ss_pred cHH-HHHHHHhcC--CCC---------------CCCC---CchhhhhHH--HhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 267 PAM-KVLMLTLQN--DPP---------------TLDT---GAAEKDQYK--AYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 267 ~~~-~~~~~~~~~--~~~---------------~~~~---~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
... +.+...... .+. .... .......+. ..+..+.+++.+||+.||++|||+.|++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 208 SDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 542 222111110 000 0000 000000001 12568899999999999999999999999
Q ss_pred Cccc
Q psy11359 324 NPFF 327 (520)
Q Consensus 324 hp~~ 327 (520)
||||
T Consensus 288 h~~~ 291 (291)
T cd07870 288 HPYF 291 (291)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=340.49 Aligned_cols=261 Identities=28% Similarity=0.547 Sum_probs=213.6
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++++.||+|+||.||+|.+..+|..||+|.++.. ........+.+|+.++++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----------------------~~~~~~~~~~~e~~~l~~~~~ 58 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE----------------------LDESKFNQIIMELDILHKAVS 58 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc----------------------cCHHHHHHHHHHHHHHHhcCC
Confidence 4799999999999999999999999888888876421 112334678899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccCCCc
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGN 187 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLKp~N 187 (520)
|||+++++++...+.+|+||||+.|++|..++.... ....+++..+..++.||+.||.|||+ +|++||||||+|
T Consensus 59 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~n 133 (286)
T cd06622 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV-----ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133 (286)
T ss_pred CcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHH
Confidence 999999999999999999999999999999886420 13478999999999999999999997 599999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC-----CCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH-----GYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~~~~~~DIwSlG~il~elltG~~P 262 (520)
|+++.++.++|+|||++..+... ......|++.|+|||.+.+.. .++.++|||||||++|+|++|..|
T Consensus 134 il~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p 206 (286)
T cd06622 134 VLVNGNGQVKLCDFGVSGNLVAS-------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206 (286)
T ss_pred EEECCCCCEEEeecCCcccccCC-------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCC
Confidence 99999999999999998655321 223456889999999985432 258899999999999999999999
Q ss_pred CCCCcHHHHHH---HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 263 YHKYPAMKVLM---LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 263 f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
|.......... ......++.++ ..++.++.+||.+||+.+|.+||++.+++.||||.....
T Consensus 207 f~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 207 YPPETYANIFAQLSAIVDGDPPTLP---------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred CCCcchhhHHHHHHHHhhcCCCCCC---------cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 97654433222 22233333222 347889999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=334.22 Aligned_cols=254 Identities=19% Similarity=0.328 Sum_probs=204.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcC---CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKA---RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
...+|++.+.||+|+||.||+|..+. .+..||+|.++ ..........+.+|+..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~----------------------~~~~~~~~~~~~~e~~~l 60 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLR----------------------AGCSDKQRRGFLAEALTL 60 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecC----------------------CCCCHHHHHHHHHHHHHH
Confidence 45789999999999999999997653 34456666543 222223345788999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++++||||+++++++..++..++||||+.+|+|.+++.. ..+.+++..+..++.||+.||.|||++|++||||
T Consensus 61 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~di 133 (266)
T cd05064 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-------HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGL 133 (266)
T ss_pred hcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 999999999999999999999999999999999999974 3457899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+|||++.++.++++|||.+........ .......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..|
T Consensus 134 kp~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p 208 (266)
T cd05064 134 AAHKVLVNSDLVCKISGFRRLQEDKSEAI----YTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERP 208 (266)
T ss_pred cHhhEEEcCCCcEEECCCcccccccccch----hcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999998754322110 1112234567899999987655 8999999999999999775 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|........+.....+..... ...++..+.+++.+||+++|.+|||+.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 209 YWDMSGQDVIKAVEDGFRLPA---------PRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred cCcCCHHHHHHHHHCCCCCCC---------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 988777665554443322221 1346778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=336.97 Aligned_cols=257 Identities=34% Similarity=0.641 Sum_probs=214.0
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||.|++|.||+|.++.+++.+|+|.+... .......++.+|++++++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~----------------------~~~~~~~~~~~e~~~l~~~~~ 58 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE----------------------INEAIQKQILRELDILHKCNS 58 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecc----------------------cChHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999999999999888888876432 112345678899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccCCCc
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGN 187 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLKp~N 187 (520)
|||+++++++...+.+++++||+.+++|.+++... ...+++..+..++.||+.||.|||+ .|++|+||||+|
T Consensus 59 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~n 131 (265)
T cd06605 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV-------QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131 (265)
T ss_pred CchhhhheeeecCCEEEEEEEecCCCcHHHHHHHc-------cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHH
Confidence 99999999999999999999999999999999752 2678999999999999999999999 999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
|+++.++.++|+|||.+..+... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||....
T Consensus 132 i~~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 203 (265)
T cd06605 132 ILVNSRGQIKLCDFGVSGQLVNS-------LAKTFVGTSSYMAPERIQGND-YSVKSDIWSLGLSLIELATGRFPYPPEN 203 (265)
T ss_pred EEECCCCCEEEeecccchhhHHH-------HhhcccCChhccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999988655321 112267899999999987654 8999999999999999999999997542
Q ss_pred -----HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 268 -----AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 268 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
............++.+.. ..++..++++|.+||..+|.+|||+.+++.||||+..
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 204 DPPDGIFELLQYIVNEPPPRLPS--------GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred cccccHHHHHHHHhcCCCCCCCh--------hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 223333333333333221 1278889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=336.00 Aligned_cols=263 Identities=32% Similarity=0.583 Sum_probs=210.2
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH-HhcCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA-MSSCH 107 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~-l~~l~ 107 (520)
++|++.+.||+|+||.||+|.++.+|+.||+|.++... ......++..|+.. ++.++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~~~~~~e~~~~~~~~~ 58 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV----------------------NSQEQKRLLMDLDISMRSVD 58 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC----------------------CcHHHHHHHHHHHHHHHHcC
Confidence 47999999999999999999999999999999775321 11122345556654 66779
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecccCCC
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN-GQIHRDIKAG 186 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~-giiHrDLKp~ 186 (520)
||||+++++++..+...|+||||++ ++|.+++..... ....+++..+..++.||+.||.|||++ +++||||||+
T Consensus 59 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~ 133 (283)
T cd06617 59 CPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYD----KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS 133 (283)
T ss_pred CCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHH
Confidence 9999999999999999999999995 689888875322 335789999999999999999999998 9999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc---CCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD---HGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
||+++.++.+||+|||++..+... .......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||
T Consensus 134 nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 207 (283)
T cd06617 134 NVLINRNGQVKLCDFGISGYLVDS------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207 (283)
T ss_pred HEEECCCCCEEEeecccccccccc------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCC
Confidence 999999999999999998765321 112235688999999988642 33788999999999999999999999
Q ss_pred CCCc-HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 264 HKYP-AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 264 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
.... ..+.+........+.++. ..++.++.+||.+||..+|.+|||+.+++.||||+....
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 208 DSWKTPFQQLKQVVEEPSPQLPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred CccccCHHHHHHHHhcCCCCCCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 6532 233344444333332221 246788999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=335.87 Aligned_cols=267 Identities=28% Similarity=0.475 Sum_probs=211.1
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
.|+..+.||+|++|.||++.+..+++.+|+|+++...... .......+.+.+|+.++++++||
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~-----------------~~~~~~~~~~~~e~~~l~~l~h~ 63 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS-----------------SEQEEVVEALRKEIRLMARLNHP 63 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCc-----------------hhHHHHHHHHHHHHHHHHHcCCC
Confidence 4888999999999999999999999999999875321100 00012456789999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++...+.+++||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++|++||||+|+||+
T Consensus 64 ~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil 135 (268)
T cd06630 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK--------YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLL 135 (268)
T ss_pred ceehhhceeccCCeEEEEEeccCCCcHHHHHHH--------hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 999999999999999999999999999999974 356889999999999999999999999999999999999
Q ss_pred EcCCC-CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 190 LGEDG-TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 190 l~~~g-~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
++.++ .++|+|||++..+...... .........|+..|+|||.+.+.. ++.++|+||+|+++|+|++|..||.....
T Consensus 136 ~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 136 IDSTGQRLRIADFGAAARLAAKGTG-AGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred EcCCCCEEEEccccccccccccccc-CCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 98776 5999999998776433111 111223457899999999987654 89999999999999999999999965432
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
............... .......+++.+.+++.+||..+|.+|||+.++++||||+
T Consensus 214 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 214 SNHLALIFKIASATT-----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred cchHHHHHHHhccCC-----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 221111111000000 0111235778999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.49 Aligned_cols=271 Identities=28% Similarity=0.431 Sum_probs=211.7
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.++||+|+||+||+|.+..+|+.||+|.+... ........+.+|+.+++++
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~----------------------~~~~~~~~~~~E~~~l~~l 60 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF----------------------EHQTFCQRTLREIKILRRF 60 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc----------------------ccchhHHHHHHHHHHHHhC
Confidence 357899999999999999999999999999999876411 0122345678899999999
Q ss_pred CCCCceEEEEEEEEC-----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 107 HHENVVTYHTSFVVK-----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~-----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+||||+++++++... ..+|+|+||+. ++|.+++. .+.+++..++.++.||+.||.|||++|++||
T Consensus 61 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---------~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~ 130 (336)
T cd07849 61 KHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIK---------TQHLSNDHIQYFLYQILRGLKYIHSANVLHR 130 (336)
T ss_pred CCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 999999999887644 35899999995 58888774 3568999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||++.++.+||+|||++........ .........||+.|+|||.+.+...++.++|||||||++|+|++|++
T Consensus 131 dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~ 208 (336)
T cd07849 131 DLKPSNLLLNTNCDLKICDFGLARIADPEHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208 (336)
T ss_pred CCCHHHEEECCCCCEEECcccceeecccccc--ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999876543222 11122346789999999987665558999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcC--CCCC-----------------CC--CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 262 PYHKYPAMKVLMLTLQN--DPPT-----------------LD--TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~--~~~~-----------------~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
||............... .+.. .. ...........++..+.+||.+||+.+|.+|||+.|
T Consensus 209 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e 288 (336)
T cd07849 209 LFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288 (336)
T ss_pred CCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHH
Confidence 99776543333222110 0000 00 000001112345788999999999999999999999
Q ss_pred HhcCccccccc
Q psy11359 321 LLKNPFFKKAK 331 (520)
Q Consensus 321 lL~hp~~~~~~ 331 (520)
+++||||....
T Consensus 289 ~l~hp~~~~~~ 299 (336)
T cd07849 289 ALAHPYLEQYH 299 (336)
T ss_pred HhcCccccccC
Confidence 99999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=332.72 Aligned_cols=260 Identities=31% Similarity=0.519 Sum_probs=208.6
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
.|++.+.||+|+||.||+|.+..++..||+|.+...... .........+.+|+.++++++||
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~------------------~~~~~~~~~~~~e~~~l~~l~h~ 64 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES------------------PETSKEVSALECEIQLLKNLQHE 64 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC------------------chhHHHHHHHHHHHHHHHHcCCC
Confidence 589999999999999999999999999999976532110 00122345688999999999999
Q ss_pred CceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 110 NVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 110 nIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||+++++++.. ...++++|||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|
T Consensus 65 ~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~--------~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~n 136 (266)
T cd06651 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA--------YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGAN 136 (266)
T ss_pred CeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 99999998875 4678999999999999999973 4568899999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
|+++.++.++|+|||++..+..... .........++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||....
T Consensus 137 il~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 137 ILRDSAGNVKLGDFGASKRLQTICM--SGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred EEECCCCCEEEccCCCccccccccc--cCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 9999999999999999876532111 111112356889999999987654 8899999999999999999999998766
Q ss_pred HHHHHHHHhcCC-CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 268 AMKVLMLTLQND-PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 268 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
............ .+. ....+++.++++| .||..+|++|||+.|+++||||+
T Consensus 214 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 214 AMAAIFKIATQPTNPQ---------LPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hHHHHHHHhcCCCCCC---------CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 554443322211 111 1234677888999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=330.51 Aligned_cols=258 Identities=29% Similarity=0.506 Sum_probs=214.2
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||.|+||.||+|.+..+|..+|+|.+..... .....+.+.+|+++++.++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~~~ 59 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM---------------------TEKEKQQLVSEVNILRELKHP 59 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC---------------------CHHHHHHHHHHHHHHHhcCCC
Confidence 58999999999999999999999999999887653211 123356688999999999999
Q ss_pred CceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH-----HCCcEecc
Q psy11359 110 NVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH-----SNGQIHRD 182 (520)
Q Consensus 110 nIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH-----~~giiHrD 182 (520)
||+++++++.. +...|++|||+.+++|.+++..... ....+++..+..++.||+.||.||| +.+++|+|
T Consensus 60 ~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~d 135 (265)
T cd08217 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKK----ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRD 135 (265)
T ss_pred ccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecC
Confidence 99999998864 4568999999999999999976422 3567899999999999999999999 99999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|||+||+++.++.+||+|||++..+..... ......|++.|+|||.+.+.. ++.++|+||||+++++|++|..|
T Consensus 136 l~p~nili~~~~~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p 209 (265)
T cd08217 136 LKPANIFLDANNNVKLGDFGLAKILGHDSS-----FAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPP 209 (265)
T ss_pred CCHHHEEEecCCCEEEecccccccccCCcc-----cccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCc
Confidence 999999999999999999999887643221 123457899999999987655 88999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
|.................+.+. ..++..+.+++.+||+.+|.+|||+.++++|||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 210 FTARNQLQLASKIKEGKFRRIP---------YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCcCHHHHHHHHhcCCCCCCc---------cccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 9877655444444333322221 3467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=330.94 Aligned_cols=262 Identities=29% Similarity=0.473 Sum_probs=210.5
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
.+|++.++||+|+||.||.|.+..+|..||+|.+...... .......+.+.+|+.++++++|
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~------------------~~~~~~~~~~~~E~~~l~~l~h 63 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES------------------PETSKEVNALECEIQLLKNLLH 63 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC------------------cccHHHHHHHHHHHHHHHhcCC
Confidence 4699999999999999999999999999999976432100 0012245678899999999999
Q ss_pred CCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 109 ENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 109 pnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
|||+++++++.+ ...+++||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||||+
T Consensus 64 ~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ 135 (265)
T cd06652 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS--------YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGA 135 (265)
T ss_pred CCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 999999998876 3568899999999999999973 356889999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
||+++.++.++|+|||++..+..... .........|+..|+|||++.+.. ++.++|+|||||++|+|++|+.||...
T Consensus 136 nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 136 NILRDSVGNVKLGDFGASKRLQTICL--SGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred HEEecCCCCEEECcCccccccccccc--cccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 99999999999999999876532111 111123356899999999987654 899999999999999999999999876
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
............. ... .....++..+.++|.+||. +|.+|||++++++|||+.
T Consensus 213 ~~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 213 EAMAAIFKIATQP-TNP-------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred chHHHHHHHhcCC-CCC-------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 5555444333221 111 1124567789999999995 899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=353.00 Aligned_cols=276 Identities=23% Similarity=0.372 Sum_probs=212.0
Q ss_pred CCCCCCCCCCCCCCCCeEEEeeeeecCceEEEEEEE-----cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccc
Q psy11359 15 SSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYC-----KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89 (520)
Q Consensus 15 ~~~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~ 89 (520)
+.+......|....++|++.+.||+|+||+||+|.+ ..++..||+|+++ ....
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~----------------------~~~~ 78 (375)
T cd05104 21 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLK----------------------PSAH 78 (375)
T ss_pred CCCCCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEecc----------------------CCcC
Confidence 334444455777788999999999999999999974 3345566666553 2222
Q ss_pred hhhHHHHHHHHHHHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc---------------------
Q psy11359 90 NTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--------------------- 147 (520)
Q Consensus 90 ~~~~~~l~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--------------------- 147 (520)
....+.+.+|+.+++.+ +||||+++++++...+..++||||+.||+|.++++......
T Consensus 79 ~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (375)
T cd05104 79 LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQR 158 (375)
T ss_pred cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhh
Confidence 23445788999999999 89999999999999999999999999999999997532100
Q ss_pred ----------------------------------------------cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 148 ----------------------------------------------NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 148 ----------------------------------------------~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
......+++..+..++.||+.||.|||++|++||
T Consensus 159 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 238 (375)
T cd05104 159 EMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHR 238 (375)
T ss_pred cccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 0012357889999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GT 260 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~ 260 (520)
||||+|||++.++.+||+|||++..+...... .......+++.|+|||++.+.. ++.++|||||||++|+|++ |.
T Consensus 239 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~ 314 (375)
T cd05104 239 DLAARNILLTHGRITKICDFGLARDIRNDSNY---VVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGS 314 (375)
T ss_pred CCchhhEEEECCCcEEEecCccceeccCcccc---cccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999766432211 1112234567899999997665 8999999999999999998 89
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
.||........+...+....... .....+.++++||.+||+.||++|||+.++++.
T Consensus 315 ~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 315 SPYPGMPVDSKFYKMIKEGYRML--------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCCCCCchHHHHHHHHhCccCC--------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99987655444433333221111 012346789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=331.65 Aligned_cols=269 Identities=26% Similarity=0.475 Sum_probs=219.9
Q ss_pred CCeEEE-eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-
Q psy11359 29 DQYEVR-EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC- 106 (520)
Q Consensus 29 ~~Y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l- 106 (520)
+-|++. ++||+|+++.|.-+....+|..+|+|++.+.. .-+..++.+|++++.++
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-----------------------gHsR~RvfREVe~f~~Cq 133 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-----------------------GHSRSRVFREVETFYQCQ 133 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC-----------------------chHHHHHHHHHHHHHHhc
Confidence 345554 58999999999999999999999999875431 22456799999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
.|+||+.++++|++++.+|||||-+.||+|...|.+ +..|++.++.++.+.|+.||.|||.+||.||||||+
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~--------~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPE 205 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK--------RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPE 205 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHH--------hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCcc
Confidence 699999999999999999999999999999999984 577999999999999999999999999999999999
Q ss_pred cEEEcCCC---CeEEeccCcceeeccCccccc--cccccccccccccCCcceec----ccCCCCcchhHHHHHHHHHHHH
Q psy11359 187 NILLGEDG---TVQIADFGVSAWLATGRDLSR--QKVRHTFVGTPCWMAPEVME----QDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 187 NILl~~~g---~vkL~DFG~a~~~~~~~~~~~--~~~~~~~~gt~~y~APE~~~----~~~~~~~~~DIwSlG~il~ell 257 (520)
|||..+.. -+|||||.+..-+....+.+. .+...+.+|+..|||||+.. +...|+.++|.||||||||.|+
T Consensus 206 NiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImL 285 (463)
T KOG0607|consen 206 NILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIML 285 (463)
T ss_pred ceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHH
Confidence 99996544 589999998765433333221 12223568999999999853 4456999999999999999999
Q ss_pred hCCCCCCCCcH--------------HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 258 TGTAPYHKYPA--------------MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 258 tG~~Pf~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.|.+||.+.-. .+.++..++.....+ +...|..+|.+.+++|..+|..|+.+|.++.++++
T Consensus 286 sGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeF-----PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 286 SGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEF-----PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred hCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcC-----ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 99999965321 233444444433333 24567889999999999999999999999999999
Q ss_pred Cccccccchh
Q psy11359 324 NPFFKKAKDK 333 (520)
Q Consensus 324 hp~~~~~~~~ 333 (520)
|||++.....
T Consensus 361 hPw~~~~~~e 370 (463)
T KOG0607|consen 361 HPWVQRCAPE 370 (463)
T ss_pred Cccccccchh
Confidence 9999976544
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=334.18 Aligned_cols=269 Identities=30% Similarity=0.500 Sum_probs=215.4
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.++........ .........+.+.+|+.+++.++||
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~-------------~~~~~~~~~~~~~~e~~~l~~l~h~ 68 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGR-------------HDSRQKDMVKALRSEIETLKDLDHL 68 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcc-------------cchHHHHHHHHHHHHHHHHHhcCCC
Confidence 689999999999999999999999999999987543211110 0001122356788999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++...+.+++||||+.|++|.++++. .+.+++..+..++.||+.||.|||++|++||||+|+||+
T Consensus 69 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil 140 (272)
T cd06629 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT--------YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLL 140 (272)
T ss_pred CcceEEEEeccCCceEEEEecCCCCcHHHHHhh--------ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEE
Confidence 999999999999999999999999999999973 467899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH-GYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
++.++.++|+|||++....... .........|+..|+|||.+.... .++.++|+||||+++|+|++|..||.....
T Consensus 141 ~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 217 (272)
T cd06629 141 VDADGICKISDFGISKKSDDIY---DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA 217 (272)
T ss_pred EcCCCeEEEeeccccccccccc---cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch
Confidence 9999999999999986543211 111223456889999999986543 478999999999999999999999976655
Q ss_pred HHHHHHHhcC-CCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQN-DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.......... ....+. ......++..+.++|.+||.++|.+|||+.++|+||||
T Consensus 218 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 218 IAAMFKLGNKRSAPPIP-----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHhhccccCCcCC-----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 5444332211 111111 11224578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=334.30 Aligned_cols=268 Identities=32% Similarity=0.549 Sum_probs=212.7
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|+..+.||.|++|.||+|.+..+++.+|+|.+... .......++.+|++++++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----------------------~~~~~~~~~~~e~~~l~~l~h 58 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD----------------------PNPDLQKQILRELEINKSCKS 58 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC----------------------CchHHHHHHHHHHHHHHhCCC
Confidence 4799999999999999999999999888888876421 112345678999999999999
Q ss_pred CCceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 109 ENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 109 pnIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
|||+++++++... ..+|+||||++|++|.+++..... ....+++..+..++.||+.||.|||+.|++|+||+|+
T Consensus 59 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~ 134 (287)
T cd06621 59 PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKK----RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPS 134 (287)
T ss_pred CCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 9999999988653 478999999999999998865322 3466899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
||+++.++.++|+|||++...... ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||...
T Consensus 135 nil~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 135 NILLTRKGQVKLCDFGVSGELVNS-------LAGTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred HEEEecCCeEEEeecccccccccc-------ccccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999998654321 112356788999999987655 899999999999999999999999765
Q ss_pred c-----HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 267 P-----AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 267 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
. ..+..........+.+..... ....+++.+++||.+||.++|.+|||+.|+++||||++...+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 207 GEPPLGPIELLSYIVNMPNPELKDEPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred cCCCCChHHHHHHHhcCCchhhccCCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 2 222222222212222211110 012346789999999999999999999999999999766554
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=331.78 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=211.7
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|.....+|.+.+.||.|+||.||+|.+..+++.||+|.+... .....++.+|+.++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------------------------~~~~~~~~~e~~~l 56 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------------------TMEVEEFLKEAAVM 56 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------------------------chHHHHHHHHHHHH
Confidence 556677899999999999999999999999888888875321 12345688999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+.++||||+++++++.....+++||||+.+++|.+++... ....+++..+..++.|++.||.|||++|++||||
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 130 (263)
T cd05052 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC------NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130 (263)
T ss_pred HhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 9999999999999999999999999999999999999753 3456899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||++++++.+||+|||++......... ......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..|
T Consensus 131 kp~nil~~~~~~~kl~df~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p 205 (263)
T cd05052 131 AARNCLVGENHLVKVADFGLSRLMTGDTYT----AHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP 205 (263)
T ss_pred CcceEEEcCCCcEEeCCCccccccccceee----ccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999998765432211 111223466899999887655 8999999999999999998 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|.+....+..........+.. ...++..+.++|.+||..+|++|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 206 YPGIDLSQVYELLEKGYRMER---------PEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCCHHHHHHHHHCCCCCCC---------CCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 988766655544443322221 1346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=338.49 Aligned_cols=259 Identities=30% Similarity=0.549 Sum_probs=213.6
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||++.+..+|+.||+|++... ......+.+.+|+++++.+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----------------------~~~~~~~~~~~E~~~l~~l 60 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG----------------------AKSSVRKQILRELQIMHEC 60 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec----------------------CcchHHHHHHHHHHHHHHc
Confidence 457899999999999999999999999888888876421 1122356789999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKA 185 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLKp 185 (520)
+||||+++++++...+.+++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+ ++++||||||
T Consensus 61 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p 132 (284)
T cd06620 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK--------GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKP 132 (284)
T ss_pred CCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh--------ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCH
Confidence 999999999999999999999999999999999873 4578999999999999999999997 6999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+||++++++.++|+|||++..+... ......|+..|+|||++.+.. ++.++|||||||++|+|+||..||..
T Consensus 133 ~nil~~~~~~~~l~d~gl~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~ 204 (284)
T cd06620 133 SNILVNSRGQIKLCDFGVSGELINS-------IADTFVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELALGKFPFAF 204 (284)
T ss_pred HHEEECCCCcEEEccCCcccchhhh-------ccCccccCcccCCHHHHccCC-CCccchHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999987654221 123457899999999987654 89999999999999999999999976
Q ss_pred CcHH-----------HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 266 YPAM-----------KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 266 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
.... ..........++.+.. ..++..+.+||.+||++||.+|||+.|+++|+||....
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 205 SNIDDDGQDDPMGILDLLQQIVQEPPPRLPS--------SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred cchhhhhhhhhhHHHHHHHHHhhccCCCCCc--------hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 5432 2222222222222211 23677899999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=335.89 Aligned_cols=258 Identities=40% Similarity=0.701 Sum_probs=215.2
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC--
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH-- 107 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~-- 107 (520)
.|++.+.||+|+||.||+|.+..++..+|+|.++.. ......+++.+|+.+++.++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~----------------------~~~~~~~~~~~e~~~l~~l~~~ 59 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD----------------------TPDDDVSDIQREVALLSQLRQS 59 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC----------------------CCchhHHHHHHHHHHHHHhccC
Confidence 588999999999999999999999888888876422 11234556888999999986
Q ss_pred -CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 108 -HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 108 -HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
||||+++++++..+...|+||||+.|++|.++++. +.+++..+..++.||+.||.|||+.|++|+||+|+
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ 130 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA---------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAA 130 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc---------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHH
Confidence 99999999999999999999999999999999852 36889999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
||+++.++.++|+|||++..+.... .......|++.|+|||.+.....++.++|+||||+++|+|++|..||...
T Consensus 131 ni~i~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 131 NILVTNTGNVKLCDFGVAALLNQNS-----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred HEEEcCCCCEEEccCCceeecCCCc-----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999987764322 11234578999999999876555789999999999999999999999877
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
.............++.+.. ..++.++.+++.+||..||.+|||+.++++|+||+...
T Consensus 206 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 206 DAFRAMMLIPKSKPPRLED--------NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ChhhhhhccccCCCCCCCc--------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 6655444332222222211 12678899999999999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=337.27 Aligned_cols=267 Identities=22% Similarity=0.347 Sum_probs=211.0
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||.||+|.+...+.... ...+++|.+...........+.+|+.++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~-----------------~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~ 66 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLS-----------------ATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcc-----------------eeeEEEEecccCCCHHHHHHHHHHHHHHHhcC
Confidence 4579999999999999999998876651100 22344444433333345567899999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcccc--------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN--------CKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~--------~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
||||+++++++......|++|||+.+++|.+++........ .....+++..+..++.||+.||.|||++|++
T Consensus 67 h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~ 146 (283)
T cd05048 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFV 146 (283)
T ss_pred CcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 99999999999999999999999999999999975322110 0125688999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT- 258 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt- 258 (520)
||||||+||++++++.++|+|||++........ ........+++.|+|||.+.+.. ++.++|||||||++|+|++
T Consensus 147 H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~ 222 (283)
T cd05048 147 HRDLAARNCLVGEGLTVKISDFGLSRDIYSADY---YRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSY 222 (283)
T ss_pred ccccccceEEEcCCCcEEECCCcceeecccccc---ccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcC
Confidence 999999999999999999999999876532211 11123346788999999987655 8999999999999999998
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|..||.+....+....+........ ...++.++.+|+.+||+.||.+|||+.+++++
T Consensus 223 g~~p~~~~~~~~~~~~i~~~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 223 GLQPYYGFSNQEVIEMIRSRQLLPC---------PEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCCCCCCCCHHHHHHHHHcCCcCCC---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999988777666554443332221 13578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=337.41 Aligned_cols=263 Identities=38% Similarity=0.638 Sum_probs=217.3
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
....|++.+.||+|+||+||+|.+..+|+.||+|.+..... .......++.+|+.+++.+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--------------------~~~~~~~~~~~Ei~~l~~l 72 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK--------------------QSNEKWQDIIKEVRFLQQL 72 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc--------------------CcHHHHHHHHHHHHHHHhC
Confidence 34669999999999999999999999999999987643211 1123345688999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+..|+||||+. |+|.+++.. ..+.+++..+..++.||+.||.|||++|++||||+|+
T Consensus 73 ~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~-------~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~ 144 (307)
T cd06607 73 RHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV-------HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAG 144 (307)
T ss_pred CCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHH-------cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcc
Confidence 99999999999999999999999996 678887754 2356899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc--cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ--DHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
||+++.++.++|+|||++..... .....|++.|+|||++.+ ...++.++||||||+++|+|+||..||.
T Consensus 145 nIl~~~~~~~kL~dfg~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 145 NILLTEPGTVKLADFGSASLVSP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred cEEECCCCCEEEeecCcceecCC---------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 99999999999999998865421 124578899999998852 2348899999999999999999999998
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhh
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~ 334 (520)
...............++.+.. ..++..+.++|.+||..+|.+|||+.+++.||||.......
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 277 (307)
T cd06607 216 NMNAMSALYHIAQNDSPTLSS--------NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPT 277 (307)
T ss_pred CccHHHHHHHHhcCCCCCCCc--------hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCCcH
Confidence 877666555544443333321 23677899999999999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=338.78 Aligned_cols=266 Identities=25% Similarity=0.363 Sum_probs=211.7
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||.|+||.||+|.+..+++.+|+|.++..... ......+.+|+.++++++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~ 62 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---------------------EGFPITSLREINILLKLQ 62 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---------------------ccchhhHHHHHHHHHhcC
Confidence 46799999999999999999999999999999977532110 112234678999999999
Q ss_pred CCCceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 108 HENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 108 HpnIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
||||+++++++... ...|+||||+. ++|.+++.. ....+++..++.++.||+.||.|||++|++||||||
T Consensus 63 h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p 134 (293)
T cd07843 63 HPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMET-------MKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKT 134 (293)
T ss_pred CCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCH
Confidence 99999999999877 88999999996 599998874 234689999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+||+++.++.++|+|||++..+.... .......+++.|+|||.+.+...++.++||||||+++|+|++|.+||..
T Consensus 135 ~nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 135 SNLLLNNRGILKICDFGLAREYGSPL-----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred HHEEECCCCcEEEeecCceeeccCCc-----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999987664321 1122346789999999987655578999999999999999999999988
Q ss_pred CcHHHHHHHHhcCCCCCCCC--------------------CchhhhhHHH--hcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDT--------------------GAAEKDQYKA--YGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
..................+. .......... +++.+.++|.+||+.+|++|||+.|+|.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 210 KSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 77665554433211100000 0000011111 4788999999999999999999999999
Q ss_pred Cccc
Q psy11359 324 NPFF 327 (520)
Q Consensus 324 hp~~ 327 (520)
||||
T Consensus 290 ~~~f 293 (293)
T cd07843 290 HPYF 293 (293)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=323.11 Aligned_cols=260 Identities=28% Similarity=0.540 Sum_probs=219.8
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHE 109 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~Hp 109 (520)
.+.+..||.|+.|+|++++.+.+|...|+|.++ ...+.+..++++..+.++... ..|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~----------------------rt~Nkee~kRILmDldvv~~s~dcp 151 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMR----------------------RTGNKEENKRILMDLDVVLKSHDCP 151 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeec----------------------ccCCHHHHHHHHHhhhHHhhccCCC
Confidence 456788999999999999999998888888764 333455677888888887766 489
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccCCCcE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGNI 188 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLKp~NI 188 (520)
+||+.+++|..+..+++.||.+ +..+..++++ -.++++|..+-++...+++||.||.. +||||||+||.||
T Consensus 152 yIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkr-------ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNI 223 (391)
T KOG0983|consen 152 YIVQCFGYFITNTDVFICMELM-STCAEKLLKR-------IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 223 (391)
T ss_pred eeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHH-------hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccce
Confidence 9999999999999999999999 4455555554 45679999999999999999999975 5899999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD--HGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|+++.|++||||||.+..+-..... ....|.+.|||||.+... ..|+-++||||||++++||+||++||.++
T Consensus 224 LlDe~GniKlCDFGIsGrlvdSkAh------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c 297 (391)
T KOG0983|consen 224 LLDERGNIKLCDFGISGRLVDSKAH------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC 297 (391)
T ss_pred EEccCCCEEeecccccceeeccccc------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence 9999999999999999887543322 234799999999998643 34899999999999999999999999986
Q ss_pred c-HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 267 P-AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 267 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
. +.+++-.++...||.++.. ..+|+.|.+|+..||++|+.+||...++|+|||+......
T Consensus 298 ~tdFe~ltkvln~ePP~L~~~-------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 298 KTDFEVLTKVLNEEPPLLPGH-------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA 358 (391)
T ss_pred CccHHHHHHHHhcCCCCCCcc-------cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence 4 6778888888888877643 3489999999999999999999999999999999876543
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=340.43 Aligned_cols=259 Identities=46% Similarity=0.799 Sum_probs=215.6
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.+.|+..+.||+|+||.||+|.+..++..||+|.++.. ......+.+.+|+.++++++
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~----------------------~~~~~~~~~~~e~~~l~~l~ 60 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE----------------------EAEDEIEDIQQEITVLSQCD 60 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccc----------------------cchHHHHHHHHHHHHHHcCC
Confidence 35688889999999999999999999888888876421 11233467899999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++..++..|+||||+.+++|.+++. .+.+++..+..++.||+.||.|||++|++|+||+|+|
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~n 131 (277)
T cd06642 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK---------PGPLEETYIATILREILKGLDYLHSERKIHRDIKAAN 131 (277)
T ss_pred CCccHhhhcccccCCceEEEEEccCCCcHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChhe
Confidence 9999999999999999999999999999999885 2468899999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
|++++++.++|+|||++..+.... .......|+..|+|||.+.+.. ++.++|+|||||++|+|+||..||....
T Consensus 132 i~i~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 132 VLLSEQGDVKLADFGVAGQLTDTQ-----IKRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred EEEeCCCCEEEccccccccccCcc-----hhhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999987654321 1123356889999999987654 8899999999999999999999998666
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
............++.+. ..++..+.++|.+||+.+|.+|||+.++++||||.....
T Consensus 206 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 206 PMRVLFLIPKNSPPTLE---------GQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred hhhHHhhhhcCCCCCCC---------cccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence 55544433333322221 245678999999999999999999999999999986554
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=355.18 Aligned_cols=248 Identities=26% Similarity=0.453 Sum_probs=207.3
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.|....+...-++-||.|+.|.||+|+.+ ++.||||+++ . .-..+|+-
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~----------------------e--------lkETdIKH 165 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVR----------------------E--------LKETDIKH 165 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHh----------------------h--------hhhhhHHH
Confidence 46666666666788999999999999765 3455555442 1 12358889
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
|++|+||||+.|.++|.....+|||||||..|-|..+++ ....+.......|..+|+.|+.|||.+.|||||
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk--------a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRD 237 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK--------AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRD 237 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh--------ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhc
Confidence 999999999999999999999999999999999999998 567888999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
||.-||||+.+..|||+|||-++.+. .....-.|+||..|||||++.... .++++|||||||+||||+||+.|
T Consensus 238 LKSPNiLIs~~d~VKIsDFGTS~e~~------~~STkMSFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiP 310 (904)
T KOG4721|consen 238 LKSPNILISYDDVVKISDFGTSKELS------DKSTKMSFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIP 310 (904)
T ss_pred cCCCceEeeccceEEeccccchHhhh------hhhhhhhhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCC
Confidence 99999999999999999999887653 223345789999999999998776 89999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp 325 (520)
|.......++..+-.+. ........+++.|+=||+.||+-.|..||++.++|.|-
T Consensus 311 YkdVdssAIIwGVGsNs--------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 311 YKDVDSSAIIWGVGSNS--------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ccccchheeEEeccCCc--------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 98877666554322221 11222346778899999999999999999999999984
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=334.55 Aligned_cols=265 Identities=25% Similarity=0.395 Sum_probs=211.6
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||.|++|.||+|.+..+|..||+|.++.... ....+.+.+|+.++++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~ 58 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE----------------------EGTPSTAIREISLMKELKHE 58 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc----------------------ccchHHHHHHHHHHHhhcCC
Confidence 58999999999999999999999999999998753211 12234577899999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++...+..++||||+. ++|.+++.... ....+++..+..++.||+.||.|||++|++||||||+||+
T Consensus 59 ~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~ 132 (284)
T cd07836 59 NIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHG-----VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLL 132 (284)
T ss_pred CEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcC-----CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEE
Confidence 99999999999999999999997 48999886421 1246899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
+++++.++|+|||++..+.... .......+++.|+|||.+.+...++.++|+|||||++|+|++|..||......
T Consensus 133 ~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~ 207 (284)
T cd07836 133 INKRGELKLADFGLARAFGIPV-----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE 207 (284)
T ss_pred ECCCCcEEEeecchhhhhcCCc-----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 9999999999999986553221 11123467889999999876655889999999999999999999999876655
Q ss_pred HHHHHHhcCCC-------------C----CCCCC--chhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 270 KVLMLTLQNDP-------------P----TLDTG--AAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 270 ~~~~~~~~~~~-------------~----~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
+....+..... + ..... .........++..++++|.+||+.||.+|||+.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 208 DQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 44433321100 0 00000 00111223567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=334.68 Aligned_cols=266 Identities=21% Similarity=0.346 Sum_probs=210.3
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCC-----CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKAR-----AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
|....++|++.+.||+|+||+||+|.+... +..||+| .+..........++.+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik----------------------~~~~~~~~~~~~~~~~ 58 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIK----------------------TVNEAASMRERIEFLN 58 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEE----------------------eccccCCHHHHHHHHH
Confidence 667889999999999999999999987532 3345554 4433222234456889
Q ss_pred HHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--cCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--NCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
|+.+++.++||||+++++++......++||||+.+++|.+++....... +.....++...+..++.|++.||.|||++
T Consensus 59 e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 138 (277)
T cd05062 59 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN 138 (277)
T ss_pred HHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9999999999999999999999999999999999999999997532110 01123467889999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
|++||||||+||++++++.++|+|||++..+....... ......+++.|+|||++.+.. ++.++|||||||++|+|
T Consensus 139 ~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el 214 (277)
T cd05062 139 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR---KGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEI 214 (277)
T ss_pred CcccCCcchheEEEcCCCCEEECCCCCccccCCcceee---cCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHH
Confidence 99999999999999999999999999987553322111 111234578899999987655 89999999999999999
Q ss_pred Hh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 257 AT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 257 lt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
++ |..||.................+... ...+..+.+++.+||+.+|++|||+.|++++
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 215 ATLAEQPYQGMSNEQVLRFVMEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99 79999887777666555554433322 2356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=336.46 Aligned_cols=270 Identities=26% Similarity=0.349 Sum_probs=212.9
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||.|++|+||+|.++.+|+.||+|.++.... .....+.+.+|+.++++++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~h 60 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE---------------------DEGVPSTAIREISLLKEMQH 60 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc---------------------cccchHHHHHHHHHHHhccC
Confidence 579999999999999999999999999999987643210 01223567889999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++......|+||||+. ++|.+++... ....+++..++.++.||+.||+|||++|++||||+|+||
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~ni 133 (294)
T PLN00009 61 GNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSS------PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNL 133 (294)
T ss_pred CCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhC------CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceE
Confidence 999999999999999999999995 6888888643 233468899999999999999999999999999999999
Q ss_pred EEcC-CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 189 LLGE-DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 189 Ll~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
+++. ++.+||+|||++....... .......+++.|+|||.+.+...++.++|||||||++|+|+||.+||....
T Consensus 134 ll~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 134 LIDRRTNALKLADFGLARAFGIPV-----RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred EEECCCCEEEEcccccccccCCCc-----cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9985 5679999999987553221 111234678999999998765558899999999999999999999998776
Q ss_pred HHHHHHHHhcCCCCCCC-------------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 268 AMKVLMLTLQNDPPTLD-------------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
..+.+............ ...........+++.+.++|.+||+.+|++||++.+++.||||.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~ 288 (294)
T PLN00009 209 EIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288 (294)
T ss_pred HHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence 65555443221100000 00011112245678899999999999999999999999999998
Q ss_pred ccc
Q psy11359 329 KAK 331 (520)
Q Consensus 329 ~~~ 331 (520)
...
T Consensus 289 ~~~ 291 (294)
T PLN00009 289 DLG 291 (294)
T ss_pred HHh
Confidence 653
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=327.69 Aligned_cols=257 Identities=36% Similarity=0.638 Sum_probs=212.9
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|+..+.||+|++|+||+|.+..++..|++|.+...... .......+.+.+|+.+++.++||
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------------------~~~~~~~~~~~~e~~~l~~~~h~ 62 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG------------------QTGQEAVKQLEQEIALLSKLQHP 62 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccc------------------ccchHHHHHHHHHHHHHHhcCCC
Confidence 588889999999999999999999999999976432110 00123456789999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++.....+|++|||+++++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||+|+||+
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~ 134 (258)
T cd06632 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK--------YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANIL 134 (258)
T ss_pred CchheeeeEecCCeEEEEEEecCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 999999999999999999999999999999973 456889999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.++.+||+|||++....... ......|++.|+|||.+.....++.++|+||||+++|+|++|..||......
T Consensus 135 ~~~~~~~kl~d~~~~~~~~~~~------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~ 208 (258)
T cd06632 135 VDTNGVVKLADFGMAKQVVEFS------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV 208 (258)
T ss_pred ECCCCCEEEccCccceeccccc------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH
Confidence 9999999999999987653322 1234578999999999865444789999999999999999999999876654
Q ss_pred HHHHHHhc-CCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 270 KVLMLTLQ-NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 270 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
........ ...+.+ ...+++.+.+|+.+||+.+|.+|||+.+++.|||+
T Consensus 209 ~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 209 AAVFKIGRSKELPPI---------PDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHhcccCCCc---------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 44433322 111111 13467889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=358.07 Aligned_cols=265 Identities=43% Similarity=0.721 Sum_probs=234.6
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
.+...+.|++.++||.|.+|.||+++.+.+|+.+|+|+.... .+.-+++.-|+++|
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~------------------------~d~deEiE~eynil 69 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT------------------------EDEEEEIELEYNML 69 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC------------------------ccccHHHHHHHHHH
Confidence 456778899999999999999999999999999999986532 22345678889999
Q ss_pred hcC-CCCCceEEEEEEEE-----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy11359 104 SSC-HHENVVTYHTSFVV-----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG 177 (520)
Q Consensus 104 ~~l-~HpnIv~~~~~~~~-----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g 177 (520)
+.+ +|||++.+|++|.. .+.+|||||||.|||.-|+++.. ....+.|..|..|++.++.||.+||.+.
T Consensus 70 ~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~------~g~rl~E~~IaYI~re~lrgl~HLH~nk 143 (953)
T KOG0587|consen 70 KKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNT------KGNRLKEEWIAYILREILRGLAHLHNNK 143 (953)
T ss_pred HhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhh------cccchhhHHHHHHHHHHHHHHHHHhhcc
Confidence 877 89999999999974 56899999999999999999875 5678999999999999999999999999
Q ss_pred cEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc----CCCCcchhHHHHHHHH
Q psy11359 178 QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD----HGYDFKADIWSLGITA 253 (520)
Q Consensus 178 iiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~~~~DIwSlG~il 253 (520)
+||||||-.|||++.+|.|||+|||++..+... ...+.+++|||+|||||++.-. ..|+..+|+||||++.
T Consensus 144 viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT-----~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITa 218 (953)
T KOG0587|consen 144 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST-----VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITA 218 (953)
T ss_pred eeeecccCceEEEeccCcEEEeeeeeeeeeecc-----cccccCcCCCcccccceeeecccCCCCCcccccchhhcccee
Confidence 999999999999999999999999999888643 3346789999999999998533 2378899999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 254 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.||.-|.+|+-.+.++..++.+..+.|+.+. .++..+++|.+||..||.+|-.+||+..++|+|||++..
T Consensus 219 IEladG~PPl~DmHPmraLF~IpRNPPPkLk-------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 219 IEMAEGAPPLCDMHPMRALFLIPRNPPPKLK-------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred ehhcCCCCCccCcchhhhhccCCCCCCcccc-------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 9999999999999999999988888887764 246778999999999999999999999999999999843
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=333.19 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=205.0
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHE 109 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~Hp 109 (520)
|++.+.||+|+||.||+|.+..++..+|+|.++.... ........+|+.++.++ +||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~----------------------~~~~~~~~~e~~~l~~l~~h~ 58 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK----------------------SLEQVNNLREIQALRRLSPHP 58 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC----------------------CchhhhHHHHHHHHhhcCCCC
Confidence 7899999999999999999999999999997642110 11112345788899988 499
Q ss_pred CceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 110 NVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 110 nIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||+++++++.+. +.+++||||+. ++|.+++.. ..+.+++..+..++.||+.||.|||++|++||||||+|
T Consensus 59 ~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-------~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~n 130 (282)
T cd07831 59 NILRLIEVLFDRKTGRLALVFELMD-MNLYELIKG-------RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPEN 130 (282)
T ss_pred CccceEEEEecCCCCcEEEEEecCC-ccHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHH
Confidence 999999999987 88999999996 588888864 23578999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
|+++. +.+||+|||++..+..... .....+++.|+|||.+.....++.++|||||||++|+|++|.+||.+.+
T Consensus 131 i~l~~-~~~kl~dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 131 ILIKD-DILKLADFGSCRGIYSKPP------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred EEEcC-CCeEEEecccccccccCCC------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 99999 9999999999876532211 1235688999999987655557899999999999999999999998776
Q ss_pred HHHHHHHHhcCC---CC------------C--CCC--CchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 268 AMKVLMLTLQND---PP------------T--LDT--GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 268 ~~~~~~~~~~~~---~~------------~--~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
..+.+....... +. . ... ..........++..+.+||.+||+++|.+|||+.++++||||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 204 ELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 554433222110 00 0 000 000111223568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=330.06 Aligned_cols=255 Identities=23% Similarity=0.438 Sum_probs=209.5
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.++||+|+||.||+|... ++..||+|.+... ....+.+.+|+.++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~------------------------~~~~~~~~~e~~~l 55 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG------------------------TMSVQAFLEEANLM 55 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC------------------------chhHHHHHHHHHHH
Confidence 6778899999999999999999999865 4556777765311 12345789999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+.++||||+++++++...+..+++|||+.+++|.++++.. ....+++..+..++.||+.||.|||++|++||||
T Consensus 56 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl 129 (261)
T cd05072 56 KTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD------EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDL 129 (261)
T ss_pred HhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 9999999999999999999999999999999999999753 3456889999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||+++.++.++|+|||++........ .......++..|+|||.+.... ++.++|||||||++|+|+| |..|
T Consensus 130 ~p~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p 204 (261)
T cd05072 130 RAANVLVSESLMCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIP 204 (261)
T ss_pred chhhEEecCCCcEEECCCccceecCCCce----eccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCC
Confidence 99999999999999999999976543211 1112334677899999987655 8899999999999999998 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|.................... ...++..+.+++.+||..+|++|||++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 205 YPGMSNSDVMSALQRGYRMPR---------MENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCCHHHHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 988766665554443322111 1246778999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=334.38 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=200.3
Q ss_pred eeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH---HHHhcCCCCCce
Q psy11359 36 VIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI---QAMSSCHHENVV 112 (520)
Q Consensus 36 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei---~~l~~l~HpnIv 112 (520)
+||+|+||.||++.+..+++.+|+|.+....... ........+|. .++...+||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~i~ 60 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--------------------KQGETLALNERIMLSLVSTGDCPFIV 60 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEcccccc--------------------chHHHHHHHHHHHHHHHhhCCCCcEe
Confidence 4899999999999999999999999875321110 01111223333 344456899999
Q ss_pred EEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcC
Q psy11359 113 TYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE 192 (520)
Q Consensus 113 ~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~ 192 (520)
.+++++...+..++||||+.|++|.+++. .++.+++..+..++.||+.||.|||++|++||||||+|||++.
T Consensus 61 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~--------~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~ 132 (279)
T cd05633 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLS--------QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE 132 (279)
T ss_pred EEEEEEecCCeEEEEEecCCCCCHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC
Confidence 99999999999999999999999999987 3467999999999999999999999999999999999999999
Q ss_pred CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH--H
Q psy11359 193 DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM--K 270 (520)
Q Consensus 193 ~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~--~ 270 (520)
++.++|+|||++...... ......||+.|+|||.+.....++.++|||||||++|+|++|..||...... .
T Consensus 133 ~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 205 (279)
T cd05633 133 HGHVRISDLGLACDFSKK-------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205 (279)
T ss_pred CCCEEEccCCcceecccc-------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH
Confidence 999999999998655321 1223478999999999865555899999999999999999999999754321 1
Q ss_pred HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchh
Q psy11359 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDK 333 (520)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~ 333 (520)
.+.......... ....++..++++|.+||..||.+|| |+.++++||||+.....
T Consensus 206 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 206 EIDRMTLTVNVE---------LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred HHHHHhhcCCcC---------CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence 221111111111 1235678999999999999999999 69999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=332.70 Aligned_cols=258 Identities=45% Similarity=0.783 Sum_probs=216.0
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
+-|++.+.||.|+||.||+|.+..++..+|+|.+... ........+.+|+.++++++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~----------------------~~~~~~~~~~~e~~~l~~l~h 61 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----------------------EAEDEIEDIQQEITVLSQCDS 61 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc----------------------cchHHHHHHHHHHHHHHhcCC
Confidence 4588899999999999999999999888888875321 112234568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++..++..|+||||+.+++|.+++. .+.+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus 62 ~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~---------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni 132 (277)
T cd06641 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---------PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 132 (277)
T ss_pred CCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhE
Confidence 999999999999999999999999999999985 24688999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++.++.++|+|||++..+.... .......|+..|+|||.+.... ++.++|+|||||++|+|++|..||.....
T Consensus 133 ~i~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 206 (277)
T cd06641 133 LLSEHGEVKLADFGVAGQLTDTQ-----IKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHP 206 (277)
T ss_pred EECCCCCEEEeecccceecccch-----hhhccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccch
Confidence 99999999999999987653321 1123457889999999987554 78899999999999999999999987766
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
...........++.+. ..++.++.++|.+||+.+|.+||++.++++||||.....
T Consensus 207 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 207 MKVLFLIPKNNPPTLE---------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred HHHHHHHhcCCCCCCC---------cccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 5555544333333222 346788999999999999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=334.20 Aligned_cols=273 Identities=21% Similarity=0.345 Sum_probs=214.2
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
|....++|++.+.||+|+||.||+|.++. .+..||+|.+ ...........+.+
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~----------------------~~~~~~~~~~~~~~ 58 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV----------------------NESASLRERIEFLN 58 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEEC----------------------CCcCCHHHHHHHHH
Confidence 67788999999999999999999997653 2334555544 22222223445788
Q ss_pred HHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--cCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--NCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
|+.+++.++||||+++++++......++||||+.+|+|.++++...... ......++...+..++.||+.||.|||++
T Consensus 59 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 138 (288)
T cd05061 59 EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK 138 (288)
T ss_pred HHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999999999999999997643211 11234557788999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
|++||||||+|||++.++.++|+|||+++.+...... .......++..|+|||.+.+.. ++.++|+|||||++|+|
T Consensus 139 ~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el 214 (288)
T cd05061 139 KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 214 (288)
T ss_pred CCcCCCCChheEEEcCCCcEEECcCCccccccccccc---cccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHH
Confidence 9999999999999999999999999998755322211 1112234577899999987655 89999999999999999
Q ss_pred Hh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc------Cccccc
Q psy11359 257 AT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK------NPFFKK 329 (520)
Q Consensus 257 lt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~------hp~~~~ 329 (520)
++ |..||......+.............. ...++.+.+++.+||+.+|++|||+.++++ ||||..
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 215 TSLAEQPYQGLSNEQVLKFVMDGGYLDQP---------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 98 79999887766655554443322221 234678999999999999999999999986 888876
Q ss_pred cc
Q psy11359 330 AK 331 (520)
Q Consensus 330 ~~ 331 (520)
..
T Consensus 286 ~~ 287 (288)
T cd05061 286 VS 287 (288)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=302.20 Aligned_cols=267 Identities=24% Similarity=0.378 Sum_probs=219.2
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchh-hHHHHHHHHHHHhcCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNT-SMDELLKEIQAMSSCH 107 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~-~~~~l~~Ei~~l~~l~ 107 (520)
.+|.-.++||+|.+|+||+|+++++++.||+|.++.+ ...+ ......+||-+++.|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrld----------------------dddegvpssalreicllkelk 59 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLD----------------------DDDEGVPSSALREICLLKELK 59 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEecc----------------------CCCCCCcHHHHHHHHHHHHhh
Confidence 4577889999999999999999999888888877543 2122 3445889999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|.|||+++++...++.+-+|+||| ..+|..|... -++.++.+.++.++.|+++||.++|++++.||||||.|
T Consensus 60 hknivrl~dvlhsdkkltlvfe~c-dqdlkkyfds-------lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqn 131 (292)
T KOG0662|consen 60 HKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDS-------LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQN 131 (292)
T ss_pred hcceeehhhhhccCceeEEeHHHh-hHHHHHHHHh-------cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcce
Confidence 999999999999999999999999 4588888875 57889999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKY 266 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~ 266 (520)
+||..+|.+||+|||+++.++-.. +-...-+-|.+|++|.++.+..-|+...|+||.|||+.|+.. |.+.|++.
T Consensus 132 llin~ngelkladfglarafgipv-----rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 132 LLINRNGELKLADFGLARAFGIPV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred EEeccCCcEEecccchhhhcCCce-----EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 999999999999999998764321 122334679999999999998889999999999999999997 88889998
Q ss_pred cHHHHHHHHhcCCC-------CCC------------CCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 267 PAMKVLMLTLQNDP-------PTL------------DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 267 ~~~~~~~~~~~~~~-------~~~------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
+-.++++.+...-. |.+ +....-....+.++..-++++.++|..+|.+|++++++++||||
T Consensus 207 dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf 286 (292)
T KOG0662|consen 207 DVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF 286 (292)
T ss_pred cHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence 88888776553211 111 00000111223455667999999999999999999999999999
Q ss_pred ccc
Q psy11359 328 KKA 330 (520)
Q Consensus 328 ~~~ 330 (520)
...
T Consensus 287 ~d~ 289 (292)
T KOG0662|consen 287 SDF 289 (292)
T ss_pred ccc
Confidence 753
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=328.33 Aligned_cols=256 Identities=29% Similarity=0.543 Sum_probs=213.6
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||+|+||.||++.++.+|..+|+|.+...... ....+.+.+|+.+++.++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------------------~~~~~~~~~E~~~l~~~~h~ 59 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP---------------------VKEKEASKKEVILLAKMKHP 59 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc---------------------chhhHHHHHHHHHHHhCCCC
Confidence 589999999999999999999999988998877532110 11235678999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++.+......++|+||+.+++|.+++... ....+++..+..++.||+.||.|||+++++|+||||+||+
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil 133 (257)
T cd08225 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ------RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIF 133 (257)
T ss_pred ChhhhhheeccCCeEEEEEecCCCCcHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEE
Confidence 9999999999999999999999999999999753 2345799999999999999999999999999999999999
Q ss_pred EcCCC-CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 190 LGEDG-TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 190 l~~~g-~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++++ .++|+|||.+..+..... ......|++.|+|||++.... ++.++|+||||+++++|++|..||.....
T Consensus 134 ~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 207 (257)
T cd08225 134 LSKNGMVAKLGDFGIARQLNDSME-----LAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNL 207 (257)
T ss_pred EcCCCCeEEecccccchhccCCcc-----cccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 98876 469999999876643221 122356899999999887654 88999999999999999999999987766
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.+.............. ..++..+.++|.+||..+|++|||+.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 208 HQLVLKICQGYFAPIS---------PNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHhcccCCCCC---------CCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 6666555444322221 3457789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=335.20 Aligned_cols=249 Identities=17% Similarity=0.240 Sum_probs=202.1
Q ss_pred CCCeEEE--eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 28 EDQYEVR--EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 28 ~~~Y~i~--~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
.++++.. ..||+|+++.||+|.. +|+.||+|.++.... ......+.+.+|+.+|++
T Consensus 17 ~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~--------------------~~~~~~~~~~~E~~~l~~ 74 (283)
T PHA02988 17 SDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK--------------------GHKVLIDITENEIKNLRR 74 (283)
T ss_pred HHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEecccccc--------------------ccHHHHHHHHHHHHHHHh
Confidence 3344444 6799999999999987 577888887643210 012235678899999999
Q ss_pred CCCCCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEe
Q psy11359 106 CHHENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN-GQIH 180 (520)
Q Consensus 106 l~HpnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~-giiH 180 (520)
++||||+++++++.+ ...+++||||+.||+|.+++.. .+.+++.....++.|++.||.|||+. +++|
T Consensus 75 l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~H 146 (283)
T PHA02988 75 IDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK--------EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY 146 (283)
T ss_pred cCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh--------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 999999999999877 4578999999999999999973 45788999999999999999999984 9999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc-CCCCcchhHHHHHHHHHHHHhC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DIwSlG~il~elltG 259 (520)
|||||+|||+++++.+||+|||++..+... .....||+.|+|||++.+. ..++.++|||||||++|+|+||
T Consensus 147 rdlkp~nill~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g 218 (283)
T PHA02988 147 KNLTSVSFLVTENYKLKIICHGLEKILSSP--------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218 (283)
T ss_pred CcCChhhEEECCCCcEEEcccchHhhhccc--------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHC
Confidence 999999999999999999999998765321 1234689999999998652 3489999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcCCC-CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
..||......+.......... +.++ ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 219 ~~Pf~~~~~~~~~~~i~~~~~~~~~~---------~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 219 KIPFENLTTKEIYDLIINKNNSLKLP---------LDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCC---------CcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 999998877666655543322 1111 245788999999999999999999999985
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=340.86 Aligned_cols=264 Identities=39% Similarity=0.656 Sum_probs=217.2
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....+.|.....||.|+||.||++.+..++..||||.+... .....+.+.+|+.+++
T Consensus 18 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----------------------~~~~~~~~~~e~~~l~ 74 (292)
T cd06658 18 GDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----------------------KQQRRELLFNEVVIMR 74 (292)
T ss_pred CchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----------------------hHHHHHHHHHHHHHHH
Confidence 34556677788999999999999999999888888876421 1223456889999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
.++||||+++++.+...+..|+||||+.+++|.+++. .+.+++..+..++.||+.||.|||++|++|||||
T Consensus 75 ~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk 145 (292)
T cd06658 75 DYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145 (292)
T ss_pred hCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCC
Confidence 9999999999999999999999999999999999885 2458899999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+||++++++.++|+|||++..+.... .......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.
T Consensus 146 p~Nill~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 146 SDSILLTSDGRIKLSDFGFCAQVSKEV-----PKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred HHHEEEcCCCCEEEccCcchhhccccc-----ccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999886543211 1123457899999999987654 8899999999999999999999998
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
.......+.......++.+.. ...++..+.++|.+||..||.+|||+.++++||||......
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 220 NEPPLQAMRRIRDNLPPRVKD-------SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred CCCHHHHHHHHHhcCCCcccc-------ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 766655544333222222111 12457789999999999999999999999999999866543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=337.41 Aligned_cols=263 Identities=43% Similarity=0.716 Sum_probs=216.4
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||++.+..++..||+|.+.... ....+.+.+|+.+++
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----------------------~~~~~~~~~e~~~l~ 71 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-----------------------QPKKELIINEILVMR 71 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-----------------------chHHHHHHHHHHHHh
Confidence 445689999999999999999999999998888888763210 122456889999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
.++||||+++++++...+..|+|+||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++|||||
T Consensus 72 ~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~ 142 (293)
T cd06647 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142 (293)
T ss_pred hcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCC
Confidence 99999999999999999999999999999999999863 357889999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+||+++.++.++|+|||++..+.... .......|++.|+|||.+.... ++.++|+||||+++|+|++|..||.
T Consensus 143 p~Nili~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~ 216 (293)
T cd06647 143 SDNILLGMDGSVKLTDFGFCAQITPEQ-----SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYL 216 (293)
T ss_pred HHHEEEcCCCCEEEccCcceecccccc-----cccccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999887553221 1223457899999999987654 8899999999999999999999998
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
................+... ....++..++++|.+||..+|.+||++.+++.|+||+..+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 217 NENPLRALYLIATNGTPELQ-------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred CCChhhheeehhcCCCCCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 76554433222222111111 12346778999999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=329.25 Aligned_cols=280 Identities=28% Similarity=0.386 Sum_probs=214.0
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchh-hHHHHHHHHHHHhcC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNT-SMDELLKEIQAMSSC 106 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~-~~~~l~~Ei~~l~~l 106 (520)
...|++...||+|.+|.||+|..+.++.+ +...+|||++..++... ......+|+.+++.+
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~k------------------r~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl 84 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDK------------------RTKEYAIKKFKGEKDGTGISMSACREIALLREL 84 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcc------------------cchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh
Confidence 45799999999999999999966655321 12345555555553332 223578999999999
Q ss_pred CCCCceEEEEEEEE-CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 HHENVVTYHTSFVV-KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 ~HpnIv~~~~~~~~-~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+||||+.+..+|.. +..+|+++||.+. +|+.+|+..... +...++...++.++.||+.|+.|||++-|+||||||
T Consensus 85 ~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~---~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKP 160 (438)
T KOG0666|consen 85 KHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRAS---KAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKP 160 (438)
T ss_pred cCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccc---hhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCc
Confidence 99999999999987 7889999999975 899999875443 346899999999999999999999999999999999
Q ss_pred CcEEEcCC----CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 186 GNILLGED----GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 186 ~NILl~~~----g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
.|||+..+ |.|||+|||+++.+.+.-. .-.....++-|.+|+|||++.+...|+.++|||++|||+.||+|-++
T Consensus 161 aNIlvmgdgperG~VKIaDlGlaR~~~~plk--pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~P 238 (438)
T KOG0666|consen 161 ANILVMGDGPERGRVKIADLGLARLFNNPLK--PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEP 238 (438)
T ss_pred ceEEEeccCCccCeeEeecccHHHHhhcccc--ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCc
Confidence 99999776 8999999999998865322 11123456789999999999999999999999999999999999888
Q ss_pred CCCCCcH------------HHHHHHHhcCCC----CCC---CCCch-----h------------hhhHHHhcHHHHHHHH
Q psy11359 262 PYHKYPA------------MKVLMLTLQNDP----PTL---DTGAA-----E------------KDQYKAYGKTFRKMIS 305 (520)
Q Consensus 262 Pf~~~~~------------~~~~~~~~~~~~----~~~---~~~~~-----~------------~~~~~~~~~~~~~li~ 305 (520)
.|.+... ...++.++.... +.+ +.... . ....+.-++...+|+.
T Consensus 239 lF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~ 318 (438)
T KOG0666|consen 239 LFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQ 318 (438)
T ss_pred cccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHH
Confidence 8854321 122223322211 000 00000 0 0011223556889999
Q ss_pred hhhccCCCCCCCHHHHhcCccccccc
Q psy11359 306 DCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 306 ~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
+||+.||.+|+|++++|+|+||+...
T Consensus 319 klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 319 KLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred HHhccCchhhccHHHHhcccccccCC
Confidence 99999999999999999999998753
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=340.02 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=203.6
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
...+|++.+.||+|+||+||+|.+..++..+++ .+|+|.+.........+++.+|+.+++.+
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~------------------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l 66 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------------------PVAIKELREATSPKANKEILDEAYVMASV 66 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccce------------------eEEEEeccccCCHHHHHHHHHHHHHHHhC
Confidence 467899999999999999999998776654211 13344433322234456788999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++... ..++|++|+.+|+|.+++.. ....+++..+..++.||+.||+|||++||+||||||+
T Consensus 67 ~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~-------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~ 138 (316)
T cd05108 67 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE-------HKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAAR 138 (316)
T ss_pred CCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHh-------ccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchh
Confidence 999999999988764 57899999999999999975 3456889999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHK 265 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~ 265 (520)
|||++.++.+||+|||++..+...... .......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+
T Consensus 139 Nill~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 139 NVLVKTPQHVKITDFGLAKLLGADEKE---YHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred heEecCCCcEEEccccccccccCCCcc---eeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999876432211 1112233467899999987655 8999999999999999998 9999987
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
.+................+ ..++..+.+++.+||..+|.+|||+.+++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 215 IPASEISSILEKGERLPQP---------PICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCHHHHHHHHhCCCCCCCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7655543322222211111 2356778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=332.47 Aligned_cols=254 Identities=30% Similarity=0.468 Sum_probs=212.7
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
.|++.+.||.|+||.||+|.+..++..||+|++...... .....+.+.+|++++++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------------------~~~~~~~~~~e~~~l~~l~h~ 60 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV--------------------EKGSVRNVLNERRILQELNHP 60 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc--------------------chhHHHHHHHHHHHHHhCCCC
Confidence 489999999999999999999999999999987532110 012356789999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++.+......++||||+.|++|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|.||+
T Consensus 61 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil 132 (258)
T cd05578 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ--------KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNIL 132 (258)
T ss_pred ChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh--------cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 999999999999999999999999999999974 357899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH-
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA- 268 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~- 268 (520)
+++++.++|+|||++....... ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||.....
T Consensus 133 ~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 205 (258)
T cd05578 133 LDEQGHVHITDFNIATKVTPDT------LTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRT 205 (258)
T ss_pred EcCCCCEEEeecccccccCCCc------cccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCcc
Confidence 9999999999999987654321 223456889999999987655 89999999999999999999999987663
Q ss_pred -HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH--HHHhcCccc
Q psy11359 269 -MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA--SELLKNPFF 327 (520)
Q Consensus 269 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta--~elL~hp~~ 327 (520)
...+........... ...++..+.++|.+||..||.+||++ .|++.||||
T Consensus 206 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 206 IRDQIRAKQETADVLY---------PATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHHhccccccC---------cccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 233322222111111 13456889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=338.28 Aligned_cols=272 Identities=27% Similarity=0.380 Sum_probs=208.2
Q ss_pred CeEEEeeeeecCceEEEEEEEcC--CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKA--RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
+|++.++||+|+||.||+|.+.. ++..||+|.+..... ......+.+.+|+.+++.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--------------------~~~~~~~~~~~e~~~l~~l~ 60 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--------------------QYTGISQSACREIALLRELK 60 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--------------------cccCccHHHHHHHHHHHhcC
Confidence 58999999999999999999998 888899988753210 11222355788999999999
Q ss_pred CCCceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 108 HENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 108 HpnIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
||||+++++++... ..+|+||||+. ++|.+++...... ....+++..++.++.||+.||.|||++|++||||||
T Consensus 61 h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp 136 (316)
T cd07842 61 HENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQA---KRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKP 136 (316)
T ss_pred CCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccC---CCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCH
Confidence 99999999999988 88999999996 5788887643221 234789999999999999999999999999999999
Q ss_pred CcEEEcC----CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 186 GNILLGE----DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 186 ~NILl~~----~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
+||+++. ++.+||+|||++..+...... ........+|+.|+|||++.+...++.++|||||||++|+|++|.+
T Consensus 137 ~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 214 (316)
T cd07842 137 ANILVMGEGPERGVVKIGDLGLARLFNAPLKP--LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214 (316)
T ss_pred HHEEEcCCCCccceEEECCCccccccCCCccc--ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCC
Confidence 9999998 899999999998765432211 1122345789999999998776668999999999999999999999
Q ss_pred CCCCCcHHH---------H---HHHHhcCC----------------------CCCCCCCchh--hhhHHHhcHHHHHHHH
Q psy11359 262 PYHKYPAMK---------V---LMLTLQND----------------------PPTLDTGAAE--KDQYKAYGKTFRKMIS 305 (520)
Q Consensus 262 Pf~~~~~~~---------~---~~~~~~~~----------------------~~~~~~~~~~--~~~~~~~~~~~~~li~ 305 (520)
||....... . +...+... .......... .......+..+.++|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 294 (316)
T cd07842 215 IFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294 (316)
T ss_pred CCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHH
Confidence 997543321 0 00111000 0000000000 0011246778999999
Q ss_pred hhhccCCCCCCCHHHHhcCccc
Q psy11359 306 DCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 306 ~~L~~dP~~Rpta~elL~hp~~ 327 (520)
+||++||++|||+.|++.||||
T Consensus 295 ~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 295 KLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhcCCcccCcCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=328.13 Aligned_cols=258 Identities=29% Similarity=0.518 Sum_probs=208.7
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... ........+.+|+.+++.++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------------------~~~~~~~~~~~e~~~l~~l~h 61 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM--------------------MDAKARQDCVKEIDLLKQLNH 61 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc--------------------CCHHHHHHHHHHHHHHHhCCC
Confidence 579999999999999999999999999999987642110 112334568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+..++||||+.+++|.+++..... ....+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 62 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni 137 (267)
T cd08228 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKK----QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANV 137 (267)
T ss_pred cceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhh----ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHE
Confidence 9999999999999999999999999999999875322 345689999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++.++.++|+|||++..+.... .......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.....
T Consensus 138 l~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~ 211 (267)
T cd08228 138 FITATGVVKLGDLGLGRFFSSKT-----TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred EEcCCCCEEECccccceeccchh-----HHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccc
Confidence 99999999999999987654321 1123457889999999987654 88999999999999999999999865432
Q ss_pred --HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 269 --MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 269 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
............+.. ....++..+.++|.+||+.+|++|||+.++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 212 NLFSLCQKIEQCDYPPL--------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred cHHHHHHHHhcCCCCCC--------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 222222222222211 123467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.05 Aligned_cols=258 Identities=40% Similarity=0.690 Sum_probs=215.5
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||.|++|.||+|.+..+++.|++|+++.. ........+.+|+..+.+++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~----------------------~~~~~~~~~~~e~~~l~~l~~ 58 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVD----------------------GDEEFRKQLLRELKTLRSCES 58 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccC----------------------cchHHHHHHHHHHHHHHhcCC
Confidence 4699999999999999999999999888888876432 111335678999999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccCCCc
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGN 187 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLKp~N 187 (520)
|||+++++++...+..++||||+.+++|.+++.. ...+++..+..++.||++||.|||+ +|++||||+|+|
T Consensus 59 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~n 130 (264)
T cd06623 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK--------VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSN 130 (264)
T ss_pred CCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHH
Confidence 9999999999999999999999999999999974 3678999999999999999999999 999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
|+++.++.++|+|||++..+..... ......++..|+|||.+.... ++.++|+||||+++|+|+||..||....
T Consensus 131 i~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 131 LLINSKGEVKIADFGISKVLENTLD-----QCNTFVGTVTYMSPERIQGES-YSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred EEECCCCCEEEccCccceecccCCC-----cccceeecccccCHhhhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999876643221 112456889999999987664 8999999999999999999999997764
Q ss_pred ---HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 268 ---AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 268 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.............+.... ..++..+.++|.+||.++|++|||+.++++||||+..
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 205 QPSFFELMQAICDGPPPSLPA--------EEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ccCHHHHHHHHhcCCCCCCCc--------ccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 233333333222222211 1167889999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=345.16 Aligned_cols=275 Identities=28% Similarity=0.406 Sum_probs=214.7
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||.|+||.||+|.++.+|..||+|.+.... ........+.+|+.+|++++
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~---------------------~~~~~~~~~~~e~~~l~~l~ 62 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------------------DVPTLAKRTLRELKILRHFK 62 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc---------------------ccccchHHHHHHHHHHHhcC
Confidence 378999999999999999999999999999999764211 00123456788999999999
Q ss_pred CCCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 108 HENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 108 HpnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
||||+++++++.. ...+++||||+. ++|.+++. ..+.+++..++.++.||+.||.|||++|++||||
T Consensus 63 h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dl 133 (334)
T cd07855 63 HDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIH--------SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDL 133 (334)
T ss_pred CCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 9999999988763 356899999995 68999886 3456899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
||+||+++.+|.+||+|||++..+...... .........|+..|+|||.+.+...++.++|||||||++|+|++|+.||
T Consensus 134 kp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf 212 (334)
T cd07855 134 KPSNLLVNEDCELRIGDFGMARGLSSSPTE-HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212 (334)
T ss_pred CHHHEEEcCCCcEEecccccceeecccCcC-CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc
Confidence 999999999999999999998765432211 1122234578999999999876555899999999999999999999999
Q ss_pred CCCcHHHHHHHHhc---CCCCCCC------------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 264 HKYPAMKVLMLTLQ---NDPPTLD------------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 264 ~~~~~~~~~~~~~~---~~~~~~~------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
........+..... ..++.+. ............+..+.++|.+||+.+|.+|||+.+++
T Consensus 213 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 213 PGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred CCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 77654433322111 1000000 00000112245688999999999999999999999999
Q ss_pred cCccccccchh
Q psy11359 323 KNPFFKKAKDK 333 (520)
Q Consensus 323 ~hp~~~~~~~~ 333 (520)
.||||......
T Consensus 293 ~~~~~~~~~~~ 303 (334)
T cd07855 293 QHPFLAQYHDP 303 (334)
T ss_pred hChhhhhccCC
Confidence 99999866554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=319.31 Aligned_cols=274 Identities=27% Similarity=0.383 Sum_probs=211.6
Q ss_pred CCCCCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHH
Q psy11359 17 SASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDEL 96 (520)
Q Consensus 17 ~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l 96 (520)
..+.....-.++.+|++.+.||.|||+.||++....++..+|+|++... . .+..+..
T Consensus 9 ~~c~~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----------------------~-~~~~e~~ 65 (302)
T KOG2345|consen 9 CVCRRGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----------------------S-QEDIEEA 65 (302)
T ss_pred eEeCCCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc----------------------c-hHHHHHH
Confidence 3333444557889999999999999999999999999888888876432 1 3567889
Q ss_pred HHHHHHHhcCCCCCceEEEEEEEE-----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHH
Q psy11359 97 LKEIQAMSSCHHENVVTYHTSFVV-----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLE 171 (520)
Q Consensus 97 ~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~ 171 (520)
++|+...++++|||+++++++... ....||+++|...|||.+.+..... ++..+++.++..|+.+|++||+
T Consensus 66 ~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~----kg~~~sE~~iL~if~gic~gL~ 141 (302)
T KOG2345|consen 66 LREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKI----KGNFVSEAQILWIFLGICRGLE 141 (302)
T ss_pred HHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhh----cCCccCHHHHHHHHHHHHHHHH
Confidence 999999999999999999887653 3459999999999999999987644 5668999999999999999999
Q ss_pred HHHHCC--cEecccCCCcEEEcCCCCeEEeccCcceeecc----CccccccccccccccccccCCcceeccc--CCCCcc
Q psy11359 172 YFHSNG--QIHRDIKAGNILLGEDGTVQIADFGVSAWLAT----GRDLSRQKVRHTFVGTPCWMAPEVMEQD--HGYDFK 243 (520)
Q Consensus 172 yLH~~g--iiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~----~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~~ 243 (520)
+||... ++||||||.|||+++.+.++|.|||.++...- .....+-.-...-..|..|+|||++.-. ...+++
T Consensus 142 ~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er 221 (302)
T KOG2345|consen 142 ALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER 221 (302)
T ss_pred HHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc
Confidence 999998 99999999999999999999999999865421 1111111111223468899999998532 237899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 244 ADIWSLGITAIEMATGTAPYHKYPAM-KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 244 ~DIwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
+|||||||+||.|+.|.-||...-.. .-+....++....+ .....+|..+.++|+.||+.||.+||++.+++
T Consensus 222 tDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~-------P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll 294 (302)
T KOG2345|consen 222 TDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISI-------PNSSRYSEALHQLIKSMLQVDPNQRPTIPELL 294 (302)
T ss_pred cchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecccccc-------CCCCCccHHHHHHHHHHhcCCcccCCCHHHHH
Confidence 99999999999999999999542110 00000111111111 11134889999999999999999999999998
Q ss_pred cC
Q psy11359 323 KN 324 (520)
Q Consensus 323 ~h 324 (520)
.+
T Consensus 295 ~~ 296 (302)
T KOG2345|consen 295 SK 296 (302)
T ss_pred HH
Confidence 64
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=345.08 Aligned_cols=265 Identities=26% Similarity=0.412 Sum_probs=208.1
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+|+.||+|.+.... ........+.+|+.+++++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l 72 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---------------------QNVTHAKRAYRELVLMKLV 72 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc---------------------cChhHHHHHHHHHHHHHhc
Confidence 4578999999999999999999999999999999764211 0122345678899999999
Q ss_pred CCCCceEEEEEEEEC------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+||||++++++|... ...|+||||+. ++|.+++.. .+++..+..++.||+.||.|||++|++|
T Consensus 73 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----------~l~~~~~~~~~~ql~~aL~~LH~~gi~H 141 (353)
T cd07850 73 NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----------DLDHERMSYLLYQMLCGIKHLHSAGIIH 141 (353)
T ss_pred CCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 999999999988644 35799999995 589888852 2889999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+||+++.++.+||+|||++....... ......|++.|+|||.+.+.. ++.++|||||||++|+|++|+
T Consensus 142 ~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~ 214 (353)
T cd07850 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTSF------MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGT 214 (353)
T ss_pred CCCCHHHEEECCCCCEEEccCccceeCCCCC------CCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCC
Confidence 9999999999999999999999997653321 123457899999999987654 899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCC---------------------CC---------C---CchhhhhHHHhcHHHHHHHHhh
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPT---------------------LD---------T---GAAEKDQYKAYGKTFRKMISDC 307 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~---------------------~~---------~---~~~~~~~~~~~~~~~~~li~~~ 307 (520)
.||...+.......+....... .. . ...........++.+++||.+|
T Consensus 215 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 294 (353)
T cd07850 215 VLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKM 294 (353)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHH
Confidence 9998766544333222110000 00 0 0000000123466789999999
Q ss_pred hccCCCCCCCHHHHhcCcccccc
Q psy11359 308 LQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 308 L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
|+.||++|||+.|+|.||||+..
T Consensus 295 L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 295 LVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred cCCChhhCcCHHHHhcChhHhhc
Confidence 99999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=342.32 Aligned_cols=272 Identities=30% Similarity=0.486 Sum_probs=208.3
Q ss_pred Eeeeeec--CceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCc
Q psy11359 34 REVIGFG--ATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENV 111 (520)
Q Consensus 34 ~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnI 111 (520)
...||+| +|++||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~~e~~~~~~l~h~ni 61 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC---------------------TEEHLKALQNEVVLSHFFRHPNI 61 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC---------------------CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3467777 999999999999999999997643210 12235678899999999999999
Q ss_pred eEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEc
Q psy11359 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191 (520)
Q Consensus 112 v~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~ 191 (520)
++++++|..++..++||||+.+++|.++++.. ....+++..+..++.||+.||.|||++|++||||||+|||++
T Consensus 62 v~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~------~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~ 135 (328)
T cd08226 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTY------FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS 135 (328)
T ss_pred ceEeeeEecCCceEEEEecccCCCHHHHHHhh------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe
Confidence 99999999999999999999999999999753 234589999999999999999999999999999999999999
Q ss_pred CCCCeEEeccCcceeeccCcccccc--ccccccccccccCCcceeccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 192 EDGTVQIADFGVSAWLATGRDLSRQ--KVRHTFVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 192 ~~g~vkL~DFG~a~~~~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
.++.++++||+.+............ .......++..|+|||++.+. ..++.++|||||||++|+|++|..||.....
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 215 (328)
T cd08226 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR 215 (328)
T ss_pred CCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh
Confidence 9999999999865433211110000 001112356679999998764 3478999999999999999999999987665
Q ss_pred HHHHHHHhcCCCCCCC-------------------------------------CCchhhhhHHHhcHHHHHHHHhhhccC
Q psy11359 269 MKVLMLTLQNDPPTLD-------------------------------------TGAAEKDQYKAYGKTFRKMISDCLQKD 311 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~~~~~li~~~L~~d 311 (520)
.......+...+.... ...........+++.+.+||.+||+.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 295 (328)
T cd08226 216 TQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQD 295 (328)
T ss_pred HHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCC
Confidence 5444333332211000 000011123456788999999999999
Q ss_pred CCCCCCHHHHhcCccccccch
Q psy11359 312 PTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 312 P~~Rpta~elL~hp~~~~~~~ 332 (520)
|.+|||+.|+|+||||+....
T Consensus 296 P~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 296 PEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred cccCCCHHHHhhCHHHHHHHH
Confidence 999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=325.51 Aligned_cols=261 Identities=31% Similarity=0.557 Sum_probs=213.2
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|.+.+.||+|+||.||+|.+..++..||+|.++.... .......+.+|+.+++.++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------------~~~~~~~~~~e~~~~~~l~~~ 59 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN---------------------DPKTIKEIADEMKVLELLKHP 59 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc---------------------chHHHHHHHHHHHHHHhCCCC
Confidence 69999999999999999999999999999998753211 023567799999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++...+.+++|+||+.+++|.+++.. .+.+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil 131 (264)
T cd06626 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH--------GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIF 131 (264)
T ss_pred ChhheeeeEecCCEEEEEEecCCCCcHHHHHhh--------cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 999999999999999999999999999999973 456889999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH--GYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
+++++.+||+|||++.......... ........+++.|+|||++.+.. .++.++||||||+++|+|++|..||....
T Consensus 132 ~~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 132 LDHNGVIKLGDFGCAVKLKNNTTTM-GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred ECCCCCEEEcccccccccCCCCCcc-cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 9999999999999987764332211 11122356889999999986543 37889999999999999999999997653
Q ss_pred H-HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 268 A-MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 268 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
. ............+.++. ...++..+.+||.+||+.+|.+|||+.+++.|||+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 211 NEFQIMFHVGAGHKPPIPD-------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred chHHHHHHHhcCCCCCCCc-------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 3 23332222222222221 13457888999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=333.36 Aligned_cols=264 Identities=26% Similarity=0.382 Sum_probs=210.4
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
|++.+.||.|++|.||+|.+..+|..||+|++...... ....+.+.+|+.+++.++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~~~~ 59 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED---------------------EGVPSTAIREISLLKELNHPN 59 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc---------------------ccchhHHHHHHHHHHhcCCCC
Confidence 67899999999999999999999999999877532110 112345788999999999999
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl 190 (520)
|+++++++...+..|++|||+. ++|.+++... ....+++..+..++.||+.||.|||+++++||||+|+||++
T Consensus 60 iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~ 132 (283)
T cd07835 60 IVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSS------PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI 132 (283)
T ss_pred ccCHhheeccCCeEEEEEeccC-cCHHHHHhhC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE
Confidence 9999999999999999999994 6999998743 22468999999999999999999999999999999999999
Q ss_pred cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q psy11359 191 GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270 (520)
Q Consensus 191 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~ 270 (520)
+.++.++|+|||++..+..... ......+++.|+|||++.+...++.++||||||+++|+|++|.+||.......
T Consensus 133 ~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 207 (283)
T cd07835 133 DREGALKLADFGLARAFGVPVR-----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID 207 (283)
T ss_pred cCCCcEEEeecccccccCCCcc-----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999865532211 11233568899999988765557899999999999999999999998776655
Q ss_pred HHHHHhcCCCCCC-----------------C--CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 271 VLMLTLQNDPPTL-----------------D--TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 271 ~~~~~~~~~~~~~-----------------~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.+........... . ...........++..+.++|.+||+++|.+|||+.|++.||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 208 QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 4443322110000 0 0001112234567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=332.09 Aligned_cols=255 Identities=28% Similarity=0.422 Sum_probs=207.2
Q ss_pred eeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEEE
Q psy11359 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHT 116 (520)
Q Consensus 37 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~~ 116 (520)
||+|+||+||+|.+..+|+.||+|.+....... ......+.+|+.++++++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 60 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK--------------------RKGEQMALNEKKILEKVSSRFIVSLAY 60 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh--------------------hhhhHHHHHHHHHHHhCCCCCEeeeee
Confidence 699999999999999999999999876432110 122345678999999999999999999
Q ss_pred EEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCe
Q psy11359 117 SFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196 (520)
Q Consensus 117 ~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~v 196 (520)
++...+.+|+||||+++++|.+++... ....+++..+..++.||+.||.|||++|++||||+|+||++++++.+
T Consensus 61 ~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~ 134 (277)
T cd05577 61 AFETKDDLCLVMTLMNGGDLKYHIYNV------GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNV 134 (277)
T ss_pred EEecCCeEEEEEecCCCCcHHHHHHHc------CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE
Confidence 999999999999999999999999753 23468999999999999999999999999999999999999999999
Q ss_pred EEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH---HHHHH
Q psy11359 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA---MKVLM 273 (520)
Q Consensus 197 kL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~---~~~~~ 273 (520)
+|+|||++..+.... ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... ...+.
T Consensus 135 ~l~dfg~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 207 (277)
T cd05577 135 RISDLGLAVELKGGK------KIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK 207 (277)
T ss_pred EEccCcchhhhccCC------ccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH
Confidence 999999887653211 123456788999999987665 89999999999999999999999976543 11111
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDK 333 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~ 333 (520)
......+.. ....+++.+.++|.+||+.+|.+|| ++.+++.||||......
T Consensus 208 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 208 RRTLEMAVE---------YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred hcccccccc---------CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 111111111 1234688999999999999999999 89999999999876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.43 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=201.9
Q ss_pred eeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEE
Q psy11359 36 VIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYH 115 (520)
Q Consensus 36 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~ 115 (520)
+||+|+||.||+|.+..+++.||+|.+....... .............+.+++.+.||||++++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 63 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-----------------KQGETLALNERIMLSLVSTGDCPFIVCMS 63 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeecccccc-----------------chhHHHHHHHHHHHHHHHhCCCCcEeeee
Confidence 4899999999999999999999999875321110 00000111122334456667899999999
Q ss_pred EEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCC
Q psy11359 116 TSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195 (520)
Q Consensus 116 ~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~ 195 (520)
+++...+.+++||||+.|++|.+++. ..+.+++..++.++.|++.||.|||+++++||||||+||+++.++.
T Consensus 64 ~~~~~~~~~~~v~e~~~g~~L~~~l~--------~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~ 135 (278)
T cd05606 64 YAFHTPDKLSFILDLMNGGDLHYHLS--------QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 135 (278)
T ss_pred eeeecCCEEEEEEecCCCCcHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC
Confidence 99999999999999999999999886 3467999999999999999999999999999999999999999999
Q ss_pred eEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH--HHHH
Q psy11359 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM--KVLM 273 (520)
Q Consensus 196 vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~--~~~~ 273 (520)
++|+|||++..+... ......|++.|+|||++.+...++.++||||+||++|+|++|..||...... ....
T Consensus 136 ~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~ 208 (278)
T cd05606 136 VRISDLGLACDFSKK-------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208 (278)
T ss_pred EEEccCcCccccCcc-------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH
Confidence 999999998655321 1234579999999999876555899999999999999999999999765321 1111
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchh
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDK 333 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~ 333 (520)
.........+ ...++..+.++|.+||..+|.+|| ++.++++||||+.....
T Consensus 209 ~~~~~~~~~~---------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 209 RMTLTMAVEL---------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred HHhhccCCCC---------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 1111111111 123578999999999999999999 99999999999876644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=323.28 Aligned_cols=258 Identities=31% Similarity=0.566 Sum_probs=218.8
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||.|+||.||++.+..++..+|+|.+..... .......+.+|+++++.++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~~~ 59 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM---------------------SEKEREDALNEVKILKKLNHP 59 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC---------------------ChHHHHHHHHHHHHHHhcCCC
Confidence 59999999999999999999999988888887643211 123456788999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
|++++++.+......++|+||+++++|.+++..... ....+++..+..++.||+.||.|||++|++|+||+|+||+
T Consensus 60 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil 135 (258)
T cd08215 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKK----EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIF 135 (258)
T ss_pred ChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhc----cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeE
Confidence 999999999999999999999999999999986421 2477999999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.++.++|+|||++....... .......|++.|+|||.+.+.. ++.++|+||+|+++++|++|..||......
T Consensus 136 ~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 209 (258)
T cd08215 136 LTSNGLVKLGDFGISKVLSSTV-----DLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLL 209 (258)
T ss_pred EcCCCcEEECCccceeecccCc-----ceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHH
Confidence 9999999999999987664322 1233457899999999987655 889999999999999999999999877666
Q ss_pred HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.............++ ..++..+.+++.+||..+|++|||+.++|+||||
T Consensus 210 ~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 210 ELALKILKGQYPPIP---------SQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 655555544333332 2467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.29 Aligned_cols=254 Identities=30% Similarity=0.388 Sum_probs=204.7
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH-HhcCCCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA-MSSCHHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~-l~~l~HpnIv~ 113 (520)
+.||.|+||.||+|.+..+|+.||+|.++...... ......+..|..+ ...++||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~~e~~~~~~~~~~~~i~~ 61 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA--------------------KNQVTNVKAERAIMMIQGESPYVAK 61 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH--------------------HHHHHHHHHHHHHHhhcCCCCCeee
Confidence 57999999999999999999999999875321100 1112234445444 44569999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++..++.+|+||||+.|++|.++++. .+.+++..+..++.||+.||.|||++|++||||+|.||+++.+
T Consensus 62 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~ 133 (260)
T cd05611 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKT--------LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT 133 (260)
T ss_pred eeeeEEcCCeEEEEEeccCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 99999999999999999999999999973 4568999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
+.++|+|||++..... .....|++.|+|||.+.+.. ++.++||||||+++|+|+||..||..........
T Consensus 134 ~~~~l~dfg~~~~~~~---------~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 203 (260)
T cd05611 134 GHLKLTDFGLSRNGLE---------NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD 203 (260)
T ss_pred CcEEEeecccceeccc---------cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 9999999998865321 23456889999999987765 8999999999999999999999998777665554
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH---HHHhcCccccccch
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA---SELLKNPFFKKAKD 332 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta---~elL~hp~~~~~~~ 332 (520)
.......... ......+++.+.++|.+||+.+|++|||+ .|++.||||.+.++
T Consensus 204 ~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 204 NILSRRINWP------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HHHhcccCCC------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 4433322111 01113568899999999999999999954 79999999987543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=330.01 Aligned_cols=265 Identities=24% Similarity=0.382 Sum_probs=212.5
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCC-----ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARA-----EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
|....++|++.+.||+|+||.||+|.++..+ ..||+|.+ ...........+.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~----------------------~~~~~~~~~~~~~~ 58 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV----------------------NENASMRERIEFLN 58 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEec----------------------CCccCHHHHHHHHH
Confidence 5677889999999999999999999887543 45555554 32222233456889
Q ss_pred HHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--cCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--NCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
|+.+++.++||||+++++++......++||||+.+++|.+++....... ......+++..+..++.||+.||.|||++
T Consensus 59 e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 138 (277)
T cd05032 59 EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK 138 (277)
T ss_pred HHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999999999999999997543211 01345678899999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
|++||||||+|||++.++.+||+|||++..+...... .......++..|+|||.+.+.. ++.++|||||||++|+|
T Consensus 139 ~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el 214 (277)
T cd05032 139 KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEM 214 (277)
T ss_pred CccccccChheEEEcCCCCEEECCcccchhhccCccc---ccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHh
Confidence 9999999999999999999999999998765332211 1122345788999999987655 89999999999999999
Q ss_pred Hh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 257 AT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 257 lt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+| |..||....................+ ..++..+.++|.+||+.+|.+|||+.+++.
T Consensus 215 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 215 ATLAEQPYQGLSNEEVLKFVIDGGHLDLP---------ENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred hccCCCCCccCCHHHHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 98 99999887776666555433322222 234788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=328.16 Aligned_cols=251 Identities=28% Similarity=0.508 Sum_probs=208.6
Q ss_pred eeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEEE
Q psy11359 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHT 116 (520)
Q Consensus 37 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~~ 116 (520)
||.|++|.||+|.+..+++.||+|++...... .....+.+.+|+.+++.++||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 60 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV--------------------ETGQQEHIFSEKEILEECNHPFIVKLYR 60 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch--------------------hhhHHHHHHHHHHHHHhCCCCCEeeeee
Confidence 69999999999999999999999987532111 0123456899999999999999999999
Q ss_pred EEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCe
Q psy11359 117 SFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196 (520)
Q Consensus 117 ~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~v 196 (520)
++..+..+++||||+.+++|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+
T Consensus 61 ~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~ 132 (262)
T cd05572 61 TFKDKKYIYMLMEYCLGGELWTILRD--------RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYV 132 (262)
T ss_pred eEEcCCccEEEEecCCCCcHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCE
Confidence 99999999999999999999999973 4568999999999999999999999999999999999999999999
Q ss_pred EEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--HHHHHHH
Q psy11359 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP--AMKVLML 274 (520)
Q Consensus 197 kL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~--~~~~~~~ 274 (520)
+|+|||++....... ......|++.|+|||.+.... ++.++|+||||+++|+|++|..||.... ..+....
T Consensus 133 ~l~df~~~~~~~~~~------~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 205 (262)
T cd05572 133 KLVDFGFAKKLKSGQ------KTWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND 205 (262)
T ss_pred EEeeCCcccccCccc------ccccccCCcCccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH
Confidence 999999987664321 123457899999999986544 8999999999999999999999998766 4444444
Q ss_pred Hhc-CCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccc
Q psy11359 275 TLQ-NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAK 331 (520)
Q Consensus 275 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~ 331 (520)
... ......+ ...++.++++|.+||+.+|.+||| +.|+++||||+...
T Consensus 206 ~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 206 ILKGNGKLEFP---------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred HhccCCCCCCC---------cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 332 1111111 123778999999999999999999 99999999998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=340.07 Aligned_cols=274 Identities=31% Similarity=0.459 Sum_probs=228.9
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+|.+.+.|+.-++||+||||.||.+..+.+|+-+|.|.+.+..+... ....-.+.|-++|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr--------------------~ge~maLnEk~iL 239 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKR--------------------KGETMALNEKQIL 239 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHh--------------------hhhHHhhHHHHHH
Confidence 56788899999999999999999999999999999998765433221 1122367899999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
.+.+.+.||.+--.|++.+.++|||..++||+|.-.|... ....|++..++-++.+|+.||++||+.+||.|||
T Consensus 240 ~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~------g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDL 313 (591)
T KOG0986|consen 240 EKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNH------GNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDL 313 (591)
T ss_pred HHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeecc------CCCCCchHHHHHHHHHHHhhHHHHHhcceeeccC
Confidence 9999999999999999999999999999999999888743 4458999999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
||+|||+++.|+++|+|+|+|..+..+.. ....+||.+|||||++.... |+...|.|||||++|+|+.|+.||
T Consensus 314 KPeNILLDd~GhvRISDLGLAvei~~g~~------~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPF 386 (591)
T KOG0986|consen 314 KPENILLDDHGHVRISDLGLAVEIPEGKP------IRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPF 386 (591)
T ss_pred ChhheeeccCCCeEeeccceEEecCCCCc------cccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCch
Confidence 99999999999999999999988765433 23458999999999998877 999999999999999999999999
Q ss_pred CCCcHH----HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhh
Q psy11359 264 HKYPAM----KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKK 334 (520)
Q Consensus 264 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~ 334 (520)
...... ++-..++ ..+ .+....+|+++++|.+.+|++||.+|. .++++-+||||+..+++.
T Consensus 387 r~~KeKvk~eEvdrr~~-~~~---------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 387 RQRKEKVKREEVDRRTL-EDP---------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred hhhhhhhhHHHHHHHHh-cch---------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 765432 2222222 221 122357899999999999999999995 578999999999988876
Q ss_pred HHHhhh
Q psy11359 335 FIQQTL 340 (520)
Q Consensus 335 ~~~~~~ 340 (520)
.-...+
T Consensus 457 leagml 462 (591)
T KOG0986|consen 457 LEAGML 462 (591)
T ss_pred HhccCC
Confidence 544433
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=343.69 Aligned_cols=269 Identities=26% Similarity=0.389 Sum_probs=211.6
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.+..++..||+|.+.... ........+.+|+.+++.++
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l~ 62 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF---------------------DNRIDAKRTLREIKLLRHLD 62 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc---------------------cccchhHHHHHHHHHHHhcC
Confidence 467999999999999999999999999999999764210 00123345778999999999
Q ss_pred CCCceEEEEEEEEC-----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 108 HENVVTYHTSFVVK-----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 108 HpnIv~~~~~~~~~-----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
||||+++++++... ..+|+||||+. ++|.+++. ..+.+++..+..++.||+.||.|||++|++|||
T Consensus 63 h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~d 133 (337)
T cd07858 63 HENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIR--------SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRD 133 (337)
T ss_pred CCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 99999999987644 35899999994 78999887 456799999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|||+||+++.++.+||+|||++....... .......++..|+|||.+.+...++.++|||||||++|+|++|.+|
T Consensus 134 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 208 (337)
T cd07858 134 LKPSNLLLNANCDLKICDFGLARTTSEKG-----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL 208 (337)
T ss_pred CCHHHEEEcCCCCEEECcCccccccCCCc-----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999987653221 1223457899999999987644489999999999999999999999
Q ss_pred CCCCcHHHHHHHHhc---CCCCC-C---------------C--CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH
Q psy11359 263 YHKYPAMKVLMLTLQ---NDPPT-L---------------D--TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321 (520)
Q Consensus 263 f~~~~~~~~~~~~~~---~~~~~-~---------------~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el 321 (520)
|.+............ ..++. . . ...........+++.+.+||.+||+++|.+|||+.++
T Consensus 209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el 288 (337)
T cd07858 209 FPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288 (337)
T ss_pred CCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 977654332221111 00000 0 0 0000112234578899999999999999999999999
Q ss_pred hcCccccccc
Q psy11359 322 LKNPFFKKAK 331 (520)
Q Consensus 322 L~hp~~~~~~ 331 (520)
++||||....
T Consensus 289 l~h~~~~~~~ 298 (337)
T cd07858 289 LAHPYLASLH 298 (337)
T ss_pred HcCcchhhhc
Confidence 9999997653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=325.33 Aligned_cols=249 Identities=27% Similarity=0.463 Sum_probs=204.4
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||.||++..+. +..+|+|.+... ....+.+.+|+.+++.++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~------------------------~~~~~~~~~e~~~l~~l~h 58 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG------------------------AMSEEDFIEEAKVMMKLSH 58 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccC------------------------CccHHHHHHHHHHHHHCCC
Confidence 569999999999999999997754 456777754311 1123568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+..++||||+.+|+|.+++.. ..+.+++..+..++.||+.||.|||++|++||||||+||
T Consensus 59 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni 131 (256)
T cd05114 59 PKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ-------RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNC 131 (256)
T ss_pred CCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHh-------CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceE
Confidence 9999999999999999999999999999999874 234688999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYP 267 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~ 267 (520)
+++.++.+||+|||.+......... ......++..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||....
T Consensus 132 ~i~~~~~~kl~d~g~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 132 LVSSTGVVKVSDFGMTRYVLDDEYT----SSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred EEcCCCeEEECCCCCccccCCCcee----ccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999988765322111 112234566899999987654 8999999999999999999 999998887
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
..+.+..+..+.....+ ...+..+.+++.+||+.+|.+|||+.++++
T Consensus 207 ~~~~~~~i~~~~~~~~~---------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 207 NYEVVEMISRGFRLYRP---------KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHHCCCCCCCC---------CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 77766666554332221 224678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=329.75 Aligned_cols=258 Identities=27% Similarity=0.381 Sum_probs=205.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..++..+++| +++|.+..........++..|+.+++++
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~------------------~~~k~~~~~~~~~~~~~~~~~~~~l~~l 66 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIP------------------VAIKTIQDRSGRQTFQEITDHMLAMGSL 66 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeE------------------EEEeecccccchHHHHHHHHHHHHHhcC
Confidence 4578999999999999999999998887755444 3344443322233456788899999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
.||||+++++++. ....++++||+.+|+|.+++.. ..+.+++..+..|+.||+.||.|||++|++||||||+
T Consensus 67 ~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~ 138 (279)
T cd05111 67 DHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQ-------HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAAR 138 (279)
T ss_pred CCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHh-------cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence 9999999999875 4567899999999999999975 3457899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHK 265 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~ 265 (520)
|||++.++.+||+|||++..+..... ........++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+
T Consensus 139 nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 139 NILLKSDSIVQIADFGVADLLYPDDK---KYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred eEEEcCCCcEEEcCCccceeccCCCc---ccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999976543221 11122345778899999987665 8999999999999999998 9999988
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
............+..+... ..++..+.+++.+||..+|.+|||+.|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 215 MRPHEVPDLLEKGERLAQP---------QICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCHHHHHHHHHCCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7665544433333222211 124567889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.48 Aligned_cols=272 Identities=25% Similarity=0.367 Sum_probs=210.4
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||.|+||.||+|.++.+++.+|+|.+...... ......+.+|+++++.+
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------------------~~~~~~~~~e~~~l~~l 64 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK---------------------DGFPITALREIKILKKL 64 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC---------------------CCcchhHHHHHHHHHhc
Confidence 368999999999999999999999999999999977432110 11123467899999999
Q ss_pred CCCCceEEEEEEEEC--------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 107 HHENVVTYHTSFVVK--------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~--------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
+||||+++++++... ..+++||||+. ++|...+.. ....+++..+..++.||++||.|||++|+
T Consensus 65 ~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~-------~~~~~~~~~~~~i~~~l~~al~~lH~~~i 136 (311)
T cd07866 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLEN-------PSVKLTESQIKCYMLQLLEGINYLHENHI 136 (311)
T ss_pred CCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhc-------cccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 999999999887643 34799999995 477777653 34579999999999999999999999999
Q ss_pred EecccCCCcEEEcCCCCeEEeccCcceeeccCccccc------cccccccccccccCCcceecccCCCCcchhHHHHHHH
Q psy11359 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSR------QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252 (520)
Q Consensus 179 iHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~------~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~i 252 (520)
+||||||+||++++++.++|+|||++........... ........|++.|+|||.+.+...++.++|||||||+
T Consensus 137 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~i 216 (311)
T cd07866 137 LHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCV 216 (311)
T ss_pred ecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHH
Confidence 9999999999999999999999999976543222111 1112345678999999998766568999999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHHhcCCCCC--------------------CCCCchhhhhHHHhcHHHHHHHHhhhccCC
Q psy11359 253 AIEMATGTAPYHKYPAMKVLMLTLQNDPPT--------------------LDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312 (520)
Q Consensus 253 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 312 (520)
+|+|++|.+||.+.........+....... ..........+..+++.+.+||.+||+.+|
T Consensus 217 l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 296 (311)
T cd07866 217 FAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296 (311)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCc
Confidence 999999999998777665544332211000 000000111233456789999999999999
Q ss_pred CCCCCHHHHhcCccc
Q psy11359 313 TKRPTASELLKNPFF 327 (520)
Q Consensus 313 ~~Rpta~elL~hp~~ 327 (520)
.+|||+.+++.||||
T Consensus 297 ~~R~t~~ell~~~~f 311 (311)
T cd07866 297 YKRLTASDALEHPYF 311 (311)
T ss_pred ccCcCHHHHhcCCCC
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=332.36 Aligned_cols=262 Identities=22% Similarity=0.352 Sum_probs=210.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCC-----CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKAR-----AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
..++|.+.+.||+|+||.||+|.+... +..||+|.++ .....+..+.+.+|++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~----------------------~~~~~~~~~~~~~e~~ 60 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK----------------------ETASNDARKDFEREAE 60 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeec----------------------ccCCHHHHHHHHHHHH
Confidence 356799999999999999999987543 4556666543 2222334567999999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc------ccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI------SNCKHGVCDEPTIATVLREVLKGLEYFHS 175 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~------~~~~~~~l~~~~i~~i~~qIl~gL~yLH~ 175 (520)
+++.++||||+++++++......|+||||+.|++|.+++...... .......+++..+..++.||+.||.|||+
T Consensus 61 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 140 (280)
T cd05049 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140 (280)
T ss_pred HHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence 999999999999999999999999999999999999999753210 01134568899999999999999999999
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
+|++||||||+||+++.++.++|+|||++..+..... ........+++.|+|||++.+.. ++.++|||||||++|+
T Consensus 141 ~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e 216 (280)
T cd05049 141 QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY---YRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWE 216 (280)
T ss_pred CCeeccccccceEEEcCCCeEEECCcccceecccCcc---eecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHH
Confidence 9999999999999999999999999999875432211 11122345678999999987665 8999999999999999
Q ss_pred HHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 256 MAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 256 llt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|++ |..||..............+...... ..++..+.+++.+||++||.+|||+.|+++
T Consensus 217 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 217 IFTYGKQPWYGLSNEEVIECITQGRLLQRP---------RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 998 99999887777666655544333222 246788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=330.85 Aligned_cols=259 Identities=40% Similarity=0.669 Sum_probs=215.6
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
..|...+.||.|++|.||++.+..+++.+++|.++.. .....+.+.+|+.+++.++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-----------------------~~~~~~~~~~e~~~l~~~~h 75 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-----------------------KQQRRELLFNEVVIMRDYQH 75 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-----------------------chhHHHHHHHHHHHHHHcCC
Confidence 4577788999999999999999999888888865321 01234568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+..++|+||+.|++|.+++.. +.+++..+..++.||+.||.|||++|++||||+|+||
T Consensus 76 ~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Ni 146 (285)
T cd06648 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSI 146 (285)
T ss_pred CChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhE
Confidence 9999999999999999999999999999999863 4688999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++.++.++|+|||.+....... .......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.....
T Consensus 147 l~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~ 220 (285)
T cd06648 147 LLTSDGRVKLSDFGFCAQVSKEV-----PRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220 (285)
T ss_pred EEcCCCcEEEcccccchhhccCC-----cccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCH
Confidence 99999999999999876543211 1123457899999999987655 89999999999999999999999987666
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
...........++.... ...++..+.+||.+||+.+|.+|||+.++++||||++...
T Consensus 221 ~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 221 LQAMKRIRDNLPPKLKN-------LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHHHHHhcCCCCCcc-------cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 55555444433322211 1236788999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=368.24 Aligned_cols=268 Identities=25% Similarity=0.368 Sum_probs=209.8
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.++||+|+||.||+|.+..+|+.||+|+++.... ......+++.+|+.++++++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~--------------------~~e~~~~rflrEi~ILs~L~H 61 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS--------------------ENPLLKKRFLREAKIAADLIH 61 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc--------------------cCHHHHHHHHHHHHHHHhCCC
Confidence 689999999999999999999999999999998753210 112234578999999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc---ccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI---SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~---~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
|||+++++++..++..|+||||++|++|.+++...... .......++...+..++.||+.||.|||++||+||||||
T Consensus 62 PNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKP 141 (932)
T PRK13184 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKP 141 (932)
T ss_pred cCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence 99999999999999999999999999999999753211 111234566788899999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCcc-------------ccccccccccccccccCCcceecccCCCCcchhHHHHHHH
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRD-------------LSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~-------------~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~i 252 (520)
+|||++.+|.++|+|||++........ ..........+||+.|||||++.+.. ++.++|||||||+
T Consensus 142 eNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVI 220 (932)
T PRK13184 142 DNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVI 220 (932)
T ss_pred heEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHH
Confidence 999999999999999999987621110 00111122457999999999987765 8999999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 253 AIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 253 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
+|+|+||..||......+.........+... .....+++.+.+++.+||+.||++|++..+.+.+
T Consensus 221 LyELLTG~~PF~~~~~~ki~~~~~i~~P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 221 LYQMLTLSFPYRRKKGRKISYRDVILSPIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred HHHHHHCCCCCCCcchhhhhhhhhccChhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999987554443322211111111 1124577889999999999999999887666543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=341.95 Aligned_cols=268 Identities=23% Similarity=0.383 Sum_probs=211.6
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
..+|++.+.||.|+||.||+|.+..+|..||+|.+.... ....+.+.+|+.++++++
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-----------------------~~~~~~~~~Ei~~l~~l~ 60 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----------------------PQSVKHALREIKIIRRLD 60 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-----------------------CchHHHHHHHHHHHHhcC
Confidence 578999999999999999999999999999998764211 123456888999999999
Q ss_pred CCCceEEEEEEEEC--------------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHH
Q psy11359 108 HENVVTYHTSFVVK--------------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYF 173 (520)
Q Consensus 108 HpnIv~~~~~~~~~--------------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yL 173 (520)
||||+++++++... ...|+||||+. ++|.+++. .+.+++..++.++.||+.||.||
T Consensus 61 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---------~~~l~~~~~~~~~~qi~~aL~~L 130 (342)
T cd07854 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE---------QGPLSEEHARLFMYQLLRGLKYI 130 (342)
T ss_pred CCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999999776643 35899999996 58988874 34688999999999999999999
Q ss_pred HHCCcEecccCCCcEEEc-CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHH
Q psy11359 174 HSNGQIHRDIKAGNILLG-EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252 (520)
Q Consensus 174 H~~giiHrDLKp~NILl~-~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~i 252 (520)
|++|++||||||+||+++ .++.++|+|||++..+...... ........|++.|+|||.+.+...++.++|||||||+
T Consensus 131 H~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvi 208 (342)
T cd07854 131 HSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI 208 (342)
T ss_pred HhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCcccc--ccccccccccccccCHHHHhCccccCchhhHHHHHHH
Confidence 999999999999999997 4567999999998765332111 1111223678899999987665558899999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCC--------------------CCchhhhhHHHhcHHHHHHHHhhhccCC
Q psy11359 253 AIEMATGTAPYHKYPAMKVLMLTLQNDPPTLD--------------------TGAAEKDQYKAYGKTFRKMISDCLQKDP 312 (520)
Q Consensus 253 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP 312 (520)
+|+|++|..||............+...+.... ...........++.++.+||.+||+.||
T Consensus 209 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 288 (342)
T cd07854 209 FAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP 288 (342)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCc
Confidence 99999999999887766655544433221111 0000111223567889999999999999
Q ss_pred CCCCCHHHHhcCcccccc
Q psy11359 313 TKRPTASELLKNPFFKKA 330 (520)
Q Consensus 313 ~~Rpta~elL~hp~~~~~ 330 (520)
.+|||+.+++.||||+..
T Consensus 289 ~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 289 MDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hhccCHHHHhCCCccccc
Confidence 999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=360.05 Aligned_cols=289 Identities=21% Similarity=0.275 Sum_probs=204.2
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCC-ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARA-EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
.++|++++.||+|+||+||+|..+... ..++.|.++...... .....++.|.+.. .......+.+|+.+|+++
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~k~~~~--~~~~~~~~~~Ei~il~~l 220 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGK----PKCERLIAKRVKA--GSRAAIQLENEILALGRL 220 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccc----hhhhhhHhHHhhc--chHHHHHHHHHHHHHHhC
Confidence 367999999999999999999766543 223333221110000 0011222222221 123456788999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+..|+|++++ +++|.+++...... .........++.++.||+.||.|||++||+||||||+
T Consensus 221 ~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~---~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~ 296 (501)
T PHA03210 221 NHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFD---WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLE 296 (501)
T ss_pred CCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhcccc---ccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 9999999999999999999999999 56888887532110 1223446778899999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC-CCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP-YHK 265 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P-f~~ 265 (520)
|||++.+|.+||+|||++..+.... .......+||+.|+|||++.+.. |+.++|||||||++|+|++|..| |..
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKER----EAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCccc----ccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 9999999999999999998764322 12233468999999999997755 89999999999999999998764 432
Q ss_pred C--cHHHHHHHHhcCCC---CCCCC-------------------CchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH
Q psy11359 266 Y--PAMKVLMLTLQNDP---PTLDT-------------------GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321 (520)
Q Consensus 266 ~--~~~~~~~~~~~~~~---~~~~~-------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el 321 (520)
. .....+...+.... ..++. .....-....++..+.++|.+||++||.+|||+.|+
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el 451 (501)
T PHA03210 372 GGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL 451 (501)
T ss_pred CCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence 2 22222222221110 00000 000000112356678899999999999999999999
Q ss_pred hcCccccccc
Q psy11359 322 LKNPFFKKAK 331 (520)
Q Consensus 322 L~hp~~~~~~ 331 (520)
|.||||....
T Consensus 452 L~hp~f~~~~ 461 (501)
T PHA03210 452 LALPLFSAEE 461 (501)
T ss_pred hhChhhhcCC
Confidence 9999998654
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=342.67 Aligned_cols=264 Identities=23% Similarity=0.401 Sum_probs=205.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
.....|+++++||+||.+.||++.....+. +|+|.+. ..........-+..||..|.+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~i-yalkkv~---------------------~~~~D~qtl~gy~nEI~lL~K 415 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQI-YALKKVV---------------------LLEADNQTLDGYRNEIALLNK 415 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcc-hhhhHHH---------------------HhhcCHHHHHHHHHHHHHHHH
Confidence 345679999999999999999998765433 3333221 122234567789999999999
Q ss_pred C-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 106 C-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 106 l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
| .|.+||++|+|-..++.+|+||||= ..+|..+++++ .+..+.-.++.++.|||.++.++|.+||||.|||
T Consensus 416 Lkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~-------~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLK 487 (677)
T KOG0596|consen 416 LKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKK-------KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLK 487 (677)
T ss_pred hcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhc-------cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCC
Confidence 9 6999999999999999999999987 46999999863 3334445899999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC----------CCCcchhHHHHHHHHH
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH----------GYDFKADIWSLGITAI 254 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----------~~~~~~DIwSlG~il~ 254 (520)
|.|+|+ -.|.+||+|||.|..+.... ..-...+.+||+.||+||.+.... ..+.++||||||||||
T Consensus 488 PANFLl-VkG~LKLIDFGIA~aI~~DT---TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILY 563 (677)
T KOG0596|consen 488 PANFLL-VKGRLKLIDFGIANAIQPDT---TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILY 563 (677)
T ss_pred cccEEE-EeeeEEeeeechhcccCccc---cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHH
Confidence 999999 56899999999998775433 223345679999999999985322 1467899999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 255 EMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 255 elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
+|+.|++||......-.-+..+......++..... -..++.++++.||+.||.+|||+.++|+|||++.
T Consensus 564 qMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 564 QMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIP------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHHhcCCchHHHHHHHHHHHhhcCCCccccccCCC------CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 99999999987665443333333322222221111 1123889999999999999999999999999985
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=343.64 Aligned_cols=276 Identities=26% Similarity=0.399 Sum_probs=215.8
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||.||+|.+..+|..+|+|.+.... ........+.+|+.++++
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~---------------------~~~~~~~~~~~E~~~l~~ 62 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF---------------------RNATDAQRTFREIMFLQE 62 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc---------------------CcchhhhhhhHHHHHHHH
Confidence 35678999999999999999999999999999999763210 001223457789999999
Q ss_pred C-CCCCceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 106 C-HHENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 106 l-~HpnIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
+ +||||+++++++... ..+|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+|||
T Consensus 63 l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~d 132 (337)
T cd07852 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA---------NILEDVHKRYIMYQLLKALKYIHSGNVIHRD 132 (337)
T ss_pred hcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 9 999999999998653 46899999996 599998863 3678899999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|||+||+++.+|.+||+|||++..+..............+.||+.|+|||.+.+...++.++||||||+++|+|+||+.|
T Consensus 133 l~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~p 212 (337)
T cd07852 133 LKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212 (337)
T ss_pred CCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999998764433211112334567899999999987666688999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCC---------------------CCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTL---------------------DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el 321 (520)
|.................... ..........+.++.++.++|.+||+.+|.+|||+.++
T Consensus 213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~i 292 (337)
T cd07852 213 FPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292 (337)
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHH
Confidence 987665544333222211000 00000111223468899999999999999999999999
Q ss_pred hcCccccccch
Q psy11359 322 LKNPFFKKAKD 332 (520)
Q Consensus 322 L~hp~~~~~~~ 332 (520)
++||||+....
T Consensus 293 l~~~~~~~~~~ 303 (337)
T cd07852 293 LEHPYVAQFHN 303 (337)
T ss_pred hhChhhhhhcc
Confidence 99999987543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=349.69 Aligned_cols=262 Identities=24% Similarity=0.418 Sum_probs=212.6
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
-.|.+..+...+.+.||+|.||+||+|+...+ ||||+++.... ..+..+.|++|+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~p---------------------t~~qlqaFKnEVa 440 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDP---------------------TPEQLQAFKNEVA 440 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCC---------------------CHHHHHHHHHHHH
Confidence 46888999999999999999999999998764 66666553321 1346788999999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
++++-+|.||+-|.+++..... .||+-+|+|-+|..++.- ....|+....+.|++||++|+.|||.++||||
T Consensus 441 ~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv-------~etkfdm~~~idIAqQiaqGM~YLHAK~IIHr 512 (678)
T KOG0193|consen 441 VLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHV-------QETKFDMNTTIDIAQQIAQGMDYLHAKNIIHR 512 (678)
T ss_pred HHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccc-------hhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 9999999999999999887766 999999999999999975 34578899999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc--cCCCCcchhHHHHHHHHHHHHhC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ--DHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DIwSlG~il~elltG 259 (520)
|||..|||+.+++.|||+|||++..-..- ..........|..+|||||+++. ...|++.+|||||||++|||+||
T Consensus 513 DLKSnNIFl~~~~kVkIgDFGLatvk~~w---~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg 589 (678)
T KOG0193|consen 513 DLKSNNIFLHEDLKVKIGDFGLATVKTRW---SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTG 589 (678)
T ss_pred hccccceEEccCCcEEEecccceeeeeee---ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhC
Confidence 99999999999999999999998653211 22233344568889999999863 34589999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
..||.......++..+-++.-. .........+++++++|+..||.+++++||++.+||.
T Consensus 590 ~lPysi~~~dqIifmVGrG~l~-----pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 590 ELPYSIQNRDQIIFMVGRGYLM-----PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cCCcCCCChhheEEEecccccC-----ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999955555554443333110 0012233566789999999999999999999999985
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=343.00 Aligned_cols=267 Identities=24% Similarity=0.360 Sum_probs=206.0
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCC-----CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKAR-----AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
|....++|++.++||.|+||.||+|.+..+ ++.||+|+++ ........+.+.+
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~----------------------~~~~~~~~~~~~~ 59 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLK----------------------EGATASEYKALMT 59 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeecc----------------------CCCCHHHHHHHHH
Confidence 777888999999999999999999975443 3556666553 2221233456888
Q ss_pred HHHHHhcC-CCCCceEEEEEEEE-CCEEEEEEEccCCCCHHHHHHHhhccc-----------------------------
Q psy11359 99 EIQAMSSC-HHENVVTYHTSFVV-KDELWLVLRLLEGGSLLDIIKHRLKIS----------------------------- 147 (520)
Q Consensus 99 Ei~~l~~l-~HpnIv~~~~~~~~-~~~~~lV~E~~~ggsL~~~i~~~~~~~----------------------------- 147 (520)
|+.++.++ +||||+++++++.. +..++++|||+.+++|.+++.......
T Consensus 60 E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (337)
T cd05054 60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSS 139 (337)
T ss_pred HHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcc
Confidence 99999999 89999999998864 467899999999999999996532100
Q ss_pred ------------------------cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCc
Q psy11359 148 ------------------------NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203 (520)
Q Consensus 148 ------------------------~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~ 203 (520)
......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~ 219 (337)
T cd05054 140 QSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL 219 (337)
T ss_pred ccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEecccc
Confidence 00123688999999999999999999999999999999999999999999999999
Q ss_pred ceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCC
Q psy11359 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPT 282 (520)
Q Consensus 204 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 282 (520)
+..+...... .......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+...+......
T Consensus 220 a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 295 (337)
T cd05054 220 ARDIYKDPDY---VRKGDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295 (337)
T ss_pred chhcccCcch---hhccCCCCCccccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC
Confidence 9766332211 1122345677899999987665 8999999999999999998 999998755444333333221111
Q ss_pred CCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 283 LDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
. .....++++.+++.+||+.+|++|||+.|+++|
T Consensus 296 ~--------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 296 R--------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred C--------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 012456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=325.80 Aligned_cols=255 Identities=23% Similarity=0.374 Sum_probs=207.1
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCC---CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKAR---AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
.++|++.+.||+|+||+||+|..+.+ ...||+|.++ .........++.+|+.+++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~----------------------~~~~~~~~~~~~~e~~~l~ 60 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK----------------------AGSSDKQRLDFLTEASIMG 60 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcC----------------------CCCChHHHHHHHHHHHHHH
Confidence 46799999999999999999988754 3356666543 2222334567889999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++...+..++||||+.+++|.+++.. ..+.+++..+..++.|++.||.|||++||+|||||
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~ 133 (266)
T cd05033 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE-------NDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLA 133 (266)
T ss_pred hCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 99999999999999999999999999999999999975 34578999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPY 263 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf 263 (520)
|+|||++.++.++|+|||++..+..... ........+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus 134 p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~ 209 (266)
T cd05033 134 ARNILVNSNLVCKVSDFGLSRRLEDSEA---TYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPY 209 (266)
T ss_pred cceEEEcCCCCEEECccchhhccccccc---ceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999987642111 11111234567899999987655 8999999999999999998 99999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
..................... ..+++.+.+++.+||+.+|++||++.+++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 210 WDMSNQDVIKAVEDGYRLPPP---------MDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 877766655544433222111 2457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.06 Aligned_cols=267 Identities=20% Similarity=0.335 Sum_probs=208.9
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCC-----ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARA-----EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDEL 96 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l 96 (520)
..|....++|++.++||+|+||+||+|.+...+ ..||+|++ .........+.+
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l----------------------~~~~~~~~~~~~ 87 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKML----------------------KPTARSSEKQAL 87 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEec----------------------CCCCChHHHHHH
Confidence 457778899999999999999999999875432 23555544 332223345678
Q ss_pred HHHHHHHhcCC-CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc----------------------------
Q psy11359 97 LKEIQAMSSCH-HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS---------------------------- 147 (520)
Q Consensus 97 ~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~---------------------------- 147 (520)
.+|+++++++. ||||+++++++.....+|+||||+.+|+|.+++.......
T Consensus 88 ~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (400)
T cd05105 88 MSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYV 167 (400)
T ss_pred HHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchh
Confidence 99999999995 9999999999999999999999999999999997532100
Q ss_pred ------------------------------------------------------------cCCCCCCCHHHHHHHHHHHH
Q psy11359 148 ------------------------------------------------------------NCKHGVCDEPTIATVLREVL 167 (520)
Q Consensus 148 ------------------------------------------------------------~~~~~~l~~~~i~~i~~qIl 167 (520)
......+++..+..++.||+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~ 247 (400)
T cd05105 168 ILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVA 247 (400)
T ss_pred hhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHH
Confidence 00123588899999999999
Q ss_pred HHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHH
Q psy11359 168 KGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIW 247 (520)
Q Consensus 168 ~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIw 247 (520)
.||.|||++|++||||||+|||++.++.+||+|||++..+...... .......+++.|+|||++.+.. ++.++|||
T Consensus 248 ~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diw 323 (400)
T cd05105 248 RGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY---VSKGSTFLPVKWMAPESIFDNL-YTTLSDVW 323 (400)
T ss_pred HHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccc---cccCCcCCCcceEChhhhcCCC-CCchhhHH
Confidence 9999999999999999999999999999999999998765432211 1122345778899999987655 89999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCC-CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 248 SLGITAIEMAT-GTAPYHKYPAMKVLMLTLQND-PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 248 SlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
||||++|+|++ |..||........+....... .... ...++..+.+++.+||+.+|++|||+.++.+
T Consensus 324 SlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK---------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCC---------CccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 99999999997 999998755443333333222 1111 1346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=327.38 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=203.6
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCce----EEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEK----CAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
..++|++.++||+|+||+||+|....+|.. ||+|++ ..........++.+|+.+
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~----------------------~~~~~~~~~~~~~~e~~~ 62 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL----------------------RENTSPKANKEILDEAYV 62 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEe----------------------cCCCCHHHHHHHHHHHHH
Confidence 457899999999999999999998877664 555554 332223445678899999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
++.++||||+++++++.. ...+++|+|+.+|+|.+++.. ..+.+++..+..++.||+.||.|||++|++|||
T Consensus 63 l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~-------~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~d 134 (279)
T cd05109 63 MAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRE-------NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRD 134 (279)
T ss_pred HHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 999999999999998875 457899999999999999974 345789999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTA 261 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~ 261 (520)
|||+|||+++++.+||+|||++..+...... .......+++.|+|||.+.+.. ++.++|||||||++|||++ |..
T Consensus 135 lkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~ 210 (279)
T cd05109 135 LAARNVLVKSPNHVKITDFGLARLLDIDETE---YHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAK 210 (279)
T ss_pred cccceEEEcCCCcEEECCCCceeecccccce---eecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999876432211 0111223567899999987654 8999999999999999998 999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
||..................... ..++..+.++|.+||..||.+|||+.+++.
T Consensus 211 p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 211 PYDGIPAREIPDLLEKGERLPQP---------PICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCCCCCHHHHHHHHHCCCcCCCC---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99876655444333332222211 245778999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=324.78 Aligned_cols=252 Identities=35% Similarity=0.550 Sum_probs=202.7
Q ss_pred EEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCc
Q psy11359 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENV 111 (520)
Q Consensus 32 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnI 111 (520)
.....||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++|+||
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-----------------------~~~~~~~~~~e~~~l~~l~h~~i 67 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-----------------------DSRYVQPLHEEIALHSYLKHRNI 67 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCC-----------------------CHHHHHHHHHHHHHHHhcCCCCe
Confidence 3446899999999999999999888888876421 12234568899999999999999
Q ss_pred eEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVC--DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 112 v~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l--~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
+++++++..++..++|+||+.+++|.+++... ...+ ++..+..++.||+.||.|||++||+||||||.||+
T Consensus 68 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil 140 (268)
T cd06624 68 VQYLGSDSENGFFKIFMEQVPGGSLSALLRSK-------WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVL 140 (268)
T ss_pred eeeeeeeccCCEEEEEEecCCCCCHHHHHHHh-------cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 99999999999999999999999999999752 2334 78899999999999999999999999999999999
Q ss_pred EcC-CCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 190 LGE-DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 190 l~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
++. ++.++|+|||++..+.... .......|++.|+|||.+... ..++.++|+||||+++|+|++|..||....
T Consensus 141 ~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 141 VNTYSGVVKISDFGTSKRLAGIN-----PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred EcCCCCeEEEecchhheecccCC-----CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 975 6799999999987653211 112234689999999998643 347899999999999999999999997644
Q ss_pred HHHHHHHHh--cCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 268 AMKVLMLTL--QNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 268 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
......... ....+.+ ...+++++++|+.+||+.+|.+|||+.+++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 216 EPQAAMFKVGMFKIHPEI---------PESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ChhhhHhhhhhhccCCCC---------CcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 322221111 1111111 23467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=360.98 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=206.6
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.+....-+++|.+.|.+|||+.||+|.+...|.+||+|.+- .. ....++.+.+||.+
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~----------------------~~-de~~L~~v~~EI~~ 87 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMY----------------------VN-DEEALNAVKREIDI 87 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeee----------------------cC-CHHHHHHHHHHHHH
Confidence 34556677899999999999999999999987777777542 22 25577889999999
Q ss_pred HhcCC-CCCceEEEEE-EEE------CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 103 MSSCH-HENVVTYHTS-FVV------KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 103 l~~l~-HpnIv~~~~~-~~~------~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
|++|+ |+|||.|+++ ... .-+++|.||||.||.|-|++..+ -...|++.+|.+|+.|+++|+.+||
T Consensus 88 MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~R------lq~~lte~eVLkIf~dv~~AVa~mH 161 (738)
T KOG1989|consen 88 MKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTR------LQTRLTEDEVLKIFYDVCEAVAAMH 161 (738)
T ss_pred HHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHH------HhccCChHHHHHHHHHHHHHHHHHh
Confidence 99995 9999999994 331 23688999999999999999977 3345999999999999999999999
Q ss_pred HCC--cEecccCCCcEEEcCCCCeEEeccCcceeeccCcccccccc-----ccccccccccCCcceec--ccCCCCcchh
Q psy11359 175 SNG--QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKV-----RHTFVGTPCWMAPEVME--QDHGYDFKAD 245 (520)
Q Consensus 175 ~~g--iiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~-----~~~~~gt~~y~APE~~~--~~~~~~~~~D 245 (520)
... |||||||-+||||+.+|..||||||.++.--.... ....+ .-...-||.|+|||.+. .+..+++|+|
T Consensus 162 ~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~-~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsD 240 (738)
T KOG1989|consen 162 YLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPT-SAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSD 240 (738)
T ss_pred cCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCc-cHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhH
Confidence 998 99999999999999999999999999864321110 00000 01124699999999864 3445899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 246 IWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 246 IwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
||+|||+||-|+....||.......++. +. ..+ .....++..+.+||..||+.||.+||++.+++.+
T Consensus 241 IWALGclLYkLCy~t~PFe~sg~laIln----g~-Y~~-------P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 241 IWALGCLLYKLCYFTTPFEESGKLAILN----GN-YSF-------PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred HHHHHHHHHHHHHhCCCcCcCcceeEEe----cc-ccC-------CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 9999999999999999998754433321 11 111 1125688999999999999999999999999864
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=322.86 Aligned_cols=255 Identities=24% Similarity=0.423 Sum_probs=207.5
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.+.||+|++|.||+|.+.. ++.||+|.++.. ....+++.+|+.++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~------------------------~~~~~~~~~e~~~l 55 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPG------------------------TMDPKDFLAEAQIM 55 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCC------------------------cccHHHHHHHHHHH
Confidence 45567889999999999999999998754 456777765421 11245688999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++++||||+++++++...+..|+||||+.+++|.+++... ....+++..+..++.|++.||.|||++|++||||
T Consensus 56 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 129 (261)
T cd05068 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG------AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDL 129 (261)
T ss_pred HHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 9999999999999999999999999999999999999753 2346899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||+++.++.++|+|||++..+...... ......++..|+|||.+.+.. ++.++|+||||+++|+|+| |+.|
T Consensus 130 ~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p 204 (261)
T cd05068 130 AARNVLVGENNICKVADFGLARVIKEDIYE----AREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMP 204 (261)
T ss_pred CcceEEEcCCCCEEECCcceEEEccCCccc----ccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCC
Confidence 999999999999999999999876422110 011122345799999987654 8999999999999999999 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|........+............ ..++..+.+++.+||+.+|.+||++.++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 205 YPGMTNAEVLQQVDQGYRMPCP---------PGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCCCHHHHHHHHHcCCCCCCC---------CcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9887766655554443222111 245678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=323.32 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=199.9
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~ 114 (520)
+.||+|+||+||+|.+..+++.+|+|.+... ...+....+.+|+.++++++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----------------------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 58 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----------------------LPPDLKAKFLQEARILKQYSHPNIVRL 58 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc----------------------CCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 4799999999999999999888888865321 112344678999999999999999999
Q ss_pred EEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCC
Q psy11359 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194 (520)
Q Consensus 115 ~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g 194 (520)
++++......++||||+.+++|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 59 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~ 131 (252)
T cd05084 59 IGVCTQKQPIYIVMELVQGGDFLTFLRT-------EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN 131 (252)
T ss_pred EEEEcCCCCeEEEEeeccCCcHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC
Confidence 9999999999999999999999999974 345688999999999999999999999999999999999999999
Q ss_pred CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q psy11359 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLM 273 (520)
Q Consensus 195 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~ 273 (520)
.+||+|||++.....+... .......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||..........
T Consensus 132 ~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~ 207 (252)
T cd05084 132 VLKISDFGMSREEEDGVYA---STGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE 207 (252)
T ss_pred cEEECccccCccccccccc---ccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH
Confidence 9999999998754322110 0011112345799999987655 8999999999999999998 999998766655444
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
......+... ...++..+.+|+.+||+++|++|||+.++++
T Consensus 208 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 208 AIEQGVRLPC---------PELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHcCCCCCC---------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4433322221 1245778999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=335.63 Aligned_cols=261 Identities=37% Similarity=0.627 Sum_probs=214.7
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
....|+....||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.+
T Consensus 19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----------------------~~~~~~~~~e~~~l~~l 75 (297)
T cd06659 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-----------------------QQRRELLFNEVVIMRDY 75 (297)
T ss_pred chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-----------------------cchHHHHHHHHHHHHhC
Confidence 3455667778999999999999999999999998764210 12235688999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++..++..|+||||+.+++|..++. ...+++..+..++.||+.||.|||++|++||||||+
T Consensus 76 ~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~ 146 (297)
T cd06659 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---------QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSD 146 (297)
T ss_pred CCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh---------hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 99999999999999999999999999999999875 245889999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
||+++.++.++|+|||++..+.... .......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 147 Nill~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 147 SILLTLDGRVKLSDFGFCAQISKDV-----PKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred HeEEccCCcEEEeechhHhhccccc-----ccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999886543221 1123467899999999987655 899999999999999999999999876
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
................. .....++..+.++|.+||+.+|.+|||+.++++||||.+...
T Consensus 221 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 221 SPVQAMKRLRDSPPPKL-------KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred CHHHHHHHHhccCCCCc-------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 65555443322221111 112346788999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=334.54 Aligned_cols=269 Identities=35% Similarity=0.580 Sum_probs=207.4
Q ss_pred eeeec--CceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceE
Q psy11359 36 VIGFG--ATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVT 113 (520)
Q Consensus 36 ~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~ 113 (520)
+||+| +++.||.+++..+++.||+|+++... ......+.+.+|+.+++.++||||++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~---------------------~~~~~~~~~~~Ei~~l~~l~h~~i~~ 63 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS---------------------CSKEDLKLLQQEIITSRQLQHPNILP 63 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc---------------------cchhHHHHHHHHHHHHHhcCCcchhh
Confidence 44444 55677777778888888888765321 11335667999999999999999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++...+..+++|||+.+++|.+++... ....+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 64 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~------~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~ 137 (314)
T cd08216 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTH------FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD 137 (314)
T ss_pred hhheeecCCeEEEEEeccCCCCHHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC
Confidence 999999999999999999999999999753 23468899999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccc--cccccccccccccccCCcceeccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDL--SRQKVRHTFVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~--~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~ 270 (520)
|.+||+|||.+..+...... ..........++..|+|||++... ..++.++|||||||++|+|++|..||.......
T Consensus 138 ~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~ 217 (314)
T cd08216 138 GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217 (314)
T ss_pred CceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999988765322211 011112345678899999998654 348899999999999999999999998766554
Q ss_pred HHHHHhcCCCCCC-C-----------------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcc
Q psy11359 271 VLMLTLQNDPPTL-D-----------------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326 (520)
Q Consensus 271 ~~~~~~~~~~~~~-~-----------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~ 326 (520)
.......+..+.+ . ...........++..+.+|+.+||+.||++|||+.++|+|||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 218 MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 4433222211100 0 000111122345678999999999999999999999999999
Q ss_pred ccccc
Q psy11359 327 FKKAK 331 (520)
Q Consensus 327 ~~~~~ 331 (520)
|+...
T Consensus 298 ~~~~~ 302 (314)
T cd08216 298 FKQCK 302 (314)
T ss_pred Hhhhc
Confidence 98665
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=324.56 Aligned_cols=254 Identities=25% Similarity=0.435 Sum_probs=205.1
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.++||+|+||+||+|.+..+ ..||+|+++.. ....+++.+|+.++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~------------------------~~~~~~~~~E~~~l 55 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG------------------------TMSPEAFLQEAQVM 55 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccC------------------------ccCHHHHHHHHHHH
Confidence 455677899999999999999999988765 35777766421 11235688999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+.++||||+++++++. ....|+||||+.+++|.+++... ....+++..+..++.|++.||.|||++|++||||
T Consensus 56 ~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl 128 (262)
T cd05071 56 KKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE------MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128 (262)
T ss_pred HhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhc------cccCCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 9999999999998774 45689999999999999999742 2346789999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||++++++.++|+|||.+..+...... ......++..|+|||++.+.. ++.++|||||||++|+|+| |..|
T Consensus 129 ~p~Nill~~~~~~~L~dfg~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p 203 (262)
T cd05071 129 RAANILVGENLVCKVADFGLARLIEDNEYT----ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVP 203 (262)
T ss_pred CcccEEEcCCCcEEeccCCceeeccccccc----cccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999766432211 112334677899999886655 8999999999999999999 8999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|...........+....+... ...++..+.++|.+||+++|.+|||+.+++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 204 YPGMVNREVLDQVERGYRMPC---------PPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCCChHHHHHHHhcCCCCCC---------ccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 987766665554443322211 1346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=328.02 Aligned_cols=255 Identities=24% Similarity=0.428 Sum_probs=212.0
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|+-...+|++.++||.|+||.||+|.+.. +..+|+|++.... ......+.+|+.++
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~-----------------------~~~~~~~~~e~~~l 56 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD-----------------------LLKQQDFQKEVQAL 56 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc-----------------------hhhHHHHHHHHHHH
Confidence 44566789999999999999999999988 8888888764221 22345688999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+.++||||+++++++...+..++||||+.+++|.+++... ....+++..+..++.||+.||.|||++|++||||
T Consensus 57 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl 130 (261)
T cd05148 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP------EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDL 130 (261)
T ss_pred hcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 9999999999999999999999999999999999999753 3456899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||+++.++.+||+|||++..+..... ......+++.|+|||.+.... ++.++||||||+++|+|++ |..|
T Consensus 131 ~~~nilv~~~~~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p 204 (261)
T cd05148 131 AARNILVGEDLVCKVADFGLARLIKEDVY-----LSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVP 204 (261)
T ss_pred CcceEEEcCCceEEEccccchhhcCCccc-----cccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999876532211 111334577899999987654 8999999999999999998 8999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|......+.+........... ...+++.+.++|.+||+.+|.+|||+.++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 205 YPGMNNHEVYDQITAGYRMPC---------PAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCcCCHHHHHHHHHhCCcCCC---------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 988777666665554322221 1355788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=319.59 Aligned_cols=254 Identities=40% Similarity=0.674 Sum_probs=216.0
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||+|++|.||++.+..+++.||+|.+..... .....+.+.+|++++++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~~~ 59 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI---------------------KEEALKSIMQEIDLLKNLKHP 59 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc---------------------CHHHHHHHHHHHHHHHhCCCC
Confidence 58999999999999999999999999999998753211 023456799999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
|++++++++......+++|||+.+++|.+++.. .+.+++..+..++.|++.||.|||++|++||||+|+||+
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~ 131 (254)
T cd06627 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKK--------FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANIL 131 (254)
T ss_pred CccEEEEEEEeCCEEEEEEecCCCCcHHHHHHh--------ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEE
Confidence 999999999999999999999999999999974 467899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.++.++|+|||++........ ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......
T Consensus 132 i~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~ 205 (254)
T cd06627 132 TTKDGVVKLADFGVATKLNDVSK-----DDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPM 205 (254)
T ss_pred ECCCCCEEEeccccceecCCCcc-----cccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 99999999999999987643321 123457899999999987655 889999999999999999999999876655
Q ss_pred HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
...........+.++ ..++..+.++|.+||..+|++|||+.+++.||||
T Consensus 206 ~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 206 AALFRIVQDDHPPLP---------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHhccCCCCCC---------CCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 555444333322221 3457889999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=334.12 Aligned_cols=273 Identities=23% Similarity=0.396 Sum_probs=209.0
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|.+.+.||+|+||.||+|.+...+..... ....+|+|.+..+.......++.+|+.++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~---------------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l 77 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPN---------------RVTKVAVKMLKSDATEKDLSDLISEMEMM 77 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccC---------------ccceEEEEeccCCCChHHHHHHHHHHHHH
Confidence 556678999999999999999999987543211000 02234444444333234456788999999
Q ss_pred hcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--------cCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 104 SSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--------NCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 104 ~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--------~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
+.+ +||||+++++++...+.+|+||||+.+++|.+++....... ......++..++..++.||+.||+|||
T Consensus 78 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH 157 (307)
T cd05098 78 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA 157 (307)
T ss_pred HHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence 999 89999999999999999999999999999999997642110 012245889999999999999999999
Q ss_pred HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 175 ~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
++|++||||||+|||++.++.+||+|||++..+...... .......+++.|+|||++.+.. ++.++|+|||||++|
T Consensus 158 ~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~ 233 (307)
T cd05098 158 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLW 233 (307)
T ss_pred HCCcccccccHHheEEcCCCcEEECCCcccccccccchh---hccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHH
Confidence 999999999999999999999999999998755321110 1111223457899999987655 899999999999999
Q ss_pred HHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 255 EMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 255 ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
+|++ |..||...+..+............. ...++.++.+||.+||..+|.+|||+.+++++
T Consensus 234 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 234 EIFTLGGSPYPGVPVEELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHcCCCCCCCcCCHHHHHHHHHcCCCCCC---------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 9998 8999987766555444433322221 13457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=327.75 Aligned_cols=262 Identities=24% Similarity=0.369 Sum_probs=207.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
..+.|.+.+.||+|++|.||+|.+.. ++..||+|.++ ..........+.+|+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~----------------------~~~~~~~~~~~~~e~~ 61 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLP----------------------ESCSEQDESDFLMEAL 61 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcC----------------------CCCCHHHHHHHHHHHH
Confidence 45779999999999999999999987 65666766543 2221233456889999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+++.++|+||+++++++......++||||+.|++|.+++........ ....+++..+..++.||+.||.|||+++++||
T Consensus 62 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~ 140 (277)
T cd05036 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPE-RPSSLTMKDLLFCARDVAKGCKYLEENHFIHR 140 (277)
T ss_pred HHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 99999999999999999999999999999999999999976432111 22368999999999999999999999999999
Q ss_pred ccCCCcEEEcCCC---CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 182 DIKAGNILLGEDG---TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 182 DLKp~NILl~~~g---~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
||||+||+++.++ .+||+|||++..+...... .......+++.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 141 dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 141 DIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY---RKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred ccchheEEEeccCCCcceEeccCccccccCCccce---ecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHc
Confidence 9999999997655 6999999998765221110 0111223456899999987655 8999999999999999997
Q ss_pred -CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 259 -GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 259 -G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|..||......+............. ...++..+.+++.+||+.+|++|||+.++++|
T Consensus 217 ~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 217 LGYMPYPGRTNQEVMEFVTGGGRLDP---------PKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999988776666554444332221 13457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=330.02 Aligned_cols=261 Identities=21% Similarity=0.362 Sum_probs=208.6
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
...+|.+.+.||+|+||+||++.+.. ++..+|+|.++ ... ....+.+.+|+.
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~----------------------~~~-~~~~~~~~~e~~ 59 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK----------------------DAS-DNARKDFHREAE 59 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecC----------------------CcC-HHHHHHHHHHHH
Confidence 45789999999999999999998633 33445555442 211 234567899999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI-----SNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~-----~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
++++++||||+++++++...+.+++||||+.+++|.+++...... .......+++..+..++.||+.||.|||++
T Consensus 60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~ 139 (288)
T cd05093 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139 (288)
T ss_pred HHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999999999999743210 001234589999999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
|++||||||+|||+++++.++|+|||++........ ........+++.|+|||++.+.. ++.++|||||||++|+|
T Consensus 140 ~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l 215 (288)
T cd05093 140 HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEI 215 (288)
T ss_pred CeeecccCcceEEEccCCcEEeccCCccccccCCce---eecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHH
Confidence 999999999999999999999999999876532211 11122344678899999987654 89999999999999999
Q ss_pred Hh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 257 AT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 257 lt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+| |..||...........+..+...... ..++..+.+|+.+||+++|.+|||+.+++.
T Consensus 216 ~t~g~~p~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 216 FTYGKQPWYQLSNNEVIECITQGRVLQRP---------RTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCcCCCC---------CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 98 99999887776666666554433221 245678999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=323.42 Aligned_cols=251 Identities=22% Similarity=0.395 Sum_probs=205.3
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.... +..+|+|.+... ....+.+.+|+.++++++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~------------------------~~~~~~~~~e~~~l~~l~ 57 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEG------------------------SMSEDEFIEEAKVMMKLS 57 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCC------------------------cccHHHHHHHHHHHhcCC
Confidence 4579999999999999999997754 334777755311 112356889999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++.....+++||||+.+++|.+++.. ....+++..+..++.||+.||.|||++|++|+||||.|
T Consensus 58 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~n 130 (256)
T cd05113 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE-------HGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARN 130 (256)
T ss_pred CCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcce
Confidence 99999999999999999999999999999999974 23468999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKY 266 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~ 266 (520)
|+++.++.+||+|||.+......... ......++..|+|||.+.+.. ++.++|||||||++|+|+| |..||...
T Consensus 131 ili~~~~~~kl~d~g~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 131 CLVDDQGCVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred EEEcCCCCEEECCCccceecCCCcee----ecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 99999999999999998765332111 111234567899999987655 8999999999999999999 99999887
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
........+.+....... ...+..+++++.+||+++|.+|||+.+++.+
T Consensus 206 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 206 NNSETVEKVSQGLRLYRP---------HLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CHHHHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 776666655554433222 2346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=328.48 Aligned_cols=265 Identities=46% Similarity=0.790 Sum_probs=220.4
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...+.|++.+.||.|++|.||+|.+..++..+++|++.... ...+.+.+|+.+++.
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~------------------------~~~~~~~~e~~~l~~ 71 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK------------------------QNKELIINEILIMKD 71 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCc------------------------hhHHHHHHHHHHHHH
Confidence 45667999999999999999999999888888888764221 134568899999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++|+||+++++++......|+|+||+.|++|.+++... ...+++..+..++.||+.||.|||++|++|+||+|
T Consensus 72 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p 144 (286)
T cd06614 72 CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-------FVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKS 144 (286)
T ss_pred CCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHh-------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCh
Confidence 99999999999999999999999999999999999853 13789999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+||+++.++.++|+|||++..+..... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..
T Consensus 145 ~ni~i~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 145 DNILLSKDGSVKLADFGFAAQLTKEKS-----KRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred hhEEEcCCCCEEECccchhhhhccchh-----hhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999998865533211 123456889999999987654 89999999999999999999999987
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhh
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~ 334 (520)
...............+... ....++..+.+||.+||+.+|.+|||+.+++.|+||..+....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 280 (286)
T cd06614 219 EPPLRALFLITTKGIPPLK-------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKE 280 (286)
T ss_pred CCHHHHHHHHHhcCCCCCc-------chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCchH
Confidence 7665544443333222211 1133678899999999999999999999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.61 Aligned_cols=267 Identities=28% Similarity=0.417 Sum_probs=213.2
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+|..||+|.+.... ........+.+|+.+++.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l 71 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---------------------QSELFAKRAYRELRLLKHM 71 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---------------------cchHHHHHHHHHHHHHHhc
Confidence 5678999999999999999999999999999998764210 0012345688999999999
Q ss_pred CCCCceEEEEEEEECC------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVKD------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+||||+++++++.... .+++||||+ |++|.+++. ...+++..++.++.||+.||.|||++||+|
T Consensus 72 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~---------~~~l~~~~~~~i~~qi~~al~~LH~~gi~H 141 (343)
T cd07880 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK---------HEKLSEDRIQFLVYQMLKGLKYIHAAGIIH 141 (343)
T ss_pred CCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 9999999999987553 469999999 789998885 346899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+||+++.++.++|+|||++...... .....+++.|+|||.+.+...++.++|+|||||++|+|++|.
T Consensus 142 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~ 213 (343)
T cd07880 142 RDLKPGNLAVNEDCELKILDFGLARQTDSE--------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213 (343)
T ss_pred CCCCHHHEEEcCCCCEEEeecccccccccC--------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999998754321 224567899999999876445889999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCC-------------------C--CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTL-------------------D--TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~-------------------~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 319 (520)
+||...........+........ . ...........+++.+.++|.+||+.||.+|||+.
T Consensus 214 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~ 293 (343)
T cd07880 214 PLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAA 293 (343)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHH
Confidence 99987765544443332211100 0 00001112245678899999999999999999999
Q ss_pred HHhcCccccccch
Q psy11359 320 ELLKNPFFKKAKD 332 (520)
Q Consensus 320 elL~hp~~~~~~~ 332 (520)
+++.||||+....
T Consensus 294 ~~l~~~~~~~~~~ 306 (343)
T cd07880 294 EALAHPYFEEFHD 306 (343)
T ss_pred HHhcCccHhhhcC
Confidence 9999999986543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=327.95 Aligned_cols=262 Identities=22% Similarity=0.352 Sum_probs=206.5
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcC----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKA----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
.++|++.+.||+|+||+||+|.... ++..+|+|.+ ...........+.+|+.++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~----------------------~~~~~~~~~~~~~~E~~~l 61 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL----------------------KDINNPQQWGEFQQEASLM 61 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEec----------------------cCCCCHHHHHHHHHHHHHH
Confidence 3679999999999999999998643 3345555544 3222233456788999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc---------cCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS---------NCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~---------~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
+.++||||+++++++......|+||||+.+++|.+++....... ......+++..+..++.||+.||.|||
T Consensus 62 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 141 (283)
T cd05090 62 AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred hhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999996432100 001235789999999999999999999
Q ss_pred HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 175 ~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
++|++||||||+|||++.++.+||+|||++..+..... ........++..|+|||++.+.. ++.++|+|||||++|
T Consensus 142 ~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ 217 (283)
T cd05090 142 SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY---YRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLW 217 (283)
T ss_pred hcCeehhccccceEEEcCCCcEEeccccccccccCCcc---eecccCCCccceecChHHhccCC-CCchhhhHHHHHHHH
Confidence 99999999999999999999999999999876543221 11123345677899999987655 899999999999999
Q ss_pred HHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 255 EMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 255 ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
+|++ |..||.+.................. ...+++.+.+++.+||+++|.+||++.+++++
T Consensus 218 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 218 EIFSFGLQPYYGFSNQEVIEMVRKRQLLPC---------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 9998 9999987666555444433322221 13467889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=331.27 Aligned_cols=268 Identities=30% Similarity=0.540 Sum_probs=210.8
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|+..+.||+|+||.||++.+..+++.||+|.+.... .......+.+|+.++.++.
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~----------------------~~~~~~~~~~e~~~l~~~~ 60 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV----------------------DEKEQKRLLMDLDVVMRSS 60 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc----------------------ChHHHHHHHHHHHHHHHhc
Confidence 356788899999999999999999999889988764221 1233456889999999995
Q ss_pred -CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecccCC
Q psy11359 108 -HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN-GQIHRDIKA 185 (520)
Q Consensus 108 -HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~-giiHrDLKp 185 (520)
||||+++++++..+...+++|||+. ++|.++....... ..+.+++..+..++.|++.||+|||+. |++||||||
T Consensus 61 ~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp 136 (288)
T cd06616 61 DCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEV---LKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKP 136 (288)
T ss_pred CCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCH
Confidence 9999999999999999999999985 5666554321110 346789999999999999999999985 999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc--CCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD--HGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
+||+++.++.++|+|||++..+.... ......|++.|+|||++.+. ..++.++|||||||++|+|++|+.||
T Consensus 137 ~Nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 210 (288)
T cd06616 137 SNILLDRNGNIKLCDFGISGQLVDSI------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210 (288)
T ss_pred HHEEEccCCcEEEeecchhHHhccCC------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCc
Confidence 99999999999999999987653221 11234688999999998765 35899999999999999999999999
Q ss_pred CCCcHH-HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 264 HKYPAM-KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 264 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
...... ..+.......++.+... ....++..+.+||.+||+++|.+|||+.++++||||+....
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~ 275 (288)
T cd06616 211 PKWNSVFDQLTQVVKGDPPILSNS-----EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE 275 (288)
T ss_pred hhcchHHHHHhhhcCCCCCcCCCc-----CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence 765432 22222233333322211 11347889999999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=323.68 Aligned_cols=254 Identities=25% Similarity=0.436 Sum_probs=205.5
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.+.||+|+||.||+|.+. .+..+|+|.++.. . ...+.+.+|+.++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~----------------------~--~~~~~~~~E~~~l 55 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPG----------------------T--MSPESFLEEAQIM 55 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCC----------------------C--CCHHHHHHHHHHH
Confidence 5556789999999999999999999766 4556777765421 1 1234688999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++++||||+++++++. ....|++|||+.+++|.+++... ....+++..+..++.||+.||.|||++|++||||
T Consensus 56 ~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di 128 (260)
T cd05070 56 KKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDG------EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDL 128 (260)
T ss_pred HhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 9999999999998875 55689999999999999999742 3456899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||++++++.++|+|||++..+...... ......++..|+|||.+.+.. ++.++||||||+++|+|++ |.+|
T Consensus 129 ~p~Nili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p 203 (260)
T cd05070 129 RSANILVGDGLVCKIADFGLARLIEDNEYT----ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVP 203 (260)
T ss_pred ccceEEEeCCceEEeCCceeeeeccCcccc----cccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCC
Confidence 999999999999999999999766432211 112234566899999986654 8899999999999999999 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|......+............. ....+..+.+|+.+||.++|.+|||+.++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 204 YPGMNNREVLEQVERGYRMPC---------PQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCCCCHHHHHHHHHcCCCCCC---------CCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 988776666655544332222 1345778999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=328.43 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=216.1
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC-
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH- 107 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~- 107 (520)
++|.+.+.||+|+||.||+|.+..+|..||+|++...... .......+.+|+.+++++.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--------------------~~~~~~~~~~e~~~~~~l~~ 60 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI--------------------KEKKVKYVKIEKEVLTRLNG 60 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc--------------------chHHHHHHHHHHHHHHhccc
Confidence 4799999999999999999999999999999987542111 0123456889999999998
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++...+..++||||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||+|+|
T Consensus 61 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~n 132 (280)
T cd05581 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK--------YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPEN 132 (280)
T ss_pred CCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 99999999999999999999999999999999974 4579999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCcccc---------------ccccccccccccccCCcceecccCCCCcchhHHHHHHH
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLS---------------RQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~---------------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~i 252 (520)
|+++.+|.++|+|||++..+....... .......+.|++.|+|||++.... ++.++|+||||++
T Consensus 133 i~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~ 211 (280)
T cd05581 133 ILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCI 211 (280)
T ss_pred eEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHH
Confidence 999999999999999987664322100 012234567899999999987654 8899999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH----HHHhcCccc
Q psy11359 253 AIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA----SELLKNPFF 327 (520)
Q Consensus 253 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta----~elL~hp~~ 327 (520)
+++|++|..||........+......... + ...+++.+.+||.+||+.+|.+|||+ .++++||||
T Consensus 212 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 212 IYQMLTGKPPFRGSNEYLTFQKILKLEYS-F---------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHhCCCCCCCccHHHHHHHHHhcCCC-C---------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 99999999999887765554444322211 1 12347889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=330.56 Aligned_cols=262 Identities=24% Similarity=0.417 Sum_probs=208.9
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDEL 96 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l 96 (520)
..|+...++|++.+.||+|+||.||+|.+.. ++..||+|.+ .........+.+
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~----------------------~~~~~~~~~~~~ 85 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKML----------------------KPTAHSSEREAL 85 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEec----------------------CccCChHHHHHH
Confidence 4577888999999999999999999998633 3334555543 332223345678
Q ss_pred HHHHHHHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11359 97 LKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS 175 (520)
Q Consensus 97 ~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~ 175 (520)
.+|+.+++++ +||||+++++++...+..|+||||+.+++|.++++.. ....+++.++..++.||+.||.|||+
T Consensus 86 ~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~ 159 (302)
T cd05055 86 MSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK------RESFLTLEDLLSFSYQVAKGMAFLAS 159 (302)
T ss_pred HHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhC------CCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999 8999999999999999999999999999999999742 22348999999999999999999999
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
+|++|+||||+|||++.++.++|+|||++..+..... ........+++.|+|||.+.+.. ++.++|||||||++|+
T Consensus 160 ~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~e 235 (302)
T cd05055 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN---YVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWE 235 (302)
T ss_pred CCeehhhhccceEEEcCCCeEEECCCcccccccCCCc---eeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHH
Confidence 9999999999999999999999999999876543221 11122345678899999987665 8999999999999999
Q ss_pred HHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 256 MAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 256 llt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|++ |..||........+........... .....++.+.+++.+||.++|++|||+.|+++
T Consensus 236 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 236 IFSLGSNPYPGMPVDSKFYKLIKEGYRMA--------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHhCCCCCcCCCCchHHHHHHHHcCCcCC--------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 998 9999987665544433333221111 11235778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=321.71 Aligned_cols=255 Identities=26% Similarity=0.446 Sum_probs=210.3
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|+...++|++.+.||+|+||+||+|.+.. +..+|+|.+... ....+++.+|+.++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~------------------------~~~~~~~~~e~~~l 55 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPG------------------------TMSPEAFLQEAQIM 55 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCC------------------------ccCHHHHHHHHHHH
Confidence 67788999999999999999999999764 466788766421 12345688999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++++||||+++++++......++||||+++++|.+++... ....++...+..++.||+.||.|||++|++|+||
T Consensus 56 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~------~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di 129 (261)
T cd05034 56 KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG------EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDL 129 (261)
T ss_pred hhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 9999999999999999989999999999999999999753 3356899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||+++.++.++|+|||++..+.... ........++..|+|||.+.+.. ++.++||||||+++|+|+| |+.|
T Consensus 130 ~p~nili~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p 204 (261)
T cd05034 130 AARNILVGENLVCKIADFGLARLIEDDE----YTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVP 204 (261)
T ss_pred chheEEEcCCCCEEECccccceeccchh----hhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999987664311 11111223467899999987655 8999999999999999999 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|.+......+...........+ ...+..+.+++.+||+.+|.+|||+.+++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 205 YPGMTNREVLEQVERGYRMPRP---------PNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 9887776666655544322221 234678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=326.04 Aligned_cols=247 Identities=22% Similarity=0.365 Sum_probs=196.7
Q ss_pred CCeEEEeee--eecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc-
Q psy11359 29 DQYEVREVI--GFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS- 105 (520)
Q Consensus 29 ~~Y~i~~~L--G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~- 105 (520)
+.|++.+.+ |.|+||.||++.++.++..+|+|.+..... .. . |+.....
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~----------------------~~----~--e~~~~~~~ 65 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF----------------------NA----I--EPMVHQLM 65 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc----------------------ch----h--hHHHHHHh
Confidence 456777766 999999999999999999999998753210 00 0 2222221
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
.+||||+++++++...+.+|+||||++|++|.+++.. .+.+++..+..++.||++||.|||++|++||||||
T Consensus 66 ~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 137 (267)
T PHA03390 66 KDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK--------EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137 (267)
T ss_pred hcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence 2799999999999999999999999999999999974 34789999999999999999999999999999999
Q ss_pred CcEEEcCCC-CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 186 GNILLGEDG-TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 186 ~NILl~~~g-~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
+||+++.++ .++|+|||++...... ....|++.|+|||++.+.. ++.++|+||||+++|+|++|..||.
T Consensus 138 ~nil~~~~~~~~~l~dfg~~~~~~~~---------~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~ 207 (267)
T PHA03390 138 ENVLYDRAKDRIYLCDYGLCKIIGTP---------SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFK 207 (267)
T ss_pred HHEEEeCCCCeEEEecCccceecCCC---------ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCC
Confidence 999999888 9999999998765321 2346899999999997655 8999999999999999999999997
Q ss_pred CCcHHHHH-HHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-HHHHhcCcccc
Q psy11359 265 KYPAMKVL-MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-ASELLKNPFFK 328 (520)
Q Consensus 265 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-a~elL~hp~~~ 328 (520)
........ ........... ...+.+++.+.+||.+||+++|.+||+ ++++|+||||.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 208 EDEDEELDLESLLKRQQKKL-------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred CCCcchhhHHHHHHhhcccC-------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 55432211 11111111110 112367889999999999999999996 59999999996
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=335.91 Aligned_cols=287 Identities=23% Similarity=0.340 Sum_probs=215.9
Q ss_pred CCCCeE-EEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 27 TEDQYE-VREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 27 ~~~~Y~-i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
..++|. +.+.||.|+||+||+|.+..+++.||+|+++....... ....+. ..........+.+|+.++++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~--~~~~~~~~~~~~~E~~~l~~ 76 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISND-------VTKDRQ--LVGMCGIHFTTLRELKIMNE 76 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccc-------cccchh--hhcccccchhHHHHHHHHHh
Confidence 456676 45789999999999999999999999998864321110 000000 00000112357899999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++...+..++||||+. ++|.+++.. ...+++..+..++.||+.||.|||++|++||||+|
T Consensus 77 l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--------~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~ 147 (335)
T PTZ00024 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR--------KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSP 147 (335)
T ss_pred CCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 999999999999999999999999996 699999863 45689999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccc---------cccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDL---------SRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~---------~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
+||+++.++.++|+|||++..+...... ..........+++.|+|||.+.+...++.++|+|||||++|+|
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999766421100 0011112345788999999987765579999999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHhcC--CCCCC--C--------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH
Q psy11359 257 ATGTAPYHKYPAMKVLMLTLQN--DPPTL--D--------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA 318 (520)
Q Consensus 257 ltG~~Pf~~~~~~~~~~~~~~~--~~~~~--~--------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta 318 (520)
+||.+||......+.+..+... .+... . ............+..+.+||.+||+++|++|||+
T Consensus 228 ~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~ 307 (335)
T PTZ00024 228 LTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307 (335)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH
Confidence 9999999887766554333221 11000 0 0000111223457889999999999999999999
Q ss_pred HHHhcCccccccc
Q psy11359 319 SELLKNPFFKKAK 331 (520)
Q Consensus 319 ~elL~hp~~~~~~ 331 (520)
+|+|.||||+...
T Consensus 308 ~~~l~~~~~~~~~ 320 (335)
T PTZ00024 308 KEALKHEYFKSDP 320 (335)
T ss_pred HHHhcCcccCCCC
Confidence 9999999998653
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=329.78 Aligned_cols=267 Identities=23% Similarity=0.406 Sum_probs=211.6
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCC-----ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARA-----EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELL 97 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~ 97 (520)
.|....++|++.+.||+|+||.||++.....+ ..+|+|. +..........++.
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~----------------------~~~~~~~~~~~~~~ 63 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM----------------------LKDDATEKDLSDLV 63 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEE----------------------ccCCCCHHHHHHHH
Confidence 45667889999999999999999999887543 3455554 43333334456788
Q ss_pred HHHHHHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--------cCCCCCCCHHHHHHHHHHHHH
Q psy11359 98 KEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--------NCKHGVCDEPTIATVLREVLK 168 (520)
Q Consensus 98 ~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--------~~~~~~l~~~~i~~i~~qIl~ 168 (520)
+|+.+++++ +||||+++++++..+..++++|||+.+|+|.+++..+.... ....+.+++..+..++.||+.
T Consensus 64 ~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 143 (293)
T cd05053 64 SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVAR 143 (293)
T ss_pred HHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHH
Confidence 999999999 89999999999999999999999999999999997532110 013457899999999999999
Q ss_pred HHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHH
Q psy11359 169 GLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWS 248 (520)
Q Consensus 169 gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwS 248 (520)
||.|||++||+||||||+|||++.++.+||+|||++..+...... .......+++.|+|||++.+.. ++.++||||
T Consensus 144 al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s 219 (293)
T cd05053 144 GMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY---RKTTNGRLPVKWMAPEALFDRV-YTHQSDVWS 219 (293)
T ss_pred HHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccce---eccCCCCCCccccCHHHhccCC-cCcccceee
Confidence 999999999999999999999999999999999998765432211 0111223467899999986654 899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 249 LGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 249 lG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|||++|+|++ |..||......+.............+ ..++..+.+|+.+||..+|.+|||+.+++++
T Consensus 220 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 220 FGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKP---------QNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred hhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------CCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 9999999997 99999887766655544443322211 2356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=329.12 Aligned_cols=264 Identities=37% Similarity=0.627 Sum_probs=216.1
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.+.|...+.||+|+||+||+|.+..+|..|++|.+..... ........+.+|+.+++.++
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~--------------------~~~~~~~~~~~E~~~l~~l~ 79 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK--------------------QTNEKWQDIIKEVKFLQQLK 79 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc--------------------CchHHHHHHHHHHHHHHhCC
Confidence 3457888899999999999999999999999987753211 11223456889999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||++++++++...+..|+||||+. ++|.+++.. ....+++..+..++.||+.||.|||++|++||||+|+|
T Consensus 80 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-------~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~n 151 (313)
T cd06633 80 HPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV-------HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGN 151 (313)
T ss_pred CCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhh
Confidence 9999999999999999999999995 688888764 34568999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc--cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ--DHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
|+++.++.++|+|||++.... ......|++.|+|||++.. ...++.++|||||||++|+|++|..||..
T Consensus 152 ili~~~~~~kL~dfg~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 152 ILLTEPGQVKLADFGSASKSS---------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred EEECCCCCEEEeecCCCcccC---------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999875321 1234578999999999842 23378899999999999999999999988
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhhHH
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFI 336 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~ 336 (520)
...............+... ...++..+++||.+||+++|.+|||+.+++.||||+.....+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~~ 285 (313)
T cd06633 223 MNAMSALYHIAQNDSPTLQ--------SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVL 285 (313)
T ss_pred CChHHHHHHHHhcCCCCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchhHHH
Confidence 7766666555444333221 13456779999999999999999999999999999976654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=321.46 Aligned_cols=285 Identities=27% Similarity=0.374 Sum_probs=228.2
Q ss_pred CCCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 19 SVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 19 ~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
+...|+......|+-+.+||+|.||.||+|+++.+|++||+|++-... +++ -......+
T Consensus 7 s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen--------------------eKe-Gfpitalr 65 (376)
T KOG0669|consen 7 SMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN--------------------EKE-GFPITALR 65 (376)
T ss_pred cccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc--------------------ccc-CCcHHHHH
Confidence 445566778889999999999999999999999999998888653221 111 12334788
Q ss_pred HHHHHhcCCCCCceEEEEEEEE--------CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVV--------KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~--------~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL 170 (520)
|+.+|..|+|+|++.+++.+.. ...+|+||.+|+. +|..++.. ....++..+|++++.+++.||
T Consensus 66 eikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn-------~~vr~sls~Ikk~Mk~Lm~GL 137 (376)
T KOG0669|consen 66 EIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSN-------RKVRFSLSEIKKVMKGLMNGL 137 (376)
T ss_pred HHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcC-------ccccccHHHHHHHHHHHHHHH
Confidence 9999999999999998877753 3359999999964 88888864 345789999999999999999
Q ss_pred HHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHH
Q psy11359 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG 250 (520)
Q Consensus 171 ~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG 250 (520)
.|+|.+.|+|||+||.|+||+.+|.+||+|||+++.+........+. ....+-|.+|++||.+.+...|+++.|||..|
T Consensus 138 ~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kpr-ytnrvvTLwYrppEllLG~r~yg~~iDiWgAg 216 (376)
T KOG0669|consen 138 YYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPR-YTNRVVTLWYRPPELLLGDREYGPPIDIWGAG 216 (376)
T ss_pred HHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCC-cccceeeeecCCHHHhhcccccCCcchhHhHH
Confidence 99999999999999999999999999999999998887666554433 44567799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHhcC---CCCCCCCCchhhhhHH----------------------HhcHHHHHHHH
Q psy11359 251 ITAIEMATGTAPYHKYPAMKVLMLTLQN---DPPTLDTGAAEKDQYK----------------------AYGKTFRKMIS 305 (520)
Q Consensus 251 ~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~----------------------~~~~~~~~li~ 305 (520)
|||.+|+||.+.|.+.....++..+.+- ..+.........+.+. .-+++..+|++
T Consensus 217 CimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle 296 (376)
T KOG0669|consen 217 CIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLE 296 (376)
T ss_pred HHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHH
Confidence 9999999999999999888777544322 1111111111111111 12457889999
Q ss_pred hhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 306 DCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 306 ~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
++|..||.+|++++++|+|.||.+....
T Consensus 297 ~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 297 KLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred HHhccCcccCcchHhhhchhhhhcCCcc
Confidence 9999999999999999999999876543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=330.99 Aligned_cols=268 Identities=25% Similarity=0.402 Sum_probs=210.4
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||.|+||.||+|.++.+|+.||+|.++.... .......+.+|+.+++++
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------------------~~~~~~~~~~e~~~~~~l 63 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE---------------------KEGFPITAIREIKILRQL 63 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc---------------------ccCchHHHHHHHHHHHhC
Confidence 45789999999999999999999999999999997753210 011234577899999999
Q ss_pred CCCCceEEEEEEEECC----------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 107 HHENVVTYHTSFVVKD----------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~----------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
+||||+++++++.+.. .+++||||+.+ +|.+++.. ....+++..+..++.||+.||.|||++
T Consensus 64 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~ 135 (302)
T cd07864 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES-------GLVHFSEDHIKSFMKQLLEGLNYCHKK 135 (302)
T ss_pred CCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999999999987654 79999999975 78777753 335689999999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
||+||||||+||++++++.+||+|||++..+..... .......+++.|+|||.+.+...++.++|||||||++|+|
T Consensus 136 ~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el 211 (302)
T cd07864 136 NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211 (302)
T ss_pred CeecCCCCHHHEEECCCCcEEeCcccccccccCCcc----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHH
Confidence 999999999999999999999999999876643221 1112235678899999887655578999999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHhcC--CC-CCC----CC-------------CchhhhhHHHhcHHHHHHHHhhhccCCCCCC
Q psy11359 257 ATGTAPYHKYPAMKVLMLTLQN--DP-PTL----DT-------------GAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316 (520)
Q Consensus 257 ltG~~Pf~~~~~~~~~~~~~~~--~~-~~~----~~-------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 316 (520)
++|.+||........+...... .+ +.. .. ..........++..+.++|.+||+.+|.+||
T Consensus 212 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 291 (302)
T cd07864 212 FTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291 (302)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC
Confidence 9999999876655544333221 11 100 00 0000112234688999999999999999999
Q ss_pred CHHHHhcCccc
Q psy11359 317 TASELLKNPFF 327 (520)
Q Consensus 317 ta~elL~hp~~ 327 (520)
|+.+++.||||
T Consensus 292 ~~~~il~~~~~ 302 (302)
T cd07864 292 TAEEALNSPWL 302 (302)
T ss_pred CHHHHhcCCCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=340.16 Aligned_cols=267 Identities=28% Similarity=0.429 Sum_probs=214.0
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|++|.||+|.+..++..||+|++..... .......+.+|+.+++.+
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~---------------------~~~~~~~~~~E~~~l~~l 71 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ---------------------SAIHAKRTYRELRLLKHM 71 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc---------------------hhhHHHHHHHHHHHHHhc
Confidence 45679999999999999999999999999999997642100 012345678899999999
Q ss_pred CCCCceEEEEEEEECCE------EEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVKDE------LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~------~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+||||+++++++...+. +++|+||+ |++|.+++. ...+++..+..++.||+.||.|||++|++|
T Consensus 72 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~---------~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H 141 (343)
T cd07851 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVK---------CQKLSDDHIQFLVYQILRGLKYIHSAGIIH 141 (343)
T ss_pred cCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 99999999988876554 89999999 779999986 256899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+||+++.++.++|+|||++...... .....+++.|+|||.+.+...++.++|||||||++|+|+||+
T Consensus 142 ~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~ 213 (343)
T cd07851 142 RDLKPSNIAVNEDCELKILDFGLARHTDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213 (343)
T ss_pred CCCCHHHeEECCCCCEEEcccccccccccc--------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCC
Confidence 999999999999999999999998765321 234578899999999876545889999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCC---------------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLD---------------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 319 (520)
.||........+..+........+ ....-...+..++..+.+||.+||+++|.+|||+.
T Consensus 214 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ 293 (343)
T cd07851 214 TLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA 293 (343)
T ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHH
Confidence 999877665554443322111000 00000111234588999999999999999999999
Q ss_pred HHhcCccccccch
Q psy11359 320 ELLKNPFFKKAKD 332 (520)
Q Consensus 320 elL~hp~~~~~~~ 332 (520)
+++.||||+....
T Consensus 294 ell~h~~~~~~~~ 306 (343)
T cd07851 294 EALAHPYLAEYHD 306 (343)
T ss_pred HHhcCCCccccCC
Confidence 9999999987644
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=321.95 Aligned_cols=254 Identities=23% Similarity=0.411 Sum_probs=205.9
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.++||+|+||.||+|.+. +++.||+|.+... ....+.+.+|+.++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~------------------------~~~~~~~~~E~~~l 55 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQG------------------------SMSPEAFLAEANLM 55 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCC------------------------CCcHHHHHHHHHHH
Confidence 5667889999999999999999999865 4567787765321 11245688999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++++||||+++++++ ..+..+++|||+.+++|.+++... ....+++.++..++.|++.||.|||++|++||||
T Consensus 56 ~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl 128 (260)
T cd05067 56 KQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTP------EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128 (260)
T ss_pred HhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccc
Confidence 999999999999886 456789999999999999998643 3457889999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||++++++.++|+|||++..+..... .......++..|+|||.+.... ++.++||||||+++|+|++ |++|
T Consensus 129 ~p~ni~i~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p 203 (260)
T cd05067 129 RAANILVSETLCCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIP 203 (260)
T ss_pred cHHhEEEcCCCCEEEccCcceeecCCCCc----ccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999876542111 1112334567899999987655 8899999999999999999 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|.................... ....+.++.++|.+||..+|++|||++++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 204 YPGMTNPEVIQNLERGYRMPR---------PDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCChHHHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 987776655544433322211 1345678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=369.76 Aligned_cols=269 Identities=26% Similarity=0.384 Sum_probs=227.6
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|+++++||+|+||.|.+++.+.+++.||.|++++....+ + ....-|..|-.+|..
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-------------r-------~~tA~F~EERDimv~ 131 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-------------R-------AETACFREERDIMVF 131 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-------------c-------hhHHHHHHHhHHHHc
Confidence 35689999999999999999999999999999999987654321 1 123458889999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
.+.+=|+.++-.|.+++++|+||||+.||+|..++. +...+++..++-++..|..||.-||+.|+|||||||
T Consensus 132 ~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlS--------k~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKP 203 (1317)
T KOG0612|consen 132 GNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLS--------KFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKP 203 (1317)
T ss_pred CCcHHHHHHHHHhcCccceEEEEecccCchHHHHHh--------hcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCc
Confidence 999999999999999999999999999999999998 456899999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc---c-CCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ---D-HGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~-~~~~~~~DIwSlG~il~elltG~~ 261 (520)
+|||++..|++||+|||.+..+...+. -.....+|||-|.+||++.. + ..|+..+|.||+||++|||+.|..
T Consensus 204 DNvLld~~GHikLADFGsClkm~~dG~----V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~T 279 (1317)
T KOG0612|consen 204 DNVLLDKSGHIKLADFGSCLKMDADGT----VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGET 279 (1317)
T ss_pred ceeEecccCcEeeccchhHHhcCCCCc----EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCC
Confidence 999999999999999999877653222 22345689999999999852 2 348999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC---HHHHhcCccccccchh
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT---ASELLKNPFFKKAKDK 333 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~elL~hp~~~~~~~~ 333 (520)
||....-.+.+-.+..... .+... ....+|.+.++||++.+. +|+.|.. ++++-.||||....+.
T Consensus 280 PFYadslveTY~KIm~hk~-~l~FP-----~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 280 PFYADSLVETYGKIMNHKE-SLSFP-----DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred cchHHHHHHHHHHHhchhh-hcCCC-----cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence 9998887777766665521 11111 113489999999999997 6999999 9999999999998883
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=320.67 Aligned_cols=254 Identities=25% Similarity=0.438 Sum_probs=204.4
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.+.||+|++|.||+|.+..+ ..+|+|.+... ....+.+.+|+.++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~------------------------~~~~~~~~~E~~~l 55 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPG------------------------TMMPEAFLQEAQIM 55 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccC------------------------CccHHHHHHHHHHH
Confidence 445667899999999999999999987664 35777765321 11235688899999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+.++||||+++++++. .+..++||||+.+++|.+++... ....+++..+..++.||+.||.|||++|++||||
T Consensus 56 ~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl 128 (260)
T cd05069 56 KKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEG------DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128 (260)
T ss_pred HhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 9999999999998875 45689999999999999999753 3345789999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||++++++.++|+|||++..+..... .......++..|+|||.+.+.. ++.++||||||+++|+|+| |..|
T Consensus 129 ~~~Nill~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p 203 (260)
T cd05069 129 RAANILVGDNLVCKIADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVP 203 (260)
T ss_pred CcceEEEcCCCeEEECCCccceEccCCcc----cccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999976643221 1112234667899999887655 8999999999999999999 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|.................... ...++..+.+++.+||.++|.+|||++++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 204 YPGMVNREVLEQVERGYRMPC---------PQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCCCHHHHHHHHHcCCCCCC---------CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 988776665554443322211 1346788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.37 Aligned_cols=260 Identities=30% Similarity=0.503 Sum_probs=211.2
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
.+|++.+.||+|+||.||+|.+..++..||+|.+...... .........+.+|+.++++++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~------------------~~~~~~~~~~~~ei~~l~~l~h 63 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS------------------QETSKEVNALECEIQLLKNLRH 63 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc------------------chhhHHHHHHHHHHHHHHHcCC
Confidence 4799999999999999999999999999999976432100 0112345678999999999999
Q ss_pred CCceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 109 ENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 109 pnIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
|||+++++++.+. ..++++|||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||||+
T Consensus 64 ~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--------~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ 135 (264)
T cd06653 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA--------YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGA 135 (264)
T ss_pred CCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 9999999998764 568999999999999999973 356889999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
||+++.++.++|+|||++........ .........|++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...
T Consensus 136 ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 136 NILRDSAGNVKLGDFGASKRIQTICM--SGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred HEEEcCCCCEEECccccccccccccc--cCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999876532111 111122457899999999987654 889999999999999999999999877
Q ss_pred cHHHHHHHHhcCC-CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 267 PAMKVLMLTLQND-PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 267 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
............. ++.+ ...+++.+.++|.+||+ +|..|||+.+++.|||.
T Consensus 213 ~~~~~~~~~~~~~~~~~~---------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 213 EAMAAIFKIATQPTKPML---------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CHHHHHHHHHcCCCCCCC---------CcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 6665554433221 1111 24567889999999999 58999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=320.02 Aligned_cols=256 Identities=29% Similarity=0.507 Sum_probs=216.1
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||.|++|.||++.++.++..+|+|.+...... .....++.+|+.++++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~~~ 59 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS---------------------QKEREDAVNEIRILASVNHP 59 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc---------------------HHHHHHHHHHHHHHHhCCCC
Confidence 589999999999999999999999888998877532211 22345678899999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++......|+||||+.+++|.+++..... ....+++..+..++.||+.||.|||++|++|+||+|+||+
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~ 135 (256)
T cd08530 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKK----KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANIL 135 (256)
T ss_pred CchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEE
Confidence 999999999999999999999999999999976432 3467899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.++.+||+|||++...... ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......
T Consensus 136 ~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~ 207 (256)
T cd08530 136 LVANDLVKIGDLGISKVLKKN-------MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207 (256)
T ss_pred EecCCcEEEeeccchhhhccC-------CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999998766432 223346889999999987655 889999999999999999999999887766
Q ss_pred HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
...........+.+. ..++.+++++|.+||+.+|.+|||+.++++||++
T Consensus 208 ~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 208 DLRYKVQRGKYPPIP---------PIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHhcCCCCCCc---------hhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 555544443333222 2567889999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=322.18 Aligned_cols=251 Identities=25% Similarity=0.438 Sum_probs=203.7
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
..+|++.+.||+|+||.||++.++ ++..+|+|.+... ....+.+.+|+.++++++
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~------------------------~~~~~~~~~e~~~l~~l~ 57 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG------------------------AMSEDDFIEEAKVMMKLS 57 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccC------------------------CCCHHHHHHHHHHHHhCC
Confidence 346899999999999999999876 4566788765321 112345788999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++...+..|+||||++|++|.+++.. ..+.+++..+..++.||+.||.|||++|++||||||+|
T Consensus 58 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~n 130 (256)
T cd05059 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE-------RKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARN 130 (256)
T ss_pred CCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHh-------cccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhh
Confidence 99999999999999999999999999999999974 23468999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKY 266 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~ 266 (520)
|++++++.+||+|||++......... ......++..|+|||.+.+.. ++.++||||||+++|+|+| |..||...
T Consensus 131 i~i~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 131 CLVGEDNVVKVSDFGLARYVLDDQYT----SSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred EEECCCCcEEECCcccceeccccccc----ccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 99999999999999998765322111 011122345799999987655 8999999999999999999 89999877
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
...+.............+ ..++..+.+++.+||..+|++|||+.++++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 206 SNSEVVESVSAGYRLYRP---------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CHHHHHHHHHcCCcCCCC---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 766655544433222211 3467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=337.19 Aligned_cols=266 Identities=25% Similarity=0.407 Sum_probs=208.6
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~~Ei~~l~~l 73 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---------------------SIIHAKRTYRELRLLKHM 73 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch---------------------hhHHHHHHHHHHHHHHHc
Confidence 34789999999999999999999999999999987643210 011235678899999999
Q ss_pred CCCCceEEEEEEEEC------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+||||+++++++... ..+|++++++ |++|.++++ ...+++..++.++.||+.||.|||++|++|
T Consensus 74 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 143 (345)
T cd07877 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK---------CQKLTDDHVQFLIYQILRGLKYIHSADIIH 143 (345)
T ss_pred CCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 999999999988643 3478899887 789988875 245899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+||+++.++.++|+|||++..... ......|++.|+|||++.+...++.++|||||||++|+|++|.
T Consensus 144 ~dlkp~NIll~~~~~~kl~dfg~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 215 (345)
T cd07877 144 RDLKPSNLAVNEDCELKILDFGLARHTDD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215 (345)
T ss_pred cCCChHHEEEcCCCCEEEecccccccccc--------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999865321 1234578999999999876555889999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCC---C----CCCc--------------hhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPT---L----DTGA--------------AEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~---~----~~~~--------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 319 (520)
.||........+..+....... + .... .........++.+.+||.+||++||.+|||+.
T Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 295 (345)
T cd07877 216 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 295 (345)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHH
Confidence 9997766544433322211000 0 0000 00000113577899999999999999999999
Q ss_pred HHhcCccccccc
Q psy11359 320 ELLKNPFFKKAK 331 (520)
Q Consensus 320 elL~hp~~~~~~ 331 (520)
+++.||||++..
T Consensus 296 e~l~h~~f~~~~ 307 (345)
T cd07877 296 QALAHAYFAQYH 307 (345)
T ss_pred HHhcChhhhhcC
Confidence 999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=327.54 Aligned_cols=263 Identities=29% Similarity=0.453 Sum_probs=212.7
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
|++.+.||.|++|.||+|.+..+|+.+++|.++.... .......+.+|+.++++++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~~~~ 59 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE---------------------SEGIPKTALREIKLLKELNHPN 59 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc---------------------cchhHHHHHHHHHHHHHhcCCC
Confidence 6788999999999999999999999999987643211 0123456888999999999999
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl 190 (520)
|+++++++..++..++||||+. ++|.+++.. ..+.+++..+..++.||+.||.|||++|++|+||||+||++
T Consensus 60 i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili 131 (283)
T cd05118 60 IIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKD-------RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI 131 (283)
T ss_pred cchHHHhhccCCCEEEEEeccC-CCHHHHHHh-------hcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE
Confidence 9999999999999999999996 489888875 34678999999999999999999999999999999999999
Q ss_pred cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q psy11359 191 GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270 (520)
Q Consensus 191 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~ 270 (520)
+.++.++|+|||.+..+.... .......++..|+|||.+.+...++.++|+||||+++|+|+||+.||......+
T Consensus 132 ~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~ 206 (283)
T cd05118 132 NTEGVLKLADFGLARSFGSPV-----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID 206 (283)
T ss_pred CCCCcEEEeeeeeeEecCCCc-----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999987764332 112234688899999998776458999999999999999999999998777655
Q ss_pred HHHHHhcCCCCCCC--------------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 271 VLMLTLQNDPPTLD--------------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 271 ~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.+............ ...........++..+++||.+||++||.+||++.+++.||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 207 QLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 54333221100000 0000112334578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=328.51 Aligned_cols=258 Identities=22% Similarity=0.357 Sum_probs=204.0
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCce--EEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEK--CAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
++|++.++||+|+||.||+|.++.++.. +++|.++ ........+.+.+|+.++.++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~----------------------~~~~~~~~~~~~~E~~~l~~l 59 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK----------------------EFASENDHRDFAGELEVLCKL 59 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcc----------------------ccCCHHHHHHHHHHHHHHHhh
Confidence 5799999999999999999998887653 4666443 111123345688999999999
Q ss_pred -CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--------cCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy11359 107 -HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--------NCKHGVCDEPTIATVLREVLKGLEYFHSNG 177 (520)
Q Consensus 107 -~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--------~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g 177 (520)
+||||+++++++.....+|+||||+.+++|.+++....... ....+.+++..+..++.||+.||+|||++|
T Consensus 60 ~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 139 (297)
T cd05089 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139 (297)
T ss_pred cCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 79999999999999999999999999999999997532110 001246889999999999999999999999
Q ss_pred cEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 178 QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 178 iiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
++||||||+|||++.++.+||+|||++...... ........+..|+|||++.... ++.++|||||||++|+|+
T Consensus 140 ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~ 212 (297)
T cd05089 140 FIHRDLAARNVLVGENLASKIADFGLSRGEEVY------VKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIV 212 (297)
T ss_pred cccCcCCcceEEECCCCeEEECCcCCCccccce------eccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999987532110 0011122345799999987655 899999999999999999
Q ss_pred h-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 258 T-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 258 t-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
+ |..||....................+ ..++..+++||.+||..+|.+|||++++++.
T Consensus 213 t~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 213 SLGGTPYCGMTCAELYEKLPQGYRMEKP---------RNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred cCCCCCCCCCCHHHHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7 99999887776665555443222211 3467889999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=339.61 Aligned_cols=256 Identities=24% Similarity=0.456 Sum_probs=214.2
Q ss_pred EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceE
Q psy11359 34 REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVT 113 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~ 113 (520)
.++||+|-||+||-|+++.+|+.||||++.+-.+. ....+.++.|+.+|.+++||+||.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp---------------------~kqesqlR~EVaILq~l~HPGiV~ 627 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP---------------------TKQESQLRNEVAILQNLHHPGIVN 627 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCC---------------------CchHHHHHHHHHHHHhcCCCCeeE
Confidence 37899999999999999999999999987542211 122367899999999999999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+-..|++.+.++.|||-+. |++.+.|-.. ..+.+++..-+-++.||+.||.|||-+||+|+||||+|||+.+.
T Consensus 628 le~M~ET~ervFVVMEKl~-GDMLEMILSs------EkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~ 700 (888)
T KOG4236|consen 628 LECMFETPERVFVVMEKLH-GDMLEMILSS------EKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA 700 (888)
T ss_pred EEEeecCCceEEEEehhhc-chHHHHHHHh------hcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC
Confidence 9999999999999999995 5666666543 56889999999999999999999999999999999999999543
Q ss_pred ---CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q psy11359 194 ---GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270 (520)
Q Consensus 194 ---g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~ 270 (520)
-.+||||||+|++++ ....+.+.+|||.|+|||+++.. +|+..-||||+|+|+|.-+.|..||....+..
T Consensus 701 ~~FPQvKlCDFGfARiIg------EksFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn 773 (888)
T KOG4236|consen 701 SPFPQVKLCDFGFARIIG------EKSFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN 773 (888)
T ss_pred CCCCceeeccccceeecc------hhhhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchh
Confidence 379999999999875 45567789999999999999754 59999999999999999999999997654432
Q ss_pred HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
. .+++..-. .+...|+.+++...+||..+|+..-++|.|.+..|.|||++....
T Consensus 774 d---QIQNAaFM-----yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 774 D---QIQNAAFM-----YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQT 827 (888)
T ss_pred H---Hhhccccc-----cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchH
Confidence 2 22221111 122346889999999999999999999999999999999997654
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=323.69 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=204.9
Q ss_pred eEEEeeeeecCceEEEEEEEcCCC---ceEEEEEeehhhhhhhHhhhccceeeEEEeecccc-hhhHHHHHHHHHHHhcC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARA---EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW-NTSMDELLKEIQAMSSC 106 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~-~~~~~~l~~Ei~~l~~l 106 (520)
|++.+.||+|+||.||+|....++ ..||+|.++ .+.. ....+.+.+|+..++.+
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~----------------------~~~~~~~~~~~~~~e~~~l~~l 58 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK----------------------LDIHTYSEIEEFLSEAACMKDF 58 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEec----------------------cCcCCHHHHHHHHHHHHHHHhC
Confidence 678899999999999999876543 556666553 2211 23456789999999999
Q ss_pred CCCCceEEEEEEEECCE------EEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVKDE------LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~------~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+||||+++++++..... .+++|||+.+++|..++....... ....+++..+..++.||+.||.|||++|++|
T Consensus 59 ~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H 136 (273)
T cd05035 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG--LPEKLPLQTLLKFMVDIALGMEYLSNRNFIH 136 (273)
T ss_pred CCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccC--CcccCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 99999999998875544 799999999999999986532111 2346899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-C
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G 259 (520)
|||||+||++++++.+||+|||++..+...... .......++..|+|||.+.... ++.++|||||||++|+|++ |
T Consensus 137 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g 212 (273)
T cd05035 137 RDLAARNCMLREDMTVCVADFGLSKKIYSGDYY---RQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRG 212 (273)
T ss_pred cccchheEEECCCCeEEECCccceeeccccccc---cccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCC
Confidence 999999999999999999999998766432211 1111233567899999986554 8999999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
..||......+.......+.....+ ..++..+.+++.+||+.||.+|||+.|++++
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 213 QTPYPGVENHEIYDYLRHGNRLKQP---------EDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCC---------cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999888777776655554333222 3467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=335.98 Aligned_cols=271 Identities=28% Similarity=0.409 Sum_probs=216.9
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||.|++|.||+|.+..++..||+|.+.... ......+.+.+|+.+++.++||
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------------------~~~~~~~~~~~e~~~l~~l~~~ 59 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF---------------------DDLIDAKRILREIKLLRHLRHE 59 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc---------------------ccchhhhhHHHHHHHHHhcCCc
Confidence 6999999999999999999999999999999764211 0022345688999999999999
Q ss_pred CceEEEEEEEECC-----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 110 NVVTYHTSFVVKD-----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 110 nIv~~~~~~~~~~-----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
||+++++++.... .+|+||||+. ++|.+++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 60 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~--------~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlk 130 (330)
T cd07834 60 NIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIK--------SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLK 130 (330)
T ss_pred chhhhhhhhcccCcccccceEEEecchh-hhHHHHHh--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9999999988765 7999999996 58998886 34589999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.++.++|+|||++......... ........+++.|+|||++.+...++.++|+||||+++|+|++|.+||.
T Consensus 131 p~nili~~~~~~~L~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 131 PSNILVNSNCDLKICDFGLARGVDPDEDE--KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred HHHEEEcCCCCEEEcccCceEeecccccc--cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 99999999999999999999876543210 1123345789999999999877468999999999999999999999998
Q ss_pred CCcHHHHHHHHhcCCCCCCCC---------------------CchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDT---------------------GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.....+.+..+.......... ..........++..+.+||.+||+++|.+|||+.+++.
T Consensus 209 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 209 GRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred CCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 877665544433321110000 00001112346788999999999999999999999999
Q ss_pred Cccccccch
Q psy11359 324 NPFFKKAKD 332 (520)
Q Consensus 324 hp~~~~~~~ 332 (520)
||||+....
T Consensus 289 ~~~~~~~~~ 297 (330)
T cd07834 289 HPYLAQLHD 297 (330)
T ss_pred CccHHhhcc
Confidence 999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.10 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=210.7
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
|++.+.||.|++|.||+|.+..+|+.+|+|.++... ........+.+|+.+++.++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---------------------~~~~~~~~~~~e~~~l~~l~~~~ 59 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---------------------EKEGFPITAIREIKLLQKLRHPN 59 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---------------------ccccchHHHHHHHHHHHhccCCC
Confidence 789999999999999999999999999999875321 00123356788999999999999
Q ss_pred ceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 111 VVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 111 Iv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|+++++++... +..++||||+. ++|.+++.. ....+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 60 i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~ni 131 (287)
T cd07840 60 IVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDS-------PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNI 131 (287)
T ss_pred eeeheeeEecCCCCcEEEEecccc-ccHHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHe
Confidence 99999999988 89999999996 589988864 235789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
++++++.++|+|||++..+..... .......+++.|+|||.+.+...++.++||||||+++|+|+||..||.....
T Consensus 132 l~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 132 LINNDGVLKLADFGLARPYTKRNS----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred EEcCCCCEEEccccceeeccCCCc----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999887643321 1122345788999999887655589999999999999999999999987776
Q ss_pred HHHHHHHhcCCCCCCCC--------------------CchhhhhHHH-hcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQNDPPTLDT--------------------GAAEKDQYKA-YGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
...+............. .......... +++.+.++|.+||..+|.+|||+.+++.||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 208 LEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 55544333211000000 0000111222 38889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=316.74 Aligned_cols=256 Identities=38% Similarity=0.645 Sum_probs=213.0
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||+|++|.||+|.+..++..|++|++...... ....+.+.+|+.++++++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~~~ 59 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---------------------EEELEALEREIRILSSLQHP 59 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---------------------hHHHHHHHHHHHHHHHcCCC
Confidence 588999999999999999999999999999987532110 23466789999999999999
Q ss_pred CceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 110 NVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 110 nIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||+++++.+... ..+++|+||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+|
T Consensus 60 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~n 131 (260)
T cd06606 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--------FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGAN 131 (260)
T ss_pred CEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHH
Confidence 999999999988 899999999999999999974 3478999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
|+++.++.++|+|||.+......... .......++..|+|||.+.... ++.++|+||||+++|+|++|..||....
T Consensus 132 i~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 132 ILVDSDGVVKLADFGCAKRLGDIETG---EGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred EEEcCCCCEEEcccccEEeccccccc---ccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999998876443211 0123457889999999987665 8999999999999999999999998766
Q ss_pred HHHHHHHHhcC--CCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 268 AMKVLMLTLQN--DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 268 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
........+.. ..+.+ ....+..+.+||.+||+.+|.+|||+.+++.||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 208 NPMAALYKIGSSGEPPEI---------PEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred chHHHHHhccccCCCcCC---------CcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 32222222221 11111 13447889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=319.70 Aligned_cols=257 Identities=32% Similarity=0.558 Sum_probs=207.8
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||.|+||.||+|.+..+|+.||+|.++.... ......+.+.+|+.++++++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------------------~~~~~~~~~~~ei~~l~~~~~ 61 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM--------------------MDAKARQDCLKEIDLLKQLDH 61 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc--------------------cchhhHHHHHHHHHHHHhCCC
Confidence 579999999999999999999999999999987642110 002235678899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
+||+++++++...+..++||||+.+++|.+++..... ....+++..+..++.||+.||.|||++|++||||+|+||
T Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni 137 (267)
T cd08224 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKK----QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANV 137 (267)
T ss_pred CCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcc----cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhE
Confidence 9999999999999999999999999999999875321 345689999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++.++.++|+|||++..+.... .......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.....
T Consensus 138 l~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~ 211 (267)
T cd08224 138 FITATGVVKLGDLGLGRFFSSKT-----TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred EECCCCcEEEeccceeeeccCCC-----cccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCc
Confidence 99999999999999987654321 1123456899999999987654 89999999999999999999999965431
Q ss_pred --HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 269 --MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 269 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.........+..+..+ ...++..+.++|.+||.++|++|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 212 NLYSLCKKIEKCDYPPLP--------ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred cHHHHHhhhhcCCCCCCC--------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1222222222111111 1356778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=324.47 Aligned_cols=255 Identities=27% Similarity=0.447 Sum_probs=199.7
Q ss_pred EEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCc
Q psy11359 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENV 111 (520)
Q Consensus 32 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnI 111 (520)
.+.+.||.|+||.||+|.....+ ......|++|.++.....+..+.+.+|++.+++++||||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~------------------~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 63 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKD------------------NDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNI 63 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTT------------------TSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTB
T ss_pred EEeeEEccCCCcEEEEEEEEccc------------------CCCCEEEEEEEeccccccccceeeeeccccccccccccc
Confidence 57889999999999999888200 011344555555443334457889999999999999999
Q ss_pred eEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEc
Q psy11359 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191 (520)
Q Consensus 112 v~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~ 191 (520)
+++++++...+.+++||||+.+|+|.+++... ....+++..+..|+.||+.||.|||+++++|++|+|.|||++
T Consensus 64 ~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~ 137 (259)
T PF07714_consen 64 VKLYGFCIENEPLFLVMEYCPGGSLDDYLKSK------NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD 137 (259)
T ss_dssp E-EEEEEESSSSEEEEEE--TTEBHHHHHHHT------CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred cccccccccccccccccccccccccccccccc------cccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999888899999999999999999864 346789999999999999999999999999999999999999
Q ss_pred CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHH
Q psy11359 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMK 270 (520)
Q Consensus 192 ~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~ 270 (520)
.++.+||+|||++........ ........+...|+|||.+.... ++.++||||||+++|||++ |+.||......+
T Consensus 138 ~~~~~Kl~~f~~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~ 213 (259)
T PF07714_consen 138 SNGQVKLSDFGLSRPISEKSK---YKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE 213 (259)
T ss_dssp TTTEEEEESTTTGEETTTSSS---EEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH
T ss_pred ccccccccccccccccccccc---ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccc
Confidence 999999999999976622211 12223345678899999987766 8999999999999999999 789999887777
Q ss_pred HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.......+...... ..++..+.++|..||..+|.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~---------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 214 IIEKLKQGQRLPIP---------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHTTEETTSB---------TTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccccccccccceec---------cchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 66555444332221 346788999999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=322.22 Aligned_cols=257 Identities=22% Similarity=0.367 Sum_probs=205.9
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCc---eEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAE---KCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
..+|++.+.||+|+||.||+|.++.++. .||+|.+. .........++..|+.+++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~----------------------~~~~~~~~~~~~~e~~~l~ 60 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK----------------------SGYTEKQRRDFLSEASIMG 60 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcC----------------------CCCCHHHHHHHHHHHHHHH
Confidence 3569999999999999999999988765 47777653 2112334567899999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++..+...++||||+.+++|.++++. ..+.+++..+..++.|++.||.|||++|++|||||
T Consensus 61 ~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~ 133 (269)
T cd05065 61 QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ-------NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLA 133 (269)
T ss_pred hCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence 99999999999999999999999999999999999975 34568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPY 263 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf 263 (520)
|+||+++.++.++|+|||++..+.................+..|+|||.+.+.. ++.++|||||||++|+|++ |..||
T Consensus 134 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~ 212 (269)
T cd05065 134 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPY 212 (269)
T ss_pred hheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCC
Confidence 999999999999999999987664322211111011111245799999987655 8999999999999999886 99999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
...........+....+... ...++..+.+++.+||+++|.+||++.+++.
T Consensus 213 ~~~~~~~~~~~i~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 213 WDMSNQDVINAIEQDYRLPP---------PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCCCHHHHHHHHHcCCcCCC---------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 88776665554433222111 1245778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=333.49 Aligned_cols=271 Identities=25% Similarity=0.373 Sum_probs=209.2
Q ss_pred CeEEEeeeeecCceEEEEEEEcCC--CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKAR--AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC- 106 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l- 106 (520)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... ........+.+|+.+++++
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l~ 59 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF---------------------SKKILAKRALRELKLLRHFR 59 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc---------------------ccchhHHHHHHHHHHHHHhc
Confidence 589999999999999999999988 8889998764210 0012244678899999999
Q ss_pred CCCCceEEEEEEEEC----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 107 HHENVVTYHTSFVVK----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
+||||+++++.+... ..+|++++|+. ++|.+++. ....+++..++.++.||+.||.|||++|++|||
T Consensus 60 ~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~--------~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~d 130 (332)
T cd07857 60 GHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIR--------SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRD 130 (332)
T ss_pred CCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 699999999875432 45889999995 68999986 456789999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|||+|||++.++.++|+|||++..+...... .........||+.|+|||++.+...++.++||||||+++|+|++|.+|
T Consensus 131 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~p 209 (332)
T cd07857 131 LKPGNLLVNADCELKICDFGLARGFSENPGE-NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPV 209 (332)
T ss_pred CCHHHeEEcCCCCEEeCcCCCceeccccccc-ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcC
Confidence 9999999999999999999999876433221 111123467899999999987655689999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCC---------------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLD---------------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el 321 (520)
|........+............ ....-.......+..+.+|+.+||+.||.+|||+.++
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l 289 (332)
T cd07857 210 FKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA 289 (332)
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 9876544333322211000000 0000011123357889999999999999999999999
Q ss_pred hcCccccccc
Q psy11359 322 LKNPFFKKAK 331 (520)
Q Consensus 322 L~hp~~~~~~ 331 (520)
+.||||+...
T Consensus 290 l~~~~~~~~~ 299 (332)
T cd07857 290 LEHPYLAIWH 299 (332)
T ss_pred hcChhhhhhc
Confidence 9999997653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=323.90 Aligned_cols=257 Identities=30% Similarity=0.531 Sum_probs=207.5
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||.||+|.+..++..+|+|.+..... .......++.+|+.+++.++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--------------------~~~~~~~~~~~e~~~l~~~~h 61 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL--------------------MDAKARADCIKEIDLLKQLNH 61 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh--------------------hhHHHHHHHHHHHHHHHHccC
Confidence 578999999999999999999999999999987642211 012234578899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++..++..+++|||+.|++|.+++..... ....+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 62 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ni 137 (267)
T cd08229 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK----QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANV 137 (267)
T ss_pred CchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 9999999999999999999999999999999875322 345789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++.++.++|+|||++..+.... .......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+...
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 211 (267)
T cd08229 138 FITATGVVKLGDLGLGRFFSSKT-----TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred EEcCCCCEEECcchhhhccccCC-----cccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 99999999999999987654322 1123457899999999987654 88999999999999999999999965432
Q ss_pred H--HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 269 M--KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 269 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
. ...........+.. ....++..+.++|.+||..+|.+|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 212 NLYSLCKKIEQCDYPPL--------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred hHHHHhhhhhcCCCCCC--------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 2 11111111111111 12346788999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=331.17 Aligned_cols=260 Identities=23% Similarity=0.366 Sum_probs=204.3
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceE--EEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKC--AIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~v--AiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
.-++|++.+.||+|+||.||+|.++.++..+ |+|.+. ..........+.+|+.++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~----------------------~~~~~~~~~~~~~Ei~~l~ 62 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----------------------EYASKDDHRDFAGELEVLC 62 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEec----------------------ccCCHHHHHHHHHHHHHHH
Confidence 3457999999999999999999998877644 444332 1111234567889999999
Q ss_pred cC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--------cCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11359 105 SC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--------NCKHGVCDEPTIATVLREVLKGLEYFHS 175 (520)
Q Consensus 105 ~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--------~~~~~~l~~~~i~~i~~qIl~gL~yLH~ 175 (520)
++ +||||+++++++..++.+|+||||+.+++|.+++....... ......+++..+..++.||+.||+|||+
T Consensus 63 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 142 (303)
T cd05088 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 142 (303)
T ss_pred HhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh
Confidence 99 89999999999999999999999999999999997542211 0123468999999999999999999999
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
+|++||||||+|||++.++.+||+|||++...... .......+++.|+|||.+.+.. ++.++|||||||++|+
T Consensus 143 ~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e 215 (303)
T cd05088 143 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWE 215 (303)
T ss_pred CCccccccchheEEecCCCcEEeCccccCcccchh------hhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHH
Confidence 99999999999999999999999999987532110 0011123466799999886654 8999999999999999
Q ss_pred HHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 256 MAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 256 llt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|+| |..||......+............. ...+++.+.+||.+||+.+|++|||+.+++.+
T Consensus 216 llt~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 216 IVSLGGTPYCGMTCAELYEKLPQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHhcCCCCcccCChHHHHHHHhcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 998 9999987666555443332211111 12357789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=314.91 Aligned_cols=253 Identities=49% Similarity=0.844 Sum_probs=213.6
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||+|++|.||++.+..++..+++|+++... ......+.+|+.++++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----------------------~~~~~~~~~e~~~l~~l~~~ 57 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES-----------------------KEKKEKIINEIQILKKCKHP 57 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc-----------------------hhHHHHHHHHHHHHHhCCCC
Confidence 5899999999999999999999998888888775321 12346788999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++......++++||+.|++|.+++.. ....+++..+..++.|++.||.|||++|++||||+|+||+
T Consensus 58 ~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~ 130 (253)
T cd05122 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS-------TNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANIL 130 (253)
T ss_pred CEeEEEEEEecCCeEEEEEecCCCCcHHHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEE
Confidence 999999999999999999999999999999874 2257899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.++.++|+|||.+........ .....|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||......
T Consensus 131 i~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 203 (253)
T cd05122 131 LTSDGEVKLIDFGLSAQLSDTKA------RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPM 203 (253)
T ss_pred EccCCeEEEeecccccccccccc------ccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 99999999999999876543221 23567899999999987665 889999999999999999999999887555
Q ss_pred HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcc
Q psy11359 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~ 326 (520)
...........+..... ..++..+.++|.+||+.||++|||+.++++|||
T Consensus 204 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 204 KALFKIATNGPPGLRNP-------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHHhcCCCCcCcc-------cccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 55444433332222211 124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=323.19 Aligned_cols=258 Identities=33% Similarity=0.472 Sum_probs=211.5
Q ss_pred eeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEEE
Q psy11359 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHT 116 (520)
Q Consensus 37 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~~ 116 (520)
||.|+||.||++.+..+|+.+++|++...... .....+.+.+|+.++++++||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~--------------------~~~~~~~~~~e~~~l~~~~h~~i~~~~~ 60 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI--------------------RKNQVDQVLTERDILSQAQSPYVVKLYY 60 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhh--------------------hhhHHHHHHHHHHHHHhCCCcchhHHHH
Confidence 68999999999999999999999987533211 0234567889999999999999999999
Q ss_pred EEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCe
Q psy11359 117 SFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196 (520)
Q Consensus 117 ~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~v 196 (520)
.+..+...|+||||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+
T Consensus 61 ~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~ 132 (265)
T cd05579 61 SFQGKKNLYLVMEYLPGGDLASLLEN--------VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHL 132 (265)
T ss_pred heecCcEEEEEEecCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCE
Confidence 99999999999999999999999974 3478999999999999999999999999999999999999999999
Q ss_pred EEeccCcceeeccCccc---cccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 197 QIADFGVSAWLATGRDL---SRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 197 kL~DFG~a~~~~~~~~~---~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
+|+|||++......... ..........+++.|+|||.+.... ++.++|+||||+++|+|++|..||..........
T Consensus 133 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 211 (265)
T cd05579 133 KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ 211 (265)
T ss_pred EEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999988754322110 0011223456889999999987665 8899999999999999999999998877766655
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH---HHHhcCccccccc
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA---SELLKNPFFKKAK 331 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta---~elL~hp~~~~~~ 331 (520)
........... ...++..+.+||.+||+.+|.+|||+ .++|+||||...+
T Consensus 212 ~~~~~~~~~~~--------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 212 NILNGKIEWPE--------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHhcCCcCCCc--------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 54443222111 01247889999999999999999999 9999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=328.80 Aligned_cols=266 Identities=23% Similarity=0.400 Sum_probs=211.3
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcC-------CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKA-------RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDEL 96 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l 96 (520)
|....++|.+.+.||+|+||.||+|.+.. .+..||+|.+ ...........+
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~----------------------~~~~~~~~~~~~ 67 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML----------------------KDDATEKDLSDL 67 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeec----------------------ccccchHHHHHH
Confidence 66788999999999999999999997532 2234555543 322223445678
Q ss_pred HHHHHHHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--------cCCCCCCCHHHHHHHHHHHH
Q psy11359 97 LKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--------NCKHGVCDEPTIATVLREVL 167 (520)
Q Consensus 97 ~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--------~~~~~~l~~~~i~~i~~qIl 167 (520)
.+|+.+++.+ +||||+++++++......|+||||+.+++|.+++....... ......++...+..++.||+
T Consensus 68 ~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~ 147 (304)
T cd05101 68 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVA 147 (304)
T ss_pred HHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHH
Confidence 9999999999 89999999999999999999999999999999997642210 01234678899999999999
Q ss_pred HHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHH
Q psy11359 168 KGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIW 247 (520)
Q Consensus 168 ~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIw 247 (520)
.||.|||++|++||||||+||+++.++.+||+|||++..+..... ........+++.|+|||++.+.. ++.++|||
T Consensus 148 ~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~ 223 (304)
T cd05101 148 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDY---YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVW 223 (304)
T ss_pred HHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccc---cccccCCCCCceeeCchhhccCC-CCchhhHH
Confidence 999999999999999999999999999999999999876643221 11122334677899999987654 89999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 248 SLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 248 SlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|||+++|+|++ |..||...+..+.............. ..++..+.+||.+||.++|.+|||+.++++.
T Consensus 224 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 224 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP---------ANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC---------CCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 99999999998 88999887776666554443322211 3467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=377.10 Aligned_cols=268 Identities=30% Similarity=0.510 Sum_probs=225.5
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
+-.-+|.-...||.|.||.||-|.+..+|...|+|-++.... . ......+.+|..++..
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~---------~------------~k~~~~i~eEm~vlE~ 1290 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS---------D------------HKTFKLIAEEMKVLEG 1290 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc---------c------------cccCcchHHHHHHHHh
Confidence 444567778899999999999999999999999997764321 1 1223447789999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++|||+|++|++-..++..+|.||||+||+|.+.+++ ++..++...+.+..|++.||.|||++|||||||||
T Consensus 1291 lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~--------gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~ 1362 (1509)
T KOG4645|consen 1291 LNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH--------GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKP 1362 (1509)
T ss_pred ccCccccccCceeecHHHHHHHHHHhccCcHHHHHHh--------cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCc
Confidence 9999999999999999999999999999999999983 55677888889999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC--CCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH--GYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
.|||++.+|.+|++|||.|..+...... -++-.....|||.|||||++.+.. +..-++||||+||++.||+||+.||
T Consensus 1363 aNI~Ld~~g~iK~~DFGsa~ki~~~~~~-~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW 1441 (1509)
T KOG4645|consen 1363 ANILLDFNGLIKYGDFGSAVKIKNNAQT-MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPW 1441 (1509)
T ss_pred cceeeecCCcEEeecccceeEecCchhc-CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCch
Confidence 9999999999999999999888655322 223345689999999999998654 4677999999999999999999999
Q ss_pred CCCcHHHHHHH-HhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 264 HKYPAMKVLML-TLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 264 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
...+..-.+|. +-.+..|.++. .++++.++||.+||..||++|.++.|+|.|.|-+...+
T Consensus 1442 ~~~dne~aIMy~V~~gh~Pq~P~---------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1442 AELDNEWAIMYHVAAGHKPQIPE---------RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred hhccchhHHHhHHhccCCCCCch---------hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence 98876655554 44455555542 37899999999999999999999999999998775544
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=326.15 Aligned_cols=264 Identities=21% Similarity=0.341 Sum_probs=205.2
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
+|++.+.||+|+||+||+|.+....... ....+++|.+..+........+.+|+.+++.++||
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~-----------------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~ 63 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRA-----------------GYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCC-----------------cceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCC
Confidence 5889999999999999999875432110 02234444444333334456789999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc----------------cCCCCCCCHHHHHHHHHHHHHHHHHH
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS----------------NCKHGVCDEPTIATVLREVLKGLEYF 173 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~----------------~~~~~~l~~~~i~~i~~qIl~gL~yL 173 (520)
||+++++.+..++..+++|||+.+++|.+++....... ......+++..+..++.|++.||.||
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L 143 (290)
T cd05045 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL 143 (290)
T ss_pred CEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999987532211 01224688999999999999999999
Q ss_pred HHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHH
Q psy11359 174 HSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253 (520)
Q Consensus 174 H~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il 253 (520)
|++|++||||||+|||+++++.+||+|||++..+....... ......++..|+|||.+.+.. ++.++||||||+++
T Consensus 144 H~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l 219 (290)
T cd05045 144 AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV---KRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLL 219 (290)
T ss_pred HHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchh---cccCCCCCccccCHHHHccCC-cchHhHHHHHHHHH
Confidence 99999999999999999999999999999987653322111 112234567899999886654 89999999999999
Q ss_pred HHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 254 IEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 254 ~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|+|+| |..||.+.................. ...++..+.+|+..||+.+|.+||++.++++
T Consensus 220 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 220 WEIVTLGGNPYPGIAPERLFNLLKTGYRMER---------PENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHhCCCCCCC---------CCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999 9999988776665544433222111 1346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=330.12 Aligned_cols=272 Identities=23% Similarity=0.385 Sum_probs=208.9
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|.+.+.||+|+||.||+|.+....... ......+|+|.+..........++.+|+.++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~---------------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l 71 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSR---------------PDQTVTVAVKMLKDNATDKDLADLISEMELM 71 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCcc---------------CCcceEEEEEecCCCCChHHHHHHHHHHHHH
Confidence 6667789999999999999999999864321100 0002234444444333344566788999999
Q ss_pred hcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc--------ccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 104 SSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI--------SNCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 104 ~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~--------~~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
+++ +||||+++++++..+..+|+||||+.+|+|.+++...... .......++...+..++.||+.||.|||
T Consensus 72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH 151 (314)
T cd05099 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE 151 (314)
T ss_pred HhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH
Confidence 999 6999999999999999999999999999999999764211 0012356899999999999999999999
Q ss_pred HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 175 ~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
++|++||||||+|||++.++.+||+|||++..+..... ........+++.|||||++.+.. ++.++|||||||++|
T Consensus 152 ~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~ 227 (314)
T cd05099 152 SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY---YKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMW 227 (314)
T ss_pred HCCeeeccccceeEEEcCCCcEEEcccccccccccccc---ccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHH
Confidence 99999999999999999999999999999875532111 01111223456899999987654 899999999999999
Q ss_pred HHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 255 EMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 255 ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+|++ |..||...+..+.+............ ..++..+.++|.+||..+|.+|||+.++++
T Consensus 228 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 228 EIFTLGGSPYPGIPVEELFKLLREGHRMDKP---------SNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999 89999887766665554443222211 245678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=327.49 Aligned_cols=285 Identities=21% Similarity=0.305 Sum_probs=215.5
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++++.||+|+||.||+|.+...+..+ .|.... .........+|+|.+.........+.+.+|+.+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l 76 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFS-EKAFAE-----NDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL 76 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCccc-cccccc-----ccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc
Confidence 4568999999999999999999988765432 111000 0011124567788777655455677899999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc---cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS---NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~---~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+||||+++++++..+...++||||+.+++|.+++....... ......+++..+..++.||+.||.|||++|++||||
T Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dl 156 (296)
T cd05051 77 SDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDL 156 (296)
T ss_pred CCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence 99999999999999999999999999999999997532110 011236899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh--CCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT--GTA 261 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt--G~~ 261 (520)
||+||+++.++.++|+|||++..+..... ........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~ 232 (296)
T cd05051 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDY---YRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQ 232 (296)
T ss_pred chhceeecCCCceEEccccceeecccCcc---eeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCC
Confidence 99999999999999999999876533221 11223445678999999987655 8999999999999999998 788
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
||........+............ .........++.++.+++.+||+.||.+|||+.++++
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 233 PYEHLTDQQVIENAGHFFRDDGR--QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCCcChHHHHHHHHhccccccc--cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 99876666555444322100000 0000111345688999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.58 Aligned_cols=262 Identities=29% Similarity=0.443 Sum_probs=210.5
Q ss_pred CeEEEeeeeecCceEEEEEEEc---CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCK---ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
.|++.+.||.|+||.||.|.+. .+|..||+|+++..... ......+++.+|+.+++++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~-------------------~~~~~~~~~~~e~~~l~~l 61 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV-------------------QKAKTTEHTRTERQVLEHI 61 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhh-------------------hcchHHHHHHHHHHHHHhc
Confidence 4899999999999999999875 47788888877532111 0122345678899999999
Q ss_pred -CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 -HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 -~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+|+||+++++++..+..+|+||||+.+++|.+++.. ...+++..+..++.||+.||.|||++|++||||+|
T Consensus 62 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p 133 (290)
T cd05613 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ--------RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKL 133 (290)
T ss_pred ccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 699999999999999999999999999999999974 45688999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
+|||++.++.++|+|||++..+.... ........|++.|+|||.+... ..++.++||||||+++|+|+||..||.
T Consensus 134 ~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 134 ENILLDSNGHVVLTDFGLSKEFHEDE----VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred HHeEECCCCCEEEeeCccceeccccc----ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999987653321 1112345789999999998653 247889999999999999999999996
Q ss_pred CCcH----HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccch
Q psy11359 265 KYPA----MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKD 332 (520)
Q Consensus 265 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~ 332 (520)
.... ...........++ . ...+++.+.+++.+||+.+|.+|| ++.+++.||||+...+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~-~---------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 210 VDGEKNSQAEISRRILKSEPP-Y---------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred cCCccccHHHHHHHhhccCCC-C---------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 4321 2222222222211 1 134678899999999999999997 8999999999998765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=330.76 Aligned_cols=267 Identities=27% Similarity=0.450 Sum_probs=210.5
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||.|+||.||+|.+..++..||+|.+.... ......+.+.+|+.+++.+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l 66 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF---------------------STPVLAKRTYRELKLLKHL 66 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc---------------------cccchhHHHHHHHHHHHhc
Confidence 5678999999999999999999999999999999764211 0012345678999999999
Q ss_pred CCCCceEEEEEEEE-CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 HHENVVTYHTSFVV-KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 ~HpnIv~~~~~~~~-~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+||||++++++|.. ....|+||||+ +++|.++++ ...+++..+..++.||+.||.|||++|++||||+|
T Consensus 67 ~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~---------~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p 136 (328)
T cd07856 67 RHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT---------SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKP 136 (328)
T ss_pred CCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 99999999999875 56799999999 678988885 34678899999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
.||+++.++.++|+|||.+..... ......+++.|+|||.+.+...++.++|||||||++|+|+||.+||..
T Consensus 137 ~Nili~~~~~~~l~dfg~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 137 SNILINENCDLKICDFGLARIQDP--------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred HHEeECCCCCEEeCccccccccCC--------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999998864321 112456788999999987655589999999999999999999999977
Q ss_pred CcHHHHHHHHh---cCCCCC----------------C--CCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 266 YPAMKVLMLTL---QNDPPT----------------L--DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 266 ~~~~~~~~~~~---~~~~~~----------------~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
........... ...+.. . ..........+.++..++++|.+||+.+|++|||+.+++.|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 209 KDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 65433221111 110000 0 00001112223567899999999999999999999999999
Q ss_pred ccccccch
Q psy11359 325 PFFKKAKD 332 (520)
Q Consensus 325 p~~~~~~~ 332 (520)
|||.....
T Consensus 289 ~~~~~~~~ 296 (328)
T cd07856 289 PYLAPYHD 296 (328)
T ss_pred CccccccC
Confidence 99976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=322.35 Aligned_cols=258 Identities=23% Similarity=0.347 Sum_probs=201.6
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCc--eEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAE--KCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
|.+.++||+|+||.||+|.+..++. .+|+|.++... ......+.+.+|+.+++.++|
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---------------------~~~~~~~~~~~E~~~l~~l~h 59 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---------------------CTRSEMEDFLSEAVCMKEFDH 59 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---------------------CCHHHHHHHHHHHHHHHhCCC
Confidence 3567899999999999999887765 46777553210 112345678899999999999
Q ss_pred CCceEEEEEEEEC------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 109 ENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 109 pnIv~~~~~~~~~------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
|||+++++++... ...+++|||+.+|+|.+++...... .....+++..+..++.||+.||.|||++||+|||
T Consensus 60 ~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 137 (272)
T cd05075 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG--DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRD 137 (272)
T ss_pred CCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhccc--CCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 9999999877532 2478999999999999988543211 1234589999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTA 261 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~ 261 (520)
|||+|||++.++.++|+|||++..+...... .......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..
T Consensus 138 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~ 213 (272)
T cd05075 138 LAARNCMLNENMNVCVADFGLSKKIYNGDYY---RQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQT 213 (272)
T ss_pred cchhheEEcCCCCEEECCCCcccccCcccce---ecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999876433211 1112334677899999987654 8999999999999999999 899
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
||..............+...... ..++..+.++|.+||+++|.+|||+.+++++
T Consensus 214 p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 214 PYPGVENSEIYDYLRQGNRLKQP---------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99877666555544443322211 2456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.91 Aligned_cols=255 Identities=28% Similarity=0.427 Sum_probs=207.9
Q ss_pred eeeeecCceEEEEEEEcCC---CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCc
Q psy11359 35 EVIGFGATAVVHSAYCKAR---AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENV 111 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnI 111 (520)
+.||+|+||.||+|.+... +..||+|.++.. ......+.+.+|+..++.++|+||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~----------------------~~~~~~~~~~~e~~~l~~~~~~~i 58 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED----------------------ASEEERKDFLKEARVMKKLGHPNV 58 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccc----------------------cchhHHHHHHHHHHHHhhcCCCCh
Confidence 4799999999999999876 777777766422 112235678999999999999999
Q ss_pred eEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEE
Q psy11359 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS-NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190 (520)
Q Consensus 112 v~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~-~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl 190 (520)
+++++++.....+++||||+.+++|.+++....... ......+++..+..++.||+.||.|||++|++||||||+||++
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili 138 (262)
T cd00192 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV 138 (262)
T ss_pred heeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE
Confidence 999999999999999999999999999998531100 0013678999999999999999999999999999999999999
Q ss_pred cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHH
Q psy11359 191 GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAM 269 (520)
Q Consensus 191 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~ 269 (520)
+.++.++|+|||.+........ ........+++.|+|||.+.... ++.++|||||||++|+|++ |..||......
T Consensus 139 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 214 (262)
T cd00192 139 GEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNE 214 (262)
T ss_pred CCCCcEEEcccccccccccccc---cccccCCCcCccccCHHHhccCC-cchhhccHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999987653321 11223456788999999987654 8999999999999999999 69999988776
Q ss_pred HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
............... ..++..+.+++.+||..+|++|||+.+++++
T Consensus 215 ~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 215 EVLEYLRKGYRLPKP---------EYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHcCCCCCCC---------ccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 666555543222221 3457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=320.80 Aligned_cols=255 Identities=23% Similarity=0.387 Sum_probs=205.0
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCc---eEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAE---KCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
..+|++.+.||+|+||.||+|.+..++. .+|+|.++ ........+.+.+|+.+++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~----------------------~~~~~~~~~~~~~e~~~l~ 60 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK----------------------AGYTEKQRRDFLSEASIMG 60 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECC----------------------CCCCHHHHHHHHHHHHHHH
Confidence 4679999999999999999999875543 46666543 2111234567899999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++..++..|+||||+++++|.+++.. ..+.+++..+..++.||+.||.|||++|++|||||
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlk 133 (267)
T cd05066 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-------HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 133 (267)
T ss_pred hCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhc
Confidence 99999999999999999999999999999999999975 34568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPY 263 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf 263 (520)
|+|||++.++.++|+|||++..+...... ........++..|+|||.+.+.. ++.++|+|||||++|++++ |..||
T Consensus 134 p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~ 210 (267)
T cd05066 134 ARNILVNSNLVCKVSDFGLSRVLEDDPEA--AYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPY 210 (267)
T ss_pred hhcEEECCCCeEEeCCCCcccccccccce--eeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCc
Confidence 99999999999999999998766432211 01111223456899999997655 8999999999999999886 99999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
......+............. ...+++.+.+++.+||+++|.+|||+.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 211 WEMSNQDVIKAIEEGYRLPA---------PMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ccCCHHHHHHHHhCCCcCCC---------CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 87766555544443322111 1245778999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=318.70 Aligned_cols=249 Identities=25% Similarity=0.432 Sum_probs=202.5
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|.....+|++.+.||+|+||.||++... |..+|+|.++. ....+.+.+|+.++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~-------------------------~~~~~~~~~e~~~l 53 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-------------------------DATAQAFLAEASVM 53 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCC-------------------------CchHHHHHHHHHHH
Confidence 5567789999999999999999999764 66777776531 11234688999999
Q ss_pred hcCCCCCceEEEEEEE-ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 104 SSCHHENVVTYHTSFV-VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~-~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
++++|+||+++++++. .....++||||+.+++|.++++.. ....+++..+..++.||+.||.|||++|++|||
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 127 (256)
T cd05082 54 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR------GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRD 127 (256)
T ss_pred HhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccc
Confidence 9999999999998765 556799999999999999999753 334588999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTA 261 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~ 261 (520)
|||+||++++++.+||+|||++....... ....++..|+|||++.... ++.++|||||||++|+|++ |..
T Consensus 128 lkp~nil~~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~ 198 (256)
T cd05082 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQ--------DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRV 198 (256)
T ss_pred cchheEEEcCCCcEEecCCccceeccccC--------CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999999886543211 2234566899999987654 8999999999999999998 999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
||................++.. ...+++.+.++|.+||+.+|++|||+.++++
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 199 PYPRIPLKDVVPRVEKGYKMDA---------PDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCHHHHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9987665554444333322221 1346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=364.98 Aligned_cols=265 Identities=31% Similarity=0.473 Sum_probs=203.6
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
..+|+.+++||+||||.||+++++-+|+.+|||+|+.. ........+.+|+..|.+|+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~----------------------~s~~~~skI~rEVk~LArLn 535 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLK----------------------ASDKLYSKILREVKLLARLN 535 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCc----------------------hHHHHHHHHHHHHHHHhhcC
Confidence 46788999999999999999999999888888877533 22345567999999999999
Q ss_pred CCCceEEEEEEEECC-----------------------------------------------------------------
Q psy11359 108 HENVVTYHTSFVVKD----------------------------------------------------------------- 122 (520)
Q Consensus 108 HpnIv~~~~~~~~~~----------------------------------------------------------------- 122 (520)
|||||+||..|.+..
T Consensus 536 HpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~ 615 (1351)
T KOG1035|consen 536 HPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESS 615 (1351)
T ss_pred CcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCcccccccccccccccc
Confidence 999999998875311
Q ss_pred ------------------------------------------------------EEEEEEEccCCCCHHHHHHHhhcccc
Q psy11359 123 ------------------------------------------------------ELWLVLRLLEGGSLLDIIKHRLKISN 148 (520)
Q Consensus 123 ------------------------------------------------------~~~lV~E~~~ggsL~~~i~~~~~~~~ 148 (520)
.+||-||||+..+|.+++...
T Consensus 616 ~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----- 690 (1351)
T KOG1035|consen 616 TDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----- 690 (1351)
T ss_pred CCcccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc-----
Confidence 068999999988888888642
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeec-------------cCccccc
Q psy11359 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA-------------TGRDLSR 215 (520)
Q Consensus 149 ~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~-------------~~~~~~~ 215 (520)
+..-.....+++++||+.||.|+|++|||||||||.|||+++++.|||+|||+|.... .......
T Consensus 691 --~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~ 768 (1351)
T KOG1035|consen 691 --HFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSN 768 (1351)
T ss_pred --ccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCC
Confidence 1111467899999999999999999999999999999999999999999999998622 0111122
Q ss_pred cccccccccccccCCcceecccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhH
Q psy11359 216 QKVRHTFVGTPCWMAPEVMEQDH--GYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQY 293 (520)
Q Consensus 216 ~~~~~~~~gt~~y~APE~~~~~~--~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (520)
.....+.+||..|+|||++.+.. .|+.|+||||||||++||+. ||...-........+. ...++.. ...+
T Consensus 769 ~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR--~g~iP~~---~~f~ 840 (1351)
T KOG1035|consen 769 DGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR--KGSIPEP---ADFF 840 (1351)
T ss_pred CcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc--cCCCCCC---cccc
Confidence 22445689999999999997655 59999999999999999995 6754433333333333 2333222 0111
Q ss_pred HHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 294 KAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 294 ~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
..--+.-..+|.+||+.||.+||||.|+|++.||..
T Consensus 841 ~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 841 DPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred cccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 112234468999999999999999999999999983
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=333.36 Aligned_cols=274 Identities=22% Similarity=0.374 Sum_probs=212.4
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.|.....+|++.+.||+|+||.||+|.+...++....+ ...+|+|.+.........+++.+|+.+
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~---------------~~~vaiK~~~~~~~~~~~~~~~~E~~~ 70 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNK---------------PVTVAVKMLKDDATDKDLSDLVSEMEM 70 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCc---------------ceeEEEEEcccccCHHHHHHHHHHHHH
Confidence 47778889999999999999999999875432211000 223444444433333456788999999
Q ss_pred HhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--------cCCCCCCCHHHHHHHHHHHHHHHHHH
Q psy11359 103 MSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--------NCKHGVCDEPTIATVLREVLKGLEYF 173 (520)
Q Consensus 103 l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--------~~~~~~l~~~~i~~i~~qIl~gL~yL 173 (520)
++++ +||||+++++++...+.++++|||+.+|+|.+++....... ......++...+..++.||+.||.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred HHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 9999 89999999999999999999999999999999997642110 01234578899999999999999999
Q ss_pred HHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHH
Q psy11359 174 HSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253 (520)
Q Consensus 174 H~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il 253 (520)
|++|++||||||+|||++.++.+||+|||+++.+...... .......+++.|+|||++.+.. ++.++|||||||++
T Consensus 151 H~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il 226 (334)
T cd05100 151 ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY---KKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLL 226 (334)
T ss_pred HHCCeeccccccceEEEcCCCcEEECCcccceeccccccc---ccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHH
Confidence 9999999999999999999999999999998765332111 1112233456899999987655 89999999999999
Q ss_pred HHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 254 IEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 254 ~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|+|++ |..||...+..+.............. ..++..+.++|.+||+.+|.+|||+.+++++
T Consensus 227 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 227 WEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP---------ANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 99998 89999887766665554443322221 2456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=327.88 Aligned_cols=259 Identities=40% Similarity=0.667 Sum_probs=212.7
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
..|....+||+|+||.||++.+..+|..||+|.+... .....+.+.+|+.+++.++|
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----------------------~~~~~~~~~~e~~~l~~l~h 76 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----------------------KQQRRELLFNEVVIMRDYQH 76 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----------------------chhHHHHHHHHHHHHHhcCC
Confidence 3445567899999999999999999888888865321 02234568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+..++||||+.+++|.+++. .+.+++..+..++.||+.||.|||++|++||||+|.||
T Consensus 77 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---------~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Ni 147 (292)
T cd06657 77 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSI 147 (292)
T ss_pred cchhheeeEEEeCCEEEEEEecCCCCcHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 999999999999999999999999999999874 34578999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++.++.++|+|||++..+.... .......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.....
T Consensus 148 lv~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~ 221 (292)
T cd06657 148 LLTHDGRVKLSDFGFCAQVSKEV-----PRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPP 221 (292)
T ss_pred EECCCCCEEEcccccceeccccc-----ccccccccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999886553211 1123457899999999886554 78999999999999999999999987666
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
...........+..+. ....++..+.+++.+||+.+|.+||++.+++.||||.....
T Consensus 222 ~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 222 LKAMKMIRDNLPPKLK-------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHHHHHhhCCcccC-------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 5544433333222221 11345778999999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=325.70 Aligned_cols=268 Identities=29% Similarity=0.549 Sum_probs=213.6
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.+.||+|+||.||+|.+..++..||+|.++... ......++.+|+.++
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~----------------------~~~~~~~~~~e~~~~ 67 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----------------------NKEENKRILMDLDVV 67 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC----------------------ChHHHHHHHHHHHHH
Confidence 5567788999999999999999999999998889988764221 122334566777766
Q ss_pred hcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEec
Q psy11359 104 SSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHR 181 (520)
Q Consensus 104 ~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHr 181 (520)
..+ .||||+++++++......|+||||+ +++|.+++.. ..+.+++..+..++.||+.||.|||+ +|++||
T Consensus 68 ~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~ 139 (296)
T cd06618 68 LKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKR-------IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHR 139 (296)
T ss_pred HhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecC
Confidence 666 5999999999999999999999998 4588887765 24578999999999999999999997 599999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc---CCCCcchhHHHHHHHHHHHHh
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD---HGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~~~DIwSlG~il~ellt 258 (520)
||+|+||++++++.++|+|||++..+..... .....+++.|+|||.+.+. ..++.++||||||+++|+|++
T Consensus 140 dl~p~nill~~~~~~kL~dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~ 213 (296)
T cd06618 140 DVKPSNILLDASGNVKLCDFGISGRLVDSKA------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT 213 (296)
T ss_pred CCcHHHEEEcCCCCEEECccccchhccCCCc------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHh
Confidence 9999999999999999999999876532211 1223578899999998644 237889999999999999999
Q ss_pred CCCCCCCCcH-HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhh
Q psy11359 259 GTAPYHKYPA-MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334 (520)
Q Consensus 259 G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~ 334 (520)
|+.||..... .+.+........+..... ..++.++.+||.+||..||.+|||+.+++.||||+......
T Consensus 214 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 283 (296)
T cd06618 214 GQFPYKNCKTEFEVLTKILQEEPPSLPPN-------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283 (296)
T ss_pred CCCCCCcchhHHHHHHHHhcCCCCCCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence 9999976433 334444444433332211 24678899999999999999999999999999999765543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=325.28 Aligned_cols=261 Identities=21% Similarity=0.349 Sum_probs=207.1
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
...+|.+.+.||+|+||.||+|.+.. ++..+++|.+. ... ....+.+.+|+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~----------------------~~~-~~~~~~~~~e~~ 59 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK----------------------DPT-LAARKDFQREAE 59 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecC----------------------Ccc-HHHHHHHHHHHH
Confidence 34679999999999999999998643 33345555432 211 223456889999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc--------ccCCCCCCCHHHHHHHHHHHHHHHHHH
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI--------SNCKHGVCDEPTIATVLREVLKGLEYF 173 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~--------~~~~~~~l~~~~i~~i~~qIl~gL~yL 173 (520)
++++++||||+++++++...+..++||||+.+++|.+++...... .....+.+++..+..++.||+.||.||
T Consensus 60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 139 (291)
T cd05094 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL 139 (291)
T ss_pred HHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999753210 001234589999999999999999999
Q ss_pred HHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHH
Q psy11359 174 HSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253 (520)
Q Consensus 174 H~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il 253 (520)
|++|++||||||+|||++.++.++|+|||++........ ........+++.|+|||.+.+.. ++.++|||||||++
T Consensus 140 H~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il 215 (291)
T cd05094 140 ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVIL 215 (291)
T ss_pred HhCCeeecccCcceEEEccCCcEEECCCCcccccCCCce---eecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHH
Confidence 999999999999999999999999999999875533211 11223345788999999987655 89999999999999
Q ss_pred HHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 254 IEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 254 ~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|+|+| |..||..................... ..++..+.+++.+||+++|.+|||+.++++
T Consensus 216 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 216 WEIFTYGKQPWFQLSNTEVIECITQGRVLERP---------RVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCC---------ccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 99999 99999877776665554443332221 235778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=358.92 Aligned_cols=150 Identities=25% Similarity=0.412 Sum_probs=134.5
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.++||+|+||+||+|.+..+++.||+|+++..... .......+.+|+.+++.++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~--------------------~~~~~~~~~~E~~~l~~l~ 62 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI--------------------NKNMVHQVQAERDALALSK 62 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc--------------------CHHHHHHHHHHHHHHHhcC
Confidence 57899999999999999999999999999999987532111 0223456889999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||++++.++.....+|+||||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 63 hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~--------~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~N 134 (669)
T cd05610 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI--------YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134 (669)
T ss_pred CCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHH
Confidence 99999999999999999999999999999999973 4568899999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcce
Q psy11359 188 ILLGEDGTVQIADFGVSA 205 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~ 205 (520)
||++.++.+||+|||+++
T Consensus 135 ILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 135 MLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEcCCCCEEEEeCCCCc
Confidence 999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=321.48 Aligned_cols=262 Identities=26% Similarity=0.328 Sum_probs=207.1
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC---C
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC---H 107 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l---~ 107 (520)
|++.+.||.|+||.||+|.++.+++.+|+|.++.... .......+.+|+.+++++ +
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~~~~ 59 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS---------------------EEGIPLSTLREIALLKQLESFE 59 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc---------------------cchhhhhHHHHHHHHHHhhccC
Confidence 7899999999999999999999999999998753211 011123455677766655 6
Q ss_pred CCCceEEEEEEEECCE-----EEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 108 HENVVTYHTSFVVKDE-----LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~-----~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
||||+++++++...+. ++++|||+. ++|.+++... ....+++..+..++.||+.||.|||++|++|+|
T Consensus 60 h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~------~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~ 132 (287)
T cd07838 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKC------PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRD 132 (287)
T ss_pred CCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 9999999999998776 999999996 5899988753 223689999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|+|+||+++.++.++|+|||++..+..... .....+++.|+|||++.+.. ++.++|+|||||++|+|++|.+|
T Consensus 133 l~~~nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~ 205 (287)
T cd07838 133 LKPQNILVTSDGQVKIADFGLARIYSFEMA------LTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPL 205 (287)
T ss_pred CChhhEEEccCCCEEEeccCcceeccCCcc------cccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCc
Confidence 999999999999999999999877643211 12345788999999997665 89999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCC---------------CCCC--CchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCc
Q psy11359 263 YHKYPAMKVLMLTLQNDPP---------------TLDT--GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~---------------~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp 325 (520)
|......+.+......... .... ..........++..+.++|.+||+.||.+||++.+++.||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~ 285 (287)
T cd07838 206 FRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285 (287)
T ss_pred ccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence 9887776665544332100 0000 0111222345678899999999999999999999999999
Q ss_pred cc
Q psy11359 326 FF 327 (520)
Q Consensus 326 ~~ 327 (520)
||
T Consensus 286 ~~ 287 (287)
T cd07838 286 YF 287 (287)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=326.36 Aligned_cols=261 Identities=18% Similarity=0.288 Sum_probs=208.2
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCC-----CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKAR-----AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
..+|++.+.||.|+||+||+|.+..+ +..||+|.++ ........+.+.+|+.+
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~----------------------~~~~~~~~~~~~~e~~~ 61 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK----------------------DKAEGPLREEFKHEAMM 61 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEcc----------------------CCCCHHHHHHHHHHHHH
Confidence 45689999999999999999987654 3456666543 22222345678899999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--------cCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--------NCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--------~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
++.++||||+++++++......++++||+.+++|.+++..+.... ......+++..+..++.|++.||.|||
T Consensus 62 ~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH 141 (283)
T cd05091 62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141 (283)
T ss_pred HhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999996431100 012345888999999999999999999
Q ss_pred HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 175 ~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
++|++||||||.|||+++++.+||+|||++..+..... ........+++.|+|||.+.... ++.++|||||||++|
T Consensus 142 ~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ 217 (283)
T cd05091 142 SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY---YKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLW 217 (283)
T ss_pred HcCccccccchhheEecCCCceEecccccccccccchh---eeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHH
Confidence 99999999999999999999999999999876532221 11122345678999999987655 899999999999999
Q ss_pred HHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 255 EMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 255 ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+|++ |..||.+....+....+......... ..++..+.+|+..||+.+|.+||++.+++.
T Consensus 218 el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 218 EVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP---------DDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 9998 89999887777666655554433221 346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=318.86 Aligned_cols=256 Identities=21% Similarity=0.349 Sum_probs=205.2
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCc---eEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAE---KCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
..++|+..+.||+|+||.||+|.+..++. .+|+|.++ ........+.+.+|+.++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~----------------------~~~~~~~~~~~~~e~~~l 60 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK----------------------PGYTEKQRQDFLSEASIM 60 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecc----------------------ccCCHHHHHHHHHHHHHH
Confidence 34579999999999999999999887654 46666543 221123456788999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++++||||+++++++...+..|+||||+.+++|.+++.. ..+.+++..+..++.|++.||.|||++|++||||
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl 133 (268)
T cd05063 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD-------HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDL 133 (268)
T ss_pred hcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 999999999999999999999999999999999999974 3467899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||+++.++.++|+|||++......... .........++.|+|||++.... ++.++|||||||++|+|++ |..|
T Consensus 134 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p 210 (268)
T cd05063 134 AARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERP 210 (268)
T ss_pred chhhEEEcCCCcEEECCCccceeccccccc--ceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999998766432211 00111122345799999987654 8999999999999999998 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|......+....+........ ...++..+.+++.+||+.+|.+||++.++++
T Consensus 211 ~~~~~~~~~~~~i~~~~~~~~---------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 211 YWDMSNHEVMKAINDGFRLPA---------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCcCCHHHHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 987766555544433221111 1245778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.49 Aligned_cols=266 Identities=26% Similarity=0.437 Sum_probs=226.2
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
....+|-.+.+||+|+||.|-+|..+.+.+.+|||+++++ |+|.- ...+--+.|-++|..
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKD-------------ViiQd-------DDvectm~EKrvLAL 405 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKD-------------VIIQD-------DDVECTMVEKRVLAL 405 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccc-------------eeeec-------Ccccceehhhhheec
Confidence 3456788999999999999999999999999999998543 43332 122234556677766
Q ss_pred C-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 106 C-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 106 l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
. +-|.++.++..|.+-+.+|+||||++||+|--.|++ -+.+.|..+.-++..|+.||-+||++|||.||||
T Consensus 406 ~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ--------~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLK 477 (683)
T KOG0696|consen 406 PGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--------VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLK 477 (683)
T ss_pred CCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHH--------hcccCCchhhhhhHHHHHHhhhhhcCCeeeeecc
Confidence 6 678899999999999999999999999999999984 5778899999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
.+|||++.+|++||+|||++..- ........+++|||.|+|||++..+. |+..+|.||+|++||||+.|++||.
T Consensus 478 LDNvmLd~eGHiKi~DFGmcKEn-----i~~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFd 551 (683)
T KOG0696|consen 478 LDNVMLDSEGHIKIADFGMCKEN-----IFDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFD 551 (683)
T ss_pred ccceEeccCCceEeeeccccccc-----ccCCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999998642 22445567899999999999998776 9999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchhhH
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~ 335 (520)
+.+..+.+..+...... ..+.+|.+..+++...|.+.|.+|.- -.++-.||||+...+.+.
T Consensus 552 GeDE~elF~aI~ehnvs----------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~ 617 (683)
T KOG0696|consen 552 GEDEDELFQAIMEHNVS----------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL 617 (683)
T ss_pred CCCHHHHHHHHHHccCc----------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence 99998888776654322 22678899999999999999999954 367888999999887654
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=334.64 Aligned_cols=268 Identities=28% Similarity=0.423 Sum_probs=209.6
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|.. .++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.++
T Consensus 11 ~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~~~~~~~e~~~l 68 (342)
T cd07879 11 WEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---------------------QSEIFAKRAYRELTLL 68 (342)
T ss_pred hcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc---------------------ccccchhHHHHHHHHH
Confidence 433 468999999999999999999999999999999764211 0012234578999999
Q ss_pred hcCCCCCceEEEEEEEEC------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy11359 104 SSCHHENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG 177 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g 177 (520)
+.++||||+++++++... ..+|+||||+. .+|..++. ..+++..+..++.||+.||.|||++|
T Consensus 69 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~ 137 (342)
T cd07879 69 KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----------HPLSEDKVQYLVYQMLCGLKYIHSAG 137 (342)
T ss_pred HhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999999999998754 35799999995 47766542 35889999999999999999999999
Q ss_pred cEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 178 QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 178 iiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
++||||||+||+++.++.++|+|||++..... ......+++.|+|||.+.+...++.++|+|||||++|+|+
T Consensus 138 i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADA--------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC--------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH
Confidence 99999999999999999999999999865321 1224578899999999876545889999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCC-------------------C--CCchhhhhHHHhcHHHHHHHHhhhccCCCCCC
Q psy11359 258 TGTAPYHKYPAMKVLMLTLQNDPPTL-------------------D--TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316 (520)
Q Consensus 258 tG~~Pf~~~~~~~~~~~~~~~~~~~~-------------------~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 316 (520)
+|+.||.+......+..+....+... . ........+...++.+.+||.+||+.||.+||
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 99999987665544433322111000 0 00000111234677899999999999999999
Q ss_pred CHHHHhcCccccccch
Q psy11359 317 TASELLKNPFFKKAKD 332 (520)
Q Consensus 317 ta~elL~hp~~~~~~~ 332 (520)
|+.+++.||||+....
T Consensus 290 ~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 290 TATEALEHPYFDSFRD 305 (342)
T ss_pred CHHHHhcCcchhhccc
Confidence 9999999999987654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=321.01 Aligned_cols=259 Identities=29% Similarity=0.502 Sum_probs=211.7
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccc-hhhHHHHHHHHHHHhcCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW-NTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~-~~~~~~l~~Ei~~l~~l~H 108 (520)
+|.+.+.||+|+||+||++.+...+..+++|+++. +..... .....++.+|+.+++.++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~e~~~l~~l~h 61 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKE-------------------IPVGELNPNETVQANQEAQLLSKLDH 61 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEecc-------------------ccccccCcchHHHHHHHHHHHHhCCC
Confidence 69999999999999999999988877777776431 111111 1223457789999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++......++||||+.+++|.+++..... ....+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~ni 137 (260)
T cd08222 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKH----TGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNI 137 (260)
T ss_pred CcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhh----cccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhhe
Confidence 9999999999999999999999999999999875322 346789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
+++. +.++|+|||++..+.... .......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.....
T Consensus 138 li~~-~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~ 210 (260)
T cd08222 138 FLKN-NLLKIGDFGVSRLLMGSC-----DLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNF 210 (260)
T ss_pred Eeec-CCEeecccCceeecCCCc-----ccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 9964 679999999987653321 1223456899999999886544 78899999999999999999999987666
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
............+..+ ..++.++.++|.+||..+|++||++.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 211 LSVVLRIVEGPTPSLP---------ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHcCCCCCCc---------chhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 6655555544333322 3567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=322.75 Aligned_cols=261 Identities=19% Similarity=0.330 Sum_probs=207.4
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
...+|++.++||+|+||.||++.+.. ++..+|+|.+. . ......+.+.+|++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~----------------------~-~~~~~~~~~~~e~~ 59 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK----------------------E-ASESARQDFQREAE 59 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecC----------------------c-CCHHHHHHHHHHHH
Confidence 45679999999999999999997543 34455555432 1 11234567899999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc-------ccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI-------SNCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~-------~~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
+++.++||||+++++++......+++|||+.+++|.+++...... .......+++..+..++.||+.||.|||
T Consensus 60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 139 (280)
T cd05092 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA 139 (280)
T ss_pred HHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999753210 0011245889999999999999999999
Q ss_pred HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 175 ~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
++|++||||||+|||+++++.++|+|||++..+..... ........+++.|+|||.+.+.. ++.++|||||||++|
T Consensus 140 ~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ 215 (280)
T cd05092 140 SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLW 215 (280)
T ss_pred HCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCce---eecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHH
Confidence 99999999999999999999999999999876532211 11122334578899999987665 899999999999999
Q ss_pred HHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 255 EMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 255 ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+|++ |.+||................+.... ..+++.+.+||.+||+.||.+||++.++++
T Consensus 216 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 216 EIFTYGKQPWYQLSNTEAIECITQGRELERP---------RTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHcCCCCCCccCCHHHHHHHHHcCccCCCC---------CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9998 99999877776666655554333221 246788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=320.25 Aligned_cols=258 Identities=23% Similarity=0.323 Sum_probs=195.7
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~ 114 (520)
+.||+|+||.||+|..... .. ...+++|.+...........+.+|+.+++.++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-~~-------------------~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~ 60 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-MS-------------------KARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60 (269)
T ss_pred CcCCccCCceEEEEEEecC-CC-------------------CeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceE
Confidence 3689999999999965432 11 223344444333323345678899999999999999999
Q ss_pred EEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCC
Q psy11359 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194 (520)
Q Consensus 115 ~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g 194 (520)
++++......|+||||+.+|+|.+++...... ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 61 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~ 137 (269)
T cd05042 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGM---VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL 137 (269)
T ss_pred EEEECCCCceEEEEEeCCCCcHHHHHHhcccc---ccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC
Confidence 99999999999999999999999999753211 223456888999999999999999999999999999999999999
Q ss_pred CeEEeccCcceeeccCccccccccccccccccccCCcceecc------cCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc
Q psy11359 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ------DHGYDFKADIWSLGITAIEMAT-GTAPYHKYP 267 (520)
Q Consensus 195 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~ 267 (520)
.+||+|||++......... .......+++.|+|||++.. ...++.++|||||||++|+|++ |..||....
T Consensus 138 ~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 138 SVKIGDYGLALEQYPEDYY---ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred cEEEeccccccccccchhe---eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 9999999988653221110 01123346778999998743 2337889999999999999999 889998877
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
..+.+..........+.... ....++..+.+++..|+ .||++|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 215 DEQVLKQVVREQDIKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHhhccCccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 76666655554433332211 12356788889999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=318.00 Aligned_cols=246 Identities=23% Similarity=0.340 Sum_probs=196.5
Q ss_pred eeeecCceEEEEEEE--cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceE
Q psy11359 36 VIGFGATAVVHSAYC--KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVT 113 (520)
Q Consensus 36 ~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~ 113 (520)
.||+|+||.||+|.. ..++..+|+|+++... ......+++.+|+.+++.++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---------------------~~~~~~~~~~~e~~~l~~l~h~~i~~ 60 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---------------------NDPALKDELLREANVMQQLDNPYIVR 60 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---------------------CcHHHHHHHHHHHHHHHhCCCCCcce
Confidence 689999999999964 4566677777653211 11224567899999999999999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++. .+..++||||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||.||+++.+
T Consensus 61 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~ 131 (257)
T cd05116 61 MIGICE-AESWMLVMELAELGPLNKFLQK--------NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ 131 (257)
T ss_pred EEEEEc-CCCcEEEEecCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC
Confidence 999875 5567899999999999999973 4568999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL 272 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~ 272 (520)
+.+||+|||++..+....... .......+++.|+|||.+.... ++.++|||||||++|+|++ |..||......+..
T Consensus 132 ~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 208 (257)
T cd05116 132 HYAKISDFGLSKALGADENYY--KAKTHGKWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208 (257)
T ss_pred CeEEECCCccccccCCCCCee--eecCCCCCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999987664332211 1111223467899999986544 8899999999999999998 99999887766665
Q ss_pred HHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 273 MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
..+.....+..+ ..+++++.++|.+||++||.+||++.++.+
T Consensus 209 ~~i~~~~~~~~~---------~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 209 QMIESGERMECP---------QRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHCCCCCCCC---------CCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 555443332222 246788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=317.15 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=197.0
Q ss_pred eeeecCceEEEEEEEc--CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceE
Q psy11359 36 VIGFGATAVVHSAYCK--ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVT 113 (520)
Q Consensus 36 ~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~ 113 (520)
.||+|+||.||+|.+. ..+..||+|++. ........+.+.+|+.++++++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~----------------------~~~~~~~~~~~~~E~~~l~~l~h~~ii~ 59 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK----------------------NENEKSVRDEMMREAEIMHQLDNPYIVR 59 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcc----------------------cccChHHHHHHHHHHHHHHhcCCCCeEE
Confidence 4899999999999775 334456666543 2222334567899999999999999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++. ....++||||+.+++|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 60 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~ 131 (257)
T cd05115 60 MIGVCE-AEALMLVMEMASGGPLNKFLSG-------KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ 131 (257)
T ss_pred EEEEEc-CCCeEEEEEeCCCCCHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC
Confidence 999875 4578999999999999999874 34578999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL 272 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~ 272 (520)
+.+||+|||++..+....... .......+++.|+|||.+.... ++.++|||||||++|+|++ |..||.........
T Consensus 132 ~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 208 (257)
T cd05115 132 HYAKISDFGLSKALGADDSYY--KARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM 208 (257)
T ss_pred CcEEeccCCccccccCCccce--eccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 999999999987654322111 1111123457899999987655 8999999999999999996 99999988777766
Q ss_pred HHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 273 MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.....+.....+ ...++++.++|.+||..+|++||++.++.+
T Consensus 209 ~~~~~~~~~~~~---------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 209 SFIEQGKRLDCP---------AECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHCCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 555554433322 245788999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=316.55 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=197.4
Q ss_pred eeeeecCceEEEEEEEcCCC---ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCc
Q psy11359 35 EVIGFGATAVVHSAYCKARA---EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENV 111 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnI 111 (520)
+.||+|+||.||+|....++ ..+|+|.+. ........+++.+|+.+++.++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~----------------------~~~~~~~~~~~~~e~~~l~~l~h~~i 58 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK----------------------QEHIAAGKKEFLREASVMAQLDHPCI 58 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecc----------------------cccchHHHHHHHHHHHHHHhcCCCCe
Confidence 47999999999999876654 556666543 22222345678999999999999999
Q ss_pred eEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEc
Q psy11359 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191 (520)
Q Consensus 112 v~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~ 191 (520)
+++++++. .+..++||||+.+++|.+++.. .+.+++..+..++.|++.||.|||.+|++||||||+|||++
T Consensus 59 v~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~ 129 (257)
T cd05060 59 VRLIGVCK-GEPLMLVMELAPLGPLLKYLKK--------RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV 129 (257)
T ss_pred eeEEEEEc-CCceEEEEEeCCCCcHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc
Confidence 99999776 5568999999999999999974 34789999999999999999999999999999999999999
Q ss_pred CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHH
Q psy11359 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMK 270 (520)
Q Consensus 192 ~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~ 270 (520)
.++.+||+|||++..+........ ......++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||......+
T Consensus 130 ~~~~~kl~df~~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~ 206 (257)
T cd05060 130 NRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206 (257)
T ss_pred CCCcEEeccccccceeecCCcccc--cccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 999999999999987644322111 111122456799999987655 8999999999999999998 999998877766
Q ss_pred HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.........+... ...++..++++|.+||.++|.+|||+.++++
T Consensus 207 ~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 207 VIAMLESGERLPR---------PEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHcCCcCCC---------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 6555544432221 1346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=326.32 Aligned_cols=261 Identities=38% Similarity=0.630 Sum_probs=214.4
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
...|...+.||+|+||.||++.+..++..+|+|.+..... ........+.+|+.+++.++
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~--------------------~~~~~~~~~~~e~~~l~~l~ 83 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK--------------------QSNEKWQDIIKEVKFLQRIK 83 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--------------------CchHHHHHHHHHHHHHHhCC
Confidence 3448999999999999999999999988899887643210 11233456889999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||++++++++..++..|+||||+. |+|.+++.. ....+++..+..++.||+.||.|||++|++||||+|+|
T Consensus 84 h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~N 155 (317)
T cd06635 84 HPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEV-------HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGN 155 (317)
T ss_pred CCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCccc
Confidence 9999999999999999999999996 588887764 24568999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc--cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ--DHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
|+++.++.++|+|||++..... .....|++.|+|||++.. ...++.++|+|||||++|+|++|.+||..
T Consensus 156 il~~~~~~~kl~dfg~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 156 ILLTEPGQVKLADFGSASIASP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred EEECCCCCEEEecCCCccccCC---------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999998764321 124568899999999742 23378999999999999999999999987
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
...............+.... ..+++.++++|.+||+.+|.+|||+.++++|+|+......
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 227 MNAMSALYHIAQNESPTLQS--------NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred ccHHHHHHHHHhccCCCCCC--------ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 76666555555443322211 2456789999999999999999999999999999765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=323.04 Aligned_cols=262 Identities=28% Similarity=0.431 Sum_probs=208.0
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC-CC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH-HE 109 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~-Hp 109 (520)
|++.+.||+|++|+||+|.+..+++.||+|.+.... .........+|+..+++++ ||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~----------------------~~~~~~~~~~e~~~l~~~~~h~ 58 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----------------------YSWEECMNLREVKSLRKLNEHP 58 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhc----------------------cchhHHHHHHHHHHHHhccCCC
Confidence 788999999999999999999998888888764211 0111223457899999998 99
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
||+++++++..++..|+||||+ +++|.+++... ....+++..+..++.||+.+|.|||++|++|+||+|+||+
T Consensus 59 ~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~ 131 (283)
T cd07830 59 NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDR------KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLL 131 (283)
T ss_pred CchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhc------ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEE
Confidence 9999999999999999999999 88999998753 2347899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.++.++|+|||++....... ......|+..|+|||++.+...++.++|+||||+++++|++|.+||......
T Consensus 132 i~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~ 205 (283)
T cd07830 132 VSGPEVVKIADFGLAREIRSRP------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI 205 (283)
T ss_pred EcCCCCEEEeecccceeccCCC------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH
Confidence 9999999999999987653321 1234568899999999876656899999999999999999999999877655
Q ss_pred HHHHHHhcCCCCCC------------------CCC--chhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 270 KVLMLTLQNDPPTL------------------DTG--AAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 270 ~~~~~~~~~~~~~~------------------~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
+............. ... ..........+..+.+||.+||+.+|.+|||+.|++.||||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 206 DQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 54433221100000 000 00011112336789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.25 Aligned_cols=263 Identities=37% Similarity=0.614 Sum_probs=215.3
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
....|...+.||.|+||.||+|.++.++..+|+|.+.... ........++.+|+.+++.+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~--------------------~~~~~~~~~~~~e~~~l~~l 72 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--------------------KQSNEKWQDIIKEVRFLQKL 72 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccc--------------------ccChHHHHHHHHHHHHHHhC
Confidence 4456888999999999999999999998888888764211 01122345688999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+|+|++++++++......|+||||+. |+|.+++.. ....+++..+..++.|++.||.|||++|++||||||.
T Consensus 73 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ 144 (308)
T cd06634 73 RHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV-------HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 144 (308)
T ss_pred CCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 99999999999999999999999996 688887754 2346889999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc--cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ--DHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
||+++.++.++|+|||++..... .....|++.|+|||.+.. ...++.++|||||||++|+|++|..||.
T Consensus 145 nil~~~~~~~kl~dfg~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 145 NILLSEPGLVKLGDFGSASIMAP---------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred hEEECCCCcEEECCcccceeecC---------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 99999999999999998865432 124568899999999742 2337889999999999999999999998
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhh
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~ 334 (520)
................+... ...++..+.+||.+||+++|.+||++.++++|||+.......
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~ 277 (308)
T cd06634 216 NMNAMSALYHIAQNESPALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277 (308)
T ss_pred cccHHHHHHHHhhcCCCCcC--------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCChh
Confidence 76665555444443332221 134677899999999999999999999999999998765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=315.04 Aligned_cols=250 Identities=26% Similarity=0.455 Sum_probs=205.6
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.+.||.|+||.||+|... |+.||+|.++.. . ...+++.+|+.++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~----------------------~--~~~~~~~~e~~~l 54 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDD----------------------S--TAAQAFLAEASVM 54 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccc----------------------h--hHHHHHHHHHHHH
Confidence 3446778999999999999999999875 677777766421 1 1356789999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+.++|+||+++++++......++||||+.+++|.++++.. ....+++..+..++.|++.||.|||++|++||||
T Consensus 55 ~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di 128 (256)
T cd05039 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR------GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDL 128 (256)
T ss_pred HhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhc
Confidence 9999999999999999999999999999999999999753 2346899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||+++.++.++|+|||.+........ ...++..|+|||.+.... ++.++||||||+++|+|++ |..|
T Consensus 129 ~p~Nili~~~~~~~l~d~g~~~~~~~~~~--------~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p 199 (256)
T cd05039 129 AARNVLVSEDLVAKVSDFGLAKEASQGQD--------SGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVP 199 (256)
T ss_pred ccceEEEeCCCCEEEcccccccccccccc--------cCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999876532111 223456799999987654 8899999999999999997 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|...+................ ...+++.+.++|.+||..+|++|||+.++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 200 YPRIPLKDVVPHVEKGYRMEA---------PEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCCCHHHHHHHHhcCCCCCC---------ccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 988766555443333222211 1346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=315.79 Aligned_cols=254 Identities=23% Similarity=0.436 Sum_probs=205.8
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.+.||+|+||.||++.+. .+..+|+|.+... ....+.+.+|+.++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~------------------------~~~~~~~~~e~~~l 55 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG------------------------SMSVEAFLAEANVM 55 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC------------------------hhHHHHHHHHHHHH
Confidence 6678899999999999999999999765 4455777755311 12345688999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+.++|+||+++++++.. ...+++|||+.+++|.+++... ....+++..+..++.||+.||.|||++|++||||
T Consensus 56 ~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl 128 (260)
T cd05073 56 KTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD------EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128 (260)
T ss_pred HhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhC------CccccCHHHHHHHHHHHHHHHHHHHhCCcccccc
Confidence 99999999999999877 7789999999999999999753 3456788999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||+++.++.++|+|||.+..+...... ......++..|+|||++.... ++.++|+|||||++|+|+| |..|
T Consensus 129 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p 203 (260)
T cd05073 129 RAANILVSASLVCKIADFGLARVIEDNEYT----AREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIP 203 (260)
T ss_pred CcceEEEcCCCcEEECCCcceeeccCCCcc----cccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCC
Confidence 999999999999999999998766432211 112234567799999987654 8999999999999999999 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|.................... ....+.++.+++.+||+++|++||++.++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 204 YPGMSNPEVIRALERGYRMPR---------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCCCCHHHHHHHHhCCCCCCC---------cccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 987766555544433322211 1346778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=319.01 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=205.4
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.++.+|..+ ...+|+|............++.+|+.+++++
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~------------------~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l 66 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKV------------------KIPVAIKVLREETSPKANKEILDEAYVMASV 66 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCc------------------ceEEEEEeccCCCCHHHHHHHHHHHHHHHhC
Confidence 4578999999999999999999988776421 1123344433333344567789999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++.. ...++||||+.+|+|.+++.. ....+++..+..++.||+.||.|||++|++||||||+
T Consensus 67 ~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~ 138 (279)
T cd05057 67 DHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN-------HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAAR 138 (279)
T ss_pred CCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcc
Confidence 99999999999887 789999999999999999975 3456899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHK 265 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~ 265 (520)
||+++.++.+||+|||++..+....... ......+++.|+|||.+.... ++.++|+||||+++|+|++ |..||..
T Consensus 139 nil~~~~~~~kL~dfg~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~ 214 (279)
T cd05057 139 NVLVKTPQHVKITDFGLAKLLDVDEKEY---HAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEG 214 (279)
T ss_pred eEEEcCCCeEEECCCcccccccCcccce---ecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999998764322111 111223456899999886544 8999999999999999998 9999988
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
....+.......+.....+ ...+..+.+++.+||..+|.+|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 215 IPAVEIPDLLEKGERLPQP---------PICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHhCCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 7766655544443322221 234567899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.21 Aligned_cols=266 Identities=25% Similarity=0.379 Sum_probs=203.2
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEc-----CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCK-----ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
|.-..++|++.++||+|+||+||+|.+. .+++.||+|+++ ..........+.+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~----------------------~~~~~~~~~~~~~ 59 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK----------------------EGATHSEHRALMS 59 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEec----------------------cCCChHHHHHHHH
Confidence 6667789999999999999999999853 345566666553 2222334556889
Q ss_pred HHHHHhcC-CCCCceEEEEEEEE-CCEEEEEEEccCCCCHHHHHHHhhccc-----------------------------
Q psy11359 99 EIQAMSSC-HHENVVTYHTSFVV-KDELWLVLRLLEGGSLLDIIKHRLKIS----------------------------- 147 (520)
Q Consensus 99 Ei~~l~~l-~HpnIv~~~~~~~~-~~~~~lV~E~~~ggsL~~~i~~~~~~~----------------------------- 147 (520)
|+.++.++ +||||+++++++.. ...+++||||+.+|+|.+++.......
T Consensus 60 E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (343)
T cd05103 60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLD 139 (343)
T ss_pred HHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcc
Confidence 99999999 78999999998865 456899999999999999997532100
Q ss_pred ------------------------------cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeE
Q psy11359 148 ------------------------------NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQ 197 (520)
Q Consensus 148 ------------------------------~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vk 197 (520)
......++...+..++.||+.||.|||++||+||||||.|||++.++.+|
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~k 219 (343)
T cd05103 140 SITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVK 219 (343)
T ss_pred ccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEE
Confidence 00123478889999999999999999999999999999999999999999
Q ss_pred EeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh
Q psy11359 198 IADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTL 276 (520)
Q Consensus 198 L~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~ 276 (520)
|+|||++..+...... .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||........+...+
T Consensus 220 l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 295 (343)
T cd05103 220 ICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295 (343)
T ss_pred EEecccccccccCcch---hhcCCCCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH
Confidence 9999998765322111 1111234567899999987654 8999999999999999997 999997655433333322
Q ss_pred cC-CCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 277 QN-DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 277 ~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
.. .....+ ..+++.+.+++..||+.+|.+|||+.++++|
T Consensus 296 ~~~~~~~~~---------~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 296 KEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred hccCCCCCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22 111111 2246789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=339.20 Aligned_cols=260 Identities=29% Similarity=0.448 Sum_probs=213.8
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeec--ccchhhHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINL--EKWNTSMDELLKEI 100 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~--~~~~~~~~~l~~Ei 100 (520)
.|...+++-.+.++||+|+||.||+|..+..+... ...||+|.... ....+.+.++++|+
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~------------------~~~VAvK~~k~~~~~~~~~~~e~m~EA 212 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFK------------------VVPVAVKTTKGSSELTKEQIKEFMKEA 212 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCce------------------eeeeEEEeecccccccHHHHHHHHHHH
Confidence 48888888899999999999999999887753300 00134444443 22355788999999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
++|++++|||||++|++...+..+++|||+|.||+|.+++++ ..+.++..+...++.+.+.||+|||++++||
T Consensus 213 rvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k-------~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IH 285 (474)
T KOG0194|consen 213 RVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKK-------NKKSLPTLEKLRFCYDAARGLEYLHSKNCIH 285 (474)
T ss_pred HHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHh-------CCCCCCHHHHHHHHHHHHhHHHHHHHCCCcc
Confidence 999999999999999999999999999999999999999996 3346999999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCcccccccccc-ccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRH-TFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT- 258 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~-~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt- 258 (520)
|||-.+|+|++.++.+||+|||+++.-.. -.... ...-...|+|||.+.... |++++|||||||++||+++
T Consensus 286 RDIAARNcL~~~~~~vKISDFGLs~~~~~------~~~~~~~~klPirWLAPEtl~~~~-~s~kTDV~sfGV~~~Eif~~ 358 (474)
T KOG0194|consen 286 RDIAARNCLYSKKGVVKISDFGLSRAGSQ------YVMKKFLKKLPIRWLAPETLNTGI-FSFKTDVWSFGVLLWEIFEN 358 (474)
T ss_pred hhHhHHHheecCCCeEEeCccccccCCcc------eeeccccccCcceecChhhhccCc-cccccchhheeeeEEeeecc
Confidence 99999999999999999999999865320 00011 112346799999998775 9999999999999999998
Q ss_pred CCCCCCCCcHHHHHHHHhc-CCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 259 GTAPYHKYPAMKVLMLTLQ-NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|..||.+....++...+.. +.+...+ ...+..+..++.+|+..+|++|||+.++.+
T Consensus 359 g~~Py~g~~~~~v~~kI~~~~~r~~~~---------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 359 GAEPYPGMKNYEVKAKIVKNGYRMPIP---------SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCCCCCCCCHHHHHHHHHhcCccCCCC---------CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 8999999999988888744 3333332 244677889999999999999999999964
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=325.34 Aligned_cols=283 Identities=24% Similarity=0.316 Sum_probs=208.2
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||.||+|.+..++.......... ......+|+|.+.........+.+.+|+++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~--------~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l 74 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEF--------DGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL 74 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCccc--------CCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC
Confidence 45789999999999999999998876543221111100 0112345666665443344556789999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc----cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS----NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~----~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
+||||+++++++......++||||+.+++|.+++....... ......+++..+..++.||+.||.|||++|++|||
T Consensus 75 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~d 154 (295)
T cd05097 75 KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRD 154 (295)
T ss_pred CCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccc
Confidence 99999999999999999999999999999999996532110 00123478899999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh--CC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT--GT 260 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt--G~ 260 (520)
|||+||+++.++.+||+|||++..+..... ........+++.|+|||++.... ++.++|+|||||++|+|++ |.
T Consensus 155 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~ 230 (295)
T cd05097 155 LATRNCLVGNHYTIKIADFGMSRNLYSGDY---YRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKE 230 (295)
T ss_pred cChhhEEEcCCCcEEecccccccccccCcc---eeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCC
Confidence 999999999999999999999876533221 11122334577899999987655 8999999999999999998 77
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.||......+............... ........+++.+.+|+.+||+.+|.+|||+.++++
T Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 231 QPYSLLSDEQVIENTGEFFRNQGRQ--IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred CCCcccChHHHHHHHHHhhhhcccc--ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 8888766555443322110000000 000011235788999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=320.68 Aligned_cols=262 Identities=22% Similarity=0.342 Sum_probs=206.3
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
..++|++.+.||+|+||.||+|.+.. ++..+|+|++. .........++.+|+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~----------------------~~~~~~~~~~~~~ei~ 60 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK----------------------EEASADMQADFQREAA 60 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecC----------------------CCcCHHHHHHHHHHHH
Confidence 45789999999999999999998753 45556666543 2222334567889999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcccc--------------CCCCCCCHHHHHHHHHHHH
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN--------------CKHGVCDEPTIATVLREVL 167 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~--------------~~~~~l~~~~i~~i~~qIl 167 (520)
++++++||||+++++++......++||||+.+++|.+++........ .....+++..+..++.||+
T Consensus 61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~ 140 (288)
T cd05050 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVA 140 (288)
T ss_pred HHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999975322110 0123578899999999999
Q ss_pred HHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHH
Q psy11359 168 KGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIW 247 (520)
Q Consensus 168 ~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIw 247 (520)
.||.|||++|++||||||.|||++.++.++|+|||++..+...... .......+++.|+|||.+.+.. ++.++|||
T Consensus 141 ~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~ 216 (288)
T cd05050 141 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---KASENDAIPIRWMPPESIFYNR-YTTESDVW 216 (288)
T ss_pred HHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccc---cccCCCccChhhcCHHHHhcCC-CCchhHHH
Confidence 9999999999999999999999999999999999998755322110 1111223466799999987655 89999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 248 SLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 248 SlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
||||++|+|++ |..||.+....+.............. ..++..+.+||.+||+.+|.+|||+.|+++
T Consensus 217 slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 217 AYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCP---------DNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999999998 88899877766665554433322111 235678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=316.60 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=193.8
Q ss_pred eeeeecCceEEEEEEEcC--CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCce
Q psy11359 35 EVIGFGATAVVHSAYCKA--RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVV 112 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv 112 (520)
+.||+|+||.||+|.... ++..+|+|.+ ...........+.+|+.++++++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~----------------------~~~~~~~~~~~~~~E~~~l~~l~h~~iv 58 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKEL----------------------RVSASVQEQMKFLEEAQPYRSLQHSNLL 58 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEec----------------------CCCCChHHHHHHHHHHHHHHhCCCCCEe
Confidence 468999999999997653 3344555544 3222223345688899999999999999
Q ss_pred EEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcC
Q psy11359 113 TYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE 192 (520)
Q Consensus 113 ~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~ 192 (520)
++++++.....+++||||+.+|+|.+++...... ....+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 59 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~ 135 (269)
T cd05087 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKA---ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA 135 (269)
T ss_pred eEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhc---ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC
Confidence 9999999999999999999999999999753211 2235677888999999999999999999999999999999999
Q ss_pred CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC------CCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy11359 193 DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH------GYDFKADIWSLGITAIEMAT-GTAPYHK 265 (520)
Q Consensus 193 ~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~------~~~~~~DIwSlG~il~ellt-G~~Pf~~ 265 (520)
++.++|+|||++........ ........|++.|+|||++.+.. .++.++||||||+++|+|++ |..||..
T Consensus 136 ~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 136 DLTVKIGDYGLSHNKYKEDY---YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred CCcEEECCccccccccCcce---eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999865422111 11122356788999999985421 25789999999999999996 9999987
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
....+................ ......+..+.+++..|+ .+|++|||+.+|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 213 LSDEQVLTYTVREQQLKLPKP----RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHhhcccCCCCCC----ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 766655443333222221111 111245677899999999 58999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=317.73 Aligned_cols=263 Identities=18% Similarity=0.273 Sum_probs=206.6
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCC----CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKAR----AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~----g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
...++|++.++||+|+||.||+|.+..+ +..|++|.+ .........+.+.+|+.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~----------------------~~~~~~~~~~~~~~e~~ 60 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV----------------------KDHASEIQVTLLLQESC 60 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEc----------------------cCCCCHHHHHHHHHHHH
Confidence 4678899999999999999999998763 345555543 32222345677899999
Q ss_pred HHhcCCCCCceEEEEEEEE-CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 102 AMSSCHHENVVTYHTSFVV-KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~-~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+++.++||||+++++++.. +...+++++|+.+++|.+++.............+++..+..++.||+.||.|||+++++|
T Consensus 61 ~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H 140 (280)
T cd05043 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIH 140 (280)
T ss_pred HHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 9999999999999998765 577899999999999999997542211112256899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-C
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G 259 (520)
|||||+||++++++.+||+|||+++.+..... ........++..|+|||++.+.. ++.++|||||||++|+|++ |
T Consensus 141 ~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g 216 (280)
T cd05043 141 KDIAARNCVIDEELQVKITDNALSRDLFPMDY---HCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLG 216 (280)
T ss_pred cccCHhhEEEcCCCcEEECCCCCcccccCCce---EEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCC
Confidence 99999999999999999999999876532211 11112234567899999987655 8999999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
++||.................... ...+++.+.+++.+||..+|++|||+.++++
T Consensus 217 ~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 217 QTPYVEIDPFEMAAYLKDGYRLAQ---------PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCcCCHHHHHHHHHcCCCCCC---------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999987766554443333222111 1235778999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=335.60 Aligned_cols=271 Identities=21% Similarity=0.346 Sum_probs=211.6
Q ss_pred CCCCCCCCCCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhH
Q psy11359 19 SVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSM 93 (520)
Q Consensus 19 ~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~ 93 (520)
.....|....++|.+.+.||+|+||.||+|.+.. ++..||+|++ .........
T Consensus 27 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l----------------------~~~~~~~~~ 84 (401)
T cd05107 27 PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKML----------------------KSTARSSEK 84 (401)
T ss_pred CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEec----------------------CCCCChhHH
Confidence 3444588888999999999999999999998653 3344555554 333223344
Q ss_pred HHHHHHHHHHhcCC-CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc-------------------------
Q psy11359 94 DELLKEIQAMSSCH-HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS------------------------- 147 (520)
Q Consensus 94 ~~l~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~------------------------- 147 (520)
+.+.+|+.+|.++. ||||+++++++...+.+++||||+.+|+|.+++.......
T Consensus 85 ~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (401)
T cd05107 85 QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQR 164 (401)
T ss_pred HHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccc
Confidence 57889999999997 9999999999999999999999999999999997532100
Q ss_pred -----------------------------------------------------------------cCCCCCCCHHHHHHH
Q psy11359 148 -----------------------------------------------------------------NCKHGVCDEPTIATV 162 (520)
Q Consensus 148 -----------------------------------------------------------------~~~~~~l~~~~i~~i 162 (520)
......++...+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 244 (401)
T cd05107 165 KSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGF 244 (401)
T ss_pred ccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHH
Confidence 001234778889999
Q ss_pred HHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCc
Q psy11359 163 LREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF 242 (520)
Q Consensus 163 ~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 242 (520)
+.||+.||.|||++|++||||||+|||+++++.+||+|||++..+...... .......+++.|+|||.+.+.. ++.
T Consensus 245 ~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~ 320 (401)
T cd05107 245 SYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY---ISKGSTFLPLKWMAPESIFNNL-YTT 320 (401)
T ss_pred HHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceeccccccc---ccCCCcCCCCceeChHHhcCCC-CCc
Confidence 999999999999999999999999999999999999999999765332211 1112345788999999987654 899
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCC-CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 243 KADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQND-PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 243 ~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
++|||||||++|||++ |..||...+..+.....+... .+.. ...++.++.+|+.+||.++|.+||++.+
T Consensus 321 ~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~e 391 (401)
T cd05107 321 LSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK---------PAHASDEIYEIMQKCWEEKFEIRPDFSQ 391 (401)
T ss_pred HhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999999999998 899998766555444433322 1111 1235788999999999999999999999
Q ss_pred HhcC
Q psy11359 321 LLKN 324 (520)
Q Consensus 321 lL~h 324 (520)
+++.
T Consensus 392 ll~~ 395 (401)
T cd05107 392 LVHL 395 (401)
T ss_pred HHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=311.35 Aligned_cols=245 Identities=24% Similarity=0.381 Sum_probs=198.1
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~ 114 (520)
++||+|+||.||+|... ++..+|+|.++.. ........+.+|+.+++.++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~----------------------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 57 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED----------------------LPQELKIKFLSEARILKQYDHPNIVKL 57 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCc----------------------CCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 47999999999999864 5777888865421 112234468899999999999999999
Q ss_pred EEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCC
Q psy11359 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194 (520)
Q Consensus 115 ~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g 194 (520)
++++...+..++||||+.+++|.+++.. ....+++..+..++.|++.+|.|||++|++||||||+||+++.++
T Consensus 58 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~ 130 (250)
T cd05085 58 IGVCTQRQPIYIVMELVPGGDFLSFLRK-------KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN 130 (250)
T ss_pred EEEEecCCccEEEEECCCCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC
Confidence 9999999999999999999999999864 345688999999999999999999999999999999999999999
Q ss_pred CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q psy11359 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLM 273 (520)
Q Consensus 195 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~ 273 (520)
.++|+|||++.....+.. .......+++.|+|||++.... ++.++||||||+++|+|++ |..||..........
T Consensus 131 ~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~ 205 (250)
T cd05085 131 VLKISDFGMSRQEDDGIY----SSSGLKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE 205 (250)
T ss_pred eEEECCCccceecccccc----ccCCCCCCcccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 999999999865432211 1111223466799999987655 8999999999999999998 999998776665554
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
........... ..++..+.+++.+||+.+|++|||+.++++
T Consensus 206 ~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 206 QVEKGYRMSCP---------QKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHcCCCCCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 44433222211 235788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=322.90 Aligned_cols=284 Identities=21% Similarity=0.325 Sum_probs=209.2
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||++.+....+. +.+.+..... ......+|+|.+...........+.+|+.+++.++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKF-MDKDFSLDVS-----GNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK 77 (296)
T ss_pred hhhceeeeeccCCCCCeEEeccccccccc-ccccccccCC-----CCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC
Confidence 45799999999999999999976654322 1111111000 11134577777765444445678999999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc---cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS---NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~---~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
||||+++++++...+..++||||+.+++|.+++....... ......+++..+..++.||+.||.|||++|++|||||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 9999999999999999999999999999999997532111 1123458889999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh--CCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT--GTAP 262 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt--G~~P 262 (520)
|+|||++.++.++|+|||++..+...... .......+++.|+|||...+.. ++.++|+|||||++|+|+| |..|
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcce---eccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999998765432211 1122234567899999876655 8999999999999999998 7899
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|......+................ .......+++.+.+|+.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 234 YSQLSDEQVIENTGEFFRDQGRQV--YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccccChHHHHHHHHHHHhhccccc--cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 987665554432211000000000 00011235678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=318.94 Aligned_cols=262 Identities=29% Similarity=0.457 Sum_probs=207.7
Q ss_pred CeEEEeeeeecCceEEEEEEEc---CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCK---ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
+|++.+.||+|++|.||++.+. .+++.||+|.++..... ......+.+.+|+.++.++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~-------------------~~~~~~~~~~~E~~~l~~~ 61 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV-------------------QKAKTAEHTRTERQVLEAV 61 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH-------------------hhhhHHHHHHHHHHHHHhc
Confidence 4899999999999999999864 45677888877532211 0122345688999999999
Q ss_pred -CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 -HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 -~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+||||+++++++..+..+++||||+.+++|.+++.. ...+++..++.++.|+++||.|||+.|++||||||
T Consensus 62 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p 133 (288)
T cd05583 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--------REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKL 133 (288)
T ss_pred cCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhh--------cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 699999999999999999999999999999999863 45688999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH-GYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
+||+++.++.++|+|||++..+.... ........|++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||.
T Consensus 134 ~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 134 ENILLDSEGHVVLTDFGLSKEFLAEE----EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred HHeEECCCCCEEEEECcccccccccc----ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999987653321 11123456899999999986543 36889999999999999999999996
Q ss_pred CCcH----HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC---HHHHhcCccccccch
Q psy11359 265 KYPA----MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT---ASELLKNPFFKKAKD 332 (520)
Q Consensus 265 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~elL~hp~~~~~~~ 332 (520)
.... ...........++ . ...++..+.++|.+||+.+|++||| +.++|+||||+...+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~-~---------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 210 VDGEQNSQSEISRRILKSKPP-F---------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred cCcccchHHHHHHHHHccCCC-C---------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 3321 1222222222111 1 1336778999999999999999998 567799999988755
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=317.94 Aligned_cols=268 Identities=19% Similarity=0.284 Sum_probs=208.0
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||.|+||.||+|+.+.++.... .+.+++|...........+.+.+|+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~-----------------~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l 65 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGG-----------------ETLVLVKALQKTKDENLQSEFRRELDMFRKL 65 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCC-----------------cceEEEEccCCccchHHHHHHHHHHHHHHhc
Confidence 34789999999999999999999876532111 2344555544433333567799999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc-ccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI-SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~-~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+||||+++++++......|+||||+.+++|.+++...... .......+++..+..++.||+.||.|||++|++||||||
T Consensus 66 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp 145 (275)
T cd05046 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAA 145 (275)
T ss_pred CCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCcc
Confidence 9999999999999999999999999999999999753210 001123689999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYH 264 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~ 264 (520)
+||+++.++.++|+|||++....... ........+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.
T Consensus 146 ~Nili~~~~~~~l~~~~~~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~ 220 (275)
T cd05046 146 RNCLVSSQREVKVSLLSLSKDVYNSE----YYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFY 220 (275)
T ss_pred ceEEEeCCCcEEEcccccccccCccc----ccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999886442211 11122345678899999887654 7899999999999999999 889997
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
................... ....++..+.+++.+||+.+|.+|||+.+++..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 221 GLSDEEVLNRLQAGKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ccchHHHHHHHHcCCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 7666555544432221111 113467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.84 Aligned_cols=251 Identities=25% Similarity=0.433 Sum_probs=204.0
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
..+|++.+.||+|+||.||+|.+.. +..+|+|.+... ....+.+.+|++++++++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~------------------------~~~~~~~~~e~~~l~~l~ 57 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREG------------------------AMSEEDFIEEAQVMMKLS 57 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCC------------------------CCCHHHHHHHHHHHHhCC
Confidence 3579999999999999999998753 667888865321 112346889999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++......++||||+.+++|.+++.. ..+.+++..+..++.|++.||.|||++|++||||||.|
T Consensus 58 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~n 130 (256)
T cd05112 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA-------QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARN 130 (256)
T ss_pred CCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHh-------CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccce
Confidence 99999999999999999999999999999999874 34568899999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKY 266 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~ 266 (520)
|+++.++.++|+|||++........ .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...
T Consensus 131 i~i~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 131 CLVGENQVVKVSDFGMTRFVLDDQY----TSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred EEEcCCCeEEECCCcceeecccCcc----cccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 9999999999999999876532211 1112234567899999987654 8999999999999999998 99999877
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
...........+.....+ ...+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 206 SNSEVVETINAGFRLYKP---------RLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CHHHHHHHHhCCCCCCCC---------CCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 666555544333222111 2246789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=313.72 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=193.5
Q ss_pred eeeeecCceEEEEEEEcCC---CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCc
Q psy11359 35 EVIGFGATAVVHSAYCKAR---AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENV 111 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnI 111 (520)
+.||+|+||.||+|.+... +..||+|.+ .........+.+.+|+.+++.++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~----------------------~~~~~~~~~~~~~~e~~~l~~l~h~~i 58 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL----------------------NRITDLEEVEQFLKEGIIMKDFSHPNV 58 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEec----------------------CccCCHHHHHHHHHHHHHHccCCCCCc
Confidence 4689999999999987543 234555543 322223345678899999999999999
Q ss_pred eEEEEEEE-ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEE
Q psy11359 112 VTYHTSFV-VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190 (520)
Q Consensus 112 v~~~~~~~-~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl 190 (520)
+++++++. .+...++||||+.+++|.+++.. ....+++..+..++.||+.||.|||+++++||||||+|||+
T Consensus 59 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili 131 (262)
T cd05058 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS-------ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML 131 (262)
T ss_pred ceEEEEeecCCCCcEEEEecCCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE
Confidence 99999765 45668999999999999999974 23456788889999999999999999999999999999999
Q ss_pred cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHH
Q psy11359 191 GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAM 269 (520)
Q Consensus 191 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~ 269 (520)
+.++.+||+|||++..+...... .........+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||......
T Consensus 132 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~ 209 (262)
T cd05058 132 DESFTVKVADFGLARDIYDKEYY-SVHNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSF 209 (262)
T ss_pred cCCCcEEECCccccccccCCcce-eecccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999998754321110 011112335677899999987654 8999999999999999999 57778776665
Q ss_pred HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+.........+.... ..+++.+.+++.+||..+|++||++.++++
T Consensus 210 ~~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 210 DITVYLLQGRRLLQP---------EYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHhcCCCCCCC---------CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 555544443332221 234678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=319.64 Aligned_cols=262 Identities=29% Similarity=0.414 Sum_probs=210.6
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
|++.+.||+|++|.||+|.+..+++.+|+|.+..... .....+.+.+|+.+++.++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---------------------~~~~~~~~~~e~~~l~~~~~~~ 59 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---------------------EEGIPSTALREISLLKELKHPN 59 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc---------------------cccccHHHHHHHHHHHhcCCCC
Confidence 6788999999999999999999999999998753210 0123456788999999999999
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl 190 (520)
|+++++++...+..++||||+. ++|.+++... ...+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 60 i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~ 131 (282)
T cd07829 60 IVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKR-------PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI 131 (282)
T ss_pred HHHHHhhhhcCCceEEEecCcC-cCHHHHHHhh-------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE
Confidence 9999999999999999999997 5999999752 2578999999999999999999999999999999999999
Q ss_pred cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q psy11359 191 GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270 (520)
Q Consensus 191 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~ 270 (520)
++++.++|+|||++........ ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||......+
T Consensus 132 ~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~ 206 (282)
T cd07829 132 NRDGVLKLADFGLARAFGIPLR-----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID 206 (282)
T ss_pred cCCCCEEEecCCcccccCCCcc-----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 9999999999999876533211 12234567889999998766458999999999999999999999998776554
Q ss_pred HHHHHhcCCC--------------------CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 271 VLMLTLQNDP--------------------PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 271 ~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
.+........ +... ........+.++..+.++|.+||..+|++||++.+++.||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 207 QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP-PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHHHHHhCCCcHHHHHhhcccccccccccccC-ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 4433221100 0000 000112223457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=322.07 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=203.2
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||.||+|.+..+|..++.+ +|+|.+..........++.+|+.+++.+
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~------------------vaiK~~~~~~~~~~~~~~~~e~~~~~~l 66 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIP------------------VAIKILNETTGPKANVEFMDEALIMASM 66 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceee------------------EEEEeccccCCHHHHHHHHHHHHHHHhC
Confidence 4678999999999999999999998877643222 3444443333333445688999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++... ..++++||+.+|+|.+++.. ....+++..+..++.||+.||.|||++|++||||||+
T Consensus 67 ~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~ 138 (303)
T cd05110 67 DHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE-------HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAAR 138 (303)
T ss_pred CCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHh-------cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccc
Confidence 999999999988654 56799999999999999874 3446889999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHK 265 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~ 265 (520)
||+++.++.+||+|||++..+...... .......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+
T Consensus 139 Nill~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 139 NVLVKSPNHVKITDFGLARLLEGDEKE---YNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred eeeecCCCceEEccccccccccCcccc---cccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999866432211 1112234577899999987655 8999999999999999997 9999987
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
............+...... ..++..+.+++.+||..+|++||++.++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 215 IPTREIPDLLEKGERLPQP---------PICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCHHHHHHHHHCCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6654443333222211111 2346678999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=319.17 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=198.8
Q ss_pred eeeecCceEEEEEEEcCCCceEEEEEeehh--hhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceE
Q psy11359 36 VIGFGATAVVHSAYCKARAEKCAIKKINLA--VVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVT 113 (520)
Q Consensus 36 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~--~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~ 113 (520)
+||+|+||.||+|....++...+.+..... .............+++|.+.... .....++.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 699999999999987766655444432110 00111112224567888776432 234457888999999999999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
+++++......++||||+++|+|..++.. ..+.+++..+..++.||++||.|||++||+||||||+|||++..
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRK-------EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEecc
Confidence 99999999999999999999999999864 34678999999999999999999999999999999999999754
Q ss_pred C-------CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH-hCCCCCCC
Q psy11359 194 G-------TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA-TGTAPYHK 265 (520)
Q Consensus 194 g-------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell-tG~~Pf~~ 265 (520)
+ .++++|||++..... .....+++.|+|||.+.+...++.++|||||||++|+|+ +|..||..
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~---------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALS---------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred CcccCccceeeecCCcccccccc---------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 4 489999998754321 112357888999999876555899999999999999985 79999987
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
.......... .... ..+ ...++.+.++|.+||+.+|.+|||+.++|++
T Consensus 225 ~~~~~~~~~~-~~~~-~~~---------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 225 RTPSEKERFY-EKKH-RLP---------EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred cChHHHHHHH-Hhcc-CCC---------CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 6554432221 1111 111 1234578999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=317.71 Aligned_cols=247 Identities=19% Similarity=0.347 Sum_probs=192.3
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~ 114 (520)
+.||+|+||+||+|.+...+....+. ...+++|.+.... ....+.+..|+.+++.++||||+++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~---------------~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~ 64 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELH---------------KTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLN 64 (258)
T ss_pred CCCCcccchhheeeeecccccccccc---------------cchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhhe
Confidence 47999999999999987665431110 2234444433211 2345678889999999999999999
Q ss_pred EEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCC
Q psy11359 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194 (520)
Q Consensus 115 ~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g 194 (520)
++++......++||||+.+|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 65 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~ 137 (258)
T cd05078 65 YGVCVCGDESIMVQEYVKFGSLDTYLKK-------NKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREE 137 (258)
T ss_pred eeEEEeCCCcEEEEecCCCCcHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEeccc
Confidence 9999999999999999999999999974 234688999999999999999999999999999999999997766
Q ss_pred C--------eEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q psy11359 195 T--------VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG-TAPYHK 265 (520)
Q Consensus 195 ~--------vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG-~~Pf~~ 265 (520)
. ++++|||++..... .....+++.|+|||++.+...++.++|||||||++|+|++| .+||..
T Consensus 138 ~~~~~~~~~~~l~d~g~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 138 DRKTGNPPFIKLSDPGISITVLP---------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred ccccCCCceEEecccccccccCC---------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 4 69999998754321 22356889999999998755589999999999999999998 577766
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
........... . ...++ ...+.++.++|.+||+.+|++|||++++++.
T Consensus 209 ~~~~~~~~~~~-~-~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 209 LDSQKKLQFYE-D-RHQLP---------APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ccHHHHHHHHH-c-cccCC---------CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 55544332211 1 11111 1234678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=313.98 Aligned_cols=254 Identities=21% Similarity=0.341 Sum_probs=204.0
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCC---CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKAR---AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
..++|.+.+.||+|+||.||+|.+... ...||+|.. .........+.+.+|+.++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~----------------------~~~~~~~~~~~~~~e~~~l 61 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC----------------------KNCTSPSVREKFLQEAYIM 61 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEec----------------------CCcCCHHHHHHHHHHHHHH
Confidence 567799999999999999999987654 234555544 2222233456789999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++++||||+++++++.. ...|+||||+.+++|.+++.. ....+++..+..++.||+.||.|||++|++||||
T Consensus 62 ~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl 133 (270)
T cd05056 62 RQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQV-------NKYSLDLASLILYSYQLSTALAYLESKRFVHRDI 133 (270)
T ss_pred HhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 99999999999998875 557899999999999999975 2345899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||+++.++.++|+|||++..+...... ......+++.|+|||.+.... ++.++||||||+++|+|++ |..|
T Consensus 134 ~p~nili~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p 208 (270)
T cd05056 134 AARNVLVSSPDCVKLGDFGLSRYLEDESYY----KASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKP 208 (270)
T ss_pred ChheEEEecCCCeEEccCceeeecccccce----ecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999998766432111 111223456899999886554 8999999999999999996 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|......+.............. ..++..+.++|.+||..+|.+|||+.+++..
T Consensus 209 f~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 209 FQGVKNNDVIGRIENGERLPMP---------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CCCCCHHHHHHHHHcCCcCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9888776666555444333221 3467889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=319.59 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=198.1
Q ss_pred CCCeEEEeeeeecCceEEEEEEE----cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYC----KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
...|++++.||+|+||.||+|.. ..++..||+|.++ ........+.+.+|+.++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~----------------------~~~~~~~~~~~~~e~~~l 60 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK----------------------PESGGNHIADLKKEIEIL 60 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcC----------------------ccccHHHHHHHHHHHHHH
Confidence 35689999999999999999975 3456666666543 222233456789999999
Q ss_pred hcCCCCCceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 104 SSCHHENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+.++||||+++++++... ...++||||++|++|.+++.. ....+++..+..++.||+.||.|||++|++||
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-------~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~ 133 (284)
T cd05079 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-------NKNKINLKQQLKYAVQICKGMDYLGSRQYVHR 133 (284)
T ss_pred HhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999999999998865 578999999999999999964 23468999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+||+++.++.++|+|||++..+...... ........|+..|+|||.+.+.. ++.++|||||||++|+|+|+..
T Consensus 134 dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~ 210 (284)
T cd05079 134 DLAARNVLVESEHQVKIGDFGLTKAIETDKEY--YTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCD 210 (284)
T ss_pred ccchheEEEcCCCCEEECCCccccccccCccc--eeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCC
Confidence 99999999999999999999999876433221 11223456778899999987654 8899999999999999999876
Q ss_pred CCCCCcH--------------HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 262 PYHKYPA--------------MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 262 Pf~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|+..... .......+... ... .....++..+.+||.+||+++|.+|||+.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 211 SESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG-KRL-------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CCccccchhhhhcccccccccHHHHHHHHHcC-ccC-------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 6432110 00001111110 000 0113467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=318.46 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=194.8
Q ss_pred CCe-EEEeeeeecCceEEEEEEE----cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 29 DQY-EVREVIGFGATAVVHSAYC----KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 29 ~~Y-~i~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
++| ++.+.||+|+||+||++.. ..++..||+|.++ ........+.+.+|+.++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~----------------------~~~~~~~~~~~~~E~~~l 60 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK----------------------RECGQQNTSGWKKEINIL 60 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEec----------------------cccChHHHHHHHHHHHHH
Confidence 445 9999999999999988653 3456667777553 221122345688999999
Q ss_pred hcCCCCCceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 104 SSCHHENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
++++||||+++++++... ..+++||||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~ 131 (283)
T cd05080 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---------HKLNLAQLLLFAQQICEGMAYLHSQHYIHR 131 (283)
T ss_pred HhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH---------cCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 999999999999988753 468999999999999999963 358999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||+++++.++|+|||++..+..+... ........++..|+|||.+.+.. ++.++||||||+++|+|+||..
T Consensus 132 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~ 208 (283)
T cd05080 132 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY--YRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCD 208 (283)
T ss_pred ccChheEEEcCCCcEEEeecccccccCCcchh--hccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCC
Confidence 99999999999999999999998766432211 11112234567799999987655 8999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCc--------hhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGA--------AEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
||......... ............. ........++..+.+++.+||+++|++|||+.+++.
T Consensus 209 p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 209 SKQSPPKKFEE--MIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCcchhhh--hhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 98654321110 0000000000000 000012345789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=315.75 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=196.6
Q ss_pred eeeeecCceEEEEEEEcCCCce--EEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CCCCc
Q psy11359 35 EVIGFGATAVVHSAYCKARAEK--CAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENV 111 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~HpnI 111 (520)
+.||+|+||.||+|.++.++.. +|+|.++ ........+.+.+|++++.++ +||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~----------------------~~~~~~~~~~~~~E~~~l~~l~~h~~i 58 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----------------------EYASKDDHRDFAGELEVLCKLGHHPNI 58 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcc----------------------ccCCHHHHHHHHHHHHHHHhhccCCCe
Confidence 4689999999999999887653 4555442 212233456788999999999 89999
Q ss_pred eEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--------cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--------NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 112 v~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--------~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+++++++.....+|+||||+.+++|.+++....... ......+++..+..++.||+.||+|||++|++||||
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~di 138 (270)
T cd05047 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 138 (270)
T ss_pred eeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 999999999999999999999999999997532110 012235889999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+|||++.++.+||+|||++...... ........++.|+|||++.... ++.++|||||||++|+|++ |..|
T Consensus 139 kp~nili~~~~~~kl~dfgl~~~~~~~------~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~p 211 (270)
T cd05047 139 AARNILVGENYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTP 211 (270)
T ss_pred ccceEEEcCCCeEEECCCCCccccchh------hhccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999987532110 0011123356799999986554 8999999999999999997 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|..................... ..++..+.+++.+||..+|.+|||+.+++.
T Consensus 212 f~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 212 YCGMTCAELYEKLPQGYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ccccCHHHHHHHHhCCCCCCCC---------CcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 9877665555444333222111 235678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=347.71 Aligned_cols=266 Identities=21% Similarity=0.354 Sum_probs=220.0
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
...+-+..+.||+|+||.||+|+...-. +......||||.++.........+|+||+.+|..|
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~-----------------p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l 546 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLL-----------------PGQDEQLVAVKALKDKAENQARQDFRREAELLAEL 546 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCC-----------------CCccceehhHhhhcccccHHHHHHHHHHHHHHHhc
Confidence 3445678899999999999999775532 11114456666666666566788999999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccC--C----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC--K----HGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~--~----~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+|||||++++++..++.+++|+||+..|+|.++++.+...... . ...++..+...|+.||+.|++||-++.+||
T Consensus 547 ~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVH 626 (774)
T KOG1026|consen 547 QHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVH 626 (774)
T ss_pred cCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccc
Confidence 9999999999999999999999999999999999865443322 1 344899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-C
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G 259 (520)
|||-..|.||+++-.|||+|||+++-..+...+ ++...-.-...|||||.+..+. ++.++|||||||+|||+++ |
T Consensus 627 RDLATRNCLVge~l~VKIsDfGLsRdiYssDYY---k~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 627 RDLATRNCLVGENLVVKISDFGLSRDIYSSDYY---KVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYG 702 (774)
T ss_pred cchhhhhceeccceEEEecccccchhhhhhhhh---cccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccc
Confidence 999999999999999999999999765332221 1111223356899999998877 9999999999999999998 9
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
+.||.+..+.+++..+-++.-- .....++.++..|+..||+..|++||++.||=
T Consensus 703 ~QPy~glSn~EVIe~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 703 KQPYYGLSNQEVIECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCcccccchHHHHHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 9999999999999887776532 22357889999999999999999999999983
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.10 Aligned_cols=248 Identities=26% Similarity=0.466 Sum_probs=201.2
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|-...++|++.+.||+|+||.||++. .+++.||+|.++.. ...+.+.+|+.++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-------------------------~~~~~~~~e~~~l 53 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-------------------------VTAQAFLEETAVM 53 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-------------------------chHHHHHHHHHHH
Confidence 34456789999999999999999985 35667777765321 1235688999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++++||||+++++++..+ ..++||||+.+++|.+++... ....+++..+..++.|++.||.|||++|++||||
T Consensus 54 ~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl 126 (254)
T cd05083 54 TKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTR------GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126 (254)
T ss_pred HhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhc------CcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 999999999999988654 579999999999999999753 3346889999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+||+++.++.++|+|||++....... .....+..|+|||.+.+.. ++.++|+|||||++|+|++ |.+|
T Consensus 127 ~p~nili~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p 197 (254)
T cd05083 127 AARNILVSEDGVAKVSDFGLARVGSMGV--------DNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAP 197 (254)
T ss_pred CcceEEEcCCCcEEECCCccceeccccC--------CCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999986542211 1223456899999887554 8999999999999999997 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|......+.......+..+.. ...++..+.+++.+||+.+|.+|||+.+++.
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 198 YPKMSLKEVKECVEKGYRMEP---------PEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CccCCHHHHHHHHhCCCCCCC---------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 988776655554443322211 1346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=335.99 Aligned_cols=270 Identities=26% Similarity=0.437 Sum_probs=235.6
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
-.+.+++..||-||||.|=++..+.....+|+|++++..+.+ +...+.+..|-++|..++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd--------------------tkQqeHv~sEr~Im~~~~ 478 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD--------------------TKQQEHVFSERNIMMECR 478 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc--------------------hhHHHHHHhHHHHHHhcC
Confidence 355778889999999999999888776678888776543221 345678899999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
.|.||++|-.|.+++.+|+.||-|-||.|+..++ ..+.|++...+-++..+++|++|||++|||+|||||+|
T Consensus 479 s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLr--------dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPEN 550 (732)
T KOG0614|consen 479 SDFIVRLYRTFRDSKYVYMLMEACLGGELWTILR--------DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPEN 550 (732)
T ss_pred chHHHHHHHHhccchhhhhhHHhhcCchhhhhhh--------hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhh
Confidence 9999999999999999999999999999999998 56889999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
.+++.+|-+||.|||+|..+.++.. .-+|||||.|.|||++... +.+.++|.||||+++|||+||.+||.+.+
T Consensus 551 llLd~~Gy~KLVDFGFAKki~~g~K------TwTFcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 551 LLLDNRGYLKLVDFGFAKKIGSGRK------TWTFCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred eeeccCCceEEeehhhHHHhccCCc------eeeecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999999999999999998875543 4589999999999999764 48999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchhhHHHhhh
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDKKFIQQTL 340 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~~~~~~ 340 (520)
++..+..++.+--. ...++.+++...+||.++...+|.+|.- +.++-+|.||...++.......+
T Consensus 624 pmktYn~ILkGid~--------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L 693 (732)
T KOG0614|consen 624 PMKTYNLILKGIDK--------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTL 693 (732)
T ss_pred hHHHHHHHHhhhhh--------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccC
Confidence 99999988876321 2223567788999999999999999976 89999999999988876555544
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.36 Aligned_cols=249 Identities=28% Similarity=0.448 Sum_probs=199.6
Q ss_pred eeeeecCceEEEEEEEcCC-Cc--eEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCc
Q psy11359 35 EVIGFGATAVVHSAYCKAR-AE--KCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENV 111 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~-g~--~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnI 111 (520)
++||+|++|+||+|.+... ++ .||+|.++ ........+.+.+|+.++++++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~----------------------~~~~~~~~~~~~~e~~~l~~l~h~~i 58 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK----------------------SDKLSDIMDDFLKEAAIMHSLDHENL 58 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecC----------------------CcccHHHHHHHHHHHHHHhhcCCCCc
Confidence 4789999999999998663 22 46666553 22222456678999999999999999
Q ss_pred eEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEc
Q psy11359 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191 (520)
Q Consensus 112 v~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~ 191 (520)
+++++++.. ...++||||+.+++|.+++... ....+++..+..++.||+.||.|||++|++||||||+||+++
T Consensus 59 v~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~ 131 (257)
T cd05040 59 IRLYGVVLT-HPLMMVTELAPLGSLLDRLRKD------ALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA 131 (257)
T ss_pred cceeEEEcC-CeEEEEEEecCCCcHHHHHHhc------ccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe
Confidence 999999988 8999999999999999999753 115689999999999999999999999999999999999999
Q ss_pred CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHH
Q psy11359 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMK 270 (520)
Q Consensus 192 ~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~ 270 (520)
.++.+||+|||++..+...... ........++..|+|||.+.... ++.++|||||||++|+|++ |..||......+
T Consensus 132 ~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 208 (257)
T cd05040 132 SDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208 (257)
T ss_pred cCCEEEeccccccccccccccc--eecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999876442221 11112345778899999987655 8999999999999999999 999998776666
Q ss_pred HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
......... .... ....++..+.+++.+||+.+|++|||+.+++.
T Consensus 209 ~~~~~~~~~-~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 209 ILKKIDKEG-ERLE-------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHhcC-CcCC-------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 554443211 1111 11245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=311.04 Aligned_cols=247 Identities=32% Similarity=0.497 Sum_probs=207.7
Q ss_pred eeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEEE
Q psy11359 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHT 116 (520)
Q Consensus 37 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~~ 116 (520)
||.|+||.||++.+..+++.+|+|+++..... .....+.+.+|+.++++++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~--------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 60 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII--------------------KRKEVEHTLTERNILSRINHPFIVKLHY 60 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc--------------------chHHHHHHHHHHHHHHHcCCCcHHHHHH
Confidence 69999999999999999999999987543211 0124567899999999999999999999
Q ss_pred EEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCe
Q psy11359 117 SFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196 (520)
Q Consensus 117 ~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~v 196 (520)
.+..+...++||||+.+++|.+++.. .+.+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.+
T Consensus 61 ~~~~~~~~~~v~e~~~~~~L~~~l~~--------~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~ 132 (250)
T cd05123 61 AFQTEEKLYLVLEYAPGGELFSHLSK--------EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHI 132 (250)
T ss_pred HeecCCeeEEEEecCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcE
Confidence 99999999999999999999999974 3468999999999999999999999999999999999999999999
Q ss_pred EEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh
Q psy11359 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTL 276 (520)
Q Consensus 197 kL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~ 276 (520)
+|+|||++....... .......++..|+|||...+.. ++.++|+||||+++|+|++|..||.............
T Consensus 133 ~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 206 (250)
T cd05123 133 KLTDFGLAKELSSEG-----SRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL 206 (250)
T ss_pred EEeecCcceecccCC-----CcccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 999999987654321 1123457889999999987655 7889999999999999999999998777655554444
Q ss_pred cCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH---HHHhcCccc
Q psy11359 277 QNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA---SELLKNPFF 327 (520)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta---~elL~hp~~ 327 (520)
... ..++ ...+..+.++|.+||..||++|||+ .++++||||
T Consensus 207 ~~~-~~~~---------~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 207 KDP-LRFP---------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred cCC-CCCC---------CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 422 1121 2347789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.05 Aligned_cols=263 Identities=24% Similarity=0.363 Sum_probs=208.7
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
..+|+++.++|+|.||.|-.+.+..++..||+|+++-- ....+..+-|+++|.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------------------------~kYreAa~iEi~vLqki~ 143 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------------------------DKYREAALIEIEVLQKIN 143 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------------------------HHHhhHHHHHHHHHHHHH
Confidence 67899999999999999999999999999999987521 223455677999999993
Q ss_pred C--CC----ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 108 H--EN----VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 108 H--pn----Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+ |+ +|.+.++|...+++|||+|.+ |.|++++++.. +...++...++.+++||++++.|||+++++|-
T Consensus 144 ~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N------~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HT 216 (415)
T KOG0671|consen 144 ESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN------NYIPFPIDHIRHMGYQLLESVAFLHDLKLTHT 216 (415)
T ss_pred hcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccC------CccccchHHHHHHHHHHHHHHHHHHhcceeec
Confidence 2 33 788889999999999999999 78999999864 55679999999999999999999999999999
Q ss_pred ccCCCcEEEcC--------------------CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCC
Q psy11359 182 DIKAGNILLGE--------------------DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD 241 (520)
Q Consensus 182 DLKp~NILl~~--------------------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ 241 (520)
||||+|||+.+ +..|+|+|||.|+.-. ....+.+.|..|+|||++.+-. ++
T Consensus 217 DLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~--------e~hs~iVsTRHYRAPEViLgLG-wS 287 (415)
T KOG0671|consen 217 DLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH--------EHHSTIVSTRHYRAPEVILGLG-WS 287 (415)
T ss_pred CCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec--------cCcceeeeccccCCchheeccC-cC
Confidence 99999999932 2248999999987642 1225678999999999998754 99
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCcHHHHH---HHHhcCCCCCCCCCc-----------------h----------hhh
Q psy11359 242 FKADIWSLGITAIEMATGTAPYHKYPAMKVL---MLTLQNDPPTLDTGA-----------------A----------EKD 291 (520)
Q Consensus 242 ~~~DIwSlG~il~elltG~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~-----------------~----------~~~ 291 (520)
..+||||+||||+|++||...|....+.+.+ ..+++..|....... . .+.
T Consensus 288 ~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckp 367 (415)
T KOG0671|consen 288 QPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKP 367 (415)
T ss_pred CccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCcc
Confidence 9999999999999999999999887765533 223332221111000 0 000
Q ss_pred hH------HHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 292 QY------KAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 292 ~~------~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.. ..-..++.+||++||.+||.+|+|+.|+|.||||+..
T Consensus 368 l~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 368 LKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 00 0112458899999999999999999999999999754
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=338.29 Aligned_cols=245 Identities=30% Similarity=0.453 Sum_probs=206.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..+.|++...+|.|+|++|..+.+..+++..++|++... ..+..+|+.++...
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---------------------------~~~~~~e~~~~~~~ 372 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---------------------------ADDNQDEIPISLLV 372 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc---------------------------ccccccccchhhhh
Confidence 467899999999999999999999999888888877432 11234566555555
Q ss_pred -CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 -HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 -~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+||||+++++++.+..+.|+|||++.|+-|.+.|.. ...+. .++..|+.||+.++.|||.+|+|||||||
T Consensus 373 ~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~--------~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp 443 (612)
T KOG0603|consen 373 RDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS--------KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKP 443 (612)
T ss_pred cCCCcceeecceecCCceeeeeehhccccHHHHHHHh--------cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCCh
Confidence 899999999999999999999999999999988863 23333 78889999999999999999999999999
Q ss_pred CcEEE-cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 186 GNILL-GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 186 ~NILl-~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
+|||+ ++.|+++|+|||.++.+... ..+.+-|..|.|||++.. .+|++++||||||++||+|++|..||.
T Consensus 444 ~NIL~~~~~g~lrltyFG~a~~~~~~--------~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~ 514 (612)
T KOG0603|consen 444 GNILLDGSAGHLRLTYFGFWSELERS--------CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFA 514 (612)
T ss_pred hheeecCCCCcEEEEEechhhhCchh--------hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccc
Confidence 99999 69999999999998765422 223356788999999984 459999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
..+....++..++..+.. ..+|..+++||.+||+.||.+|+++.+++.||||
T Consensus 515 ~~P~~~ei~~~i~~~~~s-----------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 515 AHPAGIEIHTRIQMPKFS-----------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cCCchHHHHHhhcCCccc-----------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 888876666555442221 5678999999999999999999999999999999
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.82 Aligned_cols=252 Identities=20% Similarity=0.345 Sum_probs=191.3
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~ 114 (520)
+.||+|+||.||+|............ ........+++|.+.... ......+.+|+.+++.++||||+++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~----------~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~ 69 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDG----------YSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLL 69 (262)
T ss_pred CccccCCcceEeeeecccCCCccccc----------cchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeE
Confidence 47899999999999754332111000 000113345566554322 2334568889999999999999999
Q ss_pred EEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCC
Q psy11359 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194 (520)
Q Consensus 115 ~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g 194 (520)
++++..+...++||||+.+++|..++.. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 70 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~ 142 (262)
T cd05077 70 YGVCVRDVENIMVEEFVEFGPLDLFMHR-------KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREG 142 (262)
T ss_pred EEEEecCCCCEEEEecccCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCC
Confidence 9999999999999999999999988864 345689999999999999999999999999999999999998766
Q ss_pred C-------eEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH-hCCCCCCCC
Q psy11359 195 T-------VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA-TGTAPYHKY 266 (520)
Q Consensus 195 ~-------vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell-tG~~Pf~~~ 266 (520)
. ++++|||++..+.. .....|++.|+|||.+.....++.++|||||||++|+|+ +|..||...
T Consensus 143 ~~~~~~~~~~l~d~g~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 143 IDGECGPFIKLSDPGIPITVLS---------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred ccCCCCceeEeCCCCCCccccC---------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 4 89999998865421 123467889999999875555899999999999999998 588998765
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
...+.... ....... ....+.++.+||.+||+.||.+||++.+++++
T Consensus 214 ~~~~~~~~-~~~~~~~----------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 214 TLAEKERF-YEGQCML----------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred chhHHHHH-HhcCccC----------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 54333221 1111111 01234678999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=313.05 Aligned_cols=256 Identities=19% Similarity=0.278 Sum_probs=194.1
Q ss_pred eeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEE
Q psy11359 36 VIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYH 115 (520)
Q Consensus 36 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~ 115 (520)
.||+|+||+||++.....+. + ..+++|.+.........+.+.+|+.+++.++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~-~-------------------~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 61 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTG-V-------------------ARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61 (268)
T ss_pred cCCCCcCceEEEEEEEcCCC-c-------------------ceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheE
Confidence 69999999999997544321 1 122333333332233456799999999999999999999
Q ss_pred EEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCC
Q psy11359 116 TSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195 (520)
Q Consensus 116 ~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~ 195 (520)
+.+......|+||||+.+|+|.+++..... ....+++..+..++.||+.||.|||+++++||||||+|||++.++.
T Consensus 62 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~ 137 (268)
T cd05086 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQW----HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT 137 (268)
T ss_pred EEecCCCccEEEEecCCCCcHHHHHHhhhc----ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc
Confidence 999999999999999999999999975322 2345677889999999999999999999999999999999999999
Q ss_pred eEEeccCcceeeccCccccccccccccccccccCCcceeccc------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCcH
Q psy11359 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD------HGYDFKADIWSLGITAIEMAT-GTAPYHKYPA 268 (520)
Q Consensus 196 vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~ 268 (520)
++|+|||++....... .........|++.|+|||++... ..++.++|||||||++|+|++ |..||.....
T Consensus 138 ~~l~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 214 (268)
T cd05086 138 VKVGDYGIGPSRYKED---YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214 (268)
T ss_pred EEecccccccccCcch---hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999875432111 11112345688999999997532 125789999999999999997 6789987777
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.+.+...+......+... .....+++.+.+++..|| .+|.+|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 215 REVLNHVIKDQQVKLFKP----QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHhhcccccCCC----ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 666665554433222111 111346788999999999 57999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=308.84 Aligned_cols=246 Identities=26% Similarity=0.387 Sum_probs=199.7
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~ 114 (520)
++||.|+||.||+|.+.. ++.||+|.+.... .....+.+.+|+.++++++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~----------------------~~~~~~~~~~e~~~l~~l~~~~i~~~ 57 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTL----------------------PPDLKRKFLQEAEILKQYDHPNIVKL 57 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccC----------------------CHHHHHHHHHHHHHHHhCCCCCeEEE
Confidence 479999999999999988 8889988764321 12234578999999999999999999
Q ss_pred EEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCC
Q psy11359 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194 (520)
Q Consensus 115 ~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g 194 (520)
++++......|+||||+.|++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+|||++.++
T Consensus 58 ~~~~~~~~~~~~v~e~~~~~~l~~~l~~-------~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~ 130 (251)
T cd05041 58 IGVCVQKQPIYIVMELVPGGSLLTFLRK-------KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN 130 (251)
T ss_pred EEEEecCCCeEEEEEcCCCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC
Confidence 9999999999999999999999999975 345678999999999999999999999999999999999999999
Q ss_pred CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q psy11359 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLM 273 (520)
Q Consensus 195 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~ 273 (520)
.++|+|||++......... .......++..|+|||.+.+.. ++.++|+||||+++|+|+| |..||..........
T Consensus 131 ~~~l~d~g~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~ 206 (251)
T cd05041 131 VLKISDFGMSREEEGGIYT---VSDGLKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE 206 (251)
T ss_pred cEEEeeccccccccCCcce---eccccCcceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH
Confidence 9999999998755322111 0011223456799999987655 8999999999999999999 899998776655444
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.......... ...++..+.+++.+||..+|.+|||+.|+++
T Consensus 207 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 207 RIESGYRMPA---------PQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHhcCCCCCC---------CccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 4333221111 1345778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=308.97 Aligned_cols=251 Identities=27% Similarity=0.445 Sum_probs=205.5
Q ss_pred eEEEeeeeecCceEEEEEEEcCCC----ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARA----EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
+++.+.||.|+||.||++.+..++ ..||+|.++ ........+.+.+|+..++.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~----------------------~~~~~~~~~~~~~e~~~l~~l 58 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLK----------------------EDADEQQIEEFLREARIMRKL 58 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEcc----------------------CCCChHHHHHHHHHHHHHHhc
Confidence 357789999999999999998876 666666553 222222456789999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+|+||+++++++...+..+++|||+.+++|.+++... ....+++..+..++.||+.||.|||++|++||||||+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~ 132 (258)
T smart00219 59 DHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKN------RPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAAR 132 (258)
T ss_pred CCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhh------hhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccc
Confidence 9999999999999999999999999999999999752 1122899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHK 265 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~ 265 (520)
||+++.++.++|+|||++........... ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |.+||..
T Consensus 133 nil~~~~~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 133 NCLVGENLVVKISDFGLSRDLYDDDYYKK----KGGKLPIRWMAPESLKDGK-FTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred eEEEccCCeEEEcccCCceeccccccccc----ccCCCcccccChHHhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999877654321111 0123678999999985544 8999999999999999998 8999988
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
................... ..++..+.+++.+||..+|++|||+.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 208 MSNEEVLEYLKKGYRLPKP---------ENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCHHHHHHHHhcCCCCCCC---------CcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 7766666555544433222 236788999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=311.34 Aligned_cols=273 Identities=29% Similarity=0.494 Sum_probs=223.9
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.|+.+.++.+-+..||.|+||+|++..++++|+..|+|.++.. ....+..+++.|...
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~----------------------n~~keq~rll~e~d~ 115 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSN----------------------NIEKEQKRLLMEHDT 115 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeec----------------------cchHHHHHHHHHHHH
Confidence 3666777778888999999999999999999888888877532 223456778888877
Q ss_pred Hh-cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEe
Q psy11359 103 MS-SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN-GQIH 180 (520)
Q Consensus 103 l~-~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~-giiH 180 (520)
.. .-+.||||+||+..-.++..|+.||++ ..||..+-+..... +...++|..+-.|......||.||... +|||
T Consensus 116 ~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~v---q~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIH 191 (361)
T KOG1006|consen 116 VMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSV---QKSRIPENILGHITVATVDALDYLKEELKIIH 191 (361)
T ss_pred HHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHH---HhccCcHhhhhheeeeehhHHHHHHHHhhhhh
Confidence 54 558999999999999999999999999 46776655432222 456789999999999999999999765 8999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC-CCCcchhHHHHHHHHHHHHhC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH-GYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~DIwSlG~il~elltG 259 (520)
||+||.|||++..|.+||||||.+..+..+-. ...-.|...|||||.+.... +|+-++|+||||++|||+.||
T Consensus 192 RDvKPSNILldr~G~vKLCDFGIcGqLv~SiA------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG 265 (361)
T KOG1006|consen 192 RDVKPSNILLDRHGDVKLCDFGICGQLVDSIA------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATG 265 (361)
T ss_pred ccCChhheEEecCCCEeeecccchHhHHHHHH------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecC
Confidence 99999999999999999999999876632211 12346888999999987543 599999999999999999999
Q ss_pred CCCCCCCcH-HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 260 TAPYHKYPA-MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 260 ~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
..||.+... .+++-.+..+++|.+...... ..++..+..||..||.+|-+.||...+++++||++...
T Consensus 266 ~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~----~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 266 NFPYRKWDSVFEQLCQVVIGDPPILLFDKEC----VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred CCCcchHHHHHHHHHHHHcCCCCeecCcccc----cccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 999987654 567777888888877654322 35788999999999999999999999999999998654
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=313.03 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=195.9
Q ss_pred CCCeEEEeeeeecCceEEEEEE----EcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 28 EDQYEVREVIGFGATAVVHSAY----CKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
..+|++.+.||+|+||+||+|. +..++..||+|.+... .....+.+.+|++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----------------------~~~~~~~~~~e~~~l 59 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----------------------TAEHLRDFEREIEIL 59 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----------------------CHHHHHHHHHHHHHH
Confidence 4589999999999999999997 4456777777765321 123356788999999
Q ss_pred hcCCCCCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 104 SSCHHENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
++++||||+++++++.. ...+++||||+.+++|.+++.. ....+++..+..++.||+.||.|||++|++||
T Consensus 60 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~ 132 (284)
T cd05081 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK-------HRERLDHRKLLLYASQICKGMEYLGSKRYVHR 132 (284)
T ss_pred HhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHh-------cCcCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 99999999999998754 3568999999999999999964 23468999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+||+++.++.++|+|||++..+....... .......++..|+|||++.+.. ++.++|||||||++|+|++|..
T Consensus 133 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~ 209 (284)
T cd05081 133 DLATRNILVESENRVKIGDFGLTKVLPQDKEYY--KVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSD 209 (284)
T ss_pred cCCHhhEEECCCCeEEECCCcccccccCCCcce--eecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCC
Confidence 999999999999999999999998764322110 1111223445699999987655 8999999999999999999887
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCC---------chhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTG---------AAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|+...... ............... .........++..+.+||.+||..+|++|||+.++++
T Consensus 210 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 210 KSCSPPAE--FMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred cCCCcchh--hhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 76433211 111111100000000 0000011345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=312.45 Aligned_cols=253 Identities=24% Similarity=0.401 Sum_probs=199.3
Q ss_pred eeeeecCceEEEEEEEcCCC------ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 35 EVIGFGATAVVHSAYCKARA------EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g------~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
+.||+|+||.||+|.+.... ..+|+|.+. ..........+.+|+.+++.++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~----------------------~~~~~~~~~~~~~e~~~l~~l~h 58 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR----------------------KGATDQEKKEFLKEAHLMSNFNH 58 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhh----------------------cccchhhHHHHHHHHHHHHhcCC
Confidence 36899999999999886543 456666442 21112345678899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+..++||||+.+++|.+++........ ....+++..+..++.||+.||.|||+++++|+||||+||
T Consensus 59 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni 137 (269)
T cd05044 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERF-GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNC 137 (269)
T ss_pred CCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhccc-CCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheE
Confidence 9999999999999999999999999999999975422110 234578999999999999999999999999999999999
Q ss_pred EEcCCC-----CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 189 LLGEDG-----TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 189 Ll~~~g-----~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
+++.++ .++|+|||++..+...... .......++..|+|||.+.+.. ++.++|||||||++|+|+| |..|
T Consensus 138 l~~~~~~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 138 LVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred EEecCCCCCCcceEECCccccccccccccc---ccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCC
Confidence 998877 8999999998765332211 1112335678899999987665 8999999999999999998 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|.................... ...++..+.++|.+||.++|.+||++.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 214 YPALNNQEVLQHVTAGGRLQK---------PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CcccCHHHHHHHHhcCCccCC---------cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 987766665544433222211 1345778999999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.15 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=194.1
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
+.|.-..+||+|+||+||+|..... +.||||.+. ...... ..+|.+|+.++.+++|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~----------------------~~~~~~-~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLS----------------------SNSGQG-EREFLNEVEILSRLRH 130 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-CEEEEEEec----------------------CCCCcc-hhHHHHHHHHHhcCCC
Confidence 4566678999999999999987653 666766543 222121 4569999999999999
Q ss_pred CCceEEEEEEEECC-EEEEEEEccCCCCHHHHHHHhhccccCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccc
Q psy11359 109 ENVVTYHTSFVVKD-ELWLVLRLLEGGSLLDIIKHRLKISNCKHG-VCDEPTIATVLREVLKGLEYFHSNG---QIHRDI 183 (520)
Q Consensus 109 pnIv~~~~~~~~~~-~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~-~l~~~~i~~i~~qIl~gL~yLH~~g---iiHrDL 183 (520)
||+|+++++|.+.+ +.+||+||+..|+|.+++... .. .++|....+|+.++++||+|||... ||||||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~-------~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDi 203 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGK-------KGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDI 203 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCC-------CCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCC
Confidence 99999999999988 599999999999999999752 23 8899999999999999999999964 999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCcccccccccccc-ccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTF-VGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
||.|||++++.++||+|||+|...... .....+. .||.+|+|||.+.... .+.++||||||++|+||+||+.|
T Consensus 204 KssNILLD~~~~aKlsDFGLa~~~~~~-----~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~ 277 (361)
T KOG1187|consen 204 KSSNILLDEDFNAKLSDFGLAKLGPEG-----DTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKA 277 (361)
T ss_pred CHHHeeECCCCCEEccCccCcccCCcc-----ccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcc
Confidence 999999999999999999999654320 1111122 7999999999997655 89999999999999999999988
Q ss_pred CCCCc------HHHHHHHHhcCC--CCCCCCCchhhhhHH--HhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYP------AMKVLMLTLQND--PPTLDTGAAEKDQYK--AYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~------~~~~~~~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
..... -.......+... ...++..... ..+. ..-..+..+..+|++.+|.+||++.|+++
T Consensus 278 ~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 278 VDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred cCCCCCcccccHHHHHHHHHHCcchhheeCCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 76432 111111222221 1111111110 1111 12233667888999999999999999854
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=308.32 Aligned_cols=247 Identities=19% Similarity=0.318 Sum_probs=189.8
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~ 114 (520)
+.||+|+||.||+|.+..++........ ....+++|.+..... ....+.+|+.+++.++||||+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~------------~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~ 66 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPG------------QEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKL 66 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCc------------cceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhhe
Confidence 4799999999999999887632111000 012333443332211 15678899999999999999999
Q ss_pred EEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCC
Q psy11359 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194 (520)
Q Consensus 115 ~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g 194 (520)
++++.. ...++||||+.+++|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 67 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~ 138 (259)
T cd05037 67 YGVCVR-DENIMVEEYVKFGPLDVFLHRE-------KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYG 138 (259)
T ss_pred eeEEec-CCcEEEEEcCCCCcHHHHHHhh-------ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCc
Confidence 999888 7789999999999999999752 23689999999999999999999999999999999999998877
Q ss_pred -------CeEEeccCcceeeccCccccccccccccccccccCCcceeccc-CCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy11359 195 -------TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEMAT-GTAPYHK 265 (520)
Q Consensus 195 -------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DIwSlG~il~ellt-G~~Pf~~ 265 (520)
.+||+|||++..+.. .....++..|+|||++.+. ..++.++||||||+++|+|++ |..||..
T Consensus 139 ~~~~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~ 209 (259)
T cd05037 139 LNEGYVPFIKLSDPGIPITVLS---------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209 (259)
T ss_pred cccCCceeEEeCCCCccccccc---------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence 799999999876532 1234567889999998765 358999999999999999999 6888876
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.................. .....+.++|.+||..+|.+|||+.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 210 LSSSEKERFYQDQHRLPM-----------PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCchhHHHHHhcCCCCCC-----------CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 643332222211111110 11267899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.43 Aligned_cols=273 Identities=19% Similarity=0.264 Sum_probs=192.6
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCC---CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKAR---AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
...++|++.++||+|+||+||+|.+..+ +..+|+|+..... +..+....... .........++..
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~----------~~~~~e~~~~~--~~~~~~~~~~~~~ 76 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN----------ETIVMETLVYN--NIYDIDKIALWKN 76 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC----------CchhhHHHHHH--hhhhHHHHHHHHH
Confidence 4557899999999999999999999887 6667777543210 00000000000 0001123344556
Q ss_pred HhcCCCCCceEEEEEEEECC----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 103 MSSCHHENVVTYHTSFVVKD----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
+..+.|+||+++++++.... ..+++++++ ..++.+.+.. ...+++..+..++.||+.||.|||++++
T Consensus 77 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~i 147 (294)
T PHA02882 77 IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR--------IKCKNKKLIKNIMKDMLTTLEYIHEHGI 147 (294)
T ss_pred hccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh--------hccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 67789999999998776543 357888887 4577777753 2345788999999999999999999999
Q ss_pred EecccCCCcEEEcCCCCeEEeccCcceeeccCcccc--ccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLS--RQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 179 iHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
+||||||+|||++.++.++|+|||+|+.+....... .........||+.|+|||++.+.. ++.++|||||||++|+|
T Consensus 148 iHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el 226 (294)
T PHA02882 148 SHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKW 226 (294)
T ss_pred ecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHH
Confidence 999999999999999999999999998764322111 111223457999999999987665 89999999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHhcCC-CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 257 ATGTAPYHKYPAMKVLMLTLQND-PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 257 ltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
++|.+||................ ...+.. ........++.+.+++..|+..+|++||++.++++
T Consensus 227 ~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 227 AGIKLPWKGFGHNGNLIHAAKCDFIKRLHE---GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhCCCCCCccccchHHHHHhHHHHHHHhhh---hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 99999998763322111100000 000000 01112345788999999999999999999999975
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.62 Aligned_cols=263 Identities=26% Similarity=0.437 Sum_probs=209.2
Q ss_pred CeEEEeeeeecCceEEEEEEEcC-CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc-CC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKA-RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS-CH 107 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~-l~ 107 (520)
.|++.+.||+|+||.||+|.+.. .++.+|+|.+........ .- .........++.+|+.++.+ ++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~------------~~-~~~~~~~~~~~~~e~~~l~~~~~ 67 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFG------------KD-KRERDKSIGDIVSEVTIIKEQLR 67 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccc------------cc-cccchHHHHHHHHHHHHHhhcCC
Confidence 48899999999999999999988 678899998754321110 00 00112345667889998875 79
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccCCC
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAG 186 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLKp~ 186 (520)
||||+++++++..++..++||||+.|++|.+++..... ....+++..++.++.|++.||.|||+ .|++|+||+|+
T Consensus 68 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ 143 (269)
T cd08528 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKE----KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN 143 (269)
T ss_pred CCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHH
Confidence 99999999999999999999999999999999864322 34578999999999999999999996 68999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
||+++.++.++|+|||++....... ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...
T Consensus 144 nil~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 144 NIMLGEDDKVTITDFGLAKQKQPES------KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred HEEECCCCcEEEecccceeeccccc------ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCccccc
Confidence 9999999999999999987654321 223457899999999997655 899999999999999999999999776
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
.................. ...+++.+.++|.+||+.||++|||+.|+..+
T Consensus 217 ~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 217 NMLSLATKIVEAVYEPLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CHHHHHHHHhhccCCcCC--------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 655544443333222111 12467889999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=307.03 Aligned_cols=229 Identities=24% Similarity=0.313 Sum_probs=186.6
Q ss_pred cCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEEEEEE
Q psy11359 40 GATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFV 119 (520)
Q Consensus 40 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~~~~~ 119 (520)
|.++.||+|.+..+++.||+|.++... ...+|...+....||||+++++++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------------------------~~~~~~~~~~~~~~~~i~~~~~~~~ 55 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------------------------EYSRERLTIIPHCVPNMVCLHKYIV 55 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----------------------------hhhhHHHHHHhcCCCceeehhhhee
Confidence 899999999999999999999875321 1233444555667999999999999
Q ss_pred ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEe
Q psy11359 120 VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199 (520)
Q Consensus 120 ~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~ 199 (520)
..+..++||||+.||+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+
T Consensus 56 ~~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~ 127 (237)
T cd05576 56 SEDSVFLVLQHAEGGKLWSHISK--------FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLT 127 (237)
T ss_pred cCCeEEEEEecCCCCCHHHHHHH--------hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 99999999999999999999974 3458999999999999999999999999999999999999999999999
Q ss_pred ccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC
Q psy11359 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND 279 (520)
Q Consensus 200 DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~ 279 (520)
|||.+..+... .....+++.|+|||.+.... ++.++|+||+|+++|+|++|..|+...+.... ..
T Consensus 128 df~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----~~- 192 (237)
T cd05576 128 YFSRWSEVEDS--------CDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSGIN-----TH- 192 (237)
T ss_pred cccchhccccc--------cccCCcCccccCCcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----cc-
Confidence 99987654321 12335677899999986554 78999999999999999999988754322100 00
Q ss_pred CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH-----HHHhcCccc
Q psy11359 280 PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA-----SELLKNPFF 327 (520)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~elL~hp~~ 327 (520)
.. ......+++.++++|.+||+.||++|||+ .++++||||
T Consensus 193 -~~-------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 193 -TT-------LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred -cc-------cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00 01113467889999999999999999996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=295.20 Aligned_cols=267 Identities=21% Similarity=0.400 Sum_probs=213.9
Q ss_pred CCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHH
Q psy11359 20 VSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKE 99 (520)
Q Consensus 20 ~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~E 99 (520)
..+.|. ..++|++.+++|+|-++.||.|.+..+.++|+||+++. -..+.+.+|
T Consensus 30 ~~i~wg-~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------------------------VkkkKIkRE 82 (338)
T KOG0668|consen 30 LVIDWG-NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------------------------VKKKKIKRE 82 (338)
T ss_pred eeeecc-ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------------------------HHHHHHHHH
Confidence 445675 77889999999999999999999999988999888751 224569999
Q ss_pred HHHHhcCC-CCCceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 100 IQAMSSCH-HENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 100 i~~l~~l~-HpnIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
+.+|..|. ||||++++++..+. ....||+||++..+...+.. .++...|+.++.||++||.|||++
T Consensus 83 ikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-----------tl~d~dIryY~~elLkALdyCHS~ 151 (338)
T KOG0668|consen 83 IKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP-----------TLTDYDIRYYIYELLKALDYCHSM 151 (338)
T ss_pred HHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh-----------hhchhhHHHHHHHHHHHHhHHHhc
Confidence 99999996 99999999998754 56889999998887766553 577899999999999999999999
Q ss_pred CcEecccCCCcEEEcC-CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGE-DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 177 giiHrDLKp~NILl~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
||+|||+||+|++|+. ...++|+|+|+|.++..+... ...+.+..|--||++..-+.|+..-|+|||||++..
T Consensus 152 GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~ 225 (338)
T KOG0668|consen 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 225 (338)
T ss_pred CcccccCCcceeeechhhceeeeeecchHhhcCCCcee------eeeeehhhcCCchheeechhccccHHHHHHHHHHHH
Confidence 9999999999999975 457999999999988665543 345678889999999887779999999999999999
Q ss_pred HHhCCCCC-CCCcHHHHHHHHh------------cCCCCCCCCCch---------------hhhhHHHhcHHHHHHHHhh
Q psy11359 256 MATGTAPY-HKYPAMKVLMLTL------------QNDPPTLDTGAA---------------EKDQYKAYGKTFRKMISDC 307 (520)
Q Consensus 256 lltG~~Pf-~~~~~~~~~~~~~------------~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~ 307 (520)
|+..+.|| ++.++.+++..+. ......++.... ..+...-.+++..||+.++
T Consensus 226 miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldkl 305 (338)
T KOG0668|consen 226 MIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKL 305 (338)
T ss_pred HHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHH
Confidence 99988886 5555555543221 111111111110 1111123468999999999
Q ss_pred hccCCCCCCCHHHHhcCcccccc
Q psy11359 308 LQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 308 L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
|..|..+|+||.|++.||||...
T Consensus 306 LrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 306 LRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HhhccccccchHHHhcCchHHHH
Confidence 99999999999999999999754
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=324.79 Aligned_cols=272 Identities=26% Similarity=0.397 Sum_probs=218.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
.+.-|..++.||-|+||.|.++....+...+|.|.+++..+... ........|-.||..-
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~r--------------------nQvaHVKAERDILAEA 686 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMR--------------------NQVAHVKAERDILAEA 686 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhh--------------------hhhhhhhhhhhhHhhc
Confidence 34568899999999999999999999988999998876554321 2344567788889999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+.+-||++|-+|.+++++|+||+|+.||++-.++- ..+.|.|..++-++..+..|++++|..|+|||||||+
T Consensus 687 Dn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLI--------rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPD 758 (1034)
T KOG0608|consen 687 DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI--------RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPD 758 (1034)
T ss_pred CCcceEEEEEEeccCCceEEEEeccCCccHHHHHH--------HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCcc
Confidence 99999999999999999999999999999999987 4688999999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCccee---------eccCcccc----------------------------ccccccccccccccC
Q psy11359 187 NILLGEDGTVQIADFGVSAW---------LATGRDLS----------------------------RQKVRHTFVGTPCWM 229 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~---------~~~~~~~~----------------------------~~~~~~~~~gt~~y~ 229 (520)
||||+.+|++||.|||++.- +..+.... +....+..+||+.|+
T Consensus 759 NILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyi 838 (1034)
T KOG0608|consen 759 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYI 838 (1034)
T ss_pred ceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCccc
Confidence 99999999999999999842 22211100 112235678999999
Q ss_pred CcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhc
Q psy11359 230 APEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQ 309 (520)
Q Consensus 230 APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 309 (520)
|||++... +|+..+|.||.|+|||||+.|++||....+.+..+.++. ....+.. ...-.+++++.+||.+++.
T Consensus 839 apevl~r~-g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n-w~~~l~~-----~~~~~ls~e~~~li~kLc~ 911 (1034)
T KOG0608|consen 839 APEVLART-GYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN-WRNFLHI-----PYQGNLSKEALDLIQKLCC 911 (1034)
T ss_pred ChHHhccc-CccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee-hhhcccc-----ccccccCHHHHHHHHHHhc
Confidence 99999754 599999999999999999999999987766554433221 1111111 1124578999999988775
Q ss_pred cCCCCCCC---HHHHhcCccccccchhh
Q psy11359 310 KDPTKRPT---ASELLKNPFFKKAKDKK 334 (520)
Q Consensus 310 ~dP~~Rpt---a~elL~hp~~~~~~~~~ 334 (520)
++++|.- ++++..||||+..+...
T Consensus 912 -sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 912 -SADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred -ChhhhhcccchhhhhcCccccccchHh
Confidence 6888854 67899999999887655
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=333.80 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=201.1
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
++.+.-|...+.||+||||.||+++++++|+.||||.++... .....+...+|+++|+
T Consensus 9 ~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----------------------~~r~~e~~~~Eieilk 66 (732)
T KOG4250|consen 9 SGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----------------------SLRPRERWCREIEILK 66 (732)
T ss_pred cCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc----------------------ccchHHHHHHHHHHHH
Confidence 345566788899999999999999999999999999775321 2334677899999999
Q ss_pred cCCCCCceEEEEEEEECC------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 105 SCHHENVVTYHTSFVVKD------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
+|+|||||+++++-++.. .-.+|||||.||+|+.+++... ++..|++.++..++..+..||.|||.+||
T Consensus 67 KLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PE-----N~~GLpE~e~l~lL~d~~~al~~LrEn~I 141 (732)
T KOG4250|consen 67 KLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPE-----NAYGLPESEFLDLLSDLVSALRHLRENGI 141 (732)
T ss_pred HcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcc-----cccCCCHHHHHHHHHHHHHHHHHHHHcCc
Confidence 999999999998866443 4689999999999999997532 45679999999999999999999999999
Q ss_pred EecccCCCcEEE--cCCC--CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 179 IHRDIKAGNILL--GEDG--TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 179 iHrDLKp~NILl--~~~g--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
+||||||+||++ +.+| ..||+|||.|+.+..+ ....+++||+.|.+||++..+..|+..+|.|||||++|
T Consensus 142 vHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY 215 (732)
T KOG4250|consen 142 VHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLY 215 (732)
T ss_pred eeccCCCCcEEEeecCCCceEEeeecccccccCCCC------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHH
Confidence 999999999999 4445 4799999999877543 34568899999999999986556999999999999999
Q ss_pred HHHhCCCCCCCCcHHH----HHHHHhcCCCCCCCCCchhhh---------------hHHHhcHHHHHHHHhhhccCCCCC
Q psy11359 255 EMATGTAPYHKYPAMK----VLMLTLQNDPPTLDTGAAEKD---------------QYKAYGKTFRKMISDCLQKDPTKR 315 (520)
Q Consensus 255 elltG~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~~L~~dP~~R 315 (520)
+++||..||......+ +....+...+..+..+....+ .....-..+-..+..+|..+|.+|
T Consensus 216 ~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~ 295 (732)
T KOG4250|consen 216 ECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKR 295 (732)
T ss_pred HHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHh
Confidence 9999999996443332 333333332222211111111 111222345667788888999999
Q ss_pred C
Q psy11359 316 P 316 (520)
Q Consensus 316 p 316 (520)
.
T Consensus 296 ~ 296 (732)
T KOG4250|consen 296 G 296 (732)
T ss_pred C
Confidence 8
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=306.66 Aligned_cols=258 Identities=22% Similarity=0.363 Sum_probs=200.3
Q ss_pred eEEEeeeeecCceEEEEEEEcC---CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKA---RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
|++.++||+|+||.||+|.... ++..||+|++.... ......+++.+|+++++.++
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l~ 59 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI---------------------FSSSDIEEFLREAACMKEFD 59 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc---------------------CChHHHHHHHHHHHHHhcCC
Confidence 6788999999999999998654 46677777664211 01234567889999999999
Q ss_pred CCCceEEEEEEEECC------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 108 HENVVTYHTSFVVKD------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 108 HpnIv~~~~~~~~~~------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
||||+++++++.... ..+++++|+.+|+|.+++...... .....++...+..++.||+.||.|||++||+||
T Consensus 60 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~ 137 (273)
T cd05074 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG--EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHR 137 (273)
T ss_pred CCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence 999999999887532 247899999999999987532110 022357899999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GT 260 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~ 260 (520)
||||+||+++.++.+||+|||++..+...... .......+++.|++||.+.+.. ++.++|||||||++|+|++ |.
T Consensus 138 dikp~nili~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~ 213 (273)
T cd05074 138 DLAARNCMLNENMTVCVADFGLSKKIYSGDYY---RQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQ 213 (273)
T ss_pred ccchhhEEEcCCCCEEECcccccccccCCcce---ecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCC
Confidence 99999999999999999999998765432211 1112334567899999987654 8899999999999999999 99
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
+||......+.............. ..++..+.+++.+||+.+|++|||+.+++..
T Consensus 214 ~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 214 TPYAGVENSEIYNYLIKGNRLKQP---------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCCHHHHHHHHHcCCcCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999887766555544433222111 2456789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=345.07 Aligned_cols=267 Identities=23% Similarity=0.376 Sum_probs=216.4
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
.....-++.+.||+|+||.||.|......-.+. ...||+|.+..........+|++|..+|+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~-----------------~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~ 751 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVS-----------------PIQVAVKSLKRLSSEQEVSDFLKEALLMSK 751 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCcc-----------------ceEEEEEeccccCCHHHHHHHHHHHHHHhc
Confidence 345668899999999999999997665422100 123555555554445677889999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++|||||++++++.+....+|++||++||+|..||++...... ....++..+...++.||++|++||+++++|||||-+
T Consensus 752 f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~-~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAa 830 (1025)
T KOG1095|consen 752 FDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPF-QPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAA 830 (1025)
T ss_pred CCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccC-CCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhh
Confidence 9999999999999999999999999999999999987422221 256789999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYH 264 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~ 264 (520)
.|+|++....+||+|||+|+-+........... ..-...|||||.+.... ++.++|||||||+|||++| |..||.
T Consensus 831 RNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~---a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 831 RNCLLDERRVVKIADFGLARDIYDKDYYRKHGE---AMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred hheeecccCcEEEcccchhHhhhhchheeccCc---cccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999984332221111110 12235799999998755 9999999999999999999 999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
...+.+++...+.+..-.. ...++..+.++|..||+.+|++||++..|++
T Consensus 907 ~~~n~~v~~~~~~ggRL~~---------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 907 SRSNFEVLLDVLEGGRLDP---------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CcchHHHHHHHHhCCccCC---------CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999886666543222 2457788899999999999999999999997
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=305.18 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=199.3
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcC----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKA----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
..++|++.+.||+|+||.||+|.... ++..+|+|+++.. ......+.+.+|+.+
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~----------------------~~~~~~~~~~~ei~~ 59 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS----------------------GEEQHRSDFEREIEI 59 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccc----------------------cchHHHHHHHHHHHH
Confidence 35678999999999999999998654 3666777765421 111235679999999
Q ss_pred HhcCCCCCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 103 MSSCHHENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
++.+.||||+++++++.. ....++||||+.+++|.+++.. ....+++..+..++.||+.||.|||++|++|
T Consensus 60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~-------~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H 132 (284)
T cd05038 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR-------HRDQINLKRLLLFSSQICKGMDYLGSQRYIH 132 (284)
T ss_pred HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHh-------CccccCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 999999999999999887 5679999999999999999974 2336899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+||+++.++.++|+|||++.......... .......++..|+|||.+.+.. ++.++||||||+++|+|+||.
T Consensus 133 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~ 209 (284)
T cd05038 133 RDLAARNILVESEDLVKISDFGLAKVLPEDKDYY--YVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYG 209 (284)
T ss_pred CCCCHHhEEEcCCCCEEEcccccccccccCCcce--eccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccC
Confidence 9999999999999999999999998764322211 1111234556799999887654 899999999999999999999
Q ss_pred CCCCCCcHHH--------------HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 261 APYHKYPAMK--------------VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 261 ~Pf~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.|+....... .+...+..... .. ....++.++.+++.+||.++|.+|||+.|+++
T Consensus 210 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 210 DPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER-LP-------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CCcccccchhccccccccccccHHHHHHHHHcCCc-CC-------CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9986533211 11111111110 00 01235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=314.72 Aligned_cols=276 Identities=22% Similarity=0.331 Sum_probs=222.7
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
..|..+++|-++.+||+|||+.||+|+|....++||+|+-.. -|-...++-....+...+|..+
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHql----------------NK~WrdEKKeNYhKHAcREyrI 520 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQL----------------NKNWRDEKKENYHKHACREYRI 520 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehh----------------ccchhhHhhhhHHHHHHHHHhh
Confidence 456788999999999999999999999999999999996421 1222223334456778999999
Q ss_pred HhcCCCCCceEEEEEEE-ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cE
Q psy11359 103 MSSCHHENVVTYHTSFV-VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG--QI 179 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~-~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g--ii 179 (520)
.+.|.||.||++|++|. +.+.+|-|+|||+|.+|.-|++ .++.+++.+++.|+.||+.||.||.... ||
T Consensus 521 HKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLK--------QhklmSEKEARSIiMQiVnAL~YLNEikpPII 592 (775)
T KOG1151|consen 521 HKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLK--------QHKLMSEKEARSIIMQIVNALKYLNEIKPPII 592 (775)
T ss_pred hhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHH--------hhhhhhHHHHHHHHHHHHHHHHHHhccCCCee
Confidence 99999999999999997 6678999999999999999998 5788999999999999999999999874 99
Q ss_pred ecccCCCcEEEc---CCCCeEEeccCcceeeccCccc--cccccccccccccccCCcceecc---cCCCCcchhHHHHHH
Q psy11359 180 HRDIKAGNILLG---EDGTVQIADFGVSAWLATGRDL--SRQKVRHTFVGTPCWMAPEVMEQ---DHGYDFKADIWSLGI 251 (520)
Q Consensus 180 HrDLKp~NILl~---~~g~vkL~DFG~a~~~~~~~~~--~~~~~~~~~~gt~~y~APE~~~~---~~~~~~~~DIwSlG~ 251 (520)
|-||||.|||+- .-|.+||.|||++.++...... ..-.....+.||.+|++||.+.- ....+.++||||+||
T Consensus 593 HYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGV 672 (775)
T KOG1151|consen 593 HYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGV 672 (775)
T ss_pred eeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeeh
Confidence 999999999993 4578999999999998654433 23344556889999999999853 234788999999999
Q ss_pred HHHHHHhCCCCCCCCcHHH-HHHH--HhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 252 TAIEMATGTAPYHKYPAMK-VLML--TLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 252 il~elltG~~Pf~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
|+|..+.|+-||....... ++.. ++...-.. ...-+.++.+..+||++||++.-+.|....++-.||+|.
T Consensus 673 IFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVq-------FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 673 IFYQCLYGRKPFGHNQSQQDILQENTILKATEVQ-------FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hhhhhhccCCCCCCchhHHHHHhhhchhcceecc-------CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 9999999999997654332 2221 11111011 111246788999999999999999999999999999997
Q ss_pred c
Q psy11359 329 K 329 (520)
Q Consensus 329 ~ 329 (520)
.
T Consensus 746 P 746 (775)
T KOG1151|consen 746 P 746 (775)
T ss_pred c
Confidence 4
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=305.87 Aligned_cols=134 Identities=28% Similarity=0.441 Sum_probs=117.0
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
...+|.+.++||+|-|+|||+|.|....+.||+|+++.... ..+....||++|+++
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh------------------------YtEaAlDEIklL~~v 131 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH------------------------YTEAALDEIKLLQQV 131 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH------------------------HHHHHHHHHHHHHHH
Confidence 45889999999999999999999999999999999864321 234578899999987
Q ss_pred C-----C---CCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 107 H-----H---ENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 107 ~-----H---pnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
+ | .+||++++.|.- ..++|+|+|++ |.+|..+|+.. ..+.++...++.|++|||.||.|||
T Consensus 132 ~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s------~YrGlpl~~VK~I~~qvL~GLdYLH 204 (590)
T KOG1290|consen 132 REGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS------NYRGLPLSCVKEICRQVLTGLDYLH 204 (590)
T ss_pred HhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh------CCCCCcHHHHHHHHHHHHHHHHHHH
Confidence 3 2 369999999984 45799999999 88999999875 6788999999999999999999999
Q ss_pred HC-CcEecccCCCcEEEc
Q psy11359 175 SN-GQIHRDIKAGNILLG 191 (520)
Q Consensus 175 ~~-giiHrDLKp~NILl~ 191 (520)
.. ||||-||||+|||+.
T Consensus 205 ~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 205 RECGIIHTDLKPENVLLC 222 (590)
T ss_pred HhcCccccCCCcceeeee
Confidence 86 999999999999993
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=297.33 Aligned_cols=271 Identities=23% Similarity=0.426 Sum_probs=223.4
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
..|.-.-++|.++++||+|+|+.|-.++.+.+.+.+|+|++++..+.. .+.++=...|-.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd--------------------dedidwvqtek~ 302 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND--------------------DEDIDWVQTEKH 302 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC--------------------cccchhHHhhHH
Confidence 567778889999999999999999999999999999999987654432 234444667777
Q ss_pred HHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 102 AMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 102 ~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+..+- +||.+|-++.+|.++..+++|.||++||+|--.++ ....++++.++-+...|+.||.|||++|||.
T Consensus 303 vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmq--------rqrklpeeharfys~ei~lal~flh~rgiiy 374 (593)
T KOG0695|consen 303 VFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ--------RQRKLPEEHARFYSAEICLALNFLHERGIIY 374 (593)
T ss_pred HHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehh--------hhhcCcHHHhhhhhHHHHHHHHHHhhcCeee
Confidence 77766 89999999999999999999999999999988887 4567899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
||||.+|+|++..|++||.|+|+...-- .......+++|||.|.|||++++.. |+..+|.|+||++|+||+.|+
T Consensus 375 rdlkldnvlldaeghikltdygmcke~l-----~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagr 448 (593)
T KOG0695|consen 375 RDLKLDNVLLDAEGHIKLTDYGMCKEGL-----GPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGR 448 (593)
T ss_pred eeccccceEEccCCceeecccchhhcCC-----CCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCC
Confidence 9999999999999999999999986432 2344567899999999999999877 999999999999999999999
Q ss_pred CCCCC-------CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC------CHHHHhcCccc
Q psy11359 261 APYHK-------YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP------TASELLKNPFF 327 (520)
Q Consensus 261 ~Pf~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------ta~elL~hp~~ 327 (520)
.||.- .+..+.+..++-.....++ ..+|-....+++.-|.+||.+|. -..++..|+||
T Consensus 449 spfdivgm~n~d~ntedylfqvilekqirip---------rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ff 519 (593)
T KOG0695|consen 449 SPFDIVGMDNPDMNTEDYLFQVILEKQIRIP---------RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFF 519 (593)
T ss_pred CCcceecCCCcccchhHHHHHHHhhhccccc---------ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhh
Confidence 99952 1223334444333333332 23344556788888999999994 47899999999
Q ss_pred cccchhhH
Q psy11359 328 KKAKDKKF 335 (520)
Q Consensus 328 ~~~~~~~~ 335 (520)
+...+.-.
T Consensus 520 r~idwd~l 527 (593)
T KOG0695|consen 520 RSIDWDLL 527 (593)
T ss_pred hhCCHHHH
Confidence 98776543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=333.29 Aligned_cols=275 Identities=23% Similarity=0.313 Sum_probs=181.9
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCC----CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKAR----AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~----g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
....++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ..+....+
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-------------------------~~e~~~~e- 181 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-------------------------AVEIWMNE- 181 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-------------------------hhHHHHHH-
Confidence 34678999999999999999999999998 8888888653210 00111111
Q ss_pred HHHhcCCCCCceEEEEE------EEECCEEEEEEEccCCCCHHHHHHHhhccc------------cCCCCCCCHHHHHHH
Q psy11359 101 QAMSSCHHENVVTYHTS------FVVKDELWLVLRLLEGGSLLDIIKHRLKIS------------NCKHGVCDEPTIATV 162 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~------~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~------------~~~~~~l~~~~i~~i 162 (520)
.++...+.++..+... ......+++||||+.+++|.+++....... ...........+..+
T Consensus 182 -~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i 260 (566)
T PLN03225 182 -RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTI 260 (566)
T ss_pred -HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHH
Confidence 1112222222222111 235678999999999999999997431100 001112234567889
Q ss_pred HHHHHHHHHHHHHCCcEecccCCCcEEEcC-CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC---
Q psy11359 163 LREVLKGLEYFHSNGQIHRDIKAGNILLGE-DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH--- 238 (520)
Q Consensus 163 ~~qIl~gL~yLH~~giiHrDLKp~NILl~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--- 238 (520)
+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|..+..+.. .....++||+.|||||.+....
T Consensus 261 ~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~----~~~~~~~~t~~Y~APE~~~~~~~~~ 336 (566)
T PLN03225 261 MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN----YIPKEFLLDPRYAAPEQYIMSTQTP 336 (566)
T ss_pred HHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc----cCCcccccCCCccChHHhhccCCCC
Confidence 999999999999999999999999999985 68999999999976543322 2234578999999999753221
Q ss_pred ------------------CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC-------CCCc--h---
Q psy11359 239 ------------------GYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTL-------DTGA--A--- 288 (520)
Q Consensus 239 ------------------~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------~~~~--~--- 288 (520)
.++.++|||||||+||||+++..|+.. ....+...+....... .... .
T Consensus 337 ~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 414 (566)
T PLN03225 337 SAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRR 414 (566)
T ss_pred CCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhh
Confidence 244567999999999999997766532 2222222211110000 0000 0
Q ss_pred hhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 289 EKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
........+....+||.+||++||++|||+.++|+||||+....
T Consensus 415 ~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 415 GFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred hhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 00011112344668999999999999999999999999987544
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.69 Aligned_cols=272 Identities=24% Similarity=0.398 Sum_probs=223.6
Q ss_pred CCCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 19 SVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 19 ~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
+...-+-+..++..+.++||+|.||+|++|.+...+-+ .-.||+|.+........+.+|++
T Consensus 100 ~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk-------------------~V~VAVKclr~d~l~~~mddflr 160 (1039)
T KOG0199|consen 100 SIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGK-------------------HVNVAVKCLRDDSLNAIMDDFLR 160 (1039)
T ss_pred CCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCc-------------------EEeEEEEeccCCccchhHHHHHH
Confidence 33444556677788999999999999999988775432 12344555544444557889999
Q ss_pred HHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
|+.+|.+|+|||++++|++..+ ..+.+|||++.+|+|.+.+++. ....|-......++.||+.|+.||.++++
T Consensus 161 Eas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka------~~~~llv~~Lcdya~QiA~aM~YLeskrl 233 (1039)
T KOG0199|consen 161 EASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKA------KKAILLVSRLCDYAMQIAKAMQYLESKRL 233 (1039)
T ss_pred HHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhc------cccceeHHHHHHHHHHHHHHHHHHhhhhh
Confidence 9999999999999999999887 7788999999999999999862 55778899999999999999999999999
Q ss_pred EecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 179 iHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
|||||-..|+|+-....|||+|||+.+.+..+.+.. .+.....-...|+|||.+.... ++.++|+|+|||++|||+|
T Consensus 234 vHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y--vm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFt 310 (1039)
T KOG0199|consen 234 VHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY--VMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFT 310 (1039)
T ss_pred hhhhhhhhhheecccceeeeecccceeccCCCCcce--EecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhc
Confidence 999999999999888999999999999887665532 1122223345799999998777 8999999999999999998
Q ss_pred -CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 259 -GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 259 -G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
|+.||.++....++..+..+..-. ..+.++..+.+++..||+.+|.+|||+..|...-+++
T Consensus 311 yGEePW~G~~g~qIL~~iD~~erLp---------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 311 YGEEPWVGCRGIQILKNIDAGERLP---------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred cCCCCCCCCCHHHHHHhccccccCC---------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 899999999999987766443221 2367889999999999999999999999997655544
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.56 Aligned_cols=262 Identities=22% Similarity=0.333 Sum_probs=208.6
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
......++++||+|-||.|.+|.-.. +.+||+|.++ .+.+.....+|.+||++|.+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr----------------------~~a~~~~r~~F~kEIkiLsqL 592 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILR----------------------PDATKNARNDFLKEIKILSRL 592 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC-ceEEEEeecC----------------------cccchhHHHHHHHHHHHHhcc
Confidence 45567899999999999999997654 4566666554 333344567899999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+|||||+++++|..++.+++||||++.|+|.+++.... ...+....-.+|+.||+.|+.||.+.++|||||.+.
T Consensus 593 khPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ahe------apt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~r 666 (807)
T KOG1094|consen 593 KHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHE------LPTAETAPGVSICTQIASGMAYLESLNFVHRDLATR 666 (807)
T ss_pred CCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhcc------CcccccchhHHHHHHHHHHHHHHHhhchhhcccccc
Confidence 99999999999999999999999999999999998531 122445566679999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh--CCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT--GTAPYH 264 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt--G~~Pf~ 264 (520)
|+|++.++++||+|||+++.+.++....- ....+-...|||||.+.-++ ++.++|+|+||++|||+++ .+.||.
T Consensus 667 NcLv~~e~~iKiadfgmsR~lysg~yy~v---qgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~ 742 (807)
T KOG1094|consen 667 NCLVDGEFTIKIADFGMSRNLYSGDYYRV---QGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYS 742 (807)
T ss_pred ceeecCcccEEecCcccccccccCCceee---ecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchh
Confidence 99999999999999999987765543322 22345567899999988776 8999999999999999875 789999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
...+..+....-.-.+..- ...-......++..+.++|..||..|.++|||++++-.
T Consensus 743 ~lt~e~vven~~~~~~~~~--~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 743 QLTDEQVVENAGEFFRDQG--RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred hhhHHHHHHhhhhhcCCCC--cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 8887766654322111110 01112233567888999999999999999999999854
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=315.55 Aligned_cols=294 Identities=20% Similarity=0.310 Sum_probs=196.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchh-------------h
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNT-------------S 92 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~-------------~ 92 (520)
...++|++.++||+|+||+||+|.....+...+.|..+.. ....++.||+|++....... .
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~------~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~ 215 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLT------AEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGS 215 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhcccc------ccccCceEEEEEecccchhhHHHHHhhhhhhhcc
Confidence 3678999999999999999999987655443333222111 11124567777765433211 1
Q ss_pred HHHHHHHHHHHhcCCCCCc-----eEEEEEEEE--------CCEEEEEEEccCCCCHHHHHHHhhcc-------------
Q psy11359 93 MDELLKEIQAMSSCHHENV-----VTYHTSFVV--------KDELWLVLRLLEGGSLLDIIKHRLKI------------- 146 (520)
Q Consensus 93 ~~~l~~Ei~~l~~l~HpnI-----v~~~~~~~~--------~~~~~lV~E~~~ggsL~~~i~~~~~~------------- 146 (520)
.+....|+.++.+++|.++ ++++++|.. +...||||||+.+++|.+++......
T Consensus 216 ~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~ 295 (507)
T PLN03224 216 AETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGK 295 (507)
T ss_pred cchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCC
Confidence 1223457777777766554 566666653 35689999999999999998742110
Q ss_pred ---ccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccc
Q psy11359 147 ---SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFV 223 (520)
Q Consensus 147 ---~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~ 223 (520)
.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+..+... ......
T Consensus 296 ~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~----~~~~g~ 371 (507)
T PLN03224 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF----NPLYGM 371 (507)
T ss_pred chhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc----CccccC
Confidence 0001234567889999999999999999999999999999999999999999999998655332211 111234
Q ss_pred cccccCCcceecccCC---------------------CCcchhHHHHHHHHHHHHhCCC-CCCCCcHHHHHHHHhcCCCC
Q psy11359 224 GTPCWMAPEVMEQDHG---------------------YDFKADIWSLGITAIEMATGTA-PYHKYPAMKVLMLTLQNDPP 281 (520)
Q Consensus 224 gt~~y~APE~~~~~~~---------------------~~~~~DIwSlG~il~elltG~~-Pf~~~~~~~~~~~~~~~~~~ 281 (520)
+||.|+|||.+..... ...+.||||+||++|+|++|.. ||..................
T Consensus 372 ~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~ 451 (507)
T PLN03224 372 LDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN 451 (507)
T ss_pred CCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH
Confidence 5899999998753221 1235799999999999999886 77543221111110000000
Q ss_pred ---CCCCCchhhhhHHHhcHHHHHHHHhhhccCC---CCCCCHHHHhcCccccc
Q psy11359 282 ---TLDTGAAEKDQYKAYGKTFRKMISDCLQKDP---TKRPTASELLKNPFFKK 329 (520)
Q Consensus 282 ---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~Rpta~elL~hp~~~~ 329 (520)
...........+...++..++|+.+||.++| .+|+|+.|+|+||||..
T Consensus 452 ~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 452 RWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred HHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0000011112345678899999999999866 68999999999999963
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=307.67 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=207.4
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
.+|.+....|+|-|++|.+|.+...|..||||+|+... ...+.=++|+++|++|+.
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE------------------------~M~KtGl~EleiLkKL~~ 487 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE------------------------VMHKTGLKELEILKKLND 487 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch------------------------HHhhhhhHHHHHHHHhhc
Confidence 45778888999999999999999999999999886321 122334679999999953
Q ss_pred ------CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 109 ------ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 109 ------pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
-|+++++..|...+++|||+|.+ ..+|.+++++.. ..-.|....++.++.|++.||..|...||+|.|
T Consensus 488 AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG-----~nvGL~ikaVRsYaqQLflALklLK~c~vlHaD 561 (752)
T KOG0670|consen 488 ADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYG-----RNVGLHIKAVRSYAQQLFLALKLLKKCGVLHAD 561 (752)
T ss_pred cCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhC-----cccceeehHHHHHHHHHHHHHHHHHhcCeeecc
Confidence 37999999999999999999999 689999999753 345688899999999999999999999999999
Q ss_pred cCCCcEEEcCC-CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 183 IKAGNILLGED-GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 183 LKp~NILl~~~-g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|||+||||.+. ..+||||||.|...+.+. -..+.-+..|.|||++.+-. |+...|+||+||+||||.||+.
T Consensus 562 IKPDNiLVNE~k~iLKLCDfGSA~~~~ene-------itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkI 633 (752)
T KOG0670|consen 562 IKPDNILVNESKNILKLCDFGSASFASENE-------ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKI 633 (752)
T ss_pred cCccceEeccCcceeeeccCcccccccccc-------ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccce
Confidence 99999999764 478999999987654322 12345567899999999877 9999999999999999999999
Q ss_pred CCCCCcHHHHHHHHh--cCCCCCCC----------------------------------CCchh-hh-------------
Q psy11359 262 PYHKYPAMKVLMLTL--QNDPPTLD----------------------------------TGAAE-KD------------- 291 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~--~~~~~~~~----------------------------------~~~~~-~~------------- 291 (520)
.|++..+...+.... .+..|.-. ....+ +.
T Consensus 634 lFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~d 713 (752)
T KOG0670|consen 634 LFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPD 713 (752)
T ss_pred ecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCc
Confidence 999887766654322 22111000 00000 00
Q ss_pred hHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 292 QYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 292 ~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
.....-..|++|+.+||..||++|.|..++|+||||+.
T Consensus 714 eq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 714 EQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred hhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 00112256899999999999999999999999999974
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=305.83 Aligned_cols=257 Identities=22% Similarity=0.378 Sum_probs=218.5
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
..|.....+.....+||-|-||.||.+..+...-.||+|.++.+ ....++|+.|+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED------------------------tMeveEFLkEAA 315 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------------------TMEVEEFLKEAA 315 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc------------------------chhHHHHHHHHH
Confidence 35777777888889999999999999999999888888876422 335789999999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+|+.++|||+|+++++|..+..+|||+||+..|+|.+|++.. ....++.-....++.||..|++||..+++|||
T Consensus 316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRec------nr~ev~avvLlyMAtQIsSaMeYLEkknFIHR 389 (1157)
T KOG4278|consen 316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLREC------NRSEVPAVVLLYMATQISSAMEYLEKKNFIHR 389 (1157)
T ss_pred HHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHh------chhhcchhHHHHHHHHHHHHHHHHHHhhhhhh
Confidence 999999999999999999999999999999999999999874 55667888889999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GT 260 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~ 260 (520)
||-..|.|++++..||++|||+++.+......... ...-..-|.|||-+..+. ++-++|||+||++|||+.| |.
T Consensus 390 DLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA----GAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGM 464 (1157)
T KOG4278|consen 390 DLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA----GAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGM 464 (1157)
T ss_pred hhhhhhccccccceEEeeccchhhhhcCCceeccc----CccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCC
Confidence 99999999999999999999999987533221111 111245699999987666 8899999999999999998 99
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
.||.+.+-..++.+.-.+....- ...+++.+.+|+..||++.|..||++.|+-
T Consensus 465 sPYPGidlSqVY~LLEkgyRM~~---------PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 465 SPYPGIDLSQVYGLLEKGYRMDG---------PEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCCCCccHHHHHHHHhccccccC---------CCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 99999888777765554433322 356888999999999999999999999984
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.55 Aligned_cols=263 Identities=41% Similarity=0.726 Sum_probs=223.7
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
-+..++|+++..+|.|++|.||+|+++.+++..|+|+++... .....-+.+|+-+++
T Consensus 11 rnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-----------------------~dd~~~iqqei~~~~ 67 (829)
T KOG0576|consen 11 RNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-----------------------GDDFSGIQQEIGMLR 67 (829)
T ss_pred cCCccchhheeeecCCcccchhhhcccccCchhhheeeeccC-----------------------Cccccccccceeeee
Confidence 367899999999999999999999999998888888775321 223445778999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
.++|||||.|++.+...+.+|++||||.||+|.+.-. ..+.+++.++..+++..++||+|||+.|=+|||||
T Consensus 68 dc~h~nivay~gsylr~dklwicMEycgggslQdiy~--------~TgplselqiayvcRetl~gl~ylhs~gk~hRdiK 139 (829)
T KOG0576|consen 68 DCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH--------VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIK 139 (829)
T ss_pred cCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee--------ecccchhHHHHHHHhhhhccchhhhcCCccccccc
Confidence 9999999999999999999999999999999998765 57899999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCccee--cccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM--EQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~--~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
-.|||+++.|.+|++|||.+..+.. ....+..++|||.|||||+. ....+|+..+|||++|++..|+---++|
T Consensus 140 Ganilltd~gDvklaDfgvsaqita-----ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 140 GANILLTDEGDVKLADFGVSAQITA-----TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred ccceeecccCceeecccCchhhhhh-----hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence 9999999999999999999876642 23335679999999999985 3344599999999999999999999988
Q ss_pred CCCCcHHHHHHHHhcCC--CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 263 YHKYPAMKVLMLTLQND--PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.....++..++...... ++.+.. ....++.|-+|++.+|.++|++|||++-+|.|||....
T Consensus 215 lfdlhpmr~l~LmTkS~~qpp~lkD-------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 215 LFDLHPMRALFLMTKSGFQPPTLKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ccccchHHHHHHhhccCCCCCcccC-------CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 76667776665544433 232221 13457789999999999999999999999999999765
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=307.40 Aligned_cols=252 Identities=22% Similarity=0.372 Sum_probs=208.4
Q ss_pred EEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCc
Q psy11359 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENV 111 (520)
Q Consensus 32 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnI 111 (520)
.+.+.||.|-||.||.|....-. +...-.||+|.-+.+......+.|+.|..+|++++||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~------------------kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphI 453 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPE------------------KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHI 453 (974)
T ss_pred cHHHhhcCCcccceeeeEecccc------------------cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcch
Confidence 34568999999999999765431 011234666666665556678899999999999999999
Q ss_pred eEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEc
Q psy11359 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191 (520)
Q Consensus 112 v~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~ 191 (520)
|++++++.+ ...|||||++.-|.|+.|++. ....++......++.||+.+|.|||+.++|||||-..|||+.
T Consensus 454 ikLIGv~~e-~P~WivmEL~~~GELr~yLq~-------nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs 525 (974)
T KOG4257|consen 454 IKLIGVCVE-QPMWIVMELAPLGELREYLQQ-------NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS 525 (974)
T ss_pred hheeeeeec-cceeEEEecccchhHHHHHHh-------ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec
Confidence 999998874 568999999999999999987 456788999999999999999999999999999999999999
Q ss_pred CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHH
Q psy11359 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMK 270 (520)
Q Consensus 192 ~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~ 270 (520)
....|||+|||+++++......... ...-..-|||||-+.-.. ++.++|||-||++|||++. |.-||.+..+.+
T Consensus 526 Sp~CVKLaDFGLSR~~ed~~yYkaS----~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 526 SPQCVKLADFGLSRYLEDDAYYKAS----RGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred Ccceeeecccchhhhccccchhhcc----ccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 9999999999999998654332111 112245699999987665 8999999999999999987 999999988888
Q ss_pred HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
++..+-++.....+ +.+++.+..|+.+||+++|.+||++.++..
T Consensus 601 VI~~iEnGeRlP~P---------~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 601 VIGHIENGERLPCP---------PNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred eEEEecCCCCCCCC---------CCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 88766666554443 567889999999999999999999998854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=279.86 Aligned_cols=244 Identities=37% Similarity=0.584 Sum_probs=200.3
Q ss_pred CceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEEEEEEE
Q psy11359 41 ATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVV 120 (520)
Q Consensus 41 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~~~~~~ 120 (520)
+||.||+|.+..+|..+|+|++..... ....+.+.+|++.+++++|+||+++++++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~----------------------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~ 58 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKI----------------------KKKRERILREISILKKLKHPNIVRLYDVFED 58 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccc----------------------ccHHHHHHHHHHHHHhCCCCcHHHHHhheee
Confidence 589999999999988888887753211 1115678999999999999999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEec
Q psy11359 121 KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIAD 200 (520)
Q Consensus 121 ~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~D 200 (520)
....++++||+.+++|.+++.. ...++...+..++.+++.+|.|||+.|++|+||+|.||+++.++.++|+|
T Consensus 59 ~~~~~l~~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d 130 (244)
T smart00220 59 EDKLYLVMEYCDGGDLFDLLKK--------RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLAD 130 (244)
T ss_pred CCEEEEEEeCCCCCCHHHHHHh--------ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEcc
Confidence 9999999999999999999974 22388999999999999999999999999999999999999999999999
Q ss_pred cCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC
Q psy11359 201 FGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDP 280 (520)
Q Consensus 201 FG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~ 280 (520)
||.+....... ......+++.|+|||.+.... ++.++||||||+++++|++|..||............+....
T Consensus 131 ~~~~~~~~~~~------~~~~~~~~~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~ 203 (244)
T smart00220 131 FGLARQLDPGG------LLTTFVGTPEYMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPK 203 (244)
T ss_pred ccceeeecccc------ccccccCCcCCCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC
Confidence 99988764322 223457889999999987544 78899999999999999999999987444444433333322
Q ss_pred CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 281 PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
...... ...++..+.+++.+||..+|++||++.++++||||
T Consensus 204 ~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 204 PPFPPP------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CCCccc------cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 221110 11167789999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=312.90 Aligned_cols=260 Identities=23% Similarity=0.398 Sum_probs=220.3
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
........|.++||.|-||.||+|+.+..|++ ...||||.++..-......+|+.|+.||-
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkr-------------------e~~VAIKTLK~GytekqrrdFL~EAsIMG 685 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKR-------------------EITVAIKTLKAGYTEKQRRDFLSEASIMG 685 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCc-------------------ceeEEEeeeccCccHHHHhhhhhhhhhcc
Confidence 34455678999999999999999999988743 33444444444433456678999999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++.++....+.+.||+||++.|+|..+++. ..+.|+.-++.-+++.|+.|+.||-++|+|||||-
T Consensus 686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~-------~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLA 758 (996)
T KOG0196|consen 686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ-------NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLA 758 (996)
T ss_pred cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh-------cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhh
Confidence 99999999999999999999999999999999999997 46779999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCcccccccccccccc--ccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVG--TPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTA 261 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~ 261 (520)
..|||++.+-.+|++|||+++.+..+.. ....+.-| ...|.|||.+...+ ++.++|+||||++|||.++ |+.
T Consensus 759 ARNILVNsnLvCKVsDFGLSRvledd~~----~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGER 833 (996)
T KOG0196|consen 759 ARNILVNSNLVCKVSDFGLSRVLEDDPE----AAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGER 833 (996)
T ss_pred hhheeeccceEEEeccccceeecccCCC----ccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCC
Confidence 9999999999999999999998855431 11222223 35799999998776 8999999999999999776 999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
||..+.+.+++..+-++..-..+ -+++..+..|+..||++|-.+||++.+|+.+
T Consensus 834 PYWdmSNQdVIkaIe~gyRLPpP---------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 834 PYWDMSNQDVIKAIEQGYRLPPP---------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred cccccchHHHHHHHHhccCCCCC---------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999888777543332 3578889999999999999999999999863
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=285.14 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=207.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
...+|.-+..+|.|+- .|..|.|...+++||+|++..+. .......+..+|..++..+
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf---------------------~n~~~akra~rel~l~~~v 72 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF---------------------QNQTHAKRAYRELKLMKCV 72 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc---------------------ccCccchhhhhhhhhhhhh
Confidence 4567999999999999 89999999999999999764320 0123445688999999999
Q ss_pred CCCCceEEEEEEEECC------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVKD------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+|+||++++.+|.-.+ +.|+||||+ ..+|.+.+.- .++-+.+..++.|++.|++|||+.||+|
T Consensus 73 ~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~----------elDH~tis~i~yq~~~~ik~lhs~~Iih 141 (369)
T KOG0665|consen 73 NHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILM----------ELDHETISYILYQMLCGIKHLHSAGIIH 141 (369)
T ss_pred cccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHH----------hcchHHHHHHHHHHHHHHHHHHhcceee
Confidence 9999999999998544 489999999 5799999862 3667899999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+||++..+..+||.|||+|+.-... -....++.|..|.|||++.+-. |.+.+||||+||++.||++|+
T Consensus 142 RdLkPsnivv~~~~~lKi~dfg~ar~e~~~------~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~ 214 (369)
T KOG0665|consen 142 RDLKPSNIVVNSDCTLKILDFGLARTEDTD------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGT 214 (369)
T ss_pred cccCcccceecchhheeeccchhhcccCcc------cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhce
Confidence 999999999999999999999998754321 2334578999999999998876 999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCC----------------------CC--------CCCCc--hhhhhHHHhcHHHHHHHHhhh
Q psy11359 261 APYHKYPAMKVLMLTLQNDP----------------------PT--------LDTGA--AEKDQYKAYGKTFRKMISDCL 308 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~----------------------~~--------~~~~~--~~~~~~~~~~~~~~~li~~~L 308 (520)
..|.+....+++..+...-. .. ++... ...+..+.-+..+++++.+||
T Consensus 215 Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~ML 294 (369)
T KOG0665|consen 215 VLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKML 294 (369)
T ss_pred EEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhh
Confidence 99987665555433221100 00 00000 000000122356889999999
Q ss_pred ccCCCCCCCHHHHhcCccccc
Q psy11359 309 QKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 309 ~~dP~~Rpta~elL~hp~~~~ 329 (520)
..+|++|.+++++|+||||+-
T Consensus 295 vi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 295 VIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred ccChhhcccHHHHhcCCeeee
Confidence 999999999999999999983
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=261.09 Aligned_cols=228 Identities=31% Similarity=0.506 Sum_probs=189.8
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+....++......||+|++|.|-+.++..+|+..|+|.++... ......++++|+.+.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv----------------------n~q~q~r~L~dldi~ 98 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV----------------------NSQEQKRLLMDLDII 98 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc----------------------ChHHHHHHHHhhhhh
Confidence 3344556667788999999999999999999888888775332 234567788999886
Q ss_pred hcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEec
Q psy11359 104 SSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN-GQIHR 181 (520)
Q Consensus 104 ~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~-giiHr 181 (520)
.+. .+|.+|.||+.+.....+|+.||.+ ..||..+-++..+ +++.++|..+-+|+..+..||.|||++ .+|||
T Consensus 99 ~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~----~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHR 173 (282)
T KOG0984|consen 99 MRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLK----KGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHR 173 (282)
T ss_pred ccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHh----cCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhc
Confidence 655 8999999999999999999999999 5688877766544 678999999999999999999999987 79999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccc-cccccccCCcceecc---cCCCCcchhHHHHHHHHHHHH
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHT-FVGTPCWMAPEVMEQ---DHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~-~~gt~~y~APE~~~~---~~~~~~~~DIwSlG~il~ell 257 (520)
|+||.|||++.+|++||||||.+.++.+ +...+ -.|...|||||.+.. +.+|+-++||||||++++||.
T Consensus 174 DvKPsNiLIn~~GqVKiCDFGIsG~L~d-------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA 246 (282)
T KOG0984|consen 174 DVKPSNILINYDGQVKICDFGISGYLVD-------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMA 246 (282)
T ss_pred cCCcceEEEccCCcEEEcccccceeehh-------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhh
Confidence 9999999999999999999999988743 33333 568889999999853 336999999999999999999
Q ss_pred hCCCCCCC-CcHHHHHHHHhcCCCCCCCC
Q psy11359 258 TGTAPYHK-YPAMKVLMLTLQNDPPTLDT 285 (520)
Q Consensus 258 tG~~Pf~~-~~~~~~~~~~~~~~~~~~~~ 285 (520)
++++||.. ..+.+++..+....+|.++.
T Consensus 247 ~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 247 ILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred hccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 99999964 56777777777776666653
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=281.92 Aligned_cols=272 Identities=23% Similarity=0.376 Sum_probs=211.5
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
|....+.+-.+.||.|+||+||.+.|..+|+.||+|++.-- ...-.+.+.+.+|+++|.
T Consensus 49 Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv---------------------fq~L~s~krvFre~kmLc 107 (449)
T KOG0664|consen 49 PQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV---------------------FQNLASCKRVFREIKMLS 107 (449)
T ss_pred ccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchH---------------------HHHHHHHHHHHHHHHHHH
Confidence 44555667778999999999999999999999999876311 001224567899999999
Q ss_pred cCCCCCceEEEEEEEECC-----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 105 SCHHENVVTYHTSFVVKD-----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~-----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
.++|.|++..++...-.. ++|.++|++ ..+|..+|. ....++...++-+++||++||.|||+.||.
T Consensus 108 fFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIV--------SPQ~Ls~DHvKVFlYQILRGLKYLHsA~IL 178 (449)
T KOG0664|consen 108 SFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIV--------SPQALTPDHVKVFVYQILRGLKYLHTANIL 178 (449)
T ss_pred hhccccHHHHHHhcCCCCchHHHHHHHHHHHH-Hhhhhheec--------cCCCCCcchhhhhHHHHHhhhHHHhhcchh
Confidence 999999999888766432 478899998 458888876 567899999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG 259 (520)
||||||.|+|++.|-.+||||||+++..... .......-+-|-.|+|||++.+...|+.++||||+|||+.||+-.
T Consensus 179 HRDIKPGNLLVNSNCvLKICDFGLARvee~d----~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgR 254 (449)
T KOG0664|consen 179 HRDIKPGNLLVNSNCILKICDFGLARTWDQR----DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQR 254 (449)
T ss_pred hccCCCccEEeccCceEEecccccccccchh----hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhh
Confidence 9999999999999999999999999865322 112223346688999999999988899999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcC-------------------------CCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCC
Q psy11359 260 TAPYHKYPAMKVLMLTLQN-------------------------DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK 314 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 314 (520)
+..|....+.+++..+..- .++.+..-. .......-..+..+++.++|.+||++
T Consensus 255 rILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLY-tlsS~~~~~heav~~~~~~l~~d~dk 333 (449)
T KOG0664|consen 255 KILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLY-KIASPDDKNHEAVDLLQKLLHFDPDK 333 (449)
T ss_pred hhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCcccee-eecCCcccchHHHHHHHHHhCCCCcc
Confidence 9999887777666543321 011110000 00000112245678899999999999
Q ss_pred CCCHHHHhcCccccccc
Q psy11359 315 RPTASELLKNPFFKKAK 331 (520)
Q Consensus 315 Rpta~elL~hp~~~~~~ 331 (520)
|.+..+++.|+++...+
T Consensus 334 ris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 334 RISVEEALQHRYLEEGR 350 (449)
T ss_pred cccHhhhcccccccccc
Confidence 99999999999987544
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=309.72 Aligned_cols=257 Identities=29% Similarity=0.445 Sum_probs=195.3
Q ss_pred eEEEeeeeecCce-EEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CC
Q psy11359 31 YEVREVIGFGATA-VVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HH 108 (520)
Q Consensus 31 Y~i~~~LG~G~fg-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~H 108 (520)
|.-.+.+|.|+-| .||+|... |+.||+|.+ - .+..+...+||..|+.. .|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrl----------------------l----~e~~~~A~rEi~lL~eSD~H 562 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRL----------------------L----EEFFDFAQREIQLLQESDEH 562 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHH----------------------h----hHhHHHHHHHHHHHHhccCC
Confidence 4445678999987 68888764 345665543 2 33445678999999987 79
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
||||++|+.-.++...||..|+|. .+|.+++... .. ..........+.++.|+++||++||+.+||||||||.||
T Consensus 563 ~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~-~~---d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNI 637 (903)
T KOG1027|consen 563 PNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESS-GL---DVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNI 637 (903)
T ss_pred CceEEEEeeccCCceEEEEehHhh-hhHHHHHhcc-cc---chhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceE
Confidence 999999999999999999999995 6999999852 00 011111145678999999999999999999999999999
Q ss_pred EEcC---CC--CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC-CCC
Q psy11359 189 LLGE---DG--TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG-TAP 262 (520)
Q Consensus 189 Ll~~---~g--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG-~~P 262 (520)
||.. ++ +++|+|||++..++.+.. .-+...+..||-+|+|||++.... -..++||||+||++|+.++| .+|
T Consensus 638 LI~~~~~~~~~ra~iSDfglsKkl~~~~s--S~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~Hp 714 (903)
T KOG1027|consen 638 LISVPSADGTLRAKISDFGLSKKLAGGKS--SFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHP 714 (903)
T ss_pred EEEccCCCcceeEEecccccccccCCCcc--hhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccC
Confidence 9965 33 789999999999876654 233366788999999999998776 57799999999999999995 999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
|...-..+ ..++.+... +..-... . ..+..+||.+||.++|..||+|.++|.||||.....
T Consensus 715 FGd~~~R~--~NIl~~~~~-L~~L~~~----~--d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ek 775 (903)
T KOG1027|consen 715 FGDSLERQ--ANILTGNYT-LVHLEPL----P--DCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEK 775 (903)
T ss_pred CCchHHhh--hhhhcCccc-eeeeccC----c--hHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHH
Confidence 96543332 223333221 1111100 1 117899999999999999999999999999986543
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=289.47 Aligned_cols=275 Identities=27% Similarity=0.406 Sum_probs=210.4
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcC---CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKA---RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
.|...+.|.++++||.|.|++||+|.+.. ...+||+|.+ .. .+....+..|+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i----------------------~~---ts~p~ri~~El 85 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAI----------------------YR---TSSPSRILNEL 85 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeec----------------------cc---ccCchHHHHHH
Confidence 57788899999999999999999999887 5555555544 33 34556799999
Q ss_pred HHHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 101 QAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 101 ~~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
++|..+ .+.||+++.+.+..++...+||||++..+..++.. .++..+++.+++.++.||.++|.+|||
T Consensus 86 ~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~-----------~l~~~~i~~Yl~~ll~Al~~~h~~GIv 154 (418)
T KOG1167|consen 86 EMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR-----------SLSLAEIRWYLRNLLKALAHLHKNGIV 154 (418)
T ss_pred HHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh-----------cCCHHHHHHHHHHHHHHhhhhhccCcc
Confidence 999999 69999999999999999999999999999988886 366899999999999999999999999
Q ss_pred ecccCCCcEEEc-CCCCeEEeccCcceeecc-------------------Cc--------------------cccccccc
Q psy11359 180 HRDIKAGNILLG-EDGTVQIADFGVSAWLAT-------------------GR--------------------DLSRQKVR 219 (520)
Q Consensus 180 HrDLKp~NILl~-~~g~vkL~DFG~a~~~~~-------------------~~--------------------~~~~~~~~ 219 (520)
||||||.|+|.+ ..+.-.|+|||+|..... +. ...+....
T Consensus 155 HRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~ 234 (418)
T KOG1167|consen 155 HRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSER 234 (418)
T ss_pred ccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCcccee
Confidence 999999999996 567899999999962110 00 01111222
Q ss_pred cccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHH-HH--------------HHhcCC-----
Q psy11359 220 HTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKV-LM--------------LTLQND----- 279 (520)
Q Consensus 220 ~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~-~~--------------~~~~~~----- 279 (520)
....|||+|+|||++.....-++++||||.|+|++.++++.+||-...+... ++ ..+-+.
T Consensus 235 anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ 314 (418)
T KOG1167|consen 235 ANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQ 314 (418)
T ss_pred cccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeec
Confidence 3457999999999998776678999999999999999999999854432111 00 000000
Q ss_pred ---C----------CCCC--CC-------chhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhh
Q psy11359 280 ---P----------PTLD--TG-------AAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334 (520)
Q Consensus 280 ---~----------~~~~--~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~ 334 (520)
. ..+. .. .........++..+.+|+.+||..||.+|.||+++|+||||.......
T Consensus 315 ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~ 391 (418)
T KOG1167|consen 315 KSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTE 391 (418)
T ss_pred cccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhh
Confidence 0 0000 00 000111123456889999999999999999999999999999665443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=328.03 Aligned_cols=243 Identities=19% Similarity=0.285 Sum_probs=185.0
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
.|...++||+|+||.||+|.+..+|..||+|.++.. . .....|++.+++++||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~----------------------~-----~~~~~~~~~l~~l~Hp 743 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV----------------------N-----SIPSSEIADMGKLQHP 743 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCC----------------------c-----cccHHHHHHHhhCCCC
Confidence 456677999999999999999999888998876311 0 0123468889999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecccCCC
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH---SNGQIHRDIKAG 186 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH---~~giiHrDLKp~ 186 (520)
|||++++++...+..|+||||+++|+|.++++ .+++..+..++.||++||+||| +.+|+||||||+
T Consensus 744 nIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~ 812 (968)
T PLN00113 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPE 812 (968)
T ss_pred CcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHH
Confidence 99999999999999999999999999999995 2678999999999999999999 669999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
||+++.++..++. ||.+..... .....||+.|||||++.+.. |+.++|||||||++|||+||+.||...
T Consensus 813 Nil~~~~~~~~~~-~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 813 KIIIDGKDEPHLR-LSLPGLLCT---------DTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred hEEECCCCceEEE-ecccccccc---------CCCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 9999988888775 665432211 12336899999999987655 899999999999999999999998532
Q ss_pred cH----HHHHHH-HhcCC------CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 267 PA----MKVLML-TLQND------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 267 ~~----~~~~~~-~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
.. ...... ..... .+.+... .........++.+++.+||+.||++|||+.|+++.
T Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 882 FGVHGSIVEWARYCYSDCHLDMWIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cCCCCcHHHHHHHhcCccchhheeCccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11 111100 00000 0011000 00111233467899999999999999999999853
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=281.68 Aligned_cols=251 Identities=27% Similarity=0.400 Sum_probs=191.3
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh--
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS-- 104 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~-- 104 (520)
......+.++||+|.||.||+|.... +.||||+++.. ..+.+..|-.+.+
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~~--------------------------~kqs~~~Ek~Iy~lp 259 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFPEQ--------------------------EKQSFQNEKNIYSLP 259 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccC--ceeEEEecCHH--------------------------HHHHHHhHHHHHhcc
Confidence 35667889999999999999997654 78888887632 3345677777766
Q ss_pred cCCCCCceEEEEEEEECC----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC----
Q psy11359 105 SCHHENVVTYHTSFVVKD----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN---- 176 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~---- 176 (520)
.++|+||++|++.-.-.. .+|||++|.+.|+|.+|++ ...+++....+++..|++||+|||..
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~---------~ntisw~~~cria~SmarGLa~LHee~p~~ 330 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLK---------ANTISWNSLCRIAESMARGLAHLHEELPRG 330 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHH---------hccccHHHHHHHHHHHHHHHHHhcccCCcC
Confidence 458999999998876544 8999999999999999996 46889999999999999999999974
Q ss_pred -----CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCC-----cchhH
Q psy11359 177 -----GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD-----FKADI 246 (520)
Q Consensus 177 -----giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~-----~~~DI 246 (520)
.|+|||||..||||.+|++..|+|||+|..+..+. .......-+||..|||||++.+..... .++||
T Consensus 331 d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~---~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~Dv 407 (534)
T KOG3653|consen 331 DHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGK---PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDV 407 (534)
T ss_pred CCCCCccccccccccceEEccCCcEEeeccceeEEecCCC---CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHH
Confidence 49999999999999999999999999999987544 233344579999999999998765443 46899
Q ss_pred HHHHHHHHHHHhCC------------CCCCC----Cc---HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhh
Q psy11359 247 WSLGITAIEMATGT------------APYHK----YP---AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDC 307 (520)
Q Consensus 247 wSlG~il~elltG~------------~Pf~~----~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 307 (520)
||+|.+||||++.- +||.. .+ .+..+...- ...|.++..+.. ......+++.++.|
T Consensus 408 YamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~k-K~RP~~p~~W~~----h~~~~~l~et~EeC 482 (534)
T KOG3653|consen 408 YAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRK-KQRPKIPDAWRK----HAGMAVLCETIEEC 482 (534)
T ss_pred HHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhh-ccCCCChhhhhc----CccHHHHHHHHHHH
Confidence 99999999999842 22320 11 111111111 222333222211 12335688999999
Q ss_pred hccCCCCCCCHHHHh
Q psy11359 308 LQKDPTKRPTASELL 322 (520)
Q Consensus 308 L~~dP~~Rpta~elL 322 (520)
|..||+-|.||.=+-
T Consensus 483 WDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 483 WDHDAEARLTAGCVE 497 (534)
T ss_pred cCCchhhhhhhHHHH
Confidence 999999999987663
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=303.14 Aligned_cols=272 Identities=22% Similarity=0.394 Sum_probs=210.9
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.|....+...+.+.||+|+||.|++|....-...- ......||+|...........+.+..|+++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~---------------~~~~~~VaVK~~k~~~~~~~~~~~~~El~~ 354 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKAL---------------LSIYVTVAVKMLKENASSSEKKDLMSELNV 354 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeeccccc---------------ccceEEEEEEecccccCcHHHHHHHHHHHH
Confidence 56666677788889999999999999755321100 001345666666555555677889999999
Q ss_pred HhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCC--------CCCCHHHHHHHHHHHHHHHHHH
Q psy11359 103 MSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKH--------GVCDEPTIATVLREVLKGLEYF 173 (520)
Q Consensus 103 l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~--------~~l~~~~i~~i~~qIl~gL~yL 173 (520)
|+.+ +||||+.+++++..+..+++|+||+..|+|.+++++......... ..++..+...++.||+.|++||
T Consensus 355 m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L 434 (609)
T KOG0200|consen 355 LKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL 434 (609)
T ss_pred HHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH
Confidence 9999 799999999999999999999999999999999997651111011 2489999999999999999999
Q ss_pred HHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCcccccccccccccc--ccccCCcceecccCCCCcchhHHHHHH
Q psy11359 174 HSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVG--TPCWMAPEVMEQDHGYDFKADIWSLGI 251 (520)
Q Consensus 174 H~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~~~~DIwSlG~ 251 (520)
++.++|||||-+.|||++.+..+||+|||+|+.......... ....| ...|||||.+.... |+.++||||||+
T Consensus 435 ~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~----~~~~~~LP~kWmApEsl~~~~-ft~kSDVWSfGI 509 (609)
T KOG0200|consen 435 ASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRT----KSSAGTLPVKWMAPESLFDRV-FTSKSDVWSFGI 509 (609)
T ss_pred hhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEe----cCCCCccceeecCHHHhccCc-ccccchhhHHHH
Confidence 999999999999999999999999999999985433222111 11122 23499999998744 999999999999
Q ss_pred HHHHHHh-CCCCCCCCc-HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 252 TAIEMAT-GTAPYHKYP-AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 252 il~ellt-G~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+||||+| |..||.+.. ..+.+...-.+..... ...++.++.+++..||+.+|++||++.++.+
T Consensus 510 ~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 510 LLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 9999999 999999866 4444333333333222 2456788999999999999999999999975
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=291.74 Aligned_cols=255 Identities=27% Similarity=0.377 Sum_probs=209.5
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
..+..++||+|+||+||+|.....|+.|-|+ ||||.+......+...++++|+-+|.+|+||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKip------------------VaiKvl~~~t~~~~s~e~LdeAl~masldHp 758 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIP------------------VAIKVLIEFTSPKASIELLDEALRMASLDHP 758 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecce------------------eEEEEeeccCCchhhHHHHHHHHHHhcCCCc
Confidence 3456679999999999999988876654443 5666665555566678899999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
|++++++++.... +-||++|+.+|+|.||++. ....+..+....|..||++||.|||.++++||||-..|||
T Consensus 759 nl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~-------hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVL 830 (1177)
T KOG1025|consen 759 NLLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE-------HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVL 830 (1177)
T ss_pred hHHHHhhhcccch-HHHHHHhcccchHHHHHHH-------hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhhee
Confidence 9999999998766 8899999999999999987 4567888999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPA 268 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~ 268 (520)
|..-..+||.|||++..++.....-. .....-.+-|||=|.+.... |+.++|||||||++||++| |..||.+.+.
T Consensus 831 VksP~hvkitdfgla~ll~~d~~ey~---~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 831 VKSPNHVKITDFGLAKLLAPDEKEYS---APGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred ecCCCeEEEEecchhhccCccccccc---ccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 99999999999999998765432211 11112245689999887666 9999999999999999998 9999999887
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.++-...-.+.. ..+.+.++-++.-++.+||..|+..||+++++..
T Consensus 907 ~eI~dlle~geR---------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 907 EEIPDLLEKGER---------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHhhHHHhcccc---------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 776554444332 1223556778899999999999999999999864
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=285.33 Aligned_cols=210 Identities=28% Similarity=0.443 Sum_probs=180.4
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
....+|..+..||.|+||.|++|.++.....|+||.+.+..+... +.+.- ..+-.+-.||++|..
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~D--------tWvrD-------rkLGtVp~EIqIla~ 622 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVD--------TWVRD-------RKLGTVPSEIQILAT 622 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhh--------hhhcc-------cccCccchhHHHHHH
Confidence 345669999999999999999999999999999998875433211 11110 012235569999999
Q ss_pred CC---CCCceEEEEEEEECCEEEEEEEcc-CCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 106 CH---HENVVTYHTSFVVKDELWLVLRLL-EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 106 l~---HpnIv~~~~~~~~~~~~~lV~E~~-~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
|+ |+||++++++|++++.+||+||-. +|.+|+++|. .+..++|.+++.|++|++.|+++||+.|||||
T Consensus 623 l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE--------~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhr 694 (772)
T KOG1152|consen 623 LNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIE--------FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHR 694 (772)
T ss_pred hhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhh--------ccCccchHHHHHHHHHHHhccccccccCceec
Confidence 97 999999999999999999999986 4679999998 46789999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|||-+|+.++.+|-+||+|||.|.+.. ......++||..|.|||++.+..+.+..-|||++|++||-++..+-
T Consensus 695 dikdenvivd~~g~~klidfgsaa~~k-------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 695 DIKDENVIVDSNGFVKLIDFGSAAYTK-------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred ccccccEEEecCCeEEEeeccchhhhc-------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 999999999999999999999987653 3445789999999999999999888899999999999999999999
Q ss_pred CCCC
Q psy11359 262 PYHK 265 (520)
Q Consensus 262 Pf~~ 265 (520)
||..
T Consensus 768 pyyn 771 (772)
T KOG1152|consen 768 PYYN 771 (772)
T ss_pred CCcC
Confidence 9853
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=268.96 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=192.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh--
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS-- 104 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~-- 104 (520)
...+..+.+.||+|.||.||+|..+ |..||+|++.- .+.....+|.++..
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s--------------------------rdE~SWfrEtEIYqTv 260 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS--------------------------RDERSWFRETEIYQTV 260 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecc--------------------------cchhhhhhHHHHHHHH
Confidence 3467899999999999999999775 67777777641 22334667777765
Q ss_pred cCCCCCceEEEEEEEEC----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC----
Q psy11359 105 SCHHENVVTYHTSFVVK----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN---- 176 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~---- 176 (520)
.|+|+||+.|++.-..+ .++|||++|.+.|||+||+.. ..++.....+++..++.||.+||..
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---------~tv~~~~ml~LalS~AsGLaHLH~eI~GT 331 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---------NTVTTEGMLKLALSIASGLAHLHMEIVGT 331 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh---------ccCCHHHHHHHHHHHhhhHHHHHHHHhcC
Confidence 55999999999876543 259999999999999999963 6789999999999999999999964
Q ss_pred ----CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCC-----CcchhHH
Q psy11359 177 ----GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGY-----DFKADIW 247 (520)
Q Consensus 177 ----giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-----~~~~DIw 247 (520)
.|.|||||..||||.++|...|+|+|+|.......+. -.-..+..+||..|||||++...-.. -..+|||
T Consensus 332 qgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~-idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIY 410 (513)
T KOG2052|consen 332 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDT-IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIY 410 (513)
T ss_pred CCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCc-ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHH
Confidence 3999999999999999999999999999887655432 22234567999999999998654211 1368999
Q ss_pred HHHHHHHHHHhC----------CCCCCCC----cHHHHHHHHhcC--CCCCCCCCchhhhhHHHhcHHHHHHHHhhhccC
Q psy11359 248 SLGITAIEMATG----------TAPYHKY----PAMKVLMLTLQN--DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311 (520)
Q Consensus 248 SlG~il~elltG----------~~Pf~~~----~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 311 (520)
|||.++||++.. ++||... +..+........ ..|.++..+...+ .-..+.++++.||..+
T Consensus 411 afgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~----~l~~m~klMkeCW~~N 486 (513)
T KOG2052|consen 411 AFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDP----ALRVMAKLMKECWYAN 486 (513)
T ss_pred HHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCH----HHHHHHHHHHHhhcCC
Confidence 999999999862 5688543 344444443332 2344443332222 1234678999999999
Q ss_pred CCCCCCHHHHh
Q psy11359 312 PTKRPTASELL 322 (520)
Q Consensus 312 P~~Rpta~elL 322 (520)
|.-|.||--+-
T Consensus 487 p~aRltALriK 497 (513)
T KOG2052|consen 487 PAARLTALRIK 497 (513)
T ss_pred chhhhHHHHHH
Confidence 99999987764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=242.13 Aligned_cols=214 Identities=42% Similarity=0.680 Sum_probs=184.1
Q ss_pred eeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEEE
Q psy11359 37 IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHT 116 (520)
Q Consensus 37 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~~ 116 (520)
||.|++|.||++.+..++..+++|++..... ....+.+.+|+..++.+.|++|+++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----------------------~~~~~~~~~e~~~~~~l~~~~i~~~~~ 58 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS----------------------SSLLEELLREIEILKKLNHPNIVKLYG 58 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccc----------------------hhHHHHHHHHHHHHHhcCCCCeeeEee
Confidence 6899999999999998888888887753211 113457899999999999999999999
Q ss_pred EEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcC-CCC
Q psy11359 117 SFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE-DGT 195 (520)
Q Consensus 117 ~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~-~g~ 195 (520)
++......+++|||+.|++|.+++... ...++...+..++.+++++|.+||++|++|+||+|.||+++. ++.
T Consensus 59 ~~~~~~~~~~~~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~ 131 (215)
T cd00180 59 VFEDENHLYLVMEYCEGGSLKDLLKEN-------EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK 131 (215)
T ss_pred eeecCCeEEEEEecCCCCcHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc
Confidence 999999999999999999999999742 246889999999999999999999999999999999999998 899
Q ss_pred eEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q psy11359 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLT 275 (520)
Q Consensus 196 vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~ 275 (520)
++|+|||.+........ ......+...|++||.+.....++.+.|+|++|+++++|
T Consensus 132 ~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------- 187 (215)
T cd00180 132 VKLADFGLSKLLTSDKS-----LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------- 187 (215)
T ss_pred EEEecCCceEEccCCcc-----hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------
Confidence 99999999876643221 123356788999999987653488999999999999999
Q ss_pred hcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCc
Q psy11359 276 LQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325 (520)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp 325 (520)
..+.+++.+|++.+|.+||++.++++|+
T Consensus 188 ----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4578899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=239.19 Aligned_cols=216 Identities=34% Similarity=0.548 Sum_probs=179.7
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
|.+.+.||.|++|+||++.+..+++.+|+|.+..... ....+.+.+|+..++.++|+|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------------------~~~~~~~~~e~~~~~~~~~~~ 58 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKT----------------------EKQREEFLREIRILKKLKHPN 58 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccc----------------------hHHHHHHHHHHHHHHhCCCCC
Confidence 6788999999999999999999888899988753211 013567889999999999999
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGV-CDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~-l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
++++++++......++++||+.+++|.+++... .. +++..+..++.|++.+|.+||+++++|+||+|.||+
T Consensus 59 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~ 130 (225)
T smart00221 59 IVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKK--------GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENIL 130 (225)
T ss_pred hhhheeeeecCCceEEEEeccCCCCHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 999999999999999999999999999999742 23 789999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC-CcH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK-YPA 268 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~-~~~ 268 (520)
++.++.++|+|||.+..+.... ........++..|++||.+.....++.++|+|+||+++++|++|+.||.. ...
T Consensus 131 v~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~ 206 (225)
T smart00221 131 LGMDGLVKLADFGLARFIHRDL----AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEF 206 (225)
T ss_pred EcCCCCEEEeeCceeeEecCcc----cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchh
Confidence 9999999999999988764332 01223457888999999984334478899999999999999999999977 455
Q ss_pred HHHHHHHhcCCC
Q psy11359 269 MKVLMLTLQNDP 280 (520)
Q Consensus 269 ~~~~~~~~~~~~ 280 (520)
...+...+...+
T Consensus 207 ~~~~~~~~~~~~ 218 (225)
T smart00221 207 TSLLSDVWSFGV 218 (225)
T ss_pred HHHHHHHHhcCC
Confidence 545544444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=297.22 Aligned_cols=207 Identities=17% Similarity=0.187 Sum_probs=148.8
Q ss_pred hcCCC-CCceEEEEEE-------EECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11359 104 SSCHH-ENVVTYHTSF-------VVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS 175 (520)
Q Consensus 104 ~~l~H-pnIv~~~~~~-------~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~ 175 (520)
+.++| +||++++++| ...+.++++|||+ +++|.+++.. ....+++.++..+++||++||.|||+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-------~~~~~~~~~~~~i~~qi~~al~~lH~ 98 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-------PDRSVDAFECFHVFRQIVEIVNAAHS 98 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-------ccccccHHHHHHHHHHHHHHHHHHHh
Confidence 35556 6888888887 2335688889988 6799999963 34569999999999999999999999
Q ss_pred CCcEecccCCCcEEEcCCC-------------------CeEEeccCcceeeccCcc-----c------cccccccccccc
Q psy11359 176 NGQIHRDIKAGNILLGEDG-------------------TVQIADFGVSAWLATGRD-----L------SRQKVRHTFVGT 225 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g-------------------~vkL~DFG~a~~~~~~~~-----~------~~~~~~~~~~gt 225 (520)
+||+||||||+||||+..| .+||+|||+++....... . .........+||
T Consensus 99 ~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 99 QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 9999999999999996544 456666666543211000 0 000011224689
Q ss_pred cccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHH
Q psy11359 226 PCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMIS 305 (520)
Q Consensus 226 ~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 305 (520)
+.|||||++.+.. |+.++|||||||+||||++|.+|+..... .+........+. ......+...+++.
T Consensus 179 ~~Y~APE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 246 (793)
T PLN00181 179 SWYTSPEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPP---------QILLNWPKEASFCL 246 (793)
T ss_pred cceEChhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcCh---------hhhhcCHHHHHHHH
Confidence 9999999987765 89999999999999999999888754221 111111110000 00111344568899
Q ss_pred hhhccCCCCCCCHHHHhcCcccccc
Q psy11359 306 DCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 306 ~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
+||+++|.+|||+.|+|+||||...
T Consensus 247 ~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred HhCCCChhhCcChHHHhhchhhhhh
Confidence 9999999999999999999999764
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=246.17 Aligned_cols=247 Identities=21% Similarity=0.320 Sum_probs=194.6
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
++--...+.|.+.+.||.|.||.+-+|+++.+.+.+++|.+..+ .....+|.+|.+
T Consensus 17 l~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p------------------------~tt~~dF~rEfh 72 (378)
T KOG1345|consen 17 LKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP------------------------QTTQADFVREFH 72 (378)
T ss_pred ccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc------------------------hhhHHHHHHHhc
Confidence 34445678899999999999999999999999999999987533 335677999987
Q ss_pred HHhcC-CCCCceEEEEE-EEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 102 AMSSC-HHENVVTYHTS-FVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 102 ~l~~l-~HpnIv~~~~~-~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
---.| .|.||+.-|++ |.+.+.+++++||++.|+|..-+. ...+.|..-++++.|+++||.|+|++++|
T Consensus 73 Y~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~---------~~GigE~~~K~v~~ql~SAi~fMHsknlV 143 (378)
T KOG1345|consen 73 YSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVE---------AAGIGEANTKKVFAQLLSAIEFMHSKNLV 143 (378)
T ss_pred cceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcC---------cccccHHHHHHHHHHHHHHHHHhhccchh
Confidence 76666 68999987755 667889999999999999998774 35678999999999999999999999999
Q ss_pred ecccCCCcEEEc--CCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc----CCCCcchhHHHHHHHH
Q psy11359 180 HRDIKAGNILLG--EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD----HGYDFKADIWSLGITA 253 (520)
Q Consensus 180 HrDLKp~NILl~--~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~~~~DIwSlG~il 253 (520)
|||||.+||||- +..++||||||+.+..+.... ..--+..|.+||++... ...++.+|+|.||+++
T Consensus 144 HRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~--------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~ 215 (378)
T KOG1345|consen 144 HRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK--------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIF 215 (378)
T ss_pred hcccccceEEEecCCccEEEeeecccccccCceeh--------hhhhhcccCCcHHHhhccccceEecccccchheeeee
Confidence 999999999993 445899999998765432111 12234578999986432 2256789999999999
Q ss_pred HHHHhCCCCCCCCc----HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCC
Q psy11359 254 IEMATGTAPYHKYP----AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315 (520)
Q Consensus 254 ~elltG~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 315 (520)
|.++||.+||.... +.-.++...+...+.+ ...++.+++.+..+.++-|.++|++|
T Consensus 216 f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~------P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 216 FYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL------PKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred eeeecCCCcchhhhccCchHHHHHHHhcccCccC------chhhcccCHHHHHHHHHhcCCccccc
Confidence 99999999997533 3333444444444333 23456788999999999999999999
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=228.17 Aligned_cols=167 Identities=28% Similarity=0.397 Sum_probs=130.4
Q ss_pred CCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccc
Q psy11359 134 GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDL 213 (520)
Q Consensus 134 gsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~ 213 (520)
|+|.+++.. ..+.+++.+++.++.||+.||.|||+++ ||+|||++.++.+++ ||++......
T Consensus 1 GsL~~~l~~-------~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--- 62 (176)
T smart00750 1 VSLADILEV-------RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--- 62 (176)
T ss_pred CcHHHHHHH-------hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc---
Confidence 689999975 2456999999999999999999999999 999999999999999 9998765321
Q ss_pred cccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHH-HHHhcCCCCCCCCCchhhhh
Q psy11359 214 SRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVL-MLTLQNDPPTLDTGAAEKDQ 292 (520)
Q Consensus 214 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 292 (520)
...||+.|||||++.+.. |+.++|||||||++|+|+||..||......... .............. ...
T Consensus 63 -------~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 131 (176)
T smart00750 63 -------QSRVDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD---RSN 131 (176)
T ss_pred -------cCCCcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc---ccc
Confidence 126899999999998765 899999999999999999999999765443222 22222111111110 011
Q ss_pred HHHhcH--HHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 293 YKAYGK--TFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 293 ~~~~~~--~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
...++. .+.++|.+||..+|.+|||+.++++|+|+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 223344 6999999999999999999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=237.92 Aligned_cols=266 Identities=16% Similarity=0.236 Sum_probs=210.5
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
..++++.-++-+|.||.||.|..++..++. ..+.+.+|.+.....+-....++.|..++..+.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n-----------------~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s 345 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYN-----------------DCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS 345 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcc-----------------hHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc
Confidence 456788889999999999999776542221 134455555555544556778999999999999
Q ss_pred CCCceEEEEEEEE-CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 108 HENVVTYHTSFVV-KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 108 HpnIv~~~~~~~~-~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
|||+..+.++... .+..+.++.+..-|+|..++..-..-.....+.++..++..++.|++.|++|||++|+||.||-..
T Consensus 346 H~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaR 425 (563)
T KOG1024|consen 346 HPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAAR 425 (563)
T ss_pred CCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhh
Confidence 9999999988874 456778889998899999998432222224456788899999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHK 265 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~ 265 (520)
|.+|++.-.+||+|=.+++-+-.+. ..+....--....||+||.+.... |+.++|+||||++||||+| |+.||..
T Consensus 426 NCvIdd~LqVkltDsaLSRDLFP~D---YhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~Pyae 501 (563)
T KOG1024|consen 426 NCVIDDQLQVKLTDSALSRDLFPGD---YHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAE 501 (563)
T ss_pred cceehhheeEEeccchhccccCccc---ccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccc
Confidence 9999999999999999987553221 111112222345799999997766 9999999999999999999 9999999
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.++.+.......+..... ...+++++..++..||+..|++||+.+|+..
T Consensus 502 IDPfEm~~ylkdGyRlaQ---------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 502 IDPFEMEHYLKDGYRLAQ---------PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCHHHHHHHHhccceecC---------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 999988877666644332 3567899999999999999999999999975
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-29 Score=268.10 Aligned_cols=275 Identities=24% Similarity=0.319 Sum_probs=210.8
Q ss_pred CCe-EEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 29 DQY-EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 29 ~~Y-~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
+.| ....++|.|++|.|+.+........+++|.++.. . + ..+........+..|+-+-..|+
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~--------------~--~~~s~~~~~~~i~sE~~i~~~l~ 379 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-V--------------K--PTESERKYNYNITSEFCIGSSLS 379 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcc-c--------------C--CcccHHHHhhhhhhheeeccccc
Confidence 335 5678999999998888888777766666644311 0 0 11111112222667888888999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||++.....+......+-+||||.+ +|+.++.. .+.+...++..+++||+.|+.|+|+.|+.||||||+|
T Consensus 380 h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~--------~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~en 450 (601)
T KOG0590|consen 380 HPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMS--------NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLEN 450 (601)
T ss_pred CCchhhhHHHHhhcccchhhhhcccH-HHHHHHhc--------ccccchhhhhHHHHHHHHHHHHHHhcCceeccCcccc
Confidence 99998877666666666666999998 99999973 3578899999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
+++..+|.+||+|||.+..+..+... .......++|+..|+|||++.+..+....+||||.|++++.|++|+.||....
T Consensus 451 ll~~~~g~lki~Dfg~~~vf~~~~e~-~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 451 LLVTENGILKIIDFGAASVFRYPWEK-NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred EEEecCCceEEeecCcceeeccCcch-hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 99999999999999999877554332 12445678999999999999988755667999999999999999999997655
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
..+...... ...............+..++...+.+|.+||+++|.+|.|+.+|++++||+...
T Consensus 530 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 530 KSDNSFKTN-NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred ccccchhhh-ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 443321111 111122222334556677888999999999999999999999999999998654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-25 Score=221.25 Aligned_cols=271 Identities=32% Similarity=0.480 Sum_probs=205.8
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC-
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE- 109 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp- 109 (520)
|.+.+.||.|+|+.||++.+. ..+++|.+....... ......+.+|+.++..+.|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~--------------------~~~~~~~~~e~~~~~~~~~~~ 58 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK--------------------SKEVERFLREIQILASLNHPP 58 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc--------------------hhHHHHHHHHHHHHHHccCCc
Confidence 889999999999999999988 667777664322110 12466799999999999888
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
+|+++++.+......+++++++.+++|.+++..... . ..+++..+..++.|++.++.|+|+.+++|||+||+||+
T Consensus 59 ~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil 133 (384)
T COG0515 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGR----K-GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENIL 133 (384)
T ss_pred ceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhccc----c-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHee
Confidence 799999999888889999999999999977764210 0 37899999999999999999999999999999999999
Q ss_pred EcCCC-CeEEeccCcceeeccCcccccc-ccccccccccccCCcceeccc--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 190 LGEDG-TVQIADFGVSAWLATGRDLSRQ-KVRHTFVGTPCWMAPEVMEQD--HGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 190 l~~~g-~vkL~DFG~a~~~~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~--~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
++..+ .++++|||.+..+......... .......||+.|+|||.+.+. ..++...|+||+|++++++++|..||..
T Consensus 134 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~ 213 (384)
T COG0515 134 LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213 (384)
T ss_pred ecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99888 7999999998755433221111 134567899999999999873 3589999999999999999999999877
Q ss_pred CcH---HHHHHHHhcCCCCC-CCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 266 YPA---MKVLMLTLQNDPPT-LDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 266 ~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
... .......+...... .......... ......+.+++..|+..+|..|.+..+...++|....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 214 EKNSSATSQTLKIILELPTPSLASPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred CCccccHHHHHHHHHhcCCcccccccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 653 22222222222211 1100000000 1223578899999999999999999999988666543
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-25 Score=225.77 Aligned_cols=258 Identities=22% Similarity=0.234 Sum_probs=190.5
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCC-ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARA-EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
+|++.+.||+|+||.||.+.+..++ ..+|+|..... ...... .+..|+.++..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~----------------------~~~~~~-~l~~E~~vl~~l~~ 75 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKE----------------------LGSKPS-VLKIEIQVLKKLEK 75 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEec----------------------ccCCCc-cchhHHHHHHHHhh
Confidence 8999999999999999999998875 55676654321 111111 47778888888863
Q ss_pred ----CCceEEEEEE-EECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 109 ----ENVVTYHTSF-VVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 109 ----pnIv~~~~~~-~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+++..+++.+ .....-|+||+++ |.+|.++.+.. ..+.++...+..++.|++.+|++||+.|++||||
T Consensus 76 ~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~------~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDi 148 (322)
T KOG1164|consen 76 KNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRN------PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDI 148 (322)
T ss_pred hcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhC------CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCc
Confidence 6899999999 4778899999999 89999988653 3578999999999999999999999999999999
Q ss_pred CCCcEEEcCC-----CCeEEeccCcce--eeccCccc--ccccc-ccccccccccCCcceecccCCCCcchhHHHHHHHH
Q psy11359 184 KAGNILLGED-----GTVQIADFGVSA--WLATGRDL--SRQKV-RHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253 (520)
Q Consensus 184 Kp~NILl~~~-----g~vkL~DFG~a~--~~~~~~~~--~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il 253 (520)
||.|++++.. ..+.|.|||+++ .+...... ..... ...+.||..|+++.+..+.. .+.+.|+||++.++
T Consensus 149 Kp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l 227 (322)
T KOG1164|consen 149 KPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYML 227 (322)
T ss_pred CHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHH
Confidence 9999999754 369999999998 33222211 11111 23567999999999987766 79999999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 254 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.+|+.|..||.............+......... .....+.++.++...+-..+...+|....+..
T Consensus 228 ~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 228 LELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHHhcCCCCCccccccchHHHHHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 999999999976554322221111111110000 11223456666777666677888888877754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-26 Score=230.00 Aligned_cols=188 Identities=20% Similarity=0.258 Sum_probs=138.6
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcC-CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKA-RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
+-+...++|.+.+.||+|+||+||+|.++. +++.+|||++.... .........+.+.+|++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~------------------~~~~~~~~~~~~~~E~~ 73 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEV------------------PWWSKPLARHLAAREIR 73 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccc------------------cccccHHHHHHHHHHHH
Confidence 345677889999999999999999999887 66667887652110 00000223456899999
Q ss_pred HHhcCCCCCceE-EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 102 AMSSCHHENVVT-YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 102 ~l~~l~HpnIv~-~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+|++|+|+||++ ++. .+..|+||||+.|++|.. +. ..+ ...++.|++++|.|||++||+|
T Consensus 74 iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~-~~--------~~~------~~~~~~~i~~aL~~lH~~gIiH 134 (365)
T PRK09188 74 ALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHL-AR--------PHG------DPAWFRSAHRALRDLHRAGITH 134 (365)
T ss_pred HHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHH-hC--------ccc------hHHHHHHHHHHHHHHHHCCCee
Confidence 999999999985 543 246899999999999963 21 111 1468899999999999999999
Q ss_pred ccc-CCCcEEEcCCCCeEEeccCcceeeccCcccccc---ccccccccccccCCcceecccCC-----CCcchhHH
Q psy11359 181 RDI-KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQ---KVRHTFVGTPCWMAPEVMEQDHG-----YDFKADIW 247 (520)
Q Consensus 181 rDL-Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~---~~~~~~~gt~~y~APE~~~~~~~-----~~~~~DIw 247 (520)
||| ||+|||++.++.+||+|||+|..+......... ..-.+..+++.|+|||.+..... .+...|-|
T Consensus 135 rDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 135 NDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999 999999999999999999999877543322111 11136788999999999864321 23446666
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=208.06 Aligned_cols=256 Identities=20% Similarity=0.220 Sum_probs=198.5
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
-...++|+++++||.|+||.+|.|....+|..||||+-+... ...++..|..+.+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-------------------------~hpqL~yEskvY~ 65 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-------------------------KHPQLLYESKVYR 65 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-------------------------CCcchhHHHHHHH
Confidence 356788999999999999999999999999999999754221 1234788999999
Q ss_pred cCCC-CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 105 SCHH-ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 105 ~l~H-pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
.|++ .+|..++.++.+++.-.+||+++ |.||.++..- -...|+...+.-++.|++.-++|+|.+++|||||
T Consensus 66 iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf-------C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDI 137 (341)
T KOG1163|consen 66 ILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNF-------CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDI 137 (341)
T ss_pred HhccCCCCchhhhhccccccceeeeecc-CccHHHHHHH-------HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccC
Confidence 8854 67888888888899999999999 8999999875 4567899999999999999999999999999999
Q ss_pred CCCcEEEcC---CCCeEEeccCcceeeccCccccc--cccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 184 KAGNILLGE---DGTVQIADFGVSAWLATGRDLSR--QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 184 Kp~NILl~~---~g~vkL~DFG~a~~~~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
||+|+|++- ...+.|+|||+|..+........ -.......||..|.+--...+.. -+.+.|+-|+|.+|.++.-
T Consensus 138 KPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnr 216 (341)
T KOG1163|consen 138 KPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNR 216 (341)
T ss_pred CccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeec
Confidence 999999963 45799999999987754332211 22234578999998877665544 5788999999999999999
Q ss_pred CCCCCCCCcHHHHH---HHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH
Q psy11359 259 GTAPYHKYPAMKVL---MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319 (520)
Q Consensus 259 G~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 319 (520)
|..||.+....... ..+.... .. .......+.+|.+|.-.+.-|-..--++-|...
T Consensus 217 G~LPWQglka~tk~QKyEkI~EkK-~s----~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 217 GSLPWQGLKAATKKQKYEKISEKK-MS----TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred CCCcccccchhhHHHHHHHHHHhh-cC----CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 99999986543222 2222211 11 122345678889999999888766555666543
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-25 Score=209.94 Aligned_cols=255 Identities=20% Similarity=0.233 Sum_probs=194.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
-.-.|++.++||.|+||..+.|.+.-++++||||.-.. .+..-++..|....+.|
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-------------------------kS~APQLrdEYr~YKlL 80 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-------------------------KSEAPQLRDEYRTYKLL 80 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc-------------------------cCCcchHHHHHHHHHHH
Confidence 44579999999999999999999999999999995421 23344688899988888
Q ss_pred -CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 -HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 -~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
..++|...|-+......-.||+|++ |.||.|+..- ....|+.+.+..++.|++.-++|+|++.+|.|||||
T Consensus 81 ~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~-------CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKP 152 (449)
T KOG1165|consen 81 GGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDL-------CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKP 152 (449)
T ss_pred cCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHH-------hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCc
Confidence 5799999988777888889999999 8999998875 467899999999999999999999999999999999
Q ss_pred CcEEEcCCC-----CeEEeccCcceeeccCccccccc--cccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 186 GNILLGEDG-----TVQIADFGVSAWLATGRDLSRQK--VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 186 ~NILl~~~g-----~vkL~DFG~a~~~~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
+|+||+..| .+.|+|||+|..+.......... -..+..||..||+--...+.. -+.+.|+-|||-++++++-
T Consensus 153 dNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLR 231 (449)
T KOG1165|consen 153 DNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLR 231 (449)
T ss_pred cceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhcc
Confidence 999996433 58999999999886554322222 234678999999988887776 6889999999999999999
Q ss_pred CCCCCCCCcHH--HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH
Q psy11359 259 GTAPYHKYPAM--KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319 (520)
Q Consensus 259 G~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 319 (520)
|.+||.+.... +.-...+...... .........++.+|..-+.-.-..+-.+-|..+
T Consensus 232 GsLPWQGLKA~tnK~kYeKIGe~Kr~----T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 232 GSLPWQGLKADTNKEKYEKIGETKRS----TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred CCCccccccCcchHHHHHHhcccccc----CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 99999875432 2222222221111 112334455666766666554444444445443
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=229.25 Aligned_cols=245 Identities=26% Similarity=0.396 Sum_probs=197.0
Q ss_pred eeeecCceEEEEEEE---cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC-CCCc
Q psy11359 36 VIGFGATAVVHSAYC---KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH-HENV 111 (520)
Q Consensus 36 ~LG~G~fg~Vy~a~~---~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~-HpnI 111 (520)
++|.|+||.|++++. ...|.-+|.|+.++..... +... .-..|-.++..++ ||.+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~------------~~~~---------~t~~er~il~~~~~~~f~ 59 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKV------------RDRT---------HTKQERIILAFVHNTPFL 59 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccc------------cccc---------ccccHHHHHhhccCCCce
Confidence 479999999998743 3346667877765433211 1110 2334666777775 9999
Q ss_pred eEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEc
Q psy11359 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191 (520)
Q Consensus 112 v~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~ 191 (520)
|+++..|..+..+++++++..||.|+..+. +...+++...+.+...++-+++++|+.+++|||+|++||+++
T Consensus 60 v~lhyafqt~~kl~l~ld~~rgg~lft~l~--------~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld 131 (612)
T KOG0603|consen 60 VKLHYAFQTDGKLYLILDFLRGGDLFTRLS--------KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL 131 (612)
T ss_pred eeeeeeeccccchhHhhhhcccchhhhccc--------cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec
Confidence 999999999999999999999999998886 567788999999999999999999999999999999999999
Q ss_pred CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q psy11359 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKV 271 (520)
Q Consensus 192 ~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~ 271 (520)
.+|++++.|||+++....... .|||..|||||+.. +...++|.||||+++++|+||..||.. +.
T Consensus 132 ~~Ghi~~tdfglske~v~~~~---------~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~ 195 (612)
T KOG0603|consen 132 LEGHIKLTDFGLSKEAVKEKI---------ACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DT 195 (612)
T ss_pred ccCccccCCchhhhHhHhhhh---------cccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HH
Confidence 999999999999876533221 18999999999987 378899999999999999999999987 33
Q ss_pred HHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchhhH
Q psy11359 272 LMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~ 335 (520)
...++...... ...++..+++++..++..+|.+|.- +.|+++|+||+...+.+.
T Consensus 196 ~~~Il~~~~~~----------p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l 254 (612)
T KOG0603|consen 196 MKRILKAELEM----------PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNEL 254 (612)
T ss_pred HHHHhhhccCC----------chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhH
Confidence 33343322221 2456788999999999999999965 478999999998887643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=196.69 Aligned_cols=181 Identities=16% Similarity=0.188 Sum_probs=132.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.++||.|+||.||++.+ ++..+|+|+++........+..+ -...+.+.+|++.+.+|
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~--------------f~~g~~~e~Ea~~l~rL 92 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKS--------------FVKGDYYENLIVQTDRV 92 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHh--------------hhhhHHHHHHHHHHHHH
Confidence 357899999999999999999755 46689999886432111100000 00123378999999999
Q ss_pred CCCCceEEEEEEEEC--------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 107 HHENVVTYHTSFVVK--------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~--------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
.||+|..+.+++... ...+|||||++|.+|.++.. +++ ..+.+|+.+|..||.+|+
T Consensus 93 ~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------------~~~----~~~~~i~~~l~~lH~~gi 156 (232)
T PRK10359 93 RSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------------ISE----DVKAKIKASIESLHQHGM 156 (232)
T ss_pred HHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh------------ccH----HHHHHHHHHHHHHHHcCC
Confidence 999999999887643 35899999999999988742 222 246699999999999999
Q ss_pred EecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 179 iHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
+|||+||+||+++.+| ++|+|||........... ..+.... .|+.++|+||||+++..+..
T Consensus 157 ~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~-----------------d~~vler-~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 157 VSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK-----------------DRIDLER-HYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred ccCCCChHHEEEeCCC-EEEEECCCcccccchhhH-----------------HHHHHHh-HhcccccccceeEeehHHHH
Confidence 9999999999999988 999999977544211100 0022223 37789999999999876553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=197.06 Aligned_cols=244 Identities=20% Similarity=0.271 Sum_probs=154.7
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
...+...+.||.|+++.||.+.+..+|+++|+|++..... ......+++.+|.-....+.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~--------------------~~~~~~~~~~~e~l~~~~~~ 70 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD--------------------ASANEYEQLKEEQLAITLFP 70 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST--------------------THTTHHHHHHHHHHGGGGST
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccc--------------------cchHHHHHHHHHHHHhhhhc
Confidence 3456788899999999999999999999999998864321 11234666777765555433
Q ss_pred C----------CCceEEEEEEEE---------C---C-----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHH
Q psy11359 108 H----------ENVVTYHTSFVV---------K---D-----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIA 160 (520)
Q Consensus 108 H----------pnIv~~~~~~~~---------~---~-----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~ 160 (520)
+ -.++..++.... . . +.+++|+-+ .++|.+++........ .+..+......
T Consensus 71 ~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~-~~~~l~~~arl 148 (288)
T PF14531_consen 71 GVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ-THSPLAFAARL 148 (288)
T ss_dssp T--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT-TSHHHHHHHHH
T ss_pred cCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc-ccchhHHHHHH
Confidence 2 122222222221 1 1 246778877 5789888764322211 11223333445
Q ss_pred HHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc---
Q psy11359 161 TVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD--- 237 (520)
Q Consensus 161 ~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--- 237 (520)
.+..|+++.+++||+.|++|+||+|+|+|++.+|.++|+||+.....+. . ......+..|.+||.....
T Consensus 149 ~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~------~~~~~~~~~~~PPe~~~~~~~~ 220 (288)
T PF14531_consen 149 SLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT--R------YRCSEFPVAFTPPELESCAGQF 220 (288)
T ss_dssp HHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTE--E------EEGGGS-TTTS-HHHHHHHTSC
T ss_pred HHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCc--e------eeccCCCcccCChhhhhhhccc
Confidence 5668999999999999999999999999999999999999987654321 1 1112445789999976442
Q ss_pred ----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCC
Q psy11359 238 ----HGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313 (520)
Q Consensus 238 ----~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 313 (520)
..++.+.|.|+||+++|.|++|..||........... .......++..++.||..+|+++|.
T Consensus 221 ~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------------~f~~C~~~Pe~v~~LI~~lL~~~~~ 286 (288)
T PF14531_consen 221 GQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------------DFSRCRDMPEPVQFLIRGLLQRNPE 286 (288)
T ss_dssp HHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------------GGTTSS---HHHHHHHHHHT-SSGG
T ss_pred CcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------------cchhcCCcCHHHHHHHHHHccCCcc
Confidence 2378899999999999999999999976433211000 1122236788999999999999999
Q ss_pred CC
Q psy11359 314 KR 315 (520)
Q Consensus 314 ~R 315 (520)
+|
T Consensus 287 ~R 288 (288)
T PF14531_consen 287 DR 288 (288)
T ss_dssp GS
T ss_pred cC
Confidence 88
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=223.19 Aligned_cols=238 Identities=25% Similarity=0.405 Sum_probs=178.2
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
....+|..+++|..|++|.||.++++.+.+.+|.| +++..+ +.+- ++..
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----------------------------ilRn--ilt~ 128 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----------------------------ILRN--ILTF 128 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----------------------------hhhc--cccc
Confidence 34567999999999999999999999998888884 321100 1110 2223
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
-..|.+| |+-...++ ..+.++... +.+++|||+-||+|||+||
T Consensus 129 a~npfvv---------------------gDc~tllk--------~~g~lPvdm--------vla~Eylh~ygivhrdlkp 171 (1205)
T KOG0606|consen 129 AGNPFVV---------------------GDCATLLK--------NIGPLPVDM--------VLAVEYLHSYGIVHRDLKP 171 (1205)
T ss_pred cCCccee---------------------chhhhhcc--------cCCCCcchh--------hHHhHhhccCCeecCCCCC
Confidence 3344443 45455554 234444322 8899999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCc----------cccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGR----------DLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~----------~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
+|.+|+.-|++|+.|||++....... ...++-.....+|||.|+|||++..+ +|+..+|+|++|+|+|+
T Consensus 172 dnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlye 250 (1205)
T KOG0606|consen 172 DNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYE 250 (1205)
T ss_pred CcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHH
Confidence 99999999999999999986432111 11122223456999999999998754 49999999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCC---CCHHHHhcCccccccch
Q psy11359 256 MATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR---PTASELLKNPFFKKAKD 332 (520)
Q Consensus 256 lltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pta~elL~hp~~~~~~~ 332 (520)
++.|..||.+..+.+.+...+.......+. ...++++++++|.++|+.+|..| ..+-++.+|+||+..++
T Consensus 251 FLVgcvpffGdtpeelfg~visd~i~wpE~-------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 251 FLVGCVPFFGDTPEELFGQVISDDIEWPEE-------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred HheeeeeccCCCHHHHHhhhhhhhcccccc-------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 999999999999888887766655443332 24578899999999999999999 56788889999999988
Q ss_pred hhHHHhh
Q psy11359 333 KKFIQQT 339 (520)
Q Consensus 333 ~~~~~~~ 339 (520)
...+.|.
T Consensus 324 ~~llRqk 330 (1205)
T KOG0606|consen 324 KSLLRQK 330 (1205)
T ss_pred chhhhhh
Confidence 8655544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-23 Score=192.19 Aligned_cols=162 Identities=15% Similarity=0.116 Sum_probs=112.6
Q ss_pred EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccc-eeeEEE-eecccchh-hHHHHHHHHHHHhcCCCCC
Q psy11359 34 REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAE-KCAIKK-INLEKWNT-SMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~-~~aiK~-i~~~~~~~-~~~~l~~Ei~~l~~l~Hpn 110 (520)
...||+|+||.||+|.+. +|++||+|+++.............+ ..-++. ........ ......+|++++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999999754221100000000 000000 00000011 1223457999999998887
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcEecccCCCcEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYF-HSNGQIHRDIKAGNIL 189 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yL-H~~giiHrDLKp~NIL 189 (520)
+...+.+.. ...+|||||+.|++|...+. ..+.+++..+..++.||+.+|.|+ |+.||+||||||+|||
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--------~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIl 150 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRL--------KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLL 150 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhh--------hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 754433322 22389999999887765543 345788999999999999999999 7999999999999999
Q ss_pred EcCCCCeEEeccCcceee
Q psy11359 190 LGEDGTVQIADFGVSAWL 207 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~ 207 (520)
++ ++.++|+|||+|...
T Consensus 151 i~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EE-CCcEEEEEccccccC
Confidence 98 588999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-23 Score=200.20 Aligned_cols=277 Identities=26% Similarity=0.320 Sum_probs=181.3
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEE-------Eeeh------hhhhhhHhhhccceeeEEEeecccchhhH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIK-------KINL------AVVHSAYCKARAEKCAIKKINLEKWNTSM 93 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK-------~i~~------~~~~~~~~~~~~~~~aiK~i~~~~~~~~~ 93 (520)
.-++|++.+.||+|.-+.||.|....+|...-.- -+.. ............-+.|||.+-.-...+.-
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 4466999999999999999999877643321100 0000 00001111122335666765443322222
Q ss_pred HHH----HHHHH------HH---------------hcC-CCCCceEEEEEEEEC--------------------------
Q psy11359 94 DEL----LKEIQ------AM---------------SSC-HHENVVTYHTSFVVK-------------------------- 121 (520)
Q Consensus 94 ~~l----~~Ei~------~l---------------~~l-~HpnIv~~~~~~~~~-------------------------- 121 (520)
..+ .+|.- .+ .+| +|||||++++.|.+.
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 222 22221 00 122 699999998887642
Q ss_pred -CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEE--cCCC--Ce
Q psy11359 122 -DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL--GEDG--TV 196 (520)
Q Consensus 122 -~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl--~~~g--~v 196 (520)
..+|+||.-.. -+|++|+- ....+....+-++.|+++|+.|||++||.|||||.+|||+ ++|+ .+
T Consensus 315 ~~tlylvMkrY~-~tLr~yl~---------~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~L 384 (598)
T KOG4158|consen 315 PKTLYLVMKRYR-QTLREYLW---------TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQL 384 (598)
T ss_pred CceEEEehhcch-hhHHHHHh---------cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEE
Confidence 24899999884 59999994 4567788899999999999999999999999999999999 4555 57
Q ss_pred EEeccCcceeecc-CccccccccccccccccccCCcceecccCCC-----CcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q psy11359 197 QIADFGVSAWLAT-GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGY-----DFKADIWSLGITAIEMATGTAPYHKYPAMK 270 (520)
Q Consensus 197 kL~DFG~a~~~~~-~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-----~~~~DIwSlG~il~elltG~~Pf~~~~~~~ 270 (520)
.|+|||.+-.-.. +-.....+..-..-|..+-||||+.....+. -.++|.|+.|.+.||+++..-||.+...+.
T Consensus 385 VvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~ 464 (598)
T KOG4158|consen 385 VVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML 464 (598)
T ss_pred EEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe
Confidence 8999997632111 0111111222234578899999998755432 248999999999999999999998754432
Q ss_pred HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH
Q psy11359 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321 (520)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el 321 (520)
.-....+.. . .......+++.+++++..+|+.||++|+++.=+
T Consensus 465 L~~r~Yqe~--q------LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 465 LDTRTYQES--Q------LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred echhhhhhh--h------CCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 221111111 0 112235678899999999999999999986443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-22 Score=183.61 Aligned_cols=191 Identities=16% Similarity=0.170 Sum_probs=137.5
Q ss_pred EEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccc---hhhHHHHHHHHHHHhcC-C
Q psy11359 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW---NTSMDELLKEIQAMSSC-H 107 (520)
Q Consensus 32 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~---~~~~~~l~~Ei~~l~~l-~ 107 (520)
.+...|++|+||+||.+.. .+.+++.+.+. ...+ ......+.+|+++|++| +
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~----------------------~~~~~~~~~~~~l~~rE~~iL~~L~~ 60 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLS----------------------AAPWWLRGVAWWLARREALALRQLDG 60 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccc----------------------cchhhhhhHHHHHHHHHHHHHHhcCC
Confidence 4578999999999997755 55556555432 2111 11122578999999999 4
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc-CCC
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI-KAG 186 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL-Kp~ 186 (520)
|++|++++++ +..+++|||+.|.+|.+.+.. + ...++.|++.+|.++|++||+|||| ||+
T Consensus 61 ~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~---------~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~ 121 (218)
T PRK12274 61 LPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR---------G------DLAYFRAARRLLQQLHRCGVAHNDLAKEA 121 (218)
T ss_pred CCCCCEEEEE----cCEEEEEeeecCccHHhhhhh---------h------hHHHHHHHHHHHHHHHHCcCccCCCCCcc
Confidence 5889999885 457999999999998754321 1 1357889999999999999999999 799
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccc----ccccc----ccccccccccCCcceecccCCCC-cchhHHHHHHHHHHHH
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDL----SRQKV----RHTFVGTPCWMAPEVMEQDHGYD-FKADIWSLGITAIEMA 257 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~----~~~~~----~~~~~gt~~y~APE~~~~~~~~~-~~~DIwSlG~il~ell 257 (520)
|||++.+|.++|+|||+|......... ..... ......++.|++|+.-.--...+ ...+.++.|+-+|.++
T Consensus 122 NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~ 201 (218)
T PRK12274 122 NWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFV 201 (218)
T ss_pred eEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHH
Confidence 999999999999999999854432210 00000 11123678889998643222233 5678889999999999
Q ss_pred hCCCCCCC
Q psy11359 258 TGTAPYHK 265 (520)
Q Consensus 258 tG~~Pf~~ 265 (520)
|+..|+..
T Consensus 202 ~~~~~~~~ 209 (218)
T PRK12274 202 TRRVLHWE 209 (218)
T ss_pred hccCCccc
Confidence 99988654
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-23 Score=224.23 Aligned_cols=259 Identities=20% Similarity=0.201 Sum_probs=182.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
....+|...+.||++.|=+|.+|++.+. .|++|++-+. -..-. -....+...|++ ...
T Consensus 20 d~~~e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~------------------~p~~s-L~~~~qrL~~ik-~~l 77 (1431)
T KOG1240|consen 20 DLSVECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQ------------------DPTIS-LRPFKQRLEEIK-FAL 77 (1431)
T ss_pred cCccceeeecccCchhhhhhhhccCCCc--eEEEEEEecc------------------CCCCC-chHHHHHHHHHH-HHh
Confidence 3333799999999999999999988763 3778875321 10000 012333445555 566
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++|||.++|.-+-+.++..|||-+|+. -+|.|.+.. ...+..-+.+.|+.||+.||..+|..||+|+|||.
T Consensus 78 ~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlST--------RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKs 148 (1431)
T KOG1240|consen 78 MKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLST--------RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKS 148 (1431)
T ss_pred hcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhcc--------chHHHHHHHHHHHHHHHHHHHHHHHcCcccccccc
Confidence 799999999888788888999999994 589998864 35567788999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceee--ccCccccccccccccccccccCCcceecccC---------C-CCcchhHHHHHHHH
Q psy11359 186 GNILLGEDGTVQIADFGVSAWL--ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH---------G-YDFKADIWSLGITA 253 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~--~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---------~-~~~~~DIwSlG~il 253 (520)
+||||+.-+-+.|+||..-+.. .........-...+...-.||.|||.+.... . .+++.||||+||++
T Consensus 149 ENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVi 228 (1431)
T KOG1240|consen 149 ENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVI 228 (1431)
T ss_pred ceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHH
Confidence 9999999999999999865422 1111111111122223345899999875411 1 56789999999999
Q ss_pred HHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 254 IEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 254 ~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
+||++ |++||.-. ++...-.+. ....+....+--+..+++||..|++.||++|.+|++.|+.
T Consensus 229 aELf~Eg~PlF~LS----QL~aYr~~~-----~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 229 AELFLEGRPLFTLS----QLLAYRSGN-----ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhcCCCcccHH----HHHhHhccC-----ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 99998 78888421 111111111 0011111122234578999999999999999999999974
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=183.50 Aligned_cols=163 Identities=17% Similarity=0.117 Sum_probs=114.7
Q ss_pred EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhH--hhhccceeeEEEeecccc-hhhHHHHHHHHHHHhcCCCCC
Q psy11359 34 REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAY--CKARAEKCAIKKINLEKW-NTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~--~~~~~~~~aiK~i~~~~~-~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
.+.||+|+||.||+|.+. +|+.||+|+++........ .................. ......+.+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 8999999999754211000 000000000000000000 111234568999999999998
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccCCCcEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGNIL 189 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLKp~NIL 189 (520)
|.....+.... .||||||+.|+++...+. ....++...+..++.|++.+|.++|+ +||+||||||+|||
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l--------~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRL--------KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhh--------hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 86544443332 489999999886544322 23457889999999999999999999 99999999999999
Q ss_pred EcCCCCeEEeccCcceeec
Q psy11359 190 LGEDGTVQIADFGVSAWLA 208 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~ 208 (520)
++ ++.++|+|||++..+.
T Consensus 151 l~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EE-CCCEEEEEcccceecC
Confidence 98 8999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-23 Score=211.20 Aligned_cols=183 Identities=23% Similarity=0.459 Sum_probs=134.7
Q ss_pred EEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCc
Q psy11359 124 LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203 (520)
Q Consensus 124 ~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~ 203 (520)
+||.|++|.-.+|.+||.++. .....+......|+.|++.|++| +|.+|||+||.||++..+..+||+|||+
T Consensus 331 lyI~Mn~c~~~tledWl~rr~-----~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRR-----TGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCC-----cccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhh
Confidence 678899999999999997532 23456678899999999999999 9999999999999999999999999999
Q ss_pred ceeeccCcccc-ccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC
Q psy11359 204 SAWLATGRDLS-RQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPP 281 (520)
Q Consensus 204 a~~~~~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 281 (520)
........... ........+||+.||+||.+.++. |+.++||||||++|+|+++ -..+|........ +..
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d----~r~--- 474 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERIATLTD----IRD--- 474 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHHHhhhh----hhc---
Confidence 87665433111 111233468999999999999876 9999999999999999998 3333322111111 111
Q ss_pred CCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 282 TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
+..+...+..+ +.-..|+.++|.+.|.+||++.+.-.|+|.
T Consensus 475 ----g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 475 ----GIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ----CCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 11111112222 334589999999999999988877777765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=177.86 Aligned_cols=132 Identities=17% Similarity=0.204 Sum_probs=103.3
Q ss_pred EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-----CC
Q psy11359 34 REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-----HH 108 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-----~H 108 (520)
.++||+|+|+.||. +..++.+ +||++.. .. ....+.+.+|+.++++| .|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~----------------------~~-~~~~~~~~rEi~~l~~L~~~~~~h 60 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYH----------------------RG-DGGDKEIRRELKYYAHLSRRLIDW 60 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEec----------------------cc-cchHHHHHHHHHHHHHhhccCCCC
Confidence 46899999999995 6666555 4666532 11 11345689999999999 57
Q ss_pred CCceEEEEEEEECC---E-EEEEEEc--cCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH-HHHHHCCcEec
Q psy11359 109 ENVVTYHTSFVVKD---E-LWLVLRL--LEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL-EYFHSNGQIHR 181 (520)
Q Consensus 109 pnIv~~~~~~~~~~---~-~~lV~E~--~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL-~yLH~~giiHr 181 (520)
|||+++|++++++. . +.+|||| +.+++|.++++. +.+++. ..++.|++.++ +|||+++|+||
T Consensus 61 ~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~---------~~~~e~--~~~~~~~L~~l~~yLh~~~Ivhr 129 (210)
T PRK10345 61 SGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ---------CRYEED--VAQLRQLLKKLKRYLLDNRIVTM 129 (210)
T ss_pred cccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc---------ccccHh--HHHHHHHHHHHHHHHHHCCEeec
Confidence 99999999999874 4 4478999 557999999963 235555 46788888888 99999999999
Q ss_pred ccCCCcEEEcC----CCCeEEeccC
Q psy11359 182 DIKAGNILLGE----DGTVQIADFG 202 (520)
Q Consensus 182 DLKp~NILl~~----~g~vkL~DFG 202 (520)
||||+|||++. ++.++|+||+
T Consensus 130 DlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 130 ELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred CCCHHHEEEeccCCCCCcEEEEECC
Confidence 99999999964 3379999954
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.1e-20 Score=202.88 Aligned_cols=200 Identities=23% Similarity=0.228 Sum_probs=159.0
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.+.-....|.|.+.||.|+||+||+|.... |+.||+|+-+.... .+.+ ==.++
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--------WEfY------------------I~~q~ 744 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--------WEFY------------------ICLQV 744 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--------eeee------------------ehHHH
Confidence 455677889999999999999999999888 99999997642211 1111 12233
Q ss_pred HhcCC---CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 103 MSSCH---HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 103 l~~l~---HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+.+|+ -+.|+.+...+...+.-+||+||.+.|||.+++. ..+.+++..+..+..||++.++.||..+||
T Consensus 745 ~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N--------~~~~m~e~lv~~~~~qml~ive~lH~~~II 816 (974)
T KOG1166|consen 745 MERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN--------TNKVMDEYLVMFFSCQMLRIVEHLHAMGII 816 (974)
T ss_pred HHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc--------cCCCCCchhhhHHHHHHHHHHHHHHhccee
Confidence 44444 2456667777777888899999999999999998 567899999999999999999999999999
Q ss_pred ecccCCCcEEEcC-------CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHH
Q psy11359 180 HRDIKAGNILLGE-------DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252 (520)
Q Consensus 180 HrDLKp~NILl~~-------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~i 252 (520)
|+||||+|+||.. ..-++|+|||.+.-+.--. ........++|-.|-.+|...+.. +++.+|.|.|..+
T Consensus 817 HgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp---~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~ 892 (974)
T KOG1166|consen 817 HGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFP---DGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAAT 892 (974)
T ss_pred cccCCcceeEeecccCCCCcccceEEEecccceeeeEcC---CCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHH
Confidence 9999999999942 3369999999886442211 112334567888999999887766 9999999999999
Q ss_pred HHHHHhCCC
Q psy11359 253 AIEMATGTA 261 (520)
Q Consensus 253 l~elltG~~ 261 (520)
++.||.|++
T Consensus 893 ~h~mLFG~y 901 (974)
T KOG1166|consen 893 VHVMLFGKY 901 (974)
T ss_pred HHHHHHHHH
Confidence 999999964
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-21 Score=210.89 Aligned_cols=267 Identities=25% Similarity=0.368 Sum_probs=207.4
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCC-CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKAR-AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
....|.+.+.||+|+|+.|-.+....+ ...+|.|.+.... +.....+....|..+-+.
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---------------------~~~~~~~~i~~e~~~~~~ 76 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---------------------KSEDSSEHIDTETDIQKK 76 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---------------------CccchhhhcCcccccccc
Confidence 466789999999999999988866443 2334444332111 123344556678888888
Q ss_pred CC-CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCC-CCCHHHHHHHHHHHHHHHHHHH-HCCcEecc
Q psy11359 106 CH-HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHG-VCDEPTIATVLREVLKGLEYFH-SNGQIHRD 182 (520)
Q Consensus 106 l~-HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~-~l~~~~i~~i~~qIl~gL~yLH-~~giiHrD 182 (520)
+. |+|++.+++.....+..+++++|..|+++++.+.. ... ..+......++.|+..+|.|+| ..++.|||
T Consensus 77 ~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~-------~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ 149 (601)
T KOG0590|consen 77 LSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH-------PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRD 149 (601)
T ss_pred ccccccccccCCccCCCcccccccCccccccccccccc-------CCccCCCCcchhhhhhhhccCccccCcccccccCC
Confidence 86 99999999999999999999999999999998831 333 6778899999999999999999 99999999
Q ss_pred cCCCcEEEcCCC-CeEEeccCcceeecc-Ccccccccccccccc-ccccCCcceecccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 183 IKAGNILLGEDG-TVQIADFGVSAWLAT-GRDLSRQKVRHTFVG-TPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 183 LKp~NILl~~~g-~vkL~DFG~a~~~~~-~~~~~~~~~~~~~~g-t~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG 259 (520)
|||+|.+++..+ .++++|||+|..+.. .. ........+| ++.|+|||...+.....+..|+||.|+++..|++|
T Consensus 150 ikP~n~~l~~s~~~l~~~df~~At~~~~~~g---~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g 226 (601)
T KOG0590|consen 150 IKPSNSLLDESGSALKIADFGLATAYRNKNG---AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTG 226 (601)
T ss_pred CCCccchhccCCCcccCCCchhhccccccCC---cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccC
Confidence 999999999999 999999999988755 22 2223344577 99999999998865578999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
..|+................. .......+..++....+++.+++..+|..|.+.+++..++|+..
T Consensus 227 ~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 227 ELPWDFPSRKDGRYSSWKSNK-----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CCCccccccccccceeecccc-----cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 999975444332211111111 01112345677888899999999999999999999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=175.15 Aligned_cols=165 Identities=18% Similarity=0.101 Sum_probs=117.1
Q ss_pred CCCCCeEEEeeeeecCceEEEEEE-EcCCCceEEEEEeehhhhhhhHhhhccceee-EEEee--cccc-hhhHHHHHHHH
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAY-CKARAEKCAIKKINLAVVHSAYCKARAEKCA-IKKIN--LEKW-NTSMDELLKEI 100 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~-~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~a-iK~i~--~~~~-~~~~~~l~~Ei 100 (520)
....-|.+.+.||+|+||.||+|. +..+|+.||+|+++......... ..... .+... .... ......+.+|+
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRR---DRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecch---hhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 344568999999999999999999 77889999999987432110000 00000 00000 0000 11223467899
Q ss_pred HHHhcCCCC--CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Q psy11359 101 QAMSSCHHE--NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG- 177 (520)
Q Consensus 101 ~~l~~l~Hp--nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g- 177 (520)
.++.++.+. .+.+++.. ...++||||+.|++|..+.. ....+....+..++.||+.+|.+||++|
T Consensus 102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~g~ 169 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--------KDVEPEEEEEFELYDDILEEMRKLYKEGE 169 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc--------ccCCcchHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999753 34444442 23589999999988876542 2345667778899999999999999999
Q ss_pred cEecccCCCcEEEcCCCCeEEeccCccee
Q psy11359 178 QIHRDIKAGNILLGEDGTVQIADFGVSAW 206 (520)
Q Consensus 178 iiHrDLKp~NILl~~~g~vkL~DFG~a~~ 206 (520)
++||||||+||+++ ++.++|+|||.+..
T Consensus 170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 170 LVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 99999999999998 88999999998754
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-20 Score=174.08 Aligned_cols=241 Identities=19% Similarity=0.320 Sum_probs=184.6
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchh-hHHHHHHHHHHHhcCCCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNT-SMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~-~~~~l~~Ei~~l~~l~Hp 109 (520)
..+..+|...-.|..|+++.+.+ .++.|+++. ..+.. ...+|..|.-.|+-+.||
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgn--divakil~v----------------------r~~t~risrdfneefp~lrifshp 247 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGN--DIVAKILNV----------------------REVTARISRDFNEEFPALRIFSHP 247 (448)
T ss_pred hhhhhhhccCCCcccccccccCc--chhhhhhhh----------------------hhcchhhcchhhhhCcceeeecCC
Confidence 34566778888889999987643 445555432 22222 234578888899999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecccCCCc
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG--QIHRDIKAGN 187 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g--iiHrDLKp~N 187 (520)
||+.+++.+....++.+|..|++.|+|+.++... ..-.++..++.+++..|++|+.|||+.. |----|....
T Consensus 248 nilpvlgacnsppnlv~isq~mp~gslynvlhe~------t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~h 321 (448)
T KOG0195|consen 248 NILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQ------TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKH 321 (448)
T ss_pred chhhhhhhccCCCCceEeeeeccchHHHHHHhcC------ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccce
Confidence 9999999999999999999999999999999753 3446788899999999999999999985 4444688999
Q ss_pred EEEcCCCCeEEe--ccCcceeeccCccccccccccccccccccCCcceecccCC--CCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 188 ILLGEDGTVQIA--DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG--YDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 188 ILl~~~g~vkL~--DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~--~~~~~DIwSlG~il~elltG~~Pf 263 (520)
++++++-+.+|. |--++. +. ....-.|.||+||.+..... .-.++|+|||.++++||.|.+.||
T Consensus 322 vmidedltarismad~kfsf----------qe--~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf 389 (448)
T KOG0195|consen 322 VMIDEDLTARISMADTKFSF----------QE--VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF 389 (448)
T ss_pred EEecchhhhheecccceeee----------ec--cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence 999988776663 332221 11 12234689999999875432 235799999999999999999999
Q ss_pred CCCcHHHHHHHH-hcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 264 HKYPAMKVLMLT-LQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 264 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
...++++.-+.+ +.+-...++ +.++..+.+|+.-|+..||.+||.++.++
T Consensus 390 adlspmecgmkialeglrv~ip---------pgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 390 ADLSPMECGMKIALEGLRVHIP---------PGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ccCCchhhhhhhhhccccccCC---------CCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 999998877654 334444443 45678899999999999999999988765
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=164.34 Aligned_cols=142 Identities=24% Similarity=0.331 Sum_probs=113.2
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY 114 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~ 114 (520)
+.||+|++|.||+|.. .|..+++|+......... .+ ........+.+|+.++..+.|++|+..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~------------~~---~~~~~~~~~~~E~~~l~~l~~~~i~~p 64 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHP------------EL---DERIRRERTRREARIMSRARKAGVNVP 64 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcCh------------HH---HHHHHHHHHHHHHHHHHHHHHCCCCCC
Confidence 6799999999999987 677888886532110000 00 001123467889999999999999887
Q ss_pred EEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCC
Q psy11359 115 HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194 (520)
Q Consensus 115 ~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g 194 (520)
..++...+..++||||++|++|.+++... . . ....++.+|+.+|.++|+.|++|||++|.|||++ ++
T Consensus 65 ~~~~~~~~~~~lv~e~~~G~~L~~~~~~~--------~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~ 131 (211)
T PRK14879 65 AVYFVDPENFIIVMEYIEGEPLKDLINSN--------G---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG 131 (211)
T ss_pred eEEEEeCCCCEEEEEEeCCcCHHHHHHhc--------c---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC
Confidence 77777888899999999999999998631 1 2 8889999999999999999999999999999998 78
Q ss_pred CeEEeccCccee
Q psy11359 195 TVQIADFGVSAW 206 (520)
Q Consensus 195 ~vkL~DFG~a~~ 206 (520)
.++|+|||.+..
T Consensus 132 ~~~liDf~~a~~ 143 (211)
T PRK14879 132 KIYLIDFGLAEF 143 (211)
T ss_pred CEEEEECCcccC
Confidence 999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-18 Score=163.24 Aligned_cols=158 Identities=21% Similarity=0.157 Sum_probs=113.2
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
.|.+.+.||+|+||.||++... +|+.||+|+++.............+.+..+... ...........+|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHA-SWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccc-hhHHHhHHHHHHHHHHHHHHHHc
Confidence 4888899999999999999875 799999999875321110000000111111110 11112233467899999999877
Q ss_pred C--ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 110 N--VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 110 n--Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
+ ++..++ ....++||||+.|++|..+.. ......++.+|+.++.++|+.|++||||||+|
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~N 155 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRV--------------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFN 155 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhccc--------------cccHHHHHHHHHHHHHHHHHCCCCcCCCCccc
Confidence 4 444443 345689999999999876542 13456789999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceee
Q psy11359 188 ILLGEDGTVQIADFGVSAWL 207 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~ 207 (520)
|+++.++.++|+|||++..+
T Consensus 156 ill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred EEEcCCCcEEEEECCccccC
Confidence 99999999999999988544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.5e-18 Score=176.69 Aligned_cols=208 Identities=21% Similarity=0.392 Sum_probs=157.9
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-Eec
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ-IHR 181 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi-iHr 181 (520)
|+.+.|.|+.++++.+.+...++.|.+||..|+|.|.+.. ....++.--...+++.|+.||.|||+-.| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-------~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-------EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-------cccCccHHHHHHHHHHHHHHHHHHhcCcceeee
Confidence 4678999999999999999999999999999999999985 35567888899999999999999999876 999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCC------CCcchhHHHHHHHHHH
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG------YDFKADIWSLGITAIE 255 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~------~~~~~DIwSlG~il~e 255 (520)
.|++.|.+++....+||+|||+....... ..........-...|.|||.+..... .+.+.||||||++++|
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~---~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEET---AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeccccceeeeeEEEEechhhhccccccc---ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 99999999999999999999998765320 01111111223456999999876421 3667999999999999
Q ss_pred HHhCCCCCCCCc----HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 256 MATGTAPYHKYP----AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 256 lltG~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+++...||.... +.+.+..+.......+...... .....+.+..++..||..+|..||+++++-.
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~---~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL---LNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HHhccCccccccccCChHHHHHHHHhcCCCCcCcchhh---hhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 999999997522 2233333333122111111111 1145567899999999999999999999854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.3e-18 Score=159.33 Aligned_cols=138 Identities=23% Similarity=0.287 Sum_probs=106.8
Q ss_pred eeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEE
Q psy11359 36 VIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYH 115 (520)
Q Consensus 36 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~ 115 (520)
.||+|+||+||+|. .+|..+++|+........ . .-......+++.+|++++..+.|+++....
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~------------~---~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 63 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRH------------P---ELDERIRRERTRNEARLLSRARKAGVNTPV 63 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcC------------c---hHHHHHHHHHHHHHHHHHHHHHHCCCCCCE
Confidence 48999999999998 356788888743110000 0 000112346688999999999988776655
Q ss_pred EEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCC
Q psy11359 116 TSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195 (520)
Q Consensus 116 ~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~ 195 (520)
.++...+..++||||++|++|.+++... . . .++.|++.+|.+||+.|++|+|++|.||+++ ++.
T Consensus 64 ~~~~~~~~~~lv~e~~~g~~l~~~~~~~--------~----~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~ 127 (199)
T TIGR03724 64 VYDVDPDNKTIVMEYIEGKPLKDVIEEG--------N----D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK 127 (199)
T ss_pred EEEEECCCCEEEEEEECCccHHHHHhhc--------H----H---HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc
Confidence 5666777789999999999999987531 1 0 7899999999999999999999999999998 899
Q ss_pred eEEeccCccee
Q psy11359 196 VQIADFGVSAW 206 (520)
Q Consensus 196 vkL~DFG~a~~ 206 (520)
++++|||++..
T Consensus 128 ~~liDfg~a~~ 138 (199)
T TIGR03724 128 LYLIDFGLGKY 138 (199)
T ss_pred EEEEECCCCcC
Confidence 99999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.2e-19 Score=170.78 Aligned_cols=219 Identities=21% Similarity=0.330 Sum_probs=153.4
Q ss_pred HHHhcCCCCCceEEEEEEEECC-----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKD-----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS 175 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~-----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~ 175 (520)
..+-++-|.|||+++.||.+.. ...+++||++.|+|.+++++..+ .+..+.....++|+.||+.||.|||+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~----~~~a~~~~~wkkw~tqIlsal~yLhs 194 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK----NQKALFQKAWKKWCTQILSALSYLHS 194 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH----hhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence 4455677999999999997544 48899999999999999997655 56778899999999999999999999
Q ss_pred CC--cEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHH
Q psy11359 176 NG--QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253 (520)
Q Consensus 176 ~g--iiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il 253 (520)
.. |+|+.+.++-|++..+|-+||+----.. ........+..-...-.|-++|.|||.=.... .+.++|||+||++.
T Consensus 195 ~~PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn-~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 195 CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTN-TTGASDIYKFGMCA 272 (458)
T ss_pred cCCccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccc-cccchhhhhhhHHH
Confidence 85 9999999999999999999985222111 11111111111112234678899999744333 57799999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 254 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
++|..++.--......-.....+.+....+. ...-++++.+||+..|..||++.+++.||.+-.....
T Consensus 273 lemailEiq~tnseS~~~~ee~ia~~i~~le------------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhsl 340 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESKVEVEENIANVIIGLE------------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSL 340 (458)
T ss_pred HHHHHheeccCCCcceeehhhhhhhheeecc------------CccccCcCcccccCCCCCCcchhhhhcCceeeecchH
Confidence 9999987542211111111111111111110 1123568999999999999999999999998766554
Q ss_pred hHHH
Q psy11359 334 KFIQ 337 (520)
Q Consensus 334 ~~~~ 337 (520)
+.+.
T Consensus 341 kll~ 344 (458)
T KOG1266|consen 341 KLLM 344 (458)
T ss_pred HHHh
Confidence 4433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=178.59 Aligned_cols=143 Identities=20% Similarity=0.259 Sum_probs=111.4
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE 109 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp 109 (520)
.|...+.||+|+||+||++.... ..+++|+..... ...+.+ ......+++.+|+++++.++|+
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~------------~~~~~~---~~~~~~~~~~~E~~~l~~l~~~ 396 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKG------------YRHPEL---DERLRTERTRAEARLLSEARRA 396 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC--ccceeEEEeccc------------ccchhH---HHHHHHHHHHHHHHHHHhhccc
Confidence 34568999999999999987644 344444321100 000000 0112345788999999999999
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
+|+..+.++......++||||++|++|.+++. ....++.||+.+|.|||++|++||||||+|||
T Consensus 397 ~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NIL 460 (535)
T PRK09605 397 GVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFI 460 (535)
T ss_pred CCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEE
Confidence 99988887777788899999999999999884 24578999999999999999999999999999
Q ss_pred EcCCCCeEEeccCccee
Q psy11359 190 LGEDGTVQIADFGVSAW 206 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~ 206 (520)
+ .++.++|+|||+++.
T Consensus 461 l-~~~~~~liDFGla~~ 476 (535)
T PRK09605 461 V-RDDRLYLIDFGLGKY 476 (535)
T ss_pred E-ECCcEEEEeCccccc
Confidence 9 678999999998754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.5e-17 Score=156.01 Aligned_cols=145 Identities=17% Similarity=0.203 Sum_probs=107.6
Q ss_pred eeee-ecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeeccc--chhhHHHHHHHHHHHhcCCCCCc
Q psy11359 35 EVIG-FGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK--WNTSMDELLKEIQAMSSCHHENV 111 (520)
Q Consensus 35 ~~LG-~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~--~~~~~~~l~~Ei~~l~~l~HpnI 111 (520)
..|| .||.|+||.+... +..+++|.+... .++.|.+..+- .......+.+|+.++.+|.|++|
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~------------~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi 102 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRG------------GLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGL 102 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEc------------chHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCC
Confidence 4677 8888888888764 778999987532 23333322111 01234568899999999998885
Q ss_pred --eEEEEEEEECC----EEEEEEEccCC-CCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 112 --VTYHTSFVVKD----ELWLVLRLLEG-GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 112 --v~~~~~~~~~~----~~~lV~E~~~g-gsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
++.+++...+. ..++|||+++| .+|.+++.. ..+++. .+.||+.+|.+||++||+|||||
T Consensus 103 ~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---------~~l~~~----~~~~i~~~l~~lH~~GI~HrDlk 169 (239)
T PRK01723 103 PVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE---------APLSEE----QWQAIGQLIARFHDAGVYHADLN 169 (239)
T ss_pred CCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc---------CCCCHH----HHHHHHHHHHHHHHCCCCCCCCC
Confidence 66776644322 23599999997 699998852 334544 36789999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCccee
Q psy11359 185 AGNILLGEDGTVQIADFGVSAW 206 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~ 206 (520)
|+|||++.++.++|+|||.+..
T Consensus 170 p~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 170 AHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred chhEEEcCCCCEEEEECCCccc
Confidence 9999999889999999997754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-16 Score=147.05 Aligned_cols=158 Identities=19% Similarity=0.124 Sum_probs=101.1
Q ss_pred EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccc-eeeEEEeecccchhhHHHHHHHHHHHhcCCCCC--
Q psy11359 34 REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAE-KCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN-- 110 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~-~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn-- 110 (520)
.+.||+|+||+||+|.+. +|+.||+|+++.............. ...-+................|...+.++.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999887 8999999998643211100000000 000000000000001112245667777765443
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHH-HHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccCCCcE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGNI 188 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~-~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLKp~NI 188 (520)
+.+.+.. ...++||||+.|+++.. .+... .. ...++.++.+++.++.++|. +||+||||||+||
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---------~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Ni 146 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---------RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNI 146 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh---------hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhE
Confidence 4555543 24689999999854322 11110 00 16788999999999999999 9999999999999
Q ss_pred EEcCCCCeEEeccCcceee
Q psy11359 189 LLGEDGTVQIADFGVSAWL 207 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~ 207 (520)
+++ ++.++|+|||.+...
T Consensus 147 li~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EEE-CCcEEEEECcccccc
Confidence 999 899999999988544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-16 Score=165.59 Aligned_cols=261 Identities=23% Similarity=0.303 Sum_probs=200.9
Q ss_pred CCCCeEEEeeeee--cCceEEEEEEE--cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGF--GATAVVHSAYC--KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 27 ~~~~Y~i~~~LG~--G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
....+-+...+|. |.+|.||.+.+ ..++..+|+|.-+...-. ......=++|+..
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~---------------------p~~~~~k~~~~~s 170 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP---------------------PLDSKRKLREFLS 170 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC---------------------ccccccccchhhc
Confidence 3445678889999 99999999999 889888998863221100 0011112345555
Q ss_pred HhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH----HHHHHHHCC
Q psy11359 103 MSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLK----GLEYFHSNG 177 (520)
Q Consensus 103 l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~----gL~yLH~~g 177 (520)
.+.+ .|+|.++.+..|+..+..++-+|+| |.+|..+... ....+++..++..+.+... ||.++|+.+
T Consensus 171 ~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~-------~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~ 242 (524)
T KOG0601|consen 171 HHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHT-------PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN 242 (524)
T ss_pred ccccCccccccccCcccccCCcceeeeccc-cchhHHhhhc-------ccccCCchhhhhHHhhhhhcccccccccCCCc
Confidence 5555 5999999999999999999999999 5889888875 4566889999999999999 999999999
Q ss_pred cEecccCCCcEEEcCC-CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 178 QIHRDIKAGNILLGED-GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 178 iiHrDLKp~NILl~~~-g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
++|-|+||.||++..+ ...+++|||+...+..+.............|...|++||...+- ++...|||++|.+..+-
T Consensus 243 ~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~ 320 (524)
T KOG0601|consen 243 IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEA 320 (524)
T ss_pred ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhh
Confidence 9999999999999988 89999999999888766543333333344678889999998765 89999999999999999
Q ss_pred HhCCCCCCCC--cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 257 ATGTAPYHKY--PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 257 ltG~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
.++..+.... ... ..+.......+.....+..+...+..|+..+|..|++++.++.|+++..
T Consensus 321 ~l~~~~~~~g~~~~W-----------~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 321 ILGSHLPSVGKNSSW-----------SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred HhhcccccCCCCCCc-----------cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 9987665432 111 1111222223333455667777999999999999999999999999873
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.7e-15 Score=134.71 Aligned_cols=132 Identities=18% Similarity=0.176 Sum_probs=108.2
Q ss_pred EEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC--CC
Q psy11359 33 VREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH--EN 110 (520)
Q Consensus 33 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H--pn 110 (520)
+++.||.|.++.||++.+.. ..+++|..... .. ...+.+|+.+++.+.| .+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~----------------------~~---~~~~~~e~~~~~~l~~~~~~ 54 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSR----------------------EK---GADREREVAILQLLARKGLP 54 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCC----------------------Cc---hhHHHHHHHHHHHHHHcCCC
Confidence 46789999999999998854 56777765321 10 3458899999999976 58
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecccCCCc
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN---GQIHRDIKAGN 187 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~---giiHrDLKp~N 187 (520)
+++++.++...+..+++|||+.|+++..+ +......++.+++.+|.+||.. +++|+||+|+|
T Consensus 55 ~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~N 119 (155)
T cd05120 55 VPKVLASGESDGWSYLLMEWIEGETLDEV---------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGN 119 (155)
T ss_pred CCeEEEEcCCCCccEEEEEecCCeecccC---------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcce
Confidence 99999888888899999999988766543 3456677899999999999985 69999999999
Q ss_pred EEEcCCCCeEEeccCccee
Q psy11359 188 ILLGEDGTVQIADFGVSAW 206 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~ 206 (520)
|++++.+.++++|||.+..
T Consensus 120 il~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 120 ILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEECCcEEEEEecccccC
Confidence 9999889999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.5e-16 Score=168.84 Aligned_cols=273 Identities=24% Similarity=0.353 Sum_probs=211.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
..-+.+.+.+.+-+|+++.++.+.-..+|...++|+...... +. ...++.+..+-.++-.
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~---------------i~-----~~~~~s~r~~s~~~i~ 860 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPK---------------IR-----TNDYESIRSKSNILIT 860 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchh---------------hc-----cccccccCCccCcccc
Confidence 456778888999999999999998888887777775432110 00 1122233444444444
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
-++|-++.....+......+|+++|+.|++|...+. ..+..+++..+.++..+..+++|||+..+.|||++|
T Consensus 861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~--------~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p 932 (1205)
T KOG0606|consen 861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLH--------NSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKP 932 (1205)
T ss_pred CCCCceecccCCCCCCCCcchhhHHhccCCchhhhh--------cCCCcccccccchhHHHHhhhhccccchhhcccccc
Confidence 566777777666778889999999999999999887 456778888899999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccC---------------------cc---ccc--cccccccccccccCCcceecccCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATG---------------------RD---LSR--QKVRHTFVGTPCWMAPEVMEQDHG 239 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~---------------------~~---~~~--~~~~~~~~gt~~y~APE~~~~~~~ 239 (520)
.|+|...+|..++.|||.......- .. ... ........||+.|.+||...+..
T Consensus 933 ~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~- 1011 (1205)
T KOG0606|consen 933 DSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR- 1011 (1205)
T ss_pred cchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-
Confidence 9999999999999999843221100 00 000 02234568999999999998776
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH
Q psy11359 240 YDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319 (520)
Q Consensus 240 ~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 319 (520)
....+|+|++|+++++.++|.+||....+..++..++..+.+..... ...+....+++...|..+|.+|..+.
T Consensus 1012 hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~-------~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1012 HGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGP-------EEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCc-------cccChhhhhhhhhhhccCchhccCcc
Confidence 78899999999999999999999999999988887777766554322 34577889999999999999999988
Q ss_pred ---HHhcCccccccchhh
Q psy11359 320 ---ELLKNPFFKKAKDKK 334 (520)
Q Consensus 320 ---elL~hp~~~~~~~~~ 334 (520)
++-.|+||+...+..
T Consensus 1085 ~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1085 GAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred cccccccCCccCCCCccc
Confidence 888999999877654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.3e-13 Score=145.23 Aligned_cols=162 Identities=19% Similarity=0.237 Sum_probs=101.8
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhc--------ccee--eEEEeecccc-hh----hHH--HHH
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKAR--------AEKC--AIKKINLEKW-NT----SMD--ELL 97 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~--------~~~~--aiK~i~~~~~-~~----~~~--~l~ 97 (520)
+.||+|++|.||+|..+ +|+.||||+.+......-..... .+.. ..+.++.... .+ ... ++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999875 79999999986442211100000 0000 0111111000 00 011 355
Q ss_pred HHHHHHhcCC-----CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH-HHH
Q psy11359 98 KEIQAMSSCH-----HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLK-GLE 171 (520)
Q Consensus 98 ~Ei~~l~~l~-----HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~-gL~ 171 (520)
+|+..+.++. +++|.-..-++......+|||||++|++|.++.... .. .+ ....++.+++. .+.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~------~~-~~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD------EA-GL---DRKALAENLARSFLN 271 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH------hc-CC---CHHHHHHHHHHHHHH
Confidence 6776666552 344332222233345579999999999999887532 11 11 23456666665 478
Q ss_pred HHHHCCcEecccCCCcEEEcCCCCeEEeccCcceee
Q psy11359 172 YFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207 (520)
Q Consensus 172 yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~ 207 (520)
.+|..|++|+|+||.||+++.+|.++|+|||++..+
T Consensus 272 ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 272 QVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 899999999999999999999999999999998655
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.46 E-value=9.5e-13 Score=138.56 Aligned_cols=184 Identities=15% Similarity=0.289 Sum_probs=133.5
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
|.+ +...-++.+....|.-+.++.+|.+.+.+ .... +..+...+-++.|+.++|||
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~----------------------~~~~-~~~~~~~~A~k~lKtlRHP~ 70 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYK----------------------RSNG-EVTELAKRAVKRLKTLRHPN 70 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEe----------------------CCCc-hhhHHHHHHHHHhhhccCch
Confidence 444 44444444444456666676666666543 2211 23455778889999999999
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecccCCCcEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH-SNGQIHRDIKAGNIL 189 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH-~~giiHrDLKp~NIL 189 (520)
|++|++.++.++.+|||+|-+. .|..+++.. +...+..-++||+.||.||| ..+++|++|.-..|+
T Consensus 71 Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----------~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVf 137 (690)
T KOG1243|consen 71 ILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----------GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVF 137 (690)
T ss_pred hhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----------HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEE
Confidence 9999999999999999999994 788888753 36788889999999999998 568999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG 259 (520)
|+..|..||++|.++........ ......---.|..|+.+... ....|.|-|||++++++.|
T Consensus 138 Vn~~GeWkLggle~v~~~~~~~~-----~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 138 VNESGEWKLGGLELVSKASGFNA-----PAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred EcCCCcEEEeeeEEEeccccCCc-----ccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 99999999999998754321110 11111112235666654322 2568999999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=7e-13 Score=123.58 Aligned_cols=157 Identities=17% Similarity=0.156 Sum_probs=105.1
Q ss_pred EeeeeecCceEEEEEEEcC------CCceEEEEEeehhhh--hhhHhhhccceeeEEEeecccchhhHHH----HHHHHH
Q psy11359 34 REVIGFGATAVVHSAYCKA------RAEKCAIKKINLAVV--HSAYCKARAEKCAIKKINLEKWNTSMDE----LLKEIQ 101 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~--~~~~~~~~~~~~aiK~i~~~~~~~~~~~----l~~Ei~ 101 (520)
...||.|--+.||.|.... .+..+|+|+.+.... .+...-..+.... +.... + ...... ..+|+.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf-~~~~~-k-~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRF-KDRFS-K-LNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCccc-ccCcC-C-CCHHHHHHHHHHHHHH
Confidence 3578999999999998654 358999999974321 1110000011100 00000 0 112223 348999
Q ss_pred HHhcCCC--CCceEEEEEEEECCEEEEEEEccCCCCHHH-HHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHH-HHCC
Q psy11359 102 AMSSCHH--ENVVTYHTSFVVKDELWLVLRLLEGGSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYF-HSNG 177 (520)
Q Consensus 102 ~l~~l~H--pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~-~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yL-H~~g 177 (520)
.|++|.. -++++.+.+ ...+|||||+.+..+.. .++ ...+++..+..++.|++.+|..| |..|
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---------d~~~~~~~~~~i~~~i~~~l~~l~H~~g 145 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---------DAKLNDEEMKNAYYQVLSMMKQLYKECN 145 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---------ccccCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999954 456666654 56789999997654422 121 22455667788899999999998 8999
Q ss_pred cEecccCCCcEEEcCCCCeEEeccCcceee
Q psy11359 178 QIHRDIKAGNILLGEDGTVQIADFGVSAWL 207 (520)
Q Consensus 178 iiHrDLKp~NILl~~~g~vkL~DFG~a~~~ 207 (520)
+||+||++.|||+. ++.+.|+|||.+...
T Consensus 146 lVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 146 LVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred eecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 99999999999996 578999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=2e-14 Score=153.10 Aligned_cols=172 Identities=17% Similarity=0.243 Sum_probs=104.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhc--------cce--eeEEEeeccc-chhhHH-
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKAR--------AEK--CAIKKINLEK-WNTSMD- 94 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~--------~~~--~aiK~i~~~~-~~~~~~- 94 (520)
....|+. +.||+|++|.||+|..+.+|+.||||+.+......-..... -+. -..+.++... ..+..+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3455666 79999999999999999889999999997543211000000 000 0001111100 001111
Q ss_pred -----HHHHHHHHHhcCC----CCCceEEEEEEE-ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q psy11359 95 -----ELLKEIQAMSSCH----HENVVTYHTSFV-VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLR 164 (520)
Q Consensus 95 -----~l~~Ei~~l~~l~----HpnIv~~~~~~~-~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~ 164 (520)
++.+|+..+.++. +.+.+.+-.++. .....+|||||+.|+.|.++-.-... ......+.+..+..++.
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~--g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA--GTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc--CCCHHHHHHHHHHHHHH
Confidence 2455555555542 444444333333 35667899999999999875321100 00111345555666666
Q ss_pred HHHHHHHHHHHCCcEecccCCCcEEEcCCC----CeEEeccCcceeec
Q psy11359 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDG----TVQIADFGVSAWLA 208 (520)
Q Consensus 165 qIl~gL~yLH~~giiHrDLKp~NILl~~~g----~vkL~DFG~a~~~~ 208 (520)
||+ ..|++|+|+||+||+++.+| .++++|||++..+.
T Consensus 275 Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 QVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 665 58999999999999999888 99999999987663
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.4e-12 Score=116.70 Aligned_cols=127 Identities=18% Similarity=0.147 Sum_probs=92.6
Q ss_pred EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCce-
Q psy11359 34 REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVV- 112 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv- 112 (520)
.+.|+.|.++.||++... +..+++|+..... .....+.+|+.+++.+.+.+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~------------------------~~~~~~~~E~~~l~~l~~~~~~P 56 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT------------------------ELLINRENEAENSKLAAEAGIGP 56 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCc------------------------ccccCHHHHHHHHHHHHHhCCCC
Confidence 467899999999999864 6678888653110 0112356788999888655544
Q ss_pred EEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----EecccCCCc
Q psy11359 113 TYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ-----IHRDIKAGN 187 (520)
Q Consensus 113 ~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi-----iHrDLKp~N 187 (520)
+++... ....++||||++|.++.+.- .....++.+++++|..||+.++ +|+|++|.|
T Consensus 57 ~~~~~~--~~~~~lv~e~i~G~~l~~~~----------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~N 118 (170)
T cd05151 57 KLYYFD--PETGVLITEFIEGSELLTED----------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGN 118 (170)
T ss_pred ceEEEe--CCCCeEEEEecCCCcccccc----------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCc
Confidence 444433 33458999999998775420 1123467899999999999985 999999999
Q ss_pred EEEcCCCCeEEeccCcce
Q psy11359 188 ILLGEDGTVQIADFGVSA 205 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~ 205 (520)
|+++ ++.++++|||.+.
T Consensus 119 il~~-~~~~~liDf~~a~ 135 (170)
T cd05151 119 FLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEEE-CCeEEEEeccccc
Confidence 9998 6789999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.8e-13 Score=138.38 Aligned_cols=252 Identities=23% Similarity=0.216 Sum_probs=181.7
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEc-CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCK-ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...+|..+..||.|.|+.|+..... .++..+++|-+...... ..+...-..|+.+...
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~---------------------~~~di~sl~ev~l~~~ 321 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT---------------------FASDIFSLGEVILEAI 321 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc---------------------hHhhhcchhhhhHhhH
Confidence 3467889999999999999998755 66777777754321110 0011123456666666
Q ss_pred C-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 106 C-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 106 l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
| .|.+++.++..|...+..|+-.|||+++++...+. -...+++...+++..|++.++.++|+..++|+|+|
T Consensus 322 l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~--------~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~ 393 (524)
T KOG0601|consen 322 LGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSV--------TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVK 393 (524)
T ss_pred hhcccccCCCCCCccccccccCchhhhcCcchhhhhH--------HHHhcCcchhhhhHHHHHhccccccchhhhccccc
Confidence 6 69999999999999999999999999999877764 23467889999999999999999999999999999
Q ss_pred CCcEEEcCC-CCeEEeccCcceeeccCccccccccccccccccccC-CcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 185 AGNILLGED-GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWM-APEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 185 p~NILl~~~-g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~-APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|.||++..+ +..+++|||.+..++.. ...+.++-.++ .+|++.....+..++|++|||..+.+.++|...
T Consensus 394 psni~i~~~~~~~~~~~~~~~t~~~~~--------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 394 PSNILISNDGFFSKLGDFGCWTRLAFS--------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ccceeeccchhhhhcccccccccccee--------cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 999999876 78899999987543211 11223344555 366666666689999999999999999998643
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
-...... ..+..+.-+.. ......+..+...++.+++..|+.+.++..|.-|.
T Consensus 466 s~~~~~~---~~i~~~~~p~~----------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 466 SESGVQS---LTIRSGDTPNL----------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred Ccccccc---eeeecccccCC----------CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 2221111 11111111111 22235677888999999999999999999887664
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.27 E-value=8e-11 Score=105.95 Aligned_cols=149 Identities=23% Similarity=0.318 Sum_probs=110.9
Q ss_pred EEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccc--hhhHHHHHHHHHHHhcCCCCC
Q psy11359 33 VREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW--NTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 33 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~--~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
.+.+|-+|+-+.|+++.. .|+.+.||.= +.|.++-... .-...+..+|+++|.+|.--+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~R-----------------f~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~G 71 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKER-----------------FSKRYRHPALDQKLTRKRTKQEARLLAKCRALG 71 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeec-----------------ccccccchHHHHHHHHHHHHHHHHHHHHHHHhC
Confidence 578899999999998865 4666666631 1122221111 224567788999999997767
Q ss_pred ceEEEEEEEECCEEEEEEEccCC-CCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEG-GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~g-gsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
|.-..-+|.+...-.|+|||+.| .++.+++.... ...........++++|-+.+.-||.+++||+||..+||+
T Consensus 72 I~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~------~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNil 145 (229)
T KOG3087|consen 72 IPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTM------EDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNIL 145 (229)
T ss_pred CCCceEEEEecCCCeEEEEeccchhHHHHHHHHHc------cCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceE
Confidence 76666677888888899999977 58999987642 223333444889999999999999999999999999999
Q ss_pred EcCCC---CeEEeccCccee
Q psy11359 190 LGEDG---TVQIADFGVSAW 206 (520)
Q Consensus 190 l~~~g---~vkL~DFG~a~~ 206 (520)
+..+| .+.++|||++..
T Consensus 146 l~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 146 LRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EecCCCcCceEEEeecchhc
Confidence 96554 458999998743
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.1e-11 Score=107.74 Aligned_cols=136 Identities=21% Similarity=0.304 Sum_probs=100.5
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccc--hhhHHHHHHHHHHHhcCCCCCce
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW--NTSMDELLKEIQAMSSCHHENVV 112 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~--~~~~~~l~~Ei~~l~~l~HpnIv 112 (520)
..+++|+-+.+|.+.. -|.++++|. +. -|.+....- .-..++-.+|+.++.+++--+|.
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~-Ri----------------~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~ 62 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKE-RI----------------PKRYRHPELDEKLRRERTRREARILAKAREAGVP 62 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEe-ec----------------CcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 4678999999999955 344455553 11 111111111 12345667899999999777777
Q ss_pred EEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcC
Q psy11359 113 TYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE 192 (520)
Q Consensus 113 ~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~ 192 (520)
..+-++.+.+...|+|||++|..|.+++... .-.+++.+-.-+.-||.+||+|+||.+.||++..
T Consensus 63 ~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~---------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~ 127 (204)
T COG3642 63 VPIVYDVDPDNGLIVMEYIEGELLKDALEEA---------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG 127 (204)
T ss_pred CCeEEEEcCCCCEEEEEEeCChhHHHHHHhc---------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC
Confidence 7666778888889999999999999998631 2456777777778899999999999999999966
Q ss_pred CCCeEEeccCcce
Q psy11359 193 DGTVQIADFGVSA 205 (520)
Q Consensus 193 ~g~vkL~DFG~a~ 205 (520)
++ +.++|||++.
T Consensus 128 ~~-i~~IDfGLg~ 139 (204)
T COG3642 128 GR-IYFIDFGLGE 139 (204)
T ss_pred Cc-EEEEECCccc
Confidence 54 9999999875
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.9e-10 Score=117.81 Aligned_cols=221 Identities=17% Similarity=0.232 Sum_probs=157.2
Q ss_pred ceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEEEEEEE-
Q psy11359 42 TAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVV- 120 (520)
Q Consensus 42 fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~~~~~~- 120 (520)
-.+.|+|....+|..|++|.++.. + .........-+++++++.|+|||++.++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~----------------------r-~~~~nk~t~lve~wkkl~h~NvV~frevf~t~ 345 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGD----------------------R-DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTY 345 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccc----------------------c-ccCcccchHHHHHHHHhccCceeehhhhhhhh
Confidence 468999999999888888876311 0 0011123456788999999999999999984
Q ss_pred ---CCEEEEEEEccCC-CCHHHHHHHhhccc-------cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 121 ---KDELWLVLRLLEG-GSLLDIIKHRLKIS-------NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 121 ---~~~~~lV~E~~~g-gsL~~~i~~~~~~~-------~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
+..+++|++|.++ ++|.++--...... ...+...+|..+|.++.||..||.++|+.|+..+-|.|.+||
T Consensus 346 tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIl 425 (655)
T KOG3741|consen 346 TFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKIL 425 (655)
T ss_pred ccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeE
Confidence 3468999999875 67877653211111 124456789999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q psy11359 190 LGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM 269 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~ 269 (520)
++.+.+++|...|....+.... . |-+.+ -.+-|.=.||.+++.|.||..--...
T Consensus 426 v~G~~RIriS~C~i~Dvl~~d~-----------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~--- 479 (655)
T KOG3741|consen 426 VTGKMRIRISGCGIMDVLQEDP-----------------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRT--- 479 (655)
T ss_pred eeCcceEEEecccceeeecCCC-----------------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccc---
Confidence 9888899998888665442111 0 22222 23678889999999999985421110
Q ss_pred HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 270 KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
..............++.+++++|.-+....+++ -++.+++.+
T Consensus 480 ------------d~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 480 ------------DSTQSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------cchHHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 011111123344678899999999999888887 688998864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.3e-10 Score=109.16 Aligned_cols=139 Identities=14% Similarity=0.198 Sum_probs=98.0
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC--Cce
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE--NVV 112 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp--nIv 112 (520)
+.||.|.++.||++.... |..+++|+..... .......+.+|+.+++.+.+. ++.
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~----------------------~~~~~~~~~~E~~~~~~l~~~~~~vp 60 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGA----------------------LLPSAHDVAREYRVLRALAGTGVPVP 60 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcc----------------------cCcccccHHHHHHHHHHhhCCCCCCC
Confidence 678999999999998754 5778888653211 001234588899999999653 456
Q ss_pred EEEEEEEEC---CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH--------------
Q psy11359 113 TYHTSFVVK---DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-------------- 175 (520)
Q Consensus 113 ~~~~~~~~~---~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-------------- 175 (520)
+++.+.... +..++||||++|.+|.+.+. ...+++.+...++.+++++|.+||+
T Consensus 61 ~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~ 131 (223)
T cd05154 61 KVLALCEDPSVLGTPFYVMERVDGRVLRDRLL---------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRP 131 (223)
T ss_pred CEEEECCCCCccCCceEEEEEeCCEecCCCCC---------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCC
Confidence 677666543 36789999999988766441 1234555555666666666666653
Q ss_pred ------------------------------------------CCcEecccCCCcEEEcC--CCCeEEeccCcce
Q psy11359 176 ------------------------------------------NGQIHRDIKAGNILLGE--DGTVQIADFGVSA 205 (520)
Q Consensus 176 ------------------------------------------~giiHrDLKp~NILl~~--~g~vkL~DFG~a~ 205 (520)
..++|+|++|+||+++. ++.+.|+||+.+.
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 132 GGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred CchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999988 6678999999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.5e-11 Score=127.33 Aligned_cols=160 Identities=19% Similarity=0.317 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHC-CcEecccCCCcEEEcCCCCeEEeccCcceeeccCcccc----ccccccccccccccCCcceecccCC
Q psy11359 165 EVLKGLEYFHSN-GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLS----RQKVRHTFVGTPCWMAPEVMEQDHG 239 (520)
Q Consensus 165 qIl~gL~yLH~~-giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~ 239 (520)
+++.||.|+|.. ++||+.|.|++|.++.+|..||+.|+++.....+..+. ..+......-...|.|||++....
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~- 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT- 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc-
Confidence 444999999987 79999999999999999999999999876543322211 111112233456799999998754
Q ss_pred CCcchhHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH
Q psy11359 240 YDFKADIWSLGITAIEMA-TGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA 318 (520)
Q Consensus 240 ~~~~~DIwSlG~il~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta 318 (520)
.+.++|+||+|+++|-+. .|+.-+.............. ..+.. .......++.++++-+.++|..++..||++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~----~~~~~--~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN----LLNAG--AFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc----ccccc--cccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 789999999999999998 56655543322211111000 00000 011115678999999999999999999999
Q ss_pred HHHhcCccccccc
Q psy11359 319 SELLKNPFFKKAK 331 (520)
Q Consensus 319 ~elL~hp~~~~~~ 331 (520)
.+++..|||+...
T Consensus 260 ~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 260 DLLLSIPFFSDPG 272 (700)
T ss_pred hhhhcccccCCch
Confidence 9999999998644
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.7e-10 Score=74.91 Aligned_cols=32 Identities=47% Similarity=0.808 Sum_probs=27.9
Q ss_pred eeEEEEeecccC------CcceeEEeeecCCCchhhHH
Q psy11359 430 VNLILRMRNVRR------ELNDIRFEFCIGKDTSDGIA 461 (520)
Q Consensus 430 ~~l~lr~~~~~~------~~~~i~f~f~~~~dt~~~va 461 (520)
|+|+||++|+++ ++++|+|+|++++|||++||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 679999999999 99999999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.1e-10 Score=103.46 Aligned_cols=148 Identities=18% Similarity=0.113 Sum_probs=86.8
Q ss_pred EEEEEEEcCCCceEEEEEeehhhh--hhhHhhhccceeeEE-EeecccchhhHHHHHHHHHHHhcCCCC--CceEEEEEE
Q psy11359 44 VVHSAYCKARAEKCAIKKINLAVV--HSAYCKARAEKCAIK-KINLEKWNTSMDELLKEIQAMSSCHHE--NVVTYHTSF 118 (520)
Q Consensus 44 ~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~~~aiK-~i~~~~~~~~~~~l~~Ei~~l~~l~Hp--nIv~~~~~~ 118 (520)
.||.|.. ..|.++|+|+.+.... ........+..-+.+ +..............+|.+.|.++..- ++++.+.+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 3888877 4577999999875321 111000111111000 001111122455678999999999766 45666643
Q ss_pred EECCEEEEEEEccC--CCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHH-HHHCCcEecccCCCcEEEcCCCC
Q psy11359 119 VVKDELWLVLRLLE--GGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEY-FHSNGQIHRDIKAGNILLGEDGT 195 (520)
Q Consensus 119 ~~~~~~~lV~E~~~--ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~y-LH~~giiHrDLKp~NILl~~~g~ 195 (520)
. ..+|||||+. |..+..+... .++......++.+++..+.. +|..|++|+||.+.|||++++ .
T Consensus 79 -~--~~~ivME~I~~~G~~~~~l~~~----------~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 79 -N--RNVIVMEYIGEDGVPLPRLKDV----------DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp -E--TTEEEEE--EETTEEGGCHHHC----------GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C
T ss_pred -e--CCEEEEEecCCCccchhhHHhc----------cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e
Confidence 2 3469999998 6555444331 12245677888888886555 579999999999999999876 9
Q ss_pred eEEeccCcceee
Q psy11359 196 VQIADFGVSAWL 207 (520)
Q Consensus 196 vkL~DFG~a~~~ 207 (520)
+.|+|||.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.6e-09 Score=106.45 Aligned_cols=105 Identities=19% Similarity=0.130 Sum_probs=81.3
Q ss_pred HHHHHHHHHhcCCCCCc--eEEEEEEEE-----CCEEEEEEEccCCC-CHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q psy11359 95 ELLKEIQAMSSCHHENV--VTYHTSFVV-----KDELWLVLRLLEGG-SLLDIIKHRLKISNCKHGVCDEPTIATVLREV 166 (520)
Q Consensus 95 ~l~~Ei~~l~~l~HpnI--v~~~~~~~~-----~~~~~lV~E~~~gg-sL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qI 166 (520)
.+.+|...+..|..-+| ++...+++. ...-+||||++++. +|.+++... .....+......++.++
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~------~~~~~~~~~~~~ll~~l 147 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADW------ATNPPDPRLKRMLIKRV 147 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhh------cccCCCHHHHHHHHHHH
Confidence 37788888888854443 334444443 23578999999876 899998642 12345677888999999
Q ss_pred HHHHHHHHHCCcEecccCCCcEEEcC-------CCCeEEeccCcce
Q psy11359 167 LKGLEYFHSNGQIHRDIKAGNILLGE-------DGTVQIADFGVSA 205 (520)
Q Consensus 167 l~gL~yLH~~giiHrDLKp~NILl~~-------~g~vkL~DFG~a~ 205 (520)
+..+..||.+||+|+||++.|||++. ++.+.|+||+.+.
T Consensus 148 a~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 148 ATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99999999999999999999999974 4689999999764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.1e-09 Score=102.92 Aligned_cols=156 Identities=21% Similarity=0.203 Sum_probs=111.8
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC-
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE- 109 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp- 109 (520)
+.+...||.|--|.||.|.+. .|.++|+|.=+.+...-..- .+.+.++-.+-.....-.+.....+|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkv-k~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKV-KRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhh-cchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 456789999999999999887 68999999766442211111 112222222222222233566788999999999655
Q ss_pred -CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 110 -NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 110 -nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
.|.+.++ -+...+||||++|-.|...- ++.+....++..|+.-+.-+-..|+||+|+.+-||
T Consensus 171 ~~VP~P~~----~nRHaVvMe~ieG~eL~~~r-------------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNI 233 (304)
T COG0478 171 VKVPKPIA----WNRHAVVMEYIEGVELYRLR-------------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNI 233 (304)
T ss_pred CCCCCccc----cccceeeeehcccceeeccc-------------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheE
Confidence 6776665 36678999999997665432 23556667777777777777789999999999999
Q ss_pred EEcCCCCeEEeccCcce
Q psy11359 189 LLGEDGTVQIADFGVSA 205 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~ 205 (520)
+++++|.+.++||-.+.
T Consensus 234 lV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 234 LVTEDGDIVVIDWPQAV 250 (304)
T ss_pred EEecCCCEEEEeCcccc
Confidence 99999999999997553
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.3e-08 Score=99.31 Aligned_cols=188 Identities=16% Similarity=0.235 Sum_probs=129.7
Q ss_pred EEEEEEEccCCC-CHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEecc
Q psy11359 123 ELWLVLRLLEGG-SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADF 201 (520)
Q Consensus 123 ~~~lV~E~~~gg-sL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DF 201 (520)
.+.+.|..+.|. .+..+.....+.. ....+++.-..+.++.|+.+...||.+|.+-+|+.++|+|+++++.|.|+|=
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRq--s~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQ--SYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcc--cCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcc
Confidence 378899998775 2333333221111 4456788999999999999999999999999999999999999999999987
Q ss_pred CcceeeccCccccccccccccccccccCCcceec----ccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCcH-------H
Q psy11359 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME----QDHGYDFKADIWSLGITAIEMATG-TAPYHKYPA-------M 269 (520)
Q Consensus 202 G~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~----~~~~~~~~~DIwSlG~il~elltG-~~Pf~~~~~-------~ 269 (520)
.......++ ......+|.+.|.+||.-. -...-+...|.|.||+++++++.| ++||.+... .
T Consensus 162 Dsfqi~~ng------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~ 235 (637)
T COG4248 162 DSFQINANG------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL 235 (637)
T ss_pred cceeeccCC------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence 755444332 2334568999999999753 112246789999999999999996 999976431 1
Q ss_pred H--HHHHHh-----cCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhcc--CCCCCCCHHHH
Q psy11359 270 K--VLMLTL-----QNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQK--DPTKRPTASEL 321 (520)
Q Consensus 270 ~--~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~--dP~~Rpta~el 321 (520)
+ +..... +..+...... .-.+.-+++.+..|..+|+.. .+.-|||++--
T Consensus 236 E~~Ia~g~f~ya~~~~~g~~p~P~---~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 236 ETDIAHGRFAYASDQRRGLKPPPR---SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred hhhhhcceeeechhccCCCCCCCC---CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 1 110000 1100000011 112356788899999999975 35689998754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.6e-08 Score=93.51 Aligned_cols=105 Identities=17% Similarity=0.252 Sum_probs=83.3
Q ss_pred HHHHHHHHHHhcCCCCC--ceEEEEEEEEC----CEEEEEEEccCCC-CHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q psy11359 94 DELLKEIQAMSSCHHEN--VVTYHTSFVVK----DELWLVLRLLEGG-SLLDIIKHRLKISNCKHGVCDEPTIATVLREV 166 (520)
Q Consensus 94 ~~l~~Ei~~l~~l~Hpn--Iv~~~~~~~~~----~~~~lV~E~~~gg-sL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qI 166 (520)
....+|...+..|..-+ +++.+.+.+.. ...+||||+++|. +|.+++... ...+......++.++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~--------~~~~~~~~~~ll~~l 127 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW--------EQLDPSQRRELLRAL 127 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh--------cccchhhHHHHHHHH
Confidence 35778888887775443 34555555543 2468999999884 899999742 236677889999999
Q ss_pred HHHHHHHHHCCcEecccCCCcEEEcCCC---CeEEeccCccee
Q psy11359 167 LKGLEYFHSNGQIHRDIKAGNILLGEDG---TVQIADFGVSAW 206 (520)
Q Consensus 167 l~gL~yLH~~giiHrDLKp~NILl~~~g---~vkL~DFG~a~~ 206 (520)
+..+.-||.+||+|+|++|.|||+..++ .+.++||+-+..
T Consensus 128 ~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 128 ARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999999998776 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.9e-10 Score=115.22 Aligned_cols=249 Identities=24% Similarity=0.277 Sum_probs=173.1
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
....-|....-+++|+.+.+++.+...+...+ .+++. . .....-++++|.+
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs----------------------~------~l~~rl~~eLLdK 289 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVS----------------------Q------TLSRRLAIELLDK 289 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeec----------------------c------chhhHHHHHHHHH
Confidence 34445677888999999999998776653322 33221 1 1345668899999
Q ss_pred CCCCC-ceEEEEEEEECCEEEEEEEccCCC-CHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 106 CHHEN-VVTYHTSFVVKDELWLVLRLLEGG-SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 106 l~Hpn-Iv~~~~~~~~~~~~~lV~E~~~gg-sL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++||| .+.+++.+..++..+++|+++.++ +....+.. ..-.+...+...+.+.-+++|+|+|+.--+|||
T Consensus 290 ~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~-------se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d- 361 (829)
T KOG0576|consen 290 VNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV-------SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD- 361 (829)
T ss_pred ccCCCCcccccccCCcccccchhhhhhcCCccccccCCh-------hhHhhhhhhhhhhhhhhcccccccccccccCcc-
Confidence 99999 788888888889999999999877 22222110 122344556777888889999999999778998
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
||+.. ++..+..||+....+... ....++.+|+.++|||+..... +....|.|++|.-..+|.-|.+|-
T Consensus 362 ---~~l~s-~~~~~~~~~~v~~~L~~~------~~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 362 ---NILGS-EEEVKLLDFAVPPQLTRT------MKPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ---ccccc-ccccccccccCCcccCcc------cccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCC
Confidence 77764 478999999988766422 2456789999999999887665 899999999999888888888876
Q ss_pred CCCcHHHHHHHHhcCC-CCCCCCCchhhhhHHHhcHHHH-HHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 264 HKYPAMKVLMLTLQND-PPTLDTGAAEKDQYKAYGKTFR-KMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
.. ++.+....-.+. .+.+. .. ...++.+. ++...|+..-|..|++...++.|.+|....
T Consensus 431 ~~--P~~~~~~~g~~p~s~~L~----~~---~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 431 SS--PPAVLPMIGNGPNSPMLT----DK---SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred CC--CccccCCCCCCCCccccc----hh---hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 44 111111100000 00010 00 11112222 488899999999999999999999987654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.1e-07 Score=87.26 Aligned_cols=143 Identities=14% Similarity=0.124 Sum_probs=99.7
Q ss_pred eecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC--ceEEE
Q psy11359 38 GFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN--VVTYH 115 (520)
Q Consensus 38 G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn--Iv~~~ 115 (520)
|+||.|.|+...... ..+-+|.-.-. .-+.+.. +.....+.+|+.++.+|..-+ +.+..
T Consensus 27 ~rgG~SgV~r~~~~g--~~~ylKrq~nh--------------l~~s~r~---P~g~ptf~rE~~~L~~L~~~GvPVP~pv 87 (216)
T PRK09902 27 RRNGMSGVQCVERNG--KKLYVKRMTHH--------------LFHSVRY---PFGRPTIVREVAVIKELERAGVIVPKIV 87 (216)
T ss_pred CCCCcceEEEEEeCC--cEEEEEeccCc--------------ccccccC---CCCchHHHHHHHHHHHHHHcCCCCCccc
Confidence 669999999976543 35777754210 0001110 123345899999999885433 44444
Q ss_pred EEEE-E----CCEEEEEEEccCC-CCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEE
Q psy11359 116 TSFV-V----KDELWLVLRLLEG-GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL 189 (520)
Q Consensus 116 ~~~~-~----~~~~~lV~E~~~g-gsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NIL 189 (520)
++. . .-.-+||+|-+.| -+|.+++... .-...+......++.+++..|.-||+.|+.|+|+-+.|||
T Consensus 88 -f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~------~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIl 160 (216)
T PRK09902 88 -FGEAVKIEGEWRALLVTEDMAGFISIADWYAQH------AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIY 160 (216)
T ss_pred -eeeeeccCCceEEEEEEEeCCCCccHHHHHhcC------CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhhee
Confidence 222 1 2247899997754 6899988642 2235577888899999999999999999999999999999
Q ss_pred EcCCCC--eEEeccCccee
Q psy11359 190 LGEDGT--VQIADFGVSAW 206 (520)
Q Consensus 190 l~~~g~--vkL~DFG~a~~ 206 (520)
++.+|. ++++||.-++.
T Consensus 161 l~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 161 VKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred ecCCCCeeEEEEEhhccch
Confidence 986677 99999986543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.1e-07 Score=101.30 Aligned_cols=164 Identities=22% Similarity=0.291 Sum_probs=101.1
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccc---eeeEEEeecc----cchhhHH----------HHH
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAE---KCAIKKINLE----KWNTSMD----------ELL 97 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~---~~aiK~i~~~----~~~~~~~----------~l~ 97 (520)
+.|+.++-|.||+|..+. |+.||||+.+......-.....-- .-++++.... +..+..+ ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 578999999999999876 999999998754322211110000 0011111111 0011111 245
Q ss_pred HHHHHHhcCC-----CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHH
Q psy11359 98 KEIQAMSSCH-----HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEY 172 (520)
Q Consensus 98 ~Ei~~l~~l~-----HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~y 172 (520)
+|...+.+++ .|+|.-..-+|+-...-.|+|||+.|..+.+..... ...++...+...+.++. +..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~-------~~g~d~k~ia~~~~~~f--~~q 280 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK-------SAGIDRKELAELLVRAF--LRQ 280 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH-------hcCCCHHHHHHHHHHHH--HHH
Confidence 5666666552 455544445566667778999999999999885432 23344333333222221 222
Q ss_pred HHHCCcEecccCCCcEEEcCCCCeEEeccCcceeec
Q psy11359 173 FHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208 (520)
Q Consensus 173 LH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~ 208 (520)
+-..|++|.|.+|.||++..+|.+.+.|||+...+.
T Consensus 281 ~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 281 LLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 334899999999999999999999999999886553
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.5e-06 Score=81.91 Aligned_cols=147 Identities=18% Similarity=0.249 Sum_probs=84.6
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
..+|.+.+++-......|.+- ...|..+++|..+.........- ...+| .+....+...+..++...
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~----~sf~k-------g~~~~~l~~~~~~i~~~g 96 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRF----KSFFK-------GSEYSRLINNTDKIRNEG 96 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHH----HHHhc-------cHHHHHHHHHHHHHHHcC
Confidence 456777777766555544433 44567777776643211100000 00000 111222333333333322
Q ss_pred CCCceEEEEEEE-----ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 108 HENVVTYHTSFV-----VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 108 HpnIv~~~~~~~-----~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
--.+..++-+.+ .....+++|||++|..|.++.. +++ .+...|..++.-||+.|++|+|
T Consensus 97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------------i~e----~~~~ki~~~ikqlH~~G~~HGD 160 (229)
T PF06176_consen 97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------------IDE----DLAEKIVEAIKQLHKHGFYHGD 160 (229)
T ss_pred ccccccceeeeeeeeccceeEEEEEEEEecCeecccchh------------cCH----HHHHHHHHHHHHHHHcCCccCC
Confidence 233333333333 2245679999999988876542 222 2446677889999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcc
Q psy11359 183 IKAGNILLGEDGTVQIADFGVS 204 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a 204 (520)
.+|.|+++++++ ++++||+..
T Consensus 161 ~hpgNFlv~~~~-i~iID~~~k 181 (229)
T PF06176_consen 161 PHPGNFLVSNNG-IRIIDTQGK 181 (229)
T ss_pred CCcCcEEEECCc-EEEEECccc
Confidence 999999998654 999999854
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.6e-06 Score=83.44 Aligned_cols=141 Identities=15% Similarity=0.175 Sum_probs=82.6
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC--ce
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN--VV 112 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn--Iv 112 (520)
..||+|..+.||+. .|..+++|.... ......+.+|.++++.+..-+ +.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~-------------------------~~~~~~i~~E~~~l~~l~~~glpvP 57 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNP-------------------------GFDKETIKREFDASRKVFSLGIPTP 57 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCC-------------------------CCCHHHHHHHHHHHHHHHHcCCCCC
Confidence 57899999999984 244566665421 112345788999999885433 46
Q ss_pred EEEEEEEECCEEEEEEEccCCCC-HHHH--------------HHHh-hccccCCCCCCCHHH-HHHHHHHH---------
Q psy11359 113 TYHTSFVVKDELWLVLRLLEGGS-LLDI--------------IKHR-LKISNCKHGVCDEPT-IATVLREV--------- 166 (520)
Q Consensus 113 ~~~~~~~~~~~~~lV~E~~~ggs-L~~~--------------i~~~-~~~~~~~~~~l~~~~-i~~i~~qI--------- 166 (520)
+.+.+....+..++|||+++|.+ +... +... ..+-.......+... ...+..++
T Consensus 58 ~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~ 137 (226)
T TIGR02172 58 HPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKD 137 (226)
T ss_pred ceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHH
Confidence 77777777888899999999864 2111 1110 001000001111111 11111111
Q ss_pred -HH-HHHHHHH----CCcEecccCCCcEEEcCCCCeEEeccCcce
Q psy11359 167 -LK-GLEYFHS----NGQIHRDIKAGNILLGEDGTVQIADFGVSA 205 (520)
Q Consensus 167 -l~-gL~yLH~----~giiHrDLKp~NILl~~~g~vkL~DFG~a~ 205 (520)
.. ...+|.. ..++|+|+.|.||++++++ +.|+||+.+.
T Consensus 138 ~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 138 YKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 11 1122221 1478999999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.2e-06 Score=98.31 Aligned_cols=205 Identities=21% Similarity=0.298 Sum_probs=143.5
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEEEEECCE----EEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q psy11359 92 SMDELLKEIQAMSSCHHENVVTYHTSFVVKDE----LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVL 167 (520)
Q Consensus 92 ~~~~l~~Ei~~l~~l~HpnIv~~~~~~~~~~~----~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl 167 (520)
.+.....|+..+....|+|++.++.+...+.. +.+..++|.+.++...+. .-+.++....+.+..+++
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--------~v~~i~~~~~r~~~~~~~ 296 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--------SVGSIPLETLRILHQKLL 296 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--------hccccCHHHHHHHHHHHh
Confidence 34445556777888899999999988765433 234468899999999988 457788999999999999
Q ss_pred HHHHHHHHCCcEecccCCC---cEEEcCCCCeEEe--ccCcceeeccCccccccccccccccccccCCcceecccCCCCc
Q psy11359 168 KGLEYFHSNGQIHRDIKAG---NILLGEDGTVQIA--DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF 242 (520)
Q Consensus 168 ~gL~yLH~~giiHrDLKp~---NILl~~~g~vkL~--DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 242 (520)
+||.|+|+....|.-|... +-.++..+.+.++ ||+.+..+.... ......-+..+-+||...... +..
T Consensus 297 ~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~------~~~~~~~~~~~~~~e~~~~~~-~~~ 369 (1351)
T KOG1035|consen 297 EGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE------KSFSDLLAEIRNADEDLKENT-AKK 369 (1351)
T ss_pred hhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcc------cchhhcCcccccccccccccc-chh
Confidence 9999999996655555444 3334455667776 888876654322 223344566788888876554 333
Q ss_pred --chhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 243 --KADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 243 --~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
..|+|.+|..+..+..|..+-....-..-++ .........+++.+|+.-++++|+++.+
T Consensus 370 ~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~~l-------------------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 370 SRLTDLWCLGLLLLQLSQGEDISEKSAVPVSLL-------------------DVLSTSELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred hhhhHHHHHHHHHhhhhhcCcccccccchhhhh-------------------ccccchhhhhhhhhhcchhhhhccchhh
Confidence 3699999999999998865432111111000 0111125678899999999999999999
Q ss_pred HhcCcccccc
Q psy11359 321 LLKNPFFKKA 330 (520)
Q Consensus 321 lL~hp~~~~~ 330 (520)
++.|+|.+..
T Consensus 431 ll~~~f~~~~ 440 (1351)
T KOG1035|consen 431 LLTHPFLRFP 440 (1351)
T ss_pred hhhchhcccc
Confidence 9999997643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.9e-06 Score=79.29 Aligned_cols=158 Identities=16% Similarity=0.135 Sum_probs=98.6
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhh--hccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC--C
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCK--ARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE--N 110 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~--~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp--n 110 (520)
..|.+|--+.||+|.. .++..+|+|+++.....-...+ ..+...+ +.+..........=..+|+..|+++... .
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf-~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRF-RNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhh-hcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 3667788889999976 5688999999975433211100 0111111 1111110011111235688888888543 4
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccCCCcEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGNIL 189 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLKp~NIL 189 (520)
+.+.+.+ ..-.|||||+.... ...+.-+.-.+...+...+..++++.+.-|-. .++||+||..-|||
T Consensus 132 vP~Pi~~----~~nVLvMEfIg~~g--------~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL 199 (268)
T COG1718 132 VPEPIAF----RNNVLVMEFIGDDG--------LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL 199 (268)
T ss_pred CCCceee----cCCeEEEEeccCCC--------CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence 4555543 23469999994321 00111122233344788899999999999877 89999999999999
Q ss_pred EcCCCCeEEeccCcceee
Q psy11359 190 LGEDGTVQIADFGVSAWL 207 (520)
Q Consensus 190 l~~~g~vkL~DFG~a~~~ 207 (520)
+. ++.+.|+|||.|...
T Consensus 200 ~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 200 VH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred EE-CCeEEEEECcccccc
Confidence 98 889999999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.5e-06 Score=79.60 Aligned_cols=75 Identities=16% Similarity=0.056 Sum_probs=50.1
Q ss_pred eeecCc-eEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC-CCCceEE
Q psy11359 37 IGFGAT-AVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH-HENVVTY 114 (520)
Q Consensus 37 LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~-HpnIv~~ 114 (520)
|-.|.. +.||+.... +.++.+|+... . ....+.+|+++++.+. +--+.++
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~----------------------~----~~~~~~~E~~~l~~l~~~~~vP~v 57 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPS----------------------G----PTYELEREAERLRWLAGKLPVPEV 57 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCC----------------------C----cccchHHHHHHHHHHHhcCCCCeE
Confidence 444554 789998653 35666665421 1 0224677888888873 4446677
Q ss_pred EEEEEECCEEEEEEEccCCCCHHHH
Q psy11359 115 HTSFVVKDELWLVLRLLEGGSLLDI 139 (520)
Q Consensus 115 ~~~~~~~~~~~lV~E~~~ggsL~~~ 139 (520)
+.+....+..++|||+++|.+|...
T Consensus 58 ~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 58 IDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred EEEEecCCccEEEEEeeCCccHhHh
Confidence 8777776778999999999887644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.5e-06 Score=90.71 Aligned_cols=161 Identities=20% Similarity=0.202 Sum_probs=95.2
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeec----ccc----hhhHH------HHHHHH
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINL----EKW----NTSMD------ELLKEI 100 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~----~~~----~~~~~------~l~~Ei 100 (520)
+.||.-+.|.||+|+.+. |+.||+|+-+.+...........-.++.+.++. .+. .+..+ ++.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999988 999999998644332211111111111111111 001 01111 234455
Q ss_pred HHHh----cCCCCC------ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q psy11359 101 QAMS----SCHHEN------VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170 (520)
Q Consensus 101 ~~l~----~l~Hpn------Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL 170 (520)
+... .+.|-+ |.++| |.....-.|+|||+.|..+.|.-.- ....++...+..-+.+...
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i-------~~~gi~~~~i~~~l~~~~~-- 314 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAI-------DKRGISPHDILNKLVEAYL-- 314 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHH-------HHcCCCHHHHHHHHHHHHH--
Confidence 4433 334444 44443 3334566899999999877665332 2234455544444444332
Q ss_pred HHHHHCCcEecccCCCcEEEcC----CCCeEEeccCcceee
Q psy11359 171 EYFHSNGQIHRDIKAGNILLGE----DGTVQIADFGVSAWL 207 (520)
Q Consensus 171 ~yLH~~giiHrDLKp~NILl~~----~g~vkL~DFG~a~~~ 207 (520)
+.+-..|++|.|-+|.||+++. ++.+.+-|||+...+
T Consensus 315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 2234468999999999999983 668999999998665
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.15 E-value=4.3e-05 Score=73.00 Aligned_cols=144 Identities=17% Similarity=0.204 Sum_probs=81.6
Q ss_pred EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC--Cc
Q psy11359 34 REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE--NV 111 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp--nI 111 (520)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.|... .+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-------------------------~~~~~~~~e~~~~~~l~~~~~pv 54 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-------------------------DAAERLRREAAVLRQLAEHGIPV 54 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-------------------------HHHHHHHHHHHHHHHHHHTTSBS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-------------------------CCHHHHHHHHHHHHHHHhcCCCC
Confidence 5789999999999998766 37777764321 2345677888888887433 35
Q ss_pred eEEEEEEE---ECCEEEEEEEccCCCCHHH----------------HHHHhhccccCCCCCCCHHH---------HHHH-
Q psy11359 112 VTYHTSFV---VKDELWLVLRLLEGGSLLD----------------IIKHRLKISNCKHGVCDEPT---------IATV- 162 (520)
Q Consensus 112 v~~~~~~~---~~~~~~lV~E~~~ggsL~~----------------~i~~~~~~~~~~~~~l~~~~---------i~~i- 162 (520)
.+++.... .....+++|+++.|.++.. .+....... .....+.... ....
T Consensus 55 P~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 133 (239)
T PF01636_consen 55 PRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVP-PPFSPFADWPEWRLEFLRQLESWT 133 (239)
T ss_dssp --EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSH-TTCCCHTHHHHHHHHHHHHHHHHH
T ss_pred ceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhccccc-cccccccccccccccccccccccc
Confidence 56665443 3445899999999998888 111111110 0111111100 0000
Q ss_pred -----------HHHHHH-HHHHHHH-------CCcEecccCCCcEEEc-CCCCeEEeccCcce
Q psy11359 163 -----------LREVLK-GLEYFHS-------NGQIHRDIKAGNILLG-EDGTVQIADFGVSA 205 (520)
Q Consensus 163 -----------~~qIl~-gL~yLH~-------~giiHrDLKp~NILl~-~~g~vkL~DFG~a~ 205 (520)
...+.. .+..++. ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 134 ARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 111222 3333332 3599999999999998 66777899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.15 E-value=9.3e-05 Score=69.06 Aligned_cols=151 Identities=19% Similarity=0.226 Sum_probs=96.4
Q ss_pred CCCCCCCeEEEeeeeecCc-eEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGAT-AVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
+.....+++.++.||.|.- |.||++.. .|..+|+|+++.......... .....-+-.......-..+-+..|.++
T Consensus 32 F~~h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~--~~~~~~~~~~~~~~~~y~~PF~~ECRA 107 (207)
T PF13095_consen 32 FTHHGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYT--RERFAGHETSLSTPAHYADPFNCECRA 107 (207)
T ss_pred cCCCCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccc--cccccccccccchhhhhcChHHHHHHh
Confidence 4445589999999999999 99999965 467999999654322211100 000000000000001123357778887
Q ss_pred HhcC---CCCCc--eEEEEEEEECC------------------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHH
Q psy11359 103 MSSC---HHENV--VTYHTSFVVKD------------------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTI 159 (520)
Q Consensus 103 l~~l---~HpnI--v~~~~~~~~~~------------------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i 159 (520)
..+| .+.++ |+.+++..-.. ...||.||+.... .+ .
T Consensus 108 fgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------~~----~ 166 (207)
T PF13095_consen 108 FGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------PL----Q 166 (207)
T ss_pred hHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------cc----c
Confidence 6666 45566 89999875331 1467777775432 11 2
Q ss_pred HHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcc
Q psy11359 160 ATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS 204 (520)
Q Consensus 160 ~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a 204 (520)
..-+.+|++-|..+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 234567788888899999999999999997 3589999853
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.8e-05 Score=86.99 Aligned_cols=153 Identities=15% Similarity=0.234 Sum_probs=89.6
Q ss_pred EEeeeeecCceEEEEEEEcCCC--ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC-CC
Q psy11359 33 VREVIGFGATAVVHSAYCKARA--EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH-HE 109 (520)
Q Consensus 33 i~~~LG~G~fg~Vy~a~~~~~g--~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~-Hp 109 (520)
-++.|+.|.+..+|+......+ ..+++|+. ...........+.+|+.+|+.+. |+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~----------------------p~~~~~~~~~~~~rE~~~l~~L~~~~ 99 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKK----------------------PPGKLLQSAHAVEREYQVLRALGEHT 99 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeC----------------------CCCccCccHHHHHHHHHHHHHHhhcC
Confidence 3677899999999998654432 23444432 22111122346889999999995 67
Q ss_pred Cc--eEEEEEEEEC---CEEEEEEEccCCCCHHH-----------------HHHHhhccccCCC--------C---CCCH
Q psy11359 110 NV--VTYHTSFVVK---DELWLVLRLLEGGSLLD-----------------IIKHRLKISNCKH--------G---VCDE 156 (520)
Q Consensus 110 nI--v~~~~~~~~~---~~~~lV~E~~~ggsL~~-----------------~i~~~~~~~~~~~--------~---~l~~ 156 (520)
+| .+++.++.+. +..|+||||+.|..+.+ +.+....+-.... + ..-.
T Consensus 100 ~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~ 179 (822)
T PLN02876 100 DVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCK 179 (822)
T ss_pred CCCCCcEEEEecCCCcCCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHH
Confidence 65 6777766553 45789999998865321 1111000100000 0 1112
Q ss_pred HHHHHHHHH---------------HHHHHHHHHH-----------CCcEecccCCCcEEEcC-CC-CeEEeccCcceee
Q psy11359 157 PTIATVLRE---------------VLKGLEYFHS-----------NGQIHRDIKAGNILLGE-DG-TVQIADFGVSAWL 207 (520)
Q Consensus 157 ~~i~~i~~q---------------Il~gL~yLH~-----------~giiHrDLKp~NILl~~-~g-~vkL~DFG~a~~~ 207 (520)
.++..|..| +...+.+|.. ..+||+|++++|||++. ++ .+-|.||.++..-
T Consensus 180 ~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 180 RQVERWAKQYLASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred HHHHHHHHHHHHhhcccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 344444333 2233556643 24999999999999974 33 3579999988653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00011 Score=68.98 Aligned_cols=145 Identities=17% Similarity=0.211 Sum_probs=93.1
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC------C
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH------H 108 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~------H 108 (520)
..||+|+.-.||.-- ......||+.+...... .....-..|+... .....+..+|+.-...+. +
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~----~~~~~~~~k~~~~---~~~~~~~~~E~~~y~~l~~~~~~~~ 76 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGER----RRPFKRWLKRLRP---KSRYRQNRRELRYYKQLSLRRGVDW 76 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccc----cccchhHHHhhcc---cchhHHHHHHHHHHHHHhhccCCcc
Confidence 478999999998753 34457888876544100 0001111111111 123445556665555544 7
Q ss_pred CCceEEEEEEEECCEEEEEEEccC------CCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLE------GGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~------ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
.+|.++|++.+++.-..+|+|.+. +.||.++++ .+.+++ .+ ...+-+-..||-.++|+.+|
T Consensus 77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---------~~~~~~-~~---~~~L~~f~~~l~~~~Iv~~d 143 (199)
T PF10707_consen 77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK---------EGGLTE-EL---RQALDEFKRYLLDHHIVIRD 143 (199)
T ss_pred cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH---------cCCccH-HH---HHHHHHHHHHHHHcCCeecC
Confidence 889999999999999999999964 346888885 344555 33 33444555677899999999
Q ss_pred cCCCcEEEcC--CC--CeEEec-cC
Q psy11359 183 IKAGNILLGE--DG--TVQIAD-FG 202 (520)
Q Consensus 183 LKp~NILl~~--~g--~vkL~D-FG 202 (520)
|+|.||++.. +| .+.|+| ||
T Consensus 144 l~~~NIv~~~~~~~~~~lvlIDG~G 168 (199)
T PF10707_consen 144 LNPHNIVVQRRDSGEFRLVLIDGLG 168 (199)
T ss_pred CCcccEEEEecCCCceEEEEEeCCC
Confidence 9999999953 22 466766 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.82 E-value=6.1e-05 Score=72.85 Aligned_cols=29 Identities=28% Similarity=0.503 Sum_probs=24.7
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcce
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSA 205 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~ 205 (520)
+++|+|+.|.||++++++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999876666799999763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.76 E-value=2.3e-06 Score=97.84 Aligned_cols=214 Identities=14% Similarity=0.059 Sum_probs=144.7
Q ss_pred HHHHHHHHhcCCCCCceEEEEEEE--ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHH
Q psy11359 96 LLKEIQAMSSCHHENVVTYHTSFV--VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYF 173 (520)
Q Consensus 96 l~~Ei~~l~~l~HpnIv~~~~~~~--~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yL 173 (520)
+..|...++...|+++...+.-.. ...+.|.+++|+.+|.+++.|-+... +...++..-+.....+.+.+..-+
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e----e~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE----ESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc----cCCcchhchHHHHHHHHHhccchh
Confidence 455666667788999988766544 34568999999999999999975322 345566666666666667777777
Q ss_pred HHCC-----cEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHH
Q psy11359 174 HSNG-----QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWS 248 (520)
Q Consensus 174 H~~g-----iiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwS 248 (520)
|+.. -+|++||+-|.+|..+.+++++++|+.++... .........++|.|++|++...-. ++.++|+|.
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-----~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr 1425 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-----VLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILR 1425 (2724)
T ss_pred hhcccCCccchhhhhhhhccceecCCcccccccccccccCc-----hHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHH
Confidence 7652 68999999999999999999999999874322 122334568899999999987655 788899999
Q ss_pred HHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 249 LGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 249 lG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
.|+-+|....|..+|.. .+...+++....-.. ....+-+|.+.-.....+|-..-..||.-...+..+.|-
T Consensus 1426 ~s~~ly~rs~~n~~fi~-----flq~~Lkgiidn~tf----~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1426 RSLSLYLRSDGNAYFIF-----FLQPALKGIIDNHTF----FSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHHHhcccHHHHH-----HHHHHHcCccccccc----ccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 99999999999887732 222222221111000 001111222222233333334456789888888877765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00017 Score=65.31 Aligned_cols=130 Identities=22% Similarity=0.220 Sum_probs=88.8
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
-++.+.||+|.+|.||++... |..+|+|+-+. ......+..|+++|..+.-.+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~-------------------------ds~r~~l~kEakiLeil~g~~ 76 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR-------------------------DSPRRNLEKEAKILEILAGEG 76 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecC-------------------------CcchhhHHHHHHHHHHhhhcC
Confidence 456778999999999999765 44777775432 223456899999999998776
Q ss_pred ce-EEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC-CCcE
Q psy11359 111 VV-TYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK-AGNI 188 (520)
Q Consensus 111 Iv-~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK-p~NI 188 (520)
+- ++|.+. ..++.|||+.|.+|.++... + +.. -+..+++.---|-..||-|..|. |..+
T Consensus 77 ~~p~vy~yg----~~~i~me~i~G~~L~~~~~~---------~--~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~ 137 (201)
T COG2112 77 VTPEVYFYG----EDFIRMEYIDGRPLGKLEIG---------G--DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKN 137 (201)
T ss_pred CCceEEEec----hhhhhhhhhcCcchhhhhhc---------c--cHH----HHHHHHHHHHHHHHhccchhhhcCCcee
Confidence 64 345442 23355999999888876541 0 222 23344444445667789888885 5555
Q ss_pred EEcCCCCeEEeccCccee
Q psy11359 189 LLGEDGTVQIADFGVSAW 206 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~ 206 (520)
++.+++.+.|+||..|+.
T Consensus 138 vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 138 VLVNDRDVYIIDFDSATF 155 (201)
T ss_pred EEecCCcEEEEEccchhh
Confidence 555666999999998764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00014 Score=67.71 Aligned_cols=102 Identities=18% Similarity=0.123 Sum_probs=79.0
Q ss_pred HHHHHHHhcCCC-CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11359 97 LKEIQAMSSCHH-ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS 175 (520)
Q Consensus 97 ~~Ei~~l~~l~H-pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~ 175 (520)
..|.-+|+.+.+ ++++++++++- .++|+||...+++...-.. +. .....++..+.+++.++++.+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~---l~--~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP---LS--QFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc---cc--cccccCHHHHHHHHHHHHHHHHHHhc
Confidence 348888888865 69999999883 2578999987765422000 00 11235789999999999999999998
Q ss_pred ---CCcEecccCCCcEEEcCCCCeEEeccCcceee
Q psy11359 176 ---NGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207 (520)
Q Consensus 176 ---~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~ 207 (520)
..+.-.|++|+|+-++++|++|++|...+...
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 45889999999999999999999999977544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=97.59 E-value=2.7e-05 Score=76.71 Aligned_cols=154 Identities=18% Similarity=0.162 Sum_probs=100.1
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC-C
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH-E 109 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H-p 109 (520)
|.+...||-|--+-||.+-+.. |.+.++|.=+.+...-..-+ ..+.+.-++-.....--+.-...+|...|+.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk-~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVK-NKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhh-hhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 5678899999999999998754 78888886543221110000 0111111111111111133345789999998843 2
Q ss_pred C-ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 110 N-VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 110 n-Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
. +++.++ .+..++|||++.|-.|.+.-. . ..+..+...+..-+.-|-.+|+||+|..--||
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-----------v---~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNi 233 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRH-----------V---EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNI 233 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeee-----------c---CChHHHHHHHHHHHHHHHHcCceecccchhee
Confidence 2 334333 467889999999988876542 2 22334555556666678899999999999999
Q ss_pred EEcCCCCeEEeccCcc
Q psy11359 189 LLGEDGTVQIADFGVS 204 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a 204 (520)
++.+++.++++||-..
T Consensus 234 mv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 234 MVKDDDKIVVIDFPQM 249 (465)
T ss_pred EEecCCCEEEeechHh
Confidence 9999999999999743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00099 Score=64.18 Aligned_cols=29 Identities=28% Similarity=0.507 Sum_probs=25.8
Q ss_pred CcEecccCCCcEEEcC-CCCeEEeccCcce
Q psy11359 177 GQIHRDIKAGNILLGE-DGTVQIADFGVSA 205 (520)
Q Consensus 177 giiHrDLKp~NILl~~-~g~vkL~DFG~a~ 205 (520)
+++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5899999999999987 5789999998763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00058 Score=68.29 Aligned_cols=143 Identities=15% Similarity=0.059 Sum_probs=80.0
Q ss_pred EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC--c
Q psy11359 34 REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN--V 111 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn--I 111 (520)
.+.|..|....+|+.... +..+++|+.. . ...+.+..|+.++..|.+.+ +
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~----------------------~----~~~~~~~~e~~~l~~L~~~g~~v 70 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFE----------------------K----VSAEELPFFLALLDHLAERGLPV 70 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcC----------------------C----CChHhccHHHHHHHHHHHCCCCC
Confidence 567777888899987542 3356666542 1 12344667888877774332 4
Q ss_pred eEEEEE------EEECCEEEEEEEccCCCCHHH--------HHH---Hhhccc-cCCC-----CCCCHHH--H-------
Q psy11359 112 VTYHTS------FVVKDELWLVLRLLEGGSLLD--------IIK---HRLKIS-NCKH-----GVCDEPT--I------- 159 (520)
Q Consensus 112 v~~~~~------~~~~~~~~lV~E~~~ggsL~~--------~i~---~~~~~~-~~~~-----~~l~~~~--i------- 159 (520)
.+++.. ....+..++|++|++|.++.. ..+ +.-... .... ....... .
T Consensus 71 p~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (296)
T cd05153 71 PRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLL 150 (296)
T ss_pred CccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhcccc
Confidence 454432 233556789999999876421 111 100000 0000 0000000 0
Q ss_pred -HHHHHHHHHHHHHHHH-------CCcEecccCCCcEEEcCCCCeEEeccCcc
Q psy11359 160 -ATVLREVLKGLEYFHS-------NGQIHRDIKAGNILLGEDGTVQIADFGVS 204 (520)
Q Consensus 160 -~~i~~qIl~gL~yLH~-------~giiHrDLKp~NILl~~~g~vkL~DFG~a 204 (520)
......+..++.++.. .+++|+|+.|.||++++++.+.|+||+.+
T Consensus 151 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 151 SAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred CHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 0111223344455543 36999999999999998877899999965
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0033 Score=65.38 Aligned_cols=84 Identities=15% Similarity=0.117 Sum_probs=55.8
Q ss_pred EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC---CCC
Q psy11359 34 REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH---HEN 110 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~---Hpn 110 (520)
.+.||.|.+..||++.+...++.++||..... ++.. .+.++...++...|...|+.+. ..+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~---------------~r~~-g~~wpl~~eR~~~Eae~L~~l~~~~p~~ 94 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPY---------------VRVV-GESWPLTLDRARIEAEALKIQAKYVPDL 94 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcc---------------cccc-cccccccHHHHHHHHHHHHHHHhhCCCC
Confidence 46789999999999998654457888864210 0000 1122345667788888888762 245
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCC
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGS 135 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggs 135 (520)
+++++.+ +.+..++||||+++..
T Consensus 95 VPkV~~~--D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 95 VPKVYHY--DEELAVTVMEDLSDHK 117 (401)
T ss_pred CCeEEEE--CCCCCEEEEecCCCcc
Confidence 7777765 4466789999998644
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0015 Score=64.02 Aligned_cols=28 Identities=21% Similarity=0.527 Sum_probs=24.7
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcce
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSA 205 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~ 205 (520)
.++|+|+.|.||++++++ +.|+||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 489999999999998877 7899999764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0043 Score=62.26 Aligned_cols=78 Identities=15% Similarity=-0.009 Sum_probs=53.6
Q ss_pred EEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC---
Q psy11359 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH--- 108 (520)
Q Consensus 32 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H--- 108 (520)
.-.+.||.|..+.||+..... + .+++|..+. ......+..|...|+.|.-
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-------------------------~~~~~~~~~Ea~~L~~L~~~~~ 69 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARS-------------------------FSTPGVAQQEAWKLSMLARSGT 69 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEecc-------------------------cccchHHHHHHHHHHHHccCCC
Confidence 346689999999999985433 2 355554210 0122458889999988843
Q ss_pred CCceEEEEEEEE---CCEEEEEEEccCCCCH
Q psy11359 109 ENVVTYHTSFVV---KDELWLVLRLLEGGSL 136 (520)
Q Consensus 109 pnIv~~~~~~~~---~~~~~lV~E~~~ggsL 136 (520)
-.+.++++++.. .+..+||||+++|.++
T Consensus 70 vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 70 VRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 357788877754 3668999999998765
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0013 Score=68.79 Aligned_cols=171 Identities=24% Similarity=0.310 Sum_probs=112.6
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEEEEE-CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHH
Q psy11359 94 DELLKEIQAMSSCHHENVVTYHTSFVV-KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEY 172 (520)
Q Consensus 94 ~~l~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~y 172 (520)
.++.-..+.++.+.|+|...++++-.. .....+|||++ +.+|.++.+.+. +-... ++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---------l~~~s-------~~----- 84 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---------LKDES-------LL----- 84 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---------cchhh-------hc-----
Confidence 456778889999999999999887663 34588999999 689999997542 11111 11
Q ss_pred HHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHH
Q psy11359 173 FHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252 (520)
Q Consensus 173 LH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~i 252 (520)
.+|+.|- +.++++| -++.. | |- ...+++||||+|.+
T Consensus 85 --~~~~~~~------------~~~~~td-~~~t~---------------------~--~~------~~~pKsdVwsl~~i 120 (725)
T KOG1093|consen 85 --AHGVLHL------------NIIYITD-HFLTK---------------------Y--PS------PIGPKSDVWSLGFI 120 (725)
T ss_pred --cccccee------------hhhhccc-ccccc---------------------C--CC------CCCcchhhhhHHHH
Confidence 2222221 2233444 11000 0 10 02249999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 253 AIEMATGTAPYHKYPAMKVLMLTLQNDP--PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 253 l~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
+.++.-|...+......++...+..-.. ...............++..+.++..+|+-..|..||...++.+++-|...
T Consensus 121 ~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 121 ILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 9999999888877666666554443321 11111222233445678889999999999999999999999999998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0016 Score=65.35 Aligned_cols=29 Identities=31% Similarity=0.459 Sum_probs=25.6
Q ss_pred CcEecccCCCcEEEcCC----CCeEEeccCcce
Q psy11359 177 GQIHRDIKAGNILLGED----GTVQIADFGVSA 205 (520)
Q Consensus 177 giiHrDLKp~NILl~~~----g~vkL~DFG~a~ 205 (520)
.++|+|+.|.|||++++ +.+.++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 48999999999999874 889999999763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.013 Score=59.27 Aligned_cols=30 Identities=30% Similarity=0.443 Sum_probs=25.5
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcce
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVSA 205 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a~ 205 (520)
.++||+|++|+||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999866666899999753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.018 Score=57.97 Aligned_cols=29 Identities=31% Similarity=0.520 Sum_probs=26.2
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcc
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVS 204 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a 204 (520)
.++||+|+++.||+++.++.+.|+||+.+
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccc
Confidence 57999999999999998887789999965
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0041 Score=63.45 Aligned_cols=80 Identities=18% Similarity=0.145 Sum_probs=52.2
Q ss_pred eeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC--CC-Cce
Q psy11359 36 VIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH--HE-NVV 112 (520)
Q Consensus 36 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~--Hp-nIv 112 (520)
.||-|....||++.+...++.++||.-.... +.+ .+.++-..++..-|...|+... -| .++
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~v---------------Rv~-g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP 65 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYV---------------RVV-GESWPLTLDRARIESSALIRQGEHVPHLVP 65 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHH---------------hhc-CCCCCCCccHHHHHHHHHHHhhccCccccC
Confidence 5789999999999986444679999743110 000 1234556667778888887763 24 455
Q ss_pred EEEEEEEECCEEEEEEEccCC
Q psy11359 113 TYHTSFVVKDELWLVLRLLEG 133 (520)
Q Consensus 113 ~~~~~~~~~~~~~lV~E~~~g 133 (520)
++|. .+.+...+|||+++.
T Consensus 66 ~vy~--~D~e~~~~vMEdL~~ 84 (370)
T TIGR01767 66 RIFH--FDTEMAVTVMEDLSH 84 (370)
T ss_pred eEEE--EccccceehHhhCcc
Confidence 5543 456667799999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0045 Score=62.47 Aligned_cols=162 Identities=15% Similarity=0.132 Sum_probs=97.6
Q ss_pred EEeeeeecCceEEEEEEEcCCCceEEEEEeehhhh--hhhHhhhccceeeEEEeecccchhhHH-HHHHHHHHHhcCCCC
Q psy11359 33 VREVIGFGATAVVHSAYCKARAEKCAIKKINLAVV--HSAYCKARAEKCAIKKINLEKWNTSMD-ELLKEIQAMSSCHHE 109 (520)
Q Consensus 33 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~~~aiK~i~~~~~~~~~~-~l~~Ei~~l~~l~Hp 109 (520)
+-..|..|--+.||.|.. .+|..+|||+++-..+ .+...-..++.-.---........-.. =..+|+..|++|+..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445677888999999865 4688899999862211 000000001100000000000001111 135688888888776
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcEecccCCCcE
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYF-HSNGQIHRDIKAGNI 188 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yL-H~~giiHrDLKp~NI 188 (520)
+|.-.--... ....|||+|+.+.. +- .+.-+.-.++...+..+-.|++..+.-| |..++||.||.--|+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdg-w~-------aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~ 296 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDG-WA-------APKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL 296 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCC-Cc-------CcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence 6543222222 34569999994321 10 1111345677888999999999998887 456999999999999
Q ss_pred EEcCCCCeEEeccCccee
Q psy11359 189 LLGEDGTVQIADFGVSAW 206 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~ 206 (520)
|+ .+|.+.|+|.+.+..
T Consensus 297 Ly-hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 297 LY-HDGKLYIIDVSQSVE 313 (520)
T ss_pred eE-ECCEEEEEEcccccc
Confidence 99 668999999997643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.032 Score=57.97 Aligned_cols=88 Identities=16% Similarity=0.059 Sum_probs=55.4
Q ss_pred EEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC---CC
Q psy11359 33 VREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH---HE 109 (520)
Q Consensus 33 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~---Hp 109 (520)
..+.||-|....||+..+. +..++||.-.... +. ..+.|+-..++...|+..|+.+. ..
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~---------------r~-vga~wpl~~~R~~~Ea~aL~~~~~~~p~ 97 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYI---------------RC-IGESWPMTKERAYFEATALREHGRLCPD 97 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccc---------------cC-CCccccCCccHHHHHHHHHHHhhhcCCC
Confidence 3678899999999998873 4568888643110 00 11222334555666777777663 24
Q ss_pred CceEEEEEEEECCEEEEEEEccCC--CCHHHHH
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEG--GSLLDII 140 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~g--gsL~~~i 140 (520)
+++++|.+.. +..+++||++++ ..|++.+
T Consensus 98 ~VPkVy~~de--d~~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 98 HVPEVYHFDR--TMALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred CCCeEEEECC--CCCEEEEeecCCcceehhhhh
Confidence 6778887665 556789999977 3444443
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.065 Score=53.82 Aligned_cols=28 Identities=36% Similarity=0.515 Sum_probs=24.6
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcc
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVS 204 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a 204 (520)
.+++|+|+.+.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999987 67899999954
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.011 Score=61.15 Aligned_cols=81 Identities=12% Similarity=0.036 Sum_probs=56.8
Q ss_pred EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC--CC-C
Q psy11359 34 REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH--HE-N 110 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~--Hp-n 110 (520)
.+.||-|.-..||++.+...++.|+||.-.. + ++ -.+.|+-..++..-|..+|+.+. -| +
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp--------------~-vR--v~~swpL~~~R~~~E~~aL~~~~~~~P~~ 96 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGD--------------T-AR--ISDEFKLSTNRIRIESDVLQLEEELAPGL 96 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccH--------------h-hc--cCCCCCCChHHHHHHHHHHHHHHhhCCCc
Confidence 6778999999999999854456799996421 1 11 12456677888888999988763 34 4
Q ss_pred ceEEEEEEEECCEEEEEEEccCC
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEG 133 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~g 133 (520)
++++|. .+.+...+|||+++.
T Consensus 97 VP~vy~--~D~e~~~~vMEdL~~ 117 (409)
T PRK12396 97 VPKVYL--FDSVMNCCVMEDLSD 117 (409)
T ss_pred CCeEEE--ECcHHhhHHHHhCcc
Confidence 555554 456677889999854
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.013 Score=58.05 Aligned_cols=29 Identities=28% Similarity=0.528 Sum_probs=24.4
Q ss_pred CcEecccCCCcEEEcCCCC-eEEeccCcce
Q psy11359 177 GQIHRDIKAGNILLGEDGT-VQIADFGVSA 205 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~-vkL~DFG~a~ 205 (520)
.++|+|++|.|||+++++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 3899999999999987565 5699999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.031 Score=56.23 Aligned_cols=117 Identities=15% Similarity=0.177 Sum_probs=69.3
Q ss_pred hhHHHHHHHHHHHhcCCC--CCceEEEEEEEECC--EEEEEEEccCCCCH------------------HHHHHHhhcccc
Q psy11359 91 TSMDELLKEIQAMSSCHH--ENVVTYHTSFVVKD--ELWLVLRLLEGGSL------------------LDIIKHRLKISN 148 (520)
Q Consensus 91 ~~~~~l~~Ei~~l~~l~H--pnIv~~~~~~~~~~--~~~lV~E~~~ggsL------------------~~~i~~~~~~~~ 148 (520)
.......+|+.+++.+.- --+...+.++..+. ..|.||+|++|..+ .+++...-.+..
T Consensus 63 ~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida 142 (321)
T COG3173 63 ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDA 142 (321)
T ss_pred hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCC
Confidence 345567788888887743 22334455555544 67999999988321 122211111110
Q ss_pred ------CCCCCCCHHHHHHHHHHH--------------HHHHHHHHHC--------CcEecccCCCcEEEcCCCCeEEec
Q psy11359 149 ------CKHGVCDEPTIATVLREV--------------LKGLEYFHSN--------GQIHRDIKAGNILLGEDGTVQIAD 200 (520)
Q Consensus 149 ------~~~~~l~~~~i~~i~~qI--------------l~gL~yLH~~--------giiHrDLKp~NILl~~~g~vkL~D 200 (520)
+..+.+...++..+..+. ..-..+|+.+ .++|+|+++.||++++++.+=+.|
T Consensus 143 ~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlD 222 (321)
T COG3173 143 AGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLD 222 (321)
T ss_pred cCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEe
Confidence 111112233344444333 2334556554 389999999999999888899999
Q ss_pred cCcceee
Q psy11359 201 FGVSAWL 207 (520)
Q Consensus 201 FG~a~~~ 207 (520)
|+++..-
T Consensus 223 we~~~lG 229 (321)
T COG3173 223 WELATLG 229 (321)
T ss_pred ccccccC
Confidence 9988653
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.066 Score=54.91 Aligned_cols=155 Identities=15% Similarity=0.168 Sum_probs=82.4
Q ss_pred CCCCC-CCCeEEEeeeeecCceEEEEEEEcC----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHH
Q psy11359 23 PWPNT-EDQYEVREVIGFGATAVVHSAYCKA----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELL 97 (520)
Q Consensus 23 ~~~~~-~~~Y~i~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~ 97 (520)
.|... .....-+..|-.|-+-.+|++.... .++.|++|+.... . ...++ -.
T Consensus 29 ~w~~~~~~~~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~-------------t----------~~~id-R~ 84 (344)
T PLN02236 29 KWGDVVDDEALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEG-------------V----------ELFFD-RD 84 (344)
T ss_pred hhcCCCCcCcEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCC-------------C----------Ceeec-hH
Confidence 37543 3334444555558888999986432 2356666654211 0 11111 25
Q ss_pred HHHHHHhcCCCCCc-eEEEEEEEECCEEEEEEEccCCCCHHH-----------HHHHhhccccC--CCC--CCCHHHHHH
Q psy11359 98 KEIQAMSSCHHENV-VTYHTSFVVKDELWLVLRLLEGGSLLD-----------IIKHRLKISNC--KHG--VCDEPTIAT 161 (520)
Q Consensus 98 ~Ei~~l~~l~HpnI-v~~~~~~~~~~~~~lV~E~~~ggsL~~-----------~i~~~~~~~~~--~~~--~l~~~~i~~ 161 (520)
+|..+++.+..-++ .++++.+.. . .|++|++|.+|.. +.+...++-.. ... ......+..
T Consensus 85 ~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~ 160 (344)
T PLN02236 85 DEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRN 160 (344)
T ss_pred HHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence 68888888854444 345555432 2 5899998766531 11111111000 111 111234444
Q ss_pred HHHHHH-----------------HHHHHH----HH----CCcEecccCCCcEEEcC-CCCeEEeccCcce
Q psy11359 162 VLREVL-----------------KGLEYF----HS----NGQIHRDIKAGNILLGE-DGTVQIADFGVSA 205 (520)
Q Consensus 162 i~~qIl-----------------~gL~yL----H~----~giiHrDLKp~NILl~~-~g~vkL~DFG~a~ 205 (520)
++.++. ..+..| .. ..++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 161 ~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 161 WLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 443321 111111 21 25899999999999976 5789999998764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.035 Score=56.59 Aligned_cols=28 Identities=32% Similarity=0.648 Sum_probs=24.6
Q ss_pred cEecccCCCcEEEcC-CCCeEEeccCcce
Q psy11359 178 QIHRDIKAGNILLGE-DGTVQIADFGVSA 205 (520)
Q Consensus 178 iiHrDLKp~NILl~~-~g~vkL~DFG~a~ 205 (520)
++|.||.+.|||+++ ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999974 5789999999763
|
|
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.01 Score=60.66 Aligned_cols=60 Identities=25% Similarity=0.325 Sum_probs=45.2
Q ss_pred EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcEecccCCCcEEEc
Q psy11359 123 ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYF-HSNGQIHRDIKAGNILLG 191 (520)
Q Consensus 123 ~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yL-H~~giiHrDLKp~NILl~ 191 (520)
...++-+|..|-++..+++. ...+++..++++.-...||-.+ --.+++|.|++|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~---------~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW---------KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhc---------ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 45677788999999999964 3445666777776666665543 456899999999999994
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.037 Score=55.96 Aligned_cols=103 Identities=19% Similarity=0.260 Sum_probs=69.9
Q ss_pred CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecccCCCcEEEcCCCCeEEe
Q psy11359 121 KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN-GQIHRDIKAGNILLGEDGTVQIA 199 (520)
Q Consensus 121 ~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~-giiHrDLKp~NILl~~~g~vkL~ 199 (520)
....|++|++. |++|.- + ..-..+++..++.+-+..+.-+..+ ..=|||+..+||||+ +|+|-|+
T Consensus 298 ~~y~yl~~kdh-gt~is~-i-----------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLI 363 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I-----------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLI 363 (488)
T ss_pred ceEEEEEEecC-Cceeee-e-----------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEE
Confidence 34578888887 555532 2 2234678889999988888877766 589999999999999 9999999
Q ss_pred ccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHH
Q psy11359 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSL 249 (520)
Q Consensus 200 DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSl 249 (520)
||-+++.-..+..... ..+--|-.+.|. -+...+||-+
T Consensus 364 DfklsRl~~~q~~isy----------~rldhp~lF~G~--dd~QFeIYrl 401 (488)
T COG5072 364 DFKLSRLSYSQGIISY----------NRLDHPDLFNGV--DDYQFEIYRL 401 (488)
T ss_pred EeeeeecccCCceeec----------cccCchhhhcCc--cceeeeHHHH
Confidence 9999984322222111 122334445544 3667777754
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.036 Score=52.30 Aligned_cols=101 Identities=16% Similarity=0.157 Sum_probs=68.1
Q ss_pred eeeEEEeecccchhhHHHHHHHHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHH
Q psy11359 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEP 157 (520)
Q Consensus 78 ~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~ 157 (520)
+.++|++..-.+.-...-+..+..++.+++ +|+++..- ..-.+.+|.|+|.... ...
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----------------i~~-- 143 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----------------INF-- 143 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----------------cch--
Confidence 345555554444433445678888888874 68887732 4446889999994321 111
Q ss_pred HHHHHHHHHHHHHHHHHHC--CcEecccCCCcEEEcCCCCeEEeccCc
Q psy11359 158 TIATVLREVLKGLEYFHSN--GQIHRDIKAGNILLGEDGTVQIADFGV 203 (520)
Q Consensus 158 ~i~~i~~qIl~gL~yLH~~--giiHrDLKp~NILl~~~g~vkL~DFG~ 203 (520)
..++.-=++.|.-.|+. +.+|+|-.|+||+-+..|.+||.|=+.
T Consensus 144 --~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 144 --SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred --hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 11222225677888954 699999999999999999999999874
|
The function of this family is unknown. |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.011 Score=63.06 Aligned_cols=64 Identities=25% Similarity=0.430 Sum_probs=52.7
Q ss_pred ccceeEEEEeecccC----CcceeEEeeecCCCchhhHHHHHHhccCCCCccHHHHHHHHHHHHccCC
Q psy11359 427 DRVVNLILRMRNVRR----ELNDIRFEFCIGKDTSDGIAGELVGAGLVDARDTEAISQNLELVVNGTP 490 (520)
Q Consensus 427 ~~~~~l~lr~~~~~~----~~~~i~f~f~~~~dt~~~va~e~v~~~~~~~~d~~~~a~~~~~~~~~~~ 490 (520)
+..++|.+|..+..+ ..|.|.|.|+++.||++.||+|||+.+.+++.|-..||..+..-+....
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ik 383 (632)
T KOG0584|consen 316 DPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIK 383 (632)
T ss_pred cccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeec
Confidence 344556677777652 2468999999999999999999999999999999999998887776663
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.043 Score=54.70 Aligned_cols=75 Identities=16% Similarity=0.082 Sum_probs=45.1
Q ss_pred EEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC---CC
Q psy11359 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC---HH 108 (520)
Q Consensus 32 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l---~H 108 (520)
+-.+.++.|....+|+.. .++..+.+|+-.. .....+..|..-|+.| ..
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~--------------------------~~~~~f~~Ea~gL~~L~~~~~ 71 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE--------------------------SGRDMFEGEAEGLKALAEANP 71 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG--------------------------GGCCHHHHHHHHHHHHCHTTT
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh--------------------------hhHHHHHHHHHHHHHHHhcCC
Confidence 446678889999999986 6666777775431 1123467788777777 34
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCC
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGG 134 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~gg 134 (520)
-.+++.+.+....+.-||||||++.+
T Consensus 72 ~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 72 IRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp SBS--EEEEEE-SSCCEEEEE-----
T ss_pred CCCCeEEEEEeecCCceEEEEeecCC
Confidence 45778898888877789999998766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.25 Score=49.70 Aligned_cols=29 Identities=14% Similarity=0.205 Sum_probs=26.5
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcce
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSA 205 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~ 205 (520)
++||+|+.++|||++.++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999999999999998653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.22 Score=51.72 Aligned_cols=92 Identities=17% Similarity=0.151 Sum_probs=49.9
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCC-CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKAR-AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
.|+.........+.|..|-...+|++..... +..+.+|.+ .++.. ... ....-.-.+|++
T Consensus 44 ~w~~~~~~~i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~V-----------------l~R~~-g~~-~~l~IdR~~E~~ 104 (383)
T PTZ00384 44 FWNNVNPEFIEIKKMNNGITNQVYQATLVDGDKDRYPIKSV-----------------CIKKS-STY-NSLVIDNDLQYN 104 (383)
T ss_pred ccccCCcccEEEEEeCCcccceEEEEEecCCCCCccccceE-----------------EEEec-cCC-CceEeccHHHHH
Confidence 4655544445555666688899999865432 122222211 11110 000 000011256889
Q ss_pred HHhcCCCCCc-eEEEEEEEECCEEEEEEEccCCCCHH
Q psy11359 102 AMSSCHHENV-VTYHTSFVVKDELWLVLRLLEGGSLL 137 (520)
Q Consensus 102 ~l~~l~HpnI-v~~~~~~~~~~~~~lV~E~~~ggsL~ 137 (520)
+++.|...++ .++++.+. -++|.||++|.+|.
T Consensus 105 i~~~Ls~~glgP~l~~~f~----~g~l~efIeGr~l~ 137 (383)
T PTZ00384 105 IAKLLGDNNFGPKIIGRFG----DFTIQEWVEGNTMG 137 (383)
T ss_pred HHHHHHhCCCCCeEEEecC----CEEEEEEeccccCC
Confidence 9999865444 55666553 26999999887653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.12 E-value=1.1 Score=45.43 Aligned_cols=26 Identities=31% Similarity=0.452 Sum_probs=22.5
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcc
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVS 204 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a 204 (520)
++||+|+.++|||++ + .+.|+||+.+
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~ 222 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDA 222 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCC
Confidence 689999999999995 4 5789999965
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.55 E-value=0.62 Score=49.43 Aligned_cols=27 Identities=26% Similarity=0.414 Sum_probs=22.8
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcc
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVS 204 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a 204 (520)
-++|.|+-+.|||...+ .++|+||-.|
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYA 311 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYS 311 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeeccc
Confidence 47999999999988654 4999999865
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.62 E-value=0.13 Score=51.54 Aligned_cols=50 Identities=20% Similarity=0.238 Sum_probs=34.2
Q ss_pred HHHHHHHHHHHHHHHHHHH----CCcEecccCCCcEEEcCCC------------------CeEEeccCccee
Q psy11359 157 PTIATVLREVLKGLEYFHS----NGQIHRDIKAGNILLGEDG------------------TVQIADFGVSAW 206 (520)
Q Consensus 157 ~~i~~i~~qIl~gL~yLH~----~giiHrDLKp~NILl~~~g------------------~vkL~DFG~a~~ 206 (520)
+-++.++.||+--.-++-. .+++|-||||+|||+-+.. .++|.||.+|..
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 3466677788765544433 4699999999999994332 256677777654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 520 | ||||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-113 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-113 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-46 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-45 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-45 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-45 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-45 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-45 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-39 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-36 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-35 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-35 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-35 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-35 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-35 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-35 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-35 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-35 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-35 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-35 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-34 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-33 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-33 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-32 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-32 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-32 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-32 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-32 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-32 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-32 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-29 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-29 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-29 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-26 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-22 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-22 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-22 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-22 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-22 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-22 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-21 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-21 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-21 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-18 | ||
| 2v3s_A | 96 | Structural Insights Into The Recognition Of Substra | 4e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-17 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-17 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-17 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-16 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-16 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-15 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-13 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-09 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 9e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-08 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-08 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-08 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-08 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-08 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-08 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-08 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-08 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-08 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-08 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-07 |
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2V3S|A Chain A, Structural Insights Into The Recognition Of Substrates And Activators By The Osr1 Kinase Length = 96 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 490 bits (1264), Expect = e-174
Identities = 221/327 (67%), Positives = 257/327 (78%), Gaps = 25/327 (7%)
Query: 12 MAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAY 71
M+ SS ++PW D YE++EVIG GATAVV +AYC + EK AIK+INL
Sbjct: 1 MSEDSS---ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL------- 50
Query: 72 CKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLL 131
EK TSMDELLKEIQAMS CHH N+V+Y+TSFVVKDELWLV++LL
Sbjct: 51 ---------------EKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95
Query: 132 EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
GGS+LDIIKH + K GV DE TIAT+LREVL+GLEY H NGQIHRD+KAGNILLG
Sbjct: 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG 155
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251
EDG+VQIADFGVSA+LATG D++R KVR TFVGTPCWMAPEVMEQ GYDFKADIWS GI
Sbjct: 156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGI 215
Query: 252 TAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311
TAIE+ATG APYHKYP MKVLMLTLQNDPP+L+TG +K+ K YGK+FRKMIS CLQKD
Sbjct: 216 TAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKD 275
Query: 312 PTKRPTASELLKNPFFKKAKDKKFIQQ 338
P KRPTA+ELL++ FF+KAK+K+F+Q+
Sbjct: 276 PEKRPTAAELLRHKFFQKAKNKEFLQE 302
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 410 bits (1056), Expect = e-141
Identities = 103/398 (25%), Positives = 165/398 (41%), Gaps = 74/398 (18%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
+ YE+ VIG G +L V+ A K E +++
Sbjct: 20 FLPEGGCYELLTVIGKGFE--------------------DLMTVNLARYKPTGEYVTVRR 59
Query: 84 INLEKWNTSM-DELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
INLE + M L E+ +H N+V Y +F+ +ELW+V + GS D+I
Sbjct: 60 INLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT 119
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202
+E IA +L+ VLK L+Y H G +HR +KA +IL+ DG V ++
Sbjct: 120 HFM------DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 173
Query: 203 VSAWLATGRDLSRQKVRHT----FVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEMA 257
+ + RQ+V H V W++PEV++Q+ GYD K+DI+S+GITA E+A
Sbjct: 174 SNLSMI--SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 258 TGTAPYHKYPAMKVLMLTLQNDPPTLDTGAA----------------------------- 288
G P+ PA ++L+ L P L +
Sbjct: 232 NGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPR 291
Query: 289 -------EKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK--KFIQQT 339
++ + F + CLQ++P RP+AS LL + FFK+ K + + + +
Sbjct: 292 PSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPEL 351
Query: 340 LVSVGPTFETRIQKAAKKNP--GASGRLHRTVTGEWVW 375
L V P ++ + G L +W +
Sbjct: 352 LRPVTPITNFEGSQSQDHSGIFGLVTNLEELEVDDWEF 389
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 376 bits (967), Expect = e-128
Identities = 126/334 (37%), Positives = 175/334 (52%), Gaps = 50/334 (14%)
Query: 12 MAASSSASVSVPWPNT----EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVV 67
MA S S N E+ + E IG G+ V + AIK I+L
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL--- 57
Query: 68 HSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLV 127
E+ ++++ +EI +S C V Y+ S++ +LW++
Sbjct: 58 -------------------EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98
Query: 128 LRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187
+ L GGS LD+++ G DE IAT+LRE+LKGL+Y HS +IHRDIKA N
Sbjct: 99 MEYLGGGSALDLLEP---------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAAN 149
Query: 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIW 247
+LL E G V++ADFGV+ L ++ K R+TFVGTP WMAPEV+ + YD KADIW
Sbjct: 150 VLLSEHGEVKLADFGVAGQLTD----TQIK-RNTFVGTPFWMAPEVI-KQSAYDSKADIW 203
Query: 248 SLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDC 307
SLGITAIE+A G P+ + MKVL L +N+PPTL+ Y K ++ + C
Sbjct: 204 SLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE---------GNYSKPLKEFVEAC 254
Query: 308 LQKDPTKRPTASELLKNPFFKKAKDKKFIQQTLV 341
L K+P+ RPTA ELLK+ F + K L+
Sbjct: 255 LNKEPSFRPTAKELLKHKFILRNAKKTSYLTELI 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-112
Identities = 101/315 (32%), Positives = 158/315 (50%), Gaps = 46/315 (14%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
+ +E+ +G GA V+ A K A K I
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET----------------------- 54
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
K +++ + EI+ +++C H +V ++ +LW+++ GG++ I+
Sbjct: 55 KSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---- 110
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
EP I V R++L+ L + HS IHRD+KAGN+L+ +G +++ADFGVSA
Sbjct: 111 ---DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVM----EQDHGYDFKADIWSLGITAIEMATGTAPY 263
+ QK R +F+GTP WMAPEV+ +D YD+KADIWSLGIT IEMA P+
Sbjct: 168 LK----TLQK-RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222
Query: 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
H+ M+VL+ ++DPPTL T + FR + L K+P RP+A++LL+
Sbjct: 223 HELNPMRVLLKIAKSDPPTLLTP-------SKWSVEFRDFLKIALDKNPETRPSAAQLLE 275
Query: 324 NPFFKKAKDKKFIQQ 338
+PF K +++
Sbjct: 276 HPFVSSITSNKALRE 290
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-112
Identities = 112/311 (36%), Positives = 162/311 (52%), Gaps = 45/311 (14%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
E+ ++V E +G G+ V+ A K + AIK++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV----------------------- 64
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ + E++KEI M C +VV Y+ S+ +LW+V+ GS+ DII+ R
Sbjct: 65 --ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---- 118
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
+ E IAT+L+ LKGLEY H +IHRDIKAGNILL +G ++ADFGV+ L
Sbjct: 119 ---NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267
+ K R+T +GTP WMAPEV+ Q+ GY+ ADIWSLGITAIEMA G PY
Sbjct: 176 TD----TMAK-RNTVIGTPFWMAPEVI-QEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
M+ + + N PPT + + F + CL K P +R TA++LL++PF
Sbjct: 230 PMRAIFMIPTNPPPTF------RKPEL-WSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282
Query: 328 KKAKDKKFIQQ 338
+ AK ++
Sbjct: 283 RSAKGVSILRD 293
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 329 bits (846), Expect = e-110
Identities = 114/311 (36%), Positives = 157/311 (50%), Gaps = 45/311 (14%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
+ +Y E IG GA+ V++A A ++ AI+++NL + K
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---------QQPK--------- 60
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ ++ EI M + N+V Y S++V DELW+V+ L GGSL D++
Sbjct: 61 -----KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----- 110
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
DE IA V RE L+ LE+ HSN IHRDIK+ NILLG DG+V++ DFG A +
Sbjct: 111 ----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267
+ K R T VGTP WMAPEV+ + Y K DIWSLGI AIEM G PY
Sbjct: 167 TP----EQSK-RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
++ L L N P L ++ K FR ++ CL+ D KR +A ELL++ F
Sbjct: 221 PLRALYLIATNGTPEL------QNPEK-LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273
Query: 328 KKAKDKKFIQQ 338
K AK +
Sbjct: 274 KIAKPLSSLTP 284
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = e-109
Identities = 98/311 (31%), Positives = 144/311 (46%), Gaps = 45/311 (14%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
+ IG G+T +V A K + A+K ++L
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDL----------------------- 80
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ + L E+ M H NVV + S++V +ELW+++ L+GG+L DI+
Sbjct: 81 RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----- 135
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
+E IATV VL+ L Y H+ G IHRDIK+ +ILL DG V+++DFG A +
Sbjct: 136 ----VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267
+ K R + VGTP WMAPEV+ Y + DIWSLGI IEM G PY
Sbjct: 192 SK----DVPK-RKSLVGTPYWMAPEVI-SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
++ + + PP L K+ +K R + L +DP +R TA ELL +PF
Sbjct: 246 PVQAMKRLRDSPPPKL------KNSHK-VSPVLRDFLERMLVRDPQERATAQELLDHPFL 298
Query: 328 KKAKDKKFIQQ 338
+ + +
Sbjct: 299 LQTGLPECLVP 309
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = e-109
Identities = 99/313 (31%), Positives = 143/313 (45%), Gaps = 47/313 (15%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
E + IG G+ V+ A +E AIKK++ + +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY--------------------SGK 92
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ N +++KE++ + H N + Y ++ + WLV+ GS D+++
Sbjct: 93 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVH---- 147
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
E IA V L+GL Y HS+ IHRD+KAGNILL E G V++ DFG ++ +
Sbjct: 148 ---KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEV--MEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265
A ++FVGTP WMAPEV + YD K D+WSLGIT IE+A P
Sbjct: 205 AP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
Query: 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325
AM L QN+ P L Q + + FR + CLQK P RPT+ LLK+
Sbjct: 256 MNAMSALYHIAQNESPAL--------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307
Query: 326 FFKKAKDKKFIQQ 338
F + + I
Sbjct: 308 FVLRERPPTVIMD 320
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = e-108
Identities = 108/328 (32%), Positives = 162/328 (49%), Gaps = 54/328 (16%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
+ +E+ E++G G V+ + AIK +++
Sbjct: 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------------- 60
Query: 85 NLEKWNTSMDELLKEIQAMSS-CHHENVVTYHTSFVVK------DELWLVLRLLEGGSLL 137
+E+ +EI + HH N+ TY+ +F+ K D+LWLV+ GS+
Sbjct: 61 -----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115
Query: 138 DIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQ 197
D+IK N K E IA + RE+L+GL + H + IHRDIK N+LL E+ V+
Sbjct: 116 DLIK------NTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 169
Query: 198 IADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEV----MEQDHGYDFKADIWSLGITA 253
+ DFGVSA L + + R+TF+GTP WMAPEV D YDFK+D+WSLGITA
Sbjct: 170 LVDFGVSAQLDR----TVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224
Query: 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
IEMA G P M+ L L +N P L + K + K F+ I CL K+ +
Sbjct: 225 IEMAEGAPPLCDMHPMRALFLIPRNPAPRL--------KSKKWSKKFQSFIESCLVKNHS 276
Query: 314 KRPTASELLKNPFFKKAKDKKFIQQTLV 341
+RP +L+K+PF + +++ ++ L
Sbjct: 277 QRPATEQLMKHPFIRDQPNERQVRIQLK 304
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 4e-97
Identities = 70/270 (25%), Positives = 106/270 (39%), Gaps = 23/270 (8%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWL 126
VH K +CA+KK+ LE ++E+ A + +V + + + +
Sbjct: 74 VHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPRIVPLYGAVREGPWVNI 127
Query: 127 VLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186
+ LLEGGSL +IK G E L + L+GLEY H+ +H D+KA
Sbjct: 128 FMELLEGGSLGQLIKQ--------MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKAD 179
Query: 187 NILLGEDGT-VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKAD 245
N+LL DG+ + DFG + L GT MAPEV+ D K D
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVD 238
Query: 246 IWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMIS 305
IWS + M G P+ +Y + + PP + I
Sbjct: 239 IWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREI----PPSCAPLTAQA---IQ 291
Query: 306 DCLQKDPTKRPTASELLKNPFFKKAKDKKF 335
+ L+K+P R +A EL + +
Sbjct: 292 EGLRKEPVHRASAMELRRKVGKALQEVGGL 321
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 1e-94
Identities = 86/333 (25%), Positives = 141/333 (42%), Gaps = 47/333 (14%)
Query: 12 MAASSSASVSVP----WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVV 67
M+ SS + + W T + + IG GA V+ K K +
Sbjct: 1 MSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVN---------KMVHKPSGQIM- 50
Query: 68 HSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ-AMSSCHHENVVTYHTSFVVKDELWL 126
A+K+I +LL ++ M S +V ++ + + + W+
Sbjct: 51 ------------AVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98
Query: 127 VLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI-HRDIKA 185
+ L+ S K + + V E + + +K L + N +I HRDIK
Sbjct: 99 CMELM-STSFDKFYK---YVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKP 154
Query: 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD---HGYDF 242
NILL G +++ DFG+S L + G +MAPE ++ GYD
Sbjct: 155 SNILLDRSGNIKLCDFGISG------QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDV 208
Query: 243 KADIWSLGITAIEMATGTAPYHKYPAM-KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFR 301
++D+WSLGIT E+ATG PY K+ ++ L ++ DPP L + + +F
Sbjct: 209 RSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE-----FSPSFI 263
Query: 302 KMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334
++ CL KD +KRP ELLK+PF +++
Sbjct: 264 NFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 7e-94
Identities = 84/346 (24%), Positives = 138/346 (39%), Gaps = 56/346 (16%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
+ + E +G G V K R + A+K+
Sbjct: 20 YQAEINDLENLGEMGSGTCGQVW----KMR------------------FRKTGHVIAVKQ 57
Query: 84 INLEKWNTSMDELLKEIQA-MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
+ +L ++ + S +V +F+ ++++ + L+ G + K
Sbjct: 58 MRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR 116
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGNILLGEDGTVQIADF 201
G E + + ++K L Y +G IHRD+K NILL E G +++ DF
Sbjct: 117 -------MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH----GYDFKADIWSLGITAIEMA 257
G+S L K + G +MAPE ++ YD +AD+WSLGI+ +E+A
Sbjct: 170 GISG------RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223
Query: 258 TGTAPYHKY-PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
TG PY +VL LQ +PP L + F+ + DCL KD KRP
Sbjct: 224 TGQFPYKNCKTDFEVLTKVLQEEPPLLPGH-------MGFSGDFQSFVKDCLTKDHRKRP 276
Query: 317 TASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGAS 362
++LL++ F K+ + + V V F+ + K G S
Sbjct: 277 KYNKLLEHSFIKRYETLE------VDVASWFKDVMAKTESPRSGPS 316
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 8e-90
Identities = 82/325 (25%), Positives = 130/325 (40%), Gaps = 52/325 (16%)
Query: 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINL 86
D E +G GA VV K + A+K+I
Sbjct: 5 KADDLEPIMELGRGAYGVVE---------KMRHVPSGQIM-------------AVKRIRA 42
Query: 87 EKWNTSMDELLKEIQ-AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK 145
+ LL ++ +M + VT++ + + ++W+ + L+ SL K +
Sbjct: 43 TVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVID 101
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ-IHRDIKAGNILLGEDGTVQIADFGVS 204
K E + + ++K LE+ HS IHRD+K N+L+ G V++ DFG+S
Sbjct: 102 ----KGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEV---MEQDHGYDFKADIWSLGITAIEMATGTA 261
L + G +MAPE GY K+DIWSLGIT IE+A
Sbjct: 158 G------YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211
Query: 262 PYHKYPA-MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320
PY + + L ++ P L + F S CL+K+ +RPT E
Sbjct: 212 PYDSWGTPFQQLKQVVEEPSPQLPAD--------KFSAEFVDFTSQCLKKNSKERPTYPE 263
Query: 321 LLKNPFFKKAKDK-----KFIQQTL 340
L+++PFF + K F++ L
Sbjct: 264 LMQHPFFTLHESKGTDVASFVKLIL 288
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 3e-87
Identities = 86/279 (30%), Positives = 134/279 (48%), Gaps = 24/279 (8%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELW 125
+V++ + + AIK+I + L +EI H+N+V Y SF +
Sbjct: 37 IVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95
Query: 126 LVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185
+ + + GGSL +++ + +E TI +++L+GL+Y H N +HRDIK
Sbjct: 96 IFMEQVPGGSLSALLRSK-----WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKG 150
Query: 186 GNILLG-EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD-HGYDFK 243
N+L+ G ++I+DFG S LA TF GT +MAPE++++ GY
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLAGINP-----CTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 244 ADIWSLGITAIEMATGTAPYHKYP-AMKVL-MLTLQNDPPTLDTGAAEKDQYKAYGKTFR 301
ADIWSLG T IEMATG P+++ + + + P + + A K F
Sbjct: 206 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP------ESMSAEAKAF- 258
Query: 302 KMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTL 340
I C + DP KR A++LL + F K + KK Q L
Sbjct: 259 --ILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 3e-87
Identities = 66/341 (19%), Positives = 111/341 (32%), Gaps = 72/341 (21%)
Query: 13 AASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYC 72
A S ++ E IG G V + AIK+ + S
Sbjct: 1 GAMGMKS------RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS--- 51
Query: 73 KARAEKCAIKKINLEKWNTSMDELLKEIQAMSS-CHHENVVTYHTSFVVKDELWLVLRLL 131
L+E+ A + H +VV Y +++ D + +
Sbjct: 52 ------------------VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYC 93
Query: 132 EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
GGSL D I + E + +L +V +GL Y HS +H DIK NI +
Sbjct: 94 NGGSLADAISENYR----IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 149
Query: 192 EDG-------------------TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPE 232
+I D G R G ++A E
Sbjct: 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---------RISSPQVEEGDSRFLANE 200
Query: 233 VMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQ 292
V+++++ + KADI++L +T + A + Q P +
Sbjct: 201 VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR---QGRLPRIPQV------ 251
Query: 293 YKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333
+ F +++ + DP +RP+A L+K+ A K
Sbjct: 252 ---LSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 5e-83
Identities = 86/333 (25%), Positives = 145/333 (43%), Gaps = 40/333 (12%)
Query: 8 PGRIMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVV 67
P A NT + + + IG G + V+ A C A+KK+ + +
Sbjct: 11 PPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL 70
Query: 68 HSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLV 127
A + + +KEI + +H NV+ Y+ SF+ +EL +V
Sbjct: 71 MDAKAR--------------------ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110
Query: 128 LRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187
L L + G L +IKH K + + E T+ ++ LE+ HS +HRDIK N
Sbjct: 111 LELADAGDLSRMIKHFKK----QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166
Query: 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIW 247
+ + G V++ D G+ + ++ H+ VGTP +M+PE + ++GY+FK+DIW
Sbjct: 167 VFITATGVVKLGDLGLGRFFSSKTTA-----AHSLVGTPYYMSPERIH-ENGYNFKSDIW 220
Query: 248 SLGITAIEMATGTAPYH-KYPAMKVLMLT-LQNDPPTLDTGAAEKDQYKAYGKTFRKMIS 305
SLG EMA +P++ + L Q D P L + Y + R++++
Sbjct: 221 SLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD--------HYSEELRQLVN 272
Query: 306 DCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQ 338
C+ DP KRP + + A ++
Sbjct: 273 MCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 1e-82
Identities = 74/324 (22%), Positives = 111/324 (34%), Gaps = 51/324 (15%)
Query: 8 PGRIMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVV 67
S S P + ++ +G G+ V K A+K+
Sbjct: 36 EASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR 95
Query: 68 HSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS-CHHENVVTYHTSFVVKDELWL 126
K RA K L E+ + H V ++ L+L
Sbjct: 96 GP---KDRARK------------------LAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134
Query: 127 VLRLLEGGSLLDIIKHRLKISNCKHGVC-DEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185
L G SL + G E + LR+ L L + HS G +H D+K
Sbjct: 135 QTELC-GPSLQQHCE--------AWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKP 185
Query: 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKAD 245
NI LG G ++ DFG+ +L G P +MAPE+++ Y AD
Sbjct: 186 ANIFLGPRGRCKLGDFGLL------VELGTAGAGEVQEGDPRYMAPELLQ--GSYGTAAD 237
Query: 246 IWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMIS 305
++SLG+T +E+A H + L PP G R ++
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGWQQLR--QGYLPPEFTAG---------LSSELRSVLV 286
Query: 306 DCLQKDPTKRPTASELLKNPFFKK 329
L+ DP R TA LL P ++
Sbjct: 287 MMLEPDPKLRATAEALLALPVLRQ 310
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 2e-81
Identities = 73/312 (23%), Positives = 136/312 (43%), Gaps = 42/312 (13%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++Y + IG G+ + IK+IN++ + E+
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS------RMSSKER---------- 67
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+E +E+ +++ H N+V Y SF L++V+ EGG L I +
Sbjct: 68 -----EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ----- 117
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
K + E I ++ L++ H +HRDIK+ NI L +DGTVQ+ DFG++ L
Sbjct: 118 -KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
+ +L+ +GTP +++PE+ ++ Y+ K+DIW+LG E+ T +
Sbjct: 177 STVELA-----RACIGTPYYLSPEIC-ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230
Query: 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328
+++ + P + Y R ++S +++P RP+ + +L+ F
Sbjct: 231 KNLVLKIISGSFPPVSLH---------YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281
Query: 329 KAKDKKFIQQTL 340
K +K Q +
Sbjct: 282 KRIEKFLSPQLI 293
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 9e-81
Identities = 65/273 (23%), Positives = 122/273 (44%), Gaps = 36/273 (13%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWN-TSMDELLKEIQAMSSCHHENVVTYHTSFVV----K 121
V+ + A ++ K + +E + + H N+V ++ S+ K
Sbjct: 42 VYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101
Query: 122 DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ--I 179
+ LV L+ G+L +K + V + + R++LKGL++ H+ I
Sbjct: 102 KCIVLVTELMTSGTLKTYLK--------RFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 180 HRDIKAGNILL-GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH 238
HRD+K NI + G G+V+I D G++ L R +GTP +MAPE+ E+
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLAT-------LKRASFAKAVIGTPEFMAPEMYEE-- 204
Query: 239 GYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND--PPTLDTGAAEKDQYKAY 296
YD D+++ G+ +EMAT PY + + + + P + D K
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD---------KVA 255
Query: 297 GKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329
+++I C++++ +R + +LL + FF++
Sbjct: 256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 1e-78
Identities = 83/362 (22%), Positives = 146/362 (40%), Gaps = 94/362 (25%)
Query: 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINL 86
+D +E +G G VV K H K A K I+L
Sbjct: 31 KDDDFEKISELGAGNGGVVF----KVS--------------H----KPSGLVMARKLIHL 68
Query: 87 EKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI 146
E +++++E+Q + C+ +V ++ +F E+ + + ++GGSL ++K
Sbjct: 69 EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----- 123
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI-HRDIKAGNILLGEDGTVQIADFGVSA 205
K G E + V V+KGL Y +I HRD+K NIL+ G +++ DFGVS
Sbjct: 124 ---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 206 WLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265
L + ++FVGT +M+PE ++ Y ++DIWS+G++ +EMA G P
Sbjct: 181 QLI-------DSMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPP 232
Query: 266 YPA------------------------------------------MKVLMLTLQNDPPTL 283
A ++L + PP L
Sbjct: 233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL 292
Query: 284 DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK-----KFIQQ 338
+G + F+ ++ CL K+P +R +L+ + F K++ + ++
Sbjct: 293 PSG--------VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCS 344
Query: 339 TL 340
T+
Sbjct: 345 TI 346
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-78
Identities = 80/338 (23%), Positives = 132/338 (39%), Gaps = 63/338 (18%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+E V+G GA V A + AIKKI
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----------------------- 42
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFV-------------VKDELWLVLRLLEGGS 135
+ +L E+ ++S +H+ VV Y+ +++ K L++ + E G+
Sbjct: 43 -EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGT 101
Query: 136 LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195
L D+I + R++L+ L Y HS G IHRD+K NI + E
Sbjct: 102 LYDLIHSENLNQ-------QRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN 154
Query: 196 VQIADFGVSAWLATGRDLSR---------QKVRHTFVGTPCWMAPEVMEQDHGYDFKADI 246
V+I DFG++ + D+ + + +GT ++A EV++ Y+ K D+
Sbjct: 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDM 214
Query: 247 WSLGITAIEMATG-TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMIS 305
+SLGI EM + + +K L PP D K +K+I
Sbjct: 215 YSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFD---------DNKMKVEKKIIR 265
Query: 306 DCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTLVSV 343
+ DP KRP A LL + + + I++ L S+
Sbjct: 266 LLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEALKSL 303
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 6e-77
Identities = 64/332 (19%), Positives = 121/332 (36%), Gaps = 72/332 (21%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
++ E+IG G V KA+ + + IK++
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVF----KAK------------------HRIDGKTYVIKRV 44
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE----------------LWLVL 128
++ +E++A++ H N+V Y+ + D L++ +
Sbjct: 45 KYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM 99
Query: 129 RLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188
+ G+L I+ R + D+ + ++ KG++Y HS I+RD+K NI
Sbjct: 100 EFCDKGTLEQWIEKR------RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNI 153
Query: 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWS 248
L + V+I DFG+ L R GT +M+PE + Y + D+++
Sbjct: 154 FLVDTKQVKIGDFGLV------TSLKNDGKRTRSKGTLRYMSPEQI-SSQDYGKEVDLYA 206
Query: 249 LGITAIEMATGTAPYHKYPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDC 307
LG+ E+ + L++ + + K + ++
Sbjct: 207 LGLILAELLHVCDTAFE---TSKFFTDLRDGIISDI------------FDKKEKTLLQKL 251
Query: 308 LQKDPTKRPTASELLKNPFFKKAKDKKFIQQT 339
L K P RP SE+L+ K +K + T
Sbjct: 252 LSKKPEDRPNTSEILRTLTVWKKSPEKNERHT 283
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 9e-71
Identities = 65/320 (20%), Positives = 123/320 (38%), Gaps = 58/320 (18%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+E + +G G VV +A+ K AIK+I L
Sbjct: 5 TDFEPIQCLGRGGFGVVF----EAK------------------NKVDDCNYAIKRIRLPN 42
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE------------LWLVLRLLEGGSL 136
+ +++++E++A++ H +V Y +++ K+ L++ ++L +L
Sbjct: 43 RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENL 102
Query: 137 LDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196
D + R I + + ++ + +E+ HS G +HRD+K NI D V
Sbjct: 103 KDWMNGRCTIEER-----ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 157
Query: 197 QIADFGVSAWLATGRDLSR-------QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSL 249
++ DFG+ + + VGT +M+PE + + Y K DI+SL
Sbjct: 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI-HGNSYSHKVDIFSL 216
Query: 250 GITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQ 309
G+ E+ + ++ L P L + M+ D L
Sbjct: 217 GLILFELL--YPFSTQMERVRTLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLS 265
Query: 310 KDPTKRPTASELLKNPFFKK 329
P +RP A +++N F+
Sbjct: 266 PSPMERPEAINIIENAVFED 285
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 6e-69
Identities = 71/312 (22%), Positives = 122/312 (39%), Gaps = 47/312 (15%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
P+ + YEV IG G+ K+ + K+++ AEK
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG------SMTEAEK------ 49
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKH 142
L+ E+ + H N+V Y+ + + L++V+ EGG L +I
Sbjct: 50 ---------QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 100
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ-----IHRDIKAGNILLGEDGTVQ 197
K + DE + V+ ++ L+ H +HRD+K N+ L V+
Sbjct: 101 GTK----ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156
Query: 198 IADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257
+ DFG++ L + TFVGTP +M+PE M Y+ K+DIWSLG E+
Sbjct: 157 LGDFGLARILNHDTSFA-----KTFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELC 210
Query: 258 TGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT 317
P+ + ++ + + Y ++I+ L RP+
Sbjct: 211 ALMPPFTAFSQKELAGKIREGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPS 261
Query: 318 ASELLKNPFFKK 329
E+L+NP +
Sbjct: 262 VEEILENPLILE 273
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-65
Identities = 71/382 (18%), Positives = 142/382 (37%), Gaps = 72/382 (18%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK- 88
Y + + IG G ++ V + EK + AIK +NLE+
Sbjct: 10 IYSILKQIGSGGSSKVF----QVLNEKK-------------------QIYAIKYVNLEEA 46
Query: 89 WNTSMDELLKEIQAMSSC--HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI 146
N ++D EI ++ H + ++ + + +++V+ L +K + I
Sbjct: 47 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI 105
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
D + + +L+ + H +G +H D+K N L+ DG +++ DFG++
Sbjct: 106 --------DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQ 156
Query: 207 LATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----------DHGYDFKADIWSLGITAIEM 256
+ + V+ + VGT +M PE ++ K+D+WSLG M
Sbjct: 157 MQPD---TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213
Query: 257 ATGTAPYHKYPAMKVLMLTLQND------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQK 310
G P+ + + + + P + +D ++ CL++
Sbjct: 214 TYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL--QD-----------VLKCCLKR 260
Query: 311 DPTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRTVT 370
DP +R + ELL +P+ + + Q + + + N + + +
Sbjct: 261 DPKQRISIPELLAHPYVQIQTHP--VNQMAKGTTEEMKYVLGQLVGLN--SPNSILKAAK 316
Query: 371 GEWVWSSEDEGDKSSDDEKKEK 392
+ S E SS + EK
Sbjct: 317 TLYEHYSGGESHNSSSSKTFEK 338
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-63
Identities = 62/319 (19%), Positives = 124/319 (38%), Gaps = 68/319 (21%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK- 88
Y + + IG G ++ V + EK + AIK +NLE+
Sbjct: 29 IYSILKQIGSGGSSKVF----QVLNEKK-------------------QIYAIKYVNLEEA 65
Query: 89 WNTSMDELLKEIQAMSSC--HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI 146
N ++D EI ++ H + ++ + + +++V+ L +K + I
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI 124
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
D + + +L+ + H +G +H D+K N L+ DG +++ DFG++
Sbjct: 125 --------DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQ 175
Query: 207 LATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----------DHGYDFKADIWSLGITAIEM 256
+ + V+ + VGT +M PE ++ K+D+WSLG M
Sbjct: 176 MQPD---TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
Query: 257 ATGTAPYHKYPAMKVLMLTLQND------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQK 310
G P+ + + + + P + + ++ CL++
Sbjct: 233 TYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL-------------QDVLKCCLKR 279
Query: 311 DPTKRPTASELLKNPFFKK 329
DP +R + ELL +P+ +
Sbjct: 280 DPKQRISIPELLAHPYVQI 298
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 8e-63
Identities = 69/399 (17%), Positives = 147/399 (36%), Gaps = 72/399 (18%)
Query: 15 SSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKA 74
+S+S + Y + + IG G ++ V + EK
Sbjct: 42 KASSSANECISVKGRIYSILKQIGSGGSSKVF----QVLNEKK----------------- 80
Query: 75 RAEKCAIKKINLEK-WNTSMDELLKEIQAMSSCHH--ENVVTYHTSFVVKDELWLVLRLL 131
+ AIK +NLE+ N ++D EI ++ + ++ + + +++V+
Sbjct: 81 --QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 137
Query: 132 EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
L +K K D + + +L+ + H +G +H D+K N L+
Sbjct: 138 GNIDLNSWLK--------KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI- 188
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----------DHGYD 241
DG +++ DFG++ + + V+ + VG +M PE ++
Sbjct: 189 VDGMLKLIDFGIANQMQPD---TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS 245
Query: 242 FKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND------PPTLDTGAAEKDQYKA 295
K+D+WSLG M G P+ + + + + P +
Sbjct: 246 PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL-------- 297
Query: 296 YGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAA 355
+ ++ CL++DP +R + ELL +P+ + + Q + + +
Sbjct: 298 -----QDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP--VNQMAKGTTEEMKYVLGQLV 350
Query: 356 KKN-PGASGRLHRTVTGEW-VWSSEDEGDKSSDDEKKEK 392
N P + + +T+ + S + + ++K+ K
Sbjct: 351 GLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGK 389
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 5e-60
Identities = 85/337 (25%), Positives = 137/337 (40%), Gaps = 50/337 (14%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
P + +Y +G G A E A K + K + K
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP--------------KSLLLKP 82
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRL 144
+ +++ EI S H++VV +H F D +++VL L SLL++ K
Sbjct: 83 HQR------EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK--- 133
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS 204
+ EP LR+++ G +Y H N IHRD+K GN+ L ED V+I DFG++
Sbjct: 134 -----RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264
+ + + GTP ++APEV+ G+ F+ D+WS+G + G P+
Sbjct: 189 TKVEYDGER-----KKVLCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFE 242
Query: 265 KYPAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
+ + +N+ P ++ A +I LQ DPT RPT +EL
Sbjct: 243 TSCLKETYLRIKKNEYSIPKHINPVA-------------ASLIQKMLQTDPTARPTINEL 289
Query: 322 LKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKN 358
L + FF + T +++ P F N
Sbjct: 290 LNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSN 326
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-60
Identities = 84/328 (25%), Positives = 136/328 (41%), Gaps = 50/328 (15%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
P + +Y +G G A E A K + K + K
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP--------------KSLLLKP 56
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRL 144
+ +++ EI S H++VV +H F D +++VL L SLL++ K
Sbjct: 57 HQR------EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK--- 107
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS 204
+ EP LR+++ G +Y H N IHRD+K GN+ L ED V+I DFG++
Sbjct: 108 -----RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264
+ + + GTP ++APEV+ G+ F+ D+WS+G + G P+
Sbjct: 163 TKVEYDGER-----KKVLCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
Query: 265 KYPAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
+ + +N+ P ++ A +I LQ DPT RPT +EL
Sbjct: 217 TSCLKETYLRIKKNEYSIPKHINPVA-------------ASLIQKMLQTDPTARPTINEL 263
Query: 322 LKNPFFKKAKDKKFIQQTLVSVGPTFET 349
L + FF + T +++ P F
Sbjct: 264 LNDEFFTSGYIPARLPITCLTIPPRFSI 291
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-59
Identities = 72/347 (20%), Positives = 123/347 (35%), Gaps = 65/347 (18%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKIN-- 85
+E + +G G VV A K AIK+I L A K E A+ K+
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 86 ---------------------------------LEKWNTSMDELLKEIQAMSSCHHENVV 112
+ MD +I+ M +N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 113 TYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEY 172
K L++ ++L +L D + R + + + + ++ + +E+
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR-----EHGVCLHIFIQIAEAVEF 179
Query: 173 FHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA-------TGRDLSRQKVRHTFVGT 225
HS G +HRD+K NI D V++ DFG+ + + VGT
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 226 PCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM---KVLMLTLQNDPPT 282
+M+PE + + Y K DI+SLG+ E+ Y M +++ P
Sbjct: 240 KLYMSPEQI-HGNNYSHKVDIFSLGLILFELL-----YSFSTQMERVRIITDVRNLKFPL 293
Query: 283 LDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329
L + M+ D L PT+RP A+++++N F+
Sbjct: 294 L---------FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-59
Identities = 67/313 (21%), Positives = 109/313 (34%), Gaps = 50/313 (15%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
Y + +G G + V A+K+I +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-------------------EQQDR 70
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD----ELWLVLRLLEGGSLLDIIKHRLK 145
E +E +H N++ + + E WL+L + G+L + I+
Sbjct: 71 E----EAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKD 126
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSA 205
K E I +L + +GLE H+ G HRD+K NILLG++G + D G
Sbjct: 127 ----KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
Query: 206 WLATGRDLSRQKVR----HTFVGTPCWMAPEVME--QDHGYDFKADIWSLGITAIEMATG 259
+ SRQ + T + APE+ D + D+WSLG M G
Sbjct: 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
Query: 260 TAPY-HKYPAMKVLMLTLQND--PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
PY + + L +QN P Q + ++++ + DP +RP
Sbjct: 243 EGPYDMVFQKGDSVALAVQNQLSIP----------QSPRHSSALWQLLNSMMTVDPHQRP 292
Query: 317 TASELLKNPFFKK 329
LL +
Sbjct: 293 HIPLLLSQLEALQ 305
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-57
Identities = 68/321 (21%), Positives = 131/321 (40%), Gaps = 51/321 (15%)
Query: 17 SASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARA 76
S + + + ++V ++G G+ A V+ A + AIK I+
Sbjct: 1 SLATCIGE--KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMID------------- 45
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSL 136
K A+ K + + E++ H +++ + F + ++LVL + G +
Sbjct: 46 -KKAMYKAGMV------QRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM 98
Query: 137 LDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196
+K+R E + +++ G+ Y HS+G +HRD+ N+LL + +
Sbjct: 99 NRYLKNR-------VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNI 151
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256
+IADFG++ L + +T GTP +++PE+ + ++D+WSLG +
Sbjct: 152 KIADFGLATQLKMPHEK-----HYTLCGTPNYISPEIAT-RSAHGLESDVWSLGCMFYTL 205
Query: 257 ATGTAPYHKYPAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
G P+ L + D P L A + +I L+++P
Sbjct: 206 LIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEA-------------KDLIHQLLRRNPA 252
Query: 314 KRPTASELLKNPFFKKAKDKK 334
R + S +L +PF + K
Sbjct: 253 DRLSLSSVLDHPFMSRNSSTK 273
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 4e-56
Identities = 75/341 (21%), Positives = 128/341 (37%), Gaps = 60/341 (17%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
+ + ++V+G GA + A+K+I E
Sbjct: 23 KISFCPKDVLGHGAEGTIVYR-----------------------GMFDNRDVAVKRILPE 59
Query: 88 KWNTSMDELLKEIQAMS-SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI 146
+E+Q + S H NV+ Y + + ++ + L +L + ++
Sbjct: 60 C----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQ---- 110
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT-----VQIADF 201
K T+L++ GL + HS +HRD+K NIL+ I+DF
Sbjct: 111 ---KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD--HGYDFKADIWSLGITAIEMAT- 258
G+ LA GR R GT W+APE++ +D + DI+S G + +
Sbjct: 168 GLCKKLAVGR--HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
Query: 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA 318
G+ P+ K + +L L E R++I + DP KRP+A
Sbjct: 226 GSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI-------ARELIEKMIAMDPQKRPSA 278
Query: 319 SELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNP 359
+LK+PFF + + Q + RI+K + P
Sbjct: 279 KHVLKHPFFWSLEKQLQFFQDVSD-------RIEKESLDGP 312
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 5e-56
Identities = 78/309 (25%), Positives = 129/309 (41%), Gaps = 52/309 (16%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ +E+ +G G V+ A K A+K + K ++K +E
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--------------KAQLEKAGVE- 53
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+L +E++ S H N++ + F ++L+L G++ ++
Sbjct: 54 -----HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------- 101
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
K DE AT + E+ L Y HS IHRDIK N+LLG G ++IADFG S
Sbjct: 102 -KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
+ R R GT ++ PE++E +D K D+WSLG+ E G P+
Sbjct: 161 SSR-------RTDLCGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212
Query: 269 MKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325
+ + + P + GA R +IS L+ +P++RP E+L++P
Sbjct: 213 QETYKRISRVEFTFPDFVTEGA-------------RDLISRLLKHNPSQRPMLREVLEHP 259
Query: 326 FFKKAKDKK 334
+ K
Sbjct: 260 WITANSSKP 268
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-55
Identities = 60/321 (18%), Positives = 119/321 (37%), Gaps = 27/321 (8%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ Y + + G + C+ + A+KK +++ ++ I +
Sbjct: 31 NDYRIIRTLNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY- 87
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
D+ E+Q ++ +E +T DE++++ +E S+L ++ +
Sbjct: 88 -----DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
I +++ VL Y H+ HRD+K NIL+ ++G V+++DFG S ++
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD-FKADIWSLGITAIEMATGTAP---- 262
+ GT +M PE + Y+ K DIWSLGI M P
Sbjct: 203 VDKK-------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
Query: 263 ------YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
++ + +N T + L+K+P +R
Sbjct: 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 317 TASELLKNPFFKKAKDKKFIQ 337
T+ + LK+ + + +
Sbjct: 316 TSEDALKHEWLADTNIEDLRE 336
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 5e-54
Identities = 61/338 (18%), Positives = 114/338 (33%), Gaps = 65/338 (19%)
Query: 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKIN 85
+ + + +++G GATA V K + AIK N I+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN-------------------NIS 46
Query: 86 LEKWNTSMDELLKEIQAMSSCHHENVVTYHTSF--VVKDELWLVLRLLEGGSLLDIIKHR 143
+ +D ++E + + +H+N+V L++ GSL ++
Sbjct: 47 FLR---PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--- 100
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG----EDGTVQIA 199
E VLR+V+ G+ + NG +HR+IK GNI+ ++
Sbjct: 101 --EEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME-------QDHGYDFKADIWSLGIT 252
DFG + R+L + + GT ++ P++ E Y D+WS+G+T
Sbjct: 159 DFGAA------RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 253 AIEMATGTAPYH------------------KYPAMKVLMLTLQNDPPTLDTGAAEKDQYK 294
ATG+ P+ K + +N P
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS 272
Query: 295 AYGKT-FRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331
+ ++++ L+ D K + +
Sbjct: 273 RGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 8e-54
Identities = 77/304 (25%), Positives = 126/304 (41%), Gaps = 52/304 (17%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
D +++ +G G V+ A K A+K + K ++K +E
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF--------------KSQLEKEGVEH 59
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+L +EI+ S H N++ + F + ++L+L G L ++
Sbjct: 60 ------QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ------- 106
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
KHG DE AT + E+ L Y H IHRDIK N+L+G G ++IADFG S
Sbjct: 107 -KHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
+ R R T GT ++ PE++E +D K D+W G+ E G P+
Sbjct: 166 SLR-------RRTMCGTLDYLPPEMIE-GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217
Query: 269 MKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325
+ + D PP L G+ + +IS L+ P +R ++++P
Sbjct: 218 TETHRRIVNVDLKFPPFLSDGS-------------KDLISKLLRYHPPQRLPLKGVMEHP 264
Query: 326 FFKK 329
+ K
Sbjct: 265 WVKA 268
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-52
Identities = 72/308 (23%), Positives = 127/308 (41%), Gaps = 31/308 (10%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKIN---LAVVHSAYCKARAEKCAIKKINL 86
QY +++ IG G+ VV AY + A+K ++ L +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 87 EKWNTSMDELLKEIQAMSSCHHENVVTYHT--SFVVKDELWLVLRLLEGGSLLDIIKH-R 143
+ ++++ +EI + H NVV +D L++V L+ G ++++
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
L E ++++KG+EY H IHRDIK N+L+GEDG ++IADFGV
Sbjct: 134 LS----------EDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH-GYD-FKADIWSLGITAIEMATGTA 261
S L VGTP +MAPE + + + D+W++G+T G
Sbjct: 184 SNEFKGSDAL-----LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
Query: 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
P+ + L +++ + + +I+ L K+P R E+
Sbjct: 239 PFMD-ERIMCLHSKIKSQALEF-------PDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
Query: 322 LKNPFFKK 329
+P+ +
Sbjct: 291 KLHPWVTR 298
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-52
Identities = 61/331 (18%), Positives = 112/331 (33%), Gaps = 65/331 (19%)
Query: 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKIN 85
+ + + +++G GATA V H K + AIK N
Sbjct: 6 TSNHLWLLSDILGQGATANVFRG------------------RH----KKTGDLFAIKVFN 43
Query: 86 LEKWNTSMDELLKEIQAMSSCHHENVVTYHTSF--VVKDELWLVLRLLEGGSLLDIIKHR 143
+ +D ++E + + +H+N+V L++ GSL ++
Sbjct: 44 NISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--- 100
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG----EDGTVQIA 199
E VLR+V+ G+ + NG +HR+IK GNI+ ++
Sbjct: 101 --EEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME-------QDHGYDFKADIWSLGIT 252
DFG + R+L + + GT ++ P++ E Y D+WS+G+T
Sbjct: 159 DFGAA------RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 253 AIEMATGTAPYH------------------KYPAMKVLMLTLQNDPPTLDTGAAEKDQYK 294
ATG+ P+ K + +N P
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS 272
Query: 295 AYGKT-FRKMISDCLQKDPTKRPTASELLKN 324
+ ++++ L+ D K +
Sbjct: 273 RGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-51
Identities = 67/329 (20%), Positives = 112/329 (34%), Gaps = 69/329 (20%)
Query: 14 ASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCK 73
S S +++ E + IG G +VH AIK + L
Sbjct: 4 GGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM 63
Query: 74 ARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSF--VVKDELWLVLRLL 131
E +E+ MS+ +H N+V ++ + +V+ +
Sbjct: 64 IEK----------------FQEFQREVFIMSNLNHPNIVK----LYGLMHNPPRMVMEFV 103
Query: 132 EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ--IHRDIKAGNIL 189
G L + K ++ ++ G+EY + +HRD+++ NI
Sbjct: 104 PCGDLYHRLLD-------KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156
Query: 190 LGEDG-----TVQIADFGVSAWLATGRDLSRQKVRHT--FVGTPCWMAPEVMEQDHG-YD 241
L ++ADFG LS+Q V +G WMAPE + + Y
Sbjct: 157 LQSLDENAPVCAKVADFG----------LSQQSVHSVSGLLGNFQWMAPETIGAEEESYT 206
Query: 242 FKADIWSLGITAIEMATGTAPYH--KYPAMKVLMLTLQND-----PPTLDTGAAEKDQYK 294
KAD +S + + TG P+ Y +K + + + P
Sbjct: 207 EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP---------- 256
Query: 295 AYGKTFRKMISDCLQKDPTKRPTASELLK 323
R +I C DP KRP S ++K
Sbjct: 257 ---PRLRNVIELCWSGDPKKRPHFSYIVK 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 71/332 (21%), Positives = 139/332 (41%), Gaps = 57/332 (17%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
++ +++G+G++ V A+K++ ++
Sbjct: 14 KNLVVSEKILGYGSSGTV----------VFQGSFQG-------------RPVAVKRMLID 50
Query: 88 KWNTSMDELLKEIQAMS-SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI 146
D L EI+ ++ S H NV+ Y+ S L++ L L +L D+++ + +
Sbjct: 51 F----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESK-NV 104
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL-------------GED 193
S+ + E ++LR++ G+ + HS IHRD+K NIL+ E+
Sbjct: 105 SDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH------GYDFKADIW 247
+ I+DFG+ L +G+ S + + GT W APE++E+ + DI+
Sbjct: 165 LRILISDFGLCKKLDSGQS-SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 248 SLG-ITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISD 306
S+G + ++ G P+ + + ++ + +A +IS
Sbjct: 224 SMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEA-----TDLISQ 278
Query: 307 CLQKDPTKRPTASELLKNPFFKKAKDK-KFIQ 337
+ DP KRPTA ++L++P F K +F+
Sbjct: 279 MIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLL 310
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 6e-50
Identities = 78/301 (25%), Positives = 125/301 (41%), Gaps = 58/301 (19%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ EV EV+G GA VV A RA+ AIK+I E
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW------------------------RAKDVAIKQIESES 43
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+ E++ +S +H N+V + + + LV+ EGGSL +++ +
Sbjct: 44 ---ERKAFIVELRQLSRVNHPNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPY 98
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHS---NGQIHRDIKAGNILLGEDGTV-QIADFGVS 204
+ + +G+ Y HS IHRD+K N+LL GTV +I DFG +
Sbjct: 99 Y-----TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264
D+ + G+ WMAPEV E + Y K D++S GI E+ T P+
Sbjct: 154 ------CDIQTHMTNNK--GSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFD 204
Query: 265 KY--PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
+ PA +++ P L + +++ C KDP++RP+ E++
Sbjct: 205 EIGGPAFRIMWAVHNGTRPPLIKNLPKP---------IESLMTRCWSKDPSQRPSMEEIV 255
Query: 323 K 323
K
Sbjct: 256 K 256
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 9e-50
Identities = 63/349 (18%), Positives = 124/349 (35%), Gaps = 59/349 (16%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+ VR V+ G A V+ A + A+K++ +
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL---SNE-------------------- 65
Query: 90 NTSMDELLKEIQAMSS-CHHENVVTYHTSFVVKDE-------LWLVLRLLEGGSLLDIIK 141
+++E+ M H N+V + ++ + E +L+L L G L++ +K
Sbjct: 66 EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK 125
Query: 142 HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ--IHRDIKAGNILLGEDGTVQIA 199
G T+ + + + +++ H IHRD+K N+LL GT+++
Sbjct: 126 KMES-----RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180
Query: 200 DFGVSAWLATGRDLSRQKVRH-------TFVGTPCWMAPEVME--QDHGYDFKADIWSLG 250
DFG + ++ D S R T TP + PE+++ + K DIW+LG
Sbjct: 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG 240
Query: 251 ITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQK 310
+ P+ ++++ PP + F +I LQ
Sbjct: 241 CILYLLCFRQHPFEDGAKLRIVNGKYS-IPP-----------HDTQYTVFHSLIRAMLQV 288
Query: 311 DPTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNP 359
+P +R + +E++ A + + + + P
Sbjct: 289 NPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-49
Identities = 70/328 (21%), Positives = 127/328 (38%), Gaps = 58/328 (17%)
Query: 5 SNVPGRIMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINL 64
++P A ++E IG G+ VH A
Sbjct: 13 YDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-------------- 58
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTS-MDELLKEIQAMSSCHHENVVTYHTSFVVKDE 123
A+K + + ++ ++E L+E+ M H N+V + +
Sbjct: 59 ----------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108
Query: 124 LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ--IHR 181
L +V L GSL ++ H+ + DE ++ +V KG+ Y H+ +HR
Sbjct: 109 LSIVTEYLSRGSLYRLL-HK----SGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163
Query: 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHT-FVGTPCWMAPEVMEQDHGY 240
++K+ N+L+ + TV++ DFG+S R + + GTP WMAPEV+ +
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLS------RLKASTFLSSKSAAGTPEWMAPEVLRDEP-S 216
Query: 241 DFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND-----PPTLDTGAAEKDQYKA 295
+ K+D++S G+ E+AT P+ +V+ P L+
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN----------- 265
Query: 296 YGKTFRKMISDCLQKDPTKRPTASELLK 323
+I C +P KRP+ + ++
Sbjct: 266 --PQVAAIIEGCWTNEPWKRPSFATIMD 291
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-49
Identities = 69/339 (20%), Positives = 120/339 (35%), Gaps = 63/339 (18%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
T +E++E +G G V + E+ AIK+ +++
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR------------------QEL 51
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVVT------YHTSFVVKDELWLVLRLLEGGSLLD 138
+ + + + EIQ M +H NVV+ D L + EGG L
Sbjct: 52 SPK----NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRK 107
Query: 139 IIKHRLKISNCKHGVC---DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GE 192
+ + C E I T+L ++ L Y H N IHRD+K NI+L +
Sbjct: 108 YLN--------QFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ 159
Query: 193 DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252
+I D G + ++L + ++ FVGT ++APE++EQ Y D WS G
Sbjct: 160 RLIHKIIDLGYA------KELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTL 212
Query: 253 AIEMATGTAPYHKYPAMKVLMLTLQN---DPPTLDTGAAEKDQYKAYGKT---------- 299
A E TG P+ ++ + + ++ + T
Sbjct: 213 AFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG 272
Query: 300 -FRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQ 337
+ + L +R T + F+ ++
Sbjct: 273 KLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 9e-49
Identities = 74/318 (23%), Positives = 137/318 (43%), Gaps = 54/318 (16%)
Query: 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKIN 85
ED YE+ E +G G A+V K ++ A K I ++++
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIK-----------------KRRLS 44
Query: 86 LEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK 145
+ S +E+ +E+ + H N++T H F K ++ L+L L+ GG L D + +
Sbjct: 45 SSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES 104
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL----GEDGTVQIADF 201
++ E L+++L G+ Y HS H D+K NI+L + +++ DF
Sbjct: 105 LT--------EDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATGT 260
G++ + G + GTP ++APE++ + +AD+WS+G IT I + +G
Sbjct: 157 GIAHKIEAGNEFK------NIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYI-LLSGA 208
Query: 261 APYH----KYPAMKVLMLTLQNDPPTLDTGAAE-KDQYKAYGKTFRKMISDCLQKDPTKR 315
+P+ + + + D + KD I L KDP +R
Sbjct: 209 SPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD-----------FIRRLLVKDPKRR 257
Query: 316 PTASELLKNPFFKKAKDK 333
T ++ L++ + K + +
Sbjct: 258 MTIAQSLEHSWIKAIRRR 275
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 4e-48
Identities = 78/339 (23%), Positives = 129/339 (38%), Gaps = 49/339 (14%)
Query: 5 SNVPGRIMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINL 64
N+ + +A + V + Y +G GA V K + AIK I
Sbjct: 12 ENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKK 71
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
+ + +E+ EI + S H N++ F K
Sbjct: 72 SQFDKGRYSDDNKNIEKFH----------EEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 125 WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
+LV EGG L + I +R K E A +++++L G+ Y H + +HRDIK
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFD--------ECDAANIMKQILSGICYLHKHNIVHRDIK 173
Query: 185 AGNILL---GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD 241
NILL ++I DFG+S++ + L +GT ++APEV+++ Y+
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKL------RDRLGTAYYIAPEVLKKK--YN 225
Query: 242 FKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDP-------PTLDTGAAEKDQYK 294
K D+WS G+ + G P+ ++ + + A K+
Sbjct: 226 EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEA--KE--- 280
Query: 295 AYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333
+I L D KR TA E L + + KK +
Sbjct: 281 --------LIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 8e-48
Identities = 81/340 (23%), Positives = 138/340 (40%), Gaps = 62/340 (18%)
Query: 8 PGRIMAASSSASVSVPWPNTE---DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINL 64
PG +M + +T D+Y+ + V+G G+ V K ++CA+K I+
Sbjct: 2 PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
V T + LL+E+Q + H N++ + F K
Sbjct: 62 RQVKQK--------------------TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101
Query: 125 WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
+LV + GG L D I R + S E A ++R+VL G+ Y H N +HRD+K
Sbjct: 102 YLVGEVYTGGELFDEIISRKRFS--------EVDAARIIRQVLSGITYMHKNKIVHRDLK 153
Query: 185 AGNILL---GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD 241
N+LL +D ++I DFG+S + + +GT ++APEV+ YD
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTHFEASKKM------KDKIGTAYYIAPEVLHGT--YD 205
Query: 242 FKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDP-------PTLDTGAAEKDQYK 294
K D+WS G+ + +G P++ +L + + A KD
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA--KD--- 260
Query: 295 AYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334
+I L P+ R +A + L + + + ++
Sbjct: 261 --------LIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 292
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-47
Identities = 87/362 (24%), Positives = 152/362 (41%), Gaps = 68/362 (18%)
Query: 12 MAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAY 71
+ A+ ++ + + Y+ + +G GA V K + AIK I
Sbjct: 20 LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR-------- 71
Query: 72 CKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLL 131
K ++ + K LL+E+ + H N++ + F K +LV+
Sbjct: 72 ------KTSVSTSSNSK-------LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118
Query: 132 EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL- 190
+GG L D I HR+K + E A ++++VL G+ Y H + +HRD+K N+LL
Sbjct: 119 KGGELFDEIIHRMKFN--------EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170
Query: 191 --GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWS 248
+D ++I DFG+SA + + +GT ++APEV+ + YD K D+WS
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKKM------KERLGTAYYIAPEVLRKK--YDEKCDVWS 222
Query: 249 LGITAIEMATGTAPYHKYPAMKVLMLTLQNDP-------PTLDTGAAEKDQYKAYGKTFR 301
+G+ + G P+ ++L + + GA KD
Sbjct: 223 IGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA--KD---------- 270
Query: 302 KMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFE--------TRIQK 353
+I LQ D +R +A + L++P+ K+ KK L S+ E ++ +
Sbjct: 271 -LIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQ 329
Query: 354 AA 355
AA
Sbjct: 330 AA 331
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-47
Identities = 75/313 (23%), Positives = 129/313 (41%), Gaps = 58/313 (18%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
+D + + +G GA VH ++ + IK IN K R++
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN---------KDRSQV--------- 62
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
M+++ EI+ + S H N++ F +++V+ EGG LL+ I
Sbjct: 63 ----PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSA---- 114
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIADFGVS 204
+ E +A ++++++ L YFHS +H+D+K NIL ++I DFG++
Sbjct: 115 QARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATGTAPY 263
+ GT +MAPEV ++D FK DIWS G + + TG P+
Sbjct: 175 ELFKSDEHS------TNAAGTALYMAPEVFKRD--VTFKCDIWSAGVVMYF-LLTGCLPF 225
Query: 264 HK------YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT 317
+ L A D ++ L KDP +RP+
Sbjct: 226 TGTSLEEVQQKATYKEPNYAVECRPLTPQA--VD-----------LLKQMLTKDPERRPS 272
Query: 318 ASELLKNPFFKKA 330
A+++L + +FK+A
Sbjct: 273 AAQVLHHEWFKQA 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-47
Identities = 79/334 (23%), Positives = 140/334 (41%), Gaps = 59/334 (17%)
Query: 21 SVPWPNT----EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARA 76
++P ++ + YE +E++G G ++VV K ++ A+K I+
Sbjct: 5 ALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIID------------- 51
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSS-CHHENVVTYHTSFVVKDELWLVLRLLEGGS 135
+ E+ + LKE+ + H N++ ++ +LV L++ G
Sbjct: 52 -VTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 110
Query: 136 LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195
L D + ++ +S E ++R +L+ + H +HRD+K NILL +D
Sbjct: 111 LFDYLTEKVTLS--------EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN 162
Query: 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEV-----MEQDHGYDFKADIWSLG 250
+++ DFG S L G L GTP ++APE+ + GY + D+WS G
Sbjct: 163 IKLTDFGFSCQLDPGEKLR------EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216
Query: 251 -ITAIEMATGTAP-YHKYPAM---KVLMLTLQ-NDPPTLDTGAAEKDQYKAYGKTFRKMI 304
I + G+ P +H+ + ++ Q P D KD ++
Sbjct: 217 VIMYT-LLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD-----------LV 264
Query: 305 SDCLQKDPTKRPTASELLKNPFFKK---AKDKKF 335
S L P KR TA E L +PFF++ + + F
Sbjct: 265 SRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRHF 298
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-47
Identities = 81/392 (20%), Positives = 155/392 (39%), Gaps = 60/392 (15%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
ED Y++ E +G G A+V K+ + A K I ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIK-----------------KRQSRAS 53
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ +E+ +E+ + H N++T H + + ++ L+L L+ GG L D + + +S
Sbjct: 54 RRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL----GEDGTVQIADFGV 203
E + ++++L G+ Y H+ H D+K NI+L +++ DFG+
Sbjct: 114 --------EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATGTAP 262
+ ++ GTP ++APE++ + +AD+WS+G IT I + +G +P
Sbjct: 166 A------HEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYI-LLSGASP 217
Query: 263 YH----KYPAMKVLMLTLQNDPPTLDTGAAE-KDQYKAYGKTFRKMISDCLQKDPTKRPT 317
+ + + ++ D + KD I L K+ KR T
Sbjct: 218 FLGDTKQETLANITAVSYDFDEEFFSQTSELAKD-----------FIRKLLVKETRKRLT 266
Query: 318 ASELLKNPFFKKAKDKKFIQQTLVSVGPT-----FETRIQKAAKKNPGASGRLHRT-VTG 371
E L++P+ ++ + + V + R K + L R+ +
Sbjct: 267 IQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKK 326
Query: 372 EWVWSSEDEGDKSSDDEKKEKPMNCLQEVDSS 403
+ +SED + SD E+ L S
Sbjct: 327 VHLRTSEDLRNCESDTEENIARRKALHPRRRS 358
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-47
Identities = 63/304 (20%), Positives = 122/304 (40%), Gaps = 50/304 (16%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+Q E+ E+IG G V+ + AI+ I++E+
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWH-------------------------GEVAIRLIDIER 67
Query: 89 WNTS-MDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
N + +E+ A HENVV + + + L ++ L +G +L +++
Sbjct: 68 DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA---- 123
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
V D + +E++KG+ Y H+ G +H+D+K+ N+ ++G V I DFG+ +
Sbjct: 124 ---KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSIS 179
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVM--------EQDHGYDFKADIWSLGITAIEMATG 259
+ R+ G C +APE++ E + +D+++LG E+
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239
Query: 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319
P+ PA ++ P L K+ ++ C + +RPT +
Sbjct: 240 EWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKE--------ISDILLFCWAFEQEERPTFT 291
Query: 320 ELLK 323
+L+
Sbjct: 292 KLMD 295
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 7e-47
Identities = 75/348 (21%), Positives = 131/348 (37%), Gaps = 74/348 (21%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
+ +Y ++ IG G+ VV A AIK +N K I++IN +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN--------------KNKIRQINPK 70
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
++ + E++ M HH N+ + + + + LV+ L GG LLD + + S
Sbjct: 71 D----VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126
Query: 148 NCKHGVCD--------------------------------EPTIATVLREVLKGLEYFHS 175
K + E I+ ++R++ L Y H+
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186
Query: 176 NGQIHRDIKAGNILLG--EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEV 233
G HRDIK N L + +++ DFG+S + + T GTP ++APEV
Sbjct: 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM-TTKAGTPYFVAPEV 245
Query: 234 ME-QDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQ 292
+ + Y K D WS G+ + G P+ ND T+ +
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG-----------VNDADTIS--QVLNKK 292
Query: 293 YKAYGKTFRKM-------ISDCLQKDPTKRPTASELLKNPFFKKAKDK 333
+ + +S+ L ++ +R A L++P+ + DK
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 9e-47
Identities = 59/256 (23%), Positives = 107/256 (41%), Gaps = 36/256 (14%)
Query: 80 AIKKINLEKWN-TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLD 138
A+K +N+ + E+ + H N++ + +L +V + EG SL
Sbjct: 50 AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYH 108
Query: 139 IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQI 198
+ + + + R+ +G++Y H+ IHRD+K+ NI L ED TV+I
Sbjct: 109 HLHAS-------ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKI 161
Query: 199 ADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEV--MEQDHGYDFKADIWSLGITAIEM 256
DFG++ + + + G+ WMAPEV M+ + Y F++D+++ GI E+
Sbjct: 162 GDFGLATEKSRWSGSHQFE---QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL 218
Query: 257 ATGTAPYHKYPAM---------KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDC 307
TG PY L L K ++++++C
Sbjct: 219 MTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP-------------KRMKRLMAEC 265
Query: 308 LQKDPTKRPTASELLK 323
L+K +RP+ +L
Sbjct: 266 LKKKRDERPSFPRILA 281
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-46
Identities = 65/271 (23%), Positives = 104/271 (38%), Gaps = 35/271 (12%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWL 126
+ E +K++ + + LKE++ M H NV+ + L
Sbjct: 26 AIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84
Query: 127 VLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186
+ ++GG+L IIK + +++ G+ Y HS IHRD+ +
Sbjct: 85 ITEYIKGGTLRGIIKS-------MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 187 NILLGEDGTVQIADFGVS---------AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD 237
N L+ E+ V +ADFG++ +K R+T VG P WMAPE++
Sbjct: 138 NCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197
Query: 238 HGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYG 297
YD K D++S GI E+ Y P T+D G + Y
Sbjct: 198 S-YDEKVDVFSFGIVLCEIIGRVNADPDY------------LPRTMDFGLNVRGFLDRYC 244
Query: 298 -----KTFRKMISDCLQKDPTKRPTASELLK 323
+F + C DP KRP+ +L
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-46
Identities = 74/341 (21%), Positives = 140/341 (41%), Gaps = 57/341 (16%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
ED Y++ E +G G A+V K+ + A K I ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIK-----------------KRQSRAS 53
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ S +E+ +E+ + H NV+T H + + ++ L+L L+ GG L D + + +S
Sbjct: 54 RRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL----GEDGTVQIADFGV 203
E + ++++L G+ Y H+ H D+K NI+L +++ DFG+
Sbjct: 114 --------EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATGTAP 262
+ + G + GTP ++APE++ + +AD+WS+G IT I + +G +P
Sbjct: 166 AHEIEDGVEFK------NIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYI-LLSGASP 217
Query: 263 YHKYPAMKVLMLTLQ-----NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT 317
+ + L ++ T KD I L K+ KR T
Sbjct: 218 FLGDTKQETLANITSVSYDFDEEFFSHTSELAKD-----------FIRKLLVKETRKRLT 266
Query: 318 ASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKN 358
E L++P+ +++ + + V +K +
Sbjct: 267 IQEALRHPWITPVDNQQAMVRRESVVN---LENFRKQYVRR 304
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 85/331 (25%), Positives = 133/331 (40%), Gaps = 66/331 (19%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
D+Y + + +G GA V A+ + +K AI+ I+ K AI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKR------------KFAIGS---A 178
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ + EI+ + +H ++ F +D ++VL L+EGG L D +
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKV------- 230
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIADFGVS 204
+ E T ++L ++Y H NG IHRD+K N+LL ED ++I DFG S
Sbjct: 231 -VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH--GYDFKADIWSLGITAIEMATGTAP 262
L + T GTP ++APEV+ GY+ D WSLG+ +G P
Sbjct: 290 KILGETSLMR------TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
Query: 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGK-TF------------RKMISDCLQ 309
+ + +L KDQ + GK F ++ L
Sbjct: 344 FSE-----------HRTQVSL------KDQITS-GKYNFIPEVWAEVSEKALDLVKKLLV 385
Query: 310 KDPTKRPTASELLKNPFFKKAKDKKFIQQTL 340
DP R T E L++P+ + K+ Q L
Sbjct: 386 VDPKARFTTEEALRHPWLQDEDMKRKFQDLL 416
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-46
Identities = 73/320 (22%), Positives = 129/320 (40%), Gaps = 60/320 (18%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
++Y + ++G G+ V + ++ A+K IN K + K
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN--------------KASAKNK 63
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRL 144
+ +L+E++ + H N++ ++V L GG L D I R
Sbjct: 64 DTST-------ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK 116
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIADF 201
+ S E A ++++V G+ Y H + +HRD+K NILL +D ++I DF
Sbjct: 117 RFS--------EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261
G+S + +GT ++APEV+ YD K D+WS G+ + +GT
Sbjct: 169 GLSTCFQQNTKM------KDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTP 220
Query: 262 PYHKYPAMKVLMLTLQNDP-------PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK 314
P++ +L T+ A KD +I L P+
Sbjct: 221 PFYGKNEYDILKRVETGKYAFDLPQWRTISDDA--KD-----------LIRKMLTFHPSL 267
Query: 315 RPTASELLKNPFFKKAKDKK 334
R TA++ L++P+ +K +
Sbjct: 268 RITATQCLEHPWIQKYSSET 287
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-46
Identities = 41/344 (11%), Positives = 90/344 (26%), Gaps = 40/344 (11%)
Query: 5 SNVPGRIMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINL 64
S V + V V+G A + E +
Sbjct: 49 SLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYF 108
Query: 65 AVVHSAYC--KARAEKCAIK---KINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFV 119
+ + + E ++ I +K + + + ++
Sbjct: 109 TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 168
Query: 120 VKDEL-WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178
L L +L + L + H + +V++ L H G
Sbjct: 169 DMWVLSRFFLYPRMQSNLQTFGEV-LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227
Query: 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH 238
+H ++ +I+L + G V + F R R + + PE+ +
Sbjct: 228 VHTYLRPVDIVLDQRGGVFLTGFEHL---------VRDGARVVSSVSRGFEPPELEARRA 278
Query: 239 G----------YDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAA 288
F D W+LG+ + P K A+ + +
Sbjct: 279 TISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR-SCKNIPQPV- 336
Query: 289 EKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332
R ++ L+ R + ++ P +++ +
Sbjct: 337 ------------RALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-45
Identities = 77/319 (24%), Positives = 135/319 (42%), Gaps = 54/319 (16%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
N +D Y+ E +G G AVV K+ + A K I ++
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-----------------KRRT 49
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRL 144
+ S +++ +E+ + H NV+T H + K ++ L+L L+ GG L D + +
Sbjct: 50 KSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE 109
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL----GEDGTVQIAD 200
++ E L+++L G+ Y HS H D+K NI+L ++I D
Sbjct: 110 SLT--------EEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 201 FGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATG 259
FG++ + G + GTP ++APE++ + +AD+WS+G IT I + +G
Sbjct: 162 FGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYI-LLSG 213
Query: 260 TAPYH----KYPAMKVLMLTLQNDPPTLDTGAAE-KDQYKAYGKTFRKMISDCLQKDPTK 314
+P+ + V + + + +A KD I L KDP K
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD-----------FIRRLLVKDPKK 262
Query: 315 RPTASELLKNPFFKKAKDK 333
R T + L++P+ K +
Sbjct: 263 RMTIQDSLQHPWIKPKDTQ 281
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 72/320 (22%), Positives = 125/320 (39%), Gaps = 64/320 (20%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
+ Y + IG G+ V A K + A KKI K E
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIP---------KYFVE------- 48
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRL 144
+D +EI+ M S H N++ + +F +++LV+ L GG L + + H+
Sbjct: 49 -------DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR 101
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIADF 201
E A ++++VL + Y H HRD+K N L D +++ DF
Sbjct: 102 VFR--------ESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDF 153
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATGT 260
G++A G+ + T VGTP +++P+V+E Y + D WS G + + + G
Sbjct: 154 GLAARFKPGKMMR------TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYV-LLCGY 204
Query: 261 APYHK------YPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
P+ ++ T + A + +I L K P
Sbjct: 205 PPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA--ES-----------LIRRLLTKSPK 251
Query: 314 KRPTASELLKNPFFKKAKDK 333
+R T+ + L++ +F+K
Sbjct: 252 QRITSLQALEHEWFEKQLSS 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 43/308 (13%), Positives = 96/308 (31%), Gaps = 73/308 (23%)
Query: 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNT 91
+ + + + +K + + W+T
Sbjct: 13 NFLTKLNENHSGELWKGRW------------------------QGNDIVVKVLKVRDWST 48
Query: 92 -SMDELLKEIQAMSSCHHENVVTYHTSFV------VKDELWLVLRLLEGGSLLDIIKHRL 144
+ +E + H NV+ + L+ + GSL +++ H
Sbjct: 49 RKSRDFNEECPRLRIFSHPNVLP----VLGACQSPPAPHPTLITHWMPYGSLYNVL-HEG 103
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ--IHRDIKAGNILLGEDGTVQIADFG 202
+ V D+ ++ +G+ + H+ + + ++++ ED T +I+
Sbjct: 104 T-----NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMAD 158
Query: 203 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM--EQDHGYDFKADIWSLGITAIEMATGT 260
+ + P W+APE + + + AD+WS + E+ T
Sbjct: 159 ----------VKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
Query: 261 APYHKYPAMKVLMLTLQND-----PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315
P+ M++ M PP + K++ C+ +DP KR
Sbjct: 209 VPFADLSNMEIGMKVALEGLRPTIPPGIS-------------PHVSKLMKICMNEDPAKR 255
Query: 316 PTASELLK 323
P ++
Sbjct: 256 PKFDMIVP 263
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 64/308 (20%), Positives = 117/308 (37%), Gaps = 67/308 (21%)
Query: 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNT 91
+ E+IG G V+ A+ ++ A+K + E +
Sbjct: 10 TLEEIIGIGGFGKVYRAFW--IGDEVAVKAA-------------------RHDPDEDISQ 48
Query: 92 SMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKH 151
+++ + +E + + H N++ + + L LV+ GG L ++ +I
Sbjct: 49 TIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRI----- 102
Query: 152 GVCDEPTIATVLREVLKGLEYFHSNGQ---IHRDIKAGNILLGEDG--------TVQIAD 200
+ ++ +G+ Y H IHRD+K+ NIL+ + ++I D
Sbjct: 103 ---PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159
Query: 201 FGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260
FG++ R+ R + G WMAPEV+ + +D+WS G+ E+ TG
Sbjct: 160 FGLA------REWHRTTKM-SAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGE 211
Query: 261 APYHKYPAMKVLMLTLQND-----PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315
P+ + V N P T + F K++ DC DP R
Sbjct: 212 VPFRGIDGLAVAYGVAMNKLALPIPSTCP-------------EPFAKLMEDCWNPDPHSR 258
Query: 316 PTASELLK 323
P+ + +L
Sbjct: 259 PSFTNILD 266
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 38/313 (12%), Positives = 86/313 (27%), Gaps = 29/313 (9%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLA--VVHSAYCKARAEKCAIKKINLE 87
V+G A + E + +A + + E ++ +
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLL----EGGSLLDIIKHR 143
K L+ I + + ++W++ R +L +
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE-V 197
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
L + H + +V++ L H G +H ++ +I+L + G V + F
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE- 256
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVM----EQDHGYDFKADIWSLGITAIEMATG 259
S P A ++ F D W+LG+ +
Sbjct: 257 ---HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319
P A+ ++ R ++ L+ R
Sbjct: 314 DLPNTDDAALGGSEWIFRSCKNIPQ--------------PVRALLEGFLRYPKEDRLLPL 359
Query: 320 ELLKNPFFKKAKD 332
+ ++ P +++ +
Sbjct: 360 QAMETPEYEQLRT 372
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 3e-45
Identities = 68/305 (22%), Positives = 124/305 (40%), Gaps = 48/305 (15%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+Y +G GA V +A K + ++ +K I K + + +
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK--------------KEKVLEDCWIE- 69
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRL-LEGGSLLDIIKHRLKISN 148
+ + ++ EI +S H N++ F + LV+ G L I
Sbjct: 70 DPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-------- 121
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
+H DEP + + R+++ + Y IHRDIK NI++ ED T+++ DFG +A+L
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD-FKADIWSLGITAIEMATGTAPYHKYP 267
G+ +TF GT + APEV+ + Y + ++WSLG+T + P+ +
Sbjct: 182 RGKLF------YTFCGTIEYCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
+ P + ++S LQ P +R T +L+ +P+
Sbjct: 235 ETVEAAIHP---PYLVSKEL-------------MSLVSGLLQPVPERRTTLEKLVTDPWV 278
Query: 328 KKAKD 332
+ +
Sbjct: 279 TQPVN 283
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-45
Identities = 66/309 (21%), Positives = 118/309 (38%), Gaps = 54/309 (17%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+Y + +++G G+ V + A+K + K L +
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILK-------------------KKKLRRI 46
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHT--SFVVKDELWLVLRLLEGGS--LLD-IIKHRL 144
+ KEIQ + H+NV+ K ++++V+ G +LD + + R
Sbjct: 47 PNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRF 106
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS 204
+++ GLEY HS G +H+DIK GN+LL GT++I+ GV+
Sbjct: 107 P----------VCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD-FKADIWSLGITAIEMATGTAPY 263
L T G+P + PE+ + FK DIWS G+T + TG P+
Sbjct: 157 EALHPFAA---DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213
Query: 264 HKYPAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320
K+ + P ++ L+ +P KR + +
Sbjct: 214 EGDNIYKLFENIGKGSYAIPGDCGPPL-------------SDLLKGMLEYEPAKRFSIRQ 260
Query: 321 LLKNPFFKK 329
+ ++ +F+K
Sbjct: 261 IRQHSWFRK 269
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-45
Identities = 74/316 (23%), Positives = 138/316 (43%), Gaps = 57/316 (18%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
+Y+ ++VIG G ++VV +A + A+K + + + LE
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVT------------AERLSPEQLE 140
Query: 88 KWNTSMDELLKEIQAMSS-CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI 146
+ + +E + H +++T S+ ++LV L+ G L D + ++ +
Sbjct: 141 E---VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL 197
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
S E +++R +L+ + + H+N +HRD+K NILL ++ ++++DFG S
Sbjct: 198 S--------EKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249
Query: 207 LATGRDLSRQKVRHTFVGTPCWMAPEV-----MEQDHGYDFKADIWSLG-ITAIEMATGT 260
L G L GTP ++APE+ E GY + D+W+ G I + G+
Sbjct: 250 LEPGEKLR------ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT-LLAGS 302
Query: 261 AP-YHKYPAM---KVLM--LTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
P +H+ + ++ + + KD +IS LQ DP
Sbjct: 303 PPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTV--KD-----------LISRLLQVDPE 349
Query: 314 KRPTASELLKNPFFKK 329
R TA + L++PFF++
Sbjct: 350 ARLTAEQALQHPFFER 365
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-45
Identities = 42/311 (13%), Positives = 84/311 (27%), Gaps = 20/311 (6%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+ ++ E + G +VV R E A+K + +S R + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 90 N----TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRL-LEGGSLLDIIKHRL 144
+ LL A++ +L + L + L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS-TL 181
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS 204
G + + ++++ S G +H N+ + DG + + D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH-GYDFKADIWSLGITAIEMATGTAPY 263
+ T + E + + + W LG++ + P+
Sbjct: 242 WKVGT--------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293
Query: 264 --HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
P T + KT I L D +R E
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTL---IGRFLNFDRRRRLLPLEA 350
Query: 322 LKNPFFKKAKD 332
++ P F + ++
Sbjct: 351 METPEFLQLQN 361
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 5e-45
Identities = 74/319 (23%), Positives = 130/319 (40%), Gaps = 58/319 (18%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
++Y + ++G G+ V + ++ A+K IN K + K
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN--------------KASAKNK 63
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRL 144
+ +L+E++ + H N++ ++V L GG L D I R
Sbjct: 64 DTST-------ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK 116
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIADF 201
+ S E A ++++V G+ Y H + +HRD+K NILL +D ++I DF
Sbjct: 117 RFS--------EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATGT 260
G+S + +GT ++APEV+ YD K D+WS G I I + +GT
Sbjct: 169 GLSTCFQQNTKMK------DRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYI-LLSGT 219
Query: 261 APYHKYPAMKVLMLTLQ-----NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315
P++ +L + P KD +I L P+ R
Sbjct: 220 PPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD-----------LIRKMLTFHPSLR 268
Query: 316 PTASELLKNPFFKKAKDKK 334
TA++ L++P+ +K ++
Sbjct: 269 ITATQCLEHPWIQKYSSEE 287
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-45
Identities = 82/318 (25%), Positives = 131/318 (41%), Gaps = 61/318 (19%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
D Y+V+E +G GA +VV K + A K IN +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN--------------TKKLSAR 47
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRL 144
+ +K L +E + H N+V H S + +LV L+ GG L + I R
Sbjct: 48 DFQK-------LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE 100
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIADF 201
S E + ++++L+ + Y HSNG +HR++K N+LL + V++ADF
Sbjct: 101 FYS--------EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 152
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATGT 260
G++ + H F GTP +++PEV+++D Y DIW+ G I I + G
Sbjct: 153 GLAIEVNDSEAW------HGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYI-LLVGY 204
Query: 261 APYHK------YPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
P+ Y +K + T+ A K +I L +P
Sbjct: 205 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA--KS-----------LIDSMLTVNPK 251
Query: 314 KRPTASELLKNPFFKKAK 331
KR TA + LK P+ +
Sbjct: 252 KRITADQALKVPWICNRE 269
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-45
Identities = 66/308 (21%), Positives = 125/308 (40%), Gaps = 54/308 (17%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ +++ + +G GA V A V+ + E A+K +++++
Sbjct: 7 EDWDLVQTLGEGAYGEVQLA------------------VN----RVTEEAVAVKIVDMKR 44
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+ + KEI +HENVV ++ + +L L GG L D I
Sbjct: 45 AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-------- 96
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
EP +++ G+ Y H G HRDIK N+LL E ++I+DFG++
Sbjct: 97 EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF- 155
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD-FKADIWSLGITAIEMATGTAPYH-KY 266
R +R+++ + GT ++APE++ + + D+WS GI M G P+
Sbjct: 156 --RYNNRERLLNKMCGTLPYVAPELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212
Query: 267 PAMKVLMLTLQND---PP--TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
+ + + P +D+ ++ L ++P+ R T ++
Sbjct: 213 DSCQEYSDWKEKKTYLNPWKKIDSAP-------------LALLHKILVENPSARITIPDI 259
Query: 322 LKNPFFKK 329
K+ ++ K
Sbjct: 260 KKDRWYNK 267
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-44
Identities = 86/333 (25%), Positives = 132/333 (39%), Gaps = 70/333 (21%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
D+Y + + +G GA V A+ + +K AIK I+ K
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKR----------------KFAIGS 52
Query: 88 KWNTSMDELLK-EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI 146
++ EI+ + +H ++ F +D ++VL L+EGG L D +
Sbjct: 53 AREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKV------ 105
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIADFGV 203
+ E T ++L ++Y H NG IHRD+K N+LL ED ++I DFG
Sbjct: 106 --VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH--GYDFKADIWSLG-ITAIEMATGT 260
S L + T GTP ++APEV+ GY+ D WSLG I I +G
Sbjct: 164 SKILGETSLMR------TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI-CLSGY 216
Query: 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGK-TF------------RKMISDC 307
P+ + +L KDQ + GK F ++
Sbjct: 217 PPFSE-----------HRTQVSL------KDQITS-GKYNFIPEVWAEVSEKALDLVKKL 258
Query: 308 LQKDPTKRPTASELLKNPFFKKAKDKKFIQQTL 340
L DP R T E L++P+ + K+ Q L
Sbjct: 259 LVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL 291
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-44
Identities = 84/321 (26%), Positives = 133/321 (41%), Gaps = 71/321 (22%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
D YEV+E IG G+ +V KA + A+K I+
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID------------------------ 56
Query: 88 KWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI 146
S + +EI+ + H N++T + +++V L++GG LLD I +
Sbjct: 57 ---KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF 113
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL----GEDGTVQIADFG 202
S E + VL + K +EY H+ G +HRD+K NIL G +++I DFG
Sbjct: 114 S--------EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 203 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATGTA 261
+ L + T T ++APEV+E+ GYD DIWSLG + M TG
Sbjct: 166 FAKQLRAE-----NGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYT-MLTGYT 218
Query: 262 PYHKYPAM-------KVLM--LTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311
P+ P ++ +L ++ A KD ++S L D
Sbjct: 219 PFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA--KD-----------LVSKMLHVD 265
Query: 312 PTKRPTASELLKNPFFKKAKD 332
P +R TA+ +L++P+
Sbjct: 266 PHQRLTAALVLRHPWIVHWDQ 286
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-44
Identities = 74/313 (23%), Positives = 123/313 (39%), Gaps = 48/313 (15%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
ED YE+ EVIG G +VV + ++ A+K ++
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVD------------------VAKFTS 64
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
S ++L +E H ++V ++ L++V ++G L I R
Sbjct: 65 SPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD-- 122
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIADFGVS 204
V E + +R++L+ L Y H N IHRD+K +LL V++ FGV+
Sbjct: 123 --AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATGTAPY 263
L V VGTP +MAPEV+++ Y D+W G I I + +G P+
Sbjct: 181 IQLGES-----GLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFI-LLSGCLPF 233
Query: 264 HKYPAM---KVLMLTLQNDPPTLDTGAAE-KDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319
+ ++ + +P + KD ++ L DP +R T
Sbjct: 234 YGTKERLFEGIIKGKYKMNPRQWSHISESAKD-----------LVRRMLMLDPAERITVY 282
Query: 320 ELLKNPFFKKAKD 332
E L +P+ K+
Sbjct: 283 EALNHPWLKERDR 295
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 45/316 (14%), Positives = 96/316 (30%), Gaps = 56/316 (17%)
Query: 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINL 86
V ++G GA A V+ A + +K +K
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKF-----------------VLKVQKP 105
Query: 87 EK-WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK 145
W + + ++ + + ++++ + ++ LV L G+LL+ I
Sbjct: 106 ANPWEFYI--GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAIN---L 160
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG-----------EDG 194
N V + + + +L +E H IH DIK N +LG
Sbjct: 161 YKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220
Query: 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254
+ + D G S + + + + T + E++ ++++ D + + T
Sbjct: 221 GLALIDLGQSIDM---KLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVY 276
Query: 255 EMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY--GKTFRKMISDCLQKDP 312
M GT K + + ++ + + L
Sbjct: 277 CMLFGTYMKVKNEGGECKP----------------EGLFRRLPHLDMWNEFFHVMLNIPD 320
Query: 313 TKRPTASELLKNPFFK 328
+ +LL+ K
Sbjct: 321 CHHLPSLDLLRQKLKK 336
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-43
Identities = 83/314 (26%), Positives = 128/314 (40%), Gaps = 60/314 (19%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
N + EV+G GA + V + + A+K I K+ A +
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK---------KSPAFR------ 49
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRL 144
L EI + HEN+VT + +LV++L+ GG L D I R
Sbjct: 50 --------DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG 101
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIADF 201
+ E + V+++VL ++Y H NG +HRD+K N+L E+ + I DF
Sbjct: 102 VYT--------EKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDF 153
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATGT 260
G+S G + T GTP ++APEV+ Q Y D WS+G IT I + G
Sbjct: 154 GLSKMEQNG-------IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYI-LLCGY 204
Query: 261 APYHKYPAMKVLMLTLQND-----PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315
P+++ K+ + P D + KD I L+KDP +R
Sbjct: 205 PPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD-----------FICHLLEKDPNER 253
Query: 316 PTASELLKNPFFKK 329
T + L +P+
Sbjct: 254 YTCEKALSHPWIDG 267
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 62/317 (19%), Positives = 120/317 (37%), Gaps = 60/317 (18%)
Query: 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKIN 85
++Y + E +G G +VH + + K + ++
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---------VKGTDQ------- 45
Query: 86 LEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLD-IIKHRL 144
+ KEI ++ H N++ H SF +EL ++ + G + + I
Sbjct: 46 --------VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF 97
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG--EDGTVQIADFG 202
+++ E I + + +V + L++ HS+ H DI+ NI+ T++I +FG
Sbjct: 98 ELN--------EREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG 149
Query: 203 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATGTA 261
+ L G + P + APEV + D D+WSLG + + + +G
Sbjct: 150 QARQLKPGDNFR------LLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYV-LLSGIN 201
Query: 262 PYH----KYPAMKVLMLTLQNDPPTLDTGAAE-KDQYKAYGKTFRKMISDCLQKDPTKRP 316
P+ + ++ D + E D + L K+ R
Sbjct: 202 PFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD-----------FVDRLLVKERKSRM 250
Query: 317 TASELLKNPFFKKAKDK 333
TASE L++P+ K+ ++
Sbjct: 251 TASEALQHPWLKQKIER 267
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 66/308 (21%), Positives = 125/308 (40%), Gaps = 54/308 (17%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ +++ + +G GA V A V+ + E A+K +++++
Sbjct: 7 EDWDLVQTLGEGAYGEVQLA------------------VN----RVTEEAVAVKIVDMKR 44
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+ + KEI +HENVV ++ + +L L GG L D I
Sbjct: 45 AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-------- 96
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
EP +++ G+ Y H G HRDIK N+LL E ++I+DFG++
Sbjct: 97 EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF- 155
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD-FKADIWSLGITAIEMATGTAPYH-KY 266
R +R+++ + GT ++APE++ + + D+WS GI M G P+
Sbjct: 156 --RYNNRERLLNKMCGTLPYVAPELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212
Query: 267 PAMKVLMLTLQND---PP--TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
+ + + P +D+ ++ L ++P+ R T ++
Sbjct: 213 DSCQEYSDWKEKKTYLNPWKKIDSAP-------------LALLHKILVENPSARITIPDI 259
Query: 322 LKNPFFKK 329
K+ ++ K
Sbjct: 260 KKDRWYNK 267
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 73/304 (24%), Positives = 124/304 (40%), Gaps = 53/304 (17%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
Y + + IG G A V A + AIK I+ K + +L+K
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIID--------------KTQLNPTSLQK- 60
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
L +E++ M +H N+V + L+L++ GG + D +
Sbjct: 61 ------LFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL--------V 106
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
HG E + R+++ ++Y H +HRD+KA N+LL D ++IADFG S
Sbjct: 107 AHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD-FKADIWSLGITAIEMATGTAPY--HKY 266
G L F G P + APE+ Q YD + D+WSLG+ + +G+ P+
Sbjct: 167 GGKL------DAFCGAPPYAAPELF-QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219
Query: 267 PAMKVLMLTLQ-NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325
++ +L + P + T ++ L +P KR T +++K+
Sbjct: 220 KELRERVLRGKYRIPFYMSTDC-------------ENLLKRFLVLNPIKRGTLEQIMKDR 266
Query: 326 FFKK 329
+
Sbjct: 267 WINA 270
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-43
Identities = 83/341 (24%), Positives = 137/341 (40%), Gaps = 61/341 (17%)
Query: 3 NCSNVPGRIMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKI 62
+ +++ G S + D Y+V+E +G GA +VV K + A K I
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 63 NLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD 122
N + + +K L +E + H N+V H S +
Sbjct: 63 N--------------TKKLSARDFQK-------LEREARICRKLQHPNIVRLHDSIQEES 101
Query: 123 ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182
+LV L+ GG L + I R S E + ++++L+ + Y HSNG +HR+
Sbjct: 102 FHYLVFDLVTGGELFEDIVAREFYS--------EADASHCIQQILESIAYCHSNGIVHRN 153
Query: 183 IKAGNILL---GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG 239
+K N+LL + V++ADFG++ + H F GTP +++PEV+++
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW------HGFAGTPGYLSPEVLKK-DP 206
Query: 240 YDFKADIWSLG-ITAIEMATGTAPYHK------YPAMKVLMLTLQNDP-PTLDTGAAEKD 291
Y DIW+ G I I + G P+ Y +K + T+ A K
Sbjct: 207 YSKPVDIWACGVILYI-LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA--KS 263
Query: 292 QYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332
+I L +P KR TA + LK P+ +
Sbjct: 264 -----------LIDSMLTVNPKKRITADQALKVPWICNRER 293
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-43
Identities = 67/340 (19%), Positives = 115/340 (33%), Gaps = 65/340 (19%)
Query: 13 AASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYC 72
+ S S + Q ++ + IG G V R EK A+K
Sbjct: 21 SGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVF---------- 68
Query: 73 KARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY----HTSFVVKDELWLVL 128
W E EI HEN++ + +L+L+
Sbjct: 69 ---------FTTEEASWFR---E--TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT 114
Query: 129 RLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ--------IH 180
E GSL D +K D ++ + + GL + H+ H
Sbjct: 115 DYHENGSLYDYLKST---------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH 165
Query: 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME----- 235
RD+K+ NIL+ ++GT IAD G++ + + +T VGT +M PEV++
Sbjct: 166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTN-EVDIPPNTRVGTKRYMPPEVLDESLNR 224
Query: 236 QDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAA------- 288
AD++S G+ E+A ++ L P+ +
Sbjct: 225 NHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL 284
Query: 289 -----EKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ + K++++C +P R TA + K
Sbjct: 285 RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 56/273 (20%), Positives = 102/273 (37%), Gaps = 41/273 (15%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY----HTSFVVKDELWLVLRLLEGGS 135
A+K + + E E+ HEN++ + TS +LWL+ E GS
Sbjct: 35 AVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGS 92
Query: 136 LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ--------IHRDIKAGN 187
L D ++ D + ++ + GL + H HRD+K+ N
Sbjct: 93 LYDYLQLT---------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143
Query: 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME-----QDHGYDF 242
IL+ ++G IAD G++ + + + VGT +MAPEV++
Sbjct: 144 ILVKKNGQCCIADLGLAVMHSQSTNQLDVG-NNPRVGTKRYMAPEVLDETIQVDCFDSYK 202
Query: 243 KADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAA------------EK 290
+ DIW+ G+ E+A K + + P+ + +
Sbjct: 203 RVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR 262
Query: 291 DQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ K++ +C ++P+ R TA + K
Sbjct: 263 WFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 79/329 (24%), Positives = 134/329 (40%), Gaps = 63/329 (19%)
Query: 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIK 82
D +EV +G GAT++V+ K + A+K + K
Sbjct: 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK------------------K 88
Query: 83 KINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
++ + + EI + H N++ F E+ LVL L+ GG L D I
Sbjct: 89 TVDKKI-------VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE 141
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIA 199
+ S E A ++++L+ + Y H NG +HRD+K N+L D ++IA
Sbjct: 142 KGYYS--------ERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIA 193
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMAT 258
DFG+S + + Q + T GTP + APE++ Y + D+WS+G IT I +
Sbjct: 194 DFGLS------KIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYI-LLC 245
Query: 259 GTAPYHKYPAMKVLMLTLQN------DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312
G P++ + + + N P + KD ++ + DP
Sbjct: 246 GFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD-----------LVRKLIVLDP 294
Query: 313 TKRPTASELLKNPFFK-KAKDKKFIQQTL 340
KR T + L++P+ KA + +
Sbjct: 295 KKRLTTFQALQHPWVTGKAANFVHMDTAQ 323
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 80/353 (22%), Positives = 140/353 (39%), Gaps = 64/353 (18%)
Query: 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKIN 85
+ D Y++ E +G GA VVH KA K IN +K
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--------TPYPLDK------- 92
Query: 86 LEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLD-IIKHRL 144
+ EI M+ HH ++ H +F K E+ L+L L GG L D I
Sbjct: 93 --------YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY 144
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG--EDGTVQIADFG 202
K+S E + +R+ +GL++ H + +H DIK NI+ + +V+I DFG
Sbjct: 145 KMS--------EAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 196
Query: 203 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATGTA 261
++ L + T + APE+++++ F D+W++G + + + +G +
Sbjct: 197 LATKLNPDEIVK------VTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYV-LLSGLS 248
Query: 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRK-------MISDCLQKDPTK 314
P+ ++D TL ++ ++ F I + LQK+P K
Sbjct: 249 PFAG-----------EDDLETLQ--NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK 295
Query: 315 RPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHR 367
R T + L++P+ K + S +I++ P + R
Sbjct: 296 RLTVHDALEHPWLKGDHSNL-TSRIPSSRYNKIRQKIKEKYADWPAPQPAIGR 347
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-43
Identities = 67/338 (19%), Positives = 116/338 (34%), Gaps = 65/338 (19%)
Query: 15 SSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKA 74
S S + ++E IG G V
Sbjct: 28 SGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW------------------------ 63
Query: 75 RAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY----HTSFVVKDELWLVLRL 130
R E+ A+K + + + E EI HEN++ + + +LWLV
Sbjct: 64 RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121
Query: 131 LEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ--------IHRD 182
E GSL D + + + GL + H HRD
Sbjct: 122 HEHGSLFDYLNRY---------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172
Query: 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME-----QD 237
+K+ NIL+ ++GT IAD G++ + D H VGT +MAPEV++ +
Sbjct: 173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYMAPEVLDDSINMKH 231
Query: 238 HGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAA--------- 288
+ADI+++G+ E+A + + ++ L P+++
Sbjct: 232 FESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP 291
Query: 289 ---EKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ Q + K++ +C + R TA + K
Sbjct: 292 NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-43
Identities = 69/304 (22%), Positives = 126/304 (41%), Gaps = 52/304 (17%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
Y + + +G G V + K A+K +N + I+ +++
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--------------RQKIRSLDV--- 54
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
+ ++ +EIQ + H +++ + + ++V+ + GG L D I C
Sbjct: 55 ---VGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--------C 103
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
KHG +E + +++L ++Y H + +HRD+K N+LL +IADFG+S ++
Sbjct: 104 KHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD-FKADIWSLGITAIEMATGTAPYHKYPA 268
G L T G+P + APEV+ Y + DIWS G+ + GT P+
Sbjct: 164 GEFL------RTSCGSPNYAAPEVI-SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216
Query: 269 MKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325
+ P L+ ++ LQ DP KR T ++ ++
Sbjct: 217 PTLFKKIRGGVFYIPEYLNRSV-------------ATLLMHMLQVDPLKRATIKDIREHE 263
Query: 326 FFKK 329
+FK+
Sbjct: 264 WFKQ 267
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 71/344 (20%), Positives = 135/344 (39%), Gaps = 61/344 (17%)
Query: 26 NTEDQYEVR-EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
N + Y + + +G G AVV K+ ++ A K + + R + C
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK--------KRRRGQDC----- 71
Query: 85 NLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHR 143
E+L EI + V+ H + E+ L+L GG + +
Sbjct: 72 --------RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE 123
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIAD 200
+ E + +++++L+G+ Y H N +H D+K NILL G ++I D
Sbjct: 124 ------LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 201 FGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATG 259
FG+S + +L +GTP ++APE++ D D+W++G I + + T
Sbjct: 178 FGMSRKIGHACELR------EIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYM-LLTH 229
Query: 260 TAPYH----KYPAMKVLMLTLQNDPPTLDTGAAE-KDQYKAYGKTFRKMISDCLQKDPTK 314
T+P+ + + + + + T + + D I L K+P K
Sbjct: 230 TSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATD-----------FIQSLLVKNPEK 278
Query: 315 RPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKN 358
RPTA L + + ++ + S ++ Q + ++
Sbjct: 279 RPTAEICLSHSWLQQWDFENLFHPEETSS----SSQTQDHSVRS 318
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 76/360 (21%), Positives = 129/360 (35%), Gaps = 72/360 (20%)
Query: 28 EDQYEVR---EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
Y++ + +G G+ ++ K + A+K I+ K+
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS------------------KR- 47
Query: 85 NLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHR 143
KEI A+ C H N+V H F + +LV+ LL GG L + IK +
Sbjct: 48 -------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK 100
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIAD 200
S E + ++R+++ + + H G +HRD+K N+L ++ ++I D
Sbjct: 101 KHFS--------ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIID 152
Query: 201 FGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATG 259
FG + + T T + APE++ Q +GYD D+WSLG I M +G
Sbjct: 153 FGFARLKPPD-----NQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYT-MLSG 205
Query: 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFR----KMISD--------C 307
P+ + T + + K +F K +S
Sbjct: 206 QVPFQS-----------HDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGL 254
Query: 308 LQKDPTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHR 367
L DP KR S L N + + + + + K A + R
Sbjct: 255 LTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKR 314
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 75/324 (23%), Positives = 133/324 (41%), Gaps = 60/324 (18%)
Query: 20 VSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKC 79
++ ++Y++ E +G GA +VV ++ A IN +
Sbjct: 2 ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIIN---------TKKLSAR 52
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
+K L +E + H N+V H S + +L+ L+ GG L +
Sbjct: 53 DHQK------------LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFED 100
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTV 196
I R S E + ++++L+ + + H G +HR++K N+LL + V
Sbjct: 101 IVAREYYS--------EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV 152
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIE 255
++ADFG++ + Q+ F GTP +++PEV+ +D Y D+W+ G I I
Sbjct: 153 KLADFGLAIEVEGE-----QQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYI- 205
Query: 256 MATGTAPYHK------YPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCL 308
+ G P+ Y +K + T+ A KD +I+ L
Sbjct: 206 LLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA--KD-----------LINKML 252
Query: 309 QKDPTKRPTASELLKNPFFKKAKD 332
+P+KR TA+E LK+P+
Sbjct: 253 TINPSKRITAAEALKHPWISHRST 276
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-42
Identities = 77/331 (23%), Positives = 130/331 (39%), Gaps = 61/331 (18%)
Query: 25 PNTEDQYEV-REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
ED Y++ +V+G GA A V + +++ A+K I K
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE-------------------K 48
Query: 84 INLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
+ +E++ + C H NV+ F +D +LV + GGS+L I
Sbjct: 49 QPGH----IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI-- 102
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIA 199
K +E + V+++V L++ H+ G HRD+K NIL + V+I
Sbjct: 103 ------HKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKIC 156
Query: 200 DFGVSAWLATGRDLS--RQKVRHTFVGTPCWMAPEV----MEQDHGYDFKADIWSLG-IT 252
DF + + + D S T G+ +MAPEV E+ YD + D+WSLG I
Sbjct: 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
Query: 253 AIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGK-TFR----KMISD- 306
I + +G P+ + + GK F IS
Sbjct: 217 YI-LLSGYPPFV---GRCGSDCGWDRGEACPACQNMLFESIQE-GKYEFPDKDWAHISCA 271
Query: 307 -------CLQKDPTKRPTASELLKNPFFKKA 330
L +D +R +A+++L++P+ +
Sbjct: 272 AKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-42
Identities = 67/326 (20%), Positives = 123/326 (37%), Gaps = 77/326 (23%)
Query: 28 EDQYEV-REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINL 86
D Y++ ++V+G G V + + +KCA+K + +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--------------DSPKAR--- 69
Query: 87 EKWNTSMDELLKEIQAMSSC-HHENVVT----YHTSFVVKDELWLVLRLLEGGSLLDIIK 141
+E+ ++V Y K L +++ +EGG L I+
Sbjct: 70 -----------QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ 118
Query: 142 HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQI 198
R E A ++R++ +++ HS+ HRD+K N+L +D +++
Sbjct: 119 ER------GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 199 ADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMA 257
DFG + T TP ++APEV+ YD D+WSLG I I +
Sbjct: 173 TDFGFAKETTQN-------ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYI-LL 223
Query: 258 TGTAPYH------KYPAM--KVLM--LTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISD 306
G P++ P M ++ + N + A K +I
Sbjct: 224 CGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA--KQ-----------LIRL 270
Query: 307 CLQKDPTKRPTASELLKNPFFKKAKD 332
L+ DPT+R T ++ + +P+ ++
Sbjct: 271 LLKTDPTERLTITQFMNHPWINQSMV 296
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-41
Identities = 79/351 (22%), Positives = 127/351 (36%), Gaps = 63/351 (17%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
D Y++ E +G GA VVH +A A K +
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM---------TPHESD--------- 197
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLD-IIKHRLKI 146
+ + KEIQ MS H +V H +F +E+ ++ + GG L + + K+
Sbjct: 198 -----KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM 252
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG--EDGTVQIADFGVS 204
S E +R+V KGL + H N +H D+K NI+ +++ DFG++
Sbjct: 253 S--------EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATGTAPY 263
A L + + GT + APEV E + D+WS+G ++ I + +G +P+
Sbjct: 305 AHLDPKQSV------KVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYI-LLSGLSPF 356
Query: 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRK-------MISDCLQKDPTKRP 316
+ND TL + + F I L DP R
Sbjct: 357 GG-----------ENDDETLR--NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM 403
Query: 317 TASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHR 367
T + L++P+ Q S I+ P L R
Sbjct: 404 TIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGR 454
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 66/328 (20%), Positives = 121/328 (36%), Gaps = 75/328 (22%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
+D +V+G G V + K EK A+K + + C +
Sbjct: 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------------QDCPKAR- 102
Query: 85 NLEKWNTSMDELLKEIQAMSSC-HHENVVT----YHTSFVVKDELWLVLRLLEGGSLLDI 139
+E++ ++V Y + + L +V+ L+GG L
Sbjct: 103 -------------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 149
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTV 196
I+ R E + +++ + + ++Y HS HRD+K N+L + +
Sbjct: 150 IQDR------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 203
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIE 255
++ DFG + + L T TP ++APEV+ YD D+WSLG I I
Sbjct: 204 KLTDFGFAKETTSHNSL------TTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYI- 255
Query: 256 MATGTAP-YHKYPAM-------KVLM--LTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMI 304
+ G P Y + ++ M N + K +I
Sbjct: 256 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV--KM-----------LI 302
Query: 305 SDCLQKDPTKRPTASELLKNPFFKKAKD 332
+ L+ +PT+R T +E + +P+ ++
Sbjct: 303 RNLLKTEPTQRMTITEFMNHPWIMQSTK 330
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-41
Identities = 69/327 (21%), Positives = 114/327 (34%), Gaps = 62/327 (18%)
Query: 13 AASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYC 72
+ E +Y + ++G G V + + + AIK I
Sbjct: 15 GTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIP--------- 65
Query: 73 KARAEKCAIKKINLEKWNTSMDELLK---EIQAMSSCH----HENVVTYHTSFVVKDELW 125
+ + W + + + + E+ + H V+ F ++
Sbjct: 66 ----------RNRVLGW-SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114
Query: 126 LVL-RLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184
LVL R L L D I + G E +V+ +++ HS G +HRDIK
Sbjct: 115 LVLERPLPAQDLFDYI--------TEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIK 166
Query: 185 AGNILL-GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD-F 242
NIL+ G ++ DFG A L + F GT + PE + H Y
Sbjct: 167 DENILIDLRRGCAKLIDFGSGA-------LLHDEPYTDFDGTRVYSPPEWI-SRHQYHAL 218
Query: 243 KADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRK 302
A +WSLGI +M G P+ + + L P +
Sbjct: 219 PATVWSLGILLYDMVCGDIPFERDQEILEAELHF---PAHVSPDC-------------CA 262
Query: 303 MISDCLQKDPTKRPTASELLKNPFFKK 329
+I CL P+ RP+ E+L +P+ +
Sbjct: 263 LIRRCLAPKPSSRPSLEEILLDPWMQT 289
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-41
Identities = 77/334 (23%), Positives = 132/334 (39%), Gaps = 65/334 (19%)
Query: 20 VSVPWPNTEDQYEV--REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAE 77
V+ Y V E++G G VH A K A K
Sbjct: 78 VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAK----------------- 120
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
IK ++ +E+ EI M+ H N++ + +F K+++ LV+ ++GG L
Sbjct: 121 --IIKTRGMK----DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 138 D-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG--EDG 194
D II ++ E ++++ +G+ + H +H D+K NIL +
Sbjct: 175 DRIIDESYNLT--------ELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK 226
Query: 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITA 253
++I DFG++ L GTP ++APEV+ D F D+WS+G I
Sbjct: 227 QIKIIDFGLARRYKPREKLK------VNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAY 279
Query: 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRK-------MISD 306
+ + +G +P+ ND TL+ ++ + F+ IS
Sbjct: 280 M-LLSGLSPFLG-----------DNDAETLN--NILACRWDLEDEEFQDISEEAKEFISK 325
Query: 307 CLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTL 340
L K+ + R +ASE LK+P+ K +
Sbjct: 326 LLIKEKSWRISASEALKHPWLSDHKLHSRLSAQK 359
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 68/341 (19%), Positives = 114/341 (33%), Gaps = 70/341 (20%)
Query: 15 SSSASVSVP-WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCK 73
SS + ++ EV G V A
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL----------------------- 45
Query: 74 ARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTY----HTSFVVKDELWLVLR 129
E A+K ++ + +E E+ ++ HEN++ + V +LWL+
Sbjct: 46 -LNEYVAVKIFPIQDKQSWQNE--YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102
Query: 130 LLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ----------I 179
E GSL D +K V + + + +GL Y H +
Sbjct: 103 FHEKGSLSDFLKAN---------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAIS 153
Query: 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ--- 236
HRDIK+ N+LL + T IADFG++ G+ + VGT +MAPEV+E
Sbjct: 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ---VGTRRYMAPEVLEGAIN 210
Query: 237 -DHGYDFKADIWSLGITAIEMATGTAPYHKY--PAMKVLMLTLQNDPPTLDTGAA----- 288
+ D++++G+ E+A+ M + P D
Sbjct: 211 FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK 270
Query: 289 ------EKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ Q A + I +C D R +A + +
Sbjct: 271 KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 72/329 (21%), Positives = 119/329 (36%), Gaps = 59/329 (17%)
Query: 8 PGRIMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVV 67
P + A+ A E QY+V ++G G V+S + AIK +
Sbjct: 23 PCNDLHATKLAPGK-EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---- 77
Query: 68 HSAYCKARAEKCAIKKINLEKWNTSMDE--LLKEIQAMSSCHHE--NVVTYHTSFVVKDE 123
K + W + + E+ + V+ F D
Sbjct: 78 ---------------KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 124 LWLVLRLLEG-GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182
L+L E L D I + G E + +VL+ + + H+ G +HRD
Sbjct: 123 FVLILERPEPVQDLFDFI--------TERGALQEELARSFFWQVLEAVRHCHNCGVLHRD 174
Query: 183 IKAGNILL-GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD 241
IK NIL+ G +++ DFG A L + V F GT + PE + + H Y
Sbjct: 175 IKDENILIDLNRGELKLIDFGSGA-------LLKDTVYTDFDGTRVYSPPEWI-RYHRYH 226
Query: 242 -FKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTF 300
A +WSLGI +M G P+ +++ + + +
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF-FRQRVSSEC------------- 270
Query: 301 RKMISDCLQKDPTKRPTASELLKNPFFKK 329
+ +I CL P+ RPT E+ +P+ +
Sbjct: 271 QHLIRWCLALRPSDRPTFEEIQNHPWMQD 299
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 70/304 (23%), Positives = 128/304 (42%), Gaps = 52/304 (17%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
Y + + +G G V + K A+K +N + I+ +++
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN--------------RQKIRSLDV--- 59
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
+ ++ +EIQ + H +++ + ++++V+ + GG L D I C
Sbjct: 60 ---VGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI--------C 108
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
K+G DE + +++L G++Y H + +HRD+K N+LL +IADFG+S ++
Sbjct: 109 KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD-FKADIWSLGITAIEMATGTAPYHKYPA 268
G L T G+P + APEV+ Y + DIWS G+ + GT P+
Sbjct: 169 GEFL------RTSCGSPNYAAPEVI-SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221
Query: 269 MKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325
+ P L+ ++ LQ DP KR T ++ ++
Sbjct: 222 PTLFKKICDGIFYTPQYLNPSV-------------ISLLKHMLQVDPMKRATIKDIREHE 268
Query: 326 FFKK 329
+FK+
Sbjct: 269 WFKQ 272
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 76/329 (23%), Positives = 118/329 (35%), Gaps = 64/329 (19%)
Query: 13 AASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYC 72
A ++ + +P + D+Y+ + IG G V K E A+K I
Sbjct: 4 APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE--------- 54
Query: 73 KARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLE 132
+ A N+++ EI S H N+V + + L +++
Sbjct: 55 -----RGAAIDENVQR----------EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99
Query: 133 GGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE 192
GG L + I C G E +++L G+ Y HS HRD+K N LL
Sbjct: 100 GGELYERI--------CNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG 151
Query: 193 D--GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD-FKADIWSL 249
++I DFG S + VGTP ++APEV+ YD AD+WS
Sbjct: 152 SPAPRLKICDFGYSKSSVLHSQP------KSTVGTPAYIAPEVL-LRQEYDGKIADVWSC 204
Query: 250 GITAIEMATGTAPYHKYPAMKVLMLTLQN---------DPPTLDTGAAEKDQYKAYGKTF 300
G+T M G P+ + T+Q D +
Sbjct: 205 GVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC------------- 251
Query: 301 RKMISDCLQKDPTKRPTASELLKNPFFKK 329
+IS DP R + E+ + +F K
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWFLK 280
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 70/304 (23%), Positives = 121/304 (39%), Gaps = 53/304 (17%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
Y +RE +G G+ V A +K A+K I+ + +KK ++
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFIS--------------RQLLKKSDM--- 52
Query: 90 NTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNC 149
+ +EI + H +++ + ++ +V+ GG L D I
Sbjct: 53 ---HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYI--------V 100
Query: 150 KHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
+ E ++++ +EY H + +HRD+K N+LL ++ V+IADFG+S +
Sbjct: 101 EKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD-FKADIWSLGITAIEMATGTAPYHKYPA 268
G L T G+P + APEV+ Y + D+WS GI M G P+
Sbjct: 161 GNFL------KTSCGSPNYAAPEVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213
Query: 269 MKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325
+ P L GA + +I + DP +R T E+ ++P
Sbjct: 214 PNLFKKVNSCVYVMPDFLSPGA-------------QSLIRRMIVADPMQRITIQEIRRDP 260
Query: 326 FFKK 329
+F
Sbjct: 261 WFNV 264
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 63/293 (21%), Positives = 113/293 (38%), Gaps = 41/293 (13%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
Y +R ++G G V+ A R A+K ++ + + R
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR--------------- 80
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
+ +E + +VV H + +L++ +RL+ G L +++ +
Sbjct: 81 -----MQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR--------R 127
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
G P ++R++ L+ H+ G HRD+K NIL+ D + DFG +A+
Sbjct: 128 QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFG----IASA 183
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270
+ VGT +MAPE + ++ADI++L E TG+ PY +
Sbjct: 184 TTDEKLTQLGNTVGTLYYMAPERF-SESHATYRADIYALTCVLYECLTGSPPYQGDQ-LS 241
Query: 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-PTASELL 322
V+ + P T F +I+ + K+P R T +L
Sbjct: 242 VMGAHINQAIPRPSTVRPGIPV------AFDAVIARGMAKNPEDRYVTCGDLS 288
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 55/285 (19%), Positives = 100/285 (35%), Gaps = 54/285 (18%)
Query: 80 AIKKINLEKWNTSMDELL--KEIQAMSSCHHENVVTY-----HTSFVVKDELWLVLRLLE 132
A+K + + + K I + H+N+ + + + E LV+
Sbjct: 40 AVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYP 95
Query: 133 GGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ---------IHRDI 183
GSL + D + + V +GL Y H+ HRD+
Sbjct: 96 NGSLXKYLSLH---------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDL 146
Query: 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVR---HTFVGTPCWMAPEVME----- 235
+ N+L+ DGT I+DFG+S L R + + + VGT +MAPEV+E
Sbjct: 147 NSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNL 206
Query: 236 -QDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKD--- 291
+ D+++LG+ E+ ++ + Q + T +
Sbjct: 207 RDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVS 266
Query: 292 -------------QYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ ++ ++ I DC +D R TA +
Sbjct: 267 REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 2e-35
Identities = 77/315 (24%), Positives = 135/315 (42%), Gaps = 58/315 (18%)
Query: 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINL 86
T + + V +IG G V+ + A+K + +K IK
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL--------------DKKRIKMKQG 232
Query: 87 EKWNTSMDELLKEI-QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK 145
E +++E + + +S+ +V +F D+L +L L+ GG L + L
Sbjct: 233 ETL--ALNE--RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLS 284
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSA 205
+HGV E + E++ GLE+ H+ ++RD+K NILL E G V+I+D G++
Sbjct: 285 ----QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340
Query: 206 WLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265
+ + H VGT +MAPEV+++ YD AD +SLG ++ G +P+ +
Sbjct: 341 DFSKKKP-------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
Query: 266 YPAMK---VLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR---- 315
+ + +TL P + R ++ LQ+D +R
Sbjct: 394 HKTKDKHEIDRMTLTMAVELPDSFSPEL-------------RSLLEGLLQRDVNRRLGCL 440
Query: 316 -PTASELLKNPFFKK 329
A E+ ++PFF+
Sbjct: 441 GRGAQEVKESPFFRS 455
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 47/297 (15%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
Y++ + +G G + V+ A K AIK + R ++ +K+
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-----AIFIPP---REKEETLKRFE----- 59
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
+E+ S H+N+V+ D +LV+ +EG +L + I+
Sbjct: 60 -------REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE--------S 104
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
HG T ++L G+++ H +HRDIK NIL+ + T++I DFG +A
Sbjct: 105 HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFG----IA-- 158
Query: 211 RDLSRQKVRHT--FVGTPCWMAPEVMEQDHGY--DFKADIWSLGITAIEMATGTAPYHKY 266
+ LS + T +GT + +P EQ G D DI+S+GI EM G P++
Sbjct: 159 KALSETSLTQTNHVLGTVQYFSP---EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215
Query: 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-TASELL 322
A+ + + +Q+ P D K ++ +I +KD R T E+
Sbjct: 216 TAVSIAIKHIQDSVPN-----VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMK 267
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 85/330 (25%), Positives = 129/330 (39%), Gaps = 71/330 (21%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
Y +G GA V SA K EK AIKK++ + K RA
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK-RA------------ 70
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKH 142
+E+ + HENV+ F + +LV+ ++ L I+
Sbjct: 71 --------YRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL 121
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202
+ ++ ++ ++LKGL+Y HS G +HRD+K GN+ + ED ++I DFG
Sbjct: 122 KFSEEKIQY----------LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 171
Query: 203 VSAWLATGRDLSRQKVRH--TFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260
L+R +V T + APEV+ Y+ DIWS+G EM TG
Sbjct: 172 ----------LARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
Query: 261 A--PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY--------GKTFRKMIS----- 305
Y +L + P T K+Y K F ++
Sbjct: 222 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQ 281
Query: 306 --DCLQK----DPTKRPTASELLKNPFFKK 329
D L+K D KR TA++ L +PFF+
Sbjct: 282 AADLLEKMLELDVDKRLTAAQALTHPFFEP 311
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 76/334 (22%), Positives = 131/334 (39%), Gaps = 66/334 (19%)
Query: 13 AASSSASVSVPWPNTE----DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVH 68
+ S + P P + ++ +++G G+ + V A A + + AIK + +
Sbjct: 10 PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI- 68
Query: 69 SAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVL 128
++ + + E+ MS H V + +F ++L+ L
Sbjct: 69 -------IKENKVPYVTRER------------DVMSRLDHPFFVKLYFTFQDDEKLYFGL 109
Query: 129 RLLEGGSLLDIIKHRLKISNCKHGVCDEPT----IATVLREVLKGLEYFHSNGQIHRDIK 184
+ G LL I+ K G DE A E++ LEY H G IHRD+K
Sbjct: 110 SYAKNGELLKYIR--------KIGSFDETCTRFYTA----EIVSALEYLHGKGIIHRDLK 157
Query: 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244
NILL ED +QI DFG + L+ +R ++FVGT +++PE++ + +
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQAR---ANSFVGTAQYVSPELL-TEKSACKSS 213
Query: 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFR 301
D+W+LG ++ G P+ + ++ + P A R
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA-------------R 260
Query: 302 KMISDCLQKDPTKRPT------ASELLKNPFFKK 329
++ L D TKR L +PFF+
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 61/353 (17%), Positives = 116/353 (32%), Gaps = 96/353 (27%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
+D +V+G G V + K EK A+K + +
Sbjct: 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------------------QDC 54
Query: 85 NLEKWNTSMDELLKEIQAMSSC-HHENVVT----YHTSFVVKDELWLVLRLLEGGSLLDI 139
+ +E++ ++V Y + + L +V+ L+GG L
Sbjct: 55 PKAR---------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 105
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTV 196
I+ R E + +++ + + ++Y HS HRD+K N+L + +
Sbjct: 106 IQDR------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 159
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIE 255
++ DFG A E + YD D+WSLG I I
Sbjct: 160 KLTDFG--------------------------FAKETTGE--KYDKSCDMWSLGVIMYI- 190
Query: 256 MATGTAP-YHKYPAM-------KVLM--LTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMI 304
+ G P Y + ++ M N + K +I
Sbjct: 191 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV--KM-----------LI 237
Query: 305 SDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKK 357
+ L+ +PT+R T +E + +P+ ++ V + R + ++
Sbjct: 238 RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 290
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 65/241 (26%), Positives = 104/241 (43%), Gaps = 36/241 (14%)
Query: 97 LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDE 156
KE+Q M H +V SF ++++++V+ LL GG L + L+ ++ E
Sbjct: 63 FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR----YHLQ----QNVHFKE 114
Query: 157 PTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQ 216
T+ + E++ L+Y + IHRD+K NILL E G V I DF ++ L R+
Sbjct: 115 ETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA------AMLPRE 168
Query: 217 KVRHTFVGTPCWMAPEVMEQD--HGYDFKADIWSLGITAIEMATGTAPYHKYPA---MKV 271
T GT +MAPE+ GY F D WSLG+TA E+ G PYH + ++
Sbjct: 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228
Query: 272 LMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-PTASELLKNPFF 327
+ P ++ L+ +P +R S++ P+
Sbjct: 229 VHTFETTVVTYPSAWSQEM-------------VSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
Query: 328 K 328
Sbjct: 276 N 276
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-34
Identities = 74/314 (23%), Positives = 127/314 (40%), Gaps = 55/314 (17%)
Query: 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINL 86
ED + V+G G V + KA + A KK+ K +KK
Sbjct: 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKL--------------NKKRLKKRKG 228
Query: 87 EKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI 146
+ + E + ++ H +V+ +F K +L LV+ ++ GG + ++ +
Sbjct: 229 YQG------AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI----RYHIYN 278
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
+ + EP +++ GLE+ H I+RD+K N+LL +DG V+I+D G++
Sbjct: 279 VDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV- 337
Query: 207 LATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY--- 263
+ Q + GTP +MAPE++ YDF D ++LG+T EM P+
Sbjct: 338 ----ELKAGQTKTKGYAGTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
Query: 264 -HKYPAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR---- 315
K ++ L+ P + + LQKDP KR
Sbjct: 393 GEKVENKELKQRVLEQAVTYPDKFSPAS-------------KDFCEALLQKDPEKRLGFR 439
Query: 316 -PTASELLKNPFFK 328
+ L +P F+
Sbjct: 440 DGSCDGLRTHPLFR 453
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-34
Identities = 66/299 (22%), Positives = 116/299 (38%), Gaps = 46/299 (15%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
YE+ E++GFG + VH A A+K V+ + + +
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-----VLRADLA---RDPSFYLRFR----- 60
Query: 91 TSMDELLKEIQAMSSCHHENVVT-Y---HTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI 146
+E Q ++ +H +V Y ++V+ ++G +L DI+
Sbjct: 61 -------REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----- 108
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
G V+ + + L + H NG IHRD+K NI++ V++ DFG
Sbjct: 109 ---TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG---- 161
Query: 207 LATGRDLSRQKVRHT--FVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264
+A S V T +GT +++PE + D ++D++SLG E+ TG P+
Sbjct: 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
Query: 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-TASELL 322
+ V ++ DP ++ L K+P R TA+E+
Sbjct: 221 GDSPVSVAYQHVREDPIPPSARHEGLSA------DLDAVVLKALAKNPENRYQTAAEMR 273
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-33
Identities = 86/332 (25%), Positives = 129/332 (38%), Gaps = 64/332 (19%)
Query: 15 SSSASVSVPWPNTEDQ------YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVH 68
S + + W E Q + V+G G V + +A + A KK+
Sbjct: 164 SIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKL------ 217
Query: 69 SAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVL 128
EK IKK E L E Q + + VV+ ++ KD L LVL
Sbjct: 218 --------EKKRIKKRKGEAM------ALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263
Query: 129 RLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188
L+ GG D+ H I + E E+ GLE H ++RD+K NI
Sbjct: 264 TLMNGG---DLKFH---IYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317
Query: 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWS 248
LL + G ++I+D G++ + + VGT +MAPEV+ ++ Y F D W+
Sbjct: 318 LLDDHGHIRISDLGLA------VHVPEGQTIKGRVGTVGYMAPEVV-KNERYTFSPDWWA 370
Query: 249 LGITAIEMATGTAPY----HKYPAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFR 301
LG EM G +P+ K +V L + A R
Sbjct: 371 LGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA-------------R 417
Query: 302 KMISDCLQKDPTKR-----PTASELLKNPFFK 328
+ S L KDP +R +A E+ ++P FK
Sbjct: 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 72/308 (23%), Positives = 120/308 (38%), Gaps = 62/308 (20%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
E +++ +V+G GA V+ EK I AIK++
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP------------------VAIKELREA 55
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLD-IIKHRLKI 146
+ E+L E M+S + +V + + L+ +L+ G LLD + +H+ I
Sbjct: 56 TSPKANKEILDEAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNI 114
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
+ ++ KG+ Y +HRD+ A N+L+ V+I DFG++
Sbjct: 115 G--------SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA-- 164
Query: 207 LATGRDLSR-QKVRHTFVG-TPC-WMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262
+ L +K H G P WMA E + Y ++D+WS G+T E+ T G+ P
Sbjct: 165 ----KLLGAEEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 263 YHKYPAMKVLMLTLQNDPPTLDTG-------AAEKDQYKAYGKTFRKMISDCLQKDPTKR 315
Y PA ++ + L+ G D Y ++ C D R
Sbjct: 220 YDGIPASEISSI--------LEKGERLPQPPICTIDVY--------MIMRKCWMIDADSR 263
Query: 316 PTASELLK 323
P EL+
Sbjct: 264 PKFRELII 271
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} Length = 96 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-33
Identities = 39/87 (44%), Positives = 63/87 (72%)
Query: 430 VNLILRMRNVRRELNDIRFEFCIGKDTSDGIAGELVGAGLVDARDTEAISQNLELVVNGT 489
++L+LR+RN ++ELNDIRFEF G+DT++G++ EL+ AGLVD RD ++ NL+ +V
Sbjct: 3 ISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVEEP 62
Query: 490 PRKKSVTFPLSSTLQPGEVADEKALLG 516
+SVTF L+S ++ ++ D+ L+G
Sbjct: 63 QSNRSVTFKLASGVEGSDIPDDGKLIG 89
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 59/274 (21%), Positives = 104/274 (37%), Gaps = 53/274 (19%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWL 126
V S +A A+K + L+E + + H N+V K +++
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189
Query: 127 VLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVL---REVLKGLEYFHSNGQIHRDI 183
V+ L++GG L ++ G + T+L + G+EY S IHRD+
Sbjct: 190 VMELVQGGDFLTFLR--------TEG--ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239
Query: 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK-----VRHTFVGTPCWMAPEVMEQDH 238
A N L+ E ++I+DFG+S A G + V+ W APE +
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK--------WTAPEAL-NYG 290
Query: 239 GYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAE 289
Y ++D+WS GI E + G +PY + + + P +
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV------ 344
Query: 290 KDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+++ C +P +RP+ S + +
Sbjct: 345 -----------FRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 77/334 (23%), Positives = 132/334 (39%), Gaps = 72/334 (21%)
Query: 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKIN 85
++Y+ +G GA V +A+ + A+KK++ + K R
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RT--------- 75
Query: 86 LEKWNTSMDELLKEIQAMSSCHHENVV------TYHTSFVVKDELWLVLRLLEGGSLLDI 139
+E++ + HENV+ T S ++++LV L+ L +I
Sbjct: 76 -----------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNI 123
Query: 140 IKH-RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQI 198
+K +L + + ++ ++L+GL+Y HS IHRD+K N+ + ED ++I
Sbjct: 124 VKCQKLTDDHVQF----------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 173
Query: 199 ADFGVSAWLATGRDLSRQKVRH--TFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256
DFG L+R +V T + APE+M Y+ DIWS+G E+
Sbjct: 174 LDFG----------LARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 257 ATGTA--PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY--------GKTFRKMIS- 305
TG P + L+L L P + + Y F +
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 283
Query: 306 ------DCLQK----DPTKRPTASELLKNPFFKK 329
D L+K D KR TA++ L + +F +
Sbjct: 284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-32
Identities = 63/302 (20%), Positives = 110/302 (36%), Gaps = 69/302 (22%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKC-AIKKINLAVVHSAYCKARAEKCAIKKINLE 87
QYEV+ I G ++ A + + +K + + A A AE+
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAER--------- 130
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVT-Y----HTSFVVKDELWLVLRLLEGGSLLDIIKH 142
Q ++ H ++V + HT ++V+ + G SL
Sbjct: 131 -------------QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ 177
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202
+L + L E+L L Y HS G ++ D+K NI+L E+ +++ D G
Sbjct: 178 KLPV----------AEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLG 226
Query: 203 -VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261
VS + G GTP + APE++ G DI+++G T +
Sbjct: 227 AVSRINSFG----------YLYGTPGFQAPEIVR--TGPTVATDIYTVGRTLAALTLDLP 274
Query: 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-TASE 320
+ + L D P L T + + +++ + DP +R TA E
Sbjct: 275 TRN-----GRYVDGLPEDDPVLKTYDS-----------YGRLLRRAIDPDPRQRFTTAEE 318
Query: 321 LL 322
+
Sbjct: 319 MS 320
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 70/330 (21%), Positives = 123/330 (37%), Gaps = 73/330 (22%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++YE IG G+ VV + + AIKK + + IKKI L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES----------EDDPVIKKIAL-- 50
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+EI+ + H N+V F K L LV + ++L +
Sbjct: 51 ---------REIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRY----- 95
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
E + ++ + L+ + + H + IHRD+K NIL+ + +++ DFG A
Sbjct: 96 --QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFG----FA 149
Query: 209 TGRDLSRQKVRHT-FVGTPCWM-APEVMEQDHGYDFKADIWSLG-ITAIEMATGTA---- 261
R L+ + V T W +PE++ D Y D+W++G + A E+ +G
Sbjct: 150 --RLLTGPSDYYDDEVAT-RWYRSPELLVGDTQYGPPVDVWAIGCVFA-ELLSGVPLWPG 205
Query: 262 ----------------P-------YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGK 298
+ + + D L + ++
Sbjct: 206 KSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPL------ELKFPNISY 259
Query: 299 TFRKMISDCLQKDPTKRPTASELLKNPFFK 328
++ CL DPT+R T +LL +P+F+
Sbjct: 260 PALGLLKGCLHMDPTERLTCEQLLHHPYFE 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 79/351 (22%), Positives = 133/351 (37%), Gaps = 79/351 (22%)
Query: 8 PGRIMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVV 67
G + + S+ ++YE ++G G+ +V K AIKK +
Sbjct: 10 SGVDLGTENLYFQSM------EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES-- 61
Query: 68 HSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLV 127
+ +KKI + +EI+ + HEN+V K +LV
Sbjct: 62 --------DDDKMVKKIAM-----------REIKLLKQLRHENLVNLLEVCKKKKRWYLV 102
Query: 128 LRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187
++ I+ + +G+ D + L +++ G+ + HS+ IHRDIK N
Sbjct: 103 FEFVD----HTILDD---LELFPNGL-DYQVVQKYLFQIINGIGFCHSHNIIHRDIKPEN 154
Query: 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHT-FVGTPCWM-APEVMEQDHGYDFKAD 245
IL+ + G V++ DFG A R L+ + V T W APE++ D Y D
Sbjct: 155 ILVSQSGVVKLCDFG----FA--RTLAAPGEVYDDEVAT-RWYRAPELLVGDVKYGKAVD 207
Query: 246 IWSLG-ITAIEMATGTA--------------------P-------YHKYPAMKVLMLTLQ 277
+W++G + EM G ++K P + L
Sbjct: 208 VWAIGCLVT-EMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEI 266
Query: 278 NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328
+ L + +Y + + CL DP KRP +ELL + FF+
Sbjct: 267 KEREPL------ERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 83/331 (25%), Positives = 131/331 (39%), Gaps = 72/331 (21%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
Y + +G GA V SA K AIKK+ + K RA
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-RA------------ 71
Query: 89 WNTSMDELLKEIQAMSSCHHENVV------TYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
+E++ + HENV+ T + + +LV+ + L ++KH
Sbjct: 72 --------YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKH 122
Query: 143 -RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADF 201
+L + ++ ++LKGL Y H+ G IHRD+K GN+ + ED ++I DF
Sbjct: 123 EKLGEDRIQF----------LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF 172
Query: 202 GVSAWLATGRDLSRQKVRH--TFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259
G L+RQ +V T + APEV+ Y DIWS+G EM TG
Sbjct: 173 G----------LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
Query: 260 TA--PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY--------GKTFRKMIS---- 305
+ ++ + PP + D+ K Y K F +++
Sbjct: 223 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 282
Query: 306 ---DCLQK----DPTKRPTASELLKNPFFKK 329
+ L+K D +R TA E L +P+F+
Sbjct: 283 LAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 67/332 (20%), Positives = 123/332 (37%), Gaps = 62/332 (18%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
Y V+ I G+ V + AIK++ V ++ K++
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV---- 76
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD-----ELWLVLRLLEGGSLLDIIKHR 143
L+EI+ ++ HH N++ FV + +L+LV L+ L +I +
Sbjct: 77 --------LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ 127
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
+ + +H I + +L GL H G +HRD+ GNILL ++ + I DF
Sbjct: 128 RIVISPQH-------IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN- 179
Query: 204 SAWLATGRDLSRQKVRHTF----VGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259
L+R+ V + APE++ Q G+ D+WS G EM
Sbjct: 180 ---------LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 260 TA--PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY---------GKTFRKMIS--- 305
A + ++ + P D + Y + + ++
Sbjct: 231 KALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTAD 290
Query: 306 ----DCLQK----DPTKRPTASELLKNPFFKK 329
D + K +P +R + + L++P+F+
Sbjct: 291 PVALDLIAKMLEFNPQRRISTEQALRHPYFES 322
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 54/302 (17%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
E +++ +V+G GA V+ EK I AIK++
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP------------------VAIKELREA 55
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLD-IIKHRLKI 146
+ E+L E M+S + +V + + L+ +L+ G LLD + +H+ I
Sbjct: 56 TSPKANKEILDEAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNI 114
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
+ ++ KG+ Y +HRD+ A N+L+ V+I DFG++
Sbjct: 115 G--------SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA-- 164
Query: 207 LATGRDLSRQKVRHTFVGT--PC-WMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262
+ L ++ + G P WMA E + Y ++D+WS G+T E+ T G+ P
Sbjct: 165 ----KLLGAEEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 263 YHKYPAMKVLMLTLQN---DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319
Y PA ++ + + P + T D Y ++ C D RP
Sbjct: 220 YDGIPASEISSILEKGERLPQPPICT----IDVY--------MIMVKCWMIDADSRPKFR 267
Query: 320 EL 321
EL
Sbjct: 268 EL 269
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 81/332 (24%), Positives = 127/332 (38%), Gaps = 70/332 (21%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+Y IG GA +V SAY + AIKKI+ H YC+ R
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQ-RT------------ 72
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVK-----DELWLVLRLLEGGSLLDIIK-H 142
L+EI+ + HEN++ + ++++V L+E L ++K
Sbjct: 73 --------LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ 123
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202
L + + L ++L+GL+Y HS +HRD+K N+LL ++I DFG
Sbjct: 124 HLSNDHICY----------FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 203 VSAWLATGRDLSRQKVRHTF----VGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258
LA R F V T + APE+M GY DIWS+G EM +
Sbjct: 174 ----LA--RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 259 GTA--PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY--------GKTFRKMIS--- 305
P Y +L + P D + + Y + ++
Sbjct: 228 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD 287
Query: 306 ----DCLQK----DPTKRPTASELLKNPFFKK 329
D L K +P KR + L +P+ ++
Sbjct: 288 SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 78/341 (22%), Positives = 135/341 (39%), Gaps = 77/341 (22%)
Query: 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKIN 85
+Y+ + IG GA +V +AY AIKK++ + + K RA
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK-RA--------- 71
Query: 86 LEKWNTSMDELLKEIQAMSSCHHENVV------TYHTSFVVKDELWLVLRLLEGGSLLDI 139
+E+ M +H+N++ T S ++++V+ L++ +L +
Sbjct: 72 -----------YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQV 119
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
I+ L D ++ +L ++L G+++ HS G IHRD+K NI++ D T++I
Sbjct: 120 IQMEL----------DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259
DFG LA R + +V T + APEV+ GY DIWS+G EM G
Sbjct: 170 DFG----LA--RTAGTSFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIKG 222
Query: 260 TAPYHKYPAMKVLMLTLQN-DPPTLDTGAAEKDQYKAY--------GKTFRKMISD---- 306
+ + ++ P + + + Y G +F K+ D
Sbjct: 223 GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFP 282
Query: 307 -------------------CLQKDPTKRPTASELLKNPFFK 328
L D +KR + E L++P+
Sbjct: 283 ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 74/373 (19%), Positives = 129/373 (34%), Gaps = 103/373 (27%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
D Y ++ +IG G+ V+ AY K + AIKK+N CK R
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK-RI------------ 72
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD-----ELWLVLRLLEGGSLLDIIKHR 143
L+EI ++ + ++ + + D EL++VL + + L + K
Sbjct: 73 --------LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP 123
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG- 202
+ ++ +H I T+L +L G + H +G IHRD+K N LL +D +V++ DFG
Sbjct: 124 IFLTE-EH-------IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175
Query: 203 ------VSAWLATGRDLSRQKVRHTFVGTPCWM----------APEVMEQDHGYDFKADI 246
++ + APE++ Y DI
Sbjct: 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI 235
Query: 247 WSLG-ITAIEMAT-----------------GTAPYHKYPAMKVLMLTLQND--------- 279
WS G I A E+ G++ + P + +++
Sbjct: 236 WSTGCIFA-ELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294
Query: 280 ----PPTLDTGAAEKDQYKAY--------GKTFRKMIS-------DCLQK----DPTKRP 316
P D K + Y ++ + L+ +P KR
Sbjct: 295 IIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI 354
Query: 317 TASELLKNPFFKK 329
T + L +P+ K
Sbjct: 355 TIDQALDHPYLKD 367
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 59/265 (22%), Positives = 114/265 (43%), Gaps = 37/265 (13%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWL 126
V+ K + A+K + + ++E LKE M H N+V + ++
Sbjct: 236 VYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293
Query: 127 VLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186
+ + G+LLD ++ + + ++ +EY IHR++ A
Sbjct: 294 ITEFMTYGNLLDYLREC------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 347
Query: 187 NILLGEDGTVQIADFGVSAWLA----TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF 242
N L+GE+ V++ADFG+S + T ++ ++ W APE + + +
Sbjct: 348 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--------WTAPESL-AYNKFSI 398
Query: 243 KADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQN---DPPTLDTGAAEKDQYKAYGK 298
K+D+W+ G+ E+AT G +PY +V L ++ + P G EK
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---EGCPEK-------- 447
Query: 299 TFRKMISDCLQKDPTKRPTASELLK 323
+++ C Q +P+ RP+ +E+ +
Sbjct: 448 -VYELMRACWQWNPSDRPSFAEIHQ 471
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 60/273 (21%), Positives = 111/273 (40%), Gaps = 51/273 (18%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE-- 123
V+ K + A+K + + ++E LKE M H N+V V E
Sbjct: 28 EVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLG--VCTREPP 83
Query: 124 LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183
+++ + G+LLD ++ C + + ++ +EY IHRD+
Sbjct: 84 FYIITEFMTYGNLLDYLR------ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK----VRHTFVGTPCWMAPEVMEQDHG 239
A N L+GE+ V++ADFG+S + + ++ W APE + +
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--------WTAPESL-AYNK 188
Query: 240 YDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEK 290
+ K+D+W+ G+ E+AT G +PY +V M + P +
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV------- 241
Query: 291 DQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
Y +++ C Q +P+ RP+ +E+ +
Sbjct: 242 --Y--------ELMRACWQWNPSDRPSFAEIHQ 264
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 75/341 (21%), Positives = 125/341 (36%), Gaps = 81/341 (23%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKW----NTSMDELLKEIQAMSSCHHENVVTYHTSFVV 120
A V+ K A+K+I LE T+ ++E+ + H N+VT H
Sbjct: 16 ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA----IREVSLLKDLKHANIVTLHDIIHT 71
Query: 121 KDELWLVLRLLEGGSLLDIIKHRLK--ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178
+ L LV L+ LK + +C + + + + L ++L+GL Y H
Sbjct: 72 EKSLTLVFEYLD---------KDLKQYLDDCGNII-NMHNVKLFLFQLLRGLAYCHRQKV 121
Query: 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC----WM-APEV 233
+HRD+K N+L+ E G +++ADFG L+R K T W P++
Sbjct: 122 LHRDLKPQNLLINERGELKLADFG----------LARAKSIPTKTYDNEVVTLWYRPPDI 171
Query: 234 MEQDHGYDFKADIWSLGITAIEMATGTA--------------------P-------YHKY 266
+ Y + D+W +G EMATG P
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 267 PAMKVLMLT------LQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320
K L + P LD+ A+ +++ LQ + R +A +
Sbjct: 232 EEFKTYNYPKYRAEALLSHAPRLDSDGAD-------------LLTKLLQFEGRNRISAED 278
Query: 321 LLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGA 361
+K+PFF ++ S+ E ++QK A
Sbjct: 279 AMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKEASLRSAH 319
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 82/358 (22%), Positives = 129/358 (36%), Gaps = 78/358 (21%)
Query: 8 PGRIMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVV 67
G + + P E Y +VIG G+ VV+ A E AIKK+
Sbjct: 33 DGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--- 89
Query: 68 HSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVT----YHTSFVVKDE 123
+ +E+Q M H N+V +++S KDE
Sbjct: 90 DKRFK------------------------NRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125
Query: 124 --LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181
L LVL + ++ + +H + + + ++ + L Y HS G HR
Sbjct: 126 VYLNLVLDYVPE-TVYRVARHYSRAKQ----TLPVIYVKLYMYQLFRSLAYIHSFGICHR 180
Query: 182 DIKAGNILLGED-GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGY 240
DIK N+LL D +++ DFG A + L R + +++ + + APE++ Y
Sbjct: 181 DIKPQNLLLDPDTAVLKLCDFG----SA--KQLVRGEPNVSYICSRYYRAPELIFGATDY 234
Query: 241 DFKADIWSLG-ITAIEMATGTA--PYHKYPA-----MKVLMLTLQNDPPTLDTGAAEKDQ 292
D+WS G + A E+ G P +KVL PT +
Sbjct: 235 TSSIDVWSAGCVLA-ELLLGQPIFPGDSGVDQLVEIIKVL------GTPTREQIREMNPN 287
Query: 293 YKAY----------GKTFRKM--------ISDCLQKDPTKRPTASELLKNPFFKKAKD 332
Y + K FR S L+ PT R T E + FF + +D
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 65/270 (24%), Positives = 114/270 (42%), Gaps = 51/270 (18%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE-- 123
V R K A+K I K + + L E M+ H N+V V+ +E
Sbjct: 36 DVMLG--DYRGNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLG--VIVEEKG 88
Query: 124 -LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182
L++V + GSL+D ++ R V + +V + +EY N +HRD
Sbjct: 89 GLYIVTEYMAKGSLVDYLRSR------GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142
Query: 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF 242
+ A N+L+ ED +++DFG++ ++ +D + V+ W APE + ++ +
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------WTAPEAL-REKKFST 193
Query: 243 KADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKDQY 293
K+D+WS GI E+ + G PY + P V+ M PP + Y
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV---------Y 244
Query: 294 KAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+++ +C D RP+ +L +
Sbjct: 245 --------EVMKNCWHLDAAMRPSFLQLRE 266
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 75/338 (22%), Positives = 125/338 (36%), Gaps = 74/338 (21%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++++ ++G GA VV SA K E AIKKI + R
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFAL-RT------------ 56
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVK-----DELWLVLRLLEGGSLLDIIK-H 142
L+EI+ + HEN++T +E++++ L++ L +I
Sbjct: 57 --------LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ 107
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202
L + ++ + + L+ ++ H + IHRD+K N+L+ + +++ DFG
Sbjct: 108 MLSDDHIQY----------FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFG 157
Query: 203 VSAWLATGRDLSRQKVRHTFVGTPCWM---------APEVMEQDHGYDFKADIWSLGITA 253
LA D S + APEVM Y D+WS G
Sbjct: 158 ----LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCIL 213
Query: 254 IEMATGTA--PYHKYPAMKVLMLTLQNDPPT-LDTGAAEKDQYKAY--------GKTFRK 302
E+ P Y +L+ + P + D E + + Y K
Sbjct: 214 AELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK 273
Query: 303 MIS-------DCLQK----DPTKRPTASELLKNPFFKK 329
M D LQ+ DP KR TA E L++P+ +
Sbjct: 274 MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-30
Identities = 64/272 (23%), Positives = 105/272 (38%), Gaps = 45/272 (16%)
Query: 66 VVHSAYCKARAE--KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE 123
V + R + AIK + +E+++E Q M + +V V + E
Sbjct: 25 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG--VCQAE 82
Query: 124 -LWLVLRLLEGGSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181
L LV+ + GG L ++ R +I +A +L +V G++Y +HR
Sbjct: 83 ALMLVMEMAGGGPLHKFLVGKREEIP--------VSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGY 240
D+ A N+LL +I+DFG+S L + + P W APE + +
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW---PLKWYAPECI-NFRKF 190
Query: 241 DFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKD 291
++D+WS G+T E + G PY K +V+ M PP L
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL-------- 242
Query: 292 QYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
Y ++SDC RP + +
Sbjct: 243 -Y--------ALMSDCWIYKWEDRPDFLTVEQ 265
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 71/307 (23%), Positives = 109/307 (35%), Gaps = 64/307 (20%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
E + +V+G G VH E I IK I +
Sbjct: 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIP------------------VCIKVIEDK 53
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLD-IIKHRLKI 146
S + + A+ S H ++V L LV + L GSLLD + +HR +
Sbjct: 54 SGRQSFQAVTDHMLAIGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGAL 112
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
+ ++ KG+ Y +G +HR++ A N+LL VQ+ADFGV+
Sbjct: 113 G--------PQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA-- 162
Query: 207 LATGRDLSRQKVRHTFVGT--PC-WMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262
L + + P WMA E + Y ++D+WS G+T E+ T G P
Sbjct: 163 ----DLLPPDDKQLLYSEAKTPIKWMALESI-HFGKYTHQSDVWSYGVTVWELMTFGAEP 217
Query: 263 YHKYPAMKVLMLTLQND--------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK 314
Y +V L + + + Y ++ C D
Sbjct: 218 YAGLRLAEVPDLLEKGERLAQPQICTIDV---------Y--------MVMVKCWMIDENI 260
Query: 315 RPTASEL 321
RPT EL
Sbjct: 261 RPTFKEL 267
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 79/342 (23%), Positives = 135/342 (39%), Gaps = 77/342 (22%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+Y+ + IG GA +V +AY AIKK++ + + K RA
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RA------------ 108
Query: 89 WNTSMDELLKEIQAMSSCHHENVV------TYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
+E+ M +H+N++ T + +++LV+ L++ +L +I+
Sbjct: 109 --------YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM 159
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202
L D ++ +L ++L G+++ HS G IHRD+K NI++ D T++I DFG
Sbjct: 160 EL----------DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 209
Query: 203 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262
LA R + +V T + APEV+ GY DIWS+G EM
Sbjct: 210 ----LA--RTAGTSFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKIL 262
Query: 263 YHKYPAMKVLMLTLQN-DPPTLDTGAAEKDQYKAY--------GKTFRKMISD------- 306
+ + ++ P + + + Y G TF K+ D
Sbjct: 263 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS 322
Query: 307 ----------------CLQKDPTKRPTASELLKNPFFKKAKD 332
L DP KR + + L++P+ D
Sbjct: 323 EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 51/269 (18%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE--- 123
V + K A+K I K + + L E M+ H N+V V+ +E
Sbjct: 209 VMLGDYRGN--KVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLG--VIVEEKGG 261
Query: 124 LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183
L++V + GSL+D ++ R V + +V + +EY N +HRD+
Sbjct: 262 LYIVTEYMAKGSLVDYLRSR------GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFK 243
A N+L+ ED +++DFG++ ++ +D + V+ W APE + ++ + K
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------WTAPEAL-REKKFSTK 366
Query: 244 ADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKDQYK 294
+D+WS GI E+ + G PY + P V+ M PP + Y
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV---------Y- 416
Query: 295 AYGKTFRKMISDCLQKDPTKRPTASELLK 323
++ +C D RPT +L +
Sbjct: 417 -------DVMKNCWHLDAATRPTFLQLRE 438
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 90/406 (22%), Positives = 143/406 (35%), Gaps = 115/406 (28%)
Query: 8 PGRIMAASSSASVSVPWPNTE----DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKIN 63
R SS + S+P P+++ D+YE+R +IG G+ V AY K AIKKI
Sbjct: 28 QQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL 87
Query: 64 LAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD- 122
CK R L+EI ++ +H++VV + KD
Sbjct: 88 RVFEDLIDCK-RI--------------------LREIAILNRLNHDHVVKVLDIVIPKDV 126
Query: 123 ----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178
EL++VL + + + + + ++ H I T+L +L G++Y HS G
Sbjct: 127 EKFDELYVVLEIADS-DFKKLFRTPVYLTE-LH-------IKTLLYNLLVGVKYVHSAGI 177
Query: 179 IHRDIKAGNILLGEDGTVQIADFG------------VSAWLATGRDLSRQKVRHTFVGTP 226
+HRD+K N L+ +D +V++ DFG ++ D
Sbjct: 178 LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
Query: 227 CWM----------APEVMEQDHGYDFKADIWSLG-ITAIEMATGTAPYHKYPAMK----- 270
+ APE++ Y D+WS+G I A E+ Y A +
Sbjct: 238 RQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA-ELLNMIKENVAYHADRGPLFP 296
Query: 271 -----VLMLTLQNDPPTLDTGAAEKDQY-----------------------KAYGKTFRK 302
L + +DQ K Y + F K
Sbjct: 297 GSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPK 356
Query: 303 M-------------------ISDCLQKDPTKRPTASELLKNPFFKK 329
+ L +P KR T +E L +PFFK+
Sbjct: 357 REGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 57/268 (21%), Positives = 110/268 (41%), Gaps = 38/268 (14%)
Query: 73 KARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE----LWLVL 128
E A+K + + +EI + + +HE+++ Y +D L LV+
Sbjct: 57 DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKG--CCEDAGAASLQLVM 114
Query: 129 RLLEGGSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187
+ GSL D + +H + + + +++ +G+ Y H+ IHRD+ A N
Sbjct: 115 EYVPLGSLRDYLPRHSIGL----------AQLLLFAQQICEGMAYLHAQHYIHRDLAARN 164
Query: 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTP-CWMAPEVMEQDHGYDFKADI 246
+LL D V+I DFG++ + G + R + P W APE + +++ + + +D+
Sbjct: 165 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS---PVFWYAPECL-KEYKFYYASDV 220
Query: 247 WSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQY----------KA 295
WS G+T E+ T + L+ Q L + +
Sbjct: 221 WSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEV 280
Query: 296 YGKTFRKMISDCLQKDPTKRPTASELLK 323
Y ++ +C + + + RPT L+
Sbjct: 281 Y-----HLMKNCWETEASFRPTFENLIP 303
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 58/267 (21%), Positives = 110/267 (41%), Gaps = 47/267 (17%)
Query: 77 EKCAIKKINLEKWNTSM--DELLKEIQAMSSCHHENVVTYH--TSFVVKDELWLVLRLLE 132
A+K++ + + + +EIQ + + H + +V Y + + L LV+ L
Sbjct: 53 ALVAVKQL---QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 109
Query: 133 GGSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
G L D + +HR ++ D + ++ KG+EY S +HRD+ A NIL+
Sbjct: 110 SGCLRDFLQRHRARL--------DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 161
Query: 192 EDGTVQIADFGVSAWLATGRD--LSRQK----VRHTFVGTPCWMAPEVMEQDHGYDFKAD 245
+ V+IADFG++ L +D + R+ + W APE + D+ + ++D
Sbjct: 162 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF--------WYAPESL-SDNIFSRQSD 212
Query: 246 IWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQY----------K 294
+WS G+ E+ T +M ++ P ++ +
Sbjct: 213 VWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAE 272
Query: 295 AYGKTFRKMISDCLQKDPTKRPTASEL 321
+ +++ C P RP+ S L
Sbjct: 273 VH-----ELMKLCWAPSPQDRPSFSAL 294
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 76/358 (21%), Positives = 131/358 (36%), Gaps = 93/358 (25%)
Query: 10 RIMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHS 69
SS ++ + ++Y+ E +G G VV+ KA+
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVY----KAK---------------- 41
Query: 70 AYCKARAEKCAIKKINLEKWN-----TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL 124
++ A+K+I L+ + T+ ++EI + HH N+V+ + L
Sbjct: 42 ---DSQGRIVALKRIRLDAEDEGIPSTA----IREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 125 WLVLRLLEGGSLLDIIKHRLK--ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182
LV +E LK + K G+ + I L ++L+G+ + H + +HRD
Sbjct: 95 TLVFEFME---------KDLKKVLDENKTGL-QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC----WM-APEVMEQD 237
+K N+L+ DG +++ADFG L+R T W AP+V+
Sbjct: 145 LKPQNLLINSDGALKLADFG----------LARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 238 HGYDFKADIWSLGITAIEMATGTA--------------------P-------YHKYPAMK 270
Y DIWS+G EM TG P + P K
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328
+ + + ++S+ L DP KR +A + + +P+FK
Sbjct: 255 QRTFQVFE-KKPW------SSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 74/363 (20%), Positives = 134/363 (36%), Gaps = 87/363 (23%)
Query: 8 PGRIMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVV 67
PG +M+ +++A+ D+++V + G G V K+ AIKK+
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ--- 58
Query: 68 HSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVT-----YHTSFVVKD 122
+ R L+ +Q ++ HH N+V Y +
Sbjct: 59 DPRFRN-RE--------------------LQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97
Query: 123 E--LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH--SNGQ 178
+ L +V+ + +L ++ + I L ++++ + H S
Sbjct: 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQV----APPPILIKVFLFQLIRSIGCLHLPSVNV 152
Query: 179 IHRDIKAGNILL-GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD 237
HRDIK N+L+ DGT+++ DFG A + LS + ++ + + APE++ +
Sbjct: 153 CHRDIKPHNVLVNEADGTLKLCDFG----SA--KKLSPSEPNVAYICSRYYRAPELIFGN 206
Query: 238 HGYDFKADIWSLG-ITAIEMATGTAPYHKYPA----------MKVLMLTLQNDPPTLDT- 285
Y DIWS+G I A EM G + ++VL P+ +
Sbjct: 207 QHYTTAVDIWSVGCIFA-EMMLGEP---IFRGDNSAGQLHEIVRVL------GCPSREVL 256
Query: 286 -----GAAEKDQYKAYGKTFRKM---------------ISDCLQKDPTKRPTASELLKNP 325
+ D Y + G + + +S LQ P +R E L +P
Sbjct: 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316
Query: 326 FFK 328
+F
Sbjct: 317 YFD 319
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 56/328 (17%), Positives = 114/328 (34%), Gaps = 79/328 (24%)
Query: 29 DQYEV-------REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAI 81
QY + ++G G V+ K A+
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNH-------------------KGEKINVAV 45
Query: 82 KKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE-LWLVLRLLEGGSLLD-I 139
K + + ++ + E M + H ++V ++++E W+++ L G L +
Sbjct: 46 KTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYL 103
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
+++ + T+ ++ K + Y S +HRDI NIL+ V++
Sbjct: 104 ERNKNSLK--------VLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLG 155
Query: 200 DFGVSAWLATGRDLSRQK----VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255
DFG+S ++ ++ WM+PE + + +D+W + E
Sbjct: 156 DFGLSRYIEDEDYYKASVTRLPIK--------WMSPESI-NFRRFTTASDVWMFAVCMWE 206
Query: 256 MAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISD 306
+ + G P+ V+ + PP L Y +++
Sbjct: 207 ILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL---------Y--------TLMTR 249
Query: 307 CLQKDPTKRPTASELLK--NPFFKKAKD 332
C DP+ RP +EL+ + ++ KD
Sbjct: 250 CWDYDPSDRPRFTELVCSLSDVYQMEKD 277
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 65/308 (21%), Positives = 121/308 (39%), Gaps = 58/308 (18%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
DQ++ + +G G+ V K A+K ++ K + K+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD--------------KQKVVKLK--- 83
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
++ L E + + + + +V SF L++V+ + GG + ++
Sbjct: 84 ---QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------- 133
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
+ G EP +++ EY HS I+RD+K N+L+ + G +Q+ DFG + +
Sbjct: 134 -RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
+ T GTP +APE++ GY+ D W+LG+ EMA G P+
Sbjct: 192 -------KGRTWTLCGTPEALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
Query: 269 MKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR----PTASEL 321
+++ + P + + ++ + LQ D TKR
Sbjct: 244 IQIYEKIVSGKVRFPSHFSSDL-------------KDLLRNLLQVDLTKRFGNLKNGVND 290
Query: 322 LKN-PFFK 328
+KN +F
Sbjct: 291 IKNHKWFA 298
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 74/315 (23%), Positives = 115/315 (36%), Gaps = 62/315 (19%)
Query: 25 PNTEDQYEV-------REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAE 77
P + E +G G+ VV A + K
Sbjct: 7 PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGK-------------------TV 47
Query: 78 KCAIK--KINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE-LWLVLRLLEGG 134
A+K K ++ +MD+ ++E+ AM S H N++ + VV + +V L G
Sbjct: 48 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG--VVLTPPMKMVTELAPLG 105
Query: 135 SLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
SLLD + KH+ T++ +V +G+ Y S IHRD+ A N+LL
Sbjct: 106 SLLDRLRKHQGHFL--------LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR 157
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYDFKADIWSLGIT 252
V+I DFG+ L D + P W APE + + + +D W G+T
Sbjct: 158 DLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPESL-KTRTFSHASDTWMFGVT 213
Query: 253 AIEMAT-GTAPYHKYPAMKVLMLTLQN----DPPTLDTGAAEKDQYKAYGKTFRKMISDC 307
EM T G P+ ++L + P +D Y ++ C
Sbjct: 214 LWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE----DCPQDIY--------NVMVQC 261
Query: 308 LQKDPTKRPTASELL 322
P RPT L
Sbjct: 262 WAHKPEDRPTFVALR 276
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 59/293 (20%), Positives = 108/293 (36%), Gaps = 54/293 (18%)
Query: 66 VVHSAYCKARAE--KCAIKKINLEKWNTS----MDELLKEIQAMSSCHHENVVTYHTSFV 119
V Y + + A+K + K + DELL E M + +V +
Sbjct: 32 TVKKGYYQMKKVVKTVAVKIL---KNEANDPALKDELLAEANVMQQLDNPYIVRMIG--I 86
Query: 120 VKDE-LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178
+ E LV+ + E G L ++ + + I ++ +V G++Y +
Sbjct: 87 CEAESWMLVMEMAELGPLNKYLQQNRHVK--------DKNIIELVHQVSMGMKYLEESNF 138
Query: 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQD 237
+HRD+ A N+LL +I+DFG+S L + + + + P W APE +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW---PVKWYAPECI-NY 194
Query: 238 HGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAA 288
+ + K+D+WS G+ E + G PY +V M P +
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM----- 249
Query: 289 EKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL---LKNPFFKKAKDKKFIQQ 338
Y +++ C D RP + + L+N ++ +
Sbjct: 250 ----Y--------DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHH 290
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 65/346 (18%), Positives = 121/346 (34%), Gaps = 90/346 (26%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+Y + +G G +V SA ++ AIKKI + K A
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVK-HA------------ 55
Query: 89 WNTSMDELLKEIQAMSSCHHENVV--------------TYHTSFVVKDELWLVLRLLEGG 134
L+EI+ + H+N+V S + +++V +E
Sbjct: 56 --------LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET- 106
Query: 135 SLLDIIKH-RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL-GE 192
L ++++ L + + + ++L+GL+Y HS +HRD+K N+ + E
Sbjct: 107 DLANVLEQGPLLEEHARL----------FMYQLLRGLKYIHSANVLHRDLKPANLFINTE 156
Query: 193 DGTVQIADFGVSAWLATGRDLSRQKVRHTF----VGTPCWMAPEVMEQDHGYDFKADIWS 248
D ++I DFG LA R + + T + +P ++ + Y D+W+
Sbjct: 157 DLVLKIGDFG----LA--RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 210
Query: 249 LGITAIEMAT------GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY------ 296
G EM T G + M++++ ++ + Y
Sbjct: 211 AGCIFAEMLTGKTLFAGAHELEQ---MQLILESI--PVVHEEDRQELLSVIPVYIRNDMT 265
Query: 297 --GKTFRKMISD-----------CLQKDPTKRPTASELLKNPFFKK 329
K +++ L P R TA E L +P+
Sbjct: 266 EPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLE 171
+F K+ L+ V+ L GG L+ + ++ D E++ GL+
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLM----YHIQ----SCHKFDLSRATFYAAEIILGLQ 132
Query: 172 YFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAP 231
+ HS G ++RD+K NILL +DG ++IADFG+ ++ +TF GTP ++AP
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCGTPDYIAP 187
Query: 232 EVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND---PPTLDTGAA 288
E++ Y+ D WS G+ EM G +P+H ++ ++ P L+ A
Sbjct: 188 EIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA- 245
Query: 289 EKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN-PFFK 328
+ ++ ++P KR ++ P F+
Sbjct: 246 ------------KDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 64/319 (20%), Positives = 110/319 (34%), Gaps = 94/319 (29%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWNTSMDE-----LLKEIQAMSSCHHENVVTYHTSFV 119
A V+ K A+K++ L+ +E ++EI M HEN+V +
Sbjct: 19 ATVYKGLNKTTGVYVALKEVKLDS-----EEGTPSTAIREISLMKELKHENIVRLYDVIH 73
Query: 120 VKDELWLVLRLLEG--GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG 177
+++L LV ++ +D + N G+ + + ++L+GL + H N
Sbjct: 74 TENKLTLVFEFMDNDLKKYMD----SRTVGNTPRGL-ELNLVKYFQWQLLQGLAFCHENK 128
Query: 178 QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC---------- 227
+HRD+K N+L+ + G +++ DFG L+R G P
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFG----------LARAF------GIPVNTFSSEVVTL 172
Query: 228 WM-APEVMEQDHGYDFKADIWSLGITAIEMATGTA------------------------- 261
W AP+V+ Y DIWS G EM TG
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232
Query: 262 ------------PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQ 309
+ P + + + LD + + LQ
Sbjct: 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMD-------------FLHGLLQ 279
Query: 310 KDPTKRPTASELLKNPFFK 328
+P R +A + L +P+F
Sbjct: 280 LNPDMRLSAKQALHHPWFA 298
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-28
Identities = 63/272 (23%), Positives = 106/272 (38%), Gaps = 45/272 (16%)
Query: 66 VVHSAYCKARAEKC--AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE 123
V + R ++ AIK + +E+++E Q M + +V V + E
Sbjct: 351 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG--VCQAE 408
Query: 124 -LWLVLRLLEGGSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181
L LV+ + GG L ++ R +I +A +L +V G++Y +HR
Sbjct: 409 ALMLVMEMAGGGPLHKFLVGKREEIP--------VSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGY 240
++ A N+LL +I+DFG+S L + + P W APE + +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW---PLKWYAPECI-NFRKF 516
Query: 241 DFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKD 291
++D+WS G+T E + G PY K +V+ M PP L
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL-------- 568
Query: 292 QYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
Y ++SDC RP + +
Sbjct: 569 -Y--------ALMSDCWIYKWEDRPDFLTVEQ 591
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 60/259 (23%), Positives = 110/259 (42%), Gaps = 48/259 (18%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
K A+K + + S D L E M H+ +V + + V ++ ++++ +E GSL+
Sbjct: 39 KVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV 95
Query: 138 DIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQ 197
D +K + + ++ +G+ + IHRD++A NIL+ + + +
Sbjct: 96 DFLKTP------SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCK 149
Query: 198 IADFGVSAWLA----TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
IADFG++ + T R+ ++ ++ W APE + + K+D+WS GI
Sbjct: 150 IADFGLARLIEDNEYTAREGAKFPIK--------WTAPEAI-NYGTFTIKSDVWSFGILL 200
Query: 254 IEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
E+ T G PY +V+ M+ N P L Y +++
Sbjct: 201 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL---------Y--------QLM 243
Query: 305 SDCLQKDPTKRPTASELLK 323
C ++ P RPT L
Sbjct: 244 RLCWKERPEDRPTFDYLRS 262
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 65/266 (24%), Positives = 108/266 (40%), Gaps = 41/266 (15%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWL 126
V + AIK + S + L+E Q M HE +V + + V ++ +++
Sbjct: 200 VWMGTWNGTT-RVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLY-AVVSEEPIYI 255
Query: 127 VLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186
V + GSLLD +K P + + ++ G+ Y +HRD++A
Sbjct: 256 VTEYMSKGSLLDFLKGE------TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 309
Query: 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADI 246
NIL+GE+ ++ADFG++ + +RQ + W APE + K+D+
Sbjct: 310 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEAA-LYGRFTIKSDV 364
Query: 247 WSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKDQYKAYG 297
WS GI E+ T G PY +VL M P +L +
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL---------H---- 411
Query: 298 KTFRKMISDCLQKDPTKRPTASELLK 323
++ C +K+P +RPT L
Sbjct: 412 ----DLMCQCWRKEPEERPTFEYLQA 433
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 35/226 (15%)
Query: 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170
+ +F D L V+ GG L L + V E E++ L
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELF----FHLS----RERVFTEERARFYGAEIVSAL 118
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMA 230
EY HS ++RDIK N++L +DG ++I DFG+ +S TF GTP ++A
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLA 173
Query: 231 PEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND---PPTLDTGA 287
PEV+ +D+ Y D W LG+ EM G P++ ++ L L + P TL A
Sbjct: 174 PEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232
Query: 288 AEKDQYKAYGKTFRKMISDCLQKDPTKR----PT-ASELLKNPFFK 328
+ +++ L+KDP +R P+ A E++++ FF
Sbjct: 233 -------------KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 30/291 (10%), Positives = 58/291 (19%), Gaps = 72/291 (24%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
Y + G A A + A+ V
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALT-----FVDPQGVLPDDVL------------ 75
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
E L +S V + +V + GGSL ++
Sbjct: 76 ---QETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP------ 126
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
++ + + H G + + DG V +A
Sbjct: 127 ----SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT------- 175
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK---YP 267
M + + DI +G + + P +
Sbjct: 176 ------------------MPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRS 209
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA 318
+ P + + + +Q D R +
Sbjct: 210 GLAPAERDTAGQPIEPADIDRDIPF------QISAVAARSVQGDGGIRSAS 254
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 58/274 (21%), Positives = 98/274 (35%), Gaps = 47/274 (17%)
Query: 66 VVHSAYCKARAE---KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD 122
V + + AIK + + L E M H N++ VV
Sbjct: 64 EVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG--VVTR 121
Query: 123 E--LWLVLRLLEGGSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179
+V +E GSL + H + + + +LR V G+ Y G +
Sbjct: 122 GRLAMIVTEYMENGSLDTFLRTHDGQFT--------IMQLVGMLRGVGAGMRYLSDLGYV 173
Query: 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDH 238
HRD+ A N+L+ + +++DFG+S L D + P W APE +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI---PIRWTAPEAI-AFR 229
Query: 239 GYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAE 289
+ +D+WS G+ E+ G PY V+ + P L
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHAL------ 283
Query: 290 KDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ +++ DC KD +RP S+++
Sbjct: 284 ---H--------QLMLDCWHKDRAQRPRFSQIVS 306
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 73/349 (20%), Positives = 125/349 (35%), Gaps = 103/349 (29%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+YE IG GA V+ A A+K + + + +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV----------PNGGGGGGGLPI-- 56
Query: 89 WNTSMDE--LLKEIQAMSSCHHENVVT-----YHTSFVVKDELWLVLRLLEGGSLLDIIK 141
+++ E LL+ + + H NVV + + ++ LV ++
Sbjct: 57 --STVREVALLRR---LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------- 102
Query: 142 HRLK--ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
L+ + TI ++R+ L+GL++ H+N +HRD+K NIL+ GTV++A
Sbjct: 103 QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162
Query: 200 DFGVSAWLATGRDLSRQK-VRHTFVGTPC----WM-APEVMEQDHGYDFKADIWSLG-IT 252
DFG L+R + TP W APEV+ Q Y D+WS+G I
Sbjct: 163 DFG----------LARIYSYQMAL--TPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIF 209
Query: 253 AIEMATGTA--------------------------------PYHKYPAMKVLMLTLQNDP 280
A EM P +P +Q+
Sbjct: 210 A-EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGP--RPVQSVV 266
Query: 281 PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329
P ++ A+ ++ + L +P KR +A L++ + K
Sbjct: 267 PEMEESGAQ-------------LLLEMLTFNPHKRISAFRALQHSYLHK 302
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 112 bits (284), Expect = 3e-28
Identities = 68/316 (21%), Positives = 116/316 (36%), Gaps = 96/316 (30%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWN-----TSMDELLKEIQAMSSCHHENVVTYHTSFV 119
V A + E A+K++ L+ + ++ L+EI + H+N+V H
Sbjct: 16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----LREICLLKELKHKNIVRLHDVLH 71
Query: 120 VKDELWLVLRLLEGGSLLDIIKHRLK--ISNCKHGVCDEPTIATVLREVLKGLEYFHSNG 177
+L LV + LK +C + D + + L ++LKGL + HS
Sbjct: 72 SDKKLTLVFEFCD---------QDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN 121
Query: 178 QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC---------- 227
+HRD+K N+L+ +G +++A+FG L+R G P
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFG----------LARAF------GIPVRCYSAEVVTL 165
Query: 228 WM-APEVMEQDHGYDFKADIWSLGITAIEMATGTAP------------------------ 262
W P+V+ Y D+WS G E+A P
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 263 ----------YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312
Y YP M +L N P L+ + ++ + L+ +P
Sbjct: 226 QWPSMTKLPDYKPYP-MYPATTSLVNVVPKLNATGRD-------------LLQNLLKCNP 271
Query: 313 TKRPTASELLKNPFFK 328
+R +A E L++P+F
Sbjct: 272 VQRISAEEALQHPYFS 287
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 66/237 (27%), Positives = 102/237 (43%), Gaps = 40/237 (16%)
Query: 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREV 166
+VT H +F + +L L+L + GG L L + E + + E+
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELF----THLS----QRERFTEHEVQIYVGEI 168
Query: 167 LKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVR-HTFVGT 225
+ LE+ H G I+RDIK NILL +G V + DFG+S ++ + R + F GT
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-----EFVADETERAYDFCGT 223
Query: 226 PCWMAPEV-MEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQN------ 278
+MAP++ D G+D D WSLG+ E+ TG +P+ +
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283
Query: 279 -DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR----PT-ASELLKNPFFKK 329
P + A + +I L KDP KR P A E+ ++ FF+K
Sbjct: 284 PYPQEMSALA-------------KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 65/266 (24%), Positives = 108/266 (40%), Gaps = 41/266 (15%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWL 126
V + AIK + S + L+E Q M HE +V + + V ++ +++
Sbjct: 283 VWMGTWNGTT-RVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLY-AVVSEEPIYI 338
Query: 127 VLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186
V + GSLLD +K P + + ++ G+ Y +HRD++A
Sbjct: 339 VTEYMSKGSLLDFLKGE------TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 392
Query: 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADI 246
NIL+GE+ ++ADFG++ + +RQ + W APE + K+D+
Sbjct: 393 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEAA-LYGRFTIKSDV 447
Query: 247 WSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKDQYKAYG 297
WS GI E+ T G PY +VL M P +L +
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL---------H---- 494
Query: 298 KTFRKMISDCLQKDPTKRPTASELLK 323
++ C +K+P +RPT L
Sbjct: 495 ----DLMCQCWRKEPEERPTFEYLQA 516
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 35/227 (15%)
Query: 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170
+V H +F + +L+L+L L GG L RL K + E + L E+ L
Sbjct: 88 IVKLHYAFQTEGKLYLILDFLRGGDLF----TRLS----KEVMFTEEDVKFYLAELALAL 139
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMA 230
++ HS G I+RD+K NILL E+G +++ DFG+S + +K ++F GT +MA
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHEKKAYSFCGTVEYMA 194
Query: 231 PEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND---PPTLDTGA 287
PEV+ G+ AD WS G+ EM TGT P+ + + + L+ P L A
Sbjct: 195 PEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA 253
Query: 288 AEKDQYKAYGKTFRKMISDCLQKDPTKR----PT-ASELLKNPFFKK 329
+ ++ +++P R P E+ ++ FF
Sbjct: 254 -------------QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170
+V +F +L+L+L L GG L +L+ + G+ E T L E+ L
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELF----MQLE----REGIFMEDTACFYLAEISMAL 134
Query: 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMA 230
+ H G I+RD+K NI+L G V++ DFG+ + V HTF GT +MA
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-----ESIHDGTVTHTFCGTIEYMA 189
Query: 231 PEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND---PPTLDTGA 287
PE++ G++ D WSLG +M TG P+ K + L+ PP L A
Sbjct: 190 PEIL-MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA 248
Query: 288 AEKDQYKAYGKTFRKMISDCLQKDPTKR----PT-ASELLKNPFFKK 329
R ++ L+++ R P A E+ +PFF+
Sbjct: 249 -------------RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 85/358 (23%), Positives = 126/358 (35%), Gaps = 132/358 (36%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++Y E IG G VV+ KA+ E A+KKI LEK
Sbjct: 2 EKYHGLEKIGEGTYGVVY----KAQ------NNYG-------------ETFALKKIRLEK 38
Query: 89 WN-----TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHR 143
+ T+ ++EI + H N+V + K L LV L+
Sbjct: 39 EDEGIPSTT----IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD---------QD 85
Query: 144 LK--ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADF 201
LK + C+ G+ + T + L ++L G+ Y H +HRD+K N+L+ +G ++IADF
Sbjct: 86 LKKLLDVCEGGL-ESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADF 144
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPC----------WM-APEVMEQDHGYDFKADIWSLG 250
G L+R G P W AP+V+ Y DIWS+G
Sbjct: 145 G----------LARAF------GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVG 188
Query: 251 ITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQ------------------ 292
EM GT L G +E DQ
Sbjct: 189 CIFAEMVNGTP---------------------LFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 293 ---YKAYGKTFRK-------------------MISDCLQKDPTKRPTASELLKNPFFK 328
Y F ++S L+ DP +R TA + L++ +FK
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 62/270 (22%), Positives = 111/270 (41%), Gaps = 49/270 (18%)
Query: 67 VHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWL 126
V A + K A+K + + S++ L E M + H+ +V H + V K+ +++
Sbjct: 204 VWMATYN-KHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLH-AVVTKEPIYI 259
Query: 127 VLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186
+ + GSLLD +K + P + ++ +G+ + IHRD++A
Sbjct: 260 ITEFMAKGSLLDFLKSD------EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 313
Query: 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQK----VRHTFVGTPCWMAPEVMEQDHGYDF 242
NIL+ +IADFG++ + +R+ ++ W APE + +
Sbjct: 314 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--------WTAPEAI-NFGSFTI 364
Query: 243 KADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKDQY 293
K+D+WS GI +E+ T G PY +V+ M +N P L Y
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL---------Y 415
Query: 294 KAYGKTFRKMISDCLQKDPTKRPTASELLK 323
++ C + P +RPT +
Sbjct: 416 --------NIMMRCWKNRPEERPTFEYIQS 437
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 54/259 (20%), Positives = 100/259 (38%), Gaps = 51/259 (19%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE-LWLVLRLLEGGSL 136
AIK ++ ++ L+E M H ++V V+ + +W+++ L G L
Sbjct: 45 AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGEL 102
Query: 137 LD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT 195
+ + + ++ ++ L Y S +HRDI A N+L+ +
Sbjct: 103 RSFLQVRKYSLD--------LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC 154
Query: 196 VQIADFGVSAWLATGRDLSRQK----VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251
V++ DFG+S ++ K ++ WMAPE + + +D+W G+
Sbjct: 155 VKLGDFGLSRYMEDSTYYKASKGKLPIK--------WMAPESI-NFRRFTSASDVWMFGV 205
Query: 252 TAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKDQYKAYGKTFRK 302
E+ G P+ V+ + N PPTL Y
Sbjct: 206 CMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL---------Y--------S 248
Query: 303 MISDCLQKDPTKRPTASEL 321
+++ C DP++RP +EL
Sbjct: 249 LMTKCWAYDPSRRPRFTEL 267
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 45/235 (19%)
Query: 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLE 171
V H+ F + L+ V+ + GG L+ ++ + E E+ L
Sbjct: 73 VGLHSCFQTESRLFFVIEYVNGGDLM----FHMQ----RQRKLPEEHARFYSAEISLALN 124
Query: 172 YFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAP 231
Y H G I+RD+K N+LL +G +++ D+G+ L TF GTP ++AP
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 179
Query: 232 EVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM---------KVLMLTLQND--- 279
E++ + Y F D W+LG+ EM G +P+ + + + L+
Sbjct: 180 EIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 238
Query: 280 PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR------PTASELLKNPFFK 328
P +L A ++ L KDP +R +++ +PFF+
Sbjct: 239 PRSLSVKA-------------ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 35/232 (15%)
Query: 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLR 164
+ H+ F D L+ V+ + GG L+ + ++ + G EP
Sbjct: 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM----YHIQ----QVGRFKEPHAVFYAA 128
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVG 224
E+ GL + S G I+RD+K N++L +G ++IADFG+ ++ TF G
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCG 183
Query: 225 TPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND---PP 281
TP ++APE++ Y D W+ G+ EM G AP+ ++ ++++ P
Sbjct: 184 TPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK 242
Query: 282 TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR----PT-ASELLKNPFFK 328
++ A + + K P KR P ++ ++ FF+
Sbjct: 243 SMSKEA-------------VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 75/314 (23%), Positives = 129/314 (41%), Gaps = 70/314 (22%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+++ +G G+ VH + A+K + +V ++ +E
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-------------VRLKQVE- 51
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+T DE + + +S H ++ +F ++++++ +EGG L L+
Sbjct: 52 -HT-NDE--RLM--LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF----SLLR--- 98
Query: 149 CKHGVCDEPT----IATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS 204
K P A EV LEY HS I+RD+K NILL ++G ++I DFG
Sbjct: 99 -KSQRFPNPVAKFYAA----EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG-- 151
Query: 205 AWLATGRDLSRQ--KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262
++ V +T GTP ++APEV+ Y+ D WS GI EM G P
Sbjct: 152 --------FAKYVPDVTYTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTP 202
Query: 263 YHKYPAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR---- 315
++ MK L + PP + + ++S + +D ++R
Sbjct: 203 FYDSNTMKTYEKILNAELRFPPFFNEDV-------------KDLLSRLITRDLSQRLGNL 249
Query: 316 PTASELLKN-PFFK 328
+E +KN P+FK
Sbjct: 250 QNGTEDVKNHPWFK 263
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 75/361 (20%), Positives = 125/361 (34%), Gaps = 117/361 (32%)
Query: 20 VSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKC 79
+++ + +YE + +G G A V+ KAR K +
Sbjct: 1 MALDVKSRAKRYEKLDFLGEGQFATVY----KAR------------------DKNTNQIV 38
Query: 80 AIKKINLEKWNTSMDEL----LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGS 135
AIKKI L + + D + L+EI+ + H N++ +F K + LV +E
Sbjct: 39 AIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME--- 95
Query: 136 LLDIIKHRLK--ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
L+ I + + I + L+GLEY H + +HRD+K N+LL E+
Sbjct: 96 ------TDLEVIIKDNSLVL-TPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN 148
Query: 194 GTVQIADFGVSAWLAT-----GRDLSRQKV----RHTFVGTPCWMAPEVMEQDHGYDFKA 244
G +++ADFG LA R + Q V R APE++ Y
Sbjct: 149 GVLKLADFG----LAKSFGSPNRAYTHQVVTRWYR----------APELLFGARMYGVGV 194
Query: 245 DIWSLG-ITAIEMATGTA------------------------------------PYHKYP 267
D+W++G I A E+ + +P
Sbjct: 195 DMWAVGCILA-ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 253
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
+ L + + +I +P R TA++ LK +F
Sbjct: 254 GIP-----LHHIFSAAGDDLLD-------------LIQGLFLFNPCARITATQALKMKYF 295
Query: 328 K 328
Sbjct: 296 S 296
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 60/263 (22%), Positives = 109/263 (41%), Gaps = 38/263 (14%)
Query: 77 EKCAIKKINLEKWNTS--MDELLKEIQAMSSCHHENVVTYH--TSFVVKDELWLVLRLLE 132
E A+KK+ + +T + + +EI+ + S H+N+V Y + L L++ L
Sbjct: 40 EVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 96
Query: 133 GGSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
GSL D + KH+ +I D + ++ KG+EY + IHRD+ NIL+
Sbjct: 97 YGSLRDYLQKHKERI--------DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE 148
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTP-CWMAPEVMEQDHGYDFKADIWSLG 250
+ V+I DFG++ L ++ + K P W APE + + + +D+WS G
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEFFKVKEPGES---PIFWYAPESL-TESKFSVASDVWSFG 204
Query: 251 ITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFR--------- 301
+ E+ T PA + M+ + R
Sbjct: 205 VVLYELFTYIEKSKSPPAEFMRMIGNDKQG-----QMIVFHLIELLKNNGRLPRPDGCPD 259
Query: 302 ---KMISDCLQKDPTKRPTASEL 321
++++C + +RP+ +L
Sbjct: 260 EIYMIMTECWNNNVNQRPSFRDL 282
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 36/226 (15%)
Query: 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLE 171
F D L+ V+ + GG L+ ++ K DE E++ L
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVNGGDLM----FHIQ----KSRRFDEARARFYAAEIISALM 138
Query: 172 YFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAP 231
+ H G I+RD+K N+LL +G ++ADFG+ + TF GTP ++AP
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGTPDYIAP 193
Query: 232 EVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND---PPTLDTGAA 288
E++ Q+ Y D W++G+ EM G AP+ + L ++ P L A
Sbjct: 194 EIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDA- 251
Query: 289 EKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLKN-PFFK 328
++ + K+PT R + PFFK
Sbjct: 252 ------------TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 64/231 (27%), Positives = 93/231 (40%), Gaps = 34/231 (14%)
Query: 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLR 164
+ H +V H SF D+L+ VL + GG L + L+ + EP
Sbjct: 95 NVKHPFLVGLHFSFQTADKLYFVLDYINGGELF----YHLQ----RERCFLEPRARFYAA 146
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVG 224
E+ L Y HS ++RD+K NILL G + + DFG+ ++ TF G
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNSTTSTFCG 201
Query: 225 TPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND---PP 281
TP ++APEV+ YD D W LG EM G P++ ++ L P
Sbjct: 202 TPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP 260
Query: 282 TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR----PTASELLKNPFFK 328
+ A R ++ LQKD TKR E+ + FF
Sbjct: 261 NITNSA-------------RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 72/324 (22%), Positives = 112/324 (34%), Gaps = 67/324 (20%)
Query: 16 SSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKAR 75
A V + EVIG G V+ K
Sbjct: 12 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------------------- 52
Query: 76 AEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVT-YHTSFVVKDELWLVLRLLEGG 134
CA+K +N + + L E M H NV++ + +VL ++ G
Sbjct: 53 KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 112
Query: 135 SLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
L + I + + +V KG++Y S +HRD+ A N +L E
Sbjct: 113 DLRNFIRNETHNPT--------VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 164
Query: 194 GTVQIADFGVSAWLATGRDLSRQ----KVRHTFVGTPC-WMAPEVMEQDHGYDFKADIWS 248
TV++ADFG++ RD+ + T P WMA E + Q + K+D+WS
Sbjct: 165 FTVKVADFGLA------RDMYDKEYYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWS 217
Query: 249 LGITAIEMAT-GTAPYHKYPAMKVLMLTLQ--------NDPPTLDTGAAEKDQYKAYGKT 299
G+ E+ T G PY + + LQ P L Y
Sbjct: 218 FGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL---------Y------ 262
Query: 300 FRKMISDCLQKDPTKRPTASELLK 323
+++ C RP+ SEL+
Sbjct: 263 --EVMLKCWHPKAEMRPSFSELVS 284
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 45/235 (19%)
Query: 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLE 171
V H+ F + L+ V+ + GG L+ ++ + E E+ L
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDLM----FHMQ----RQRKLPEEHARFYSAEISLALN 167
Query: 172 YFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAP 231
Y H G I+RD+K N+LL +G +++ D+G+ L TF GTP ++AP
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 222
Query: 232 EVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAM---------KVLMLTLQND--- 279
E++ + Y F D W+LG+ EM G +P+ + + + L+
Sbjct: 223 EIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 281
Query: 280 PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR------PTASELLKNPFFK 328
P +L A ++ L KDP +R +++ +PFF+
Sbjct: 282 PRSLSVKA-------------ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 3e-27
Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 35/232 (15%)
Query: 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLR 164
+ H+ F D L+ V+ + GG L+ + ++ + G EP
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM----YHIQ----QVGRFKEPHAVFYAA 449
Query: 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVG 224
E+ GL + S G I+RD+K N++L +G ++IADFG+ ++ TF G
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCG 504
Query: 225 TPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND---PP 281
TP ++APE++ Y D W+ G+ EM G AP+ ++ ++++ P
Sbjct: 505 TPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK 563
Query: 282 TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLKNPFFK 328
++ A + + K P KR ++ ++ FF+
Sbjct: 564 SMSKEA-------------VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 56/267 (20%), Positives = 109/267 (40%), Gaps = 46/267 (17%)
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE----LWLVLRLLE 132
E+ A+K + E + +L KEI+ + + +HEN+V Y + ++ + L++ L
Sbjct: 51 EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKG--ICTEDGGNGIKLIMEFLP 108
Query: 133 GGSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
GSL + + K++ KI+ ++ KG++Y S +HRD+ A N+L+
Sbjct: 109 SGSLKEYLPKNKNKINL--------KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 160
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQK------VRHTFVGTPCWMAPEVMEQDHGYDFKAD 245
+ V+I DFG++ + T ++ K V W APE + + +D
Sbjct: 161 SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF--------WYAPECL-MQSKFYIASD 211
Query: 246 IWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQY----------K 294
+WS G+T E+ T + ++ K+ +
Sbjct: 212 VWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDE 271
Query: 295 AYGKTFRKMISDCLQKDPTKRPTASEL 321
Y +++ C + P+ R + L
Sbjct: 272 VY-----QLMRKCWEFQPSNRTSFQNL 293
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 59/261 (22%), Positives = 106/261 (40%), Gaps = 34/261 (13%)
Query: 77 EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYH--TSFVVKDELWLVLRLLEGG 134
E A+KK+ + + +EI+ + S H+N+V Y + L L++ L G
Sbjct: 71 EVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 135 SLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
SL D + KH+ +I D + ++ KG+EY + IHRD+ NIL+ +
Sbjct: 130 SLRDYLQKHKERI--------DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 181
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTP-CWMAPEVMEQDHGYDFKADIWSLGIT 252
V+I DFG++ L ++ + K P W APE + + + +D+WS G+
Sbjct: 182 NRVKIGDFGLTKVLPQDKEYYKVKEPGES---PIFWYAPESL-TESKFSVASDVWSFGVV 237
Query: 253 AIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFR----------- 301
E+ T PA + M+ + R
Sbjct: 238 LYELFTYIEKSKSPPAEFMRMIGNDKQG-----QMIVFHLIELLKNNGRLPRPDGCPDEI 292
Query: 302 -KMISDCLQKDPTKRPTASEL 321
++++C + +RP+ +L
Sbjct: 293 YMIMTECWNNNVNQRPSFRDL 313
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 78/311 (25%), Positives = 125/311 (40%), Gaps = 56/311 (18%)
Query: 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINL 86
T +++E +++G G V KA A+K +KK +
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMK-------------------ILKKEVI 186
Query: 87 EKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI 146
+ L E + + + H + SF D L V+ GG L L
Sbjct: 187 VA-KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF----FHLS- 240
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGNILLGEDGTVQIADFGVSA 205
+ V E E++ L+Y HS ++RD+K N++L +DG ++I DFG+
Sbjct: 241 ---RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297
Query: 206 WLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265
+ TF GTP ++APEV+E D+ Y D W LG+ EM G P++
Sbjct: 298 -----EGIKDGATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
Query: 266 YPAMKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR----PT- 317
K+ L L + P TL A + ++S L+KDP +R
Sbjct: 352 QDHEKLFELILMEEIRFPRTLGPEA-------------KSLLSGLLKKDPKQRLGGGSED 398
Query: 318 ASELLKNPFFK 328
A E++++ FF
Sbjct: 399 AKEIMQHRFFA 409
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 59/306 (19%), Positives = 114/306 (37%), Gaps = 60/306 (19%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++VIG G V+ K + K + AIK +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP------------------VAIKTLKAGY 85
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE--LWLVLRLLEGGSLLDIIKHRLKI 146
+ L E M H N++ V+ + ++ +E G+L ++ +
Sbjct: 86 TEKQRVDFLGEAGIMGQFSHHNIIRLEG--VISKYKPMMIITEYMENGALDKFLREK--- 140
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
G + +LR + G++Y + +HRD+ A NIL+ + +++DFG+S
Sbjct: 141 ----DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
Query: 207 LATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYH 264
L + + P W APE + + +D+WS GI E+ T G PY
Sbjct: 197 LEDDPEATYTTSGGKI---PIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYW 252
Query: 265 KYPAMKVL--------MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
+ +V+ + T + P + Y +++ C Q++ +RP
Sbjct: 253 ELSNHEVMKAINDGFRLPTPMDCPSAI---------Y--------QLMMQCWQQERARRP 295
Query: 317 TASELL 322
++++
Sbjct: 296 KFADIV 301
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 62/276 (22%), Positives = 104/276 (37%), Gaps = 51/276 (18%)
Query: 67 VHSAYCKARAEK---CAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVT-YHTSFVVKD 122
V+ K CA+K +N + + L E M H NV++ +
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164
Query: 123 ELWLVLRLLEGGSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181
+VL ++ G L + I + + +V KG+++ S +HR
Sbjct: 165 SPLVVLPYMKHGDLRNFIRNETHNPTV--------KDLIGFGLQVAKGMKFLASKKFVHR 216
Query: 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-----WMAPEVMEQ 236
D+ A N +L E TV++ADFG++ RD+ ++ T WMA E + Q
Sbjct: 217 DLAARNCMLDEKFTVKVADFGLA------RDMYDKEFDSVHNKTGAKLPVKWMALESL-Q 269
Query: 237 DHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGA 287
+ K+D+WS G+ E+ T G PY + +L + P L
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL---- 325
Query: 288 AEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
Y +++ C RP+ SEL+
Sbjct: 326 -----Y--------EVMLKCWHPKAEMRPSFSELVS 348
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 72/353 (20%), Positives = 122/353 (34%), Gaps = 115/353 (32%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
QYE IG GA V KAR K A+K++ ++
Sbjct: 11 QQYECVAEIGEGAYGKVF----KARD-----------------LKNGGRFVALKRVRVQT 49
Query: 89 WN-----TSMDE--LLKEIQAMSSCHHENVVT-----YHTSFVVKDELWLVLRLLEGGSL 136
+++ E +L+ + + H NVV + + +L LV ++
Sbjct: 50 GEEGMPLSTIREVAVLRH---LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD---- 102
Query: 137 LDIIKHRLK--ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194
L + TI ++ ++L+GL++ HS+ +HRD+K NIL+ G
Sbjct: 103 -----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG 157
Query: 195 TVQIADFGVSAWLATGRDLSRQK-VRHTFVGTPC----WM-APEVMEQDHGYDFKADIWS 248
+++ADFG L+R + T W APEV+ Q Y D+WS
Sbjct: 158 QIKLADFG----------LARIYSFQMAL--TSVVVTLWYRAPEVLLQSS-YATPVDLWS 204
Query: 249 LG-ITAIEMATGTA--------------------------------PYHKYPAMKVLMLT 275
+G I A EM P + +
Sbjct: 205 VGCIFA-EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA--QP 261
Query: 276 LQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328
++ +D + ++ CL +P KR +A L +P+F+
Sbjct: 262 IEKFVTDIDELGKD-------------LLLKCLTFNPAKRISAYSALSHPYFQ 301
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 84/341 (24%), Positives = 132/341 (38%), Gaps = 85/341 (24%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
E Y +VIG G+ VV A +++ AIKK+ +
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLV-----------------------ESDEVAIKKVLQD 75
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVT----YHTSFVVKDE--LWLVLRLLEGGSLLDIIK 141
K +E+Q M H NVV ++++ KDE L LVL + ++ +
Sbjct: 76 K-----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASR 129
Query: 142 HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL-GEDGTVQIAD 200
H K+ I + ++L+ L Y HS G HRDIK N+LL G +++ D
Sbjct: 130 HYAKLKQ----TMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185
Query: 201 FGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG-ITAIEMATG 259
FG A + L + +++ + + APE++ Y DIWS G + A E+ G
Sbjct: 186 FG----SA--KILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA-ELMQG 238
Query: 260 TAPYHKYPA----------MKVLMLTLQNDPPTLDTGAAEKDQYKAY----------GKT 299
+P +KVL P+ + Y + K
Sbjct: 239 QP---LFPGESGIDQLVEIIKVL------GTPSREQIKTMNPNYMEHKFPQIRPHPFSKV 289
Query: 300 FRK--------MISDCLQKDPTKRPTASELLKNPFFKKAKD 332
FR +IS L+ P+ R TA E L +PFF + +
Sbjct: 290 FRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 71/332 (21%), Positives = 123/332 (37%), Gaps = 74/332 (22%)
Query: 19 SVSVPWPNTEDQYEV-------REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAY 71
S N + + +++G G V K
Sbjct: 17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGT--------------- 61
Query: 72 CKARAEKCAIKKINLEKWNTS-MDELLKEIQAMSSCHHENVVT-----YHTSFVVKDELW 125
+ K A+K + L+ + ++E L E M H NV+ S +
Sbjct: 62 ----SLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117
Query: 126 LVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185
++L ++ G L + + + KH T+ + ++ G+EY + +HRD+ A
Sbjct: 118 VILPFMKYGDLHTYLLYSRLETGPKH--IPLQTLLKFMVDIALGMEYLSNRNFLHRDLAA 175
Query: 186 GNILLGEDGTVQIADFGVSAWLATG---RDLSRQK--VRHTFVGTPCWMAPEVMEQDHGY 240
N +L +D TV +ADFG+S + +G R K V+ W+A E + D Y
Sbjct: 176 RNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK--------WIAIESL-ADRVY 226
Query: 241 DFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKD 291
K+D+W+ G+T E+AT G PY ++ + ++ L
Sbjct: 227 TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDEL-------- 278
Query: 292 QYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
Y +++ C + DP RPT S L
Sbjct: 279 -Y--------EIMYSCWRTDPLDRPTFSVLRL 301
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-27
Identities = 58/271 (21%), Positives = 102/271 (37%), Gaps = 50/271 (18%)
Query: 67 VHSAYCKARAEK---CAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE 123
VH + AIK ++ ++ L+E M H ++V V+ +
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG--VITEN 463
Query: 124 -LWLVLRLLEGGSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181
+W+++ L G L + + + ++ ++ L Y S +HR
Sbjct: 464 PVWIIMELCTLGELRSFLQVRKFSLD--------LASLILYAYQLSTALAYLESKRFVHR 515
Query: 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVG-TPC-WMAPEVMEQDHG 239
DI A N+L+ + V++ DFG+S R + G P WMAPE +
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLS------RYMEDSTYYKASKGKLPIKWMAPESI-NFRR 568
Query: 240 YDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEK 290
+ +D+W G+ E+ G P+ V+ + N PPTL
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL------- 621
Query: 291 DQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
Y +++ C DP++RP +EL
Sbjct: 622 --Y--------SLMTKCWAYDPSRRPRFTEL 642
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 62/324 (19%), Positives = 103/324 (31%), Gaps = 108/324 (33%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWN-----TSMDELLKEIQAMSSCHHENVVTYHTSFV 119
V+ A E AIK+I LE T+ ++E+ + H N++ +
Sbjct: 48 GEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA----IREVSLLKELQHRNIIELKSVIH 103
Query: 120 VKDELWLVLRLLEG--GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG 177
L L+ E +D K+ I + L +++ G+ + HS
Sbjct: 104 HNHRLHLIFEYAENDLKKYMD-----------KNPDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 178 QIHRDIKAGNILL-----GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC----- 227
+HRD+K N+LL E ++I DFG L+R G P
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFG----------LARAF------GIPIRQFTH 196
Query: 228 -----WM-APEVMEQDHGYDFKADIWSLGITAIEMATGTA-------------------- 261
W PE++ Y DIWS+ EM T
Sbjct: 197 EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256
Query: 262 -----------------PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304
+ K+ + + LD + ++
Sbjct: 257 PDDTTWPGVTALPDWKQSFPKFRGKTL----KRVLGALLDDEGLD-------------LL 299
Query: 305 SDCLQKDPTKRPTASELLKNPFFK 328
+ L+ DP KR +A L++P+F
Sbjct: 300 TAMLEMDPVKRISAKNALEHPYFS 323
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 63/248 (25%), Positives = 107/248 (43%), Gaps = 45/248 (18%)
Query: 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINL 86
D +E+ +VIG GA + V K + A+K +N K L
Sbjct: 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN------------------KWDML 100
Query: 87 EKWNTS--MDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRL 144
++ S +E +++ + + + H +F ++ L+LV+ GG LL ++
Sbjct: 101 KRGEVSCFREE--RDV--LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLS--- 153
Query: 145 KISNCKHGVC-DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
K G L E++ ++ H G +HRDIK NILL G +++ADFG
Sbjct: 154 -----KFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208
Query: 204 SAWLATGRDLSRQKVR-HTFVGTPCWMAPEVMEQ------DHGYDFKADIWSLGITAIEM 256
+ + VR VGTP +++PE+++ Y + D W+LG+ A EM
Sbjct: 209 CL-----KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263
Query: 257 ATGTAPYH 264
G P++
Sbjct: 264 FYGQTPFY 271
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 59/271 (21%), Positives = 104/271 (38%), Gaps = 43/271 (15%)
Query: 67 VHSAYCKARAEK---CAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE 123
V S K ++K AIK + + + L E M H N++
Sbjct: 61 VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 124 LWLVLRLLEGGSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182
+ +V +E GSL + KH + + + +LR + G++Y G +HRD
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFT--------VIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-WMAPEVMEQDHGYD 241
+ A NIL+ + +++DFG+ L + + P W +PE + +
Sbjct: 173 LAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI---PIRWTSPEAI-AYRKFT 228
Query: 242 FKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKDQ 292
+D+WS GI E+ + G PY + V+ + + P L
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL--------- 279
Query: 293 YKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
Y +++ DC QKD RP +++
Sbjct: 280 Y--------QLMLDCWQKDRNNRPKFEQIVS 302
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ +E+ +VIG GA V K + A+K +N + +K+
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-------------LKRAETAC 120
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGG---SLLDIIKHRLK 145
+E +++ + + + + T H +F + L+LV+ GG +LL + RL
Sbjct: 121 ---FREE--RDV--LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL- 172
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSA 205
E L E++ ++ H +HRDIK NIL+ +G +++ADFG
Sbjct: 173 ---------PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 206 WLATGRDLSRQKVR-HTFVGTPCWMAPEVME----QDHGYDFKADIWSLGITAIEMATGT 260
+ + V+ VGTP +++PE+++ Y + D WSLG+ EM G
Sbjct: 224 -----KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
Query: 261 APYH 264
P++
Sbjct: 279 TPFY 282
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 75/312 (24%), Positives = 125/312 (40%), Gaps = 58/312 (18%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ YEV +VIG GA V K+ + A+K ++ + IK+ +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-------------IKRSDSAF 115
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDII-KHRLKIS 147
+E ++I M+ + VV +F L++V+ + GG L++++ + +
Sbjct: 116 ---FWEE--RDI--MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV--- 165
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
E EV+ L+ HS G IHRD+K N+LL + G +++ADFG
Sbjct: 166 -------PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG----T 214
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQ---DHGYDFKADIWSLGITAIEMATGTAP-Y 263
+ T VGTP +++PEV++ D Y + D WS+G+ EM G P Y
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274
Query: 264 HKYPA-MKVLMLTLQND---PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR---P 316
++ +N P D K+ A D R
Sbjct: 275 ADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA------------FLTDREVRLGRN 322
Query: 317 TASELLKNPFFK 328
E+ ++ FFK
Sbjct: 323 GVEEIKRHLFFK 334
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 70/344 (20%), Positives = 121/344 (35%), Gaps = 80/344 (23%)
Query: 19 SVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEK 78
S V W +D Y++ +G G + V A EK +K +
Sbjct: 27 SHVVEW-GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------------- 72
Query: 79 CAIKKINLE-KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE----LWLVLRLLEG 133
KKI E K +L+ ++ N++T +VKD LV +
Sbjct: 73 -KKKKIKREIK-------ILENLR-----GGPNIITLAD--IVKDPVSRTPALVFEHVNN 117
Query: 134 GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL-GE 192
+ + L + + + E+LK L+Y HS G +HRD+K N+++ E
Sbjct: 118 TDFKQLYQ-TLTDYDIRF----------YMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 166
Query: 193 DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252
+++ D+G LA + + V + + PE++ YD+ D+WSLG
Sbjct: 167 HRKLRLIDWG----LA--EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM 220
Query: 253 AIEMATGTAPY---HKYPAMKVLMLTLQNDPPTLD----TGAAEKDQYKAY-----GKTF 300
M P+ H V + + D ++ K +
Sbjct: 221 LASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW 280
Query: 301 RKMIS------------DCLQK----DPTKRPTASELLKNPFFK 328
+ + D L K D R TA E +++P+F
Sbjct: 281 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 63/273 (23%), Positives = 111/273 (40%), Gaps = 53/273 (19%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE-- 123
VV K + A+K I + S DE +E Q M H +V ++ V E
Sbjct: 23 VVKLGKWKGQY-DVAVKMIKEG--SMSEDEFFQEAQTMMKLSHPKLVKFYG--VCSKEYP 77
Query: 124 LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183
+++V + G LL+ ++ + + + +V +G+ + S+ IHRD+
Sbjct: 78 IYIVTEYISNGCLLNYLRSH-------GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDL 130
Query: 184 KAGNILLGEDGTVQIADFGVSAWLA----TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG 239
A N L+ D V+++DFG++ ++ ++ V+ W APEV
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK--------WSAPEVF-HYFK 181
Query: 240 YDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEK 290
Y K+D+W+ GI E+ + G PY Y +V+ + T+
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI------- 234
Query: 291 DQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
Y +++ C + P KRPT +LL
Sbjct: 235 --Y--------QIMYSCWHELPEKRPTFQQLLS 257
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 61/295 (20%), Positives = 113/295 (38%), Gaps = 57/295 (19%)
Query: 67 VHSAYCKARAE---KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE 123
V+ +A+ +CAIK ++ ++ L+E M +H NV+ ++
Sbjct: 37 VYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIG--IMLPP 94
Query: 124 ---LWLVLRLLEGGSLLDIIK-HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179
++L + G LL I+ + + + + +V +G+EY +
Sbjct: 95 EGLPHVLLPYMCHGDLLQFIRSPQRNPT--------VKDLISFGLQVARGMEYLAEQKFV 146
Query: 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC-----WMAPEVM 234
HRD+ A N +L E TV++ADFG++ RD+ ++ W A E +
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLA------RDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 235 EQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDT 285
Q + + K+D+WS G+ E+ T G PY + + + P +L
Sbjct: 201 -QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL-- 257
Query: 286 GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK--NPFFKKAKDKKFIQQ 338
Y +++ C + DP RPT L+ ++Q
Sbjct: 258 -------Y--------QVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQL 297
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 60/271 (22%), Positives = 117/271 (43%), Gaps = 49/271 (18%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELW 125
+VH Y + +K AIK + + S ++ ++E + M H +V + + + +
Sbjct: 23 LVHLGYWLNK-DKVAIK--TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79
Query: 126 LVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185
LV +E G L D ++ + G+ T+ + +V +G+ Y IHRD+ A
Sbjct: 80 LVTEFMEHGCLSDYLRTQ-------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA 132
Query: 186 GNILLGEDGTVQIADFGVSAWLA----TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD 241
N L+GE+ ++++DFG++ ++ T ++ V+ W +PEV Y
Sbjct: 133 RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--------WASPEVF-SFSRYS 183
Query: 242 FKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEKDQ 292
K+D+WS G+ E+ + G PY +V+ + + +
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV--------- 234
Query: 293 YKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
Y ++++ C ++ P RP S LL+
Sbjct: 235 Y--------QIMNHCWRERPEDRPAFSRLLR 257
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 68/337 (20%), Positives = 117/337 (34%), Gaps = 77/337 (22%)
Query: 16 SSASVSVPWPNTEDQYEV-------REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVH 68
S +S + + ++G G V A K
Sbjct: 3 DSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGS------------ 50
Query: 69 SAYCKARAEKCAIKKINLEKWNTS-MDELLKEIQAMSSCHHENVV------TYHTSFVVK 121
K A+K + + +S ++E L+E M H +V +
Sbjct: 51 -------FVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103
Query: 122 DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181
++L ++ G L + N + T+ + ++ G+EY S IHR
Sbjct: 104 PIPMVILPFMKHGDLHAFLLASRIGENPFN--LPLQTLVRFMVDIACGMEYLSSRNFIHR 161
Query: 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK------VRHTFVGTPCWMAPEVME 235
D+ A N +L ED TV +ADFG+S + +G D RQ V+ W+A E +
Sbjct: 162 DLAARNCMLAEDMTVCVADFGLSRKIYSG-DYYRQGCASKLPVK--------WLALESL- 211
Query: 236 QDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTG 286
D+ Y +D+W+ G+T E+ T G PY ++ + +
Sbjct: 212 ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEV--- 268
Query: 287 AAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
Y ++ C DP +RP+ + L
Sbjct: 269 ------Y--------DLMYQCWSADPKQRPSFTCLRM 291
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 62/270 (22%), Positives = 109/270 (40%), Gaps = 58/270 (21%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
+ AIK +N E L E M + +VV +++ L+ G L
Sbjct: 57 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 116
Query: 138 D-IIKHRLKISNCKHGVCDEPTIATVL---REVLKGLEYFHSNGQIHRDIKAGNILLGED 193
+ R ++N P+++ ++ E+ G+ Y ++N +HRD+ A N ++ ED
Sbjct: 117 SYLRSLRPAMANNPVL--APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174
Query: 194 GTVQIADFGVSAWLATGRDLSRQK-----------VRHTFVGTPCWMAPEVMEQDHGYDF 242
TV+I DFG++ RD+ VR WM+PE + +D +
Sbjct: 175 FTVKIGDFGMT------RDIYETDYYRKGGKGLLPVR--------WMSPESL-KDGVFTT 219
Query: 243 KADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQ--------NDPPTLDTGAAEKDQY 293
+D+WS G+ E+AT PY +VL ++ N P L +
Sbjct: 220 YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDML---------F 270
Query: 294 KAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+++ C Q +P RP+ E++
Sbjct: 271 --------ELMRMCWQYNPKMRPSFLEIIS 292
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 58/272 (21%), Positives = 109/272 (40%), Gaps = 53/272 (19%)
Query: 66 VVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE-- 123
VV + + AIK I + S DE ++E + M + HE +V + V +
Sbjct: 39 VVKYGKWRGQY-DVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYG--VCTKQRP 93
Query: 124 LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183
++++ + G LL+ ++ + + ++V + +EY S +HRD+
Sbjct: 94 IFIITEYMANGCLLNYLREM-------RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 146
Query: 184 KAGNILLGEDGTVQIADFGVSAWLA----TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG 239
A N L+ + G V+++DFG+S ++ T S+ VR W PEV+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR--------WSPPEVL-MYSK 197
Query: 240 YDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDTGAAEK 290
+ K+DIW+ G+ E+ + G PY ++ + + +
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV------- 250
Query: 291 DQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
Y ++ C + +RPT LL
Sbjct: 251 --Y--------TIMYSCWHEKADERPTFKILL 272
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 62/273 (22%), Positives = 105/273 (38%), Gaps = 54/273 (19%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSS-CHHENVVTYHTSFVVKDELWLVLRLLEGGSL 136
A+K + T + L+ E++ +S +H N+V + + ++ G L
Sbjct: 55 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 114
Query: 137 LD-IIKHRLKISNCKHGVCDEPTIATVL---------REVLKGLEYFHSNGQIHRDIKAG 186
L+ + + R K L +V KG+ + S IHRD+ A
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174
Query: 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQK-----------VRHTFVGTPCWMAPEVME 235
NILL +I DFG++ RD+ V+ WMAPE +
Sbjct: 175 NILLTHGRITKICDFGLA------RDIKNDSNYVVKGNARLPVK--------WMAPESI- 219
Query: 236 QDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQN----DPPTLDTGAAEK 290
+ Y F++D+WS GI E+ + G++PY P ++ P A
Sbjct: 220 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH----APA 275
Query: 291 DQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ Y ++ C DP KRPT ++++
Sbjct: 276 EMY--------DIMKTCWDADPLKRPTFKQIVQ 300
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 55/291 (18%), Positives = 105/291 (36%), Gaps = 68/291 (23%)
Query: 64 LAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSF---VV 120
LA H+ + A+K + E ++ + +E + ++ H+++V F
Sbjct: 59 LAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIV----RFFGVCT 113
Query: 121 KDE-LWLVLRLLEGGSLLD-IIKHRLKISNCKHGVCDEPTIATV------LREVLKGLEY 172
+ L +V + G L + H G P + +V G+ Y
Sbjct: 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173
Query: 173 FHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK-----------VRHT 221
+HRD+ N L+G+ V+I DFG+S RD+ +R
Sbjct: 174 LAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------RDIYSTDYYRVGGRTMLPIR-- 225
Query: 222 FVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQ--- 277
WM PE + + ++D+WS G+ E+ T G P+++ + + Q
Sbjct: 226 ------WMPPESI-LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE 278
Query: 278 -----NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
PP + Y ++ C Q++P +R + ++
Sbjct: 279 LERPRACPPEV---------Y--------AIMRGCWQREPQQRHSIKDVHA 312
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 87/360 (24%), Positives = 131/360 (36%), Gaps = 100/360 (27%)
Query: 19 SVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEK 78
SV P+ + +YE IG G V KAR + +K
Sbjct: 7 SVECPFCDEVSKYEKLAKIGQGTFGEVF----KAR------------------HRKTGQK 44
Query: 79 CAIKKINLEKWN-----TSMDELLKEIQAMSSCHHENVVT--------YHTSFVVKDELW 125
A+KK+ +E T+ L+EI+ + HENVV K ++
Sbjct: 45 VALKKVLMENEKEGFPITA----LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 100
Query: 126 LVLRLLEGGSLLDIIKHRLK--ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183
LV E H L +SN I V++ +L GL Y H N +HRD+
Sbjct: 101 LVFDFCE---------HDLAGLLSNVLVKF-TLSEIKRVMQMLLNGLYYIHRNKILHRDM 150
Query: 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC----WM-APEVMEQDH 238
KA N+L+ DG +++ADFG LA L++ + + T W PE++ +
Sbjct: 151 KAANVLITRDGVLKLADFG----LARAFSLAKNSQPNRY--TNRVVTLWYRPPELLLGER 204
Query: 239 GYDFKADIWSLG-ITAIEMATGTA--------------------P-------YHKYPAMK 270
Y D+W G I A EM T + Y +
Sbjct: 205 DYGPPIDLWGAGCIMA-EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 263
Query: 271 VLMLTLQNDPPTLDTGAAEKDQYKAYGKTF--RKMISDCLQKDPTKRPTASELLKNPFFK 328
L L + + KD+ KAY + +I L DP +R + + L + FF
Sbjct: 264 KLELV-KGQKRKV------KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 51/308 (16%), Positives = 108/308 (35%), Gaps = 72/308 (23%)
Query: 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMD 94
E +G G + + + + + + +K ++ +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHET---------------EVLLKVLD----KAHRN 54
Query: 95 ---ELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLD-IIKHRLKISNCK 150
+ MS H+++V + V DE LV ++ GSL + K++ I+
Sbjct: 55 YSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCIN--- 111
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL--------GEDGTVQIADFG 202
V +++ + + N IH ++ A NILL G ++++D G
Sbjct: 112 -----ILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166
Query: 203 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTA 261
+S + +D+ ++++ W+ PE +E + D WS G T E+ + G
Sbjct: 167 ISITVL-PKDILQERIP--------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
Query: 262 PYHKYPAMKVLMLTLQN------DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR 315
P + + L L +I++C+ +P R
Sbjct: 218 PLSALDSQRKLQFYEDRHQLPAPKAAEL---------A--------NLINNCMDYEPDHR 260
Query: 316 PTASELLK 323
P+ +++
Sbjct: 261 PSFRAIIR 268
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 57/363 (15%), Positives = 113/363 (31%), Gaps = 100/363 (27%)
Query: 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI 84
+ +Y + + +G G+ +V + ++ A+KK+ Y
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ---DPRYK------------ 47
Query: 85 NLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRL 144
+E+ M H N++ F + K+
Sbjct: 48 ------------NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNG 95
Query: 145 KISNCKHGVCDEP--------------TIATVLRE-------------------VLKGLE 171
++ K + + T+ VL+ + + +
Sbjct: 96 VNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155
Query: 172 YFHSNGQIHRDIKAGNILL-GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMA 230
+ HS G HRDIK N+L+ +D T+++ DFG A + L + ++ + + A
Sbjct: 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG----SA--KKLIPSEPSVAYICSRFYRA 209
Query: 231 PEVMEQDHGYDFKADIWSLG-ITAIEMATGTA--PYHKYPA-----MKVLMLTLQNDPPT 282
PE+M Y D+WS+G + E+ G ++++ PT
Sbjct: 210 PELMLGATEYTPSIDLWSIGCVFG-ELILGKPLFSGETSIDQLVRIIQIM------GTPT 262
Query: 283 LDTGAAEKDQYKAY----------GKTFRKM--------ISDCLQKDPTKRPTASELLKN 324
+ Y K + + L+ +P R E + +
Sbjct: 263 KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322
Query: 325 PFF 327
PFF
Sbjct: 323 PFF 325
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 77/366 (21%), Positives = 135/366 (36%), Gaps = 93/366 (25%)
Query: 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARA--EKCAIKK 83
+ +YE+ + +G GA +V + + E A+KKI A +S + R E I
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ-RTFRE---IM- 60
Query: 84 INLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD--ELWLVLRLLEGGSLLDIIK 141
+L E+ HEN+V + +++LV +E L +I+
Sbjct: 61 ------------ILTELS-----GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIR 102
Query: 142 H-RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIAD 200
L+ + ++ V+ +++K ++Y HS G +HRD+K NILL + V++AD
Sbjct: 103 ANILEPVHKQY----------VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVAD 152
Query: 201 FG------VSAWLATGRDLSRQKVRHTFVGTPCWM----------APEVMEQDHGYDFKA 244
FG + LS + F + APE++ Y
Sbjct: 153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI 212
Query: 245 DIWSLG-ITAIEMATGTA--PYHKY-------------PAMKVL-----------MLTLQ 277
D+WSLG I E+ G P P+ + + + +L+
Sbjct: 213 DMWSLGCILG-EILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLK 271
Query: 278 NDP--PTLDTGAAEKDQYKAYGKTFRK---------MISDCLQKDPTKRPTASELLKNPF 326
+ K K ++ LQ +P KR +A++ LK+PF
Sbjct: 272 EKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF 331
Query: 327 FKKAKD 332
+
Sbjct: 332 VSIFHN 337
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 52/289 (17%), Positives = 105/289 (36%), Gaps = 63/289 (21%)
Query: 64 LAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE 123
LA ++ A+K + + + + +E + +++ HE++V ++ +
Sbjct: 33 LAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEHIVKFY-GVCGDGD 90
Query: 124 -LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIAT--------VLREVLKGLEYFH 174
L +V ++ G L ++ + + ++ G+ Y
Sbjct: 91 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 150
Query: 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK-----------VRHTFV 223
S +HRD+ N L+G + V+I DFG+S RD+ +R
Sbjct: 151 SQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDVYSTDYYRVGGHTMLPIR---- 200
Query: 224 GTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQ----- 277
WM PE + + ++D+WS G+ E+ T G P+ + +V+ Q
Sbjct: 201 ----WMPPESI-MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLE 255
Query: 278 ---NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
P + Y ++ C Q++P +R E+ K
Sbjct: 256 RPRVCPKEV---------Y--------DVMLGCWQREPQQRLNIKEIYK 287
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 54/289 (18%), Positives = 104/289 (35%), Gaps = 62/289 (21%)
Query: 64 LAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE 123
+ + + AIK + + +E E + H NVV V KD+
Sbjct: 27 KGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLL-GVVTKDQ 85
Query: 124 -LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIAT--------VLREVLKGLEYFH 174
L ++ G L + + R S+ D + ++ ++ G+EY
Sbjct: 86 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS 145
Query: 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK-----------VRHTFV 223
S+ +H+D+ N+L+ + V+I+D G+ R++ +R
Sbjct: 146 SHHVVHKDLATRNVLVYDKLNVKISDLGLF------REVYAADYYKLLGNSLLPIR---- 195
Query: 224 GTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQ----- 277
WMAPE + + +DIWS G+ E+ + G PY Y V+ +
Sbjct: 196 ----WMAPEAI-MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP 250
Query: 278 ---NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ P + Y ++ +C + P++RP ++
Sbjct: 251 CPDDCPAWV---------Y--------ALMIECWNEFPSRRPRFKDIHS 282
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 61/270 (22%), Positives = 116/270 (42%), Gaps = 51/270 (18%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSS-CHHENVVTYHTSFVVKDELWLVLRLLEGGSL 136
A+K + + + +L+ E++ M H+N++ + L++++ G+L
Sbjct: 69 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 137 LD-IIKHRLKISNCKHGVCDEPTIATVLREVL-------KGLEYFHSNGQIHRDIKAGNI 188
+ + R + + P ++++ +G+EY S IHRD+ A N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 189 LLGEDGTVQIADFGVSAWLATGRDLSRQK-----------VRHTFVGTPCWMAPEVMEQD 237
L+ E+ ++IADFG++ RD++ V+ WMAPE + D
Sbjct: 189 LVTENNVMKIADFGLA------RDINNIDYYKKTTNGRLPVK--------WMAPEAL-FD 233
Query: 238 HGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQN---DPPTLDTGAAEKDQY 293
Y ++D+WS G+ E+ T G +PY P ++ L + D P + Y
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPAN----CTNELY 289
Query: 294 KAYGKTFRKMISDCLQKDPTKRPTASELLK 323
M+ DC P++RPT +L++
Sbjct: 290 --------MMMRDCWHAVPSQRPTFKQLVE 311
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 61/267 (22%), Positives = 104/267 (38%), Gaps = 50/267 (18%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSS-CHHENVVTYHTSFVVKDELWLVLRLLEGGSL 136
K A+K + + L+ E++ MS HEN+V + + ++ G L
Sbjct: 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 137 LDIIKHRLKISNCKHGVCDEPTIATVLR------EVLKGLEYFHSNGQIHRDIKAGNILL 190
L+ ++ + ++ + A+ +V +G+ + S IHRD+ A N+LL
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197
Query: 191 GEDGTVQIADFGVSAWLATGRDLSRQK-----------VRHTFVGTPCWMAPEVMEQDHG 239
+I DFG LA RD+ V+ WMAPE + D
Sbjct: 198 TNGHVAKIGDFG----LA--RDIMNDSNYIVKGNARLPVK--------WMAPESI-FDCV 242
Query: 240 YDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQN----DPPTLDTGAAEKDQYK 294
Y ++D+WS GI E+ + G PY +++ P A K+ Y
Sbjct: 243 YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAF----APKNIY- 297
Query: 295 AYGKTFRKMISDCLQKDPTKRPTASEL 321
++ C +PT RPT ++
Sbjct: 298 -------SIMQACWALEPTHRPTFQQI 317
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 64/272 (23%), Positives = 110/272 (40%), Gaps = 53/272 (19%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSS-CHHENVVT-YHTSFVVKDELWLVLRLLEGGS 135
A+K + ++ L+ E++ + HH NVV L +++ + G+
Sbjct: 59 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 136 LLDIIK-HRLKISNCKHGVCDEPTIATVLREVL-------KGLEYFHSNGQIHRDIKAGN 187
L ++ R + K D L ++ KG+E+ S IHRD+ A N
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178
Query: 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQK-----------VRHTFVGTPCWMAPEVMEQ 236
ILL E V+I DFG++ RD+ + ++ WMAPE +
Sbjct: 179 ILLSEKNVVKICDFGLA------RDIYKDPDYVRKGDARLPLK--------WMAPETI-F 223
Query: 237 DHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQN----DPPTLDTGAAEKD 291
D Y ++D+WS G+ E+ + G +PY + L+ P +
Sbjct: 224 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY----TTPE 279
Query: 292 QYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
Y + + DC +P++RPT SEL++
Sbjct: 280 MY--------QTMLDCWHGEPSQRPTFSELVE 303
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 59/282 (20%), Positives = 110/282 (39%), Gaps = 68/282 (24%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
A+K + + + +LL E + +H +V+ + + L L++ + GSL
Sbjct: 55 TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 138 D-------------IIKHRLKISNCKHGVCDEPTIATVLR---EVLKGLEYFHSNGQIHR 181
S+ H T+ ++ ++ +G++Y +HR
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174
Query: 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK-----------VRHTFVGTPCWMA 230
D+ A NIL+ E ++I+DFG+S RD+ + V+ WMA
Sbjct: 175 DLAARNILVAEGRKMKISDFGLS------RDVYEEDSYVKRSQGRIPVK--------WMA 220
Query: 231 PEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPP 281
E + DH Y ++D+WS G+ E+ T G PY P ++ M N
Sbjct: 221 IESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSE 279
Query: 282 TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ Y +++ C +++P KRP +++ K
Sbjct: 280 EM---------Y--------RLMLQCWKQEPDKRPVFADISK 304
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 62/266 (23%), Positives = 102/266 (38%), Gaps = 50/266 (18%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
+ A+K + + L E +S +H+N+V + +++L L+ GG L
Sbjct: 103 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 162
Query: 138 DIIKHRLKISNCKHGVCDEPTIATVL---REVLKGLEYFHSNGQIHRDIKAGNILL---G 191
L+ + + + +L R++ G +Y N IHRDI A N LL G
Sbjct: 163 SF----LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 218
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQ----KVRHTFVGTP-CWMAPEVMEQDHGYDFKADI 246
+I DFG++ RD+ R K + P WM PE + + K D
Sbjct: 219 PGRVAKIGDFGMA------RDIYRAGYYRKGGCAML--PVKWMPPEAF-MEGIFTSKTDT 269
Query: 247 WSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQ--------NDPPTLDTGAAEKDQYKAYG 297
WS G+ E+ + G PY +VL N P + Y
Sbjct: 270 WSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPV---------Y---- 316
Query: 298 KTFRKMISDCLQKDPTKRPTASELLK 323
++++ C Q P RP + +L+
Sbjct: 317 ----RIMTQCWQHQPEDRPNFAIILE 338
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 67/371 (18%), Positives = 123/371 (33%), Gaps = 84/371 (22%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKIN-LEK 88
+Y + +G+G + V A A+K + + A +I L++
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR--------GDKVYTEAAEDEIKLLQR 71
Query: 89 WNTSMDELLKEIQAMSSCH--HENVVTYHTSFVVKDELW----LVLRLLEGGSLLDIIKH 142
+ + +++ F K +V +L G +LL +IK
Sbjct: 72 --------VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIK- 121
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ-IHRDIKAGNILLGE------DGT 195
+H + + +++L GL+Y H IH DIK N+L+
Sbjct: 122 -----KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176
Query: 196 VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255
++IAD G + W + + T + +PEV+ + ADIWS E
Sbjct: 177 IKIADLGNACWY--------DEHYTNSIQTREYRSPEVL-LGAPWGCGADIWSTACLIFE 227
Query: 256 MATG--------TAPYHKYPAMKVLMLTLQNDPPT--LDTGA----------AEKDQYKA 295
+ TG Y K ++ L + P+ L G ++ K
Sbjct: 228 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 287
Query: 296 YGKTFRKMISD------------------CLQKDPTKRPTASELLKNPFFKKAKDKKFIQ 337
++++ LQ DP KR A L+ +P+ K + I+
Sbjct: 288 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 347
Query: 338 QTLVSVGPTFE 348
+ +
Sbjct: 348 VPDRELYGSGS 358
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 72/319 (22%), Positives = 120/319 (37%), Gaps = 70/319 (21%)
Query: 65 AVVHSAYCKARA--EKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD 122
V+ A K + A+K+I + S +EI + H NV++ F+
Sbjct: 35 GHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQKVFLSHA 91
Query: 123 E--LWLVLRLLEGGSLLDIIK-HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179
+ +WL+ E L IIK HR +N K + ++L ++L G+ Y H+N +
Sbjct: 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 150
Query: 180 HRDIKAGNILLGED----GTVQIADFGVSAWLATGRDLSRQK---VRHTFVGTPC----W 228
HRD+K NIL+ + G V+IAD G +R ++ P W
Sbjct: 151 HRDLKPANILVMGEGPERGRVKIADMG----------FARLFNSPLKPLADLDPVVVTFW 200
Query: 229 M-APEVMEQDHGYDFKADIWSLG-ITAIEMATGTAPYHKYPAMKVLMLTLQND------- 279
APE++ Y DIW++G I A E+ T +H +D
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFA-ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259
Query: 280 ---PPTLDT--GAAEKDQYKAYGKTFRK-------------------------MISDCLQ 309
P + ++ K FR+ ++ L
Sbjct: 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 319
Query: 310 KDPTKRPTASELLKNPFFK 328
DP KR T+ + +++P+F
Sbjct: 320 MDPIKRITSEQAMQDPYFL 338
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 63/267 (23%), Positives = 102/267 (38%), Gaps = 50/267 (18%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE--LWLVLRLLEGGS 135
+ A+K + + L E +S +H+N+V V ++++ L+ GG
Sbjct: 62 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILMELMAGGD 119
Query: 136 LLD-IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---G 191
L + + R + S + V R++ G +Y N IHRDI A N LL G
Sbjct: 120 LKSFLRETRPRPSQPSS--LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 177
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQ----KVRHTFVGTP-CWMAPEVMEQDHGYDFKADI 246
+I DFG++ RD+ R K + P WM PE + + K D
Sbjct: 178 PGRVAKIGDFGMA------RDIYRASYYRKGGCAML--PVKWMPPEAF-MEGIFTSKTDT 228
Query: 247 WSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQ--------NDPPTLDTGAAEKDQYKAYG 297
WS G+ E+ + G PY +VL N P + Y
Sbjct: 229 WSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPV---------Y---- 275
Query: 298 KTFRKMISDCLQKDPTKRPTASELLKN 324
++++ C Q P RP + +L+
Sbjct: 276 ----RIMTQCWQHQPEDRPNFAIILER 298
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 64/278 (23%), Positives = 114/278 (41%), Gaps = 67/278 (24%)
Query: 78 KCAIKKINLEKWNTSMDE---LLKEIQAMSS-CHHENVVTYHTSFVVKDELWLVLRLLEG 133
K A+K + K + + + L+ E++ M H+N++ + L++++
Sbjct: 103 KVAVKML---KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 159
Query: 134 GSLLD-IIKHRLKISNCKHGVCDEPTIATVLREVL-------KGLEYFHSNGQIHRDIKA 185
G+L + + R + P ++++ +G+EY S IHRD+ A
Sbjct: 160 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219
Query: 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQK-----------VRHTFVGTPCWMAPEVM 234
N+L+ ED ++IADFG++ RD+ V+ WMAPE +
Sbjct: 220 RNVLVTEDNVMKIADFGLA------RDIHHIDYYKKTTNGRLPVK--------WMAPEAL 265
Query: 235 EQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVL--------MLTLQNDPPTLDT 285
D Y ++D+WS G+ E+ T G +PY P ++ M N L
Sbjct: 266 F-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNEL-- 322
Query: 286 GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
Y M+ DC P++RPT +L++
Sbjct: 323 -------Y--------MMMRDCWHAVPSQRPTFKQLVE 345
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 63/278 (22%), Positives = 110/278 (39%), Gaps = 59/278 (21%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSS-CHHENVVTYHTSFVVKDELWLVLRLLEGGSL 136
+ A+K + + ++ + L+ E++ M+ HEN+V + + ++L+ G L
Sbjct: 77 QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 136
Query: 137 LD-IIKHRLKISNCKHGVCDEPTIATVL--------------REVLKGLEYFHSNGQIHR 181
L+ + R K S + ++ + +V KG+E+ +HR
Sbjct: 137 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196
Query: 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK-----------VRHTFVGTPCWMA 230
D+ A N+L+ V+I DFG++ RD+ V+ WMA
Sbjct: 197 DLAARNVLVTHGKVVKICDFGLA------RDIMSDSNYVVRGNARLPVK--------WMA 242
Query: 231 PEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQN----DPPTLDT 285
PE + + Y K+D+WS GI E+ + G PY P +QN D P
Sbjct: 243 PESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFY-- 299
Query: 286 GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
A ++ Y ++ C D KRP+ L
Sbjct: 300 --ATEEIY--------IIMQSCWAFDSRKRPSFPNLTS 327
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 61/270 (22%), Positives = 116/270 (42%), Gaps = 51/270 (18%)
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSS-CHHENVVTYHTSFVVKDELWLVLRLLEGGSL 136
A+K + + + +L+ E++ M H+N++ + L++++ G+L
Sbjct: 115 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 174
Query: 137 LD-IIKHRLKISNCKHGVCDEPTIATVLREVL-------KGLEYFHSNGQIHRDIKAGNI 188
+ + R + + P ++++ +G+EY S IHRD+ A N+
Sbjct: 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234
Query: 189 LLGEDGTVQIADFGVSAWLATGRDLSRQK-----------VRHTFVGTPCWMAPEVMEQD 237
L+ E+ ++IADFG++ RD++ V+ WMAPE + D
Sbjct: 235 LVTENNVMKIADFGLA------RDINNIDYYKKTTNGRLPVK--------WMAPEAL-FD 279
Query: 238 HGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQN---DPPTLDTGAAEKDQY 293
Y ++D+WS G+ E+ T G +PY P ++ L + D P + Y
Sbjct: 280 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPAN----CTNELY 335
Query: 294 KAYGKTFRKMISDCLQKDPTKRPTASELLK 323
M+ DC P++RPT +L++
Sbjct: 336 --------MMMRDCWHAVPSQRPTFKQLVE 357
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 67/280 (23%), Positives = 121/280 (43%), Gaps = 56/280 (20%)
Query: 72 CKARAEK------CAIKKINLEKWNTSMDE---LLKEIQAMSS-CHHENVVTYHTSFVVK 121
KAR +K AIK++ K S D+ E++ + HH N++ + +
Sbjct: 42 LKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98
Query: 122 DELWLVLRLLEGGSLLD-IIKHRLKISN----CKHGVCDEPTIATVL---REVLKGLEYF 173
L+L + G+LLD + K R+ ++ + + +L +V +G++Y
Sbjct: 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158
Query: 174 HSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK------VRHTFVGTPC 227
IHRD+ A NIL+GE+ +IADFG L+ G+++ +K VR
Sbjct: 159 SQKQFIHRDLAARNILVGENYVAKIADFG----LSRGQEVYVKKTMGRLPVR-------- 206
Query: 228 WMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQN---DPPTL 283
WMA E + Y +D+WS G+ E+ + G PY ++ Q + P
Sbjct: 207 WMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 265
Query: 284 DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ + Y ++ C ++ P +RP+ +++L
Sbjct: 266 ----CDDEVY--------DLMRQCWREKPYERPSFAQILV 293
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 58/300 (19%), Positives = 101/300 (33%), Gaps = 76/300 (25%)
Query: 64 LAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSF---VV 120
A A+K + E + +E M+ + N+V
Sbjct: 65 QARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV----KLLGVCA 120
Query: 121 KDE-LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVL---------------- 163
+ + L+ + G L + ++ + C D T A V
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180
Query: 164 REVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK------ 217
R+V G+ Y +HRD+ N L+GE+ V+IADFG+S R++
Sbjct: 181 RQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------RNIYSADYYKADG 234
Query: 218 -----VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKV 271
+R WM PE + + Y ++D+W+ G+ E+ + G PY+ +V
Sbjct: 235 NDAIPIR--------WMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285
Query: 272 LMLTLQ--------NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ N P L Y ++ C K P RP+ + +
Sbjct: 286 IYYVRDGNILACPENCPLEL---------Y--------NLMRLCWSKLPADRPSFCSIHR 328
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 75/364 (20%), Positives = 132/364 (36%), Gaps = 91/364 (25%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+YEV +VIG G+ V AY + A+K + N ++
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR---------------------NEKR 135
Query: 89 W-NTSMDEL--LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK 145
+ + +E+ L+ ++ + NV+ +F ++ + + LL +L ++IK
Sbjct: 136 FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIK---- 190
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG--TVQIADFGV 203
N G P + +L+ L+ H N IH D+K NILL + G +++ DFG
Sbjct: 191 -KNKFQGF-SLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA-- 261
S Q+V +T++ + + APEV+ Y D+WSLG E+ TG
Sbjct: 249 SC-------YEHQRV-YTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLL 299
Query: 262 PYHKYPAMKVLMLTLQNDPPT----------------------LDTGAAEKDQYKAYGKT 299
P M+ L P T ++ G++
Sbjct: 300 PGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRS 359
Query: 300 FRKMISD-------------------------CLQKDPTKRPTASELLKNPFFKKAKDKK 334
R + CL+ DP R T + L++P+ ++ K
Sbjct: 360 RRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP 419
Query: 335 FIQQ 338
+
Sbjct: 420 PTGE 423
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 5e-21
Identities = 78/396 (19%), Positives = 129/396 (32%), Gaps = 132/396 (33%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+Y V +G+G + V ++ + A+K + + H
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYT------------------ 77
Query: 89 WNTSMDEL--LKEIQAMSSCH--HENVVTYHTSFVVKDE----LWLVLRLLEGGSLLDII 140
T++DE+ LK ++ E VV F + + +V +L G LL I
Sbjct: 78 -ETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWI 135
Query: 141 KHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGNILLG-------- 191
+ P + ++++VL+GL+Y H+ IH DIK NILL
Sbjct: 136 IK------SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189
Query: 192 -----------------------------------------EDGTVQIADFGVSAWLATG 210
E V+IAD G + W+
Sbjct: 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV--- 246
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMK 270
K + T + + EV+ GY+ ADIWS A E+ATG + + +
Sbjct: 247 -----HKHFTEDIQTRQYRSLEVLI-GSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300
Query: 271 V--------LMLTLQNDPPT--LDTGAAEKDQYKAYG----------------------- 297
L++ L P + G K+ + G
Sbjct: 301 YTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEW 360
Query: 298 -----KTFRKMISDCLQKDPTKRPTASELLKNPFFK 328
F + L+ P KR TA+E L++P+
Sbjct: 361 SQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 8e-21
Identities = 74/269 (27%), Positives = 117/269 (43%), Gaps = 58/269 (21%)
Query: 80 AIKKINLEKWNTSM---DELLKEIQAMSSCHHENVVT---YHTSFVVKDELWLVLRLLEG 133
A+KK+ T+ + +EI+ M+ C HEN+V + + D+L LV +
Sbjct: 58 AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD---GDDLCLVYVYMPN 114
Query: 134 GSLLDII-----------KHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182
GSLLD + R KI+ G A G+ + H N IHRD
Sbjct: 115 GSLLDRLSCLDGTPPLSWHMRCKIAQ---G------AA-------NGINFLHENHHIHRD 158
Query: 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHT---FVGTPCWMAPEVMEQDHG 239
IK+ NILL E T +I+DFG LA R + VGT +MAPE + G
Sbjct: 159 IKSANILLDEAFTAKISDFG----LA--RASEKFAQTVMTSRIVGTTAYMAPEAL---RG 209
Query: 240 Y-DFKADIWSLGITAIEMATGTAPYHKYPAMKVLM---LTLQNDPPTLDTGAAEK-DQYK 294
K+DI+S G+ +E+ TG ++ ++L+ ++++ T++ +K +
Sbjct: 210 EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA- 268
Query: 295 AYGKTFRKMI---SDCLQKDPTKRPTASE 320
+ M S CL + KRP +
Sbjct: 269 -DSTSVEAMYSVASQCLHEKKNKRPDIKK 296
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 74/358 (20%), Positives = 119/358 (33%), Gaps = 90/358 (25%)
Query: 29 DQYEVREVIG---FGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI- 84
+YE+ + +G FG VV +C K A+K +
Sbjct: 14 ARYEIVDTLGEGAFGK--VV----------ECIDHKAG------------GRHVAVKIVK 49
Query: 85 NLEKW-NTSMDEL--LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIK 141
N++++ + E+ L+ + V F + +V LL G S D IK
Sbjct: 50 NVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIK 108
Query: 142 HRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADF 201
N I + ++ K + + HSN H D+K NIL + + +
Sbjct: 109 -----ENGFLPF-RLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162
Query: 202 GVSAWLATGRDLSRQKVR--------------HTFVGTPCWMAPEVMEQDHGYDFKADIW 247
+ R L ++ T V T + APEV+ G+ D+W
Sbjct: 163 KIKR---DERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVI-LALGWSQPCDVW 218
Query: 248 SLGITAIEMATGTA--PYHKYPAMKVLMLTLQNDPPT--LDTGAAEK---------DQYK 294
S+G IE G P H +M + P + K D++
Sbjct: 219 SIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHS 278
Query: 295 AYGKTFRK---------------------MISDCLQKDPTKRPTASELLKNPFFKKAK 331
+ G+ + +I L+ DP KR T E LK+PFF K
Sbjct: 279 SAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 79/366 (21%), Positives = 126/366 (34%), Gaps = 100/366 (27%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
D+YE+ +IG G+ V AY + E AIK I N +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK---------------------NKKA 92
Query: 89 W-NTSMDE--LLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK 145
+ N + E LL+ + + +V F+ ++ L LV +L +L D+++
Sbjct: 93 FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLR---- 147
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSN--GQIHRDIKAGNILLGEDG--TVQIADF 201
+ GV +++ L + + IH D+K NILL ++I DF
Sbjct: 148 -NTNFRGV-SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT--- 258
G S Q++ + ++ + + +PEV+ YD D+WSLG +EM T
Sbjct: 206 GSSCQ-------LGQRI-YQYIQSRFYRSPEVL-LGMPYDLAIDMWSLGCILVEMHTGEP 256
Query: 259 ------------------GTAPYH--------------------------------KYPA 268
G P H K P
Sbjct: 257 LFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPG 316
Query: 269 MKVLM--LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
+ L L ++ P Y K F+ +I L DP R L++ F
Sbjct: 317 TRKLHNILGVETGGPGGRRAGESGHTVADYLK-FKDLILRMLDYDPKTRIQPYYALQHSF 375
Query: 327 FKKAKD 332
FKK D
Sbjct: 376 FKKTAD 381
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 54/171 (31%), Positives = 82/171 (47%), Gaps = 33/171 (19%)
Query: 164 REVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK--VRHT 221
+V KG+E+ S IHRD+ A NILL E V+I DFG++ RD+ + VR
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RDIYKDPDYVRKG 253
Query: 222 FVGTP-CWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKV---LMLTL 276
P WMAPE + D Y ++D+WS G+ E+ + G +P YP +K+ L
Sbjct: 254 DARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKIDEEFCRRL 309
Query: 277 QN----DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+ P + Y + + DC +P++RPT SEL++
Sbjct: 310 KEGTRMRAPDY----TTPEMY--------QTMLDCWHGEPSQRPTFSELVE 348
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 78/358 (21%), Positives = 123/358 (34%), Gaps = 90/358 (25%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ + V +G G V + A+K + N++K
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR---------------------NIKK 73
Query: 89 W-NTSMDEL--LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK 145
+ ++ E LK+IQ ++ N+V YH F+ D + L+ L G SL +II
Sbjct: 74 YTRSAKIEADILKKIQNDDINNN-NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIIT---- 127
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSA 205
N +G I E+LK L Y H D+K NILL + +
Sbjct: 128 -RNNYNGF-HIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185
Query: 206 WLATGRDLSRQKVRHTFV-----GTPCWM--------------APEVMEQDHGYDFKADI 246
+ R K T + G + APEV+ + G+D +D+
Sbjct: 186 TDGKKIQIYRTK--STGIKLIDFGCATFKSDYHGSIINTRQYRAPEVI-LNLGWDVSSDM 242
Query: 247 WSLGITAIEMATGTA--PYHKYPAMKVLMLTLQNDPPT--LDTGAA-------EKDQYKA 295
WS G E+ TG+ H++ +M ++ P L KD+ K
Sbjct: 243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKL 302
Query: 296 YGKT-------------------------FRKMISDCLQKDPTKRPTASELLKNPFFK 328
F + LQ DPT RP+ +ELLK+ F +
Sbjct: 303 AWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 66/363 (18%), Positives = 121/363 (33%), Gaps = 84/363 (23%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI-NLE 87
++YE+ +G G V AR + + A+K I N+
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGK---------------------SQVALKIIRNVG 57
Query: 88 KW-NTSMDEL--LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRL 144
K+ + E+ LK+I+ + V F + + LL G + + +K
Sbjct: 58 KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLK--- 113
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS 204
N P + + ++ L + H N H D+K NIL + + S
Sbjct: 114 --ENNFQPY-PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170
Query: 205 AWLATGRDLSRQKVR--------------HTFVGTPCWMAPEVMEQDHGYDFKADIWSLG 250
+ + +R T V T + PEV+ + G+ D+WS+G
Sbjct: 171 C---EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVI-LELGWAQPCDVWSIG 226
Query: 251 ITAIEMATGTA--PYHKYPAMKVLMLTLQNDPPT--LDTGAAEK---------DQYKAYG 297
E G H+ V+M + P+ + +K D+ + G
Sbjct: 227 CILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDG 286
Query: 298 KTFRK---------------------MISDCLQKDPTKRPTASELLKNPFFKKAKDKKFI 336
+ ++ ++ L+ DP +R T +E L +PFF ++
Sbjct: 287 RYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERS 346
Query: 337 QQT 339
T
Sbjct: 347 FHT 349
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 63/273 (23%), Positives = 110/273 (40%), Gaps = 58/273 (21%)
Query: 80 AIKKINLEKWNTSM---DELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSL 136
A+K+ S +E EI+ +S C H ++V+ ++E+ L+ + +E G+L
Sbjct: 67 ALKRRT----PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 137 LDIIKHRLKISNCKHGVCDEPT---IATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
K L S+ I +GL Y H+ IHRD+K+ NILL E+
Sbjct: 123 ----KRHLYGSDLPTMSMSWEQRLEICI---GAARGLHYLHTRAIIHRDVKSINILLDEN 175
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRH--TFV-GTPCWMAPE-VMEQDHGYDFKADIWSL 249
+I DFG+S T D + H T V GT ++ PE ++ + K+D++S
Sbjct: 176 FVPKITDFGISK-KGTELDQT-----HLSTVVKGTLGYIDPEYFIKG-RLTE-KSDVYSF 227
Query: 250 GITAIEMATGTAPYHKYPAMKVLMLTLQNDP--------PTLDTGAAE-------KDQYK 294
G+ E+ ++ +L + + + G E D+ +
Sbjct: 228 GVVLFEVLCA---------RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIR 278
Query: 295 AYGKTFRKMI---SDCLQKDPTKRPTASELLKN 324
++ RK CL RP+ ++L
Sbjct: 279 P--ESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 64/269 (23%), Positives = 99/269 (36%), Gaps = 53/269 (19%)
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
A+K++ E+ + E++ +S H N++ + E LV + GS+
Sbjct: 58 AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV--- 114
Query: 140 IKHRLKISNCKHGVCDEPT---IATVLREVLKGLEYFHSNGQ---IHRDIKAGNILLGED 193
L+ D P IA +GL Y H + IHRD+KA NILL E+
Sbjct: 115 -ASCLRERPESQPPLDWPKRQRIAL---GSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRH---TFVGTPCWMAPE-VMEQDHGY-DFKADIWS 248
+ DFG LA L K H GT +APE + G K D++
Sbjct: 171 FEAVVGDFG----LAK---LMDYKDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFG 220
Query: 249 LGITAIEMATGTAP--YHKYPAMKVLML-----TLQNDP-------PTLDTGAAEKDQYK 294
G+ +E+ TG + +ML L + L +++
Sbjct: 221 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE--- 277
Query: 295 AYGKTFRKMI---SDCLQKDPTKRPTASE 320
++I C Q P +RP SE
Sbjct: 278 -----VEQLIQVALLCTQSSPMERPKMSE 301
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 52/256 (20%), Positives = 85/256 (33%), Gaps = 60/256 (23%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89
+ V + IG G + E AIK LE
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-------------------------LEPM 44
Query: 90 NTSMDELLKEIQAMSS-CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+ +L E + + + + +VL LL G SL D+
Sbjct: 45 KSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDL------ 97
Query: 149 CKHGVCDEPTIATVLR---EVLKGLEYFHSNGQIHRDIKAGNILLGEDGT-----VQIAD 200
C ++ TVL +++ +EY HS I+RD+K N L+G G + I D
Sbjct: 98 CDR----TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIID 153
Query: 201 FGVSAWLATGRDLSRQKV-----RHTFVGTPCWMAPEV---MEQDHGYDFKADIWSLGIT 252
F ++ D +K + GT +M+ EQ + D+ +LG
Sbjct: 154 FALAKEY---IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ----SRRDDLEALGHM 206
Query: 253 AIEMATGTAPYHKYPA 268
+ G+ P+ A
Sbjct: 207 FMYFLRGSLPWQGLKA 222
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 57/254 (22%), Positives = 87/254 (34%), Gaps = 56/254 (22%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++Y + IG G+ ++ A E+ AIK E
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-------------------------EC 43
Query: 89 WNTSMDELLKEIQ---AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK 145
T +L E + M + T D +V+ LL G SL D+
Sbjct: 44 VKTKHPQLHIESKIYKMMQGGVG--IPTIRWCGAEGDYNVMVMELL-GPSLEDLFN---- 96
Query: 146 ISNCKHGVCDEPTIATVLR---EVLKGLEYFHSNGQIHRDIKAGNILLGEDGT---VQIA 199
C ++ TVL +++ +EY HS IHRD+K N L+G V I
Sbjct: 97 --FCSRKF----SLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII 150
Query: 200 DFGVSAWLATGRDLSRQKVR--HTFVGTPCWM---APEVMEQDHGYDFKADIWSLGITAI 254
DFG++ R R GT + +EQ + D+ SLG +
Sbjct: 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ----SRRDDLESLGYVLM 206
Query: 255 EMATGTAPYHKYPA 268
G+ P+ A
Sbjct: 207 YFNLGSLPWQGLKA 220
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 46/254 (18%), Positives = 83/254 (32%), Gaps = 54/254 (21%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
Y+V IG G+ V+ ++ AIK E
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-------------------------EP 44
Query: 89 WNTSMDELLKEIQAMSS-CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ +L E + + + LV+ LL G SL D++
Sbjct: 45 RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLD------ 97
Query: 148 NCKHGVCDEPTIATVLR---EVLKGLEYFHSNGQIHRDIKAGNILLGEDGT-----VQIA 199
C + ++ TV ++L ++ H ++RDIK N L+G + + +
Sbjct: 98 LCGR----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 153
Query: 200 DFGVSAWLATGRDLSR--QKVRHTFVGTPCWM---APEVMEQDHGYDFKADIWSLGITAI 254
DFG+ + + + GT +M EQ + D+ +LG +
Sbjct: 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ----SRRDDLEALGHVFM 209
Query: 255 EMATGTAPYHKYPA 268
G+ P+ A
Sbjct: 210 YFLRGSLPWQGLKA 223
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 56/257 (21%), Positives = 90/257 (35%), Gaps = 62/257 (24%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+++ + IG G+ ++ E+ AIK E
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------------EN 41
Query: 89 WNTSMDELLKEIQ---AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK 145
T +LL E + + + V D LV+ LL G SL D+
Sbjct: 42 VKTKHPQLLYESKIYRILQGGTG--IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF--- 95
Query: 146 ISNCKHGVCDEPTIATVLR---EVLKGLEYFHSNGQIHRDIKAGNILLGEDGT---VQIA 199
C + ++ TVL +++ +E+ HS +HRDIK N L+G V I
Sbjct: 96 ---CSRKL----SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148
Query: 200 DFGVSAWLATGRDLSRQKV-----RHTFVGTPCWM---APEVMEQDHGYDFKADIWSLGI 251
DFG++ RD S + GT + +EQ + D+ SLG
Sbjct: 149 DFGLAKKY---RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ----SRRDDLESLGY 201
Query: 252 TAIEMATGTAPYHKYPA 268
+ G+ P+ A
Sbjct: 202 VLMYFLRGSLPWQGLKA 218
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 44/257 (17%), Positives = 92/257 (35%), Gaps = 44/257 (17%)
Query: 30 QYEVREVIGFGATAVVHSAY--------CKARAEKCAIK--KINLAVVHSAYCKARAEKC 79
Q++++ +++ A + +K ++K + + + RA
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRA--- 99
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDEL-WLVLRLLEGGSLLD 138
K + + KW S + T V +D+ +LVL L G SL
Sbjct: 100 -AKPLQVNKWKKL-----------YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS 146
Query: 139 IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQI 198
+ V E ++ V +L LE+ H N +H ++ A NI + + Q+
Sbjct: 147 ALDV------SPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQV 200
Query: 199 --ADFGVS-AWLATGRDLS-RQKVRHTFVGTPCWM---APEVMEQDHGYDFKADIWSLGI 251
A +G + + +G+ ++ + R G ++ + ++D+ SLG
Sbjct: 201 TLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP----SRRSDLQSLGY 256
Query: 252 TAIEMATGTAPYHKYPA 268
++ G P+
Sbjct: 257 CMLKWLYGFLPWTNCLP 273
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 53/256 (20%), Positives = 96/256 (37%), Gaps = 39/256 (15%)
Query: 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIK--KINLAVVHSAYCKARAEKCAIKKINLE 87
Q+ + + IG G +++ A+ + EK A K+ + + + + KK ++
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELW--LVLRLLEGGSLLDIIKHRLK 145
KW ++ + + + K + +V+ L G L I
Sbjct: 98 KW---IERKQLDYLGIPLFY------GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT 147
Query: 146 ISNCKHGVCDEPTIATVLR---EVLKGLEYFHSNGQIHRDIKAGNILLG--EDGTVQIAD 200
+TVL+ +L LEY H N +H DIKA N+LLG V +AD
Sbjct: 148 FK-----------KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLAD 196
Query: 201 FGVS-AWLATGRDLS-RQKVRHTFVGTPCWM---APEVMEQDHGYDFKADIWSLGITAIE 255
+G+S + G ++ R GT + A + + ++D+ LG +
Sbjct: 197 YGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL----SRRSDVEILGYCMLR 252
Query: 256 MATGTAPYHKYPAMKV 271
G P+ + V
Sbjct: 253 WLCGKLPWEQNLKDPV 268
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 1e-09
Identities = 56/354 (15%), Positives = 103/354 (29%), Gaps = 74/354 (20%)
Query: 22 VPWPN--TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKC 79
VP+ + ++ + E IG G V AIK I +
Sbjct: 11 VPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADH--TPVAIKIIAIEG------PDLVNGS 62
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVK------------------ 121
K + + L + E + ++ V+
Sbjct: 63 HQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122
Query: 122 ------------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKG 169
D+L++VL GG L+ ++ +L T ++L ++
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLS---------SLATAKSILHQLTAS 173
Query: 170 LEYFHSNGQI-HRDIKAGNILLGEDGTVQIAD-----------FGVSAWLATGRDLSRQK 217
L ++ + HRD+ GN+LL + ++ G+ + LSR +
Sbjct: 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID-YTLSRLE 232
Query: 218 VRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT-APYHKYPAMKVLMLTL 276
V M ++ D Y F DI+ L G PY + L +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQF--DIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 277 QNDPPTLDTG-AAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329
Q K + F + + + +A++LL K
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNF--------SSATDLLCQHSLFK 336
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 29/121 (23%), Positives = 46/121 (38%), Gaps = 14/121 (11%)
Query: 158 TIATVLR---EVLKGLEYFHSNGQIHRDIKAGNILLG--EDGTVQIADFGVSA--WLATG 210
+ TVL+ +L LEY H + +H DIKA N+LL V + D+G++
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 211 RDLSRQKVRHTFVGTPCWM---APEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267
+ GT + A + + D+ LG I+ TG P+
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAP----SRRGDLEILGYCMIQWLTGHLPWEDNL 265
Query: 268 A 268
Sbjct: 266 K 266
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 6e-05
Identities = 60/450 (13%), Positives = 116/450 (25%), Gaps = 151/450 (33%)
Query: 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRL----KISNCKHGVCDEPTIATV 162
HH + +H F E + DI+ +CK V D P
Sbjct: 1 HHHH---HHMDFET-GEHQYQYK--------DILSVFEDAFVDNFDCKD-VQDMP----- 42
Query: 163 LREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQK-VRHT 221
+ +L E H ++ V W LS+Q+ +
Sbjct: 43 -KSILSKEEIDH--------------IIMSKDAVSGTLRLF--WTL----LSKQEEMVQK 81
Query: 222 FVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPP 281
FV EV+ + Y F + S P + P
Sbjct: 82 FVE-------EVLRIN--YKF---LMS-------------PIKT-----------EQRQP 105
Query: 282 TLDTGAAEKDQYKAYGKTFRKMISD--CLQKDPTKRPTASELLKNPFFKKAKDKKFI--- 336
++ T + Y + ++ +D K R L+ + + K +
Sbjct: 106 SMMT--------RMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL-LELRPAKNVLID 156
Query: 337 ------QQTLVSVGPTFET-RIQKAAKKNPGASGRLHRTVTGEWVWSSEDEGDKSSDDEK 389
+ + + K K ++ W+ + + +S +
Sbjct: 157 GVLGSGKTWVAL-----DVCLSYKVQCKMDF---KIF------WL----NLKNCNSPETV 198
Query: 390 KEKPMN-CLQEVDSSGEEEDRVVNLILRMRNVSSGEEEDRVVNLILR---------MRNV 439
E Q + D N+ LR+ + + L+ + NV
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRI-----HSIQAELRRLLKSKPYENCLLVLLNV 253
Query: 440 RRELNDIR-FEF-C----IGKDTS--DGIAG--------ELVGAGLVDARDTEAISQNLE 483
+ F C + D ++ + L + + L+
Sbjct: 254 Q-NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD 312
Query: 484 LVVNGTPRKKSVTFPLSSTLQPGEVADEKA 513
PR+ T P ++ + D A
Sbjct: 313 CRPQDLPREVLTTNPRRLSIIAESIRDGLA 342
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 520 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 99.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.05 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.77 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.58 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.08 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.04 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.95 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.56 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.47 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.15 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.12 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.99 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.88 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.84 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.77 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.77 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.59 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.23 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.91 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.65 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.06 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.52 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-64 Score=499.76 Aligned_cols=268 Identities=26% Similarity=0.424 Sum_probs=234.4
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
..-++|++.++||+|+||+||+|+++.+|+.||+|++++..... ....+.+.+|+++|++
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~--------------------~~~~~~~~~E~~il~~ 88 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK--------------------ENKVPYVTRERDVMSR 88 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHTT
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC--------------------HHHHHHHHHHHHHHHh
Confidence 34467999999999999999999999999999999987543321 2245679999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
|+|||||+++++|.+++.+|||||||+||+|.++++. .+.+++..++.|+.||+.||+|||++|||||||||
T Consensus 89 l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~--------~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKP 160 (311)
T 4aw0_A 89 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--------IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP 160 (311)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred CCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCH
Confidence 9999999999999999999999999999999999984 46799999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.+|.+||+|||+|+.+.... ......+++|||.|||||++.+.. |+.++|||||||++|+|+||.+||.+
T Consensus 161 eNILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~ 236 (311)
T 4aw0_A 161 ENILLNEDMHIQITDFGTAKVLSPES---KQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRA 236 (311)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTT---TCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHeEEcCCCCEEEEEcCCceecCCCC---CcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999998875432 223345789999999999998765 99999999999999999999999999
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH------HhcCccccccchhhH
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE------LLKNPFFKKAKDKKF 335 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e------lL~hp~~~~~~~~~~ 335 (520)
.+....+..+...... ++ ..+++++++||.+||++||++|||+.| +++||||+...+...
T Consensus 237 ~~~~~~~~~i~~~~~~-~p---------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 237 GNEGLIFAKIIKLEYD-FP---------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp SSHHHHHHHHHHTCCC-CC---------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred CCHHHHHHHHHcCCCC-CC---------cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 8888887777766533 22 346889999999999999999999998 588999998876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-63 Score=502.47 Aligned_cols=263 Identities=27% Similarity=0.497 Sum_probs=226.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++++.||+|+||+||+|+++.+|+.||||+++..... ....+.+.+|+.+|++
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---------------------~~~~~~~~~E~~il~~ 79 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS---------------------SKEREESRREVAVLAN 79 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC---------------------HHHHHHHHHHHHHHHH
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC---------------------HHHHHHHHHHHHHHHH
Confidence 3458999999999999999999999999999999988643211 2345679999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
|+|||||+++++|.+++.+|||||||+||+|.++|... +...+++..++.|+.||+.||.|||++|||||||||
T Consensus 80 l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~------~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp 153 (350)
T 4b9d_A 80 MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ------KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKS 153 (350)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCG
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCH
Confidence 99999999999999999999999999999999999754 456789999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+||||+.+|.+||+|||+|+.+... .....+.+|||.|||||++.+.. |+.++|||||||+||+|+||++||.+
T Consensus 154 ~NILl~~~g~vKl~DFGla~~~~~~-----~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~ 227 (350)
T 4b9d_A 154 QNIFLTKDGTVQLGDFGIARVLNST-----VELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEA 227 (350)
T ss_dssp GGEEECTTCCEEECSTTEESCCCHH-----HHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred HHEEECCCCCEEEcccccceeecCC-----cccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999876432 22345678999999999998765 99999999999999999999999999
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.+..+.+..+..+..+.+. ..+|+++++||.+||++||.+|||+.|+|+||||++.
T Consensus 228 ~~~~~~~~~i~~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 228 GSMKNLVLKIISGSFPPVS---------LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp SSHHHHHHHHHHTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred cCHHHHHHHHHcCCCCCCC---------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9988888888877655443 3578899999999999999999999999999999754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-62 Score=496.41 Aligned_cols=260 Identities=39% Similarity=0.665 Sum_probs=229.2
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
..+|++++.||+|+||+||+|.++.+|+.||||+++... ....+.+.+|+.+|++|+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-----------------------~~~~~~~~~Ei~il~~l~ 129 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-----------------------QQRRELLFNEVVIMRDYQ 129 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-----------------------CSSGGGGHHHHHHHHHCC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-----------------------hhHHHHHHHHHHHHHhCC
Confidence 467999999999999999999999999999999886321 112234789999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||||+++++|.+++.+|||||||+||+|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+|
T Consensus 130 HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~---------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 200 (346)
T 4fih_A 130 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 200 (346)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHH
Confidence 99999999999999999999999999999999963 468999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
|||+.+|.+||+|||+|+.+.... ....+++|||.|||||++.+.. |+.++|||||||++|||+||.+||.+.+
T Consensus 201 ILl~~~g~vKl~DFGla~~~~~~~-----~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 201 ILLTHDGRVKLSDFGFCAQVSKEV-----PRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp EEECTTCCEEECCCTTCEECCSSS-----CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EEECCCCCEEEecCcCceecCCCC-----CcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999999999999999998765322 2345689999999999987655 9999999999999999999999999998
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
..+.+..+....++.+.. +..+++++++||.+||++||++|||+.|+|+||||++...
T Consensus 275 ~~~~~~~i~~~~~~~~~~-------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 275 PLKAMKMIRDNLPPRLKN-------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHHHHHHHHHSSCCCCSC-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHHHHcCCCCCCCc-------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 888887777665544432 3568899999999999999999999999999999987654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-62 Score=482.02 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=210.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
.-++|++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.+|++|
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--------------------~~~~~~~~~Ei~il~~l 70 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK--------------------SDMQGRIEREISYLRLL 70 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------------------------CHHHHHHHHHHHHHC
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC--------------------HHHHHHHHHHHHHHHHC
Confidence 3478999999999999999999999999999999886432211 22356789999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+|||||+++++|.+++.+|+||||+ +|+|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+
T Consensus 71 ~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~--------~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~ 141 (275)
T 3hyh_A 71 RHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ--------RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPE 141 (275)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH--------SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTT
T ss_pred CCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChH
Confidence 9999999999999999999999999 7899999974 467999999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.+|.+||+|||+|+.... .....+.+|||.|||||++.+..+++.++|||||||++|+|+||++||.+.
T Consensus 142 NILl~~~~~vkl~DFGla~~~~~------~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 142 NLLLDEHLNVKIADFGLSNIMTD------GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp TEEECTTCCEEECCSSCC---------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HeEECCCCCEEEeecCCCeecCC------CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999976542 223346799999999999988775678999999999999999999999988
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
+....+..+....+. ++ ..+|+++++||.+||++||++|||+.|+++||||+..
T Consensus 216 ~~~~~~~~i~~~~~~-~p---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 216 SIPVLFKNISNGVYT-LP---------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp SHHHHHHHHHHTCCC-CC---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred CHHHHHHHHHcCCCC-CC---------CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 777766665554432 22 3478899999999999999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-61 Score=500.13 Aligned_cols=261 Identities=39% Similarity=0.662 Sum_probs=230.0
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++++.||+|+||+||+|.++.+|+.||||+++... ....+.+.+|+.+|++|
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-----------------------~~~~~~~~~Ei~il~~l 205 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-----------------------QQRRELLFNEVVIMRDY 205 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-----------------------CSSGGGHHHHHHHHHHC
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-----------------------hhHHHHHHHHHHHHHhC
Confidence 3567999999999999999999999999999999875321 11234588999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+|||||+++++|.+++.+|||||||+||+|.++++. +.+++.+++.|+.||+.||+|||++|||||||||+
T Consensus 206 ~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~---------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~ 276 (423)
T 4fie_A 206 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 276 (423)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTT
T ss_pred CCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHH
Confidence 999999999999999999999999999999999963 45899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
||||+.+|.+||+|||+|+.+.... ....+++|||.|||||++.+.. |+.++|||||||++|||++|++||.+.
T Consensus 277 NILl~~~g~vKl~DFGla~~~~~~~-----~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~ 350 (423)
T 4fie_A 277 SILLTHDGRVKLSDFGFCAQVSKEV-----PRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNE 350 (423)
T ss_dssp TEEECTTCCEEECCCTTCEECCSSC-----CCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred HEEEcCCCCEEEecCccceECCCCC-----ccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999998765322 2345789999999999997655 999999999999999999999999999
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
...+.+..+..+.++.+.. +..+++++++||.+||++||.+|||+.|+|+||||++...
T Consensus 351 ~~~~~~~~i~~~~~~~~~~-------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 351 PPLKAMKMIRDNLPPRLKN-------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp CHHHHHHHHHHSCCCCCSC-------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CHHHHHHHHHcCCCCCCcc-------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 8888888777765544432 2467899999999999999999999999999999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-61 Score=477.40 Aligned_cols=256 Identities=24% Similarity=0.426 Sum_probs=215.7
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
..|++.++||+|+||+||+|.++.++..||+|++..... .....+.+.+|+.+|++|+|
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------------------~~~~~~~~~~E~~il~~l~H 84 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---------------------TKSERQRFKEEAEMLKGLQH 84 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---------------------CHHHHHHHHHHHHHHHTCCC
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---------------------CHHHHHHHHHHHHHHHhCCC
Confidence 335888999999999999999999999999998753311 12345679999999999999
Q ss_pred CCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecc
Q psy11359 109 ENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG--QIHRD 182 (520)
Q Consensus 109 pnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g--iiHrD 182 (520)
||||+++++|.+ +..+|||||||+||+|.++++. .+.+++..++.|+.||+.||.|||++| |||||
T Consensus 85 pnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~--------~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRD 156 (290)
T 3fpq_A 85 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--------FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRD 156 (290)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCC
T ss_pred CCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecc
Confidence 999999999975 3568999999999999999984 467899999999999999999999999 99999
Q ss_pred cCCCcEEEc-CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 183 IKAGNILLG-EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 183 LKp~NILl~-~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|||+|||++ .+|.+||+|||+|+... .....+.+|||.|||||++.+. |+.++|||||||+||+|+||++
T Consensus 157 lKp~NILl~~~~g~vKl~DFGla~~~~-------~~~~~~~~GTp~YmAPE~~~~~--y~~~~DiwSlGvilyelltg~~ 227 (290)
T 3fpq_A 157 LKCDNIFITGPTGSVKIGDLGLATLKR-------ASFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp CCGGGEEESSTTSCEEECCTTGGGGCC-------TTSBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSC
T ss_pred cChhheeEECCCCCEEEEeCcCCEeCC-------CCccCCcccCccccCHHHcCCC--CCcHHHHHHHHHHHHHHHHCCC
Confidence 999999997 48999999999997542 2234567999999999998653 9999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
||.+......+...+...... ......+++++++||.+||++||++|||+.|+|+||||++
T Consensus 228 Pf~~~~~~~~~~~~i~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 228 PYSECQNAAQIYRRVTSGVKP-------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp TTTTCSSHHHHHHHHTTTCCC-------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCCCcHHHHHHHHHcCCCC-------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 998766655555544432211 1122456789999999999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=484.15 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=219.5
Q ss_pred CCeEEEeeeeecCceEEEEEEEc---CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCK---ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
++|++++.||+|+||+||+|++. .+++.||+|+++.... +. ....++.+|+.+|++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--------------~~-------~~~~~~~~E~~il~~ 82 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL--------------KV-------RDRVRTKMERDILVE 82 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEE--------------EE-------EECC------CCCCC
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHc--------------Ch-------HHHHHHHHHHHHHHH
Confidence 67999999999999999999884 4678899998853211 00 111247789999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
|+|||||+++++|.+++.+|||||||+||+|.++++. .+.+++.+++.++.||+.||+|||++|||||||||
T Consensus 83 l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--------~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp 154 (304)
T 3ubd_A 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK--------EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKP 154 (304)
T ss_dssp CCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHH--------HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCG
T ss_pred CCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCH
Confidence 9999999999999999999999999999999999984 46799999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.+|.+||+|||+|+..... .....+.+|||.|||||++.+.. |+.++|||||||++|+|+||++||.+
T Consensus 155 ~NILl~~~g~vKl~DFGla~~~~~~-----~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~ 228 (304)
T 3ubd_A 155 ENILLDEEGHIKLTDFGLSKESIDH-----EKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQG 228 (304)
T ss_dssp GGEEECTTSCEEEESSEEEEC----------CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHeEEcCCCCEEecccccceeccCC-----CccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCC
Confidence 9999999999999999999865332 22345679999999999997665 99999999999999999999999999
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchhhH
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~ 335 (520)
.+..+.+..+....+.. + ..+|+++++||.+||++||++||| ++|+++||||+..++...
T Consensus 229 ~~~~~~~~~i~~~~~~~-p---------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l 293 (304)
T 3ubd_A 229 KDRKETMTMILKAKLGM-P---------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL 293 (304)
T ss_dssp SSHHHHHHHHHHCCCCC-C---------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred cCHHHHHHHHHcCCCCC-C---------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHH
Confidence 88888887777665432 1 347889999999999999999999 479999999998876543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=482.93 Aligned_cols=264 Identities=29% Similarity=0.412 Sum_probs=219.5
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+....+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------------------------~~~E~~il 104 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------------------------RVEELVAC 104 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------------------------CTHHHHTT
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------------------------HHHHHHHH
Confidence 33455679999999999999999999999999999998753210 23699999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++|+|||||+++++|.+++.+|||||||+||+|.++++. .+.+++..++.|+.||+.||+|||++|||||||
T Consensus 105 ~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--------~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 176 (336)
T 4g3f_A 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--------MGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176 (336)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Confidence 999999999999999999999999999999999999984 367999999999999999999999999999999
Q ss_pred CCCcEEEcCCC-CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 184 KAGNILLGEDG-TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g-~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
||+||||+.+| .+||+|||+|+.+..............++|||.|||||++.+.. |+.++|||||||+||+|+||++|
T Consensus 177 Kp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~P 255 (336)
T 4g3f_A 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHP 255 (336)
T ss_dssp CGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCC
Confidence 99999999888 69999999998875433222222334578999999999998765 99999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH-------------hcCccccc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL-------------LKNPFFKK 329 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el-------------L~hp~~~~ 329 (520)
|.+......+..+....++. ...+..+++.+.+||.+||++||.+|||+.|+ |+|||+..
T Consensus 256 f~~~~~~~~~~~i~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 256 WTQYFRGPLCLKIASEPPPI-------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp STTTCCSCCHHHHHHSCCGG-------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred CCCCCHHHHHHHHHcCCCCc-------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 98877666666655544321 12235678999999999999999999999998 56888875
Q ss_pred cc
Q psy11359 330 AK 331 (520)
Q Consensus 330 ~~ 331 (520)
.+
T Consensus 329 ~~ 330 (336)
T 4g3f_A 329 YK 330 (336)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-58 Score=478.23 Aligned_cols=274 Identities=29% Similarity=0.422 Sum_probs=224.2
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++++.||+|+||+||+|.++.+|+.||||+++.... .....+.+.+|+++|++|+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~---------------------~~~~~~~~~~Ei~il~~l~ 111 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD---------------------VVTNAKRTLRELKILKHFK 111 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS---------------------SHHHHHHHHHHHHHHHHCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc---------------------chHHHHHHHHHHHHHHhcC
Confidence 4689999999999999999999999999999998753211 1234567889999999999
Q ss_pred CCCceEEEEEEEE------CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 108 HENVVTYHTSFVV------KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 108 HpnIv~~~~~~~~------~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
|||||++++++.. .+.+|||||||. |+|.+++. ..+.+++..++.|++||+.||.|||++|||||
T Consensus 112 HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~--------~~~~l~~~~~~~~~~qil~al~ylH~~~iiHR 182 (398)
T 4b99_A 112 HDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIH--------SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHR 182 (398)
T ss_dssp CTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHT--------SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred CCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCC
Confidence 9999999999864 367999999995 68999997 56789999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||++.+|.+||+|||+|+.+...... ......+++||+.|||||++.+..+|+.++||||+||++|||+||++
T Consensus 183 DlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~ 261 (398)
T 4b99_A 183 DLKPSNLLVNENCELKIGDFGMARGLCTSPAE-HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261 (398)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCBCC--------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSC
T ss_pred CcCccccccCCCCCEEEeecceeeecccCccc-cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCC
Confidence 99999999999999999999999876433221 23334578999999999999887778999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCC--CCCCC-------------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 262 PYHKYPAMKVLMLTLQND--PPTLD-------------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~--~~~~~-------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
||.+.+..+.+..+.... ++... ........++.+++++.+||.+||++||.+|||+.|
T Consensus 262 pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 341 (398)
T 4b99_A 262 LFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 341 (398)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 999988877776554321 11000 000011223456899999999999999999999999
Q ss_pred HhcCccccccch
Q psy11359 321 LLKNPFFKKAKD 332 (520)
Q Consensus 321 lL~hp~~~~~~~ 332 (520)
+|+||||+....
T Consensus 342 ~L~Hp~f~~~~~ 353 (398)
T 4b99_A 342 ALRHPFLAKYHD 353 (398)
T ss_dssp HTTSGGGTTTCC
T ss_pred HhcCHhhCcCCC
Confidence 999999986543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=453.24 Aligned_cols=264 Identities=24% Similarity=0.423 Sum_probs=201.1
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ......+.+.+|+.+|++|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----------------------~~~~~~~~~~~E~~il~~l~H 62 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP----------------------NRELAREKVMREVKALAKLEH 62 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC----------------------SSHHHHHHHHHHHHHHTTCCC
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc----------------------CCHHHHHHHHHHHHHHHhCCC
Confidence 3699999999999999999999999999998877532 113345678999999999999
Q ss_pred CCceEEEEEEEECC------------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 109 ENVVTYHTSFVVKD------------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 109 pnIv~~~~~~~~~~------------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
||||+++++|.+.+ .+|+|||||.||+|.++++.... ....++..++.|+.||+.||+|||++
T Consensus 63 pnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-----~~~~~~~~~~~i~~qi~~al~ylH~~ 137 (299)
T 4g31_A 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-----IEERERSVCLHIFLQIAEAVEFLHSK 137 (299)
T ss_dssp TTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCS-----GGGSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCC-----CChhHHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999998644 37999999999999999985321 12345677899999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCcccc-------ccccccccccccccCCcceecccCCCCcchhHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLS-------RQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSL 249 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~-------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSl 249 (520)
|||||||||+|||++.+|.+||+|||+|+.+....... ......+.+|||.|||||++.+.. |+.++|||||
T Consensus 138 ~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSl 216 (299)
T 4g31_A 138 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSL 216 (299)
T ss_dssp TCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHH
T ss_pred cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHH
Confidence 99999999999999999999999999998775432211 111234568999999999998765 9999999999
Q ss_pred HHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 250 GITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 250 G~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
||++|||++ ||................. . ...+...++.+.+||.+||++||.+|||+.|+|+||||+.
T Consensus 217 Gvilyell~---Pf~~~~~~~~~~~~~~~~~--~------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 217 GLILFELLY---PFSTQMERVRTLTDVRNLK--F------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHHHHHS---CCSSHHHHHHHHHHHHTTC--C------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHHHHcc---CCCCccHHHHHHHHHhcCC--C------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 999999996 8865433222222222211 1 1233556778899999999999999999999999999987
Q ss_pred cc
Q psy11359 330 AK 331 (520)
Q Consensus 330 ~~ 331 (520)
..
T Consensus 286 ~~ 287 (299)
T 4g31_A 286 LD 287 (299)
T ss_dssp C-
T ss_pred CC
Confidence 54
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-57 Score=461.42 Aligned_cols=270 Identities=24% Similarity=0.392 Sum_probs=210.4
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEc---CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCK---ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
|...++|++.+.||+|+||+||+|.++ .+++.||+|.+.. . ....++.+|++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~----------------------~---~~~~~~~~E~~ 71 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIP----------------------T---SHPIRIAAELQ 71 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECT----------------------T---SCHHHHHHHHH
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcc----------------------c---cCHHHHHHHHH
Confidence 456788999999999999999999886 3466677776532 1 12346889999
Q ss_pred HHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 102 AMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 102 ~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+|+.+ +|||||+++++|.+++.+|+||||++||+|.++++ .+++.+++.+++||+.||+|||++||||
T Consensus 72 ~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-----------~l~~~~~~~~~~qll~al~ylH~~gIiH 140 (361)
T 4f9c_A 72 CLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-----------SLSFQEVREYMLNLFKALKRIHQFGIVH 140 (361)
T ss_dssp HHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-----------TCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-----------CCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 99998 79999999999999999999999999999999983 3889999999999999999999999999
Q ss_pred cccCCCcEEEcCC-CCeEEeccCcceeeccCccc-----------------------cccccccccccccccCCcceecc
Q psy11359 181 RDIKAGNILLGED-GTVQIADFGVSAWLATGRDL-----------------------SRQKVRHTFVGTPCWMAPEVMEQ 236 (520)
Q Consensus 181 rDLKp~NILl~~~-g~vkL~DFG~a~~~~~~~~~-----------------------~~~~~~~~~~gt~~y~APE~~~~ 236 (520)
|||||+|||++.+ +.+||+|||+|+........ .......+.+|||.|||||++.+
T Consensus 141 RDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 220 (361)
T 4f9c_A 141 RDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK 220 (361)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT
T ss_pred CcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence 9999999999876 89999999999865432210 11122345689999999999988
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhcC---------------------CCCC------------
Q psy11359 237 DHGYDFKADIWSLGITAIEMATGTAPYHKY-PAMKVLMLTLQN---------------------DPPT------------ 282 (520)
Q Consensus 237 ~~~~~~~~DIwSlG~il~elltG~~Pf~~~-~~~~~~~~~~~~---------------------~~~~------------ 282 (520)
...|+.++||||+||++|+|+||++||... +...++..+... ..+.
T Consensus 221 ~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 300 (361)
T 4f9c_A 221 CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRG 300 (361)
T ss_dssp CSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-
T ss_pred CCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcc
Confidence 777999999999999999999999999543 333333222110 0000
Q ss_pred -----------CCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 283 -----------LDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 283 -----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
..........+..+|+++++||.+||++||++|||++|+|+||||+..
T Consensus 301 ~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 301 MDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp ---------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 000001112335678999999999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-57 Score=450.49 Aligned_cols=266 Identities=20% Similarity=0.342 Sum_probs=219.8
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHH
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKE 99 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~E 99 (520)
....++|.+.+.||+|+||+||+|.+.. ++..||||+++. . .....+++.+|
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~----------------------~-~~~~~~~f~~E 65 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD----------------------A-SDNARKDFHRE 65 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS----------------------C-CHHHHHHHHHH
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC----------------------C-ChHHHHHHHHH
Confidence 4567889999999999999999998753 466677776532 1 13345679999
Q ss_pred HHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc-----ccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 100 IQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI-----SNCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 100 i~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~-----~~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
+++|++|+|||||++++++.+++.+|||||||+||+|.++++..... .......+++.++..|+.||+.||.|||
T Consensus 66 ~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 145 (299)
T 4asz_A 66 AELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA 145 (299)
T ss_dssp HHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999763210 0113457999999999999999999999
Q ss_pred HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 175 ~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
+++||||||||+|||++.++.+||+|||+|+....... ........||+.|||||++.+.. |+.++|||||||+||
T Consensus 146 ~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~---~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~ 221 (299)
T 4asz_A 146 SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLW 221 (299)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC---EEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHH
T ss_pred hCCcccCccCHhhEEECCCCcEEECCcccceecCCCCc---eeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHH
Confidence 99999999999999999999999999999986543221 12233457999999999998766 999999999999999
Q ss_pred HHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 255 EMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 255 ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
||+| |+.||.+.+..+.+..+..+..+..+ ..+++++.+||.+||+.||++|||+.|++ +|++
T Consensus 222 Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p---------~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 222 EIFTYGKQPWYQLSNNEVIECITQGRVLQRP---------RTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 9999 99999999988888887777654433 35688999999999999999999999994 4554
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-56 Score=481.63 Aligned_cols=272 Identities=27% Similarity=0.402 Sum_probs=227.2
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
+.+.++|+++++||+|+||+||+|+++.+|+.||+|++++..+... ...........++.+++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~-----------------~~~~~~~~E~~~l~ll~ 247 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----------------QGETLALNERIMLSLVS 247 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----------------TCHHHHHHHHHHHHHHS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchh-----------------hhHHHHHHHHHHHHHHh
Confidence 4467889999999999999999999999999999999976543211 00112223345677888
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
.++|||||+++++|.+.+.+|||||||.||+|.++|.. .+.+++..++.|+.||+.||+|||++||||||||
T Consensus 248 ~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~--------~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLK 319 (689)
T 3v5w_A 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--------HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319 (689)
T ss_dssp SSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--------HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred hCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence 99999999999999999999999999999999999984 4679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+||||+.+|++||+|||+|..+... ...+++|||.|||||++.+..+|+.++|||||||+||+|+||.+||.
T Consensus 320 PeNILld~~G~vKL~DFGlA~~~~~~-------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~ 392 (689)
T 3v5w_A 320 PANILLDEHGHVRISDLGLACDFSKK-------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392 (689)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSC-------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred hHHeEEeCCCCEEecccceeeecCCC-------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999876432 24567999999999999766569999999999999999999999997
Q ss_pred CCcH---HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchhhHH
Q psy11359 265 KYPA---MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDKKFI 336 (520)
Q Consensus 265 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~~ 336 (520)
+... ......+.... ..++ ..+|+++++||.+||++||.+|++ ++|+++||||+..++....
T Consensus 393 ~~~~~~~~~i~~~i~~~~-~~~p---------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~ 462 (689)
T 3v5w_A 393 QHKTKDKHEIDRMTLTMA-VELP---------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVF 462 (689)
T ss_dssp GGGCCCHHHHHHHHHHCC-CCCC---------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHH
T ss_pred CCChHHHHHHHHhhcCCC-CCCC---------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHH
Confidence 6432 23333333332 2222 357899999999999999999998 7999999999998887654
Q ss_pred Hh
Q psy11359 337 QQ 338 (520)
Q Consensus 337 ~~ 338 (520)
..
T Consensus 463 ~~ 464 (689)
T 3v5w_A 463 LQ 464 (689)
T ss_dssp TT
T ss_pred cC
Confidence 33
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-56 Score=445.34 Aligned_cols=265 Identities=25% Similarity=0.448 Sum_probs=211.7
Q ss_pred CCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 21 SVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 21 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
...|....+++++.+.||+|+||+||+|.... .||||+++.. .......+.+.+|+
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~---------------------~~~~~~~~~f~~E~ 83 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVV---------------------DPTPEQFQAFRNEV 83 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCS---------------------SCCHHHHHHHHHHH
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEec---------------------CCCHHHHHHHHHHH
Confidence 34588899999999999999999999997543 4777766421 11134567899999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
.+|++|+|||||++++++. ++.+|||||||+||+|.+++.. ..+.+++.++..|+.||+.||.|||++||||
T Consensus 84 ~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~IiH 155 (307)
T 3omv_A 84 AVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHV-------QETKFQMFQLIDIARQTAQGMDYLHAKNIIH 155 (307)
T ss_dssp HHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHT-------SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence 9999999999999999775 5678999999999999999974 3567999999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc--CCCCcchhHHHHHHHHHHHHh
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD--HGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~~~DIwSlG~il~ellt 258 (520)
|||||+|||+++++.+||+|||+|+...... ........+||+.|||||++.+. ..|+.++|||||||+||||+|
T Consensus 156 RDlKp~NILl~~~~~~Ki~DFGla~~~~~~~---~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ellt 232 (307)
T 3omv_A 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWS---GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT 232 (307)
T ss_dssp SCCCSSSEEEETTEEEEECCCSSCBC---------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred CccCHHHEEECCCCcEEEeeccCceecccCC---cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHH
Confidence 9999999999999999999999998764322 12223457899999999998643 248999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|+.||.+......+...+......... ...+..+++.+.+||.+||++||++|||+.|++++
T Consensus 233 g~~Pf~~~~~~~~~~~~~~~~~~~p~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 233 GELPYSHINNRDQIIFMVGRGYASPDL----SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp SSCTTTTCCCHHHHHHHHHTTCCCCCS----TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCc----ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999877666655554432211110 11234678899999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-56 Score=448.40 Aligned_cols=265 Identities=19% Similarity=0.321 Sum_probs=213.7
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
+....++|.+.++||+|+||+||+|.++. +++.||||+++. . .....+++.+
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~----------------------~-~~~~~~~f~~ 92 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----------------------A-SESARQDFQR 92 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC----------------------C-SHHHHHHHHH
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc----------------------C-CHHHHHHHHH
Confidence 34556789999999999999999998753 566677776532 1 1334577999
Q ss_pred HHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc-------ccCCCCCCCHHHHHHHHHHHHHHHH
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI-------SNCKHGVCDEPTIATVLREVLKGLE 171 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~-------~~~~~~~l~~~~i~~i~~qIl~gL~ 171 (520)
|+.+|++|+|||||++++++.+.+.+|||||||++|+|.++++..... .....+.+++.++..|+.||+.||.
T Consensus 93 E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~ 172 (329)
T 4aoj_A 93 EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMV 172 (329)
T ss_dssp HHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999999753211 0113457999999999999999999
Q ss_pred HHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHH
Q psy11359 172 YFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251 (520)
Q Consensus 172 yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~ 251 (520)
|||+++||||||||+||||+.++.+||+|||+|+.+..... .......+||+.|||||++.+.. |+.++|||||||
T Consensus 173 yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~---~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gv 248 (329)
T 4aoj_A 173 YLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGV 248 (329)
T ss_dssp HHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHH
T ss_pred HHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCc---ceecCcccccccccChhhhcCCC-CCccccccchHH
Confidence 99999999999999999999999999999999987643221 12234568999999999998766 999999999999
Q ss_pred HHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 252 TAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 252 il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
+||||+| |+.||.+....+.+..+..+..+..+ ..+++++.+||.+||++||++|||+.|++++
T Consensus 249 vl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p---------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 249 VLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP---------RACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCC---------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCc---------ccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999999 99999999988888777776554433 3568899999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-56 Score=444.06 Aligned_cols=266 Identities=19% Similarity=0.298 Sum_probs=219.7
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEc-----CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCK-----ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
+.....++++.+.||+|+||+||+|... .+++.||||+++ ........+++.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~----------------------~~~~~~~~~~f~~ 78 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK----------------------DKAEGPLREEFRH 78 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECC----------------------C-CCC-CHHHHHH
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEEC----------------------cccChHHHHHHHH
Confidence 3456678999999999999999999864 345566666653 2222345678999
Q ss_pred HHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcccc--------CCCCCCCHHHHHHHHHHHHHHH
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN--------CKHGVCDEPTIATVLREVLKGL 170 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~--------~~~~~l~~~~i~~i~~qIl~gL 170 (520)
|+.+|++|+|||||++++++..++.++||||||++|+|.+++..+..... .....+++..+..|+.||+.||
T Consensus 79 E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl 158 (308)
T 4gt4_A 79 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 158 (308)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999975422110 0135689999999999999999
Q ss_pred HHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHH
Q psy11359 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG 250 (520)
Q Consensus 171 ~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG 250 (520)
+|||+++||||||||+||||++++.+||+|||+|+.+.... ........+||+.|||||++.+.. |+.++||||||
T Consensus 159 ~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~---~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfG 234 (308)
T 4gt4_A 159 EYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD---YYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYG 234 (308)
T ss_dssp HHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGG---CBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHH
T ss_pred HHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCC---ceeEecccccCCcccCHHHHhCCC-CCccchhhhHH
Confidence 99999999999999999999999999999999998664322 122234568999999999998766 99999999999
Q ss_pred HHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 251 ITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 251 ~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|+||||+| |..||.+....+++..+..+.....+ ..+++.+.+|+.+||+.||++|||+.||+++
T Consensus 235 vvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p---------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 235 VVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCP---------DDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999 89999999988888777665544332 3568889999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=475.47 Aligned_cols=262 Identities=26% Similarity=0.433 Sum_probs=229.3
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.++.+|+.||+|+++... ....+.+.+|+.+|+.|+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-----------------------~~~~~~~~~Ei~il~~l~ 212 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----------------------ESDKETVRKEIQTMSVLR 212 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----------------------HHHHHHHHHHHHHHHHTC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-----------------------hhhHHHHHHHHHHHHhCC
Confidence 478999999999999999999999999999999875321 223456889999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||||+++++|.+++.+|||||||.||+|+++|.. ..+.+++.+++.+++||+.||.|||++||+||||||+|
T Consensus 213 hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~-------~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~N 285 (573)
T 3uto_A 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-------EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285 (573)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC-------TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH-------hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence 99999999999999999999999999999999964 45679999999999999999999999999999999999
Q ss_pred EEEcC--CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 188 ILLGE--DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 188 ILl~~--~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
||++. .|.+||+|||+|+.+... ....+.+||+.|||||++.+.. |+.++|||||||+||+|++|.+||.+
T Consensus 286 ill~~~~~~~vKl~DFG~a~~~~~~------~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~ 358 (573)
T 3uto_A 286 IMFTTKRSNELKLIDFGLTAHLDPK------QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGG 358 (573)
T ss_dssp EEESSSSCCCEEECCCSSCEECCTT------SEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred ccccCCCCCCEEEeeccceeEccCC------CceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99975 489999999999887532 2234678999999999998765 99999999999999999999999999
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
....+.+..+........ ...+..+++++++||.+||++||.+|||+.|+|+||||+....
T Consensus 359 ~~~~~~~~~i~~~~~~~~------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 359 ENDDETLRNVKSCDWNMD------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp SSHHHHHHHHHTTCCCCC------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred cCHHHHHHHHHhCCCCCC------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 988888877766543322 2234568999999999999999999999999999999997554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-55 Score=444.17 Aligned_cols=271 Identities=23% Similarity=0.348 Sum_probs=220.4
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.+.||+|+||+||+|.+...+..++.| .||+|.+.........+.+.+|+.+|
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k-----------------~VAvK~l~~~~~~~~~~~~~~E~~il 121 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCR-----------------TVAVKMLKEGATHSEHRALMSELKIL 121 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEE-----------------EEEEEEECTTCCHHHHHHHHHHHHHH
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCe-----------------EEEEEEEccccChHHHHHHHHHHHHH
Confidence 6677899999999999999999999988765544433 35666665554455677899999999
Q ss_pred hcCCC-CCceEEEEEEEE-CCEEEEEEEccCCCCHHHHHHHhhccc--------cCCCCCCCHHHHHHHHHHHHHHHHHH
Q psy11359 104 SSCHH-ENVVTYHTSFVV-KDELWLVLRLLEGGSLLDIIKHRLKIS--------NCKHGVCDEPTIATVLREVLKGLEYF 173 (520)
Q Consensus 104 ~~l~H-pnIv~~~~~~~~-~~~~~lV~E~~~ggsL~~~i~~~~~~~--------~~~~~~l~~~~i~~i~~qIl~gL~yL 173 (520)
++++| ||||+++++|.. ++.+|||||||++|+|.++|+...... ......+++..+..|+.||++||+||
T Consensus 122 ~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL 201 (353)
T 4ase_A 122 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 201 (353)
T ss_dssp HHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH
T ss_pred HHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH
Confidence 99965 899999999876 457999999999999999998643211 11245689999999999999999999
Q ss_pred HHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHH
Q psy11359 174 HSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253 (520)
Q Consensus 174 H~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il 253 (520)
|+++||||||||+|||+++++.+||+|||+|+.+...... ......+||+.|||||++.+.. |+.++|||||||+|
T Consensus 202 H~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~---~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 202 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLL 277 (353)
T ss_dssp HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS---EEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred hhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCc---eeeccccccccccCHHHHhcCC-CCCcccEeehHHHH
Confidence 9999999999999999999999999999999876433221 1234568999999999998765 99999999999999
Q ss_pred HHHHh-CCCCCCCCcHHHHHHHH-hcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 254 IEMAT-GTAPYHKYPAMKVLMLT-LQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 254 ~ellt-G~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|||+| |..||.+......+... ..+..+..+ ..+++++.+||.+||+.||++|||+.|+++|
T Consensus 278 ~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p---------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 278 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCC---------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 99998 99999887654444333 333333332 3467899999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=417.67 Aligned_cols=260 Identities=25% Similarity=0.435 Sum_probs=226.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+|+.
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~~E~~~l~~ 70 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL---------------------NPTSLQKLFREVRIMKI 70 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---------------------CHHHHHHHHHHHHHHHH
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC---------------------CHHHHHHHHHHHHHHHh
Confidence 456789999999999999999999999999999998754311 12345678999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++...+.+|+||||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||
T Consensus 71 l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp 142 (328)
T 3fe3_A 71 LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA--------HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKA 142 (328)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH--------HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred CCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCH
Confidence 9999999999999999999999999999999999974 35689999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.++.+||+|||++..+..+ ......+||+.|+|||++.+...++.++|||||||++|+|+||..||.+
T Consensus 143 ~NIll~~~~~~kl~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 143 ENLLLDADMNIKIADFGFSNEFTVG------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp GGEEECTTSCEEECSTTCCGGGSSS------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEEcCCCCEEEeeccCceecCCC------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 9999999999999999998765432 2234578999999999998776456899999999999999999999999
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.........+..+..... ..+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 217 ~~~~~~~~~i~~~~~~~p----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 217 QNLKELRERVLRGKYRIP----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp SSHHHHHHHHHHCCCCCC----------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred CCHHHHHHHHHhCCCCCC----------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 888777776666543221 2367889999999999999999999999999999854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=412.80 Aligned_cols=257 Identities=25% Similarity=0.301 Sum_probs=194.1
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
..+|.+.++||+|+||+||+|.+ +|+.||||+++... ........|+..+.+++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~------------------------~~~~~~e~Ei~~~~~l~ 55 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------------------------ERSWFREAEIYQTVMLR 55 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG------------------------HHHHHHHHHHHTSTTCC
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------------------------hhhHHHHHHHHHHhcCC
Confidence 35799999999999999999987 57788888774221 11112345677777899
Q ss_pred CCCceEEEEEEEECC----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-------
Q psy11359 108 HENVVTYHTSFVVKD----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN------- 176 (520)
Q Consensus 108 HpnIv~~~~~~~~~~----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~------- 176 (520)
|||||++++++..++ .+||||||++||+|.++++. ..+++..+.+++.|++.||.|||++
T Consensus 56 HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~---------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~ 126 (303)
T 3hmm_A 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126 (303)
T ss_dssp CTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB
T ss_pred CCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCC
Confidence 999999999998654 68999999999999999974 3588999999999999999999987
Q ss_pred -CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC-----CCCcchhHHHHH
Q psy11359 177 -GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH-----GYDFKADIWSLG 250 (520)
Q Consensus 177 -giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~~~~~~DIwSlG 250 (520)
+||||||||+|||++.++.+||+|||+|+........ ........+||+.|||||++.+.. .|+.++||||||
T Consensus 127 ~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~G 205 (303)
T 3hmm_A 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp CCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTE-ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred CCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCc-eeeecccccccccccCHHHhcccccccCCccChhHhhhhHH
Confidence 9999999999999999999999999999877544322 112233568999999999987542 267899999999
Q ss_pred HHHHHHHhCCCCCCCC--------------cHHHHHHHHhcC--CCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCC
Q psy11359 251 ITAIEMATGTAPYHKY--------------PAMKVLMLTLQN--DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK 314 (520)
Q Consensus 251 ~il~elltG~~Pf~~~--------------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 314 (520)
|+||||+||.+||... .....+...... ..+.++... .....+..+.+|+.+||+.||++
T Consensus 206 vvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~----~~~~~~~~l~~li~~cl~~dP~~ 281 (303)
T 3hmm_A 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW----QSCEALRVMAKIMRECWYANGAA 281 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----GSSHHHHHHHHHHHTTCCSSGGG
T ss_pred HHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccc----cchHHHHHHHHHHHHHcccCHhH
Confidence 9999999997765321 112222222221 122222111 11234567899999999999999
Q ss_pred CCCHHHHhcC
Q psy11359 315 RPTASELLKN 324 (520)
Q Consensus 315 Rpta~elL~h 324 (520)
|||+.|+++.
T Consensus 282 RPt~~ei~~~ 291 (303)
T 3hmm_A 282 RLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=404.62 Aligned_cols=263 Identities=42% Similarity=0.699 Sum_probs=227.1
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.+++
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~~E~~~l~ 72 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----------------------QPKKELIINEILVMR 72 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-----------------------CSCHHHHHHHHHHHH
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-----------------------ccHHHHHHHHHHHHh
Confidence 456788999999999999999999999999999999875321 123456889999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++...+.+|+||||+.|++|.+++.. ..+++..++.++.||+.||.|||++||+|||||
T Consensus 73 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlk 143 (297)
T 3fxz_A 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143 (297)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred cCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Confidence 99999999999999999999999999999999999974 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.++.+||+|||++..+.... .......||+.|+|||++.+.. |+.++|||||||++|+|+||..||.
T Consensus 144 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~ 217 (297)
T 3fxz_A 144 SDNILLGMDGSVKLTDFGFCAQITPEQ-----SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL 217 (297)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSTT-----CCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred HHHEEECCCCCEEEeeCCCceecCCcc-----cccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999988764322 1234568999999999997765 8999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
................+.... ...+++.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 218 NENPLRALYLIATNGTPELQN-------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp TSCHHHHHHHHHHHCSCCCSC-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CCCHHHHHHHHHhCCCCCCCC-------ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 888777666555444333221 2467889999999999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=411.84 Aligned_cols=266 Identities=26% Similarity=0.444 Sum_probs=229.1
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++++.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.+|+.+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~E~~~l~~l 62 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--------------------KDEVAHTVTESRVLQNT 62 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHHSC
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh--------------------hhHHHHHHHHHHHHHhC
Confidence 4578999999999999999999999999999999987543211 22456788999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+
T Consensus 63 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 134 (337)
T 1o6l_A 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--------ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134 (337)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--------HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred CCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHH
Confidence 999999999999999999999999999999999974 357899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.+|.+||+|||++...... .......+||+.|+|||++.+.. |+.++|||||||++|+|++|..||...
T Consensus 135 NIll~~~g~vkL~DFG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 135 NLMLDKDGHIKITDFGLCKEGISD-----GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp GEEECTTSCEEECCCTTCBCSCCT-----TCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HEEECCCCCEEEeeccchhhcccC-----CCcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCC
Confidence 999999999999999998753221 22234678999999999997655 899999999999999999999999988
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhhHH
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKKFI 336 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~~ 336 (520)
........+...... ++ ..+++++.+||.+||++||.+|| ++.|+++||||+...+....
T Consensus 209 ~~~~~~~~i~~~~~~-~p---------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~ 273 (337)
T 1o6l_A 209 DHERLFELILMEEIR-FP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273 (337)
T ss_dssp SHHHHHHHHHHCCCC-CC---------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred CHHHHHHHHHcCCCC-CC---------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 777766666554322 21 34688999999999999999999 99999999999988765543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=417.85 Aligned_cols=266 Identities=25% Similarity=0.426 Sum_probs=224.8
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|+++++||+|+||+||+|+++.+|+.||+|+++...... ....+.+.+|+.+++.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~--------------------~~~~~~~~~E~~il~~ 79 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ--------------------DDDVECTMTEKRILSL 79 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--------------------HTTHHHHHHHHHHHHH
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcc--------------------hhHHHHHHHHHHHHHh
Confidence 45688999999999999999999999999999999987543221 2245668899999998
Q ss_pred C-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 106 C-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 106 l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+ +||||+++++++.+.+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+|||||
T Consensus 80 ~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk 151 (353)
T 3txo_A 80 ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK--------SRRFDEARARFYAAEIISALMFLHDKGIIYRDLK 151 (353)
T ss_dssp TTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred ccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Confidence 8 799999999999999999999999999999999984 3568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.+|.+||+|||++..... ......+.+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.
T Consensus 152 p~NILl~~~g~ikL~DFG~a~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~ 225 (353)
T 3txo_A 152 LDNVLLDHEGHCKLADFGMCKEGIC-----NGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFE 225 (353)
T ss_dssp GGGEEECTTSCEEECCCTTCBCSCC--------------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HHHEEECCCCCEEEccccceeeccc-----CCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCC
Confidence 9999999999999999999875322 122345678999999999997665 8999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH------HHHhcCccccccchhhH
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA------SELLKNPFFKKAKDKKF 335 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta------~elL~hp~~~~~~~~~~ 335 (520)
.....+.+..+........ ..+++.+.+||.+||++||.+||++ .|+++||||+...+...
T Consensus 226 ~~~~~~~~~~i~~~~~~~p----------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l 292 (353)
T 3txo_A 226 AENEDDLFEAILNDEVVYP----------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL 292 (353)
T ss_dssp CSSHHHHHHHHHHCCCCCC----------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHH
T ss_pred CCCHHHHHHHHHcCCCCCC----------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHH
Confidence 9888888777776543321 2367889999999999999999999 89999999998776543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=414.48 Aligned_cols=298 Identities=73% Similarity=1.179 Sum_probs=213.0
Q ss_pred CCCCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHH
Q psy11359 18 ASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELL 97 (520)
Q Consensus 18 ~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~ 97 (520)
.+...+|....++|++.+.||+|+||+||+|.+..+++.||+|++... ......+++.
T Consensus 4 ~s~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------------~~~~~~~~~~ 61 (303)
T 2vwi_A 4 DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE----------------------KCQTSMDELL 61 (303)
T ss_dssp ---------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------------------------
T ss_pred cccccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhh----------------------hcchhHHHHH
Confidence 344678899999999999999999999999999999888888876432 1122345688
Q ss_pred HHHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy11359 98 KEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG 177 (520)
Q Consensus 98 ~Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g 177 (520)
+|+.++++++||||+++++++...+..++||||+.|++|.+++...........+.+++..+..++.||+.||.|||++|
T Consensus 62 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 141 (303)
T 2vwi_A 62 KEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141 (303)
T ss_dssp ----CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999999999999999999998644333224567999999999999999999999999
Q ss_pred cEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 178 QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 178 iiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
++||||||+||+++.++.+||+|||++..+................||+.|+|||++.+...++.++|||||||++|+|+
T Consensus 142 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 221 (303)
T 2vwi_A 142 QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221 (303)
T ss_dssp CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999987655443333334456789999999999876445899999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhhHHH
Q psy11359 258 TGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQ 337 (520)
Q Consensus 258 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~~ 337 (520)
||..||................++..............+++.+.+||.+||+.||.+|||+.++++||||+....++.++
T Consensus 222 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~q 301 (303)
T 2vwi_A 222 TGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQ 301 (303)
T ss_dssp HSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----------
T ss_pred hCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCcccc
Confidence 99999999888877777777766655444333344456788999999999999999999999999999999877655443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=414.79 Aligned_cols=270 Identities=23% Similarity=0.452 Sum_probs=230.4
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.++.+|+.||+|+++...... .......+.+.+|+.+|++
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~-----------------~~~~~~~~~~~~E~~il~~ 71 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA-----------------SRRGVCREEIEREVSILRQ 71 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTT-----------------CSSSBCHHHHHHHHHHHTT
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccc-----------------ccchhHHHHHHHHHHHHHh
Confidence 45678999999999999999999999999999999886432110 0011245679999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++.....+|+||||+.||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||
T Consensus 72 l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp 143 (361)
T 2yab_A 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA--------QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKP 143 (361)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT--------TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 999999999999999999999999999999999996 456799999999999999999999999999999999
Q ss_pred CcEEEcCCC----CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 186 GNILLGEDG----TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 186 ~NILl~~~g----~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
+|||++.++ .+||+|||++..+..+. .....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+
T Consensus 144 ~NIll~~~~~~~~~vkl~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~ 216 (361)
T 2yab_A 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGV------EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGAS 216 (361)
T ss_dssp GGEEESCTTSSSCCEEECCCSSCEECCTTC------CCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCC
T ss_pred HHEEEeCCCCCccCEEEEecCCceEcCCCC------ccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCC
Confidence 999998776 79999999998764322 234568999999999997655 8999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
||.+....+.+..+....... ....+..+++.+++||.+||.+||.+|||+.|+|+||||+.....
T Consensus 217 Pf~~~~~~~~~~~i~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 282 (361)
T 2yab_A 217 PFLGDTKQETLANITAVSYDF------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ 282 (361)
T ss_dssp SSCCSSHHHHHHHHHTTCCCC------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHH
T ss_pred CCCCCCHHHHHHHHHhcCCCC------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchh
Confidence 999988877776665543221 233456789999999999999999999999999999999976543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=404.94 Aligned_cols=264 Identities=25% Similarity=0.459 Sum_probs=229.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.+++.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~E~~~l~~l 63 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR--------------------LKQVEHTNDERLMLSIV 63 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHHSC
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--------------------hhHHHHHHHHHHHHhhC
Confidence 4578999999999999999999999999999999987543211 12356688999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++.+...+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+
T Consensus 64 ~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 135 (318)
T 1fot_A 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--------SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPE 135 (318)
T ss_dssp CBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--------TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred CCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChh
Confidence 999999999999999999999999999999999984 467899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.+|.+||+|||++..... ...+.+||+.|+|||++.+.. |+.++|||||||++|+|++|..||...
T Consensus 136 NIll~~~g~~kL~Dfg~a~~~~~--------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 136 NILLDKNGHIKITDFGFAKYVPD--------VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp GEEECTTSCEEECCCSSCEECSS--------CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eEEEcCCCCEEEeecCcceecCC--------ccccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 99999999999999999976532 234568999999999987655 899999999999999999999999988
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhhHHH
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKKFIQ 337 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~~~ 337 (520)
........+....... + ..+++++.+||.+||+.||.+|| +++++++||||+...+.....
T Consensus 207 ~~~~~~~~i~~~~~~~-p---------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~ 272 (318)
T 1fot_A 207 NTMKTYEKILNAELRF-P---------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLS 272 (318)
T ss_dssp SHHHHHHHHHHCCCCC-C---------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHT
T ss_pred CHHHHHHHHHhCCCCC-C---------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHh
Confidence 8877777766654321 1 34678999999999999999999 999999999999887765433
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=407.16 Aligned_cols=261 Identities=23% Similarity=0.394 Sum_probs=226.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.+++.+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------------------------~~~~~~~~~E~~~l~~l 58 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------------------------GTDQVLVKKEISILNIA 58 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------------------------THHHHHHHHHHHHHHHS
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------------------------cccHHHHHHHHHHHHhC
Confidence 467899999999999999999999999999999876421 22345688999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++.+.+.+|+||||++|++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 59 ~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-------~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~ 131 (321)
T 1tki_A 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINT-------SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE 131 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS-------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence 999999999999999999999999999999999963 3457999999999999999999999999999999999
Q ss_pred cEEEcC--CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 187 NILLGE--DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 187 NILl~~--~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|||++. ++.+||+|||++..+..+. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 132 NIl~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~ 204 (321)
T 1tki_A 132 NIIYQTRRSSTIKIIEFGQARQLKPGD------NFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp GEEESSSSCCCEEECCCTTCEECCTTC------EEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred HEEEccCCCCCEEEEECCCCeECCCCC------ccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCc
Confidence 999986 7899999999998764322 234567999999999997664 8999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
.......+..+....... ....+..++.++.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 205 ~~~~~~~~~~i~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 205 AETNQQIIENIMNAEYTF------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp CSSHHHHHHHHHHTCCCC------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred CCCHHHHHHHHHcCCCCC------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 988887777666654322 2334567899999999999999999999999999999998653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=409.98 Aligned_cols=267 Identities=26% Similarity=0.461 Sum_probs=227.8
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|..++.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~E~~il~ 72 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM--------------------DDDVECTMVEKRVLS 72 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHH
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh--------------------hhhHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999987543211 223456788999998
Q ss_pred cC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 105 SC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 105 ~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
.+ +||||+++++++.+.+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||
T Consensus 73 ~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 144 (345)
T 1xjd_A 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--------CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144 (345)
T ss_dssp HHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred hcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCC
Confidence 76 999999999999999999999999999999999984 356899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
||+|||++.+|.+||+|||++...... .......+||+.|+|||++.+.. |+.++|||||||++|+|++|..||
T Consensus 145 kp~NIll~~~g~vkL~DFG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf 218 (345)
T 1xjd_A 145 KLDNILLDKDGHIKIADFGMCKENMLG-----DAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPF 218 (345)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCCCCT-----TCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ChhhEEECCCCCEEEeEChhhhhcccC-----CCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCC
Confidence 999999999999999999998754321 12235678999999999997755 899999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH-HHhcCccccccchhhH
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS-ELLKNPFFKKAKDKKF 335 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~-elL~hp~~~~~~~~~~ 335 (520)
........+..+....+. ++ ..+++++++||.+||+.||.+||++. ++++||||+...+...
T Consensus 219 ~~~~~~~~~~~i~~~~~~-~p---------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l 281 (345)
T 1xjd_A 219 HGQDEEELFHSIRMDNPF-YP---------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 281 (345)
T ss_dssp CCSSHHHHHHHHHHCCCC-CC---------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred CCCCHHHHHHHHHhCCCC-CC---------cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHH
Confidence 988887777666555432 21 24688999999999999999999998 9999999998876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=412.94 Aligned_cols=284 Identities=32% Similarity=0.548 Sum_probs=224.8
Q ss_pred CCCCCCCCCeEEEeeeeec--CceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFG--ATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKE 99 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~E 99 (520)
.++....++|++.++||+| +||+||+|.++.+|+.||+|+++.... .....+.+.+|
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~~E 76 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC---------------------SNEMVTFLQGE 76 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS---------------------CHHHHHHHHHH
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc---------------------ChHHHHHHHHH
Confidence 3456788999999999999 999999999999999999998764311 12345678899
Q ss_pred HHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 100 IQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 100 i~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+.++++++||||+++++++...+.+|+||||+.+|+|.+++... ..+.+++..++.++.||+.||.|||++||+
T Consensus 77 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 150 (389)
T 3gni_B 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH------FMDGMNELAIAYILQGVLKALDYIHHMGYV 150 (389)
T ss_dssp HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT------CTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh------cccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 99999999999999999999999999999999999999999853 346799999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccc--cccccccccccccccCCcceeccc-CCCCcchhHHHHHHHHHHH
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDL--SRQKVRHTFVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~--~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DIwSlG~il~el 256 (520)
||||||+|||++.+|.+||+|||.+......... .........+||+.|+|||++.+. ..|+.++|||||||++|+|
T Consensus 151 HrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el 230 (389)
T 3gni_B 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230 (389)
T ss_dssp CCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHH
Confidence 9999999999999999999999998765332211 111222345899999999999763 3489999999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHhcCCCCCCCC------------------------------------CchhhhhHHHhcHHH
Q psy11359 257 ATGTAPYHKYPAMKVLMLTLQNDPPTLDT------------------------------------GAAEKDQYKAYGKTF 300 (520)
Q Consensus 257 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~ 300 (520)
++|..||.+......+........+.+.. ..........+++.+
T Consensus 231 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 310 (389)
T 3gni_B 231 ANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310 (389)
T ss_dssp HHSSCTTTTCCSTTHHHHC--------------------------------------------------------CCHHH
T ss_pred HHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHH
Confidence 99999998766655554433322111000 000111335578899
Q ss_pred HHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 301 RKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 301 ~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
.+||.+||++||.+|||+.|+|+||||+....
T Consensus 311 ~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 311 HHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred HHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 99999999999999999999999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=401.01 Aligned_cols=272 Identities=24% Similarity=0.358 Sum_probs=218.6
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++++.||+|+||+||+|.+. +|+.||+|+++.... .......+.+|+.+++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------------------~~~~~~~~~~E~~~l~ 74 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE---------------------DEGIPSTAIREISLLK 74 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC---------------------------CHHHHHHHHHHHHH
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc---------------------cchhhHHHHHHHHHHH
Confidence 456789999999999999999999985 488888887753210 0223467889999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++..++.+++||||+. ++|.+++.. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 75 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dik 146 (311)
T 3niz_A 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE-------NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146 (311)
T ss_dssp HCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHT-------CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc
Confidence 9999999999999999999999999997 589888874 34569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.++.+||+|||++..+.... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.
T Consensus 147 p~NIl~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (311)
T 3niz_A 147 PQNLLINSDGALKLADFGLARAFGIPV-----RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221 (311)
T ss_dssp GGGEEECTTCCEEECCCTTCEETTSCC-----C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hHhEEECCCCCEEEccCcCceecCCCc-----ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999998764321 122345789999999999876668999999999999999999999998
Q ss_pred CCcHHHHHHHHhc---CCCCCCC-----------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 265 KYPAMKVLMLTLQ---NDPPTLD-----------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 265 ~~~~~~~~~~~~~---~~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
+......+..... ...+... ...........+++++.+||.+||++||.+|||+.|+|+|
T Consensus 222 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 222 GVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 7766554433322 1111100 0011112234577899999999999999999999999999
Q ss_pred ccccccc
Q psy11359 325 PFFKKAK 331 (520)
Q Consensus 325 p~~~~~~ 331 (520)
|||+...
T Consensus 302 p~f~~~~ 308 (311)
T 3niz_A 302 PYFKDLD 308 (311)
T ss_dssp GGGTTSC
T ss_pred cccccCC
Confidence 9998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=406.27 Aligned_cols=264 Identities=23% Similarity=0.402 Sum_probs=230.2
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.+++
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------~~~~~~~~~E~~~l~ 96 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK--------------------LKQIEHTLNEKRILQ 96 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHT
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc--------------------HHHHHHHHHHHHHHH
Confidence 346689999999999999999999999999999999986543211 124567889999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
.++||||+++++++.+.+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+|||||
T Consensus 97 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 168 (350)
T 1rdq_E 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168 (350)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--------HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred hCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCc
Confidence 99999999999999999999999999999999999985 3568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.+|.+||+|||++..+... ....+||+.|+|||++.+.. |+.++|||||||++|+|++|..||.
T Consensus 169 p~NIll~~~g~~kL~DFg~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~ 239 (350)
T 1rdq_E 169 PENLLIDQQGYIQVTDFGFAKRVKGR--------TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSC--------BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cceEEECCCCCEEEcccccceeccCC--------cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCC
Confidence 99999999999999999999865321 23568999999999997655 8999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchhhH
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~ 335 (520)
..........+....... + ..+++.+.+||.+||+.||.+||+ +.++++||||+...+...
T Consensus 240 ~~~~~~~~~~i~~~~~~~-p---------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~ 305 (350)
T 1rdq_E 240 ADQPIQIYEKIVSGKVRF-P---------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305 (350)
T ss_dssp CSSHHHHHHHHHHCCCCC-C---------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred CCCHHHHHHHHHcCCCCC-C---------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHH
Confidence 888877777666654322 1 346889999999999999999998 999999999998776543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=403.85 Aligned_cols=271 Identities=27% Similarity=0.465 Sum_probs=229.2
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+|..||+|+++...... .......+.+.+|+.+|++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----------------~~~~~~~~~~~~E~~~l~~ 70 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKS-----------------SRRGVSREDIEREVSILKE 70 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTT-----------------CSSSBCHHHHHHHHHHHHH
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccc-----------------ccchhhHHHHHHHHHHHHh
Confidence 44578999999999999999999999999999999876432110 0011246779999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++.....+|+||||+.|++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||
T Consensus 71 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp 142 (326)
T 2y0a_A 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--------EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKP 142 (326)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT--------TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHH--------hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCH
Confidence 999999999999999999999999999999999996 456799999999999999999999999999999999
Q ss_pred CcEEEcCCC----CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 186 GNILLGEDG----TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 186 ~NILl~~~g----~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
+|||++.++ .+||+|||++..+.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..
T Consensus 143 ~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~ 215 (326)
T 2y0a_A 143 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGN------EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGAS 215 (326)
T ss_dssp GGEEESCSSSSSCCEEECCCTTCEECCTTS------CCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCC
T ss_pred HHEEEecCCCCCCCEEEEECCCCeECCCCC------ccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcC
Confidence 999998877 89999999998764322 123467999999999987655 8999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhh
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~ 334 (520)
||.+....+.+.......... ....+..++..+.+||.+||++||.+|||+.|+|+||||+......
T Consensus 216 pf~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 282 (326)
T 2y0a_A 216 PFLGDTKQETLANVSAVNYEF------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282 (326)
T ss_dssp SSCCSSHHHHHHHHHHTCCCC------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCc------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcchh
Confidence 999888777766655443221 1234456789999999999999999999999999999998765443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=416.26 Aligned_cols=268 Identities=24% Similarity=0.442 Sum_probs=220.8
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
.....++|+++++||+|+||+||+|+++.+++.||+|+++...... ....+.+.+|..++
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~--------------------~~~~~~~~~E~~il 106 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND--------------------DEDIDWVQTEKHVF 106 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------------------------CCHHHHHHHHH
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC--------------------HHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999987542211 11234578899999
Q ss_pred hcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 104 SSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 104 ~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
.++ +||||++++++|.+.+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+|||
T Consensus 107 ~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrD 178 (396)
T 4dc2_A 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR--------QRKLPEEHARFYSAEISLALNYLHERGIIYRD 178 (396)
T ss_dssp HHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred HhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecc
Confidence 877 899999999999999999999999999999999984 35689999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|||+|||++.+|.+||+|||++..... ......+++||+.|+|||++.+.. |+.++|||||||++|+|++|.+|
T Consensus 179 LKp~NILl~~~g~ikL~DFGla~~~~~-----~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~P 252 (396)
T 4dc2_A 179 LKLDNVLLDSEGHIKLTDYGMCKEGLR-----PGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSP 252 (396)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCCCC-----TTCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCHHHEEECCCCCEEEeecceeeeccc-----CCCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999875322 122345678999999999998765 89999999999999999999999
Q ss_pred CCCCc---------HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH------HHHhcCccc
Q psy11359 263 YHKYP---------AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA------SELLKNPFF 327 (520)
Q Consensus 263 f~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta------~elL~hp~~ 327 (520)
|.... .......+... ...++ ..+++++++||.+||++||.+||++ .|+++||||
T Consensus 253 f~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p---------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 253 FDIVGSSDNPDQNTEDYLFQVILEK-QIRIP---------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp STTTTC------CCHHHHHHHHHHC-CCCCC---------TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred CcccccccccchhhHHHHHHHHhcc-ccCCC---------CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 96432 11122223332 22222 3468899999999999999999995 799999999
Q ss_pred cccchhhH
Q psy11359 328 KKAKDKKF 335 (520)
Q Consensus 328 ~~~~~~~~ 335 (520)
+...+...
T Consensus 323 ~~i~w~~l 330 (396)
T 4dc2_A 323 RNVDWDMM 330 (396)
T ss_dssp TTCCHHHH
T ss_pred cCCCHHHH
Confidence 98877653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=394.01 Aligned_cols=268 Identities=25% Similarity=0.377 Sum_probs=216.7
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||+||+|.+..+|+.||+|+++... ........+.+|+.++++++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l~h 60 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---------------------DDEGVPSSALREICLLKELKH 60 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---------------------SSTTHHHHHHHHHHHHTTCCC
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC---------------------CcCCcchHHHHHHHHHhcCCC
Confidence 68999999999999999999999999999999875321 112345678899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++..++.+++||||+.+ +|.+++.. ..+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 61 ~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-------~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Ni 132 (292)
T 3o0g_A 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS-------CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132 (292)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH-------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 9999999999999999999999965 67776654 457799999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC-CCCCc
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP-YHKYP 267 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P-f~~~~ 267 (520)
|++.++.+||+|||++..+.... .......||+.|+|||++.+...++.++|||||||++|+|+||..| |....
T Consensus 133 l~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~ 207 (292)
T 3o0g_A 133 LINRNGELKLANFGLARAFGIPV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_dssp EECTTSCEEECCCTTCEECCSCC-----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred EEcCCCCEEEeecccceecCCcc-----ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC
Confidence 99999999999999998764321 2234567899999999998776689999999999999999988777 55555
Q ss_pred HHHHHHHHhcC--CCCCC-----------------CCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 268 AMKVLMLTLQN--DPPTL-----------------DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 268 ~~~~~~~~~~~--~~~~~-----------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
....+...... .+... ............+++.+++||.+||+.||.+|||+.|+|+||||+
T Consensus 208 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 287 (292)
T 3o0g_A 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp HHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccc
Confidence 54444433221 11000 000001112235788999999999999999999999999999998
Q ss_pred cc
Q psy11359 329 KA 330 (520)
Q Consensus 329 ~~ 330 (520)
..
T Consensus 288 ~~ 289 (292)
T 3o0g_A 288 DF 289 (292)
T ss_dssp TC
T ss_pred cC
Confidence 64
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=420.98 Aligned_cols=266 Identities=24% Similarity=0.417 Sum_probs=225.3
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
.+...++|++.+.||+|+||+||+|.+..+|+.+|+|++...... ....+.+.+|+.++
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~---------------------~~~~~~~~~E~~il 64 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS---------------------ARDHQKLEREARIC 64 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH---------------------HHHHHHHHHHHHHH
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC---------------------HHHHHHHHHHHHHH
Confidence 344567899999999999999999999999999999987532111 22456789999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++++||||+++++++.+.+.+|+||||+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||
T Consensus 65 ~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~--------~~~~~e~~~~~i~~qil~aL~~lH~~givHrDl 136 (444)
T 3soa_A 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA--------REYYSEADASHCIQQILEAVLHCHQMGVVHRNL 136 (444)
T ss_dssp HHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH--------CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred HhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 999999999999999999999999999999999999984 467999999999999999999999999999999
Q ss_pred CCCcEEEc---CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 184 KAGNILLG---EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 184 Kp~NILl~---~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
||+|||++ .++.+||+|||++..+.... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|.
T Consensus 137 Kp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~ 210 (444)
T 3soa_A 137 KPENLLLASKLKGAAVKLADFGLAIEVEGEQ-----QAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGY 210 (444)
T ss_dssp SSTTEEESBSSTTCCEEECCCSSCBCCCTTC-----CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSS
T ss_pred CHHHEEEeccCCCCcEEEccCceeEEecCCC-----ceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCC
Confidence 99999997 46789999999997664322 2234568999999999997655 899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
+||...........+..+...... ..+..+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 211 ~Pf~~~~~~~~~~~i~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 211 PPFWDEDQHRLYQQIKAGAYDFPS------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp CSCCCSSHHHHHHHHHHTCCCCCT------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred CCCCCccHHHHHHHHHhCCCCCCc------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999998887777766665433221 1235678999999999999999999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=406.17 Aligned_cols=266 Identities=25% Similarity=0.406 Sum_probs=228.0
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|..++..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~--------------------~~~~~~~~~E~~~l~~ 76 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ--------------------DDDVECTMVEKRVLAL 76 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHTC
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc--------------------chHHHHHHHHHHHHHh
Confidence 35678999999999999999999999999999999987543211 2235668899999998
Q ss_pred C-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 106 C-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 106 l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+ +||||+++++++.+.+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+|||||
T Consensus 77 ~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk 148 (353)
T 2i0e_A 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--------VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 148 (353)
T ss_dssp TTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred cCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCC
Confidence 8 899999999999999999999999999999999984 3568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.+|.+||+|||++...... .......+||+.|+|||++.+.. |+.++|||||||++|+|++|..||.
T Consensus 149 p~NIll~~~g~vkL~DFG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~ 222 (353)
T 2i0e_A 149 LDNVMLDSEGHIKIADFGMCKENIWD-----GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFE 222 (353)
T ss_dssp GGGEEECTTSCEEECCCTTCBCCCCT-----TCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HHHEEEcCCCcEEEEeCCcccccccC-----CcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCC
Confidence 99999999999999999998753221 12245678999999999997655 8999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchhhH
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~ 335 (520)
.......+..+....... + ..+++++.+||.+||++||.+||+ +.++++||||+...+...
T Consensus 223 ~~~~~~~~~~i~~~~~~~-p---------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l 288 (353)
T 2i0e_A 223 GEDEDELFQSIMEHNVAY-P---------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 288 (353)
T ss_dssp CSSHHHHHHHHHHCCCCC-C---------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHH
T ss_pred CCCHHHHHHHHHhCCCCC-C---------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHH
Confidence 888877777666654322 1 357889999999999999999994 699999999998776543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=408.76 Aligned_cols=270 Identities=28% Similarity=0.449 Sum_probs=226.8
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+....++|++++.||+|+||+||+|.+..+++.||+|+++...... ......+.+|+.+|
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~--------------------~~~~~~~~~E~~il 69 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE--------------------RNEVRNVFKELQIM 69 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHH
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc--------------------HHHHHHHHHHHHHH
Confidence 4556789999999999999999999999999999999886543211 22456789999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+.++||||++++++|.+.+.+|+||||+.||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||
T Consensus 70 ~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~--------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDl 141 (384)
T 4fr4_A 70 QGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ--------QNVHFKEETVKLFICELVMALDYLQNQRIIHRDM 141 (384)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH--------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 99999999999999999999999999999999999997 4567999999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc--cCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ--DHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||+|||++.+|.+||+|||++..+... ......+||+.|+|||++.. ...|+.++|||||||++|+|++|..
T Consensus 142 kp~NIll~~~g~vkL~DFG~a~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~ 215 (384)
T 4fr4_A 142 KPDNILLDEHGHVHITDFNIAAMLPRE------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215 (384)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTT------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred cHHHeEECCCCCEEEeccceeeeccCC------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCC
Confidence 999999999999999999999876432 22346789999999999864 2348999999999999999999999
Q ss_pred CCCCCc---HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-HHHHhcCccccccchhhHHH
Q psy11359 262 PYHKYP---AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-ASELLKNPFFKKAKDKKFIQ 337 (520)
Q Consensus 262 Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-a~elL~hp~~~~~~~~~~~~ 337 (520)
||.... .......... .....+ ..+++.+.+||.+||++||.+||+ +.++++||||+...+....+
T Consensus 216 Pf~~~~~~~~~~~~~~~~~-~~~~~p---------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~ 285 (384)
T 4fr4_A 216 PYHIRSSTSSKEIVHTFET-TVVTYP---------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQ 285 (384)
T ss_dssp SSCCCTTSCHHHHHHHHHH-CCCCCC---------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHT
T ss_pred CCCCCCCccHHHHHHHHhh-cccCCC---------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHh
Confidence 997432 2222222222 222221 346789999999999999999998 99999999999887765443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=404.47 Aligned_cols=269 Identities=27% Similarity=0.452 Sum_probs=223.4
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.++.+|+.||+|+++....... .....+.+.+|+.+++.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~~~~~E~~~l~~l 83 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS------------------PGLSTEDLKREASICHML 83 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTS------------------SSCCHHHHHHHHHHHHHC
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccc------------------ccchHHHHHHHHHHHHhC
Confidence 35689999999999999999999999999999998864322110 012356799999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+.+|+||||+.|++|.+++..... ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 84 ~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~ 159 (351)
T 3c0i_A 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD----AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPH 159 (351)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChH
Confidence 999999999999999999999999999999999876433 3456899999999999999999999999999999999
Q ss_pred cEEEcCCCC---eEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 187 NILLGEDGT---VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 187 NILl~~~g~---vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
|||++.++. +||+|||++..+.... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|..||
T Consensus 160 NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf 233 (351)
T 3c0i_A 160 CVLLASKENSAPVKLGGFGVAIQLGESG-----LVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPF 233 (351)
T ss_dssp GEEECSSSTTCCEEECCCTTCEECCTTS-----CBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred HeEEecCCCCCcEEEecCcceeEecCCC-----eeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCC
Confidence 999976554 9999999998764322 1234568999999999997665 899999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.+... .....+....... ....+..+++.+.+||.+||++||.+|||+.|+|+||||+..
T Consensus 234 ~~~~~-~~~~~i~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 234 YGTKE-RLFEGIIKGKYKM------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp CSSHH-HHHHHHHHTCCCC------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred CCcHH-HHHHHHHcCCCCC------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 87543 3344444332211 123445688999999999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=408.51 Aligned_cols=261 Identities=28% Similarity=0.476 Sum_probs=223.9
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.++.+|+.||+|+++.... .....+.+.+|+.++++++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------------------~~~~~~~~~~E~~il~~l~ 86 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---------------------SARDFQKLEREARICRKLQ 86 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------------------CHHHHHHHHHHHHHHHHCC
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC---------------------CHHHHHHHHHHHHHHHhCC
Confidence 4679999999999999999999999999999998753211 1234567899999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++.+.+..|+||||+.||+|.+++. ..+.+++..+..++.||+.||.|||++||+||||||+|
T Consensus 87 hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~N 158 (362)
T 2bdw_A 87 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--------AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPEN 158 (362)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT--------TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGG
T ss_pred CCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH--------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHH
Confidence 9999999999999999999999999999999996 45678999999999999999999999999999999999
Q ss_pred EEEcCC---CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 188 ILLGED---GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 188 ILl~~~---g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
||++.+ +.+||+|||++..+... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.
T Consensus 159 Ill~~~~~~~~~kl~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 159 LLLASKAKGAAVKLADFGLAIEVNDS------EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp EEESCSSTTCCEEECCCTTCBCCTTC------CSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEEecCCCCCCEEEeecCcceEecCC------cccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCC
Confidence 999754 46999999999766432 2234568999999999997655 8999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
..........+..+..... ...+..+++++.+||.+||++||.+|||+.++|+||||+..
T Consensus 232 ~~~~~~~~~~i~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 232 DEDQHRLYAQIKAGAYDYP------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp CSSHHHHHHHHHHTCCCCC------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred CCCHHHHHHHHHhCCCCCC------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 8887777666655543221 12345678999999999999999999999999999999753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=394.75 Aligned_cols=267 Identities=27% Similarity=0.392 Sum_probs=214.2
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||+||+|.+ .+|+.||+|+++.... .....+.+.+|+.++++++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~---------------------~~~~~~~~~~E~~~l~~l~h 59 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE---------------------DEGIPSTTIREISILKELKH 59 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG---------------------GGCCCHHHHHHHHGGGGCCC
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc---------------------ccccchhHHHHHHHHHhcCC
Confidence 6899999999999999999998 6788888887753211 01223568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+.+|+||||+.+ +|.+++.. ..+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 60 ~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 131 (288)
T 1ob3_A 60 SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV-------CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131 (288)
T ss_dssp TTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHT-------STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHh-------cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 9999999999999999999999975 99999874 346799999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.+|.+||+|||++..+.... .......||+.|+|||++.+...++.++|||||||++|+|+||..||.+...
T Consensus 132 l~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (288)
T 1ob3_A 132 LINREGELKIADFGLARAFGIPV-----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (288)
T ss_dssp EECTTSCEEECCTTHHHHHCC--------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEcCCCCEEEeECccccccCccc-----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999987653211 1123457899999999997766689999999999999999999999998877
Q ss_pred HHHHHHHhcC--CCCCC--CC---------------CchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 269 MKVLMLTLQN--DPPTL--DT---------------GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 269 ~~~~~~~~~~--~~~~~--~~---------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
...+...... .+... .. ..........+++.+.+||.+||++||.+|||+.|+|+||||+.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 207 ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 6666544321 11000 00 00001122457889999999999999999999999999999985
Q ss_pred c
Q psy11359 330 A 330 (520)
Q Consensus 330 ~ 330 (520)
.
T Consensus 287 ~ 287 (288)
T 1ob3_A 287 N 287 (288)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=403.10 Aligned_cols=265 Identities=24% Similarity=0.444 Sum_probs=220.9
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|+++.+++.||+|+++..... .....+.+.+|+.++++
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--------------------~~~~~~~~~~E~~~l~~ 65 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN--------------------DDEDIDWVQTEKHVFEQ 65 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC--------------------SHHHHHHHHHHHHHHHH
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc--------------------chHHHHHHHHHHHHHHh
Confidence 4567899999999999999999999999999999988643211 12345668899999998
Q ss_pred C-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 106 C-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 106 l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+ +||||+++++++.+.+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+|||||
T Consensus 66 ~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 137 (345)
T 3a8x_A 66 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR--------QRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 137 (345)
T ss_dssp TTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred cCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 8 899999999999999999999999999999999974 3568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.+|.+||+|||++...... .......+||+.|+|||++.+.. |+.++|||||||++|+|++|..||.
T Consensus 138 p~NIll~~~g~~kL~DFG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~ 211 (345)
T 3a8x_A 138 LDNVLLDSEGHIKLTDYGMCKEGLRP-----GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFD 211 (345)
T ss_dssp GGGEEECTTSCEEECCGGGCBCSCCT-----TCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred HHHEEECCCCCEEEEeccccccccCC-----CCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcC
Confidence 99999999999999999998753221 12234678999999999997755 8999999999999999999999996
Q ss_pred CC---------cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH------HHHhcCccccc
Q psy11359 265 KY---------PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA------SELLKNPFFKK 329 (520)
Q Consensus 265 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta------~elL~hp~~~~ 329 (520)
.. ........+... ...++ ..++..+++||.+||++||.+||++ .|+++||||+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~i~~~-~~~~p---------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 212 IVGSSDNPDQNTEDYLFQVILEK-QIRIP---------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp TTTC-------CHHHHHHHHHHC-CCCCC---------TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CcccccccccccHHHHHHHHHcC-CCCCC---------CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 52 112222223322 22222 3468899999999999999999995 89999999998
Q ss_pred cchhh
Q psy11359 330 AKDKK 334 (520)
Q Consensus 330 ~~~~~ 334 (520)
..+..
T Consensus 282 ~~w~~ 286 (345)
T 3a8x_A 282 VDWDM 286 (345)
T ss_dssp CCHHH
T ss_pred CCHHH
Confidence 76654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=393.46 Aligned_cols=273 Identities=23% Similarity=0.369 Sum_probs=218.0
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.++++++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l~ 60 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---------------------DDPVIKKIALREIRMLKQLK 60 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC---------------------C-HHHHHHHHHHHHHHHHCC
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc---------------------cchHHHHHHHHHHHHHHhCC
Confidence 368999999999999999999999999999999764211 11234566889999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++...+..++||||+.+++|.+++. ..+.+++..+..++.||+.||.|||++||+||||||+|
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~N 132 (311)
T 4agu_A 61 HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--------YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPEN 132 (311)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH--------TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCCccchhheeecCCeEEEEEEeCCCchHHHHHh--------hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhh
Confidence 9999999999999999999999999999999887 45679999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
||++.++.+||+|||++..+.... .......||+.|+|||++.+...++.++|||||||++|+|+||.+||.+..
T Consensus 133 il~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 133 ILITKHSVIKLCDFGFARLLTGPS-----DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp EEECTTSCEEECCCTTCEECC-----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEEcCCCCEEEeeCCCchhccCcc-----cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999998764322 122345799999999999876668999999999999999999999999887
Q ss_pred HHHHHHHHhcCC---------------------CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcc
Q psy11359 268 AMKVLMLTLQND---------------------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326 (520)
Q Consensus 268 ~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~ 326 (520)
............ .+..............+++.+.+||.+||++||.+|||+.|+|+|||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 208 DVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 766554332210 01111111112233567889999999999999999999999999999
Q ss_pred ccccchhh
Q psy11359 327 FKKAKDKK 334 (520)
Q Consensus 327 ~~~~~~~~ 334 (520)
|+......
T Consensus 288 f~~~~~~~ 295 (311)
T 4agu_A 288 FENIREIE 295 (311)
T ss_dssp GTTCC---
T ss_pred HHhccCHH
Confidence 99876543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=402.52 Aligned_cols=274 Identities=22% Similarity=0.329 Sum_probs=213.9
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
+-....++|++.+.||+|+||+||+|.+..+++.||+|+++.... .....+.+.+|+.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~~E~~~ 86 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---------------------EEGVPGTAIREVSL 86 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------------------------CHHHHHH
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc---------------------ccccchhHHHHHHH
Confidence 345567899999999999999999999999999999998753211 01223457789999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
+++++||||+++++++..++.+|+||||+. ++|.+++.. .+.+++..++.++.||+.||.|||++||+|||
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~D 157 (329)
T 3gbz_A 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDK--------NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRD 157 (329)
T ss_dssp GGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH--------CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCC
Confidence 999999999999999999999999999997 599999974 45689999999999999999999999999999
Q ss_pred cCCCcEEEc-----CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 183 IKAGNILLG-----EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 183 LKp~NILl~-----~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
|||+|||++ .++.+||+|||++..+.... ......+||+.|+|||++.+...++.++|||||||++|+|+
T Consensus 158 lkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 232 (329)
T 3gbz_A 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI-----RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232 (329)
T ss_dssp CCGGGEEEEC-----CCEEEECCTTHHHHHC----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEecCCCCccceEEECcCCCccccCCcc-----cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999994 45569999999997654221 12234578999999999987666899999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhcCC--CCC------------------CCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC
Q psy11359 258 TGTAPYHKYPAMKVLMLTLQND--PPT------------------LDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT 317 (520)
Q Consensus 258 tG~~Pf~~~~~~~~~~~~~~~~--~~~------------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 317 (520)
+|..||........+....... +.. .............+++++.+||.+||++||.+|||
T Consensus 233 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 312 (329)
T 3gbz_A 233 MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312 (329)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC
Confidence 9999999888776665544321 110 00111111222347899999999999999999999
Q ss_pred HHHHhcCccccccc
Q psy11359 318 ASELLKNPFFKKAK 331 (520)
Q Consensus 318 a~elL~hp~~~~~~ 331 (520)
+.|+|+||||+...
T Consensus 313 ~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 313 AKNALEHPYFSHND 326 (329)
T ss_dssp HHHHHTSGGGSSSC
T ss_pred HHHHhCCcccCCCC
Confidence 99999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=409.04 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=216.9
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+|+.||+|+++...... ......+.+|+.+++.
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~E~~~l~~ 65 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK--------------------SDMHMRVEREISYLKL 65 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCSHHHHHHHHHHTT
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc--------------------hhHHHHHHHHHHHHHh
Confidence 34578999999999999999999999999999999986543221 1223468899999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++...+.+++||||+ +|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||
T Consensus 66 l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp 136 (336)
T 3h4j_B 66 LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE--------KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKP 136 (336)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHH--------HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCST
T ss_pred CCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCch
Confidence 99999999999999999999999999 7899999974 35689999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.++.+||+|||++.....+ ......+||+.|+|||++.+...+++++|||||||++|+|++|..||..
T Consensus 137 ~NIll~~~~~~kl~DFG~s~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 137 ENLLLDDNLNVKIADFGLSNIMTDG------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp TTEEECTTCCEEECCSSCTBTTTTS------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred hhEEEcCCCCEEEEEeccceeccCC------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999998765432 2234568999999999998766458899999999999999999999976
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
......... +... .......+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 211 ~~~~~~~~~--------i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 211 EFIPNLFKK--------VNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp SSSTTCBCC--------CCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ccHHHHHHH--------HHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 433221110 0000 011123578899999999999999999999999999999753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=401.29 Aligned_cols=269 Identities=26% Similarity=0.391 Sum_probs=217.4
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEc---CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCK---ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKE 99 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~E 99 (520)
+.....++|++.+.||+|+||+||+|++. .+|+.||+|+++..... ........+.+|
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-------------------~~~~~~~~~~~E 71 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-------------------RNAKDTAHTKAE 71 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------------------------H
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-------------------hhhhHHHHHHHH
Confidence 44567789999999999999999999986 67888999987532110 001234457889
Q ss_pred HHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 100 IQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 100 i~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+.+|++++||||+++++++...+.+|+||||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+
T Consensus 72 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~al~~lH~~~iv 143 (327)
T 3a62_A 72 RNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER--------EGIFMEDTACFYLAEISMALGHLHQKGII 143 (327)
T ss_dssp HHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 9999999999999999999999999999999999999999974 35688999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG 259 (520)
||||||+|||++.+|.+||+|||++...... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 144 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g 217 (327)
T 3a62_A 144 YRDLKPENIMLNHQGHVKLTDFGLCKESIHD-----GTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTG 217 (327)
T ss_dssp CCCCCTTTEEECTTSCEEECCCSCC---------------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHS
T ss_pred cccCCHHHeEECCCCcEEEEeCCcccccccC-----CccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHC
Confidence 9999999999999999999999998754321 12234568999999999997655 89999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhh
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKK 334 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~ 334 (520)
..||........+..+....... + ..+++.+++||.+||+.||.+|| ++.|+++||||+...+..
T Consensus 218 ~~pf~~~~~~~~~~~i~~~~~~~-p---------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~ 287 (327)
T 3a62_A 218 APPFTGENRKKTIDKILKCKLNL-P---------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEE 287 (327)
T ss_dssp SCSCCCSSHHHHHHHHHHTCCCC-C---------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHhCCCCC-C---------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHH
Confidence 99999888777776666543321 1 34678999999999999999999 899999999999876654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=407.94 Aligned_cols=264 Identities=26% Similarity=0.383 Sum_probs=207.9
Q ss_pred CCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 21 SVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 21 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
..+.....++|++++.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+
T Consensus 12 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------------------~~~~~~~~~E~ 67 (361)
T 3uc3_A 12 DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG------------------------AAIDENVQREI 67 (361)
T ss_dssp CCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS------------------------TTSCHHHHHHH
T ss_pred CccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC------------------------ccccHHHHHHH
Confidence 334556778999999999999999999999999999999987532 11224588999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
.++++++||||+++++++...+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+|
T Consensus 68 ~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH 139 (361)
T 3uc3_A 68 INHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN--------AGRFSEDEARFFFQQLLSGVSYCHSMQICH 139 (361)
T ss_dssp HHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTCCS
T ss_pred HHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999999999999999974 356899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCC--eEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 181 RDIKAGNILLGEDGT--VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 181 rDLKp~NILl~~~g~--vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
|||||+|||++.++. +||+|||++..... .......+||+.|+|||++.+...++.++|||||||++|+|++
T Consensus 140 ~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 213 (361)
T 3uc3_A 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL------HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213 (361)
T ss_dssp CCCCGGGEEECSSSSCCEEECCCCCC---------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCceEEEeecCccccccc------cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHh
Confidence 999999999987665 99999999864321 1223456799999999999876634455999999999999999
Q ss_pred CCCCCCCCcH----HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 259 GTAPYHKYPA----MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 259 G~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
|.+||..... ...+........ .++. ...+++.+.+||.+||++||.+|||+.|+++||||.+.
T Consensus 214 g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~-------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 214 GAYPFEDPEEPRDYRKTIQRILSVKY-SIPD-------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp SSCSCC----CCCHHHHHHHHHTTCC-CCCT-------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCCCCCCCccHHHHHHHHHHHhcCCC-CCCC-------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 9999986543 222222222221 1111 12467899999999999999999999999999999754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=402.94 Aligned_cols=264 Identities=24% Similarity=0.395 Sum_probs=218.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+.+++.+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~~E~~~l~~l 62 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----------------------AVDCPENIKKEICINKML 62 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------------------CHHHHHHHHHHC
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc----------------------ccchHHHHHHHHHHHHhC
Confidence 3578999999999999999999999999999999875321 112234588999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+..|+||||+.|++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+
T Consensus 63 ~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--------~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~ 134 (323)
T 3tki_A 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--------PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134 (323)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSB--------TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHh--------hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchH
Confidence 99999999999999999999999999999999886 4567999999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.++.+||+|||++..+.... ........+||+.|+|||++.+...++.++|||||||++|+|++|..||...
T Consensus 135 NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 211 (323)
T 3tki_A 135 NLLLDERDNLKISDFGLATVFRYNN---RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (323)
T ss_dssp GEEECTTCCEEECCCTTCEECEETT---EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred HEEEeCCCCEEEEEeeccceeccCC---cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999998664322 1222345689999999999987664588999999999999999999999876
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.................. .+..+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 212 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 212 SDSCQEYSDWKEKKTYLN-------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp CTTSHHHHHHHTTCTTST-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred chHHHHHHHHhcccccCC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 554333322222222111 235678999999999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=397.58 Aligned_cols=276 Identities=23% Similarity=0.354 Sum_probs=208.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++++.||+|+||+||+|.++.+|+.||+|+++.. ......+.+.+|+.+++++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------------~~~~~~~~~~~E~~~l~~l 60 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD----------------------SEEGTPSTAIREISLMKEL 60 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECC----------------------STTCSCHHHHHHHHHHTTC
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecc----------------------cccccHHHHHHHHHHHHhc
Confidence 346899999999999999999999999999999877532 1122345688999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++..++.+|+||||+. ++|.+++....... ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 61 ~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~ 137 (317)
T 2pmi_A 61 KHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGN--TPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQ 137 (317)
T ss_dssp CBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSS--CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccc--cccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChH
Confidence 99999999999999999999999997 69999997653221 3356899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.+|.+||+|||++..+.... .......||+.|+|||++.+...++.++|||||||++|+|+||..||.+.
T Consensus 138 NIl~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 138 NLLINKRGQLKLGDFGLARAFGIPV-----NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp GEEECTTCCEEECCCSSCEETTSCC-----CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred HeEEcCCCCEEECcCccceecCCCc-----ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999998764321 12234578999999999977656899999999999999999999999988
Q ss_pred cHHHHHHHHhcC--CC-CCCCCCc---------------------hhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 267 PAMKVLMLTLQN--DP-PTLDTGA---------------------AEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 267 ~~~~~~~~~~~~--~~-~~~~~~~---------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
.....+..+... .+ ....... ........++..+.+||.+||++||.+|||+.|+|
T Consensus 213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 213 NDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp SHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 876666544321 11 1000000 00011124678999999999999999999999999
Q ss_pred cCccccccch
Q psy11359 323 KNPFFKKAKD 332 (520)
Q Consensus 323 ~hp~~~~~~~ 332 (520)
+||||+....
T Consensus 293 ~hp~f~~~~~ 302 (317)
T 2pmi_A 293 HHPWFAEYYH 302 (317)
T ss_dssp TSGGGGGGCC
T ss_pred CChhhhcccc
Confidence 9999986543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=389.65 Aligned_cols=264 Identities=27% Similarity=0.489 Sum_probs=218.0
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..++..||+|++... ......+.+.+|+.++++
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----------------------~~~~~~~~~~~E~~~l~~ 76 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD----------------------RSQVPMEQIEAEIEVLKS 76 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGG----------------------GCCSCHHHHHHHHHHHHT
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecc----------------------ccchhHHHHHHHHHHHHh
Confidence 3557899999999999999999999999888888877532 113346779999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++......|+||||+.|++|.+++..... ....+++..++.++.||+.||.|||++||+||||||
T Consensus 77 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp 152 (285)
T 3is5_A 77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA----RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKP 152 (285)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred CCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhh----cccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCH
Confidence 9999999999999999999999999999999999975433 346799999999999999999999999999999999
Q ss_pred CcEEE---cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 186 GNILL---GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 186 ~NILl---~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
+|||+ +.++.+||+|||++..+... .......||+.|+|||++.+. ++.++|||||||++|+|++|..|
T Consensus 153 ~NIl~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~il~~ll~g~~p 224 (285)
T 3is5_A 153 ENILFQDTSPHSPIKIIDFGLAELFKSD------EHSTNAAGTALYMAPEVFKRD--VTFKCDIWSAGVVMYFLLTGCLP 224 (285)
T ss_dssp GGEEESSSSTTCCEEECCCCCCCC----------------CTTGGGCCHHHHTTC--CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred HHEEEecCCCCCCEEEEeeecceecCCc------ccCcCcccccCcCChHHhccC--CCcccCeehHHHHHHHHHhCCCC
Confidence 99999 45678999999999765432 223456799999999998643 89999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
|.+..............+..... ...+++.+.+||.+||++||.+|||+.|+|+||||+++
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 225 FTGTSLEEVQQKATYKEPNYAVE-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCC---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred CCCCCHHHHHhhhccCCcccccc-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 99887776665554443322211 12367889999999999999999999999999999853
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=394.10 Aligned_cols=281 Identities=25% Similarity=0.408 Sum_probs=215.1
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhH-hhhccceeeEEEeec--ccchhhHHHHHHHHHH
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAY-CKARAEKCAIKKINL--EKWNTSMDELLKEIQA 102 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-~~~~~~~~aiK~i~~--~~~~~~~~~l~~Ei~~ 102 (520)
...++|++.+.||+|+||+||+|.+..+++.||+|++......... +.........+.... .......+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3567899999999999999999999999999999998754321110 000000000000000 0001234578999999
Q ss_pred HhcCCCCCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 103 MSSCHHENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+++++||||+++++++.. ...+|+||||+.+++|.+++ ..+.+++..++.++.||+.||.|||++||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 160 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---------TLKPLSEDQARFYFQDLIKGIEYLHYQKIIH 160 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---------CSSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 999999999999999986 67899999999999998754 3467999999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCC--CCcchhHHHHHHHHHHHHh
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG--YDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~--~~~~~DIwSlG~il~ellt 258 (520)
|||||+|||++.++.+||+|||++..+.... .......||+.|+|||++.+... ++.++|||||||++|+|++
T Consensus 161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-----ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECSSSS-----CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred cCCCHHHEEECCCCCEEEecCCCcccccccc-----ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 9999999999999999999999998764322 12335689999999999876542 4788999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
|..||...........+....... +. ...+++.+.+||.+||++||.+|||+.|+++||||+
T Consensus 236 g~~pf~~~~~~~~~~~~~~~~~~~-~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 236 GQCPFMDERIMCLHSKIKSQALEF-PD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCC-CS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred CCCCCCCccHHHHHHHHhcccCCC-CC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 999998877665554444332221 11 134678899999999999999999999999999996
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=406.94 Aligned_cols=267 Identities=28% Similarity=0.422 Sum_probs=219.8
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH-Hh
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA-MS 104 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~-l~ 104 (520)
...++|++++.||+|+||+||+|+++.+++.||+|+++...... ......+.+|..+ ++
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~--------------------~~~~~~~~~e~~~ll~ 94 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK--------------------KKEEKHIMSERNVLLK 94 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------------------------CCBC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh--------------------hHHHHHHHHHHHHHHH
Confidence 35578999999999999999999999999999999986542211 1123345667766 56
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
.++||||++++++|.+.+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+|||||
T Consensus 95 ~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk 166 (373)
T 2r5t_A 95 NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR--------ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK 166 (373)
T ss_dssp CCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred hCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 78999999999999999999999999999999999984 3568899999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.+|.+||+|||++..... ........+||+.|+|||++.+.. |+.++|||||||++|+|++|..||.
T Consensus 167 p~NIll~~~g~ikL~DFG~a~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~ 240 (373)
T 2r5t_A 167 PENILLDSQGHIVLTDFGLCKENIE-----HNSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFY 240 (373)
T ss_dssp GGGEEECTTSCEEECCCCBCGGGBC-----CCCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred HHHEEECCCCCEEEeeCcccccccc-----CCCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999875322 122345678999999999997655 8999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH----HHHhcCccccccchhhHH
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA----SELLKNPFFKKAKDKKFI 336 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta----~elL~hp~~~~~~~~~~~ 336 (520)
.....+....++..... +. ..++..+++||.+||++||.+||++ .++++||||+...+....
T Consensus 241 ~~~~~~~~~~i~~~~~~-~~---------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~ 306 (373)
T 2r5t_A 241 SRNTAEMYDNILNKPLQ-LK---------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLI 306 (373)
T ss_dssp CSBHHHHHHHHHHSCCC-CC---------SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHH
T ss_pred CCCHHHHHHHHHhcccC-CC---------CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHH
Confidence 98888777766655322 11 3467889999999999999999997 699999999988776543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=391.25 Aligned_cols=260 Identities=37% Similarity=0.615 Sum_probs=223.7
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
..|...+.||+|+||+||+|.+..+|+.||+|+++... ....+.+.+|+.++++++|
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-----------------------~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-----------------------QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----------------------CCSHHHHHHHHHHHTTCCC
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-----------------------hhHHHHHHHHHHHHHhCCC
Confidence 35899999999999999999999999999999875321 2235668899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+..|+||||+.|++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 172 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---------QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSI 172 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH---------hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 999999999999999999999999999999984 35689999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.++.+||+|||++..+..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVP-----KRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSC-----CBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EECCCCcEEEeeeeeeeecccCcc-----ccccccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999987643221 224568999999999997655 89999999999999999999999998877
Q ss_pred HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
...........++.+.. ...+++.+.+||.+||+.||.+|||+.|+++||||......
T Consensus 247 ~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 304 (321)
T 2c30_A 247 VQAMKRLRDSPPPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLP 304 (321)
T ss_dssp HHHHHHHHHSSCCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred HHHHHHHhcCCCCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCc
Confidence 77666555554443321 24578899999999999999999999999999999876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=404.86 Aligned_cols=264 Identities=27% Similarity=0.448 Sum_probs=224.2
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||+|.++.+|+.||+|++.... ......+.+|+.+|+
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----------------------~~~~~~~~~E~~il~ 103 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----------------------PLDKYTVKNEISIMN 103 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----------------------HHHHHHHHHHHHHHT
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----------------------hhhHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999875321 123446889999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++.....+|+||||+.||+|.+++.. ....+++..+..++.||+.||.|||++||+|||||
T Consensus 104 ~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlk 176 (387)
T 1kob_A 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-------EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 176 (387)
T ss_dssp TCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC-------TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred hCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence 99999999999999999999999999999999999863 33578999999999999999999999999999999
Q ss_pred CCcEEEcC--CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 185 AGNILLGE--DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 185 p~NILl~~--~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|+|||++. ++.+||+|||++..+.... ......||+.|+|||++.+.. ++.++|||||||++|+|+||..|
T Consensus 177 p~NIll~~~~~~~vkL~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P 249 (387)
T 1kob_A 177 PENIMCETKKASSVKIIDFGLATKLNPDE------IVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSP 249 (387)
T ss_dssp GGGEEESSTTCCCEEECCCTTCEECCTTS------CEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCS
T ss_pred hHHeEEecCCCCceEEEecccceecCCCc------ceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCC
Confidence 99999974 5789999999998764321 223457999999999997655 89999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
|.+......+..+......... ..+..+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 250 f~~~~~~~~~~~i~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 250 FAGEDDLETLQNVKRCDWEFDE------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCS------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CCCCCHHHHHHHHHhCCCCCCc------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 9988877777666554322211 12346788999999999999999999999999999998643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=412.28 Aligned_cols=268 Identities=26% Similarity=0.382 Sum_probs=225.5
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.++||+|+||+||+|.++.+++.||+|+++....... ...+.+.+|+.+++.
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~--------------------~~~~~~~~E~~il~~ 125 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR--------------------SDSAFFWEERDIMAF 125 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT--------------------CCCSTHHHHHHHHHH
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhh--------------------HHHHHHHHHHHHHHh
Confidence 466889999999999999999999999999999999875322111 112347889999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||++++++|.+.+.+|+||||+.||+|.++++. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 126 l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp 196 (410)
T 3v8s_A 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 196 (410)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCH
Confidence 9999999999999999999999999999999999963 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCC---CCcchhHHHHHHHHHHHHhCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG---YDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---~~~~~DIwSlG~il~elltG~~P 262 (520)
+|||++.+|.+||+|||++..+.... .....+.+||+.|+|||++.+... |+.++|||||||++|+|+||.+|
T Consensus 197 ~NILl~~~g~ikL~DFG~a~~~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P 272 (410)
T 3v8s_A 197 DNMLLDKSGHLKLADFGTCMKMNKEG----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272 (410)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTS----EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCT
T ss_pred HHeeECCCCCEEEeccceeEeeccCC----cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCC
Confidence 99999999999999999998764322 112346789999999999875432 78899999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCC-CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCC--CCCHHHHhcCccccccchh
Q psy11359 263 YHKYPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK--RPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~~~~~~~~ 333 (520)
|...........+..... ...+ ....+++++++||.+||+.+|.+ |+++.|+++||||+...+.
T Consensus 273 f~~~~~~~~~~~i~~~~~~~~~p-------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 273 FYADSLVGTYSKIMNHKNSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp TCCSSHHHHHHHHHTHHHHCCCC-------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred CCCCChhhHHHHHHhccccccCC-------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 998888777766654311 1111 11356889999999999998988 9999999999999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=400.31 Aligned_cols=285 Identities=25% Similarity=0.332 Sum_probs=226.2
Q ss_pred CCCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 19 SVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 19 ~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
+...++....++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~~ 65 (351)
T 3mi9_A 7 SVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---------------------KEGFPITALR 65 (351)
T ss_dssp -CCCTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC---------------------SSSSCHHHHH
T ss_pred cccccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc---------------------cccchHHHHH
Confidence 3455667788999999999999999999999999999999997743210 0122345789
Q ss_pred HHHHHhcCCCCCceEEEEEEEE--------CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVV--------KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGL 170 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~--------~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL 170 (520)
|+.++++++||||+++++++.. .+.+|+||||+. ++|.+.+.. ....+++..++.++.||+.||
T Consensus 66 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-------~~~~~~~~~~~~i~~qi~~~l 137 (351)
T 3mi9_A 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSN-------VLVKFTLSEIKRVMQMLLNGL 137 (351)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHC-------TTSCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhh-------ccCCCCHHHHHHHHHHHHHHH
Confidence 9999999999999999999987 456999999996 488888864 345799999999999999999
Q ss_pred HHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHH
Q psy11359 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG 250 (520)
Q Consensus 171 ~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG 250 (520)
.|||++||+||||||+|||++.++.+||+|||++..+...... .........||+.|+|||++.+...++.++||||||
T Consensus 138 ~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 216 (351)
T 3mi9_A 138 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS-QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216 (351)
T ss_dssp HHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSS-SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHH
T ss_pred HHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccc-cccccCCcccccCccCchhhcCCCCCCcHhHHHHHH
Confidence 9999999999999999999999999999999999876533322 222234568999999999998766689999999999
Q ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHhcC---CCCCCCCCchh-------------------hhhHHHhcHHHHHHHHhhh
Q psy11359 251 ITAIEMATGTAPYHKYPAMKVLMLTLQN---DPPTLDTGAAE-------------------KDQYKAYGKTFRKMISDCL 308 (520)
Q Consensus 251 ~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~~-------------------~~~~~~~~~~~~~li~~~L 308 (520)
|++|+|+||.+||.+......+..+... .++........ .......++.+.+||.+||
T Consensus 217 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 296 (351)
T 3mi9_A 217 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 296 (351)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHh
Confidence 9999999999999988776665544321 11111111100 0001123788999999999
Q ss_pred ccCCCCCCCHHHHhcCccccccchh
Q psy11359 309 QKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 309 ~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
+.||.+|||+.|+|+||||+.....
T Consensus 297 ~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 297 VLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp CSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred cCChhhCCCHHHHhCCCCcCCCCCc
Confidence 9999999999999999999865443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=415.42 Aligned_cols=266 Identities=27% Similarity=0.443 Sum_probs=219.1
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.++||+|+||.||+|.+..+|+.||+|+++...... ......+.+|+.+++
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~ 203 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA--------------------KDEVAHTLTENRVLQ 203 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC---------------------------------CCC
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh--------------------hHHHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999986432211 122345778999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccc
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDI 183 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDL 183 (520)
.++||||+++++++...+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||+ +||+||||
T Consensus 204 ~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDl 275 (446)
T 4ejn_A 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR--------ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275 (446)
T ss_dssp CCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH--------HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCC
T ss_pred hCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCC
Confidence 99999999999999999999999999999999999974 3578999999999999999999998 99999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+.. |+.++|||||||++|+|++|..||
T Consensus 276 kp~NIll~~~~~~kl~DFG~a~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf 349 (446)
T 4ejn_A 276 KLENLMLDKDGHIKITDFGLCKEGIK-----DGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF 349 (446)
T ss_dssp CGGGEEECSSSCEEECCCCCCCTTCC----------CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CHHHEEECCCCCEEEccCCCceeccC-----CCcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCC
Confidence 99999999999999999999875322 122234578999999999997665 899999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhh
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKK 334 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~ 334 (520)
...........+....... + ..+++.+.+||.+||++||.+|| |+.|+++||||+...+..
T Consensus 350 ~~~~~~~~~~~i~~~~~~~-p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~ 415 (446)
T 4ejn_A 350 YNQDHEKLFELILMEEIRF-P---------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415 (446)
T ss_dssp CCSSHHHHHHHHHHCCCCC-C---------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred CCCCHHHHHHHHHhCCCCC-C---------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence 9888777776666554322 1 34678999999999999999999 999999999999876554
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=415.09 Aligned_cols=261 Identities=25% Similarity=0.435 Sum_probs=226.0
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+|+.||+|+++...... ....+.+.+|+.+++.
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~--------------------~~~~~~~~~Ei~~l~~ 72 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS--------------------LDVVGKIRREIQNLKL 72 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTTHHHHHHHHHHHTT
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC--------------------HHHHHHHHHHHHHHHh
Confidence 35688999999999999999999999999999999886432211 1235678999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++...+.+|+||||+.||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||
T Consensus 73 l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp 144 (476)
T 2y94_A 73 FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC--------KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKP 144 (476)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTT--------SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSG
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccH
Confidence 999999999999999999999999999999999996 456799999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.++.+||+|||++..+..+ ....+.+||+.|+|||++.+...++.++|||||||++|+|++|..||..
T Consensus 145 ~NIll~~~~~vkL~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 145 ENVLLDAHMNAKIADFGLSNMMSDG------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp GGEEECTTCCEEECCCSSCEECCTT------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEEecCCCeEEEeccchhhcccc------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 9999999999999999999876432 2234568999999999998776457899999999999999999999998
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.........+..+.... + ..+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 219 ~~~~~~~~~i~~~~~~~-p---------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 219 DHVPTLFKKICDGIFYT-P---------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp SSSHHHHHHHHTTCCCC-C---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCHHHHHHHHhcCCcCC-C---------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 77766666555543221 1 2467889999999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=383.00 Aligned_cols=265 Identities=27% Similarity=0.467 Sum_probs=225.3
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.++++
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~~e~~~l~~ 61 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---------------------SARDFQKLEREARICRK 61 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---------------------CHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC---------------------CHHHHHHHHHHHHHHHH
Confidence 356889999999999999999999999999999998754321 12345678899999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++...+..++||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||
T Consensus 62 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp 133 (284)
T 3kk8_A 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA--------REFYSEADASHCIQQILESIAYCHSNGIVHRNLKP 133 (284)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred cCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCH
Confidence 9999999999999999999999999999999999974 35689999999999999999999999999999999
Q ss_pred CcEEEcCCCC---eEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 186 GNILLGEDGT---VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 186 ~NILl~~~g~---vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
+||+++.++. +||+|||++....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..|
T Consensus 134 ~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p 206 (284)
T 3kk8_A 134 ENLLLASKAKGAAVKLADFGLAIEVNDSE------AWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPP 206 (284)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECCSSC------BCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCS
T ss_pred HHEEEecCCCCCcEEEeeceeeEEcccCc------cccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCC
Confidence 9999976554 9999999997664322 223467999999999997765 89999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
|..................... ..+..+++.+.+||.+||++||.+|||+.|+|+||||+....
T Consensus 207 f~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 207 FWDEDQHRLYAQIKAGAYDYPS------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp SCCSSHHHHHHHHHHTCCCCCT------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred CCCCchhHHHHHHHhccccCCc------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9988877766665554332211 123467889999999999999999999999999999987544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=410.02 Aligned_cols=272 Identities=23% Similarity=0.357 Sum_probs=227.1
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.++||+|+||+||+|.++.+++.||+|+++....... ...+.+.+|+.++..
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~--------------------~~~~~~~~E~~il~~ 130 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR--------------------AETACFREERDVLVN 130 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHT--------------------TTTCCHHHHHHHHHH
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhH--------------------HHHHHHHHHHHHHHh
Confidence 456789999999999999999999999999999999875432111 112237889999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||++++++|.+.+.+|+||||+.||+|.+++.. ..+.+++..++.++.||+.||.|||++||+||||||
T Consensus 131 ~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~-------~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp 203 (437)
T 4aw2_A 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK-------FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKP 203 (437)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT-------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCH
Confidence 9999999999999999999999999999999999974 356799999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc----cCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----DHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
+|||++.+|.+||+|||++..+..... ......+||+.|+|||++.. ...|+.++|||||||++|||+||.+
T Consensus 204 ~NILl~~~g~vkL~DFGla~~~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~ 279 (437)
T 4aw2_A 204 DNILMDMNGHIRLADFGSCLKLMEDGT----VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279 (437)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTSC----EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSC
T ss_pred HHeeEcCCCCEEEcchhhhhhcccCCC----cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCC
Confidence 999999999999999999976643221 12234689999999999862 3348999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCC-CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCC--CCCHHHHhcCccccccchhh
Q psy11359 262 PYHKYPAMKVLMLTLQND-PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK--RPTASELLKNPFFKKAKDKK 334 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~~~~~~~~~ 334 (520)
||......+.+..++... ...++. ....+++++++||.+||..+|.+ |++++|+++||||+...+..
T Consensus 280 Pf~~~~~~~~~~~i~~~~~~~~~p~------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 280 PFYAESLVETYGKIMNHKERFQFPT------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp TTCCSSHHHHHHHHHTHHHHCCCCS------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred CCCCCChhHHHHhhhhccccccCCc------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 999888777776655321 011111 01346889999999999888888 99999999999999887764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=398.72 Aligned_cols=269 Identities=24% Similarity=0.369 Sum_probs=214.1
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++++.||+|+||+||+|.+..+++.||+|+++.... ......+.+|+.++++++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~~E~~~l~~l~h 59 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE----------------------EGAPCTAIREVSLLKDLKH 59 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------------------------CCCCCCCHHHHSCCCC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc----------------------cccchhHHHHHHHHHhcCC
Confidence 689999999999999999999999999999998753211 0011124469999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+.+++||||+. ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 60 ~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NI 131 (324)
T 3mtl_A 60 ANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD-------CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 131 (324)
T ss_dssp TTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHH-------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGE
T ss_pred CCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHE
Confidence 999999999999999999999996 599999875 345789999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.++.+||+|||++....... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+...
T Consensus 132 l~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (324)
T 3mtl_A 132 LINERGELKLADFGLARAKSIPT-----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206 (324)
T ss_dssp EECTTCCEEECSSSEEECC-----------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EECCCCCEEEccCcccccccCCc-----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999987653221 1223457899999999998766689999999999999999999999998887
Q ss_pred HHHHHHHhcC--CC-CCCCCCc-----------------hhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 269 MKVLMLTLQN--DP-PTLDTGA-----------------AEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 269 ~~~~~~~~~~--~~-~~~~~~~-----------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
.+.+...... .+ ....... ........+++.+.+||.+||+.||.+|||+.|+|+||||.
T Consensus 207 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 286 (324)
T 3mtl_A 207 EEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286 (324)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred HHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence 7666544331 11 1110000 01122345788999999999999999999999999999998
Q ss_pred ccch
Q psy11359 329 KAKD 332 (520)
Q Consensus 329 ~~~~ 332 (520)
....
T Consensus 287 ~~~~ 290 (324)
T 3mtl_A 287 SLGE 290 (324)
T ss_dssp GGCS
T ss_pred hccc
Confidence 7644
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=407.87 Aligned_cols=274 Identities=26% Similarity=0.394 Sum_probs=210.8
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++++.||+|+||+||+|.+..+|+.||+|++.... ........+.+|+.+++++.
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---------------------~~~~~~~~~~~E~~~l~~l~ 66 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---------------------QNSTDAQRTFREIMILTELS 66 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----------------------CCHHHHHHHHHHHHHHHHTT
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc---------------------cChHHHHHHHHHHHHHHhcc
Confidence 368999999999999999999999999999999774211 11234567889999999996
Q ss_pred -CCCceEEEEEEEECC--EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 108 -HENVVTYHTSFVVKD--ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 108 -HpnIv~~~~~~~~~~--~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
||||+++++++...+ .+|+||||+. ++|.++++. +.+++..++.++.||+.||.|||++||+|||||
T Consensus 67 ~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk 136 (388)
T 3oz6_A 67 GHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA---------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMK 136 (388)
T ss_dssp TCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH---------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred CCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCC
Confidence 999999999998654 7999999996 689999964 468899999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCcccc----------------ccccccccccccccCCcceecccCCCCcchhHHH
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLS----------------RQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWS 248 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~----------------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwS 248 (520)
|+|||++.++.+||+|||+++.+....... ........+||+.|+|||++.+...|+.++||||
T Consensus 137 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 216 (388)
T 3oz6_A 137 PSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWS 216 (388)
T ss_dssp GGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHH
T ss_pred HHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHH
Confidence 999999999999999999998764321110 1122345689999999999987666999999999
Q ss_pred HHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC------------------------------CCCchhh-------h
Q psy11359 249 LGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTL------------------------------DTGAAEK-------D 291 (520)
Q Consensus 249 lG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~-------~ 291 (520)
|||++|+|++|.+||.+......+..++....... ....... .
T Consensus 217 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (388)
T 3oz6_A 217 LGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296 (388)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccc
Confidence 99999999999999999888777665542211000 0000000 0
Q ss_pred hHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 292 QYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 292 ~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
....+++.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 297 ~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 297 PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHN 337 (388)
T ss_dssp TTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCC
T ss_pred ccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcC
Confidence 00145789999999999999999999999999999986543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=419.28 Aligned_cols=265 Identities=28% Similarity=0.468 Sum_probs=228.9
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.++||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.+++
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------------------~~~~~~~~~~~E~~~l~ 81 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV--------------------KQKTDKESLLREVQLLK 81 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------------------CBSSCHHHHHHHHHHHT
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhc--------------------ccchHHHHHHHHHHHHH
Confidence 4456789999999999999999999999999999998753311 01234667999999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++.....+|+||||+.|++|.+++. ..+.+++..++.++.||+.||.|||++||+|||||
T Consensus 82 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 153 (484)
T 3nyv_A 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII--------SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 153 (484)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH--------TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 9999999999999999999999999999999999997 45679999999999999999999999999999999
Q ss_pred CCcEEE---cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 185 AGNILL---GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 185 p~NILl---~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|+|||+ +.++.+||+|||++..+.... .....+||+.|+|||++.+. |+.++|||||||++|+|++|.+
T Consensus 154 p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~ 225 (484)
T 3nyv_A 154 PENLLLESKSKDANIRIIDFGLSTHFEASK------KMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCP 225 (484)
T ss_dssp GGGEEESSSSTTCCEEECCTTHHHHBCCCC------SHHHHTTGGGTCCHHHHHTC--CCTHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEEecCCCCCcEEEEeeeeeEEccccc------ccccCCCCccccCceeecCC--CCCcceeHHHHHHHHHHHHCCC
Confidence 999999 567899999999997664322 23456799999999998763 8999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
||.+......+..+..+..... ...+..+++.+++||.+||++||.+|||+.|+|+||||+...
T Consensus 226 pf~~~~~~~~~~~i~~~~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 226 PFNGANEYDILKKVEKGKYTFE------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCC------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCCCCCHHHHHHHHHcCCCCCC------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 9999888887777666543221 223467899999999999999999999999999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=400.05 Aligned_cols=259 Identities=27% Similarity=0.460 Sum_probs=205.0
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+++.||+|+++.. ...+.+.+|+.+++++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------------------------~~~~~~~~E~~~l~~l 105 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-------------------------VDKKIVRTEIGVLLRL 105 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------------------------CHHHHHC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------------------------hhHHHHHHHHHHHHhC
Confidence 456799999999999999999999999999999987521 1123477899999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+.+++||||+.|++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+
T Consensus 106 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~ 177 (349)
T 2w4o_A 106 SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV--------EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177 (349)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT--------TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred CCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcc
Confidence 99999999999999999999999999999999996 4567899999999999999999999999999999999
Q ss_pred cEEEcC---CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 187 NILLGE---DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 187 NILl~~---~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
|||++. ++.+||+|||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus 178 NIll~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf 250 (349)
T 2w4o_A 178 NLLYATPAPDAPLKIADFGLSKIVEHQ------VLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPF 250 (349)
T ss_dssp GEEESSSSTTCCEEECCCC----------------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cEEEecCCCCCCEEEccCccccccCcc------cccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCC
Confidence 999975 889999999998765321 2234568999999999998765 899999999999999999999999
Q ss_pred CCCcHHHHHH-HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 264 HKYPAMKVLM-LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 264 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
.......... .+........ ...+..++..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 251 ~~~~~~~~~~~~i~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 251 YDERGDQFMFRRILNCEYYFI------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp CCTTCHHHHHHHHHTTCCCCC------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred CCCcccHHHHHHHHhCCCccC------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 8766554333 3333322211 112346788999999999999999999999999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=417.75 Aligned_cols=262 Identities=26% Similarity=0.456 Sum_probs=224.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.++||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+|+++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~~E~~~l~~l 78 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK---------------------NKDTSTILREVELLKKL 78 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB---------------------CSCHHHHHHHHHHHHHC
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc---------------------chHHHHHHHHHHHHHhC
Confidence 458899999999999999999999999999999988643211 12356789999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++.....+|+||||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+
T Consensus 79 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~ 150 (486)
T 3mwu_A 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK--------RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE 150 (486)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred CCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchH
Confidence 999999999999999999999999999999999974 356899999999999999999999999999999999
Q ss_pred cEEEc---CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 187 NILLG---EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 187 NILl~---~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
|||++ .++.+||+|||++..+... ......+||+.|+|||++.+. |+.++|||||||++|+|++|.+||
T Consensus 151 Nil~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf 222 (486)
T 3mwu_A 151 NILLESKEKDCDIKIIDFGLSTCFQQN------TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPF 222 (486)
T ss_dssp GEEESSSSTTCCEEECSCSCTTTBCCC----------CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred HEEEecCCCCCCEEEEECCcCeECCCC------CccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCC
Confidence 99994 4568999999999765432 223456899999999999764 899999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
.+....+.+..+..+..... ...+..+++.+++||.+||++||.+|||+.++|+||||+...
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 223 YGKNEYDILKRVETGKYAFD------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp CCSSHHHHHHHHHHTCCCSC------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CCCCHHHHHHHHHhCCCCCC------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 99888887777666543221 223467899999999999999999999999999999998653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=416.60 Aligned_cols=275 Identities=26% Similarity=0.404 Sum_probs=225.8
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|+++++||+|+||+||+|.++.+++.||+|++............. ........+.+.+|+.+|+
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~ 101 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDD----------NKNIEKFHEEIYNEISLLK 101 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC--------------------------CTHHHHHHHHHHHH
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhccccccccc----------chhhHHHHHHHHHHHHHHH
Confidence 345688999999999999999999999999999999986543221100000 0001234577999999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++.....+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+|||||
T Consensus 102 ~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 173 (504)
T 3q5i_A 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN--------RHKFDECDAANIMKQILSGICYLHKHNIVHRDIK 173 (504)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--------HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred hCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCc
Confidence 99999999999999999999999999999999999974 3568999999999999999999999999999999
Q ss_pred CCcEEEcCCC---CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 185 AGNILLGEDG---TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 185 p~NILl~~~g---~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|+|||++.++ .+||+|||++..+.... .....+||+.|+|||++.+. |+.++|||||||++|+|++|.+
T Consensus 174 p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~ 245 (504)
T 3q5i_A 174 PENILLENKNSLLNIKIVDFGLSSFFSKDY------KLRDRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYP 245 (504)
T ss_dssp GGGEEESSTTCCSSEEECCCTTCEECCTTS------CBCCCCSCTTTCCHHHHTTC--BCTHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEEecCCCCccEEEEECCCCEEcCCCC------ccccccCCcCCCCHHHhccC--CCchHHHHHHHHHHHHHHhCCC
Confidence 9999998776 69999999998764322 23456799999999998743 8999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
||.+......+..+..+.... ....+..+++++++||.+||++||.+|||+.|+|+||||+...
T Consensus 246 pf~~~~~~~~~~~i~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 246 PFGGQNDQDIIKKVEKGKYYF------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp SSCCSSHHHHHHHHHHCCCCC------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCCCCCHHHHHHHHHcCCCCC------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 999988888777766654321 2334567899999999999999999999999999999998654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=406.04 Aligned_cols=271 Identities=25% Similarity=0.351 Sum_probs=225.2
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.++||+|+||+||+|+++.+|+.||+|++++...... ...+.+.+|+.++..
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~--------------------~~~~~~~~E~~il~~ 117 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR--------------------GEVSCFREERDVLVN 117 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH--------------------GGGCCHHHHHHHHHH
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhH--------------------HHHHHHHHHHHHHHh
Confidence 456889999999999999999999999999999999875432211 122347889999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||++++++|.+.+.+|+||||+.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||
T Consensus 118 ~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp 190 (412)
T 2vd5_A 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF-------GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190 (412)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCH
Confidence 99999999999999999999999999999999999752 34789999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc------cCCCCcchhHHHHHHHHHHHHhC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ------DHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~~~~DIwSlG~il~elltG 259 (520)
+|||++.+|.+||+|||++..+..... ......+||+.|+|||++.. ...|+.++|||||||++|||++|
T Consensus 191 ~NILld~~g~vkL~DFGla~~~~~~~~----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG 266 (412)
T 2vd5_A 191 DNILLDRCGHIRLADFGSCLKLRADGT----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266 (412)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTSC----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHS
T ss_pred HHeeecCCCCEEEeechhheeccCCCc----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhC
Confidence 999999999999999999987643221 12235689999999999873 23489999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcCC-CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCC---CCHHHHhcCccccccchhh
Q psy11359 260 TAPYHKYPAMKVLMLTLQND-PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR---PTASELLKNPFFKKAKDKK 334 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pta~elL~hp~~~~~~~~~ 334 (520)
..||......+.+..+.... ...++ .....+++++++||.+||. +|.+| ++++|+++||||+...+..
T Consensus 267 ~~Pf~~~~~~~~~~~i~~~~~~~~~p------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 267 QTPFYADSTAETYGKIVHYKEHLSLP------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp SCTTCCSSHHHHHHHHHTHHHHCCCC----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred CCCCCCCCHHHHHHHHHhcccCcCCC------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 99999888777666555321 01111 0123578999999999999 99998 5999999999999877654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=381.32 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=224.3
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..++..||+|++.... ....+.+.+|+.+++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-----------------------~~~~~~~~~E~~~l~~l 63 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-----------------------VEDVDRFKQEIEIMKSL 63 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-----------------------CSCHHHHHHHHHHHHTC
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-----------------------cchHHHHHHHHHHHHhC
Confidence 4578999999999999999999999998889988775321 12356789999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++......|+||||+.|++|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~ 135 (277)
T 3f3z_A 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH--------KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPE 135 (277)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH--------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred CCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHH
Confidence 999999999999999999999999999999999974 356899999999999999999999999999999999
Q ss_pred cEEE---cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 187 NILL---GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 187 NILl---~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
|||+ +.++.+||+|||++..+.... ......||+.|+|||++.+. ++.++||||||+++|+|+||..||
T Consensus 136 Nil~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~ 207 (277)
T 3f3z_A 136 NFLFLTDSPDSPLKLIDFGLAARFKPGK------MMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPF 207 (277)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECCTTS------CBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred HEEEecCCCCCcEEEEecccceeccCcc------chhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCC
Confidence 9999 788899999999998764322 23456799999999998654 899999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
................... ....+..+++.+.+||.+||++||.+|||+.++|+||||+..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 208 SAPTDSEVMLKIREGTFTF------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp CCSSHHHHHHHHHHCCCCC------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred CCCCHHHHHHHHHhCCCCC------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 9888877776666554322 123345678999999999999999999999999999999753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=393.34 Aligned_cols=279 Identities=25% Similarity=0.385 Sum_probs=224.5
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+-...++|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~~~~~~~E~~~l 78 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---------------------DDKMVKKIAMREIKLL 78 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS---------------------SCHHHHHHHHHHHHHH
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC---------------------CchHHHHHHHHHHHHH
Confidence 3466789999999999999999999999999999999764221 1122345688999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++++||||+++++++...+.+|+||||+.+++|.+++. ..+.+++..+..++.||+.||.|||++||+||||
T Consensus 79 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dl 150 (331)
T 4aaa_A 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--------FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150 (331)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH--------STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred hhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh--------hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCc
Confidence 99999999999999999999999999999998988876 4567999999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
||+|||++.++.+||+|||++..+.... .......||+.|+|||++.+...++.++|||||||++|+|++|..||
T Consensus 151 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 225 (331)
T 4aaa_A 151 KPENILVSQSGVVKLCDFGFARTLAAPG-----EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225 (331)
T ss_dssp CGGGEEECTTSCEEECCCTTC-----------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ChheEEEcCCCcEEEEeCCCceeecCCc-----cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999997654322 12334579999999999987656899999999999999999999999
Q ss_pred CCCcHHHHHHHHhcC---------------------CCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 264 HKYPAMKVLMLTLQN---------------------DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
........+...... ..+.+.........+..+++.+.+||.+||++||.+|||+.|+|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 305 (331)
T 4aaa_A 226 PGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305 (331)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred CCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHh
Confidence 988776655443321 01111112222333456789999999999999999999999999
Q ss_pred cCccccccchhhHH
Q psy11359 323 KNPFFKKAKDKKFI 336 (520)
Q Consensus 323 ~hp~~~~~~~~~~~ 336 (520)
+||||+........
T Consensus 306 ~hp~f~~~~~~~~~ 319 (331)
T 4aaa_A 306 HHDFFQMDGFAERF 319 (331)
T ss_dssp GSHHHHGGGHHHHH
T ss_pred cCchhccCChhhhh
Confidence 99999976554433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=417.53 Aligned_cols=264 Identities=28% Similarity=0.463 Sum_probs=221.8
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++++.||+|+||+||+|.++.++..||+|+++..... ......+.+|+.+++
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------------------~~~~~~~~~E~~~l~ 91 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS---------------------TSSNSKLLEEVAVLK 91 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------------------------CTTHHHHHHHHHHT
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC---------------------chHHHHHHHHHHHHH
Confidence 34456899999999999999999999999999999987643211 122456899999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
.++||||+++++++.....+|+||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+|||||
T Consensus 92 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 163 (494)
T 3lij_A 92 LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--------MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLK 163 (494)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred hCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence 999999999999999999999999999999999999753 568999999999999999999999999999999
Q ss_pred CCcEEEcC---CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 185 AGNILLGE---DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 185 p~NILl~~---~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|+|||++. ++.+||+|||++..+.... .....+||+.|+|||++.+. |+.++|||||||++|+|++|.+
T Consensus 164 p~Nil~~~~~~~~~~kl~DfG~a~~~~~~~------~~~~~~gt~~y~aPE~l~~~--~~~~~DiwslG~il~~ll~g~~ 235 (494)
T 3lij_A 164 PENLLLESKEKDALIKIVDFGLSAVFENQK------KMKERLGTAYYIAPEVLRKK--YDEKCDVWSIGVILFILLAGYP 235 (494)
T ss_dssp GGGEEESCSSTTCCEEECCCTTCEECBTTB------CBCCCCSCTTTCCHHHHTTC--BCTHHHHHHHHHHHHHHHHSSC
T ss_pred hhhEEEeCCCCCCcEEEEECCCCeECCCCc------cccccCCCcCeeCHHHHccc--CCCchhHHHHHHHHHHHHhCCC
Confidence 99999965 4569999999998764322 23456899999999998643 8999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
||.+....+.+..+........ ...+..+++.+++||.+||++||.+|||+.|+|+||||+...
T Consensus 236 pf~~~~~~~~~~~i~~~~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 236 PFGGQTDQEILRKVEKGKYTFD------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCC------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhCCCCCC------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 9999888887777666543322 223457889999999999999999999999999999998653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=412.92 Aligned_cols=277 Identities=27% Similarity=0.418 Sum_probs=202.7
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.++.+|+.||||++.... ......+++.+|+.+|+++
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---------------------~~~~~~~~~~~E~~~l~~l 109 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---------------------EDLIDCKRILREIAILNRL 109 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT---------------------SSHHHHHHHHHHHHHHHHC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh---------------------cCHHHHHHHHHHHHHHHhC
Confidence 4578999999999999999999999999999999774221 1123456789999999999
Q ss_pred CCCCceEEEEEEEEC-----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 107 HHENVVTYHTSFVVK-----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~-----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+||||+++++++... ..+|+||||+ +++|.++++ ..+.+++..++.++.||+.||.|||++||+||
T Consensus 110 ~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~--------~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHr 180 (458)
T 3rp9_A 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFR--------TPVYLTELHIKTLLYNLLVGVKYVHSAGILHR 180 (458)
T ss_dssp CCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHH--------SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred CCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcc--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCC
Confidence 999999999999543 5799999998 679999997 45679999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCcccc----------------------ccccccccccccccCCcceecccCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLS----------------------RQKVRHTFVGTPCWMAPEVMEQDHG 239 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~----------------------~~~~~~~~~gt~~y~APE~~~~~~~ 239 (520)
||||+|||++.++.+||+|||+++.+....... ........+||+.|+|||++.....
T Consensus 181 DlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 260 (458)
T 3rp9_A 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN 260 (458)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCC
T ss_pred CCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCC
Confidence 999999999999999999999998764322110 0112345789999999998765556
Q ss_pred CCcchhHHHHHHHHHHHHh-----------CCCCCCCCcH--------------------HHHHHHHh--cCCCC-----
Q psy11359 240 YDFKADIWSLGITAIEMAT-----------GTAPYHKYPA--------------------MKVLMLTL--QNDPP----- 281 (520)
Q Consensus 240 ~~~~~DIwSlG~il~ellt-----------G~~Pf~~~~~--------------------~~~~~~~~--~~~~~----- 281 (520)
|+.++|||||||++|||+| |.+||.+... ...+..+. .+.+.
T Consensus 261 ~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~ 340 (458)
T 3rp9_A 261 YTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIE 340 (458)
T ss_dssp CCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHh
Confidence 9999999999999999999 6777765431 11111111 01000
Q ss_pred --------------CCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 282 --------------TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 282 --------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
...........+...++++.+||.+||++||.+|||+.|+|+||||+.....
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 341 ALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp TSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred hcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 0000111122334568999999999999999999999999999999976543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=396.24 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=214.6
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.++||+|+||+||+|.+..+++.||+|+++.. ......+..|+.+++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------------------~~~~~~~~~e~~~l~~l 88 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI------------------------KKYTRSAKIEADILKKI 88 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------------------------HHHHHHHHHHHHHHHHT
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc------------------------hhhhhhhHHHHHHHHHh
Confidence 358899999999999999999999999999999987421 22345577899999988
Q ss_pred C-----CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 107 H-----HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 107 ~-----HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
. ||||+++++++...+.+|+||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||
T Consensus 89 ~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 161 (360)
T 3llt_A 89 QNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN------NYNGFHIEDIKLYCIEILKALNYLRKMSLTHT 161 (360)
T ss_dssp CCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence 6 999999999999999999999999 99999999864 34569999999999999999999999999999
Q ss_pred ccCCCcEEEcC-------------------------CCCeEEeccCcceeeccCccccccccccccccccccCCcceecc
Q psy11359 182 DIKAGNILLGE-------------------------DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ 236 (520)
Q Consensus 182 DLKp~NILl~~-------------------------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 236 (520)
||||+|||++. ++.+||+|||++..... ......||+.|+|||++.+
T Consensus 162 Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--------~~~~~~gt~~y~aPE~~~~ 233 (360)
T 3llt_A 162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--------YHGSIINTRQYRAPEVILN 233 (360)
T ss_dssp CCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--------CCCSCCSCGGGCCHHHHTT
T ss_pred CCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--------CCcCccCcccccCcHHHcC
Confidence 99999999975 78999999999976432 1235689999999999987
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCC-------------------------Cchh--
Q psy11359 237 DHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDT-------------------------GAAE-- 289 (520)
Q Consensus 237 ~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~-- 289 (520)
.. ++.++|||||||++|+|+||..||........+........+.... ....
T Consensus 234 ~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 312 (360)
T 3llt_A 234 LG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSIN 312 (360)
T ss_dssp CC-CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHH
T ss_pred CC-CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchh
Confidence 65 8999999999999999999999998877766554433221111100 0000
Q ss_pred ---------hhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 290 ---------KDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 290 ---------~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
.......++.+.+||.+||++||.+|||+.|+|+||||+
T Consensus 313 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 313 SIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 000112247788999999999999999999999999996
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=388.94 Aligned_cols=271 Identities=24% Similarity=0.459 Sum_probs=228.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+|+.||+|+++...... .......+.+.+|+.++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~~~~~~~E~~~l~~ 71 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA-----------------SRRGVSREEIEREVSILRQ 71 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSS-----------------CSSSBCHHHHHHHHHHHHH
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccc-----------------cccchhHHHHHHHHHHHHh
Confidence 34578999999999999999999999999999999876421110 0111246779999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++.....+++||||+.|++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||
T Consensus 72 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp 143 (321)
T 2a2a_A 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA--------QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKP 143 (321)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH--------TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCh
Confidence 999999999999999999999999999999999997 456789999999999999999999999999999999
Q ss_pred CcEEEcCCC----CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 186 GNILLGEDG----TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 186 ~NILl~~~g----~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
+|||++.++ .+||+|||++..+.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..
T Consensus 144 ~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~ 216 (321)
T 2a2a_A 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGV------EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGAS 216 (321)
T ss_dssp GGEEESCTTSSSCCEEECCCTTCEECCTTC------CCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCC
T ss_pred HHEEEecCCCCcCCEEEccCccceecCccc------cccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCC
Confidence 999998887 79999999998764322 123457999999999997655 8999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhh
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~ 334 (520)
||........+..+....... ....+..++..+.+||.+||++||.+|||+.|+++||||+......
T Consensus 217 pf~~~~~~~~~~~i~~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~ 283 (321)
T 2a2a_A 217 PFLGDTKQETLANITSVSYDF------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283 (321)
T ss_dssp SSCCSSHHHHHHHHHTTCCCC------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHH
T ss_pred CCCCCCHHHHHHHHHhccccc------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCccc
Confidence 999888777766655443221 1233456788999999999999999999999999999998765443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=393.84 Aligned_cols=257 Identities=26% Similarity=0.473 Sum_probs=197.6
Q ss_pred CCeEEE---eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 29 DQYEVR---EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 29 ~~Y~i~---~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
++|++. +.||+|+||+||+|.++.+|+.||+|++.. .....+.+|+.+++.
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--------------------------~~~~~~~~e~~~l~~ 61 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--------------------------RMEANTQKEITALKL 61 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG--------------------------GGHHHHHHHHHHHHH
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh--------------------------hhhhhHHHHHHHHHH
Confidence 567776 789999999999999999999999998752 123457889999999
Q ss_pred CC-CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 106 CH-HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 106 l~-HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+. ||||+++++++.+....|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+|||||
T Consensus 62 l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 133 (325)
T 3kn6_A 62 CEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK--------KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK 133 (325)
T ss_dssp TTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--------CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred hcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Confidence 96 99999999999999999999999999999999984 4679999999999999999999999999999999
Q ss_pred CCcEEEcCCC---CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 185 AGNILLGEDG---TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 185 p~NILl~~~g---~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|+|||++.++ .+||+|||++....... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|..
T Consensus 134 p~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~ 207 (325)
T 3kn6_A 134 PENLLFTDENDNLEIKIIDFGFARLKPPDN-----QPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQV 207 (325)
T ss_dssp GGGEEEEC----CEEEECCCTTCEECCC---------------------------CC-CCHHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEEecCCCcccEEEeccccceecCCCC-----CcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCC
Confidence 9999997665 89999999998654322 2234567899999999997665 8999999999999999999999
Q ss_pred CCCCCcH-------HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 262 PYHKYPA-------MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 262 Pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
||..... .+.+..+..+... . ....+..+++++++||.+||++||.+|||+.|+++||||+...
T Consensus 208 pf~~~~~~~~~~~~~~~~~~i~~~~~~-~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 208 PFQSHDRSLTCTSAVEIMKKIKKGDFS-F-----EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp TTC-------CCCHHHHHHHHTTTCCC-C-----CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CCCCCccccccccHHHHHHHHHcCCCC-C-----CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 9976432 2333333333221 1 2234567899999999999999999999999999999998653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=388.73 Aligned_cols=273 Identities=24% Similarity=0.319 Sum_probs=213.6
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+|+.||+|+++..... .........+.+|+.+++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~~~~~~e~~~l~~l 68 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGG------------------GGGGGLPISTVREVALLRRL 68 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCC------------------TTSSCCCHHHHHHHHHHHHH
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccc------------------ccccccchhHHHHHHHHHHH
Confidence 467899999999999999999999999999999987532110 00011223466777777666
Q ss_pred ---CCCCceEEEEEEEECC-----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 107 ---HHENVVTYHTSFVVKD-----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 107 ---~HpnIv~~~~~~~~~~-----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
+||||+++++++.... .+++||||+. ++|.+++... ....+++..++.++.||+.||.|||++||
T Consensus 69 ~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~i~~qi~~al~~lH~~~i 141 (308)
T 3g33_A 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA------PPPGLPAETIKDLMRQFLRGLDFLHANCI 141 (308)
T ss_dssp HHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTC------CTTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 4999999999998765 5899999996 6999999853 33459999999999999999999999999
Q ss_pred EecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 179 iHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
+||||||+|||++.++.+||+|||++..+... .......||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 142 vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~ 214 (308)
T 3g33_A 142 VHRDLKPENILVTSGGTVKLADFGLARIYSYQ------MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFR 214 (308)
T ss_dssp CCSCCCTTTEEECTTSCEEECSCSCTTTSTTC------CCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTT
T ss_pred ccCCCCHHHEEEcCCCCEEEeeCccccccCCC------cccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHh
Confidence 99999999999999999999999998765322 2234568999999999997765 8999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhcCC--CCCCC---------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH
Q psy11359 259 GTAPYHKYPAMKVLMLTLQND--PPTLD---------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~~~--~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el 321 (520)
|.+||.+......+..+.... ++... ...........+++.+.+||.+||++||.+|||+.|+
T Consensus 215 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 294 (308)
T 3g33_A 215 RKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294 (308)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHH
Confidence 999999888777665543321 11000 0001122334578899999999999999999999999
Q ss_pred hcCccccccc
Q psy11359 322 LKNPFFKKAK 331 (520)
Q Consensus 322 L~hp~~~~~~ 331 (520)
|+||||+...
T Consensus 295 l~h~~~~~~~ 304 (308)
T 3g33_A 295 LQHSYLHKDE 304 (308)
T ss_dssp HTSTTC----
T ss_pred hcCccccCCC
Confidence 9999998653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=382.80 Aligned_cols=258 Identities=27% Similarity=0.405 Sum_probs=219.6
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..++..||+|++....... ......+.+|+.+++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~l 66 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK--------------------AGVEHQLRREVEIQSHL 66 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--------------------HTCHHHHHHHHHHHTTC
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch--------------------hhHHHHHHHHHHHHHcC
Confidence 5678999999999999999999999999999999886433211 12345688999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++......++||||+.+++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+
T Consensus 67 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~ 138 (279)
T 3fdn_A 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK--------LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138 (279)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGG
T ss_pred CCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChH
Confidence 999999999999999999999999999999999975 356899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.++.++|+|||++..... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...
T Consensus 139 Nili~~~~~~~l~Dfg~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 139 NLLLGSAGELKIADFGWSVHAPS-------SRRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp GEEECTTSCEEECSCCEESCC---------------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred hEEEcCCCCEEEEeccccccCCc-------ccccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999998854422 1223567999999999987665 899999999999999999999999988
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
................. ..+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 211 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 211 TYQETYKRISRVEFTFP----------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp SHHHHHHHHHHTCCCCC----------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred cHHHHHHHHHhCCCCCC----------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 77766655544432221 2467889999999999999999999999999999754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=417.36 Aligned_cols=268 Identities=29% Similarity=0.448 Sum_probs=225.4
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.++||+|+||.||+|.++.+|+.||+|++....... ......+.+|+.+|++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~--------------------~~~~~~~~~E~~iL~~ 240 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--------------------RKGEAMALNEKQILEK 240 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHHH
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh--------------------hHHHHHHHHHHHHHHH
Confidence 56788999999999999999999999999999999987543211 1234568899999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++.+.+.+|+||||+.||+|.+++... ....+++..++.++.||+.||.|||++||+||||||
T Consensus 241 l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~------~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKP 314 (576)
T 2acx_A 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM------GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314 (576)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred cCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCch
Confidence 99999999999999999999999999999999999743 234599999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.+|.+||+|||++..+..+. .....+||+.|+|||++.+.. |+.++|||||||++|+|++|..||..
T Consensus 315 eNILld~~g~vKL~DFGla~~~~~~~------~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~ 387 (576)
T 2acx_A 315 ENILLDDHGHIRISDLGLAVHVPEGQ------TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQ 387 (576)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTC------CEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSC
T ss_pred heEEEeCCCCeEEEecccceecccCc------cccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999998764322 223468999999999997755 89999999999999999999999987
Q ss_pred CcH---HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhhH
Q psy11359 266 YPA---MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 266 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~ 335 (520)
... ...+...+...+..++ ..+++++++||.+||++||.+|| ++.|+++||||+...+...
T Consensus 388 ~~~~~~~~~i~~~i~~~~~~~p---------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l 456 (576)
T 2acx_A 388 RKKKIKREEVERLVKEVPEEYS---------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL 456 (576)
T ss_dssp SSSCCCHHHHHHHHHHCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHH
T ss_pred cccchhHHHHHHHhhcccccCC---------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHH
Confidence 532 2222222222222222 35788999999999999999999 8999999999998776543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=405.22 Aligned_cols=278 Identities=26% Similarity=0.415 Sum_probs=213.4
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+|+.||||+++... ......+.+.+|+.+|++
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---------------------~~~~~~~~~~~E~~~l~~ 81 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---------------------EDLIDCKRILREITILNR 81 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---------------------TSHHHHHHHHHHHHHHHH
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---------------------cChHHHHHHHHHHHHHHH
Confidence 45688999999999999999999999999999999875321 112345678999999999
Q ss_pred CCCCCceEEEEEEEEC-----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 106 CHHENVVTYHTSFVVK-----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~-----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
++||||+++++++... ..+|+||||+. ++|.++++ ..+.+++..++.++.||+.||.|||++||+|
T Consensus 82 l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--------~~~~l~~~~~~~i~~qil~aL~~LH~~givH 152 (432)
T 3n9x_A 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFK--------TPIFLTEEHIKTILYNLLLGENFIHESGIIH 152 (432)
T ss_dssp CCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHH--------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred cCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHh--------ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999866 57999999995 69999997 4567999999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCcccc-----------------ccccccccccccccCCcceecccCCCCcc
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLS-----------------RQKVRHTFVGTPCWMAPEVMEQDHGYDFK 243 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~-----------------~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 243 (520)
|||||+|||++.++.+||+|||+++.+....... ........+||+.|+|||++.....|+.+
T Consensus 153 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~ 232 (432)
T 3n9x_A 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232 (432)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTH
T ss_pred CCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcc
Confidence 9999999999999999999999998764432110 01223567899999999997666669999
Q ss_pred hhHHHHHHHHHHHHhCC-----------CCCCCCc-----------------HHHHHHHHh--cCCCC------------
Q psy11359 244 ADIWSLGITAIEMATGT-----------APYHKYP-----------------AMKVLMLTL--QNDPP------------ 281 (520)
Q Consensus 244 ~DIwSlG~il~elltG~-----------~Pf~~~~-----------------~~~~~~~~~--~~~~~------------ 281 (520)
+|||||||++|+|++|. ++|.+.. ...++..+. .+.++
T Consensus 233 ~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~ 312 (432)
T 3n9x_A 233 IDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV 312 (432)
T ss_dssp HHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred cccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHH
Confidence 99999999999999854 4443322 111111111 01110
Q ss_pred -------CCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 282 -------TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 282 -------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
...........+..+++.+.+||.+||++||.+|||+.|+|+||||+.....
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 313 IKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 0000111122335678999999999999999999999999999999976554
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=398.51 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=214.0
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.++.+|+.||+|++.... ....+|+.++.++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------------------------~~~~~E~~~l~~~ 72 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---------------------------RDPTEEIEILLRY 72 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT---------------------------CCCHHHHHHHHHH
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc---------------------------CChHHHHHHHHHh
Confidence 4578999999999999999999999999999999875321 0134688888877
Q ss_pred -CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 -HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 -~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+||||+++++++.+.+.+|+||||+.||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||
T Consensus 73 ~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~--------~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp 144 (342)
T 2qr7_A 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL--------RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKP 144 (342)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH--------TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred cCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHH--------HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCH
Confidence 89999999999999999999999999999999997 456799999999999999999999999999999999
Q ss_pred CcEEEcCC----CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 186 GNILLGED----GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 186 ~NILl~~~----g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
+|||+.++ +.+||+|||++..+.... ....+.+||+.|+|||++.+.. |+.++|||||||++|+|++|..
T Consensus 145 ~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~ 218 (342)
T 2qr7_A 145 SNILYVDESGNPESIRICDFGFAKQLRAEN-----GLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYT 218 (342)
T ss_dssp GGEEESSSSCSGGGEEECCCTTCEECBCTT-----CCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEEecCCCCcCeEEEEECCCcccCcCCC-----CceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCC
Confidence 99998432 359999999998764322 2234568999999999997654 8999999999999999999999
Q ss_pred CCCCC---cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 262 PYHKY---PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 262 Pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
||... ...+.+..+..+..... ...+..+++.+++||.+||.+||.+|||+.++++||||...
T Consensus 219 Pf~~~~~~~~~~~~~~i~~~~~~~~------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 219 PFANGPDDTPEEILARIGSGKFSLS------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp SSCSSTTSCHHHHHHHHHHCCCCCC------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CCCCCCcCCHHHHHHHHccCCcccC------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 99763 33444444444432221 11235678999999999999999999999999999999653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=401.46 Aligned_cols=269 Identities=21% Similarity=0.350 Sum_probs=217.0
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||+|.+..+|+.||+|++.... ....+|+.+|+
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------------------------~~~~~E~~il~ 55 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---------------------------RYKNRELDIMK 55 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---------------------------TSCCHHHHHHT
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---------------------------chHHHHHHHHH
Confidence 456789999999999999999999999999999999774210 11236999999
Q ss_pred cCCCCCceEEEEEEEE--------------------------------------CCEEEEEEEccCCCCHHHHHHHhhcc
Q psy11359 105 SCHHENVVTYHTSFVV--------------------------------------KDELWLVLRLLEGGSLLDIIKHRLKI 146 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~--------------------------------------~~~~~lV~E~~~ggsL~~~i~~~~~~ 146 (520)
.++||||++++++|.. ...+++||||+. ++|.+++.....
T Consensus 56 ~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~- 133 (383)
T 3eb0_A 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR- 133 (383)
T ss_dssp TCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHH-
T ss_pred HcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-
Confidence 9999999999999854 334899999997 588888875433
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEc-CCCCeEEeccCcceeeccCccccccccccccccc
Q psy11359 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG-EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGT 225 (520)
Q Consensus 147 ~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~-~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt 225 (520)
..+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+.... ......||
T Consensus 134 ---~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~t 204 (383)
T 3eb0_A 134 ---SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE------PSVAYICS 204 (383)
T ss_dssp ---TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS------CCCCCCCC
T ss_pred ---cCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC------CCcCcccC
Confidence 457899999999999999999999999999999999999997 68999999999998764322 23356789
Q ss_pred cccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC-------------------CCCCCCC
Q psy11359 226 PCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQND-------------------PPTLDTG 286 (520)
Q Consensus 226 ~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-------------------~~~~~~~ 286 (520)
+.|+|||++.+...|+.++|||||||++|+|++|.+||.+....+.+..+.... .+.....
T Consensus 205 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 284 (383)
T 3eb0_A 205 RFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284 (383)
T ss_dssp SSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCC
T ss_pred CCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcc
Confidence 999999998876669999999999999999999999999988777665554310 1111111
Q ss_pred chhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 287 AAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 287 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
.........+++.+.+||.+||++||.+|||+.|+|+||||+...
T Consensus 285 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp CHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred cHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence 112222345788999999999999999999999999999998653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=399.14 Aligned_cols=261 Identities=27% Similarity=0.402 Sum_probs=217.8
Q ss_pred CCeEE--EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 29 DQYEV--REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 29 ~~Y~i--~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..|.+ .+.||+|+||.||+|.+..+|+.||+|+++... ....+.+.+|+.+|+++
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-----------------------~~~~~~~~~E~~~l~~l 143 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-----------------------MKDKEEVKNEISVMNQL 143 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-----------------------HHHHHHHHHHHHHHTTC
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-----------------------cccHHHHHHHHHHHHhC
Confidence 44655 678999999999999999999999999875321 12346789999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+.+|+||||++|++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+
T Consensus 144 ~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 216 (373)
T 2x4f_A 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID-------ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE 216 (373)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHH-------TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHH
Confidence 999999999999999999999999999999999875 3356899999999999999999999999999999999
Q ss_pred cEEE--cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 187 NILL--GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 187 NILl--~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|||+ +.++.+||+|||++..+.... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 217 NIll~~~~~~~~kl~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 217 NILCVNRDAKQIKIIDFGLARRYKPRE------KLKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp GEEEEETTTTEEEECCCSSCEECCTTC------BCCCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred HEEEecCCCCcEEEEeCCCceecCCcc------ccccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 9999 567899999999998764322 223457999999999987655 8999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
+......+..+........ ...+..+++++++||.+||++||.+|||+.|+|+||||+....
T Consensus 290 ~~~~~~~~~~i~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 290 GDNDAETLNNILACRWDLE------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp CSSHHHHHHHHHHTCCCSC------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred CCCHHHHHHHHHhccCCCC------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 9888877777666543221 1233567899999999999999999999999999999987654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=408.20 Aligned_cols=266 Identities=26% Similarity=0.397 Sum_probs=210.4
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++++.||+|+||+||+|.+..+|+.||||++..... .....+++.+|+.+|+.++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~---------------------~~~~~~~~~~E~~~l~~l~ 119 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---------------------NQTHAKRAYRELVLMKCVN 119 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG---------------------SHHHHHHHHHHHHHHHHCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc---------------------ChHHHHHHHHHHHHHHhCC
Confidence 4789999999999999999999999999999998753211 1234567889999999999
Q ss_pred CCCceEEEEEEEEC------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 108 HENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 108 HpnIv~~~~~~~~~------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
||||+++++++... ..+|+||||+.+ +|.+.+. ..+++..++.++.||+.||.|||++||+||
T Consensus 120 hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~----------~~l~~~~~~~~~~qil~aL~~lH~~~iiHr 188 (464)
T 3ttj_A 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ----------MELDHERMSYLLYQMLCGIKHLHSAGIIHR 188 (464)
T ss_dssp CTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred CCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh----------hcCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 99999999999754 468999999965 5777764 248899999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|++
T Consensus 189 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~ 261 (464)
T 3ttj_A 189 DLKPSNIVVKSDCTLKILDFGLARTAGTS------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKI 261 (464)
T ss_dssp CCCGGGEEECTTSCEEECCCCCC-----C------CCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCChHhEEEeCCCCEEEEEEEeeeecCCC------cccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999765432 2234578999999999998765 9999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCC---------------------CCCCch-----------hhhhHHHhcHHHHHHHHhhhc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPT---------------------LDTGAA-----------EKDQYKAYGKTFRKMISDCLQ 309 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~---------------------~~~~~~-----------~~~~~~~~~~~~~~li~~~L~ 309 (520)
||.+....+++..+....... ...... ........++++++||.+||+
T Consensus 262 pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~ 341 (464)
T 3ttj_A 262 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341 (464)
T ss_dssp SSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcC
Confidence 999988776665543311100 000000 001112337789999999999
Q ss_pred cCCCCCCCHHHHhcCccccccch
Q psy11359 310 KDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 310 ~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
+||.+|||+.|+|+||||+....
T Consensus 342 ~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 342 IDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp SSTTTSCCHHHHHTSTTTGGGCC
T ss_pred CChhhCCCHHHHhcChhhhhccC
Confidence 99999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=379.96 Aligned_cols=261 Identities=24% Similarity=0.422 Sum_probs=218.3
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
.......|++.+.||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.++
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~---------------------~~~~~~~~~~e~~~l 79 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---------------------TKSERQRFKEEAEML 79 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---------------------CHHHHHHHHHHHHHH
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh---------------------CHHHHHHHHHHHHHH
Confidence 45677789999999999999999999999999999988753211 123456789999999
Q ss_pred hcCCCCCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q psy11359 104 SSCHHENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG-- 177 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g-- 177 (520)
++++||||+++++++.. ...+++||||+++++|.+++.. .+.+++..++.++.||+.||.|||++|
T Consensus 80 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ 151 (290)
T 1t4h_A 80 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--------FKVMKIKVLRSWCRQILKGLQFLHTRTPP 151 (290)
T ss_dssp TTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred HhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHH--------ccCCCHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 99999999999999875 4569999999999999999974 356889999999999999999999999
Q ss_pred cEecccCCCcEEEc-CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 178 QIHRDIKAGNILLG-EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 178 iiHrDLKp~NILl~-~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
++||||||+|||++ .++.+||+|||++..... .......||+.|+|||++.+. ++.++|||||||++|+|
T Consensus 152 i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l 222 (290)
T 1t4h_A 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-------SFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEM 222 (290)
T ss_dssp CCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-------TSBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHH
T ss_pred EEECCCCHHHEEEECCCCCEEEeeCCCcccccc-------cccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHH
Confidence 99999999999997 789999999999865422 223456799999999988643 89999999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 257 ATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 257 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
++|..||................... .......++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 223 ATSEYPYSECQNAAQIYRRVTSGVKP-------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCC-------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HhCCCCCCCcCcHHHHHHHHhccCCc-------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 99999998866655554444332211 1122456788999999999999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=393.28 Aligned_cols=282 Identities=25% Similarity=0.395 Sum_probs=225.3
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..++..||+|++........ .....+.+.+|+.++++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------------------~~~~~~~~~~E~~~l~~ 84 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI------------------NPKDVERIKTEVRLMKK 84 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---------------------CHHHHHHHHHHHHHH
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhccc------------------CHHHHHHHHHHHHHHHh
Confidence 456789999999999999999999999999999998865422110 12345679999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--------------------------------cCCCCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--------------------------------NCKHGV 153 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--------------------------------~~~~~~ 153 (520)
++||||+++++++.+.+..++||||+.||+|.+++....... ......
T Consensus 85 l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (345)
T 3hko_A 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFV 164 (345)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHH
T ss_pred CCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999999985211100 001223
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCC--CeEEeccCcceeeccCccccccccccccccccccCCc
Q psy11359 154 CDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG--TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAP 231 (520)
Q Consensus 154 l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~AP 231 (520)
+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+...... .........||+.|+||
T Consensus 165 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~gt~~y~aP 243 (345)
T 3hko_A 165 QREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG-EYYGMTTKAGTPYFVAP 243 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------CCCGGGCCH
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc-ccccccccCCCccccCc
Confidence 46788999999999999999999999999999999998776 8999999999876432211 11123456799999999
Q ss_pred ceeccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhcc
Q psy11359 232 EVMEQD-HGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQK 310 (520)
Q Consensus 232 E~~~~~-~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (520)
|++.+. ..++.++|||||||++|+|++|..||.................... ...+..+++.+.+||.+||++
T Consensus 244 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE------NPNYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT------SGGGGGSCHHHHHHHHHHSCS
T ss_pred hhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC------CcccccCCHHHHHHHHHHcCC
Confidence 998642 4489999999999999999999999999888877777666543322 123356789999999999999
Q ss_pred CCCCCCCHHHHhcCccccccch
Q psy11359 311 DPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 311 dP~~Rpta~elL~hp~~~~~~~ 332 (520)
||.+|||+.++|+||||+...+
T Consensus 318 ~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 318 NVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp CTTTSCCHHHHHHSHHHHTTSS
T ss_pred ChhHCCCHHHHhcChhhccChH
Confidence 9999999999999999987543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=387.00 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=205.7
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-C
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-H 107 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~ 107 (520)
++|++.++||+|+||+||+|.+..+|+.||+|++..... ......+...|+..+.++ +
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~~e~~~~~~~~~ 115 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR---------------------GPKDRARKLAEVGSHEKVGQ 115 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC---------------------SHHHHHHHHHHHHHHHHHCC
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc---------------------ChHHHHHHHHHHHHHHHhcC
Confidence 679999999999999999999999999999997642210 112233455555555544 9
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++...+.+|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 116 h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 187 (311)
T 3p1a_A 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW-------GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPAN 187 (311)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHH-------CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHH
Confidence 999999999999999999999999 77999998763 4569999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
||++.++.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 188 Ill~~~~~~kl~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~ 259 (311)
T 3p1a_A 188 IFLGPRGRCKLGDFGLLVELGTA------GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGE 259 (311)
T ss_dssp EEECGGGCEEECCCTTCEECC------------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHH
T ss_pred EEECCCCCEEEccceeeeecccC------CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999998766432 22334579999999999876 38999999999999999999977765543
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
....+ .... ........+++.+.+||.+||++||.+|||+.|+|+||||++
T Consensus 260 ~~~~~---~~~~--------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 260 GWQQL---RQGY--------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHH---TTTC--------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHH---hccC--------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 32222 1111 112334567899999999999999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=411.57 Aligned_cols=270 Identities=27% Similarity=0.444 Sum_probs=226.3
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
+...++|++.++||+|+||.||+|.++.+|+.||+|+++...... ....+.+.+|+.+++
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~--------------------~~~~~~~~~E~~iL~ 240 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK--------------------RKGYQGAMVEKKILA 240 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHH
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh--------------------hHHHHHHHHHHHHHH
Confidence 356688999999999999999999999999999999986543211 123567889999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||++++++|...+.+|+||||+.||+|.+++..... ....+++..++.++.||+.||.|||++||+|||||
T Consensus 241 ~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~----~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLK 316 (543)
T 3c4z_A 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDE----DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLK 316 (543)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSST----TSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred hcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhc----ccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Confidence 99999999999999999999999999999999999975321 24579999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.+|.+||+|||++..+.... ......+||+.|+|||++.+.. |+.++|||||||++|+|+||.+||.
T Consensus 317 P~NILl~~~g~vkL~DFGla~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~ 390 (543)
T 3c4z_A 317 PENVLLDDDGNVRISDLGLAVELKAGQ-----TKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFR 390 (543)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTC-----CCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hHHEEEeCCCCEEEeecceeeeccCCC-----cccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCC
Confidence 999999999999999999998764322 1234568999999999998754 8999999999999999999999997
Q ss_pred CCc----HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchhh
Q psy11359 265 KYP----AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDKK 334 (520)
Q Consensus 265 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~ 334 (520)
... .......+..... ..+ ..+++.+.+||.+||++||.+||+ +.++++||||+...+..
T Consensus 391 ~~~~~~~~~~~~~~i~~~~~-~~p---------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~ 459 (543)
T 3c4z_A 391 ARGEKVENKELKQRVLEQAV-TYP---------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQ 459 (543)
T ss_dssp CTTCCCCHHHHHHHHHHCCC-CCC---------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHH
T ss_pred CCccchhHHHHHHHHhhccc-CCC---------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHH
Confidence 653 2333333333322 221 356889999999999999999996 58999999999877654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=379.23 Aligned_cols=263 Identities=22% Similarity=0.415 Sum_probs=198.1
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+.++++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~ 67 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK--------------------AGMVQRVQNEVKIHCQ 67 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHTT
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh--------------------hhHHHHHHHHHHHHHh
Confidence 45578999999999999999999999999999999886432211 1234678999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++...+..|+||||+.+++|.+++.. ..+.+++..++.++.||+.||.|||++|++||||||
T Consensus 68 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 140 (278)
T 3cok_A 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-------RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTL 140 (278)
T ss_dssp BCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT-------CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCG
T ss_pred CCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 9999999999999999999999999999999999974 346789999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+||+++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||..
T Consensus 141 ~Nili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 141 SNLLLTRNMNIKIADFGLATQLKMPH-----EKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp GGEEECTTCCEEECCCTTCEECC----------------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEEcCCCCEEEEeecceeeccCCC-----CcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999997764221 1123467999999999987655 89999999999999999999999987
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
......+........ . ....++.++.+||.+||+.||.+|||+.++++||||....
T Consensus 215 ~~~~~~~~~~~~~~~-~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 215 DTVKNTLNKVVLADY-E---------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp CSCC-----CCSSCC-C---------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred hhHHHHHHHHhhccc-C---------CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 554433322221111 1 1134678999999999999999999999999999998654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=406.85 Aligned_cols=276 Identities=26% Similarity=0.448 Sum_probs=212.4
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.+..+++.||+|++.......... ........+.+|+.+|++++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~---------------~~~~~~~~~~~E~~~l~~l~ 198 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA---------------READPALNVETEIEILKKLN 198 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC-----------------------CCHHHHHHHHHHCC
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccccc---------------ccchhHHHHHHHHHHHHhCC
Confidence 578999999999999999999999999999999987542211000 00112234789999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++. .+.+|+||||+.+|+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 199 hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~N 269 (419)
T 3i6u_A 199 HPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVV--------GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 269 (419)
T ss_dssp CTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTS--------SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred CCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHh--------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHh
Confidence 999999999875 566899999999999999886 45679999999999999999999999999999999999
Q ss_pred EEEcCCC---CeEEeccCcceeeccCccccccccccccccccccCCcceecc--cCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 188 ILLGEDG---TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ--DHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 188 ILl~~~g---~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
||++.++ .+||+|||++..+.. .......+||+.|+|||++.+ ...|+.++|||||||++|+|+||.+|
T Consensus 270 Ill~~~~~~~~~kl~DFG~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p 343 (419)
T 3i6u_A 270 VLLSSQEEDCLIKITDFGHSKILGE------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343 (419)
T ss_dssp EEESSSSSSCCEEECCSSTTTSCC-----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred EEEecCCCcceEEEeecccceecCC------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 9996544 599999999976542 222345789999999999853 34488999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhhHHHh
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQ 338 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~~~ 338 (520)
|........+...+....... ....+..+++.+.+||.+||++||.+|||+.|+|+||||+....+...++
T Consensus 344 f~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~ 414 (419)
T 3i6u_A 344 FSEHRTQVSLKDQITSGKYNF-----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 414 (419)
T ss_dssp SCCCSSSCCHHHHHHTTCCCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHHHHHH
T ss_pred CCCCcchHHHHHHHhcCCCCC-----CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHHHHHH
Confidence 976544322322222221111 12344568899999999999999999999999999999997766554443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=379.50 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=222.8
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..++..||+|++....... ....+.+.+|+.++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~ 70 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK--------------------EGVEHQLRREIEIQSH 70 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHHT
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch--------------------HHHHHHHHHHHHHHhc
Confidence 45688999999999999999999999999999999886432211 1234568999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++...+.+|+||||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||
T Consensus 71 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 142 (284)
T 2vgo_A 71 LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK--------HGRFDEQRSATFMEELADALHYCHERKVIHRDIKP 142 (284)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG
T ss_pred CCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCH
Confidence 9999999999999999999999999999999999985 35689999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+||+++.++.+||+|||++...... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||..
T Consensus 143 ~Nil~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 143 ENLLMGYKGELKIADFGWSVHAPSL-------RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp GGEEECTTCCEEECCCTTCEECSSS-------CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred HHEEEcCCCCEEEecccccccCccc-------ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999998665321 123567999999999997665 89999999999999999999999998
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
................ ++ ..++..+++||.+||+.||.+|||+.++++||||+..
T Consensus 215 ~~~~~~~~~~~~~~~~-~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 215 PSHTETHRRIVNVDLK-FP---------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp SSHHHHHHHHHTTCCC-CC---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred CCHhHHHHHHhccccC-CC---------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 8777666555544322 11 3467889999999999999999999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=402.66 Aligned_cols=269 Identities=25% Similarity=0.385 Sum_probs=215.4
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
+......+|++.+.||+|+||+||+|.+..+++.||+|+++.. ......+.+|+.+
T Consensus 91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------------------------~~~~~~~~~E~~~ 146 (429)
T 3kvw_A 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------------------------KRFHRQAAEEIRI 146 (429)
T ss_dssp TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------------------------HHHHHHHHHHHHH
T ss_pred CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------------------------cchHHHHHHHHHH
Confidence 3344567899999999999999999999999999999987522 1223456677777
Q ss_pred HhcC------CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 103 MSSC------HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 103 l~~l------~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
++.+ +|+||+++++++.....+++||||+. ++|.+++... ....+++..++.++.||+.||.|||++
T Consensus 147 l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~aL~~LH~~ 219 (429)
T 3kvw_A 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKN------KFQGFSLPLVRKFAHSILQCLDALHKN 219 (429)
T ss_dssp HHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 7766 67899999999999999999999995 6999999864 345699999999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCC--eEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGT--VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~--vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
||+||||||+|||++.++. +||+|||++..... .....+||+.|+|||++.+.. |+.++|||||||++|
T Consensus 220 ~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~--------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ 290 (429)
T 3kvw_A 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--------RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILA 290 (429)
T ss_dssp TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC--------CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHH
T ss_pred CeecCCCCHHHeEEccCCCcceEEeecccceecCC--------cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHH
Confidence 9999999999999999887 99999999865421 123568999999999998766 899999999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHhcCCCCCC-------------------------------------------------CC
Q psy11359 255 EMATGTAPYHKYPAMKVLMLTLQNDPPTL-------------------------------------------------DT 285 (520)
Q Consensus 255 elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~ 285 (520)
+|+||.+||.+....+.+..+........ ..
T Consensus 291 elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (429)
T 3kvw_A 291 ELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370 (429)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccc
Confidence 99999999998887666544332100000 00
Q ss_pred CchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 286 GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 286 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
...........++.+.+||.+||++||.+|||+.|+|+||||+...
T Consensus 371 ~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp SCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred hhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 0000111123378899999999999999999999999999998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=391.09 Aligned_cols=261 Identities=37% Similarity=0.626 Sum_probs=222.6
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.+.|++.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--------------------~~~~~~~~~~~E~~~l~~l~ 112 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--------------------QSNEKWQDIIKEVRFLQKLR 112 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS--------------------CHHHHHHHHHHHHHHHHHCC
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc--------------------cchHHHHHHHHHHHHHHhCC
Confidence 3569999999999999999999999999999998753211 11234567899999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++..++..|+||||+. |+|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||+|
T Consensus 113 hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 184 (348)
T 1u5q_A 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV-------HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 184 (348)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH-------HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGG
T ss_pred CCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 9999999999999999999999996 689888864 24578999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc--cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ--DHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
||++.++.+||+|||++..+.. .....||+.|+|||++.+ ...++.++|||||||++|+|+||..||..
T Consensus 185 Ill~~~~~~kL~DfG~a~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 185 ILLSEPGLVKLGDFGSASIMAP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp EEEETTTEEEECCCTTCBSSSS---------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EEECCCCCEEEeeccCceecCC---------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999876532 234679999999999852 33489999999999999999999999998
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
......+........+.... ..+++.+.+||.+||+.||.+|||+.++++||||......
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 256 MNAMSALYHIAQNESPALQS--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp SCHHHHHHHHHHSCCCCCCC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred CChHHHHHHHHhcCCCCCCC--------CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 88877776666665443321 3467889999999999999999999999999999876543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=389.32 Aligned_cols=262 Identities=23% Similarity=0.419 Sum_probs=208.0
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.+.||+|+||+||+|.++.+|+.||+|+++.. ......+.+.+|+.+|++++|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----------------------~~~~~~~~~~~E~~~l~~l~h 63 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP----------------------NRELAREKVMREVKALAKLEH 63 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECC----------------------STTTHHHHHHHHHHHHTSCCC
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecC----------------------CchhHHHHHHHHHHHHHhCCC
Confidence 5799999999999999999999999888888877532 123345779999999999999
Q ss_pred CCceEEEEEEEECC---------------------------------------------------------EEEEEEEcc
Q psy11359 109 ENVVTYHTSFVVKD---------------------------------------------------------ELWLVLRLL 131 (520)
Q Consensus 109 pnIv~~~~~~~~~~---------------------------------------------------------~~~lV~E~~ 131 (520)
|||++++++|.+.. .+++||||+
T Consensus 64 pniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 143 (332)
T 3qd2_B 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLC 143 (332)
T ss_dssp TTBCCEEEEEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECC
T ss_pred CCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEec
Confidence 99999999987643 389999999
Q ss_pred CCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCc
Q psy11359 132 EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGR 211 (520)
Q Consensus 132 ~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~ 211 (520)
.|++|.+++..... ....++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 144 ~~~~L~~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 218 (332)
T 3qd2_B 144 RKENLKDWMNRRCS-----LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218 (332)
T ss_dssp CSSCHHHHHHTCCS-----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-
T ss_pred CCCCHHHHHhcccC-----ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccch
Confidence 99999999985322 2345667899999999999999999999999999999999999999999999998775432
Q ss_pred cccc-------cccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCC
Q psy11359 212 DLSR-------QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLD 284 (520)
Q Consensus 212 ~~~~-------~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 284 (520)
.... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..|+.. .............
T Consensus 219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~---- 291 (332)
T 3qd2_B 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKF---- 291 (332)
T ss_dssp -------------CCCSCC-CGGGSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCC----
T ss_pred hhccccccccccccccccCCCcCccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCC----
Confidence 1111 12234567999999999997765 89999999999999999998776522 1112222221111
Q ss_pred CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 285 TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
.......++.+.+||.+||++||.+|||+.|+|+||||+.
T Consensus 292 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 292 -----PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp -----CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred -----CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 1233566788999999999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=380.84 Aligned_cols=268 Identities=29% Similarity=0.499 Sum_probs=208.7
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+....++|++.+.||+|+||+||+|.+..+|+.||+|+++.... .....+.+.++...+
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~~~~~~~ 60 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---------------------SQEQKRLLMDLDISM 60 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C---------------------HHHHHHHHHHHHHHH
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC---------------------cHHHHHHHHHHHHHH
Confidence 45678899999999999999999999999999999998753211 012233455566668
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN-GQIHRD 182 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~-giiHrD 182 (520)
+.++||||+++++++...+..++||||+. |+|.+++..... ..+.+++..++.++.||+.||.|||++ |++|||
T Consensus 61 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d 135 (290)
T 3fme_A 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVID----KGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRD 135 (290)
T ss_dssp TTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCC
T ss_pred HhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCC
Confidence 88999999999999999999999999996 599888875433 457899999999999999999999998 999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceec---ccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME---QDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~~~DIwSlG~il~elltG 259 (520)
|||+|||++.++.+||+|||++..+... .......||+.|+|||++. ....++.++|||||||++|+|+||
T Consensus 136 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g 209 (290)
T 3fme_A 136 VKPSNVLINALGQVKMCDFGISGYLVDD------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209 (290)
T ss_dssp CSGGGCEECTTCCEEBCCC---------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHEEECCCCCEEEeecCCccccccc------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHC
Confidence 9999999999999999999999765432 1223447999999999972 334489999999999999999999
Q ss_pred CCCCCCC-cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 260 TAPYHKY-PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 260 ~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
..||... .....+........+.... ..+++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 210 ~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 210 RFPYDSWGTPFQQLKQVVEEPSPQLPA--------DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp SCSSCCCSCHHHHHHHHHHSCCCCCCT--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCCccccCchHHHHHHHhccCCCCccc--------ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 9999863 3444444444443333321 35688999999999999999999999999999998543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=377.86 Aligned_cols=264 Identities=24% Similarity=0.401 Sum_probs=219.7
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+.+|+.+++.++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------------------~~~~~~~~~~~e~~~l~~l~ 63 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----------------------RAVDCPENIKKEICINKMLN 63 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGG----------------------GCTTHHHHHHHHHHHHHTCC
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeec----------------------cchhhhHHHHHHHHHHHhcC
Confidence 35799999999999999999999999888888877532 11234567899999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++...+..|+||||+.+++|.+++. ....+++..+..++.||+.||.|||++|++||||||+|
T Consensus 64 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N 135 (276)
T 2yex_A 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--------PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 135 (276)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB--------TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHh--------hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHH
Confidence 9999999999999999999999999999999885 34678999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
|+++.++.+||+|||++..+.... .........||+.|+|||++.+...++.++||||||+++|+|++|..||....
T Consensus 136 il~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 136 LLLDERDNLKISDFGLATVFRYNN---RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp EEECTTCCEEECCCTTCEECEETT---EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred EEEccCCCEEEeeCCCccccCCCc---chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999997664322 11223456799999999999876545789999999999999999999998765
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
................ ..+..+++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 213 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 213 DSCQEYSDWKEKKTYL-------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp TTSHHHHHHHTTCTTS-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred hHHHHHHHhhhccccc-------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 4322222222221111 12356788999999999999999999999999999998653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=381.15 Aligned_cols=262 Identities=29% Similarity=0.476 Sum_probs=224.4
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
+...++|++.+.||+|+||+||+|.+..+++.||+|++...... .....+.+.+|+.+++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--------------------~~~~~~~~~~e~~~l~ 70 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--------------------KPHQREKMSMEISIHR 70 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--------------------SHHHHHHHHHHHHHHH
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc--------------------CHHHHHHHHHHHHHHH
Confidence 46778999999999999999999999999999999987543211 1234567899999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++...+..++||||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++|||||
T Consensus 71 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~ 142 (294)
T 2rku_A 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142 (294)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred hCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 99999999999999999999999999999999999874 3568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++||||||+++|+|+||..||.
T Consensus 143 p~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~ 216 (294)
T 2rku_A 143 LGNLFLNEDLEVKIGDFGLATKVEYDG-----ERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFE 216 (294)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSTT-----CCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred hHhEEEcCCCCEEEEeccCceecccCc-----cccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999998764322 1223467999999999987655 8999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.....+........... ++ ..+++.+.++|.+||+.||.+|||+.++++||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~-~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 217 TSCLKETYLRIKKNEYS-IP---------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp CSSHHHHHHHHHTTCCC-CC---------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred CCCHHHHHHHHhhccCC-Cc---------cccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 87776666555443322 11 3467889999999999999999999999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=379.25 Aligned_cols=274 Identities=27% Similarity=0.488 Sum_probs=226.2
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||.||+|.++.+|+.||+|+++....... ..+......+.+.+|+.+++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~~~~~~~~~~e~~~l~ 78 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF--------------SAEEVQELREATLKEVDILR 78 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTC--------------CHHHHHHHHHHHHHHHHHHH
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEeccccccc--------------CHHHHHHHHHHHHHHHHHHH
Confidence 3567899999999999999999999999999999998864321000 00001223567889999999
Q ss_pred cCC-CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 105 SCH-HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 105 ~l~-HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++. ||||+++++++......++||||+.+++|.+++.. ...+++..+..++.||+.||.|||++|++||||
T Consensus 79 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 150 (298)
T 1phk_A 79 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--------KVTLSEKETRKIMRALLEVICALHKLNIVHRDL 150 (298)
T ss_dssp HHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 995 99999999999999999999999999999999974 356899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc-----cCCCCcchhHHHHHHHHHHHHh
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ-----DHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~~~DIwSlG~il~ellt 258 (520)
||+||+++.++.+||+|||++..+.... ......||+.|+|||++.+ ...++.++||||||+++|+|++
T Consensus 151 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~ 224 (298)
T 1phk_A 151 KPENILLDDDMNIKLTDFGFSCQLDPGE------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224 (298)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred CcceEEEcCCCcEEEecccchhhcCCCc------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH
Confidence 9999999999999999999998764322 2234679999999999852 3347899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
|..||...........+......... ..+..++..+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 225 g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 225 GSPPFWHRKQMLMLRMIMSGNYQFGS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred CCCCCcCccHHHHHHHHhcCCcccCc------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 99999988777766665554432211 123567899999999999999999999999999999987644
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=382.43 Aligned_cols=271 Identities=36% Similarity=0.634 Sum_probs=224.5
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----------------------~~~~~~~~~~e~~~l~ 71 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-----------------------SEEELEDYIVEIEILA 71 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------------------------CCHHHHHHHHHHHH
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-----------------------CHHHHHHHHHHHHHHh
Confidence 35678899999999999999999999999999999987421 0234567899999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
.++||||+++++++...+.+++||||+.+++|.+++.. ..+.+++..+..++.||+.||.|||++|++|||||
T Consensus 72 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk 144 (302)
T 2j7t_A 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE-------LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144 (302)
T ss_dssp HCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHH-------HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred cCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHh-------hccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence 99999999999999999999999999999999999875 24568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceec----ccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME----QDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~----~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|+|||++.++.+||+|||++..... .........||+.|+|||++. ....++.++|||||||++|+|++|.
T Consensus 145 p~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 219 (302)
T 2j7t_A 145 AGNVLMTLEGDIRLADFGVSAKNLK-----TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219 (302)
T ss_dssp GGGEEECTTSCEEECCCHHHHHHHH-----HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSS
T ss_pred HHHEEECCCCCEEEEECCCCccccc-----cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCC
Confidence 9999999999999999998754321 111223467999999999984 2344899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhhHHH
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQ 337 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~~ 337 (520)
.||................++.... ...++..+.+||.+||+.||.+|||+.++++||||+.......+.
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~ 289 (302)
T 2j7t_A 220 PPHHELNPMRVLLKIAKSDPPTLLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289 (302)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCCCSS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHHH
T ss_pred CCCccCCHHHHHHHHhccCCcccCC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccchhHH
Confidence 9999888877776666655443321 245688999999999999999999999999999999877654433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=390.55 Aligned_cols=268 Identities=24% Similarity=0.413 Sum_probs=221.7
Q ss_pred CCCCeEEE-eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 27 TEDQYEVR-EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 27 ~~~~Y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
..++|.+. +.||+|+||+||+|.+..+|+.||+|+++.... .......+.+|+.+++.
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~~e~~~l~~ 84 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR---------------------GQDCRAEILHEIAVLEL 84 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET---------------------TEECHHHHHHHHHHHHH
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc---------------------chHHHHHHHHHHHHHHh
Confidence 45678888 899999999999999999999999998753210 12235678999999999
Q ss_pred C-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 106 C-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 106 l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+ +||||+++++++...+.+|+||||+.||+|.+++... ..+.+++..++.++.||+.||.|||++||+|||||
T Consensus 85 l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dik 158 (327)
T 3lm5_A 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE------LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK 158 (327)
T ss_dssp TTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSC------C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred ccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCC
Confidence 9 5699999999999999999999999999999988532 34679999999999999999999999999999999
Q ss_pred CCcEEEcC---CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 185 AGNILLGE---DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 185 p~NILl~~---~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|+|||++. ++.+||+|||++..+.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..
T Consensus 159 p~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~ 231 (327)
T 3lm5_A 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHAC------ELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTS 231 (327)
T ss_dssp GGGEEESCBTTBCCEEECCGGGCEEC---------------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSC
T ss_pred hHHEEEecCCCCCcEEEeeCccccccCCcc------ccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCC
Confidence 99999987 7899999999998764322 223467999999999997665 8999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhh
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~ 334 (520)
||..................... ..+..+++.+.+||.+||++||.+|||+.++|+||||+......
T Consensus 232 pf~~~~~~~~~~~i~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 232 PFVGEDNQETYLNISQVNVDYSE------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCT------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred CCCCCCchHHHHHHHhcccccCc------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 99988877776655544322211 12346788999999999999999999999999999999876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=394.12 Aligned_cols=275 Identities=27% Similarity=0.382 Sum_probs=216.4
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||+|.+..+|+.||+|+++....... .......+.+|+.+++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~~~~~E~~~l~ 67 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA------------------KDGINRTALREIKLLQ 67 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------------------------CTHHHHHHHHHH
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh------------------hhhhhHHHHHHHHHHh
Confidence 4567899999999999999999999999999999998754311100 0111235789999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++...+.+++||||+.+ +|.+++.. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 68 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 139 (346)
T 1ua2_A 68 ELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD-------NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK 139 (346)
T ss_dssp HCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTT-------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred hCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHh-------cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCC
Confidence 99999999999999999999999999975 89988864 34578999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.+|.+||+|||++..+.... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.
T Consensus 140 p~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 140 PNNLLLDENGVLKLADFGLAKSFGSPN-----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp GGGEEECTTCCEEECCCGGGSTTTSCC-----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HHHEEEcCCCCEEEEecccceeccCCc-----ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999997654321 123356799999999999776668999999999999999999999999
Q ss_pred CCcHHHHHHHHhcC--CCCCC--C--------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcc
Q psy11359 265 KYPAMKVLMLTLQN--DPPTL--D--------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326 (520)
Q Consensus 265 ~~~~~~~~~~~~~~--~~~~~--~--------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~ 326 (520)
+......+..+... .+... . ...........++..+.+||.+||+.||.+|||+.|+|+|||
T Consensus 215 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 215 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred CCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 88877766554432 11100 0 000111233567889999999999999999999999999999
Q ss_pred cccc
Q psy11359 327 FKKA 330 (520)
Q Consensus 327 ~~~~ 330 (520)
|+..
T Consensus 295 f~~~ 298 (346)
T 1ua2_A 295 FSNR 298 (346)
T ss_dssp GTSS
T ss_pred hhcC
Confidence 9864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=380.96 Aligned_cols=267 Identities=40% Similarity=0.721 Sum_probs=221.3
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||+|.+..+|+.||+|++... ...+.+.+|+.+++
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------------------------~~~~~~~~e~~~l~ 79 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-------------------------SDLQEIIKEISIMQ 79 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-------------------------SCCHHHHHHHHHHH
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-------------------------HHHHHHHHHHHHHH
Confidence 45678899999999999999999999999999999987521 12356889999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++...+.+|+||||+.+++|.+++.. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 80 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~ 152 (314)
T 3com_A 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL-------RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIK 152 (314)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-------HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred hCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcC
Confidence 99999999999999999999999999999999999974 34678999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+||+++.++.+||+|||++..+.... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.
T Consensus 153 p~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~ 226 (314)
T 3com_A 153 AGNILLNTEGHAKLADFGVAGQLTDTM-----AKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYA 226 (314)
T ss_dssp GGGEEECTTCCEEECCCTTCEECBTTB-----SCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred HHHEEECCCCCEEEeecccchhhhhhc-----cccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999997764321 1223567999999999987655 8999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhhHH
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFI 336 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~ 336 (520)
...............++.... ...++..+.+||.+||..||.+|||+.++++||||+........
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~ 291 (314)
T 3com_A 227 DIHPMRAIFMIPTNPPPTFRK-------PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSIL 291 (314)
T ss_dssp TSCHHHHHHHHHHSCCCCCSS-------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGG
T ss_pred CCChHHHHHHHhcCCCcccCC-------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchHH
Confidence 887776666555554433321 24568899999999999999999999999999999987654433
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=375.58 Aligned_cols=260 Identities=24% Similarity=0.434 Sum_probs=214.2
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||.||+|.+..+|+.||+|+++...... ....+.+.+|+.+++.+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~e~~~l~~l 68 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRS--------------------LDVVGKIKREIQNLKLF 68 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHHTC
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccc--------------------hhHHHHHHHHHHHHhcC
Confidence 5678999999999999999999999999999999886432211 22356789999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+..|+||||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+
T Consensus 69 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 140 (276)
T 2h6d_A 69 RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK--------HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPE 140 (276)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH--------HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGG
T ss_pred CCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChh
Confidence 999999999999999999999999999999999974 356899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
||+++.++.+||+|||++...... .......||+.|+|||++.+....+.++||||||+++|+|++|..||...
T Consensus 141 Nil~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 141 NVLLDAHMNAKIADFGLSNMMSDG------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp GEEECTTSCEEECCCCGGGCCCC-------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hEEECCCCCEEEeecccccccCCC------cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999998765432 12234579999999999987654578999999999999999999999887
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
............... ++ ..++..+.++|.+||+.||.+|||+.++++||||+..
T Consensus 215 ~~~~~~~~~~~~~~~-~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 215 HVPTLFKKIRGGVFY-IP---------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp SHHHHHHHHHHCCCC-CC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cHHHHHHHhhcCccc-Cc---------hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 766655554443322 11 2457889999999999999999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=389.25 Aligned_cols=263 Identities=29% Similarity=0.472 Sum_probs=224.8
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
+...++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.+++
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--------------------~~~~~~~~~~E~~~l~ 96 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--------------------KPHQREKMSMEISIHR 96 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--------------------SHHHHHHHHHHHHHHH
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc--------------------CHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999999999999987543211 1234567899999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++...+.+|+||||+.+++|.+++.. .+.+++..++.++.||+.||.|||++||+|||||
T Consensus 97 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 168 (335)
T 2owb_A 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168 (335)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH--------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred hCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Confidence 99999999999999999999999999999999999874 3568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.++.+||+|||++..+.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 169 p~NIl~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~ 242 (335)
T 2owb_A 169 LGNLFLNEDLEVKIGDFGLATKVEYDG-----ERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFE 242 (335)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSTT-----CCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred chhEEEcCCCCEEEeeccCceecccCc-----ccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCC
Confidence 999999999999999999998764322 1223467999999999997655 8999999999999999999999998
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
................. +. ..+++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~-~~---------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 243 TSCLKETYLRIKKNEYS-IP---------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp CSSHHHHHHHHHHTCCC-CC---------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred CCCHHHHHHHHhcCCCC-CC---------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 87776666555444322 11 34678899999999999999999999999999998653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=422.85 Aligned_cols=266 Identities=25% Similarity=0.404 Sum_probs=230.4
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|+++++||+|+||+||+|.++.+++.||+|+++...... ....+.+..|..++..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~--------------------~~~~~~~~~E~~~l~~~ 398 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ--------------------DDDVECTMVEKRVLALP 398 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH--------------------TTTTHHHHHHHHHHTCT
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc--------------------HHHHHHHHHHHHHHHhc
Confidence 4578999999999999999999999999999999987543211 12345688899999988
Q ss_pred -CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 -HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 -~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+||||++++.++.+.+.+||||||+.||+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||
T Consensus 399 ~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp 470 (674)
T 3pfq_A 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--------VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKL 470 (674)
T ss_dssp TCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCS
T ss_pred cCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCCh
Confidence 799999999999999999999999999999999985 35689999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+||||+.+|.+||+|||++...... .....+++||+.|+|||++.+.. |+.++|||||||+||||++|.+||.+
T Consensus 471 ~NILl~~~g~ikL~DFGla~~~~~~-----~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~ 544 (674)
T 3pfq_A 471 DNVMLDSEGHIKIADFGMCKENIWD-----GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEG 544 (674)
T ss_dssp TTEEECSSSCEEECCCTTCEECCCT-----TCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hhEEEcCCCcEEEeecceeeccccC-----CcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCC
Confidence 9999999999999999999754321 22245678999999999997665 89999999999999999999999999
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH-----HHHhcCccccccchhhHH
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA-----SELLKNPFFKKAKDKKFI 336 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~elL~hp~~~~~~~~~~~ 336 (520)
....+.+..+........ ..+++++.+||.+||++||.+||++ .|+++||||+...+....
T Consensus 545 ~~~~~~~~~i~~~~~~~p----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~ 610 (674)
T 3pfq_A 545 EDEDELFQSIMEHNVAYP----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE 610 (674)
T ss_dssp SSHHHHHHHHHSSCCCCC----------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHT
T ss_pred CCHHHHHHHHHhCCCCCC----------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHH
Confidence 888888877776543321 3578899999999999999999998 999999999988776543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=395.34 Aligned_cols=267 Identities=27% Similarity=0.400 Sum_probs=213.1
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+++.+|+.+|+++
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l 81 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---------------------QSELFAKRAYRELRLLKHM 81 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---------------------SSHHHHHHHHHHHHHHHHC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---------------------cCHHHHHHHHHHHHHHHhC
Confidence 4578999999999999999999999999999999774321 0123456789999999999
Q ss_pred CCCCceEEEEEEEEC------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+||||+++++++... ..+|+||||+ |++|.++++. +.+++..++.++.||+.||.|||++||+|
T Consensus 82 ~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH 151 (367)
T 1cm8_A 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---------EKLGEDRIQFLVYQMLKGLRYIHAAGIIH 151 (367)
T ss_dssp CBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999865 3469999999 8899999973 46899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+|||++.++.+||+|||++..... .....+||+.|+|||++.+...|+.++|||||||++|+|++|+
T Consensus 152 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 223 (367)
T 1cm8_A 152 RDLKPGNLAVNEDCELKILDFGLARQADS--------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223 (367)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCS--------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred cCcCHHHEEEcCCCCEEEEeeeccccccc--------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999986532 1235689999999999987556999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCC---------------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLD---------------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 319 (520)
+||.+......+..+......... ....-.......++.+.+||.+||+.||.+|||+.
T Consensus 224 ~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~ 303 (367)
T 1cm8_A 224 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 303 (367)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHH
Confidence 999988776666544321110000 00001112245688999999999999999999999
Q ss_pred HHhcCccccccch
Q psy11359 320 ELLKNPFFKKAKD 332 (520)
Q Consensus 320 elL~hp~~~~~~~ 332 (520)
|+|+||||+....
T Consensus 304 e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 304 EALAHPYFESLHD 316 (367)
T ss_dssp HHHHSGGGTTTC-
T ss_pred HHhcChHHHhhcC
Confidence 9999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=378.96 Aligned_cols=262 Identities=45% Similarity=0.780 Sum_probs=226.7
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....+.|++.+.||+|+||+||+|.+..+++.||+|+++.. ......+.+.+|+.+++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------------~~~~~~~~~~~e~~~l~ 75 (303)
T 3a7i_A 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----------------------EAEDEIEDIQQEITVLS 75 (303)
T ss_dssp ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETT----------------------TCSTTHHHHHHHHHHHH
T ss_pred CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccc----------------------ccHHHHHHHHHHHHHHH
Confidence 34567799999999999999999999999888888877532 11334677999999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++.....+|+||||+.|++|.+++. .+.+++..+..++.||+.||.|||++|++|||||
T Consensus 76 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 146 (303)
T 3a7i_A 76 QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---------PGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146 (303)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT---------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred hCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence 9999999999999999999999999999999999984 3578999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+||+++.++.+||+|||++..+.... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.
T Consensus 147 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~ 220 (303)
T 3a7i_A 147 AANVLLSEHGEVKLADFGVAGQLTDTQ-----IKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHS 220 (303)
T ss_dssp GGGEEECTTSCEEECCCTTCEECBTTB-----CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred hheEEECCCCCEEEeecccceecCccc-----cccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCC
Confidence 999999999999999999997764322 1224567999999999997665 8999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
...............++.+. ..++..+.+||.+||++||.+|||+.++++||||.....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 221 ELHPMKVLFLIPKNNPPTLE---------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp TSCHHHHHHHHHHSCCCCCC---------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred CcCHHHHHHHhhcCCCCCCc---------cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 88887777666665554433 346788999999999999999999999999999976543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=375.35 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=212.0
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC- 106 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l- 106 (520)
.++|++.+.||+|+||+||+|.+..+++.||+|+++.... ......++.+|+..+..+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~~e~~~~~~l~ 68 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA---------------------GSVDEQNALREVYAHAVLG 68 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT---------------------TSHHHHHHHHHHHHHHHSC
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc---------------------ccHHHHHHHHHHHHHHHhC
Confidence 4679999999999999999999999999999998753211 122455788999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+.+++||||++|++|.+++..... ..+.+++..++.++.||+.||.|||++||+||||||+
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~ 144 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYR----IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPS 144 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHH
Confidence 999999999999999999999999999999999986433 2367899999999999999999999999999999999
Q ss_pred cEEEcCC-------------------CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHH
Q psy11359 187 NILLGED-------------------GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIW 247 (520)
Q Consensus 187 NILl~~~-------------------g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIw 247 (520)
|||++.+ ..+||+|||++...... ....||+.|+|||++.+...++.++|||
T Consensus 145 NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~ 215 (289)
T 1x8b_A 145 NIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---------QVEEGDSRFLANEVLQENYTHLPKADIF 215 (289)
T ss_dssp GEEEC--------------------CCCEEECCCTTCEETTCS---------CCCCCCGGGCCHHHHTTCCTTHHHHHHH
T ss_pred HEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---------cccCCCccccChhHhcCCCCCCchhhHH
Confidence 9999844 47999999998765421 2346999999999998765577899999
Q ss_pred HHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 248 SLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 248 SlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
||||++|+|++|.+|+....... .......+.++ ..+++.+.+||.+||+.||.+|||+.++++||||
T Consensus 216 slG~il~~l~~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 216 ALALTVVCAAGAEPLPRNGDQWH---EIRQGRLPRIP---------QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp HHHHHHHHHTTCCCCCSSSHHHH---HHHTTCCCCCS---------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred HHHHHHHHHhcCCCCCcchhHHH---HHHcCCCCCCC---------cccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 99999999999998876544332 23333333222 3467899999999999999999999999999999
Q ss_pred cccc
Q psy11359 328 KKAK 331 (520)
Q Consensus 328 ~~~~ 331 (520)
+...
T Consensus 284 ~~~~ 287 (289)
T 1x8b_A 284 LSAS 287 (289)
T ss_dssp ----
T ss_pred hhhc
Confidence 8653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=384.47 Aligned_cols=270 Identities=26% Similarity=0.439 Sum_probs=209.8
Q ss_pred CCCCCeEEE-eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 26 NTEDQYEVR-EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 26 ~~~~~Y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
...++|++. +.||+|+||+||+|.+..+++.||+|+++.. .....+.+.+|+.+++
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------------~~~~~~~~~~E~~~l~ 65 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ-----------------------PGHIRSRVFREVEMLY 65 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC-----------------------SSCCHHHHHHHHHHHH
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC-----------------------cchhHHHHHHHHHHHH
Confidence 356789996 7899999999999999999999999987421 0223567899999999
Q ss_pred cC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 105 SC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 105 ~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++ +||||+++++++...+.+|+||||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||
T Consensus 66 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 137 (316)
T 2ac3_A 66 QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK--------RRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137 (316)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Confidence 85 799999999999999999999999999999999985 356899999999999999999999999999999
Q ss_pred CCCcEEEcCCCC---eEEeccCcceeeccCcccc--ccccccccccccccCCcceecc----cCCCCcchhHHHHHHHHH
Q psy11359 184 KAGNILLGEDGT---VQIADFGVSAWLATGRDLS--RQKVRHTFVGTPCWMAPEVMEQ----DHGYDFKADIWSLGITAI 254 (520)
Q Consensus 184 Kp~NILl~~~g~---vkL~DFG~a~~~~~~~~~~--~~~~~~~~~gt~~y~APE~~~~----~~~~~~~~DIwSlG~il~ 254 (520)
||+|||++.++. +||+|||++..+....... ........+||+.|+|||++.+ ...++.++|||||||++|
T Consensus 138 kp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~ 217 (316)
T 2ac3_A 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217 (316)
T ss_dssp CGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHH
T ss_pred CHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHH
Confidence 999999987765 9999999987654322111 1112234579999999999864 123789999999999999
Q ss_pred HHHhCCCCCCCCcH---------------HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH
Q psy11359 255 EMATGTAPYHKYPA---------------MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319 (520)
Q Consensus 255 elltG~~Pf~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 319 (520)
+|+||..||..... ......+.... ..+ ....+..+++.+++||.+||+.||.+|||+.
T Consensus 218 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 291 (316)
T 2ac3_A 218 ILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK-YEF-----PDKDWAHISCAAKDLISKLLVRDAKQRLSAA 291 (316)
T ss_dssp HHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCC-CCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HHHHCCCCCcccccccccccccccchhHHHHHHHHHhccC-ccc-----CchhcccCCHHHHHHHHHHhhCChhhCCCHH
Confidence 99999999976532 11222222222 111 1223456789999999999999999999999
Q ss_pred HHhcCccccccch
Q psy11359 320 ELLKNPFFKKAKD 332 (520)
Q Consensus 320 elL~hp~~~~~~~ 332 (520)
|+|+||||+....
T Consensus 292 e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 292 QVLQHPWVQGCAP 304 (316)
T ss_dssp HHHHSTTCC----
T ss_pred HHhcChhhcCCCC
Confidence 9999999986543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=376.88 Aligned_cols=266 Identities=26% Similarity=0.485 Sum_probs=221.7
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.+..+|+.||+|+++...... .......+.+.+|+.++++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----------------~~~~~~~~~~~~E~~~l~~l~ 66 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSS-----------------SRRGVSREEIEREVNILREIR 66 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTT-----------------CSSSBCHHHHHHHHHHHHHCC
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccc-----------------cccchHHHHHHHHHHHHHhCC
Confidence 467999999999999999999999999999999876432110 011224677999999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++......++||||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|
T Consensus 67 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N 138 (283)
T 3bhy_A 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--------KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPEN 138 (283)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHH
Confidence 99999999999999999999999999999999974 3568999999999999999999999999999999999
Q ss_pred EEEcCCC----CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 188 ILLGEDG----TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 188 ILl~~~g----~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
|+++.++ .+||+|||++..+.... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus 139 il~~~~~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~ 211 (283)
T 3bhy_A 139 IMLLDKNVPNPRIKLIDFGIAHKIEAGN------EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPF 211 (283)
T ss_dssp EEESCSSSSSCCEEECCCTTCEECC--------------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEEecCCCCCCceEEEecccceeccCCC------cccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCC
Confidence 9998776 89999999997764322 123457999999999987655 899999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
........+.......... ....+..++..+.+||.+||+.||.+|||+.++++||||+...
T Consensus 212 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 212 LGETKQETLTNISAVNYDF------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CCSSHHHHHHHHHTTCCCC------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred CCcchHHHHHHhHhcccCC------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 9887776665554432211 1233456788999999999999999999999999999998654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=397.89 Aligned_cols=256 Identities=23% Similarity=0.437 Sum_probs=201.9
Q ss_pred CCCeEEE-eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh-c
Q psy11359 28 EDQYEVR-EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS-S 105 (520)
Q Consensus 28 ~~~Y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~-~ 105 (520)
.++|.+. ++||+|+||+||+|.++.+|+.||+|+++. ...+.+|+.++. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----------------------------~~~~~~E~~~~~~~ 111 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------------------------CPKARREVELHWRA 111 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----------------------------SHHHHHHHHHHHHH
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----------------------------chhHHHHHHHHHHh
Confidence 4678877 799999999999999999999999997641 124677888874 5
Q ss_pred CCCCCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 106 CHHENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 106 l~HpnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
++||||++++++|.. ...+|+||||+.||+|.+++... ....+++..++.++.||+.||.|||++||+||
T Consensus 112 ~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 185 (400)
T 1nxk_A 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR------GDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185 (400)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---------CCBHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred cCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 589999999999876 56799999999999999999742 23469999999999999999999999999999
Q ss_pred ccCCCcEEEcC---CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 182 DIKAGNILLGE---DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 182 DLKp~NILl~~---~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
||||+|||++. ++.+||+|||++...... ......+||+.|+|||++.+.. |+.++|||||||++|+|++
T Consensus 186 Dlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~ 258 (400)
T 1nxk_A 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSH------NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLC 258 (400)
T ss_dssp CCCGGGEEESSSSTTCCEEECCCTTCEECC-----------------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHH
T ss_pred CcCcceEEEecCCCCccEEEEecccccccCCC------CccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHh
Confidence 99999999987 789999999999865422 1234568999999999997655 8999999999999999999
Q ss_pred CCCCCCCCcHHH----HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 259 GTAPYHKYPAMK----VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 259 G~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
|..||....... ....+..+... .. ...+..++.++.+||.+||+.||.+|||+.|+++||||...
T Consensus 259 g~~pf~~~~~~~~~~~~~~~i~~~~~~-~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 259 GYPPFYSNHGLAISPGMKTRIRMGQYE-FP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp SSCSCCCCTTCSSCCSHHHHHHHTCCC-CC-----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CCCCCCCCccccccHHHHHHHHcCccc-CC-----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 999997654321 11122222111 11 11234678999999999999999999999999999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=382.54 Aligned_cols=267 Identities=39% Similarity=0.699 Sum_probs=218.8
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
.....++|++.+.||+|+||.||+|.+..+|+.||+|++... ....+.+.+|+.++
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------------------------~~~~~~~~~e~~~l 74 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------------------GDEEEEIKQEINML 74 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------------------SSTTHHHHHHHHHH
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC------------------------cccHHHHHHHHHHH
Confidence 456778999999999999999999999999999999977421 12235688999999
Q ss_pred hcC-CCCCceEEEEEEEE------CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 104 SSC-HHENVVTYHTSFVV------KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 104 ~~l-~HpnIv~~~~~~~~------~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
+++ +||||+++++++.. ...+|+||||+.+++|.+++... ....+++..++.++.||+.||.|||++
T Consensus 75 ~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~ 148 (326)
T 2x7f_A 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT------KGNTLKEEWIAYICREILRGLSHLHQH 148 (326)
T ss_dssp HHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS------GGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc------ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 998 89999999999987 56899999999999999999853 235789999999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc----cCCCCcchhHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----DHGYDFKADIWSLGIT 252 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~~~~DIwSlG~i 252 (520)
|++||||||+|||++.++.+||+|||++..+.... .......||+.|+|||++.. ...++.++|||||||+
T Consensus 149 ~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 223 (326)
T 2x7f_A 149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223 (326)
T ss_dssp TCCCCCCSGGGEEECTTCCEEECCCTTTC------------------CCGGGCCHHHHC--------CCTTHHHHHHHHH
T ss_pred CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc-----cccccccCCccccChhhhccccccCcCCCccchHHHHHHH
Confidence 99999999999999999999999999987653221 12335679999999999862 2348899999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 253 AIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 253 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
+|+|+||..||.................+.... ..++..+.+||.+||..||.+|||+.++++||||+....
T Consensus 224 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 224 AIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp HHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC--------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred HHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc--------cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 999999999999888777766665554433221 346789999999999999999999999999999987654
Q ss_pred h
Q psy11359 333 K 333 (520)
Q Consensus 333 ~ 333 (520)
.
T Consensus 296 ~ 296 (326)
T 2x7f_A 296 E 296 (326)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=380.57 Aligned_cols=260 Identities=28% Similarity=0.465 Sum_probs=220.4
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+|+.||+|+++... ....+.+.+|+.++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~~e~~~l~~ 62 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-----------------------AFRDSSLENEIAVLKK 62 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------------------------HHHHHHHHHHH
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-----------------------ccchHHHHHHHHHHHh
Confidence 34578999999999999999999999999999999875321 1123458899999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++...+.+|+||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||
T Consensus 63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp 134 (304)
T 2jam_A 63 IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE--------RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKP 134 (304)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--------HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCG
T ss_pred CCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH
Confidence 9999999999999999999999999999999999974 35689999999999999999999999999999999
Q ss_pred CcEEE---cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 186 GNILL---GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 186 ~NILl---~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
+||++ +.++.+||+|||++..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..|
T Consensus 135 ~NIl~~~~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p 206 (304)
T 2jam_A 135 ENLLYLTPEENSKIMITDFGLSKMEQN-------GIMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPP 206 (304)
T ss_dssp GGCEESSSSTTCCEEBCSCSTTCCCCC-------BTTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCT
T ss_pred HHEEEecCCCCCCEEEccCCcceecCC-------CccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCC
Confidence 99999 7788999999999865422 1223457999999999997665 89999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
|...........+........ ...+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 207 f~~~~~~~~~~~i~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 207 FYEETESKLFEKIKEGYYEFE------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp TTTSCHHHHHHHHHHCCCCCC------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CCCCCHHHHHHHHHcCCCCCC------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 998877776666555432211 11234678899999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=389.81 Aligned_cols=266 Identities=26% Similarity=0.534 Sum_probs=222.8
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-C
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-H 107 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~ 107 (520)
++|++.+.||+|+||.||+|.+..+|+.||+|+++..... ..........+.+.+|+.+++++ +
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~---------------~~~~~~~~~~~~~~~E~~~l~~l~~ 158 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAER---------------LSPEQLEEVREATRRETHILRQVAG 158 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSC---------------CCHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccc---------------cCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 5799999999999999999999999999999988643110 00001122356688999999999 8
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++......|+||||+.|++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|
T Consensus 159 hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~N 230 (365)
T 2y7j_A 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--------KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230 (365)
T ss_dssp CTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 99999999999999999999999999999999974 3568999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc-----CCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD-----HGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~~~~DIwSlG~il~elltG~~P 262 (520)
||++.+|.+||+|||++..+.... .....+||+.|+|||++.+. ..++.++|||||||++|+|+||..|
T Consensus 231 Il~~~~~~ikl~DfG~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~p 304 (365)
T 2y7j_A 231 ILLDDNMQIRLSDFGFSCHLEPGE------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304 (365)
T ss_dssp EEECTTCCEEECCCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred EEECCCCCEEEEecCcccccCCCc------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCC
Confidence 999999999999999998765322 22356899999999998632 2488999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
|........+..+....... ....+..++..+.+||.+||+.||.+|||+.++|+||||++
T Consensus 305 f~~~~~~~~~~~i~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 305 FWHRRQILMLRMIMEGQYQF------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SCCSSHHHHHHHHHHTCCCC------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCCHHHHHHHHHhCCCCC------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 98877776666555543221 12234567889999999999999999999999999999973
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=388.67 Aligned_cols=267 Identities=22% Similarity=0.408 Sum_probs=216.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+++.||+|+++.... ........+.+|+.++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------~~~~~~~~~~~E~~~l~~ 68 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA--------------------RDPSFYLRFRREAQNAAA 68 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT--------------------TSHHHHHHHHHHHTTCCC
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc--------------------CCHHHHHHHHHHHHHHHc
Confidence 457889999999999999999999999999999998754311 112345678999999999
Q ss_pred CCCCCceEEEEEEEECC----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 106 CHHENVVTYHTSFVVKD----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
++||||+++++++.... ..|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||
T Consensus 69 l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 140 (311)
T 3ork_A 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--------EGPMTPKRAIEVIADACQALNFSHQNGIIHR 140 (311)
T ss_dssp CCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHH--------HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred CCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcC
Confidence 99999999999988654 35999999999999999974 3568999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||++.++.+||+|||++..+..... .........||+.|+|||++.+.. ++.++|||||||++|+|+||+.
T Consensus 141 dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~ 217 (311)
T 3ork_A 141 DVKPANIMISATNAVKVMDFGIARAIADSGN--SVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEP 217 (311)
T ss_dssp CCCGGGEEEETTSCEEECCCSCC--------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCHHHEEEcCCCCEEEeeccCccccccccc--ccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999977643321 112233467999999999997765 8999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
||................+.. .......+++.+.+||.+||++||.+||++.+++.|+|++.
T Consensus 218 pf~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 218 PFTGDSPVSVAYQHVREDPIP------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp SCCCSSHHHHHHHHHHCCCCC------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCCChHHHHHHHhcCCCCC------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 999988877766666553322 12233467899999999999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=400.25 Aligned_cols=268 Identities=26% Similarity=0.334 Sum_probs=213.3
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
...+|++.+.||+|+||+||+|.+..+|+.||||++.... ....+|+++|+.+
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------------------------~~~~~E~~il~~l 104 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---------------------------RFKNRELQIMRKL 104 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---------------------------TSCCHHHHHHHTC
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---------------------------hhHHHHHHHHHHc
Confidence 3457999999999999999999999999999999774210 0133699999999
Q ss_pred CCCCceEEEEEEEEC----C--EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVK----D--ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~----~--~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+||||++++++|... + .+++||||+.+ +|.+++..... ....+++..++.++.||+.||.|||++||+|
T Consensus 105 ~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 179 (420)
T 1j1b_A 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSR----AKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 179 (420)
T ss_dssp CCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred CCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999988642 2 37799999964 78777765332 4578999999999999999999999999999
Q ss_pred cccCCCcEEEcCC-CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 181 RDIKAGNILLGED-GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 181 rDLKp~NILl~~~-g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG 259 (520)
|||||+|||++.+ +.+||+|||+++.+..+. .....+||+.|+|||++.+...|+.++|||||||++|+|++|
T Consensus 180 rDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G 253 (420)
T 1j1b_A 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253 (420)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCTTC------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred cCCChhhEEEeCCCCeEEeccchhhhhcccCC------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhC
Confidence 9999999999855 678999999998764322 223568999999999997765699999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcCC-------------------CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 260 TAPYHKYPAMKVLMLTLQND-------------------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
++||.+....+.+..++... .+.+............+++++.+||.+||++||.+|||+.|
T Consensus 254 ~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e 333 (420)
T 1j1b_A 254 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 333 (420)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHH
Confidence 99999888776665544310 00010000111112346889999999999999999999999
Q ss_pred HhcCccccccch
Q psy11359 321 LLKNPFFKKAKD 332 (520)
Q Consensus 321 lL~hp~~~~~~~ 332 (520)
+|+||||+....
T Consensus 334 ~l~hp~f~~~~~ 345 (420)
T 1j1b_A 334 ACAHSFFDELRD 345 (420)
T ss_dssp HHTSGGGGGGGC
T ss_pred HhCCHhhccccc
Confidence 999999986543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=390.66 Aligned_cols=262 Identities=29% Similarity=0.553 Sum_probs=217.1
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||+|.+..++..||+|+++.. ......+.+.+|+.+++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~----------------------~~~~~~~~~~~E~~~l~ 86 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE----------------------IKPAIRNQIIRELQVLH 86 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC----------------------CCHHHHHHHHHHHGGGG
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc----------------------cCHHHHHHHHHHHHHHH
Confidence 34678899999999999999999999999888888877432 12334567899999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccc
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN-GQIHRDI 183 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~-giiHrDL 183 (520)
+++||||+++++++...+.+|+||||+.|++|.+++.. .+.+++..+..++.||+.||.|||+. ||+||||
T Consensus 87 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dl 158 (360)
T 3eqc_A 87 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--------AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 158 (360)
T ss_dssp GCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCC
T ss_pred HCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCc
Confidence 99999999999999999999999999999999999975 35689999999999999999999996 9999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
||+|||++.++.+||+|||++..+.. .......||+.|+|||++.+.. ++.++|||||||++|+|+||..||
T Consensus 159 kp~Nil~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf 230 (360)
T 3eqc_A 159 KPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPI 230 (360)
T ss_dssp SGGGEEECTTCCEEECCCCCCHHHHH-------HC----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCS
T ss_pred cHHHEEECCCCCEEEEECCCCccccc-------ccccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999865421 2234568999999999997765 899999999999999999999999
Q ss_pred CCCcHHHHHHHHh------------------------------------------cCCCCCCCCCchhhhhHHHhcHHHH
Q psy11359 264 HKYPAMKVLMLTL------------------------------------------QNDPPTLDTGAAEKDQYKAYGKTFR 301 (520)
Q Consensus 264 ~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (520)
............. ...++.. ....++.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 302 (360)
T 3eqc_A 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL--------PSGVFSLEFQ 302 (360)
T ss_dssp SCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCC--------CTTTSCHHHH
T ss_pred CCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCC--------CcccccHHHH
Confidence 8765544322111 0000000 0123678999
Q ss_pred HHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 302 KMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 302 ~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
+||.+||+.||.+|||+.|+|+||||+....
T Consensus 303 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 303 DFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred HHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 9999999999999999999999999986543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=389.29 Aligned_cols=272 Identities=26% Similarity=0.409 Sum_probs=220.3
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++++.||+|+||+||+|.+..+++.||+|++.. .......+.+.+|+.++++
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----------------------~~~~~~~~~~~~E~~~l~~ 81 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----------------------FEHQTYCQRTLREIKILLR 81 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----------------------TTCHHHHHHHHHHHHHHHH
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc----------------------ccCcHHHHHHHHHHHHHHh
Confidence 445789999999999999999999999988888887642 1123345678999999999
Q ss_pred CCCCCceEEEEEEEEC-----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 106 CHHENVVTYHTSFVVK-----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~-----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
++||||+++++++... ..+|+||||+. ++|.++++. +.+++..++.++.||+.||.|||++||+|
T Consensus 82 l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 151 (364)
T 3qyz_A 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT---------QHLSNDHICYFLYQILRGLKYIHSANVLH 151 (364)
T ss_dssp CCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred cCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 9999999999999754 46999999996 599999964 45899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+|||++.++.+||+|||++........ ........+||+.|+|||++.+...++.++|||||||++|+|++|.
T Consensus 152 ~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 229 (364)
T 3qyz_A 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229 (364)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCGGGC--BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred CCCChHhEEECCCCCEEEEeCcceEecCCCCC--ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCC
Confidence 99999999999999999999999987643322 1122345689999999999876666899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcC--CCCC-------------------CCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH
Q psy11359 261 APYHKYPAMKVLMLTLQN--DPPT-------------------LDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~--~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 319 (520)
+||.+....+.+..+... .+.. .............+++.+.+||.+||++||.+|||+.
T Consensus 230 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 309 (364)
T 3qyz_A 230 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309 (364)
T ss_dssp CSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 999887765555443321 1000 0000111222345688999999999999999999999
Q ss_pred HHhcCccccccc
Q psy11359 320 ELLKNPFFKKAK 331 (520)
Q Consensus 320 elL~hp~~~~~~ 331 (520)
|+|+||||+...
T Consensus 310 e~l~hp~~~~~~ 321 (364)
T 3qyz_A 310 QALAHPYLEQYY 321 (364)
T ss_dssp HHHTSGGGTTTC
T ss_pred HHhcCcchhhcc
Confidence 999999998653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=396.40 Aligned_cols=267 Identities=28% Similarity=0.384 Sum_probs=211.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
...+|++.++||+|+||+||+|.+..++. +|+|++... . ....+|+.+|+.+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~----------------------~-----~~~~~E~~il~~l 89 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD----------------------K-----RFKNRELQIMRIV 89 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECC----------------------T-----TSCCHHHHHHHTC
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecC----------------------c-----chHHHHHHHHHhC
Confidence 45679999999999999999999988765 777765311 0 0123699999999
Q ss_pred CCCCceEEEEEEEECCE------EEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVKDE------LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~------~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+||||+++++++..... +++||||+.+ +|...+..... ....+++..++.++.||+.||.|||++||+|
T Consensus 90 ~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 164 (394)
T 4e7w_A 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAK----LKQTMPMLLIKLYMYQLLRSLAYIHSIGICH 164 (394)
T ss_dssp CCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence 99999999999975433 8899999975 55555543322 3567999999999999999999999999999
Q ss_pred cccCCCcEEEc-CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 181 RDIKAGNILLG-EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 181 rDLKp~NILl~-~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG 259 (520)
|||||+|||++ .++.+||+|||++..+..+. .....+||+.|+|||++.+...|+.++|||||||++|+|++|
T Consensus 165 rDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 238 (394)
T 4e7w_A 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238 (394)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCTTC------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCHHHEEEcCCCCcEEEeeCCCcccccCCC------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999998 79999999999998764332 223568899999999998766699999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcC-------------------CCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 260 TAPYHKYPAMKVLMLTLQN-------------------DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
++||.+....+.+..+... ..+..............+++++.+||.+||++||.+|||+.|
T Consensus 239 ~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (394)
T 4e7w_A 239 QPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIE 318 (394)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHH
Confidence 9999998877666554431 011111111111122347889999999999999999999999
Q ss_pred HhcCccccccch
Q psy11359 321 LLKNPFFKKAKD 332 (520)
Q Consensus 321 lL~hp~~~~~~~ 332 (520)
+++||||+....
T Consensus 319 ~l~hp~f~~~~~ 330 (394)
T 4e7w_A 319 ALCHPFFDELRT 330 (394)
T ss_dssp HHTSGGGSTTTS
T ss_pred HhcChhhhhhcc
Confidence 999999987544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=382.59 Aligned_cols=263 Identities=21% Similarity=0.360 Sum_probs=212.2
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+++.||+|+++. ...+.+.+|+.++++
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--------------------------~~~~~~~~E~~~l~~ 86 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------------------------VKKKKIKREIKILEN 86 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--------------------------CCHHHHHHHHHHHHH
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--------------------------cchHHHHHHHHHHHH
Confidence 345789999999999999999999999999999997641 223568899999999
Q ss_pred CC-CCCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 106 CH-HENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 106 l~-HpnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
++ ||||+++++++.. ....++||||+.+++|.++++ .+++..++.++.||+.||.|||++||+|||
T Consensus 87 l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 155 (330)
T 3nsz_A 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----------TLTDYDIRFYMYEILKALDYCHSMGIMHRD 155 (330)
T ss_dssp HTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG-----------GCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred cCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH-----------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence 96 9999999999997 678999999999999999874 378999999999999999999999999999
Q ss_pred cCCCcEEEcCCC-CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 183 IKAGNILLGEDG-TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 183 LKp~NILl~~~g-~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|||+|||++.++ .+||+|||++..+.... ......||+.|+|||++.+...++.++|||||||++|+|++|..
T Consensus 156 ikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 229 (330)
T 3nsz_A 156 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229 (330)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECCTTC------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred CCHHHEEEcCCCCEEEEEeCCCceEcCCCC------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCC
Confidence 999999998776 89999999998764332 22345799999999999875669999999999999999999999
Q ss_pred CCCCC-cHHHHHHHHhc------------CCCCCCCC---------------CchhhhhHHHhcHHHHHHHHhhhccCCC
Q psy11359 262 PYHKY-PAMKVLMLTLQ------------NDPPTLDT---------------GAAEKDQYKAYGKTFRKMISDCLQKDPT 313 (520)
Q Consensus 262 Pf~~~-~~~~~~~~~~~------------~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~L~~dP~ 313 (520)
||... .....+..... ........ ..........+++.+.+||.+||++||.
T Consensus 230 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 309 (330)
T 3nsz_A 230 PFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 309 (330)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGG
T ss_pred CcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcc
Confidence 99433 22222211110 00000000 0001112234789999999999999999
Q ss_pred CCCCHHHHhcCccccccc
Q psy11359 314 KRPTASELLKNPFFKKAK 331 (520)
Q Consensus 314 ~Rpta~elL~hp~~~~~~ 331 (520)
+|||+.|+|+||||+...
T Consensus 310 ~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 310 SRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp GSCCHHHHHTSGGGTTCC
T ss_pred cCCCHHHHhcCccHhhhc
Confidence 999999999999998654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=384.57 Aligned_cols=273 Identities=27% Similarity=0.436 Sum_probs=214.6
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... +.. ........+.+|+.++++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~---~~~~~~~~~~~E~~~l~~l~ 73 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAI------------GSA---READPALNVETEIEILKKLN 73 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC------------------------------CHHHHHHHHHHCC
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhh------------ccc---ccchhhhhHHHHHHHHHhCC
Confidence 468999999999999999999999999999999886432110 000 00122345889999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++..+. .|+||||+.+++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 74 h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N 144 (322)
T 2ycf_A 74 HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVV--------GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144 (322)
T ss_dssp CTTBCCEEEEEESSS-EEEEEECCTTEETHHHHS--------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHh--------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999987655 899999999999999986 45679999999999999999999999999999999999
Q ss_pred EEEcCCCC---eEEeccCcceeeccCccccccccccccccccccCCcceec--ccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 188 ILLGEDGT---VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME--QDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 188 ILl~~~g~---vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
||++.++. +||+|||++..+... .......||+.|+|||++. +...++.++|||||||++|+|++|..|
T Consensus 145 Il~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 218 (322)
T 2ycf_A 145 VLLSSQEEDCLIKITDFGHSKILGET------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218 (322)
T ss_dssp EEESSSSSSCCEEECCCTTCEECCCC------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEEecCCCCCeEEEccCccceecccc------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99986654 999999999776422 1223567999999999974 234489999999999999999999999
Q ss_pred CCCCcHHHHHHH-HhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchhhHH
Q psy11359 263 YHKYPAMKVLML-TLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFI 336 (520)
Q Consensus 263 f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~ 336 (520)
|........+.. ........ ....+..+++.+.+||.+||+.||.+|||+.++|+||||+....+...
T Consensus 219 f~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~~~~ 287 (322)
T 2ycf_A 219 FSEHRTQVSLKDQITSGKYNF------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 287 (322)
T ss_dssp SCSTTCSSCHHHHHHHTCCCC------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHHHHH
T ss_pred CcccchHHHHHHHHHhCcccc------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHHHHH
Confidence 976543322222 22221111 122345678999999999999999999999999999999976654433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=377.72 Aligned_cols=263 Identities=25% Similarity=0.387 Sum_probs=215.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+.+|+.+++++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------~~~~~~~~~~~~e~~~l~~l 68 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP--------------------REKEETLKRFEREVHNSSQL 68 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCS--------------------SCCHHHHHHHHHHHHHHTTC
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCc--------------------cccHHHHHHHHHHHHHHhcC
Confidence 4678999999999999999999999999999999874321 11134567799999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+.+|+||||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+
T Consensus 69 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~ 140 (294)
T 4eqm_A 69 SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES--------HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQ 140 (294)
T ss_dssp CBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH--------HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred CCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 999999999999999999999999999999999974 357899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.++.+||+|||++..+.... ........||+.|+|||++.+.. ++.++|||||||++|+|+||..||.+.
T Consensus 141 Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 141 NILIDSNKTLKIFDFGIAKALSETS----LTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp GEEECTTSCEEECCCSSSTTC-----------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred HEEECCCCCEEEEeCCCcccccccc----ccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999987653221 11233467999999999998765 899999999999999999999999998
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
..............+.. .......+++.+.++|.+||++||.+||+..+.+.+.|.
T Consensus 216 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 216 TAVSIAIKHIQDSVPNV-----TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp CHHHHHHHHHSSCCCCH-----HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred ChHHHHHHHhhccCCCc-----chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 88777666665543322 122335678999999999999999999966666555544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=372.31 Aligned_cols=266 Identities=26% Similarity=0.461 Sum_probs=222.9
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
|...++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~~e~~~l~ 60 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---------------------TEAEKQMLVSEVNLLR 60 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC---------------------CHHHHHHHHHHHHHHH
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC---------------------CHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999999999999998753211 1234567899999999
Q ss_pred cCCCCCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----
Q psy11359 105 SCHHENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG----- 177 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g----- 177 (520)
+++||||+++++++.. ...+|+||||++|++|.+++..... ....+++..++.++.||+.||.|||++|
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ 136 (279)
T 2w5a_A 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK----ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136 (279)
T ss_dssp HCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHHC-----
T ss_pred hcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcc----cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCe
Confidence 9999999999998865 5789999999999999999986433 3456899999999999999999999999
Q ss_pred cEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 178 QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 178 iiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
++||||||+|||++.++.+||+|||++..+.... .......||+.|+|||++.+.. ++.++||||||+++|+|+
T Consensus 137 ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~ 210 (279)
T 2w5a_A 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-----SFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELC 210 (279)
T ss_dssp -CCCCCSGGGEEECSSSCEEECCCCHHHHC---C-----HHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHH
T ss_pred eEEeccchhhEEEcCCCCEEEecCchheeecccc-----ccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999987654321 1223467999999999997665 899999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 258 TGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 258 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
||..||...........+..+..+.++ ..++..+.++|.+||+.||.+|||+.|+++|+|+...
T Consensus 211 ~g~~p~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 211 ALMPPFTAFSQKELAGKIREGKFRRIP---------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HCCCCCcccCHHHHHHHHhhcccccCC---------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 999999988777666666555443332 3467899999999999999999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=386.98 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=215.0
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+++.||+|+++....... ..+. ....+.+.+|+.+++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~--------~~~~-------~~~~~~~~~E~~~l~~l 86 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLED--------CWIE-------DPKLGKVTLEIAILSRV 86 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTT--------SEEE-------ETTTEEEEHHHHHHTTC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccc--------cccc-------hHHHHHHHHHHHHHHhC
Confidence 45789999999999999999999999999999999875432110 0000 01122366799999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCC-CHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGG-SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~gg-sL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+||||+++++++...+.+++||||+.+| +|.+++. ..+.+++..++.++.||+.||.|||++||+||||||
T Consensus 87 ~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp 158 (335)
T 3dls_A 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID--------RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKD 158 (335)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHH--------TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred CCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCH
Confidence 9999999999999999999999998766 9999997 456799999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||++.++.+||+|||++..+.... .....+||+.|+|||++.+...++.++|||||||++|+|++|..||..
T Consensus 159 ~NIll~~~~~~kL~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 159 ENIVIAEDFTIKLIDFGSAAYLERGK------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTC------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred HHEEEcCCCcEEEeecccceECCCCC------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 99999999999999999998764322 234567999999999998776458999999999999999999999976
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.... .... .. ....+++.+.+||.+||++||.+|||+.++++||||+..
T Consensus 233 ~~~~------~~~~-~~---------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 233 LEET------VEAA-IH---------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp GGGG------TTTC-CC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHH------Hhhc-cC---------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 3321 0100 00 012367899999999999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=374.43 Aligned_cols=272 Identities=28% Similarity=0.427 Sum_probs=210.3
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.+..+|+.||+|+++.. ....+.+.+|+.++++++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------------~~~~~~~~~E~~~l~~l~ 60 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT------------------------EEKLSTILSEVMLLASLN 60 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE------------------------HHHHHHHHHHHHHHTTCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc------------------------HHHHHHHHHHHHHHHhcC
Confidence 35799999999999999999999999999999976421 234567899999999999
Q ss_pred CCCceEEEEEEEE-------------CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 108 HENVVTYHTSFVV-------------KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 108 HpnIv~~~~~~~~-------------~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
||||+++++++.. ...+|+||||++|++|.+++.. ....+++..++.++.||+.||.|||
T Consensus 61 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~LH 133 (303)
T 1zy4_A 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-------ENLNQQRDEYWRLFRQILEALSYIH 133 (303)
T ss_dssp CTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH-------SCGGGCHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc-------cccccchHHHHHHHHHHHHHHHHHH
Confidence 9999999999875 3568999999999999999985 3446788999999999999999999
Q ss_pred HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCcccc---------ccccccccccccccCCcceecccCCCCcchh
Q psy11359 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLS---------RQKVRHTFVGTPCWMAPEVMEQDHGYDFKAD 245 (520)
Q Consensus 175 ~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~---------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~D 245 (520)
++|++||||||+|||++.++.+||+|||++..+....... .........||+.|+|||++.+...++.++|
T Consensus 134 ~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 213 (303)
T 1zy4_A 134 SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKID 213 (303)
T ss_dssp HTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHH
T ss_pred hCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhh
Confidence 9999999999999999999999999999987654321100 0122345679999999999986655899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCc
Q psy11359 246 IWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325 (520)
Q Consensus 246 IwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp 325 (520)
||||||++|+|++ ||............+......++.. .....++.+.+||.+||+.||.+|||+.++++||
T Consensus 214 i~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 214 MYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPD-----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp HHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTT-----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred HHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCcc-----ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 9999999999998 6654333333333333222222111 1234567899999999999999999999999999
Q ss_pred cccccchhhHHHh
Q psy11359 326 FFKKAKDKKFIQQ 338 (520)
Q Consensus 326 ~~~~~~~~~~~~~ 338 (520)
||+.........+
T Consensus 286 ~~~~~~~~~~~~~ 298 (303)
T 1zy4_A 286 WLPVKHQDEVIKE 298 (303)
T ss_dssp CSCCCCHHHHHHH
T ss_pred CcCCCChHHHHHH
Confidence 9987665544433
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=394.03 Aligned_cols=266 Identities=26% Similarity=0.427 Sum_probs=202.0
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++++.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l~ 86 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---------------------QSIIHAKRTYRELRLLKHMK 86 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT---------------------SSHHHHHHHHHHHHHHHHCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc---------------------cCHHHHHHHHHHHHHHHhCC
Confidence 478999999999999999999999999999999874321 01234567889999999999
Q ss_pred CCCceEEEEEEEEC------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 108 HENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 108 HpnIv~~~~~~~~~------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
||||+++++++... ..+|+||||+ +++|.++++ .+.+++..++.++.||+.||.|||++||+||
T Consensus 87 hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~ 156 (367)
T 2fst_X 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK---------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 156 (367)
T ss_dssp CTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred CCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence 99999999998754 5689999999 789999885 3568999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||++.++.+||+|||++..... .....+||+.|+|||++.+...|+.++|||||||++|+|++|.+
T Consensus 157 Dlkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 228 (367)
T 2fst_X 157 DLKPSNLAVNEDCELKILDFGLARHTAD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228 (367)
T ss_dssp CCCGGGEEECTTCCEEECC-----------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCCHhhEEECCCCCEEEeeccccccccc--------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999876432 12356899999999999875569999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcC--CCC-----CCC--------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 262 PYHKYPAMKVLMLTLQN--DPP-----TLD--------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~--~~~-----~~~--------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
||.+......+..+... .+. .+. ........+...++.+.+||.+||++||.+|||+.|
T Consensus 229 pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e 308 (367)
T 2fst_X 229 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308 (367)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHH
Confidence 99988877666544331 110 000 000111223456889999999999999999999999
Q ss_pred HhcCccccccch
Q psy11359 321 LLKNPFFKKAKD 332 (520)
Q Consensus 321 lL~hp~~~~~~~ 332 (520)
+|+||||+....
T Consensus 309 ~L~hp~~~~~~~ 320 (367)
T 2fst_X 309 ALAHAYFAQYHD 320 (367)
T ss_dssp HHTSGGGTTTCC
T ss_pred HhcChhhhhccC
Confidence 999999986543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=389.59 Aligned_cols=265 Identities=26% Similarity=0.402 Sum_probs=207.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+.+|+.+++.+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~~~~~~~E~~~l~~l 81 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---------------------QNQTHAKRAYRELVLMKCV 81 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT---------------------SSHHHHHHHHHHHHHHHHC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc---------------------CChHHHHHHHHHHHHHHhc
Confidence 3578999999999999999999999999999999875321 1123456788999999999
Q ss_pred CCCCceEEEEEEEECC------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVKD------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+||||+++++++...+ .+|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+|
T Consensus 82 ~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~ivH 150 (371)
T 2xrw_A 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ----------MELDHERMSYLLYQMLCGIKHLHSAGIIH 150 (371)
T ss_dssp CCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh----------hccCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 9999999999998655 7899999996 58888885 24889999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 151 ~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~ 223 (371)
T 2xrw_A 151 RDLKPSNIVVKSDCTLKILDFGLARTAGTS------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGG 223 (371)
T ss_dssp SCCCGGGEEECTTSCEEECCCCC----------------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSS
T ss_pred ccCCHHHEEEcCCCCEEEEEeecccccccc------cccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999765322 1233568999999999998755 899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCC---------------------CCCc-----------hhhhhHHHhcHHHHHHHHhhh
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTL---------------------DTGA-----------AEKDQYKAYGKTFRKMISDCL 308 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~---------------------~~~~-----------~~~~~~~~~~~~~~~li~~~L 308 (520)
.||.+......+..+........ .... .........+..+++||.+||
T Consensus 224 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL 303 (371)
T 2xrw_A 224 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 303 (371)
T ss_dssp CSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHC
Confidence 99998887776665544321110 0000 000112334778999999999
Q ss_pred ccCCCCCCCHHHHhcCcccccc
Q psy11359 309 QKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 309 ~~dP~~Rpta~elL~hp~~~~~ 330 (520)
+.||.+|||+.|+|+||||+..
T Consensus 304 ~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 304 VIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp CSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCChhhCCCHHHHhCCcchhhh
Confidence 9999999999999999999754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=386.72 Aligned_cols=263 Identities=22% Similarity=0.401 Sum_probs=206.9
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+. +++.||+|+++... ......+.+.+|+.+|++
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------------------~~~~~~~~~~~E~~~l~~ 63 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE---------------------ADNQTLDSYRNEIAYLNK 63 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT---------------------CCHHHHHHHHHHHHHHHH
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc---------------------cchHHHHHHHHHHHHHHh
Confidence 46788999999999999999999884 57788888765321 112345778999999999
Q ss_pred CCC--CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 106 CHH--ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 106 l~H--pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++| |||+++++++.....+|+|||+ .+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||
T Consensus 64 l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDi 134 (343)
T 3dbq_A 64 LQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--------KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 134 (343)
T ss_dssp HTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHH--------SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred hhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 976 9999999999999999999995 58899999984 467899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc----------cCCCCcchhHHHHHHHH
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----------DHGYDFKADIWSLGITA 253 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----------~~~~~~~~DIwSlG~il 253 (520)
||+|||++ ++.+||+|||++..+.... ........+||+.|+|||++.+ ...++.++|||||||++
T Consensus 135 kp~NIll~-~~~~kl~DFG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il 210 (343)
T 3dbq_A 135 KPANFLIV-DGMLKLIDFGIANQMQPDT---TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210 (343)
T ss_dssp CGGGEEEE-TTEEEECCCSSSCCC---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHH
T ss_pred CcceEEEE-CCcEEEeecccccccCccc---ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHH
Confidence 99999996 6889999999997764322 1112345689999999999864 13489999999999999
Q ss_pred HHHHhCCCCCCCCcHH-HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 254 IEMATGTAPYHKYPAM-KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 254 ~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
|+|++|..||...... ..+......... ... ....+..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 211 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~-------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 211 YYMTYGKTPFQQIINQISKLHAIIDPNHE-IEF-------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp HHHHHSSCTTTTCCSHHHHHHHHHCTTSC-CCC-------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHhCCCcchhhhhHHHHHHHHhcCCcc-cCC-------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 9999999999875433 233333322111 110 123457899999999999999999999999999998543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=387.71 Aligned_cols=268 Identities=28% Similarity=0.442 Sum_probs=215.8
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEc---CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCK---ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
...++|++.+.||+|+||+||+|.+. .+|+.||+|+++... ..+. ....+.+.+|+.+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-------------~~~~------~~~~~~~~~E~~~ 111 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT-------------IVQK------AKTTEHTRTERQV 111 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEE-------------EEEE------ESSGGGCCCHHHH
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHH-------------hhhh------hhHHHHHHHHHHH
Confidence 34478999999999999999999985 578999999875221 1110 1122346679999
Q ss_pred HhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 103 MSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 103 l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
++++ +||||+++++++...+.+|+||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||
T Consensus 112 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~ 183 (355)
T 1vzo_A 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--------ERFTEHEVQIYVGEIVLALEHLHKLGIIYR 183 (355)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 9999 7999999999999999999999999999999999753 568999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc-CCCCcchhHHHHHHHHHHHHhCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DIwSlG~il~elltG~ 260 (520)
||||+|||++.++.+||+|||++..+.... .......+||+.|+|||++.+. ..++.++|||||||++|+|+||.
T Consensus 184 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~ 259 (355)
T 1vzo_A 184 DIKLENILLDSNGHVVLTDFGLSKEFVADE----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259 (355)
T ss_dssp CCCGGGEEECTTSCEEESCSSEEEECCGGG----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred CCCHHHEEECCCCcEEEeeCCCCeecccCC----CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 999999999999999999999998654221 1223456899999999999753 34789999999999999999999
Q ss_pred CCCCCCc----HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccc
Q psy11359 261 APYHKYP----AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAK 331 (520)
Q Consensus 261 ~Pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~ 331 (520)
.||.... ............++ .+ ..++..+.+||.+||++||.+|| |+.|+++||||+...
T Consensus 260 ~pf~~~~~~~~~~~~~~~~~~~~~~-~~---------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 260 SPFTVDGEKNSQAEISRRILKSEPP-YP---------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp CTTSCTTSCCCHHHHHHHHHHCCCC-CC---------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CCCccCCccchHHHHHHHHhccCCC-CC---------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 9996432 22333333333222 11 34678899999999999999999 999999999999776
Q ss_pred hhh
Q psy11359 332 DKK 334 (520)
Q Consensus 332 ~~~ 334 (520)
+..
T Consensus 330 ~~~ 332 (355)
T 1vzo_A 330 WDD 332 (355)
T ss_dssp HHH
T ss_pred hhH
Confidence 543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=391.62 Aligned_cols=287 Identities=24% Similarity=0.338 Sum_probs=208.6
Q ss_pred ccccCCCCCCCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccch
Q psy11359 11 IMAASSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90 (520)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~ 90 (520)
+|+.++............++|++.+.||+|+||+||+|.+..+|+.||+|++... .
T Consensus 5 ~~s~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------------------~ 60 (360)
T 3e3p_A 5 MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------------------------P 60 (360)
T ss_dssp -------CBSSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC------------------------T
T ss_pred ccccccccChhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC------------------------c
Confidence 3444444443333445668999999999999999999999999999999976421 1
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEEEEECCE-------EEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHH
Q psy11359 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE-------LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVL 163 (520)
Q Consensus 91 ~~~~~l~~Ei~~l~~l~HpnIv~~~~~~~~~~~-------~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~ 163 (520)
.......++++.++.++||||+++++++..... +++||||+.+ +|.+.+..... ....+++..++.++
T Consensus 61 ~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~~~ 135 (360)
T 3e3p_A 61 RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYR----RQVAPPPILIKVFL 135 (360)
T ss_dssp TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHT----TTCCCCHHHHHHHH
T ss_pred cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhh----cccCCCHHHHHHHH
Confidence 112246678888899999999999999976433 8999999975 66666554322 45678999999999
Q ss_pred HHHHHHHHHHH--HCCcEecccCCCcEEEcC-CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCC
Q psy11359 164 REVLKGLEYFH--SNGQIHRDIKAGNILLGE-DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGY 240 (520)
Q Consensus 164 ~qIl~gL~yLH--~~giiHrDLKp~NILl~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 240 (520)
.||+.||.||| ++||+||||||+|||++. ++.+||+|||++..+.... ......||+.|+|||++.+...+
T Consensus 136 ~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~ 209 (360)
T 3e3p_A 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE------PNVAYICSRYYRAPELIFGNQHY 209 (360)
T ss_dssp HHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS------CCCSTTSCGGGCCHHHHTTCSSC
T ss_pred HHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC------CcccccCCcceeCHHHHcCCCCC
Confidence 99999999999 999999999999999986 8999999999998764322 22356789999999999776668
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC------------CC------Cchhhh----hHHHhcH
Q psy11359 241 DFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTL------------DT------GAAEKD----QYKAYGK 298 (520)
Q Consensus 241 ~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------------~~------~~~~~~----~~~~~~~ 298 (520)
+.++|||||||++|+|+||..||........+..+........ .. ...... ....+++
T Consensus 210 ~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (360)
T 3e3p_A 210 TTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAK 289 (360)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHH
T ss_pred CcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccH
Confidence 9999999999999999999999998877666655443110000 00 000000 0112567
Q ss_pred HHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 299 TFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 299 ~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
.+.+||.+||++||.+|||+.|+|+||||+....
T Consensus 290 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 290 EAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 8999999999999999999999999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=392.50 Aligned_cols=262 Identities=22% Similarity=0.394 Sum_probs=208.2
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+.. ++.||+|+++.... .....+.+.+|+.+|++|
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~---------------------~~~~~~~~~~Ei~~l~~l 111 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA---------------------DNQTLDSYRNEIAYLNKL 111 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC---------------------CHHHHHHHHHHHHHHHHH
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc---------------------cHHHHHHHHHHHHHHHHc
Confidence 34569999999999999999999875 88888887753211 133467799999999999
Q ss_pred C--CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 107 H--HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 107 ~--HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
. ||||+++++++...+.+|+||| +.+++|.+++.. .+.+++..++.++.||+.||.|||++||+|||||
T Consensus 112 ~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlk 182 (390)
T 2zmd_A 112 QQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK--------KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182 (390)
T ss_dssp TTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH--------CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCC
T ss_pred ccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 6 5999999999999999999999 558899999984 3578899999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc----------CCCCcchhHHHHHHHHH
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD----------HGYDFKADIWSLGITAI 254 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------~~~~~~~DIwSlG~il~ 254 (520)
|+|||++ ++.+||+|||++..+..... .......+||+.|+|||++.+. ..|+.++|||||||++|
T Consensus 183 p~NIll~-~~~~kl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ 258 (390)
T 2zmd_A 183 PANFLIV-DGMLKLIDFGIANQMQPDTT---SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258 (390)
T ss_dssp GGGEEES-SSCEEECCCSSSCCC------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHH
T ss_pred HHHEEEE-CCeEEEEecCccccccCCCc---cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHH
Confidence 9999995 68999999999987643221 1123456899999999998641 24899999999999999
Q ss_pred HHHhCCCCCCCCcHH-HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 255 EMATGTAPYHKYPAM-KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 255 elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
+|++|..||...... ..+...+..... ... ....+..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 259 ell~G~~Pf~~~~~~~~~~~~~~~~~~~-~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 259 YMTYGKTPFQQIINQISKLHAIIDPNHE-IEF-------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHSSCTTTTCCCHHHHHHHHHCTTSC-CCC-------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHCCCcchhhhHHHHHHHHHhCcccc-CCC-------CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 999999999875433 333333332211 110 122367899999999999999999999999999998543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=378.96 Aligned_cols=272 Identities=23% Similarity=0.366 Sum_probs=213.6
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+|+.||+|++... .....+.+.+|+.++++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------------~~~~~~~~~~e~~~l~~ 64 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----------------------DPQSVKHALREIKIIRR 64 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----------------------SHHHHHHHHHHHHHHHT
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----------------------ChHHHHHHHHHHHHHHh
Confidence 3568899999999999999999999999999998876421 12345678999999999
Q ss_pred CCCCCceEEEEEEE--------------ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHH
Q psy11359 106 CHHENVVTYHTSFV--------------VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLE 171 (520)
Q Consensus 106 l~HpnIv~~~~~~~--------------~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~ 171 (520)
++||||+++++++. ....+|+||||+. |+|.+++. .+.+++..++.++.||+.||.
T Consensus 65 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---------~~~~~~~~~~~~~~qi~~~l~ 134 (320)
T 2i6l_A 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE---------QGPLLEEHARLFMYQLLRGLK 134 (320)
T ss_dssp CCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT---------TCCCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh---------cCCccHHHHHHHHHHHHHHHH
Confidence 99999999999873 3468999999997 69999984 357899999999999999999
Q ss_pred HHHHCCcEecccCCCcEEEc-CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHH
Q psy11359 172 YFHSNGQIHRDIKAGNILLG-EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG 250 (520)
Q Consensus 172 yLH~~giiHrDLKp~NILl~-~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG 250 (520)
|||++||+||||||+|||++ .++.+||+|||++..+..... .........||+.|+|||++.+...++.++||||||
T Consensus 135 ~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 212 (320)
T 2i6l_A 135 YIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS--HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212 (320)
T ss_dssp HHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHH
T ss_pred HHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcc--cccccccccccccccCcHHhcCcccCCchhhhHhHH
Confidence 99999999999999999996 567999999999986643211 112233457899999999987655699999999999
Q ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCC--------------------CchhhhhHHHhcHHHHHHHHhhhcc
Q psy11359 251 ITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDT--------------------GAAEKDQYKAYGKTFRKMISDCLQK 310 (520)
Q Consensus 251 ~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~li~~~L~~ 310 (520)
|++|+|+||..||...........+....+..... ..........++..+.+||.+||+.
T Consensus 213 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 292 (320)
T 2i6l_A 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTF 292 (320)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCC
Confidence 99999999999999888776665554433221100 0001122345789999999999999
Q ss_pred CCCCCCCHHHHhcCccccccch
Q psy11359 311 DPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 311 dP~~Rpta~elL~hp~~~~~~~ 332 (520)
||.+|||+.|+|+||||+....
T Consensus 293 dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 293 SPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp SGGGSCCHHHHHTSHHHHTTCC
T ss_pred CccccCCHHHHhCCcccccccC
Confidence 9999999999999999986543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=379.37 Aligned_cols=260 Identities=22% Similarity=0.364 Sum_probs=216.4
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCce---EEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEK---CAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKE 99 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~---vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~E 99 (520)
.+....++|++.+.||+|+||+||+|.+..++.. ||+|+++ ........+.+.+|
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~----------------------~~~~~~~~~~~~~E 100 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK----------------------AGYTERQRRDFLSE 100 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEEC----------------------TTCCHHHHHHHHHH
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecC----------------------CCCCHHHHHHHHHH
Confidence 4456778999999999999999999999876543 6776653 22223456679999
Q ss_pred HHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 100 IQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 100 i~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+.++++++||||+++++++...+..|+||||++|++|.++++. ..+.+++..+..++.||+.||.|||++||+
T Consensus 101 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 173 (325)
T 3kul_A 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-------HDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173 (325)
T ss_dssp HHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT-------TTTCSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh-------cccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 9999999999999999999999999999999999999999974 346799999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT- 258 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt- 258 (520)
||||||+|||++.++.+||+|||++..+...... ........+|+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 174 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~ 250 (325)
T 3kul_A 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA--AYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAY 250 (325)
T ss_dssp CSCCSGGGEEECTTCCEEECCCSSCEECC----C--CEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCcceEEECCCCCEEECCCCcccccccCccc--eeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcC
Confidence 9999999999999999999999999876543221 11223345688999999997665 8999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|..||....................+ ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 251 g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 251 GERPYWNMTNRDVISSVEEGYRLPAP---------MGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp SCCTTTTSCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHcCCCCCCC---------CCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999998888777766655433322 356789999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=374.25 Aligned_cols=265 Identities=23% Similarity=0.391 Sum_probs=217.8
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||.||+|.+..+++.||+|+++...... .....+.+.+|+.++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-------------------~~~~~~~~~~E~~~l~~l~ 64 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-------------------IPNGEANVKKEIQLLRRLR 64 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH-------------------STTHHHHHHHHHHHHTTCC
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc-------------------cchhHHHHHHHHHHHHhcC
Confidence 578999999999999999999999999999999886532211 1234567899999999999
Q ss_pred CCCceEEEEEEE--ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 108 HENVVTYHTSFV--VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 108 HpnIv~~~~~~~--~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
||||+++++++. ....+|+||||+.++ |.+++... ..+.+++..+..++.||+.||.|||++|++||||||
T Consensus 65 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp 137 (305)
T 2wtk_C 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV------PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKP 137 (305)
T ss_dssp CTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHS------TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred CCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhC------cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCc
Confidence 999999999984 456799999999766 88887653 456799999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH-GYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
+|||++.++.+||+|||++..+.... .........||+.|+|||++.+.. .++.++|||||||++|+|++|..||.
T Consensus 138 ~NIl~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (305)
T 2wtk_C 138 GNLLLTTGGTLKISALGVAEALHPFA---ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214 (305)
T ss_dssp GGEEECTTCCEEECCCTTCEECCTTC---SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccEEEcCCCcEEeeccccccccCccc---cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999998764322 112233567999999999987543 24789999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
..........+...... +. ..+++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 215 ~~~~~~~~~~i~~~~~~-~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 215 GDNIYKLFENIGKGSYA-IP---------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp CSSHHHHHHHHHHCCCC-CC---------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred CchHHHHHHHHhcCCCC-CC---------CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 87776666555544322 11 24678899999999999999999999999999998654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=380.38 Aligned_cols=274 Identities=25% Similarity=0.379 Sum_probs=218.0
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+|+.||+|+++. .........+.+|+.++++
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------------------~~~~~~~~~~~~E~~~l~~ 65 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----------------------FDKPLFALRTLREIKILKH 65 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----------------------CSSHHHHHHHHHHHHHHHH
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc----------------------cccchHHHHHHHHHHHHHh
Confidence 456899999999999999999999999988888887642 1113345568899999999
Q ss_pred CCCCCceEEEEEEEEC-----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 106 CHHENVVTYHTSFVVK-----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~-----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
++||||+++++++... ...|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+|
T Consensus 66 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH 135 (353)
T 2b9h_A 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST---------QMLSDDHIQYFIYQTLRAVKVLHGSNVIH 135 (353)
T ss_dssp CCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 9999999999988754 67999999996 699999864 46899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccc-----cccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSR-----QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
|||||+|||++.++.+||+|||++..+........ .......+||+.|+|||++.+...++.++|||||||++|+
T Consensus 136 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 215 (353)
T 2b9h_A 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215 (353)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHH
Confidence 99999999999999999999999987643221111 1112346899999999998765568999999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhc--CCCCCCC--------------------CCchhhhhHHHhcHHHHHHHHhhhccCCC
Q psy11359 256 MATGTAPYHKYPAMKVLMLTLQ--NDPPTLD--------------------TGAAEKDQYKAYGKTFRKMISDCLQKDPT 313 (520)
Q Consensus 256 lltG~~Pf~~~~~~~~~~~~~~--~~~~~~~--------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 313 (520)
|++|.+||.+......+..... +.+.... ........+..+++.+.+||.+||+.||.
T Consensus 216 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 295 (353)
T 2b9h_A 216 LFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295 (353)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGG
T ss_pred HHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcc
Confidence 9999999998876655543321 1111000 00011222346789999999999999999
Q ss_pred CCCCHHHHhcCccccccc
Q psy11359 314 KRPTASELLKNPFFKKAK 331 (520)
Q Consensus 314 ~Rpta~elL~hp~~~~~~ 331 (520)
+|||+.|+|+||||+...
T Consensus 296 ~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 296 KRITAKEALEHPYLQTYH 313 (353)
T ss_dssp GSCCHHHHHTSGGGTTTC
T ss_pred cCCCHHHHhcCccccccC
Confidence 999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=377.54 Aligned_cols=268 Identities=22% Similarity=0.377 Sum_probs=215.5
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.++||+|+||+||+|.+..+|+.||+|+++... .....+.+.+|+.++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~~E~~~l~~ 63 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----------------------FLRPVDVQMREFEVLKK 63 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----------------------GGSCHHHHHHHHHHHHH
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc----------------------ccchHHHHHHHHHHHHh
Confidence 45788999999999999999999999999999999875321 12335668899999999
Q ss_pred CCCCCceEEEEEEEECC--EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 106 CHHENVVTYHTSFVVKD--ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~--~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++||||+++++++.... .+|+||||+.|++|.+++..... ...+++..++.++.||+.||.|||++||+||||
T Consensus 64 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl 138 (319)
T 4euu_A 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-----AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138 (319)
T ss_dssp CCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGG-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCC
Confidence 99999999999998755 78999999999999999985321 234899999999999999999999999999999
Q ss_pred CCCcEEE----cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc-------cCCCCcchhHHHHHHH
Q psy11359 184 KAGNILL----GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ-------DHGYDFKADIWSLGIT 252 (520)
Q Consensus 184 Kp~NILl----~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~~~~~~DIwSlG~i 252 (520)
||+|||+ +.++.+||+|||++..+.... ......||+.|+|||++.. ...++.++|||||||+
T Consensus 139 kp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i 212 (319)
T 4euu_A 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDE------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (319)
T ss_dssp SGGGEEEEECTTSCEEEEECCCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHH
T ss_pred CHHHEEEeccCCCCceEEEccCCCceecCCCC------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHH
Confidence 9999999 777889999999998764332 2234679999999999862 2448999999999999
Q ss_pred HHHHHhCCCCCCCCc----HHHHHHHHhcCCCCCCCCCc---------------hhhhhHHHhcHHHHHHHHhhhccCCC
Q psy11359 253 AIEMATGTAPYHKYP----AMKVLMLTLQNDPPTLDTGA---------------AEKDQYKAYGKTFRKMISDCLQKDPT 313 (520)
Q Consensus 253 l~elltG~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~li~~~L~~dP~ 313 (520)
+|+|+||..||.... ....+...+...++...... ........++..+.+||.+||+.||+
T Consensus 213 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 292 (319)
T 4euu_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292 (319)
T ss_dssp HHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTT
T ss_pred HHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChh
Confidence 999999999996432 23444444444432211100 00122356778899999999999999
Q ss_pred CCCCHHHHhcCcc
Q psy11359 314 KRPTASELLKNPF 326 (520)
Q Consensus 314 ~Rpta~elL~hp~ 326 (520)
+|||++|+|+||-
T Consensus 293 ~R~s~~ell~h~~ 305 (319)
T 4euu_A 293 KCWGFDQFFAETS 305 (319)
T ss_dssp TSCCHHHHHHHHH
T ss_pred hhccHHHhhhccH
Confidence 9999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=400.57 Aligned_cols=265 Identities=14% Similarity=0.159 Sum_probs=206.6
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH-
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI- 100 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei- 100 (520)
..|....++|++.+.||+|+||+||+|.+..+|+.||+|+++.... ......+.+.+|+
T Consensus 66 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--------------------~~~~~~~~~~~E~~ 125 (377)
T 3byv_A 66 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--------------------PPSNAIKQMKEEVL 125 (377)
T ss_dssp ESSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC---------------------CCTTHHHHHHHHHH
T ss_pred eecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc--------------------cchHHHHHHHHHHH
Confidence 3456667899999999999999999999999999999998753211 1123456789999
Q ss_pred --HHHhcCCCCCceEEE-------EEEEECC-----------------EEEEEEEccCCCCHHHHHHHhhccccCCCCCC
Q psy11359 101 --QAMSSCHHENVVTYH-------TSFVVKD-----------------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVC 154 (520)
Q Consensus 101 --~~l~~l~HpnIv~~~-------~~~~~~~-----------------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l 154 (520)
+++++++|||||+++ +++...+ ..|+||||+ +|+|.+++........ ....+
T Consensus 126 ~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~-~~~~l 203 (377)
T 3byv_A 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS-THKSL 203 (377)
T ss_dssp GGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT-TTHHH
T ss_pred HHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc-ccccc
Confidence 556666899999988 7766553 289999999 6899999986533221 12234
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCccee
Q psy11359 155 DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVM 234 (520)
Q Consensus 155 ~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~ 234 (520)
++..+..|+.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... ......+| +.|+|||++
T Consensus 204 ~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~--------~~~~~~~g-~~y~aPE~~ 274 (377)
T 3byv_A 204 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--------ARVVSSVS-RGFEPPELE 274 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT--------CEEECCCC-TTCCCHHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecC--------CcccCCCC-cCccChhhh
Confidence 458888999999999999999999999999999999999999999999987532 12345678 999999999
Q ss_pred ccc----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHH
Q psy11359 235 EQD----------HGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMI 304 (520)
Q Consensus 235 ~~~----------~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 304 (520)
.+. ..|+.++|||||||++|+|+||..||............. .....+++.+.+||
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~--------------~~~~~~~~~~~~li 340 (377)
T 3byv_A 275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF--------------RSCKNIPQPVRALL 340 (377)
T ss_dssp HHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG--------------SSCCCCCHHHHHHH
T ss_pred cccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh--------------hhccCCCHHHHHHH
Confidence 876 238999999999999999999999997644322111111 11245688999999
Q ss_pred HhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 305 SDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 305 ~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
.+||+.||.+|||+.|+++||||+...
T Consensus 341 ~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 341 EGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 999999999999999999999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=377.99 Aligned_cols=265 Identities=26% Similarity=0.347 Sum_probs=212.3
Q ss_pred CCCCeEEEeeeeecCceEEEEEEE-cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYC-KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~-~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
..++|++.+.||+|+||+||+|.+ ..+++.||+|+++.. ....+.+.+|+.+++.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------------------------~~~~~~~~~e~~~l~~ 67 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------------------------DRYCEAARSEIQVLEH 67 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------------------------HHHHHHHHHHHHHHHH
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------------------------CchhHHHHHHHHHHHH
Confidence 457999999999999999999999 567888888876421 2234567889999888
Q ss_pred CCCC------CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 106 CHHE------NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 106 l~Hp------nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
++|+ +|+++++++...+.+++||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+
T Consensus 68 l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 140 (339)
T 1z57_A 68 LNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN------GFLPFRLDHIRKMAYQICKSVNFLHSNKLT 140 (339)
T ss_dssp HHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhc------CCCCCcHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 8765 4999999999999999999999 89999999863 334689999999999999999999999999
Q ss_pred ecccCCCcEEEcC-------------------CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCC
Q psy11359 180 HRDIKAGNILLGE-------------------DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGY 240 (520)
Q Consensus 180 HrDLKp~NILl~~-------------------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 240 (520)
||||||+|||++. ++.+||+|||++..... ......||+.|+|||++.+.. +
T Consensus 141 H~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~-~ 211 (339)
T 1z57_A 141 HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--------HHSTLVSTRHYRAPEVILALG-W 211 (339)
T ss_dssp CCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--------CCCSSCSCGGGCCHHHHTTSC-C
T ss_pred CCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc--------ccccccCCccccChHHhhCCC-C
Confidence 9999999999987 67899999999876422 123468999999999997655 8
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC--------------------CCCchh-----------
Q psy11359 241 DFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTL--------------------DTGAAE----------- 289 (520)
Q Consensus 241 ~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~----------- 289 (520)
+.++|||||||++|+|++|..||......+..........+.. ......
T Consensus 212 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (339)
T 1z57_A 212 SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPL 291 (339)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG
T ss_pred CcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcch
Confidence 9999999999999999999999988776654433221110000 000000
Q ss_pred ---hhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 290 ---KDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 290 ---~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
.......++.+.+||.+||+.||.+|||+.|+++||||+..+
T Consensus 292 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 292 KEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred hhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 000123467899999999999999999999999999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=367.91 Aligned_cols=256 Identities=24% Similarity=0.440 Sum_probs=216.8
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.|....++|++.+.||+|+||+||+|.+.. +..||+|++... ....+++.+|+.+
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~------------------------~~~~~~~~~E~~~ 58 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG------------------------AMSEEDFIEEAEV 58 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTT------------------------SBCHHHHHHHHHH
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccc------------------------ccCHHHHHHHHHH
Confidence 467788999999999999999999999874 566777776422 1234568999999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
+++++||||+++++++.+....++||||+++++|.+++.. ..+.+++..+..++.||+.||.|||++|++|||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~d 131 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-------QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 131 (269)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT-------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh-------cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999999999999999999999999999975 356789999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTA 261 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~ 261 (520)
|||+||+++.++.+||+|||++....... ........||+.|+|||++.+.. ++.++||||||+++|+|++ |..
T Consensus 132 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~ 206 (269)
T 4hcu_A 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKI 206 (269)
T ss_dssp CCGGGEEECGGGCEEECCTTGGGGBCCHH----HHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cchheEEEcCCCCEEeccccccccccccc----cccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCC
Confidence 99999999999999999999997653321 11223456788999999997665 8999999999999999999 999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
||....................+ ..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 207 PYENRSNSEVVEDISTGFRLYKP---------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TTTTCCHHHHHHHHHTTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHhcCccCCCC---------CcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99988887777666655333322 3457889999999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=384.50 Aligned_cols=278 Identities=23% Similarity=0.365 Sum_probs=212.7
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+.. |..||+|++........ ...........+.+.+|+.+++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~------------~~~~~~~~~~~~~~~~E~~~l~~l 86 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGR------------TVNILSDSFLCKRVLREIRLLNHF 86 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTS------------CEEGGGSHHHHHHHHHHHHHHHHC
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccc------------hhhhhhhhhHHHHHHHHHHHHHhC
Confidence 46789999999999999999999866 89999998753211100 000111133457899999999999
Q ss_pred CCCCceEEEEEEEEC-----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 107 HHENVVTYHTSFVVK-----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~-----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+||||+++++++... ..+|+||||+. |+|.+++.. ....+++..++.++.||+.||.|||++||+||
T Consensus 87 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 158 (362)
T 3pg1_A 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-------QRIVISPQHIQYFMYHILLGLHVLHEAGVVHR 158 (362)
T ss_dssp CCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-------TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred CCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-------cccCCCHHHHHHHHHHHHHHHHHHHHCcCEec
Confidence 999999999998653 36899999996 689998874 45579999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||++.++.+||+|||++...... .......||+.|+|||++.+...++.++|||||||++|+|++|..
T Consensus 159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 159 DLHPGNILLADNNDITICDFNLAREDTAD------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp CCCGGGEEECTTCCEEECCTTC---------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCChHHEEEcCCCCEEEEecCcccccccc------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 99999999999999999999998754322 223346799999999999875569999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCC-----------------------CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCH
Q psy11359 262 PYHKYPAMKVLMLTLQND-----------------------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA 318 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta 318 (520)
||.+......+....... ..... ..........+++.+.+||.+||+.||.+|||+
T Consensus 233 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 311 (362)
T 3pg1_A 233 LFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP-ARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311 (362)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCC-CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCC-hhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence 999877665554433210 00000 111122234568889999999999999999999
Q ss_pred HHHhcCccccccch
Q psy11359 319 SELLKNPFFKKAKD 332 (520)
Q Consensus 319 ~elL~hp~~~~~~~ 332 (520)
.|+|+||||+....
T Consensus 312 ~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 312 EQALRHPYFESLFD 325 (362)
T ss_dssp HHHHTSGGGTTTCC
T ss_pred HHHHcCchhhhccC
Confidence 99999999987644
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=371.20 Aligned_cols=261 Identities=26% Similarity=0.453 Sum_probs=220.9
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.+..+++.||+|+++.... .....+.+.+|+.++++++
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~ 79 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA---------------------KNKDTSTILREVELLKKLD 79 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB---------------------SSSCHHHHHHHHHHHHTCC
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc---------------------chHHHHHHHHHHHHHHhcc
Confidence 4689999999999999999999999999999998753211 1234567899999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
||||+++++++...+.+|+||||+.+++|.+++... +.+++..+..++.||+.||.|||++|++||||||+|
T Consensus 80 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~N 151 (287)
T 2wei_A 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPEN 151 (287)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred CCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhh
Confidence 999999999999999999999999999999998743 468999999999999999999999999999999999
Q ss_pred EEEcCC---CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 188 ILLGED---GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 188 ILl~~~---g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+++.+ +.+||+|||++....... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.
T Consensus 152 Ilv~~~~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 152 ILLESKEKDCDIKIIDFGLSTCFQQNT------KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp EEESCSSTTCCEEECSTTGGGTBCCCS------SCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEEecCCCcccEEEeccCcceeecCCC------ccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCC
Confidence 999653 479999999987654322 12345689999999998764 8999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
................... ...+..+++.+.+||.+||++||.+|||+.|+|+||||+...
T Consensus 224 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 224 GKNEYDILKRVETGKYAFD------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp CSSHHHHHHHHHHCCCCCC------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred CCCHHHHHHHHHcCCCCCC------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 8887776665555432211 122356788999999999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=384.25 Aligned_cols=266 Identities=23% Similarity=0.403 Sum_probs=217.4
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcC-------CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKA-------RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDEL 96 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l 96 (520)
|....++|++.+.||+|+||+||+|.+.. ++..||+|++ .........+.+
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~----------------------~~~~~~~~~~~~ 133 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML----------------------KDDATEKDLSDL 133 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEEC----------------------CTTCBHHHHHHH
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEe----------------------cCCcCHHHHHHH
Confidence 45567899999999999999999998753 3334555554 333334456789
Q ss_pred HHHHHHHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc--------ccCCCCCCCHHHHHHHHHHHH
Q psy11359 97 LKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI--------SNCKHGVCDEPTIATVLREVL 167 (520)
Q Consensus 97 ~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~--------~~~~~~~l~~~~i~~i~~qIl 167 (520)
.+|+.+|+++ +||||+++++++...+.+|+||||+.||+|.+++...... .......+++..+..++.||+
T Consensus 134 ~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 213 (370)
T 2psq_A 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 213 (370)
T ss_dssp HHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHH
Confidence 9999999999 8999999999999999999999999999999999864211 001234689999999999999
Q ss_pred HHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHH
Q psy11359 168 KGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIW 247 (520)
Q Consensus 168 ~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIw 247 (520)
.||.|||++||+||||||+|||++.+|.+||+|||++..+...... .......||+.|+|||++.+.. |+.++|||
T Consensus 214 ~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvw 289 (370)
T 2psq_A 214 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEALFDRV-YTHQSDVW 289 (370)
T ss_dssp HHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTT---CTTTTTTSCGGGCCHHHHHTCC-CCHHHHHH
T ss_pred HHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccce---ecccCCCcccceECHhHhcCCC-CCcHHHHH
Confidence 9999999999999999999999999999999999999866432211 1223456789999999997665 99999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 248 SLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 248 SlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
||||++|+|+| |..||.+.+..+.......+.....+ ..++..+.+||.+||+.||.+|||+.|++++
T Consensus 290 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 290 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 99999988777666655555433332 3467889999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=389.18 Aligned_cols=262 Identities=27% Similarity=0.415 Sum_probs=207.7
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.++||+|+||+||+|.+..+++.||+|+++.. ....+.+.+|+.+++.++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------------------~~~~~~~~~E~~~l~~l~ 91 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------------------------EHYTETALDEIRLLKSVR 91 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------------------------HHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------------------------CcchHHHHHHHHHHHHHh
Confidence 57899999999999999999999999999999987421 223456889999999885
Q ss_pred --------CCCceEEEEEEE----ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11359 108 --------HENVVTYHTSFV----VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS 175 (520)
Q Consensus 108 --------HpnIv~~~~~~~----~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~ 175 (520)
||||+++++++. ....+|+||||+ +++|.+++... ..+.+++..++.++.||+.||.|||+
T Consensus 92 ~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~------~~~~~~~~~~~~i~~qi~~aL~~lH~ 164 (397)
T 1wak_A 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS------NYQGLPLPCVKKIIQQVLQGLDYLHT 164 (397)
T ss_dssp HSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT------TTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhc------ccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 788999999998 456799999999 67888877653 34679999999999999999999999
Q ss_pred C-CcEecccCCCcEEEcCCC-------------------------------------------------CeEEeccCcce
Q psy11359 176 N-GQIHRDIKAGNILLGEDG-------------------------------------------------TVQIADFGVSA 205 (520)
Q Consensus 176 ~-giiHrDLKp~NILl~~~g-------------------------------------------------~vkL~DFG~a~ 205 (520)
+ ||+||||||+|||++.++ .+||+|||++.
T Consensus 165 ~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~ 244 (397)
T 1wak_A 165 KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC 244 (397)
T ss_dssp TTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCE
T ss_pred hCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccc
Confidence 9 999999999999998775 79999999997
Q ss_pred eeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc------HHHHHHH---Hh
Q psy11359 206 WLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP------AMKVLML---TL 276 (520)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~------~~~~~~~---~~ 276 (520)
..... ....+||+.|+|||++.+.. |+.++|||||||++|+|+||..||.... ....+.. .+
T Consensus 245 ~~~~~--------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 315 (397)
T 1wak_A 245 WVHKH--------FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315 (397)
T ss_dssp ETTBC--------SCSCCSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHH
T ss_pred ccccc--------CccCCCCCcccCChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhc
Confidence 75321 23457999999999998765 8999999999999999999999997543 1222211 11
Q ss_pred cCCCCC--------------------CC----CCch-----hhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 277 QNDPPT--------------------LD----TGAA-----EKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 277 ~~~~~~--------------------~~----~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
...+.. +. .... ........++.+.+||.+||++||.+|||+.|+|+||||
T Consensus 316 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 395 (397)
T 1wak_A 316 GKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395 (397)
T ss_dssp CSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred CCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence 111000 00 0000 000123456789999999999999999999999999999
Q ss_pred cc
Q psy11359 328 KK 329 (520)
Q Consensus 328 ~~ 329 (520)
+.
T Consensus 396 ~~ 397 (397)
T 1wak_A 396 NS 397 (397)
T ss_dssp GC
T ss_pred cC
Confidence 63
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=374.59 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=205.5
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.|....++|++.+.||+|+||+||+|.+ +|+.||+|++.... ......+++.+|+.+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~---------------------~~~~~~~~~~~E~~~ 87 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD---------------------FHAERVNEFLREVAI 87 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC---------------------CSHHHHHHHHHHHHH
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC---------------------CCHHHHHHHHHHHHH
Confidence 3556778999999999999999999976 46778888764221 112345678999999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEe
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG--QIH 180 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g--iiH 180 (520)
+++++||||+++++++.....+++||||+.|++|.+++..... ...+++..+..++.||+.||.|||++| |+|
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH 162 (309)
T 3p86_A 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-----REQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162 (309)
T ss_dssp HHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTH-----HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCC
T ss_pred HHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEC
Confidence 9999999999999999999999999999999999999974211 123899999999999999999999999 999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|+||.
T Consensus 163 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~ 236 (309)
T 3p86_A 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-----LSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQ 236 (309)
T ss_dssp TTCCGGGEEECTTCCEEECCCC----------------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCC
T ss_pred CCCChhhEEEeCCCcEEECCCCCCccccccc-----cccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999987543221 1233568999999999998765 899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCC-CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 261 APYHKYPAMKVLMLTLQND-PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.||................ ...++ ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 237 ~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 237 QPWGNLNPAQVVAAVGFKCKRLEIP---------RNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCCC---------ccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999888776665543222 22221 357889999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=379.47 Aligned_cols=260 Identities=24% Similarity=0.371 Sum_probs=208.9
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+++.+++| +|+|.+.........+++.+|+.++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~------------------vaiK~~~~~~~~~~~~~~~~E~~~l~~ 73 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP------------------VAIKELREATSPKANKEILDEAYVMAS 73 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEE------------------EEEEEC-------CHHHHHHHHHHHHH
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEE------------------EEEeecccccCHHHHHHHHHHHHHHHh
Confidence 46688999999999999999999999888877555 345555443334556789999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++.... .++|++|+.+|+|.+++.. ..+.+++..+..|+.||+.||.|||++||+||||||
T Consensus 74 l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp 145 (327)
T 3poz_A 74 VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE-------HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145 (327)
T ss_dssp CCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH-------STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred CCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCh
Confidence 99999999999998654 7899999999999999976 356799999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYH 264 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~ 264 (520)
+|||++.++.+||+|||++..+..... ........||+.|+|||++.+.. ++.++|||||||++|+|+| |..||.
T Consensus 146 ~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~ 221 (327)
T 3poz_A 146 RNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp GGEEEEETTEEEECCTTHHHHHTTTCC----------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred heEEECCCCCEEEccCcceeEccCCcc---cccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCcc
Confidence 999999999999999999987643322 11223456788999999998765 8999999999999999999 999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
.................... ..++..+.+++.+||+.||.+|||+.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 222 GIPASEISSILEKGERLPQP---------PICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TCCGGGHHHHHHTTCCCCCC---------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCC---------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 87776665555444332222 3467789999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=385.42 Aligned_cols=265 Identities=28% Similarity=0.401 Sum_probs=213.5
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.+
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~~E~~~l~~l 98 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---------------------SEIFAKRAYRELLLLKHM 98 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS---------------------SHHHHHHHHHHHHHHHHC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc---------------------chhHHHHHHHHHHHHHhc
Confidence 34789999999999999999999999999999998753211 122456788999999999
Q ss_pred CCCCceEEEEEEEECCEE------EEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVKDEL------WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~------~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+||||+++++++...+.. |+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+|
T Consensus 99 ~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 167 (371)
T 4exu_A 99 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----------MEFSEEKIQYLVYQMLKGLKYIHSAGVVH 167 (371)
T ss_dssp CCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh----------cCCCHHHHHHHHHHHHHHHHHHHHCCCcC
Confidence 999999999999876654 99999996 68888763 34899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+|||++.++.+||+|||++..... .....+||+.|+|||++.+...++.++|||||||++|+|+||.
T Consensus 168 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 239 (371)
T 4exu_A 168 RDLKPGNLAVNEDCELKILDFGLARHADA--------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239 (371)
T ss_dssp SCCCGGGEEECTTCCEEECSTTCC----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CCcCHHHeEECCCCCEEEEecCccccccc--------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999875432 1235678999999999987556999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCC---------------------CCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTL---------------------DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 319 (520)
.||.+....+.+........... ............+++.+.+||.+||++||.+|||+.
T Consensus 240 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 319 (371)
T 4exu_A 240 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 319 (371)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHH
Confidence 99998877666554432111000 000011122345689999999999999999999999
Q ss_pred HHhcCccccccc
Q psy11359 320 ELLKNPFFKKAK 331 (520)
Q Consensus 320 elL~hp~~~~~~ 331 (520)
|+|+||||+...
T Consensus 320 ell~hp~f~~~~ 331 (371)
T 4exu_A 320 QALTHPFFEPFR 331 (371)
T ss_dssp HHHTSGGGTTTC
T ss_pred HHhcCcccccCC
Confidence 999999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=369.75 Aligned_cols=259 Identities=22% Similarity=0.383 Sum_probs=215.7
Q ss_pred CCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHH
Q psy11359 20 VSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKE 99 (520)
Q Consensus 20 ~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~E 99 (520)
....|....++|++.+.||+|+||+||+|.+. ++..||+|+++.. ....+++.+|
T Consensus 15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------------------------~~~~~~~~~E 69 (283)
T 3gen_A 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG------------------------SMSEDEFIEE 69 (283)
T ss_dssp -CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTT------------------------SBCHHHHHHH
T ss_pred CCCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCC------------------------CCCHHHHHHH
Confidence 34578889999999999999999999999876 5566777776422 1234568999
Q ss_pred HHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 100 IQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 100 i~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+.++++++||||+++++++...+.+|+||||+.+++|.+++.. ..+.+++..+..++.||+.||.|||++||+
T Consensus 70 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 142 (283)
T 3gen_A 70 AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-------MRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142 (283)
T ss_dssp HHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHC-------GGGCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHH-------hccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999999999999999975 235689999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT- 258 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt- 258 (520)
||||||+|||++.++.+||+|||++....... ........+|+.|+|||++.+.. ++.++||||||+++|+|+|
T Consensus 143 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~ 217 (283)
T 3gen_A 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSL 217 (283)
T ss_dssp CSSCSGGGEEECTTSCEEECSTTGGGGBCCHH----HHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTT
T ss_pred CCCCccceEEEcCCCCEEEccccccccccccc----cccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999997653321 11123345788999999998665 8999999999999999998
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|..||....................+ ..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 218 g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 218 GKMPYERFTNSETAEHIAQGLRLYRP---------HLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp TCCTTTTSCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccChhHHHHHHhcccCCCCC---------CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999988887777666655433322 3457889999999999999999999999976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=375.94 Aligned_cols=273 Identities=22% Similarity=0.353 Sum_probs=200.8
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCc---eEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAE---KCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
+....++|++.+.||+|+||+||+|.+..++. .||+|+++.... .....+.+.+|+
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~~E~ 76 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII---------------------ASSDIEEFLREA 76 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------------------------CHHHHHHHHHH
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc---------------------CHHHHHHHHHHH
Confidence 45677899999999999999999999887764 677776642210 123467799999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEE------EEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDEL------WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~------~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
.++++++||||+++++++...... ++||||+.+++|.+++....... ....+++..+..++.||+.||.|||
T Consensus 77 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~LH 154 (323)
T 3qup_A 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE--NPFNLPLQTLVRFMVDIACGMEYLS 154 (323)
T ss_dssp HHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccc--cccccCHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999877655 99999999999999997643211 2336899999999999999999999
Q ss_pred HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 175 ~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
++||+||||||+|||++.++.+||+|||++..+...... .......+|+.|+|||++.+.. ++.++|||||||++|
T Consensus 155 ~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ 230 (323)
T 3qup_A 155 SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY---RQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMW 230 (323)
T ss_dssp HTTCCCSCCSGGGEEECTTSCEEECCCCC--------------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHH
T ss_pred cCCcccCCCCcceEEEcCCCCEEEeeccccccccccccc---cccccccCcccccCchhhcCCC-CCCccchhhHHHHHH
Confidence 999999999999999999999999999999776433211 1123345788999999997765 899999999999999
Q ss_pred HHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-------HHHHhcCcc
Q psy11359 255 EMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-------ASELLKNPF 326 (520)
Q Consensus 255 ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------a~elL~hp~ 326 (520)
+|++ |..||..................... ..+++.+.+||.+||+.||.+||| +++++.|||
T Consensus 231 ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 231 EIMTRGQTPYAGIENAEIYNYLIGGNRLKQP---------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHhCCCCCccccChHHHHHHHhcCCCCCCC---------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 9999 99999988877777666655433332 356788999999999999999999 666778999
Q ss_pred ccccch
Q psy11359 327 FKKAKD 332 (520)
Q Consensus 327 ~~~~~~ 332 (520)
+.....
T Consensus 302 ~~~~~~ 307 (323)
T 3qup_A 302 VLSTSQ 307 (323)
T ss_dssp ------
T ss_pred hcCCCC
Confidence 976543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=391.82 Aligned_cols=273 Identities=13% Similarity=0.134 Sum_probs=196.9
Q ss_pred CCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 21 SVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 21 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
...|......|++.+.||+|+||+||+|.+..+|+.||+|+++..... .....+.+.+|+
T Consensus 54 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~~E~ 113 (371)
T 3q60_A 54 DSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN--------------------SRSELERLHEAT 113 (371)
T ss_dssp EETTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT--------------------HHHHHHHHHHHH
T ss_pred EecCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc--------------------cccHHHHHHHHH
Confidence 334555667799999999999999999999999999999988643211 123455677885
Q ss_pred H---HHhcCCCCCceEEE-------EEEEEC-----------------CEEEEEEEccCCCCHHHHHHHhhccccCCCCC
Q psy11359 101 Q---AMSSCHHENVVTYH-------TSFVVK-----------------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGV 153 (520)
Q Consensus 101 ~---~l~~l~HpnIv~~~-------~~~~~~-----------------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~ 153 (520)
. +|+. +||||++++ +++... ..+|+||||+. |+|.+++.... ..
T Consensus 114 ~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-------~~ 184 (371)
T 3q60_A 114 FAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-------FV 184 (371)
T ss_dssp HHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-------HS
T ss_pred HHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-------cc
Confidence 4 5555 799988865 555443 34899999998 89999998642 23
Q ss_pred CCHHHH------HHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccc
Q psy11359 154 CDEPTI------ATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPC 227 (520)
Q Consensus 154 l~~~~i------~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~ 227 (520)
+++..+ ..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ......||+.
T Consensus 185 ~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~t~~ 256 (371)
T 3q60_A 185 YVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT--------RGPASSVPVT 256 (371)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC--------EEEGGGSCGG
T ss_pred cchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCC--------CccCccCCcC
Confidence 344455 67779999999999999999999999999999999999999999976531 1114467799
Q ss_pred cCCcceecc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC-CCCCCCCCchhhhhHHHhcHHHHHHHH
Q psy11359 228 WMAPEVMEQ-DHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQN-DPPTLDTGAAEKDQYKAYGKTFRKMIS 305 (520)
Q Consensus 228 y~APE~~~~-~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~ 305 (520)
|+|||++.+ ...|+.++|||||||++|+|+||..||......... .... .................+++.+.+||.
T Consensus 257 y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 334 (371)
T 3q60_A 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG--SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG 334 (371)
T ss_dssp GCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT--CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHH
T ss_pred CcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc--chhhhhhhhccccccchhhccCCCHHHHHHHH
Confidence 999999975 134899999999999999999999999765322100 0000 000000000111122467899999999
Q ss_pred hhhccCCCCCCCHHHHhcCccccccch
Q psy11359 306 DCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 306 ~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
+||++||.+|||+.++|+||||+....
T Consensus 335 ~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 335 RFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp HHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred HHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 999999999999999999999987644
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=364.01 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=215.9
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.+.||+|+||+||+|.+. ++..||+|+++.. ....+++.+|+.++
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------------------------~~~~~~~~~E~~~l 57 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEG------------------------SMSEDEFFQEAQTM 57 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBT------------------------TBCHHHHHHHHHHH
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccC------------------------CCcHHHHHHHHHHH
Confidence 4567889999999999999999999776 4566777776421 12345689999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++++||||+++++++......++||||+++++|.+++... ...+++..+..++.||+.||.|||++|++||||
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di 130 (268)
T 3sxs_A 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-------GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDL 130 (268)
T ss_dssp HHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHH-------GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSC
T ss_pred HhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCc
Confidence 9999999999999999999999999999999999999763 345899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+|||++.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++||||||+++|+|+| |..|
T Consensus 131 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p 205 (268)
T 3sxs_A 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQY----VSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMP 205 (268)
T ss_dssp SGGGEEECTTCCEEECCTTCEEECCTTCE----EECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCT
T ss_pred CcceEEECCCCCEEEccCccceecchhhh----hcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999987643321 1123345678899999997655 8999999999999999999 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|....................+ ..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 206 YDLYTNSEVVLKVSQGHRLYRP---------HLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TTTSCHHHHHHHHHTTCCCCCC---------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccccChHHHHHHHHcCCCCCCC---------CcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9988887777666655443332 2357789999999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=386.53 Aligned_cols=270 Identities=21% Similarity=0.309 Sum_probs=220.2
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEE-----cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYC-----KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
+....++|++.+.||+|+||+||+|.. ..++..||+|+++ .........++.+
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~----------------------~~~~~~~~~~~~~ 123 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP----------------------EVCSEQDELDFLM 123 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECC----------------------SSCCHHHHHHHHH
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecc----------------------cccChhhHHHHHH
Confidence 345668899999999999999999994 4455566666553 2222344567889
Q ss_pred HHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
|+.++++++||||+++++++......|+||||+.||+|.+++........ ....+++..+..++.||+.||.|||++||
T Consensus 124 E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 202 (367)
T 3l9p_A 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS-QPSSLAMLDLLHVARDIACGCQYLEENHF 202 (367)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccC-ccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 99999999999999999999999999999999999999999987533211 33568999999999999999999999999
Q ss_pred EecccCCCcEEEcCCC---CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 179 IHRDIKAGNILLGEDG---TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 179 iHrDLKp~NILl~~~g---~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
+||||||+|||++.+| .+||+|||++..+..... ........||+.|+|||++.+.. ++.++|||||||++|+
T Consensus 203 vHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~e 278 (367)
T 3l9p_A 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWE 278 (367)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS---CTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHH
T ss_pred eCCCCChhhEEEecCCCCceEEECCCccccccccccc---cccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHH
Confidence 9999999999998555 599999999975532211 11223457899999999997665 9999999999999999
Q ss_pred HHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 256 MAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 256 llt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
|+| |..||......+.......+...... ..++..+.+||.+||+.||.+|||+.+++++.++..
T Consensus 279 llt~g~~pf~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 279 IFSLGYMPYPSKSNQEVLEFVTSGGRMDPP---------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 998 99999998888877776665443332 346788999999999999999999999999877643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=375.70 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=212.6
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+++.+++| +++|.+.........+.+.+|+.++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~k------------------v~iK~~~~~~~~~~~~~~~~E~~~l~~ 73 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP------------------VAIKELREATSPKANKEILDEAYVMAS 73 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEE------------------EEEEEECCCSSCCCHHHHHHHHHHHTT
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEE------------------EEEEeeccccCHHHHHHHHHHHHHHHh
Confidence 46788999999999999999999999998888776 355666554445567889999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++.... .++|++|+.+|+|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||
T Consensus 74 l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 145 (327)
T 3lzb_A 74 VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE-------HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145 (327)
T ss_dssp CCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH-------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred CCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCH
Confidence 99999999999998655 8899999999999999986 356799999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYH 264 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~ 264 (520)
+|||++.++.+||+|||++..+..... ........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.
T Consensus 146 ~NIl~~~~~~~kL~DfG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~ 221 (327)
T 3lzb_A 146 RNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp GGEEEEETTEEEECCTTC-------------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred HHEEEcCCCCEEEccCcceeEccCccc---cccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999987643321 11223446788999999998765 8999999999999999999 999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.................... ..++..+.+||.+||+.||.+|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 222 GIPASEISSILEKGERLPQP---------PICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp TCCGGGHHHHHHTTCCCCCC---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCC---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88777666555554433322 346788999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=380.14 Aligned_cols=260 Identities=27% Similarity=0.378 Sum_probs=212.2
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..++..+++|+ |+|.+...........+.+|+.++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv------------------~~K~~~~~~~~~~~~~~~~e~~~l~~ 71 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPV------------------CIKVIEDKSGRQSFQAVTDHMLAIGS 71 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEE------------------EEEEECCTTSCSCBCSCCHHHHHHHT
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEE------------------EEEeccccccHHHHHHHHHHHHHHhc
Confidence 467889999999999999999999999988766553 34444333323334457789999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++. ....++||||+.+|+|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||
T Consensus 72 l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp 143 (325)
T 3kex_A 72 LDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ-------HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAA 143 (325)
T ss_dssp CCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHS-------SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSS
T ss_pred CCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHH-------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccch
Confidence 99999999999886 5668999999999999999974 235788999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYH 264 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~ 264 (520)
+|||++.++.+||+|||++..+..... ........||+.|+|||++.+.. ++.++|||||||++|+|+| |..||.
T Consensus 144 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~ 219 (325)
T 3kex_A 144 RNVLLKSPSQVQVADFGVADLLPPDDK---QLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYA 219 (325)
T ss_dssp TTEEESSSSCEEECSCSGGGGSCCCTT---CCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred heEEECCCCeEEECCCCcccccCcccc---cccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCcc
Confidence 999999999999999999987643321 12234557888999999997665 8999999999999999999 999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
...................+ ..++..+.++|.+||+.||.+|||+.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 220 GLRLAEVPDLLEKGERLAQP---------QICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TSCTTHHHHHHHTTCBCCCC---------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ccCHHHHHHHHHcCCCCCCC---------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87776666555554433322 2356678899999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=373.90 Aligned_cols=272 Identities=24% Similarity=0.359 Sum_probs=215.4
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEc-CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCK-ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
...++|++.+.||+|+||+||+|.+. .+|+.||+|+++..... ......+.+|+.+++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~~e~~~l~ 66 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE---------------------EGMPLSTIREVAVLR 66 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT---------------------TSCBCTHHHHHHHHH
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc---------------------ccCCchhhHHHHHHH
Confidence 34578999999999999999999995 67888999987532110 011123556776666
Q ss_pred cC---CCCCceEEEEEEE-----ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 105 SC---HHENVVTYHTSFV-----VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 105 ~l---~HpnIv~~~~~~~-----~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
.+ +||||+++++++. ....+++||||+. |+|.+++... ....+++..++.++.||+.||.|||++
T Consensus 67 ~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~ 139 (326)
T 1blx_A 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV------PEPGVPTETIKDMMFQLLRGLDFLHSH 139 (326)
T ss_dssp HHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS------CTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc------ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 55 8999999999987 4567999999997 6999999863 345689999999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
||+||||||+|||++.++.+||+|||++..+... .......||+.|+|||++.+.. ++.++|||||||++|+|
T Consensus 140 gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l 212 (326)
T 1blx_A 140 RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ------MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEM 212 (326)
T ss_dssp TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG------GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHH
T ss_pred CceeccCCHHHeEEcCCCCEEEecCcccccccCC------CCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHH
Confidence 9999999999999999999999999998765321 2234567999999999997765 89999999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHhcC--CCCC--CC-------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH
Q psy11359 257 ATGTAPYHKYPAMKVLMLTLQN--DPPT--LD-------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319 (520)
Q Consensus 257 ltG~~Pf~~~~~~~~~~~~~~~--~~~~--~~-------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 319 (520)
+||..||.+......+..+... .+.. .. ...........++..+++||.+||+.||.+|||+.
T Consensus 213 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 292 (326)
T 1blx_A 213 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 292 (326)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHH
Confidence 9999999988877666554421 0000 00 00011122345788999999999999999999999
Q ss_pred HHhcCccccccch
Q psy11359 320 ELLKNPFFKKAKD 332 (520)
Q Consensus 320 elL~hp~~~~~~~ 332 (520)
|+++||||+....
T Consensus 293 e~l~hp~~~~~~~ 305 (326)
T 1blx_A 293 SALSHPYFQDLER 305 (326)
T ss_dssp HHHTSGGGTTCCC
T ss_pred HHhcCccccccch
Confidence 9999999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=367.21 Aligned_cols=258 Identities=21% Similarity=0.370 Sum_probs=203.9
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCC---ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARA---EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKE 99 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~E 99 (520)
.|....++|++.+.||+|+||+||+|.+..++ ..||+|.++ ........+.+.+|
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~----------------------~~~~~~~~~~~~~e 66 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK----------------------NCTSDSVREKFLQE 66 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECT----------------------TTTSHHHHHHHHHH
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecc----------------------ccCCHHHHHHHHHH
Confidence 46778899999999999999999999987643 346666543 22223456779999
Q ss_pred HHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 100 IQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 100 i~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+.++++++||||+++++++ .++..|+||||+.+++|.+++.. ....+++..+..++.||+.||.|||++|++
T Consensus 67 ~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 138 (281)
T 1mp8_A 67 ALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQV-------RKYSLDLASLILYAYQLSTALAYLESKRFV 138 (281)
T ss_dssp HHHHHTCCCTTBCCEEEEE-CSSSCEEEEECCTTEEHHHHHHH-------TTTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHhCCCCccceEEEEE-ccCccEEEEecCCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9999999999999999987 45678999999999999999975 345689999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT- 258 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt- 258 (520)
||||||+|||++.++.+||+|||++..+..... .......+|+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 139 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~ 213 (281)
T 1mp8_A 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY----YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMH 213 (281)
T ss_dssp CSCCSGGGEEEEETTEEEECC-----------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTT
T ss_pred cccccHHHEEECCCCCEEECccccccccCcccc----cccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhc
Confidence 999999999999999999999999977643221 1123346788999999997655 8999999999999999997
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|..||...........+........+ ..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 214 g~~pf~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 214 GVKPFQGVKNNDVIGRIENGERLPMP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp SCCTTTTCCGGGHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999987777666655554433322 3568899999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=381.68 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=210.4
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.+..+++.||+|+++.. .....++.+|+.+++.++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------------~~~~~~~~~e~~~l~~l~ 108 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------------------------KAFLNQAQIEVRLLELMN 108 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------------------------HHHHHHHHHHHHHHHHHH
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------------------------HHHHHHHHHHHHHHHHHH
Confidence 57899999999999999999999999999999987421 223456778888888774
Q ss_pred -CC-----CceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCcE
Q psy11359 108 -HE-----NVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH--SNGQI 179 (520)
Q Consensus 108 -Hp-----nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH--~~gii 179 (520)
|+ +|+++++++...+.+|+||||+. ++|.+++... ..+.+++..++.++.||+.||.||| +.||+
T Consensus 109 ~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~al~~lH~~~~~iv 181 (382)
T 2vx3_A 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNT------NFRGVSLNLTRKFAQQMCTALLFLATPELSII 181 (382)
T ss_dssp HCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT------TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEE
T ss_pred hcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhc------CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEE
Confidence 55 49999999999999999999995 5999999864 3356899999999999999999999 46899
Q ss_pred ecccCCCcEEEc--CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 180 HRDIKAGNILLG--EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 180 HrDLKp~NILl~--~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
||||||+|||++ .++.+||+|||++..... .....+||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 182 HrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell 252 (382)
T 2vx3_A 182 HCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--------RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMH 252 (382)
T ss_dssp CCCCSGGGEEESSTTSCCEEECCCTTCEETTC--------CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHH
T ss_pred cCCCCcccEEEecCCCCcEEEEeccCceeccc--------ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHH
Confidence 999999999995 477899999999976532 123568999999999998765 899999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCCC-----------------CC------------------c-hhhh----------
Q psy11359 258 TGTAPYHKYPAMKVLMLTLQNDPPTLD-----------------TG------------------A-AEKD---------- 291 (520)
Q Consensus 258 tG~~Pf~~~~~~~~~~~~~~~~~~~~~-----------------~~------------------~-~~~~---------- 291 (520)
||.+||.+......+..+......... .. . ....
T Consensus 253 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 332 (382)
T 2vx3_A 253 TGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPG 332 (382)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGG
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCC
Confidence 999999988777666544332110000 00 0 0000
Q ss_pred --------hHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 292 --------QYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 292 --------~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
.....++.+++||.+||++||.+|||+.|+|+||||+...
T Consensus 333 ~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 333 GRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp GTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred ccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence 0001225789999999999999999999999999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=372.45 Aligned_cols=256 Identities=25% Similarity=0.404 Sum_probs=208.3
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-----------------------~~~~~~~~~~E~~~l~~l 64 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----------------------DEETQRTFLKEVKVMRCL 64 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-----------------------CHHHHHHHHHHHHHHTTC
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-----------------------CHHHHHHHHHHHHHHHhC
Confidence 568899999999999999999999999999998876311 134566799999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+..++||||+.|++|.++++. ..+.+++..+..++.||+.||.|||++||+||||||+
T Consensus 65 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~ 137 (310)
T 3s95_A 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-------MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137 (310)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-------CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTT
T ss_pred CCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcC
Confidence 999999999999999999999999999999999985 3567999999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCcccc---------ccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLS---------RQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~---------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
|||++.++.+||+|||++..+....... ........+||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 138 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~ 216 (310)
T 3s95_A 138 NCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEII 216 (310)
T ss_dssp SEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHH
T ss_pred eEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHh
Confidence 9999999999999999998764332211 011122568999999999998755 899999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCCCCCc---hhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 258 TGTAPYHKYPAMKVLMLTLQNDPPTLDTGA---AEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 258 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+|..||........ ...... ........+++.+.++|.+||+.||.+|||+.++++
T Consensus 217 ~g~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 217 GRVNADPDYLPRTM----------DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HTCCSSTTTSCBCT----------TSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCcchhhhHH----------HHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999865322100 000000 000012346778999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=379.33 Aligned_cols=262 Identities=23% Similarity=0.424 Sum_probs=184.1
Q ss_pred CCCCCeEEEe-eeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 26 NTEDQYEVRE-VIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 26 ~~~~~Y~i~~-~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
...++|++.+ +||+|+||+||+|.++.+|+.||+|++... . .........++
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------------------~---~~~~e~~~~~~ 77 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------------------------P---KARQEVDHHWQ 77 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------------------------H---HHHHHHHHHHH
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------------------------H---HHHHHHHHHHH
Confidence 4567899965 699999999999999999999999987421 1 11222233456
Q ss_pred cCCCCCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 105 SCHHENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
.+.||||+++++++.. +..+++||||+.||+|.+++... ....+++..++.++.||+.||.|||++||+|
T Consensus 78 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~------~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH 151 (336)
T 3fhr_A 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER------GDQAFTEREAAEIMRDIGTAIQFLHSHNIAH 151 (336)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-------CCCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 7799999999999986 45689999999999999999853 3357999999999999999999999999999
Q ss_pred cccCCCcEEEcC---CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 181 RDIKAGNILLGE---DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 181 rDLKp~NILl~~---~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
|||||+|||++. ++.+||+|||++..... .......||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 152 ~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~ 223 (336)
T 3fhr_A 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-------NALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILL 223 (336)
T ss_dssp SCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------------CH-HHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEEecCCCceEEEeccccceeccc-------cccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHH
Confidence 999999999975 45699999999976532 2233567899999999986655 899999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 258 TGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 258 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
+|..||................. ..........+..+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 224 ~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 224 CGFPPFYSNTGQAISPGMKRRIR--LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp HSSCCC-----------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HCCCCCCCccchhhhhhHHHhhh--ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 99999976554332111110000 000000112234678899999999999999999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=375.43 Aligned_cols=267 Identities=22% Similarity=0.351 Sum_probs=212.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCC-ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARA-EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
..++|++.+.||+|+||+||+|.+..++ +.||+|+++.. ....+.+.+|+.+++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------------------------~~~~~~~~~E~~~l~~ 72 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------------------------GKYREAARLEINVLKK 72 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------------------------HHHHHHHHHHHHHHHH
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------------------------ccchhHHHHHHHHHHH
Confidence 4689999999999999999999998876 57888876421 2234567889999998
Q ss_pred CCCCC------ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 106 CHHEN------VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 106 l~Hpn------Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
++|++ ++.+++++...+.+++||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+
T Consensus 73 l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~------~~~~~~~~~~~~i~~qi~~~L~~lH~~~iv 145 (355)
T 2eu9_A 73 IKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKEN------NFQPYPLPHVRHMAYQLCHALRFLHENQLT 145 (355)
T ss_dssp HHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 87665 999999999999999999999 77888888753 335799999999999999999999999999
Q ss_pred ecccCCCcEEE-------------------cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCC
Q psy11359 180 HRDIKAGNILL-------------------GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGY 240 (520)
Q Consensus 180 HrDLKp~NILl-------------------~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 240 (520)
||||||+|||+ +.++.+||+|||++..... ......||+.|+|||++.+.. +
T Consensus 146 H~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~-~ 216 (355)
T 2eu9_A 146 HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--------HHTTIVATRHYRPPEVILELG-W 216 (355)
T ss_dssp CCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS--------CCCSSCSCGGGCCHHHHTTCC-C
T ss_pred cCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc--------cccCCcCCCcccCCeeeecCC-C
Confidence 99999999999 5678999999999976422 123468999999999997665 8
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--CCCC------------------CCCCchhh----------
Q psy11359 241 DFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQN--DPPT------------------LDTGAAEK---------- 290 (520)
Q Consensus 241 ~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~------------------~~~~~~~~---------- 290 (520)
+.++|||||||++|+|+||..||........+...... ..+. ........
T Consensus 217 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (355)
T 2eu9_A 217 AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL 296 (355)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG
T ss_pred CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcc
Confidence 99999999999999999999999887765544322211 1110 00000000
Q ss_pred ----hhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 291 ----DQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 291 ----~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
......+..+.+||.+||+.||.+|||+.|+|+||||+.....
T Consensus 297 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 297 KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343 (355)
T ss_dssp GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCHH
T ss_pred cccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCChh
Confidence 0011235689999999999999999999999999999976543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=365.48 Aligned_cols=265 Identities=32% Similarity=0.506 Sum_probs=210.1
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|....+||+|+||+||+|.+..+++.||+|.++.. .....+.+.+|+.+++.+
T Consensus 20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------------------~~~~~~~~~~e~~~l~~l 76 (295)
T 2clq_A 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-----------------------DSRYSQPLHEEIALHKHL 76 (295)
T ss_dssp CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-----------------------CC---HHHHHHHHHHHTC
T ss_pred cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-----------------------chHHHHHHHHHHHHHHhC
Confidence 334444555999999999999999999999999977421 022346689999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+.+++||||+.+++|.+++.... ....+++..++.++.||+.||.|||++|++||||||+
T Consensus 77 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 151 (295)
T 2clq_A 77 KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW-----GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGD 151 (295)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT-----CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred CCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc-----cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChh
Confidence 99999999999999999999999999999999997531 1235678999999999999999999999999999999
Q ss_pred cEEEcC-CCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 187 NILLGE-DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 187 NILl~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|||++. ++.+||+|||++..+.... .......||+.|+|||++.+. ..++.++||||||+++|+|++|..||.
T Consensus 152 Nil~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 152 NVLINTYSGVLKISDFGTSKRLAGIN-----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp GEEEETTTCCEEECCTTTCEESCC----------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred hEEEECCCCCEEEeecccccccCCCC-----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 999987 8999999999997664321 123356799999999998654 237899999999999999999999997
Q ss_pred CCcHHHHH--HHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 265 KYPAMKVL--MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 265 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
........ ........+.++ ..+++.+.+||.+||++||.+|||+.++|+||||+.....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 288 (295)
T 2clq_A 227 ELGEPQAAMFKVGMFKVHPEIP---------ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288 (295)
T ss_dssp GGSSHHHHHHHHHHHCCCCCCC---------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred CCCchhHHHHhhcccccccccc---------ccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence 54332222 111222222221 3567899999999999999999999999999999866543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=378.37 Aligned_cols=290 Identities=20% Similarity=0.308 Sum_probs=224.1
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEe-ecccchhhHHHHHHHHHHHhc
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKI-NLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i-~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
..++|++.+.||+|+||+||+|.+ +|+.||+|++........ ....+.. .........+.+.+|+.++++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 99 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKK-------RDFTKSNNDKISIKSKYDDFKNELQIITD 99 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSC-------EEECCCSSSSCCEEEHHHHHHHHHHHHTT
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccch-------hhhccccchhhhHHhHHHHHHHHHHHHHh
Confidence 457899999999999999999999 899999999875433211 0000000 000011234779999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIK 184 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLK 184 (520)
++||||+++++++...+.+|+||||++|++|.+++.............+++..++.++.||+.||.|||+ +|++|||||
T Consensus 100 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~ 179 (348)
T 2pml_X 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179 (348)
T ss_dssp CCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred CCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence 9999999999999999999999999999999998332111111136789999999999999999999999 999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCc-chhHHHHHHHHHHHHhCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF-KADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~-~~DIwSlG~il~elltG~~Pf 263 (520)
|+|||++.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||
T Consensus 180 p~Nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 180 PSNILMDKNGRVKLSDFGESEYMVDK-------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp GGGEEECTTSCEEECCCTTCEECBTT-------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred hHhEEEcCCCcEEEeccccccccccc-------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999876432 2345679999999999987644666 999999999999999999999
Q ss_pred CCCcH-HHHHHHHhcCCCCCCCCCc----------hhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 264 HKYPA-MKVLMLTLQNDPPTLDTGA----------AEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 264 ~~~~~-~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
..... ............ ..+... ........+++.+.+||.+||+.||.+|||+.|+++||||+....
T Consensus 253 ~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 253 SLKISLVELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp CCSSCSHHHHHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred CCCCcHHHHHHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 88776 444444443322 222100 001112457889999999999999999999999999999997654
Q ss_pred h
Q psy11359 333 K 333 (520)
Q Consensus 333 ~ 333 (520)
.
T Consensus 332 ~ 332 (348)
T 2pml_X 332 E 332 (348)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=384.30 Aligned_cols=260 Identities=23% Similarity=0.379 Sum_probs=218.4
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
..|....++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+++.+|+.
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------------------~~~~~~~~~~~E~~ 164 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET----------------------LPPDLKAKFLQEAR 164 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT----------------------SCHHHHTTTTHHHH
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc----------------------CCHHHHHHHHHHHH
Confidence 35778889999999999999999999999999999999977522 11223445889999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+|++++||||+++++++...+.+|+||||+.||+|.++++.. ...+++..+..++.||+.||.|||++||+||
T Consensus 165 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr 237 (377)
T 3cbl_A 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-------GARLRVKTLLQMVGDAAAGMEYLESKCCIHR 237 (377)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHH-------GGGCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCc
Confidence 999999999999999999999999999999999999999853 3458899999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GT 260 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~ 260 (520)
||||+|||++.++.+||+|||++........ ........+++.|+|||++.+.. ++.++|||||||++|||+| |.
T Consensus 238 Dlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~ 313 (377)
T 3cbl_A 238 DLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGA 313 (377)
T ss_dssp CCSGGGEEECTTCCEEECCGGGCEECTTSEE---ECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSC
T ss_pred ccCHHHEEEcCCCcEEECcCCCceecCCCce---eecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999976533211 11112234678899999997665 8999999999999999998 99
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.||..............+.....+ ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 314 ~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 314 SPYPNLSNQQTREFVEKGGRLPCP---------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CSSTTSCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999998877776665554433322 346788999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=381.65 Aligned_cols=274 Identities=24% Similarity=0.398 Sum_probs=221.3
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.|....++|++.+.||+|+||+||+|.+..+++. .......+|+|++...........+.+|+.+
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~---------------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~ 127 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKD---------------KPNRVTKVAVKMLKSDATEKDLSDLISEMEM 127 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTT---------------CTTCEEEEEEEEECTTCCHHHHHHHHHHHHH
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEcccccc---------------ccccceEEEEEeeccccCHHHHHHHHHHHHH
Confidence 4777889999999999999999999998654310 0001233444444444334556789999999
Q ss_pred HhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--------cCCCCCCCHHHHHHHHHHHHHHHHHH
Q psy11359 103 MSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--------NCKHGVCDEPTIATVLREVLKGLEYF 173 (520)
Q Consensus 103 l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--------~~~~~~l~~~~i~~i~~qIl~gL~yL 173 (520)
++++ +||||+++++++...+.+|+||||+.+|+|.+++....... ......+++..++.++.||+.||.||
T Consensus 128 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 207 (382)
T 3tt0_A 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207 (382)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 9999 99999999999999999999999999999999998643110 01235699999999999999999999
Q ss_pred HHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHH
Q psy11359 174 HSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253 (520)
Q Consensus 174 H~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il 253 (520)
|++||+||||||+|||++.++.+||+|||++..+..... ........||+.|+|||++.+.. ++.++|||||||++
T Consensus 208 H~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il 283 (382)
T 3tt0_A 208 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLL 283 (382)
T ss_dssp HHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCT---TCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHH
T ss_pred HhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccc---cccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHH
Confidence 999999999999999999999999999999986643221 12223456789999999997655 89999999999999
Q ss_pred HHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 254 IEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 254 ~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|+|+| |..||..................... ..+++.+.+||.+||+.||.+|||+.|++++
T Consensus 284 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 284 WEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999 99999988877777666655443332 3467889999999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=386.65 Aligned_cols=275 Identities=25% Similarity=0.362 Sum_probs=194.0
Q ss_pred CCCeEE-EeeeeecCceEEEEEEEc--CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 28 EDQYEV-REVIGFGATAVVHSAYCK--ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 28 ~~~Y~i-~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
.+.|++ .++||+|+||+||+|.++ .+++.||+|++... .....+.+|+.+|+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-------------------------~~~~~~~~E~~~l~ 73 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-------------------------GISMSACREIALLR 73 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-------------------------SCCHHHHHHHHHHH
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-------------------------CCCHHHHHHHHHHH
Confidence 456777 458999999999999976 46777888766421 11235789999999
Q ss_pred cCCCCCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccc-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 105 SCHHENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKIS-NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~-~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+|+||||+++++++.. ...+|+||||+. ++|.+++....... ......+++..++.++.||+.||.|||++||+||
T Consensus 74 ~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~ 152 (405)
T 3rgf_A 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHR 152 (405)
T ss_dssp HCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred hcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCC
Confidence 9999999999999975 678999999995 58999887543221 1123459999999999999999999999999999
Q ss_pred ccCCCcEEE----cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 182 DIKAGNILL----GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 182 DLKp~NILl----~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
||||+|||+ +.++.+||+|||++..+..... ........+||+.|+|||++.+...|+.++|||||||++|+|+
T Consensus 153 Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 230 (405)
T 3rgf_A 153 DLKPANILVMGEGPERGRVKIADMGFARLFNSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230 (405)
T ss_dssp CCCGGGEEECCSSTTTTCEEECCTTCCC------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHH
T ss_pred CcCHHHeEEecCCCCCCcEEEEECCCceecCCCCc--ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHH
Confidence 999999999 6778999999999987643221 1122345789999999999987666999999999999999999
Q ss_pred hCCCCCCCCcHH---------HHHHHHhc--CCCCCCC-CCchh----hhh---------------------HHHhcHHH
Q psy11359 258 TGTAPYHKYPAM---------KVLMLTLQ--NDPPTLD-TGAAE----KDQ---------------------YKAYGKTF 300 (520)
Q Consensus 258 tG~~Pf~~~~~~---------~~~~~~~~--~~~~~~~-~~~~~----~~~---------------------~~~~~~~~ 300 (520)
||.+||...... ..+..+.. +.+.... ..... ... ....++.+
T Consensus 231 ~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (405)
T 3rgf_A 231 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 310 (405)
T ss_dssp HSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHH
T ss_pred hCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHH
Confidence 999999765431 22222211 1111110 00000 000 00116788
Q ss_pred HHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 301 RKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 301 ~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.+||.+||++||.+|||+.|+|+||||+..
T Consensus 311 ~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~ 340 (405)
T 3rgf_A 311 FHLLQKLLTMDPIKRITSEQAMQDPYFLED 340 (405)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred HHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence 999999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=381.82 Aligned_cols=267 Identities=24% Similarity=0.374 Sum_probs=213.1
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEE-----cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYC-----KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELL 97 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~ 97 (520)
.|....++|++.+.||+|+||+||+|.+ ..+++.||+|+++ ........+.+.
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~----------------------~~~~~~~~~~~~ 73 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK----------------------EGATHSEHRALM 73 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEEC----------------------TTCCHHHHHHHH
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEec----------------------CcCCHHHHHHHH
Confidence 4677889999999999999999999984 4455666666653 222234456799
Q ss_pred HHHHHHhcC-CCCCceEEEEEEEECC-EEEEEEEccCCCCHHHHHHHhhccc----------------------------
Q psy11359 98 KEIQAMSSC-HHENVVTYHTSFVVKD-ELWLVLRLLEGGSLLDIIKHRLKIS---------------------------- 147 (520)
Q Consensus 98 ~Ei~~l~~l-~HpnIv~~~~~~~~~~-~~~lV~E~~~ggsL~~~i~~~~~~~---------------------------- 147 (520)
+|+.+++++ +||||+++++++...+ .+++||||+.||+|.+++.......
T Consensus 74 ~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (359)
T 3vhe_A 74 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRL 153 (359)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------
T ss_pred HHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccc
Confidence 999999999 8999999999998755 4999999999999999998642200
Q ss_pred ------------------------------cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeE
Q psy11359 148 ------------------------------NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQ 197 (520)
Q Consensus 148 ------------------------------~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vk 197 (520)
......+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~k 233 (359)
T 3vhe_A 154 DSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233 (359)
T ss_dssp ------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred cccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEE
Confidence 00122389999999999999999999999999999999999999999999
Q ss_pred EeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh
Q psy11359 198 IADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTL 276 (520)
Q Consensus 198 L~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~ 276 (520)
|+|||++..+..... ........||+.|+|||++.+.. ++.++|||||||++|+|+| |..||.+......+...+
T Consensus 234 l~Dfg~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 309 (359)
T 3vhe_A 234 ICDFGLARDIYKDPD---YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309 (359)
T ss_dssp ECCCGGGSCTTSCTT---CEEC--CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred EEeccceeeeccccc---chhccccCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH
Confidence 999999976643322 12233567899999999997655 8999999999999999998 999998876544444333
Q ss_pred cCC-CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 277 QND-PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 277 ~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
... ....+ ..+++.+.++|.+||+.||.+|||+.|+++|
T Consensus 310 ~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 310 KEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCC---------CCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 322 22221 3467889999999999999999999999976
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=370.10 Aligned_cols=267 Identities=21% Similarity=0.363 Sum_probs=217.5
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELL 97 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~ 97 (520)
.|....++|++.+.||+|+||.||+|.+.. ++..||+|+++ ........+.+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~----------------------~~~~~~~~~~~~ 74 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK----------------------ENASPSELRDLL 74 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECC----------------------TTCCHHHHHHHH
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEecc----------------------CCCCHHHHHHHH
Confidence 466778999999999999999999998843 34556666553 333344567899
Q ss_pred HHHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc----------------cCCCCCCCHHHHHH
Q psy11359 98 KEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS----------------NCKHGVCDEPTIAT 161 (520)
Q Consensus 98 ~Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~----------------~~~~~~l~~~~i~~ 161 (520)
+|+.++++++||||+++++++...+.+++||||+.|++|.+++....... ......+++..+..
T Consensus 75 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (314)
T 2ivs_A 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154 (314)
T ss_dssp HHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHH
T ss_pred HHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHH
Confidence 99999999999999999999999999999999999999999998643210 00123489999999
Q ss_pred HHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCC
Q psy11359 162 VLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD 241 (520)
Q Consensus 162 i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ 241 (520)
++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...... .......+|+.|+|||++.+.. ++
T Consensus 155 i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~ 230 (314)
T 2ivs_A 155 FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY---VKRSQGRIPVKWMAIESLFDHI-YT 230 (314)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCE---ECSSCCCSCGGGCCHHHHHHCE-EC
T ss_pred HHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccc---eeccCCCCcccccChhhhcCCC-cC
Confidence 9999999999999999999999999999999999999999999876433211 1123456789999999997655 89
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 242 FKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 242 ~~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
.++|||||||++|+|+| |..||..................... ..+++.+.++|.+||+.||.+|||+.+
T Consensus 231 ~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERP---------DNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCC---------ccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999999999999 99999887776666555544333222 356889999999999999999999999
Q ss_pred HhcC
Q psy11359 321 LLKN 324 (520)
Q Consensus 321 lL~h 324 (520)
++++
T Consensus 302 l~~~ 305 (314)
T 2ivs_A 302 ISKD 305 (314)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=373.45 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=217.7
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
+....++|++.+.||+|+||.||+|.+.. +++.||+|+++ ........+.+.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~----------------------~~~~~~~~~~~~~ 99 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK----------------------EEASADMQADFQR 99 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECC----------------------TTCCHHHHHHHHH
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEec----------------------cccCHHHHHHHHH
Confidence 45577899999999999999999999873 44667776653 2222345677999
Q ss_pred HHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc----------------cCCCCCCCHHHHHHH
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS----------------NCKHGVCDEPTIATV 162 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~----------------~~~~~~l~~~~i~~i 162 (520)
|+.++++++||||+++++++...+.+|+||||+.+++|.+++....... ......+++..++.+
T Consensus 100 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 179 (343)
T 1luf_A 100 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 179 (343)
T ss_dssp HHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHH
T ss_pred HHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHH
Confidence 9999999999999999999999999999999999999999998632110 001267999999999
Q ss_pred HHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCc
Q psy11359 163 LREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF 242 (520)
Q Consensus 163 ~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 242 (520)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ........||+.|+|||++.+.. ++.
T Consensus 180 ~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~-~~~ 255 (343)
T 1luf_A 180 ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY---YKADGNDAIPIRWMPPESIFYNR-YTT 255 (343)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC---BC----CCBCGGGCCHHHHHHCC-CCH
T ss_pred HHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCcc---ccccCCCcccceecChhhhccCC-cCc
Confidence 99999999999999999999999999999999999999999876543221 11223457899999999987665 899
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH
Q psy11359 243 KADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321 (520)
Q Consensus 243 ~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el 321 (520)
++|||||||++|+|+| |..||..............+.....+ ..+++.+.++|.+||+.||.+|||+.++
T Consensus 256 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~ 326 (343)
T 1luf_A 256 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSI 326 (343)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 9999999999999999 99999988887777666655443332 3567889999999999999999999999
Q ss_pred hcC
Q psy11359 322 LKN 324 (520)
Q Consensus 322 L~h 324 (520)
+++
T Consensus 327 ~~~ 329 (343)
T 1luf_A 327 HRI 329 (343)
T ss_dssp HHH
T ss_pred HHH
Confidence 863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=364.59 Aligned_cols=258 Identities=22% Similarity=0.401 Sum_probs=220.4
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
..|....++|++.+.||+|+||+||+|.+..++..||+|++... ....+.+.+|+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------------~~~~~~~~~E~~ 61 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------------------TMEVEEFLKEAA 61 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC------------------------STHHHHHHHHHH
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC------------------------HHHHHHHHHHHH
Confidence 36888999999999999999999999999999888888876421 234567899999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
++++++||||+++++++...+.+|+||||+.|++|.+++... ....+++..+..++.||+.||.|||++|++||
T Consensus 62 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~ 135 (288)
T 3kfa_A 62 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135 (288)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHC------CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCS
T ss_pred HHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhc------ccCCccHhHHHHHHHHHHHHHHHHHHCCccCC
Confidence 999999999999999999999999999999999999999753 44668999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GT 260 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~ 260 (520)
||||+||+++.++.+||+|||++....... ........+|+.|+|||++.+.. ++.++||||||+++|+|++ |.
T Consensus 136 dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~ 210 (288)
T 3kfa_A 136 DLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGM 210 (288)
T ss_dssp CCSGGGEEECGGGCEEECCCCGGGTSCSSS----SEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCcceEEEcCCCCEEEccCccceeccCCc----cccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999997654322 12223456788999999997665 8999999999999999999 99
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.||....................+ ..+++.+.+||.+||..||.+|||+.++++
T Consensus 211 ~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 211 SPYPGIDLSQVYELLEKDYRMERP---------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CSSTTCCGGGHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHhccCCCCCC---------CCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 999887766655554444332222 356789999999999999999999999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=358.52 Aligned_cols=253 Identities=23% Similarity=0.439 Sum_probs=202.1
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+. |..||+|+++.... .......+.+.+|+.+++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-------------------~~~~~~~~~~~~e~~~l~~ 62 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPD-------------------EDISQTIENVRQEAKLFAM 62 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC-----------------------------CHHHHHHHHHHHHH
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCc-------------------ccHHHHHHHHHHHHHHHHh
Confidence 35678999999999999999999975 78899998753211 1112345678999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecc
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG---QIHRD 182 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g---iiHrD 182 (520)
++||||+++++++...+..++||||+.|++|.+++. .+.+++..++.++.||+.||.|||++| ++|||
T Consensus 63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~d 133 (271)
T 3dtc_A 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS---------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRD 133 (271)
T ss_dssp CCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT---------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSC
T ss_pred cCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecC
Confidence 999999999999999999999999999999999984 457899999999999999999999999 99999
Q ss_pred cCCCcEEEcC--------CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 183 IKAGNILLGE--------DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 183 LKp~NILl~~--------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
|||+|||++. ++.+||+|||++..+... ......||+.|+|||++.+.. ++.++||||||+++|
T Consensus 134 ikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ 205 (271)
T 3dtc_A 134 LKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-------TKMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLW 205 (271)
T ss_dssp CSGGGEEESSCCSSSCCSSCCEEECCCCC--------------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHH
T ss_pred CchHHEEEecccccccccCcceEEccCCcccccccc-------cccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHH
Confidence 9999999975 778999999998765322 122457999999999997665 899999999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 255 EMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 255 elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
+|++|..||..................... ...+++.+.++|.+||+.||.+|||+.|++++
T Consensus 206 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 206 ELLTGEVPFRGIDGLAVAYGVAMNKLALPI--------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 999999999988877666655544322111 13567889999999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=378.28 Aligned_cols=267 Identities=25% Similarity=0.374 Sum_probs=208.4
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
+...++|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+.+.+|+.+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------------~~~~~~~~~e~~~l~ 70 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------------------------KVYTEAAEDEIKLLQ 70 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------------------------HHHHHHHHHHHHHHH
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------------------------ccchhhhhHHHHHHH
Confidence 34568999999999999999999999999999999987522 123456788999888
Q ss_pred cCC-----------CCCceEEEEEEEECC----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q psy11359 105 SCH-----------HENVVTYHTSFVVKD----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKG 169 (520)
Q Consensus 105 ~l~-----------HpnIv~~~~~~~~~~----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~g 169 (520)
+++ ||||+++++++...+ .+++||||+ +++|.+++... ..+.+++..+..++.||+.|
T Consensus 71 ~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~i~~qi~~a 143 (373)
T 1q8y_A 71 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY------EHRGIPLIYVKQISKQLLLG 143 (373)
T ss_dssp HHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT------TTSCCCHHHHHHHHHHHHHH
T ss_pred HhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh------hccCCcHHHHHHHHHHHHHH
Confidence 876 899999999998654 799999999 89999999864 34569999999999999999
Q ss_pred HHHHHHC-CcEecccCCCcEEEc------CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCc
Q psy11359 170 LEYFHSN-GQIHRDIKAGNILLG------EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF 242 (520)
Q Consensus 170 L~yLH~~-giiHrDLKp~NILl~------~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 242 (520)
|.|||++ ||+||||||+|||++ ..+.+||+|||++..+... .....||+.|+|||++.+.. ++.
T Consensus 144 L~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~-~~~ 214 (373)
T 1q8y_A 144 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAP-WGC 214 (373)
T ss_dssp HHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCC-CCT
T ss_pred HHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--------CCCCCCCccccCcHHHhCCC-CCc
Confidence 9999998 999999999999994 3448999999999765321 23457999999999998765 899
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHH---hcCCCC-----------------------CCCCCch--
Q psy11359 243 KADIWSLGITAIEMATGTAPYHKYPA------MKVLMLT---LQNDPP-----------------------TLDTGAA-- 288 (520)
Q Consensus 243 ~~DIwSlG~il~elltG~~Pf~~~~~------~~~~~~~---~~~~~~-----------------------~~~~~~~-- 288 (520)
++|||||||++|+|+||..||..... ...+... +...+. .......
T Consensus 215 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (373)
T 1q8y_A 215 GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLED 294 (373)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHH
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhh
Confidence 99999999999999999999976442 1112111 111100 0000000
Q ss_pred ----hhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 289 ----EKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 289 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
.......++..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 295 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 0001135678899999999999999999999999999998653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=366.45 Aligned_cols=257 Identities=19% Similarity=0.341 Sum_probs=208.1
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||+|.+..++..++++ ...+|+|.+.... ....+.+.+|+.+++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~---------------~~~va~K~~~~~~-~~~~~~~~~E~~~l~ 67 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLH---------------ETEVLLKVLDKAH-RNYSESFFEAASMMS 67 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEE---------------EEEEEEEEECGGG-GGGHHHHHHHHHHHH
T ss_pred EechhHeeeeeeeccCCCceEEEEEEeccccccccc---------------chhhhhhhccccc-HHHHHHHHHHHHHHH
Confidence 346789999999999999999999999887644443 3445555554322 345677999999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++...+..++||||+.|++|.+++.. ....+++..+..++.||+.||.|||++||+|||||
T Consensus 68 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk 140 (289)
T 4fvq_A 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-------NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVC 140 (289)
T ss_dssp TSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH-------TGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred hCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcC
Confidence 99999999999999999999999999999999999985 23448999999999999999999999999999999
Q ss_pred CCcEEEcCCCC--------eEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 185 AGNILLGEDGT--------VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 185 p~NILl~~~g~--------vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
|+|||++.++. +||+|||++..... .....||+.|+|||++.+...++.++|||||||++|+|
T Consensus 141 p~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 211 (289)
T 4fvq_A 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLP---------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211 (289)
T ss_dssp GGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC---------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHH
T ss_pred cceEEEecCCcccccccceeeeccCcccccccC---------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHH
Confidence 99999988876 99999998854321 12356899999999998745589999999999999999
Q ss_pred Hh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 257 AT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 257 lt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
++ |.+||............. .. ...+ ...++.+.+||.+||+.||.+|||+.++++|
T Consensus 212 ~~g~~~~~~~~~~~~~~~~~~-~~-~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 212 CSGGDKPLSALDSQRKLQFYE-DR-HQLP---------APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HTTTCCTTTTSCHHHHHHHHH-TT-CCCC---------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCccccchHHHHHHhh-cc-CCCC---------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99 456666555444433222 21 1111 1235678999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=366.52 Aligned_cols=272 Identities=21% Similarity=0.342 Sum_probs=222.1
Q ss_pred CCCCCCCCCCCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhh
Q psy11359 18 ASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTS 92 (520)
Q Consensus 18 ~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~ 92 (520)
...+..|....++|++.+.||+|+||+||+|.+.. +++.||+|.+ ........
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~----------------------~~~~~~~~ 71 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----------------------NEAASMRE 71 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEEC----------------------CTTSCHHH
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEec----------------------ccccCHHH
Confidence 34455688889999999999999999999998873 4555666654 33322344
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc--ccCCCCCCCHHHHHHHHHHHHHHH
Q psy11359 93 MDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI--SNCKHGVCDEPTIATVLREVLKGL 170 (520)
Q Consensus 93 ~~~l~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~--~~~~~~~l~~~~i~~i~~qIl~gL 170 (520)
...+.+|+.++++++||||+++++++...+..++||||+.+++|.+++...... .......+++..+..++.||+.||
T Consensus 72 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 151 (322)
T 1p4o_A 72 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151 (322)
T ss_dssp HHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHH
Confidence 567899999999999999999999999999999999999999999999764321 111235678999999999999999
Q ss_pred HHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHH
Q psy11359 171 EYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG 250 (520)
Q Consensus 171 ~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG 250 (520)
.|||++||+||||||+|||++.++.+||+|||++........ ........||+.|+|||++.+.. ++.++||||||
T Consensus 152 ~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG 227 (322)
T 1p4o_A 152 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFG 227 (322)
T ss_dssp HHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGC---EEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHH
T ss_pred HHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccc---cccccCCCCCCCccChhhhccCC-CCchhhHHHHH
Confidence 999999999999999999999999999999999876533221 11223456789999999987665 89999999999
Q ss_pred HHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 251 ITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 251 ~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|++|+|+| |..||..................... ..++..+.+||.+||+.||.+|||+.|++++
T Consensus 228 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 228 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999 89999988877776666555433222 3567889999999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=376.98 Aligned_cols=264 Identities=29% Similarity=0.426 Sum_probs=210.8
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|.+.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.++++++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~~E~~~l~~l~ 81 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---------------------SEIFAKRAYRELLLLKHMQ 81 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS---------------------SHHHHHHHHHHHHHHHHCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc---------------------chHHHHHHHHHHHHHHhcC
Confidence 4689999999999999999999999999999998753210 1223567889999999999
Q ss_pred CCCceEEEEEEEECCE------EEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 108 HENVVTYHTSFVVKDE------LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~------~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
||||+++++++..... +|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||
T Consensus 82 h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~ 150 (353)
T 3coi_A 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHR 150 (353)
T ss_dssp CTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred CCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 9999999999987654 599999996 58877653 348999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||++.++.+||+|||++..... ......||+.|+|||++.+...++.++|||||||++|+|++|..
T Consensus 151 dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~ 222 (353)
T 3coi_A 151 DLKPGNLAVNEDCELKILDFGLARHADA--------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222 (353)
T ss_dssp SCCGGGEEECTTCCEEECSTTCTTC----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCCHHHEeECCCCcEEEeecccccCCCC--------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999875432 12346789999999998875558999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCC--CCC-----C------------C--CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 262 PYHKYPAMKVLMLTLQND--PPT-----L------------D--TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~--~~~-----~------------~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
||.+......+..+.... ++. + . ...........+++.+.+||.+||+.||.+|||+.+
T Consensus 223 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 302 (353)
T 3coi_A 223 LFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302 (353)
T ss_dssp SSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 999877665554433210 000 0 0 000001122456889999999999999999999999
Q ss_pred HhcCccccccc
Q psy11359 321 LLKNPFFKKAK 331 (520)
Q Consensus 321 lL~hp~~~~~~ 331 (520)
+|+||||+...
T Consensus 303 ~l~hp~f~~~~ 313 (353)
T 3coi_A 303 ALTHPFFEPFR 313 (353)
T ss_dssp HHTSGGGTTTC
T ss_pred HhcCcchhhcc
Confidence 99999998643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=357.31 Aligned_cols=256 Identities=24% Similarity=0.436 Sum_probs=215.2
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.|....++|++.+.||+|+||+||+|.+. ++..||+|++... ....+.+.+|+.+
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~------------------------~~~~~~~~~e~~~ 56 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG------------------------AMSEEDFIEEAEV 56 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT------------------------TBCHHHHHHHHHH
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEcccc------------------------CCCHHHHHHHHHH
Confidence 36677889999999999999999999986 5667888876432 1123568999999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
+++++||||+++++++...+..++||||+.+++|.+++.. ..+.+++..+..++.||+.||.|||++|++|||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 129 (267)
T 3t9t_A 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT-------QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129 (267)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHH-------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSS
T ss_pred HHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhh-------CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 9999999999999999999999999999999999999975 346789999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTA 261 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~ 261 (520)
|||+||+++.++.+||+|||++....... ........||+.|+|||++.+.. ++.++||||||+++|+|++ |..
T Consensus 130 l~p~Nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~ 204 (267)
T 3t9t_A 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKI 204 (267)
T ss_dssp CCGGGEEECGGGCEEECCTTGGGGBCCHH----HHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CchheEEECCCCCEEEccccccccccccc----ccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCC
Confidence 99999999999999999999987653211 11123446788999999997655 8999999999999999999 999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
||...........+........+ ..++..+.++|.+||+.||.+|||+.+++++
T Consensus 205 p~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 205 PYENRSNSEVVEDISTGFRLYKP---------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp TTTTCCHHHHHHHHHTTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHhcCCcCCCC---------ccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99988777766665554333222 2457889999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=361.44 Aligned_cols=259 Identities=23% Similarity=0.358 Sum_probs=214.5
Q ss_pred CCCCCCCeEEEe-eeeecCceEEEEEEEc--CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 24 WPNTEDQYEVRE-VIGFGATAVVHSAYCK--ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 24 ~~~~~~~Y~i~~-~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
|....++|.+.+ .||+|+||+||+|.+. .++..||+|+++ ........+.+.+|+
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~----------------------~~~~~~~~~~~~~E~ 61 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK----------------------QGTEKADTEEMMREA 61 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEEC----------------------SSCCHHHHHHHHHHH
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecC----------------------CccchhHHHHHHHHH
Confidence 455678888887 9999999999999864 355567777654 222244567899999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
.++++++||||+++++++ ..+..++||||+.+++|.+++.. ....+++..+..++.||+.||.|||++|++|
T Consensus 62 ~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 133 (287)
T 1u59_A 62 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG-------KREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133 (287)
T ss_dssp HHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT-------CTTTSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh-------CCccCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 999999999999999998 56679999999999999999964 3467999999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-C
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G 259 (520)
|||||+|||++.++.+||+|||++..+...... ........||+.|+|||++.+.. ++.++|||||||++|+|+| |
T Consensus 134 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g 210 (287)
T 1u59_A 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYG 210 (287)
T ss_dssp CCCSGGGEEEEETTEEEECCCTTCEECTTCSCE--ECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTS
T ss_pred CCCchheEEEcCCCCEEECcccceeeeccCcce--eeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999876433221 11223346789999999997655 8999999999999999998 9
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
..||...........+.....+..+ ..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 211 ~~p~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 211 QKPYKKMKGPEVMAFIEQGKRMECP---------PECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp CCTTTTCCTHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCcccCCHHHHHHHHhcCCcCCCC---------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999988777766665555433332 3568899999999999999999999999976
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=365.48 Aligned_cols=257 Identities=23% Similarity=0.396 Sum_probs=202.6
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEE----EcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAY----CKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
....++|++.+.||+|+||+||+|. +..+++.||+|++... .....+.+.+|+
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------------------~~~~~~~~~~E~ 62 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----------------------TEEHLRDFEREI 62 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----------------------CHHHHHHHHHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----------------------CHHHHHHHHHHH
Confidence 4577899999999999999999998 5667778888876421 133456789999
Q ss_pred HHHhcCCCCCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 101 QAMSSCHHENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
.++++++||||+++++++.. ...+++||||+.+++|.+++.. ....+++..+..++.||+.||.|||++||
T Consensus 63 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 135 (295)
T 3ugc_A 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-------HKERIDHIKLLQYTSQICKGMEYLGTKRY 135 (295)
T ss_dssp HHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHH-------CGGGCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHh-------cccccCHHHHHHHHHHHHHHHHHHhcCCc
Confidence 99999999999999999864 4568999999999999999975 23458999999999999999999999999
Q ss_pred EecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 179 iHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
+||||||+|||++.++.+||+|||++..+..... .........||+.|+|||++.+.. ++.++|||||||++|+|+|
T Consensus 136 vH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~ 212 (295)
T 3ugc_A 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--FFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFT 212 (295)
T ss_dssp CCSCCSGGGEEEEETTEEEECCCCSCC---------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHH
T ss_pred ccCCCCHhhEEEcCCCeEEEccCcccccccCCcc--eeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999987643322 112233456788899999998765 8999999999999999999
Q ss_pred CCCCCCCCcHHH----------------HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 259 GTAPYHKYPAMK----------------VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 259 G~~Pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
|..||....... ............. ...+++.+.+||.+||+.||.+|||+.|++
T Consensus 213 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~el~ 283 (295)
T 3ugc_A 213 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---------PDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283 (295)
T ss_dssp TTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCC---------CcCcCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 999986543221 1111111111111 135678999999999999999999999998
Q ss_pred c
Q psy11359 323 K 323 (520)
Q Consensus 323 ~ 323 (520)
+
T Consensus 284 ~ 284 (295)
T 3ugc_A 284 L 284 (295)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=372.30 Aligned_cols=270 Identities=24% Similarity=0.365 Sum_probs=214.2
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEc-----CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCK-----ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDEL 96 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l 96 (520)
..|....++|++.+.||+|+||+||+|.+. .++..||+|+++. .......+.+
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~----------------------~~~~~~~~~~ 95 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE----------------------KADSSEREAL 95 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------------------------CHHH
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccc----------------------ccCHHHHHHH
Confidence 357778899999999999999999999973 3455677776642 1112344678
Q ss_pred HHHHHHHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc---------------cCCCCCCCHHHHH
Q psy11359 97 LKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS---------------NCKHGVCDEPTIA 160 (520)
Q Consensus 97 ~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~---------------~~~~~~l~~~~i~ 160 (520)
.+|+.+++++ +||||+++++++...+.+|+||||+++|+|.+++....... ......+++..+.
T Consensus 96 ~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 175 (344)
T 1rjb_A 96 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 175 (344)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHH
T ss_pred HHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHH
Confidence 9999999999 99999999999999999999999999999999998532100 0012458999999
Q ss_pred HHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCC
Q psy11359 161 TVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGY 240 (520)
Q Consensus 161 ~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 240 (520)
.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ........||+.|+|||++.+.. +
T Consensus 176 ~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~-~ 251 (344)
T 1rjb_A 176 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN---YVVRGNARLPVKWMAPESLFEGI-Y 251 (344)
T ss_dssp HHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT---SEEETTEEECGGGCCHHHHHHCC-C
T ss_pred HHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCcc---ceeccCccCccCccCHHHhccCC-C
Confidence 9999999999999999999999999999999999999999999986643321 12233456889999999987665 8
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH
Q psy11359 241 DFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319 (520)
Q Consensus 241 ~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 319 (520)
+.++|||||||++|+|+| |..||........+...+........ ...+++.+.+||.+||+.||.+|||+.
T Consensus 252 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ 323 (344)
T 1rjb_A 252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ--------PFYATEEIYIIMQSCWAFDSRKRPSFP 323 (344)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCC--------CCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 999999999999999998 99999887655555444443211110 134678899999999999999999999
Q ss_pred HHhcCc
Q psy11359 320 ELLKNP 325 (520)
Q Consensus 320 elL~hp 325 (520)
++++|.
T Consensus 324 ~l~~~l 329 (344)
T 1rjb_A 324 NLTSFL 329 (344)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999763
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=371.01 Aligned_cols=276 Identities=30% Similarity=0.521 Sum_probs=200.1
Q ss_pred CCCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 19 SVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 19 ~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
++...|....++|++.+.||+|+||.||+|.++.+|+.||+|+++.. .......++.+
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----------------------~~~~~~~~~~~ 69 (327)
T 3aln_A 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST----------------------VDEKEQKQLLM 69 (327)
T ss_dssp CCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECC----------------------CCHHHHHHHHH
T ss_pred ChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecc----------------------cCchHHHHHHH
Confidence 34456778889999999999999999999999999988998877532 11223445666
Q ss_pred HHH-HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-
Q psy11359 99 EIQ-AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN- 176 (520)
Q Consensus 99 Ei~-~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~- 176 (520)
|+. +++.++||||+++++++...+..++||||+.+ +|.+++...... ....+++..+..++.||+.||.|||++
T Consensus 70 e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 145 (327)
T 3aln_A 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSV---LDDVIPEEILGKITLATVKALNHLKENL 145 (327)
T ss_dssp HHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHT---TCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhh---hcccCcHHHHHHHHHHHHHHHHHHhccC
Confidence 666 67788999999999999999999999999975 888888753221 356789999999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceec---ccCCCCcchhHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME---QDHGYDFKADIWSLGITA 253 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~~~DIwSlG~il 253 (520)
|++||||||+|||++.++.+||+|||++..+.... ......||+.|+|||++. ....++.++|||||||++
T Consensus 146 ~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 219 (327)
T 3aln_A 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL 219 (327)
T ss_dssp SCCCSCCCGGGEEEETTTEEEECCCSSSCC------------------------------------CCSHHHHHHHHHHH
T ss_pred CEeECCCCHHHEEEcCCCCEEEccCCCceeccccc------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHH
Confidence 99999999999999999999999999987654321 122347999999999984 233489999999999999
Q ss_pred HHHHhCCCCCCCCcHH-HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 254 IEMATGTAPYHKYPAM-KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 254 ~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
|+|++|..||...... ..+.....+.++.+.. .....+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus 220 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 220 YELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN-----SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp HHHHHSCCCSSCC-------CCCCCSCCCCCCC-----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC-----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 9999999999875432 2222222222222211 11235788999999999999999999999999999998654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=371.67 Aligned_cols=275 Identities=21% Similarity=0.294 Sum_probs=216.8
Q ss_pred CCCCCCCCCCCCeEEEeeeeecCceEEEEEE-----EcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhH
Q psy11359 19 SVSVPWPNTEDQYEVREVIGFGATAVVHSAY-----CKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSM 93 (520)
Q Consensus 19 ~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~ 93 (520)
+.........++|++.+.||+|+||+||+|. +..++..||+|.+. ........
T Consensus 20 s~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~----------------------~~~~~~~~ 77 (327)
T 2yfx_A 20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP----------------------EVCSEQDE 77 (327)
T ss_dssp CGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECC----------------------SSCCHHHH
T ss_pred chhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEec----------------------cccchhhH
Confidence 3333445677899999999999999999998 55666667777653 22223445
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHH
Q psy11359 94 DELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYF 173 (520)
Q Consensus 94 ~~l~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yL 173 (520)
.++.+|+.++++++||||+++++++......|+||||+.|++|.+++....... .....+++..+..++.||+.||.||
T Consensus 78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~L 156 (327)
T 2yfx_A 78 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP-SQPSSLAMLDLLHVARDIACGCQYL 156 (327)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCS-SSTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccc-cccccccHHHHHHHHHHHHHHHHHH
Confidence 678999999999999999999999999999999999999999999998643211 1225689999999999999999999
Q ss_pred HHCCcEecccCCCcEEEcC---CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHH
Q psy11359 174 HSNGQIHRDIKAGNILLGE---DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLG 250 (520)
Q Consensus 174 H~~giiHrDLKp~NILl~~---~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG 250 (520)
|++||+||||||+|||++. ++.+||+|||++..+..... ........||+.|+|||++.+.. ++.++||||||
T Consensus 157 H~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG 232 (327)
T 2yfx_A 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFG 232 (327)
T ss_dssp HHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC---------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHH
T ss_pred hhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccc---cccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHH
Confidence 9999999999999999984 44699999999875533221 11223457899999999987665 89999999999
Q ss_pred HHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 251 ITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 251 ~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
|++|+|+| |..||..................... ..++..+.++|.+||+.||.+|||+.+++++.|+..
T Consensus 233 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 233 VLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP---------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 99999998 99999988777766666555433322 346788999999999999999999999999987643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=365.20 Aligned_cols=266 Identities=28% Similarity=0.531 Sum_probs=202.0
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+....++|++.+.||+|+||+||+|.+..+|+.||+|+++..... ....+.+..+..++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~~~~~~~ 78 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK---------------------EENKRILMDLDVVL 78 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH---------------------HHHHHHHHHHHHHH
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc---------------------hHHHHHHHHHHHHH
Confidence 455678899999999999999999999999999999987532110 11223345555678
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN-GQIHRD 182 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~-giiHrD 182 (520)
+.++||||+++++++...+.+|+||||+ ++.+..+... ..+.+++..+..++.||+.||.|||++ |++|||
T Consensus 79 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~d 150 (318)
T 2dyl_A 79 KSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR-------MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 150 (318)
T ss_dssp HTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH-------HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_pred HhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH-------hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCC
Confidence 8889999999999999999999999999 6666666553 346789999999999999999999995 999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc----cCCCCcchhHHHHHHHHHHHHh
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----DHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~~~~DIwSlG~il~ellt 258 (520)
|||+|||++.++.+||+|||++..+.... ......||+.|+|||++.. ...++.++|||||||++|+|++
T Consensus 151 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~ 224 (318)
T 2dyl_A 151 VKPSNILLDERGQIKLCDFGISGRLVDDK------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224 (318)
T ss_dssp CCGGGEEECTTSCEEECCCTTC--------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEECCCCCEEEEECCCchhccCCc------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHh
Confidence 99999999999999999999987654321 2234579999999999852 3348899999999999999999
Q ss_pred CCCCCCCC-cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 259 GTAPYHKY-PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 259 G~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
|..||... .....+.......++.++.. ..+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 225 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 225 GQFPYKNCKTDFEVLTKVLQEEPPLLPGH-------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp SSCTTTTCCSHHHHHHHHHHSCCCCCCSS-------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred CCCCCCCCCccHHHHHHHhccCCCCCCcc-------CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 99999874 44455555555554443321 24678999999999999999999999999999998643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=357.85 Aligned_cols=259 Identities=18% Similarity=0.197 Sum_probs=209.9
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+|+.||+|++... ...+.+.+|+.+++.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------------------~~~~~~~~e~~~~~~ 61 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-------------------------SDAPQLRDEYRTYKL 61 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-------------------------TTSCCHHHHHHHHHH
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-------------------------CccHHHHHHHHHHHH
Confidence 3567899999999999999999999999999999976421 112247889999999
Q ss_pred C-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 106 C-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 106 l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+ +|+||+++++++......++||||+ +++|.+++.. ....+++..+..++.||+.||.|||++||+|||||
T Consensus 62 l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 133 (298)
T 1csn_A 62 LAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL-------CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK 133 (298)
T ss_dssp TTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-------TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred HhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHH-------hccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 9 8999999999999999999999999 9999999985 34569999999999999999999999999999999
Q ss_pred CCcEEEcCCCC-----eEEeccCcceeeccCccccc--cccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 185 AGNILLGEDGT-----VQIADFGVSAWLATGRDLSR--QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 185 p~NILl~~~g~-----vkL~DFG~a~~~~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
|+|||++.++. +||+|||++..+........ ........||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 134 p~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~ 212 (298)
T 1csn_A 134 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFL 212 (298)
T ss_dssp GGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHH
T ss_pred HHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHH
Confidence 99999987765 99999999987754322111 11234568999999999987765 899999999999999999
Q ss_pred hCCCCCCCCc---HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 258 TGTAPYHKYP---AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 258 tG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+|+.||.... ....+.......... ........+++.+.++|.+||+.||.+|||+.++++
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 213 RGSLPWQGLKAATNKQKYERIGEKKQST-----PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HSSCTTSSCCSCCHHHHHHHHHHHHHHS-----CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCCCcchhhccccHHHHHHHHhhccCc-----cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 9999998743 222222221111000 011223467889999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=367.91 Aligned_cols=257 Identities=19% Similarity=0.198 Sum_probs=206.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+|+.||+|++.... ..+.+.+|+.++++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~E~~~l~~l 61 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-------------------------RAPQLHLEYRFYKQL 61 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-------------------------SSCCHHHHHHHHHHH
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-------------------------chHHHHHHHHHHHHh
Confidence 4578999999999999999999999999999999875321 112478999999999
Q ss_pred -CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 -HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 -~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+||||+++++++...+..++||||+ +++|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||
T Consensus 62 ~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp 133 (330)
T 2izr_A 62 GSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDL-------CDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKP 133 (330)
T ss_dssp CSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred hCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 9999999999999999999999999 9999999985 346799999999999999999999999999999999
Q ss_pred CcEEEcCCCC-----eEEeccCcceeeccCccccc--cccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 186 GNILLGEDGT-----VQIADFGVSAWLATGRDLSR--QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 186 ~NILl~~~g~-----vkL~DFG~a~~~~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
+|||++.++. +||+|||++..+........ ........||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 134 ~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~ 212 (330)
T 2izr_A 134 ENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLR 212 (330)
T ss_dssp GGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHH
T ss_pred HHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhc
Confidence 9999998887 99999999987644322111 11234678999999999998765 8999999999999999999
Q ss_pred CCCCCCCCcH---HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 259 GTAPYHKYPA---MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 259 G~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|..||..... .+.+..+........ .......++ ++.++|..||+.||.+||++.++++
T Consensus 213 g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 213 GSLPWQGLKADTLKERYQKIGDTKRATP-----IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp SSCTTTTCCCSSHHHHHHHHHHHHHHSC-----HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCCCccccccccHHHHHHHHHhhhccCC-----HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 9999987432 222222211110000 011112244 8999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=369.97 Aligned_cols=266 Identities=24% Similarity=0.378 Sum_probs=214.8
Q ss_pred CCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHH
Q psy11359 20 VSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKE 99 (520)
Q Consensus 20 ~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~E 99 (520)
+..+.....++|++.+.||+|+||+||+|.+..+++.||+|+++....... ... ...+.+.+|
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----------~~~------~~~~~~~~E 96 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-----------GEL------PNGTRVPME 96 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCE-----------EEC------TTCCEEEHH
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhh-----------hhh------hhhhHHHHH
Confidence 334556678899999999999999999999999999999999865422100 000 011235678
Q ss_pred HHHHhcCC--CCCceEEEEEEEECCEEEEEEEccCC-CCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 100 IQAMSSCH--HENVVTYHTSFVVKDELWLVLRLLEG-GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 100 i~~l~~l~--HpnIv~~~~~~~~~~~~~lV~E~~~g-gsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
+.++++++ ||||+++++++...+..++|||++.+ ++|.+++.. .+.+++..++.++.||+.||.|||++
T Consensus 97 ~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~ 168 (320)
T 3a99_A 97 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE--------RGALQEELARSFFWQVLEAVRHCHNC 168 (320)
T ss_dssp HHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH--------HCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99999985 59999999999999999999999976 899999985 35689999999999999999999999
Q ss_pred CcEecccCCCcEEEc-CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLG-EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 177 giiHrDLKp~NILl~-~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
||+||||||+|||++ +++.+||+|||++..+... ......||+.|+|||++.+...++.++|||||||++|+
T Consensus 169 ~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~e 241 (320)
T 3a99_A 169 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 241 (320)
T ss_dssp TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHH
T ss_pred CcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHH
Confidence 999999999999998 7899999999999876422 22346799999999998776645789999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 256 MATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 256 lltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
|+||..||..... . .... ... ...+++.+.+||.+||+.||.+|||+.++++||||+.....
T Consensus 242 l~~g~~pf~~~~~--~----~~~~-~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 242 MVCGDIPFEHDEE--I----IRGQ-VFF---------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303 (320)
T ss_dssp HHHSSCSCCSHHH--H----HHCC-CCC---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred HHHCCCCCCChhh--h----hccc-ccc---------cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence 9999999976322 1 1111 111 13467889999999999999999999999999999976543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=368.12 Aligned_cols=267 Identities=23% Similarity=0.402 Sum_probs=216.6
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcC-------CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKA-------RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDE 95 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~ 95 (520)
.|....++|++.+.||+|+||+||+|.+.. ++..||+|++ .........+.
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~----------------------~~~~~~~~~~~ 86 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----------------------KDDATEKDLSD 86 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEEC----------------------CTTCCHHHHHH
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeee----------------------ccCCcHHHHHH
Confidence 477788999999999999999999999863 4445565554 33333445678
Q ss_pred HHHHHHHHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--------cCCCCCCCHHHHHHHHHHH
Q psy11359 96 LLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--------NCKHGVCDEPTIATVLREV 166 (520)
Q Consensus 96 l~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--------~~~~~~l~~~~i~~i~~qI 166 (520)
+.+|+.+++++ +||||+++++++...+.+|+||||+.+++|.+++....... ......+++..+..++.||
T Consensus 87 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 166 (334)
T 2pvf_A 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 166 (334)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHH
Confidence 99999999999 99999999999999999999999999999999998542110 0012358999999999999
Q ss_pred HHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhH
Q psy11359 167 LKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADI 246 (520)
Q Consensus 167 l~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DI 246 (520)
+.||.|||++||+||||||+|||++.++.+||+|||++..+...... .......+|+.|+|||++.+.. ++.++||
T Consensus 167 ~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 242 (334)
T 2pvf_A 167 ARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEALFDRV-YTHQSDV 242 (334)
T ss_dssp HHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSE---ECCSCCCCCGGGCCHHHHHHCE-ECHHHHH
T ss_pred HHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccc---cccCCCCcccceeChHHhcCCC-cChHHHH
Confidence 99999999999999999999999999999999999999876433211 1123346788999999987655 8999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 247 WSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 247 wSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|||||++|+|+| |..||......+.............. ..++..+.++|.+||+.||.+|||+.+++++
T Consensus 243 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 243 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCC---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999 99999988777766655554433322 3467889999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=365.09 Aligned_cols=263 Identities=21% Similarity=0.337 Sum_probs=208.9
Q ss_pred CCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCc----eEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHH
Q psy11359 21 SVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAE----KCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDEL 96 (520)
Q Consensus 21 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l 96 (520)
.+.+.....+|++.+.||+|+||+||+|.+..++. .||+|++ ...........+
T Consensus 36 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~----------------------~~~~~~~~~~~~ 93 (333)
T 1mqb_A 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL----------------------KAGYTEKQRVDF 93 (333)
T ss_dssp --CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEE----------------------CTTCCHHHHHHH
T ss_pred hccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEc----------------------CCCCCHHHHHHH
Confidence 44566788899999999999999999998876532 3565554 332223455678
Q ss_pred HHHHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 97 LKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 97 ~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
.+|+.++++++||||+++++++...+..++||||+.+++|.+++.. ..+.+++..+..++.||+.||.|||++
T Consensus 94 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~ 166 (333)
T 1mqb_A 94 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-------KDGEFSVLQLVGMLRGIAAGMKYLANM 166 (333)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH-------TTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999999999999999999975 356799999999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
||+||||||+|||++.++.+||+|||++..+...... ........+|+.|+|||++.+.. ++.++|||||||++|+|
T Consensus 167 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el 243 (333)
T 1mqb_A 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA--TYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEV 243 (333)
T ss_dssp TCCCSCCCGGGEEECTTCCEEECCCCC-------------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHH
T ss_pred CeeCCCCChheEEECCCCcEEECCCCcchhhcccccc--ccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHH
Confidence 9999999999999999999999999999876432211 11122345688999999997655 89999999999999999
Q ss_pred Hh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 257 AT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 257 lt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
++ |..||..................... ..++..+.++|.+||+.||.+|||+.+++++
T Consensus 244 lt~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 244 MTYGERPYWELSNHEVMKAINDGFRLPTP---------MDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHTTCCCCCC---------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HcCCCCCcccCCHHHHHHHHHCCCcCCCc---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99 99999888877766655554332221 3467889999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=365.33 Aligned_cols=271 Identities=23% Similarity=0.368 Sum_probs=216.7
Q ss_pred CCCCCCCCCCCeEEEeeeeecCceEEEEEEE-----cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHH
Q psy11359 20 VSVPWPNTEDQYEVREVIGFGATAVVHSAYC-----KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMD 94 (520)
Q Consensus 20 ~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~ 94 (520)
....|....++|++.+.||+|+||+||+|.+ ..+++.||+|+++ ........+
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~----------------------~~~~~~~~~ 71 (313)
T 1t46_A 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK----------------------PSAHLTERE 71 (313)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEEC----------------------TTCCHHHHH
T ss_pred CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcC----------------------cchhHHHHH
Confidence 3445777889999999999999999999986 3455666666653 222234457
Q ss_pred HHHHHHHHHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc----------cCCCCCCCHHHHHHHH
Q psy11359 95 ELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS----------NCKHGVCDEPTIATVL 163 (520)
Q Consensus 95 ~l~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~----------~~~~~~l~~~~i~~i~ 163 (520)
.+.+|+.+++++ +||||+++++++...+..++||||+.+|+|.+++....... ......+++..+..++
T Consensus 72 ~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (313)
T 1t46_A 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151 (313)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHH
T ss_pred HHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHH
Confidence 799999999999 99999999999999999999999999999999998642110 0012358999999999
Q ss_pred HHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcc
Q psy11359 164 REVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFK 243 (520)
Q Consensus 164 ~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 243 (520)
.||+.||.|||++|++||||||+|||++.++.+||+|||++........ ........||+.|+|||++.+.. ++.+
T Consensus 152 ~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~ 227 (313)
T 1t46_A 152 YQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN---YVVKGNARLPVKWMAPESIFNCV-YTFE 227 (313)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT---SEECSSSEECGGGCCHHHHHHCC-CCHH
T ss_pred HHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEcccccccccccccc---ceeccCCCCcceeeChHHhcCCC-CChH
Confidence 9999999999999999999999999999999999999999977644322 11233456789999999987665 8999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 244 ADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 244 ~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
+|||||||++|+|+| |..||..................... ...++..+.++|.+||+.||.+|||+.|++
T Consensus 228 ~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell 299 (313)
T 1t46_A 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS--------PEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (313)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCC--------cccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 999999999999999 99999877655444443332221111 134678899999999999999999999998
Q ss_pred cC
Q psy11359 323 KN 324 (520)
Q Consensus 323 ~h 324 (520)
++
T Consensus 300 ~~ 301 (313)
T 1t46_A 300 QL 301 (313)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=369.47 Aligned_cols=273 Identities=22% Similarity=0.350 Sum_probs=216.1
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.|....++|++.+.||+|+||+||+|.+..++...+ ...+|+|.+.........+.+.+|+.+
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~ 102 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDA-----------------VLKVAVKMLKSTAHADEKEALMSELKI 102 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCC-----------------CCEEEEEEECTTCCHHHHHHHHHHHHH
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccc-----------------hhHHHHHhcccccChHHHHHHHHHHHH
Confidence 467778999999999999999999999988765211 123344444433334456779999999
Q ss_pred HhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcccc------CCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11359 103 MSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN------CKHGVCDEPTIATVLREVLKGLEYFHS 175 (520)
Q Consensus 103 l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~------~~~~~l~~~~i~~i~~qIl~gL~yLH~ 175 (520)
++++ +||||+++++++...+.+|+||||+.+|+|.+++........ .....+++..+..++.||+.||.|||+
T Consensus 103 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 9999 899999999999999999999999999999999986532210 013568999999999999999999999
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
+||+||||||+|||++.++.+||+|||++..+..... ........||+.|+|||++.+.. ++.++|||||||++|+
T Consensus 183 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e 258 (333)
T 2i1m_A 183 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN---YIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWE 258 (333)
T ss_dssp TTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTT---SEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHH
T ss_pred CCcccCCcccceEEECCCCeEEECccccccccccccc---eeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHH
Confidence 9999999999999999999999999999986643321 11223456788999999987665 8999999999999999
Q ss_pred HHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 256 MAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 256 llt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|+| |..||..................... ...+++.+.++|.+||+.||.+|||+.+++++
T Consensus 259 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 259 IFSLGLNPYPGILVNSKFYKLVKDGYQMAQ--------PAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HTTTSCCSSTTCCSSHHHHHHHHHTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCcccchhHHHHHHHhcCCCCCC--------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 999 99999876654444433332211111 12357889999999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=358.62 Aligned_cols=259 Identities=21% Similarity=0.327 Sum_probs=212.4
Q ss_pred CCCCCCCCeEEEe-eeeecCceEEEEEEE--cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHH
Q psy11359 23 PWPNTEDQYEVRE-VIGFGATAVVHSAYC--KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKE 99 (520)
Q Consensus 23 ~~~~~~~~Y~i~~-~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~E 99 (520)
.+....++|++.+ .||+|+||+||+|.+ ..+++.||+|+++... ......+++.+|
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---------------------~~~~~~~~~~~e 68 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------------------NDPALKDELLAE 68 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------------------------CHHHHHHHHH
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc---------------------cCHHHHHHHHHH
Confidence 3455678999999 999999999999954 5667778888764221 012345679999
Q ss_pred HHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 100 IQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 100 i~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+.++++++||||+++++++ ..+..++||||+.+++|.+++.. .+.+++..+..++.||+.||.|||++|++
T Consensus 69 ~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~ 139 (291)
T 1xbb_A 69 ANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ--------NRHVKDKNIIELVHQVSMGMKYLEESNFV 139 (291)
T ss_dssp HHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH--------CTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh--------CcCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 9999999999999999998 67788999999999999999974 45689999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT- 258 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt- 258 (520)
||||||+|||++.++.+||+|||++..+...... ........||+.|+|||++.+.. ++.++||||||+++|+|+|
T Consensus 140 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~ 216 (291)
T 1xbb_A 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSY 216 (291)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE--EEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTT
T ss_pred cCCCCcceEEEeCCCcEEEccCCcceeeccCCCc--ccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhc
Confidence 9999999999999999999999999876443221 11122345678999999997655 8899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|..||.................+..+ ..+++.+.++|.+||+.||.+|||+.++++
T Consensus 217 g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 217 GQKPYRGMKGSEVTAMLEKGERMGCP---------AGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999988877776666555443332 356889999999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=375.76 Aligned_cols=260 Identities=21% Similarity=0.361 Sum_probs=202.7
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEc---CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCK---ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKE 99 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~E 99 (520)
......++|++.+.||+|+||.||+|.++ .++..||+|+++. .......+++.+|
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~----------------------~~~~~~~~~~~~E 96 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV----------------------GYTEKQRRDFLGE 96 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCT----------------------TCCHHHHHHHHHH
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecC----------------------ccCHHHHHHHHHH
Confidence 34456678999999999999999999887 4555677776542 2223345679999
Q ss_pred HHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 100 IQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 100 i~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+.++++++||||+++++++...+.+|+||||+.+++|.+++.. ....+++..+..++.||+.||.|||++||+
T Consensus 97 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 169 (373)
T 2qol_A 97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-------HDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169 (373)
T ss_dssp HHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT-------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 9999999999999999999999999999999999999999974 345799999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT- 258 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt- 258 (520)
||||||+|||++.++.+||+|||++..+...... ........+|+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 170 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~ 246 (373)
T 2qol_A 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA--AYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSY 246 (373)
T ss_dssp CSCCCGGGEEECTTCCEEECCC------------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCcceEEEcCCCCEEECcCccccccccCCcc--ceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhC
Confidence 9999999999999999999999999876432211 11112234678899999997665 8999999999999999998
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|..||......+.............. ..++..+.++|.+||+.||.+|||+.++++
T Consensus 247 g~~P~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 247 GERPYWEMSNQDVIKAVDEGYRLPPP---------MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp C-CTTTTCCHHHHHHHHHTTEECCCC---------TTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCC---------ccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 99999988877766655544222211 246788999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=380.26 Aligned_cols=251 Identities=25% Similarity=0.426 Sum_probs=211.8
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
..|....++|++.+.||+|+||.||+|... |+.||+|+++.. ...+.+.+|+.
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~-------------------------~~~~~~~~E~~ 238 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-------------------------ATAQAFLAEAS 238 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC-------------------------TTSHHHHHHHH
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc-------------------------hHHHHHHHHHH
Confidence 357788899999999999999999999875 667888876421 13456899999
Q ss_pred HHhcCCCCCceEEEEEEEECC-EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 102 AMSSCHHENVVTYHTSFVVKD-ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~-~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+|++++||||+++++++...+ .+|+||||+.+|+|.++++.. ....+++..+..++.||+.||.|||++||+|
T Consensus 239 ~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH 312 (450)
T 1k9a_A 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR------GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312 (450)
T ss_dssp HHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH------CTTTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 999999999999999988665 799999999999999999864 3345799999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-C
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G 259 (520)
|||||+|||++.++.+||+|||++...... .....+|+.|+|||++.+.. ++.++|||||||++|+|+| |
T Consensus 313 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~--------~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g 383 (450)
T 1k9a_A 313 RDLAARNVLVSEDNVAKVSDFGLTKEASST--------QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFG 383 (450)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEECC--------------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCCHhhEEECCCCCEEEeeCCCccccccc--------ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999998754221 12336788999999997665 8999999999999999998 9
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
..||......+....+..+.....+ ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 384 ~~P~~~~~~~~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 384 RVPYPRIPLKDVVPRVEKGYKMDAP---------DGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCSSTTSCTTTHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCC---------CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999988777666665555433322 356889999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=365.29 Aligned_cols=258 Identities=25% Similarity=0.339 Sum_probs=202.5
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|-...++|++.++||+|+||+||+|.+. ++.||+|+++.. ........+|+.++
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~------------------------~~~~~~~~~E~~~l 72 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ------------------------DKQSWQNEYEVYSL 72 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG------------------------GHHHHHHHHHHHTS
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC------------------------chHHHHHHHHHHHH
Confidence 3456688999999999999999999875 678888877432 12233456799999
Q ss_pred hcCCCCCceEEEEEEEECC----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC---
Q psy11359 104 SSCHHENVVTYHTSFVVKD----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN--- 176 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~--- 176 (520)
++++||||+++++++.... .+|+||||+.+|+|.++++. +.+++..+..++.||+.||.|||++
T Consensus 73 ~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~i~~qi~~al~~LH~~~~~ 143 (322)
T 3soc_A 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---------NVVSWNELCHIAETMARGLAYLHEDIPG 143 (322)
T ss_dssp TTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHTCCEEE
T ss_pred hcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHhhccc
Confidence 9999999999999998743 48999999999999999974 3589999999999999999999999
Q ss_pred -------CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc----CCCCcchh
Q psy11359 177 -------GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD----HGYDFKAD 245 (520)
Q Consensus 177 -------giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~~~~D 245 (520)
||+||||||+|||++.++.+||+|||++..+..... ........||+.|+|||++.+. ..++.++|
T Consensus 144 l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 220 (322)
T 3soc_A 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS---AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220 (322)
T ss_dssp ETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSC---CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHH
T ss_pred cccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccC---ccccccCccCccccCHhhcccccccCcCCCccch
Confidence 999999999999999999999999999987754332 1123346899999999998763 22567899
Q ss_pred HHHHHHHHHHHHhCCCCCCCCcH---------------HHHHHH-HhcCC-CCCCCCCchhhhhHHHhcHHHHHHHHhhh
Q psy11359 246 IWSLGITAIEMATGTAPYHKYPA---------------MKVLML-TLQND-PPTLDTGAAEKDQYKAYGKTFRKMISDCL 308 (520)
Q Consensus 246 IwSlG~il~elltG~~Pf~~~~~---------------~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L 308 (520)
||||||++|+|+||..||.+... ...+.. ..... .+.+.. .......++.+.+||.+||
T Consensus 221 iwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl 296 (322)
T 3soc_A 221 MYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD----YWQKHAGMAMLCETIEECW 296 (322)
T ss_dssp HHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCG----GGGSSHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccc----cccccchHHHHHHHHHHHc
Confidence 99999999999999999965321 111211 11111 111111 1111234567999999999
Q ss_pred ccCCCCCCCHHHHhc
Q psy11359 309 QKDPTKRPTASELLK 323 (520)
Q Consensus 309 ~~dP~~Rpta~elL~ 323 (520)
+.||.+|||+.|+++
T Consensus 297 ~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 297 DHDAEARLSAGCVGE 311 (322)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=389.88 Aligned_cols=257 Identities=22% Similarity=0.401 Sum_probs=218.7
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.|....++|++.+.||+|+||.||+|.++.++..||+|.++.. ....+++.+|+.+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------------------------~~~~~~~~~E~~~ 269 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------------------TMEVEEFLKEAAV 269 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS------------------------SSCHHHHHHHHHH
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc------------------------ccchHHHHHHHHH
Confidence 5777889999999999999999999999999888888876421 1235679999999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
|++++||||+++++++.....+|+||||+.+|+|.++++.. ....+++..+..++.||+.||.|||++||+|||
T Consensus 270 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrD 343 (495)
T 1opk_A 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRN 343 (495)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS------CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc------CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 99999999999999999999999999999999999999853 345689999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTA 261 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~ 261 (520)
|||+|||++.++.+||+|||++..+..... .......+|+.|+|||++.... ++.++|||||||++|+|+| |..
T Consensus 344 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~ 418 (495)
T 1opk_A 344 LAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMS 418 (495)
T ss_dssp CSGGGEEECGGGCEEECCTTCEECCTTCCE----ECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CChhhEEECCCCcEEEeecccceeccCCce----eecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCC
Confidence 999999999999999999999987643211 1122345678999999997665 8999999999999999999 999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
||.+..................+ ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 419 p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 419 PYPGIDLSQVYELLEKDYRMERP---------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 99988776666555444322221 356789999999999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=358.32 Aligned_cols=260 Identities=22% Similarity=0.361 Sum_probs=207.0
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEE----EcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAY----CKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
+.....++|++.+.||+|+||.||+|. +..+++.||+|+++. .......+.+.+
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~----------------------~~~~~~~~~~~~ 72 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP----------------------ESGGNHIADLKK 72 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------------------------CCHHHHHH
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecc----------------------cccchhHHHHHH
Confidence 344566789999999999999999998 566777788887642 222334577999
Q ss_pred HHHHHhcCCCCCceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
|+.++++++||||+++++++... ..+++||||+.+++|.+++.. ....+++..+..++.||+.||.|||++
T Consensus 73 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~ 145 (302)
T 4e5w_A 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-------NKNKINLKQQLKYAVQICKGMDYLGSR 145 (302)
T ss_dssp HHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHH-------HTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh-------ccccCCHHHHHHHHHHHHHHHHHhhcC
Confidence 99999999999999999999876 679999999999999999965 245689999999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
||+||||||+|||++.++.+||+|||++..+..... .........||+.|+|||++.+.. ++.++|||||||++|+|
T Consensus 146 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l 222 (302)
T 4e5w_A 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE--YYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHEL 222 (302)
T ss_dssp TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCC--EEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHH
T ss_pred CcccCCCchheEEEcCCCCEEECcccccccccCCCc--ceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHH
Confidence 999999999999999999999999999987654332 112234457899999999987665 88999999999999999
Q ss_pred HhCCCCCCCCc--------------HHHHHHHHhc-CCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH
Q psy11359 257 ATGTAPYHKYP--------------AMKVLMLTLQ-NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321 (520)
Q Consensus 257 ltG~~Pf~~~~--------------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el 321 (520)
+||..|+.... ....+..... ...... ...+++.+.+||.+||+.||.+|||+.++
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l 293 (302)
T 4e5w_A 223 LTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC---------PPNCPDEVYQLMRKCWEFQPSNRTSFQNL 293 (302)
T ss_dssp HTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred HHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCC---------CCCCCHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 99998864321 1111111111 111111 13567899999999999999999999999
Q ss_pred hc
Q psy11359 322 LK 323 (520)
Q Consensus 322 L~ 323 (520)
++
T Consensus 294 l~ 295 (302)
T 4e5w_A 294 IE 295 (302)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=382.53 Aligned_cols=266 Identities=25% Similarity=0.369 Sum_probs=200.5
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+.....+|.+.++||+|+||+||. ....+|+.||||++.... ...+.+|+.+|
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--------------------------~~~~~~E~~~l 71 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--------------------------FSFADREVQLL 71 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--------------------------EEECHHHHHHH
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--------------------------HHHHHHHHHHH
Confidence 344566799999999999999763 455678888888774211 01246799999
Q ss_pred hcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 104 SSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 104 ~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
+.+ +|||||++++++.+...+|+||||+. |+|.+++.. ....+++..+..++.||+.||.|||++||+|||
T Consensus 72 ~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 143 (432)
T 3p23_A 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ-------KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRD 143 (432)
T ss_dssp HHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHS-------SSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHh-------cCCCccchhHHHHHHHHHHHHHHHHHCcCEeCC
Confidence 999 89999999999999999999999995 699999975 234455667789999999999999999999999
Q ss_pred cCCCcEEEcC---CC--CeEEeccCcceeeccCccccccccccccccccccCCcceecc--cCCCCcchhHHHHHHHHHH
Q psy11359 183 IKAGNILLGE---DG--TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ--DHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 183 LKp~NILl~~---~g--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DIwSlG~il~e 255 (520)
|||+|||++. ++ .+||+|||++..+..+.. ........+||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 144 lKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~e 221 (432)
T 3p23_A 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH--SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 221 (432)
T ss_dssp CSTTSEEECCCBTTTBCCEEECCTTEEECC--------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHH
T ss_pred CCHHHEEEecCCCCCceeEEEecccceeeccCCCc--ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHH
Confidence 9999999953 33 578999999987653321 1122345689999999999874 2347889999999999999
Q ss_pred HHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 256 MAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 256 llt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
|+| |..||.......... .......... ......+..+.+||.+||+.||.+|||+.++++||||+.....
T Consensus 222 llt~g~~pf~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 222 VISEGSHPFGKSLQRQANI-LLGACSLDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp HHTTSCBTTBSTTTHHHHH-HTTCCCCTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHHH
T ss_pred HHcCCCCCcchhhHHHHHH-HhccCCcccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHHH
Confidence 999 999996654433322 2222111110 0113456678999999999999999999999999999876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=382.63 Aligned_cols=256 Identities=23% Similarity=0.438 Sum_probs=214.3
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
..|....++|++.+.||+|+||+||+|.+.. +..||+|+++.. ....+.+.+|+.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~------------------------~~~~~~~~~E~~ 235 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG------------------------SMSVEAFLAEAN 235 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTT------------------------SBCHHHHHHHHH
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCC------------------------CccHHHHHHHHH
Confidence 4577888999999999999999999998864 566777766421 124567999999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+|++++||||+++++++. .+.+|+||||+.+|+|.++++.. ....+++..+..++.||+.||.|||++||+||
T Consensus 236 ~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr 308 (454)
T 1qcf_A 236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD------EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308 (454)
T ss_dssp HHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH------HHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 999999999999999886 67799999999999999999753 12357899999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GT 260 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~ 260 (520)
||||+|||++.++.+||+|||+++.+.... ........+|+.|+|||++.... ++.++|||||||++|+|+| |.
T Consensus 309 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~ 383 (454)
T 1qcf_A 309 DLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGR 383 (454)
T ss_dssp SCSGGGEEECTTCCEEECSTTGGGGBCCHH----HHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCHHHEEECCCCcEEEeeCCCceEcCCCc----eeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCC
Confidence 999999999999999999999997653221 11122345678999999997665 8999999999999999999 99
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.||.+....+....+..+.....+ ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 384 ~P~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 384 IPYPGMSNPEVIRALERGYRMPRP---------ENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CSSTTCCHHHHHHHHHHTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 999998888777666655333222 356789999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=356.33 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=206.0
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+..+++.||+|++......... ......+.+.+|+.++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----------------~~~~~~~~~~~E~~~l~~ 79 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET----------------EMIEKFQEFQREVFIMSN 79 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCH----------------HHHCCSHHHHHHHHHHTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccch----------------hHHHHHHHHHHHHHHHHh
Confidence 4668899999999999999999999999999999987532211000 001122678999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccc
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG--QIHRDI 183 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g--iiHrDL 183 (520)
++||||+++++++.... ++||||+.+++|.+++.. ....+++..+..++.||+.||.|||++| ++||||
T Consensus 80 l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~di 150 (287)
T 4f0f_A 80 LNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD-------KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150 (287)
T ss_dssp CCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHC-------TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCC
T ss_pred CCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhc-------ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCC
Confidence 99999999999986555 699999999999999874 4567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCC-----eEEeccCcceeeccCccccccccccccccccccCCcceecc-cCCCCcchhHHHHHHHHHHHH
Q psy11359 184 KAGNILLGEDGT-----VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ-DHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 184 Kp~NILl~~~g~-----vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~~DIwSlG~il~ell 257 (520)
||+|||++.++. +||+|||++..... ......||+.|+|||++.. ...++.++|||||||++|+|+
T Consensus 151 kp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~ 222 (287)
T 4f0f_A 151 RSPNIFLQSLDENAPVCAKVADFGLSQQSVH--------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222 (287)
T ss_dssp SGGGEEESCCCTTCSCCEEECCCTTCBCCSS--------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH
T ss_pred CcceEEEeccCCCCceeEEeCCCCccccccc--------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH
Confidence 999999988776 99999999864321 2234679999999999843 233789999999999999999
Q ss_pred hCCCCCCCCcHHHH--HHHHhcC-CCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 258 TGTAPYHKYPAMKV--LMLTLQN-DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 258 tG~~Pf~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+|..||........ ....... ..+... ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 223 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 223 TGEGPFDEYSYGKIKFINMIREEGLRPTIP---------EDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HSSCTTTTCCCCHHHHHHHHHHSCCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCccccccHHHHHHHHhccCCCCCCC---------cccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999986554332 2222222 222221 356889999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=366.58 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=202.4
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
.....++|++.+.||+|+||+||+|.+..+++.||+|+++........ .......+.+|+.++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----------------~~~~~~~~~~e~~~l 88 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS-----------------PLSDSVTCPLEVALL 88 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-------------------------CCCCHHHHHH
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccc-----------------cchhhHHHHHHHHHH
Confidence 445678899999999999999999999999999999988643221100 001122356788888
Q ss_pred hcC----CCCCceEEEEEEEECCEEEEEEEc-cCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 104 SSC----HHENVVTYHTSFVVKDELWLVLRL-LEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 104 ~~l----~HpnIv~~~~~~~~~~~~~lV~E~-~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
+++ +||||+++++++...+..++|||| +.+++|.+++.. .+.+++..++.++.||+.||.|||++||
T Consensus 89 ~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~i 160 (312)
T 2iwi_A 89 WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--------KGPLGEGPSRCFFGQVVAAIQHCHSRGV 160 (312)
T ss_dssp HHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH--------HCSCCHHHHHHHHHHHHHHHHHHHHHTE
T ss_pred HhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 888 899999999999999999999999 789999999985 3468999999999999999999999999
Q ss_pred EecccCCCcEEEc-CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 179 IHRDIKAGNILLG-EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 179 iHrDLKp~NILl~-~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
+||||||+|||++ .++.+||+|||++..+... ......||+.|+|||++.+...++.++|||||||++|+|+
T Consensus 161 ~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 233 (312)
T 2iwi_A 161 VHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233 (312)
T ss_dssp ECCCCSGGGEEEETTTTEEEECCCSSCEECCSS-------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred eecCCChhhEEEeCCCCeEEEEEcchhhhcccC-------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHH
Confidence 9999999999998 8899999999999876432 1235679999999999876654566999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 258 TGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 258 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
+|..||..... . .... ..+ ...++..+.+||.+||+.||.+|||+.|+++||||+....
T Consensus 234 ~g~~pf~~~~~--~----~~~~-~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 234 CGDIPFERDQE--I----LEAE-LHF---------PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp HSSCSCCSHHH--H----HHTC-CCC---------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred HCCCCCCChHH--H----hhhc-cCC---------cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 99999976322 1 1111 111 1346788999999999999999999999999999986543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=354.11 Aligned_cols=252 Identities=17% Similarity=0.276 Sum_probs=209.7
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+....++|++.+.||+|+||+||+|.+. ++.||+|+++.... .....+.+.+|+.++
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~---------------------~~~~~~~~~~E~~~l 61 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW---------------------STRKSRDFNEECPRL 61 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC---------------------CHHHHHHHHHHGGGG
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc---------------------CHHHHHHHHHHHHHH
Confidence 4567789999999999999999999985 77788887653211 123456799999999
Q ss_pred hcCCCCCceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cE
Q psy11359 104 SSCHHENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG--QI 179 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g--ii 179 (520)
++++||||+++++++... ...++||||++||+|.+++... ....+++..+..++.||+.||.|||++| ++
T Consensus 62 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~ 135 (271)
T 3kmu_A 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG------TNFVVDQSQAVKFALDMARGMAFLHTLEPLIP 135 (271)
T ss_dssp CCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC------SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCT
T ss_pred HhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCcee
Confidence 999999999999999876 7899999999999999999742 2336899999999999999999999999 99
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC--CCCcchhHHHHHHHHHHHH
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH--GYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~~DIwSlG~il~ell 257 (520)
||||||+|||++.++.++|+|||++.... .....||+.|+|||++.+.. .++.++|||||||++|+|+
T Consensus 136 H~dikp~Nil~~~~~~~~l~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 205 (271)
T 3kmu_A 136 RHALNSRSVMIDEDMTARISMADVKFSFQ----------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205 (271)
T ss_dssp TCCCSGGGEEECTTSCEEEEGGGSCCTTS----------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHH
T ss_pred cCCCccceEEEcCCcceeEEeccceeeec----------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999998764321 22457899999999987643 1334899999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhcCC-CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 258 TGTAPYHKYPAMKVLMLTLQND-PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 258 tG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
||..||................ .+..+ ..+++.+.++|.+||+.||.+|||+.++++
T Consensus 206 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 206 TREVPFADLSNMEIGMKVALEGLRPTIP---------PGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HCSCTTTTSCHHHHHHHHHHSCCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCccccChHHHHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999888777766555443 22221 356889999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=358.46 Aligned_cols=269 Identities=24% Similarity=0.452 Sum_probs=199.5
Q ss_pred CCCCCCCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHH
Q psy11359 16 SSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDE 95 (520)
Q Consensus 16 ~~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~ 95 (520)
++..-..++....++|++.+.||+|+||+||+|.+.. .||+|+++... ......+.
T Consensus 11 ~~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~---------------------~~~~~~~~ 66 (289)
T 3og7_A 11 GSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA---------------------PTPQQLQA 66 (289)
T ss_dssp -------CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS---------------------CCHHHHHH
T ss_pred CCCCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC---------------------CCHHHHHH
Confidence 3333444577889999999999999999999997643 47777664221 11334677
Q ss_pred HHHHHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11359 96 LLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS 175 (520)
Q Consensus 96 l~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~ 175 (520)
+.+|+.++++++||||++++++ .....+++||||+.|++|.+++.. ....+++..+..++.||+.||.|||+
T Consensus 67 ~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~qi~~~L~~lH~ 138 (289)
T 3og7_A 67 FKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHA-------SETKFEMKKLIDIARQTARGMDYLHA 138 (289)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEE-ECSSSCEEEEECCCEEEHHHHHTT-------C---CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCcEEEEEee-ccCCccEEEEEecCCCcHHHHHhh-------ccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 8999999999999999999995 456678999999999999999964 34678999999999999999999999
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceec--ccCCCCcchhHHHHHHHH
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME--QDHGYDFKADIWSLGITA 253 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~~~~DIwSlG~il 253 (520)
+||+||||||+|||++.++.+||+|||++....... .........||+.|+|||++. ....++.++|||||||++
T Consensus 139 ~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 215 (289)
T 3og7_A 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS---GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215 (289)
T ss_dssp TTCCCSCCCGGGEEEETTTEEEECCCC---------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHH
T ss_pred CCcccccCccceEEECCCCCEEEccceecccccccc---ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHH
Confidence 999999999999999999999999999987654221 122234567999999999986 233478899999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 254 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|+|++|..||........+............. ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 216 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 216 YELMTGQLPYSNINNRDQIIEMVGRGSLSPDL----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHCCCCccccchHHHHHHHhcccccCcch----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999998866655554443332111111 1112457889999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=368.07 Aligned_cols=270 Identities=20% Similarity=0.286 Sum_probs=211.3
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
......++|++.+.||+|+||+||+|.+. +|..||+|++... .....+.+.+|+.+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----------------------~~~~~~~~~~E~~~ 88 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE-----------------------SSQGIEEFETEIET 88 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC-----------------------CSSHHHHHHHHHHG
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc-----------------------ChHHHHHHHHHHHH
Confidence 34456789999999999999999999864 6778888865321 12345678999999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
++.++||||+++++++...+..++||||+.+|+|.+++..... ....+++..+..++.||+.||.|||++|++|||
T Consensus 89 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~d 164 (321)
T 2qkw_B 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL----PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164 (321)
T ss_dssp GGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCC----CSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCC----CccccCHHHHHHHHHHHHHHHHHhcCCCeecCC
Confidence 9999999999999999999999999999999999998854211 234689999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|||+|||++.++.+||+|||++....... .........||+.|+|||++.+.. ++.++|||||||++|+|+||..|
T Consensus 165 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p 240 (321)
T 2qkw_B 165 VKSINILLDENFVPKITDFGISKKGTELD---QTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSA 240 (321)
T ss_dssp CCSTTEEECTTCCEEECCCTTCEECSSSS---CCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTT
T ss_pred CCHHHEEECCCCCEEEeeccccccccccc---ccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCc
Confidence 99999999999999999999997653221 112234457999999999987665 89999999999999999999999
Q ss_pred CCCCcHHHH------H-HHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 263 YHKYPAMKV------L-MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 263 f~~~~~~~~------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|....+... . .......................++..+.+++.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp CSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 975432111 0 0111111111111111112234667889999999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=355.97 Aligned_cols=257 Identities=18% Similarity=0.324 Sum_probs=208.3
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCC---CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKAR---AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
|....++|++.+.||+|+||+||+|.+... +..||+|.++ ........+.+.+|+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~----------------------~~~~~~~~~~~~~E~ 64 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK----------------------KDCTLDNKEKFMSEA 64 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECC----------------------TTSCHHHHHHHHHHH
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecc----------------------cccCchHHHHHHHHH
Confidence 566788999999999999999999987653 2346666543 332234567799999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
.++++++||||+++++++.. +..|+||||+.+++|.+++... ...+++..+..++.||+.||.|||++|++|
T Consensus 65 ~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 136 (281)
T 3cc6_A 65 VIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERN-------KNSLKVLTLVLYSLQICKAMAYLESINCVH 136 (281)
T ss_dssp HHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHH-------TTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhc-------cccCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 99999999999999998764 4568999999999999999752 456899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-C
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G 259 (520)
|||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|+| |
T Consensus 137 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g 211 (281)
T 3cc6_A 137 RDIAVRNILVASPECVKLGDFGLSRYIEDEDY----YKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFG 211 (281)
T ss_dssp CCCSGGGEEEEETTEEEECCCCGGGCC-------------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCccceEEECCCCcEEeCccCCCcccccccc----cccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCC
Confidence 99999999999999999999999876543221 1123346788999999997655 8999999999999999998 9
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
..||....................+ ..+++.+.++|.+||..||.+|||+.|++++
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 212 KQPFFWLENKDVIGVLEKGDRLPKP---------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CCTTTTSCGGGHHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccCChHHHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999876666555554444333222 3467889999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=359.65 Aligned_cols=259 Identities=23% Similarity=0.358 Sum_probs=202.9
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
+...++|++.+.||+|+||+||+|.+..+++.||+|+++..... .....+.+.+|+.+++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------------------~~~~~~~~~~e~~~l~ 89 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS--------------------DPVFRTRMQREARTAG 89 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG--------------------SHHHHHHHHHHHHHHT
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc--------------------CHHHHHHHHHHHHHHh
Confidence 45568899999999999999999999999999999987532111 1223567899999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+++||||+++++++...+.+|+||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++||+|||||
T Consensus 90 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlk 161 (309)
T 2h34_A 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR--------QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVK 161 (309)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH--------HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCC
Confidence 99999999999999999999999999999999999984 3568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.++.+||+|||++....... ........||+.|+|||++.+.. ++.++||||||+++|+|+||..||.
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 162 PENILVSADDFAYLVDFGIASATTDEK----LTQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp GGGEEECTTSCEEECSCCC--------------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred hHHEEEcCCCCEEEecCccCccccccc----cccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999987654321 11223457999999999987665 8999999999999999999999998
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-CHHHHhc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-TASELLK 323 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-ta~elL~ 323 (520)
........ ..+....+.. ......+++.+.++|.+||++||.+|| |+.++++
T Consensus 237 ~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 237 GDQLSVMG-AHINQAIPRP------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp SCHHHHHH-HHHHSCCCCG------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CchHHHHH-HHhccCCCCc------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 87655333 3333222211 122346788999999999999999999 8888874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=362.99 Aligned_cols=261 Identities=23% Similarity=0.368 Sum_probs=210.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceE--EEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKC--AIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~v--AiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
...++|++.+.||+|+||+||+|.+..+|..+ |+|.++. .......+.+.+|+.++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~----------------------~~~~~~~~~~~~E~~~l 79 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----------------------YASKDDHRDFAGELEVL 79 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC----------------------C------CHHHHHHHHH
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecc----------------------ccchHHHHHHHHHHHHH
Confidence 34588999999999999999999999988755 7776532 11123345689999999
Q ss_pred hcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc--------ccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 104 SSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI--------SNCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 104 ~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~--------~~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
+++ +||||+++++++...+.+|+||||+.+++|.+++...... .......+++..++.++.||+.||.|||
T Consensus 80 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 159 (327)
T 1fvr_A 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 159 (327)
T ss_dssp TTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH
T ss_pred HhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 999 9999999999999999999999999999999999753210 0012357999999999999999999999
Q ss_pred HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 175 ~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
++||+||||||+|||++.++.+||+|||++..... ........+|+.|+|||++.+.. ++.++|||||||++|
T Consensus 160 ~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ 232 (327)
T 1fvr_A 160 QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV------YVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLW 232 (327)
T ss_dssp HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCE------ECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHH
T ss_pred hCCccCCCCccceEEEcCCCeEEEcccCcCccccc------cccccCCCCCccccChhhhcccc-CCchhcchHHHHHHH
Confidence 99999999999999999999999999999864321 11123346788999999987655 899999999999999
Q ss_pred HHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 255 EMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 255 ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
+|+| |..||..................... ..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 233 ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 233 EIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHGGGTCCCCCC---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCCCcHHHHHHHhhcCCCCCCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9998 99999988877766555544322221 3567889999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=373.04 Aligned_cols=274 Identities=17% Similarity=0.164 Sum_probs=203.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCC-----CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKAR-----AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
..++|++.+.||+|+||+||+|.+..+ ++.||+|++......... +.-+++ .........|+.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----e~~~~~-------~~~~~~~~~e~~ 100 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT-----ELKFYQ-------RAAKPEQIQKWI 100 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHH-----HHHHHH-------HHCCHHHHHHHH
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHH-----HHHHHH-------hhhhhHHHHHHH
Confidence 455899999999999999999999775 578888887643211000 000000 111234566788
Q ss_pred HHhcCCCCCceEEEEEEEEC----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy11359 102 AMSSCHHENVVTYHTSFVVK----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG 177 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g 177 (520)
.++.++||||+++++++... ...|+||||+ |++|.+++.. ..+.+++..+..++.||+.||.|||++|
T Consensus 101 ~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~lH~~~ 172 (364)
T 3op5_A 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-------NAKRFSRKTVLQLSLRILDILEYIHEHE 172 (364)
T ss_dssp HHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-------TTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 88999999999999999864 4589999999 9999999975 3467999999999999999999999999
Q ss_pred cEecccCCCcEEEc--CCCCeEEeccCcceeeccCccccc--cccccccccccccCCcceecccCCCCcchhHHHHHHHH
Q psy11359 178 QIHRDIKAGNILLG--EDGTVQIADFGVSAWLATGRDLSR--QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253 (520)
Q Consensus 178 iiHrDLKp~NILl~--~~g~vkL~DFG~a~~~~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il 253 (520)
|+||||||+|||++ .++.+||+|||++..+........ ........||+.|+|||++.+.. ++.++|||||||++
T Consensus 173 iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l 251 (364)
T 3op5_A 173 YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCM 251 (364)
T ss_dssp EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHH
T ss_pred eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHH
Confidence 99999999999998 889999999999987654322111 11224567999999999998765 89999999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHhc-CCCCCCCCCchhhhh--HHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 254 IEMATGTAPYHKYPAMKVLMLTLQ-NDPPTLDTGAAEKDQ--YKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 254 ~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|+|+||..||.+............ .....+.. ..... ...+++++.+||..||+.||.+|||+.++++
T Consensus 252 ~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 252 IQWLTGHLPWEDNLKDPKYVRDSKIRYRENIAS--LMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHH--HHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhCCCCccccccCHHHHHHHHHHhhhhHHH--HHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 999999999985332222111110 00000000 00000 0345889999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=358.73 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=209.1
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
.+....+|++.+.||+|+||+||+|.+..++.. ...+|+|.+.........+.+.+|+.++
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------------------~~~~avk~~~~~~~~~~~~~~~~E~~~l 80 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK-------------------KIHCAVKSLNRITDIGEVSQFLTEGIIM 80 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC------------------------CEEEEEEEETTCCSHHHHHHHHHHHHHH
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCc-------------------eeEEEEEecccCCCHHHHHHHHHHHHHH
Confidence 345667899999999999999999987654321 1123444444333345567899999999
Q ss_pred hcCCCCCceEEEEEEE-ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 104 SSCHHENVVTYHTSFV-VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~-~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
++++||||+++++++. .++..++||||+.+++|.++++. ....+++..+..++.||+.||.|||++|++|||
T Consensus 81 ~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 153 (298)
T 3f66_A 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRD 153 (298)
T ss_dssp HTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC-------TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh-------cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 9999999999999865 56678999999999999999974 356689999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTA 261 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~ 261 (520)
|||+|||++.++.+||+|||++..+...... .........||+.|+|||++.+.. ++.++|||||||++|+|++ |.+
T Consensus 154 ikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~ 231 (298)
T 3f66_A 154 LAARNCMLDEKFTVKVADFGLARDMYDKEYY-SVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAP 231 (298)
T ss_dssp CSGGGEEECTTCCEEECSCGGGCCCSCGGGC-BC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CchheEEECCCCCEEECcccccccccccchh-ccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999876433221 122233457889999999997665 8999999999999999999 777
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
||....................+ ..+++.+.++|.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 232 PYPDVNTFDITVYLLQGRRLLQP---------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp SSTTSCTTTHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccCCHHHHHHHHhcCCCCCCC---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 88777766666655555443332 345788999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=354.53 Aligned_cols=256 Identities=23% Similarity=0.411 Sum_probs=212.6
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
..|....++|++.+.||+|+||+||+|.+. ++..||+|+++.. ....+.+.+|+.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~------------------------~~~~~~~~~E~~ 60 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG------------------------SMSPDAFLAEAN 60 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT------------------------SSCHHHHHHHHH
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCC------------------------cccHHHHHHHHH
Confidence 357888899999999999999999999875 4566777766421 123467899999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
++++++||||+++++++. .+..++||||+.|++|.+++... ....+++..+..++.||+.||.|||++|++||
T Consensus 61 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 133 (279)
T 1qpc_A 61 LMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP------SGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133 (279)
T ss_dssp HHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH------HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 999999999999999876 55689999999999999999642 12368999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GT 260 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~ 260 (520)
||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++||||||+++|+|++ |.
T Consensus 134 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~ 208 (279)
T 1qpc_A 134 DLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGR 208 (279)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECSSSCE----ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCHhhEEEcCCCCEEECCCcccccccCccc----ccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999987643221 1123446788999999997655 8999999999999999999 99
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.||......+.............. ..+++.+.++|.+||..||.+|||+.++++
T Consensus 209 ~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 209 IPYPGMTNPEVIQNLERGYRMVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccCHHHHHHHHhcccCCCCc---------ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999988777766655544332221 356789999999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=361.46 Aligned_cols=264 Identities=22% Similarity=0.393 Sum_probs=206.2
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
.....++|++.+.||+|+||.||+|.+. +++.||+|+++... ......+.+.+|+.++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------------------~~~~~~~~~~~E~~~l 80 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE---------------------ADNQTLDSYRNEIAYL 80 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS---------------------CCHHHHHHHHHHHHHH
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc---------------------ccccchHHHHHHHHHH
Confidence 4456788999999999999999999885 47788888765321 1123467789999999
Q ss_pred hcCC--CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 104 SSCH--HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 104 ~~l~--HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
++++ ||||+++++++...+.+|+||| +.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||
T Consensus 81 ~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 151 (313)
T 3cek_A 81 NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK--------KKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 151 (313)
T ss_dssp HHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH--------CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 9996 5999999999999999999999 558899999984 4578999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc----------CCCCcchhHHHHHH
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD----------HGYDFKADIWSLGI 251 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------~~~~~~~DIwSlG~ 251 (520)
||||+|||++ ++.+||+|||++..+..... ........||+.|+|||++.+. ..++.++|||||||
T Consensus 152 dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~ 227 (313)
T 3cek_A 152 DLKPANFLIV-DGMLKLIDFGIANQMQPDTT---SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227 (313)
T ss_dssp CCCGGGEEEE-TTEEEECCCSSSCC-----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHH
T ss_pred CCCcccEEEE-CCeEEEeeccccccccCccc---cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHH
Confidence 9999999995 58999999999976643221 1122345799999999998651 24889999999999
Q ss_pred HHHHHHhCCCCCCCCcHH-HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 252 TAIEMATGTAPYHKYPAM-KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 252 il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
++|+|++|..||...... ..+......... ... ....+..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 228 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 228 ILYYMTYGKTPFQQIINQISKLHAIIDPNHE-IEF-------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC-CCC-------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHHhCCCchhhHHHHHHHHHHHHhcccc-cCC-------cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 999999999999765433 233333222111 110 12346789999999999999999999999999999854
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=355.27 Aligned_cols=260 Identities=31% Similarity=0.531 Sum_probs=201.6
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||.||+|.+..+|+.||+|+++.... ......+.+.+|+.++++
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------~~~~~~~~~~~E~~~l~~ 88 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL--------------------MDAKARADCIKEIDLLKQ 88 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS--------------------CCHHHHHHHHHHHHHHHT
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc--------------------cCHHHHHHHHHHHHHHHh
Confidence 455789999999999999999999999999999998753211 012345678999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
++||||+++++++...+..++||||+.+++|.+++..... ....+++..++.++.||+.||.|||++|++||||||
T Consensus 89 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p 164 (310)
T 2wqm_A 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK----QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKP 164 (310)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred CCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcc----cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcH
Confidence 9999999999999999999999999999999999976433 356789999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+||+++.+|.+||+|||++..+.... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+
T Consensus 165 ~NIl~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~ 238 (310)
T 2wqm_A 165 ANVFITATGVVKLGDLGLGRFFSSKT-----TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYG 238 (310)
T ss_dssp GGEEECTTSCEEECCC-----------------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred HHEEEcCCCCEEEEeccceeeecCCC-----ccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999987654321 1223457999999999987655 89999999999999999999999975
Q ss_pred Cc--HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 266 YP--AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 266 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.. .............+... ...+++.+.+||.+||..||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 239 DKMNLYSLCKKIEQCDYPPLP--------SDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp --CCHHHHHHHHHTTCSCCCC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchhHHHHHHHhhcccCCCCc--------ccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 43 22222223332222211 1356789999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=360.29 Aligned_cols=265 Identities=23% Similarity=0.338 Sum_probs=206.7
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcC---CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKA---RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
+....++|++.+.||+|+||+||+|.+.. ++..||+|+++... ......+.+.+|+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---------------------~~~~~~~~~~~e~ 87 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN---------------------SSQREIEEFLSEA 87 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C---------------------CCHHHHHHHHHHH
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc---------------------cchhHHHHHHHHH
Confidence 45677899999999999999999998776 44467777654211 1123456789999
Q ss_pred HHHhcCCCCCceEEEEEEEECC-----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKD-----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS 175 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~-----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~ 175 (520)
.++++++||||+++++++.... ..++||||+.+++|.+++....... ....+++..++.++.||+.||.|||+
T Consensus 88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~ 165 (313)
T 3brb_A 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET--GPKHIPLQTLLKFMVDIALGMEYLSN 165 (313)
T ss_dssp HHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTT--SCCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhc--CCccCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999999998654 3599999999999999996532211 44679999999999999999999999
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
+||+||||||+|||++.++.+||+|||++..+...... .......+++.|+|||++.+.. ++.++|||||||++|+
T Consensus 166 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e 241 (313)
T 3brb_A 166 RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY---RQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWE 241 (313)
T ss_dssp TTCCCCCCSGGGEEECTTSCEEECSCSCC-------------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHH
T ss_pred CCcccCCCCcceEEEcCCCcEEEeecCcceeccccccc---CcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHH
Confidence 99999999999999999999999999999766433211 1123456788999999997655 8999999999999999
Q ss_pred HHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 256 MAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 256 llt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|++ |..||..................... ..+++.+.++|.+||..||.+|||+.+++++
T Consensus 242 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 242 IATRGMTPYPGVQNHEMYDYLLHGHRLKQP---------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHTTSCCSSTTCCGGGHHHHHHTTCCCCCB---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCccCCHHHHHHHHHcCCCCCCC---------ccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999 99999888777666666555433322 3567889999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=354.47 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=199.1
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+ +|+.||+|++... ....+.+|.+++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--------------------------~~~~~~~e~~~~~~ 56 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR--------------------------DEKSWFRETELYNT 56 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG--------------------------GHHHHHHHHHHHHH
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc--------------------------cchhhHHHHHHHHH
Confidence 3567899999999999999999987 5778888876421 22345566666655
Q ss_pred --CCCCCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH-----
Q psy11359 106 --CHHENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH----- 174 (520)
Q Consensus 106 --l~HpnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH----- 174 (520)
++||||+++++++.. ...+|+||||+.+|+|.++++ ...+++..+..++.||+.||.|||
T Consensus 57 ~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 127 (301)
T 3q4u_A 57 VMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---------LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127 (301)
T ss_dssp TCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT---------TCCBCHHHHHHHHHHHHHHHHHHHSCBCS
T ss_pred hhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh---------hcccCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 899999999998764 246899999999999999994 357899999999999999999999
Q ss_pred ---HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCC-----CCcchhH
Q psy11359 175 ---SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG-----YDFKADI 246 (520)
Q Consensus 175 ---~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-----~~~~~DI 246 (520)
++||+||||||+|||++.++.+||+|||++.......... ........||+.|+|||++.+... ++.++||
T Consensus 128 ~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dv 206 (301)
T 3q4u_A 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL-DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206 (301)
T ss_dssp TTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE-ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHH
T ss_pred ccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccc-cccccccccccceeChhhhcCcCCCCcccCCchhhH
Confidence 9999999999999999999999999999998765433221 111234589999999999976532 4479999
Q ss_pred HHHHHHHHHHHhC----------CCCCCCCc----HHHHHHHHhcCC--CCCCCCCchhhhhHHHhcHHHHHHHHhhhcc
Q psy11359 247 WSLGITAIEMATG----------TAPYHKYP----AMKVLMLTLQND--PPTLDTGAAEKDQYKAYGKTFRKMISDCLQK 310 (520)
Q Consensus 247 wSlG~il~elltG----------~~Pf~~~~----~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (520)
|||||++|+|+|| ..||.... ............ .+.++ .......+++.+.+||.+||+.
T Consensus 207 wslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~ 282 (301)
T 3q4u_A 207 WAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQ 282 (301)
T ss_dssp HHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhc
Confidence 9999999999999 88885432 222222222221 12221 1112235678899999999999
Q ss_pred CCCCCCCHHHHhc
Q psy11359 311 DPTKRPTASELLK 323 (520)
Q Consensus 311 dP~~Rpta~elL~ 323 (520)
||.+|||+.++++
T Consensus 283 dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 283 NPSARLTALRIKK 295 (301)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=376.55 Aligned_cols=269 Identities=24% Similarity=0.360 Sum_probs=196.5
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..+.|.+.++||+|+||+||.+ ...+|+.||+|++... ..+.+.+|+.+++++
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~--------------------------~~~~~~~E~~~l~~l 65 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID--------------------------FCDIALMEIKLLTES 65 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG--------------------------GHHHHHHHHHHHHHH
T ss_pred hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH--------------------------HHHHHHHHHHHHHhc
Confidence 4566788899999999999875 4567888888876421 234578899999876
Q ss_pred -CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 -HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 -~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+||||+++++++...+.+|+||||+. |+|.+++........ .....++..+..++.||+.||.|||++||+||||||
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp 143 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDE-NLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKP 143 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC-------------CCHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCch-hhhhccchhHHHHHHHHHHHHHHHHHCCccccCCCh
Confidence 89999999999999999999999995 699999975321110 001123445678999999999999999999999999
Q ss_pred CcEEEcCC-------------CCeEEeccCcceeeccCccccccccccccccccccCCcceecc------cCCCCcchhH
Q psy11359 186 GNILLGED-------------GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ------DHGYDFKADI 246 (520)
Q Consensus 186 ~NILl~~~-------------g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~~~~DI 246 (520)
+|||++.+ +.+||+|||++..+....... .......+||+.|+|||++.+ ...++.++||
T Consensus 144 ~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 222 (434)
T 2rio_A 144 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF-RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222 (434)
T ss_dssp GGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCCTHHHH
T ss_pred HhEEEecCcccccccccCCCceEEEEcccccceecCCCCccc-eeeecCCCCCCCccCHHHhccccccccccCcchhhhh
Confidence 99999654 489999999998775432211 112235689999999999865 2348999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCc
Q psy11359 247 WSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325 (520)
Q Consensus 247 wSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp 325 (520)
|||||++|+|+| |..||......... .+......... .......+++++.+||.+||+.||.+|||+.++++||
T Consensus 223 wSlG~il~ellt~g~~Pf~~~~~~~~~--i~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 223 FSMGCVFYYILSKGKHPFGDKYSRESN--IIRGIFSLDEM---KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp HHHHHHHHHHHTTSCCTTCSTTTHHHH--HHHTCCCCCCC---TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HhHHHHHHHHHhCCCCCCCCchhhHHH--HhcCCCCcccc---cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 999999999999 99999765443322 22221111000 0111245678999999999999999999999999999
Q ss_pred ccccc
Q psy11359 326 FFKKA 330 (520)
Q Consensus 326 ~~~~~ 330 (520)
||+..
T Consensus 298 ~f~~~ 302 (434)
T 2rio_A 298 LFWPK 302 (434)
T ss_dssp GGSCH
T ss_pred ccCCc
Confidence 99754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=362.96 Aligned_cols=267 Identities=24% Similarity=0.369 Sum_probs=211.5
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEc-----CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCK-----ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELL 97 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~ 97 (520)
.|....++|++.+.||+|+||+||+|.+. .+++.||+|+++ ........+.+.
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~----------------------~~~~~~~~~~~~ 78 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK----------------------EGATHSEHRALM 78 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEEC----------------------TTCCHHHHHHHH
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecc----------------------cCCCcHHHHHHH
Confidence 36677899999999999999999999864 455666666653 222234456789
Q ss_pred HHHHHHhcC-CCCCceEEEEEEEECC-EEEEEEEccCCCCHHHHHHHhhccc--------cCCCCCCCHHHHHHHHHHHH
Q psy11359 98 KEIQAMSSC-HHENVVTYHTSFVVKD-ELWLVLRLLEGGSLLDIIKHRLKIS--------NCKHGVCDEPTIATVLREVL 167 (520)
Q Consensus 98 ~Ei~~l~~l-~HpnIv~~~~~~~~~~-~~~lV~E~~~ggsL~~~i~~~~~~~--------~~~~~~l~~~~i~~i~~qIl 167 (520)
+|+.+++++ +||||+++++++...+ .+++||||+.|++|.+++....... ......+++..+..++.||+
T Consensus 79 ~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~ 158 (316)
T 2xir_A 79 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 158 (316)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHH
T ss_pred HHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHH
Confidence 999999999 7999999999988654 5999999999999999998532100 00122388999999999999
Q ss_pred HHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHH
Q psy11359 168 KGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIW 247 (520)
Q Consensus 168 ~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIw 247 (520)
.||.|||++||+||||||+|||++.++.+||+|||++..+..... ........||+.|+|||++.+.. ++.++|||
T Consensus 159 ~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~ 234 (316)
T 2xir_A 159 KGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD---YVRKGDARLPLKWMAPETIFDRV-YTIQSDVW 234 (316)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT---SEEETTEEECGGGCCHHHHHHCC-CCHHHHHH
T ss_pred HHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCcc---ceeccCCCcceeecCchhhcccc-ccchhHHH
Confidence 999999999999999999999999999999999999976643221 11223457899999999997665 89999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCcHHHHHHHHh-cCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 248 SLGITAIEMAT-GTAPYHKYPAMKVLMLTL-QNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 248 SlG~il~ellt-G~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
||||++|+|+| |..||........+...+ ........ ..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 235 slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 235 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999998 999998766444333332 22222221 2467889999999999999999999999976
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=355.11 Aligned_cols=251 Identities=24% Similarity=0.422 Sum_probs=203.4
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
..|....++|++.+.||+|+||+||+|.+. |+.||+|+++. ....+.+.+|+.
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-------------------------~~~~~~~~~E~~ 66 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-------------------------DATAQAFLAEAS 66 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCC-------------------------CC--HHHHHTHH
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecc-------------------------hhHHHHHHHHHH
Confidence 357778899999999999999999999874 67788887642 113456899999
Q ss_pred HHhcCCCCCceEEEEEEEEC-CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 102 AMSSCHHENVVTYHTSFVVK-DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~-~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
++++++||||+++++++... +.+|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++|++|
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 140 (278)
T 1byg_A 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140 (278)
T ss_dssp HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc------cccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 99999999999999987654 47899999999999999997642 224789999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-C
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G 259 (520)
|||||+||+++.++.+||+|||++...... .....+++.|+|||++.+.. ++.++||||||+++|+|+| |
T Consensus 141 ~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g 211 (278)
T 1byg_A 141 RDLAARNVLVSEDNVAKVSDFGLTKEASST--------QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFG 211 (278)
T ss_dssp SCCSGGGEEECTTSCEEECCCCC--------------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTS
T ss_pred cCCCcceEEEeCCCcEEEeecccccccccc--------ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCC
Confidence 999999999999999999999998754321 12346789999999987655 8999999999999999998 9
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
..||...+................. ..+++.+.++|.+||+.||.+|||+.++++
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 212 RVPYPRIPLKDVVPRVEKGYKMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CCSCTTSCGGGHHHHHTTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCc---------ccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 9999887766666555444333222 356889999999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=373.39 Aligned_cols=265 Identities=22% Similarity=0.381 Sum_probs=213.1
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.++||+|+||+||+|.+..+|+.||+|+++... .....+.+.+|+.++++
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------------~~~~~~~~~~E~~~l~~ 63 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----------------------FLRPVDVQMREFEVLKK 63 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----------------------GGSCHHHHHHHHHHHHH
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc----------------------ccchHHHHHHHHHHHHh
Confidence 35678999999999999999999999999999999875321 12335668899999999
Q ss_pred CCCCCceEEEEEEEECC--EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 106 CHHENVVTYHTSFVVKD--ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~--~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++||||+++++++.... ..|+||||+.||+|.++++... ....+++..++.++.||+.||.|||++||+||||
T Consensus 64 l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 138 (396)
T 4eut_A 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-----NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138 (396)
T ss_dssp CCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGG-----GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhh-----cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCc
Confidence 99999999999998755 7899999999999999997532 1234899999999999999999999999999999
Q ss_pred CCCcEEE----cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc-------CCCCcchhHHHHHHH
Q psy11359 184 KAGNILL----GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD-------HGYDFKADIWSLGIT 252 (520)
Q Consensus 184 Kp~NILl----~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-------~~~~~~~DIwSlG~i 252 (520)
||+|||+ +.++.+||+|||++..+.... ......||+.|+|||++.+. ..++.++|||||||+
T Consensus 139 kp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~i 212 (396)
T 4eut_A 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDE------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (396)
T ss_dssp CGGGEEEEECTTSCEEEEECCGGGCEECCCGG------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEeecCCCceeEEEecCCCceEccCCC------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHH
Confidence 9999999 677789999999998764322 23356799999999998641 237889999999999
Q ss_pred HHHHHhCCCCCCCC----cHHHHHHHHhcCCCCCCCCCch---------------hhhhHHHhcHHHHHHHHhhhccCCC
Q psy11359 253 AIEMATGTAPYHKY----PAMKVLMLTLQNDPPTLDTGAA---------------EKDQYKAYGKTFRKMISDCLQKDPT 313 (520)
Q Consensus 253 l~elltG~~Pf~~~----~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~L~~dP~ 313 (520)
+|+|+||..||... ...+.+...+.+.++....... .......++..+.++|.+||+.||+
T Consensus 213 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~ 292 (396)
T 4eut_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292 (396)
T ss_dssp HHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTT
T ss_pred HHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChh
Confidence 99999999999642 2345555555555432211100 0112256778899999999999999
Q ss_pred CCCCHHHHhc
Q psy11359 314 KRPTASELLK 323 (520)
Q Consensus 314 ~Rpta~elL~ 323 (520)
+|||+.++++
T Consensus 293 ~R~s~~e~l~ 302 (396)
T 4eut_A 293 KCWGFDQFFA 302 (396)
T ss_dssp TSCCHHHHHH
T ss_pred hhccHHHHHH
Confidence 9999999865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=354.48 Aligned_cols=248 Identities=24% Similarity=0.402 Sum_probs=206.3
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||.||+|.+..+|+.||+|+++.. .+.+.+|+.++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------------------------~~~~~~e~~~l~~l~ 62 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---------------------------NEKAEREVKALAKLD 62 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC---------------------------SGGGHHHHHHHHHCC
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc---------------------------cHHHHHHHHHHHhCC
Confidence 35799999999999999999999999999999987521 023678999999999
Q ss_pred CCCceEEEEEEEE----------------CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHH
Q psy11359 108 HENVVTYHTSFVV----------------KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLE 171 (520)
Q Consensus 108 HpnIv~~~~~~~~----------------~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~ 171 (520)
||||+++++++.. ...+|+||||+.+++|.+++... ....+++..+..++.||+.||.
T Consensus 63 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~ 136 (284)
T 2a19_B 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR------RGEKLDKVLALELFEQITKGVD 136 (284)
T ss_dssp CTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG------GGSCCCHHHHHHHHHHHHHHHH
T ss_pred CCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc------cCCCCCHHHHHHHHHHHHHHHH
Confidence 9999999998864 44589999999999999999864 3457899999999999999999
Q ss_pred HHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHH
Q psy11359 172 YFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251 (520)
Q Consensus 172 yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~ 251 (520)
|||++||+||||||+|||++.++.+||+|||++..+.... ......||+.|+|||++.+.. ++.++||||||+
T Consensus 137 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ 209 (284)
T 2a19_B 137 YIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG------KRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGL 209 (284)
T ss_dssp HHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS------CCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHH
T ss_pred HHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc------cccccCCcccccChhhhccCC-CcchhhhHHHHH
Confidence 9999999999999999999999999999999998764322 123457999999999997655 899999999999
Q ss_pred HHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 252 TAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 252 il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
++|+|++|..||.... .......... + ...++..+.++|.+||+.||.+|||+.|+++|++...
T Consensus 210 il~~l~~~~~~~~~~~--~~~~~~~~~~---~---------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 210 ILAELLHVCDTAFETS--KFFTDLRDGI---I---------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHSCCSSHHHHH--HHHHHHHTTC---C---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHHhcCCcchhHH--HHHHHhhccc---c---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 9999999998874321 1222111111 1 1346788999999999999999999999999877654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=365.57 Aligned_cols=266 Identities=25% Similarity=0.343 Sum_probs=206.7
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+....++|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.++
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------------~~~~~~~~~~E~~~l 80 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----------------------EQQDREEAQREADMH 80 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----------------------SHHHHHHHHHHHHHH
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----------------------CHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999976421 123456789999999
Q ss_pred hcCCCCCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 104 SSCHHENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+.++||||+++++++.. ....|+||||+.+++|.+++..... ....+++..++.++.||+.||.|||++||+
T Consensus 81 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 156 (317)
T 2buj_A 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKD----KGNFLTEDQILWLLLGICRGLEAIHAKGYA 156 (317)
T ss_dssp HTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 99999999999999873 3478999999999999999986433 356799999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccc----cccccccccccccCCcceecccC--CCCcchhHHHHHHHH
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSR----QKVRHTFVGTPCWMAPEVMEQDH--GYDFKADIWSLGITA 253 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~----~~~~~~~~gt~~y~APE~~~~~~--~~~~~~DIwSlG~il 253 (520)
||||||+|||++.++.+||+|||++........... ........||+.|+|||++.+.. .++.++|||||||++
T Consensus 157 H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 236 (317)
T 2buj_A 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236 (317)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHH
Confidence 999999999999999999999998876432111000 01112346899999999986543 268899999999999
Q ss_pred HHHHhCCCCCCCCcHH-HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 254 IEMATGTAPYHKYPAM-KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 254 ~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|+|++|..||...... ........... ..+ ....+++.+.++|.+||+.||.+|||+.+++++
T Consensus 237 ~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 237 YAMMFGEGPYDMVFQKGDSVALAVQNQL-SIP-------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHHSSCTTHHHHHTTSCHHHHHHCC---CC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCChhhhhcccchhhHHhhccC-CCC-------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 9999999999532110 01111111111 111 113567899999999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=368.10 Aligned_cols=276 Identities=18% Similarity=0.192 Sum_probs=201.5
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcC---CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKA---RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
...++|++.+.||+|+||+||+|.+.. ++..+|+|++......... +..+++ ......+.+|+..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~-----e~~~~~-------~~~~~~~~~e~~~ 101 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-----ELKFYQ-------RVAKKDCIKKWIE 101 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHH-----HHHHHH-------HHCCHHHHHHHHH
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHH-----HHHHHH-------HHhhhHHHHHHHh
Confidence 356789999999999999999999988 7888888887643110000 000000 0122347789999
Q ss_pred HhcCCCCCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 103 MSSCHHENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
++.++||||+++++++.. ...+|+||||+ |++|.+++.. .+.+++..++.++.||+.||.|||++||
T Consensus 102 ~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~i 172 (345)
T 2v62_A 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ--------NGTFKKSTVLQLGIRMLDVLEYIHENEY 172 (345)
T ss_dssp HHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG--------GGBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 999999999999999998 78899999999 9999999864 3478999999999999999999999999
Q ss_pred EecccCCCcEEEcCCC--CeEEeccCcceeeccCcccc--ccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 179 IHRDIKAGNILLGEDG--TVQIADFGVSAWLATGRDLS--RQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 179 iHrDLKp~NILl~~~g--~vkL~DFG~a~~~~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
+||||||+|||++.++ .+||+|||++..+....... .........||+.|+|||++.+.. ++.++|||||||++|
T Consensus 173 vH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ 251 (345)
T 2v62_A 173 VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCML 251 (345)
T ss_dssp ECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHH
T ss_pred eCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHH
Confidence 9999999999998777 99999999998765332211 112224568999999999998765 899999999999999
Q ss_pred HHHhCCCCCCCCcH-HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 255 EMATGTAPYHKYPA-MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 255 elltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+|+||..||..... ..............++...........+++.+.++|.+||..||.+|||+.++++
T Consensus 252 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 252 RWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999964221 1111111111001111000000001157889999999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=353.32 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=209.4
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCc---eEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAE---KCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
+...-.|++.++||+|+||+||+|.+..++. .||+|.+ .........+.+.+|+.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~----------------------~~~~~~~~~~~~~~E~~ 74 (298)
T 3pls_A 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL----------------------SRITEMQQVEAFLREGL 74 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEE----------------------TTCCSHHHHHHHHHHHH
T ss_pred cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeec----------------------cccccHHHHHHHHHHHH
Confidence 4455578889999999999999999766544 4555554 33333445678999999
Q ss_pred HHhcCCCCCceEEEEEEEECCEE-EEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDEL-WLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~-~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
++++++||||+++++++...+.. ++||||+.+++|.+++.. ....+++..+..++.||+.||.|||++|++|
T Consensus 75 ~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H 147 (298)
T 3pls_A 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-------PQRNPTVKDLISFGLQVARGMEYLAEQKFVH 147 (298)
T ss_dssp HHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC-------TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc-------cccCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 99999999999999999876655 999999999999999974 3567899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-C
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G 259 (520)
|||||+|||++.++.+||+|||++..+...... .........||+.|+|||.+.+.. ++.++|||||||++|+|+| |
T Consensus 148 ~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~ 225 (298)
T 3pls_A 148 RDLAARNCMLDESFTVKVADFGLARDILDREYY-SVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRG 225 (298)
T ss_dssp SCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG-CSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTS
T ss_pred CCCCcceEEEcCCCcEEeCcCCCcccccCCccc-ccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCC
Confidence 999999999999999999999999765432211 122233457899999999997665 8999999999999999999 5
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.+||..................... ..+++.+.++|.+||+.||.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 226 APPYRHIDPFDLTHFLAQGRRLPQP---------EYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CCTTTTSCGGGHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCccCCHHHHHHHhhcCCCCCCC---------ccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 5666666665555555444333222 346788999999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=362.44 Aligned_cols=257 Identities=24% Similarity=0.357 Sum_probs=208.0
Q ss_pred CCCCCeEEEeeeeecCceEEEEEE----EcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAY----CKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
...++|++.+.||+|+||+||+|. +..+++.||+|++... .....+.+.+|+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------------------~~~~~~~~~~E~~ 76 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----------------------GPDQQRDFQREIQ 76 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----------------------CHHHHHHHHHHHH
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----------------------CHHHHHHHHHHHH
Confidence 466899999999999999999998 5667777888876421 1234567899999
Q ss_pred HHhcCCCCCceEEEEEEE--ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 102 AMSSCHHENVVTYHTSFV--VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~--~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
++++++||||+++++++. ....+|+||||++|++|.+++... ...+++..+..++.||+.||.|||++||+
T Consensus 77 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~iv 149 (327)
T 3lxl_A 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-------RARLDASRLLLYSSQICKGMEYLGSRRCV 149 (327)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHH-------GGGCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 999999999999999987 456799999999999999999853 34589999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG 259 (520)
||||||+|||++.++.+||+|||++..+...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 150 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g 226 (327)
T 3lxl_A 150 HRDLAARNILVESEAHVKIADFGLAKLLPLDKDY--YVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTY 226 (327)
T ss_dssp CSCCSGGGEEEEETTEEEECCGGGCEECCTTCSE--EECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTT
T ss_pred CCCCChhhEEECCCCCEEEcccccceecccCCcc--ceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999876543321 12233456899999999987665 89999999999999999999
Q ss_pred CCCCCCCcHHH--------------HH-HHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 260 TAPYHKYPAMK--------------VL-MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 260 ~~Pf~~~~~~~--------------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
..||....... .. ........... ...+++.+.+||.+||++||.+|||+.+++++
T Consensus 227 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 227 CDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA---------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp TCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccchhhhhcccccccccHHHHHHHhhcccCCCC---------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99986543321 11 11111111111 13568899999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=378.25 Aligned_cols=257 Identities=25% Similarity=0.430 Sum_probs=210.0
Q ss_pred CCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 21 SVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 21 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
...|....++|++.+.||+|+||+||+|.+.. +..||+|+++.. ....+.+.+|+
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~------------------------~~~~~~~~~E~ 230 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPG------------------------TMSPEAFLQEA 230 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTT------------------------SSCHHHHHHHH
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccC------------------------CCCHHHHHHHH
Confidence 34588888999999999999999999999875 345777766421 12346789999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
.+|++++||||+++++++.. +.+|+||||+.+|+|.++++.. ....+++..+..++.||+.||.|||++||+|
T Consensus 231 ~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 303 (452)
T 1fmk_A 231 QVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE------TGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303 (452)
T ss_dssp HHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH------HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 99999999999999998865 6789999999999999999753 2346899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-C
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G 259 (520)
|||||+|||++.++.+||+|||++..+..... .......+|+.|+|||++.... ++.++|||||||++|+|+| |
T Consensus 304 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g 378 (452)
T 1fmk_A 304 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKG 378 (452)
T ss_dssp SCCSGGGEEECGGGCEEECCCCTTC------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCChhhEEECCCCCEEECCCccceecCCCce----ecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCC
Confidence 99999999999999999999999976643211 1123345788999999987665 8999999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
..||.+....+....+..+.....+ ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 379 ~~P~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 379 RVPYPGMVNREVLDQVERGYRMPCP---------PECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999998887777666555433222 356788999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=356.50 Aligned_cols=263 Identities=25% Similarity=0.384 Sum_probs=205.4
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcC-CCc--eEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKA-RAE--KCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
.......++|++.+.||+|+||+||+|.+.. ++. .||+|+++.... ......+.+.+
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--------------------~~~~~~~~~~~ 70 (291)
T 1u46_A 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--------------------SQPEAMDDFIR 70 (291)
T ss_dssp CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------------------------CHHHHHHHH
T ss_pred cccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc--------------------CCHHHHHHHHH
Confidence 3445677899999999999999999998654 333 477776642211 11235677999
Q ss_pred HHHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
|+.++++++||||+++++++.... .++||||+.+++|.+++... .+.+++..+..++.||+.||.|||++|+
T Consensus 71 e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i 142 (291)
T 1u46_A 71 EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH-------QGHFLLGTLSRYAVQVAEGMGYLESKRF 142 (291)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHH-------GGGSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhc-------cCCcCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 999999999999999999988655 88999999999999999863 3468899999999999999999999999
Q ss_pred EecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 179 iHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
+||||||+|||++.++.+||+|||++..+..... .........+|+.|+|||++.+.. ++.++||||||+++|+|++
T Consensus 143 ~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~ 219 (291)
T 1u46_A 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD--HYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFT 219 (291)
T ss_dssp ECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC--EEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred ccCCCchheEEEcCCCCEEEcccccccccccccc--chhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999987643322 111223456788999999987655 8999999999999999999
Q ss_pred -CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 259 -GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 259 -G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|..||..................... ...++..+.++|.+||..||.+|||+.++++
T Consensus 220 ~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 220 YGQEPWIGLNGSQILHKIDKEGERLPR--------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TSCCTTTTCCHHHHHHHHHTSCCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcccCCHHHHHHHHHccCCCCCC--------CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999988877776665544322111 1356889999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.20 Aligned_cols=270 Identities=21% Similarity=0.309 Sum_probs=208.8
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.+.||+|+||+||+|.+. +|+.||+|+++... .......+.+|+.+++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------------~~~~~~~~~~e~~~l~ 82 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEER----------------------TQGGELQFQTEVEMIS 82 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC---------------------------CCCHHHHHHHGGG
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEecccc----------------------CchHHHHHHHHHHHHH
Confidence 346688999999999999999999754 57888888775321 1112225889999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcEec
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN---GQIHR 181 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~---giiHr 181 (520)
+++||||+++++++...+..++||||+.+|+|.+++..... ....+++..+..++.||+.||.|||++ ||+||
T Consensus 83 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~ 158 (326)
T 3uim_A 83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE----SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158 (326)
T ss_dssp TCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCST----TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECC
T ss_pred hccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Confidence 99999999999999999999999999999999999985422 344699999999999999999999999 99999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||++.++.+||+|||++..+.... ........||+.|+|||++.+.. ++.++|||||||++|+|+||..
T Consensus 159 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~ 233 (326)
T 3uim_A 159 DVKAANILLDEEFEAVVGDFGLAKLMDYKD----THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQR 233 (326)
T ss_dssp CCSGGGEEECTTCCEEECCCSSCEECCSSS----SCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCC
T ss_pred CCchhhEEECCCCCEEeccCccccccCccc----ccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCC
Confidence 999999999999999999999998764322 22234456999999999997665 8999999999999999999999
Q ss_pred CCCCCc--------HHHHHHHHhcCCC-CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcc
Q psy11359 262 PYHKYP--------AMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326 (520)
Q Consensus 262 Pf~~~~--------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~ 326 (520)
||.... ............. ..+.............+..+.+++.+||+.||.+|||+.|+++|..
T Consensus 234 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 234 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred cccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 995211 0011110011100 0000001111223456688999999999999999999999998743
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=370.01 Aligned_cols=260 Identities=23% Similarity=0.321 Sum_probs=200.1
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCC---ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARA---EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
+.....|++.+.||+|+||+||+|.+..++ ..||+|. ++........+++.+|+.
T Consensus 85 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~----------------------~~~~~~~~~~~~~~~E~~ 142 (373)
T 3c1x_A 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS----------------------LNRITDIGEVSQFLTEGI 142 (373)
T ss_dssp CSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEE----------------------CCSCSCSHHHHHHHHHHT
T ss_pred ChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEE----------------------cCCCCCHHHHHHHHHHHH
Confidence 345567999999999999999999876442 2345554 433333445678999999
Q ss_pred HHhcCCCCCceEEEEEEE-ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 102 AMSSCHHENVVTYHTSFV-VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~-~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
++++++||||+++++++. .++..++||||+.+|+|.++++. ....+++..+..++.||+.||.|||++||+|
T Consensus 143 il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 215 (373)
T 3c1x_A 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 215 (373)
T ss_dssp TSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC-------TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh-------cccCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 999999999999999875 45678999999999999999974 3456889999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-C
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G 259 (520)
|||||+|||++.++.+||+|||++..+...... .........+|+.|+|||++.+.. ++.++|||||||++|+|+| |
T Consensus 216 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~ 293 (373)
T 3c1x_A 216 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFD-SVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRG 293 (373)
T ss_dssp SCCCGGGEEECTTCCEEECCC----------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTS
T ss_pred CccchheEEECCCCCEEEeeccccccccccccc-cccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCc
Confidence 999999999999999999999999765432211 111223456788999999997665 8999999999999999999 7
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
.+||......+.......+.....+ ..++..+.++|.+||+.||.+|||+.+++++
T Consensus 294 ~~p~~~~~~~~~~~~~~~~~~~~~p---------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 294 APPYPDVNTFDITVYLLQGRRLLQP---------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CCSCTTSCSSCHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899877665555555554433222 3467889999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=355.42 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=200.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEE----cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYC----KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
..+.|++++.||+|+||+||++.. ..+++.||+|+++ ........+.+.+|+.+
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~----------------------~~~~~~~~~~~~~E~~~ 86 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----------------------ADAGPQHRSGWKQEIDI 86 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEEC----------------------TTCCHHHHHHHHHHHHH
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEec----------------------cccChHHHHHHHHHHHH
Confidence 334459999999999999988754 3456666666653 32223456779999999
Q ss_pred HhcCCCCCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 103 MSSCHHENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+++++||||+++++++.. ...+++||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~i~~~l~~~l~~LH~~~ivH 157 (318)
T 3lxp_A 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---------HSIGLAQLLLFAQQICEGMAYLHAQHYIH 157 (318)
T ss_dssp HHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG---------SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh---------CCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 999999999999999998 4689999999999999999963 34899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+|||++.++.+||+|||++..+...... ........||+.|+|||++.+.. ++.++|||||||++|+|+||.
T Consensus 158 ~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~ 234 (318)
T 3lxp_A 158 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY--YRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHC 234 (318)
T ss_dssp SCCSGGGEEECTTCCEEECCGGGCEECCTTCSE--EEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTT
T ss_pred CCCchheEEEcCCCCEEECCccccccccccccc--cccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999877543321 12233456889999999997655 889999999999999999999
Q ss_pred CCCCCCcHHH---------------HHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 261 APYHKYPAMK---------------VLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 261 ~Pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.||....... ............. ...+++.+.+||.+||+.||.+|||+.|+++
T Consensus 235 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 235 DSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR---------PDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccccchhhhhhhcccccchhHHHHHHHHhcccCCCC---------CccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9996543211 1111111111111 1356789999999999999999999999984
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=350.11 Aligned_cols=258 Identities=21% Similarity=0.241 Sum_probs=203.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+|+.||+|++... ...+++.+|+.+++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------------------~~~~~~~~e~~~l~~l 61 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-------------------------TKHPQLHIESKIYKMM 61 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESC-------------------------SSCCHHHHHHHHHHHH
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCC-------------------------cchhHHHHHHHHHHHh
Confidence 457899999999999999999999999999999976421 1123488999999999
Q ss_pred CCCCceEEEEE-EEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 HHENVVTYHTS-FVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 ~HpnIv~~~~~-~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+|++++..+.. +......++||||+ +++|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||
T Consensus 62 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 133 (296)
T 3uzp_A 62 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF-------CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKP 133 (296)
T ss_dssp TTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred hcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHh-------hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence 88876655544 46788899999999 9999999975 345799999999999999999999999999999999
Q ss_pred CcEEEc---CCCCeEEeccCcceeeccCcccccc--ccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 186 GNILLG---EDGTVQIADFGVSAWLATGRDLSRQ--KVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 186 ~NILl~---~~g~vkL~DFG~a~~~~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
+|||++ .++.+||+|||++..+......... .......||+.|+|||++.+.. ++.++|||||||++|+|+||+
T Consensus 134 ~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~ 212 (296)
T 3uzp_A 134 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGS 212 (296)
T ss_dssp GGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred HHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCC
Confidence 999994 8889999999999876543321111 1234568999999999998765 899999999999999999999
Q ss_pred CCCCCCcHH---HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 261 APYHKYPAM---KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 261 ~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.||...... ..+......... .........+++.+.+||.+||+.||.+|||+.++++
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 213 LPWQGLKAATKRQKYERISEKKMS-----TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CTTSSCCCSSSSSHHHHHHHHHHH-----SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCCCCcCchhhhhhhhhhcccccC-----CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 999764321 111111110000 0011122457889999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=366.53 Aligned_cols=259 Identities=17% Similarity=0.220 Sum_probs=202.9
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCC--------CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHH
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKAR--------AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELL 97 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~--------g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~ 97 (520)
...++|++.+.||+|+||+||+|.+..+ ++.||+|+++. . +.+.
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~----------------------~------~~~~ 90 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAK----------------------D------GRLF 90 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEET----------------------T------STHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecc----------------------c------chHH
Confidence 3468999999999999999999999985 66666666532 1 2478
Q ss_pred HHHHHHhcCCCCCceE---------------EEEEEEE-CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHH
Q psy11359 98 KEIQAMSSCHHENVVT---------------YHTSFVV-KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIAT 161 (520)
Q Consensus 98 ~Ei~~l~~l~HpnIv~---------------~~~~~~~-~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~ 161 (520)
+|+.++++++||||++ +++++.. +...|+||||+ +++|.+++... ..+.+++..+..
T Consensus 91 ~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~------~~~~l~~~~~~~ 163 (352)
T 2jii_A 91 NEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS------PKHVLSERSVLQ 163 (352)
T ss_dssp HHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS------GGGCCCHHHHHH
T ss_pred HHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC------CcCCCCHHHHHH
Confidence 8999999999999887 6777776 78899999999 99999999853 236799999999
Q ss_pred HHHHHHHHHHHHHHCCcEecccCCCcEEEcCCC--CeEEeccCcceeeccCcccc--ccccccccccccccCCcceeccc
Q psy11359 162 VLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG--TVQIADFGVSAWLATGRDLS--RQKVRHTFVGTPCWMAPEVMEQD 237 (520)
Q Consensus 162 i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g--~vkL~DFG~a~~~~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~ 237 (520)
++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+....... .........||+.|+|||++.+.
T Consensus 164 i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 243 (352)
T 2jii_A 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC 243 (352)
T ss_dssp HHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC
Confidence 999999999999999999999999999999988 99999999998765332211 11122445899999999999776
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHh---cCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCC
Q psy11359 238 HGYDFKADIWSLGITAIEMATGTAPYHKYP-AMKVLMLTL---QNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313 (520)
Q Consensus 238 ~~~~~~~DIwSlG~il~elltG~~Pf~~~~-~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 313 (520)
. ++.++|||||||++|+|+||..||.... ....+.... ...+..+.. ....+..+++.+.+||.+||+.||.
T Consensus 244 ~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~ 319 (352)
T 2jii_A 244 G-PSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVG---PCGHWIRPSETLQKYLKVVMALTYE 319 (352)
T ss_dssp C-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEEC---TTSCEECCCHHHHHHHHHHHTCCTT
T ss_pred C-CCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhh---hccccCCCcHHHHHHHHHHHhCChh
Confidence 5 8999999999999999999999998653 222222111 111111111 1111235688999999999999999
Q ss_pred CCCCHHHHhc
Q psy11359 314 KRPTASELLK 323 (520)
Q Consensus 314 ~Rpta~elL~ 323 (520)
+|||+.++++
T Consensus 320 ~Rps~~~l~~ 329 (352)
T 2jii_A 320 EKPPYAMLRN 329 (352)
T ss_dssp CCCCHHHHHH
T ss_pred hCCCHHHHHH
Confidence 9999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=348.68 Aligned_cols=258 Identities=21% Similarity=0.233 Sum_probs=200.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ..+.+.+|+.+++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~e~~~l~~l 61 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-------------------------KHPQLHIESKIYKMM 61 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------------------------CCCHHHHHHHHHHH
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-------------------------cchHHHHHHHHHHHh
Confidence 4578999999999999999999999999999999754221 112378899999999
Q ss_pred CCCCceEEEE-EEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 HHENVVTYHT-SFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 ~HpnIv~~~~-~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+|++++..+. ++...+..++||||+ +++|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||
T Consensus 62 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 133 (296)
T 4hgt_A 62 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF-------CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKP 133 (296)
T ss_dssp TTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-------TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred cCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 8877666554 446788999999999 9999999975 345799999999999999999999999999999999
Q ss_pred CcEEE---cCCCCeEEeccCcceeeccCccccc--cccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 186 GNILL---GEDGTVQIADFGVSAWLATGRDLSR--QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 186 ~NILl---~~~g~vkL~DFG~a~~~~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
+|||+ +.++.+||+|||++..+........ ........||+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 134 ~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~ 212 (296)
T 4hgt_A 134 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGS 212 (296)
T ss_dssp GGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred HHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCC
Confidence 99999 7889999999999987754332111 12234568999999999998765 899999999999999999999
Q ss_pred CCCCCCcHH---HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 261 APYHKYPAM---KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 261 ~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.||...... ..+......... .........+++.+.+||.+||+.||.+|||+.++++
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 213 LPWQGLKAATKRQKYERISEKKMS-----TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CTTSSCCCSSSSSHHHHHHHHHHH-----SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCCcccchhhhhhhhhhhhccccc-----chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 999764321 111111100000 0011122456889999999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=349.34 Aligned_cols=243 Identities=21% Similarity=0.410 Sum_probs=194.1
Q ss_pred CCCCCCeEEE-eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 25 PNTEDQYEVR-EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 25 ~~~~~~Y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
....++|.+. +.||+|+||+||+|.+..+++.||+|+++. ...+.+|+.++
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------------------------~~~~~~e~~~~ 64 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------------------------CPKARREVELH 64 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----------------------------SHHHHHHHHHH
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----------------------------cHHHHHHHHHH
Confidence 4456778887 789999999999999999999999997641 12467888887
Q ss_pred -hcCCCCCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 104 -SSCHHENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 104 -~~l~HpnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
+.++||||+++++++.. ...+|+||||+.|++|.+++... ....+++..++.++.||+.||.|||++||
T Consensus 65 ~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 138 (299)
T 3m2w_A 65 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR------GDQAFTEREASEIMKSIGEAIQYLHSINI 138 (299)
T ss_dssp HHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHC------TTCCCBHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 56699999999999987 67899999999999999999863 34579999999999999999999999999
Q ss_pred EecccCCCcEEEcC---CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 179 IHRDIKAGNILLGE---DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 179 iHrDLKp~NILl~~---~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
+||||||+|||++. ++.+||+|||++.... + ..++.++|||||||++|+
T Consensus 139 ~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------------~-~~~~~~~DiwslG~il~e 190 (299)
T 3m2w_A 139 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------------G-EKYDKSCDMWSLGVIMYI 190 (299)
T ss_dssp ECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------------T-CGGGGHHHHHHHHHHHHH
T ss_pred ccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------------c-ccCCchhhHHHHHHHHHH
Confidence 99999999999987 7899999999875431 1 227889999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 256 MATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 256 lltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
|+||..||............... ............+..+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 191 l~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 191 LLCGYPPFYSNHGLAISPGMKTR--IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHSSCSCCC-------CCSCCS--SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHCCCCCCCCcchhhhHHHHHH--HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 99999999765543322111110 001111112233456899999999999999999999999999999998653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=364.38 Aligned_cols=254 Identities=18% Similarity=0.176 Sum_probs=200.4
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEE-----EEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSA-----YCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a-----~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
+....++|++.+.||+|+||+||+| .+..+++.||+|+++. ....++.+
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--------------------------~~~~~~~~ 113 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--------------------------ANPWEFYI 113 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS--------------------------CCHHHHHH
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC--------------------------CChhHHHH
Confidence 4456788999999999999999999 4677777777776642 22446788
Q ss_pred HHHHHhcCC---CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11359 99 EIQAMSSCH---HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS 175 (520)
Q Consensus 99 Ei~~l~~l~---HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~ 175 (520)
|+++++.++ |+||+++++++...+..|+||||+.||+|.+++...... ..+.+++..+..++.||+.||.|||+
T Consensus 114 e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~lH~ 190 (365)
T 3e7e_A 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT---PEKVMPQGLVISFAMRMLYMIEQVHD 190 (365)
T ss_dssp HHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTS---TTCSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcc---cccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 888888886 999999999999999999999999999999999864332 34679999999999999999999999
Q ss_pred CCcEecccCCCcEEEcC-----------CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcch
Q psy11359 176 NGQIHRDIKAGNILLGE-----------DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~-----------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~ 244 (520)
+||+||||||+|||++. ++.+||+|||+|..+.... ........+||+.|||||++.+.. |+.++
T Consensus 191 ~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~ 266 (365)
T 3e7e_A 191 CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP---KGTIFTAKCETSGFQCVEMLSNKP-WNYQI 266 (365)
T ss_dssp TTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSC---TTEEECCSSCTTSCCCHHHHTTCC-BSTHH
T ss_pred CCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccC---CCceeeeecCCCCCCChHHhcCCC-CCccc
Confidence 99999999999999988 8999999999997654221 222334568999999999998766 89999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 245 DIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 245 DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|||||||++|+|+||+.||......... +. ..+. . ...++.+.+++..||+.+|.+|++..+.+.+
T Consensus 267 DiwslG~il~elltg~~pf~~~~~~~~~---~~---~~~~-~-------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 267 DYFGVAATVYCMLFGTYMKVKNEGGECK---PE---GLFR-R-------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp HHHHHHHHHHHHHHSSCCCEEEETTEEE---EC---SCCT-T-------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCccccCCCCcee---ec---hhcc-c-------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 9999999999999999999543321100 00 0000 0 0235678899999999999999765555543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=382.64 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=207.2
Q ss_pred CCCCCCeEEEe-eeeecCceEEEEEEEcC--CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 25 PNTEDQYEVRE-VIGFGATAVVHSAYCKA--RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 25 ~~~~~~Y~i~~-~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
....++|.+.+ .||+|+||+||+|.++. ++..||||+++ ........+++.+|+.
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~----------------------~~~~~~~~~~~~~E~~ 388 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK----------------------QGTEKADTEEMMREAQ 388 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECC----------------------CCCSSTTHHHHHHHHH
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcC----------------------CCCChHHHHHHHHHHH
Confidence 34456677777 89999999999998764 34456666553 2222345678999999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+|++++|||||++++++.. +.+|+||||+.+|+|.+++.. ....+++..+..++.||+.||.|||++||+||
T Consensus 389 il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHr 460 (613)
T 2ozo_A 389 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG-------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460 (613)
T ss_dssp HHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT-------CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcC
Confidence 9999999999999999875 569999999999999999964 35679999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GT 260 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~ 260 (520)
||||+|||++.++.+||+|||++..+...... ........+|+.|+|||++.+.. ++.++|||||||++|||+| |.
T Consensus 461 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~ 537 (613)
T 2ozo_A 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQ 537 (613)
T ss_dssp CCSGGGEEEEETTEEEECCCSTTTTCC----------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCHHHEEEcCCCcEEEeeccCcccccCCCce--eeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999766432211 11122334678999999997655 9999999999999999998 99
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.||......+....+..+.....+ ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 538 ~Pf~~~~~~~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 538 KPYKKMKGPEVMAFIEQGKRMECP---------PECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CTTTTCCSHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCC---------CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998888777766665543332 357889999999999999999999999974
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=352.78 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=196.5
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||.||+|.+. |+.||+|++... ......+|.+++..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--------------------------~~~~~~~e~~~~~~ 85 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT--------------------------EEASWFRETEIYQT 85 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG--------------------------GHHHHHHHHHHHTS
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc--------------------------ccchhhhHHHHHHH
Confidence 34578999999999999999999875 788888876421 12334555566554
Q ss_pred --CCCCCceEEEEEEEEC----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC---
Q psy11359 106 --CHHENVVTYHTSFVVK----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN--- 176 (520)
Q Consensus 106 --l~HpnIv~~~~~~~~~----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~--- 176 (520)
++||||+++++++... ..+|+||||+.+|+|.++++. ..+++..+..++.||+.||.|||++
T Consensus 86 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 156 (337)
T 3mdy_A 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---------TTLDAKSMLKLAYSSVSGLCHLHTEIFS 156 (337)
T ss_dssp TTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHSCBCS
T ss_pred HhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 4999999999999987 789999999999999999964 3589999999999999999999999
Q ss_pred -----CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCc------chh
Q psy11359 177 -----GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDF------KAD 245 (520)
Q Consensus 177 -----giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~------~~D 245 (520)
||+||||||+|||++.++.+||+|||++..+...... .........||+.|+|||++.+.. +.. ++|
T Consensus 157 ~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~D 234 (337)
T 3mdy_A 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE-VDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMAD 234 (337)
T ss_dssp TTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC----------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHH
T ss_pred hccCCCEEecccchHHEEECCCCCEEEEeCCCceeecccccc-ccCCCCCCccCcceeChhhccccc-CCccccCccccc
Confidence 9999999999999999999999999999776433221 111123568999999999997654 343 499
Q ss_pred HHHHHHHHHHHHhC----------CCCCCCCc----HHHHHHHHhcC--CCCCCCCCchhhhhHHHhcHHHHHHHHhhhc
Q psy11359 246 IWSLGITAIEMATG----------TAPYHKYP----AMKVLMLTLQN--DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQ 309 (520)
Q Consensus 246 IwSlG~il~elltG----------~~Pf~~~~----~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 309 (520)
||||||++|+|+|| ..||.... ........... ..+..+ .......+++.+.+||.+||+
T Consensus 235 iwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~ 310 (337)
T 3mdy_A 235 MYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP----NRWSSDECLRQMGKLMTECWA 310 (337)
T ss_dssp HHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHSC
T ss_pred hHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCcccc----ccchhhHHHHHHHHHHHHhhh
Confidence 99999999999999 77775432 12222222211 112211 111223577889999999999
Q ss_pred cCCCCCCCHHHHhcC
Q psy11359 310 KDPTKRPTASELLKN 324 (520)
Q Consensus 310 ~dP~~Rpta~elL~h 324 (520)
.||.+|||+.++++|
T Consensus 311 ~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 311 HNPASRLTALRVKKT 325 (337)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred hChhhCCCHHHHHHH
Confidence 999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=358.49 Aligned_cols=260 Identities=23% Similarity=0.362 Sum_probs=187.9
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+.....+|++.++||+|+||+||+|.+..+|+.||+|++... .....+.+.+|+.++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------------~~~~~~~~~~e~~~l 79 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----------------------EEEKNRAIIQEVCFM 79 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----------------------SHHHHHHHHHHHHHH
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----------------------chHHHHHHHHHHHHH
Confidence 445567899999999999999999999999999999976321 123456788999999
Q ss_pred hcCC-CCCceEEEEEEEE--------CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 104 SSCH-HENVVTYHTSFVV--------KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 104 ~~l~-HpnIv~~~~~~~~--------~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
+++. ||||+++++++.. ...+++||||+. |+|.+++.... ..+.+++..++.++.||+.||.|||
T Consensus 80 ~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH 153 (337)
T 3ll6_A 80 KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-----SRGPLSCDTVLKIFYQTCRAVQHMH 153 (337)
T ss_dssp HHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-----TTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9995 9999999999953 345899999995 79999987532 3457999999999999999999999
Q ss_pred HCC--cEecccCCCcEEEcCCCCeEEeccCcceeeccCccccc-------cccccccccccccCCcceec--ccCCCCcc
Q psy11359 175 SNG--QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSR-------QKVRHTFVGTPCWMAPEVME--QDHGYDFK 243 (520)
Q Consensus 175 ~~g--iiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~-------~~~~~~~~gt~~y~APE~~~--~~~~~~~~ 243 (520)
++| |+||||||+|||++.++.+||+|||++..+........ ........||+.|+|||++. ....++.+
T Consensus 154 ~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~ 233 (337)
T 3ll6_A 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK 233 (337)
T ss_dssp TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHH
T ss_pred hCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChH
Confidence 999 99999999999999999999999999987654322110 01112456999999999984 23348899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 244 ADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 244 ~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+|||||||++|+|+||..||................+ ....+..+.+||.+||+.||.+|||+.|+++
T Consensus 234 ~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 301 (337)
T 3ll6_A 234 QDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPP------------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVH 301 (337)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------------CCCCT------------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhHHHHHHHHHHHHhCCCCCcchhHHHhhcCcccCCc------------ccccchHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999976554433322111110 1234556889999999999999999999998
Q ss_pred C
Q psy11359 324 N 324 (520)
Q Consensus 324 h 324 (520)
|
T Consensus 302 ~ 302 (337)
T 3ll6_A 302 Q 302 (337)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=360.26 Aligned_cols=262 Identities=24% Similarity=0.418 Sum_probs=209.2
Q ss_pred CCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHH
Q psy11359 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQ 101 (520)
Q Consensus 22 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~ 101 (520)
..|....++|++.+.||+|+||+||+|.+.. .+|+|+++.... .....+.+.+|+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~---------------------~~~~~~~~~~e~~ 81 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD---------------------NEDQLKAFKREVM 81 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC---------------------CCCCCCCCCTTGG
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC---------------------CHHHHHHHHHHHH
Confidence 4588889999999999999999999998754 488887653210 0112234667999
Q ss_pred HHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 102 AMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
++++++||||+++++++...+.+++||||+.|++|.+++.. ....+++..+..++.||+.||.|||++|++||
T Consensus 82 ~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~ 154 (319)
T 2y4i_B 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD-------AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHK 154 (319)
T ss_dssp GGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS-------SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 99999999999999999999999999999999999999964 33478999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc--------cCCCCcchhHHHHHHHH
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ--------DHGYDFKADIWSLGITA 253 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~~~~DIwSlG~il 253 (520)
||||+|||++ ++.+||+|||++...................||+.|+|||++.+ ...++.++|||||||++
T Consensus 155 dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il 233 (319)
T 2y4i_B 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233 (319)
T ss_dssp CCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHH
T ss_pred CCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHH
Confidence 9999999997 78999999999876533222222223344579999999999864 23478999999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 254 IEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 254 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|+|++|..||.................+.... ..++..+.++|.+||..||.+|||+.++++
T Consensus 234 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 234 YELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHhccCCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999888777766655554433321 235678999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=383.43 Aligned_cols=255 Identities=22% Similarity=0.344 Sum_probs=205.8
Q ss_pred CCCCeEEEe-eeeecCceEEEEEEE--cCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 27 TEDQYEVRE-VIGFGATAVVHSAYC--KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 27 ~~~~Y~i~~-~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
....+.+.. .||+|+||+||+|.+ +.+++.||||+++... ......+++.+|+.+|
T Consensus 366 ~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---------------------~~~~~~~~~~~E~~il 424 (635)
T 4fl3_A 366 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------------------NDPALKDELLAEANVM 424 (635)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG---------------------GCGGGHHHHHHHHHHH
T ss_pred cchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc---------------------CCHHHHHHHHHHHHHH
Confidence 334455544 899999999999955 4556778888764321 1123457799999999
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
++++|||||++++++. .+.+++||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||
T Consensus 425 ~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDL 495 (635)
T 4fl3_A 425 QQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQ--------NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 495 (635)
T ss_dssp HHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHHH--------CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HhCCCCCEeeEEEEEe-cCCEEEEEEccCCCCHHHHHhh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCC
Confidence 9999999999999886 4568999999999999999973 467899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy11359 184 KAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262 (520)
Q Consensus 184 Kp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~P 262 (520)
||+|||++.++.+||+|||++..+...... ........||+.|+|||++.+.. ++.++|||||||++|+|+| |..|
T Consensus 496 kp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~P 572 (635)
T 4fl3_A 496 AARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKP 572 (635)
T ss_dssp SGGGEEEEETTEEEECCTTHHHHTTC---------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ChHhEEEeCCCCEEEEEcCCccccccCccc--cccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999876433221 11223345788999999997655 8999999999999999998 9999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
|.+....+....+..+.....+ ..+++++.+||.+||+.||.+|||+.++++
T Consensus 573 f~~~~~~~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 573 YRGMKGSEVTAMLEKGERMGCP---------AGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp STTCCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9998888877777666544333 356889999999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=381.66 Aligned_cols=257 Identities=25% Similarity=0.432 Sum_probs=214.2
Q ss_pred CCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 21 SVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 21 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
...|....++|++.+.||+|+||.||+|.+.. +..||||+++.. ....+++.+|+
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~------------------------~~~~~~~~~E~ 313 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPG------------------------TMSPEAFLQEA 313 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTT------------------------SSCHHHHHHHH
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCC------------------------CCCHHHHHHHH
Confidence 34588889999999999999999999999875 345777766421 12346789999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
.+|++|+||||+++++++.. +.+||||||+.+|+|.++++.. ....+++..+..++.||+.||.|||++||+|
T Consensus 314 ~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH 386 (535)
T 2h8h_A 314 QVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE------TGKYLRLPQLVDMAAQIASGMAYVERMNYVH 386 (535)
T ss_dssp HHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH------HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 99999999999999998865 6789999999999999999753 2245889999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-C
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G 259 (520)
|||||+|||++.++.+||+|||++..+.... ........+++.|+|||++.... ++.++|||||||+||+|+| |
T Consensus 387 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g 461 (535)
T 2h8h_A 387 RDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKG 461 (535)
T ss_dssp SCCSGGGEEECGGGCEEECCTTSTTTCCCHH----HHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTT
T ss_pred CCCCHhhEEEcCCCcEEEcccccceecCCCc----eecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999997653211 11122345778999999987665 8999999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
..||.+....+.+..+..+...... ..++..+.+||.+||+.||.+|||+.++++
T Consensus 462 ~~P~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 462 RVPYPGMVNREVLDQVERGYRMPCP---------PECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999998887777666555333222 356788999999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=349.80 Aligned_cols=247 Identities=30% Similarity=0.512 Sum_probs=195.1
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++.+.||+|+||+||+|.+. ++.||+|++.. ....+.+.+|+.++++
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-------------------------~~~~~~~~~E~~~l~~ 57 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-------------------------ESERKAFIVELRQLSR 57 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-------------------------TTHHHHHHHHHHHHHH
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-------------------------hhHHHHHHHHHHHHhc
Confidence 45678999999999999999999874 56677776531 2235678999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecc
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS---NGQIHRD 182 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~---~giiHrD 182 (520)
++||||+++++++. +..++||||++|++|.+++.... ....+++..+..++.||+.||.|||+ +||+|||
T Consensus 58 l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~d 130 (307)
T 2eva_A 58 VNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAE-----PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130 (307)
T ss_dssp CCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSS-----SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCC
T ss_pred CCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccC-----CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCC
Confidence 99999999999876 45899999999999999997431 12347899999999999999999999 8999999
Q ss_pred cCCCcEEEcCCCC-eEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 183 IKAGNILLGEDGT-VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 183 LKp~NILl~~~g~-vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|||+|||++.++. +||+|||++..+... .....||+.|+|||++.+.. ++.++|||||||++|+|+||..
T Consensus 131 lkp~NIll~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~ 201 (307)
T 2eva_A 131 LKPPNLLLVAGGTVLKICDFGTACDIQTH--------MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRK 201 (307)
T ss_dssp CSGGGEEEETTTTEEEECCCCC--------------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCC
T ss_pred CChhHEEEeCCCCEEEEcccccccccccc--------cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCC
Confidence 9999999988886 799999998754321 12346999999999997655 8999999999999999999999
Q ss_pred CCCCCcH--HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 262 PYHKYPA--MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 262 Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
||..... ............+.. ...+++.+.++|.+||+.||.+|||+.+++++
T Consensus 202 p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 202 PFDEIGGPAFRIMWAVHNGTRPPL---------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp TTTTTCSSHHHHHHHHHTTCCCCC---------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CchhhCccHHHHHHHHhcCCCCCc---------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9975432 223223333322222 13567889999999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=351.91 Aligned_cols=260 Identities=23% Similarity=0.343 Sum_probs=192.0
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH--HHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK--EIQ 101 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~--Ei~ 101 (520)
+....++|++.+.||+|+||+||+|.. +++.||+|+++.. ....+.. |+.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------~~~~~~~e~~~~ 59 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA--------------------------NRQNFINEKNIY 59 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG--------------------------GHHHHHHHHHHH
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc--------------------------chhhHHHHHHHH
Confidence 456778999999999999999999976 5778888877532 1222333 444
Q ss_pred HHhcCCCCCceEEEEEEEE-----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 102 AMSSCHHENVVTYHTSFVV-----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 102 ~l~~l~HpnIv~~~~~~~~-----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
.+..++||||+++++.+.. ...+++||||+++|+|.++++. ..+++..+..++.||+.||.|||++
T Consensus 60 ~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~i~~qi~~~L~~LH~~ 130 (336)
T 3g2f_A 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---------HTSDWVSSCRLAHSVTRGLAYLHTE 130 (336)
T ss_dssp TSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh---------cccchhHHHHHHHHHHHHHHHHHhh
Confidence 4556899999999986653 2368999999999999999964 2348899999999999999999999
Q ss_pred ---------CcEecccCCCcEEEcCCCCeEEeccCcceeeccCcccc---ccccccccccccccCCcceeccc------C
Q psy11359 177 ---------GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLS---RQKVRHTFVGTPCWMAPEVMEQD------H 238 (520)
Q Consensus 177 ---------giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~---~~~~~~~~~gt~~y~APE~~~~~------~ 238 (520)
||+||||||+|||++.++.+||+|||++..+....... .........||+.|+|||++.+. .
T Consensus 131 ~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 210 (336)
T 3g2f_A 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE 210 (336)
T ss_dssp BCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHH
T ss_pred hccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccc
Confidence 99999999999999999999999999998765432211 12223356799999999998762 2
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCc-----------------HHHHHHHHhc--CCCCCCCCCchhhhhHHHhcHH
Q psy11359 239 GYDFKADIWSLGITAIEMATGTAPYHKYP-----------------AMKVLMLTLQ--NDPPTLDTGAAEKDQYKAYGKT 299 (520)
Q Consensus 239 ~~~~~~DIwSlG~il~elltG~~Pf~~~~-----------------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 299 (520)
.++.++|||||||++|+|+||..||.... .......... ...+.++... .....+++.
T Consensus 211 ~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 287 (336)
T 3g2f_A 211 SALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW---KENSLAVRS 287 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC---CCCSHHHHH
T ss_pred ccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc---ccccchHHH
Confidence 26678999999999999999976653211 1111111111 1112221111 111345678
Q ss_pred HHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 300 FRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 300 ~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
+.+||.+||+.||.+|||+.|+++
T Consensus 288 l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 288 LKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCChhhCcchHHHHH
Confidence 999999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=352.37 Aligned_cols=259 Identities=24% Similarity=0.402 Sum_probs=205.0
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEE----EcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAY----CKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLK 98 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~ 98 (520)
+.....++|++.+.||+|+||.||+|. +..+|+.||+|+++.. .....+.+.+
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------------------~~~~~~~~~~ 91 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----------------------TEEHLRDFER 91 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-----------------------CSHHHHHHHH
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-----------------------CHHHHHHHHH
Confidence 344567889999999999999999998 4567777888876421 1334567999
Q ss_pred HHHHHhcCCCCCceEEEEEEEEC--CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy11359 99 EIQAMSSCHHENVVTYHTSFVVK--DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN 176 (520)
Q Consensus 99 Ei~~l~~l~HpnIv~~~~~~~~~--~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~ 176 (520)
|+.++++++||||+++++++... ..+++||||+++++|.+++.. ....+++..+..++.||+.||.|||++
T Consensus 92 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~ 164 (326)
T 2w1i_A 92 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-------HKERIDHIKLLQYTSQICKGMEYLGTK 164 (326)
T ss_dssp HHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHH-------STTSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHh-------cccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99999999999999999988754 378999999999999999985 345689999999999999999999999
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
||+||||||+|||++.++.+||+|||++..+...... ........+|+.|+|||++.+.. ++.++|||||||++|+|
T Consensus 165 ~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el 241 (326)
T 2w1i_A 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY--YKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYEL 241 (326)
T ss_dssp TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSE--EECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHH
T ss_pred CEeccCCCcceEEEcCCCcEEEecCcchhhccccccc--cccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHH
Confidence 9999999999999999999999999999876543221 11123346788899999987665 89999999999999999
Q ss_pred HhCCCCCCCCcHHH---------------HHHHHhc-CCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 257 ATGTAPYHKYPAMK---------------VLMLTLQ-NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 257 ltG~~Pf~~~~~~~---------------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
+||..||....... .+...+. ...... ...+++.+.+||.+||+.||.+|||+.+
T Consensus 242 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rps~~e 312 (326)
T 2w1i_A 242 FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---------PDGCPDEIYMIMTECWNNNVNQRPSFRD 312 (326)
T ss_dssp HHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCC---------CCcccHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999986432110 0111111 111111 1356789999999999999999999999
Q ss_pred Hhc
Q psy11359 321 LLK 323 (520)
Q Consensus 321 lL~ 323 (520)
+++
T Consensus 313 l~~ 315 (326)
T 2w1i_A 313 LAL 315 (326)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=346.96 Aligned_cols=265 Identities=26% Similarity=0.361 Sum_probs=204.6
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
..|...+.||+|+||+||+|.+ +++.||+|++..... .......+.+.+|+.++++++|
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-------------------~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVD-------------------ITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTT-------------------SCTTTHHHHHHHHHHHHHHCCC
T ss_pred cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccC-------------------cchHHHHHHHHHHHHHHHhcCC
Confidence 3456668999999999999976 577888887642110 0112345679999999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++...+..++||||+.+++|.+++.... ....+++..+..++.||+.||.|||++|++||||||+||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Ni 164 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-----GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANI 164 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-----GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHE
Confidence 999999999999999999999999999999997532 245689999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.++.+||+|||++........ ........||+.|+|||++.+. ++.++|||||||++|+|+||..||.....
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQ---TVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSS---CEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred EEcCCCcEEEeecccccccccccc---cccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 999999999999999976543221 1123346799999999998754 78999999999999999999999976543
Q ss_pred HHH---HHHHhcCCCCCCCCC--chhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 269 MKV---LMLTLQNDPPTLDTG--AAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 269 ~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
... +..........+... .........++..+.++|.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 211 111111111100000 00001124567789999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=379.97 Aligned_cols=256 Identities=21% Similarity=0.372 Sum_probs=210.2
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCC---ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARA---EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
+....++|++.+.||+|+||+||+|.+..++ ..||+|.+ .........+.+.+|+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~----------------------~~~~~~~~~~~~~~E~ 442 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC----------------------KNCTSDSVREKFLQEA 442 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEEC----------------------SSTTCHHHHHHHHHHH
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEe----------------------cccCCHHHHHHHHHHH
Confidence 5566788999999999999999999987653 34555544 3332334557799999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
.++++++||||+++++++. ++.+|+||||+.+|+|.++++. ....+++..+..++.||+.||.|||++||+|
T Consensus 443 ~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~givH 514 (656)
T 2j0j_A 443 LTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV-------RKFSLDLASLILYAYQLSTALAYLESKRFVH 514 (656)
T ss_dssp HHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHH-------TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 9999999999999999884 5678999999999999999975 3456899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-C
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G 259 (520)
|||||+|||++.++.+||+|||++..+..... .......||+.|+|||++.+.. ++.++|||||||++|+|++ |
T Consensus 515 rDikp~NILl~~~~~vkL~DFG~a~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g 589 (656)
T 2j0j_A 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY----YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHG 589 (656)
T ss_dssp SCCSGGGEEEEETTEEEECCCCCCCSCCC--------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTS
T ss_pred cccchHhEEEeCCCCEEEEecCCCeecCCCcc----eeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcC
Confidence 99999999999999999999999987643221 1122346788999999997664 8999999999999999997 9
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
..||.+....+....+..+.....+ ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 590 ~~Pf~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 590 VKPFQGVKNNDVIGRIENGERLPMP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CCTTTTCCHHHHHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCC---------ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999998887777666665444332 356789999999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=363.25 Aligned_cols=258 Identities=20% Similarity=0.241 Sum_probs=206.7
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.++||+|+||.||+|.+..+++.||||+++... ...++.+|+.+++.|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-------------------------~~~~~~~E~~il~~L 59 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------------------------KHPQLLYESKIYRIL 59 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-------------------------SSCCHHHHHHHHHHT
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------------------------ccHHHHHHHHHHHHh
Confidence 4678999999999999999999999999999999765321 112378899999999
Q ss_pred CC-CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 HH-ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 ~H-pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
.| ++|..+..++...+..+|||||+ +++|.+++.. ..+.+++..++.|+.||+.||.|||++||+||||||
T Consensus 60 ~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP 131 (483)
T 3sv0_A 60 QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF-------CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131 (483)
T ss_dssp TTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred cCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCc
Confidence 76 56666777778899999999999 9999999975 356799999999999999999999999999999999
Q ss_pred CcEEE---cCCCCeEEeccCcceeeccCccccc--cccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 186 GNILL---GEDGTVQIADFGVSAWLATGRDLSR--QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 186 ~NILl---~~~g~vkL~DFG~a~~~~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
+|||| +.++.+||+|||++..+........ ........||+.|+|||++.+.. ++.++|||||||+||+|++|.
T Consensus 132 ~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~ 210 (483)
T 3sv0_A 132 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGS 210 (483)
T ss_dssp GGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred ceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCC
Confidence 99999 5889999999999987754332111 11223678999999999998765 899999999999999999999
Q ss_pred CCCCCCcH---HHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 261 APYHKYPA---MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 261 ~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
.||..... ...+..+...... .........++.++.+||..||+.+|.+||++.+|++
T Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~-----~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 211 LPWQGLKAGTKKQKYEKISEKKVA-----TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp CTTSSCCCSSHHHHHHHHHHHHHH-----SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCCccccchhHHHHHHHHhhcccc-----ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99987543 1222111111000 0012233567899999999999999999999998875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=387.66 Aligned_cols=273 Identities=25% Similarity=0.313 Sum_probs=208.7
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
+...++|++.+.||+|+||+||+|.+..+|+.||+|+++.. ......+.+.+|+.+++
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~----------------------~~~~~~~~~~~Ei~iL~ 67 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----------------------LSPKNRERWCLEIQIMK 67 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC----------------------CCHHHHHHHHHHHHHHH
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc----------------------CCHHHHHHHHHHHHHHH
Confidence 34558899999999999999999999999888888876421 11334567899999999
Q ss_pred cCCCCCceEEEEEEEE------CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 105 SCHHENVVTYHTSFVV------KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~------~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
+++||||+++++++.. .+..|+||||+.||+|.+++.... ....+++..++.++.||+.||.|||++||
T Consensus 68 ~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-----~~~~lse~~i~~I~~QLl~aL~yLHs~gI 142 (676)
T 3qa8_A 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-----NCCGLKEGPIRTLLSDISSALRYLHENRI 142 (676)
T ss_dssp HCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-----CTTCCCSSHHHHHHHHHHHHHHHHHHTTB
T ss_pred hCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 9999999999998765 677899999999999999997521 22368999999999999999999999999
Q ss_pred EecccCCCcEEEcCCCC---eEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHH
Q psy11359 179 IHRDIKAGNILLGEDGT---VQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255 (520)
Q Consensus 179 iHrDLKp~NILl~~~g~---vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~e 255 (520)
+||||||+|||++.++. +||+|||++..+.... ......||+.|+|||++.+.. ++.++|||||||++|+
T Consensus 143 VHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~------~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLye 215 (676)
T 3qa8_A 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE------LCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFE 215 (676)
T ss_dssp CCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC------CCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHH
T ss_pred ccCCCCHHHeEeecCCCceeEEEccccccccccccc------ccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHH
Confidence 99999999999987664 9999999997664322 234568999999999997665 8999999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhc---------CC----CCCCCC-CchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH
Q psy11359 256 MATGTAPYHKYPAMKVLMLTLQ---------ND----PPTLDT-GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321 (520)
Q Consensus 256 lltG~~Pf~~~~~~~~~~~~~~---------~~----~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el 321 (520)
|+||..||........+..... .. ...... ..........+++.+.+||.+||.+||.+|||+.++
T Consensus 216 LltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 216 CITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp HHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred HHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 9999999976533322110000 00 000000 000112234578899999999999999999999999
Q ss_pred hcCccccccc
Q psy11359 322 LKNPFFKKAK 331 (520)
Q Consensus 322 L~hp~~~~~~ 331 (520)
++||||+...
T Consensus 296 L~hp~F~~l~ 305 (676)
T 3qa8_A 296 PNVGCFQALD 305 (676)
T ss_dssp CCCTTHHHHH
T ss_pred hcCHHHHHHH
Confidence 9999998654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.57 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=201.6
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc--
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS-- 105 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~-- 105 (520)
.++|++.+.||+|+||+||+|.+ +|+.||+|+++. .....+.+|++++..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~--------------------------~~~~~~~~e~~~~~~~~ 92 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS--------------------------REERSWFREAEIYQTVM 92 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG--------------------------GGHHHHHHHHHHHHHSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc--------------------------hhHHHHHHHHHHHHHhh
Confidence 37899999999999999999987 478888887642 123457788888887
Q ss_pred CCCCCceEEEEEEEECC----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH-------
Q psy11359 106 CHHENVVTYHTSFVVKD----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH------- 174 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH------- 174 (520)
++||||+++++++.... .+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||
T Consensus 93 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~ 163 (342)
T 1b6c_B 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---------YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163 (342)
T ss_dssp CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc---------cCccHHHHHHHHHHHHHHHHHHHHHHhhhc
Confidence 79999999999998776 89999999999999999964 35889999999999999999999
Q ss_pred -HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCC-----CCcchhHHH
Q psy11359 175 -SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG-----YDFKADIWS 248 (520)
Q Consensus 175 -~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-----~~~~~DIwS 248 (520)
++||+||||||+|||++.++.+||+|||++.......... ........||+.|+|||++.+... ++.++||||
T Consensus 164 ~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~s 242 (342)
T 1b6c_B 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 242 (342)
T ss_dssp CBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEE-EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHH
T ss_pred ccCCeeeCCCCHHHEEECCCCCEEEEECCCceecccccccc-ccccccCCcCcccCCHhhhcccccccccccCCcccHHH
Confidence 8999999999999999999999999999998765433211 112345679999999999876532 236899999
Q ss_pred HHHHHHHHHhC----------CCCCCCCc----HHHHHHHHhcC--CCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCC
Q psy11359 249 LGITAIEMATG----------TAPYHKYP----AMKVLMLTLQN--DPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312 (520)
Q Consensus 249 lG~il~elltG----------~~Pf~~~~----~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 312 (520)
|||++|+|+|| ..||.... ....+...... ..+.++... .....+..+.+||.+||+.||
T Consensus 243 lG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp 318 (342)
T 1b6c_B 243 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW----QSCEALRVMAKIMRECWYANG 318 (342)
T ss_dssp HHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----GTSHHHHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccc----cchhHHHHHHHHHHHHhccCh
Confidence 99999999999 78886542 12222222222 122222111 113456789999999999999
Q ss_pred CCCCCHHHHhcC
Q psy11359 313 TKRPTASELLKN 324 (520)
Q Consensus 313 ~~Rpta~elL~h 324 (520)
.+|||+.++++|
T Consensus 319 ~~Rps~~~i~~~ 330 (342)
T 1b6c_B 319 AARLTALRIKKT 330 (342)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCCCHHHHHHH
Confidence 999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=364.56 Aligned_cols=263 Identities=13% Similarity=0.148 Sum_probs=198.2
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
+......|++.++||+|+||+||+|.+..+|+.||||+++.... ......+.+.+|+.++
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~--------------------~~~~~~~~~~~E~~~~ 132 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--------------------PPSNAIKQMKEEVLRL 132 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------------------------CCHHHHHHHHGG
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC--------------------ccHHHHHHHHHHHHHH
Confidence 34455569999999999999999999999999999998752211 0112356689999999
Q ss_pred hcCCC-CC---------------------ceEEEEEEEE-----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCH
Q psy11359 104 SSCHH-EN---------------------VVTYHTSFVV-----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDE 156 (520)
Q Consensus 104 ~~l~H-pn---------------------Iv~~~~~~~~-----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~ 156 (520)
+.++| +| ...+..++.. ...++++|+++ +++|.++++....... ..+.+++
T Consensus 133 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~-~~~~l~~ 210 (413)
T 3dzo_A 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS-THKSLVH 210 (413)
T ss_dssp GGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTT-TSHHHHH
T ss_pred HhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccc-cCCCCCH
Confidence 99977 22 1111122222 23477888877 6899999964322111 3456788
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceec-
Q psy11359 157 PTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVME- 235 (520)
Q Consensus 157 ~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~- 235 (520)
..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ....+| +.|+|||++.
T Consensus 211 ~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------~~~~~g-~~y~aPE~~~~ 281 (413)
T 3dzo_A 211 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------AVSPIG-RGFAPPETTAE 281 (413)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--------ECCCCC-TTTCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--------cccCCC-CceeCchhhhc
Confidence 899999999999999999999999999999999999999999999998764321 345678 9999999983
Q ss_pred --------ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhh
Q psy11359 236 --------QDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDC 307 (520)
Q Consensus 236 --------~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 307 (520)
....|+.++|||||||++|+|+||+.||............+. ....+++.+.+||.+|
T Consensus 282 ~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~--------------~~~~~~~~~~~li~~~ 347 (413)
T 3dzo_A 282 RMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR--------------SCKNIPQPVRALLEGF 347 (413)
T ss_dssp HTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS--------------SCCCCCHHHHHHHHHH
T ss_pred cccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh--------------hcccCCHHHHHHHHHH
Confidence 223378899999999999999999999987654332211111 1135678999999999
Q ss_pred hccCCCCCCCHHHHhcCccccccc
Q psy11359 308 LQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 308 L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
|++||.+|||+.++++||||+...
T Consensus 348 l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 348 LRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp TCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ccCChhhCcCHHHHHhCHHHHHHH
Confidence 999999999999999999998654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=347.33 Aligned_cols=256 Identities=21% Similarity=0.264 Sum_probs=197.0
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+ +|+.||+|+++....... ........+.+.+|+.+++.+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~---------------~~~~~~~~~~~~~E~~~l~~l 80 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLV---------------NGSHQKTFEEILPEIIISKEL 80 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCB---------------TTBCCBCHHHHHHHHHHHHHH
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCcccc---------------ccccchhHHHHHHHHHHHHHH
Confidence 457899999999999999999998 678899998764311000 001123456788899998888
Q ss_pred C---------CCCceEEEEEEEE------------------------------CCEEEEEEEccCCCCHHHHHHHhhccc
Q psy11359 107 H---------HENVVTYHTSFVV------------------------------KDELWLVLRLLEGGSLLDIIKHRLKIS 147 (520)
Q Consensus 107 ~---------HpnIv~~~~~~~~------------------------------~~~~~lV~E~~~ggsL~~~i~~~~~~~ 147 (520)
+ ||||+++++++.. .+.+|+||||+.+|++.+.+.
T Consensus 81 ~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~------ 154 (336)
T 2vuw_A 81 SLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR------ 154 (336)
T ss_dssp HHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT------
T ss_pred HHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH------
Confidence 5 8888888877542 678999999999998777663
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecccCCCcEEEcCCC--------------------CeEEeccCccee
Q psy11359 148 NCKHGVCDEPTIATVLREVLKGLEYFH-SNGQIHRDIKAGNILLGEDG--------------------TVQIADFGVSAW 206 (520)
Q Consensus 148 ~~~~~~l~~~~i~~i~~qIl~gL~yLH-~~giiHrDLKp~NILl~~~g--------------------~vkL~DFG~a~~ 206 (520)
.+.+++..++.++.||+.||.||| ++||+||||||+|||++.+| .+||+|||+|+.
T Consensus 155 ---~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~ 231 (336)
T 2vuw_A 155 ---TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRL 231 (336)
T ss_dssp ---TTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBE
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEe
Confidence 256899999999999999999999 99999999999999998887 899999999987
Q ss_pred eccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHH-HHHHHhCCCCCCCCcHHHHHH-HHhcCCCCCCC
Q psy11359 207 LATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT-AIEMATGTAPYHKYPAMKVLM-LTLQNDPPTLD 284 (520)
Q Consensus 207 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~i-l~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~ 284 (520)
+.. ...+||+.|||||++.+. .+.++||||||++ .+++++|..||.......... .........
T Consensus 232 ~~~----------~~~~gt~~y~aPE~~~g~--~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 297 (336)
T 2vuw_A 232 ERD----------GIVVFCDVSMDEDLFTGD--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK-- 297 (336)
T ss_dssp EET----------TEEECCCCTTCSGGGCCC--SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS--
T ss_pred cCC----------CcEEEeecccChhhhcCC--CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC--
Confidence 642 235899999999999865 3889999998777 778899999985422111111 222111111
Q ss_pred CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh-cCcccc
Q psy11359 285 TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL-KNPFFK 328 (520)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL-~hp~~~ 328 (520)
.......+..+++++++||.+||++| |+.|+| +||||+
T Consensus 298 -~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 298 -TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp -SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred -cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 11122345678999999999999976 999999 999995
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=262.52 Aligned_cols=92 Identities=42% Similarity=0.760 Sum_probs=90.5
Q ss_pred cceeEEEEeecccCCcceeEEeeecCCCchhhHHHHHHhccCCCCccHHHHHHHHHHHHccCCCceeEEEeccCCCCCCC
Q psy11359 428 RVVNLILRMRNVRRELNDIRFEFCIGKDTSDGIAGELVGAGLVDARDTEAISQNLELVVNGTPRKKSVTFPLSSTLQPGE 507 (520)
Q Consensus 428 ~~~~l~lr~~~~~~~~~~i~f~f~~~~dt~~~va~e~v~~~~~~~~d~~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (520)
++++|+||+||+++|||||+|+|.+|+|||+|||+|||+|||||++|+++||+||+|+|+++...|++||+|+|||.++|
T Consensus 1 ~pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~~~~~~ksvtF~L~sg~~~~e 80 (96)
T 2v3s_A 1 GPISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVEEPQSNRSVTFKLASGVEGSD 80 (96)
T ss_dssp CCEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHHCTTTCSEEEEECGGGSSSSS
T ss_pred CCeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHhCcccceEEEEEeccCCCCCC
Confidence 47999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccceeceec
Q psy11359 508 VADEKALLGLEI 519 (520)
Q Consensus 508 ~~~~~~~~~~~~ 519 (520)
+|||++||||||
T Consensus 81 ~pDe~~LiGfAQ 92 (96)
T 2v3s_A 81 IPDDGKLIGFAQ 92 (96)
T ss_dssp CCBGGGTBSEEE
T ss_pred CCchhheeeEEE
Confidence 999999999997
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=332.31 Aligned_cols=231 Identities=16% Similarity=0.113 Sum_probs=186.5
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||.||+|.+..+|+.||+|+++.... ......+.+.+|+.+++++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--------------------~~~~~~~~~~~e~~~l~~l 88 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV--------------------LPDDVLQETLSRTLRLSRI 88 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC--------------------SCHHHHHHHHHHHHHHHTC
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc--------------------cCHHHHHHHHHHHHHHhcC
Confidence 34789999999999999999999999999999998753211 0123456789999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||+++++++...+..|+||||++|++|.++++. + ....++..++.||+.||.|||++||+||||||+
T Consensus 89 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---------~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~ 158 (286)
T 3uqc_A 89 DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT---------S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPS 158 (286)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT---------C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred CCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc---------C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcc
Confidence 999999999999999999999999999999999842 2 356678999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.+|.+||+++| |++| ++.++|||||||++|+|+||+.||.+.
T Consensus 159 NIll~~~g~~kl~~~~-------------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~ 205 (286)
T 3uqc_A 159 RVRVSIDGDVVLAYPA-------------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEA 205 (286)
T ss_dssp GEEEETTSCEEECSCC-------------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCC
T ss_pred cEEEcCCCCEEEEecc-------------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 9999999999998554 3332 789999999999999999999999875
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
.....+...... ..............+++.+.+||.+||++||.+| |+.|+++.
T Consensus 206 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 206 GVRSGLAPAERD---TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp SBCCCSEECCBC---TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CcchhhHHHHHH---hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 432211000000 0000111223345688999999999999999999 99999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=370.73 Aligned_cols=242 Identities=21% Similarity=0.295 Sum_probs=199.8
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcC-CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKA-RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
.++|++.+.||+|+||+||+|.+.. +|+.||||++.. .......+.+.+|+.+++++
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~----------------------~~~~~~~~~~~~E~~~l~~l 136 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH----------------------SGDAEAQAMAMAERQFLAEV 136 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCS----------------------SCCHHHHHHHHHHHGGGGGC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCc----------------------cCCHHHHHHHHHHHHHHHhc
Confidence 4789999999999999999999986 678888886632 11234456788999999999
Q ss_pred CCCCceEEEEEEEECCE-----EEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 107 HHENVVTYHTSFVVKDE-----LWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~-----~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+||||+++++++...+. .||||||+.|++|.+++. ..+++..+..|+.||+.||.|||++||+||
T Consensus 137 ~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~giiHr 206 (681)
T 2pzi_A 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----------QKLPVAEAIAYLLEILPALSYLHSIGLVYN 206 (681)
T ss_dssp CCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred CCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Confidence 99999999999987655 799999999999998764 268999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||++.+ .+||+|||++..+... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+
T Consensus 207 Dlkp~NIll~~~-~~kl~DFG~a~~~~~~---------~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~ 274 (681)
T 2pzi_A 207 DLKPENIMLTEE-QLKLIDLGAVSRINSF---------GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLP 274 (681)
T ss_dssp CCSGGGEEECSS-CEEECCCTTCEETTCC---------SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCC
T ss_pred ccChHHeEEeCC-cEEEEecccchhcccC---------CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCC
Confidence 999999999875 9999999999765321 345799999999998765 5899999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
||.+... ..+. ........++.+.+||.+||++||.+||+..+.+.|+|+..
T Consensus 275 ~~~~~~~------------~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 275 TRNGRYV------------DGLP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp EETTEEC------------SSCC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCccccc------------cccc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 9865211 0111 11122346788999999999999999999999999998854
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=324.63 Aligned_cols=240 Identities=14% Similarity=0.143 Sum_probs=159.1
Q ss_pred eeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CCCCceE
Q psy11359 35 EVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVT 113 (520)
Q Consensus 35 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~HpnIv~ 113 (520)
..++.|+++.+..++..-.|+.+|+|++.+.... +....+......+++.+|+++|+++ .|+||++
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~-------------~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~ 306 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPH-------------GILTAEESQRNKYELHNEIKFLTQPPAGFDAPA 306 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCST-------------TCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCC
T ss_pred hccccCCcccccccccccccceeEEEEEeccccc-------------ccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeE
Confidence 3456677777777777677788888877543211 1111112234567899999999999 7999999
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCC
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~ 193 (520)
++++++++..+||||||++|++|.++|+ ..+.+++. .|+.||+.||+|||++|||||||||+|||++.+
T Consensus 307 ~~~~~ed~~~~yLVMEyv~G~~L~d~i~--------~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d 375 (569)
T 4azs_A 307 VLAHGENAQSGWLVMEKLPGRLLSDMLA--------AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR 375 (569)
T ss_dssp EEEEEECSSEEEEEEECCCSEEHHHHHH--------TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT
T ss_pred EEEEEEECCEEEEEEecCCCCcHHHHHH--------hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC
Confidence 9999999999999999999999999998 45667764 578999999999999999999999999999999
Q ss_pred CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy11359 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLM 273 (520)
Q Consensus 194 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~ 273 (520)
|.+||+|||+|+.+.... ....+.+||+.|||||++.+. +..++|+||+|+++++|.++..|+ .
T Consensus 376 g~vKL~DFGlAr~~~~~~-----~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~~---------~ 439 (569)
T 4azs_A 376 QHARLIDFGSIVTTPQDC-----SWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSNW---------L 439 (569)
T ss_dssp SCEEECCCTTEESCC--------CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHHH---------H
T ss_pred CCEEEeecccCeeCCCCC-----ccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccchh---------H
Confidence 999999999998764322 224567899999999999765 678899999999998887764332 1
Q ss_pred HHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 274 LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
..+...+.. ...+..+...++..+|..|+.......++|..
T Consensus 440 ~~l~~~~~~--------------~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 440 YAVWQEPVE--------------RWNFVLLLALFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HHHHTSCGG--------------GCSHHHHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred HHhhcCCCC--------------CCcHHHHHHHHhCCCCCCCCChhhhccchhHH
Confidence 111111110 11234566667777888888777777777654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=268.72 Aligned_cols=198 Identities=17% Similarity=0.169 Sum_probs=146.3
Q ss_pred EEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCc
Q psy11359 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENV 111 (520)
Q Consensus 32 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnI 111 (520)
...++||+|+||+||+| ...+..+++|........... .......+++.+|+++|++++||||
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~---------------~~~~~~~~~~~~E~~il~~l~h~nI 401 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDER---------------LDENIRKSRTAREARYLALVKDFGI 401 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHH---------------HHHHHHHHHHHHHHHHHHHGGGGTC
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchh---------------hhhHHHHHHHHHHHHHHHhcCCCCc
Confidence 34679999999999999 455778888865321110000 0001234568999999999999999
Q ss_pred eEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEc
Q psy11359 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191 (520)
Q Consensus 112 v~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~ 191 (520)
+++..++...+..||||||++|++|.++++. +..++.||+.||.|||++||+||||||+|||++
T Consensus 402 v~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~----------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~ 465 (540)
T 3en9_A 402 PAPYIFDVDLDNKRIMMSYINGKLAKDVIED----------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD 465 (540)
T ss_dssp CCCCEEEEETTTTEEEEECCCSEEHHHHSTT----------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES
T ss_pred CceEEEEEeCCccEEEEECCCCCCHHHHHHH----------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC
Confidence 9655555677888999999999999999852 568999999999999999999999999999998
Q ss_pred CCCCeEEeccCcceeeccCccccc--cccccccccccccCCcceeccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 192 EDGTVQIADFGVSAWLATGRDLSR--QKVRHTFVGTPCWMAPEVMEQD-HGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 192 ~~g~vkL~DFG~a~~~~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
. .+||+|||+++.+........ ......++||+.|||||++... ..|+..+|+||..+-.++.+.++.+|.
T Consensus 466 ~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 466 K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 8 999999999987743221100 0023467899999999999751 237888999999999999888877774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=221.65 Aligned_cols=162 Identities=17% Similarity=0.259 Sum_probs=116.8
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
|.+.+.||+|+||.||+|.+ .+|+.||+|+++............ ..+. ...........+.+|+.+|++++|++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~-~~~~----~~~w~~~~~~~~~~E~~~l~~l~~~~ 165 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEK-RDYG----DLHFSVLAIRSARNEFRALQKLQGLA 165 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC------------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhh-hhhc----chhhHHHHHHHHHHHHHHHHhccCCC
Confidence 33449999999999999999 889999999986432110000000 0000 00000124567899999999998555
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEE
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL 190 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl 190 (520)
+..+ +.. +..|+||||++|++|.+ +. ......++.||+.||.|||++||+||||||+|||+
T Consensus 166 v~~~---~~~-~~~~lvmE~~~g~~L~~-l~--------------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl 226 (282)
T 1zar_A 166 VPKV---YAW-EGNAVLMELIDAKELYR-VR--------------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV 226 (282)
T ss_dssp SCCE---EEE-ETTEEEEECCCCEEGGG-CC--------------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred cCeE---Eec-cceEEEEEecCCCcHHH-cc--------------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE
Confidence 5443 333 45699999999999987 42 12345799999999999999999999999999999
Q ss_pred cCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc
Q psy11359 191 GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ 236 (520)
Q Consensus 191 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 236 (520)
+ +|.+||+|||++. .+..++|||++..
T Consensus 227 ~-~~~vkl~DFG~a~------------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSV------------------EVGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCE------------------ETTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCe------------------ECCCCCHHHHHHH
Confidence 9 9999999999874 2446789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.1e-21 Score=186.77 Aligned_cols=159 Identities=16% Similarity=0.147 Sum_probs=111.9
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCce--EEEEEeehhhhhhh----HhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEK--CAIKKINLAVVHSA----YCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~----~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.-|++.+.||+|+||.||+|.+..+|+. ||+|+++....... +.......-.++ ..........+.+|+.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~ 123 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRR---ISPKEKVFIWTEKEFRN 123 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC-------CHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhc---cChHHHHHHHHHHHHHH
Confidence 3488999999999999999999888999 99998754311000 000000000000 00011223468899999
Q ss_pred HhcCCCCCc--eEEEEEEEECCEEEEEEEccCC-C----CHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH-
Q psy11359 103 MSSCHHENV--VTYHTSFVVKDELWLVLRLLEG-G----SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH- 174 (520)
Q Consensus 103 l~~l~HpnI--v~~~~~~~~~~~~~lV~E~~~g-g----sL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH- 174 (520)
|+.|.|++| +.++.. +..+|||||+.+ | +|.++... .++..+..++.||+.||.|||
T Consensus 124 l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----------~~~~~~~~i~~qi~~~l~~lH~ 188 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----------LKELDVEGIFNDVVENVKRLYQ 188 (258)
T ss_dssp HHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----------cChHHHHHHHHHHHHHHHHHHH
Confidence 999988764 444432 356899999942 3 77766431 235578899999999999999
Q ss_pred HCCcEecccCCCcEEEcCCCCeEEeccCcceee
Q psy11359 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207 (520)
Q Consensus 175 ~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~ 207 (520)
++||+||||||+|||++. .++|+|||+|...
T Consensus 189 ~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 189 EAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999999988 9999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=7.1e-19 Score=179.58 Aligned_cols=152 Identities=18% Similarity=0.186 Sum_probs=103.7
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEE-Eeecccchh-----hHHHHHHHHHHH
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIK-KINLEKWNT-----SMDELLKEIQAM 103 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK-~i~~~~~~~-----~~~~l~~Ei~~l 103 (520)
-|++...||+|+||.||+|.+. +|+.||||+++...... +.+.-. ......... ..-...+|...|
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sf-------r~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISF-------RTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECC-------CCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccH-------HHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 3899999999999999999985 69999999986432110 000000 000011010 111234688888
Q ss_pred hcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 104 SSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
.+|.+.++.-..-+.... .+|||||+.|++|.++. +.+....++.||+.+|.|||++|||||||
T Consensus 168 ~rL~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~--------------~~~~~~~l~~qll~~l~~lH~~gIVHrDL 231 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVS--------------SVPDPASLYADLIALILRLAKHGLIHGDF 231 (397)
T ss_dssp HHHHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCC--------------CCSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHhcCCCCCeeeeccC--ceEEEEecCCccHhhhc--------------ccHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 888666553222222222 37999999998875432 12345678999999999999999999999
Q ss_pred CCCcEEEcCCC----------CeEEeccCcce
Q psy11359 184 KAGNILLGEDG----------TVQIADFGVSA 205 (520)
Q Consensus 184 Kp~NILl~~~g----------~vkL~DFG~a~ 205 (520)
||.|||++++| .+.|+||+.+.
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 99999998776 38999999764
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.8e-15 Score=117.68 Aligned_cols=67 Identities=24% Similarity=0.455 Sum_probs=61.0
Q ss_pred ccceeEEEEeeccc---CCcc---eeEEeeecCCCchhhHHHHHHhccCCCCccHHHHHHHHHHHHccCCCce
Q psy11359 427 DRVVNLILRMRNVR---RELN---DIRFEFCIGKDTSDGIAGELVGAGLVDARDTEAISQNLELVVNGTPRKK 493 (520)
Q Consensus 427 ~~~~~l~lr~~~~~---~~~~---~i~f~f~~~~dt~~~va~e~v~~~~~~~~d~~~~a~~~~~~~~~~~~~~ 493 (520)
..+|+|.||+.|++ |+.+ +|+|+|++++|||++||+|||++|+++.+|+.+||.+|+.-|......|
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~~r~R 95 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIKRKR 95 (98)
Confidence 46899999999994 7788 9999999999999999999999999999999999999999997765443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1.4e-12 Score=126.65 Aligned_cols=139 Identities=16% Similarity=0.075 Sum_probs=109.1
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-C
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-H 107 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~ 107 (520)
+.|++...+|.|+.+.||++... +..+++|+...... .....+.+|+.+++.| .
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~-----------------------~~~~~~~~E~~~l~~l~~ 68 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK-----------------------GTTYDVEREKDMMLWLEG 68 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT-----------------------TSTTCHHHHHHHHHHHTT
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC-----------------------CCHHHHHHHHHHHHHHhc
Confidence 45999999999999999999743 57788887642110 1122488899999988 4
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH------------
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS------------ 175 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~------------ 175 (520)
+..+.+++.++...+..|+||||++|.+|.+.+. +......++.++.++|..||+
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~ 135 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSL 135 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCH
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccC-------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchH
Confidence 6778899999999999999999999999987531 112345788999999999998
Q ss_pred -----------------------------------------------CCcEecccCCCcEEEcCCCCeEEeccCcce
Q psy11359 176 -----------------------------------------------NGQIHRDIKAGNILLGEDGTVQIADFGVSA 205 (520)
Q Consensus 176 -----------------------------------------------~giiHrDLKp~NILl~~~g~vkL~DFG~a~ 205 (520)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 136 DSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999776566799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.1e-11 Score=119.54 Aligned_cols=137 Identities=17% Similarity=0.110 Sum_probs=96.7
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
....|.+..+.+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.+
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--------------------------~~~~~~~E~~~l~~l 70 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--------------------------ALNELQDEAARLSWL 70 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--------------------------TTSCHHHHHHHHHHH
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--------------------------cchhhhHHHHHHHHH
Confidence 344577766655677799999954 45677888865311 112377899999888
Q ss_pred CCCC--ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------
Q psy11359 107 HHEN--VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG------- 177 (520)
Q Consensus 107 ~Hpn--Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g------- 177 (520)
.+.+ +.+++.+....+..|+||||++|.+|. .. . . ....++.+++..|..||+..
T Consensus 71 ~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---------~--~---~~~~~~~~l~~~l~~lh~~~~~~~~~~ 134 (264)
T 1nd4_A 71 ATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---------H--L---APAEKVSIMADAMRRLHTLDPATCPFD 134 (264)
T ss_dssp HTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---------C--C---CHHHHHHHHHHHHHHHTTSCGGGCCCB
T ss_pred HhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---------c--C---CHhHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 5444 556888888778899999999998873 11 0 1 11245666666666666543
Q ss_pred ---------------------------------------------------cEecccCCCcEEEcCCCCeEEeccCccee
Q psy11359 178 ---------------------------------------------------QIHRDIKAGNILLGEDGTVQIADFGVSAW 206 (520)
Q Consensus 178 ---------------------------------------------------iiHrDLKp~NILl~~~g~vkL~DFG~a~~ 206 (520)
++|+|++|.|||+++++.+.|+|||.+..
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 135 HQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999997643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.4e-10 Score=118.03 Aligned_cols=142 Identities=11% Similarity=0.144 Sum_probs=103.8
Q ss_pred EEEeeeeecCceEEEEEEEcCCCceEEEEEee--hhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC--
Q psy11359 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKIN--LAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH-- 107 (520)
Q Consensus 32 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~--~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~-- 107 (520)
..++.|+.|.+..||++... +..+++|+.. .... ......+.+|+.+++.|.
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~----------------------~~~~~~~~~E~~~l~~L~~~ 96 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL----------------------LPSAHAIEREYRVMDALAGT 96 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC--------------------------------CHHHHHHHHHHHTTS
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC----------------------CCcHHHHHHHHHHHHHhhcC
Confidence 34678899999999998754 3567777543 1100 012235788999999886
Q ss_pred CCCceEEEEEEEEC---CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH---------
Q psy11359 108 HENVVTYHTSFVVK---DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS--------- 175 (520)
Q Consensus 108 HpnIv~~~~~~~~~---~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~--------- 175 (520)
+..+++++.++.+. +..|+||||++|.++.+. ....+++.+...++.++++.|..||+
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~----------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~ 166 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ----------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLG 166 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT----------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCT
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC----------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhcccc
Confidence 44578888887765 348999999998776431 12346788899999999999999997
Q ss_pred -------------------------------------------------CCcEecccCCCcEEEcCCCC--eEEeccCcc
Q psy11359 176 -------------------------------------------------NGQIHRDIKAGNILLGEDGT--VQIADFGVS 204 (520)
Q Consensus 176 -------------------------------------------------~giiHrDLKp~NILl~~~g~--vkL~DFG~a 204 (520)
..++|+|++|+|||++.++. +.|+||+.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a 246 (359)
T 3dxp_A 167 DYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELS 246 (359)
T ss_dssp TSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTC
T ss_pred ccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccc
Confidence 35899999999999987653 689999988
Q ss_pred eee
Q psy11359 205 AWL 207 (520)
Q Consensus 205 ~~~ 207 (520)
..-
T Consensus 247 ~~g 249 (359)
T 3dxp_A 247 TLG 249 (359)
T ss_dssp EEE
T ss_pred ccC
Confidence 653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.1e-10 Score=116.10 Aligned_cols=187 Identities=16% Similarity=0.209 Sum_probs=118.7
Q ss_pred EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CCCC--
Q psy11359 34 REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HHEN-- 110 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~Hpn-- 110 (520)
++.++.|....||++. ..+++|+.+. ......+.+|+.+|+.+ .+..
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-------------------------~~~~~~~~~E~~~l~~l~~~~~v~ 74 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-------------------------SRGSTNLFNEVNILKRIHNKLPLP 74 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS-------------------------HHHHHHHHHHHHHHHHHTTSSSSC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC-------------------------cchHHHHHHHHHHHHHHHhcCCCC
Confidence 3468999999999873 3466665321 12345688999999887 4433
Q ss_pred ceEEEEEEEECC---EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH------------
Q psy11359 111 VVTYHTSFVVKD---ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS------------ 175 (520)
Q Consensus 111 Iv~~~~~~~~~~---~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~------------ 175 (520)
+.+.+....... ..|+||++++|.+|.+... ..++..+...++.|++..|..||+
T Consensus 75 vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~----------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~ 144 (304)
T 3sg8_A 75 IPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL----------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVL 144 (304)
T ss_dssp CCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH----------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBC
T ss_pred CCceEeecCCCCCCCcceEEEcccCCeECCcccc----------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchh
Confidence 344444433333 3488999999988865432 235677777888888888888886
Q ss_pred ----------------------------------------------CCcEecccCCCcEEEcC--CCCeEEeccCcceee
Q psy11359 176 ----------------------------------------------NGQIHRDIKAGNILLGE--DGTVQIADFGVSAWL 207 (520)
Q Consensus 176 ----------------------------------------------~giiHrDLKp~NILl~~--~g~vkL~DFG~a~~~ 207 (520)
..++|+|++|.||+++. .+.+.|+||+.+...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 145 DFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp CHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 13699999999999987 456889999988754
Q ss_pred ccCcccccccc---------ccccccccccCC-cceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 208 ATGRDLSRQKV---------RHTFVGTPCWMA-PEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 208 ~~~~~~~~~~~---------~~~~~gt~~y~A-PE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
....+...... ...+........ |+.... .....+.|++|.+++.+.+|..+|
T Consensus 225 ~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 225 DPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred ChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 32222111000 000000001111 222111 122368999999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=5.2e-07 Score=87.40 Aligned_cols=133 Identities=15% Similarity=0.208 Sum_probs=94.4
Q ss_pred eeeecCce-EEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC-CCCceE
Q psy11359 36 VIGFGATA-VVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH-HENVVT 113 (520)
Q Consensus 36 ~LG~G~fg-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~-HpnIv~ 113 (520)
.+..|..+ .||+......+..+++|.... .....+.+|...|+.|. +--+.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------------------------~~~~~~~~E~~~l~~l~~~vPVP~ 84 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG--------------------------SVANDVTDEMVRLNWLTAFMPLPT 84 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET--------------------------HHHHHHHHHHHHHHHHTTTSCCCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC--------------------------CCHhHHHHHHHHHHHhccCCCcCe
Confidence 34445544 799988877777777776532 12345788999988873 333677
Q ss_pred EEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------
Q psy11359 114 YHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN----------------- 176 (520)
Q Consensus 114 ~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~----------------- 176 (520)
++.++.+.+..|+|||+++|.++.+..... ......+..++...|..||+.
T Consensus 85 v~~~~~~~~~~~lvme~l~G~~~~~~~~~~------------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~ 152 (272)
T 4gkh_A 85 IKHFIRTPDDAWLLTTAIPGKTAFQVLEEY------------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQ 152 (272)
T ss_dssp EEEEEEETTEEEEEEECCCSEEHHHHHHHC------------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHH
T ss_pred EEEEEEECCeEEEEEEeeCCccccccccCC------------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhh
Confidence 888899999999999999999888765421 122334555555555555531
Q ss_pred -----------------------------------------CcEecccCCCcEEEcCCCCeEEeccCccee
Q psy11359 177 -----------------------------------------GQIHRDIKAGNILLGEDGTVQIADFGVSAW 206 (520)
Q Consensus 177 -----------------------------------------giiHrDLKp~NILl~~~g~vkL~DFG~a~~ 206 (520)
.++|+|+.+.|||++.++.+-|+||+.+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 153 AQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999998877778999997643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=6.3e-07 Score=88.92 Aligned_cols=134 Identities=19% Similarity=0.129 Sum_probs=89.6
Q ss_pred EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCC---C
Q psy11359 34 REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHE---N 110 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hp---n 110 (520)
.+.++.|....||+. |..+++|+.+. ......+.+|+.+|+.|.+. .
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-------------------------~~~~~~~~~E~~~L~~L~~~~~v~ 73 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-------------------------QQGADELNKEIQLLPLLVGCVKVN 73 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-------------------------HHHHHHHHHHHHHHHHHTTTCSSB
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-------------------------chHHHHHHHHHHHHHHHHhcCCCC
Confidence 456788999999988 45667775321 12345688999999998642 3
Q ss_pred ceEEEEEEE-ECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-------------
Q psy11359 111 VVTYHTSFV-VKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSN------------- 176 (520)
Q Consensus 111 Iv~~~~~~~-~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~------------- 176 (520)
+.+.+.+.. ..+..|+||+|++|.+|.+..- ..++..+...++.|+.+.|..||+.
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~----------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~ 143 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM----------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVT 143 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHH----------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBC
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhh----------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChH
Confidence 556666664 3455789999999988876321 1123344444444444444444432
Q ss_pred -----------------------------------------------CcEecccCCCcEEEcC---CCC-eEEeccCcce
Q psy11359 177 -----------------------------------------------GQIHRDIKAGNILLGE---DGT-VQIADFGVSA 205 (520)
Q Consensus 177 -----------------------------------------------giiHrDLKp~NILl~~---~g~-vkL~DFG~a~ 205 (520)
.++|+|++|.|||++. ++. +.|+||+.+.
T Consensus 144 ~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 144 NLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp CHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3599999999999987 455 4899999876
Q ss_pred ee
Q psy11359 206 WL 207 (520)
Q Consensus 206 ~~ 207 (520)
.-
T Consensus 224 ~g 225 (306)
T 3tdw_A 224 IS 225 (306)
T ss_dssp EE
T ss_pred CC
Confidence 53
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=9.1e-06 Score=83.39 Aligned_cols=84 Identities=19% Similarity=0.090 Sum_probs=50.0
Q ss_pred EEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC--C-
Q psy11359 33 VREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH--E- 109 (520)
Q Consensus 33 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H--p- 109 (520)
-.+.||.|.++.||++.....+..+++|....... .. .+.+....+++..|+.+++.+.. |
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r---------------~~-~~~~~~~~~r~~~E~~~L~~l~~~~~~ 97 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAK---------------VV-GESWPLTIDRARIESSALIRQGEHVPH 97 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-----------------------CCCCTTHHHHHHHHHHHHHTTCGG
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhc---------------cc-CCCCcCcHHHHHHHHHHHHHhhhhCCC
Confidence 35689999999999997766677888887541100 00 00111123456778888887632 3
Q ss_pred CceEEEEEEEECCEEEEEEEccCCC
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGG 134 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~gg 134 (520)
.+.+++.+ +.+..++|||++.|.
T Consensus 98 ~vP~~~~~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 98 LVPRVFYS--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp GSCCEEEE--ETTTTEEEECCCTTS
T ss_pred CcCeEEEE--cCCccEEEEEeCCCc
Confidence 34456543 455678999999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=2.2e-05 Score=78.28 Aligned_cols=30 Identities=30% Similarity=0.521 Sum_probs=26.9
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcce
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVSA 205 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a~ 205 (520)
..++|+|++++|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 479999999999999888899999999653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=4.8e-06 Score=84.04 Aligned_cols=87 Identities=9% Similarity=-0.043 Sum_probs=52.5
Q ss_pred eEEEeee-eecCceEEEEEEEcC------CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 31 YEVREVI-GFGATAVVHSAYCKA------RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 31 Y~i~~~L-G~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
....+.| +.|....+|+..... ++..+++|+...... . .. .....+.+|+.++
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~-----------~--------~~-~~~~~~~~E~~~l 81 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAED-----------V--------PV-FPTYRLDHQFEVI 81 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGG-----------C--------CS-SSCCCHHHHHHHH
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCc-----------c--------cc-CchhHHHHHHHHH
Confidence 3456778 888889999886531 145667765432100 0 00 0012367788888
Q ss_pred hcCC-C--CCceEEEEEEEEC---CEEEEEEEccCCCCHH
Q psy11359 104 SSCH-H--ENVVTYHTSFVVK---DELWLVLRLLEGGSLL 137 (520)
Q Consensus 104 ~~l~-H--pnIv~~~~~~~~~---~~~~lV~E~~~ggsL~ 137 (520)
+.|. + -.+.+++.+.... ...|+||||++|.++.
T Consensus 82 ~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 82 RLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp HHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred HHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 8773 2 3466777766544 3468999999886643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00019 Score=74.14 Aligned_cols=33 Identities=24% Similarity=0.453 Sum_probs=28.1
Q ss_pred HHCCcEecccCCCcEEEcCCCCeEEeccCcceee
Q psy11359 174 HSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207 (520)
Q Consensus 174 H~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~ 207 (520)
+...++|+|++|.|||++.++ +.|+||+.+.+-
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 345799999999999998776 999999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00011 Score=72.26 Aligned_cols=29 Identities=24% Similarity=0.251 Sum_probs=24.7
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCccee
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAW 206 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~ 206 (520)
.++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 5667889999997754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00075 Score=62.51 Aligned_cols=136 Identities=18% Similarity=0.121 Sum_probs=91.2
Q ss_pred CCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCcc
Q psy11359 134 GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH-SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRD 212 (520)
Q Consensus 134 gsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH-~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~ 212 (520)
.||.++++. ...+++|+++|.++.|.+.+|.-+- ...-..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~-------~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 33 LSLEEILRL-------YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEHHHHHHH-------HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHH-------cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------
Confidence 379999987 4779999999999999999988862 22222334457899999999988864 2110
Q ss_pred ccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhh
Q psy11359 213 LSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQ 292 (520)
Q Consensus 213 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (520)
.....+.|||... ...+.+.=|||||+++|.-+--..|- ..
T Consensus 98 ----------~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e---------------------------~e 138 (229)
T 2yle_A 98 ----------AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE---------------------------NE 138 (229)
T ss_dssp -------------------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT---------------------------TE
T ss_pred ----------ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc---------------------------cc
Confidence 1123567888763 23578889999999999988732221 01
Q ss_pred HHHhcHHHHHHHHhhhcc-------------------------CCCCCCCHHHHhc
Q psy11359 293 YKAYGKTFRKMISDCLQK-------------------------DPTKRPTASELLK 323 (520)
Q Consensus 293 ~~~~~~~~~~li~~~L~~-------------------------dP~~Rpta~elL~ 323 (520)
...+|+.+..||..|..- .+..|+|.+++++
T Consensus 139 E~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 139 ERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp EECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred chhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 145688888899888754 2467888888875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0011 Score=65.46 Aligned_cols=76 Identities=12% Similarity=-0.013 Sum_probs=56.9
Q ss_pred EEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC---CC
Q psy11359 33 VREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH---HE 109 (520)
Q Consensus 33 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~---Hp 109 (520)
-.+.|+.|....+|+... .+..+++|+... .....+..|+..|+.|. ..
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~--------------------------~~~~~~~~E~~~L~~L~~~~~v 91 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINER--------------------------SYRSMFRAEADQLALLAKTNSI 91 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEG--------------------------GGHHHHHHHHHHHHHHHHTTSS
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCc--------------------------ccHHHHHHHHHHHHHHHhhCCC
Confidence 357789999999999864 455677775431 12445788988888873 35
Q ss_pred CceEEEEEEEECCEEEEEEEccCCCCH
Q psy11359 110 NVVTYHTSFVVKDELWLVLRLLEGGSL 136 (520)
Q Consensus 110 nIv~~~~~~~~~~~~~lV~E~~~ggsL 136 (520)
.+++.+.+....+..|+||||++|.++
T Consensus 92 ~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 92 NVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp BCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred CcceEEEEeecCCceEEEEEeccCCCC
Confidence 678888888878899999999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0023 Score=63.12 Aligned_cols=148 Identities=13% Similarity=0.059 Sum_probs=76.9
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHEN 110 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~Hpn 110 (520)
..-.+.|+.|....+|+..... | .+++|+.+.. ...+.+..|+.+++.|...+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~-------------------------~~~~~l~~e~~~l~~L~~~g 76 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-------------------------VEKNDLPFFLGLMQHLAAKG 76 (322)
T ss_dssp EEEEEEECC---EEEEEEEESS-C-CEEEEEECC----------------------------CCHHHHHHHHHHHHHHTT
T ss_pred ceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC-------------------------CCHHHHHHHHHHHHHHHHCC
Confidence 3446678888889999987542 2 5667765321 01123556777776663212
Q ss_pred --ceEEEE------EEEECCEEEEEEEccCCCCHH-----------HHHHHhhccc-cCCCC---CCCHHHHHHH-----
Q psy11359 111 --VVTYHT------SFVVKDELWLVLRLLEGGSLL-----------DIIKHRLKIS-NCKHG---VCDEPTIATV----- 162 (520)
Q Consensus 111 --Iv~~~~------~~~~~~~~~lV~E~~~ggsL~-----------~~i~~~~~~~-~~~~~---~l~~~~i~~i----- 162 (520)
+.+++. +....+..+++|+|++|.++. ..+.+.-... ..... ..........
T Consensus 77 ~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~ 156 (322)
T 2ppq_A 77 LSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSE 156 (322)
T ss_dssp CCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHG
T ss_pred CCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHH
Confidence 223321 122356789999999886431 1111110000 00000 0111111110
Q ss_pred ----------HHHHHHHHHHHHH-------CCcEecccCCCcEEEcCCCCeEEeccCcce
Q psy11359 163 ----------LREVLKGLEYFHS-------NGQIHRDIKAGNILLGEDGTVQIADFGVSA 205 (520)
Q Consensus 163 ----------~~qIl~gL~yLH~-------~giiHrDLKp~NILl~~~g~vkL~DFG~a~ 205 (520)
...+...+.+++. .+++|+|++++|||++.++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 157 ERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0113444555553 369999999999999877666899999764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0014 Score=66.72 Aligned_cols=145 Identities=14% Similarity=0.143 Sum_probs=80.9
Q ss_pred EeeeeecCceEEEEEEEcC-------CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 34 REVIGFGATAVVHSAYCKA-------RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
++.|..|-...+|++.... .+..+++|+.. . .......+.+|..+++.|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g----------------------~--~~~~~~~~~rE~~vl~~L 110 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYG----------------------A--ILQGVDSLVLESVMFAIL 110 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------------------------CCHHHHHHHHHHHHHH
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECC----------------------C--ccchHHHHHHHHHHHHHH
Confidence 3466678888899987642 23556666431 0 011344566899998887
Q ss_pred CCCC-ceEEEEEEEECCEEEEEEEccCCCCHH-----------HHHHHhhccccC--C-CCCC--CHHHHHHHHHHHHH-
Q psy11359 107 HHEN-VVTYHTSFVVKDELWLVLRLLEGGSLL-----------DIIKHRLKISNC--K-HGVC--DEPTIATVLREVLK- 168 (520)
Q Consensus 107 ~Hpn-Iv~~~~~~~~~~~~~lV~E~~~ggsL~-----------~~i~~~~~~~~~--~-~~~l--~~~~i~~i~~qIl~- 168 (520)
.-.+ ..+++..+. + .+||||++|.+|. .+.+....+-.. . .+.. -..++.+|+.|+..
T Consensus 111 ~~~gv~P~ll~~~~--~--g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~ 186 (379)
T 3feg_A 111 AERSLGPQLYGVFP--E--GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDL 186 (379)
T ss_dssp HHTTSSCCEEEEET--T--EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHC
T ss_pred HhcCCCCeEEEEcC--C--ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhc
Confidence 4223 355665443 3 3999999876542 111111111100 1 1112 24567777766533
Q ss_pred ------------------HHHHHH----HC----CcEecccCCCcEEEcCC----CCeEEeccCccee
Q psy11359 169 ------------------GLEYFH----SN----GQIHRDIKAGNILLGED----GTVQIADFGVSAW 206 (520)
Q Consensus 169 ------------------gL~yLH----~~----giiHrDLKp~NILl~~~----g~vkL~DFG~a~~ 206 (520)
.+..|. .. .++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 187 ~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 187 PPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred cCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233333 22 48999999999999776 7899999997643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00061 Score=67.77 Aligned_cols=32 Identities=28% Similarity=0.309 Sum_probs=27.2
Q ss_pred CCcEecccCCCcEEEcCC----CCeEEeccCcceee
Q psy11359 176 NGQIHRDIKAGNILLGED----GTVQIADFGVSAWL 207 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~----g~vkL~DFG~a~~~ 207 (520)
..++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 369999999999999764 68999999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.004 Score=64.43 Aligned_cols=74 Identities=8% Similarity=0.003 Sum_probs=45.8
Q ss_pred EEeeeeecCceEEEEEEEcC-------CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 33 VREVIGFGATAVVHSAYCKA-------RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 33 i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
-++.|+.|....+|++.... .+..+++|+.. .. ...+.+.+|+.+++.
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~----------------------~~---~~~~~li~E~~~l~~ 131 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF----------------------NP---ETESHLVAESVIFTL 131 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC----------------------SC---CCHHHHHHHHHHHHH
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeC----------------------CC---CcHHHHHHHHHHHHH
Confidence 45678888899999997653 23455555431 10 011345678888888
Q ss_pred CCCCCc-eEEEEEEEECCEEEEEEEccCCCC
Q psy11359 106 CHHENV-VTYHTSFVVKDELWLVLRLLEGGS 135 (520)
Q Consensus 106 l~HpnI-v~~~~~~~~~~~~~lV~E~~~ggs 135 (520)
|...++ +++++.+. + .+|+||++|.+
T Consensus 132 L~~~g~~P~l~~~~~--~--g~v~e~l~G~~ 158 (429)
T 1nw1_A 132 LSERHLGPKLYGIFS--G--GRLEEYIPSRP 158 (429)
T ss_dssp HHHTTSSSCEEEEET--T--EEEECCCCEEE
T ss_pred HHhCCCCCcEEEEeC--C--CEEEEEeCCcc
Confidence 743334 56665443 3 38999998643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0087 Score=62.36 Aligned_cols=76 Identities=13% Similarity=0.108 Sum_probs=45.8
Q ss_pred EEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCc-
Q psy11359 33 VREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENV- 111 (520)
Q Consensus 33 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnI- 111 (520)
-++.|+.|-...+|++.....+..+++|+.... ....-.-.+|..+++.|...++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~------------------------~~~~idR~~E~~vl~~L~~~gl~ 167 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPK------------------------TDEIINREREKKISCILYNKNIA 167 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-------------------------CCSCSCHHHHHHHHHHHTTSSSB
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCC------------------------hhhhcCHHHHHHHHHHHHhcCCC
Confidence 356788888999999987654466777764211 0000012578888888865455
Q ss_pred eEEEEEEEECCEEEEEEEccCCCCH
Q psy11359 112 VTYHTSFVVKDELWLVLRLLEGGSL 136 (520)
Q Consensus 112 v~~~~~~~~~~~~~lV~E~~~ggsL 136 (520)
.+++..+ .+ .+||||++|.+|
T Consensus 168 P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 168 KKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp CCEEEEE--TT--EEEEECCCSEEC
T ss_pred CCEEEEe--CC--eEEEEeeCCccC
Confidence 4666665 23 359999987543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0083 Score=58.18 Aligned_cols=78 Identities=8% Similarity=-0.094 Sum_probs=51.3
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC-C
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH-H 108 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~-H 108 (520)
+..-++.+|.|..+.||+... .+|+.|++|+.... . ......+..|+..|+.|. .
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~----------------------~-~~~~~~~~~Ea~~L~~L~~~ 71 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDD----------------------A-PALDGLFRAEALGLDWLGRS 71 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTT----------------------C-CCCTTHHHHHHHHHHHHTCS
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCC----------------------C-cchhhHHHHHHHHHHHHHhh
Confidence 456678899999999999975 46778888864311 0 111234678998888773 2
Q ss_pred --CCceEEEEEEEECCEEEEEEEccCCCC
Q psy11359 109 --ENVVTYHTSFVVKDELWLVLRLLEGGS 135 (520)
Q Consensus 109 --pnIv~~~~~~~~~~~~~lV~E~~~ggs 135 (520)
--+++.+.+ .. -++||||+.++.
T Consensus 72 ~~vpvP~v~~~--~~--~~lv~e~l~~~~ 96 (288)
T 3f7w_A 72 FGSPVPQVAGW--DD--RTLAMEWVDERP 96 (288)
T ss_dssp TTCCSCCEEEE--ET--TEEEEECCCCCC
T ss_pred CCCCcceEEec--cC--ceEEEEeecccC
Confidence 124455543 22 378999998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0092 Score=58.84 Aligned_cols=28 Identities=32% Similarity=0.386 Sum_probs=24.2
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcce
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVSA 205 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a~ 205 (520)
..++|+|++++|||++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 3589999999999998 4 89999999764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0026 Score=64.26 Aligned_cols=29 Identities=24% Similarity=0.415 Sum_probs=24.1
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCccee
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAW 206 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~ 206 (520)
.++|+|+++.|||++.++ +.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 589999999999997654 89999997653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.23 E-value=0.051 Score=54.02 Aligned_cols=30 Identities=33% Similarity=0.576 Sum_probs=27.0
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCccee
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAW 206 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~ 206 (520)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 589999999999998888999999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.91 E-value=0.076 Score=54.57 Aligned_cols=29 Identities=24% Similarity=0.430 Sum_probs=25.6
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCccee
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSAW 206 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~~ 206 (520)
.++|+|+.++||+ +.++.+.|+||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 3899999999999 7788999999998754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.65 E-value=0.22 Score=50.63 Aligned_cols=29 Identities=38% Similarity=0.618 Sum_probs=24.7
Q ss_pred cEecccCCCcEEE------cCCCCeEEeccCccee
Q psy11359 178 QIHRDIKAGNILL------GEDGTVQIADFGVSAW 206 (520)
Q Consensus 178 iiHrDLKp~NILl------~~~g~vkL~DFG~a~~ 206 (520)
++|+|+.+.|||+ ++++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3467899999998754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.06 E-value=2.3 Score=39.02 Aligned_cols=115 Identities=9% Similarity=0.028 Sum_probs=78.3
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCC-CHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGG-SLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~gg-sL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
.||+++.. .+-.+.+.+.+.++.-..+ ++.. + ..++....++++.+|+....++ ..-+|-=|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----------k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P 107 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----------KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAP 107 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----------GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----------HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEec
Confidence 68999876 5666777777766655422 2222 2 3467889999999999887444 4457888999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
+||+++.++.+++.=.|+-.. ++|.- ++...=.-.+=|++..++++++.|.
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~----------------------l~P~~------~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNV----------------------VDPLP------VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGEEECTTSCEEESCCEETTT----------------------BSCCC------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred ceEEEcCCCCEEEEEccCccC----------------------CCCCC------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999987775321 23321 2222223456788899999988873
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.52 E-value=2.9 Score=38.42 Aligned_cols=114 Identities=11% Similarity=0.070 Sum_probs=77.9
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHH-HHHHCCcEecccCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLE-YFHSNGQIHRDIKA 185 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~-yLH~~giiHrDLKp 185 (520)
.||++ -..+-.+++.+.+.++.-+++.=+..++ .++....++++.+|+.... ++ ..-+|-=|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----------~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----------KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----------TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----------hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeC
Confidence 58888 3445577888888877764443344444 3567888999988888665 33 4557888999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
+||+++.++.++|.=.|+- .-++|.-+ +..-=.-++=|++..++.+++.|
T Consensus 113 ~NL~f~~~~~p~i~hRGi~----------------------~~lpP~e~------~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVK----------------------ESLPPDEW------DDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp GGEEECTTCCEEESCCEET----------------------TTBSSCSC------CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred ceEEEeCCCcEEEEEcCCc----------------------ccCCCCCC------CHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999999999877752 22344321 11112335667888888888777
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 520 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-76 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-72 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-70 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-68 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-67 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-67 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-66 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-63 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-62 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-61 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-60 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-60 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-58 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-56 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-55 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-55 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-54 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-54 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-54 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-53 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-52 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-51 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-50 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-50 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-49 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-48 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-48 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-48 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-47 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-46 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-34 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-16 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 3e-76
Identities = 102/312 (32%), Positives = 153/312 (49%), Gaps = 46/312 (14%)
Query: 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKIN 85
N ED +E+ +G GA V+ A K + A K I+
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--------------------- 47
Query: 86 LEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK 145
K +++ + EI ++SC H N+V +F ++ LW+++ GG++ ++
Sbjct: 48 --KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-- 103
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSA 205
E I V ++ L L Y H N IHRD+KAGNIL DG +++ADFGVSA
Sbjct: 104 -----ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA 158
Query: 206 WLATGRDLSRQKVRHTFVGTPCWMAPEVM----EQDHGYDFKADIWSLGITAIEMATGTA 261
R +F+GTP WMAPEV+ +D YD+KAD+WSLGIT IEMA
Sbjct: 159 KNTRTIQ-----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213
Query: 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
P+H+ M+VL+ +++PPTL Q + F+ + CL+K+ R T S+L
Sbjct: 214 PHHELNPMRVLLKIAKSEPPTL-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
Query: 322 LKNPFFKKAKDK 333
L++PF +K
Sbjct: 267 LQHPFVTVDSNK 278
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 229 bits (584), Expect = 8e-72
Identities = 98/315 (31%), Positives = 144/315 (45%), Gaps = 47/315 (14%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
E + IG G+ V+ A +E AIKK++ + S
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS------------------ 55
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
N +++KE++ + H N + Y ++ + WLV+ G + + H+ +
Sbjct: 56 --NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ 113
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
E IA V L+GL Y HS+ IHRD+KAGNILL E G V++ DFG ++ +
Sbjct: 114 --------EVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVME--QDHGYDFKADIWSLGITAIEMATGTAPYHK 265
A ++FVGTP WMAPEV+ + YD K D+WSLGIT IE+A P
Sbjct: 166 APA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
Query: 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325
AM L QN+ P L + + + FR + CLQK P RPT+ LLK+
Sbjct: 217 MNAMSALYHIAQNESPALQS--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268
Query: 326 FFKKAKDKKFIQQTL 340
F + + I +
Sbjct: 269 FVLRERPPTVIMDLI 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 4e-70
Identities = 112/304 (36%), Positives = 150/304 (49%), Gaps = 45/304 (14%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
+ +Y E IG GA+ V++A A ++ AI+++NL
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL----------------------- 55
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ + ++ EI M + N+V Y S++V DELW+V+ L GGSL D++
Sbjct: 56 QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----- 110
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
DE IA V RE L+ LE+ HSN IHRDIK+ NILLG DG+V++ DFG A +
Sbjct: 111 ----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267
Q R T VGTP WMAPEV+ Y K DIWSLGI AIEM G PY
Sbjct: 167 TPE-----QSKRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327
++ L L N P L + FR ++ CL D KR +A ELL++ F
Sbjct: 221 PLRALYLIATNGTPEL-------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
Query: 328 KKAK 331
K AK
Sbjct: 274 KIAK 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 4e-68
Identities = 65/301 (21%), Positives = 124/301 (41%), Gaps = 40/301 (13%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ +++ + +G GA V A + E A+K +++ ++
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----------------------KR 42
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+ + KEI +HENVV ++ + +L L GG L D I+
Sbjct: 43 AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE------- 95
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
EP +++ G+ Y H G HRDIK N+LL E ++I+DFG++
Sbjct: 96 -PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF- 153
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
R +R+++ + GT ++APE++++ + D+WS GI M G P+ +
Sbjct: 154 --RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211
Query: 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328
+ L + +K ++ L ++P+ R T ++ K+ ++
Sbjct: 212 SCQEYSDWKEKKTYL-------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
Query: 329 K 329
K
Sbjct: 265 K 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 8e-68
Identities = 76/301 (25%), Positives = 128/301 (42%), Gaps = 46/301 (15%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ +E+ +G G V+ A K A+K + KA+ EK ++
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF---------KAQLEKAGVEH----- 51
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+L +E++ S H N++ + F ++L+L G++ ++
Sbjct: 52 ------QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------- 98
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
K DE AT + E+ L Y HS IHRDIK N+LLG G ++IADFG S
Sbjct: 99 -KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
+ R R T GT ++ PE++ + +D K D+WSLG+ E G P+
Sbjct: 158 SSR-------RTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209
Query: 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328
+ + + D + R +IS L+ +P++RP E+L++P+
Sbjct: 210 QETYKRISRVEFTFPDF----------VTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
Query: 329 K 329
Sbjct: 260 A 260
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 3e-67
Identities = 79/353 (22%), Positives = 139/353 (39%), Gaps = 78/353 (22%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
+D +E +G G VV K A K I+L E
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----------------------E 42
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+++++E+Q + C+ +V ++ +F E+ + + ++GGSL ++K
Sbjct: 43 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK------ 96
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
K G E + V V+KGL Y + +HRD+K NIL+ G +++ DFGVS
Sbjct: 97 --KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154
Query: 207 LATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH-- 264
L ++FVGT +M+PE + Q Y ++DIWS+G++ +EMA G P
Sbjct: 155 LIDSM-------ANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206
Query: 265 -----KYPAMKVLMLTLQNDPPTLDTGAAEKDQY-------------------------- 293
+ + PP T Y
Sbjct: 207 DAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP 266
Query: 294 -KAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK-----KFIQQTL 340
+ F+ ++ CL K+P +R +L+ + F K++ + ++ T+
Sbjct: 267 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTI 319
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 218 bits (555), Expect = 6e-67
Identities = 74/342 (21%), Positives = 124/342 (36%), Gaps = 45/342 (13%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
D Y++ E +G GA VVH +A A K +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT-----------------------P 62
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+ + + KEIQ MS H +V H +F +E+ ++ + GG L + +
Sbjct: 63 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD------ 116
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG--EDGTVQIADFGVSAW 206
+H E +R+V KGL + H N +H D+K NI+ +++ DFG++
Sbjct: 117 -EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-- 173
Query: 207 LATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266
L ++ GT + APEV E + D+WS+G+ + + +G +P+
Sbjct: 174 ----AHLDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGE 228
Query: 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
+ L D D + + + I L DP R T + L++P+
Sbjct: 229 NDDETLRNVKSCDWNMDD------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282
Query: 327 FKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRLHRT 368
Q S I+ P L R
Sbjct: 283 LTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRI 324
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 214 bits (547), Expect = 1e-66
Identities = 75/307 (24%), Positives = 134/307 (43%), Gaps = 40/307 (13%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ YE +E++G G ++VV K ++ A+K I+ + E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIID--------------VTGGGSFSAEE 48
Query: 89 WNTSMDELLKEIQAMSSCH-HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ LKE+ + H N++ ++ +LV L++ G L D + ++ +S
Sbjct: 49 VQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS 108
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
E ++R +L+ + H +HRD+K NILL +D +++ DFG S L
Sbjct: 109 --------EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVME-----QDHGYDFKADIWSLGITAIEMATGTAP 262
G L GTP ++APE++E GY + D+WS G+ + G+ P
Sbjct: 161 DPGEKL------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
Query: 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
+ M +L + + + ++ Y T + ++S L P KR TA E L
Sbjct: 215 FWHRKQMLMLRMIMSGNYQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268
Query: 323 KNPFFKK 329
+PFF++
Sbjct: 269 AHPFFQQ 275
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 214 bits (547), Expect = 8e-66
Identities = 74/312 (23%), Positives = 130/312 (41%), Gaps = 45/312 (14%)
Query: 20 VSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKC 79
V V + D Y++ E +G GA VVH KA K IN
Sbjct: 20 VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--------------- 64
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139
+ + EI M+ HH ++ H +F K E+ L+L L GG L D
Sbjct: 65 --------PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 116
Query: 140 IKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL--GEDGTVQ 197
I E + +R+ +GL++ H + +H DIK NI+ + +V+
Sbjct: 117 IAAE-------DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVK 169
Query: 198 IADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257
I DFG++ L+ ++ T + APE++++ F D+W++G+ +
Sbjct: 170 IIDFGLA------TKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLL 222
Query: 258 TGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT 317
+G +P+ ++ L + D ++D + + + I + LQK+P KR T
Sbjct: 223 SGLSPFAGEDDLETLQNVKRCDWEF------DEDAFSSVSPEAKDFIKNLLQKEPRKRLT 276
Query: 318 ASELLKNPFFKK 329
+ L++P+ K
Sbjct: 277 VHDALEHPWLKG 288
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-64
Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 47/305 (15%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ YEV IG G+ K+ + K+++ + A
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA------------------ 45
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE--LWLVLRLLEGGSLLDIIKHRLKI 146
L+ E+ + H N+V Y+ + + L++V+ EGG L +I K
Sbjct: 46 ---EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK- 101
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ-----IHRDIKAGNILLGEDGTVQIADF 201
+ DE + V+ ++ L+ H +HRD+K N+ L V++ DF
Sbjct: 102 ---ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261
G++ L + FVGTP +M+PE M Y+ K+DIWSLG E+
Sbjct: 159 GLARILNHDTSFA-----KAFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMP 212
Query: 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
P+ + ++ + + Y ++I+ L RP+ E+
Sbjct: 213 PFTAFSQKELAGKIREGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEI 263
Query: 322 LKNPF 326
L+NP
Sbjct: 264 LENPL 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 9e-63
Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 32/272 (11%)
Query: 65 AVVHSAYCKARAEKCAIKKINLEKWN-TSMDELLKEIQAMSSCHHENVVTYHTSFVV--- 120
V+ + A ++ K + +E + + H N+V ++ S+
Sbjct: 23 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82
Query: 121 -KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQ- 178
K + LV L+ G+L +K + V + + R++LKGL++ H+
Sbjct: 83 GKKCIVLVTELMTSGTLKTYLK--------RFKVMKIKVLRSWCRQILKGLQFLHTRTPP 134
Query: 179 -IHRDIKAGNILL-GEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ 236
IHRD+K NI + G G+V+I D G++ L R +GTP +MAPE+ E+
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLAT-------LKRASFAKAVIGTPEFMAPEMYEE 187
Query: 237 DHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAY 296
YD D+++ G+ +EMAT PY + + + + K
Sbjct: 188 --KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS-------FDKVA 238
Query: 297 GKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328
+++I C++++ +R + +LL + FF+
Sbjct: 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 3e-62
Identities = 66/303 (21%), Positives = 122/303 (40%), Gaps = 43/303 (14%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
W + Q V + IG G+ V+ A+K
Sbjct: 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH-------------------------GDVAVKM 37
Query: 84 INLEKWNTS-MDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
+N+ + E+ + H N++ + + +L +V + EG SL +
Sbjct: 38 LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHI 96
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202
+ + + R+ +G++Y H+ IHRD+K+ NI L ED TV+I DFG
Sbjct: 97 I-------ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFG 149
Query: 203 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEV--MEQDHGYDFKADIWSLGITAIEMATGT 260
++ + S G+ WMAPEV M+ + Y F++D+++ GI E+ TG
Sbjct: 150 LATVKS---RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206
Query: 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320
PY ++ + + D + K ++++++CL+K +RP +
Sbjct: 207 LPYSNINNRDQIIFMVGRGYLSPDLSKVRSN----CPKAMKRLMAECLKKKRDERPLFPQ 262
Query: 321 LLK 323
+L
Sbjct: 263 ILA 265
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (518), Expect = 4e-62
Identities = 84/340 (24%), Positives = 135/340 (39%), Gaps = 51/340 (15%)
Query: 24 WPNTE---DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCA 80
W E D Y+ R+V+G GA + V A K + AIK I
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK---------------- 44
Query: 81 IKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDII 140
+ + EI + H N+V + L+L+++L+ GG L D I
Sbjct: 45 ------KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 98
Query: 141 KHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQ 197
+ G E + ++ +VL ++Y H G +HRD+K N+L ED +
Sbjct: 99 V--------EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM 150
Query: 198 IADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257
I+DFG+S + V T GTP ++APEV+ Y D WS+G+ A +
Sbjct: 151 ISDFGLS------KMEDPGSVLSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYILL 203
Query: 258 TGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT 317
G P++ K+ L+ + + + + + I ++KDP KR T
Sbjct: 204 CGYPPFYDENDAKLFEQILKAEYEF------DSPYWDDISDSAKDFIRHLMEKDPEKRFT 257
Query: 318 ASELLKNPFFKK--AKDKKFIQQTLVSVGPTFETRIQKAA 355
+ L++P+ A DK Q + F K A
Sbjct: 258 CEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQA 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-61
Identities = 76/323 (23%), Positives = 129/323 (39%), Gaps = 48/323 (14%)
Query: 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIK 82
P + ++ +++G G+ + V A A + + AIK + +
Sbjct: 2 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK------------- 48
Query: 83 KINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
+ + +E MS H V + +F ++L+ L + G LL I
Sbjct: 49 -------ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-- 99
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202
K G DE E++ LEY H G IHRD+K NILL ED +QI DFG
Sbjct: 100 ------RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 153
Query: 203 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262
+ L+ S+Q ++FVGT +++PE++ + +D+W+LG ++ G P
Sbjct: 154 TAKVLSPE---SKQARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPP 209
Query: 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE-- 320
+ + ++ + + + R ++ L D TKR E
Sbjct: 210 FRAGNEYLIFQKIIKLEYDFPEK----------FFPKARDLVEKLLVLDATKRLGCEEME 259
Query: 321 ----LLKNPFFKKAKDKKFIQQT 339
L +PFF+ + QQT
Sbjct: 260 GYGPLKAHPFFESVTWENLHQQT 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-60
Identities = 63/339 (18%), Positives = 125/339 (36%), Gaps = 46/339 (13%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++Y + E +G G +VH + + K + +
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----------------------- 41
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
T + KEI ++ H N++ H SF +EL ++ + G + + I
Sbjct: 42 -GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS----- 95
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG--EDGTVQIADFGVSAW 206
+E I + + +V + L++ HS+ H DI+ NI+ T++I +FG +
Sbjct: 96 --AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA-- 151
Query: 207 LATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266
R L P + APEV Q D+WSLG + +G P+
Sbjct: 152 ----RQLKPGDNFRLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206
Query: 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPF 326
+++ + + +++ +K + L K+ R TASE L++P+
Sbjct: 207 TNQQIIENIMNAEYT------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260
Query: 327 FKKAKDKKFIQQTLVSVGPTFETRIQKAAKKNPGASGRL 365
K+ ++ + + + K ++ R+
Sbjct: 261 LKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARI 299
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-60
Identities = 74/327 (22%), Positives = 132/327 (40%), Gaps = 44/327 (13%)
Query: 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKIN 85
N +D Y+ E +G G AVV K+ + A K I ++
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKK-----------------RRTK 49
Query: 86 LEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK 145
+ S +++ +E+ + H NV+T H + K ++ L+L L+ GG L D
Sbjct: 50 SSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF------ 103
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGT----VQIADF 201
+ E L+++L G+ Y HS H D+K NI+L + ++I DF
Sbjct: 104 --LAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161
Query: 202 GVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261
G++ + GTP ++APE++ + +AD+WS+G+ + +G +
Sbjct: 162 GLA------HKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGAS 214
Query: 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
P+ + L + D + + + I L KDP KR T +
Sbjct: 215 PFLGDTKQETLANVSAVNYEFED------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
Query: 322 LKNPFFKKAKDKKFIQQTLVSVGPTFE 348
L++P+ K ++ + P FE
Sbjct: 269 LQHPWIKPKDTQQALSSAWSH--PQFE 293
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 194 bits (493), Expect = 8e-58
Identities = 70/305 (22%), Positives = 130/305 (42%), Gaps = 44/305 (14%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ + V +IG G V+ + A+K ++ K+I +++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK-----------------KRIKMKQ 46
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
T + +S+ +V +F D+L +L L+ GG L +
Sbjct: 47 GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS------- 99
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
+HGV E + E++ GLE+ H+ ++RD+K NILL E G V+I+D G++ +
Sbjct: 100 -QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
+ H VGT +MAPEV+++ YD AD +SLG ++ G +P+ ++
Sbjct: 159 KKKP-------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211
Query: 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLK 323
+ + + ++ R ++ LQ+D +R A E+ +
Sbjct: 212 KDKHEIDRMTLTMAV-------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
Query: 324 NPFFK 328
+PFF+
Sbjct: 265 SPFFR 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 8e-58
Identities = 67/317 (21%), Positives = 121/317 (38%), Gaps = 46/317 (14%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
W + E +V+G GA V +A ++ ++ A+K
Sbjct: 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV-----------------AVKM 74
Query: 84 INLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
+ + ++ + L+ E++ M+ HEN+V + + ++L+ G LL+ ++
Sbjct: 75 LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS 134
Query: 143 RLKISNCKH---------------GVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187
+ + + V + +V KG+E+ +HRD+ A N
Sbjct: 135 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194
Query: 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIW 247
+L+ V+I DFG++ + + S VR WMAPE + + Y K+D+W
Sbjct: 195 VLVTHGKVVKICDFGLARDIMSD---SNYVVRGNARLPVKWMAPESL-FEGIYTIKSDVW 250
Query: 248 SLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISD 306
S GI E+ + G PY P +QN DQ + ++
Sbjct: 251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM--------DQPFYATEEIYIIMQS 302
Query: 307 CLQKDPTKRPTASELLK 323
C D KRP+ L
Sbjct: 303 CWAFDSRKRPSFPNLTS 319
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-56
Identities = 74/340 (21%), Positives = 119/340 (35%), Gaps = 60/340 (17%)
Query: 20 VSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKC 79
V P+ + +YE IG G V A + +K A+KK+ + +
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI------ 54
Query: 80 AIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE--------LWLVLRLL 131
L+EI+ + HENVV K ++LV
Sbjct: 55 ---------------TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC 99
Query: 132 EGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
E + +K + I V++ +L GL Y H N +HRD+KA N+L+
Sbjct: 100 EHDLAGLLSNVLVKFTL--------SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT 151
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251
DG +++ADFG++ + ++ S+ V T + PE++ + Y D+W G
Sbjct: 152 RDGVLKLADFGLARAFSLAKN-SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 210
Query: 252 TAIEMATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGK------------- 298
EM T + L L Q D Y+ Y K
Sbjct: 211 IMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKD 270
Query: 299 ---------TFRKMISDCLQKDPTKRPTASELLKNPFFKK 329
+I L DP +R + + L + FF
Sbjct: 271 RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 6e-56
Identities = 70/314 (22%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ + + +++G G+ V A K + AIK + VV
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM------------------- 42
Query: 89 WNTSMDELLKEIQAMS-SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ ++ + E + +S + H + +F K+ L+ V+ L GG L+ I+ K
Sbjct: 43 -DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF- 100
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
D E++ GL++ HS G ++RD+K NILL +DG ++IADFG+
Sbjct: 101 -------DLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267
G +TF GTP ++APE++ Y+ D WS G+ EM G +P+H
Sbjct: 154 MLGDAK-----TNTFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA-SELLKNPF 326
++ ++P K + ++ ++P KR ++ ++P
Sbjct: 208 EEELFHSIRMDNPFYPRW----------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 257
Query: 327 FKKAKDKKFIQQTL 340
F++ ++ ++ +
Sbjct: 258 FREINWEELERKEI 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-55
Identities = 65/302 (21%), Positives = 114/302 (37%), Gaps = 53/302 (17%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
W + ++ + IG G V R K A+K
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLG------------------------DYRGNKVAVKC 37
Query: 84 INLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFV-VKDELWLVLRLLEGGSLLDIIKH 142
I + + L E M+ H N+V V K L++V + GSL+D ++
Sbjct: 38 IKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 94
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202
R V + +V + +EY N +HRD+ A N+L+ ED +++DFG
Sbjct: 95 R------GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 148
Query: 203 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTA 261
++ ++ +D T W APE + ++ + K+D+WS GI E+ + G
Sbjct: 149 LTKEASSTQD--------TGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRV 199
Query: 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321
PY + P V+ + G +++ +C D RP+ +L
Sbjct: 200 PYPRIPLKDVVPRVEKGYKMDAPDGCPPA---------VYEVMKNCWHLDAAMRPSFLQL 250
Query: 322 LK 323
+
Sbjct: 251 RE 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 4e-55
Identities = 65/319 (20%), Positives = 127/319 (39%), Gaps = 64/319 (20%)
Query: 29 DQYEV-REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
D Y+V +V+G G V + K EK A+K +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------------------------ 46
Query: 88 KWNTSMDELLKEIQAMS-SCHHENVV----TYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
+ +E++ + ++V Y + + L +V+ L+GG L I+
Sbjct: 47 ----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD 102
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILL---GEDGTVQIA 199
R E + +++ + + ++Y HS HRD+K N+L + +++
Sbjct: 103 R------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 156
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259
DFG + ++ + T TP ++APEV+ YD D+WSLG+ + G
Sbjct: 157 DFGFA------KETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCG 209
Query: 260 TAPYHK------YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
P++ P MK + Q + P ++ + + +I + L+ +PT
Sbjct: 210 YPPFYSNHGLAISPGMKTRIRMGQYEFP--------NPEWSEVSEEVKMLIRNLLKTEPT 261
Query: 314 KRPTASELLKNPFFKKAKD 332
+R T +E + +P+ ++
Sbjct: 262 QRMTITEFMNHPWIMQSTK 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 7e-55
Identities = 64/310 (20%), Positives = 109/310 (35%), Gaps = 50/310 (16%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
E QY+V ++G G V+S + AIK + +I+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-----------------DRISDW 45
Query: 88 KWNTSMDELLKEIQAMSSCH--HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK 145
+ + E+ + V+ F D L+L E L
Sbjct: 46 GELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--- 102
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED-GTVQIADFGVS 204
+ G E + +VL+ + + H+ G +HRDIK NIL+ + G +++ DFG
Sbjct: 103 ----ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 158
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264
A L + V F GT + PE + + A +WSLGI +M G P+
Sbjct: 159 ALL-------KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211
Query: 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324
+ + + + +I CL P+ RPT E+ +
Sbjct: 212 HDEEIIRGQVFFRQRVS----------------SECQHLIRWCLALRPSDRPTFEEIQNH 255
Query: 325 PFFKKAKDKK 334
P+ + +
Sbjct: 256 PWMQDVLLPQ 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (466), Expect = 1e-54
Identities = 60/296 (20%), Positives = 103/296 (34%), Gaps = 37/296 (12%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++ +VIG G V S + K ++ AIK +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFV-------------------AIKTLKSGY 66
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+ L E M H NV+ + ++ +E GSL ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN----- 121
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
G + +LR + G++Y +HRD+ A NIL+ + +++DFG+S +L
Sbjct: 122 --DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYP 267
W APE + Q + +D+WS GI E+ + G PY
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAI-QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
V+ Q+ +++ DC QKD RP +++
Sbjct: 239 NQDVINAIEQDYRLPPPMDCPSA---------LHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-54
Identities = 64/308 (20%), Positives = 111/308 (36%), Gaps = 45/308 (14%)
Query: 29 DQYEVREV-IGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
D + ++ +G G V + R ++ + AIK +
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDV--------------------AIKVLKQG 47
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+E+++E Q M + +V + L LV+ + GG L +
Sbjct: 48 TEKADTEEMMREAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVG----- 101
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
K +A +L +V G++Y +HRD+ A N+LL +I+DFG+S L
Sbjct: 102 --KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKY 266
G D S R W APE + + ++D+WS G+T E + G PY K
Sbjct: 160 --GADDSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216
Query: 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL---LK 323
+V+ Q + ++SDC RP + ++
Sbjct: 217 KGPEVMAFIEQGKRMECPPECPPE---------LYALMSDCWIYKWEDRPDFLTVEQRMR 267
Query: 324 NPFFKKAK 331
++ A
Sbjct: 268 ACYYSLAS 275
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-54
Identities = 66/307 (21%), Positives = 115/307 (37%), Gaps = 41/307 (13%)
Query: 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINL 86
E +++ +V+G GA V+ EK I AIK++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP------------------VAIKELRE 48
Query: 87 EKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI 146
+ E+L E M+S + +V + + L+ +L+ G LLD ++
Sbjct: 49 ATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREH--- 104
Query: 147 SNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAW 206
+ ++ KG+ Y +HRD+ A N+L+ V+I DFG++
Sbjct: 105 ----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160
Query: 207 LATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHK 265
L ++ WMA E + Y ++D+WS G+T E+ T G+ PY
Sbjct: 161 LGAE---EKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216
Query: 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325
PA ++ + + + ++ C D RP EL+
Sbjct: 217 IPASEISSILEKGERLPQPPICTID---------VYMIMVKCWMIDADSRPKFRELIIE- 266
Query: 326 FFKKAKD 332
F K A+D
Sbjct: 267 FSKMARD 273
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 183 bits (465), Expect = 3e-54
Identities = 69/330 (20%), Positives = 129/330 (39%), Gaps = 55/330 (16%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+++ +G G+ VH + A+K + +V
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL------------------ 45
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
++ E +S H ++ +F ++++++ +EGG L +
Sbjct: 46 --KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL--------L 95
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
K P EV LEY HS I+RD+K NILL ++G ++I DFG + ++
Sbjct: 96 RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV- 154
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
V +T GTP ++APEV+ Y+ D WS GI EM G P++
Sbjct: 155 -------PDVTYTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206
Query: 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLK 323
MK L + + + + ++S + +D ++R ++
Sbjct: 207 MKTYEKILNAELRFPPF----------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256
Query: 324 NPFFKKAKDKKFIQQTLVSVGPTFETRIQK 353
+P+FK+ +K + + + +E IQ+
Sbjct: 257 HPWFKEVVWEKLLSRNIE---TPYEPPIQQ 283
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 181 bits (461), Expect = 4e-54
Identities = 61/304 (20%), Positives = 124/304 (40%), Gaps = 41/304 (13%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
D+YE+ E++GFG + VH A A+K + + +L +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL--------------------RADLAR 46
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE----LWLVLRLLEGGSLLDIIKHRL 144
+ +E Q ++ +H +V + + + ++V+ ++G +L DI+
Sbjct: 47 DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--- 103
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS 204
G V+ + + L + H NG IHRD+K NI++ V++ DFG++
Sbjct: 104 -----TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 158
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264
+A + Q +GT +++PE + D ++D++SLG E+ TG P+
Sbjct: 159 RAIADSGNSVTQ--TAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFT 215
Query: 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324
+ V ++ DP +++ ++ L K+P R + ++
Sbjct: 216 GDSPVSVAYQHVREDPI------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269
Query: 325 PFFK 328
+
Sbjct: 270 DLVR 273
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-54
Identities = 71/317 (22%), Positives = 125/317 (39%), Gaps = 49/317 (15%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ ++ +++G G V KA A+K + V+ +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA------------------- 45
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+ + E + + + H + +F D L V+ GG L +
Sbjct: 46 -KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS------- 97
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
+ V E E++ LEY HS ++RDIK N++L +DG ++I DFG+
Sbjct: 98 -RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
S TF GTP ++APEV+ +D+ Y D W LG+ EM G P++
Sbjct: 157 -----SDGATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLK 323
++ L L + T + +++ L+KDP +R A E+++
Sbjct: 211 ERLFELILMEEIRFPRT----------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260
Query: 324 NPFFKKAKDKKFIQQTL 340
+ FF + +Q+ L
Sbjct: 261 HRFFLSINWQDVVQKKL 277
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-53
Identities = 67/315 (21%), Positives = 112/315 (35%), Gaps = 49/315 (15%)
Query: 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNT 91
E + +G G A V+ A K + AIKKI E +
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIK------------------LGHRSEAKDG 42
Query: 92 SMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKH 151
L+EI+ + H N++ +F K + LV +E + I +
Sbjct: 43 INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-------- 94
Query: 152 GVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGR 211
V I + L+GLEY H + +HRD+K N+LL E+G +++ADFG++
Sbjct: 95 LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--- 151
Query: 212 DLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKV 271
S + V T + APE++ Y D+W++G E+ +
Sbjct: 152 --SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 209
Query: 272 LMLTLQNDPPTLDTGAAE------------------KDQYKAYGKTFRKMISDCLQKDPT 313
L + + + + A G +I +P
Sbjct: 210 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC 269
Query: 314 KRPTASELLKNPFFK 328
R TA++ LK +F
Sbjct: 270 ARITATQALKMKYFS 284
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-53
Identities = 62/296 (20%), Positives = 115/296 (38%), Gaps = 47/296 (15%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ + IG G +VH Y + +K AIK I
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNK-----------------------DKVAIKTIREGA 41
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
S ++ ++E + M H +V + + + + LV +E G L D ++ +
Sbjct: 42 --MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ----- 94
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
G+ T+ + +V +G+ Y IHRD+ A N L+GE+ ++++DFG++ ++
Sbjct: 95 --RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYP 267
+ W +PEV Y K+D+WS G+ E+ + G PY
Sbjct: 153 DDQY----TSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+V+ A+ ++++ C ++ P RP S LL+
Sbjct: 208 NSEVVEDISTGFRLYKPRLASTH---------VYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (456), Expect = 4e-53
Identities = 56/317 (17%), Positives = 102/317 (32%), Gaps = 47/317 (14%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
+ E IG GA V A + A+K
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMV-----------------AVKM 50
Query: 84 INLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHR 143
+ E + +E M+ + N+V V + L+ + G L + ++
Sbjct: 51 LKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM 110
Query: 144 LKISNCKHGVC----------------DEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187
+ C + R+V G+ Y +HRD+ N
Sbjct: 111 SPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170
Query: 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIW 247
L+GE+ V+IADFG+S + + K WM PE + + Y ++D+W
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSA---DYYKADGNDAIPIRWMPPESI-FYNRYTTESDVW 226
Query: 248 SLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISD 306
+ G+ E+ + G PY+ +V+ + + ++
Sbjct: 227 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLE---------LYNLMRL 277
Query: 307 CLQKDPTKRPTASELLK 323
C K P RP+ + +
Sbjct: 278 CWSKLPADRPSFCSIHR 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 6e-53
Identities = 59/297 (19%), Positives = 108/297 (36%), Gaps = 47/297 (15%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ +G G VV + + AIK I
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQ-----------------------YDVAIKMIKEGS 40
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
S DE ++E + M + HE +V + + ++++ + G LL+ +
Sbjct: 41 --MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-------R 91
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
+ + ++V + +EY S +HRD+ A N L+ + G V+++DFG+S ++
Sbjct: 92 EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYP 267
W PEV+ + K+DIW+ G+ E+ + G PY ++
Sbjct: 152 D----DEYTSSVGSKFPVRWSPPEVL-MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324
+ Q A+EK ++ C + +RPT LL N
Sbjct: 207 NSETAEHIAQGLRLYRPHLASEK---------VYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 8e-53
Identities = 57/271 (21%), Positives = 108/271 (39%), Gaps = 28/271 (10%)
Query: 65 AVVHSAYCKAR--AEKCAIKKINLEKWNTSM-DELLKEIQAMSSCHHENVVTYHTSFVVK 121
V Y + + + A+K + E + ++ DELL E M + +V
Sbjct: 21 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI-GICEA 79
Query: 122 DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181
+ LV+ + E G L + ++ + I ++ +V G++Y + +HR
Sbjct: 80 ESWMLVMEMAELGPLNKYL--------QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYD 241
D+ A N+LL +I+DFG+S L D + K + W APE + + +
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWYAPECI-NYYKFS 188
Query: 242 FKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTF 300
K+D+WS G+ E + G PY +V + + + G +
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE---------M 239
Query: 301 RKMISDCLQKDPTKRPTASEL---LKNPFFK 328
+++ C D RP + + L+N ++
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-52
Identities = 72/331 (21%), Positives = 121/331 (36%), Gaps = 58/331 (17%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+Y IG GA +V SAY + AIKKI+ +
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP----------------------FE 45
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSF----VVKDELWLVLRLLEGGSLLDIIKHRL 144
T L+EI+ + HEN++ + + + + ++ L G L ++K
Sbjct: 46 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-- 103
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS 204
I L ++L+GL+Y HS +HRD+K N+LL ++I DFG++
Sbjct: 104 -------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 156
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264
D +V T + APE+M GY DIWS+G EM + +
Sbjct: 157 RVADPDHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214
Query: 265 KYPAMKVL--MLTLQNDPPTLDTGAAEKDQYKAYGKT-------------------FRKM 303
+ L +L + P D + + Y + +
Sbjct: 215 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 274
Query: 304 ISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334
+ L +P KR + L +P+ ++ D
Sbjct: 275 LDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 177 bits (450), Expect = 2e-52
Identities = 73/321 (22%), Positives = 118/321 (36%), Gaps = 56/321 (17%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++Y E IG G VV+ A E A+KKI LEK
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-----------------------YGETFALKKIRLEK 38
Query: 89 WNTSM-DELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ + ++EI + H N+V + K L LV L+ +
Sbjct: 39 EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---- 94
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
G + T + L ++L G+ Y H +HRD+K N+L+ +G ++IADFG++
Sbjct: 95 ----GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF 150
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267
+ + T + AP+V+ Y DIWS+G EM GT +
Sbjct: 151 GIP-----VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTF-------------------RKMISDCL 308
LM + + Y F ++S L
Sbjct: 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265
Query: 309 QKDPTKRPTASELLKNPFFKK 329
+ DP +R TA + L++ +FK+
Sbjct: 266 KLDPNQRITAKQALEHAYFKE 286
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-52
Identities = 67/308 (21%), Positives = 112/308 (36%), Gaps = 49/308 (15%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
W + + +G G V + AIK
Sbjct: 12 WEIPRESLRLEVKLGQGCFGEVWMGTWN-----------------------GTTRVAIKT 48
Query: 84 INLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHR 143
+ S + L+E Q M HE +V + + V ++ +++V + GSLLD +K
Sbjct: 49 LK--PGTMSPEAFLQEAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGE 105
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
P + + ++ G+ Y +HRD++A NIL+GE+ ++ADFG+
Sbjct: 106 ------TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 159
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262
+ + +RQ W APE + K+D+WS GI E+ T G P
Sbjct: 160 ARLIEDNEYTARQ----GAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVP 214
Query: 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
Y +VL + E ++ C +K+P +RPT L
Sbjct: 215 YPGMVNREVLDQVERGYRMPCPPECPES---------LHDLMCQCWRKEPEERPTFEYLQ 265
Query: 323 K--NPFFK 328
+F
Sbjct: 266 AFLEDYFT 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-51
Identities = 65/313 (20%), Positives = 117/313 (37%), Gaps = 54/313 (17%)
Query: 23 PWPNTE-----DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAE 77
PW E + ++ E +G G V Y
Sbjct: 2 PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGH-----------------------T 38
Query: 78 KCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLL 137
K A+K + + + S D L E M H+ +V + + V ++ ++++ +E GSL+
Sbjct: 39 KVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV 95
Query: 138 DIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQ 197
D +K + + ++ +G+ + IHRD++A NIL+ + + +
Sbjct: 96 DFLKTP------SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCK 149
Query: 198 IADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257
IADFG++ + + R W APE + + K+D+WS GI E+
Sbjct: 150 IADFGLARLIED----NEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIV 204
Query: 258 T-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
T G PY +V+ + E+ +++ C ++ P RP
Sbjct: 205 THGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE---------LYQLMRLCWKERPEDRP 255
Query: 317 TASELLK--NPFF 327
T L FF
Sbjct: 256 TFDYLRSVLEDFF 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-51
Identities = 65/325 (20%), Positives = 124/325 (38%), Gaps = 41/325 (12%)
Query: 16 SSASVSVP--WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCK 73
S+A V VP W ++ + +G G+ +V+ K + ++
Sbjct: 5 SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV----------- 53
Query: 74 ARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEG 133
AIK +N E L E M + +VV +++ L+
Sbjct: 54 ------AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 107
Query: 134 GSLLDIIKH--RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191
G L ++ +N + + E+ G+ Y ++N +HRD+ A N ++
Sbjct: 108 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 167
Query: 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGI 251
ED TV+I DFG++ + + + + WM+PE + +D + +D+WS G+
Sbjct: 168 EDFTVKIGDFGMTRDI---YETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGV 223
Query: 252 TAIEMATGT-APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQK 310
E+AT PY +VL ++ + +++ C Q
Sbjct: 224 VLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM---------LFELMRMCWQY 274
Query: 311 DPTKRPTASELLK------NPFFKK 329
+P RP+ E++ P F++
Sbjct: 275 NPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 6e-51
Identities = 64/322 (19%), Positives = 119/322 (36%), Gaps = 46/322 (14%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ + ++VIG G V A K + AIK++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDA--------------------AIKRMKEYA 49
Query: 89 WNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHR---- 143
+ E++ + HH N++ + + L+L + G+LLD ++
Sbjct: 50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 109
Query: 144 ----LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIA 199
I+N + +V +G++Y IHRD+ A NIL+GE+ +IA
Sbjct: 110 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169
Query: 200 DFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT- 258
DFG+S R + WMA E + Y +D+WS G+ E+ +
Sbjct: 170 DFGLS------RGQEVYVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSL 222
Query: 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTA 318
G PY ++ Q ++ ++ C ++ P +RP+
Sbjct: 223 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE---------VYDLMRQCWREKPYERPSF 273
Query: 319 SELLKNPFFKKAKDKKFIQQTL 340
+++L + + K ++ TL
Sbjct: 274 AQILVSLNRMLEERKTYVNTTL 295
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 8e-51
Identities = 73/323 (22%), Positives = 118/323 (36%), Gaps = 52/323 (16%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+ ++ E IG G VV+ A K E A+KKI L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS--------------- 46
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
++EI + +H N+V +++L+LV L +
Sbjct: 47 ------TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA----- 95
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
P I + L ++L+GL + HS+ +HRD+K N+L+ +G +++ADFG++
Sbjct: 96 --LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
+ V T + APE++ Y DIWSLG EM T A +
Sbjct: 154 V-----PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208
Query: 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRK-------------------MISDCLQ 309
+ L + + Y +F K ++S L
Sbjct: 209 IDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLH 268
Query: 310 KDPTKRPTASELLKNPFFKKAKD 332
DP KR +A L +PFF+
Sbjct: 269 YDPNKRISAKAALAHPFFQDVTK 291
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-50
Identities = 67/312 (21%), Positives = 118/312 (37%), Gaps = 41/312 (13%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
W ++ + +G GA V A + A A A+K
Sbjct: 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDA-----------------AMTVAVKM 60
Query: 84 INLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
+ T + L+ E++ +S +H N+V + + ++ G LL+ ++
Sbjct: 61 LKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR 120
Query: 143 R----------LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE 192
+ I D + + +V KG+ + S IHRD+ A NILL
Sbjct: 121 KRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180
Query: 193 DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGIT 252
+I DFG++ + S V+ WMAPE + + Y F++D+WS GI
Sbjct: 181 GRITKICDFGLARDIKND---SNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIF 236
Query: 253 AIEMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKD 311
E+ + G++PY P ++ L A + ++ C D
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE--------MYDIMKTCWDAD 288
Query: 312 PTKRPTASELLK 323
P KRPT ++++
Sbjct: 289 PLKRPTFKQIVQ 300
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 5e-50
Identities = 75/366 (20%), Positives = 119/366 (32%), Gaps = 64/366 (17%)
Query: 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIK 82
P E Y +VIG G+ VV+ A E AIKK+
Sbjct: 14 PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------------------ 55
Query: 83 KINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDE------LWLVLRLLEGGSL 136
+E+Q M H N+V F E L LVL +
Sbjct: 56 ---------DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 106
Query: 137 LDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTV 196
+ +H + + + ++ + L Y HS G HRDIK N+LL D V
Sbjct: 107 -RVARHYSR----AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 161
Query: 197 Q-IADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIE 255
+ DFG + + L R + +++ + + APE++ Y D+WS G E
Sbjct: 162 LKLCDFGSA------KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215
Query: 256 MATGTAPYHKYPAMKVLMLTLQ-------------------NDPPTLDTGAAEKDQYKAY 296
+ G + + L+ ++ P + K
Sbjct: 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 275
Query: 297 GKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQQTLVSVGPTFETRIQKAAK 356
+ S L+ PT R T E + FF + +D F Q+ +
Sbjct: 276 PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSS 335
Query: 357 KNPGAS 362
P A+
Sbjct: 336 NPPLAT 341
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 6e-50
Identities = 66/310 (21%), Positives = 124/310 (40%), Gaps = 38/310 (12%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
W D+ + + +G GA V A + + K A+K
Sbjct: 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVT---------------KVAVKM 52
Query: 84 INLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKH 142
+ + + +L+ E++ M H+N++ + L++++ G+L + ++
Sbjct: 53 LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 112
Query: 143 R--------LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDG 194
R S+ + + +V +G+EY S IHRD+ A N+L+ ED
Sbjct: 113 RRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 172
Query: 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254
++IADFG++ + K WMAPE + D Y ++D+WS G+
Sbjct: 173 VMKIADFGLARDIHHIDY---YKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLW 228
Query: 255 EMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPT 313
E+ T G +PY P ++ L + + + M+ DC P+
Sbjct: 229 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPS 279
Query: 314 KRPTASELLK 323
+RPT +L++
Sbjct: 280 QRPTFKQLVE 289
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (433), Expect = 6e-50
Identities = 54/309 (17%), Positives = 99/309 (32%), Gaps = 43/309 (13%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++Y + IG G+ ++ A E+ AIK +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV------------------------ 42
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
T +L E + + + + +++ L G SL D+
Sbjct: 43 -KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----- 96
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNIL---LGEDGTVQIADFGVSA 205
T+ + +++ +EY HS IHRD+K N L + V I DFG++
Sbjct: 97 --SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
Query: 206 WLATGRDLS--RQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263
R + GT + + + D+ SLG + G+ P+
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPW 213
Query: 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS---E 320
A + + T + K Y F ++ C +P S +
Sbjct: 214 QGLKAATKRQKYERISEKKMST--PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271
Query: 321 LLKNPFFKK 329
L +N F ++
Sbjct: 272 LFRNLFHRQ 280
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 7e-50
Identities = 68/307 (22%), Positives = 116/307 (37%), Gaps = 43/307 (14%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
E + E +G G+ VV A + A+K + +
Sbjct: 7 EKDLRLLEKLGDGSFGVVRRGEWDAP-------------------SGKTVSVAVKCLKPD 47
Query: 88 KWNT--SMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLK 145
+ +MD+ ++E+ AM S H N++ + V+ + +V L GSLLD ++
Sbjct: 48 VLSQPEAMDDFIREVNAMHSLDHRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKH-- 104
Query: 146 ISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSA 205
G T++ +V +G+ Y S IHRD+ A N+LL V+I DFG+
Sbjct: 105 -----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159
Query: 206 WLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYH 264
L D ++ W APE + + + +D W G+T EM T G P+
Sbjct: 160 ALPQNDD--HYVMQEHRKVPFAWCAPESL-KTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216
Query: 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324
++L + + + + ++ C P RPT L
Sbjct: 217 GLNGSQILHKIDKEGERL--------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD- 267
Query: 325 PFFKKAK 331
F +A+
Sbjct: 268 -FLLEAQ 273
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 2e-49
Identities = 66/324 (20%), Positives = 115/324 (35%), Gaps = 54/324 (16%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+YE E IG G V A + E A+K++ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS--------------- 46
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
L+EI + H+N+V H +L LV + K +
Sbjct: 47 ------SALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE--------FCDQDLKKYFD 92
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
+G D + + L ++LKGL + HS +HRD+K N+L+ +G +++A+FG++
Sbjct: 93 SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
+ V T + P+V+ Y D+WS G E+A P
Sbjct: 153 IP-----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 269 MKVLM--------------------LTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCL 308
+ + L P + + T R ++ + L
Sbjct: 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLL 267
Query: 309 QKDPTKRPTASELLKNPFFKKAKD 332
+ +P +R +A E L++P+F
Sbjct: 268 KCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (427), Expect = 5e-49
Identities = 64/320 (20%), Positives = 124/320 (38%), Gaps = 47/320 (14%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
W ++ +G G V+ K + A+K +
Sbjct: 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-------------------- 51
Query: 84 INLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHR 143
+ ++E LKE M H N+V + +++ + G+LLD ++
Sbjct: 52 ----EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE- 106
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
C + + ++ +EY IHRD+ A N L+GE+ V++ADFG+
Sbjct: 107 -----CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 161
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262
S + + + W APE + + + K+D+W+ G+ E+AT G +P
Sbjct: 162 SRLMTGDTYTAHAGAK----FPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSP 216
Query: 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
Y +V L ++ G EK +++ C Q +P+ RP+ +E+
Sbjct: 217 YPGIDLSQVYELLEKDYRMERPEGCPEK---------VYELMRACWQWNPSDRPSFAEIH 267
Query: 323 K--NPFFKKAKDKKFIQQTL 340
+ F+++ +++ L
Sbjct: 268 QAFETMFQESSISDEVEKEL 287
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 6e-49
Identities = 56/301 (18%), Positives = 107/301 (35%), Gaps = 42/301 (13%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
+ ++ E+ IG G VH + + A AIK
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSP-------------------ENPALAVAIKT 42
Query: 84 INLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHR 143
++ ++ L+E M H ++V + ++ +W+++ L G L ++ R
Sbjct: 43 CKNCTSDSVREKFLQEALTMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVR 101
Query: 144 LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGV 203
D ++ ++ L Y S +HRDI A N+L+ + V++ DFG+
Sbjct: 102 -------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154
Query: 204 SAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAP 262
S ++ S WMAPE + + +D+W G+ E+ G P
Sbjct: 155 SRYMED----STYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKP 209
Query: 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322
+ V+ + + +++ C DP++RP +EL
Sbjct: 210 FQGVKNNDVIGRIENGERLPMPPNCPPT---------LYSLMTKCWAYDPSRRPRFTELK 260
Query: 323 K 323
Sbjct: 261 A 261
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-48
Identities = 77/326 (23%), Positives = 119/326 (36%), Gaps = 54/326 (16%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
Y + +G GA V SA K AIKK+ + K
Sbjct: 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-------------- 62
Query: 88 KWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+E++ + HENV+ F + L + +L
Sbjct: 63 -------RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL--- 112
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWL 207
KH E I ++ ++LKGL Y H+ G IHRD+K GN+ + ED ++I DFG++
Sbjct: 113 -MKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171
Query: 208 ATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267
+V T + APEV+ Y DIWS+G EM TG +
Sbjct: 172 --------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223
Query: 268 AMKV--LMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKM-------------------ISD 306
+ ++ + PP + D+ K Y K ++ +
Sbjct: 224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 283
Query: 307 CLQKDPTKRPTASELLKNPFFKKAKD 332
L D +R TA E L +P+F+ D
Sbjct: 284 MLVLDAEQRVTAGEALAHPYFESLHD 309
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-48
Identities = 73/333 (21%), Positives = 123/333 (36%), Gaps = 61/333 (18%)
Query: 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE 87
+ QYE IG GA V A K A+K++ ++
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDL---------------------KNGGRFVALKRVRVQ 44
Query: 88 KWNTSMDE-LLKEIQAM---SSCHHENVVTYHTSFVV-----KDELWLVLRLLEGGSLLD 138
M ++E+ + + H NVV V + +L LV ++
Sbjct: 45 TGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY 104
Query: 139 IIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQI 198
+ K TI ++ ++L+GL++ HS+ +HRD+K NIL+ G +++
Sbjct: 105 LDKV-------PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 157
Query: 199 ADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258
ADFG R S Q + V T + APEV+ Y D+WS+G EM
Sbjct: 158 ADFG------LARIYSFQMALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFR 210
Query: 259 GTAPYHKYPAMKVL--MLTLQNDPPTLDTGAAEKDQYKAYGKT---------------FR 301
+ + L +L + P D +A+ +
Sbjct: 211 RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK 270
Query: 302 KMISDCLQKDPTKRPTASELLKNPFFKKAKDKK 334
++ CL +P KR +A L +P+F+ + K
Sbjct: 271 DLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 303
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (425), Expect = 4e-48
Identities = 62/317 (19%), Positives = 119/317 (37%), Gaps = 52/317 (16%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
DQ++ + +G G+ V K A+K ++ V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK------------------- 81
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
++ L E + + + + +V SF L++V+ + GG + +
Sbjct: 82 -LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-------- 132
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
+ G EP +++ EY HS I+RD+K N+L+ + G +Q+ DFG +
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-- 190
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
+ T GTP +APE++ GY+ D W+LG+ EMA G P+
Sbjct: 191 ------VKGRTWTLCGTPEALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
Query: 269 MKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKR-----PTASELLK 323
+++ + + + ++ + LQ D TKR +++
Sbjct: 244 IQIYEKIVSGKVRFPSH----------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
Query: 324 NPFFKKAKDKKFIQQTL 340
+ +F Q+ +
Sbjct: 294 HKWFATTDWIAIYQRKV 310
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-48
Identities = 75/322 (23%), Positives = 128/322 (39%), Gaps = 47/322 (14%)
Query: 29 DQYEVREVIGFGATAVVHSAYC---KARAEKCAIKKINLAVVHSAYCKARAEKCAIKKIN 85
+ +E+ +V+G GA V + A+K + KK
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL-------------------KKAT 64
Query: 86 LEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRL 144
+ + + + E Q + +VT H +F + +L L+L + GG L + R
Sbjct: 65 IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE 124
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVS 204
+ + E + + E++ LE+ H G I+RDIK NILL +G V + DFG+S
Sbjct: 125 RFT--------EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176
Query: 205 AWLATGRDLSRQKVRHTFVGTPCWMAPEVME-QDHGYDFKADIWSLGITAIEMATGTAPY 263
+ + F GT +MAP+++ D G+D D WSLG+ E+ TG +P+
Sbjct: 177 KEFVA----DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232
Query: 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TA 318
+ +E + + +I L KDP KR A
Sbjct: 233 TVDGEKNSQAEISRRILK------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 286
Query: 319 SELLKNPFFKKAKDKKFIQQTL 340
E+ ++ FF+K + +
Sbjct: 287 DEIKEHLFFQKINWDDLAAKKV 308
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 166 bits (421), Expect = 9e-48
Identities = 59/342 (17%), Positives = 111/342 (32%), Gaps = 76/342 (22%)
Query: 19 SVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEK 78
S V W N +D Y++ +G G + V A EK +K +
Sbjct: 26 SHVVEWGNQDD-YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------------- 69
Query: 79 CAIKKINLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFV--VKDELWLVLRLLEGGS 135
++ +EI+ + + N++T V LV +
Sbjct: 70 -----------PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD 118
Query: 136 LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG-EDG 194
+ + + I + E+LK L+Y HS G +HRD+K N+++ E
Sbjct: 119 FKQLYQTL-----------TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 167
Query: 195 TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254
+++ D+G++ + G++ + V + + PE++ YD+ D+WSLG
Sbjct: 168 KLRLIDWGLAEFYHPGQE------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221
Query: 255 EMATGTAPY----------------------------HKYPAMKVLMLTLQNDPPTLDTG 286
M P+ + L
Sbjct: 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 281
Query: 287 AAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328
+ + L+ D R TA E +++P+F
Sbjct: 282 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-47
Identities = 56/296 (18%), Positives = 104/296 (35%), Gaps = 38/296 (12%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++VIG G V+ K + K + AIK +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP------------------VAIKTLKAGY 48
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+ L E M H N++ + ++ +E G+L ++
Sbjct: 49 TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE------ 102
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
K G + +LR + G++Y + +HRD+ A NIL+ + +++DFG+S L
Sbjct: 103 -KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYP 267
D W APE + + +D+WS GI E+ T G PY +
Sbjct: 162 D--DPEATYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 218
Query: 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323
+V+ +++ C Q++ +RP ++++
Sbjct: 219 NHEVMKAINDGFRLPTPMDCPSA---------IYQLMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-47
Identities = 62/304 (20%), Positives = 108/304 (35%), Gaps = 39/304 (12%)
Query: 22 VPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAI 81
V + EVIG G V+ + CA+
Sbjct: 20 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDN-------------------DGKKIHCAV 60
Query: 82 KKINLEKWNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD-ELWLVLRLLEGGSLLDII 140
K +N + + L E M H NV++ + + +VL ++ G L + I
Sbjct: 61 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120
Query: 141 KHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIAD 200
+ + +V KG+++ S +HRD+ A N +L E TV++AD
Sbjct: 121 -------RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 173
Query: 201 FGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-G 259
FG++ + ++ + WMA E + Q + K+D+WS G+ E+ T G
Sbjct: 174 FGLARDM-YDKEFDSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRG 231
Query: 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319
PY + + LQ + +++ C RP+ S
Sbjct: 232 APPYPDVNTFDITVYLLQGRRLLQPEYCPDP---------LYEVMLKCWHPKAEMRPSFS 282
Query: 320 ELLK 323
EL+
Sbjct: 283 ELVS 286
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-46
Identities = 67/325 (20%), Positives = 122/325 (37%), Gaps = 54/325 (16%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++Y+ +G GA V +A+ + A+KK++ + K
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK--------------- 62
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISN 148
+E++ + HENV+ F L + L+ + +
Sbjct: 63 ------RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY----LVTHLMGADLNNI 112
Query: 149 CKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLA 208
K + + ++ ++L+GL+Y HS IHRD+K N+ + ED ++I DFG++
Sbjct: 113 VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT- 171
Query: 209 TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268
+V T + APE+M Y+ DIWS+G E+ TG +
Sbjct: 172 -------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224
Query: 269 MKVL--MLTLQNDPPTLDTGAAEKDQYKAYGKTFRKM-------------------ISDC 307
+ L +L L P + + Y ++ +M +
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 284
Query: 308 LQKDPTKRPTASELLKNPFFKKAKD 332
L D KR TA++ L + +F + D
Sbjct: 285 LVLDSDKRITAAQALAHAYFAQYHD 309
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-46
Identities = 66/324 (20%), Positives = 114/324 (35%), Gaps = 65/324 (20%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
++E IG G V K R E+ A+K + +
Sbjct: 3 RTIVLQESIGKGRFGEVWRG------------------------KWRGEEVAVKIFSSRE 38
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD----ELWLVLRLLEGGSLLDIIKHRL 144
+ E EI HEN++ + + + +LWLV E GSL D +
Sbjct: 39 ERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY- 95
Query: 145 KISNCKHGVCDEPTIATVLREVLKGLEYFHS--------NGQIHRDIKAGNILLGEDGTV 196
+ + GL + H HRD+K+ NIL+ ++GT
Sbjct: 96 --------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147
Query: 197 QIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHG-----YDFKADIWSLGI 251
IAD G++ + D + + VGT +MAPEV++ +ADI+++G+
Sbjct: 148 CIADLGLAVRHDSATD-TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 206
Query: 252 TAIEMATGTAPYHKYPAMKVLMLTLQNDPPT------------LDTGAAEKDQYKAYGKT 299
E+A + + ++ L P+ L + Q +
Sbjct: 207 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV 266
Query: 300 FRKMISDCLQKDPTKRPTASELLK 323
K++ +C + R TA + K
Sbjct: 267 MAKIMRECWYANGAARLTALRIKK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 5e-46
Identities = 66/311 (21%), Positives = 119/311 (38%), Gaps = 40/311 (12%)
Query: 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKK 83
W D+ ++ + +G GA V A + + + A+K
Sbjct: 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV-----------------AVKM 50
Query: 84 INLEKWNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDE-LWLVLRLLEGGSLLDIIK 141
+ ++ L+ E++ + HH NVV + L +++ + G+L ++
Sbjct: 51 LKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR 110
Query: 142 HR--------LKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGED 193
+ + + + +V KG+E+ S IHRD+ A NILL E
Sbjct: 111 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170
Query: 194 GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253
V+I DFG++ + D R + WMAPE + D Y ++D+WS G+
Sbjct: 171 NVVKICDFGLARDIYKDPDYVR---KGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLL 226
Query: 254 IEMATGTA-PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDP 312
E+ + A PY + L+ + + DC +P
Sbjct: 227 WEIFSLGASPYPGVKIDEEFCRRLKEGTR--------MRAPDYTTPEMYQTMLDCWHGEP 278
Query: 313 TKRPTASELLK 323
++RPT SEL++
Sbjct: 279 SQRPTFSELVE 289
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 70/342 (20%), Positives = 126/342 (36%), Gaps = 77/342 (22%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
+Y+ + IG GA +V +AY AIKK++ + + K
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK--------------- 61
Query: 89 WNTSMDELLKEIQAMSSCHHENVVTYHTSFVVKD------ELWLVLRLLEGGSLLDIIKH 142
+E+ M +H+N+++ F + +++LV+ L++ I
Sbjct: 62 ------RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 115
Query: 143 RLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFG 202
D ++ +L ++L G+++ HS G IHRD+K NI++ D T++I DFG
Sbjct: 116 -----------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 164
Query: 203 VSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262
++ R + +V T + APEV+ GY DIWS+G EM
Sbjct: 165 LA------RTAGTSFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKIL 217
Query: 263 YHKYPAMKVLMLTLQNDPPTLDT--------------------------------GAAEK 290
+ + ++ A+
Sbjct: 218 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS 277
Query: 291 DQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332
+ K R ++S L DP KR + + L++P+ D
Sbjct: 278 EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (368), Expect = 1e-40
Identities = 44/307 (14%), Positives = 87/307 (28%), Gaps = 52/307 (16%)
Query: 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEK 88
Y+V IG G+ V+ ++ AIK
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR------------------------ 40
Query: 89 WNTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS 147
+ +L E + + + LV+ LL +
Sbjct: 41 -RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC----- 94
Query: 148 NCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGE-----DGTVQIADFG 202
T+A +++L ++ H ++RDIK N L+G + + DFG
Sbjct: 95 ---GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151
Query: 203 VSAWLA--TGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260
+ + + + + GT +M+ + D+ +LG + G+
Sbjct: 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGS 210
Query: 261 APYHKYPAM----KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316
P+ A K + + L ++ + + F K + P
Sbjct: 211 LPWQGLKAATNKQKYERIGEKKQSTPL------RELCAGFPEEFYKYMHYARNLAFDATP 264
Query: 317 TASELLK 323
L
Sbjct: 265 DYDYLQG 271
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (327), Expect = 3e-34
Identities = 60/346 (17%), Positives = 111/346 (32%), Gaps = 58/346 (16%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
Y + +G+G + V A A+K + V++ A E ++++N
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDA--- 69
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
+ S +++ F K + + ++ + I +
Sbjct: 70 --------DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVF---EVLGENLLALIKKYE 118
Query: 151 HGVCDEPTIATVLREVLKGLEY-FHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLAT 209
H + + +++L GL+Y G IH DIK N+L+ + + A L
Sbjct: 119 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 178
Query: 210 GRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY------ 263
+ T + +PEV+ + ADIWS E+ TG +
Sbjct: 179 ACWYDEH--YTNSIQTREYRSPEVL-LGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235
Query: 264 -------HKYPAMKVLM-------------------------LTLQNDPPTLDTGAAEKD 291
H +++L ++ P D +
Sbjct: 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295
Query: 292 QYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDKKFIQ 337
K K +S LQ DP KR A L+ +P+ K + I+
Sbjct: 296 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.0 bits (186), Expect = 1e-16
Identities = 36/234 (15%), Positives = 74/234 (31%), Gaps = 53/234 (22%)
Query: 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWN 90
+ +++G G + V + Y + + +C +K + + K +L
Sbjct: 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVK-----FHKVGHTSFKKVKEKRDYGDLHFSV 55
Query: 91 TSMDELLKEIQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCK 150
++ E +A+ V + +++ L I +
Sbjct: 56 LAIRSARNEFRALQKLQGLAVPKVYAWE----GNAVLMEL---------------IDAKE 96
Query: 151 HGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATG 210
VL +L+ + F+ G +H D+ N+L+ E+G + I DF S
Sbjct: 97 LYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS------ 149
Query: 211 RDLSRQKVRHTFVGTPCWMAPEVMEQDHG---------YDFKADIWSLGITAIE 255
V E++E+D Y + DI S ++
Sbjct: 150 ------------VEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 520 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.81 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.63 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.17 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-61 Score=472.27 Aligned_cols=262 Identities=24% Similarity=0.400 Sum_probs=221.1
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.++.+|+.||+|+++... .....+.+.+|+.+|++++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----------------------~~~~~~~~~~Ei~~l~~l~ 61 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----------------------AVDCPENIKKEICINKMLN 61 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------------------CHHHHHHHHHTCC
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----------------------cchHHHHHHHHHHHHHhCC
Confidence 468999999999999999999999999999999875321 1122345889999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||||++++++.+++.+|+|||||+||+|.++++ ..+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 62 HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~--------~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~N 133 (271)
T d1nvra_ 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--------PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 133 (271)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB--------TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred CCCEeeEeeeeccCceeEEEEeccCCCcHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHH
Confidence 9999999999999999999999999999999986 45679999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
||++.+|.+||+|||+|..+.... ........+||+.|||||++.+...++.++|||||||++|+|+||++||....
T Consensus 134 ILl~~~~~~KL~DFG~a~~~~~~~---~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 134 LLLDERDNLKISDFGLATVFRYNN---RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp EEECTTCCEEECCCTTCEECEETT---EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred EEECCCCCEEEccchhheeeccCC---ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 999999999999999998764332 22334567899999999999877656789999999999999999999998765
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
................. .+..+++++++||.+||++||++|||++|+|+||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 211 DSCQEYSDWKEKKTYLN-------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp TTSHHHHHHHTTCTTST-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred hHHHHHHHHhcCCCCCC-------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 54444333333322221 23567899999999999999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-60 Score=465.89 Aligned_cols=256 Identities=28% Similarity=0.419 Sum_probs=225.5
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
-++|++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.+|++++
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~--------------------~~~~~~~~~E~~il~~l~ 64 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK--------------------AGVEHQLRREVEIQSHLR 64 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHHTCC
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC--------------------hHHHHHHHHHHHHHHhcC
Confidence 468999999999999999999999999999999987543221 223566899999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||||++++++.+++.+|+|||||.||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 65 hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~--------~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~N 136 (263)
T d2j4za1 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK--------LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136 (263)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccc
Confidence 99999999999999999999999999999999984 3578999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
||++.+|.+||+|||+|...... .....+||+.|||||++.+.. |+.++|||||||++|+|+||++||.+.+
T Consensus 137 ill~~~~~~kl~DFG~a~~~~~~-------~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 137 LLLGSAGELKIADFGWSVHAPSS-------RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp EEECTTSCEEECCCCSCSCCCCC-------CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ceecCCCCEeecccceeeecCCC-------cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 99999999999999999765322 234568999999999998765 8999999999999999999999999888
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
..+.+..+....+. ++ ..+++++++||.+||++||.+|||++|+|+||||+.
T Consensus 209 ~~~~~~~i~~~~~~-~p---------~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 209 YQETYKRISRVEFT-FP---------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHHHTTCCC-CC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHHcCCCC-CC---------ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 87777766655432 21 346889999999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-60 Score=468.62 Aligned_cols=261 Identities=43% Similarity=0.703 Sum_probs=228.3
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.++.+|+.||+|+++... ....+.+.+|+.+|+++
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-----------------------~~~~~~~~~E~~il~~l 74 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----------------------QPKKELIINEILVMREN 74 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-----------------------CSCHHHHHHHHHHHHHC
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-----------------------ChHHHHHHHHHHHHHhC
Confidence 4568999999999999999999999999999999875321 12345689999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+|||||+++++|.+++.+|+|||||+||+|.+++.. +.+++.+++.+++||+.||.|||++||+||||||+
T Consensus 75 ~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~ 145 (293)
T d1yhwa1 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145 (293)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred CCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHH
Confidence 999999999999999999999999999999998863 46899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.+|.+||+|||+|..+.... ......+||+.|||||++.+.. |+.++|||||||++|+|+||.+||.+.
T Consensus 146 NILl~~~~~vkl~DFG~a~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 146 NILLGMDGSVKLTDFGFCAQITPEQ-----SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp GEEECTTCCEEECCCTTCEECCSTT-----CCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred HeEECCCCcEeeccchhheeecccc-----ccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCC
Confidence 9999999999999999998765332 2234568999999999998765 899999999999999999999999998
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
.....+........+.+.. +..+++.+++||.+||++||.+|||+.|+|+||||+....
T Consensus 220 ~~~~~~~~~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~ 278 (293)
T d1yhwa1 220 NPLRALYLIATNGTPELQN-------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (293)
T ss_dssp CHHHHHHHHHHHCSCCCSS-------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CHHHHHHHHHhCCCCCCCC-------cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCC
Confidence 8888777766655444322 2467899999999999999999999999999999986543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-60 Score=467.15 Aligned_cols=263 Identities=37% Similarity=0.650 Sum_probs=228.9
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.+.|++++.||+|+||+||+|+++.+|+.||+|+++... ....+.+.+|+++|++|+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-----------------------~~~~~~~~~E~~il~~l~ 67 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-----------------------EEELEDYMVEIDILASCD 67 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-----------------------SGGGGGTHHHHHHHHHCC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-----------------------HHHHHHHHHHHHHHHhCC
Confidence 467999999999999999999999999999999875321 223456889999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||||++++++.+++.+|+|||||.||+|.+++.. ..+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 68 HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~-------~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~N 140 (288)
T d2jfla1 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-------LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGN 140 (288)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-------HTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhh
Confidence 99999999999999999999999999999999875 34679999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc----cCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ----DHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
||++.+|.+||+|||+|..+... .....+.+||+.|||||++.. ...|+.++|||||||++|+|+||++||
T Consensus 141 Ill~~~~~~Kl~DFG~a~~~~~~-----~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf 215 (288)
T d2jfla1 141 ILFTLDGDIKLADFGVSAKNTRT-----IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH 215 (288)
T ss_dssp EEECTTSCEEECCCTTCEECHHH-----HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eeECCCCCEEEEechhhhccCCC-----cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCC
Confidence 99999999999999999765321 122346789999999999842 334899999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
.+....+.+..+....++.+.. ...+++++++||.+||++||.+|||+.|+|+||||+....
T Consensus 216 ~~~~~~~~~~~i~~~~~~~~~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~ 277 (288)
T d2jfla1 216 HELNPMRVLLKIAKSEPPTLAQ-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277 (288)
T ss_dssp TTSCGGGHHHHHHHSCCCCCSS-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCC
T ss_pred CCCCHHHHHHHHHcCCCCCCCc-------cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 9988888888888776655432 2467899999999999999999999999999999986543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-59 Score=464.58 Aligned_cols=265 Identities=26% Similarity=0.427 Sum_probs=227.0
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
-++|++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+++|++++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--------------------~~~~~~~~~E~~il~~l~ 66 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK--------------------ENKVPYVTRERDVMSRLD 66 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHHHCC
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC--------------------HHHHHHHHHHHHHHHHcC
Confidence 367999999999999999999999999999999987543221 224567999999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||||+++++|.+++.+|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 67 HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~--------~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~N 138 (288)
T d1uu3a_ 67 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--------IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138 (288)
T ss_dssp STTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc--------cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccc
Confidence 99999999999999999999999999999999884 4679999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
||++++|.+||+|||+|..+..... .....+.+||+.|||||++.+.. |+.++|||||||++|+|+||.+||.+.+
T Consensus 139 Ill~~~~~vkl~DFG~a~~~~~~~~---~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 139 ILLNEDMHIQITDFGTAKVLSPESK---QARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp EEECTTSCEEECCCTTCEECC-------------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCCCceEEecccccceecccCCc---ccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcC
Confidence 9999999999999999987753321 22234568999999999998765 8999999999999999999999999988
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH------HhcCccccccchhh
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE------LLKNPFFKKAKDKK 334 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e------lL~hp~~~~~~~~~ 334 (520)
....+..+....+. ++ ..+++++++||.+||++||.+|||++| +++||||+...+..
T Consensus 215 ~~~~~~~i~~~~~~-~p---------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 215 EYLIFQKIIKLEYD-FP---------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277 (288)
T ss_dssp HHHHHHHHHTTCCC-CC---------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred HHHHHHHHHcCCCC-CC---------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence 88877777665432 22 346889999999999999999999998 57899999876654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-59 Score=460.22 Aligned_cols=260 Identities=25% Similarity=0.465 Sum_probs=214.3
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++++.||+|+||+||+|+++.+|+.||+|+++..... ....+.+.+|+++|++++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---------------------~~~~~~~~~E~~il~~l~ 61 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---------------------EAEKQMLVSEVNLLRELK 61 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC---------------------HHHHHHHHHHHHHTTSCC
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC---------------------HHHHHHHHHHHHHHHHCC
Confidence 57899999999999999999999999999999987543211 224567899999999999
Q ss_pred CCCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEe
Q psy11359 108 HENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG-----QIH 180 (520)
Q Consensus 108 HpnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g-----iiH 180 (520)
|||||++++++.+ .+.+|+|||||+||+|.+++..... ..+.+++..++.++.||+.||.|||++| |||
T Consensus 62 HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~----~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiH 137 (269)
T d2java1 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK----ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 137 (269)
T ss_dssp CTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHHCC-------
T ss_pred CCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccc----cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEe
Confidence 9999999999964 4568999999999999999976433 3567999999999999999999999976 999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+|||++.+|.+||+|||+|..+.... ......+|||.|||||++.+.. |+.++|||||||++|+|+||+
T Consensus 138 rDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~ 211 (269)
T d2java1 138 RDLKPANVFLDGKQNVKLGDFGLARILNHDT-----SFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALM 211 (269)
T ss_dssp --CCGGGEEECTTSCEEECCHHHHHHC----------------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred CcCchhhcCcCCCCcEEEeeccceeecccCC-----CccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCC
Confidence 9999999999999999999999998764322 2234578999999999997665 899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccc
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFF 327 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~ 327 (520)
+||.+.+..+....+..+..+.++ ..+|+++.+||.+||++||.+|||+.|+|+|||+
T Consensus 212 ~Pf~~~~~~~~~~~i~~~~~~~~~---------~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 212 PPFTAFSQKELAGKIREGKFRRIP---------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CSCCCSSHHHHHHHHHHTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999998888877777766554443 3578899999999999999999999999999996
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-59 Score=455.98 Aligned_cols=257 Identities=24% Similarity=0.422 Sum_probs=215.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
....|++.++||+|+||+||+|.++.++..||+|.+..... .....+.+.+|+++|+++
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~---------------------~~~~~~~~~~E~~il~~l 65 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---------------------TKSERQRFKEEAEMLKGL 65 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---------------------CHHHHHHHHHHHHHHTTC
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---------------------CHHHHHHHHHHHHHHHhC
Confidence 33445888899999999999999999999999988753211 123456789999999999
Q ss_pred CCCCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEe
Q psy11359 107 HHENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG--QIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g--iiH 180 (520)
+|||||+++++|.. +..+|+||||++||+|.++++. .+.+++..++.|+.||+.||+|||++| |+|
T Consensus 66 ~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~--------~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiH 137 (270)
T d1t4ha_ 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--------FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIH 137 (270)
T ss_dssp CCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCC
T ss_pred CCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc--------cccccHHHHHHHHHHHHHHHHHHHHCCCCEEe
Confidence 99999999999975 4568999999999999999974 357899999999999999999999999 999
Q ss_pred cccCCCcEEEc-CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 181 RDIKAGNILLG-EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 181 rDLKp~NILl~-~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG 259 (520)
|||||+|||++ +++.+||+|||+|.... .....+.+|||.|||||++.+. |+.++|||||||++|+|+||
T Consensus 138 rDiKp~NILl~~~~~~~Kl~DFGla~~~~-------~~~~~~~~GT~~Y~aPE~~~~~--~~~~~DIwSlGvilyel~~g 208 (270)
T d1t4ha_ 138 RDLKCDNIFITGPTGSVKIGDLGLATLKR-------ASFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATS 208 (270)
T ss_dssp SCCCGGGEEESSTTSCEEECCTTGGGGCC-------TTSBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHS
T ss_pred CCcChhhceeeCCCCCEEEeecCcceecc-------CCccCCcccCccccCHHHhCCC--CCCcCchhhHHHHHHHHHHC
Confidence 99999999996 58999999999997542 2234567899999999998753 99999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
+.||.+......+...+...... .......++++.+||.+||++||++|||+.|+|+||||+
T Consensus 209 ~~Pf~~~~~~~~~~~~i~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 209 EYPYSECQNAAQIYRRVTSGVKP-------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp SCTTTTCSSHHHHHHHHTTTCCC-------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCCCCCcccHHHHHHHHHcCCCC-------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99998776665555444432221 112345688999999999999999999999999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-58 Score=464.27 Aligned_cols=265 Identities=26% Similarity=0.437 Sum_probs=231.7
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
+-++|++++.||+|+||+||+|+++.+|+.||+|++++..... ....+.+.+|+.+|+++
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~--------------------~~~~~~~~~E~~il~~l 62 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--------------------KDEVAHTVTESRVLQNT 62 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHHSC
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC--------------------HHHHHHHHHHHHHHHhC
Confidence 4568999999999999999999999999999999987543321 22456789999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+||||++++++|.+++.+|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+
T Consensus 63 ~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~--------~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~ 134 (337)
T d1o6la_ 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--------ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134 (337)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--------HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred CCCCEEEEEeeeccccccccceeccCCCchhhhhhc--------ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHH
Confidence 999999999999999999999999999999999984 467899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.+|.+||+|||+|+..... .......+|||.|||||++.+.. |+.++|||||||++|+|+||++||.+.
T Consensus 135 NILl~~~g~vkl~DFG~a~~~~~~-----~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 135 NLMLDKDGHIKITDFGLCKEGISD-----GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp GEEECTTSCEEECCCTTCBCSCCT-----TCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HeEecCCCCEEEeecccccccccC-----CcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCc
Confidence 999999999999999999765322 22345679999999999998765 899999999999999999999999998
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhhH
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~ 335 (520)
...+....+....+.. + ..+|+++++||.+||++||.+|+ ++.|+++||||+...+...
T Consensus 209 ~~~~~~~~i~~~~~~~-p---------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l 272 (337)
T d1o6la_ 209 DHERLFELILMEEIRF-P---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272 (337)
T ss_dssp SHHHHHHHHHHCCCCC-C---------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred CHHHHHHHHhcCCCCC-C---------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHH
Confidence 8887777766654332 2 35788999999999999999999 4999999999998766543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-59 Score=469.79 Aligned_cols=269 Identities=28% Similarity=0.522 Sum_probs=216.3
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++++.||+|+||+||+|.++.+|+.||+|+++.. ......+.+.+|+.+|++
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~----------------------~~~~~~~~~~~Ei~il~~ 60 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE----------------------IKPAIRNQIIRELQVLHE 60 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC----------------------CCTTHHHHHHHHGGGGGG
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh----------------------hCHHHHHHHHHHHHHHHh
Confidence 4578999999999999999999999999988888877532 113345678999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecccC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-NGQIHRDIK 184 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-~giiHrDLK 184 (520)
++|||||+++++|.+++.+|+||||+.||+|.+++.+ .+.+++..++.++.||+.||.|||+ +||+|||||
T Consensus 61 l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~--------~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiK 132 (322)
T d1s9ja_ 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--------AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 132 (322)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCS
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccC
Confidence 9999999999999999999999999999999999984 3568999999999999999999997 599999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|+|||++.+|.+||+|||+|..+.. ....+++||+.|||||++.+.. |+.++||||+||++|||+||+.||.
T Consensus 133 P~NILl~~~~~vkl~DFGla~~~~~-------~~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 133 PSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp GGGEEECTTCCEEECCCCCCHHHHH-------HTC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred HHHeeECCCCCEEEeeCCCccccCC-------CccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999999986532 2334679999999999998765 9999999999999999999999997
Q ss_pred CCcHHHHHHHH---hcCCCCCC--------------------CCCchhh-----------hhHHHhcHHHHHHHHhhhcc
Q psy11359 265 KYPAMKVLMLT---LQNDPPTL--------------------DTGAAEK-----------DQYKAYGKTFRKMISDCLQK 310 (520)
Q Consensus 265 ~~~~~~~~~~~---~~~~~~~~--------------------~~~~~~~-----------~~~~~~~~~~~~li~~~L~~ 310 (520)
........... ..+.+... ....... .....+|.++++||.+||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ 284 (322)
T d1s9ja_ 205 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284 (322)
T ss_dssp CCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCC
Confidence 65433221100 00000000 0000000 00023578999999999999
Q ss_pred CCCCCCCHHHHhcCccccccch
Q psy11359 311 DPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 311 dP~~Rpta~elL~hp~~~~~~~ 332 (520)
||.+|||++|+|+||||+....
T Consensus 285 dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 285 NPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp STTTSCCHHHHHTSHHHHHHHH
T ss_pred ChhHCcCHHHHhhCHhhCcCCc
Confidence 9999999999999999986543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-58 Score=461.57 Aligned_cols=261 Identities=30% Similarity=0.486 Sum_probs=211.5
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.++||+|+||+||+|+++.+|+.||+|++..... ....+.+.+|+.+|++|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----------------------~~~~~~~~~Ei~il~~l 64 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL----------------------EGKEGSMENEIAVLHKI 64 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------------------------CHHHHHHHTC
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh----------------------hhHHHHHHHHHHHHHhC
Confidence 45779999999999999999999999999999998864321 11224577899999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+|||||++++++.+++.+|+|||||+||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+
T Consensus 65 ~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~--------~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~ 136 (307)
T d1a06a_ 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--------EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPE 136 (307)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH--------TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhh--------cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEeccc
Confidence 99999999999999999999999999999999997 4578999999999999999999999999999999999
Q ss_pred cEEEc---CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 187 NILLG---EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 187 NILl~---~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
|||+. ++|.+||+|||+|.....+ ....+.+||+.|||||++.+.. |+.++|||||||++|+|+||.+||
T Consensus 137 Nil~~~~~~~~~vkl~DFG~a~~~~~~------~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf 209 (307)
T d1a06a_ 137 NLLYYSLDEDSKIMISDFGLSKMEDPG------SVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPF 209 (307)
T ss_dssp GEEESSSSTTCCEEECCC------------------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ceeecccCCCceEEEeccceeEEccCC------CeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCC
Confidence 99994 5789999999999765432 2234578999999999998765 899999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.+.........+......... ..+..+|+++++||.+||++||.+|||+.|+|+||||+..
T Consensus 210 ~~~~~~~~~~~i~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 210 YDENDAKLFEQILKAEYEFDS------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp CCSSHHHHHHHHHTTCCCCCT------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CCCCHHHHHHHHhccCCCCCC------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 998888777777665433221 1235678999999999999999999999999999999753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-58 Score=459.93 Aligned_cols=259 Identities=37% Similarity=0.602 Sum_probs=225.4
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
+.|++++.||+|+||+||+|.+..+|+.||||+++..... .....+.+.+|+.+|++|+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--------------------~~~~~~~~~~Ei~il~~l~H 74 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--------------------SNEKWQDIIKEVRFLQKLRH 74 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSC--------------------HHHHHHHHHHHHHHHTTCCC
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhcc--------------------CHHHHHHHHHHHHHHHHCCC
Confidence 4599999999999999999999999999999987532111 12345678999999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
||||++++++.+++.+|+|||||.||+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 75 pnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~--------~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI 146 (309)
T d1u5ra_ 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146 (309)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH--------TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred CCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceE
Confidence 9999999999999999999999999999877663 46799999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD--HGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|++.+|.+||+|||+|..... ....+||+.|||||++.+. ..|+.++|||||||++|+|++|..||.+.
T Consensus 147 Ll~~~~~~Kl~DFG~a~~~~~---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 147 LLSEPGLVKLGDFGSASIMAP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp EEETTTEEEECCCTTCBSSSS---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EECCCCCEEEeecccccccCC---------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 999999999999999976432 2346899999999998642 34899999999999999999999999998
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
.....+..+..+..+.+.. ..+|+.+++||.+||++||.+|||++|+|+||||+....
T Consensus 218 ~~~~~~~~i~~~~~~~~~~--------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 218 NAMSALYHIAQNESPALQS--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp CHHHHHHHHHHSCCCCCSC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred CHHHHHHHHHhCCCCCCCC--------CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 8888888777776555432 346889999999999999999999999999999986543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-58 Score=455.38 Aligned_cols=270 Identities=27% Similarity=0.458 Sum_probs=229.3
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
+..++|++.+.||+|+||+||+|+++.+|+.||+|+++..... ........+.+.+|+.+|++
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~-----------------~~~~~~~~~~~~~E~~il~~ 69 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTK-----------------SSRRGVSREDIEREVSILKE 69 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSST-----------------TCSSSBCHHHHHHHHHHHHH
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcc-----------------hhhhhHHHHHHHHHHHHHHh
Confidence 3457899999999999999999999999999999988643211 11112346789999999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
|+|||||+++++|.+.+.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||
T Consensus 70 l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~--------~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp 141 (293)
T d1jksa_ 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--------KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKP 141 (293)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcc--------ccccchhHHHHHHHHHHHHHHhhhhcceeeccccc
Confidence 9999999999999999999999999999999999985 35799999999999999999999999999999999
Q ss_pred CcEEEcCCC----CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 186 GNILLGEDG----TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 186 ~NILl~~~g----~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
+|||++.+| .+||+|||+|..+..+. ...+..||+.|||||++.+.. |+.++|||||||++|+|+||+.
T Consensus 142 ~Nill~~~~~~~~~vkl~DfG~a~~~~~~~------~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~ 214 (293)
T d1jksa_ 142 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGN------EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGAS 214 (293)
T ss_dssp GGEEESCSSSSSCCEEECCCTTCEECTTSC------BCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSC
T ss_pred ceEEEecCCCcccceEecchhhhhhcCCCc------cccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCC
Confidence 999998766 59999999998764332 234568999999999998755 8999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccchh
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKDK 333 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~~ 333 (520)
||.+.+..+.+..+....... ....+..+|+.+++||.+||++||.+|||++|+|+||||+.....
T Consensus 215 Pf~~~~~~~~~~~i~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 215 PFLGDTKQETLANVSAVNYEF------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp SSCCSSHHHHHHHHHTTCCCC------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred CCCCCCHHHHHHHHHhcCCCC------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence 999988888877766654322 123445688999999999999999999999999999999865543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.8e-58 Score=465.76 Aligned_cols=265 Identities=26% Similarity=0.430 Sum_probs=229.1
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++++.||+|+||+||+|.++.+|+.||+|++.... ....+.+.+|+.+|+
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-----------------------~~~~~~~~~E~~il~ 78 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----------------------ESDKETVRKEIQTMS 78 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-----------------------HHHHHHHHHHHHHHH
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-----------------------hhhHHHHHHHHHHHH
Confidence 344578999999999999999999999999999999875321 223467899999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+|+|||||+++++|.+++.+|+|||||+||+|.+++.. ..+.+++..++.++.||+.||.|||++||||||||
T Consensus 79 ~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~-------~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiK 151 (350)
T d1koaa2 79 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-------EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 151 (350)
T ss_dssp HTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC-------TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeec
Confidence 99999999999999999999999999999999999953 45679999999999999999999999999999999
Q ss_pred CCcEEEc--CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 185 AGNILLG--EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 185 p~NILl~--~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|+|||++ .+|.+||+|||+|..+... ....+..||+.|||||++.+.. |+.++|||||||++|+|+||.+|
T Consensus 152 p~NIll~~~~~~~vkL~DFG~a~~~~~~------~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~P 224 (350)
T d1koaa2 152 PENIMFTTKRSNELKLIDFGLTAHLDPK------QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSP 224 (350)
T ss_dssp GGGEEESSTTSCCEEECCCTTCEECCTT------SCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCS
T ss_pred hhHeeeccCCCCeEEEeecchheecccc------cccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCC
Confidence 9999995 4689999999999876432 2234678999999999998765 89999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccch
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAKD 332 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~~ 332 (520)
|.+....+.+..+........ ...+..+++++++||.+||++||++|||++|+|+||||+....
T Consensus 225 f~~~~~~~~~~~i~~~~~~~~------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 225 FGGENDDETLRNVKSCDWNMD------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp SCCSSHHHHHHHHHHTCCCSC------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred CCCCCHHHHHHHHHhCCCCCC------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 999888888777766543322 1233568899999999999999999999999999999986543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-57 Score=456.28 Aligned_cols=261 Identities=25% Similarity=0.448 Sum_probs=229.9
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
-++|++++.||+|+||+||+|+++.+|+.||+|+++...... ....+.+.+|+.+|++++
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~--------------------~~~~~~~~~E~~il~~l~ 62 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR--------------------LKQVEHTNDERLMLSIVT 62 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHHSCC
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC--------------------HHHHHHHHHHHHHHHhcc
Confidence 357999999999999999999999999999999987543221 224567899999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||||++++++.+.+.+|+||||+.||+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 63 HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~N 134 (316)
T d1fota_ 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--------SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPEN 134 (316)
T ss_dssp BTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--------TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred CcChhheeeeEeeCCeeeeEeeecCCccccccccc--------cccccccHHHHHHHHHHHhhhhhccCcEEccccCchh
Confidence 99999999999999999999999999999999984 5678899999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
||++.+|.+||+|||+|..+... ..+.+||+.|||||++.+.. |+.++|||||||++|+|+||+.||.+.+
T Consensus 135 ILl~~~g~vkL~DFG~a~~~~~~--------~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 135 ILLDKNGHIKITDFGFAKYVPDV--------TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp EEECTTSCEEECCCSSCEECSSC--------BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred eeEcCCCCEEEecCccceEeccc--------cccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcC
Confidence 99999999999999999876422 23578999999999997665 8999999999999999999999999988
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhhH
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~ 335 (520)
..+....+........ ..++++++++|.+||++||.+|+ |++++++||||+...+...
T Consensus 206 ~~~~~~~i~~~~~~~p----------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l 268 (316)
T d1fota_ 206 TMKTYEKILNAELRFP----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268 (316)
T ss_dssp HHHHHHHHHHCCCCCC----------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred HHHHHHHHHcCCCCCC----------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHH
Confidence 8888877776654321 34688999999999999999996 9999999999998876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-57 Score=463.27 Aligned_cols=262 Identities=27% Similarity=0.455 Sum_probs=227.7
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
...++|++++.||+|+||+||+|.++.+|+.||+|+++... ....+.+.+|+.+|++
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------------------~~~~~~~~~Ei~il~~ 82 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----------------------PLDKYTVKNEISIMNQ 82 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----------------------HHHHHHHHHHHHHHTT
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----------------------hhHHHHHHHHHHHHHh
Confidence 34578999999999999999999999999999999875321 1234568899999999
Q ss_pred CCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 106 CHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 106 l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
|+|||||+++++|.+++.+|||||||+||+|.+++.. ....+++.+++.|+.||+.||.|||++||+||||||
T Consensus 83 l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~-------~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp 155 (352)
T d1koba_ 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-------EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 155 (352)
T ss_dssp CCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC-------TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 9999999999999999999999999999999998763 345799999999999999999999999999999999
Q ss_pred CcEEEc--CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11359 186 GNILLG--EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPY 263 (520)
Q Consensus 186 ~NILl~--~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf 263 (520)
+|||++ .+|.+||+|||+|..+... ....+..||+.|||||++.+.. |+.++|||||||++|+|+||.+||
T Consensus 156 ~NILl~~~~~~~vkL~DFGla~~~~~~------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf 228 (352)
T d1koba_ 156 ENIMCETKKASSVKIIDFGLATKLNPD------EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPF 228 (352)
T ss_dssp GGEEESSTTCCCEEECCCTTCEECCTT------SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred ccccccccCCCeEEEeecccceecCCC------CceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCC
Confidence 999997 6789999999999877532 2344578999999999997765 999999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.+......+..+......... ..+..+++++++||.+||++||.+|||+.|+|+||||+..
T Consensus 229 ~~~~~~~~~~~i~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 229 AGEDDLETLQNVKRCDWEFDE------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CCSSHHHHHHHHHHCCCCCCS------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCCCHHHHHHHHHhCCCCCCc------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999888888777765543221 1234678999999999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-57 Score=459.16 Aligned_cols=262 Identities=23% Similarity=0.403 Sum_probs=230.5
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++++.||+|+||+||+|+++.+|+.||+|++....... ....+.+.+|+.+|+++
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~--------------------~~~~~~~~~E~~il~~l 98 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK--------------------LKQIEHTLNEKRILQAV 98 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHTTC
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC--------------------HHHHHHHHHHHHHHHHc
Confidence 3578999999999999999999999999999999986543221 12456789999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+|||||++++++.....+++||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+
T Consensus 99 ~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~--------~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~ 170 (350)
T d1rdqe_ 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170 (350)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--------HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred CCCcEeecccccccccccccccccccccchhhhHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHH
Confidence 999999999999999999999999999999999974 357999999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.+|.+||+|||+|+.+... ..+.+||+.|||||++.+.. |+.++|||||||++|+|+||.+||.+.
T Consensus 171 NILl~~~g~ikL~DFG~a~~~~~~--------~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 171 NLLIDQQGYIQVTDFGFAKRVKGR--------TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp GEEECTTSCEEECCCTTCEECSSC--------BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HcccCCCCCEEeeeceeeeecccc--------cccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCc
Confidence 999999999999999999876421 23568999999999998765 899999999999999999999999998
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccchhhH
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~ 335 (520)
.....+..+....+... ..+++++.+||.+||++||.+|+ |++++++||||+...+...
T Consensus 242 ~~~~~~~~i~~~~~~~p----------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~ 305 (350)
T d1rdqe_ 242 QPIQIYEKIVSGKVRFP----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305 (350)
T ss_dssp SHHHHHHHHHHCCCCCC----------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred CHHHHHHHHhcCCCCCC----------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHH
Confidence 88887777766654322 34788999999999999999995 9999999999998766543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.6e-57 Score=443.23 Aligned_cols=268 Identities=28% Similarity=0.510 Sum_probs=228.1
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|+++.+|+.||+|+++....... ..+......+.+.+|+.+|++|+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~--------------~~~~~~~~~~~~~~E~~~l~~l~ 67 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF--------------SAEEVQELREATLKEVDILRKVS 67 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTC--------------CHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccch--------------hHHHHHHHHHHHHHHHHHHHHhc
Confidence 4789999999999999999999999999999999865322110 00011223456889999999996
Q ss_pred -CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 108 -HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 108 -HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
|||||++++++.+++.+||||||++||+|.++++. .+.+++..++.++.||+.||+|||++||+||||||+
T Consensus 68 ~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~--------~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~ 139 (277)
T d1phka_ 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--------KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE 139 (277)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence 99999999999999999999999999999999984 357999999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecc-----cCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQ-----DHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|||++.++.+||+|||++..+..+. .....+||+.|+|||++.+ ...++.++||||+||++|+|+||++
T Consensus 140 Nill~~~~~~kl~DFG~a~~~~~~~------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~ 213 (277)
T d1phka_ 140 NILLDDDMNIKLTDFGFSCQLDPGE------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213 (277)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eEEEcCCCCeEEccchheeEccCCC------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCC
Confidence 9999999999999999998775432 2245689999999999863 2347889999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
||.+.+.......+........ ......+|+++++||.+||++||++|||+.|+|+||||+.
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 214 PFWHRKQMLMLRMIMSGNYQFG------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCC------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCCCCHHHHHHHHHhCCCCCC------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 9999988887777776543321 1123578999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-56 Score=458.62 Aligned_cols=268 Identities=26% Similarity=0.388 Sum_probs=221.8
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
+-++|++.++||+|+||+||+|.++.+|+.||+|++......... .........+++.+++.+
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~-----------------~~~~~~~e~~~~~~l~~~ 64 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-----------------GETLALNERIMLSLVSTG 64 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHT-----------------CHHHHHHHHHHHHHHSSS
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhh-----------------HHHHHHHHHHHHHHHhcC
Confidence 357899999999999999999999999999999998754332110 011122334567888899
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+|||||+++++|.+.+.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+
T Consensus 65 ~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~--------~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~ 136 (364)
T d1omwa3 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--------HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA 136 (364)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred CCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHh--------cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccc
Confidence 999999999999999999999999999999999984 467889999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKY 266 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~ 266 (520)
|||++.+|.+||+|||+|+.+... .....+||+.|||||++.....|+.++|||||||++|+|+||+.||...
T Consensus 137 NILl~~~g~iKl~DFGla~~~~~~-------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 137 NILLDEHGHVRISDLGLACDFSKK-------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp GEEECSSSCEEECCCTTCEECSSS-------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEEcCCCcEEEeeeceeeecCCC-------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999876432 2345689999999999976666999999999999999999999999865
Q ss_pred cHHHH--HHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCC-----HHHHhcCccccccchhhH
Q psy11359 267 PAMKV--LMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPT-----ASELLKNPFFKKAKDKKF 335 (520)
Q Consensus 267 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~ 335 (520)
..... +.......+..++ ..+++++++||.+||++||.+||| |+|+++||||+...+...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~ 276 (364)
T d1omwa3 210 KTKDKHEIDRMTLTMAVELP---------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 276 (364)
T ss_dssp CSSCHHHHHHHSSSCCCCCC---------SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHH
T ss_pred CHHHHHHHHHhcccCCCCCC---------CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHH
Confidence 43322 2222222222221 357889999999999999999999 799999999998776543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=450.56 Aligned_cols=260 Identities=23% Similarity=0.398 Sum_probs=225.6
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++++.||+|+||+||+|.++.+|+.||+|+++.. ......+.+|+++|+++
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~------------------------~~~~~~~~~Ei~il~~l 58 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------------------------GTDQVLVKKEISILNIA 58 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------------------------THHHHHHHHHHHHHHHS
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC------------------------cccHHHHHHHHHHHHhC
Confidence 457899999999999999999999999999999987532 11234578999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+|||||+++++|.+++.+|+|||||+||+|.+++.. ....+++.+++.|+.||+.||+|||++||+||||||+
T Consensus 59 ~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~-------~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~ 131 (321)
T d1tkia_ 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINT-------SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE 131 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS-------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCccccccc
Confidence 999999999999999999999999999999999963 3347999999999999999999999999999999999
Q ss_pred cEEEcCC--CCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11359 187 NILLGED--GTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH 264 (520)
Q Consensus 187 NILl~~~--g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~ 264 (520)
|||++.+ +.+||+|||++...... .......||+.|+|||.+.+.. |+.++|||||||++|+|++|.+||.
T Consensus 132 NIll~~~~~~~ikl~DFG~~~~~~~~------~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~ 204 (321)
T d1tkia_ 132 NIIYQTRRSSTIKIIEFGQARQLKPG------DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp GEEESSSSCCCEEECCCTTCEECCTT------CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ceeecCCCceEEEEcccchhhccccC------CcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCC
Confidence 9999754 48999999999876432 2234568999999999987665 8999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 265 KYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
.......+..+....... ....+..+|+++++||.+||++||.+|||+.|+|+||||++.
T Consensus 205 ~~~~~~~~~~i~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 205 AETNQQIIENIMNAEYTF------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CSSHHHHHHHHHHTCCCC------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCHHHHHHHHHhCCCCC------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 988888877776654322 233456789999999999999999999999999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=448.26 Aligned_cols=262 Identities=26% Similarity=0.477 Sum_probs=225.8
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh-cCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS-SCH 107 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~-~l~ 107 (520)
++|++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.++. .++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~--------------------~~~~~~~~~e~~~l~~~~~ 61 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM--------------------DDDVECTMVEKRVLSLAWE 61 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH--------------------TTCHHHHHHHHHHHHHHTT
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC--------------------hHHHHHHHHHHHHHHHhCC
Confidence 68999999999999999999999999999999987543221 223456777777765 789
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||||++++++.+++.+|+||||++||+|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|
T Consensus 62 hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~--------~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~N 133 (320)
T d1xjda_ 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--------CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDN 133 (320)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--------HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred CCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccc
Confidence 99999999999999999999999999999999984 4568999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYP 267 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~ 267 (520)
||++++|.+||+|||++...... ........||+.|+|||++.+.. |+.++|||||||++|+|+||+.||.+..
T Consensus 134 iL~~~~~~~kl~DFG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 134 ILLDKDGHIKIADFGMCKENMLG-----DAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp EEECTTSCEEECCCTTCBCCCCT-----TCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeecCCCceeccccchhhhcccc-----cccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999765432 22234568999999999998765 8999999999999999999999999988
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH-HHhcCccccccchhh
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS-ELLKNPFFKKAKDKK 334 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~-elL~hp~~~~~~~~~ 334 (520)
....+..+....+. ++ +.+|+++.+||.+||++||.+|||+. ++++||||+..++..
T Consensus 208 ~~~~~~~i~~~~~~-~p---------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~ 265 (320)
T d1xjda_ 208 EEELFHSIRMDNPF-YP---------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE 265 (320)
T ss_dssp HHHHHHHHHHCCCC-CC---------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred HHHHHHHHHcCCCC-CC---------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHH
Confidence 88777766655432 22 35688999999999999999999995 899999999876543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=445.09 Aligned_cols=268 Identities=26% Similarity=0.357 Sum_probs=216.5
Q ss_pred EEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCCCCc
Q psy11359 32 EVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHHENV 111 (520)
Q Consensus 32 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~HpnI 111 (520)
+.+++||+|+||+||+|+++.+|+.||||+++....... .....+.+.+|+.+|++++||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~------------------~~~~~~~~~~Ei~il~~l~hpnI 62 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA------------------KDGINRTALREIKLLQELSHPNI 62 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------------------------CTHHHHHHHHHHHCCCTTB
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh------------------hHHHHHHHHHHHHHHHhCCCCCE
Confidence 357899999999999999999999999998864321100 01122458899999999999999
Q ss_pred eEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcEEEc
Q psy11359 112 VTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNILLG 191 (520)
Q Consensus 112 v~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~ 191 (520)
|++++++..++.+|+||||+.|+++..++. ..+.+++..++.+++||+.||+|||++||+||||||+|||++
T Consensus 63 v~~~~~~~~~~~~~ivmE~~~~~~~~~~~~--------~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~ 134 (299)
T d1ua2a_ 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKD--------NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 134 (299)
T ss_dssp CCEEEEECCTTCCEEEEECCSEEHHHHHTT--------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred eEEEeeeccCCceeehhhhhcchHHhhhhh--------cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec
Confidence 999999999999999999998887766654 467799999999999999999999999999999999999999
Q ss_pred CCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q psy11359 192 EDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPAMKV 271 (520)
Q Consensus 192 ~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~~~~ 271 (520)
.++.+||+|||+|..+.... ......+||+.|||||++.+...|+.++|||||||++|+|+||.+||.+....+.
T Consensus 135 ~~~~~KL~DFG~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~ 209 (299)
T d1ua2a_ 135 ENGVLKLADFGLAKSFGSPN-----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 209 (299)
T ss_dssp TTCCEEECCCGGGSTTTSCC-----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCccccccCccccccCCCc-----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH
Confidence 99999999999997654322 2234568999999999998776689999999999999999999999999888777
Q ss_pred HHHHhcC--CCCCC----------------CCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 272 LMLTLQN--DPPTL----------------DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 272 ~~~~~~~--~~~~~----------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
+..+... .+... ............+++++.+||.+||++||++||||.|+|+||||+..
T Consensus 210 l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 210 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 6554421 11000 00111122334678999999999999999999999999999999854
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=438.34 Aligned_cols=270 Identities=27% Similarity=0.401 Sum_probs=220.8
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++++.||+|+||+||+|.+..+|+.||+|+++..... ....+.+.+|+++|++++|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---------------------~~~~~~~~~Ei~il~~l~H 60 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET---------------------EGVPSTAIREISLLKELNH 60 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------------------------CCHHHHHHHHHHTTCCC
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC---------------------hHHHHHHHHHHHHHHhCCC
Confidence 6899999999999999999999999999999987532110 1224568899999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
||||+++++|.+++.+|+||||+.+ ++.+++... ..+.+++..++.++.||+.||+|||++|||||||||+||
T Consensus 61 p~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~------~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNI 133 (298)
T d1gz8a_ 61 PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS------ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133 (298)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHT------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CcEEEeccccccccceeEEEeecCC-chhhhhhhh------cccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchhe
Confidence 9999999999999999999999964 566666543 456799999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.++.+||+|||+|...... ........||+.|+|||++.....++.++|||||||++|+|++|+.||.+...
T Consensus 134 l~~~~~~~kl~DFG~a~~~~~~-----~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~ 208 (298)
T d1gz8a_ 134 LINTEGAIKLADFGLARAFGVP-----VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208 (298)
T ss_dssp EECTTSCEEECSTTHHHHHCCC-----SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eecccCcceeccCCcceeccCC-----cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH
Confidence 9999999999999999765432 22334568999999999988777678999999999999999999999998887
Q ss_pred HHHHHHHhcC--CCCCCCC-----------------CchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 269 MKVLMLTLQN--DPPTLDT-----------------GAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 269 ~~~~~~~~~~--~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
.+.+...... .+..... ..........+++++.+||.+||++||.+|||+.|+|+||||+.
T Consensus 209 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 209 IDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 7766554322 1111000 00011223456889999999999999999999999999999986
Q ss_pred cc
Q psy11359 330 AK 331 (520)
Q Consensus 330 ~~ 331 (520)
..
T Consensus 289 ~~ 290 (298)
T d1gz8a_ 289 VT 290 (298)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=445.41 Aligned_cols=262 Identities=23% Similarity=0.404 Sum_probs=211.6
Q ss_pred CCCCCeEEEe-eeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 26 NTEDQYEVRE-VIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 26 ~~~~~Y~i~~-~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
...++|++.. .||+|+||+||+|.+..+|+.||||+++. ...+.+|+.++.
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----------------------------~~~~~~E~~~~~ 59 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------------------------CPKARREVELHW 59 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----------------------------SHHHHHHHHHHH
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----------------------------cHHHHHHHHHHH
Confidence 3457899875 69999999999999999999999998742 124678999865
Q ss_pred c-CCCCCceEEEEEEEE----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 105 S-CHHENVVTYHTSFVV----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 105 ~-l~HpnIv~~~~~~~~----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+ ++|||||+++++|.+ +..+|+|||||+||+|.++++.+ ....+++.+++.|+.||+.||.|||++||+
T Consensus 60 ~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~------~~~~l~e~~~~~i~~qi~~al~ylH~~~ii 133 (335)
T d2ozaa1 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR------GDQAFTEREASEIMKSIGEAIQYLHSINIA 133 (335)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSC------SCCCEEHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhc------CCCCcCHHHHHHHHHHHHHHHHHHHHcCCc
Confidence 5 589999999999976 46799999999999999999742 345799999999999999999999999999
Q ss_pred ecccCCCcEEEcC---CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 180 HRDIKAGNILLGE---DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 180 HrDLKp~NILl~~---~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
||||||+|||++. ++.+||+|||+|+...... .....+||+.|||||++.+.. |+.++|||||||++|+|
T Consensus 134 HRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~l 206 (335)
T d2ozaa1 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN------SLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYIL 206 (335)
T ss_dssp CCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC------CCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccceeeeccCCC------ccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHH
Confidence 9999999999974 5679999999998764322 234568999999999998765 99999999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 257 ATGTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 257 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
+||.+||.+................ .....+...+..+|+++++||.+||++||++|||+.|+|+||||+..
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 207 LCGYPPFYSNHGLAISPGMKTRIRM--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp TTSSCSCEETTCC--------CCCS--CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred hhCCCCCCCCCHHHHHHHHHHHHhc--CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 9999999776544433222211110 01111223456789999999999999999999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=433.12 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=212.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.++||+|+||+||+|.+..+|+.||||+++....... .. .....++.+|+.+|+++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------~~------~~~~~~~~~E~~il~~l 64 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-----------GE------LPNGTRVPMEVVLLKKV 64 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCE-----------EE------CTTCCEEEHHHHHHHHH
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccch-----------hh------hhHHHHHHHHHHHHHHh
Confidence 35789999999999999999999999999999999875432110 00 00112256799999988
Q ss_pred C--CCCceEEEEEEEECCEEEEEEEccCC-CCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccc
Q psy11359 107 H--HENVVTYHTSFVVKDELWLVLRLLEG-GSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDI 183 (520)
Q Consensus 107 ~--HpnIv~~~~~~~~~~~~~lV~E~~~g-gsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDL 183 (520)
+ |||||++++++.+.+.+|+||||+.+ +++.+++.. .+.+++.+++.++.||+.||.|||++||+||||
T Consensus 65 ~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~--------~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDi 136 (273)
T d1xwsa_ 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE--------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDI 136 (273)
T ss_dssp CSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH--------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Confidence 6 89999999999999999999999976 688888874 357899999999999999999999999999999
Q ss_pred CCCcEEEcC-CCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 184 KAGNILLGE-DGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 184 Kp~NILl~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
||+|||++. ++.+||+|||+|..... ....+.+||+.|||||++.+...++.++|||||||++|+|+||+.|
T Consensus 137 Kp~NIll~~~~~~vkl~DFG~a~~~~~-------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~P 209 (273)
T d1xwsa_ 137 KDENILIDLNRGELKLIDFGSGALLKD-------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209 (273)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCS-------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccceEEecCCCeEEECccccceeccc-------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCC
Confidence 999999984 57999999999976532 2234678999999999998776567889999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccccc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
|..... +..... .+. ..+|+++++||.+||++||++|||++|+|+||||+...
T Consensus 210 f~~~~~------i~~~~~-~~~---------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 210 FEHDEE------IIRGQV-FFR---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp CCSHHH------HHHCCC-CCS---------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred CCCchH------Hhhccc-CCC---------CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 976332 122211 111 34688999999999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-55 Score=433.82 Aligned_cols=257 Identities=21% Similarity=0.364 Sum_probs=216.8
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.|....++|++.+.||+|+||+||+|.++.+|+.||||+++.. ....+++.+|+.+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~------------------------~~~~~~~~~E~~i 66 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------------------TMEVEEFLKEAAV 66 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT------------------------CSCHHHHHHHHHH
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc------------------------cchHHHHHHHHHH
Confidence 4888889999999999999999999999999999999877422 2235679999999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
|++|+|||||++++++.+++.+|+||||+++|+|.+++... ....+++..+..++.||+.||+|||++||+|||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 140 (287)
T d1opja_ 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 140 (287)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS------CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhc------cccchHHHHHHHHHHHHHHHHHHHHHCCcccCc
Confidence 99999999999999999999999999999999999999753 456899999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|||+|||++.++.+||+|||+|+....... .......||+.|||||++.+.. |+.++|||||||++|||++|..|
T Consensus 141 lKp~NILl~~~~~~Kl~DFG~a~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p 215 (287)
T d1opja_ 141 LAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMS 215 (287)
T ss_dssp CSGGGEEECGGGCEEECCCCCTTTCCSSSS----EEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccCeEEECCCCcEEEccccceeecCCCCc----eeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCC
Confidence 999999999999999999999987643221 1223456899999999998765 99999999999999999996665
Q ss_pred C-CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 263 Y-HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 263 f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
| ...+..........+..+..+ ..+++.+.+||.+||+.||.+|||+.|+++
T Consensus 216 ~~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 216 PYPGIDLSQVYELLEKDYRMERP---------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp SSTTCCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcchHHHHHHHHhcCCCCCCC---------ccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 5 444444444433333333222 356889999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-54 Score=432.04 Aligned_cols=264 Identities=22% Similarity=0.358 Sum_probs=206.6
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHh
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMS 104 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~ 104 (520)
....++|++.++||+|+||+||+|.++.+++.. ..+|+|.+.........+++.+|+++|+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~-------------------~~vavK~~~~~~~~~~~~~~~~E~~~l~ 82 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKRE-------------------IFVAIKTLKSGYTEKQRRDFLSEASIMG 82 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CC-------------------EEEEEEECCSSCCHHHHHHHHHHHHHHT
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEE-------------------EEEEEEEECcccCHHHHHHHHHHHHHHH
Confidence 345678999999999999999999998776431 1233444433333455678999999999
Q ss_pred cCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccC
Q psy11359 105 SCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIK 184 (520)
Q Consensus 105 ~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLK 184 (520)
+|+|||||++++++..++.+|+|||||+||+|.+++.. ..+.+++.++..++.||++||.|||++||+|||||
T Consensus 83 ~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~-------~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlK 155 (299)
T d1jpaa_ 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-------NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLA 155 (299)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT-------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc-------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccc
Confidence 99999999999999999999999999999999999875 45679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy11359 185 AGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPY 263 (520)
Q Consensus 185 p~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf 263 (520)
|+||||+.++.+||+|||+|+.+................||+.|||||++.+.. |+.++|||||||++|||+| |++||
T Consensus 156 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf 234 (299)
T d1jpaa_ 156 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPY 234 (299)
T ss_dssp GGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCC
Confidence 999999999999999999998775443322222233456899999999997765 9999999999999999998 89999
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 264 HKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
.+....+....+..+..+..+ ..+++.+.+||.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 235 WDMTNQDVINAIEQDYRLPPP---------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCC---------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 998888877776665443332 3467889999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-54 Score=428.72 Aligned_cols=266 Identities=27% Similarity=0.373 Sum_probs=214.8
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|+++++||+|+||+||+|+++ +|+.||+|+++.... .....+.+.+|+.+|++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---------------------~~~~~~~~~~E~~il~~l~h 59 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE---------------------DEGIPSTTIREISILKELKH 59 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG---------------------GGCCCHHHHHHHHGGGGCCC
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc---------------------ChHHHHHHHHHHHHHHhCCC
Confidence 68999999999999999999986 778888887753211 01234578999999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
||||+++++|...+..+++|||+.++.+..+.+ ..+.+++..++.++.||+.||+|||++|||||||||+||
T Consensus 60 pnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NI 131 (286)
T d1ob3a_ 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--------CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131 (286)
T ss_dssp TTBCCEEEEEECSSCEEEEEECCSEEHHHHHHT--------STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CcEEeeeeecccCCceeEEEEeehhhhHHHHHh--------hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCcee
Confidence 999999999999999999999998766666654 467899999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHKYPA 268 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~~~~ 268 (520)
|++.++.+||+|||.+....... .......|++.|+|||.+.+...++.++|||||||++|+|++|++||.+...
T Consensus 132 ll~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~ 206 (286)
T d1ob3a_ 132 LINREGELKIADFGLARAFGIPV-----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (286)
T ss_dssp EECTTSCEEECCTTHHHHHCC--------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eEcCCCCEEecccccceecccCc-----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH
Confidence 99999999999999997764322 1233457999999999998777789999999999999999999999998877
Q ss_pred HHHHHHHhcC--CCCCCC-----------------CCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCccccc
Q psy11359 269 MKVLMLTLQN--DPPTLD-----------------TGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKK 329 (520)
Q Consensus 269 ~~~~~~~~~~--~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~ 329 (520)
.+.+...... .+.... ...........+++.+++||.+||++||++|||+.|+|+||||++
T Consensus 207 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 207 ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 7666544321 110000 000011223456889999999999999999999999999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=426.89 Aligned_cols=262 Identities=23% Similarity=0.410 Sum_probs=218.2
Q ss_pred CCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 21 SVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 21 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
...|....++|++.+.||+|+||+||+|.++ +++.||||+++.. ....+.+.+|+
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~------------------------~~~~~~~~~E~ 59 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG------------------------SMSPDAFLAEA 59 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT------------------------SSCHHHHHHHH
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC------------------------cCCHHHHHHHH
Confidence 3468888899999999999999999999976 5667888876421 22346799999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
.+|++++|||||++++++. ++.+|+||||+++|+|.+++... ....+++..+..++.||++||.|||++||+|
T Consensus 60 ~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~------~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivH 132 (272)
T d1qpca_ 60 NLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP------SGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132 (272)
T ss_dssp HHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH------HHHTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 9999999999999999775 56679999999999999987643 2235899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC-
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG- 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG- 259 (520)
|||||+||||++++.+||+|||+|+.+..... .......||+.|||||++.... |+.++|||||||++|||+||
T Consensus 133 rDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~ 207 (272)
T d1qpca_ 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHG 207 (272)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEECSSSCE----ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTT
T ss_pred CccchhheeeecccceeeccccceEEccCCcc----ccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCC
Confidence 99999999999999999999999987754322 2233567999999999998665 89999999999999999995
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc--Ccccc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK--NPFFK 328 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~--hp~~~ 328 (520)
.+||......+.+..+..+..+..+ ..+++++.+||.+||+.||++|||++++++ |+||.
T Consensus 208 ~~~~~~~~~~~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 208 RIPYPGMTNPEVIQNLERGYRMVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCc---------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 5666666666666666555444332 356788999999999999999999999998 77875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=427.82 Aligned_cols=263 Identities=24% Similarity=0.444 Sum_probs=210.4
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
.|....++|++.+.||+|+||+||+|..+ ..||||+++... ......+.+.+|+.+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~---------------------~~~~~~~~~~~E~~~ 57 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA---------------------PTPQQLQAFKNEVGV 57 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSS---------------------CCTTHHHHHHHHHHH
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEccc---------------------CCHHHHHHHHHHHHH
Confidence 47788899999999999999999999643 357877764221 113356789999999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
|++++|||||++++++. ++.+++||||++||+|.+++.. ..+.+++..+..++.||++||+|||++||||||
T Consensus 58 l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~-------~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrD 129 (276)
T d1uwha_ 58 LRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHI-------IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 129 (276)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHT-------SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhh-------ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccc
Confidence 99999999999999764 5678999999999999999974 356799999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceeccc--CCCCcchhHHHHHHHHHHHHhCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQD--HGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||+|||++.++.+||+|||+|........ .....+..||+.|||||++.+. ..|+.++|||||||++|||+||+
T Consensus 130 lKp~NiLl~~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~ 206 (276)
T d1uwha_ 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSG---SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206 (276)
T ss_dssp CCGGGEEEETTSSEEECCCCCSCC---------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCHHHEEEcCCCCEEEccccceeeccccCC---cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCC
Confidence 999999999999999999999977643221 1223456899999999998643 24899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
.||.+......+............ .......+++.+.+||.+||+.||++|||+.|++++
T Consensus 207 ~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 207 LPYSNINNRDQIIFMVGRGYLSPD----LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CTTTTCCCHHHHHHHHHHTSCCCC----GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCChHHHHHHHHhcCCCCCc----chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999987776665554443221111 111234578899999999999999999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.1e-54 Score=426.17 Aligned_cols=265 Identities=23% Similarity=0.404 Sum_probs=214.2
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++.+.||+|+||+||+|.+..+|+.||+|+++..... .....+.+.+|+++|+++
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------------------~~~~~~~~~~E~~~l~~~ 64 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR--------------------DPSFYLRFRREAQNAAAL 64 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT--------------------CHHHHHHHHHHHHHHHTC
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc--------------------CHHHHHHHHHHHHHHHhc
Confidence 468899999999999999999999999999999988643211 123456789999999999
Q ss_pred CCCCceEEEEEEEECC----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 107 HHENVVTYHTSFVVKD----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
+|||||++++++...+ .+|+||||++|++|.+++.. .+.+++.+++.++.||+.||+|||++||+|||
T Consensus 65 ~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~--------~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrD 136 (277)
T d1o6ya_ 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--------EGPMTPKRAIEVIADACQALNFSHQNGIIHRD 136 (277)
T ss_dssp CCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHH--------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred CCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcc
Confidence 9999999999998654 48999999999999999874 46799999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|||+|||++.++.++|+|||.+........ ........+||+.|||||++.+.. |+.++|||||||++|+|+||.+|
T Consensus 137 iKP~NIll~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~P 213 (277)
T d1o6ya_ 137 VKPANIMISATNAVKVMDFGIARAIADSGN--SVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPP 213 (277)
T ss_dssp CSGGGEEEETTSCEEECCCTTCEECC------------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcccccCccccceeehhhhhhhhccccc--cccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCC
Confidence 999999999999999999999876543322 222345678999999999997665 89999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
|.+....+.+...+...+... ......+|+++.+||.+||++||.+||+..+.|.|+|++
T Consensus 214 f~~~~~~~~~~~~~~~~~~~~------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 214 FTGDSPVSVAYQHVREDPIPP------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCCSSHHHHHHHHHHCCCCCG------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHhcCCCCC------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999988888887777654332 122356789999999999999999999544444566654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=425.51 Aligned_cols=261 Identities=23% Similarity=0.378 Sum_probs=216.3
Q ss_pred CCCCCeEEEee-eeecCceEEEEEEEcCC--CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 26 NTEDQYEVREV-IGFGATAVVHSAYCKAR--AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 26 ~~~~~Y~i~~~-LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
...++|.+.+. ||+|+||+||+|.++.+ +..||||+++ ........+++.+|+.+
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~----------------------~~~~~~~~~~~~~E~~i 62 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK----------------------QGTEKADTEEMMREAQI 62 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEEC----------------------SSCCHHHHHHHHHHHHH
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEC----------------------hhcCHHHHHHHHHHHHH
Confidence 45678999995 99999999999987654 3356666553 33334456789999999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
|++++|||||++++++.. +.+|+||||++||+|.+++.. ..+.+++..+..++.||+.||.|||++||+|||
T Consensus 63 l~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrD 134 (285)
T d1u59a_ 63 MHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG-------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 134 (285)
T ss_dssp HHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTT-------CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhc-------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCc
Confidence 999999999999998864 568999999999999999853 456799999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTA 261 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~ 261 (520)
|||+|||++.++.+||+|||+|+.+..... .........||+.|||||++.+.. |+.++|||||||++|||+| |+.
T Consensus 135 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~ 211 (285)
T d1u59a_ 135 LAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQK 211 (285)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECTTCSC--EECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CchhheeeccCCceeeccchhhhccccccc--ccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCC
Confidence 999999999999999999999988754332 122233567899999999997665 8999999999999999998 999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh---cCcccc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL---KNPFFK 328 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL---~hp~~~ 328 (520)
||.+....+....+..+..+..+ ..+++++.+||.+||+.||++|||+.+++ +|+|+.
T Consensus 212 Pf~~~~~~~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 212 PYKKMKGPEVMAFIEQGKRMECP---------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TTTTCCTHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCCC---------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99988887777766666554433 35788999999999999999999999984 566553
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=434.41 Aligned_cols=274 Identities=23% Similarity=0.363 Sum_probs=216.2
Q ss_pred CCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 21 SVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 21 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
..-|....++|++.++||+|+||+||+|.+..+++..+ ...||+|.+...........+.+|+
T Consensus 29 ~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~ 91 (325)
T d1rjba_ 29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGV-----------------SIQVAVKMLKEKADSSEREALMSEL 91 (325)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSC-----------------EEEEEEEEECC------CHHHHHHH
T ss_pred CccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccc-----------------eeEEEEEEeccccCHHHHHHHHHHH
Confidence 34577788999999999999999999999887654211 1123444443333334456789999
Q ss_pred HHHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc---------------cCCCCCCCHHHHHHHHH
Q psy11359 101 QAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS---------------NCKHGVCDEPTIATVLR 164 (520)
Q Consensus 101 ~~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~---------------~~~~~~l~~~~i~~i~~ 164 (520)
.+|+++ +|||||++++++.+.+.+|+|||||+||+|.++++...... ....+.+++..++.++.
T Consensus 92 ~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 171 (325)
T d1rjba_ 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 171 (325)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHH
T ss_pred HHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHH
Confidence 999998 89999999999999999999999999999999997542110 01234689999999999
Q ss_pred HHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcch
Q psy11359 165 EVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKA 244 (520)
Q Consensus 165 qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~ 244 (520)
||+.||.|||++|||||||||+|||++.++.+||+|||+|+....... .....+..||+.|||||++.+.. |+.++
T Consensus 172 qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~-~~~~~ 247 (325)
T d1rjba_ 172 QVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN---YVVRGNARLPVKWMAPESLFEGI-YTIKS 247 (325)
T ss_dssp HHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT---SEEETTEEECGGGCCHHHHHHCC-CCHHH
T ss_pred HHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCc---eeeeccccCCCccCChHHHcCCC-CCcce
Confidence 999999999999999999999999999999999999999987644322 12233567899999999998765 99999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC-CCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 245 DIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQNDP-PTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 245 DIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
|||||||++|||+| |.+||.+.+....+...+.... +.. ...+++++++||.+||+.||++|||++||+
T Consensus 248 DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 248 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ---------PFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred eccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC---------CCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 99999999999998 8999998777666665555432 211 135688999999999999999999999999
Q ss_pred cC
Q psy11359 323 KN 324 (520)
Q Consensus 323 ~h 324 (520)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-54 Score=422.81 Aligned_cols=257 Identities=22% Similarity=0.364 Sum_probs=209.5
Q ss_pred eEEE-eeeeecCceEEEEEEEcC--CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 31 YEVR-EVIGFGATAVVHSAYCKA--RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 31 Y~i~-~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
+.+. ++||+|+||+||+|.+.. +++.||||+++... ......+++.+|+.+|++++
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---------------------~~~~~~~~~~~E~~il~~l~ 66 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------------------NDPALKDELLAEANVMQQLD 66 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------------------------CHHHHHHHHHHHHHHTCC
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh---------------------CCHHHHHHHHHHHHHHHhCC
Confidence 4444 479999999999998654 45667777664211 11234567999999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||||++++++.. +..||||||+++|+|.++++. .+.+++..+..|+.||+.||.|||++||+||||||+|
T Consensus 67 HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~--------~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~N 137 (277)
T d1xbba_ 67 NPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ--------NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 137 (277)
T ss_dssp CTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH--------CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhh--------ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchh
Confidence 9999999999864 567899999999999999974 5679999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKY 266 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~ 266 (520)
||++.+|.+||+|||+++.+..... .........||+.|||||++.+.. |+.++|||||||++|||+| |++||.+.
T Consensus 138 ill~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 138 VLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp EEEEETTEEEECCCTTCEECCTTCS--EEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred hcccccCcccccchhhhhhcccccc--ccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCC
Confidence 9999999999999999987654332 122233467999999999998765 8999999999999999998 89999998
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH---hcCccccc
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL---LKNPFFKK 329 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el---L~hp~~~~ 329 (520)
...+....+..+.++..+ ..+++++.+||.+||+.||.+|||++++ |+|+|++.
T Consensus 215 ~~~~~~~~i~~~~~~~~p---------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 215 KGSEVTAMLEKGERMGCP---------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCC---------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 888777776666554443 3568899999999999999999999998 45666543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-54 Score=427.10 Aligned_cols=270 Identities=25% Similarity=0.362 Sum_probs=212.7
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCC-CceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhc
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKAR-AEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSS 105 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~ 105 (520)
..++|++++.||+|+||+||+|++..+ ++.||||+++..... ......+.+|+.+|+.
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~---------------------~~~~~~~~~E~~~l~~ 63 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE---------------------EGMPLSTIREVAVLRH 63 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT---------------------TSCBCTHHHHHHHHHH
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc---------------------chHHHHHHHHHHHHHH
Confidence 457999999999999999999999766 567888887532110 0111235567776665
Q ss_pred C---CCCCceEEEEEEEE-----CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy11359 106 C---HHENVVTYHTSFVV-----KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG 177 (520)
Q Consensus 106 l---~HpnIv~~~~~~~~-----~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g 177 (520)
| +||||++++++|.. ...++++|||+.++.+...... ....+++..++.++.||+.||+|||++|
T Consensus 64 l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~aL~yLH~~~ 136 (305)
T d1blxa_ 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-------PEPGVPTETIKDMMFQLLRGLDFLHSHR 136 (305)
T ss_dssp HHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHS-------CTTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5 89999999999864 2468999999988766554432 5677999999999999999999999999
Q ss_pred cEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHH
Q psy11359 178 QIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMA 257 (520)
Q Consensus 178 iiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ell 257 (520)
|+||||||+|||++.+|.+||+|||++..... ........||+.|||||++.+.. |+.++||||+||++|+|+
T Consensus 137 ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~------~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell 209 (305)
T d1blxa_ 137 VVHRDLKPQNILVTSSGQIKLADFGLARIYSF------QMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMF 209 (305)
T ss_dssp CCCCCCCGGGEEECTTCCEEECSCCSCCCCCG------GGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHH
T ss_pred EEecCCCccEEEEcCCCCeeecchhhhhhhcc------cccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHH
Confidence 99999999999999999999999999875432 23345678999999999997765 999999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhcCC--CCC--C-------------CCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 258 TGTAPYHKYPAMKVLMLTLQND--PPT--L-------------DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 258 tG~~Pf~~~~~~~~~~~~~~~~--~~~--~-------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
||++||.+....+.+..+.... +.. . ............+++.+.+||.+||++||++|||+.|
T Consensus 210 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e 289 (305)
T d1blxa_ 210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289 (305)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 9999999888777765543211 000 0 0001111223457889999999999999999999999
Q ss_pred HhcCccccccc
Q psy11359 321 LLKNPFFKKAK 331 (520)
Q Consensus 321 lL~hp~~~~~~ 331 (520)
+|+||||+...
T Consensus 290 ~L~Hpff~~i~ 300 (305)
T d1blxa_ 290 ALSHPYFQDLE 300 (305)
T ss_dssp HHTSGGGTTCC
T ss_pred HhcChhhcCch
Confidence 99999998654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-54 Score=418.69 Aligned_cols=251 Identities=24% Similarity=0.436 Sum_probs=204.1
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.+. ++..||||+++.. ....+++.+|++++++++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~------------------------~~~~~~~~~E~~~l~~l~ 58 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG------------------------AMSEEDFIEEAEVMMKLS 58 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS------------------------SSCHHHHHHHHHHHHHCC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC------------------------cCcHHHHHHHHHHHHhcC
Confidence 357999999999999999999986 4566788766421 223467999999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||||++++++..++.+|+||||+.+|+|.+++.. ....+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 59 HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~N 131 (263)
T d1sm2a_ 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-------QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 131 (263)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT-------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGG
T ss_pred CCCcccccceeccCCceEEEEEecCCCcHHHHhhc-------cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhh
Confidence 99999999999999999999999999999999875 45678999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKY 266 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~ 266 (520)
||++.++.+||+|||+++.+..... .......||+.|||||++.+.. |+.++|||||||++|||+| |.+||...
T Consensus 132 ill~~~~~~Kl~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 132 CLVGENQVIKVSDFGMTRFVLDDQY----TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp EEECGGGCEEECSCC----------------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred eeecCCCCeEecccchheeccCCCc----eeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999987643322 1223467999999999998765 9999999999999999999 57778777
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
...+.+..+..+..+..+ ..+++++.+||.+||++||++|||++|+++|
T Consensus 207 ~~~~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 207 SNSEVVEDISTGFRLYKP---------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CHHHHHHHHHHTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCc---------cccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 777777666665444332 3457889999999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=426.26 Aligned_cols=277 Identities=25% Similarity=0.323 Sum_probs=216.7
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
+.....++|++++.||+|+||+||+|.++.+|+.||||++..... .......+.+|+.+
T Consensus 4 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---------------------~~~~~~~~~~E~~i 62 (318)
T d3blha1 4 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---------------------KEGFPITALREIKI 62 (318)
T ss_dssp TTSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C---------------------TTSSCHHHHHHHHH
T ss_pred CCCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---------------------chHHHHHHHHHHHH
Confidence 445567999999999999999999999999999999998753211 02234568899999
Q ss_pred HhcCCCCCceEEEEEEEE--------CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 103 MSSCHHENVVTYHTSFVV--------KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~--------~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
|++++||||+++++++.. +..+|+||||+.++.+..+.. ....+++..++.+++||+.||.|||
T Consensus 63 l~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~--------~~~~~~~~~~~~i~~qil~~l~~lH 134 (318)
T d3blha1 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--------VLVKFTLSEIKRVMQMLLNGLYYIH 134 (318)
T ss_dssp HHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTC--------TTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhh--------cccccccHHHHHHHHHHHHHHHHhc
Confidence 999999999999999864 346899999997765554332 4567899999999999999999999
Q ss_pred HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 175 ~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
++||+||||||+|||++.++.+||+|||++..+...... ......+.+||+.|+|||++.+...|++++|||||||++|
T Consensus 135 ~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~ 213 (318)
T d3blha1 135 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS-QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 213 (318)
T ss_dssp HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred cCCEEecCcCchheeecCCCcEEeeecceeeeccccccc-ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceee
Confidence 999999999999999999999999999999876533222 2233445689999999999987767999999999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHhc---CCCCCCCCC-------------------chhhhhHHHhcHHHHHHHHhhhccCC
Q psy11359 255 EMATGTAPYHKYPAMKVLMLTLQ---NDPPTLDTG-------------------AAEKDQYKAYGKTFRKMISDCLQKDP 312 (520)
Q Consensus 255 elltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~~L~~dP 312 (520)
+|++|++||.+......+..... ..++..... ....-.....++.+++||.+||++||
T Consensus 214 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 293 (318)
T d3blha1 214 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 293 (318)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSST
T ss_pred eHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCCh
Confidence 99999999988777665543322 111111100 00011112347789999999999999
Q ss_pred CCCCCHHHHhcCccccc
Q psy11359 313 TKRPTASELLKNPFFKK 329 (520)
Q Consensus 313 ~~Rpta~elL~hp~~~~ 329 (520)
++|||+.|+|+||||+.
T Consensus 294 ~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 294 AQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTSCCHHHHHHSGGGSS
T ss_pred hHCcCHHHHHcChhhcc
Confidence 99999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=412.84 Aligned_cols=250 Identities=22% Similarity=0.390 Sum_probs=216.4
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++.++||+|+||+||+|+++ +++.||||+++.. ....+++.+|+.++++++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~------------------------~~~~~~~~~Ev~~~~~l~H 58 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG------------------------SMSEDEFIEEAKVMMNLSH 58 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESS------------------------SSCHHHHHHHHHHHHTCCC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcC------------------------cCCHHHHHHHHHHHHhcCC
Confidence 67999999999999999999985 6677888876532 2234579999999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||+++++++.+++.+++||||+++|+|.+++.. ....+++..+.+++.||++||.|||++||+||||||+||
T Consensus 59 pnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~-------~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Ni 131 (258)
T d1k2pa_ 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-------MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 131 (258)
T ss_dssp TTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHS-------GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGE
T ss_pred CceeeEEEEEeeCCceEEEEEccCCCcHHHhhhc-------cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeE
Confidence 9999999999999999999999999999999875 345788999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHKYP 267 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~~~ 267 (520)
|++.++.+||+|||++..+...... ......||+.|+|||++.+.. |+.++|||||||++|||+| |+.||.+..
T Consensus 132 ll~~~~~~kl~DfG~a~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 132 LVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp EECTTCCEEECCCSSCCBCSSSSCC----CCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred EEcCCCcEEECcchhheeccCCCce----eecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 9999999999999999876443221 223467999999999998766 8999999999999999998 899999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 268 AMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
..+....+..+.....+ ..+++++.+||.+||++||++|||+.++++|
T Consensus 207 ~~~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 207 NSETAEHIAQGLRLYRP---------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCc---------ccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 88887777665444333 3467889999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=416.38 Aligned_cols=258 Identities=21% Similarity=0.370 Sum_probs=208.2
Q ss_pred CCCCCCCCeEEEeeeeecCceEEEEEEEcCCC---ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHH
Q psy11359 23 PWPNTEDQYEVREVIGFGATAVVHSAYCKARA---EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKE 99 (520)
Q Consensus 23 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~E 99 (520)
.|....++|++.+.||+|+||+||+|.+..++ ..||+|.+ .........+.+.+|
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~----------------------~~~~~~~~~~~~~~E 58 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC----------------------KNCTSDSVREKFLQE 58 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEEC----------------------TTTTSHHHHHHHHHH
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEe----------------------ccccCHHHHHHHHHH
Confidence 37778899999999999999999999987653 23555543 333334456789999
Q ss_pred HHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11359 100 IQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQI 179 (520)
Q Consensus 100 i~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gii 179 (520)
+.+|++++|||||++++++. ++.+|+||||+.+|+|.+++.. ..+.+++..+..++.||++||.|||++||+
T Consensus 59 ~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~-------~~~~l~~~~~~~~~~qi~~gl~ylH~~~ii 130 (273)
T d1mp8a_ 59 ALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV-------RKYSLDLASLILYAYQLSTALAYLESKRFV 130 (273)
T ss_dssp HHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH-------TTTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhc-------cCCCCCHHHHHHHHHHHHHHhhhhcccCee
Confidence 99999999999999999985 5678999999999999999875 456799999999999999999999999999
Q ss_pred ecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-
Q psy11359 180 HRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT- 258 (520)
Q Consensus 180 HrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt- 258 (520)
||||||+||+++.++.+||+|||+|+.+..... .......||+.|+|||++.+.. |+.++|||||||++|||+|
T Consensus 131 HrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~----~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~ 205 (273)
T d1mp8a_ 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY----YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMH 205 (273)
T ss_dssp CSCCSGGGEEEEETTEEEECC-----------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTT
T ss_pred ccccchhheeecCCCcEEEccchhheeccCCcc----eeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhc
Confidence 999999999999999999999999987643221 1223457899999999998665 9999999999999999998
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 259 GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 259 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|.+||......+....+..+..+.++ ..+|+.+.+||.+||+.||.+|||+.|+++|
T Consensus 206 g~~P~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 206 GVKPFQGVKNNDVIGRIENGERLPMP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp SCCTTTTCCGGGHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999998888888777766554433 4578899999999999999999999999876
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-53 Score=428.76 Aligned_cols=266 Identities=25% Similarity=0.322 Sum_probs=213.1
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.-+|+.+++||+|+||+||+|+++.+|+.||||+++... ....+|+.+|++|+
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---------------------------~~~~~Ei~il~~l~ 71 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---------------------------RFKNRELQIMRKLD 71 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---------------------------SSCCHHHHHHHHCC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc---------------------------hHHHHHHHHHHhcC
Confidence 347999999999999999999999999999999875320 01346999999999
Q ss_pred CCCceEEEEEEEEC------CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 108 HENVVTYHTSFVVK------DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 108 HpnIv~~~~~~~~~------~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
||||++++++|... ..+||||||+.++ +.+.+..... ....+++.+++.|++||+.||+|||++||+||
T Consensus 72 h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~----~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHr 146 (350)
T d1q5ka_ 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSR----AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 146 (350)
T ss_dssp CTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred CCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhh----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Confidence 99999999998643 3589999999655 5444443222 45679999999999999999999999999999
Q ss_pred ccCCCcEEEcCCC-CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 182 DIKAGNILLGEDG-TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 182 DLKp~NILl~~~g-~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
||||+|||++.++ .+||+|||++..+... ....+.+||+.|+|||.+.+...|+.++||||+||++|||++|+
T Consensus 147 DiKp~NILl~~~~~~~kl~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~ 220 (350)
T d1q5ka_ 147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220 (350)
T ss_dssp CCCGGGEEECTTTCCEEECCCTTCEECCTT------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTS
T ss_pred CCCcceEEEecCCCceeEecccchhhccCC------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCC
Confidence 9999999998775 8999999999876432 22345689999999999887767999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcC--C-----------------CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH
Q psy11359 261 APYHKYPAMKVLMLTLQN--D-----------------PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~--~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el 321 (520)
+||......+.+..+... . .+..............+++++.+||.+||++||.+|||+.|+
T Consensus 221 ~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 300 (350)
T d1q5ka_ 221 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300 (350)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 999988877666554321 0 011111111112234578899999999999999999999999
Q ss_pred hcCccccccc
Q psy11359 322 LKNPFFKKAK 331 (520)
Q Consensus 322 L~hp~~~~~~ 331 (520)
|+||||+...
T Consensus 301 L~Hp~f~~~~ 310 (350)
T d1q5ka_ 301 CAHSFFDELR 310 (350)
T ss_dssp HTSGGGGGGG
T ss_pred hcCHhhcccc
Confidence 9999998653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-53 Score=428.87 Aligned_cols=266 Identities=27% Similarity=0.390 Sum_probs=212.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|+++++||+|+||+||+|.++.+|+.||||+++.... .....+.+.+|+++|+++
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---------------------~~~~~~~~~~Ei~il~~l 74 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ---------------------SELFAKRAYRELRLLKHM 74 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS---------------------SHHHHHHHHHHHHHHHHC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc---------------------ChHHHHHHHHHHHHHHhc
Confidence 46799999999999999999999999999999998753211 123456789999999999
Q ss_pred CCCCceEEEEEEEECC------EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 107 HHENVVTYHTSFVVKD------ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~------~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
+|||||+++++|...+ .+|+||||+ |.+|..+++. +.+++..++.+++||+.||.|||++||+|
T Consensus 75 ~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~~IiH 144 (346)
T d1cm8a_ 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---------EKLGEDRIQFLVYQMLKGLRYIHAAGIIH 144 (346)
T ss_dssp CBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh---------ccccHHHHHHHHHHHHHHHHHHHhCCCcc
Confidence 9999999999998654 579999999 7788888753 56999999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCC
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGT 260 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~ 260 (520)
|||||+|||++.++.+||+|||+|..... .....+||+.|+|||++.+...++.++||||+||++|+|++|.
T Consensus 145 rDiKp~NIL~~~~~~~kl~Dfg~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~ 216 (346)
T d1cm8a_ 145 RDLKPGNLAVNEDCELKILDFGLARQADS--------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216 (346)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCS--------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred cccCcchhhcccccccccccccceeccCC--------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCc
Confidence 99999999999999999999999976532 1245689999999999987666899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCCCCC---------------------CCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHH
Q psy11359 261 APYHKYPAMKVLMLTLQNDPPTL---------------------DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTAS 319 (520)
Q Consensus 261 ~Pf~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 319 (520)
+||.+......+........... ............+++.+.+||.+||.+||.+|||+.
T Consensus 217 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 296 (346)
T d1cm8a_ 217 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296 (346)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 99998877665543322111000 000011122345688999999999999999999999
Q ss_pred HHhcCccccccc
Q psy11359 320 ELLKNPFFKKAK 331 (520)
Q Consensus 320 elL~hp~~~~~~ 331 (520)
|+|+||||+...
T Consensus 297 eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 297 EALAHPYFESLH 308 (346)
T ss_dssp HHHHSGGGTTTC
T ss_pred HHhcChhhCcCC
Confidence 999999998654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-53 Score=422.53 Aligned_cols=260 Identities=24% Similarity=0.370 Sum_probs=211.6
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|+++++||+|+||+||+|.+..+|+.+|+| ||+|++.........+++.+|+.+|+++
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~------------------vavK~~~~~~~~~~~~~~~~E~~~l~~l 68 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP------------------VAIKELREATSPKANKEILDEAYVMASV 68 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEE------------------EEEEEECC----CTHHHHHHHHHHHHHC
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEE------------------EEEEEeccccCHHHHHHHHHHHHHHHhC
Confidence 3467999999999999999999999988766555 4566655444445677899999999999
Q ss_pred CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 107 HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
+|||||++++++.+ +..+++|||+.+|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+
T Consensus 69 ~HpnIv~l~g~~~~-~~~~~v~e~~~~~~l~~~~~~-------~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~ 140 (317)
T d1xkka_ 69 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE-------HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 140 (317)
T ss_dssp CCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHHH-------TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CCCCEeeEEEEEec-CCeeEEEEeccCCcccccccc-------cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhh
Confidence 99999999999876 456788999999999999876 5678999999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy11359 187 NILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTAPYHK 265 (520)
Q Consensus 187 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~Pf~~ 265 (520)
|||++.++.+||+|||+|+.+..... ........||+.|||||++.+.. |+.++|||||||++|||+| |.+||.+
T Consensus 141 NIll~~~~~~kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 141 NVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp GEEEEETTEEEECCCSHHHHTTTTCC-----------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cceeCCCCCeEeeccccceecccccc---cccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999987644322 12223457899999999998765 9999999999999999998 8999998
Q ss_pred CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCc
Q psy11359 266 YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNP 325 (520)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp 325 (520)
.+..+....+..+..+..+ ..+++.+.+||.+||+.||.+|||+.|+++|.
T Consensus 217 ~~~~~~~~~i~~~~~~~~p---------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 217 IPASEISSILEKGERLPQP---------PICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp SCGGGHHHHHHHTCCCCCC---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCC---------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 8777766666555544332 35678899999999999999999999999873
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=412.02 Aligned_cols=268 Identities=24% Similarity=0.356 Sum_probs=219.3
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCCC
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~H 108 (520)
++|++++.||+|+||+||+|.+..+|+.||||+++... ......+++.+|+.+|+.++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---------------------~~~~~~~~~~~E~~il~~l~h 60 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---------------------DDEGVPSSALREICLLKELKH 60 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---------------------SSTTHHHHHHHHHHHHTTCCC
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh---------------------CChHHHHHHHHHHHHHHhcCc
Confidence 68999999999999999999999999999999875321 112346778999999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
|||++++++|.....+++||+++.|++|..++. ..+.+++..++.++.|++.||+|||++||+||||||+||
T Consensus 61 ~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~--------~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NI 132 (292)
T d1unla_ 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--------CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132 (292)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH--------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCEEeeccccccccceeEEeeeccccccccccc--------cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccc
Confidence 999999999999999999999999999888876 567889999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCC-CCc
Q psy11359 189 LLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYH-KYP 267 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~-~~~ 267 (520)
|++.++.+||+|||.+........ ......+++.|+|||++.+...++.++|||||||++|+|++|..||. +.+
T Consensus 133 li~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 207 (292)
T d1unla_ 133 LINRNGELKLANFGLARAFGIPVR-----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_dssp EECTTCCEEECCCTTCEECCSCCS-----CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred ccccCCceeeeecchhhcccCCCc-----cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC
Confidence 999999999999999987653322 22345678999999999877768999999999999999999998864 444
Q ss_pred HHHHHHHHhc--CCCC-----------------CCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccc
Q psy11359 268 AMKVLMLTLQ--NDPP-----------------TLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFK 328 (520)
Q Consensus 268 ~~~~~~~~~~--~~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~ 328 (520)
..+.+..... ..+. ..............+++.+++||.+||++||.+||||+|+|+||||+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~ 287 (292)
T d1unla_ 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp HHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred HHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence 3433332211 1110 00111111223346788999999999999999999999999999998
Q ss_pred cc
Q psy11359 329 KA 330 (520)
Q Consensus 329 ~~ 330 (520)
..
T Consensus 288 ~~ 289 (292)
T d1unla_ 288 DF 289 (292)
T ss_dssp SC
T ss_pred CC
Confidence 54
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-52 Score=421.16 Aligned_cols=267 Identities=21% Similarity=0.348 Sum_probs=213.3
Q ss_pred CCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 21 SVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 21 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
.+.|. ..++|+++++||+|+||+||+|+++.+|+.||||+++. ...+++.+|+
T Consensus 28 ~~~~~-~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~--------------------------~~~~~~~~Ei 80 (328)
T d3bqca1 28 VVEWG-NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------------------------VKKKKIKREI 80 (328)
T ss_dssp CCCCC-CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--------------------------SCHHHHHHHH
T ss_pred ccCCC-CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH--------------------------HHHHHHHHHH
Confidence 44454 45789999999999999999999999999999998742 1235688999
Q ss_pred HHHhcCC-CCCceEEEEEEEE--CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy11359 101 QAMSSCH-HENVVTYHTSFVV--KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNG 177 (520)
Q Consensus 101 ~~l~~l~-HpnIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~g 177 (520)
.+|++++ ||||++++++|.. ...+++||||+.+++|..+ .+.+++..++.+++||+.||.|||++|
T Consensus 81 ~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~-----------~~~l~e~~i~~i~~qil~aL~~LH~~g 149 (328)
T d3bqca1 81 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL-----------YQTLTDYDIRFYMYEILKALDYCHSMG 149 (328)
T ss_dssp HHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGT-----------TTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHhhcc
Confidence 9999995 9999999999985 4569999999999998654 346899999999999999999999999
Q ss_pred cEecccCCCcEEEcCCC-CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHH
Q psy11359 178 QIHRDIKAGNILLGEDG-TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEM 256 (520)
Q Consensus 178 iiHrDLKp~NILl~~~g-~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~el 256 (520)
|+||||||+|||++.++ .+||+|||+|..+.... .....+||+.|+|||.+.+...|+.++||||+||++|+|
T Consensus 150 IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~ 223 (328)
T d3bqca1 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 223 (328)
T ss_dssp EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccccccceEEcCCCCeeeecccccceeccCCC------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHh
Confidence 99999999999998655 69999999998765432 234568999999999998877789999999999999999
Q ss_pred HhCCCCCCCCcHH-HHHHHHhc-------------CCC--------------CCCCCCchhhhhHHHhcHHHHHHHHhhh
Q psy11359 257 ATGTAPYHKYPAM-KVLMLTLQ-------------NDP--------------PTLDTGAAEKDQYKAYGKTFRKMISDCL 308 (520)
Q Consensus 257 ltG~~Pf~~~~~~-~~~~~~~~-------------~~~--------------~~~~~~~~~~~~~~~~~~~~~~li~~~L 308 (520)
++|..||...... ........ ... ...............+++++++||.+||
T Consensus 224 ~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL 303 (328)
T d3bqca1 224 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303 (328)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHS
T ss_pred ccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHc
Confidence 9999999754432 11111100 000 0000000111233457899999999999
Q ss_pred ccCCCCCCCHHHHhcCccccccc
Q psy11359 309 QKDPTKRPTASELLKNPFFKKAK 331 (520)
Q Consensus 309 ~~dP~~Rpta~elL~hp~~~~~~ 331 (520)
++||.+|||++|+|+||||+...
T Consensus 304 ~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 304 RYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999998653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=409.63 Aligned_cols=259 Identities=21% Similarity=0.339 Sum_probs=202.8
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
-+.|++.++||+|+||+||+|..+.++... ...||+|+++.........++.+|+.+|++|+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~------------------~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~ 67 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKK------------------EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CC------------------EEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEE------------------EEEEEEEEECcccChHHHHHHHHHHHHHHhcC
Confidence 357999999999999999999987764210 12344444444333445667999999999999
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCc
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGN 187 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~N 187 (520)
|||||++++++...+.+++||||+.+++|.+++.. ..+.+++..+..++.||+.||+|||++||+||||||+|
T Consensus 68 H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~-------~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~N 140 (283)
T d1mqba_ 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-------KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN 140 (283)
T ss_dssp CTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH-------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred CCCEeeeeEEEecCCceEEEEEecccCcchhhhhc-------ccccccHHHHHHHHHHHHHhhhhccccccccCccccce
Confidence 99999999999999999999999999999998875 45679999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC-CCCCCCC
Q psy11359 188 ILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG-TAPYHKY 266 (520)
Q Consensus 188 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG-~~Pf~~~ 266 (520)
|||+.++.+||+|||+++.+...... ........||+.|||||++.+.. |+.++|||||||++|||+|| .+||...
T Consensus 141 ILl~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~ 217 (283)
T d1mqba_ 141 ILVNSNLVCKVSDFGLSRVLEDDPEA--TYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWEL 217 (283)
T ss_dssp EEECTTCCEEECCCCC-------------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEECCCCeEEEcccchhhcccCCCcc--ceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccC
Confidence 99999999999999999876543221 12233457899999999997765 99999999999999999995 5556666
Q ss_pred cHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 267 PAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
...+.+..+..+..+..+ ..++..+.+||.+||+.||++|||+.|+++
T Consensus 218 ~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 218 SNHEVMKAINDGFRLPTP---------MDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CHHHHHHHHHTTCCCCCC---------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHhccCCCCCc---------hhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 666666555554433332 346788999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-52 Score=421.44 Aligned_cols=271 Identities=26% Similarity=0.395 Sum_probs=213.9
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
..++|++++.||+|+||+||+|.++.+|+.||||+++.. ......+.+.+|+.+|++|
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----------------------~~~~~~~~~~~Ei~il~~l 63 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----------------------EHQTYCQRTLREIKILLRF 63 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT----------------------TCHHHHHHHHHHHHHHHHC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh----------------------cChHHHHHHHHHHHHHHHc
Confidence 346799999999999999999999999988888877532 1233456789999999999
Q ss_pred CCCCceEEEEEEEECC-----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 107 HHENVVTYHTSFVVKD-----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 107 ~HpnIv~~~~~~~~~~-----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
+||||+++++++.... .+|++ +|+.||+|.++++. +.+++..++.++.||+.||+|||++|||||
T Consensus 64 ~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~---------~~l~~~~i~~i~~qil~al~yLH~~~iiHR 133 (345)
T d1pmea_ 64 RHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKT---------QHLSNDHICYFLYQILRGLKYIHSANVLHR 133 (345)
T ss_dssp CCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred CCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence 9999999999987543 34555 55669999999964 368999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||++.+|.+||+|||++........ ........+||+.|+|||++.....|+.++||||+||++|+|++|++
T Consensus 134 DIKp~NILl~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~ 211 (345)
T d1pmea_ 134 DLKPSNLLLNTTCDLKICDFGLARVADPDHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 211 (345)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCGGGC--BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCcceEEECCCCCEEEcccCceeeccCCCc--cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCC
Confidence 9999999999999999999999987644322 22234557899999999998776668999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCC---------------------CCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHH
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPT---------------------LDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASE 320 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 320 (520)
||................... .............+++++++||.+||++||.+|||+.|
T Consensus 212 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e 291 (345)
T d1pmea_ 212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291 (345)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 998876655543332110000 00001112233456789999999999999999999999
Q ss_pred HhcCccccccc
Q psy11359 321 LLKNPFFKKAK 331 (520)
Q Consensus 321 lL~hp~~~~~~ 331 (520)
+|+||||+...
T Consensus 292 ~L~hpf~~~~~ 302 (345)
T d1pmea_ 292 ALAHPYLEQYY 302 (345)
T ss_dssp HHTSGGGTTTC
T ss_pred HhcCHhhccCC
Confidence 99999998543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=412.14 Aligned_cols=264 Identities=24% Similarity=0.429 Sum_probs=213.0
Q ss_pred CCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 21 SVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 21 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
.-.|....++|++.+.||+|+||+||+|.++.+ ..||||+++.. ....+.+.+|+
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~------------------------~~~~~~~~~E~ 63 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG------------------------TMSPEAFLQEA 63 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT------------------------SSCHHHHHHHH
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc------------------------cCCHHHHHHHH
Confidence 446888889999999999999999999998765 45777776422 22346799999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIH 180 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiH 180 (520)
.+|++++|||||++++++. .+.+|+||||+.+|+|..++... ..+.+++.++..++.||+.||.|||++||+|
T Consensus 64 ~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~------~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH 136 (285)
T d1fmka3 64 QVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE------TGKYLRLPQLVDMAAQIASGMAYVERMNYVH 136 (285)
T ss_dssp HHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHH------HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhc------ccccchHHHHHHHHHHHHHHHHHHhhhheec
Confidence 9999999999999999985 56689999999999999998654 2356899999999999999999999999999
Q ss_pred cccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC-
Q psy11359 181 RDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG- 259 (520)
Q Consensus 181 rDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG- 259 (520)
|||||+||||+.++.+||+|||+++.+..... .......||+.|+|||++.... ++.++|||||||++|||+||
T Consensus 137 ~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~ 211 (285)
T d1fmka3 137 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKG 211 (285)
T ss_dssp SCCSGGGEEECGGGCEEECCCCTTC------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTT
T ss_pred ccccceEEEECCCCcEEEcccchhhhccCCCc----eeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCC
Confidence 99999999999999999999999986643321 2233457999999999998765 89999999999999999995
Q ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc--Ccccccc
Q psy11359 260 TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK--NPFFKKA 330 (520)
Q Consensus 260 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~--hp~~~~~ 330 (520)
.+||......+.+..+..+.....+ ..+++++++||.+||+.||++|||+++++. ++||...
T Consensus 212 ~p~~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 212 RVPYPGMVNREVLDQVERGYRMPCP---------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCC---------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 5566666666666665555433332 356889999999999999999999999987 7788643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=417.02 Aligned_cols=267 Identities=27% Similarity=0.421 Sum_probs=216.2
Q ss_pred CCCCeEEEeeeeecCceEEEEEEEc---CCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 27 TEDQYEVREVIGFGATAVVHSAYCK---ARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 27 ~~~~Y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
.-++|++++.||+|+||+||+|++. .+|+.||+|+++.... .+ .....+.+.+|+++|
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~-------------~~------~~~~~~~~~~E~~il 82 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI-------------VQ------KAKTTEHTRTERQVL 82 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEE-------------EE------EESSGGGCCCHHHHH
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHh-------------cc------chHHHHHHHHHHHHH
Confidence 3478999999999999999999884 4688899998753211 00 012234578899999
Q ss_pred hcCCC-CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 104 SSCHH-ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 104 ~~l~H-pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
++++| |||+++++++.+...+++||||+.||+|.+++.. .+.+++..++.++.||+.||+|||++||+|||
T Consensus 83 ~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~--------~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrD 154 (322)
T d1vzoa_ 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ--------RERFTEHEVQIYVGEIVLALEHLHKLGIIYRD 154 (322)
T ss_dssp HHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH--------HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHh--------cccccHHHHHHHHHHHHHHHHHhhcCCEEecc
Confidence 99966 8999999999999999999999999999999984 45678999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC-CCCcchhHHHHHHHHHHHHhCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH-GYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~DIwSlG~il~elltG~~ 261 (520)
|||+|||++.+|.+||+|||++..+.... .....+..||+.|+|||.+.+.. .++.++|||||||+||+|+||+.
T Consensus 155 iKp~Nill~~~~~vkL~DFG~a~~~~~~~----~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~ 230 (322)
T d1vzoa_ 155 IKLENILLDSNGHVVLTDFGLSKEFVADE----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230 (322)
T ss_dssp CCGGGEEECTTSCEEESCSSEEEECCGGG----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccceeecCCCCEEEeeccchhhhcccc----cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCC
Confidence 99999999999999999999998764322 22234568999999999997543 47889999999999999999999
Q ss_pred CCCCCcHHHH----HHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC-----CHHHHhcCccccccch
Q psy11359 262 PYHKYPAMKV----LMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP-----TASELLKNPFFKKAKD 332 (520)
Q Consensus 262 Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~ 332 (520)
||........ ........+ .+ ...+++++++||.+||++||.+|| |++|+++||||+....
T Consensus 231 PF~~~~~~~~~~~i~~~~~~~~~-~~---------~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 231 PFTVDGEKNSQAEISRRILKSEP-PY---------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp TTSCTTSCCCHHHHHHHHHHCCC-CC---------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred CCCCCCHHHHHHHHHHhcccCCC-CC---------cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 9976543222 222222222 11 135789999999999999999999 5899999999998765
Q ss_pred hh
Q psy11359 333 KK 334 (520)
Q Consensus 333 ~~ 334 (520)
..
T Consensus 301 ~~ 302 (322)
T d1vzoa_ 301 DD 302 (322)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=421.74 Aligned_cols=265 Identities=24% Similarity=0.350 Sum_probs=213.2
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|+++++||+|+||+||+|++..+|+.||||+++.... .....+++.+|+++|++|+
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------------------~~~~~~~~~~Ei~il~~l~ 75 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---------------------SIIHAKRTYRELRLLKHMK 75 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS---------------------SHHHHHHHHHHHHHHHHCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc---------------------ChHHHHHHHHHHHHHHhcC
Confidence 4789999999999999999999999999999998753211 1234567889999999999
Q ss_pred CCCceEEEEEEEEC-----CEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 108 HENVVTYHTSFVVK-----DELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 108 HpnIv~~~~~~~~~-----~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
|||||++++++... ...+++|+|+.||+|.+++. .+.+++..++.+++||+.||+|||++||+|||
T Consensus 76 h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~---------~~~l~e~~~~~i~~qil~aL~~LH~~giiHrD 146 (348)
T d2gfsa1 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---------CQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 146 (348)
T ss_dssp CTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT---------TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc---------cccccHHHHHHHHHHHHHHHHHHHhCCCcccc
Confidence 99999999998743 34566677778999999984 35699999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAP 262 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~P 262 (520)
|||+|||++.+|.+|++|||++.... ....+..||+.|+|||++.+...++.++|||||||++|+|++|.+|
T Consensus 147 iKp~NILi~~~~~~kl~dfg~a~~~~--------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~p 218 (348)
T d2gfsa1 147 LKPSNLAVNEDCELKILDFGLARHTD--------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218 (348)
T ss_dssp CCGGGEEECTTCCEEECCC----CCT--------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCCccccccccccccccccchhcccC--------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCC
Confidence 99999999999999999999986542 2234568999999999988777689999999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCC---------------------CCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH
Q psy11359 263 YHKYPAMKVLMLTLQNDPPTL---------------------DTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL 321 (520)
Q Consensus 263 f~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el 321 (520)
|.+.........+........ .........+..+++++++||.+||++||.+|||+.|+
T Consensus 219 F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el 298 (348)
T d2gfsa1 219 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298 (348)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence 988776655544432211100 00011112234578999999999999999999999999
Q ss_pred hcCcccccc
Q psy11359 322 LKNPFFKKA 330 (520)
Q Consensus 322 L~hp~~~~~ 330 (520)
|+||||++.
T Consensus 299 L~Hp~f~~~ 307 (348)
T d2gfsa1 299 LAHAYFAQY 307 (348)
T ss_dssp HTSGGGTTT
T ss_pred hcCHhhCCC
Confidence 999999865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-52 Score=403.63 Aligned_cols=250 Identities=25% Similarity=0.432 Sum_probs=206.6
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.+.||+|+||+||+|..+ |++||+|+++. ....+.+.+|+.++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~-------------------------~~~~~~~~~E~~~l 54 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-------------------------DATAQAFLAEASVM 54 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCC-------------------------CC--HHHHHTHHHH
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECc-------------------------HHHHHHHHHHHHHH
Confidence 7788899999999999999999999884 66788887642 12345689999999
Q ss_pred hcCCCCCceEEEEEEEE-CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 104 SSCHHENVVTYHTSFVV-KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 104 ~~l~HpnIv~~~~~~~~-~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
++++||||+++++++.+ ++.+|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||+++|+|||
T Consensus 55 ~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~------~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~d 128 (262)
T d1byga_ 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 128 (262)
T ss_dssp TTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcC------CCCCCHHHHHHHHHHHHhhccccccCceeccc
Confidence 99999999999999864 466899999999999999997542 23588999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTA 261 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~ 261 (520)
|||+|||++.+|.+||+|||++..... ......+|+.|+|||++.+.. ++.++|||||||++|||+| |.+
T Consensus 129 lkp~Nil~~~~~~~kl~dfg~s~~~~~--------~~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~ 199 (262)
T d1byga_ 129 LAARNVLVSEDNVAKVSDFGLTKEASS--------TQDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRV 199 (262)
T ss_dssp CSGGGEEECTTSCEEECCCCC--------------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cchHhheecCCCCEeecccccceecCC--------CCccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCC
Confidence 999999999999999999999876432 223457899999999997765 8999999999999999998 799
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
||...+..+....+..+..+.++ ..+++++++||.+||+.||.+|||+.+++++
T Consensus 200 p~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 200 PYPRIPLKDVVPRVEKGYKMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp SCTTSCGGGHHHHHTTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCCC---------ccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 99988887777776665544443 3467889999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=410.04 Aligned_cols=271 Identities=23% Similarity=0.348 Sum_probs=204.0
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.++||+|+||+||+|.+...+...+ ++.||+|.++........+.+.+|..++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~-----------------~~~vAvK~l~~~~~~~~~~~~~~e~~~l 70 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTAT-----------------CRTVAVKMLKEGATHSEHRALMSELKIL 70 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSC-----------------EEEEEEEEC----CHHHHHHHHHHHHHH
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccC-----------------CeEEEEEEEccccCcHHHHHHHHHHHHH
Confidence 56677899999999999999999999876543221 1234444444333344556788888888
Q ss_pred hcC-CCCCceEEEEEEEE-CCEEEEEEEccCCCCHHHHHHHhhccc--------cCCCCCCCHHHHHHHHHHHHHHHHHH
Q psy11359 104 SSC-HHENVVTYHTSFVV-KDELWLVLRLLEGGSLLDIIKHRLKIS--------NCKHGVCDEPTIATVLREVLKGLEYF 173 (520)
Q Consensus 104 ~~l-~HpnIv~~~~~~~~-~~~~~lV~E~~~ggsL~~~i~~~~~~~--------~~~~~~l~~~~i~~i~~qIl~gL~yL 173 (520)
.++ +|+||+.+++++.. +..+++|||||++|+|.++++...... ......+++..+..++.||++||.||
T Consensus 71 ~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl 150 (299)
T d1ywna1 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 150 (299)
T ss_dssp HHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH
T ss_pred HhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH
Confidence 776 78999999998775 456899999999999999998643211 01234689999999999999999999
Q ss_pred HHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHH
Q psy11359 174 HSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITA 253 (520)
Q Consensus 174 H~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il 253 (520)
|++|||||||||+|||++.++.+||+|||+|+....... ........||+.|||||++.+.. |+.++|||||||++
T Consensus 151 H~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil 226 (299)
T d1ywna1 151 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD---YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLL 226 (299)
T ss_dssp HHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTT---SCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred HhCCCcCCcCCccceeECCCCcEEEccCcchhhcccccc---ccccCceeeCccccchhHhhcCC-CCcccceeehHHHH
Confidence 999999999999999999999999999999986643322 12234568999999999998765 89999999999999
Q ss_pred HHHHhC-CCCCCCCcHHHHHHHHh-cCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 254 IEMATG-TAPYHKYPAMKVLMLTL-QNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 254 ~elltG-~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
|||+|| .+||.+......+...+ .+..+..+ ..+++++.+||.+||+.||++|||+.|+++|
T Consensus 227 ~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 227 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999986 57888766555444333 33333222 3467899999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=408.16 Aligned_cols=272 Identities=24% Similarity=0.397 Sum_probs=217.9
Q ss_pred CCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 24 WPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 24 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
|....++|++.+.||+|+||.||+|++..+++...-+ ...||+|+++.........++.+|...+
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~---------------~~~vAvK~~~~~~~~~~~~~~~~e~~~l 72 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR---------------VTKVAVKMLKSDATEKDLSDLISEMEMM 72 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCC---------------EEEEEEECCCTTCCHHHHHHHHHHHHHH
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccC---------------ceEEEEEEECcccChHHHHHHHHHHHHH
Confidence 8888999999999999999999999987764321111 2345555555554455667889999999
Q ss_pred hcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc--------ccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 104 SSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI--------SNCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 104 ~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~--------~~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
.++ +|||||++++++.+++.+|+||||+++|+|.++|..+... .......+++.++..++.||+.||+|||
T Consensus 73 ~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH 152 (299)
T d1fgka_ 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 152 (299)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh
Confidence 888 8999999999999999999999999999999999764321 0113456899999999999999999999
Q ss_pred HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 175 ~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
++|||||||||+|||++.++.+||+|||++........ ........||+.|+|||.+.+.. |+.++|||||||++|
T Consensus 153 ~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ 228 (299)
T d1fgka_ 153 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLW 228 (299)
T ss_dssp HTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCT---TCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHH
T ss_pred hCCEEeeeecccceeecCCCCeEeccchhhcccccccc---ccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHH
Confidence 99999999999999999999999999999987654332 22234567999999999997765 999999999999999
Q ss_pred HHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 255 EMAT-GTAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 255 ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
||+| |.+||...+.......+..+..+..+ ..+++.+.+||.+||++||.+|||+.|+++
T Consensus 229 ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 229 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHcCCCCCCC---------ccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 9998 79999988887777666655544443 346788999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=416.10 Aligned_cols=264 Identities=27% Similarity=0.416 Sum_probs=202.9
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|+++++||+|+||+||+|.++.+|+.||||+++.... ......++.+|+.+|++++
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~---------------------~~~~~~~~~~Ei~il~~l~ 74 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---------------------NQTHAKRAYRELVLMKCVN 74 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS---------------------SHHHHHHHHHHHHHHHHCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc---------------------CHHHHHHHHHHHHHHHhcC
Confidence 3689999999999999999999999999999998753211 1234557899999999999
Q ss_pred CCCceEEEEEEEE------CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy11359 108 HENVVTYHTSFVV------KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHR 181 (520)
Q Consensus 108 HpnIv~~~~~~~~------~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHr 181 (520)
|||||+++++|.. ...+|+||||+.| ++.+.+. +.+++..++.+++||+.||.|||++||+||
T Consensus 75 hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~----------~~~~~~~i~~~~~qil~gl~~LH~~giiHr 143 (355)
T d2b1pa1 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ----------MELDHERMSYLLYQMLCGIKHLHSAGIIHR 143 (355)
T ss_dssp CTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred CCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhh----------cCCCHHHHHHHHHHHHHHHHHhhhcccccc
Confidence 9999999999964 3689999999965 4555442 458999999999999999999999999999
Q ss_pred ccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 182 DIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 182 DLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
||||+|||++.++.+|++|||++...... ......+||+.|+|||++.+.. +++++||||+||++|+|++|++
T Consensus 144 DlKP~Nil~~~~~~~kl~df~~~~~~~~~------~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~ 216 (355)
T d2b1pa1 144 DLKPSNIVVKSDCTLKILDFGLARTAGTS------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_dssp CCCGGGEEECTTCCEEECCCCC---------------------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSC
T ss_pred cCCccccccccccceeeechhhhhccccc------cccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCC
Confidence 99999999999999999999998765432 2234568999999999998754 8999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhc----------------------CCCCCCCCC----------chhhhhHHHhcHHHHHHHHhhhc
Q psy11359 262 PYHKYPAMKVLMLTLQ----------------------NDPPTLDTG----------AAEKDQYKAYGKTFRKMISDCLQ 309 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~----------------------~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~L~ 309 (520)
||.+.........+.. ..+...... ..........++++++||.+||+
T Consensus 217 pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~ 296 (355)
T d2b1pa1 217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296 (355)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCc
Confidence 9987765554433221 111110000 00111234568899999999999
Q ss_pred cCCCCCCCHHHHhcCcccccc
Q psy11359 310 KDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 310 ~dP~~Rpta~elL~hp~~~~~ 330 (520)
+||++||||+|+|+||||+..
T Consensus 297 ~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 297 IDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp SSTTTSCCHHHHHTSTTTGGG
T ss_pred CChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=405.43 Aligned_cols=261 Identities=22% Similarity=0.353 Sum_probs=213.0
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCCCce--EEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHH
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKARAEK--CAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAM 103 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l 103 (520)
..-++|++.++||+|+||+||+|.++.+|.. ||||.+ .........+++.+|+.+|
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~----------------------~~~~~~~~~~~~~~E~~~l 64 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM----------------------KEYASKDDHRDFAGELEVL 64 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEE----------------------ECC------CHHHHHHHHH
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEE----------------------CcccChHHHHHHHHHHHHH
Confidence 4558999999999999999999999988765 444443 2222233456799999999
Q ss_pred hcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhcc--------ccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11359 104 SSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKI--------SNCKHGVCDEPTIATVLREVLKGLEYFH 174 (520)
Q Consensus 104 ~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~--------~~~~~~~l~~~~i~~i~~qIl~gL~yLH 174 (520)
+++ +|||||++++++.+++.+|+||||++||+|.++++..... .......+++..+..++.||+.||.|||
T Consensus 65 ~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH 144 (309)
T d1fvra_ 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 144 (309)
T ss_dssp TTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH
T ss_pred HhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh
Confidence 999 7999999999999999999999999999999999753211 1124578999999999999999999999
Q ss_pred HCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHH
Q psy11359 175 SNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAI 254 (520)
Q Consensus 175 ~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ 254 (520)
++||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||.+.+.. |+.++|||||||++|
T Consensus 145 ~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ 217 (309)
T d1fvra_ 145 QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLW 217 (309)
T ss_dssp HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE------CCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHH
T ss_pred cCCccccccccceEEEcCCCceEEcccccccccccc------ccccceecCCcccchHHhccCC-CCccceeehhHHHHH
Confidence 999999999999999999999999999999755321 1223457899999999997765 899999999999999
Q ss_pred HHHhC-CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 255 EMATG-TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 255 elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
||++| .+||...+..+....+..+..+..+ ..+++++.+||.+||++||++|||+.|++++
T Consensus 218 ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 218 EIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHGGGTCCCCCC---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99996 4678888888777766665444332 3568899999999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-50 Score=403.46 Aligned_cols=264 Identities=20% Similarity=0.296 Sum_probs=215.7
Q ss_pred CCCCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHH
Q psy11359 25 PNTEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKE 99 (520)
Q Consensus 25 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~E 99 (520)
....++|++.+.||+|+||+||+|+.+. +++.||||++ +........+++.+|
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i----------------------~~~~~~~~~~~~~~E 66 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML----------------------KEEASADMQADFQRE 66 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEEC----------------------CTTCCHHHHHHHHHH
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEE----------------------ChhcChHHHHHHHHH
Confidence 3457789999999999999999998764 3445555554 333334456789999
Q ss_pred HHHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc----------------cCCCCCCCHHHHHHHH
Q psy11359 100 IQAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS----------------NCKHGVCDEPTIATVL 163 (520)
Q Consensus 100 i~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~----------------~~~~~~l~~~~i~~i~ 163 (520)
+.+|++++||||+++++++...+..++||||+.+|+|.+++....... ......+++..+..++
T Consensus 67 ~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 146 (301)
T d1lufa_ 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 146 (301)
T ss_dssp HHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHH
T ss_pred HHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHH
Confidence 999999999999999999999999999999999999999997532210 0123458999999999
Q ss_pred HHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcc
Q psy11359 164 REVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFK 243 (520)
Q Consensus 164 ~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 243 (520)
.||+.||+|||++|+|||||||+|||++.++.+||+|||+|..+.... ......+..||+.|+|||.+.+.. |+.+
T Consensus 147 ~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~-~t~k 222 (301)
T d1lufa_ 147 RQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---YYKADGNDAIPIRWMPPESIFYNR-YTTE 222 (301)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG---CBC----CCBCGGGCCHHHHHHCC-CCHH
T ss_pred HHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCc---cccccCCCCcCcCcCCHHHHccCC-CChh
Confidence 999999999999999999999999999999999999999997664332 122234567899999999998765 9999
Q ss_pred hhHHHHHHHHHHHHhCC-CCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 244 ADIWSLGITAIEMATGT-APYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 244 ~DIwSlG~il~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
+|||||||++|||++|. +||......+....+..+..+..+ ..+++++.+||.+||+.||++|||+.||+
T Consensus 223 sDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p---------~~~~~~~~~li~~cl~~~P~~RPt~~ev~ 293 (301)
T d1lufa_ 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIH 293 (301)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 99999999999999985 789998888888777666544332 35678999999999999999999999996
Q ss_pred c
Q psy11359 323 K 323 (520)
Q Consensus 323 ~ 323 (520)
+
T Consensus 294 ~ 294 (301)
T d1lufa_ 294 R 294 (301)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=401.45 Aligned_cols=273 Identities=21% Similarity=0.326 Sum_probs=222.9
Q ss_pred CCCCCCCCCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHH
Q psy11359 21 SVPWPNTEDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEI 100 (520)
Q Consensus 21 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei 100 (520)
+-.|....++|++.+.||+|+||+||+|.++...... ....||+|+++..........+.+|+
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~-----------------~~~~VAvK~~~~~~~~~~~~~~~~E~ 74 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDE-----------------PETRVAIKTVNEAASMRERIEFLNEA 74 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTE-----------------EEEEEEEEECCTTSCHHHHHHHHHHH
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCC-----------------CCcEEEEEEECcccChHHHHHHHHHH
Confidence 3458888999999999999999999999886421100 02344445444443344556789999
Q ss_pred HHHhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc--cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy11359 101 QAMSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS--NCKHGVCDEPTIATVLREVLKGLEYFHSNGQ 178 (520)
Q Consensus 101 ~~l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~--~~~~~~l~~~~i~~i~~qIl~gL~yLH~~gi 178 (520)
+++++++|||||++++++..++..++||||+.+|+|.+++....... ......+++..+..++.||++||.|||+++|
T Consensus 75 ~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~i 154 (308)
T d1p4oa_ 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF 154 (308)
T ss_dssp HHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence 99999999999999999999999999999999999999997543211 1133457899999999999999999999999
Q ss_pred EecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh
Q psy11359 179 IHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT 258 (520)
Q Consensus 179 iHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt 258 (520)
+||||||+|||++.++.+||+|||+|+.+.... .........||+.|+|||.+.+.. ++.++|||||||++|||+|
T Consensus 155 vHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~---~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t 230 (308)
T d1p4oa_ 155 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD---YYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 230 (308)
T ss_dssp BCSCCSGGGEEECTTCCEEECCTTCCCGGGGGG---CEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHH
T ss_pred eeceEcCCceeecCCceEEEeecccceeccCCc---ceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHh
Confidence 999999999999999999999999998764332 222234457999999999998766 8999999999999999999
Q ss_pred C-CCCCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhc
Q psy11359 259 G-TAPYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLK 323 (520)
Q Consensus 259 G-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~ 323 (520)
| .+||.+.+..+.+..+..+..+..+ ..+++.+.++|.+||+.+|++|||+.++++
T Consensus 231 ~~~~p~~~~~~~~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 231 LAEQPYQGLSNEQVLRFVMEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TSCCTTTTSCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8 5889998888888777665544432 346788999999999999999999999997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-51 Score=399.29 Aligned_cols=258 Identities=26% Similarity=0.392 Sum_probs=203.2
Q ss_pred CCCCCeEEEeeeeecCceEEEEEEEcCC-C--ceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHH
Q psy11359 26 NTEDQYEVREVIGFGATAVVHSAYCKAR-A--EKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQA 102 (520)
Q Consensus 26 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~~-g--~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~ 102 (520)
...++|++.+.||+|+||.||+|+...+ + ..||||+++.... ......+++.+|+.+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~--------------------~~~~~~~~~~~Ei~~ 64 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--------------------SQPEAMDDFIREVNA 64 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------------------------CHHHHHHHHHHHH
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc--------------------CCHHHHHHHHHHHHH
Confidence 3457899999999999999999986543 2 2467776542211 112345679999999
Q ss_pred HhcCCCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy11359 103 MSSCHHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRD 182 (520)
Q Consensus 103 l~~l~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrD 182 (520)
|++++|||||++++++.+ +.+++||||+++|+|.+++... .+.+++..+..++.||+.||.|||++||+|||
T Consensus 65 l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~-------~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrD 136 (273)
T d1u46a_ 65 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH-------QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRD 136 (273)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHH-------GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcc-------cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeee
Confidence 999999999999999965 5678999999999999988763 45689999999999999999999999999999
Q ss_pred cCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHh-CCC
Q psy11359 183 IKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMAT-GTA 261 (520)
Q Consensus 183 LKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~ellt-G~~ 261 (520)
|||+|||++.++.+||+|||++..+..... .........||+.|+|||++.+.. ++.++|||||||++|||+| |++
T Consensus 137 ikp~NIll~~~~~vkl~DfGl~~~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~ 213 (273)
T d1u46a_ 137 LAARNLLLATRDLVKIGDFGLMRALPQNDD--HYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQE 213 (273)
T ss_dssp CCGGGEEEEETTEEEECCCTTCEECCC-CC--EEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCC
T ss_pred ecHHHhccccccceeeccchhhhhcccCCC--cceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCC
Confidence 999999999999999999999987644332 222233456888999999998765 8999999999999999998 899
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
||.+....+....+....... + ....+++.+.+||.+||.+||++|||+.|++
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~-~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 214 PWIGLNGSQILHKIDKEGERL-P-------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp TTTTCCHHHHHHHHHTSCCCC-C-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCcCHHHHHHHHHhCCCCC-C-------CcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 999998888877665543211 1 1245678999999999999999999999996
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-50 Score=400.66 Aligned_cols=274 Identities=23% Similarity=0.357 Sum_probs=220.5
Q ss_pred CCCCCCCCCCCCCCCCeEEEeeeeecCceEEEEEEEcC-----CCceEEEEEeehhhhhhhHhhhccceeeEEEeecccc
Q psy11359 15 SSSASVSVPWPNTEDQYEVREVIGFGATAVVHSAYCKA-----RAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKW 89 (520)
Q Consensus 15 ~~~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~ 89 (520)
++..++...|....++|++.++||+|+||.||+|.... +++.||+| +++....
T Consensus 9 ~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK----------------------~i~~~~~ 66 (311)
T d1t46a_ 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK----------------------MLKPSAH 66 (311)
T ss_dssp TTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEE----------------------EECTTCC
T ss_pred cccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEE----------------------EECcccC
Confidence 34445555788888999999999999999999998743 33445554 4444444
Q ss_pred hhhHHHHHHHHHHHhcC-CCCCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccc----------cCCCCCCCHHH
Q psy11359 90 NTSMDELLKEIQAMSSC-HHENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKIS----------NCKHGVCDEPT 158 (520)
Q Consensus 90 ~~~~~~l~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~----------~~~~~~l~~~~ 158 (520)
.....++.+|+.+++++ +|||||++++++.+.+.+|+|||||.+|+|.++++...... ......+++..
T Consensus 67 ~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 146 (311)
T d1t46a_ 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146 (311)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHH
T ss_pred HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHH
Confidence 55667899999999999 79999999999999999999999999999999997643210 11334689999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC
Q psy11359 159 IATVLREVLKGLEYFHSNGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH 238 (520)
Q Consensus 159 i~~i~~qIl~gL~yLH~~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 238 (520)
+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+..
T Consensus 147 ~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~ 223 (311)
T d1t46a_ 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN---YVVKGNARLPVKWMAPESIFNCV 223 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT---SEECSSSEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCc---ceEeeecccChHHcCHHHhcCCC
Confidence 999999999999999999999999999999999999999999999987654322 22334568999999999997665
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhc-CCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCC
Q psy11359 239 GYDFKADIWSLGITAIEMAT-GTAPYHKYPAMKVLMLTLQ-NDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRP 316 (520)
Q Consensus 239 ~~~~~~DIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 316 (520)
++.++|||||||++|||+| |.+||...+....+...+. +.++..+ ..+++.+.+||.+||++||.+||
T Consensus 224 -~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~Li~~cl~~dP~~RP 293 (311)
T d1t46a_ 224 -YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP---------EHAPAEMYDIMKTCWDADPLKRP 293 (311)
T ss_dssp -CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred -CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc---------ccccHHHHHHHHHHcCCChhHCc
Confidence 8999999999999999998 7777877766555544443 3322222 34678899999999999999999
Q ss_pred CHHHHhc
Q psy11359 317 TASELLK 323 (520)
Q Consensus 317 ta~elL~ 323 (520)
|+.++++
T Consensus 294 s~~~il~ 300 (311)
T d1t46a_ 294 TFKQIVQ 300 (311)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=392.34 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=203.4
Q ss_pred CeEEEeeeeecCceEEEEEEEcCCCc---eEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC
Q psy11359 30 QYEVREVIGFGATAVVHSAYCKARAE---KCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC 106 (520)
Q Consensus 30 ~Y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l 106 (520)
.+...++||+|+||+||+|.+..++. .||||. ++........+++.+|+.+|++|
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~----------------------~~~~~~~~~~~~~~~E~~~l~~l 85 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS----------------------LNRITDIGEVSQFLTEGIIMKDF 85 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEE----------------------ECCCCCHHHHHHHHHHHHHHHTC
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEE----------------------ECcccCHHHHHHHHHHHHHHHhC
Confidence 34457899999999999999876532 345554 44333355678899999999999
Q ss_pred CCCCceEEEEEEEE-CCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCC
Q psy11359 107 HHENVVTYHTSFVV-KDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKA 185 (520)
Q Consensus 107 ~HpnIv~~~~~~~~-~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp 185 (520)
+|||||++++++.. +..+++||||+++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||
T Consensus 86 ~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~-------~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~ 158 (311)
T d1r0pa_ 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAA 158 (311)
T ss_dssp CCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHC-------TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcc-------ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccH
Confidence 99999999999876 4689999999999999999875 455678899999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy11359 186 GNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTAPYHK 265 (520)
Q Consensus 186 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~Pf~~ 265 (520)
+|||+++++.+||+|||+++.+...... .........||+.|+|||.+.... ++.++|||||||++|||+||..||..
T Consensus 159 ~NILl~~~~~~kL~DFG~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 159 RNCMLDEKFTVKVADFGLARDMYDKEFD-SVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp GGEEECTTCCEEECSSGGGCCTTTTTCC-CTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred HhEeECCCCCEEEecccchhhccccccc-cceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 9999999999999999999876543222 222233467999999999988765 89999999999999999997766654
Q ss_pred -CcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcC
Q psy11359 266 -YPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKN 324 (520)
Q Consensus 266 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h 324 (520)
............+..+..+ ..+++.+.+||.+||+.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~i~~g~~~~~p---------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 237 DVNTFDITVYLLQGRRLLQP---------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ------CHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCc---------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3344444444555444332 3467889999999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-48 Score=387.43 Aligned_cols=264 Identities=22% Similarity=0.255 Sum_probs=203.4
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.... ..+++.+|++++++++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-------------------------~~~~~~~E~~i~~~l~ 60 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-------------------------KHPQLHIESKIYKMMQ 60 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-------------------------TSCCHHHHHHHHHHST
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-------------------------cCHHHHHHHHHHHHcc
Confidence 468999999999999999999999999999999765321 1123788999999997
Q ss_pred CCC-ceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 108 HEN-VVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 108 Hpn-Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
|+| |+.++.++...+..++||||+ +++|.+.+.. ..+.+++..+..++.||+.||+|||++|||||||||+
T Consensus 61 ~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~ 132 (299)
T d1ckia_ 61 GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF-------CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD 132 (299)
T ss_dssp TSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred CCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhh-------ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHh
Confidence 665 555667778899999999999 6778777764 4668999999999999999999999999999999999
Q ss_pred cEEEc---CCCCeEEeccCcceeeccCccccc--cccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11359 187 NILLG---EDGTVQIADFGVSAWLATGRDLSR--QKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATGTA 261 (520)
Q Consensus 187 NILl~---~~g~vkL~DFG~a~~~~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG~~ 261 (520)
|||++ .+..+||+|||+|+.+........ .......+||+.|||||++.+.. |+.++|||||||++|||+||..
T Consensus 133 NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~ 211 (299)
T d1ckia_ 133 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSL 211 (299)
T ss_dssp GEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSC
T ss_pred hccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCC
Confidence 99985 355799999999998765433221 22334678999999999998765 8999999999999999999999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHH---hcCccc
Q psy11359 262 PYHKYPAMKVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASEL---LKNPFF 327 (520)
Q Consensus 262 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el---L~hp~~ 327 (520)
||.................... ..........+|+++.+||.+||+.+|++||++.++ |+|+|.
T Consensus 212 P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 212 PWQGLKAATKRQKYERISEKKM--STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp TTCCCC-------HHHHHHHHH--HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHHhhcccC--CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 9987655433322111100000 000122335678999999999999999999999865 455544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=379.03 Aligned_cols=257 Identities=24% Similarity=0.297 Sum_probs=193.8
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|.+.+.||+|+||+||+|+. +|+.||||+++... ........|+..+++++
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------------------------~~~~~~e~ei~~~~~~~ 55 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------------------------ERSWFREAEIYQTVMLR 55 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------------------------HHHHHHHHHHHTSTTCC
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------------------------hhHHHHHHHHHHHhhCC
Confidence 46899999999999999999986 57788888764221 11111234566667889
Q ss_pred CCCceEEEEEEEECC----EEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHH--------
Q psy11359 108 HENVVTYHTSFVVKD----ELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHS-------- 175 (520)
Q Consensus 108 HpnIv~~~~~~~~~~----~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~-------- 175 (520)
|||||++++++..++ .+|+||||+++|+|.++++. ..+++..+..++.|++.||.|||+
T Consensus 56 HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~ 126 (303)
T d1vjya_ 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126 (303)
T ss_dssp CTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB
T ss_pred CCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccC
Confidence 999999999998654 68999999999999999974 358899999999999999999997
Q ss_pred CCcEecccCCCcEEEcCCCCeEEeccCcceeeccCccccccccccccccccccCCcceecccC-----CCCcchhHHHHH
Q psy11359 176 NGQIHRDIKAGNILLGEDGTVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDH-----GYDFKADIWSLG 250 (520)
Q Consensus 176 ~giiHrDLKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~~~~~~DIwSlG 250 (520)
+||+||||||+||||+.+|.+||+|||++..+...... ........+||+.|||||++.+.. .++.++||||||
T Consensus 127 ~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~G 205 (303)
T d1vjya_ 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp CEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTE-ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred CCeeccccCccceEEcCCCCeEEEecCccccccCCCcc-eeccccceecccCcCChhhccccccccCCCcCcchhhhhhH
Confidence 59999999999999999999999999999887554332 122334578999999999986542 156789999999
Q ss_pred HHHHHHHhCCCCCCCCc--------------HHHHHHHHhcCC--CCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCC
Q psy11359 251 ITAIEMATGTAPYHKYP--------------AMKVLMLTLQND--PPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTK 314 (520)
Q Consensus 251 ~il~elltG~~Pf~~~~--------------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 314 (520)
|+||||+||..||.... ............ .+.++. ..........+.+|+.+||+.||++
T Consensus 206 vvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~----~~~~~~~~~~l~~li~~cl~~dp~~ 281 (303)
T d1vjya_ 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAA 281 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG----GGGGCHHHHHHHHHHHTTCCSSGGG
T ss_pred HHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCc----ccCChHHHHHHHHHHHHHcccCHhH
Confidence 99999999988763211 112222222211 122211 1112234567899999999999999
Q ss_pred CCCHHHHhcC
Q psy11359 315 RPTASELLKN 324 (520)
Q Consensus 315 Rpta~elL~h 324 (520)
|||+.|++++
T Consensus 282 Rps~~ei~~~ 291 (303)
T d1vjya_ 282 RLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.1e-46 Score=371.76 Aligned_cols=256 Identities=18% Similarity=0.202 Sum_probs=205.9
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|++.+.||+|+||+||+|.+..+|+.||+|+++.. ...+.+.+|++.++.|.
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------------------------~~~~~~~~e~~~~~~l~ 58 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-------------------------SDAPQLRDEYRTYKLLA 58 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-------------------------TTSCCHHHHHHHHHHTT
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-------------------------cCcHHHHHHHHHHHHhc
Confidence 47899999999999999999999999999999976421 01123778999999996
Q ss_pred C-CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCC
Q psy11359 108 H-ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAG 186 (520)
Q Consensus 108 H-pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~ 186 (520)
| +||+.+++++......|+||||+ |++|.++++. ....+++..+..++.|++.||+|||++||+||||||+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~-------~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~ 130 (293)
T d1csna_ 59 GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL-------CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD 130 (293)
T ss_dssp TCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-------TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred CCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh-------hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCcc
Confidence 5 89999999999999999999999 7899999875 4567999999999999999999999999999999999
Q ss_pred cEEEcC-----CCCeEEeccCcceeeccCccc--cccccccccccccccCCcceecccCCCCcchhHHHHHHHHHHHHhC
Q psy11359 187 NILLGE-----DGTVQIADFGVSAWLATGRDL--SRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADIWSLGITAIEMATG 259 (520)
Q Consensus 187 NILl~~-----~g~vkL~DFG~a~~~~~~~~~--~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DIwSlG~il~elltG 259 (520)
|||++. ++.+||+|||+|+.+...... ........++||+.|||||++.+.. ++.++|||||||++|+|+||
T Consensus 131 Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg 209 (293)
T d1csna_ 131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRG 209 (293)
T ss_dssp GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred ceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhC
Confidence 999964 578999999999887543221 1222344678999999999998765 99999999999999999999
Q ss_pred CCCCCCCcHH---HHHHHHhcCCCCCCCCCchhhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHh
Q psy11359 260 TAPYHKYPAM---KVLMLTLQNDPPTLDTGAAEKDQYKAYGKTFRKMISDCLQKDPTKRPTASELL 322 (520)
Q Consensus 260 ~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL 322 (520)
..||.+.... ............. ......+.+++++.+++..|+..+|++||+++.+.
T Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~-----~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 210 SLPWQGLKAATNKQKYERIGEKKQST-----PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp SCTTSSCCSCCHHHHHHHHHHHHHHS-----CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CCcCCCccchhHHHHHHHHHhccCCC-----ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 9999754322 2221111110000 11223356788999999999999999999987764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-44 Score=368.22 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=197.2
Q ss_pred CCCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 28 EDQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 28 ~~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+++.++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~------------------------~~~~~~~~~Ei~~l~~l~ 67 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------------------------KVYTEAAEDEIKLLQRVN 67 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------------------------HHHHHHHHHHHHHHHHHH
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc------------------------ccchHHHHHHHHHHHHhc
Confidence 46799999999999999999999999999999987632 122345778888887775
Q ss_pred -----------CCCceEEEEEEEE--CCEEEEEEEccCCCC-HHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHH
Q psy11359 108 -----------HENVVTYHTSFVV--KDELWLVLRLLEGGS-LLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYF 173 (520)
Q Consensus 108 -----------HpnIv~~~~~~~~--~~~~~lV~E~~~ggs-L~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yL 173 (520)
|+||+++++++.. ....+++|+++..+. ........ ....+++..++.++.||+.||.||
T Consensus 68 ~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~i~~i~~qil~al~~l 141 (362)
T d1q8ya_ 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY------EHRGIPLIYVKQISKQLLLGLDYM 141 (362)
T ss_dssp HTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHT------TTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred chhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccc------cccCCcHHHHHHHHHHHHHHHHHH
Confidence 5789999988864 456777777765543 33333322 567889999999999999999999
Q ss_pred HH-CCcEecccCCCcEEEcCCC------CeEEeccCcceeeccCccccccccccccccccccCCcceecccCCCCcchhH
Q psy11359 174 HS-NGQIHRDIKAGNILLGEDG------TVQIADFGVSAWLATGRDLSRQKVRHTFVGTPCWMAPEVMEQDHGYDFKADI 246 (520)
Q Consensus 174 H~-~giiHrDLKp~NILl~~~g------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DI 246 (520)
|+ +||+||||||+|||++.++ .++|+|||.+..... .....+||+.|+|||++.+.. |+.++||
T Consensus 142 h~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--------~~~~~~gt~~y~aPE~~~~~~-~~~~~Di 212 (362)
T d1q8ya_ 142 HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--------HYTNSIQTREYRSPEVLLGAP-WGCGADI 212 (362)
T ss_dssp HHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--------CCCSCCSCGGGCCHHHHHTCC-CCTHHHH
T ss_pred hhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--------ccccccccccccChhhccccC-CCccccc
Confidence 98 8999999999999997655 399999999876432 234568999999999988655 8999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCcHH------HHHH---HHhcCC-----------------------CCCCCCCch------
Q psy11359 247 WSLGITAIEMATGTAPYHKYPAM------KVLM---LTLQND-----------------------PPTLDTGAA------ 288 (520)
Q Consensus 247 wSlG~il~elltG~~Pf~~~~~~------~~~~---~~~~~~-----------------------~~~~~~~~~------ 288 (520)
||+||++++|++|+.||...... ..+. ..+... .........
T Consensus 213 wSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (362)
T d1q8ya_ 213 WSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE 292 (362)
T ss_dssp HHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH
T ss_pred cchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhccc
Confidence 99999999999999999754321 1111 111110 000000000
Q ss_pred hhhhHHHhcHHHHHHHHhhhccCCCCCCCHHHHhcCcccccc
Q psy11359 289 EKDQYKAYGKTFRKMISDCLQKDPTKRPTASELLKNPFFKKA 330 (520)
Q Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~~~~~ 330 (520)
........++++.+||.+||.+||.+||||+|+|+||||+..
T Consensus 293 ~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 293 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred ccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 001124567899999999999999999999999999999844
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=7.3e-26 Score=208.79 Aligned_cols=150 Identities=19% Similarity=0.238 Sum_probs=109.3
Q ss_pred eEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecc--cchhhHHHHHHHHHHHhcCCC
Q psy11359 31 YEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLE--KWNTSMDELLKEIQAMSSCHH 108 (520)
Q Consensus 31 Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~--~~~~~~~~l~~Ei~~l~~l~H 108 (520)
|-+.++||+|+||+||+|.+. +|+.||||+++...... +....++.... ..........+|+..+.++.|
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~ 73 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSF-------KKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 73 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC-------------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchh-------hhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccC
Confidence 468899999999999999985 68999999886432210 01111111000 111233456679999999999
Q ss_pred CCceEEEEEEEECCEEEEEEEccCCCCHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecccCCCcE
Q psy11359 109 ENVVTYHTSFVVKDELWLVLRLLEGGSLLDIIKHRLKISNCKHGVCDEPTIATVLREVLKGLEYFHSNGQIHRDIKAGNI 188 (520)
Q Consensus 109 pnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~i~~~~~~~~~~~~~l~~~~i~~i~~qIl~gL~yLH~~giiHrDLKp~NI 188 (520)
++++..+++. . .+++|||+.+..+. .++...+..++.||+.+|.|||++||+||||||+||
T Consensus 74 ~~v~~~~~~~--~--~~lvme~~~~~~~~---------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NI 134 (191)
T d1zara2 74 LAVPKVYAWE--G--NAVLMELIDAKELY---------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNV 134 (191)
T ss_dssp SSSCCEEEEE--T--TEEEEECCCCEEGG---------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred CCcceEEEec--C--CEEEEEeecccccc---------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhhe
Confidence 9999987652 2 37999999875432 244566788999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcceeec
Q psy11359 189 LLGEDGTVQIADFGVSAWLA 208 (520)
Q Consensus 189 Ll~~~g~vkL~DFG~a~~~~ 208 (520)
|+++++ ++|+|||+|....
T Consensus 135 Lv~~~~-~~liDFG~a~~~~ 153 (191)
T d1zara2 135 LVSEEG-IWIIDFPQSVEVG 153 (191)
T ss_dssp EEETTE-EEECCCTTCEETT
T ss_pred eeeCCC-EEEEECCCcccCC
Confidence 998654 8999999987653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=7.4e-07 Score=83.49 Aligned_cols=86 Identities=12% Similarity=-0.056 Sum_probs=57.9
Q ss_pred CCeEEEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC-
Q psy11359 29 DQYEVREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH- 107 (520)
Q Consensus 29 ~~Y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~- 107 (520)
..|++++..+-++.+.||+.. ..+..+++|...... ......+.+|...+..|.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~-----------------------~~~~~~~~~E~~~l~~l~~ 68 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRY-----------------------KGTTYDVEREKDMMLWLEG 68 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGG-----------------------TTSTTCHHHHHHHHHHHTT
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCc-----------------------ccchhhHHHHHHHHHHHhc
Confidence 357777776666668999874 345556666543211 112224677888887763
Q ss_pred CCCceEEEEEEEECCEEEEEEEccCCCCHHHH
Q psy11359 108 HENVVTYHTSFVVKDELWLVLRLLEGGSLLDI 139 (520)
Q Consensus 108 HpnIv~~~~~~~~~~~~~lV~E~~~ggsL~~~ 139 (520)
+--+.+++.+...++..|+||++++|.++.+.
T Consensus 69 ~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred cCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 33367788888889999999999999887654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.98 E-value=6.1e-06 Score=82.31 Aligned_cols=84 Identities=19% Similarity=0.109 Sum_probs=51.1
Q ss_pred EeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcC-CC--CC
Q psy11359 34 REVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSC-HH--EN 110 (520)
Q Consensus 34 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l-~H--pn 110 (520)
.+.||.|....||++.+...++.+++|....... +..+.+....++...|+..|+.+ .+ ..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r----------------~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~ 94 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAK----------------VVGESWPLTIDRARIESSALIRQGEHVPHL 94 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGG----------------C--CCCCCCTTHHHHHHHHHHHHHTTCGGG
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhc----------------ccCCCCCCCHHHHHHHHHHHHHhhhhCCCC
Confidence 4568999999999999888888888886432100 00112233445567788888766 23 34
Q ss_pred ceEEEEEEEECCEEEEEEEccCCCC
Q psy11359 111 VVTYHTSFVVKDELWLVLRLLEGGS 135 (520)
Q Consensus 111 Iv~~~~~~~~~~~~~lV~E~~~ggs 135 (520)
+++++. .+.+..++|||++.+..
T Consensus 95 vP~v~~--~d~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 95 VPRVFY--SDTEMAVTVMEDLSHLK 117 (392)
T ss_dssp SCCEEE--EETTTTEEEECCCTTSE
T ss_pred cceEEE--EcCCCCEEEEeccCCcc
Confidence 555654 35666789999997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.81 E-value=3.4e-05 Score=71.34 Aligned_cols=80 Identities=18% Similarity=0.152 Sum_probs=50.1
Q ss_pred CCeEEEeeeeecC-ceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC
Q psy11359 29 DQYEVREVIGFGA-TAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH 107 (520)
Q Consensus 29 ~~Y~i~~~LG~G~-fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~ 107 (520)
.-+++... ..|. -+.||+.... .+..+++|.... . ....+.+|+..++.|.
T Consensus 11 ~g~~~~~~-~~G~s~~~v~r~~~~-~~~~~vlK~~~~----------------------~----~~~~l~~E~~~l~~L~ 62 (255)
T d1nd4a_ 11 FGYDWAQQ-TIGCSDAAVFRLSAQ-GRPVLFVKTDLS----------------------G----ALNELQDEAARLSWLA 62 (255)
T ss_dssp TTCEEEEC-SCTTSSCEEEEEECT-TSCCEEEEEECS----------------------C----TTSCHHHHHHHHHHHH
T ss_pred cCCceEEc-CCcccCCeEEEEEeC-CCCEEEEEeCCc----------------------c----CHhHHHHHHHHHHHHH
Confidence 33444433 4444 4788988653 345566665321 1 1123677888877763
Q ss_pred C--CCceEEEEEEEECCEEEEEEEccCCCCH
Q psy11359 108 H--ENVVTYHTSFVVKDELWLVLRLLEGGSL 136 (520)
Q Consensus 108 H--pnIv~~~~~~~~~~~~~lV~E~~~ggsL 136 (520)
. -.+.+++.+..+.+..++||++++|.++
T Consensus 63 ~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 63 TTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp TTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred hcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3 2356678877888889999999987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.63 E-value=0.002 Score=61.65 Aligned_cols=27 Identities=33% Similarity=0.497 Sum_probs=22.2
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcce
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSA 205 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~ 205 (520)
++||+|+.|.|||+++ + ..++||+-++
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 5899999999999964 3 4589999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.57 E-value=0.0032 Score=61.85 Aligned_cols=81 Identities=9% Similarity=-0.016 Sum_probs=46.2
Q ss_pred EEeeeeecCceEEEEEEEcCCCceEEEEEeehhhhhhhHhhhccceeeEEEeecccchhhHHHHHHHHHHHhcCC-CCCc
Q psy11359 33 VREVIGFGATAVVHSAYCKARAEKCAIKKINLAVVHSAYCKARAEKCAIKKINLEKWNTSMDELLKEIQAMSSCH-HENV 111 (520)
Q Consensus 33 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~aiK~i~~~~~~~~~~~l~~Ei~~l~~l~-HpnI 111 (520)
-++.|+.|-.=.+|++........ + +...+.++++... . ....-...+|..+++.+. +.-.
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~--~-------------~~~~~~vllRi~g-~--~~~~idr~~E~~i~~~ls~~gl~ 107 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPP--I-------------RNEPNKVLLRVYF-N--PETESHLVAESVIFTLLSERHLG 107 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCC--S-------------SSCCSEEEEEEEC-S--CCCHHHHHHHHHHHHHHHHTTSS
T ss_pred EEEEcCCccccceEEEEeCCCCcc--c-------------cCCCCcEEEEecC-C--cchhhHHHHHHHHHHHHHhCCCC
Confidence 346788888899999977643100 0 0002233333322 1 122234567888888884 4334
Q ss_pred eEEEEEEEECCEEEEEEEccCCCC
Q psy11359 112 VTYHTSFVVKDELWLVLRLLEGGS 135 (520)
Q Consensus 112 v~~~~~~~~~~~~~lV~E~~~ggs 135 (520)
.+++.++. + ++|+||++|.+
T Consensus 108 Pkll~~~~--~--g~I~efi~g~~ 127 (395)
T d1nw1a_ 108 PKLYGIFS--G--GRLEEYIPSRP 127 (395)
T ss_dssp SCEEEEET--T--EEEECCCCEEE
T ss_pred CeEEEEcC--C--ceEEEEecccc
Confidence 56776653 2 68999998754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.17 E-value=0.021 Score=53.57 Aligned_cols=29 Identities=28% Similarity=0.418 Sum_probs=26.2
Q ss_pred CcEecccCCCcEEEcCCCCeEEeccCcce
Q psy11359 177 GQIHRDIKAGNILLGEDGTVQIADFGVSA 205 (520)
Q Consensus 177 giiHrDLKp~NILl~~~g~vkL~DFG~a~ 205 (520)
|+||+|+.++||+++.++..-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 69999999999999988777899999764
|